Citrus Sinensis ID: 044746
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
ID ![]() | Alignment graph ![]() | Length ![]() |
Definition ![]() |
RBH(Q2H) ![]() |
RBH(H2Q) ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 202 | 2.2.26 [Sep-21-2011] | |||||||
| Q9FLV4 | 872 | G-type lectin S-receptor- | no | no | 0.940 | 0.217 | 0.398 | 2e-31 | |
| O64477 | 828 | G-type lectin S-receptor- | no | no | 0.628 | 0.153 | 0.476 | 3e-28 | |
| Q8RWZ5 | 821 | G-type lectin S-receptor- | no | no | 0.569 | 0.140 | 0.474 | 3e-26 | |
| Q39203 | 797 | G-type lectin S-receptor- | no | no | 0.589 | 0.149 | 0.460 | 2e-24 | |
| Q9XID3 | 829 | G-type lectin S-receptor- | no | no | 0.594 | 0.144 | 0.458 | 3e-24 | |
| Q9FID6 | 813 | Probable receptor-like pr | no | no | 0.584 | 0.145 | 0.413 | 1e-22 | |
| Q94C25 | 452 | Probable receptor-like pr | no | no | 0.599 | 0.267 | 0.385 | 4e-22 | |
| Q39202 | 832 | G-type lectin S-receptor- | no | no | 0.826 | 0.200 | 0.342 | 2e-21 | |
| O65238 | 872 | G-type lectin S-receptor- | no | no | 0.495 | 0.114 | 0.465 | 2e-21 | |
| Q9ZRF9 | 540 | Probable LRR receptor-lik | no | no | 0.792 | 0.296 | 0.341 | 6e-21 |
| >sp|Q9FLV4|Y5248_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080 OS=Arabidopsis thaliana GN=At5g24080 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 135 bits (339), Expect = 2e-31, Method: Compositional matrix adjust.
Identities = 82/206 (39%), Positives = 115/206 (55%), Gaps = 16/206 (7%)
Query: 8 GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV-----GSEDT------ETY 56
G T + +D++L E + F + I + + NLV SED+ E
Sbjct: 551 GETLVAVKRLDRALSHGERE----FITEVNTIGSMHHMNLVRLCGYCSEDSHRLLVYEYM 606
Query: 57 IKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE 116
I G L F N+L + EI V+T++GIAY HE+CR +I+H DIKPE++LLD+
Sbjct: 607 INGSLDKWIFSSEQTANLLDWRTRFEIAVATAQGIAYFHEQCRNRIIHCDIKPENILLDD 666
Query: 117 NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
NF PK +DFGLAK+ REH+H+ T R T G APE +T K DV+S+GMLL E+
Sbjct: 667 NFCPKVSDFGLAKMMGREHSHVV-TMIRGTRGYLAPEWVSNRPITVKADVYSYGMLLLEI 725
Query: 177 VGRRRNLEKEISEGQEWFPKWGREEV 202
VG RRNL+ ++P W +E+
Sbjct: 726 VGGRRNLDMSYDAEDFFYPGWAYKEL 751
|
Arabidopsis thaliana (taxid: 3702) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|O64477|Y2913_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At2g19130 OS=Arabidopsis thaliana GN=At2g19130 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 124 bits (312), Expect = 3e-28, Method: Compositional matrix adjust.
Identities = 61/128 (47%), Positives = 86/128 (67%), Gaps = 1/128 (0%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
+K +LG+ +I + T++G+AYLH+ECR I+H DIKPE++LLD F PK ADFGLAKL
Sbjct: 584 EKIVLGWKLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAKL 643
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190
R+ + + +T R T G APE ++T K DV+S+GM+LFE+V RRN E+ +E
Sbjct: 644 VGRDFSRVLTT-MRGTRGYLAPEWISGVAITAKADVYSYGMMLFELVSGRRNTEQSENEK 702
Query: 191 QEWFPKWG 198
+FP W
Sbjct: 703 VRFFPSWA 710
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q8RWZ5|SD25_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-5 OS=Arabidopsis thaliana GN=SD25 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 118 bits (295), Expect = 3e-26, Method: Compositional matrix adjust.
Identities = 55/116 (47%), Positives = 81/116 (69%), Gaps = 1/116 (0%)
Query: 82 EIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141
I + T+KG+AYLHE+C +IVH DIKPE++LLD+NF K +DFGLAKL RE +H+ +T
Sbjct: 594 NIALGTAKGLAYLHEDCDARIVHCDIKPENILLDDNFNAKVSDFGLAKLMTREQSHVFTT 653
Query: 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKW 197
R T G APE Y++++K DV+S+GM+L E++G R+N + + + FP +
Sbjct: 654 -MRGTRGYLAPEWITNYAISEKSDVYSYGMVLLELIGGRKNYDPSETSEKCHFPSF 708
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39203|SD22_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase SD2-2 OS=Arabidopsis thaliana GN=SD22 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 112 bits (279), Expect = 2e-24, Method: Compositional matrix adjust.
Identities = 59/128 (46%), Positives = 79/128 (61%), Gaps = 9/128 (7%)
Query: 83 IEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142
I + T+KGIAYLHE CR I+H DIKPE++LLD ++ K +DFGLAKL R+ + + +T
Sbjct: 562 IALGTAKGIAYLHEGCRDCIIHCDIKPENILLDSDYNAKVSDFGLAKLLGRDFSRVLAT- 620
Query: 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNL--------EKEISEGQEWF 194
R T G APE +T K DV+SFGM L E++G RRN+ EKE + +F
Sbjct: 621 MRGTWGYVAPEWISGLPITTKADVYSFGMTLLELIGGRRNVIVNSDTLGEKETEPEKWFF 680
Query: 195 PKWGREEV 202
P W E+
Sbjct: 681 PPWAAREI 688
|
Serine/threonine-protein kinase. Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9XID3|Y1343_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300 OS=Arabidopsis thaliana GN=At1g34300 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 111 bits (277), Expect = 3e-24, Method: Compositional matrix adjust.
Identities = 55/120 (45%), Positives = 72/120 (60%)
Query: 82 EIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141
I + T+KGI YLHEECR IVH DIKPE++L+D+NF K +DFGLAKL N + +
Sbjct: 584 NIALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMS 643
Query: 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGREE 201
R T G APE +T K DV+S+GM+L E+V +RN + + F W EE
Sbjct: 644 SVRGTRGYLAPEWLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEE 703
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9FID6|Y5392_ARATH Probable receptor-like protein kinase At5g39020 OS=Arabidopsis thaliana GN=At5g39020 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 106 bits (265), Expect = 1e-22, Method: Compositional matrix adjust.
Identities = 50/121 (41%), Positives = 76/121 (62%), Gaps = 3/121 (2%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT 139
L I + ++G+ YLH C+ +IVH+DIKP+++LLD+NF PK ADFGLAKL + + ++
Sbjct: 593 LYGIALGIARGLEYLHYGCKTRIVHFDIKPQNILLDDNFCPKVADFGLAKLCEKRESILS 652
Query: 140 STGRRRTPGCEAPELW--MPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ-EWFPK 196
R T G APE+ M ++ K DV+S+GML+ +++G R +E G +FP
Sbjct: 653 LIDTRGTIGYIAPEVVSRMYGGISHKSDVYSYGMLVLDMIGARNKVETTTCNGSTAYFPD 712
Query: 197 W 197
W
Sbjct: 713 W 713
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: - |
| >sp|Q94C25|Y5005_ARATH Probable receptor-like protein kinase At5g20050 OS=Arabidopsis thaliana GN=At5g20050 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 104 bits (260), Expect = 4e-22, Method: Compositional matrix adjust.
Identities = 49/127 (38%), Positives = 81/127 (63%), Gaps = 6/127 (4%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L + Q ++ + +K +AYLH +CR KI+H D+KPE++LLDENF DFGL+KL R+
Sbjct: 205 LSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFGLSKLIARD 264
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ--- 191
+ + T R T G APE + + +++K DV+S+G++L E++G RR++ + +
Sbjct: 265 ESRVL-TDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSISRVEVKETKKK 323
Query: 192 --EWFPK 196
E+FP+
Sbjct: 324 KLEYFPR 330
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q39202|RLK1_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase RLK1 OS=Arabidopsis thaliana GN=RLK1 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 102 bits (254), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 60/175 (34%), Positives = 98/175 (56%), Gaps = 8/175 (4%)
Query: 19 KSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFY-LLCK 71
K LD +++D F + ++I + NLV ++ + FL G L +
Sbjct: 563 KKLDRLDLDNEKEFKNEVKVIGQIHHKNLVRLIGFCNEGQSQMIVYEFLPQGTLANFLFR 622
Query: 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131
+ + + I V+ ++GI YLHEEC ++I+H DIKP+++LLDE + P+ +DFGLAKL
Sbjct: 623 RPRPSWEDRKNIAVAIARGILYLHEECSEQIIHCDIKPQNILLDEYYTPRISDFGLAKLL 682
Query: 132 NREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
T+ T T R T G APE + +T K DV+S+G++L E+V ++ ++ E
Sbjct: 683 LMNQTY-TLTNIRGTKGYVAPEWFRNSPITSKVDVYSYGVMLLEIVCCKKAVDLE 736
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|O65238|Y5537_ARATH G-type lectin S-receptor-like serine/threonine-protein kinase At5g35370 OS=Arabidopsis thaliana GN=At5g35370 PE=2 SV=2 | Back alignment and function description |
|---|
Score = 102 bits (253), Expect = 2e-21, Method: Compositional matrix adjust.
Identities = 47/101 (46%), Positives = 73/101 (72%), Gaps = 1/101 (0%)
Query: 82 EIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141
+I + T++G+AYLH C QKI+H D+KPE++LL ++F PK +DFGL+KL N+E + + +T
Sbjct: 615 DIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQEESSLFTT 674
Query: 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRN 182
R T G APE ++++K DV+S+GM+L E+V R+N
Sbjct: 675 -MRGTRGYLAPEWITNAAISEKADVYSYGMVLLELVSGRKN 714
|
Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q9ZRF9|RPK1_ARATH Probable LRR receptor-like serine/threonine-protein kinase RPK1 OS=Arabidopsis thaliana GN=RPK1 PE=1 SV=1 | Back alignment and function description |
|---|
Score = 100 bits (249), Expect = 6e-21, Method: Compositional matrix adjust.
Identities = 57/167 (34%), Positives = 91/167 (54%), Gaps = 7/167 (4%)
Query: 34 SPQRMIAADNFSNLVGSEDTET---YIKGFLAMGPFYLLCK---KNILGFGQLREIEVST 87
S M+ N L+G +ET I +L+ G K K + + L +I +
Sbjct: 307 SALEMVRHPNLVMLIGYHASETEMFLIYNYLSGGNLQDFIKERSKAAIEWKVLHKIALDV 366
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
++ ++YLHE+C K++H DIKP ++LLD N+ +DFGL+KL +H+T TG T
Sbjct: 367 ARALSYLHEQCSPKVLHRDIKPSNILLDNNYNAYLSDFGLSKLLGTSQSHVT-TGVAGTF 425
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWF 194
G APE M V++K DV+S+G++L E++ +R L+ S + F
Sbjct: 426 GYVAPEYAMTCRVSEKADVYSYGIVLLELISDKRALDPSFSSHENGF 472
|
Involved in the main abscisic acid-mediated (ABA) signaling pathway and in early ABA perception. Together with RPK2, required for pattern formation along the radial axis (e.g. the apical embryonic domain cell types that generate cotyledon primordia), and the apical-basal axis (e.g. differentiation of the basal pole during early embryogenesis). Arabidopsis thaliana (taxid: 3702) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST 
Original result of BLAST against Nonredundant Database
GI ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 202 | ||||||
| 356532654 | 418 | PREDICTED: G-type lectin S-receptor-like | 0.930 | 0.449 | 0.459 | 2e-53 | |
| 357449317 | 396 | Protein kinase [Medicago truncatula] gi| | 0.930 | 0.474 | 0.478 | 2e-53 | |
| 356556192 | 414 | PREDICTED: G-type lectin S-receptor-like | 0.935 | 0.456 | 0.465 | 3e-53 | |
| 357449331 | 411 | BRASSINOSTEROID INSENSITIVE 1-associated | 0.648 | 0.318 | 0.679 | 2e-48 | |
| 357449319 | 463 | Receptor-like protein kinase [Medicago t | 0.930 | 0.406 | 0.439 | 3e-48 | |
| 356558290 | 367 | PREDICTED: G-type lectin S-receptor-like | 0.767 | 0.422 | 0.562 | 9e-48 | |
| 351726118 | 364 | protein kinase [Glycine max] gi|22345256 | 0.896 | 0.497 | 0.448 | 6e-47 | |
| 356532652 | 407 | PREDICTED: G-type lectin S-receptor-like | 0.648 | 0.321 | 0.659 | 9e-46 | |
| 356558282 | 443 | PREDICTED: G-type lectin S-receptor-like | 0.648 | 0.295 | 0.613 | 5e-43 | |
| 225454761 | 491 | PREDICTED: G-type lectin S-receptor-like | 0.613 | 0.252 | 0.653 | 2e-42 |
| >gi|356532654|ref|XP_003534886.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 214 bits (545), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 114/248 (45%), Positives = 142/248 (57%), Gaps = 60/248 (24%)
Query: 10 TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGP---- 65
++F+T IDK L+ ME +KPIRFT Q IA DN+SNL+GS T KG G
Sbjct: 47 SKFLTLAIDKFLNDMEREKPIRFTDQQLRIATDNYSNLLGSGGFGTVYKGIFTNGTMVAV 106
Query: 66 --------------------------------FYLLCKKNIL--------GFGQL----- 80
Y C +N L G G L
Sbjct: 107 KVLRGSSNKKIEEQFMAEVGTIGRIHHFNLVRLYGFCFENNLIALVYEYMGNGSLDKYLF 166
Query: 81 -----------REIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+I V T++GIAYLHEEC+Q+I+HYDIKP ++LLD NF PK ADFGLAK
Sbjct: 167 HEKKTLGYEKLHDIAVGTARGIAYLHEECQQRIIHYDIKPGNILLDRNFNPKVADFGLAK 226
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189
L NR++THIT TG R TPG APELWMP+ +T KCDV+S+GMLLFE++GRRRNL+ +++E
Sbjct: 227 LCNRDNTHITMTGGRGTPGYAAPELWMPFPITHKCDVYSYGMLLFEIIGRRRNLDIKLAE 286
Query: 190 GQEWFPKW 197
QEWFP W
Sbjct: 287 SQEWFPTW 294
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357449317|ref|XP_003594935.1| Protein kinase [Medicago truncatula] gi|355483983|gb|AES65186.1| Protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 214 bits (544), Expect = 2e-53, Method: Compositional matrix adjust.
Identities = 111/232 (47%), Positives = 140/232 (60%), Gaps = 44/232 (18%)
Query: 10 TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGP---- 65
+ FIT T+DK L+ ME +KPIRFT Q IA DN+S +GS KG L+ G
Sbjct: 43 SHFITVTMDKFLNDMEKEKPIRFTDQQLRIATDNYSYRLGSGGFGVVYKGSLSDGTMIAV 102
Query: 66 --------------------------------FYLLC-KKNILGF-------GQLREIEV 85
Y C +KN++ G L +I +
Sbjct: 103 KVLHGSSDKRIDQQFMAEVGTIGKVHHFNLARLYGYCFEKNLIALVYEYMRNGSLDQIAI 162
Query: 86 STSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR 145
T++GIAYLHEEC+Q+I+HYDIKP ++LLD NF PK ADFGLAKL NRE+THIT +G R
Sbjct: 163 GTARGIAYLHEECQQRIIHYDIKPGNILLDTNFNPKVADFGLAKLCNRENTHITMSGGRG 222
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKW 197
TPG APELWMP+ VT KCDV+SFG+LLFE++GRRRN + ++E QEWFP W
Sbjct: 223 TPGYAAPELWMPFPVTHKCDVYSFGILLFEIIGRRRNHDVNLAESQEWFPIW 274
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356556192|ref|XP_003546410.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 213 bits (542), Expect = 3e-53, Method: Compositional matrix adjust.
Identities = 116/249 (46%), Positives = 143/249 (57%), Gaps = 60/249 (24%)
Query: 9 STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGP--- 65
++F+T IDK L+ ME +KPIRFT Q IA DN+SNL+GS T KG G
Sbjct: 42 GSKFLTLAIDKFLNDMEREKPIRFTDQQLRIATDNYSNLLGSGGFGTVYKGIFTNGTMVA 101
Query: 66 ---------------------------------FYLLC-KKNI-------LGFGQL---- 80
Y C +KN+ +G G L
Sbjct: 102 VKVLRGSSDKKIEEQFMAEVGTIGRIHHFNLVRLYGFCFEKNLIALVYEYMGNGSLDKYL 161
Query: 81 ------------REIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA 128
EI V T++GIAYLHEECRQ+I+HYDIKP ++LLD NF PK ADFGLA
Sbjct: 162 FHEKKTLGYEKLHEIAVGTARGIAYLHEECRQRIIHYDIKPGNILLDRNFNPKVADFGLA 221
Query: 129 KLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188
KL N+++THIT TG R TPG APELWMP+ +T KCDV+SFGMLLFE++GRRRNL+ + +
Sbjct: 222 KLCNKDNTHITMTGGRGTPGYAAPELWMPFPITHKCDVYSFGMLLFEIIGRRRNLDIKRA 281
Query: 189 EGQEWFPKW 197
E QEWFP W
Sbjct: 282 ESQEWFPIW 290
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357449331|ref|XP_003594942.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase [Medicago truncatula] gi|124359372|gb|ABN05838.1| Protein kinase [Medicago truncatula] gi|355483990|gb|AES65193.1| BRASSINOSTEROID INSENSITIVE 1-associated receptor kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 197 bits (500), Expect = 2e-48, Method: Compositional matrix adjust.
Identities = 89/131 (67%), Positives = 106/131 (80%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YLL +KN LG+ +L EI + T++GIAYLHE C +IVHYDIKP ++LLD NF PK ADFG
Sbjct: 160 YLLHEKNALGYEKLHEIAIGTARGIAYLHELCEHRIVHYDIKPGNILLDGNFNPKVADFG 219
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
LAKL NRE+THIT TG R TPG APELWMP+ +T KCDV+SFGMLLFE+VGRRRNL+ +
Sbjct: 220 LAKLCNRENTHITMTGGRGTPGYAAPELWMPFPITHKCDVYSFGMLLFEIVGRRRNLDIK 279
Query: 187 ISEGQEWFPKW 197
+E QEWFP W
Sbjct: 280 NTESQEWFPIW 290
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357449319|ref|XP_003594936.1| Receptor-like protein kinase [Medicago truncatula] gi|355483984|gb|AES65187.1| Receptor-like protein kinase [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 196 bits (499), Expect = 3e-48, Method: Compositional matrix adjust.
Identities = 109/248 (43%), Positives = 138/248 (55%), Gaps = 60/248 (24%)
Query: 10 TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGP---- 65
++FIT T+DK L+ ME +KPIRFT Q IA DN+SNL+GS T KG + G
Sbjct: 95 SQFITLTMDKFLNDMEREKPIRFTGQQLRIATDNYSNLLGSGGFGTVYKGIFSNGTMVAV 154
Query: 66 --------------------------------FYLLC-KKNI-------LGFGQLREIEV 85
Y C ++N+ +G G L
Sbjct: 155 KVLRGSSNKKIDEQFMAEVGTIGRIHHFNLVRLYGFCFERNLIALVYEYMGNGSLDRYLF 214
Query: 86 STSKGIAY----------------LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+K + Y LHEEC+ +I+HYDIKP ++LLD+NF+PK ADFGLAK
Sbjct: 215 HETKVLGYEKLHEIAIGTARGIAYLHEECQHRIIHYDIKPGNILLDKNFYPKVADFGLAK 274
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189
NRE+THIT TG R TPG APELWMP+ +T KCDV+SFGMLLFE++GRRRNL + +E
Sbjct: 275 NCNRENTHITMTGGRGTPGYAAPELWMPFPITHKCDVYSFGMLLFEIIGRRRNLAIKNTE 334
Query: 190 GQEWFPKW 197
QEWFP W
Sbjct: 335 SQEWFPIW 342
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558290|ref|XP_003547440.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 195 bits (496), Expect = 9e-48, Method: Compositional matrix adjust.
Identities = 90/160 (56%), Positives = 114/160 (71%), Gaps = 5/160 (3%)
Query: 43 NFSNLVG---SEDTETYIKGFLAMGPF--YLLCKKNILGFGQLREIEVSTSKGIAYLHEE 97
N L+G D + ++ G YL +K LG+ +L EI V ++GIAYLHE+
Sbjct: 82 NLVQLIGFCFERDLRALVYEYMENGSLDRYLFHEKKTLGYEKLYEIAVGIARGIAYLHED 141
Query: 98 CRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMP 157
C+Q+I+HYDIKP ++LLD NF PK ADFGLAKL NR++THIT TG R TPG APELWMP
Sbjct: 142 CKQRIIHYDIKPGNILLDHNFNPKVADFGLAKLCNRDNTHITMTGGRGTPGYAAPELWMP 201
Query: 158 YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKW 197
+ VT KCDV+S+GMLLFE+VGRRRN++ + E QEWFP W
Sbjct: 202 FPVTHKCDVYSYGMLLFEIVGRRRNVDTNLPESQEWFPVW 241
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|351726118|ref|NP_001235580.1| protein kinase [Glycine max] gi|223452564|gb|ACM89609.1| protein kinase [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 192 bits (488), Expect = 6e-47, Method: Compositional matrix adjust.
Identities = 108/241 (44%), Positives = 134/241 (55%), Gaps = 60/241 (24%)
Query: 17 IDKSLDAMEMDKPIRFTSPQRMIAADN-----------------FSN--------LVGSE 51
+DK L+ ME +KPIRFT Q IA DN FSN L GS
Sbjct: 1 MDKFLNDMEREKPIRFTDQQLRIATDNYSFLLGSGGFGVVYKGSFSNGTIVAVKVLRGSS 60
Query: 52 DT-----------------------------ETYIKG----FLAMGPF--YLLCKKNILG 76
D E +++ ++ G YL + L
Sbjct: 61 DKRIDEQFMAEVGTIGKVHHFNLVRLYGFCFERHLRALVYEYMVNGALEKYLFHENTTLS 120
Query: 77 FGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT 136
F +L EI V T++GIAYLHEEC+Q+I+HYDIKP ++LLD NF PK ADFGLAKL NR++T
Sbjct: 121 FEKLHEIAVGTARGIAYLHEECQQRIIHYDIKPGNILLDRNFCPKVADFGLAKLCNRDNT 180
Query: 137 HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPK 196
HI+ TG R TPG APELW+P+ VT KCDV+SFGMLLFE++GRRRN + E Q WFP
Sbjct: 181 HISMTGGRGTPGYAAPELWLPFPVTHKCDVYSFGMLLFEIIGRRRNHNINLPESQVWFPM 240
Query: 197 W 197
W
Sbjct: 241 W 241
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356532652|ref|XP_003534885.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At5g24080-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 188 bits (478), Expect = 9e-46, Method: Compositional matrix adjust.
Identities = 87/132 (65%), Positives = 103/132 (78%), Gaps = 1/132 (0%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL + L F +L EI V T++GIAYLHEEC+Q+I+HYDIKP ++LLD NF PK ADFG
Sbjct: 154 YLFHESMTLSFEKLHEIAVGTARGIAYLHEECQQRIIHYDIKPGNILLDRNFNPKVADFG 213
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEK 185
LAKL NRE TH+T T R TPG APELWMP + VT KCDV+SFGMLLFE++GRRRNL+
Sbjct: 214 LAKLCNREITHLTLTKSRGTPGYAAPELWMPNFPVTHKCDVYSFGMLLFEIIGRRRNLDV 273
Query: 186 EISEGQEWFPKW 197
E+ E QEWFP W
Sbjct: 274 ELVESQEWFPVW 285
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|356558282|ref|XP_003547436.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Glycine max] | Back alignment and taxonomy information |
|---|
Score = 179 bits (454), Expect = 5e-43, Method: Compositional matrix adjust.
Identities = 81/132 (61%), Positives = 103/132 (78%), Gaps = 1/132 (0%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL + + F +L EI + T+KG+AYLHEEC+Q+I+HYDIKP ++LLD N PK ADFG
Sbjct: 193 YLFDENRTIEFEKLHEIAIGTAKGLAYLHEECQQRIIHYDIKPGNILLDRNLNPKVADFG 252
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEK 185
LAK+ NR++THIT T R TPG APELWMP + +T KCDV+SFGMLLFE++GRRRNL+
Sbjct: 253 LAKVCNRKNTHITLTRGRGTPGYAAPELWMPNFPITHKCDVYSFGMLLFEILGRRRNLDI 312
Query: 186 EISEGQEWFPKW 197
+ +E QEWFP W
Sbjct: 313 DHAESQEWFPIW 324
|
Source: Glycine max Species: Glycine max Genus: Glycine Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225454761|ref|XP_002272528.1| PREDICTED: G-type lectin S-receptor-like serine/threonine-protein kinase At1g34300-like [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 177 bits (450), Expect = 2e-42, Method: Compositional matrix adjust.
Identities = 81/124 (65%), Positives = 96/124 (77%)
Query: 77 FGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT 136
+G+ EI V T+KGIAYLHEECRQ+I+HYDIKP +VLLD F PK ADFGLAKL NR+ T
Sbjct: 258 WGKFEEIAVGTAKGIAYLHEECRQRIIHYDIKPANVLLDAVFSPKLADFGLAKLCNRDST 317
Query: 137 HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPK 196
+ TG R TPG APELW PY VT KCDV+SFGMLLFE+VGRRRN + +SE ++W P+
Sbjct: 318 QVPVTGFRGTPGYAAPELWKPYPVTCKCDVYSFGMLLFEMVGRRRNHDASLSETRQWLPR 377
Query: 197 WGRE 200
W E
Sbjct: 378 WTWE 381
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST 
Original result of BLAST against Gene Ontology (AMIGO)
ID ![]() |
Alignment graph ![]() |
Length ![]() |
Definition ![]() |
Q cover ![]() |
H cover ![]() |
Identity ![]() |
E-value ![]() |
| Query | 202 | ||||||
| TAIR|locus:2059103 | 828 | AT2G19130 [Arabidopsis thalian | 0.613 | 0.149 | 0.496 | 6.1e-27 | |
| TAIR|locus:2147635 | 452 | AT5G20050 [Arabidopsis thalian | 0.599 | 0.267 | 0.401 | 6.5e-25 | |
| TAIR|locus:2116525 | 821 | SD2-5 "S-domain-2 5" [Arabidop | 0.633 | 0.155 | 0.459 | 2.3e-24 | |
| TAIR|locus:2026155 | 829 | AT1G34300 [Arabidopsis thalian | 0.584 | 0.142 | 0.466 | 7.1e-24 | |
| TAIR|locus:2182603 | 872 | AT5G35370 [Arabidopsis thalian | 0.529 | 0.122 | 0.445 | 3e-21 | |
| TAIR|locus:2204480 | 666 | AT1G66910 [Arabidopsis thalian | 0.628 | 0.190 | 0.401 | 3.2e-21 | |
| TAIR|locus:2176707 | 579 | AT5G38250 [Arabidopsis thalian | 0.603 | 0.210 | 0.434 | 4.9e-21 | |
| TAIR|locus:2176737 | 665 | PR5K "PR5-like receptor kinase | 0.584 | 0.177 | 0.424 | 6.7e-21 | |
| TAIR|locus:2176697 | 588 | AT5G38240 [Arabidopsis thalian | 0.603 | 0.207 | 0.434 | 1.4e-20 | |
| TAIR|locus:2019688 | 674 | AT1G66930 [Arabidopsis thalian | 0.767 | 0.229 | 0.385 | 1.5e-20 |
| TAIR|locus:2059103 AT2G19130 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 313 (115.2 bits), Expect = 6.1e-27, P = 6.1e-27
Identities = 64/129 (49%), Positives = 91/129 (70%)
Query: 71 KKNILGFGQLR-EIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+K +LG+ +LR +I + T++G+AYLH+ECR I+H DIKPE++LLD F PK ADFGLAK
Sbjct: 584 EKIVLGW-KLRFQIALGTARGLAYLHDECRDCIIHCDIKPENILLDSQFCPKVADFGLAK 642
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188
L R+ + + +T R T G APE W+ ++T K DV+S+GM+LFE+V RRN E+ +
Sbjct: 643 LVGRDFSRVLTT-MRGTRGYLAPE-WISGVAITAKADVYSYGMMLFELVSGRRNTEQSEN 700
Query: 189 EGQEWFPKW 197
E +FP W
Sbjct: 701 EKVRFFPSW 709
|
|
| TAIR|locus:2147635 AT5G20050 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 263 (97.6 bits), Expect = 6.5e-25, Sum P(2) = 6.5e-25
Identities = 51/127 (40%), Positives = 84/127 (66%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L + Q ++ + +K +AYLH +CR KI+H D+KPE++LLDENF DFGL+KL R+
Sbjct: 205 LSWEQRYQVAIDVAKALAYLHHDCRSKILHLDVKPENILLDENFRAVVTDFGLSKLIARD 264
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK-EISEGQ-- 191
+ + T R T G APE + + +++K DV+S+G++L E++G RR++ + E+ E +
Sbjct: 265 ESRVL-TDIRGTRGYLAPEWLLEHGISEKSDVYSYGIVLLEMIGGRRSISRVEVKETKKK 323
Query: 192 --EWFPK 196
E+FP+
Sbjct: 324 KLEYFPR 330
|
|
| TAIR|locus:2116525 SD2-5 "S-domain-2 5" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 289 (106.8 bits), Expect = 2.3e-24, P = 2.3e-24
Identities = 63/137 (45%), Positives = 93/137 (67%)
Query: 60 FLAMGPF--YLLCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL 114
FL+ G ++ KK+ +L + I + T+KG+AYLHE+C +IVH DIKPE++LL
Sbjct: 567 FLSKGSLERWIFRKKDGDVLLDWDTRFNIALGTAKGLAYLHEDCDARIVHCDIKPENILL 626
Query: 115 DENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLL 173
D+NF K +DFGLAKL RE +H+ +T R T G APE W+ Y++++K DV+S+GM+L
Sbjct: 627 DDNFNAKVSDFGLAKLMTREQSHVFTT-MRGTRGYLAPE-WITNYAISEKSDVYSYGMVL 684
Query: 174 FEVVGRRRNLE-KEISE 189
E++G R+N + E SE
Sbjct: 685 LELIGGRKNYDPSETSE 701
|
|
| TAIR|locus:2026155 AT1G34300 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 271 (100.5 bits), Expect = 7.1e-24, Sum P(2) = 7.1e-24
Identities = 56/120 (46%), Positives = 74/120 (61%)
Query: 83 IEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142
I + T+KGI YLHEECR IVH DIKPE++L+D+NF K +DFGLAKL N + +
Sbjct: 585 IALGTAKGITYLHEECRDCIVHCDIKPENILVDDNFAAKVSDFGLAKLLNPKDNRYNMSS 644
Query: 143 RRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGREE 201
R T G APE W+ +T K DV+S+GM+L E+V +RN + + F W EE
Sbjct: 645 VRGTRGYLAPE-WLANLPITSKSDVYSYGMVLLELVSGKRNFDVSEKTNHKKFSIWAYEE 703
|
|
| TAIR|locus:2182603 AT5G35370 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 251 (93.4 bits), Expect = 3.0e-21, Sum P(2) = 3.0e-21
Identities = 49/110 (44%), Positives = 79/110 (71%)
Query: 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR 133
+L + + +I + T++G+AYLH C QKI+H D+KPE++LL ++F PK +DFGL+KL N+
Sbjct: 607 VLEWQERFDIALGTARGLAYLHSGCDQKIIHCDVKPENILLHDHFQPKISDFGLSKLLNQ 666
Query: 134 EHTHITSTGRRRTPGCEAPELWMPYS-VTQKCDVFSFGMLLFEVVGRRRN 182
E + + +T R T G APE W+ + +++K DV+S+GM+L E+V R+N
Sbjct: 667 EESSLFTT-MRGTRGYLAPE-WITNAAISEKADVYSYGMVLLELVSGRKN 714
|
|
| TAIR|locus:2204480 AT1G66910 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 258 (95.9 bits), Expect = 3.2e-21, P = 3.2e-21
Identities = 53/132 (40%), Positives = 82/132 (62%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
K + + + +L I + ++G+ YLH CR +IVH+DIKP++VLLD+N PK +DFGLAKL
Sbjct: 436 KSSTMDWRELYGIALGVARGLEYLHHGCRTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKL 495
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMP-YS-VTQKCDVFSFGMLLFEVVGRRRNLEKE-- 186
R+ + ++ R T G APE++ Y V+ K DV+S+GML+ +++G R E
Sbjct: 496 CERKESILSLMDTRGTIGYIAPEVFSRVYGRVSHKSDVYSYGMLVLDIIGARNKTSTEDT 555
Query: 187 -ISEGQEWFPKW 197
S +FP+W
Sbjct: 556 TSSTSSMYFPEW 567
|
|
| TAIR|locus:2176707 AT5G38250 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 255 (94.8 bits), Expect = 4.9e-21, P = 4.9e-21
Identities = 56/129 (43%), Positives = 81/129 (62%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L L I + ++G+ YLH C+ +IVH+DIKP++VLLDEN PK ADFGLAKL ++
Sbjct: 359 LDVSTLYGIALGVARGLEYLHYGCKTRIVHFDIKPQNVLLDENLRPKVADFGLAKLCEKQ 418
Query: 135 HTHITSTGRRRTPGCEAPELW--MPYSVTQKCDVFSFGMLLFEVVGRRRNLEK----EIS 188
+ ++ R T G APEL+ M SV+ K DV+S+GML+ E++G R N E+ + +
Sbjct: 419 ESILSLLDTRGTIGYIAPELFSRMYGSVSHKSDVYSYGMLVLEMIGAR-NKERVQNADPN 477
Query: 189 EGQEWFPKW 197
+FP W
Sbjct: 478 NSSAYFPDW 486
|
|
| TAIR|locus:2176737 PR5K "PR5-like receptor kinase" [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 255 (94.8 bits), Expect = 6.7e-21, P = 6.7e-21
Identities = 53/125 (42%), Positives = 82/125 (65%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
+L ++ V S+G+ YLH C +IVH+DIKP+++L+DEN PK +DFGLAKL + + I
Sbjct: 428 RLYDVAVGISRGLEYLHNRCVTRIVHFDIKPQNILMDENLCPKISDFGLAKLCKNKESII 487
Query: 139 TSTGRRRTPGCEAPELWMPY--SVTQKCDVFSFGMLLFEVVGRRRNLEK-EIS---EGQE 192
+ R T G APE++ +V+ K DV+S+GM++ E++G + N+EK E S G
Sbjct: 488 SMLHMRGTFGYIAPEMFSKNFGAVSHKSDVYSYGMVVLEMIGAK-NIEKVEYSGSNNGSM 546
Query: 193 WFPKW 197
+FP+W
Sbjct: 547 YFPEW 551
|
|
| TAIR|locus:2176697 AT5G38240 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 251 (93.4 bits), Expect = 1.4e-20, P = 1.4e-20
Identities = 56/129 (43%), Positives = 81/129 (62%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L L I + ++GI YLH C+++IVH+DIKP++VLLDEN PK ADFGLAKL ++
Sbjct: 367 LDVSTLYGIALGVARGIEYLHFGCKKRIVHFDIKPQNVLLDENLKPKVADFGLAKLCEKQ 426
Query: 135 HTHITSTGRRRTPGCEAPELWMP-Y-SVTQKCDVFSFGMLLFEVVGRRRNLEK----EIS 188
+ ++ R T G APEL+ Y +V+ K DV+S+GML+ E+ G R N E+ + +
Sbjct: 427 ESILSLLDTRGTIGYIAPELFSRVYGNVSHKSDVYSYGMLVLEMTGAR-NKERVQNADSN 485
Query: 189 EGQEWFPKW 197
+FP W
Sbjct: 486 NSSAYFPDW 494
|
|
| TAIR|locus:2019688 AT1G66930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 252 (93.8 bits), Expect = 1.5e-20, P = 1.5e-20
Identities = 64/166 (38%), Positives = 97/166 (58%)
Query: 43 NFSNLVG--SEDTE-TYIKGFLAMGPF-YLLCKKN--ILGFGQLREIEVSTSKGIAYLHE 96
N +L+G SE + I FL G + +K IL L I + ++G+ YLH
Sbjct: 401 NIVSLLGFCSEGSRRAIIYEFLENGSLDKFISEKTSVILDLTALYGIALGVARGLEYLHY 460
Query: 97 ECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWM 156
C+ +IVH+DIKP++VLLD+N PK +DFGLAKL ++ + ++ R T G APE+
Sbjct: 461 GCKTRIVHFDIKPQNVLLDDNLSPKVSDFGLAKLCEKKESVMSLMDTRGTIGYIAPEMIS 520
Query: 157 P-Y-SVTQKCDVFSFGMLLFEVVGRRRN--LEKEISEGQE-WFPKW 197
Y SV+ K DV+S+GML+FE++G R+ + + G +FP+W
Sbjct: 521 RVYGSVSHKSDVYSYGMLVFEMIGARKKERFGQNSANGSSMYFPEW 566
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries 
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server 
Original result from Ezypred Server
Fail to connect to Ezypred Server
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING 
Original result from the STRING server
| Your Input: | |||||||||||
| GSVIVG00036852001 | SubName- Full=Chromosome chr4 scaffold_83, whole genome shotgun sequence; (359 aa) | ||||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against CDD database part I
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 202 | |||
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 7e-21 | |
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 1e-20 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 1e-20 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 2e-14 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 4e-14 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 4e-14 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 5e-14 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 5e-14 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-13 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 2e-12 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 3e-12 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 5e-12 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 1e-11 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 5e-11 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-11 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-10 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 2e-10 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 2e-10 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 3e-10 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 4e-10 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 4e-10 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 5e-10 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 6e-10 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 6e-10 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 9e-10 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 1e-09 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 1e-09 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 1e-09 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 2e-09 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 2e-09 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-09 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 4e-09 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 6e-09 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 7e-09 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 8e-09 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 8e-09 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 9e-09 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 9e-09 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 1e-08 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 1e-08 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-08 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-08 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 1e-08 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 2e-08 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-08 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-08 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-08 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 3e-08 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 3e-08 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 3e-08 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 3e-08 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 3e-08 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-08 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 4e-08 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 4e-08 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 4e-08 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 5e-08 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 5e-08 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 6e-08 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 8e-08 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 8e-08 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 1e-07 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 1e-07 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 1e-07 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 1e-07 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 1e-07 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-07 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 1e-07 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-07 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-07 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 2e-07 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-07 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 2e-07 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-07 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 3e-07 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 3e-07 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 3e-07 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-07 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 4e-07 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 4e-07 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 4e-07 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 5e-07 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 5e-07 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 5e-07 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 6e-07 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 6e-07 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 6e-07 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 7e-07 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 7e-07 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 8e-07 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 9e-07 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 1e-06 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 1e-06 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-06 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 1e-06 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-06 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 1e-06 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 1e-06 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 2e-06 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 2e-06 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 2e-06 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 2e-06 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 2e-06 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 2e-06 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 2e-06 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-06 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-06 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 3e-06 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 3e-06 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 3e-06 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 3e-06 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 3e-06 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 3e-06 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 4e-06 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 4e-06 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 4e-06 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 5e-06 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 5e-06 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 6e-06 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 6e-06 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 7e-06 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 7e-06 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 8e-06 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 8e-06 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-06 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 9e-06 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 9e-06 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 1e-05 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 1e-05 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 1e-05 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 1e-05 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 1e-05 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-05 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 1e-05 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 1e-05 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 1e-05 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 1e-05 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 1e-05 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 2e-05 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 2e-05 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-05 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-05 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 2e-05 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 3e-05 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 3e-05 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 3e-05 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 3e-05 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 3e-05 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 3e-05 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 4e-05 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 4e-05 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 4e-05 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 4e-05 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 4e-05 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 4e-05 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 4e-05 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 4e-05 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 4e-05 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 5e-05 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 5e-05 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-05 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 5e-05 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 6e-05 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 6e-05 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 6e-05 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-05 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 6e-05 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-05 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 7e-05 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 7e-05 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 7e-05 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 8e-05 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 9e-05 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 9e-05 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 9e-05 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 9e-05 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 1e-04 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 1e-04 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 1e-04 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-04 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 1e-04 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 1e-04 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-04 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 1e-04 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 1e-04 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 1e-04 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 1e-04 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-04 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 1e-04 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 1e-04 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-04 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 2e-04 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 2e-04 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 2e-04 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 2e-04 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 2e-04 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-04 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 2e-04 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 2e-04 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 2e-04 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 2e-04 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-04 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 3e-04 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 3e-04 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 3e-04 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 3e-04 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 3e-04 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 3e-04 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 4e-04 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 4e-04 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 4e-04 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-04 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 4e-04 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 4e-04 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 5e-04 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 6e-04 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 6e-04 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 6e-04 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 7e-04 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 7e-04 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 7e-04 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 8e-04 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 0.001 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 0.001 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 0.001 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 0.001 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 0.001 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 0.001 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 0.001 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 0.001 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 0.001 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 0.001 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 0.001 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 0.001 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 0.002 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 0.002 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 0.002 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 0.002 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 0.002 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 0.002 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 0.002 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 0.002 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 0.002 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 0.002 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 0.002 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 0.002 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 0.002 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 0.002 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 0.003 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 0.003 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 0.003 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 0.003 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 0.003 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 0.003 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 0.003 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 0.003 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 0.004 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 0.004 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 0.004 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 7e-21
Identities = 44/169 (26%), Positives = 77/169 (45%), Gaps = 18/169 (10%)
Query: 17 IDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGPF--------YL 68
I K + +++ +R + + N L G + E ++ +L M + L
Sbjct: 26 IKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHL--YLVM-EYCEGGSLKDLL 82
Query: 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF-PKAADFGL 127
+ L ++ I + +G+ YLH I+H D+KPE++LLD + K ADFGL
Sbjct: 83 KENEGKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGL 139
Query: 128 AKLYNREHTHITSTGRRRTPGCEAPELWM-PYSVTQKCDVFSFGMLLFE 175
+KL TP APE+ + ++K D++S G++L+E
Sbjct: 140 SKLLT--SDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYE 186
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 85.7 bits (213), Expect = 1e-20
Identities = 46/145 (31%), Positives = 69/145 (47%), Gaps = 15/145 (10%)
Query: 42 DNFSNLVGSEDTETYIKGFLAM-----GP-FYLLCKKNILGFGQLREIEVSTSKGIAYLH 95
N L + E + +L M G F LL K+ L + R + YLH
Sbjct: 57 PNIVRLYDVFEDEDKL--YLVMEYCEGGDLFDLLKKRGRLSEDEARFYLRQILSALEYLH 114
Query: 96 EECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELW 155
+ IVH D+KPE++LLDE+ K ADFGLA+ + T G TP APE+
Sbjct: 115 S---KGIVHRDLKPENILLDEDGHVKLADFGLARQLDPGEKLTTFVG---TPEYMAPEVL 168
Query: 156 MPYSVTQKCDVFSFGMLLFE-VVGR 179
+ + D++S G++L+E + G+
Sbjct: 169 LGKGYGKAVDIWSLGVILYELLTGK 193
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 85.8 bits (213), Expect = 1e-20
Identities = 40/116 (34%), Positives = 63/116 (54%), Gaps = 6/116 (5%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
F L + L + ++I + +G+ YLH I+H D+KPE++LLDEN K ADF
Sbjct: 86 FDYLSRGGPLSEDEAKKIALQILRGLEYLHS---NGIIHRDLKPENILLDENGVVKIADF 142
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYS-VTQKCDVFSFGMLLFEVVGRR 180
GLAK + + T TP APE+ + + K DV+S G++L+E++ +
Sbjct: 143 GLAKKLLKSSSS--LTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGK 196
|
Length = 260 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 69.1 bits (170), Expect = 2e-14
Identities = 35/104 (33%), Positives = 49/104 (47%), Gaps = 8/104 (7%)
Query: 77 FGQLREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131
FG+L E + +G+AYLH IVH DIK ++L+D + K ADFG AK
Sbjct: 95 FGKLPEPVIRKYTRQILEGLAYLH---SNGIVHRDIKGANILVDSDGVVKLADFGCAKRL 151
Query: 132 NREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
T + R TP APE+ + D++S G + E
Sbjct: 152 GDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIE 195
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 4e-14
Identities = 33/111 (29%), Positives = 54/111 (48%), Gaps = 5/111 (4%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L L L ++ + +KG+ YL + VH D+ + L+ EN K +DFG
Sbjct: 91 FLRKHGEKLTLKDLLQMALQIAKGMEYLES---KNFVHRDLAARNCLVTENLVVKISDFG 147
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
L++ +Y ++ G+ APE T K DV+SFG+LL+E+
Sbjct: 148 LSRDIYEDDYYRKRGGGKLPIKWM-APESLKDGKFTSKSDVWSFGVLLWEI 197
|
Length = 258 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 68.3 bits (168), Expect = 4e-14
Identities = 34/117 (29%), Positives = 55/117 (47%), Gaps = 18/117 (15%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL + L L + ++G+ YL + +H D+ + L+ EN K +DFG
Sbjct: 91 YLRKNRPKLSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDFG 147
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEV 176
L++ LY+ ++ R G + P WM T K DV+SFG+LL+E+
Sbjct: 148 LSRDLYDDDYY--------RKRGGKLPIRWMAPESLKEGKFTSKSDVWSFGVLLWEI 196
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 68.3 bits (167), Expect = 5e-14
Identities = 40/115 (34%), Positives = 63/115 (54%), Gaps = 21/115 (18%)
Query: 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-L 130
K+++GFG + +KG+ YL +K VH D+ + +LDE+F K ADFGLA+ +
Sbjct: 98 KDLIGFG------LQVAKGMEYLAS---KKFVHRDLAARNCMLDESFTVKVADFGLARDI 148
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMP------YSVTQKCDVFSFGMLLFEVVGR 179
Y++E+ + G + P WM T K DV+SFG+LL+E++ R
Sbjct: 149 YDKEYYSV-----HNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTR 198
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 67.9 bits (167), Expect = 5e-14
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 13/96 (13%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ YLH +KI+H DIKP+++ L N K DFG++K+ + + T G TP
Sbjct: 115 ALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLS-STVDLAKTVVG---TP 167
Query: 148 GCEAPELW--MPYSVTQKCDVFSFGMLLFEVVGRRR 181
+PEL PY+ K D++S G +L+E+ +
Sbjct: 168 YYLSPELCQNKPYN--YKSDIWSLGCVLYELCTLKH 201
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 66.4 bits (163), Expect = 2e-13
Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 11/114 (9%)
Query: 67 YLL-CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
YL + L L + ++G+ YL + +H D+ + L+ EN K +DF
Sbjct: 91 YLRKNRPKELSLSDLLSFALQIARGMEYLE---SKNFIHRDLAARNCLVGENLVVKISDF 147
Query: 126 GLAKLYNREHTHITSTGR---RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
GL++ + + G+ R APE T K DV+SFG+LL+E+
Sbjct: 148 GLSRDLYDDDYYKVKGGKLPIRWM----APESLKEGKFTSKSDVWSFGVLLWEI 197
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 63.5 bits (155), Expect = 2e-12
Identities = 28/104 (26%), Positives = 45/104 (43%), Gaps = 6/104 (5%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
+ YLH + I+H DIKP+++LLDE DF +A +T TPG
Sbjct: 112 ALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKV---TPDTLTTSTSGTPGY 165
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193
APE+ + D +S G+ +E + +R ++
Sbjct: 166 MAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRTIRDQ 209
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 63.0 bits (154), Expect = 3e-12
Identities = 31/89 (34%), Positives = 42/89 (47%), Gaps = 10/89 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
KG+ YLH I+H DIK ++LL + K DFGL+ + T G TP
Sbjct: 109 KGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKARNTMVG---TPY 162
Query: 149 CEAPELW--MPYSVTQKCDVFSFGMLLFE 175
APE+ PY K D++S G+ E
Sbjct: 163 WMAPEVINGKPYD--YKADIWSLGITAIE 189
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 62.6 bits (153), Expect = 5e-12
Identities = 33/113 (29%), Positives = 53/113 (46%), Gaps = 15/113 (13%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
+K+ L L + +KG+ YL +K VH D+ + L+ E+ K +DFGL++
Sbjct: 98 EKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRD 154
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMPYSV------TQKCDVFSFGMLLFEVV 177
+ + TG + P WM T K DV+SFG+LL+E+
Sbjct: 155 VYDDDYYRKKTGGK------LPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIF 201
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 1e-11
Identities = 35/89 (39%), Positives = 49/89 (55%), Gaps = 11/89 (12%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ LHE QKI+H D+K ++LL N K D G++K+ + T G TP
Sbjct: 114 RGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNMAK-TQIG---TPH 166
Query: 149 CEAPELW--MPYSVTQKCDVFSFGMLLFE 175
APE+W PYS K D++S G LL+E
Sbjct: 167 YMAPEVWKGRPYS--YKSDIWSLGCLLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 59.9 bits (146), Expect = 5e-11
Identities = 33/86 (38%), Positives = 47/86 (54%), Gaps = 8/86 (9%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRTPGC 149
YLH + I++ D+KPE++LLD N + K DFG AK L + + T T G TP
Sbjct: 106 FEYLH---NRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQKTW-TFCG---TPEY 158
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFE 175
APE+ + D +S G+LL+E
Sbjct: 159 VAPEIILNKGYDFSVDYWSLGILLYE 184
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 59.0 bits (143), Expect = 9e-11
Identities = 35/108 (32%), Positives = 59/108 (54%), Gaps = 11/108 (10%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L L ++ ++G+AYL E Q +H D+ ++L+ E+ K ADFGLA+L +E
Sbjct: 101 LPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLI-KE 156
Query: 135 HTHITSTGR---RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGR 179
+++S + + T APE + + K DV+SFG+LL+E+
Sbjct: 157 DVYLSSDKKIPYKWT----APEAASHGTFSTKSDVWSFGILLYEMFTY 200
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 58.8 bits (143), Expect = 1e-10
Identities = 32/95 (33%), Positives = 45/95 (47%), Gaps = 15/95 (15%)
Query: 86 STSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR 145
T KG+ YLH K +H DIK ++LL+E K ADFG++ +T T +R
Sbjct: 107 QTLKGLEYLH---SNKKIHRDIKAGNILLNEEGQAKLADFGVS-------GQLTDTMAKR 156
Query: 146 -----TPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
TP APE+ K D++S G+ E
Sbjct: 157 NTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIE 191
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 58.4 bits (142), Expect = 2e-10
Identities = 43/145 (29%), Positives = 64/145 (44%), Gaps = 22/145 (15%)
Query: 43 NFSNLV---GSEDTETY---IKGFLAMGPFYLLCKKNILGFGQLREIEVSTS-----KGI 91
N+V GS +T I + G + KK FG E V+ +G+
Sbjct: 57 KHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKK----FGPFPESLVAVYVYQVLQGL 112
Query: 92 AYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRTPGCE 150
AYLHE Q ++H DIK ++L ++ K ADFG+A KL + + G TP
Sbjct: 113 AYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKDDASVVG---TPYWM 166
Query: 151 APELWMPYSVTQKCDVFSFGMLLFE 175
APE+ + D++S G + E
Sbjct: 167 APEVIEMSGASTASDIWSLGCTVIE 191
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 58.6 bits (142), Expect = 2e-10
Identities = 29/110 (26%), Positives = 50/110 (45%), Gaps = 4/110 (3%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL ++ + +L KG+ YL Q+ +H D+ ++L++ K +DFG
Sbjct: 98 YLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFG 154
Query: 127 LAKLYNREHTHITSTGRRRTPG-CEAPELWMPYSVTQKCDVFSFGMLLFE 175
LAK+ + + +P APE + DV+SFG+ L+E
Sbjct: 155 LAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYE 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 57.8 bits (140), Expect = 3e-10
Identities = 37/136 (27%), Positives = 64/136 (47%), Gaps = 14/136 (10%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL +K LG L ++ + + YL +H D+ + L+ E+ K +DFG
Sbjct: 89 YLRERKGKLGTEWLLDMCSDVCEAMEYLESNG---FIHRDLAARNCLVGEDNVVKVSDFG 145
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
LA+ Y + + +S G + PE++ + K DV+SFG+L++EV
Sbjct: 146 LAR-YVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEV---------- 194
Query: 187 ISEGQEWFPKWGREEV 202
SEG+ + ++ EV
Sbjct: 195 FSEGKMPYERFSNSEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 57.3 bits (139), Expect = 4e-10
Identities = 27/79 (34%), Positives = 40/79 (50%), Gaps = 6/79 (7%)
Query: 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTPGCEAPELWM 156
++H D+KP ++ LD N K DFGLAK+ + T G TP +PE
Sbjct: 128 GNTVLHRDLKPANIFLDANNNVKLGDFGLAKILG-HDSSFAKTYVG---TPYYMSPEQLN 183
Query: 157 PYSVTQKCDVFSFGMLLFE 175
S +K D++S G L++E
Sbjct: 184 HMSYDEKSDIWSLGCLIYE 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 56.9 bits (138), Expect = 4e-10
Identities = 37/104 (35%), Positives = 55/104 (52%), Gaps = 6/104 (5%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY-NR 133
L QL ++ ++G+AYL + +H D+ ++L+ EN K ADFGLA+L +
Sbjct: 100 LRLPQLVDMAAQIAEGMAYLE---SRNYIHRDLAARNILVGENLVCKIADFGLARLIEDD 156
Query: 134 EHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
E+T G + APE T K DV+SFG+LL E+V
Sbjct: 157 EYT--AREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 5e-10
Identities = 33/89 (37%), Positives = 47/89 (52%), Gaps = 11/89 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRTPG 148
+ YLH I++ D+KPE++LLD + K DFGLAK L + T G TP
Sbjct: 105 ALEYLH---SLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGSRTNTFCG---TPE 158
Query: 149 CEAPELWM--PYSVTQKCDVFSFGMLLFE 175
APE+ + Y + D +S G+LL+E
Sbjct: 159 YLAPEVLLGKGY--GKAVDWWSLGVLLYE 185
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 56.8 bits (138), Expect = 6e-10
Identities = 28/106 (26%), Positives = 52/106 (49%), Gaps = 21/106 (19%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG------- 142
+ YLH + I+H D+KPE++LLD++ K DFG AK+ + + ++ G
Sbjct: 114 ALEYLH---SKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDS 170
Query: 143 -----RRR------TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
RRR T +PEL + D+++ G ++++++
Sbjct: 171 QIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQML 216
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 56.5 bits (137), Expect = 6e-10
Identities = 32/96 (33%), Positives = 47/96 (48%), Gaps = 13/96 (13%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK--LYNREHTHITSTGRRR-- 145
+ YLH I+H D+KP+++L+D N K DFGL+K L R+ +
Sbjct: 105 ALEYLH---SNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRI 161
Query: 146 --TPGCEAPE--LWMPYSVTQKCDVFSFGMLLFEVV 177
TP APE L +S T D +S G +L+E +
Sbjct: 162 VGTPDYIAPEVILGQGHSKT--VDWWSLGCILYEFL 195
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 56.8 bits (137), Expect = 9e-10
Identities = 36/97 (37%), Positives = 53/97 (54%), Gaps = 8/97 (8%)
Query: 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR--RTPGCEA 151
+H + ++H DIK ++LL N K DFG +K+Y T GR TP A
Sbjct: 156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYA--ATVSDDVGRTFCGTPYYVA 213
Query: 152 PELWM--PYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
PE+W PYS +K D+FS G+LL+E++ +R + E
Sbjct: 214 PEIWRRKPYS--KKADMFSLGVLLYELLTLKRPFDGE 248
|
Length = 496 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 12/96 (12%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTHITSTGRRR 145
+G+A+ H I+H D+KPE++L++ K ADFGLA+ + R +TH T R
Sbjct: 109 QGLAFCH---SHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYR 165
Query: 146 TPGCEAPELWMPYSV-TQKCDVFSFGMLLFEVVGRR 180
APEL + + D++S G + E++ RR
Sbjct: 166 -----APELLLGDKGYSTPVDIWSVGCIFAELLSRR 196
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 56.2 bits (136), Expect = 1e-09
Identities = 47/134 (35%), Positives = 66/134 (49%), Gaps = 36/134 (26%)
Query: 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLY 131
ILG +I V+T K + YL EE KI+H D+KP ++LLD N K DFG++ +L
Sbjct: 107 EILG-----KIAVATVKALNYLKEEL--KIIHRDVKPSNILLDRNGNIKLCDFGISGQLV 159
Query: 132 NREHTHITSTGRRRTPGCE---APELWMP-----YSVTQKCDVFSFGMLLFEVVGRRRNL 183
+ S + R GC APE P Y V + DV+S G+ L+EV
Sbjct: 160 D-------SIAKTRDAGCRPYMAPERIDPSARDGYDV--RSDVWSLGITLYEV------- 203
Query: 184 EKEISEGQEWFPKW 197
+ G+ +PKW
Sbjct: 204 ----ATGKFPYPKW 213
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.9 bits (135), Expect = 1e-09
Identities = 35/99 (35%), Positives = 53/99 (53%), Gaps = 4/99 (4%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
QL ++ + G+AYL Q +H D+ +VL+ EN K ADFGLA++ +E +
Sbjct: 104 QLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVI-KEDIYE 159
Query: 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
G + APE + + K DV+SFG+LL E+V
Sbjct: 160 AREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIV 198
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 55.9 bits (133), Expect = 2e-09
Identities = 34/105 (32%), Positives = 50/105 (47%), Gaps = 11/105 (10%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTH 137
+ I + YLH + I+H DIKPE++LLD + K DFGLAKL +
Sbjct: 102 EALFILAQILSALEYLHS---KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGST 158
Query: 138 ITSTGRRR----TPGCEAPELWMPYS---VTQKCDVFSFGMLLFE 175
+ TPG APE+ + S + D++S G+ L+E
Sbjct: 159 SSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYE 203
|
Length = 384 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 2e-09
Identities = 32/106 (30%), Positives = 53/106 (50%), Gaps = 14/106 (13%)
Query: 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR 133
++ Q + +G+ YL E + VH D+ +VL+ E+ K +DFGLAK ++
Sbjct: 98 VITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQ 154
Query: 134 EHTHITSTGR---RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
+G+ + T APE + K DV+SFG+LL+E+
Sbjct: 155 GQD----SGKLPVKWT----APEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 55.1 bits (133), Expect = 3e-09
Identities = 39/95 (41%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRTP 147
KG++YLH +KI+H DIKP ++LL K DFG++ +L N T TG T
Sbjct: 116 KGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLAG--TFTG---TS 167
Query: 148 GCEAPE--LWMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE PYS+T DV+S G+ L EV R
Sbjct: 168 FYMAPERIQGKPYSIT--SDVWSLGLTLLEVAQNR 200
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 54.3 bits (131), Expect = 4e-09
Identities = 32/98 (32%), Positives = 45/98 (45%), Gaps = 9/98 (9%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR--RRT 146
+G+AYLH IVH DIKP ++ LD N K DFG A T + + T
Sbjct: 110 EGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGT 166
Query: 147 PGCEAPELWMPYSVTQK---CDVFSFGMLLFEVV-GRR 180
P APE+ D++S G ++ E+ G+R
Sbjct: 167 PAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 53.8 bits (129), Expect = 6e-09
Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 4/110 (3%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL ++ L + + +G+AYL ++H D+ + L+ EN K +DFG
Sbjct: 89 YLRAQRGKFSQETLLGMCLDVCEGMAYLESSN---VIHRDLAARNCLVGENQVVKVSDFG 145
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
+ + + + +STG + +PE++ + K DV+SFG+L++EV
Sbjct: 146 MTRFV-LDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 54.0 bits (131), Expect = 7e-09
Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 6/52 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN---REHTH 137
+G+AY H +I+H D+KP+++L++ + K ADFGLA+ + R +TH
Sbjct: 109 RGLAYCH---SHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLRTYTH 157
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 53.9 bits (129), Expect = 8e-09
Identities = 38/105 (36%), Positives = 55/105 (52%), Gaps = 18/105 (17%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
QL + + G+ YL E ++ +H D+ +VL+ EN K ADFGL++ E ++
Sbjct: 120 QLLQFASDVATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSR---GEEVYV 173
Query: 139 TSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
T R P WM YSV T K DV+SFG+LL+E+V
Sbjct: 174 KKTMGR------LPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIV 212
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 8e-09
Identities = 35/103 (33%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
QL ++ + G+AY+ R VH D++ ++L+ EN K ADFGLA+L ++ +
Sbjct: 103 QLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGENLVCKVADFGLARLI-EDNEYT 158
Query: 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
G + APE + T K DV+SFG+LL E+ + R
Sbjct: 159 ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 53.7 bits (130), Expect = 9e-09
Identities = 37/118 (31%), Positives = 58/118 (49%), Gaps = 20/118 (16%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
K +L ++ + T +G+ YLH I+H D+KP ++L+ + K ADFGLA+
Sbjct: 95 KSIVLTPADIKSYMLMTLRGLEYLH---SNWILHRDLKPNNLLIASDGVLKLADFGLARS 151
Query: 131 Y---NREHTH--ITSTGRRRTPGCEAPELWM---PYSVTQKCDVFSFGMLLFEVVGRR 180
+ NR+ TH +T R APEL Y V D++S G + E++ R
Sbjct: 152 FGSPNRKMTHQVVTRWYR-------APELLFGARHYGVG--VDMWSVGCIFAELLLRV 200
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 53.4 bits (129), Expect = 9e-09
Identities = 27/70 (38%), Positives = 41/70 (58%), Gaps = 12/70 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN----REHTHITSTGRR 144
KG+AY+H I+H D+KP ++L+ + K ADFGLA+L++ R ++H +T
Sbjct: 110 KGVAYMHAN---GIMHRDLKPANLLISADGVLKIADFGLARLFSEEEPRLYSHQVATRWY 166
Query: 145 RTPGCEAPEL 154
R APEL
Sbjct: 167 R-----APEL 171
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 53.5 bits (128), Expect = 1e-08
Identities = 35/107 (32%), Positives = 57/107 (53%), Gaps = 4/107 (3%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L QL ++ + G+AY+ R +H D++ ++L+ +N K ADFGLA+L +
Sbjct: 99 LKLPQLVDMAAQIADGMAYIE---RMNYIHRDLRAANILVGDNLVCKIADFGLARLI-ED 154
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
+ + G + APE + T K DV+SFG+LL E+V + R
Sbjct: 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 29/88 (32%), Positives = 46/88 (52%), Gaps = 13/88 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK--LYNREHTHITSTGRRRTP 147
G+ LH+ + I+H DIKPE++L+D+ K DFGL++ L N++ TP
Sbjct: 109 GVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLENKKFVG--------TP 157
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
APE + + D +S G ++FE
Sbjct: 158 DYLAPETILGVGDDKMSDWWSLGCVIFE 185
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 53.3 bits (129), Expect = 1e-08
Identities = 18/47 (38%), Positives = 29/47 (61%), Gaps = 3/47 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH 135
+G+ YLH I+H DIK ++L++ + K ADFGLA+ Y + +
Sbjct: 111 EGLQYLH---SNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 1e-08
Identities = 32/92 (34%), Positives = 50/92 (54%), Gaps = 8/92 (8%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRTPG 148
G+ +LH+ +IV+ D+KPE+VLLD++ + +D GLA +L + GR TPG
Sbjct: 107 GLEHLHQR---RIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKKIK----GRAGTPG 159
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ D F+ G L+E++ R
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGR 191
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 53.1 bits (128), Expect = 1e-08
Identities = 29/97 (29%), Positives = 48/97 (49%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRT 146
+ G+AYL +K VH D+ + ++ E+ K DFG+ + +Y ++ G
Sbjct: 129 ADGMAYLAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGL--- 182
Query: 147 PGCEAPELWM-PYSV-----TQKCDVFSFGMLLFEVV 177
P WM P S+ T K DV+SFG++L+E+
Sbjct: 183 ----LPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMA 215
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-08
Identities = 44/172 (25%), Positives = 73/172 (42%), Gaps = 32/172 (18%)
Query: 22 DAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGPFYL----LCKKNILGF 77
D ME+++ ++ + + I N L+G E PFY+ + N+L +
Sbjct: 42 DTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREP---------PFYIITEFMTYGNLLDY 92
Query: 78 GQLREIEVST-------------SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAAD 124
LRE S + YL ++ +H D+ + L+ EN K AD
Sbjct: 93 --LRECNRQEVNAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVAD 147
Query: 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
FGL++L T+ G + APE + K DV++FG+LL+E+
Sbjct: 148 FGLSRLM-TGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEI 198
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.5 bits (126), Expect = 2e-08
Identities = 34/113 (30%), Positives = 57/113 (50%), Gaps = 9/113 (7%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L KKN L +L ++ + + G+ YL + +H D+ + L+ EN K +DFG
Sbjct: 82 FLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN---CIHRDLAARNCLVGENNVLKISDFG 138
Query: 127 LAKLYNREHTHI--TSTGRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
+++ E I S G ++ P APE T + DV+S+G+LL+E
Sbjct: 139 MSR---EEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWET 188
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 52.5 bits (127), Expect = 2e-08
Identities = 36/113 (31%), Positives = 58/113 (51%), Gaps = 16/113 (14%)
Query: 93 YLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152
YLH IV+ D+KPE++LLD + + K DFG AK + T+ T G TP AP
Sbjct: 116 YLHSL---DIVYRDLKPENLLLDSDGYIKITDFGFAK-RVKGRTY-TLCG---TPEYLAP 167
Query: 153 ELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
E+ + + D ++ G+L++E + G + ++I EG+ FP +
Sbjct: 168 EIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGKVRFPSF 220
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 52.6 bits (126), Expect = 2e-08
Identities = 38/129 (29%), Positives = 58/129 (44%), Gaps = 14/129 (10%)
Query: 57 IKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE 116
I ++ +G K+ L QL +G+AYLH Q +H D+ +VLLD
Sbjct: 86 IMEYVPLGSLRDYLPKHKLNLAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDN 142
Query: 117 NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKC------DVFSFG 170
+ K DFGLAK H + R R G ++P W ++ DV+SFG
Sbjct: 143 DRLVKIGDFGLAKAVPEGHEYY----RVREDG-DSPVFWYAVECLKENKFSYASDVWSFG 197
Query: 171 MLLFEVVGR 179
+ L+E++
Sbjct: 198 VTLYELLTH 206
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-08
Identities = 31/90 (34%), Positives = 50/90 (55%), Gaps = 3/90 (3%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
S+G+ YL E K+VH D+ +VL+ E K +DFGL++ E +++ + R
Sbjct: 137 SRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPV 193
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
A E + T + DV+SFG+LL+E+V
Sbjct: 194 KWMAIESLFDHIYTTQSDVWSFGVLLWEIV 223
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 52.3 bits (125), Expect = 3e-08
Identities = 34/102 (33%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
+ F L ++G+ YL QK +H D+ +VL+ EN K ADFGLA+ N
Sbjct: 134 MTFKDLVSCTYQVARGMEYL---ASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNI 190
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
+ +T R APE T + DV+SFG+L++E+
Sbjct: 191 DYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEI 232
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 52.4 bits (126), Expect = 3e-08
Identities = 35/97 (36%), Positives = 51/97 (52%), Gaps = 13/97 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN-REHTHITS---TGRR 144
+G+ YLH I+H DIKP ++L++ N K DFGLA++ E H+T T
Sbjct: 114 RGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDESKHMTQEVVTQYY 170
Query: 145 RTPGCEAPELWM-PYSVTQKCDVFSFGMLLFEVVGRR 180
R APE+ M T D++S G + E++GRR
Sbjct: 171 R-----APEILMGSRHYTSAVDIWSVGCIFAELLGRR 202
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 3e-08
Identities = 33/107 (30%), Positives = 55/107 (51%), Gaps = 4/107 (3%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L L ++ + G+AY+ R +H D++ ++L+ + K ADFGLA+L +
Sbjct: 99 LKLPNLVDMAAQVAAGMAYIE---RMNYIHRDLRSANILVGDGLVCKIADFGLARLI-ED 154
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
+ + G + APE + T K DV+SFG+LL E+V + R
Sbjct: 155 NEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGR 201
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 51.9 bits (125), Expect = 3e-08
Identities = 36/97 (37%), Positives = 50/97 (51%), Gaps = 16/97 (16%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL-AKLYNREHTHI 138
LRE T +G+AYLHE K++H DIK +++LL +N K DFG+ A+L +
Sbjct: 119 LRE----TLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLGRRN 171
Query: 139 TSTGRRRTPGCEAPEL-----WMPYSVTQKCDVFSFG 170
T G TP APE+ S + DV+S G
Sbjct: 172 TFIG---TPYWMAPEVIACDEQPDASYDARSDVWSLG 205
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 52.0 bits (124), Expect = 3e-08
Identities = 33/105 (31%), Positives = 55/105 (52%), Gaps = 18/105 (17%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
QL ++G+ YL + ++ +H D+ ++L+ EN+ K ADFGL++ + ++
Sbjct: 113 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV 166
Query: 139 TSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
T R P WM YSV T DV+S+G+LL+E+V
Sbjct: 167 KKTMGR------LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 205
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 51.8 bits (125), Expect = 4e-08
Identities = 31/92 (33%), Positives = 48/92 (52%), Gaps = 11/92 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS-TGRRRTP 147
+G+ YLH Q ++H DIK +++LL ++ K ADFG A +E + S G TP
Sbjct: 127 QGLEYLH---SQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKSKRNSVVG---TP 180
Query: 148 GCEAPELWM--PYSVTQKCDVFSFGMLLFEVV 177
APE+ Y K D++S G++ E+
Sbjct: 181 YWMAPEVIKRKDYG--PKVDIWSLGIMCIEMA 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 51.9 bits (124), Expect = 4e-08
Identities = 36/103 (34%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNR 133
L F L ++G+ YL QK +H D+ +VL+ E+ K ADFGLA+ ++N
Sbjct: 131 LTFKDLVSCAYQVARGMEYL---ASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNI 187
Query: 134 EHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
++ T+ GR APE T + DV+SFG+LL+E+
Sbjct: 188 DYYKKTTNGRLPVKWM-APEALFDRVYTHQSDVWSFGVLLWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 51.6 bits (123), Expect = 4e-08
Identities = 33/99 (33%), Positives = 56/99 (56%), Gaps = 4/99 (4%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
+L + ++G+AY+ R+ +H D++ +VL+ E+ K ADFGLA++ ++ +
Sbjct: 104 KLIDFSAQIAEGMAYIE---RKNYIHRDLRAANVLVSESLMCKIADFGLARVI-EDNEYT 159
Query: 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
G + APE S T K DV+SFG+LL+E+V
Sbjct: 160 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIV 198
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 51.5 bits (123), Expect = 5e-08
Identities = 33/105 (31%), Positives = 55/105 (52%), Gaps = 18/105 (17%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
QL ++G+ YL + ++ +H D+ ++L+ EN+ K ADFGL++ + ++
Sbjct: 125 QLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSR---GQEVYV 178
Query: 139 TSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
T R P WM YSV T DV+S+G+LL+E+V
Sbjct: 179 KKTMGR------LPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIV 217
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 51.4 bits (123), Expect = 5e-08
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 13/95 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRT-P 147
KG+ YLH + I+H DIK ++L+D K +DFG++K + + ST P
Sbjct: 117 KGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISK---KLEANSLSTKTNGARP 170
Query: 148 GCEAPELWMPYSV------TQKCDVFSFGMLLFEV 176
+ WM V T+K D++S G L+ E+
Sbjct: 171 SLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEM 205
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 50.9 bits (122), Expect = 6e-08
Identities = 27/99 (27%), Positives = 50/99 (50%), Gaps = 7/99 (7%)
Query: 87 TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRR 145
++Y+H+ I+H DIK ++ L + K DFG++K+ E++ T G
Sbjct: 110 IVSAVSYIHKA---GILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYSMAETVVG--- 163
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLE 184
TP +PEL K D+++ G +L+E++ +R +
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFD 202
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.8 bits (122), Expect = 8e-08
Identities = 34/99 (34%), Positives = 48/99 (48%), Gaps = 22/99 (22%)
Query: 87 TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR- 145
T KG+AYLHE +H DIK ++LL E+ K ADFG++ +T+T +R
Sbjct: 110 TLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVS-------AQLTATIAKRK 159
Query: 146 ----TPGCEAPE-----LWMPYSVTQKCDVFSFGMLLFE 175
TP APE Y KCD+++ G+ E
Sbjct: 160 SFIGTPYWMAPEVAAVERKGGY--DGKCDIWALGITAIE 196
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 51.0 bits (122), Expect = 8e-08
Identities = 36/114 (31%), Positives = 58/114 (50%), Gaps = 20/114 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ Y+H +VH D+KP ++L++EN K DFGLA++ + + T ST R P
Sbjct: 119 RGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQMTGYVSTRYYRAP- 174
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGREEV 202
E W Y V + D++S G + E++ EG+ FP G++ V
Sbjct: 175 -EIMLTWQKYDV--EVDIWSAGCIFAEML-----------EGKPLFP--GKDHV 212
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 50.3 bits (120), Expect = 1e-07
Identities = 32/98 (32%), Positives = 55/98 (56%), Gaps = 4/98 (4%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
QL E+ +G+AYL E +Q I H D+ + L+D+ K +DFGL++ Y + +
Sbjct: 101 QLLEMCKDVCEGMAYL--ESKQFI-HRDLAARNCLVDDQGCVKVSDFGLSR-YVLDDEYT 156
Query: 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
+S G + PE+ + + K DV++FG+L++EV
Sbjct: 157 SSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEV 194
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 50.6 bits (121), Expect = 1e-07
Identities = 38/117 (32%), Positives = 60/117 (51%), Gaps = 15/117 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL-YNREHTHITSTGRRRTPG 148
G+ +LH ++ I++ D+K ++VLLD++ K ADFG+ K N E T G TP
Sbjct: 108 GLQFLH---KKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGEGKASTFCG---TPD 161
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ + D +SFG+LL+E ++G+ L I + FP+W
Sbjct: 162 YIAPEILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFPRW 218
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.3 bits (121), Expect = 1e-07
Identities = 33/96 (34%), Positives = 47/96 (48%), Gaps = 19/96 (19%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT 139
LRE+ G+ YLHE + +H DIK ++LL E K ADFG++ +T
Sbjct: 104 LREV----LLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVS-------GQLT 149
Query: 140 STGRRR-----TPGCEAPELWMPYSVTQKCDVFSFG 170
ST +R TP APE+ +K D++S G
Sbjct: 150 STMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLG 185
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 30/92 (32%), Positives = 42/92 (45%), Gaps = 10/92 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS----TGRRR 145
G+ YLH IVH DIK ++L D K DFG +K + T TG
Sbjct: 116 GVEYLH---SNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTG--- 169
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
TP +PE+ +K DV+S G + E++
Sbjct: 170 TPYWMSPEVISGEGYGRKADVWSVGCTVVEML 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 50.2 bits (120), Expect = 1e-07
Identities = 36/109 (33%), Positives = 55/109 (50%), Gaps = 17/109 (15%)
Query: 80 LREIEVS-----TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L+E+E++ +G+AYLH R +H DIK ++LL E K ADFG A L +
Sbjct: 112 LQEVEIAAICHGALQGLAYLHSHER---IHRDIKAGNILLTEPGTVKLADFGSASLVSPA 168
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQ---KCDVFSFGMLLFEVVGRR 180
++ + TP APE+ + Q K DV+S G+ E+ R+
Sbjct: 169 NSFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-07
Identities = 36/124 (29%), Positives = 61/124 (49%), Gaps = 18/124 (14%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
QL + + ++G+ YL +K+VH D+ ++L+ E+ K +DFGLA++
Sbjct: 101 QLLQFSLDVAEGMEYLES---KKLVHRDLAARNILVSEDGVAKVSDFGLARV-GSMGVDN 156
Query: 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWG 198
+ + T APE + K DV+S+G+LL+EV S G+ +PK
Sbjct: 157 SKLPVKWT----APEALKHKKFSSKSDVWSYGVLLWEV----------FSYGRAPYPKMS 202
Query: 199 REEV 202
+EV
Sbjct: 203 LKEV 206
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 50.0 bits (119), Expect = 1e-07
Identities = 30/92 (32%), Positives = 49/92 (53%), Gaps = 6/92 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ +LH C IVH D+KPE++L+ K ADFGLA++Y+ + T T
Sbjct: 119 RGLDFLHANC---IVHRDLKPENILVTSGGQVKLADFGLARIYS---CQMALTPVVVTLW 172
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ + + D++S G + E+ R+
Sbjct: 173 YRAPEVLLQSTYATPVDMWSVGCIFAEMFRRK 204
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 50.1 bits (120), Expect = 2e-07
Identities = 36/88 (40%), Positives = 48/88 (54%), Gaps = 9/88 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
G+ YLHE KIV+ D+K +++LLD F K ADFGL K TST G TP
Sbjct: 113 GLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCK-EGMGFGDRTSTFCG---TP 165
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
APE+ S T+ D + G+L++E
Sbjct: 166 EFLAPEVLTETSYTRAVDWWGLGVLIYE 193
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 50.0 bits (120), Expect = 2e-07
Identities = 29/112 (25%), Positives = 46/112 (41%), Gaps = 30/112 (26%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-------------- 136
+ +H + +H DIKP+++L+D + K ADFGL K N+
Sbjct: 114 LDSVH---KLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFR 170
Query: 137 -----HITSTGRRR--------TPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
+RR TP APE+ +CD +S G++L+E
Sbjct: 171 DNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYE 222
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 49.5 bits (118), Expect = 2e-07
Identities = 32/92 (34%), Positives = 44/92 (47%), Gaps = 7/92 (7%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST----GRR 144
G+AYLH C +VH DIK +V+L N K DFG A+ H T +
Sbjct: 113 DGVAYLHNNC---VVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMH 169
Query: 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
TP APE+ +K D++S G +FE+
Sbjct: 170 GTPYWMAPEVINESGYGRKSDIWSIGCTVFEM 201
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 49.4 bits (118), Expect = 2e-07
Identities = 32/99 (32%), Positives = 52/99 (52%), Gaps = 18/99 (18%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN---REHTHITSTGRRR 145
+G+A+ H +++H D+KP+++L++ K ADFGLA+ + R +TH T R
Sbjct: 111 QGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYR 167
Query: 146 TP----GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
P GC+ YS D++S G + E+V RR
Sbjct: 168 APEILLGCKY------YSTA--VDIWSLGCIFAEMVTRR 198
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 2e-07
Identities = 34/103 (33%), Positives = 47/103 (45%), Gaps = 18/103 (17%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL-AKLYNREHTHI 138
L+E KG+ YLH +H DIK ++LL E+ K ADFG+ A L
Sbjct: 108 LKE----VLKGLEYLH---SNGQIHRDIKAGNILLGEDGSVKIADFGVSASLA----DGG 156
Query: 139 TSTGRRR-----TPGCEAPELWMP-YSVTQKCDVFSFGMLLFE 175
T + R TP APE+ + K D++SFG+ E
Sbjct: 157 DRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIE 199
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 49.0 bits (117), Expect = 3e-07
Identities = 29/85 (34%), Positives = 47/85 (55%), Gaps = 5/85 (5%)
Query: 93 YLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152
YLH+E ++IVH D+ P +++L E+ DFGLAK E + +TS C P
Sbjct: 128 YLHKE--KRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPE-SKLTSVVGTILYSC--P 182
Query: 153 ELWMPYSVTQKCDVFSFGMLLFEVV 177
E+ +K DV++FG +L+++
Sbjct: 183 EIVKNEPYGEKADVWAFGCILYQMC 207
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 49.3 bits (118), Expect = 3e-07
Identities = 35/115 (30%), Positives = 58/115 (50%), Gaps = 26/115 (22%)
Query: 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLY 131
+ILG ++ V+ K + YL E+ ++H D+KP ++LLD + K DFG++ +L
Sbjct: 114 DILG-----KMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRL- 165
Query: 132 NREHTHITSTGRRRTPGCEA---PELWMP------YSVTQKCDVFSFGMLLFEVV 177
+ S + R+ GC A PE P Y + + DV+S G+ L E+
Sbjct: 166 ------VDSKAKTRSAGCAAYMAPERIDPPDPNPKYDI--RADVWSLGISLVELA 212
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 49.1 bits (117), Expect = 3e-07
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 5/91 (5%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
G+ +LH+ ++I++ D+KPE+VLLD + + +D GLA + + G TPG
Sbjct: 109 GLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGF 163
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
APEL D F+ G+ L+E++ R
Sbjct: 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAAR 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 49.2 bits (118), Expect = 3e-07
Identities = 28/101 (27%), Positives = 52/101 (51%), Gaps = 18/101 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR---EHT-----HITS 140
+G+ Y+H ++H D+KP ++L++E+ + DFG+A+ + EH ++ +
Sbjct: 118 RGLKYIHSAN---VIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVAT 174
Query: 141 TGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRR 180
R APEL + T D++S G + E++GRR
Sbjct: 175 RWYR------APELLLSLPEYTTAIDMWSVGCIFAEMLGRR 209
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-07
Identities = 28/115 (24%), Positives = 44/115 (38%), Gaps = 21/115 (18%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLL 114
+ G L KK +G E + G+ YLH+ + VH DIK ++L+
Sbjct: 83 LVPGGSLAKLLKK----YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILV 135
Query: 115 DENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSF 169
D N K ADFG+AK + ++ + WM V + +
Sbjct: 136 DTNGVVKLADFGMAK-------QVVEFSFAKS--FKGSPYWMAPEVIAQQGGYGL 181
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 48.8 bits (116), Expect = 4e-07
Identities = 35/115 (30%), Positives = 55/115 (47%), Gaps = 5/115 (4%)
Query: 63 MGPFYLLCKKNI-LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPK 121
+GP +KN + + E+ S G+ YL E VH D+ +VLL + K
Sbjct: 79 LGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAK 135
Query: 122 AADFGLAKLYNREHTHITSTGRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
+DFGL+K + + + + P APE Y + K DV+SFG+L++E
Sbjct: 136 ISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWE 190
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 48.9 bits (116), Expect = 4e-07
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ Y+H I+H D+KP ++ ++E+ K DFGLA+ HT TG T
Sbjct: 131 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRW 182
Query: 149 CEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ WM Y+ T D++S G ++ E++ R
Sbjct: 183 YRAPEIMLNWMHYNQT--VDIWSVGCIMAELLTGR 215
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 4e-07
Identities = 30/98 (30%), Positives = 52/98 (53%), Gaps = 5/98 (5%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144
V +KG++YL E +++VH D+ +VL+ K DFGLAKL + + + G +
Sbjct: 116 VQIAKGMSYLEE---KRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGK 172
Query: 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV--GRR 180
A E + T K DV+S+G+ ++E++ G +
Sbjct: 173 VPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 48.6 bits (116), Expect = 5e-07
Identities = 30/97 (30%), Positives = 52/97 (53%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRT 146
++G+ +L +K +H D+ +VL+ E+ K ADFGLA+ +++ ++ T+ GR
Sbjct: 142 ARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGR--- 195
Query: 147 PGCEAPELWMPYSV------TQKCDVFSFGMLLFEVV 177
P WM T + DV+SFG+LL+E+
Sbjct: 196 ----LPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIF 228
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 5e-07
Identities = 29/94 (30%), Positives = 50/94 (53%), Gaps = 4/94 (4%)
Query: 94 LHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152
LH + I+H D+K +++LLD++ K DFG++K+ + + T G TP +P
Sbjct: 114 LHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSKAYTVVG---TPCYISP 170
Query: 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
EL QK D+++ G +L+E+ +R E
Sbjct: 171 ELCEGKPYNQKSDIWALGCVLYELASLKRAFEAA 204
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 48.4 bits (116), Expect = 5e-07
Identities = 36/106 (33%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH--THITSTGRRRT 146
+G+ +LH IVH D+KP+++L+ + K ADFGLA++Y+ E T + T R
Sbjct: 118 RGVDFLHSHR---IVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMALTSVVVTLWYR- 173
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQE 192
APE+ + S D++S G + E+ RRR L + SE +
Sbjct: 174 ----APEVLLQSSYATPVDMWSVGCIFAELF-RRRPLFRGTSEADQ 214
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 48.3 bits (115), Expect = 6e-07
Identities = 20/44 (45%), Positives = 30/44 (68%), Gaps = 3/44 (6%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR 133
GIAYLH R+ IVH DIKP ++L++ K ADFG++++ +
Sbjct: 180 GIAYLH---RRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQ 220
|
Length = 353 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 48.0 bits (115), Expect = 6e-07
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 18/94 (19%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR--- 145
KG+ YLH + + I+H DIKP ++L++ K ADFG++K + +T +
Sbjct: 110 KGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISK-------VLENTLDQCNTF 160
Query: 146 --TPGCEAPE--LWMPYSVTQKCDVFSFGMLLFE 175
T +PE YS D++S G+ L E
Sbjct: 161 VGTVTYMSPERIQGESYSY--AADIWSLGLTLLE 192
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 6e-07
Identities = 33/102 (32%), Positives = 51/102 (50%), Gaps = 3/102 (2%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L F L ++G+ YL +K +H D+ +VL+ E+ K ADFGLA+ +
Sbjct: 137 LSFKDLVSCAYQVARGMEYL---ASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHI 193
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
+ +T R APE T + DV+SFG+LL+E+
Sbjct: 194 DYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEI 235
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 48.1 bits (114), Expect = 7e-07
Identities = 42/142 (29%), Positives = 65/142 (45%), Gaps = 15/142 (10%)
Query: 42 DNFSNLVG---SEDTETYI-KGFLAMGPF--YLLCK-KNILGFGQLREIEVSTSKGIAYL 94
N L+G E YI ++A G YL + +++LG L + + + + YL
Sbjct: 59 SNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYL 118
Query: 95 HEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154
VH D+ +VL+ E+ K +DFGL K E + TG+ APE
Sbjct: 119 EA---NNFVHRDLAARNVLVSEDNVAKVSDFGLTK----EASSTQDTGKLPVK-WTAPEA 170
Query: 155 WMPYSVTQKCDVFSFGMLLFEV 176
+ K DV+SFG+LL+E+
Sbjct: 171 LREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 7e-07
Identities = 31/90 (34%), Positives = 51/90 (56%), Gaps = 11/90 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPG 148
G+ ++HE ++++H DIK +++ L +N K DFG A+L + T G TP
Sbjct: 112 GVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAYACTYVG---TPY 165
Query: 149 CEAPELW--MPYSVTQKCDVFSFGMLLFEV 176
PE+W MPY+ K D++S G +L+E+
Sbjct: 166 YVPPEIWENMPYN--NKSDIWSLGCILYEL 193
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 47.7 bits (113), Expect = 8e-07
Identities = 37/119 (31%), Positives = 59/119 (49%), Gaps = 26/119 (21%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI----TSTGRRR 145
G+ LH+E +IV+ D+KPE++LLD++ + +D GLA H+ T GR
Sbjct: 114 GLEDLHQE---RIVYRDLKPENILLDDHGHIRISDLGLA-------VHVPEGQTIKGRVG 163
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG------------RRRNLEKEISEGQE 192
T G APE+ T D ++ G LL+E++ +R +E+ + E QE
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQE 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 47.4 bits (113), Expect = 9e-07
Identities = 32/111 (28%), Positives = 50/111 (45%), Gaps = 16/111 (14%)
Query: 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL-AKLYNREHT 136
Q+R + + + +LH K++H D+K ++LL + K ADFG+ AK +
Sbjct: 103 PQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK 159
Query: 137 HITSTGRRRTPGCEAPELWM-------PYSVTQKCDVFSFGMLLFEVVGRR 180
T G TP APE+ PY K D++S G+ L E+
Sbjct: 160 RDTFIG---TPYWMAPEVVACETFKDNPYD--YKADIWSLGITLIELAQME 205
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 47.5 bits (113), Expect = 1e-06
Identities = 39/114 (34%), Positives = 54/114 (47%), Gaps = 18/114 (15%)
Query: 93 YLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152
YLH + I++ D+KPE++LLD K DFG AK + T T G TP AP
Sbjct: 133 YLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKV-PDRTF-TLCG---TPEYLAP 184
Query: 153 ELWMPYSVTQKCDVFSFGMLLFE-VVGRR--------RNLEKEISEGQEWFPKW 197
E+ + D ++ G+LL+E + G R EK I G+ FP W
Sbjct: 185 EVIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTPFRIYEK-ILAGRLKFPNW 237
|
Length = 329 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 47.4 bits (112), Expect = 1e-06
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 12/110 (10%)
Query: 73 NILGFGQLREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
++L G E +++T KG+ YLH E K +H DIK +VLL E K ADFG+
Sbjct: 91 DLLRAGPFDEFQIATMLKEILKGLDYLHSE---KKIHRDIKAANVLLSEQGDVKLADFGV 147
Query: 128 A-KLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
A +L + + T G TP APE+ + K D++S G+ E+
Sbjct: 148 AGQLTDTQIKRNTFVG---TPFWMAPEVIQQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 47.3 bits (112), Expect = 1e-06
Identities = 32/103 (31%), Positives = 53/103 (51%), Gaps = 9/103 (8%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
GI +LH IV+ D+KPE+VLLD+ + +D GLA T T R T G
Sbjct: 107 GILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK---TITQRAGTNGY 160
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRR---RNLEKEISE 189
APE+ + D F+ G ++E+V R ++ ++++++
Sbjct: 161 MAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDHKEKVAK 203
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 47.2 bits (112), Expect = 1e-06
Identities = 34/104 (32%), Positives = 57/104 (54%), Gaps = 6/104 (5%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY-NR 133
L +L ++ ++G+A++ R+ +H D++ ++L+ E K ADFGLA+L +
Sbjct: 99 LTINKLIDMAAQIAEGMAFIE---RKNYIHRDLRAANILVSETLCCKIADFGLARLIEDN 155
Query: 134 EHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
E+T G + APE + T K DV+SFG+LL E+V
Sbjct: 156 EYT--AREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV 197
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 1e-06
Identities = 35/103 (33%), Positives = 54/103 (52%), Gaps = 11/103 (10%)
Query: 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHT 136
GQL + + G+ YL E VH D+ ++L++ N K +DFGL++ L + E T
Sbjct: 106 GQLVGMLRGIASGMKYLSEMN---YVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEAT 162
Query: 137 HITSTGR---RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
+ T G+ R T APE T DV+SFG++++EV
Sbjct: 163 YTTKGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEV 201
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 47.0 bits (111), Expect = 1e-06
Identities = 38/109 (34%), Positives = 54/109 (49%), Gaps = 10/109 (9%)
Query: 73 NILGFGQLREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
++L G L E +++T KG+ YLH E K +H DIK +VLL E+ K ADFG+
Sbjct: 91 DLLEPGPLDETQIATILREILKGLDYLHSE---KKIHRDIKAANVLLSEHGEVKLADFGV 147
Query: 128 AKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
A T I TP APE+ + K D++S G+ E+
Sbjct: 148 AG--QLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 47.1 bits (112), Expect = 1e-06
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 17/95 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR--- 145
K +++LH Q ++H DIK +S+LL + K +DFG ++E RR+
Sbjct: 126 KALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKE------VPRRKSLV 176
Query: 146 -TPGCEAPELW--MPYSVTQKCDVFSFGMLLFEVV 177
TP APE+ +PY + D++S G+++ E+V
Sbjct: 177 GTPYWMAPEVISRLPYGT--EVDIWSLGIMVIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 47.0 bits (112), Expect = 2e-06
Identities = 38/124 (30%), Positives = 62/124 (50%), Gaps = 21/124 (16%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK--LYNREHTHITSTGRRRTP 147
G+ +LHE + I++ D+K ++VLLD K ADFG+ K + T T G TP
Sbjct: 108 GLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGVTTS-TFCG---TP 160
Query: 148 GCEAPEL--WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE--------ISEGQEWFPKW 197
APE+ + PY D ++ G+LL+E++ + E + I E + +P+W
Sbjct: 161 DYIAPEILSYQPYGPA--VDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYPRW 218
Query: 198 GREE 201
+E
Sbjct: 219 LSKE 222
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-06
Identities = 30/103 (29%), Positives = 55/103 (53%), Gaps = 4/103 (3%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
+L + ++G+A++ ++ +H D++ ++L+ + K ADFGLA++ ++ +
Sbjct: 103 KLIDFSAQIAEGMAFIE---QRNYIHRDLRAANILVSASLVCKIADFGLARVI-EDNEYT 158
Query: 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
G + APE S T K DV+SFG+LL E+V R
Sbjct: 159 AREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGR 201
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-06
Identities = 32/105 (30%), Positives = 55/105 (52%), Gaps = 17/105 (16%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
Q+ + ++ K ++ LH Q ++H DIK +S+LL + K +DFG ++E
Sbjct: 117 QIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKE---- 169
Query: 139 TSTGRRR----TPGCEAPELW--MPYSVTQKCDVFSFGMLLFEVV 177
RR+ TP APEL +PY + D++S G+++ E+V
Sbjct: 170 --VPRRKSLVGTPYWMAPELISRLPYG--PEVDIWSLGIMVIEMV 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 46.9 bits (111), Expect = 2e-06
Identities = 33/103 (32%), Positives = 55/103 (53%), Gaps = 5/103 (4%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNR 133
L F L ++G+ YL ++ +H D+ +VL+ E+ K ADFGLA+ +++
Sbjct: 131 LSFKDLVSCAYQVARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDI 187
Query: 134 EHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
++ TS GR APE T + DV+SFG+L++E+
Sbjct: 188 DYYKKTSNGRLPVKWM-APEALFDRVYTHQSDVWSFGILMWEI 229
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 46.9 bits (112), Expect = 2e-06
Identities = 33/103 (32%), Positives = 44/103 (42%), Gaps = 17/103 (16%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE---HTHITSTGRRRT 146
GI YLHE I+H DIK ++L+D K ADFGLA+ Y+ G R+
Sbjct: 127 GINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKY 183
Query: 147 PGC------EAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
PEL Y T D++ G + E+ RR
Sbjct: 184 TNLVVTRWYRPPELLLGERRY--TTAVDIWGIGCVFAEMFTRR 224
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 46.8 bits (111), Expect = 2e-06
Identities = 30/111 (27%), Positives = 51/111 (45%), Gaps = 7/111 (6%)
Query: 83 IEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142
IE +G+ YLH Q+I+H D+K E++ +++ D G A+ + G
Sbjct: 162 IEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAPAFLGLAG 218
Query: 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNL-EKEISEGQE 192
T APE+ K D++S G++LFE++ + E S +E
Sbjct: 219 TVET---NAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPEE 266
|
Length = 357 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.5 bits (111), Expect = 2e-06
Identities = 35/98 (35%), Positives = 53/98 (54%), Gaps = 16/98 (16%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN---REHTHITSTGRRR 145
+GIAY H +++H D+KP+++L+D K ADFGLA+ + R +TH T R
Sbjct: 110 QGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVRTYTHEVVTLWYR 166
Query: 146 TPGCEAPELWM---PYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ + YS D++S G + E+V RR
Sbjct: 167 -----APEILLGSRQYSTP--VDIWSIGCIFAEMVNRR 197
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 2e-06
Identities = 37/116 (31%), Positives = 57/116 (49%), Gaps = 26/116 (22%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-K 129
++ILG +I VS K + YLH + ++H D+KP +VL++ N K DFG++
Sbjct: 101 PEDILG-----KIAVSIVKALEYLHS--KLSVIHRDVKPSNVLINRNGQVKLCDFGISGY 153
Query: 130 LYNREHTHITSTGRRRTPGCE---APELWMP------YSVTQKCDVFSFGMLLFEV 176
L + S + GC+ APE P Y V K DV+S G+ + E+
Sbjct: 154 LVD-------SVAKTIDAGCKPYMAPERINPELNQKGYDV--KSDVWSLGITMIEL 200
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 2e-06
Identities = 32/105 (30%), Positives = 53/105 (50%), Gaps = 13/105 (12%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
L +I V+ KG+ YLHE + KI+H D+KP ++L++ K DFG++ +
Sbjct: 101 ILGKIAVAVLKGLTYLHE--KHKIIHRDVKPSNILVNSRGQIKLCDFGVS-------GQL 151
Query: 139 TSTGRRRTPGCE---APELWMPYSVTQKCDVFSFGMLLFEV-VGR 179
++ + G APE + K D++S G+ L E+ GR
Sbjct: 152 VNSLAKTFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATGR 196
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 46.6 bits (110), Expect = 3e-06
Identities = 32/105 (30%), Positives = 51/105 (48%), Gaps = 3/105 (2%)
Query: 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131
K +L L +KG+ +L +K +H D+ ++LL EN K DFGLA+
Sbjct: 173 KKVLTLEDLICYSFQVAKGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDI 229
Query: 132 NREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
++ ++ R APE T + DV+SFG+LL+E+
Sbjct: 230 YKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEI 274
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.4 bits (111), Expect = 3e-06
Identities = 29/100 (29%), Positives = 45/100 (45%), Gaps = 17/100 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ YLH ++H D+KP ++L++ N K DFGLA R T
Sbjct: 114 RGLKYLH---SANVIHRDLKPSNILVNSNCDLKICDFGLA----RGVDPDEDEKGFLTEY 166
Query: 149 CE-----APEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APEL Y T+ D++S G + E++ R+
Sbjct: 167 VVTRWYRAPELLLSSSRY--TKAIDIWSVGCIFAELLTRK 204
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 46.3 bits (110), Expect = 3e-06
Identities = 32/88 (36%), Positives = 51/88 (57%), Gaps = 9/88 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
G+A+LH +KI+H DIK ++ LD K D G+AKL + ++T+ +T G TP
Sbjct: 113 GLAHLH---SKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLS-DNTNFANTIVG---TP 165
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
+PEL +K DV++ G++L+E
Sbjct: 166 YYLSPELCEDKPYNEKSDVWALGVVLYE 193
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 46.2 bits (110), Expect = 3e-06
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 26/119 (21%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITS---TGRR 144
+ IAY H I+H DIKPE++L+ E+ K DFG A+ L R + +T T
Sbjct: 111 QAIAYCH---SHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPASPLTDYVATRWY 167
Query: 145 RTPGCEAPELWMPYSVTQK-CDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGREEV 202
R APEL + + K DV++ G ++ E+ +G+ FP G ++
Sbjct: 168 R-----APELLVGDTNYGKPVDVWAIGCIM-----------AELLDGEPLFP--GDSDI 208
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 3e-06
Identities = 32/92 (34%), Positives = 49/92 (53%), Gaps = 13/92 (14%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
KG+ Y+H I+H D+KP ++ ++E+ K DFGLA+ T TG T
Sbjct: 129 KGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLAR-----QTDSEMTGYVVTRW 180
Query: 149 CEAPEL---WMPYSVTQKCDVFSFGMLLFEVV 177
APE+ WM Y TQ D++S G ++ E++
Sbjct: 181 YRAPEVILNWMHY--TQTVDIWSVGCIMAEML 210
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 45.9 bits (109), Expect = 3e-06
Identities = 42/166 (25%), Positives = 74/166 (44%), Gaps = 23/166 (13%)
Query: 43 NFSNLVGSEDTETYIKGFLAMGPFYLL--CKKNILGFGQ--LREIEVSTSKGIAYLHEEC 98
N +G E TE Y+ FL P + C + F + +R +G+AYLH
Sbjct: 69 NIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLH--- 125
Query: 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY 158
+ I+H D+K +++L+D + K +DFG++K + + + + + + APE+ Y
Sbjct: 126 SKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSY 185
Query: 159 --SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGREEV 202
+ K D++S G ++ E+ RR W EE
Sbjct: 186 SQGYSAKVDIWSLGCVVLEMFAGRR--------------PWSDEEA 217
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-06
Identities = 28/92 (30%), Positives = 51/92 (55%), Gaps = 6/92 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ +LH ++VH D+KP+++L+ + K ADFGLA++Y+ + + T T
Sbjct: 121 RGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ---MALTSVVVTLW 174
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ + S D++S G + E+ R+
Sbjct: 175 YRAPEVLLQSSYATPVDLWSVGCIFAEMFRRK 206
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 45.8 bits (108), Expect = 4e-06
Identities = 33/109 (30%), Positives = 49/109 (44%), Gaps = 17/109 (15%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
LG Q+ I + G+ YL Q VH D+ + L+ N K DFG+++
Sbjct: 120 LGLSQMLHIASQIASGMVYL---ASQHFVHRDLATRNCLVGANLLVKIGDFGMSR----- 171
Query: 135 HTHITSTGRRRTPG-CEAPELWMP------YSVTQKCDVFSFGMLLFEV 176
+ ST R G P WMP T + DV+SFG++L+E+
Sbjct: 172 --DVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 218
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 45.5 bits (108), Expect = 4e-06
Identities = 30/97 (30%), Positives = 51/97 (52%), Gaps = 16/97 (16%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN---REHTHITSTGRRRT 146
GI + H ++++H D+KP+++L+D K ADFGLA+ + R +TH T R
Sbjct: 113 GILFCH---SRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYR- 168
Query: 147 PGCEAPELWMP---YSVTQKCDVFSFGMLLFEVVGRR 180
APE+ + YS D++S G + E+ ++
Sbjct: 169 ----APEVLLGSPRYST--PVDIWSIGTIFAEMATKK 199
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 45.4 bits (107), Expect = 5e-06
Identities = 42/155 (27%), Positives = 76/155 (49%), Gaps = 14/155 (9%)
Query: 30 IRFTSPQRMIAADNFSNLVG-----SEDTETYI-KGFLAMGPF--YLLCKKNILGFGQLR 81
I+F S R++ + N+V ++ YI + G F +L KK+ L QL
Sbjct: 37 IKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLV 96
Query: 82 EIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141
+ + + G+AYL + +H D+ + L+ EN K +DFG+++ + +S+
Sbjct: 97 KFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSR--QEDDGIYSSS 151
Query: 142 GRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
G ++ P APE + + DV+S+G+LL+E
Sbjct: 152 GLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWE 186
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 45.7 bits (108), Expect = 5e-06
Identities = 29/78 (37%), Positives = 46/78 (58%), Gaps = 6/78 (7%)
Query: 102 IVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTPGCEAPELWMPYS 159
+++ D+KPE++LLD DFGL KL N + T+T G TP APEL + +
Sbjct: 114 VIYRDLKPENILLDYQGHIALCDFGLCKL-NMKDDDKTNTFCG---TPEYLAPELLLGHG 169
Query: 160 VTQKCDVFSFGMLLFEVV 177
T+ D ++ G+LL+E++
Sbjct: 170 YTKAVDWWTLGVLLYEML 187
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 45.1 bits (107), Expect = 6e-06
Identities = 31/96 (32%), Positives = 52/96 (54%), Gaps = 18/96 (18%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY--NREHTHITSTGRRRT 146
KG+ YL ++ VH D+ ++L++ K DFGL K+ ++E+ + R
Sbjct: 119 KGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV------RE 169
Query: 147 PGCEAPELW-MPYSVTQ-----KCDVFSFGMLLFEV 176
PG E+P W P S+T+ DV+SFG++L+E+
Sbjct: 170 PG-ESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.3 bits (107), Expect = 6e-06
Identities = 39/148 (26%), Positives = 62/148 (41%), Gaps = 23/148 (15%)
Query: 43 NFSNLVGSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSK----------GIA 92
N++G D T FYL+ ++ +S K G+
Sbjct: 72 QHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQTDLQKIMGHPLSEDKVQYLVYQMLCGLK 131
Query: 93 YLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152
Y+H I+H D+KP ++ ++E+ K DFGLA+ H TG T AP
Sbjct: 132 YIH---SAGIIHRDLKPGNLAVNEDCELKILDFGLAR-----HADAEMTGYVVTRWYRAP 183
Query: 153 EL---WMPYSVTQKCDVFSFGMLLFEVV 177
E+ WM Y Q D++S G ++ E++
Sbjct: 184 EVILNWMHY--NQTVDIWSVGCIMAEML 209
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 45.4 bits (108), Expect = 7e-06
Identities = 32/96 (33%), Positives = 51/96 (53%), Gaps = 12/96 (12%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS---TGRRR 145
+G+ Y+H ++H D+KP ++LL+ N K DFGLA+ + + +T T R
Sbjct: 119 RGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGDFMTEYVVTRWYR 175
Query: 146 TPGCEAPELWMPYS-VTQKCDVFSFGMLLFEVVGRR 180
APEL + S T DV+S G + E++GR+
Sbjct: 176 -----APELLLNCSEYTTAIDVWSVGCIFAELLGRK 206
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 7e-06
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
++G+ +L +K +H D+ ++LL EN K DFGLA+ ++ ++ R
Sbjct: 184 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPL 240
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
APE T + DV+SFG+LL+E+
Sbjct: 241 KWMAPESIFDKVYTTQSDVWSFGVLLWEI 269
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-06
Identities = 30/92 (32%), Positives = 51/92 (55%), Gaps = 13/92 (14%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ Y+H I+H D+KP +V ++E+ + DFGLA+ + E T +T R
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDEMTGYVATRWYR--- 182
Query: 149 CEAPEL---WMPYSVTQKCDVFSFGMLLFEVV 177
APE+ WM Y+ Q D++S G ++ E++
Sbjct: 183 --APEIMLNWMHYN--QTVDIWSVGCIMAELL 210
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 8e-06
Identities = 34/109 (31%), Positives = 54/109 (49%), Gaps = 17/109 (15%)
Query: 80 LREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L+E+E++ +G+AYLH ++H DIK ++LL E K ADFG A +
Sbjct: 118 LQEVEIAAITHGALQGLAYLHSHN---MIHRDIKAGNILLTEPGQVKLADFGSASKSSPA 174
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQ---KCDVFSFGMLLFEVVGRR 180
++ + TP APE+ + Q K DV+S G+ E+ R+
Sbjct: 175 NSFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 217
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 45.0 bits (107), Expect = 8e-06
Identities = 30/95 (31%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ Y+H I+H D+KP ++ ++E+ K DFGLA+ + E T +T R
Sbjct: 129 RGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDEMTGYVATRWYR--- 182
Query: 149 CEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ WM Y Q D++S G ++ E++ +
Sbjct: 183 --APEIMLNWMHY--NQTVDIWSVGCIMAELLTGK 213
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 44.8 bits (106), Expect = 9e-06
Identities = 32/94 (34%), Positives = 51/94 (54%), Gaps = 17/94 (18%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
G+AYL E +K VH D+ + L+ EN K ADFGL++ +I S +
Sbjct: 142 GMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSR-------NIYSADYYKASEN 191
Query: 150 EA-PELWMP-----YS-VTQKCDVFSFGMLLFEV 176
+A P WMP Y+ T + DV+++G++L+E+
Sbjct: 192 DAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 45.0 bits (106), Expect = 9e-06
Identities = 30/104 (28%), Positives = 54/104 (51%), Gaps = 13/104 (12%)
Query: 102 IVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVT 161
IV+ D+KPE++LLD++ F K DFG AK+ + + TP APE+ +
Sbjct: 152 IVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTRTYTLCG-----TPEYIAPEILLNVGHG 206
Query: 162 QKCDVFSFGMLLFEVV--------GRRRNLEKEISEGQEWFPKW 197
+ D ++ G+ ++E++ + ++I EG +FPK+
Sbjct: 207 KAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKF 250
|
Length = 340 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 44.7 bits (106), Expect = 1e-05
Identities = 31/98 (31%), Positives = 51/98 (52%), Gaps = 6/98 (6%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
Q++ + + +G+ YLHE I+H D+K ++LL + K ADFGLA+ Y +
Sbjct: 109 QVKCLMLQLLRGLQYLHENF---IIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKPM 165
Query: 139 TSTGRRRTPGCEAPELWMPYSV-TQKCDVFSFGMLLFE 175
T + T APEL + + T D+++ G +L E
Sbjct: 166 TP--KVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAE 201
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 44.3 bits (105), Expect = 1e-05
Identities = 27/91 (29%), Positives = 43/91 (47%), Gaps = 4/91 (4%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
+ G+AYL + VH D+ +VLL K +DFG+++ + +T R P
Sbjct: 105 AMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161
Query: 148 -GCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
APE + K DV+S+G+ L+E
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAF 192
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 1e-05
Identities = 28/81 (34%), Positives = 39/81 (48%), Gaps = 7/81 (8%)
Query: 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQ 162
VH DIKPE+VL+D K ADFG A + S TP APE+ +
Sbjct: 124 VHRDIKPENVLIDRTGHIKLADFGSAARLTAN-KMVNSKLPVGTPDYIAPEVLTTMNGDG 182
Query: 163 K------CDVFSFGMLLFEVV 177
K CD +S G++ +E++
Sbjct: 183 KGTYGVECDWWSLGVIAYEMI 203
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-05
Identities = 41/131 (31%), Positives = 61/131 (46%), Gaps = 11/131 (8%)
Query: 51 EDTETYI-KGFLAMGPFYLLCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYD 106
ED YI GF G Y K+ +L Q+ E V + + YLHE+ I+H D
Sbjct: 71 EDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEK---HILHRD 127
Query: 107 IKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCD 165
+K ++V L K D G+A+ L N+ T G TP +PEL+ K D
Sbjct: 128 LKTQNVFLTRTNIIKVGDLGIARVLENQCDMASTLIG---TPYYMSPELFSNKPYNYKSD 184
Query: 166 VFSFGMLLFEV 176
V++ G ++E+
Sbjct: 185 VWALGCCVYEM 195
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-05
Identities = 35/105 (33%), Positives = 56/105 (53%), Gaps = 16/105 (15%)
Query: 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY--NREH 135
G LR I + G+ YL + VH D+ ++L++ N K +DFGL+++ + E
Sbjct: 111 GMLRGI----AAGMKYLSD---MNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEG 163
Query: 136 THITSTGR---RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
T+ TS G+ R T APE T DV+SFG++++EV+
Sbjct: 164 TYTTSGGKIPIRWT----APEAIAYRKFTSASDVWSFGIVMWEVM 204
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 44.6 bits (105), Expect = 1e-05
Identities = 27/88 (30%), Positives = 47/88 (53%)
Query: 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153
L E +K++H D+K ++ L K DFG +K Y+ + ++ TP APE
Sbjct: 182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPE 241
Query: 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
LW ++K D++S G++L+E++ R
Sbjct: 242 LWERKRYSKKADMWSLGVILYELLTLHR 269
|
Length = 478 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-05
Identities = 36/114 (31%), Positives = 54/114 (47%), Gaps = 17/114 (14%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
K I + H + IVH DIKPE++L+ N K DFG A+ + E ++ T T
Sbjct: 111 KAIHWCH---KNDIVHRDIKPENLLISHNDVLKLCDFGFARNLS-EGSNANYTEYVATRW 166
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGREEV 202
+PEL + + D++S G +L E+S+GQ FP G E+
Sbjct: 167 YRSPELLLGAPYGKAVDMWSVGCIL-----------GELSDGQPLFP--GESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 44.2 bits (104), Expect = 1e-05
Identities = 28/93 (30%), Positives = 48/93 (51%), Gaps = 3/93 (3%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144
V +KG+ YL E +++VH D+ +VL+ K DFGLAKL + + G +
Sbjct: 116 VQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGK 172
Query: 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
A E + T + DV+S+G+ ++E++
Sbjct: 173 VPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 44.2 bits (105), Expect = 1e-05
Identities = 30/91 (32%), Positives = 49/91 (53%), Gaps = 10/91 (10%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNRE-HTHITSTGRRRT 146
K + ++H R I H DIKPE++L+ ++ K ADFG + +Y++ +T ST R
Sbjct: 111 KSLDHMH---RNGIFHRDIKPENILIKDDIL-KLADFGSCRGIYSKPPYTEYISTRWYRA 166
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
P C L Y K D+++ G + FE++
Sbjct: 167 PEC---LLTDGY-YGPKMDIWAVGCVFFEIL 193
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-05
Identities = 32/97 (32%), Positives = 50/97 (51%), Gaps = 12/97 (12%)
Query: 83 IEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNR-EHTHI-T 139
I V+ +G+ YL+ R I+H DIKP ++L++ K DFG++ +L N T + T
Sbjct: 108 IAVAVVEGLTYLYNVHR--IMHRDIKPSNILVNSRGQIKLCDFGVSGELINSIADTFVGT 165
Query: 140 STGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
ST +PE T K DV+S G+ + E+
Sbjct: 166 ST-------YMSPERIQGGKYTVKSDVWSLGISIIEL 195
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 44.0 bits (104), Expect = 1e-05
Identities = 31/89 (34%), Positives = 45/89 (50%), Gaps = 9/89 (10%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTPG 148
+ YLH I++ D+KPE++LLD DFGL K EH+ TST G TP
Sbjct: 109 LGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCK-EGIEHSKTTSTFCG---TPE 161
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
APE+ + D + G +L+E++
Sbjct: 162 YLAPEVLRKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 30/105 (28%), Positives = 56/105 (53%), Gaps = 17/105 (16%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
Q+ + +S + ++YLH Q ++H DIK +S+LL + K +DFG ++E
Sbjct: 119 QIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKE---- 171
Query: 139 TSTGRRR----TPGCEAPELW--MPYSVTQKCDVFSFGMLLFEVV 177
+R+ TP APE+ +PY + D++S G+++ E++
Sbjct: 172 --VPKRKSLVGTPYWMAPEVISRLPYGT--EVDIWSLGIMVIEMI 212
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 44.1 bits (105), Expect = 2e-05
Identities = 21/59 (35%), Positives = 32/59 (54%), Gaps = 3/59 (5%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+ NIL R I K + Y+H ++H D+KP ++LL+ + K ADFGLA+
Sbjct: 100 RANILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLAR 155
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 43.9 bits (103), Expect = 2e-05
Identities = 34/109 (31%), Positives = 55/109 (50%), Gaps = 17/109 (15%)
Query: 80 LREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L+E+E++ +G+AYLH ++H DIK ++LL E K ADFG A + +
Sbjct: 122 LQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA 178
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQ---KCDVFSFGMLLFEVVGRR 180
++ + TP APE+ + Q K DV+S G+ E+ R+
Sbjct: 179 NSFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 221
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 43.5 bits (102), Expect = 2e-05
Identities = 38/110 (34%), Positives = 56/110 (50%), Gaps = 12/110 (10%)
Query: 73 NILGFGQLREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
++L G L E ++T KG+ YLH E + +H DIK +VLL E K ADFG+
Sbjct: 91 DLLKPGPLEETYIATILREILKGLDYLHSE---RKIHRDIKAANVLLSEQGDVKLADFGV 147
Query: 128 A-KLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
A +L + + T G TP APE+ + K D++S G+ E+
Sbjct: 148 AGQLTDTQIKRNTFVG---TPFWMAPEVIKQSAYDFKADIWSLGITAIEL 194
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 43.7 bits (103), Expect = 2e-05
Identities = 28/89 (31%), Positives = 47/89 (52%), Gaps = 3/89 (3%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
++G+ +L +K +H D+ ++LL EN K DFGLA+ ++ ++ R
Sbjct: 183 ARGMEFL---ASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPL 239
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
APE T + DV+SFG+LL+E+
Sbjct: 240 KWMAPESIFDKVYTTQSDVWSFGVLLWEI 268
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.3 bits (103), Expect = 3e-05
Identities = 32/109 (29%), Positives = 51/109 (46%), Gaps = 23/109 (21%)
Query: 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE--- 134
+R I +G+A++H + H D+KPE++L+ K ADFGLA RE
Sbjct: 99 SVIRSIIYQILQGLAHIH---KHGFFHRDLKPENLLVSGPEVVKIADFGLA----REIRS 151
Query: 135 ---HTHITSTGRRRTPGCEAPELWM---PYSVTQKCDVFSFGMLLFEVV 177
+T ST R APE+ + YS D+++ G ++ E+
Sbjct: 152 RPPYTDYVSTRWYR-----APEILLRSTSYS--SPVDIWALGCIMAELY 193
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 43.3 bits (102), Expect = 3e-05
Identities = 33/99 (33%), Positives = 52/99 (52%), Gaps = 17/99 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYN---REHTHITSTGRR 144
+GIAY H +++H D+KP+++L+D K ADFGLA+ + R TH T
Sbjct: 113 RGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVRTFTHEVVTLWY 169
Query: 145 RTPGCEAPELWM---PYSVTQKCDVFSFGMLLFEVVGRR 180
R APE+ + YS D++S G + E+V ++
Sbjct: 170 R-----APEILLGSRHYST--PVDIWSVGCIFAEMVNQK 201
|
Length = 294 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-05
Identities = 31/102 (30%), Positives = 52/102 (50%), Gaps = 8/102 (7%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAK-LYNREHTHITSTG 142
V S G+ ++H+ +KI+H DIK +++ L +N K DFG+A+ L + T G
Sbjct: 108 VQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMELAYTCVG 164
Query: 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLE 184
TP +PE+ K D++S G +L+E+ + E
Sbjct: 165 ---TPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFE 203
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 3e-05
Identities = 25/94 (26%), Positives = 43/94 (45%), Gaps = 6/94 (6%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144
V + G+ YL ++ +H D+ ++LL + K DFGL + + H
Sbjct: 104 VQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHL 160
Query: 145 RTP--GCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
+ P C APE + + DV+ FG+ L+E+
Sbjct: 161 KVPFAWC-APESLRTRTFSHASDVWMFGVTLWEM 193
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 3e-05
Identities = 31/115 (26%), Positives = 55/115 (47%), Gaps = 6/115 (5%)
Query: 64 GPF--YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPK 121
GP +L KK+ + + E+ S G+ YL + VH D+ +VLL + K
Sbjct: 79 GPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAK 135
Query: 122 AADFGLAKLYNREHTHITSTGRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
+DFGL+K + ++ + + P APE + + DV+S+G+ ++E
Sbjct: 136 ISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWE 190
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.2 bits (102), Expect = 3e-05
Identities = 30/93 (32%), Positives = 47/93 (50%), Gaps = 20/93 (21%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRTPGC 149
+ YLH ++IV+ D+KPE++LLD+ K DFG AK L +R T C
Sbjct: 114 LEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDRTWTL-----------C 159
Query: 150 EAPELWMPYSVTQK-----CDVFSFGMLLFEVV 177
PE P + K D ++ G+L++E++
Sbjct: 160 GTPEYLAPEVIQSKGHNKAVDWWALGILIYEML 192
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-05
Identities = 35/136 (25%), Positives = 61/136 (44%), Gaps = 14/136 (10%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL ++ L L + +G+ YL R +H D+ + L+ K +DFG
Sbjct: 89 YLRQRQGKLSKDMLLSMCQDVCEGMEYLE---RNSFIHRDLAARNCLVSSTGVVKVSDFG 145
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
+ + Y + + +S+G + PE++ + K DV+SFG+L++EV
Sbjct: 146 MTR-YVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEV---------- 194
Query: 187 ISEGQEWFPKWGREEV 202
+EG+ F K EV
Sbjct: 195 FTEGKMPFEKKSNYEV 210
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-05
Identities = 36/119 (30%), Positives = 56/119 (47%), Gaps = 26/119 (21%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI----TSTGRRR 145
G+ LH R++IV+ D+KPE++LLD+ + +D GLA I T GR
Sbjct: 114 GLEDLH---RERIVYRDLKPENILLDDYGHIRISDLGLA-------VEIPEGETIRGRVG 163
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG------------RRRNLEKEISEGQE 192
T G APE+ T D + G L++E++ +R +E+ + E QE
Sbjct: 164 TVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQE 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-05
Identities = 31/92 (33%), Positives = 50/92 (54%), Gaps = 13/92 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR--RTP 147
G+ +LH + I++ D+K ++V+LD K ADFG+ K E+ T R TP
Sbjct: 113 GLFFLH---SKGIIYRDLKLDNVMLDAEGHIKIADFGMCK----ENIFGGKTTRTFCGTP 165
Query: 148 GCEAPE--LWMPYSVTQKCDVFSFGMLLFEVV 177
APE + PY + D ++FG+LL+E++
Sbjct: 166 DYIAPEIIAYQPYG--KSVDWWAFGVLLYEML 195
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 42.9 bits (101), Expect = 4e-05
Identities = 31/106 (29%), Positives = 54/106 (50%), Gaps = 16/106 (15%)
Query: 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH 137
G LR I + G+ YL E VH D+ ++L++ N K +DFGL++ + +
Sbjct: 110 GMLRGI----AAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSD 162
Query: 138 ITSTGRRRTPGCEAPELWM-PYSV-----TQKCDVFSFGMLLFEVV 177
T T + G + P W P ++ T DV+S+G++++EV+
Sbjct: 163 PTYTS---SLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVM 205
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 43.0 bits (101), Expect = 4e-05
Identities = 29/89 (32%), Positives = 50/89 (56%), Gaps = 8/89 (8%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
G+ ++H + +V+ D+KP ++LLDE+ + +D GLA ++++ H S G T G
Sbjct: 109 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASVG---THGY 161
Query: 150 EAPE-LWMPYSVTQKCDVFSFGMLLFEVV 177
APE L + D FS G +LF+++
Sbjct: 162 MAPEVLQKGVAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 43.1 bits (102), Expect = 4e-05
Identities = 35/146 (23%), Positives = 60/146 (41%), Gaps = 39/146 (26%)
Query: 68 LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
LL KK+ + R T I +H + +H DIKP+++LLD K +DFGL
Sbjct: 91 LLMKKDTFTEEETRFYIAETILAIDSIH---KLGYIHRDIKPDNLLLDAKGHIKLSDFGL 147
Query: 128 AKLYNREH---------------------THITSTGR-------RR--------TPGCEA 151
+ H ++S + RR TP A
Sbjct: 148 CTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIA 207
Query: 152 PELWMPYSVTQKCDVFSFGMLLFEVV 177
PE+++ ++CD +S G++++E++
Sbjct: 208 PEVFLQTGYNKECDWWSLGVIMYEML 233
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 42.8 bits (101), Expect = 4e-05
Identities = 33/109 (30%), Positives = 52/109 (47%), Gaps = 17/109 (15%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L QL +I V + G+ YL Q VH D+ + L+ + K DFG+++
Sbjct: 119 LTLSQLLQIAVQIASGMVYL---ASQHFVHRDLATRNCLVGYDLVVKIGDFGMSR----- 170
Query: 135 HTHITSTGRRRTPGCEA-PELWM-PYSV-----TQKCDVFSFGMLLFEV 176
+ +T R G P WM P S+ T + DV+SFG++L+E+
Sbjct: 171 --DVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 4e-05
Identities = 30/93 (32%), Positives = 51/93 (54%), Gaps = 3/93 (3%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144
V +KG++YL EE R +VH D+ +VL+ K DFGLA+L + + T + G +
Sbjct: 116 VQIAKGMSYL-EEVR--LVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGK 172
Query: 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
A E + T + DV+S+G+ ++E++
Sbjct: 173 VPIKWMALESILHRRFTHQSDVWSYGVTVWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 4e-05
Identities = 29/94 (30%), Positives = 46/94 (48%), Gaps = 12/94 (12%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTHITSTGRRR-- 145
+G++YLHE +I+H D+K ++L+D + ADFG A R T G +
Sbjct: 114 RGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAA---RLAAKGTGAGEFQGQ 167
Query: 146 ---TPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
T APE+ + CDV+S G ++ E+
Sbjct: 168 LLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEM 201
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 42.6 bits (100), Expect = 5e-05
Identities = 37/124 (29%), Positives = 55/124 (44%), Gaps = 6/124 (4%)
Query: 57 IKGFLAMGPF--YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL 114
I FL G YL KN + Q + V KG+ YL ++ VH D+ +VL+
Sbjct: 86 IMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLV 142
Query: 115 DENFFPKAADFGLAKLYNREHTHITSTGRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLL 173
+ K DFGL K + + T +P APE + DV+SFG+ L
Sbjct: 143 ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTL 202
Query: 174 FEVV 177
+E++
Sbjct: 203 YELL 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 42.7 bits (100), Expect = 5e-05
Identities = 37/114 (32%), Positives = 53/114 (46%), Gaps = 9/114 (7%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
FY L ++ + R + + YLH IV+ D+KPE++LLD DF
Sbjct: 84 FYHLQRERCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDF 140
Query: 126 GLAKLYNREHTHITST--GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
GL K N EH TST G TP APE+ + D + G +L+E++
Sbjct: 141 GLCK-ENIEHNGTTSTFCG---TPEYLAPEVLHKQPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-05
Identities = 35/113 (30%), Positives = 55/113 (48%), Gaps = 25/113 (22%)
Query: 78 GQLREIEVS-----TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
G L E++++ T +G+AYLH + + +H DIK ++LL +N K ADFG+A
Sbjct: 101 GPLSELQIAYVCRETLQGLAYLHSKGK---MHRDIKGANILLTDNGDVKLADFGVA---- 153
Query: 133 REHTHITSTGRRRTPGCEAPELWMPYSV---------TQKCDVFSFGMLLFEV 176
IT+T +R P WM V Q CD+++ G+ E+
Sbjct: 154 ---AKITATIAKRKSFIGTP-YWMAPEVAAVEKNGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 5e-05
Identities = 31/109 (28%), Positives = 48/109 (44%), Gaps = 17/109 (15%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L GQ+ I + G+ YL VH D+ + L+ + K DFG+++
Sbjct: 119 LTLGQMLAIASQIASGMVYL---ASLHFVHRDLATRNCLVGQGLVVKIGDFGMSR----- 170
Query: 135 HTHITSTGRRRTPG-CEAPELWMP------YSVTQKCDVFSFGMLLFEV 176
I ST R G P WMP T + D++SFG++L+E+
Sbjct: 171 --DIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEI 217
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-05
Identities = 33/131 (25%), Positives = 52/131 (39%), Gaps = 45/131 (34%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL---------AKLYN--------- 132
I +H + +H DIKP+++L+D + K DFGL +K Y
Sbjct: 114 IESVH---KMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDS 170
Query: 133 -----------------------REHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSF 169
R+H + TP APE+ + TQ CD +S
Sbjct: 171 MEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSV 230
Query: 170 GMLLFE-VVGR 179
G++L+E +VG+
Sbjct: 231 GVILYEMLVGQ 241
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 42.5 bits (100), Expect = 6e-05
Identities = 30/77 (38%), Positives = 44/77 (57%), Gaps = 4/77 (5%)
Query: 102 IVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRTPGCEAPELWMPYSV 160
I++ D+KPE++LLDE K DFGL+K + E + G T APE+
Sbjct: 119 IIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEKKAYSFCG---TVEYMAPEVVNRRGH 175
Query: 161 TQKCDVFSFGMLLFEVV 177
TQ D +SFG+L+FE++
Sbjct: 176 TQSADWWSFGVLMFEML 192
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 6e-05
Identities = 17/43 (39%), Positives = 30/43 (69%), Gaps = 3/43 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131
KG+A+ H ++H D+KP+++L+++N K ADFGLA+ +
Sbjct: 110 KGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAF 149
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 6e-05
Identities = 35/116 (30%), Positives = 57/116 (49%), Gaps = 17/116 (14%)
Query: 68 LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
L C L F L + + G+ YL VH D+ + L+ +N+ K ADFG+
Sbjct: 120 LACNSKSLSFSTLLYMATQIASGMRYLES---LNFVHRDLATRNCLVGKNYTIKIADFGM 176
Query: 128 AK-LYNREHTHITSTGRRRTPGCEAPELWMPY-SV-----TQKCDVFSFGMLLFEV 176
++ LY+ ++ + + R P P WM + SV T K DV++FG+ L+E+
Sbjct: 177 SRNLYSSDYYRV----QGRAP---LPIRWMAWESVLLGKFTTKSDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 42.3 bits (99), Expect = 6e-05
Identities = 32/112 (28%), Positives = 57/112 (50%), Gaps = 8/112 (7%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
Y L + + ++R G+ ++H + +V+ D+KP ++LLDE+ + +D G
Sbjct: 86 YHLSQHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLG 142
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPE-LWMPYSVTQKCDVFSFGMLLFEVV 177
LA ++++ H S G T G APE L + D FS G +LF+++
Sbjct: 143 LACDFSKKKPH-ASVG---THGYMAPEVLQKGTAYDSSADWFSLGCMLFKLL 190
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.3 bits (100), Expect = 7e-05
Identities = 31/94 (32%), Positives = 51/94 (54%), Gaps = 5/94 (5%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTP 147
+G+ Y+H ++H D+KP ++LL+ N K DFGLA++ + EH H T T
Sbjct: 117 RGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATR 173
Query: 148 GCEAPELWMPYS-VTQKCDVFSFGMLLFEVVGRR 180
APE+ + T+ D++S G +L E++ R
Sbjct: 174 WYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNR 207
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 7e-05
Identities = 18/41 (43%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+G+ Y H R+K++H D+KP+++L++E K ADFGLA+
Sbjct: 115 RGLNYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-05
Identities = 19/57 (33%), Positives = 31/57 (54%), Gaps = 3/57 (5%)
Query: 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
N L ++R+ +GI + H I+H DIKPE++L+ ++ K DFG A+
Sbjct: 95 NGLDESRVRKYLFQILRGIEFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFAR 148
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 7e-05
Identities = 17/41 (41%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+G+AY H +++++H D+KP+++L+ E K ADFGLA+
Sbjct: 114 RGLAYCH---QRRVLHRDLKPQNLLISERGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 42.0 bits (99), Expect = 8e-05
Identities = 34/123 (27%), Positives = 52/123 (42%), Gaps = 16/123 (13%)
Query: 60 FLAM-----GPF-YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVL 113
+LAM G F LL +L R + + LH +H D+KPE+ L
Sbjct: 77 YLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALH---ELGYIHRDLKPENFL 133
Query: 114 LDENFFPKAADFGLAK-LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGML 172
+D + K DFGL+K + ++ + S P APE+ D +S G +
Sbjct: 134 IDASGHIKLTDFGLSKGIVTYANSVVGS------PDYMAPEVLRGKGYDFTVDYWSLGCM 187
Query: 173 LFE 175
L+E
Sbjct: 188 LYE 190
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-05
Identities = 27/93 (29%), Positives = 47/93 (50%), Gaps = 3/93 (3%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144
V +KG+ YL E +++VH D+ +VL+ K DFGLA+L + + G +
Sbjct: 116 VQIAKGMMYLEE---RRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGK 172
Query: 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
A E T + DV+S+G+ ++E++
Sbjct: 173 MPIKWMALECIHYRKFTHQSDVWSYGVTIWELM 205
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 42.0 bits (98), Expect = 9e-05
Identities = 31/105 (29%), Positives = 47/105 (44%), Gaps = 17/105 (16%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
Q+ I + G+ YL Q VH D+ + L+ EN K DFG+++ +
Sbjct: 121 QMLHIAQQIAAGMVYL---ASQHFVHRDLATRNCLVGENLLVKIGDFGMSR-------DV 170
Query: 139 TSTGRRRTPG-CEAPELWMP------YSVTQKCDVFSFGMLLFEV 176
ST R G P WMP T + DV+S G++L+E+
Sbjct: 171 YSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEI 215
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 41.9 bits (98), Expect = 9e-05
Identities = 21/57 (36%), Positives = 36/57 (63%), Gaps = 3/57 (5%)
Query: 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
NI+ ++ +G+AY H R+K++H D+KP+++L++E K ADFGLA+
Sbjct: 99 NIMSMHNVKIFLYQILRGLAYCH---RRKVLHRDLKPQNLLINERGELKLADFGLAR 152
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 41.8 bits (98), Expect = 9e-05
Identities = 43/144 (29%), Positives = 59/144 (40%), Gaps = 39/144 (27%)
Query: 52 DTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPES 111
D TY+ GP L Q I+ + +AYLH + I+H D+K E+
Sbjct: 171 DLFTYVDR---SGP---------LPLEQAITIQRRLLEALAYLHG---RGIIHRDVKTEN 215
Query: 112 VLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRTPGC---------EAPELWM--PYS 159
+ LDE DFG A KL H TP C +PEL PY
Sbjct: 216 IFLDEPENAVLGDFGAACKL--DAHPD--------TPQCYGWSGTLETNSPELLALDPYC 265
Query: 160 VTQKCDVFSFGMLLFEVVGRRRNL 183
K D++S G++LFE+ + L
Sbjct: 266 A--KTDIWSAGLVLFEMSVKNVTL 287
|
Length = 392 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 29/94 (30%), Positives = 51/94 (54%), Gaps = 6/94 (6%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS--TGRRRTP 147
G+ Y+H ++H D+KP ++L++ + K DFGLA+ ++ T T
Sbjct: 117 GLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATR 173
Query: 148 GCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRR 180
APE+ + + S T+ DV+S G +L E++GR+
Sbjct: 174 WYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRK 207
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 29/93 (31%), Positives = 45/93 (48%), Gaps = 12/93 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL-AKLYNREHTHITSTGRRRTPG 148
G+ +LH K +H D+K ++LL K DFG+ A+L + TS G TP
Sbjct: 136 GLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLRRNTSVG---TPF 189
Query: 149 CEAPEL-----WMPYSVTQKCDVFSFGMLLFEV 176
APE+ + + +CDV+S G+ E+
Sbjct: 190 WMAPEVIACEQQLDSTYDARCDVWSLGITAIEL 222
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 41.6 bits (97), Expect = 1e-04
Identities = 32/109 (29%), Positives = 52/109 (47%), Gaps = 17/109 (15%)
Query: 80 LREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L+E+E++ +G+AYLH ++H D+K ++LL E K DFG A +
Sbjct: 112 LQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA 168
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQ---KCDVFSFGMLLFEVVGRR 180
+ + TP APE+ + Q K DV+S G+ E+ R+
Sbjct: 169 NXFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERK 211
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 35/123 (28%), Positives = 56/123 (45%), Gaps = 22/123 (17%)
Query: 89 KGIAYLHEEC-------RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141
+ I Y E C R++IV+ D+KPE++LLD+ + +D GLA T
Sbjct: 103 RAIFYAAELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE---TVR 159
Query: 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG------------RRRNLEKEISE 189
GR T G APE+ T D + G L++E++ +R +++ + E
Sbjct: 160 GRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKE 219
Query: 190 GQE 192
QE
Sbjct: 220 DQE 222
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 28/89 (31%), Positives = 46/89 (51%), Gaps = 6/89 (6%)
Query: 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153
+H + VH DIKP++VLLD N + ADFG N++ T + S+ TP +PE
Sbjct: 115 IHSIHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT-VQSSVAVGTPDYISPE 173
Query: 154 LWMPYS-----VTQKCDVFSFGMLLFEVV 177
+ +CD +S G+ ++E++
Sbjct: 174 ILQAMEDGMGKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 41.3 bits (97), Expect = 1e-04
Identities = 28/103 (27%), Positives = 50/103 (48%), Gaps = 18/103 (17%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT 139
+RE+ V+ + Y+H + ++H DIK ++L+ K DFG+A L N
Sbjct: 107 IREVLVA----LKYIH---KVGVIHRDIKAANILVTNTGNVKLCDFGVAALLN------Q 153
Query: 140 STGRRRT----PGCEAPELWMP-YSVTQKCDVFSFGMLLFEVV 177
++ +R T P APE+ K D++S G+ ++E+
Sbjct: 154 NSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMA 196
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 37/110 (33%), Positives = 53/110 (48%), Gaps = 24/110 (21%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
Q+R + T + + YLHE KI+H D+K ++L + K ADFG++ R
Sbjct: 104 QIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTR----- 155
Query: 139 TSTGRRR-----TPGCEAPELWM-------PYSVTQKCDVFSFGMLLFEV 176
T +RR TP APE+ M PY K DV+S G+ L E+
Sbjct: 156 --TIQRRDSFIGTPYWMAPEVVMCETSKDRPYDY--KADVWSLGITLIEM 201
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 41.6 bits (98), Expect = 1e-04
Identities = 17/42 (40%), Positives = 28/42 (66%), Gaps = 3/42 (7%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131
G+ Y+H R KI+H D+K ++L+ ++ K ADFGLA+ +
Sbjct: 131 GLYYIH---RNKILHRDMKAANILITKDGILKLADFGLARAF 169
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 1e-04
Identities = 34/112 (30%), Positives = 55/112 (49%), Gaps = 23/112 (20%)
Query: 78 GQLREIEVS-----TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
G L E +++ T +G+ YLH + + +H DIK ++LL +N K ADFG++
Sbjct: 101 GPLSESQIAYVSRETLQGLYYLHSKGK---MHRDIKGANILLTDNGHVKLADFGVS---- 153
Query: 133 REHTHITSTGRRR-----TPGCEAPELWM---PYSVTQKCDVFSFGMLLFEV 176
IT+T +R TP APE+ Q CD+++ G+ E+
Sbjct: 154 ---AQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIEL 202
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 41.5 bits (97), Expect = 1e-04
Identities = 27/70 (38%), Positives = 39/70 (55%), Gaps = 13/70 (18%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR--- 145
+G+A+LH K++H DIK ++VLL EN K DFG++ +R + GRR
Sbjct: 132 RGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR------TVGRRNTFI 182
Query: 146 -TPGCEAPEL 154
TP APE+
Sbjct: 183 GTPYWMAPEV 192
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 1e-04
Identities = 30/114 (26%), Positives = 57/114 (50%), Gaps = 18/114 (15%)
Query: 73 NILGFGQLREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
+I+ +L E +++T + + YLH Q ++H DIK +S+LL + K +DFG
Sbjct: 107 DIVSQTRLNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGF 163
Query: 128 AKLYNREHTHITSTGRRR----TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
+++ +R+ TP APE+ + D++S G+++ E+V
Sbjct: 164 CAQISKD------VPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMV 211
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 1e-04
Identities = 18/41 (43%), Positives = 31/41 (75%), Gaps = 3/41 (7%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+G++Y H ++KI+H D+KP+++L++E K ADFGLA+
Sbjct: 114 RGLSYCH---KRKILHRDLKPQNLLINEKGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 1e-04
Identities = 26/70 (37%), Positives = 40/70 (57%), Gaps = 13/70 (18%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR--- 145
+G+++LH+ K++H DIK ++VLL EN K DFG++ +R + GRR
Sbjct: 122 RGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDR------TVGRRNTFI 172
Query: 146 -TPGCEAPEL 154
TP APE+
Sbjct: 173 GTPYWMAPEV 182
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 1e-04
Identities = 36/123 (29%), Positives = 60/123 (48%), Gaps = 17/123 (13%)
Query: 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHT 136
G LR I + G+ YL + VH D+ ++L++ N K +DFGL++ L +
Sbjct: 110 GMLRGI----ASGMKYLSD---MGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA 162
Query: 137 HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV--GRR-------RNLEKEI 187
T+ G + APE T DV+S+G++++EV+ G R +++ K I
Sbjct: 163 AYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAI 222
Query: 188 SEG 190
EG
Sbjct: 223 EEG 225
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 33/95 (34%), Positives = 53/95 (55%), Gaps = 13/95 (13%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR--R 145
S G+ +LH R+ I++ D+K ++V+LD K ADFG+ K EH T R
Sbjct: 111 SVGLFFLH---RRGIIYRDLKLDNVMLDSEGHIKIADFGMCK----EHMVDGVTTRTFCG 163
Query: 146 TPGCEAPEL--WMPYSVTQKCDVFSFGMLLFEVVG 178
TP APE+ + PY + D +++G+LL+E++
Sbjct: 164 TPDYIAPEIIAYQPYG--KSVDWWAYGVLLYEMLA 196
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 41.2 bits (96), Expect = 2e-04
Identities = 36/134 (26%), Positives = 63/134 (47%), Gaps = 9/134 (6%)
Query: 45 SNLVGSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVH 104
S LVG D + +LA G + + + GQ+ + + + +LH +++H
Sbjct: 84 SYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALDFLHS---NQVIH 138
Query: 105 YDIKPESVLLDENFFPKAADFGL-AKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQK 163
DIK +++LL + K DFG A++ + T G TP APE+ + K
Sbjct: 139 RDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMVG---TPYWMAPEVVTRKAYGPK 195
Query: 164 CDVFSFGMLLFEVV 177
D++S G++ E+V
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 31/92 (33%), Positives = 47/92 (51%), Gaps = 5/92 (5%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
G+ Y H ++ +H DIK ++LL+ K ADFGLA+LYN E + T + T
Sbjct: 128 GLNYCH---KKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEESR-PYTNKVITLWY 183
Query: 150 EAPELWM-PYSVTQKCDVFSFGMLLFEVVGRR 180
PEL + DV+S G +L E+ ++
Sbjct: 184 RPPELLLGEERYGPAIDVWSCGCILGELFTKK 215
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 40.9 bits (96), Expect = 2e-04
Identities = 27/92 (29%), Positives = 43/92 (46%), Gaps = 7/92 (7%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS-TGR 143
V + ++H ++I+H DIKP +V + K D GL + ++ + T S G
Sbjct: 113 VQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG- 168
Query: 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
TP +PE K D++S G LL+E
Sbjct: 169 --TPYYMSPERIHENGYNFKSDIWSLGCLLYE 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 41.1 bits (96), Expect = 2e-04
Identities = 30/90 (33%), Positives = 51/90 (56%), Gaps = 9/90 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK--LYNREHTHITSTGRRRTP 147
G+ +LH + I++ D+K ++V+LD + K ADFG+ K ++ ++ T G TP
Sbjct: 108 GLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFG-DNRASTFCG---TP 160
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
APE+ T D +SFG+LL+E++
Sbjct: 161 DYIAPEILQGLKYTFSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 28/99 (28%), Positives = 48/99 (48%), Gaps = 17/99 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRT 146
+ G+ YL + +H D+ + +L+EN ADFGL+ K+YN ++ R+
Sbjct: 122 ASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY-------RQG 171
Query: 147 PGCEAPELWMPYS------VTQKCDVFSFGMLLFEVVGR 179
+ P W+ T K DV+SFG+ ++E+ R
Sbjct: 172 RIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATR 210
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 40.8 bits (95), Expect = 2e-04
Identities = 31/97 (31%), Positives = 46/97 (47%), Gaps = 20/97 (20%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR---- 145
G+ +LH +I+H D+K ++LL K DFG++ +TST RR
Sbjct: 140 GLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVS-------AQLTSTRLRRNTSV 189
Query: 146 -TPGCEAPEL-----WMPYSVTQKCDVFSFGMLLFEV 176
TP APE+ YS +CDV+S G+ E+
Sbjct: 190 GTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIEL 226
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 35/125 (28%), Positives = 57/125 (45%), Gaps = 20/125 (16%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRTPG 148
G+ LH E V+ D+KPE++LLD+ + +D GLA K+ E GR T G
Sbjct: 114 GLEDLHRE---NTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGESIR----GRVGTVG 166
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVG------------RRRNLEKEISEGQEWFPK 196
APE+ T D + G L++E++ +R +++ + E +E +
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVYSA 226
Query: 197 WGREE 201
EE
Sbjct: 227 KFSEE 231
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 32/95 (33%), Positives = 47/95 (49%), Gaps = 9/95 (9%)
Query: 84 EVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL-YNREHTHITSTG 142
EV+++ I YLH I++ D+KPE++LLD DFGL K E T T G
Sbjct: 104 EVASA--IGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEETTSTFCG 158
Query: 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
TP APE+ + D + G +L+E++
Sbjct: 159 ---TPEYLAPEVLRKEPYDRTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 30/91 (32%), Positives = 47/91 (51%), Gaps = 7/91 (7%)
Query: 88 SKGIAYL-HEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRT 146
+KG+A+L + C +H D+ +VLL K DFGLA+ + ++ G R
Sbjct: 151 AKGMAFLASKNC----IHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYV-VKGNARL 205
Query: 147 P-GCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
P APE T + DV+S+G+LL+E+
Sbjct: 206 PVKWMAPESIFNCVYTFESDVWSYGILLWEI 236
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 2e-04
Identities = 31/90 (34%), Positives = 49/90 (54%), Gaps = 9/90 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK--LYNREHTHITSTGRRRTP 147
G+ +LH + IV+ D+K +++LLD + K ADFG+ K + T T G TP
Sbjct: 108 GLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGDAKTC-TFCG---TP 160
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
APE+ + D +SFG+LL+E++
Sbjct: 161 DYIAPEILLGQKYNTSVDWWSFGVLLYEML 190
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 40.7 bits (95), Expect = 3e-04
Identities = 35/110 (31%), Positives = 51/110 (46%), Gaps = 5/110 (4%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL K+NI + IE S + I YLHE +I+H DIK E++ ++ DFG
Sbjct: 172 YLAAKRNI-AICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFG 227
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
A + + G T APEL D++S G++LFE+
Sbjct: 228 -AACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEM 276
|
Length = 391 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 18/41 (43%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
KGIA+ HE +++H D+KP+++L+++ K ADFGLA+
Sbjct: 111 KGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLAR 148
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (95), Expect = 3e-04
Identities = 27/85 (31%), Positives = 43/85 (50%), Gaps = 12/85 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN---REHTHITSTGRRRT 146
G+A+LH+ I+H D+K ++LL+ K DFGLA+ Y + +T + T R
Sbjct: 118 GVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKPYTQLVVTLWYR- 173
Query: 147 PGCEAPELWM-PYSVTQKCDVFSFG 170
APEL + + D++S G
Sbjct: 174 ----APELLLGAKEYSTAIDMWSVG 194
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 30/126 (23%), Positives = 54/126 (42%), Gaps = 24/126 (19%)
Query: 61 LAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFP 120
L P L + L + V + G+ YL + +H D+ + +L E+
Sbjct: 103 LGGLPEKLPLQT-------LLKFMVDIALGMEYLSN---RNFIHRDLAARNCMLREDMTV 152
Query: 121 KAADFGLA-KLYNREHTHITSTGRRRTPGCEAPELWMPYS------VTQKCDVFSFGMLL 173
ADFGL+ K+Y+ ++ R+ + P W+ T K DV++FG+ +
Sbjct: 153 CVADFGLSKKIYSGDYY-------RQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTM 205
Query: 174 FEVVGR 179
+E+ R
Sbjct: 206 WEIATR 211
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 35/115 (30%), Positives = 56/115 (48%), Gaps = 14/115 (12%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150
+ +LH+ IV+ D+KPE++LLD DFGL+K N T+T T
Sbjct: 109 LEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDNKTTNTFCGTTEYL- 163
Query: 151 APELWM-PYSVTQKCDVFSFGMLLFEV--------VGRRRNLEKEISEGQEWFPK 196
APE+ + T+ D +S G+L+FE+ + + + I+ G+ FPK
Sbjct: 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNIAFGKVRFPK 218
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 3e-04
Identities = 35/117 (29%), Positives = 59/117 (50%), Gaps = 22/117 (18%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK--LYNREHTH 137
L EI ++ + +LH +Q I++ D+KPE++LLD K DFGL K ++ TH
Sbjct: 106 LSEISLA----LEHLH---QQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGTVTH 158
Query: 138 ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV---------GRRRNLEK 185
T G T APE+ M + D +S G L+++++ R++ ++K
Sbjct: 159 -TFCG---TIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDK 211
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 3e-04
Identities = 37/129 (28%), Positives = 52/129 (40%), Gaps = 19/129 (14%)
Query: 54 ETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVL 113
E G L YL K L L S +AYL ++ VH DI +VL
Sbjct: 86 ELAPLGELRS---YLQVNKYSLDLASLILYSYQLSTALAYLES---KRFVHRDIAARNVL 139
Query: 114 LDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWM-PYSV-----TQKCDVF 167
+ K DFGL++ E + S G+ P WM P S+ T DV+
Sbjct: 140 VSSPDCVKLGDFGLSRYLEDESYYKASKGK-------LPIKWMAPESINFRRFTSASDVW 192
Query: 168 SFGMLLFEV 176
FG+ ++E+
Sbjct: 193 MFGVCMWEI 201
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 40.1 bits (94), Expect = 4e-04
Identities = 24/98 (24%), Positives = 51/98 (52%), Gaps = 18/98 (18%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTH-------ITS 140
+G+ Y+H ++H D+KP +V ++ E+ K DFGLA++ + ++H + +
Sbjct: 125 RGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVT 181
Query: 141 TGRRRTPGCEAPELWM-PYSVTQKCDVFSFGMLLFEVV 177
R +P L + P + T+ D+++ G + E++
Sbjct: 182 KWYR------SPRLLLSPNNYTKAIDMWAAGCIFAEML 213
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 40.4 bits (94), Expect = 4e-04
Identities = 34/110 (30%), Positives = 51/110 (46%), Gaps = 5/110 (4%)
Query: 68 LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
L+ + L + L + G+ +L + VH D+ +VL+ E K DFGL
Sbjct: 229 LINESPALSYMDLVGFSYQVANGMEFL---ASKNCVHRDLAARNVLICEGKLVKICDFGL 285
Query: 128 AKLYNREHTHITSTGRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
A+ R+ +I S G P APE T DV+SFG+LL+E+
Sbjct: 286 ARDIMRDSNYI-SKGSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEI 334
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 4e-04
Identities = 38/153 (24%), Positives = 69/153 (45%), Gaps = 12/153 (7%)
Query: 24 MEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREI 83
+E+ + +++ QR D ++ GS D+E +K L+ L ++L F
Sbjct: 192 LEIKEASKYSDIQRSNY-DRPASYKGSNDSE--VKNLLSDDGSEGLTTLDLLSF------ 242
Query: 84 EVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR 143
++G+ +L + VH D+ +VLL + K DFGLA+ + +++
Sbjct: 243 TYQVARGMEFL---ASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGST 299
Query: 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
APE T DV+S+G+LL+E+
Sbjct: 300 FLPVKWMAPESIFDNLYTTLSDVWSYGILLWEI 332
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 40.0 bits (93), Expect = 4e-04
Identities = 31/99 (31%), Positives = 53/99 (53%), Gaps = 9/99 (9%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
G+ +LH + I++ D+K ++V+LD K ADFG+ K +T+ TP
Sbjct: 113 GLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENMWDGVTTKTFCGTPDY 167
Query: 150 EAPEL--WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
APE+ + PY + D ++FG+LL+E++ + E E
Sbjct: 168 IAPEIIAYQPYG--KSVDWWAFGVLLYEMLAGQAPFEGE 204
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 40.2 bits (94), Expect = 4e-04
Identities = 27/119 (22%), Positives = 51/119 (42%), Gaps = 8/119 (6%)
Query: 81 REIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS 140
R+I + +K + +LH C +V ++ PE +++D P L L + S
Sbjct: 783 RKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCTDTKCFIS 841
Query: 141 TGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGR 199
+ APE +T+K D++ FG++L E++ + + E +W R
Sbjct: 842 SAYV------APETRETKDITEKSDIYGFGLILIELLTGKSPADAE-FGVHGSIVEWAR 893
|
Length = 968 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 39.7 bits (93), Expect = 4e-04
Identities = 21/80 (26%), Positives = 39/80 (48%), Gaps = 11/80 (13%)
Query: 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR---E 134
+++I T + + + H + +H D+KPE++L+ + K DFG A++ +
Sbjct: 100 HLIKKIIWQTLQAVNFCH---KHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGDD 156
Query: 135 HTHITSTGRRRTPGCEAPEL 154
+T +T R APEL
Sbjct: 157 YTDYVATRWYR-----APEL 171
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 39.5 bits (92), Expect = 5e-04
Identities = 31/110 (28%), Positives = 52/110 (47%), Gaps = 10/110 (9%)
Query: 70 CKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
K L Q+ E + G+ Y+H+ ++I+H D+K +++ L N K DFG+
Sbjct: 96 LKHTGKTLSENQVCEWFIQLLLGVHYMHQ---RRILHRDLKAKNIFLKNNLL-KIGDFGV 151
Query: 128 AK-LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
++ L T TG TP +PE K D++S G +L+E+
Sbjct: 152 SRLLMGSCDLATTFTG---TPYYMSPEALKHQGYDSKSDIWSLGCILYEM 198
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 39.6 bits (93), Expect = 6e-04
Identities = 17/47 (36%), Positives = 26/47 (55%), Gaps = 7/47 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYN 132
G+ YLH ++H D+KP ++L+ E K D GLA+L+N
Sbjct: 120 GVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFN 163
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 6e-04
Identities = 28/103 (27%), Positives = 41/103 (39%), Gaps = 21/103 (20%)
Query: 101 KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSV 160
I++ DIK E++LLD DFGL+K + + R C E P +
Sbjct: 125 GIIYRDIKLENILLDSEGHVVLTDFGLSKEF------LAEEEERAYSFCGTIEYMAPEVI 178
Query: 161 TQK-------CDVFSFGMLLFEV--------VGRRRNLEKEIS 188
D +S G+L FE+ V +N + EIS
Sbjct: 179 RGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEIS 221
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 39.2 bits (91), Expect = 6e-04
Identities = 18/41 (43%), Positives = 28/41 (68%), Gaps = 3/41 (7%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+G+AY+H Q I+H D+KP+++L+ K ADFGLA+
Sbjct: 114 RGLAYIH---GQHILHRDLKPQNLLISYLGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 39.4 bits (92), Expect = 7e-04
Identities = 23/79 (29%), Positives = 40/79 (50%), Gaps = 5/79 (6%)
Query: 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVT- 161
+H D+KP+++LLD++ K ADFG + T TP +PE+
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMVRCDTA-VGTPDYISPEVLKSQGGDG 222
Query: 162 ---QKCDVFSFGMLLFEVV 177
++CD +S G+ L+E++
Sbjct: 223 YYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 39.3 bits (91), Expect = 7e-04
Identities = 29/110 (26%), Positives = 52/110 (47%), Gaps = 11/110 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
GI +LH I+H D+KP ++++ + K DFGLA+ T T T
Sbjct: 131 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAG---TSFMMTPYVVTRYY 184
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGR 199
APE+ + + D++S G ++ E+V K + G+++ +W +
Sbjct: 185 RAPEVILGMGYKENVDIWSVGCIMGEMV-----RHKILFPGRDYIDQWNK 229
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 39.0 bits (91), Expect = 7e-04
Identities = 33/109 (30%), Positives = 57/109 (52%), Gaps = 14/109 (12%)
Query: 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLY 131
NILG +I ++ +G+ YL E+ KI+H D+KP ++L++ K DFG++ +L
Sbjct: 99 NILG-----KISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLI 151
Query: 132 NREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV-VGR 179
+ + G R +PE T + D++S G+ L E+ +GR
Sbjct: 152 DSMAN--SFVGTRSY---MSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 8e-04
Identities = 35/138 (25%), Positives = 61/138 (44%), Gaps = 17/138 (12%)
Query: 45 SNLVGSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVH 104
S LVG D + +LA G + + + GQ+ + + + +LH +++H
Sbjct: 85 SYLVG--DELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIH 139
Query: 105 YDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR-----TPGCEAPELWMPYS 159
DIK +++LL + K DFG IT +R TP APE+ +
Sbjct: 140 RDIKSDNILLGMDGSVKLTDFGFC-------AQITPEQSKRSTMVGTPYWMAPEVVTRKA 192
Query: 160 VTQKCDVFSFGMLLFEVV 177
K D++S G++ E++
Sbjct: 193 YGPKVDIWSLGIMAIEMI 210
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 38.8 bits (90), Expect = 0.001
Identities = 35/141 (24%), Positives = 53/141 (37%), Gaps = 46/141 (32%)
Query: 103 VHYDIKPESVLLDENFFPKAADFGL---------AKLYN--------------------- 132
+H DIKP+++L+D + K DFGL +K Y
Sbjct: 123 IHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPAN 182
Query: 133 ---------------REHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFE-V 176
R+H + TP APE+ + TQ CD +S G++L+E +
Sbjct: 183 CRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEML 242
Query: 177 VGRRRNLEKEISEGQEWFPKW 197
VG+ L + E Q W
Sbjct: 243 VGQPPFLAQTPLETQMKVINW 263
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 38.9 bits (90), Expect = 0.001
Identities = 35/109 (32%), Positives = 51/109 (46%), Gaps = 22/109 (20%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA----KLYNRE 134
Q++ I + + YLH KI+H D+K +VLL + K ADFG++ K R
Sbjct: 111 QIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQRR 167
Query: 135 HTHITSTGRRRTPGCEAPELWM-------PYSVTQKCDVFSFGMLLFEV 176
+ I TP APE+ M PY K D++S G+ L E+
Sbjct: 168 DSFIG------TPYWMAPEVVMCETMKDTPYDY--KADIWSLGITLIEM 208
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 38.6 bits (89), Expect = 0.001
Identities = 36/134 (26%), Positives = 62/134 (46%), Gaps = 9/134 (6%)
Query: 45 SNLVGSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVH 104
S LVG D + +LA G + + + Q+ + + + +LH +++H
Sbjct: 84 SFLVG--DELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECLQALEFLHA---NQVIH 138
Query: 105 YDIKPESVLLDENFFPKAADFGL-AKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQK 163
DIK ++VLL + K DFG A++ + T G TP APE+ + K
Sbjct: 139 RDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSKRSTMVG---TPYWMAPEVVTRKAYGPK 195
Query: 164 CDVFSFGMLLFEVV 177
D++S G++ E+V
Sbjct: 196 VDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 5/92 (5%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144
V + ++H ++++H DIKP +V + K D GL + ++ + T S
Sbjct: 113 VQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--V 167
Query: 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
TP +PE K D++S G LL+E+
Sbjct: 168 GTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.001
Identities = 20/51 (39%), Positives = 30/51 (58%), Gaps = 2/51 (3%)
Query: 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA 128
LR I + KG+ +L EE I+H D+KP +VL++ N K DFG++
Sbjct: 102 DVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVS 150
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 38.7 bits (90), Expect = 0.001
Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 3/89 (3%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
+KG+++L + +H D+ ++LL K DFGLA+ + ++ R
Sbjct: 224 AKGMSFL---ASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPV 280
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
APE T + DV+S+G+LL+E+
Sbjct: 281 KWMAPESIFNCVYTFESDVWSYGILLWEI 309
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 38.4 bits (89), Expect = 0.001
Identities = 29/112 (25%), Positives = 51/112 (45%), Gaps = 17/112 (15%)
Query: 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-L 130
K+ L G I + + G+ YL VH D+ ++L+ E K +D GL++ +
Sbjct: 118 KSSLDHGDFLHIAIQIAAGMEYLSSHF---FVHKDLAARNILIGEQLHVKISDLGLSREI 174
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMPYSV------TQKCDVFSFGMLLFEV 176
Y+ ++ R P P WMP + D++SFG++L+E+
Sbjct: 175 YSADYY-------RVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 27/102 (26%), Positives = 53/102 (51%), Gaps = 9/102 (8%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHI 138
L ++ ++ +G+AYL E + +I+H D+KP ++L++ K DFG++ +L +
Sbjct: 105 LGKVSIAVLRGLAYLRE--KHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162
Query: 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV-VGR 179
T +PE + + D++S G+ L E+ +GR
Sbjct: 163 VGTRSYM-----SPERLQGTHYSVQSDIWSMGLSLVELAIGR 199
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 38.5 bits (89), Expect = 0.001
Identities = 28/102 (27%), Positives = 52/102 (50%), Gaps = 9/102 (8%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHI 138
L ++ ++ KG+ YL E + KI+H D+KP ++L++ K DFG++ +L +
Sbjct: 105 LGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSMANSF 162
Query: 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV-VGR 179
T + PE + + D++S G+ L E+ +GR
Sbjct: 163 VGTRSYMS-----PERLQGTHYSVQSDIWSMGLSLVEMAIGR 199
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 28/106 (26%), Positives = 50/106 (47%), Gaps = 17/106 (16%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTH 137
QL + + + G++YLH ++ ++H DI + ++DE K D L++ L+ ++ H
Sbjct: 118 QLVHMAIQIACGMSYLH---KRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDY-H 173
Query: 138 ITSTGRRRTPGCEAPELWMPYSVTQK------CDVFSFGMLLFEVV 177
R P WM DV+SFG+LL+E++
Sbjct: 174 CLGDNENR------PVKWMALESLVNKEYSSASDVWSFGVLLWELM 213
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.001
Identities = 31/109 (28%), Positives = 47/109 (43%), Gaps = 3/109 (2%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL + LG Q+ + I Y+H + I+H DIK E+VL++ DFG
Sbjct: 249 YLGARLRPLGLAQVTAVARQLLSAIDYIH---GEGIIHRDIKTENVLVNGPEDICLGDFG 305
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
A + G T APE+ T D++S G+++FE
Sbjct: 306 AACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 38.2 bits (89), Expect = 0.001
Identities = 28/107 (26%), Positives = 51/107 (47%), Gaps = 7/107 (6%)
Query: 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL- 130
K+ L I + + G+ YL VH D+ + L+ E K +DFGL++
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDI 174
Query: 131 YNREHTHITSTGRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
Y+ ++ + S + P PE + T + D++SFG++L+E+
Sbjct: 175 YSADYYRVQS--KSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEI 219
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 23/77 (29%), Positives = 38/77 (49%), Gaps = 2/77 (2%)
Query: 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYS 159
++++H DIKP +V + K D GL + ++ + T S TP +PE
Sbjct: 125 RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSL--VGTPYYMSPERIHENG 182
Query: 160 VTQKCDVFSFGMLLFEV 176
K D++S G LL+E+
Sbjct: 183 YNFKSDIWSLGCLLYEM 199
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 27/100 (27%), Positives = 48/100 (48%), Gaps = 17/100 (17%)
Query: 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGR 143
V +KG+ YL E +VH ++ ++LL + + ADFG+A LY + + S +
Sbjct: 116 VQIAKGMYYLEEHR---MVHRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHK 172
Query: 144 RRTPGCEAPELWMPYS------VTQKCDVFSFGMLLFEVV 177
P WM T + DV+S+G+ ++E++
Sbjct: 173 -------TPIKWMALESILFGRYTHQSDVWSYGVTVWEMM 205
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 29/107 (27%), Positives = 50/107 (46%), Gaps = 17/107 (15%)
Query: 77 FGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREH 135
+ L + + G+ YL VH D+ + L+ +N+ K ADFG+++ LY+ ++
Sbjct: 129 YSTLIFMATQIASGMKYLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDY 185
Query: 136 THITSTGRRRTPGCEAPELWMPYS------VTQKCDVFSFGMLLFEV 176
I GR P WM + T DV++FG+ L+E+
Sbjct: 186 YRI--QGR-----AVLPIRWMSWESILLGKFTTASDVWAFGVTLWEI 225
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 30/95 (31%), Positives = 47/95 (49%), Gaps = 8/95 (8%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR--- 145
+G++YLH IVH DIK ++L D K DFG +K + ++ TG R
Sbjct: 117 EGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASK--RLQTICMSGTGIRSVTG 171
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
TP +PE+ +K DV+S G + E++ +
Sbjct: 172 TPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEK 206
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 38.0 bits (88), Expect = 0.002
Identities = 25/90 (27%), Positives = 45/90 (50%), Gaps = 5/90 (5%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRT 146
+ G+AYL+ +K VH D+ + ++ +F K DFG+ + +Y ++ G
Sbjct: 129 ADGMAYLNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPV 185
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
APE T D++SFG++L+E+
Sbjct: 186 RWM-APESLKDGVFTTSSDMWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 38.1 bits (88), Expect = 0.002
Identities = 37/143 (25%), Positives = 59/143 (41%), Gaps = 36/143 (25%)
Query: 68 LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
LL KK+ L + T I +H+ +H DIKP+++LLD K +DFGL
Sbjct: 91 LLMKKDTLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGL 147
Query: 128 AKLYNREH--------THITST------------------GRRR-------TPGCEAPEL 154
+ H TH + RR+ TP APE+
Sbjct: 148 CTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEV 207
Query: 155 WMPYSVTQKCDVFSFGMLLFEVV 177
+M + CD +S G++++E++
Sbjct: 208 FMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 38.3 bits (89), Expect = 0.002
Identities = 26/94 (27%), Positives = 41/94 (43%), Gaps = 11/94 (11%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREH----THITSTG 142
+A H Q IVH D+KP+++++ K DFG+ L +T T
Sbjct: 91 ALACAH---NQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDADVATLTRTT 147
Query: 143 RRR-TPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
TP APE VT D++++G++ E
Sbjct: 148 EVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLE 181
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 26/88 (29%), Positives = 44/88 (50%), Gaps = 6/88 (6%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
GI +LH I+H D+KP ++++ + K DFGLA+ T+ T T
Sbjct: 135 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAC---TNFMMTPYVVTRYY 188
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFEVV 177
APE+ + + D++S G ++ E+V
Sbjct: 189 RAPEVILGMGYKENVDIWSVGCIMGELV 216
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 19/43 (44%), Positives = 27/43 (62%), Gaps = 4/43 (9%)
Query: 93 YLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL-YNRE 134
YLH R I+H D+KP+++L+ K DFGL+K+ NRE
Sbjct: 119 YLH---RHGIIHRDLKPDNMLISNEGHIKLTDFGLSKVTLNRE 158
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 37.9 bits (88), Expect = 0.002
Identities = 28/118 (23%), Positives = 46/118 (38%), Gaps = 45/118 (38%)
Query: 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREH-------------THITSTGR------ 143
+H DIKP+++L+D K +DFGL+ ++++H R
Sbjct: 123 IHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVD 182
Query: 144 ------------------RR--------TPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
RR TP APE+++ Q+CD +S G ++FE
Sbjct: 183 SINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFE 240
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 37.8 bits (88), Expect = 0.002
Identities = 26/100 (26%), Positives = 41/100 (41%), Gaps = 16/100 (16%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-----LYNREHTHITSTGR 143
G+ LH + +H D+ P ++ ++ K ADFGLA+ Y+ + + R
Sbjct: 130 NGLNVLH---KWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQR 186
Query: 144 RR-------TPGCEAPELWM-PYSVTQKCDVFSFGMLLFE 175
R T APEL M D++S G + E
Sbjct: 187 REEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226
|
Length = 335 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.002
Identities = 24/95 (25%), Positives = 41/95 (43%), Gaps = 18/95 (18%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRTP 147
G+ +L + VH D+ + L+ K + L+K +YN E+ + +
Sbjct: 128 LGMDHLS---NARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEYYKLRNA------ 178
Query: 148 GCEAPELWMPYSVTQ------KCDVFSFGMLLFEV 176
P W+ Q K DV+SFG+L++EV
Sbjct: 179 --LIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEV 211
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 37.7 bits (87), Expect = 0.002
Identities = 29/91 (31%), Positives = 42/91 (46%), Gaps = 7/91 (7%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL-YNREHTHITSTGRRRT 146
+ + YLH IV+ D+KPE++LLD DFGL K + T T G T
Sbjct: 106 ASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQSDTTTTFCG---T 159
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
P APE+ D + G +L+E++
Sbjct: 160 PEYLAPEVIRKQPYDNTVDWWCLGAVLYEML 190
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 37.6 bits (87), Expect = 0.002
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 12/96 (12%)
Query: 91 IAYLHEECRQ--------KIVHYDIKPESVLLDENFFPKAADFGL-AKLYNREHTHITST 141
IA + EC Q +++H DIK +++LL + K DFG A++ + T
Sbjct: 117 IAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSKRSTMV 176
Query: 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
G TP APE+ + K D++S G++ E+V
Sbjct: 177 G---TPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMV 209
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 30/95 (31%), Positives = 48/95 (50%), Gaps = 15/95 (15%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
+ G+AYL+ K VH D+ + ++ E+F K DFG+ + + T R+
Sbjct: 129 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTR-----DIYETDYYRKGGK 180
Query: 148 GCEAPELWM-PYSV-----TQKCDVFSFGMLLFEV 176
G P WM P S+ T DV+SFG++L+E+
Sbjct: 181 GL-LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 29/93 (31%), Positives = 47/93 (50%), Gaps = 5/93 (5%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
S + YLHE + I++ D+K ++VLLD K D+G+ K R T++ TP
Sbjct: 106 SLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTP 160
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ D ++ G+L+FE++ R
Sbjct: 161 NYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 28/95 (29%), Positives = 44/95 (46%), Gaps = 20/95 (21%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
GI +LH I+H D+KP ++++ + K DFGLA+ T TP
Sbjct: 130 GIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLAR--------TAGTSFMMTPYV 178
Query: 150 -----EAPE--LWMPYSVTQKCDVFSFGMLLFEVV 177
APE L M Y + D++S G ++ E++
Sbjct: 179 VTRYYRAPEVILGMGYK--ENVDIWSVGCIMGEMI 211
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 37.4 bits (87), Expect = 0.003
Identities = 33/99 (33%), Positives = 42/99 (42%), Gaps = 20/99 (20%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFPKAADFGLAKLYNREHTHITSTGRR 144
+KG YL E +H DI + LL K ADFG+A+ I
Sbjct: 126 AKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMAR-------DIYRASYY 175
Query: 145 RTPGCEA-PELWMPYSV------TQKCDVFSFGMLLFEV 176
R G P WMP T K DV+SFG+LL+E+
Sbjct: 176 RKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEI 214
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 37.5 bits (87), Expect = 0.003
Identities = 27/95 (28%), Positives = 47/95 (49%), Gaps = 15/95 (15%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
++G+ +L + +H D+ +VLL + K DFGLA+ + ++ R
Sbjct: 222 AQGMDFL---ASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNAR--- 275
Query: 148 GCEAPELWM-PYSV-----TQKCDVFSFGMLLFEV 176
P WM P S+ T + DV+S+G+LL+E+
Sbjct: 276 ---LPVKWMAPESIFDCVYTVQSDVWSYGILLWEI 307
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.003
Identities = 31/111 (27%), Positives = 54/111 (48%), Gaps = 12/111 (10%)
Query: 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFP-----KAADFGLA 128
+L +L +I + +KG YL + +H D+ + L+ E + K DFGLA
Sbjct: 102 LLTLKELLDICLDVAKGCVYLE---QMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158
Query: 129 K-LYNREHTHITSTGRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
+ +Y ++ G P APE + T + DV+SFG+L++E++
Sbjct: 159 RDIYKSDYYRKE--GEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEIL 207
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 25/79 (31%), Positives = 42/79 (53%), Gaps = 5/79 (6%)
Query: 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYS--- 159
+H D+KP+++LLD++ K ADFG N+E T TP +PE+
Sbjct: 164 IHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTA-VGTPDYISPEVLKSQGGDG 222
Query: 160 -VTQKCDVFSFGMLLFEVV 177
++CD +S G+ L+E++
Sbjct: 223 YYGRECDWWSVGVFLYEML 241
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 37.3 bits (86), Expect = 0.003
Identities = 35/143 (24%), Positives = 58/143 (40%), Gaps = 36/143 (25%)
Query: 68 LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
LL KK+ L + + T I +H+ +H DIKP+++LLD K +DFGL
Sbjct: 91 LLMKKDTLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGL 147
Query: 128 AKLYNREH----------------THITSTGRRR-----------------TPGCEAPEL 154
+ H T +R+ TP APE+
Sbjct: 148 CTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEV 207
Query: 155 WMPYSVTQKCDVFSFGMLLFEVV 177
+M + CD +S G++++E++
Sbjct: 208 FMQTGYNKLCDWWSLGVIMYEML 230
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 37.0 bits (85), Expect = 0.003
Identities = 25/80 (31%), Positives = 43/80 (53%), Gaps = 6/80 (7%)
Query: 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQ 162
VH DIKP+++L+D N + ADFG + L E + S+ TP +PE+ +
Sbjct: 124 VHRDIKPDNILMDMNGHIRLADFG-SCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGK 182
Query: 163 -----KCDVFSFGMLLFEVV 177
+CD +S G+ ++E++
Sbjct: 183 GKYGPECDWWSLGVCMYEML 202
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 37.2 bits (86), Expect = 0.004
Identities = 28/96 (29%), Positives = 47/96 (48%), Gaps = 5/96 (5%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150
+ +LH+ + I++ D+K ++VLLD K ADFG+ K T++ TP
Sbjct: 109 LMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCK--EGIFNGKTTSTFCGTPDYI 163
Query: 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
APE+ D ++ G+LL+E++ E E
Sbjct: 164 APEILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAE 199
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 37.0 bits (85), Expect = 0.004
Identities = 16/41 (39%), Positives = 30/41 (73%), Gaps = 3/41 (7%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+G++Y+H+ + I+H D+KP+++L+ + K ADFGLA+
Sbjct: 114 RGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLAR 151
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 37.1 bits (86), Expect = 0.004
Identities = 29/134 (21%), Positives = 57/134 (42%), Gaps = 33/134 (24%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAA--DFGLAKLYNRE------------- 134
I Y+H + ++H D+KP+++LL F + D+G A E
Sbjct: 125 TIEYVHS---KGVLHRDLKPDNILL--GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERN 179
Query: 135 --HTHITSTGR-RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV----------GRRR 181
++ +T G+ TP APE + ++ D+++ G++L++++ GR+
Sbjct: 180 ICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKI 239
Query: 182 NLEKEISEGQEWFP 195
+ I E P
Sbjct: 240 SYRDVILSPIEVAP 253
|
Length = 932 |
Conserved Domains Detected by HHsearch 
Original result of HHsearch against CDD database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 202 | |||
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 99.98 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 99.98 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 99.98 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 99.98 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 99.98 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 99.98 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 99.98 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 99.98 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 99.98 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 99.98 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 99.98 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 99.98 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 99.97 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 99.97 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 99.97 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 99.97 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 99.97 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 99.97 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 99.97 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 99.97 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 99.97 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 99.97 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 99.97 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 99.97 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 99.97 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 99.97 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 99.97 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 99.97 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 99.97 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 99.97 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 99.97 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 99.97 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 99.97 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 99.97 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 99.97 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 99.97 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 99.97 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 99.97 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 99.97 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 99.97 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 99.97 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 99.97 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 99.97 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 99.97 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 99.97 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 99.97 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 99.97 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 99.97 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 99.97 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 99.97 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 99.97 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 99.97 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 99.97 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 99.97 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 99.96 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 99.96 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 99.96 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 99.96 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 99.96 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 99.96 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 99.96 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 99.96 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 99.96 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 99.96 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 99.96 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 99.96 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 99.96 | |
| PTZ00284 | 467 | protein kinase; Provisional | 99.96 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 99.96 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 99.96 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 99.96 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 99.96 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 99.96 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 99.96 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 99.96 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 99.96 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 99.96 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 99.96 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 99.96 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 99.96 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 99.96 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 99.96 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 99.96 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 99.96 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 99.96 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 99.96 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 99.96 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 99.96 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 99.96 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 99.96 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 99.96 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 99.96 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 99.96 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 99.96 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 99.95 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 99.95 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 99.95 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 99.95 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 99.95 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 99.95 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 99.95 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 99.95 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 99.95 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 99.95 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 99.95 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 99.95 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 99.95 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 99.95 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 99.95 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 99.95 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 99.95 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 99.95 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 99.95 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 99.95 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 99.95 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 99.95 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 99.95 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 99.95 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 99.95 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 99.95 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 99.95 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 99.95 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 99.95 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 99.95 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 99.95 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 99.95 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 99.95 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 99.95 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 99.95 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 99.95 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 99.95 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 99.95 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 99.95 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.95 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 99.95 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 99.95 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 99.95 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 99.95 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 99.95 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 99.95 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 99.95 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 99.95 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 99.95 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 99.95 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 99.95 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 99.95 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 99.95 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 99.95 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 99.95 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 99.95 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 99.95 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 99.95 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 99.95 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 99.95 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 99.95 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 99.95 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 99.95 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 99.95 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 99.95 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 99.95 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 99.95 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 99.95 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 99.95 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 99.95 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 99.94 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 99.94 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 99.94 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 99.94 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 99.94 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 99.94 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 99.94 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 99.94 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 99.94 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 99.94 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 99.94 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 99.94 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 99.94 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 99.94 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 99.94 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 99.94 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 99.94 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 99.94 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 99.94 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 99.94 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 99.94 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 99.94 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 99.94 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 99.94 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 99.94 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 99.94 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 99.94 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 99.94 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 99.94 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 99.94 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 99.94 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 99.94 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 99.94 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 99.94 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 99.94 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 99.94 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 99.94 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 99.94 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 99.94 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 99.94 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 99.94 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 99.94 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 99.94 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 99.94 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 99.94 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 99.94 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 99.94 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 99.94 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 99.94 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 99.94 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 99.94 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 99.94 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 99.94 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 99.94 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 99.94 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 99.94 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 99.94 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 99.94 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 99.94 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 99.94 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 99.93 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 99.93 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 99.93 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 99.93 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 99.93 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.93 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 99.93 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 99.93 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 99.93 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 99.93 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 99.93 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 99.93 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 99.93 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 99.93 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 99.93 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 99.93 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 99.93 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 99.93 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 99.93 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 99.93 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 99.93 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 99.93 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 99.93 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 99.93 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 99.93 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 99.93 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.93 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 99.93 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 99.93 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 99.93 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 99.93 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 99.93 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.93 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 99.93 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 99.93 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 99.93 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 99.92 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 99.92 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 99.92 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 99.92 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 99.92 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 99.92 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 99.92 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 99.92 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 99.91 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 99.91 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 99.91 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 99.91 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.91 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.9 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 99.9 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 99.9 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.9 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 99.9 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 99.9 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 99.89 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.89 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.89 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.88 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.87 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 99.86 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.85 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.85 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.85 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 99.84 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.84 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.8 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.8 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.79 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.78 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.75 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.75 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.71 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.7 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.7 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.69 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.68 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.66 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.66 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.62 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.62 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.58 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.57 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.57 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.52 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.5 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.42 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.41 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.38 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.35 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.3 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.28 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.26 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.22 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.2 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.13 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.11 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.03 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 98.99 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.92 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 98.8 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 98.74 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 98.56 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 98.54 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 98.5 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 98.49 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 98.49 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.37 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 98.36 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 98.34 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 98.31 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.21 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 98.13 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 97.99 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 97.75 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 97.43 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 97.4 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 97.36 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 97.19 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 96.48 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 96.4 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 96.23 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 95.21 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 95.18 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 94.83 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 94.69 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.6 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 94.56 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 94.5 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 94.49 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 94.26 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 94.23 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 94.21 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 93.87 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 93.66 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 93.63 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 93.6 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 93.02 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 92.94 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 92.89 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 92.75 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.13 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.02 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.01 | |
| PRK06148 | 1013 | hypothetical protein; Provisional | 91.88 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 91.78 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 91.53 | |
| PLN02236 | 344 | choline kinase | 91.38 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 90.9 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 90.88 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 90.16 | |
| PRK06149 | 972 | hypothetical protein; Provisional | 89.58 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 89.42 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 88.01 | |
| COG4499 | 434 | Predicted membrane protein [Function unknown] | 87.65 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 87.39 | |
| PTZ00384 | 383 | choline kinase; Provisional | 84.83 | |
| PF02958 | 294 | EcKinase: Ecdysteroid kinase; InterPro: IPR004119 | 83.9 | |
| PRK09550 | 401 | mtnK methylthioribose kinase; Reviewed | 83.69 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 82.67 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 82.6 |
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-40 Score=258.70 Aligned_cols=183 Identities=20% Similarity=0.300 Sum_probs=153.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
|||++++..+..||.|--.... ...+....+..|..++...+|+|+|+ ..++.++++||+.+|+|..+++..
T Consensus 26 Vykg~h~~~~~~VAIK~i~~~~-l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~ 104 (429)
T KOG0595|consen 26 VYKGRHKKSGTEVAIKCIAKKK-LNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRG 104 (429)
T ss_pred EEEeEeccCCceEEeeeehhhc-cCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcC
Confidence 7999999888888876432221 12222334667888888999999885 567788999999999999999776
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC------CceEEeeeecceeccccCcccccCCCCCCC
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN------FFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~------~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
.+++..++.++.||+.||++||+ ++||||||||+|||++.. -.+||+|||+|+.+.... .....+|+|
T Consensus 105 ~l~e~t~r~Fm~QLA~alq~L~~---~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~---~a~tlcGSp 178 (429)
T KOG0595|consen 105 RLPEATARHFMQQLASALQFLHE---NNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGS---MAETLCGSP 178 (429)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchh---HHHHhhCCc
Confidence 79999999999999999999999 999999999999999764 468999999999876433 345578899
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
.|||||++...+|+.|+|+||+|+++|++++|++||+.....+
T Consensus 179 lYMAPEV~~~~~YdAKADLWSiG~Ilyq~l~g~~Pf~a~t~~e 221 (429)
T KOG0595|consen 179 LYMAPEVIMSQQYDAKADLWSIGTILYQCLTGKPPFDAETPKE 221 (429)
T ss_pred cccCHHHHHhccccchhhHHHHHHHHHHHHhCCCCccccCHHH
Confidence 9999999999999999999999999999999999999665543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-39 Score=249.90 Aligned_cols=183 Identities=21% Similarity=0.295 Sum_probs=157.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||.+|.+..+++.|.|+.++..-.+.........|..++...+||-++ ..++..+++.+++.||.|+..++ .+
T Consensus 41 V~~Vrk~dt~kiYAmKvl~K~~iv~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg 120 (357)
T KOG0598|consen 41 VFQVRKKDTGKIYAMKVLKKKKIVEKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREG 120 (357)
T ss_pred EEEEEEcccCceeehhhhhhhHhhhhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcC
Confidence 678899999999999998777666554555567777788889999776 35666789999999999988886 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..++.++.+|+.||.|||+ .+||||||||+|||++..|+++|+||||++..-... ......+||+.|||||
T Consensus 121 ~F~E~~arfYlaEi~lAL~~LH~---~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~--~~t~tfcGT~eYmAPE 195 (357)
T KOG0598|consen 121 RFSEDRARFYLAEIVLALGYLHS---KGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG--DATRTFCGTPEYMAPE 195 (357)
T ss_pred CcchhHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHeeecCCCcEEEeccccchhcccCC--CccccccCCccccChH
Confidence 79999999999999999999999 999999999999999999999999999998532221 1234478999999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..|+..+|+||+|+++|||++|.+||...+.
T Consensus 196 il~~~gy~~~vDWWsLGillYeML~G~pPF~~~~~ 230 (357)
T KOG0598|consen 196 ILLGKGYDKAVDWWSLGILLYEMLTGKPPFYAEDV 230 (357)
T ss_pred HHhcCCCCcccchHhHHHHHHHHhhCCCCCcCccH
Confidence 99999999999999999999999999999987664
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=254.30 Aligned_cols=185 Identities=19% Similarity=0.252 Sum_probs=160.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
+|++++..+++.+|.|+-.+..........+...|..+-...+|+||++ ...+.+++.|.++.++|..+.+++
T Consensus 34 cYe~~~~~tge~~A~KvVpk~~l~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk 113 (592)
T KOG0575|consen 34 CYEARDLDTGEVVAVKVVPKKLLKKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRK 113 (592)
T ss_pred EEEEEEcCCCcEEEEEEeehHHhcCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcC
Confidence 5889998888888888876655555556667888888888999999986 445567889999999999988754
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.+++.+..||+.||.|||+ .+|||||||..|++++.+.++||+|||||..+..+.. ...+.+|||.|+|||
T Consensus 114 ~ltEpEary~l~QIv~GlkYLH~---~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~E--rk~TlCGTPNYIAPE 188 (592)
T KOG0575|consen 114 PLTEPEARYFLRQIVEGLKYLHS---LGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDGE--RKKTLCGTPNYIAPE 188 (592)
T ss_pred CCCcHHHHHHHHHHHHHHHHHHh---cCceecccchhheeecCcCcEEecccceeeeecCccc--ccceecCCCcccChh
Confidence 59999999999999999999999 9999999999999999999999999999997754422 234568899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
++.....+..+||||+||++|-|+.|+|||....-.+
T Consensus 189 Vl~k~gHsfEvDiWSlGcvmYtLL~G~PPFetk~vke 225 (592)
T KOG0575|consen 189 VLNKSGHSFEVDIWSLGCVMYTLLVGRPPFETKTVKE 225 (592)
T ss_pred HhccCCCCCchhhhhhhhHHHhhhhCCCCcccchHHH
Confidence 9999999999999999999999999999999876544
|
|
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=243.29 Aligned_cols=178 Identities=21% Similarity=0.282 Sum_probs=153.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------cc-cceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------ED-TETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~~-~~~~~~~~~~~~~l~~~~~~- 72 (202)
|||++++.++++.|.|+- ......+..+.+..|..+....+++.+++. .+ ...+.+|||++|+|..+.+.
T Consensus 95 V~kv~Hk~t~~i~AlK~I--~~~~~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~ 172 (364)
T KOG0581|consen 95 VYKVRHKPTGKIYALKVI--LLNIDPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRV 172 (364)
T ss_pred EEEEEEcCCCeEEEEEee--cccCCHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhc
Confidence 799999999999999875 223333445567777777778899999862 22 36688999999999998865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+++++.....++.++++||.|||.. ++||||||||+|+|+...|.+||+|||.++.+.+. ...+..||..||||
T Consensus 173 g~i~E~~L~~ia~~VL~GL~YLh~~--~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS----~a~tfvGT~~YMsP 246 (364)
T KOG0581|consen 173 GRIPEPVLGKIARAVLRGLSYLHEE--RKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS----IANTFVGTSAYMSP 246 (364)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhhc--cCeeeccCCHHHeeeccCCCEEeccccccHHhhhh----hcccccccccccCh
Confidence 6799999999999999999999963 89999999999999999999999999999876554 23557889999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|-+.+..|+.++||||||+.++|+++|+.|+...
T Consensus 247 ERi~g~~Ys~~sDIWSLGLsllE~a~GrfP~~~~ 280 (364)
T KOG0581|consen 247 ERISGESYSVKSDIWSLGLSLLELAIGRFPYPPP 280 (364)
T ss_pred hhhcCCcCCcccceecccHHHHHHhhCCCCCCCc
Confidence 9999999999999999999999999999999875
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=246.90 Aligned_cols=186 Identities=19% Similarity=0.271 Sum_probs=156.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhc-c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCK-K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~ 72 (202)
|++|++..++..+|.||..+.--....+..-...|...+... +||-++. .....+++.++.++|.|..+++ .
T Consensus 89 V~~A~~~~t~keYAiKVl~K~~Iike~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~ 168 (604)
T KOG0592|consen 89 VVLAREKATGKEYAIKVLDKRYIIKEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKY 168 (604)
T ss_pred EEEeeecCCCceeeHhhhhHHHHHhhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHh
Confidence 789999999999999998777666666666666676655554 8886653 4445668889999999888775 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc---------ccc--C
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH---------ITS--T 141 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~---------~~~--~ 141 (202)
+.+++..++.++.+|+.||+|||+ +|||||||||+|||++.+++++|.|||.|+.++..... ... .
T Consensus 169 Gsfde~caR~YAAeIldAleylH~---~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~ 245 (604)
T KOG0592|consen 169 GSFDETCARFYAAEILDALEYLHS---NGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRS 245 (604)
T ss_pred CcchHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCccc
Confidence 679999999999999999999999 99999999999999999999999999999987543221 112 4
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
..+||-.|.+||++.....+..+|+|+|||++|+|+.|.+||...++-
T Consensus 246 SFVGTAeYVSPElL~~~~~~~~sDiWAlGCilyQmlaG~PPFra~Ney 293 (604)
T KOG0592|consen 246 SFVGTAEYVSPELLNDSPAGPSSDLWALGCILYQMLAGQPPFRAANEY 293 (604)
T ss_pred ceeeeecccCHHHhcCCCCCcccchHHHHHHHHHHhcCCCCCccccHH
Confidence 478999999999999999999999999999999999999999976654
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=244.27 Aligned_cols=181 Identities=24% Similarity=0.336 Sum_probs=148.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------cc-cceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------ED-TETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~~-~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++..++... ||+|+.......... ...|..|..++...+|||+++. .. ...++++|+++|+|..++..
T Consensus 57 V~~~~~~g~~~-vavK~~~~~~~~~~~-~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~ 134 (362)
T KOG0192|consen 57 VYKGKWRGTDV-VAVKIISDPDFDDES-RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKK 134 (362)
T ss_pred EEEEEeCCcee-EEEEEecchhcChHH-HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhc
Confidence 56666666555 555544333322222 5679999999999999998841 12 35799999999999999955
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEecCCCCcEEEcCCC-ceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQK-IVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~-iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
..+++..+..++.+|+.|+.|||+ .+ ||||||||+|+|++.++ ++||+|||+++...... ...+...||+.
T Consensus 135 ~~~~l~~~~~l~~aldiArGm~YLH~---~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~--~~~~~~~GT~~ 209 (362)
T KOG0192|consen 135 RKRKLPLKVRLRIALDIARGMEYLHS---EGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK--TSMTSVAGTYR 209 (362)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHhc---CCCeeecccChhhEEEcCCCCEEEECCCccceeecccc--ccccCCCCCcc
Confidence 679999999999999999999999 77 99999999999999997 99999999998755432 22344678999
Q ss_pred ccCCcccC--CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWM--PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~--~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||||++. ...|+.|+||||||+++|||+||+.||.+..+
T Consensus 210 wMAPEv~~~~~~~~~~K~DvySFgIvlWEl~t~~~Pf~~~~~ 251 (362)
T KOG0192|consen 210 WMAPEVLRGEKSPYTEKSDVYSFGIVLWELLTGEIPFEDLAP 251 (362)
T ss_pred ccChhhhcCCCCcCCccchhhhHHHHHHHHHHCCCCCCCCCH
Confidence 99999999 66999999999999999999999999998776
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-36 Score=229.81 Aligned_cols=181 Identities=20% Similarity=0.291 Sum_probs=156.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
|..+|.+.++.+.|.|+.++.......+..-...|..++....||-++ ...+...+++++.++|.|+.++++ +
T Consensus 60 V~LVr~k~~g~yYAmKvL~k~~vVklKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~ 139 (355)
T KOG0616|consen 60 VHLVREKHSGNYYAMKVLDKQKVVKLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSG 139 (355)
T ss_pred EEEEEEccCCceeehhhcCHHHHHHHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcC
Confidence 456788889999999998877666555555566777778888888654 245566788999999999988865 6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
++++..++.++.|++.||+|||+ ++|++|||||+|||++++|.+|+.|||.|+..... ....+|||-|+|||
T Consensus 140 rF~e~~arFYAAeivlAleylH~---~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~r-----T~TlCGTPeYLAPE 211 (355)
T KOG0616|consen 140 RFSEPHARFYAAEIVLALEYLHS---LDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSGR-----TWTLCGTPEYLAPE 211 (355)
T ss_pred CCCchhHHHHHHHHHHHHHHHHh---cCeeeccCChHHeeeccCCcEEEEeccceEEecCc-----EEEecCCccccChH
Confidence 79999999999999999999999 99999999999999999999999999999976532 34578899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.++..+++.++|.||||+++|||+.|.+||...++.
T Consensus 212 ii~sk~ynkavDWWalGVLIYEMlaG~pPF~~~~~~ 247 (355)
T KOG0616|consen 212 IIQSKGYNKAVDWWALGVLIYEMLAGYPPFYDDNPI 247 (355)
T ss_pred HhhcCCCCcchhHHHHHHHHHHHHcCCCCCcCCChH
Confidence 999999999999999999999999999999987774
|
|
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=245.06 Aligned_cols=188 Identities=21% Similarity=0.297 Sum_probs=161.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||.|+.+.++.+.|.|+.++.+.....+..-...|..++...+.+.++ ....+.+++|+|++||.+..++ +.+
T Consensus 157 VrLarKk~Tg~iyAmK~LkKS~M~~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~ 236 (550)
T KOG0605|consen 157 VRLARKKDTGEIYAMKILKKSEMLKKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKD 236 (550)
T ss_pred EEEEEEccCCcEEeeecccHHHHHhhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcC
Confidence 789999999999999999998888777777677787778887777665 5778889999999999988777 456
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecccc-------------------
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE------------------- 134 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~------------------- 134 (202)
.+++..++.++.+++.|++-+|+ .|+|||||||+|+|++..|++||+||||+..+...
T Consensus 237 ~L~e~~arfYiaE~vlAI~~iH~---~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~ 313 (550)
T KOG0605|consen 237 TLTEDWARFYIAETVLAIESIHQ---LGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEA 313 (550)
T ss_pred cCchHHHHHHHHHHHHHHHHHHH---cCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccC
Confidence 79999999999999999999999 99999999999999999999999999999643110
Q ss_pred ----Ccc---ccc-------------------CCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 135 ----HTH---ITS-------------------TGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 135 ----~~~---~~~-------------------~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
... ... ...+|||-|||||++.+..|+..+|+||+||++|||+.|.|||+.+.+
T Consensus 314 ~~~~~~~~~~~~~~~~~~~~~~~w~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp 393 (550)
T KOG0605|consen 314 KPSDFPKFNTPRSTMSRREQLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETP 393 (550)
T ss_pred CCccccccccccchhhHHHHHHHHHhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 000 000 124799999999999999999999999999999999999999999988
Q ss_pred ccc
Q 044746 189 EGQ 191 (202)
Q Consensus 189 ~~~ 191 (202)
++.
T Consensus 394 ~~T 396 (550)
T KOG0605|consen 394 QET 396 (550)
T ss_pred HHH
Confidence 763
|
|
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-36 Score=244.42 Aligned_cols=187 Identities=21% Similarity=0.243 Sum_probs=153.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc--------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG--------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~--------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
|||||+..+++.||.|-.+... ...+.++-...|..++...+|+||+. ..+..+++.+||+. .|.+++..
T Consensus 133 VYkAr~~~tgkivALKKvr~d~-~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMdh-DL~GLl~~ 210 (560)
T KOG0600|consen 133 VYKARDLETGKIVALKKVRFDN-EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMDH-DLSGLLSS 210 (560)
T ss_pred eeEeeecccCcEEEEEEeeccc-CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEecccc-hhhhhhcC
Confidence 8999999999999975433332 22334555678888999999999874 23556677788874 56666655
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 N--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. .|+..+++.++.|++.||+|||+ ++|+|||||..|||++.+|.+||+|||||+++....... .+..+-|..|.
T Consensus 211 p~vkft~~qIKc~mkQLl~Gl~~cH~---~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~~~-~T~rVvTLWYR 286 (560)
T KOG0600|consen 211 PGVKFTEPQIKCYMKQLLEGLEYCHS---RGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGSAP-YTSRVVTLWYR 286 (560)
T ss_pred CCcccChHHHHHHHHHHHHHHHHHhh---cCeeeccccccceEEcCCCCEEeccccceeeccCCCCcc-cccceEEeecc
Confidence 4 69999999999999999999999 999999999999999999999999999999775544322 34445599999
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcccccc
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~ 193 (202)
|||++.+. .|+..+|+||.||++.||++|++.|.+..+.+|..
T Consensus 287 pPELLLG~t~Yg~aVDlWS~GCIl~El~~gkPI~~G~tEveQl~ 330 (560)
T KOG0600|consen 287 PPELLLGATSYGTAVDLWSVGCILAELFLGKPILQGRTEVEQLH 330 (560)
T ss_pred ChHHhcCCcccccceeehhhhHHHHHHHcCCCCcCCccHHHHHH
Confidence 99999875 79999999999999999999999999998877644
|
|
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-36 Score=245.30 Aligned_cols=194 Identities=27% Similarity=0.413 Sum_probs=155.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc---c---ccc-cceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV---G---SED-TETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i---~---~~~-~~~~~~~~~~~~~l~~~~~~~ 73 (202)
|||+.-.++ ..||+|..... .... ..+|..|...+...+|+|++ | +++ ...++.+|+++|+|.+.+...
T Consensus 91 VYkG~l~~~-~~vAVK~~~~~--~~~~-~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~ 166 (361)
T KOG1187|consen 91 VYKGVLSDG-TVVAVKRLSSN--SGQG-EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGK 166 (361)
T ss_pred EEEEEECCC-CEEEEEEecCC--CCcc-hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCC
Confidence 566666666 55665522221 1111 44599999999999999876 3 333 478999999999999888554
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccc-cCcccccCCCCCCCcc
Q 044746 74 ---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR-EHTHITSTGRRRTPGC 149 (202)
Q Consensus 74 ---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~-~~~~~~~~~~~gt~~y 149 (202)
.++|..+.+|+.++|.||+|||..+..+|||||||+.|||+|.++.+||+|||+|+.... ....... . .||.+|
T Consensus 167 ~~~~L~W~~R~kIa~g~A~gL~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~~~~~~~~-~-~gt~gY 244 (361)
T KOG1187|consen 167 KGEPLDWETRLKIALGAARGLAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEGDTSVSTT-V-MGTFGY 244 (361)
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCccccceeee-c-CCCCcc
Confidence 689999999999999999999998877899999999999999999999999999975543 2211111 1 679999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccccccccccccc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGRE 200 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~ 200 (202)
+|||+...+..+.++||||||++++|++||++|.+...+.++..+..|++.
T Consensus 245 ~~PEy~~~g~lt~KsDVySFGVvllElitgr~~~d~~~~~~~~~l~~w~~~ 295 (361)
T KOG1187|consen 245 LAPEYASTGKLTEKSDVYSFGVVLLELITGRKAVDQSRPRGELSLVEWAKP 295 (361)
T ss_pred CChhhhccCCcCcccccccchHHHHHHHhCCcccCCCCCcccccHHHHHHH
Confidence 999999988999999999999999999999999998776666668888754
|
|
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-36 Score=250.25 Aligned_cols=195 Identities=21% Similarity=0.293 Sum_probs=165.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccc---cc---cccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSN---LV---GSEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~---~i---~~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
|+++..++.+++.|.|+.++..-...+.......|..+.... +||= .. ...+..+++++|..||.+..+.+.+
T Consensus 384 V~lae~k~~~e~yAIK~LKK~~Il~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~~~~~ 463 (694)
T KOG0694|consen 384 VLLAELKGTNEYYAIKVLKKGDILQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHHIHTD 463 (694)
T ss_pred EEEEEEcCCCcEEEEEEeeccceeccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEEEecc
Confidence 677888999999999999988877777666666666655443 5773 22 4566778999999999988888889
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..++.++..++.||+|||+ ++||+||||.+|||+|..|++||+|||+++..- .......+.+|||.|||||
T Consensus 464 ~F~e~rarfyaAev~l~L~fLH~---~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m--~~g~~TsTfCGTpey~aPE 538 (694)
T KOG0694|consen 464 VFSEPRARFYAAEVVLGLQFLHE---NGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGM--GQGDRTSTFCGTPEFLAPE 538 (694)
T ss_pred cccHHHHHHHHHHHHHHHHHHHh---cCceeeecchhheEEcccCcEEecccccccccC--CCCCccccccCChhhcChh
Confidence 99999999999999999999999 999999999999999999999999999998432 1222345678999999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc--------cccccccccc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG--------QEWFPKWGRE 200 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~--------~~~~~~~~~~ 200 (202)
++.+..|+..+|+|||||++|||+.|+.||.++++++ +..||.|+..
T Consensus 539 il~e~~Yt~aVDWW~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~~~yP~~ls~ 593 (694)
T KOG0694|consen 539 VLTEQSYTRAVDWWGLGVLLYEMLVGESPFPGDDEEEVFDSIVNDEVRYPRFLSK 593 (694)
T ss_pred hhccCcccchhhHHHHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCCCCCCCcccH
Confidence 9999999999999999999999999999999887764 5667888764
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-36 Score=230.06 Aligned_cols=184 Identities=19% Similarity=0.245 Sum_probs=153.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc--------cceEEEEEccCCchhhhhc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED--------TETYIKGFLAMGPFYLLCK- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~l~~~~~- 71 (202)
|||++....+..+|.|--. ..............|..++...+||||+.... ...++++++..|.|...++
T Consensus 35 vykv~~~~~g~l~a~K~i~-f~~md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~ 113 (375)
T KOG0591|consen 35 VYKVQCLLDGKLVALKKIQ-FGMMDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKH 113 (375)
T ss_pred eEEeeeccCcchhhhhhcc-hhhccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHH
Confidence 7899999888888866443 33333334455778888999999999985333 3568899999999988873
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhCC-CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 72 ----KNILGFGQLREIEVSTSKGIAYLHEEC-RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 72 ----~~~~~~~~~~~~~~~i~~~l~~lH~~~-~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
+..+++..+.++..|++.||..||+.. ...|+||||||.||+++.+|.+||+|||+++.+....+. ....+||
T Consensus 114 ~K~qkr~ipE~~Vwk~f~QL~~AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~~tf--A~S~VGT 191 (375)
T KOG0591|consen 114 FKKQKRLIPEKTVWKYFVQLCRALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSKTTF--AHSLVGT 191 (375)
T ss_pred HHhccccCchHHHHHHHHHHHHHHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcchhHH--HHhhcCC
Confidence 446999999999999999999999833 134899999999999999999999999999987655443 3457899
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.||+||.+...+|+.++||||+||++|||+.-++||.+++
T Consensus 192 PyYMSPE~i~~~~Y~~kSDiWslGCllyEMcaL~~PF~g~n 232 (375)
T KOG0591|consen 192 PYYMSPERIHESGYNFKSDIWSLGCLLYEMCALQSPFYGDN 232 (375)
T ss_pred CcccCHHHHhcCCCCcchhHHHHHHHHHHHHhcCCCccccc
Confidence 99999999999999999999999999999999999998874
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-35 Score=240.25 Aligned_cols=181 Identities=20% Similarity=0.245 Sum_probs=154.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||-|+....++.||.|..... .+.+...+..|..++....|+|++. .++..+++++|+++|+|.++.....
T Consensus 289 vy~A~~~~~~~~VaiK~m~l~---~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~~ 365 (550)
T KOG0578|consen 289 VYVARKISTKQEVAIKRMDLR---KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKTR 365 (550)
T ss_pred eeeeeeccCCceEEEEEEEec---cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhccc
Confidence 677888888888887654332 2222334667777788888998773 4577899999999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++++++.||+|||. ++|||||||.+|||++.+|.+||+|||++..+...... .....|||.|||||+
T Consensus 366 ~~E~qIA~Icre~l~aL~fLH~---~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~K--R~TmVGTPYWMAPEV 440 (550)
T KOG0578|consen 366 MTEGQIAAICREILQGLKFLHA---RGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQSK--RSTMVGTPYWMAPEV 440 (550)
T ss_pred ccHHHHHHHHHHHHHHHHHHHh---cceeeeccccceeEeccCCcEEEeeeeeeeccccccCc--cccccCCCCccchhh
Confidence 9999999999999999999999 99999999999999999999999999999877655432 344678999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.....|++++||||||++.+||+.|++||-.+.+-
T Consensus 441 vtrk~YG~KVDIWSLGIMaIEMveGEPPYlnE~Pl 475 (550)
T KOG0578|consen 441 VTRKPYGPKVDIWSLGIMAIEMVEGEPPYLNENPL 475 (550)
T ss_pred hhhcccCccccchhhhhHHHHHhcCCCCccCCChH
Confidence 99999999999999999999999999999876554
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-36 Score=237.76 Aligned_cols=182 Identities=21% Similarity=0.303 Sum_probs=148.2
Q ss_pred CccccCCCcceeehhhhchhhhhcc----CCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 2 EKPRNRGSTRFITRTIDKSLDAMEM----DKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 2 ~k~~~~~~~~~v~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
-+|-.+.+++.||.|+-.+...... .+....+.|..++...+||+++. .....+.++|+++||.|++..-
T Consensus 189 kla~e~~tgk~vAiKIi~krk~~~~s~~~~~~~~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv 268 (475)
T KOG0615|consen 189 KLAYEKKTGKQVAIKIINKRKSTGCSRAIAKTRDVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVV 268 (475)
T ss_pred EEEEEcccCcEEEeeeeehhhcccccccccchhhhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHH
Confidence 3566788889999888655544332 23334568888999999998874 4445578999999999988775
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC---CceEEeeeecceeccccCcccccCCCCCCC
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN---FFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~---~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
. +.+.+...+.++.|++.|+.|||+ +||+||||||+|||+..+ ..+|++|||+|+..+... .+.+.+|||
T Consensus 269 ~nk~l~ed~~K~~f~Qll~avkYLH~---~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~s---fm~TlCGTp 342 (475)
T KOG0615|consen 269 ANKYLREDLGKLLFKQLLTAVKYLHS---QGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEGS---FMKTLCGTP 342 (475)
T ss_pred hccccccchhHHHHHHHHHHHHHHHH---cCcccccCCcceEEeccCCcceEEEecccchhhccccce---ehhhhcCCc
Confidence 4 458999999999999999999999 999999999999999866 889999999999765332 345678999
Q ss_pred cccCCcccCCCC---CCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 148 GCEAPELWMPYS---VTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 148 ~y~aPe~~~~~~---~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.|.|||++.... +..++|+||+||+||-+++|.+||.+...+
T Consensus 343 sYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPFS~~~~~ 387 (475)
T KOG0615|consen 343 SYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPFSEEYTD 387 (475)
T ss_pred cccChhheecCCeecccchheeeeccceEEEEeccCCCcccccCC
Confidence 999999998654 334789999999999999999999876543
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-35 Score=243.41 Aligned_cols=181 Identities=19% Similarity=0.282 Sum_probs=159.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
|-.|++..+++.+|+|+-.+..+.....+..+..|..++....|+|++. .....+++.+|+++|.|+.++ .++
T Consensus 28 vrlakh~~TGqlaaiKii~k~~~~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG 107 (786)
T KOG0588|consen 28 VRLAKHAETGQLAAIKIIPKRSELSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKG 107 (786)
T ss_pred ehhhhcccccceeEEEeeccccccccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhC
Confidence 3468889999999999977776777778889999999999999998874 556677899999999988776 677
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
++++.++.+++.||+.|+.|||. .+|+||||||+|+|++..+++||+|||+|.+...+... .+.+|+|+|.|||
T Consensus 108 ~l~e~eaa~ff~QIi~gv~yCH~---~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gklL---eTSCGSPHYA~PE 181 (786)
T KOG0588|consen 108 PLPEREAAHFFRQILDGVSYCHA---FNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGKLL---ETSCGSPHYAAPE 181 (786)
T ss_pred CCCCHHHHHHHHHHHHHHHHHhh---hcceeccCCchhhhhhcccCEeeeccceeecccCCccc---cccCCCcccCCch
Confidence 89999999999999999999999 99999999999999999999999999999876555443 4467899999999
Q ss_pred ccCCCCCC-chhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVT-QKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~-~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++++.+|+ .++||||+|++|+.|+||+.||++++
T Consensus 182 IV~G~pYdG~~sDVWSCGVILfALLtG~LPFdDdN 216 (786)
T KOG0588|consen 182 IVSGRPYDGRPSDVWSCGVILFALLTGKLPFDDDN 216 (786)
T ss_pred hhcCCCCCCCccccchhHHHHHHHHhCCCCCCCcc
Confidence 99999886 67999999999999999999999544
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-36 Score=228.53 Aligned_cols=189 Identities=20% Similarity=0.214 Sum_probs=154.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
|||+|++.++++||.|.-...++....+.. -..|..++....|+|++. ...-..++.+|++..-|..+... +
T Consensus 18 V~KCrnk~TgqIVAIKkF~Esedd~~VkKI-AlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dhTvL~eLe~~p~ 96 (396)
T KOG0593|consen 18 VMKCRNKDTGQIVAIKKFVESEDDPVVKKI-ALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDHTVLHELERYPN 96 (396)
T ss_pred EEEeccCCcccEEEEEeeccCCccHHHHHH-HHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecchHHHHHHHhccC
Confidence 799999999999998865554443332222 346777888889998763 55556789999987766655543 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.++...++.++.|++.|+.|+|+ +++||||+||+|||++.++.+||+|||.|+.+..+.. ..+..+.|..|.|||
T Consensus 97 G~~~~~vk~~l~Q~l~ai~~cHk---~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pgd--~YTDYVATRWYRaPE 171 (396)
T KOG0593|consen 97 GVPSELVKKYLYQLLKAIHFCHK---NNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPGD--NYTDYVATRWYRAPE 171 (396)
T ss_pred CCCHHHHHHHHHHHHHHhhhhhh---cCeecccCChhheEEecCCcEEeccchhhHhhcCCcc--hhhhhhhhhhccChh
Confidence 49999999999999999999999 9999999999999999999999999999997763221 223345589999999
Q ss_pred ccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcccccccc
Q 044746 154 LWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFP 195 (202)
Q Consensus 154 ~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~~~ 195 (202)
++.+ .+|+..+||||+||++.||++|.+.|.+.++-+|.+.+
T Consensus 172 LLvGDtqYG~pVDiWAiGCv~aEl~~G~pL~PG~SDiDQLy~I 214 (396)
T KOG0593|consen 172 LLVGDTQYGKPVDIWAIGCVFAELLTGEPLWPGRSDIDQLYLI 214 (396)
T ss_pred hhcccCcCCCcccchhhhHHHHHHhcCCcCCCCcchHHHHHHH
Confidence 9988 68999999999999999999999999999988876644
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-35 Score=241.93 Aligned_cols=180 Identities=21% Similarity=0.296 Sum_probs=155.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
|||+|.+.+.++||.|...+....+. ..+.+..|..+....+|+||+. .....+++.+|..+ .|..++. .+
T Consensus 18 VYKgrrK~t~~~vAik~i~K~gr~~k-~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~ 95 (808)
T KOG0597|consen 18 VYKGRRKYTIQVVAIKFIDKSGRNEK-ELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDG 95 (808)
T ss_pred eeecccccceeEEEEEEehhcCCchH-HHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhcc
Confidence 89999999999999988666544432 2445788888999999999884 45566789999887 7777775 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.++++.++.++.++.+||.|||+ ++|+|||+||+|||++..+.+|++|||+++.++.. ....+...|||.|||||
T Consensus 96 ~lpEe~v~~~a~~LVsaL~yLhs---~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~--t~vltsikGtPlYmAPE 170 (808)
T KOG0597|consen 96 KLPEEQVRAIAYDLVSALYYLHS---NRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTN--TSVLTSIKGTPLYMAPE 170 (808)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---cCcccccCCcceeeecCCCceeechhhhhhhcccC--ceeeeeccCcccccCHH
Confidence 79999999999999999999999 99999999999999999999999999999976543 33456678999999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+..+.+|+..+|+||+||++||+++|+|||...+
T Consensus 171 lv~e~pyd~~sDlWslGcilYE~~~G~PPF~a~s 204 (808)
T KOG0597|consen 171 LVEEQPYDHTSDLWSLGCILYELYVGQPPFYARS 204 (808)
T ss_pred HHcCCCccchhhHHHHHHHHHHHhcCCCCchHHH
Confidence 9999999999999999999999999999998654
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-34 Score=231.78 Aligned_cols=182 Identities=19% Similarity=0.245 Sum_probs=145.7
Q ss_pred CCccccCCCcceeehhhhchhhhh-c-cCCcccCCcHHHHHHhcc-cccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM-E-MDKPIRFTSPQRMIAADN-FSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~-~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
|+++++..++..||.|+....... . ......+..|..+....+ |||++. ......++++|..+|.|++++.
T Consensus 33 V~~a~~~~t~~~vAiKii~~~~~~~~~~~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~ 112 (370)
T KOG0583|consen 33 VKLAKHRLTGEKVAIKIIDRKKVSSKSQKLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIV 112 (370)
T ss_pred EEEeeeccCCCeEEEEEechhcccccccccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHH
Confidence 567778778788888864443111 1 122333445666666666 888764 4444678999999999988886
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-CceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
. +++++.+++.++.|+++|++|||+ ++|+||||||+|+|++.+ +++||+|||++.... .........+||+.|
T Consensus 113 ~~g~l~E~~ar~~F~Qlisav~y~H~---~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~--~~~~~l~t~cGsp~Y 187 (370)
T KOG0583|consen 113 NKGRLKEDEARKYFRQLISAVAYCHS---RGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP--GEDGLLKTFCGSPAY 187 (370)
T ss_pred HcCCCChHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEecCCCCCEEEeccccccccC--CCCCcccCCCCCccc
Confidence 6 789999999999999999999999 999999999999999999 999999999998763 112234557889999
Q ss_pred cCCcccCCCC-CC-chhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPYS-VT-QKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~-~~-~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||++.+.. |+ .++||||+|++||.|++|+.||++..
T Consensus 188 ~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml~G~~PF~d~~ 227 (370)
T KOG0583|consen 188 AAPEVLSGKGTYSGKAADVWSLGVILYVLLCGRLPFDDSN 227 (370)
T ss_pred CCHHHhCCCCCcCCchhhhhhhHHHHHHHHhCCCCCCCcc
Confidence 9999999877 76 77999999999999999999999855
|
|
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-34 Score=222.34 Aligned_cols=186 Identities=20% Similarity=0.259 Sum_probs=146.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc--------ccccceEEEEEccCCchhhhhc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG--------SEDTETYIKGFLAMGPFYLLCK- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~--------~~~~~~~~~~~~~~~~l~~~~~- 71 (202)
||||++..++++||.|-.+...+.. --+.--..|..++...+|+||+. .-+..+++++|++. .|..++.
T Consensus 92 VYRakdk~t~eIVALKr~kmekek~-GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~Eh-DLksl~d~ 169 (419)
T KOG0663|consen 92 VYRAKDKKTDEIVALKRLKMEKEKE-GFPITSLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVEH-DLKSLMET 169 (419)
T ss_pred EEEeccCCcceeEEeeecccccccC-CCcchhHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHHh-hHHHHHHh
Confidence 8999999999999976554443221 22344456677777778999863 22334456666664 3433332
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 -KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++..+++.++.|+++|++|||. +.|+|||||++|+|+...|.+|++|||+|+.++...... +..+-|..|.
T Consensus 170 m~q~F~~~evK~L~~QlL~glk~lH~---~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp~k~~--T~lVVTLWYR 244 (419)
T KOG0663|consen 170 MKQPFLPGEVKTLMLQLLRGLKHLHD---NWILHRDLKTSNLLLSHKGILKIADFGLAREYGSPLKPY--TPLVVTLWYR 244 (419)
T ss_pred ccCCCchHHHHHHHHHHHHHHHHHhh---ceeEecccchhheeeccCCcEEecccchhhhhcCCcccC--cceEEEeeec
Confidence 2479999999999999999999999 999999999999999999999999999999887664332 3334489999
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcccccc
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~ 193 (202)
|||++.+. .|++..|+||+||++.|+++++|-|.+.+.-+|.+
T Consensus 245 aPELLLG~~tyst~iDMWSvGCI~aE~l~~kPlf~G~sE~dQl~ 288 (419)
T KOG0663|consen 245 APELLLGAKTYSTAVDMWSVGCIFAELLTQKPLFPGKSEIDQLD 288 (419)
T ss_pred CHHHhcCCcccCcchhhhhHHHHHHHHHhcCCCCCCCchHHHHH
Confidence 99999875 69999999999999999999999999988877643
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-34 Score=227.27 Aligned_cols=179 Identities=25% Similarity=0.295 Sum_probs=142.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc--------cceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED--------TETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--------~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+..++.+.|+|........ ....+..|..++...+|++|+...+ ...++++|.++|+|..++.+
T Consensus 33 V~l~~~~~~g~~~AvK~v~~~~~~---~~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~ 109 (313)
T KOG0198|consen 33 VYLATNKKTGELMAVKSVELEDSP---TSESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKR 109 (313)
T ss_pred EEEEEecCCCcceeeeeeecccch---hHHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHH
Confidence 455666655666666553332111 1444778888888889999986555 47799999999999999976
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccc-cCcccccCCCCCCCc
Q 044746 73 N--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNR-EHTHITSTGRRRTPG 148 (202)
Q Consensus 73 ~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~-~~~~~~~~~~~gt~~ 148 (202)
. .+++..++.+.+|+++||.|||+ ++++||||||+|||++. ++.+||+|||+++.... ...........||+.
T Consensus 110 ~g~~l~E~~v~~ytr~iL~GL~ylHs---~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~ 186 (313)
T KOG0198|consen 110 YGGKLPEPLVRRYTRQILEGLAYLHS---KGIVHCDIKPANILLDPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPN 186 (313)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCcccceEEEeCCCCeEEeccCccccccccccccccccccccCCcc
Confidence 5 59999999999999999999999 99999999999999999 79999999999986553 111122334678999
Q ss_pred ccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 149 CEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 149 y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|||||++..+ ....++||||+||++.||+||++||..
T Consensus 187 ~maPEvi~~g~~~~~~sDiWSlGCtVvEM~Tg~~PW~~ 224 (313)
T KOG0198|consen 187 YMAPEVIRNGEVARRESDIWSLGCTVVEMLTGKPPWSE 224 (313)
T ss_pred ccCchhhcCCCcCCccchhhhcCCEEEeccCCCCcchh
Confidence 9999999853 333589999999999999999999987
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-34 Score=232.19 Aligned_cols=186 Identities=22% Similarity=0.302 Sum_probs=149.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++...++.+|.|+.+.....+.+....+..|..+....+|++++. .....+++++++++|+|..++. .+
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~ 96 (363)
T cd05628 17 VRLVQKKDTGHVYAMKILRKADMLEKEQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKD 96 (363)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcC
Confidence 6888888888899988866544333333445666767777778887763 3445678899999999988875 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc----------------
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH---------------- 137 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~---------------- 137 (202)
.+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.++|+|||+++........
T Consensus 97 ~l~~~~~~~~~~qi~~aL~~lH~---~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (363)
T cd05628 97 TLTEEETQFYIAETVLAIDSIHQ---LGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTF 173 (363)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccc
Confidence 69999999999999999999999 99999999999999999999999999998754321100
Q ss_pred -----------------cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 138 -----------------ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 138 -----------------~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.......||+.|+|||++.+..++.++|+||+||++|||++|+.||.+..+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~ 242 (363)
T cd05628 174 QNMNSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242 (363)
T ss_pred cccccccccchhhhccccccccccCCccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHH
Confidence 0012346899999999999889999999999999999999999999865543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-33 Score=221.38 Aligned_cols=188 Identities=17% Similarity=0.176 Sum_probs=162.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccc------cccccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSN------LVGSEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~i~~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||.++.++++.+.|.||..+.......+..+.+.|.-++...+||= .+....+.+++++|++||.|..+.++.
T Consensus 93 VyL~~l~~t~~~fAmKVmdK~~l~~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp 172 (459)
T KOG0610|consen 93 VYLVELRGTNCLFAMKVMDKESLASRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQP 172 (459)
T ss_pred EEEEEecCCCceEEEEEecHHHHhhhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCC
Confidence 7999999999999999988888788888999999999999999993 346778889999999999987777554
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecccc-----------------
Q 044746 74 --ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE----------------- 134 (202)
Q Consensus 74 --~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~----------------- 134 (202)
.+++..++.++.+++.||+|||- .|||+|||||+|||+..+|++.|+||.|+......
T Consensus 173 ~~~fse~~aRFYaAEvl~ALEYLHm---lGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~ 249 (459)
T KOG0610|consen 173 GKRFSESAARFYAAEVLLALEYLHM---LGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPS 249 (459)
T ss_pred CCccchhhHHHHHHHHHHHHHHHHh---hceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcc
Confidence 59999999999999999999999 99999999999999999999999999998643100
Q ss_pred ---------------C-c---------------------ccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHH
Q 044746 135 ---------------H-T---------------------HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177 (202)
Q Consensus 135 ---------------~-~---------------------~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~ 177 (202)
. . ...+...+||-.|+|||++.+...+.++|+|+||+++|||+
T Consensus 250 ~~~~~~s~f~~r~~~~~~~~~k~~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmL 329 (459)
T KOG0610|consen 250 CRSRQPSCFSPRCLSSSKKRKKKDESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEML 329 (459)
T ss_pred cccccccccccchhccccccccccccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHH
Confidence 0 0 01122357889999999999999999999999999999999
Q ss_pred cCCCCCcchhcccc
Q 044746 178 GRRRNLEKEISEGQ 191 (202)
Q Consensus 178 ~g~~p~~~~~~~~~ 191 (202)
.|+-||.+.+.++.
T Consensus 330 yG~TPFKG~~~~~T 343 (459)
T KOG0610|consen 330 YGTTPFKGSNNKET 343 (459)
T ss_pred hCCCCcCCCCchhh
Confidence 99999999887654
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-33 Score=224.41 Aligned_cols=184 Identities=22% Similarity=0.257 Sum_probs=153.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||+|+.+-.+.+||.|+. .++....+ ...+..|.......+|||++. .+...++++-+|.+|++.++++.
T Consensus 42 V~~A~c~p~~e~VAIK~i-nLEkc~~~-ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~ 119 (516)
T KOG0582|consen 42 VYLARCIPTNEVVAIKII-NLEKCNND-LDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYY 119 (516)
T ss_pred eeeeeecccCCEEEEEEe-ehhhhhhh-HHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHc
Confidence 799999999999998875 33344333 566788888888999999985 45667899999999999988854
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-ccc-CCCCCCCcc
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITS-TGRRRTPGC 149 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~-~~~~gt~~y 149 (202)
..+++..+..+.+++++||.|||. +|.||||+|+.|||++.+|.+||+|||.+..+...... ... ....||++|
T Consensus 120 ~~Gl~E~~Ia~iLre~LkaL~YLH~---~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~w 196 (516)
T KOG0582|consen 120 PDGLEEASIATILREVLKALDYLHQ---NGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCW 196 (516)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHh---cCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccc
Confidence 348999999999999999999999 99999999999999999999999999988765433211 112 456889999
Q ss_pred cCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 150 EAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 150 ~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
||||+++. ..|+.|+||||||++..|+.+|..||....+.
T Consensus 197 mAPEvl~q~~~GYdfKaDIwSfGITA~ELA~G~aPf~k~pPm 238 (516)
T KOG0582|consen 197 MAPEVLMQQLHGYDFKADIWSFGITACELAHGHAPFSKYPPM 238 (516)
T ss_pred cChHHhhhcccCccchhhhhhhhHHHHHHhcCCCCcccCChH
Confidence 99999653 57999999999999999999999999887754
|
|
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-33 Score=209.75 Aligned_cols=184 Identities=21% Similarity=0.267 Sum_probs=147.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||||++..+++.||.|--+.. +........-..|...+...+|+|++ +..+...++.+|++ .+|...++..
T Consensus 18 Vyka~d~~t~~~VAIKKIkl~-~~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~ 95 (318)
T KOG0659|consen 18 VYKARDTETGKRVAIKKIKLG-NAKDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKN 95 (318)
T ss_pred EEEEEecCCCcEEEEEEeecc-ccccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccc
Confidence 799999999988886432222 22222233345677777888889876 46777789999987 4666666544
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.++..+++.++.++++|++|||+ +.|+|||+||.|+|++.+|.+|++|||+++.........+.. +-|..|.||
T Consensus 96 i~l~pa~iK~y~~m~LkGl~y~H~---~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~~~~~~--V~TRWYRAP 170 (318)
T KOG0659|consen 96 IILSPADIKSYMLMTLKGLAYCHS---KWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNRIQTHQ--VVTRWYRAP 170 (318)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHh---hhhhcccCCccceEEcCCCcEEeecccchhccCCCCcccccc--eeeeeccCh
Confidence 48999999999999999999999 999999999999999999999999999999876554433322 348899999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcccc
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~ 191 (202)
|++.|. .|+..+|+||.||++.||+.|.|-|.++++-+|
T Consensus 171 ELLfGsr~Yg~~VDmWavGCI~AELllr~P~fpG~sDidQ 210 (318)
T KOG0659|consen 171 ELLFGSRQYGTGVDMWAVGCIFAELLLRVPFFPGDSDIDQ 210 (318)
T ss_pred HHhccchhcCCcchhhhHHHHHHHHHccCCCCCCCchHHH
Confidence 998874 799999999999999999999999998887665
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-33 Score=230.82 Aligned_cols=184 Identities=17% Similarity=0.244 Sum_probs=149.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.+|.|+.+............+..|..+....+|++++. .....+++++++++|+|..++....
T Consensus 59 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~ 138 (370)
T cd05621 59 VQLVRHKSSQKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD 138 (370)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC
Confidence 6888898888888888765433333333344666777778888998764 4455678899999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
++...+..++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||++......... ......||+.|+|||+
T Consensus 139 ~~~~~~~~~~~qil~aL~~LH~---~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~aPE~ 214 (370)
T cd05621 139 VPEKWAKFYTAEVVLALDAIHS---MGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETGMV-RCDTAVGTPDYISPEV 214 (370)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEEecccceecccCCce-ecccCCCCcccCCHHH
Confidence 9999999999999999999999 99999999999999999999999999999865432211 1234568999999999
Q ss_pred cCCC----CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPY----SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~----~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+. .++.++|+||+||++|||++|++||.....
T Consensus 215 ~~~~~~~~~~~~~~DiwSlG~ilyell~G~~Pf~~~~~ 252 (370)
T cd05621 215 LKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPFYADSL 252 (370)
T ss_pred HhccCCCCCCCcccCEEeehHHHHHHHhCCCCCCCCCH
Confidence 8753 377899999999999999999999976543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-33 Score=225.49 Aligned_cols=182 Identities=19% Similarity=0.272 Sum_probs=145.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.+|.|+.+............+..|..+....+|++++. ..+..+++++++++++|...+.. +
T Consensus 11 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 90 (323)
T cd05571 11 VILVREKATGKYYAMKILKKEVIIAKDEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER 90 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcC
Confidence 6889998888888888765433222222334555666777778887653 44556789999999999877754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||+|||+ .+|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||
T Consensus 91 ~~~~~~~~~~~~qi~~~L~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~--~~~~~~~gt~~y~aPE 165 (323)
T cd05571 91 VFSEDRARFYGAEIVSALGYLHS---CDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPE 165 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC--CcccceecCccccChh
Confidence 68999999999999999999999 999999999999999999999999999987432211 1123346899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.+..++.++|+||+||+++||++|+.||....
T Consensus 166 ~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~ 199 (323)
T cd05571 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQD 199 (323)
T ss_pred hhcCCCCCccccCcccchhhhhhhcCCCCCCCCC
Confidence 9998899999999999999999999999997644
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-33 Score=227.99 Aligned_cols=184 Identities=18% Similarity=0.251 Sum_probs=148.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.+|.|+..............+..|..+....+|++++. .+....++++++++|+|..++....
T Consensus 59 Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~~~ 138 (371)
T cd05622 59 VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 138 (371)
T ss_pred EEEEEECCCCcEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhcC
Confidence 6888998888888888765433332223334556666777788888763 4455678999999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
++...+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++......... ......||+.|+|||+
T Consensus 139 ~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aPE~ 214 (371)
T cd05622 139 VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEV 214 (371)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCcc-cccCcccCccccCHHH
Confidence 9999999999999999999999 99999999999999999999999999999865432211 1234568999999999
Q ss_pred cCCC----CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPY----SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~----~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+... .++.++|+||+||++|||++|++||.....
T Consensus 215 l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~ 252 (371)
T cd05622 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (371)
T ss_pred HhccCCCccCCCccceeehhHHHHHHHhCCCCCCCCCH
Confidence 8753 378899999999999999999999986543
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-33 Score=222.51 Aligned_cols=182 Identities=21% Similarity=0.291 Sum_probs=146.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.+|.|+.+............+..|..+....+|++++. ..+...++++++++++|..++. .+
T Consensus 9 Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 88 (312)
T cd05585 9 VMQVRKRDTQRIYALKTIRKAHIVSRSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREG 88 (312)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcC
Confidence 6889998888888887654433222233344556667777788998763 3455678899999999988774 44
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... ......||+.|+|||
T Consensus 89 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE 163 (312)
T cd05585 89 RFDLSRARFYTAELLCALENLHK---FNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDDD--KTNTFCGTPEYLAPE 163 (312)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHeEECCCCcEEEEECcccccCccCCC--ccccccCCcccCCHH
Confidence 69999999999999999999999 9999999999999999999999999999875322211 123356899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.+..++.++|+||+||+++||++|++||....
T Consensus 164 ~~~~~~~~~~~DvwslGvil~el~tg~~pf~~~~ 197 (312)
T cd05585 164 LLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDEN 197 (312)
T ss_pred HHcCCCCCCccceechhHHHHHHHhCCCCcCCCC
Confidence 9999899999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.7e-33 Score=228.55 Aligned_cols=185 Identities=19% Similarity=0.288 Sum_probs=148.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.+|.|+..............+..|..+....+|++++. ..+...++++++++|+|..++.. .
T Consensus 17 Vy~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~ 96 (381)
T cd05626 17 VCLACKVDTHALYAMKTLRKKDVLNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRME 96 (381)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcC
Confidence 7899999999999988765543333333445677777778888887763 45556789999999999888754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-----------------
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT----------------- 136 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~----------------- 136 (202)
.+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++.......
T Consensus 97 ~~~e~~~~~~~~qi~~aL~~LH~---~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (381)
T cd05626 97 VFPEVLARFYIAELTLAIESVHK---MGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEP 173 (381)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCc
Confidence 58999999999999999999999 9999999999999999999999999999753211000
Q ss_pred ----------------------------ccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 137 ----------------------------HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 137 ----------------------------~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
........||+.|+|||++.+..++.++||||+||++|||++|++||....+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~ 253 (381)
T cd05626 174 SDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTP 253 (381)
T ss_pred ccccccccccccccccchhhccccccccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCH
Confidence 0001234689999999999988899999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=227.33 Aligned_cols=185 Identities=20% Similarity=0.302 Sum_probs=148.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.||.|+.+............+..|..+....+|++++. .+...+++++++++|+|..++.. .
T Consensus 17 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~ 96 (364)
T cd05599 17 VRLVQKKDTGHIYAMKKLRKSEMLEKEQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKD 96 (364)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcC
Confidence 6889998888888888765543333333445666777778888888763 45556788999999999888754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc---------------
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI--------------- 138 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~--------------- 138 (202)
.+++..+..++.|++.||+|||+ .+++||||||+|||++.++.++|+|||+++.........
T Consensus 97 ~l~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (364)
T cd05599 97 TFTEEETRFYIAETILAIDSIHK---LGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLD 173 (364)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccc
Confidence 68999999999999999999999 999999999999999999999999999987543211000
Q ss_pred ---------------------ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 139 ---------------------TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 139 ---------------------~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
......||+.|+|||++....++.++|+||+||+++||++|++||....+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~ 244 (364)
T cd05599 174 FISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNP 244 (364)
T ss_pred cccccccccccccchhhcccccccccccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCH
Confidence 01124589999999999988999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.8e-33 Score=222.74 Aligned_cols=183 Identities=20% Similarity=0.289 Sum_probs=146.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.+|.|+..............+..|.......+|++++. ..+..+++++++++++|...+.. .
T Consensus 11 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~ 90 (328)
T cd05593 11 VILVREKASGKYYAMKILKKEVIIAKDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRER 90 (328)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcC
Confidence 6889998888888888765433222233344556667777788887753 34556788999999999877754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....... ......||+.|+|||
T Consensus 91 ~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE 165 (328)
T cd05593 91 VFSEDRTRFYGAEIVSALDYLHS---GKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDAA--TMKTFCGTPEYLAPE 165 (328)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeEECCCCcEEEecCcCCccCCCccc--ccccccCCcCccChh
Confidence 69999999999999999999999 9999999999999999999999999999875322111 123356899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++|+||+||++|+|++|+.||.....
T Consensus 166 ~~~~~~~~~~~DiwslGvil~elltG~~Pf~~~~~ 200 (328)
T cd05593 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (328)
T ss_pred hhcCCCCCccCCccccchHHHHHhhCCCCCCCCCH
Confidence 99988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.5e-32 Score=220.96 Aligned_cols=183 Identities=19% Similarity=0.282 Sum_probs=145.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..++..+|.|+.+............+..|..+....+|++++. ..+..+++++++++++|..++.. .
T Consensus 11 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 90 (323)
T cd05595 11 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER 90 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcC
Confidence 6888888888888887755433222222334555667777788887763 33456688999999999877754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... ......||+.|+|||
T Consensus 91 ~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE 165 (323)
T cd05595 91 VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPE 165 (323)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEEcCCCCEEecccHHhccccCCCC--ccccccCCcCcCCcc
Confidence 68999999999999999999999 9999999999999999999999999999874322111 123346799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++|+||+||++|||++|+.||.....
T Consensus 166 ~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~~ 200 (323)
T cd05595 166 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 200 (323)
T ss_pred cccCCCCCchhchhhhHHHHHHHHhCCCCCCCCCH
Confidence 99988999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.4e-33 Score=228.73 Aligned_cols=185 Identities=19% Similarity=0.305 Sum_probs=147.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.+|.|+..............+..|..+....+|++++. ......++++++++|+|..++.. +
T Consensus 17 Vy~a~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~ 96 (382)
T cd05625 17 VCLARKVDTKALYAMKTLRKKDVLLRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMG 96 (382)
T ss_pred EEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC
Confidence 7899999899988888755443322333445667777777888887763 44556789999999999888754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC------------------
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH------------------ 135 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~------------------ 135 (202)
.+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||++.......
T Consensus 97 ~~~e~~~~~~~~qi~~al~~lH~---~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (382)
T cd05625 97 IFPEDLARFYIAELTCAVESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDF 173 (382)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccc
Confidence 68999999999999999999999 999999999999999999999999999975321000
Q ss_pred ---------------------------cccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 136 ---------------------------THITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 136 ---------------------------~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.........||+.|+|||++.+..++.++|+||+||++|||++|++||....+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 253 (382)
T cd05625 174 SNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTP 253 (382)
T ss_pred cccccccccccccccccchhhhhccccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCH
Confidence 00001224689999999999988999999999999999999999999986554
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.1e-32 Score=218.44 Aligned_cols=180 Identities=18% Similarity=0.265 Sum_probs=146.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.+|.|+..............+..|.......+|++++. ......++++++++++|..++.. +
T Consensus 17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 96 (291)
T cd05612 17 VHLVRDRISEHYYALKVMAIPEVIRLKQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSG 96 (291)
T ss_pred EEEEEEcCCCCEEEEEEEEHHHHhhhHHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcC
Confidence 6888988888888887754433222233344666777778888898763 34556788999999999888754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++..... .....|++.|+|||
T Consensus 97 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~aPE 168 (291)
T cd05612 97 RFSNSTGLFYASEIVCALEYLHS---KEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-----TWTLCGTPEYLAPE 168 (291)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-----cccccCChhhcCHH
Confidence 68999999999999999999999 99999999999999999999999999998765322 12345799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++||||+||++|+|++|+.||.....
T Consensus 169 ~~~~~~~~~~~DiwSlG~il~~l~~g~~pf~~~~~ 203 (291)
T cd05612 169 VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNP 203 (291)
T ss_pred HHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=226.20 Aligned_cols=184 Identities=17% Similarity=0.245 Sum_probs=148.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++...+..+|.|+.+............+..|..+....+|++++. ......++++++++|+|..++....
T Consensus 59 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~ 138 (370)
T cd05596 59 VQLVRHKSSKQVYAMKLLSKFEMIKRSDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNYD 138 (370)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHhcC
Confidence 6888888888888887765433322223334556777778888888763 3445678999999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
++...+..++.|++.||.|||+ ++|+||||||+|||++.++.++|+|||++......... ......||+.|+|||+
T Consensus 139 l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~~-~~~~~~gt~~y~aPE~ 214 (370)
T cd05596 139 IPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGMV-RCDTAVGTPDYISPEV 214 (370)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCcc-cCCCCCCCcCeECHHH
Confidence 9999999999999999999999 99999999999999999999999999999865432211 1233568999999999
Q ss_pred cCCC----CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPY----SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~----~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+... .++.++|+||+||++|||++|++||.....
T Consensus 215 ~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~ 252 (370)
T cd05596 215 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSL 252 (370)
T ss_pred hccCCCCCCCCCceeeeehhHHHHHHHhCCCCcCCCCH
Confidence 8653 478899999999999999999999987544
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=99.98 E-value=1.4e-32 Score=220.53 Aligned_cols=183 Identities=21% Similarity=0.252 Sum_probs=142.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHH-HHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQ-RMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++.+.++.||.|+.+............+..+. ......+|++++. .++...++++++++++|..++..
T Consensus 11 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~ 90 (316)
T cd05592 11 VMLAELKGTNEFFAIKALKKDVVLEDDDVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSS 90 (316)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHc
Confidence 789999888888888876543322222222222333 3333457777653 44556789999999999887744
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..++...+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+++...... .......||+.|+||
T Consensus 91 ~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~--~~~~~~~gt~~y~aP 165 (316)
T cd05592 91 GRFDEARARFYAAEIICGLQFLHK---KGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE--GKASTFCGTPDYIAP 165 (316)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC--CccccccCCccccCH
Confidence 569999999999999999999999 999999999999999999999999999997543222 122345679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||+++||++|+.||.+...
T Consensus 166 E~~~~~~~~~~~DvwslG~il~ell~G~~Pf~~~~~ 201 (316)
T cd05592 166 EILKGQKYNESVDWWSFGVLLYEMLIGQSPFHGEDE 201 (316)
T ss_pred HHHcCCCCCCcccchhHHHHHHHHHhCCCCCCCCCH
Confidence 999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=8.6e-33 Score=222.83 Aligned_cols=180 Identities=19% Similarity=0.308 Sum_probs=149.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.+|.|+.+............+..|..+....+|++++. ..+...++++++.+++|...+.. +
T Consensus 34 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 113 (329)
T PTZ00263 34 VRIAKHKGTGEYYAIKCLKKREILKMKQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAG 113 (329)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcC
Confidence 6889998888888888765544333334455667777778888998763 44556788999999999887754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...... ....||+.|+|||
T Consensus 114 ~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~gt~~y~aPE 185 (329)
T PTZ00263 114 RFPNDVAKFYHAELVLAFEYLHS---KDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDRT-----FTLCGTPEYLAPE 185 (329)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEECCCCCEEEeeccCceEcCCCc-----ceecCChhhcCHH
Confidence 68999999999999999999999 999999999999999999999999999998654322 2346799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++|+||+||++|||++|+.||.+..+
T Consensus 186 ~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 220 (329)
T PTZ00263 186 VIQSKGHGKAVDWWTMGVLLYEFIAGYPPFFDDTP 220 (329)
T ss_pred HHcCCCCCCcceeechHHHHHHHHcCCCCCCCCCH
Confidence 99988899999999999999999999999976543
|
|
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-33 Score=228.93 Aligned_cols=186 Identities=20% Similarity=0.312 Sum_probs=148.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.+|.|+..............+..|..++...+|++++. .++...++++++++|+|..++.. +
T Consensus 17 V~~a~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~ 96 (376)
T cd05598 17 VCLVRKVDTNALYAMKTLRKADVLMRNQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLG 96 (376)
T ss_pred EEEEEECCCCCEEEEEEEcHHHHHhhhhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC
Confidence 7889998889999988765543333333445667777778888887763 45567789999999999988755 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC------------------
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH------------------ 135 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~------------------ 135 (202)
.++...+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++.......
T Consensus 97 ~~~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (376)
T cd05598 97 IFEEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEP 173 (376)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccc
Confidence 58899999999999999999999 999999999999999999999999999975321000
Q ss_pred -----------------------cccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 136 -----------------------THITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 136 -----------------------~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.........||+.|+|||++.+..++.++||||+||++|||++|+.||....+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 250 (376)
T cd05598 174 SEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPA 250 (376)
T ss_pred cccccccccccccchhhhhhhhcccccccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHH
Confidence 000112346899999999999989999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.2e-33 Score=228.45 Aligned_cols=185 Identities=21% Similarity=0.316 Sum_probs=146.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.+|.|+.........+....+..|..+....+|++++. .....+++++++++|+|..++.. .
T Consensus 17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~ 96 (377)
T cd05629 17 VRLVQKKDTGKIYAMKTLLKSEMFKKDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYD 96 (377)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHHHhHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcC
Confidence 6888888888888888755433322333345666777777788888763 44567789999999999887754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-------------c---
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-------------H--- 137 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-------------~--- 137 (202)
.+++..++.++.|++.||+|||+ .+|+||||||+||+++.++.++|+|||+++....... .
T Consensus 97 ~~~~~~~~~~~~ql~~aL~~LH~---~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (377)
T cd05629 97 TFSEDVTRFYMAECVLAIEAVHK---LGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRI 173 (377)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEEeeccccccccccccccccccccccccccccc
Confidence 68999999999999999999999 9999999999999999999999999999863211000 0
Q ss_pred -----------------------------cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 138 -----------------------------ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 138 -----------------------------~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.......||+.|+|||++.+..++.++|+||+||+++||++|++||....+
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~ 253 (377)
T cd05629 174 DNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENS 253 (377)
T ss_pred ccccccccccccccccchhhhhhhhhcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCH
Confidence 000124589999999999988899999999999999999999999976554
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.98 E-value=7.6e-33 Score=223.34 Aligned_cols=180 Identities=18% Similarity=0.238 Sum_probs=147.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.||.|+.+............+..|.......+|++++. .+...+++++++++++|..++.. .
T Consensus 17 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~ 96 (333)
T cd05600 17 VFLAKKKDTGEIVALKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLG 96 (333)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcC
Confidence 6889998888888888765443332233344566666777777887763 44556788999999999998854 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++..... ......||+.|+|||
T Consensus 97 ~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-----~~~~~~gt~~y~aPE 168 (333)
T cd05600 97 VLSEDHARFYMAEMFEAVDALHE---LGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-----YANSVVGSPDYMAPE 168 (333)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEEEeCcCCccccc-----ccCCcccCccccChh
Confidence 68999999999999999999999 9999999999999999999999999999975433 223456799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++||||+||++|||++|++||.....
T Consensus 169 ~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~~ 203 (333)
T cd05600 169 VLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTP 203 (333)
T ss_pred HhcCCCCCCccceecchHHHhhhhhCCCCCCCCCH
Confidence 99988999999999999999999999999976554
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.5e-32 Score=214.38 Aligned_cols=181 Identities=19% Similarity=0.209 Sum_probs=143.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++..+++.+|.|...............+..|..+....+|++++. ..+...++++++.+|+|.....
T Consensus 16 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~ 95 (285)
T cd05631 16 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 95 (285)
T ss_pred EEEEEEecCCceEEEEEeeHhhhhhhhhHHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhC
Confidence 6788888778888877543322222222234556667777778887653 4445678899999999976653
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ .....||+.|+|
T Consensus 96 ~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~y~a 169 (285)
T cd05631 96 NPGFDEQRAIFYAAELCCGLEDLQR---ERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGET---VRGRVGTVGYMA 169 (285)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCCe---ecCCCCCCCccC
Confidence 2358999999999999999999999 9999999999999999999999999999986533221 233467999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||++.+..++.++||||+||++|||++|+.||....
T Consensus 170 PE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~~~ 205 (285)
T cd05631 170 PEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRK 205 (285)
T ss_pred HhhhcCCCCCcccCchhHHHHHHHHHhCCCCCCCCC
Confidence 999999899999999999999999999999998644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=99.98 E-value=5.1e-33 Score=226.68 Aligned_cols=186 Identities=22% Similarity=0.318 Sum_probs=149.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++...++.+|.|+.+.......+....+..|..+....+|++++. .....+++++++++|+|..++. .+
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~ 96 (360)
T cd05627 17 VRLVQKKDTGHIYAMKILRKADMLEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKD 96 (360)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcC
Confidence 6888888888888888765544333444455666766677778887653 4456678999999999988875 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc----------------
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH---------------- 137 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~---------------- 137 (202)
.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.........
T Consensus 97 ~l~~~~~~~~~~qi~~~L~~lH~---~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (360)
T cd05627 97 TLSEEATQFYIAETVLAIDAIHQ---LGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSF 173 (360)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCcccccc
Confidence 69999999999999999999999 99999999999999999999999999998744211100
Q ss_pred -----------------cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 138 -----------------ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 138 -----------------~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.......||+.|+|||++.+..++.++|+||+||++|||++|++||....+.
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~ 242 (360)
T cd05627 174 QNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQ 242 (360)
T ss_pred cccccccccccccccccccccccCCCccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHH
Confidence 0012346899999999999989999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.3e-32 Score=212.42 Aligned_cols=184 Identities=21% Similarity=0.269 Sum_probs=141.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccc-ccc------cc------ccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSN-LVG------SE------DTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i~------~~------~~~~~~~~~~~~~~l~ 67 (202)
||||+...++++||.|..+-..+. .-.+.--..|..++...+|+| ++. .. +...++.++.+ ..|.
T Consensus 27 Vykar~~~~g~~VALKkirl~~~~-EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~d-~DL~ 104 (323)
T KOG0594|consen 27 VYKARSKRTGKFVALKKIRLEFEE-EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFLD-RDLK 104 (323)
T ss_pred EEEEEEecCCCEEEEEEEeccccc-cCCCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEeec-ccHH
Confidence 799999999999997764433222 123444567777778888887 542 11 13334555554 3444
Q ss_pred hhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 68 LLCKK-----NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 68 ~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
.++.. ..++...++.++.||+.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+...-+... .+.
T Consensus 105 ~ymd~~~~~~~g~~~~~ik~~m~Qll~gl~~~H~---~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip~~~--yt~ 179 (323)
T KOG0594|consen 105 KYMDSLPKKPQGLPPRLIKSFMRQLLRGLAFLHS---HGILHRDLKPQNLLISSSGVLKLADFGLARAFSIPMRT--YTP 179 (323)
T ss_pred HHHHhccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCcceEEECCCCcEeeeccchHHHhcCCccc--ccc
Confidence 44432 347778999999999999999999 99999999999999999999999999999965533322 344
Q ss_pred CCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcccc
Q 044746 143 RRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~ 191 (202)
..+|..|.|||++.+. .|++.+||||+||+++||+++++-|.+.++.+|
T Consensus 180 evvTlWYRaPEvLlGs~~Ys~~vDiWs~GcIfaEm~~~~~LFpG~se~~q 229 (323)
T KOG0594|consen 180 EVVTLWYRAPEVLLGSTSYSTSVDIWSLGCIFAEMFTRRPLFPGDSEIDQ 229 (323)
T ss_pred cEEEeeccCHHHhcCCCcCCCCcchHhHHHHHHHHHhCCCCCCCCcHHHH
Confidence 5668999999999886 799999999999999999999999998887543
|
|
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-32 Score=219.28 Aligned_cols=183 Identities=20% Similarity=0.244 Sum_probs=142.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccc-cc------cccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSN-LV------GSEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~i------~~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++.+.++.+|.|+.+............+..|.......++++ ++ ...+..+++++++++++|...+..
T Consensus 16 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~ 95 (324)
T cd05587 16 VMLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV 95 (324)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHc
Confidence 6889998888888888765433222222334445555555555543 32 234556788999999999877744
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........ ......||+.|+||
T Consensus 96 ~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP 170 (324)
T cd05587 96 GKFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGGK--TTRTFCGTPDYIAP 170 (324)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCCC--ceeeecCCccccCh
Confidence 568999999999999999999999 9999999999999999999999999999874321111 12334679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||++|||++|+.||.....
T Consensus 171 E~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (324)
T cd05587 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDE 206 (324)
T ss_pred hhhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 999998899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.4e-32 Score=222.53 Aligned_cols=180 Identities=18% Similarity=0.230 Sum_probs=143.9
Q ss_pred CCccccCCCc-ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGST-RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~-~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++.+...+ ..+|.|...............+..|..+....+|++++. ..+..+++++++.+|+|..++..
T Consensus 46 Vy~a~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~ 125 (340)
T PTZ00426 46 VILATYKNEDFPPVAIKRFEKSKIIKQKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRN 125 (340)
T ss_pred EEEEEEECCCCeEEEEEEEEHHHhhhhhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence 5777655443 566666543333222333345667777888888998763 44556789999999999888854
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||+++..... .....||+.|+||
T Consensus 126 ~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-----~~~~~gt~~y~aP 197 (340)
T PTZ00426 126 KRFPNDVGCFYAAQIVLIFEYLQS---LNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-----TYTLCGTPEYIAP 197 (340)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-----cceecCChhhcCH
Confidence 468999999999999999999999 99999999999999999999999999999865322 1234679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||++|||++|++||....+
T Consensus 198 E~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~~~ 233 (340)
T PTZ00426 198 EILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEP 233 (340)
T ss_pred HHHhCCCCCccccccchhhHHHHHhcCCCCCCCCCH
Confidence 999988899999999999999999999999987554
|
|
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-32 Score=218.37 Aligned_cols=183 Identities=23% Similarity=0.290 Sum_probs=144.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHH---Hhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI---AADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++...++.+|.|+.+............+..|..+. ...+|++++. .+...+++++++++++|.....
T Consensus 15 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~ 94 (324)
T cd05589 15 VLLAEYKKTGELYAIKALKKGDIIARDEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH 94 (324)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhh
Confidence 688888888888888876543322222223333333322 3456777653 4455678999999999999888
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...... .......|++.|+|
T Consensus 95 ~~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~g~~~y~a 169 (324)
T cd05589 95 TDVFSEPRAVFYAACVVLGLQYLHE---NKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG--DRTSTFCGTPEFLA 169 (324)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHh---CCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC--CcccccccCccccC
Confidence 8889999999999999999999999 999999999999999999999999999987432211 11233567999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||.+.+..++.++|+||+||++|||++|+.||.....
T Consensus 170 PE~~~~~~~~~~~DiwslG~il~el~~G~~pf~~~~~ 206 (324)
T cd05589 170 PEVLTETSYTRAVDWWGLGVLIYEMLVGESPFPGDDE 206 (324)
T ss_pred HhHhcCCCCCcccchhhHHHHHHHHHhCCCCCCCCCH
Confidence 9999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=218.01 Aligned_cols=183 Identities=21% Similarity=0.259 Sum_probs=142.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccc-ccc------cccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFS-NLV------GSEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~i------~~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.||.|+.+............+..|.......+++ .++ ...+..+++++++++++|..++..
T Consensus 16 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~ 95 (323)
T cd05615 16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQV 95 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHc
Confidence 688999888888988876544322222233344454444444433 332 233456688999999999887755
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... ......||+.|+||
T Consensus 96 ~~l~~~~~~~i~~qi~~al~~lH~---~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP 170 (323)
T cd05615 96 GKFKEPQAVFYAAEISVGLFFLHR---RGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDGV--TTRTFCGTPDYIAP 170 (323)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeccccccccCCCCc--cccCccCCccccCH
Confidence 569999999999999999999999 9999999999999999999999999999875322211 12334579999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||+++||++|++||....+
T Consensus 171 E~~~~~~~~~~~DiwslGvil~elltG~~pf~~~~~ 206 (323)
T cd05615 171 EIIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDE 206 (323)
T ss_pred HHHcCCCCCCccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 999988899999999999999999999999987654
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-32 Score=204.23 Aligned_cols=180 Identities=20% Similarity=0.257 Sum_probs=147.2
Q ss_pred CCccccCCCcceeehhh-hchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCch-hhhhcc
Q 044746 1 MEKPRNRGSTRFITRTI-DKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPF-YLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l-~~~~~~ 72 (202)
|+|+.++.+++..+.|+ .... .......++..|..++....||+|+ .+.++.+++.++++++.| +++..+
T Consensus 27 VrRc~~~~tg~~fa~kiin~~k--~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R 104 (355)
T KOG0033|consen 27 VRRCVHKTTGLEFAAKIINTKK--LSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAR 104 (355)
T ss_pred HHHHHhccchHHHHHHHhhhhh--hccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHH
Confidence 45555655555555544 3222 2233566788899999999999886 467788899999999987 455566
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
..+++..+..+++||+++|.|+|+ ++|+|||+||+|+++.+ .--+||+|||++..++ ......+..|||+|
T Consensus 105 ~~ySEa~aSH~~rQiLeal~yCH~---n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~---~g~~~~G~~GtP~f 178 (355)
T KOG0033|consen 105 EFYSEADASHCIQQILEALAYCHS---NGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVN---DGEAWHGFAGTPGY 178 (355)
T ss_pred HHHHHHHHHHHHHHHHHHHHHHHh---cCceeccCChhheeeeeccCCCceeecccceEEEeC---CccccccccCCCcc
Confidence 678999999999999999999999 99999999999999964 3458999999998776 23345778899999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||||++...+|+..+|||+.|++|+-|+.|.+||.+++.
T Consensus 179 maPEvvrkdpy~kpvDiW~cGViLfiLL~G~~PF~~~~~ 217 (355)
T KOG0033|consen 179 LSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 217 (355)
T ss_pred cCHHHhhcCCCCCcchhhhhhHHHHHHHhCCCCCCCccH
Confidence 999999999999999999999999999999999998544
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.7e-32 Score=218.57 Aligned_cols=184 Identities=21% Similarity=0.266 Sum_probs=140.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccc------cccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLV------GSEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+.+............+..+....... ++++++ ...+...++++++++|+|...+..
T Consensus 16 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~ 95 (323)
T cd05616 16 VMLAERKGTDELYAIKILKKDVVIQDDDVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQV 95 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHc
Confidence 688999888888888875543222222222233333333333 444433 234456689999999999877744
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||+++...... .......||+.|+||
T Consensus 96 ~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aP 170 (323)
T cd05616 96 GRFKEPHAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG--VTTKTFCGTPDYIAP 170 (323)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC--CccccCCCChhhcCH
Confidence 569999999999999999999999 999999999999999999999999999987532211 112345679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++.+..++.++|+||+||++|||++|+.||......
T Consensus 171 E~~~~~~~~~~~DiwSlGvil~elltg~~Pf~~~~~~ 207 (323)
T cd05616 171 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 207 (323)
T ss_pred HHhcCCCCCCccchhchhHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.9e-32 Score=217.67 Aligned_cols=183 Identities=22% Similarity=0.269 Sum_probs=142.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHH-Hhcccccccc------ccccceEEEEEccCCchhhhhc-c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI-AADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~ 72 (202)
||++++..+++.+|.|+.+............+..+.... ...+|++++. ..+..+++++++++++|..++. .
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~ 90 (320)
T cd05590 11 VMLARLKESGRLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKS 90 (320)
T ss_pred EEEEEEcCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHc
Confidence 688999888888888875443222222222333343333 3446887763 3445678899999999987764 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...... .......||+.|+||
T Consensus 91 ~~l~~~~~~~~~~ql~~~L~~lH~---~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aP 165 (320)
T cd05590 91 RRFDEARARFYAAEITSALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG--KTTSTFCGTPDYIAP 165 (320)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC--CcccccccCccccCH
Confidence 569999999999999999999999 999999999999999999999999999987532211 112335689999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||++|||++|+.||.....
T Consensus 166 E~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~~ 201 (320)
T cd05590 166 EILQEMLYGPSVDWWAMGVLLYEMLCGHAPFEAENE 201 (320)
T ss_pred HHHcCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 999988899999999999999999999999976554
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-32 Score=219.92 Aligned_cols=183 Identities=20% Similarity=0.306 Sum_probs=142.1
Q ss_pred CCccccCCCcceeehhh-hchhhhhccCCcccCCcHHHHHHhcccccccc------ccc-cceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTI-DKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SED-TETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~-~~~~~~~~~~~~~l~~~~~~ 72 (202)
||+|+....+..||.|- .++.... +....+.+-..+.....|+|+|. ... ...+++|+|+ .+|+++++.
T Consensus 26 V~la~~~~~~~~VAIK~MK~Kf~s~--ee~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~Md-~NLYqLmK~ 102 (538)
T KOG0661|consen 26 VYLAKSKETGELVAIKKMKKKFYSW--EECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFMD-CNLYQLMKD 102 (538)
T ss_pred EEEeeecCCCceeeHHHHHhhhccH--HHHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhhh-hhHHHHHhh
Confidence 78999988888888654 3333322 22233333333344444888763 333 6677788776 578887765
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 N--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
+ .+++..++.|+.||+.||+|+|. +|+.|||+||+|||+.....+||+|||+|+.+...... +..+.|..|+
T Consensus 103 R~r~fse~~irnim~QilqGL~hiHk---~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~SkpPY---TeYVSTRWYR 176 (538)
T KOG0661|consen 103 RNRLFSESDIRNIMYQILQGLAHIHK---HGFFHRDLKPENILISGNDVIKIADFGLAREVRSKPPY---TEYVSTRWYR 176 (538)
T ss_pred cCCcCCHHHHHHHHHHHHHHHHHHHh---cCcccccCChhheEecccceeEecccccccccccCCCc---chhhhccccc
Confidence 4 49999999999999999999999 99999999999999999999999999999976543332 3345599999
Q ss_pred CCcccC-CCCCCchhhHHHHHHHHHHHHcCCCCCcchhccccc
Q 044746 151 APELWM-PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQE 192 (202)
Q Consensus 151 aPe~~~-~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~ 192 (202)
|||++. ..-|+.+.|+||+||+++|+.+-++.|.+.++-+|.
T Consensus 177 APEvLLrs~~Ys~pvD~wA~GcI~aEl~sLrPLFPG~sE~Dqi 219 (538)
T KOG0661|consen 177 APEVLLRSGYYSSPVDMWAVGCIMAELYSLRPLFPGASEIDQI 219 (538)
T ss_pred chHHhhhccccCCchHHHHHHHHHHHHHHhcccCCCCcHHHHH
Confidence 999876 457999999999999999999999999998887763
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=211.66 Aligned_cols=182 Identities=19% Similarity=0.232 Sum_probs=144.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh----
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC---- 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~---- 70 (202)
||++.+...++.++.|...............+..|..+....+|++++. ......++++++++++|...+
T Consensus 9 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~ 88 (280)
T cd05608 9 VSACQMRATGKLYACKKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVD 88 (280)
T ss_pred EEEEEEccCCcEEEEEeeeHHHHhhhHHHHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhcc
Confidence 6888888777777776654433222223344556777777888887763 334566889999999997665
Q ss_pred -ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 71 -KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 71 -~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
....+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........ ......||+.|
T Consensus 89 ~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~g~~~y 163 (280)
T cd05608 89 EENPGFPEPRACFYTAQIISGLEHLHQ---RRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS--KTKGYAGTPGF 163 (280)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc--cccccCCCcCc
Confidence 23458999999999999999999999 9999999999999999999999999999976543222 12334679999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||.+.+..++.++|+||+|+++|||++|+.||....
T Consensus 164 ~aPE~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 201 (280)
T cd05608 164 MAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRARG 201 (280)
T ss_pred cCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99999999999999999999999999999999997643
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-32 Score=221.52 Aligned_cols=158 Identities=25% Similarity=0.426 Sum_probs=135.4
Q ss_pred cccCCcHHHHHHhcccccccc-----cc-ccceEEEEEccCCchhhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 044746 29 PIRFTSPQRMIAADNFSNLVG-----SE-DTETYIKGFLAMGPFYLLCKK---NILGFGQLREIEVSTSKGIAYLHEECR 99 (202)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~i~-----~~-~~~~~~~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~ 99 (202)
...|..|..++...+|++++. .. +-..++++++..|+|.++++. ..+...+.+.++.|||+|++||.+
T Consensus 245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes--- 321 (468)
T KOG0197|consen 245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLES--- 321 (468)
T ss_pred hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHh---
Confidence 345778999999999998873 22 235799999999999999976 469999999999999999999999
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG- 178 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~- 178 (202)
+++|||||...|||++.+..+|++||||++...++.+... .+..-+..|.|||.+..+.|+.++||||||++|||++|
T Consensus 322 ~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d~~Y~~~-~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~ 400 (468)
T KOG0197|consen 322 KNYIHRDLAARNILVDEDLVVKISDFGLARLIGDDEYTAS-EGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTY 400 (468)
T ss_pred CCccchhhhhhheeeccCceEEEcccccccccCCCceeec-CCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhcc
Confidence 9999999999999999999999999999996655544333 23333778999999999999999999999999999998
Q ss_pred CCCCCcchhccc
Q 044746 179 RRRNLEKEISEG 190 (202)
Q Consensus 179 g~~p~~~~~~~~ 190 (202)
|+.|+.+....+
T Consensus 401 G~~py~~msn~e 412 (468)
T KOG0197|consen 401 GRVPYPGMSNEE 412 (468)
T ss_pred CCCCCCCCCHHH
Confidence 999988776544
|
|
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.8e-32 Score=222.19 Aligned_cols=185 Identities=19% Similarity=0.300 Sum_probs=151.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.+|.|+.+............+..|.......+|++++. .+...+++++++.+++|..++.. +
T Consensus 17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 96 (350)
T cd05573 17 VWLVRDKDTGQVYAMKVLRKSDMIKRNQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKD 96 (350)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhccHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcC
Confidence 6889998888888888765544333344455677777788888887663 45566789999999999888755 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC------------------
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH------------------ 135 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~------------------ 135 (202)
.++...+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......
T Consensus 97 ~l~~~~~~~i~~qi~~aL~~LH~---~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (350)
T cd05573 97 VFPEETARFYIAELVLALDSVHK---LGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNV 173 (350)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccc
Confidence 79999999999999999999999 999999999999999999999999999998654322
Q ss_pred ---------cccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 136 ---------THITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 136 ---------~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.........||+.|+|||++.+..++.++||||+||+++||++|+.||.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~ 235 (350)
T cd05573 174 LVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTL 235 (350)
T ss_pred cccccccccccccccccccCccccCHHHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCH
Confidence 00112335689999999999999999999999999999999999999986653
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-32 Score=217.99 Aligned_cols=184 Identities=19% Similarity=0.268 Sum_probs=142.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHH-hcccccccc------ccccceEEEEEccCCchhhhhc-c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIA-ADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~ 72 (202)
||++++.+.++.+|.|+.+.......+....+..|..+.. ..+|++++. ..+..+++++++++++|...+. .
T Consensus 11 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~ 90 (321)
T cd05591 11 VMLAELKGTDEVYAIKVLKKDVILQDDDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRS 90 (321)
T ss_pred EEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHc
Confidence 6888888888888887754432222222233334444333 346777653 3445678999999999977664 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........ ......||+.|+||
T Consensus 91 ~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP 165 (321)
T cd05591 91 RKFDEPRSRFYAAEVTLALMFLHR---HGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNGV--TTTTFCGTPDYIAP 165 (321)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEeecccceecccCCc--cccccccCccccCH
Confidence 568999999999999999999999 9999999999999999999999999999875322211 12334679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++.+..++.++|+||+||++|||++|+.||....++
T Consensus 166 E~~~~~~~~~~~DvwslG~il~el~tg~~Pf~~~~~~ 202 (321)
T cd05591 166 EILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNED 202 (321)
T ss_pred HHHcCCCCCCccceechhHHHHHHhcCCCCCCCCCHH
Confidence 9999888999999999999999999999999876543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=218.65 Aligned_cols=180 Identities=22% Similarity=0.265 Sum_probs=142.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhc-c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCK-K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~ 72 (202)
||++++...++.+|.|+.+.......+....+..|..+.... +|++++. .....+++++++++++|..++. .
T Consensus 11 V~~~~~~~~~~~~aiK~i~~~~~~~~~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~ 90 (329)
T cd05588 11 VLLVELKKTRRIYAMKVIKKELVNDDEDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQ 90 (329)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHc
Confidence 688888888888888876544332222233344555544443 7887764 3345678999999999987764 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...... .......||+.|+||
T Consensus 91 ~~l~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~--~~~~~~~gt~~y~aP 165 (329)
T cd05588 91 RKLPEEHARFYSAEISLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG--DTTSTFCGTPNYIAP 165 (329)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEECcCccccccccCC--CccccccCCccccCH
Confidence 579999999999999999999999 999999999999999999999999999987422111 112335679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|++.+..++.++|+||+||++|||++|+.||+.
T Consensus 166 E~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~ 198 (329)
T cd05588 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred HHHcCCCCCCccceechHHHHHHHHHCCCCccc
Confidence 999998999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-31 Score=213.15 Aligned_cols=182 Identities=20% Similarity=0.282 Sum_probs=158.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
|-+|....+++.||.|.-++..-........+..|..+....|||+||. ..+-..++|+|..+|.|++++.. +
T Consensus 69 Vk~A~e~~sgR~VAiKsIrKdkIkdeqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~ 148 (668)
T KOG0611|consen 69 VKLAYEHKSGREVAIKSIRKDKIKDEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERG 148 (668)
T ss_pred eeehhhccCCcEeehhhhhhhhcccHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhc
Confidence 4467888899999998877766555556677889999999999999874 34445689999999999999954 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.+++.+++||.+|+.|+|. ++++|||||.+|||++.++++|++|||++.++..... ....+|+|-|.+||
T Consensus 149 ~LsErEaRhfFRQIvSAVhYCHk---nrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~kf---LqTFCGSPLYASPE 222 (668)
T KOG0611|consen 149 SLSEREARHFFRQIVSAVHYCHK---NRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKKF---LQTFCGSPLYASPE 222 (668)
T ss_pred cccHHHHHHHHHHHHHHHHHHhh---ccceecccchhheeecCCCCeeeeccchhhhhccccH---HHHhcCCcccCCcc
Confidence 69999999999999999999999 9999999999999999999999999999988766544 34567899999999
Q ss_pred ccCCCCCC-chhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVT-QKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~-~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
...+.+|. +.+|.||+|++||-|+.|..||++.+.
T Consensus 223 IvNG~PY~GPEVDsWsLGvLLYtLVyGtMPFDG~Dh 258 (668)
T KOG0611|consen 223 IVNGTPYKGPEVDSWSLGVLLYTLVYGTMPFDGRDH 258 (668)
T ss_pred ccCCCCCCCCccchhhHHHHHHHHhhcccccCCchH
Confidence 99999886 679999999999999999999998654
|
|
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.5e-32 Score=218.50 Aligned_cols=182 Identities=19% Similarity=0.215 Sum_probs=142.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc------ccccceEEEEEccCCchhhhhc-c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~ 72 (202)
||++++..+++.+|.|+.+.......+....+..|..+... .+|++++. .....+++++++++++|..++. .
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 90 (327)
T cd05617 11 VLLVRLKKNDQIYAMKVVKKELVHDDEDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQ 90 (327)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence 68888888888888887654433222223334455444433 35776653 3344568899999999987764 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...... .......||+.|+||
T Consensus 91 ~~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aP 165 (327)
T cd05617 91 RKLPEEHARFYAAEICIALNFLHE---RGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG--DTTSTFCGTPNYIAP 165 (327)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC--CceecccCCcccCCH
Confidence 579999999999999999999999 999999999999999999999999999987432211 112335679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.+..++.++|+||+||++|||++|+.||....
T Consensus 166 E~~~~~~~~~~~DiwslGvil~ell~g~~pf~~~~ 200 (327)
T cd05617 166 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIIT 200 (327)
T ss_pred HHHCCCCCCchheeehhHHHHHHHHhCCCCCCccC
Confidence 99999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=215.38 Aligned_cols=183 Identities=20% Similarity=0.253 Sum_probs=141.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHH-Hhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI-AADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+.+............+..|.... ...+|++++. ..+...++++++++|+|..++..
T Consensus 11 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~ 90 (316)
T cd05619 11 VFLAELKGTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSC 90 (316)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence 688999888888888765543222112222233333333 3457887653 34456689999999999888865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...... .......||+.|+||
T Consensus 91 ~~~~~~~~~~~~~qi~~al~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aP 165 (316)
T cd05619 91 HKFDLPRATFYAAEIICGLQFLHS---KGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD--AKTCTFCGTPDYIAP 165 (316)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC--CceeeecCCccccCH
Confidence 468999999999999999999999 999999999999999999999999999987432111 112334679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||++|||++|+.||.....
T Consensus 166 E~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (316)
T cd05619 166 EILLGQKYNTSVDWWSFGVLLYEMLIGQSPFHGHDE 201 (316)
T ss_pred HHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCCCH
Confidence 999988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-32 Score=219.78 Aligned_cols=183 Identities=22% Similarity=0.209 Sum_probs=155.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc---c---ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV---G---SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i---~---~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
|||+.+...++.||.|+..-. ...+....++.|...+...+.+++. | .+...+.+|+++.+|++.+.++.+.
T Consensus 29 Vyk~~d~~t~k~vAiKii~Le--~~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~ 106 (467)
T KOG0201|consen 29 VYKAIDNKTKKVVAIKIIDLE--EAEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGN 106 (467)
T ss_pred eeeeeeccccceEEEEEechh--hcchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCC
Confidence 799999999999999885332 2223344567777788888777664 2 4556678899999999999998877
Q ss_pred C-CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 75 L-GFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 75 ~-~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
+ .+.+...+.++++.|+.|+|+ .+.||||+|+.||++..+|.+||+|||++..+....... ....|||.|||||
T Consensus 107 ~~~E~~i~~ilre~l~~l~ylH~---~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~~rr--~tfvGTPfwMAPE 181 (467)
T KOG0201|consen 107 ILDEFEIAVILREVLKGLDYLHS---EKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTVKRR--KTFVGTPFWMAPE 181 (467)
T ss_pred CCccceeeeehHHHHHHhhhhhh---cceecccccccceeEeccCcEEEEecceeeeeechhhcc--ccccccccccchh
Confidence 6 888999999999999999999 999999999999999999999999999998766544332 5578999999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
++.+..|+.++||||||++.+||++|.||+.+..++.
T Consensus 182 VI~~~~Y~~KADIWSLGITaiEla~GePP~s~~hPmr 218 (467)
T KOG0201|consen 182 VIKQSGYDTKADIWSLGITAIELAKGEPPHSKLHPMR 218 (467)
T ss_pred hhccccccchhhhhhhhHHHHHHhcCCCCCcccCcce
Confidence 9998899999999999999999999999999888753
|
|
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.6e-31 Score=215.88 Aligned_cols=182 Identities=21% Similarity=0.282 Sum_probs=135.1
Q ss_pred CCcccc-----CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccccc-------cccceEEEEEccCCchh
Q 044746 1 MEKPRN-----RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGS-------EDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~-----~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~-------~~~~~~~~~~~~~~~l~ 67 (202)
||++++ ...+..||+|+.+.... ......+..|..+.... +|+|++.. .+...++++++++|+|.
T Consensus 23 Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~ 100 (338)
T cd05102 23 VVEASAFGIDKKSSCNTVAVKMLKEGAT--ASEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLS 100 (338)
T ss_pred EEEEEEeccCCcccchhhheeccccccc--hHHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHH
Confidence 566653 33445677666543211 11123355555555555 78887642 22346789999999998
Q ss_pred hhhcc---------------------------------------------------------------CCCCHHHHHHHH
Q 044746 68 LLCKK---------------------------------------------------------------NILGFGQLREIE 84 (202)
Q Consensus 68 ~~~~~---------------------------------------------------------------~~~~~~~~~~~~ 84 (202)
.++.. ..+++..+..++
T Consensus 101 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 180 (338)
T cd05102 101 NFLRAKREFFSPYREKSPKQRGRFRAMVEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYS 180 (338)
T ss_pred HHHHhcchhcccccccchhhhhhhhhhhhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHH
Confidence 77743 237788899999
Q ss_pred HHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchh
Q 044746 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKC 164 (202)
Q Consensus 85 ~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~ 164 (202)
.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+++...............+++.|+|||++.+..++.++
T Consensus 181 ~qi~~aL~~LH~---~~ivHrDiKp~Nil~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 257 (338)
T cd05102 181 FQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQS 257 (338)
T ss_pred HHHHHHHHHHHH---CCEECCCCccceEEEcCCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCccc
Confidence 999999999999 99999999999999999999999999999865433222222233456789999999988899999
Q ss_pred hHHHHHHHHHHHHc-CCCCCcchh
Q 044746 165 DVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 165 Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
|||||||++|||++ |..||....
T Consensus 258 DiwslG~il~el~~~g~~pf~~~~ 281 (338)
T cd05102 258 DVWSFGVLLWEIFSLGASPYPGVQ 281 (338)
T ss_pred CHHHHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999997 999998644
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.7e-32 Score=217.65 Aligned_cols=183 Identities=19% Similarity=0.289 Sum_probs=142.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCccc-CCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIR-FTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+.............. +..+..+....+|++++. ..+...++++++++++|..++..
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 90 (325)
T cd05602 11 VLLARHKAEEKFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE 90 (325)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHHhhhHHHHHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhc
Confidence 6899998888888888765433222111122 222333455667887763 34456788999999999887754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..++...+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... ......||+.|+||
T Consensus 91 ~~~~~~~~~~~~~qi~~~L~~lH~---~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~~--~~~~~~gt~~y~aP 165 (325)
T cd05602 91 RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHNG--TTSTFCGTPEYLAP 165 (325)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEEccCCCCcccccCCC--CcccccCCccccCH
Confidence 458899999999999999999999 9999999999999999999999999999875322111 12335689999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++||||+||++|||++|++||.....
T Consensus 166 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 201 (325)
T cd05602 166 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 201 (325)
T ss_pred HHHcCCCCCCccccccccHHHHHHhcCCCCCCCCCH
Confidence 999998999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-32 Score=224.66 Aligned_cols=150 Identities=24% Similarity=0.326 Sum_probs=130.7
Q ss_pred HHHHHhcccccccccc------ccceEEEEEccCCchhhhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 044746 36 QRMIAADNFSNLVGSE------DTETYIKGFLAMGPFYLLCKKN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIK 108 (202)
Q Consensus 36 ~~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk 108 (202)
+..+...+|+|||... ...+++|+|+..|.|+.+++.+ .++......+..+|+.|+.|||. +.|||||||
T Consensus 163 IKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~---hKIIHRDLK 239 (904)
T KOG4721|consen 163 IKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHL---HKIIHRDLK 239 (904)
T ss_pred HHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHH---hhHhhhccC
Confidence 4456677888888533 4456899999999999999765 59999999999999999999999 999999999
Q ss_pred CCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 109 PESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 109 ~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
..||||..+..+||+|||.++..... .+.....||..|||||++...+.+.|+|||||||+||||+||+-||.+...
T Consensus 240 SPNiLIs~~d~VKIsDFGTS~e~~~~---STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdVds 316 (904)
T KOG4721|consen 240 SPNILISYDDVVKISDFGTSKELSDK---STKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDVDS 316 (904)
T ss_pred CCceEeeccceEEeccccchHhhhhh---hhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCccccch
Confidence 99999999999999999999865443 334567899999999999999999999999999999999999999987666
Q ss_pred ccc
Q 044746 189 EGQ 191 (202)
Q Consensus 189 ~~~ 191 (202)
...
T Consensus 317 sAI 319 (904)
T KOG4721|consen 317 SAI 319 (904)
T ss_pred hee
Confidence 543
|
|
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.5e-32 Score=217.54 Aligned_cols=182 Identities=18% Similarity=0.280 Sum_probs=142.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccC-CcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRF-TSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+..............+ ..+.......+|++++. ......++++++++++|..++..
T Consensus 11 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~ 90 (323)
T cd05575 11 VLLAKHKADGKFYAVKVLQKKAILKKKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRE 90 (323)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhc
Confidence 68899988888888887544322222222222 23333456678888764 34456788999999999877754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....... ......||+.|+||
T Consensus 91 ~~~~~~~~~~~~~qi~~~l~~lH~---~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP 165 (323)
T cd05575 91 RSFPEPRARFYAAEIASALGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHSK--TTSTFCGTPEYLAP 165 (323)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCCC--ccccccCChhhcCh
Confidence 468999999999999999999999 9999999999999999999999999999875322111 12334679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.+..++.++|+|||||++|||++|++||....
T Consensus 166 E~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 200 (323)
T cd05575 166 EVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (323)
T ss_pred hhhcCCCCCccccccccchhhhhhhcCCCCCCCCC
Confidence 99999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-32 Score=219.48 Aligned_cols=184 Identities=19% Similarity=0.289 Sum_probs=145.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...+..+|.|+.+............+..|.......+|++++. ..+..+++++++++++|..++.. .
T Consensus 11 V~~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 90 (325)
T cd05594 11 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER 90 (325)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcC
Confidence 6888888888888888765433222222334455666677778887753 34556789999999999887754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+. .+++||||||+||+++.++.++|+|||+++....... ......||+.|+|||
T Consensus 91 ~l~~~~~~~~~~qi~~aL~~lH~~--~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE 166 (325)
T cd05594 91 VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDGA--TMKTFCGTPEYLAPE 166 (325)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCCc--ccccccCCcccCCHH
Confidence 689999999999999999999962 6999999999999999999999999999875322211 122345799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++|+||+||++|||++|+.||.....
T Consensus 167 ~~~~~~~~~~~DiwslG~il~el~tG~~Pf~~~~~ 201 (325)
T cd05594 167 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 201 (325)
T ss_pred HHccCCCCCccccccccceeeeeccCCCCCCCCCH
Confidence 99988899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.2e-32 Score=217.01 Aligned_cols=182 Identities=18% Similarity=0.264 Sum_probs=142.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH-HHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++...++.++.|+..............+..+ ..+....+|++++. ......++++++++++|...+..
T Consensus 11 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 90 (321)
T cd05603 11 VLLAKRKSDGSFYAVKVLQKKTILKKKEQNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRE 90 (321)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHHHhhHHHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc
Confidence 68999988888888887544322222222223333 33456678888764 33456688999999999776644
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..++...+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ......||+.|+||
T Consensus 91 ~~~~~~~~~~~~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aP 165 (321)
T cd05603 91 RCFLEPRARFYAAEVASAIGYLHS---LNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPEE--TTSTFCGTPEYLAP 165 (321)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCCC--ccccccCCcccCCH
Confidence 568999999999999999999999 9999999999999999999999999999875322111 12334679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+.+..++.++|+||+||++|||++|++||....
T Consensus 166 E~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 200 (321)
T cd05603 166 EVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD 200 (321)
T ss_pred HHhcCCCCCCcCcccccchhhhhhhcCCCCCCCCC
Confidence 99998889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-31 Score=215.34 Aligned_cols=183 Identities=20% Similarity=0.231 Sum_probs=141.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHH-Hhccccccc------cccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI-AADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++...+..+|.|+.+............+..|.... ...+|++++ ...+..+++++++.+++|..++..
T Consensus 11 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~ 90 (316)
T cd05620 11 VLLAELKGKGEYFAVKALKKDVVLIDDDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDK 90 (316)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhcchHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHc
Confidence 688888888888888775543222112222233333333 334677665 344566788999999999877754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||+|||+ ++++||||||+||+++.++.++|+|||+++...... .......||+.|+||
T Consensus 91 ~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~gt~~y~aP 165 (316)
T cd05620 91 GRFDLYRATFYAAEIVCGLQFLHS---KGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD--NRASTFCGTPDYIAP 165 (316)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC--CceeccCCCcCccCH
Confidence 468999999999999999999999 999999999999999999999999999987432111 112345679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||+++||++|+.||.....
T Consensus 166 E~~~~~~~~~~~DiwslGvil~el~~g~~Pf~~~~~ 201 (316)
T cd05620 166 EILQGLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDE 201 (316)
T ss_pred HHHcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 999998999999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=218.11 Aligned_cols=183 Identities=19% Similarity=0.233 Sum_probs=142.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH-HHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+..............+..+ ..+....+|++++. ..+...++++++.+++|...+..
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 90 (325)
T cd05604 11 VLLAKRKLDGKCYAVKVLQKKIVLNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRE 90 (325)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHc
Confidence 68888888888888887654332222222233333 33456678888763 34456788999999999777644
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++...... .......||+.|+||
T Consensus 91 ~~~~~~~~~~~~~qi~~al~~lH~---~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~--~~~~~~~gt~~y~aP 165 (325)
T cd05604 91 RSFPEPRARFYAAEIASALGYLHS---INIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS--DTTTTFCGTPEYLAP 165 (325)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC--CCcccccCChhhCCH
Confidence 569999999999999999999999 999999999999999999999999999987432211 112345679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||+++||++|++||.....
T Consensus 166 E~~~~~~~~~~~DvwslG~il~el~~G~~pf~~~~~ 201 (325)
T cd05604 166 EVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDV 201 (325)
T ss_pred HHHcCCCCCCcCccccccceehhhhcCCCCCCCCCH
Confidence 999998999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.2e-32 Score=218.46 Aligned_cols=183 Identities=21% Similarity=0.276 Sum_probs=145.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.+|.|+..............+..+..+....+|++++. ..+..+++++++.+|+|..++..
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~ 96 (331)
T cd05624 17 VAVVKMKHTERIYAMKILNKWEMLKRAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFE 96 (331)
T ss_pred EEEEEECCCCCEEEEEEEeHHHHHhhHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhc
Confidence 6888888888888888765433332223334566666677777776652 45567799999999999998864
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||+|||+ ++|+||||||+||+++.++.++|+|||++......... ......||+.|+||
T Consensus 97 ~~l~~~~~~~~~~qi~~~L~~lH~---~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~aP 172 (331)
T cd05624 97 DRLPEDMARFYIAEMVLAIHSIHQ---LHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGTV-QSSVAVGTPDYISP 172 (331)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCce-eeccccCCcccCCH
Confidence 468999999999999999999999 99999999999999999999999999999865433221 12234689999999
Q ss_pred cccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMP-----YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~-----~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.+ ..++.++|+||+|+++|||++|+.||....
T Consensus 173 E~~~~~~~~~~~~~~~~DiwSlGvil~ell~g~~Pf~~~~ 212 (331)
T cd05624 173 EILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred HHHhccccCCCCCCCcccEEeeehhhhhhhhCCCCccCCC
Confidence 99875 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=216.33 Aligned_cols=183 Identities=20% Similarity=0.255 Sum_probs=145.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.+|.|+..............+..|..+....+|++++. ..+..+++++++++++|..++..
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~ 96 (331)
T cd05597 17 VAVVKMKNTGQVYAMKILNKWEMLKRAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE 96 (331)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhc
Confidence 6888888888888888765443333333344666666677777887653 45567799999999999988854
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++......... ......||+.|+||
T Consensus 97 ~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aP 172 (331)
T cd05597 97 DRLPEDMARFYLAEMVLAIDSVHQ---LGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGTV-QSNVAVGTPDYISP 172 (331)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCCc-cccceeccccccCH
Confidence 469999999999999999999999 99999999999999999999999999998765432221 11224579999999
Q ss_pred cccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMP-----YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~-----~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.. ..++.++|+||+||++|||++|+.||....
T Consensus 173 E~~~~~~~~~~~~~~~~DiwslG~~l~el~~g~~Pf~~~~ 212 (331)
T cd05597 173 EILQAMEDGKGRYGPECDWWSLGVCMYEMLYGETPFYAES 212 (331)
T ss_pred HHHhhccccccCCCCcceeehhhhHHHHHhhCCCCCCCCC
Confidence 99863 357789999999999999999999997644
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.5e-32 Score=220.02 Aligned_cols=183 Identities=20% Similarity=0.255 Sum_probs=147.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.+|.|+.+.......+....+..|..+....+|++++. ......++++++++++|..++..
T Consensus 17 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 96 (330)
T cd05601 17 VQVVREKATGDIYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYE 96 (330)
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhc
Confidence 6888888888888888765543333334445667777777778887653 34456788999999999998865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ......||+.|+||
T Consensus 97 ~~l~~~~~~~~~~qi~~aL~~lH~---~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~-~~~~~~gt~~y~aP 172 (330)
T cd05601 97 DQFDEDMAQFYLAELVLAIHSVHQ---MGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKMV-NSKLPVGTPDYIAP 172 (330)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEcccCchHheEECCCCCEEeccCCCCeECCCCCce-eeecccCCccccCH
Confidence 469999999999999999999999 99999999999999999999999999999865433222 22334679999999
Q ss_pred cccC------CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWM------PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~------~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++. ...++.++||||+||++|||++|+.||....
T Consensus 173 E~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~~~ 213 (330)
T cd05601 173 EVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGT 213 (330)
T ss_pred HHhccccccccCCCCCcceeecccceeeeeccCCCCCCCCC
Confidence 9986 4567889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=216.17 Aligned_cols=180 Identities=23% Similarity=0.285 Sum_probs=140.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHH-Hhcccccccc------ccccceEEEEEccCCchhhhhc-c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI-AADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~ 72 (202)
||++++..+++.+|.|+.+............+..|.... ...+|++++. ..+...++++++++++|...+. .
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~ 90 (329)
T cd05618 11 VLLVRLKKTERIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 90 (329)
T ss_pred EEEEEECCCCCEEEEEEEEhhHhcchhHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHc
Confidence 688999888888888775543222222222344444433 3347887764 3345678899999999977664 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... ......||+.|+||
T Consensus 91 ~~l~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aP 165 (329)
T cd05618 91 RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPGD--TTSTFCGTPNYIAP 165 (329)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCCC--ccccccCCccccCH
Confidence 569999999999999999999999 9999999999999999999999999999875322111 12335679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|++.+..++.++|+||+||++|||++|+.||..
T Consensus 166 E~~~~~~~~~~~DiwslG~il~el~~g~~Pf~~ 198 (329)
T cd05618 166 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 198 (329)
T ss_pred HHHcCCCCCCccceecccHHHHHHhhCCCCCcc
Confidence 999998999999999999999999999999963
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=216.36 Aligned_cols=183 Identities=19% Similarity=0.257 Sum_probs=144.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||+++....++.++.|+..............+..+.......+|++++. .....+++++++++|+|..++..
T Consensus 17 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~ 96 (332)
T cd05623 17 VAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFE 96 (332)
T ss_pred EEEEEECCCCCEEEEEEEeHHHHHHhhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhc
Confidence 6788888888888888765443333333334566666666777776652 34556789999999999998865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ......||+.|+||
T Consensus 97 ~~l~~~~~~~~~~qi~~al~~lH~---~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~~-~~~~~~gt~~y~aP 172 (332)
T cd05623 97 DRLPEDMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISP 172 (332)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCHHHEEECCCCCEEEeecchheecccCCcc-eecccccCccccCH
Confidence 568999999999999999999999 99999999999999999999999999998754332221 12234689999999
Q ss_pred cccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++. ...++.++|+||+||++|||++|+.||....
T Consensus 173 E~~~~~~~~~~~~~~~~DvwSlGvil~ell~g~~Pf~~~~ 212 (332)
T cd05623 173 EILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAES 212 (332)
T ss_pred HHHhccccCCCCCCCcCCEEeeHHHHHHHhcCCCCCCCCC
Confidence 9986 3457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.9e-32 Score=200.91 Aligned_cols=181 Identities=17% Similarity=0.163 Sum_probs=157.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccccc------ceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDT------ETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~~~~~~l~~~~~~-- 72 (202)
||.||.+.+.-+||.||.-+.+-....-.+.+..|.-+..+.+|||++...++ .+++.++..+|.++..+..
T Consensus 38 vYlarekks~~IvalKVlfKsqi~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~ 117 (281)
T KOG0580|consen 38 VYLAREKKSLFIVALKVLFKSQILKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGR 117 (281)
T ss_pred EeEeeeccCCcEEEEeeeeHHHHHHhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcc
Confidence 79999999999999999766665555667778888888999999999865444 3588999999999998863
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++.....+..|++.|+.|+|. +++||||+||+|+|++..+..|++|||-+...+. ......+||.-|.+
T Consensus 118 ~~~f~e~~~a~Yi~q~A~Al~y~h~---k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~----~kR~tlcgt~dyl~ 190 (281)
T KOG0580|consen 118 MKRFDEQRAATYIKQLANALLYCHL---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS----NKRKTLCGTLDYLP 190 (281)
T ss_pred cccccccchhHHHHHHHHHHHHhcc---CCcccCCCCHHHhccCCCCCeeccCCCceeecCC----CCceeeecccccCC
Confidence 348899999999999999999999 9999999999999999999999999998865432 12344678999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||+..+..++..+|+|++|++.||++.|.+||.....
T Consensus 191 pEmv~~~~hd~~Vd~w~lgvl~yeflvg~ppFes~~~ 227 (281)
T KOG0580|consen 191 PEMVEGRGHDKFVDLWSLGVLCYEFLVGLPPFESQSH 227 (281)
T ss_pred HhhcCCCCccchhhHHHHHHHHHHHHhcCCchhhhhh
Confidence 9999999999999999999999999999999998773
|
|
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=213.25 Aligned_cols=183 Identities=21% Similarity=0.269 Sum_probs=141.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc------ccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++++..+++.+|.|+.+............+..|..+... .+|++++. ..+..+++++++.+++|...+...
T Consensus 11 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 90 (318)
T cd05570 11 VLLAELKGTDELYAVKVLKKDVILQDDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRS 90 (318)
T ss_pred EEEEEECCCCCEEEEEEEEHHHHhhhhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHc
Confidence 68888888888888877654432222223333444444433 36777663 344567889999999998777544
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....... ......|++.|+||
T Consensus 91 ~~l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~g~~~y~aP 165 (318)
T cd05570 91 GRFDEPRARFYAAEIVLGLQFLHE---RGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGGV--TTSTFCGTPDYIAP 165 (318)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeEccCCCHHHeEECCCCcEEecccCCCeecCcCCC--cccceecCccccCH
Confidence 79999999999999999999999 9999999999999999999999999999874221111 12234579999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||++++|++|+.||.....
T Consensus 166 E~~~~~~~~~~~DiwslGvil~~l~~G~~pf~~~~~ 201 (318)
T cd05570 166 EILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDE 201 (318)
T ss_pred HHhcCCCCCcchhhhhHHHHHHHHhhCCCCCCCCCH
Confidence 999998999999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=7.4e-32 Score=210.51 Aligned_cols=187 Identities=18% Similarity=0.228 Sum_probs=143.7
Q ss_pred CCccccCCCcceeeh-hhhchhhhhccCCcccCCcHHHHHHhcccccccc-----------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITR-TIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----------~~~~~~~~~~~~~~~~l~~ 68 (202)
|.+|.+..++..||. |+...- ......++-..|...+.+.+|+|+++ ...-.+++.++| +..|..
T Consensus 38 VcsA~~~~t~~~VAIKKi~~~F--~~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~ 114 (359)
T KOG0660|consen 38 VCSAKDKRTGEKVAIKKILNPF--ENQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQ 114 (359)
T ss_pred EEEEEEcCCCCEeehhhhhhhh--hchHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHH
Confidence 456667777777764 333221 12223445567777788888998874 222233445555 578888
Q ss_pred hhccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 69 LCKKNI-LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 69 ~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
+++.+. ++...+..+..|++.||.|+|+ .+++||||||.|++++.+..+|++|||+|+...........+...-|.
T Consensus 115 iik~~~~L~d~H~q~f~YQiLrgLKyiHS---AnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTR 191 (359)
T KOG0660|consen 115 IIKSQQDLTDDHAQYFLYQILRGLKYIHS---ANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKFFEDGFMTEYVATR 191 (359)
T ss_pred HHHcCccccHHHHHHHHHHHHHhcchhhc---ccccccccchhheeeccCCCEEeccccceeeccccCcccchhcceeee
Confidence 888887 9999999999999999999999 899999999999999999999999999999775432222234556699
Q ss_pred cccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcccccc
Q 044746 148 GCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193 (202)
Q Consensus 148 ~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~ 193 (202)
.|.|||++.. ..|+...||||.||++.||++|++-|.+.+.-+|..
T Consensus 192 WYRAPElll~~~~Yt~aiDiWSvGCI~AEmL~gkplFpG~d~v~Ql~ 238 (359)
T KOG0660|consen 192 WYRAPELLLNSSEYTKAIDIWSVGCILAEMLTGKPLFPGKDYVHQLQ 238 (359)
T ss_pred eecCHHHHhccccccchhhhhhhhHHHHHHHcCCCCCCCCchHHHHH
Confidence 9999998764 579999999999999999999999999988776643
|
|
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.6e-31 Score=224.68 Aligned_cols=184 Identities=19% Similarity=0.262 Sum_probs=144.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc--------------cceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED--------------TETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~--------------~~~~~~~~~~~~~l 66 (202)
||++++...++.+|.|+....... .....++..|.......+|++++.... ...++++++++|+|
T Consensus 48 Vy~a~~~~~g~~vAvK~i~~~~~~-~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL 126 (496)
T PTZ00283 48 VLCAKRVSDGEPFAVKVVDMEGMS-EADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDL 126 (496)
T ss_pred EEEEEEcCCCCEEEEEEEecccCC-HHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcH
Confidence 688888888888888875432211 122234555666666677777664211 23477889999999
Q ss_pred hhhhcc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccC
Q 044746 67 YLLCKK-----NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141 (202)
Q Consensus 67 ~~~~~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~ 141 (202)
..++.. ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++............
T Consensus 127 ~~~l~~~~~~~~~l~e~~~~~i~~qll~aL~~lH~---~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~~~~~ 203 (496)
T PTZ00283 127 RQEIKSRAKTNRTFREHEAGLLFIQVLLAVHHVHS---KHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSDDVGR 203 (496)
T ss_pred HHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccccccc
Confidence 887743 358999999999999999999999 999999999999999999999999999998654332222234
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
...||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 204 ~~~Gt~~Y~aPE~~~~~~~s~k~DVwSlGvilyeLltG~~Pf~~~~~ 250 (496)
T PTZ00283 204 TFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGENM 250 (496)
T ss_pred cccCCcceeCHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 45689999999999998999999999999999999999999976543
|
|
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.2e-31 Score=213.21 Aligned_cols=187 Identities=19% Similarity=0.210 Sum_probs=147.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccC------Cc-----ccCCcHHHHHHhcccccccc--------ccccceEEEEEc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMD------KP-----IRFTSPQRMIAADNFSNLVG--------SEDTETYIKGFL 61 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~------~~-----~~~~~~~~~~~~~~~~~~i~--------~~~~~~~~~~~~ 61 (202)
|-+|++...++++|.|+..+.+..... .. .+...|..++....|+|++. ..+..+++.+|+
T Consensus 113 VkLar~~~~~~l~AiKil~K~~~~~~~~~~~~~a~~~~~~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~ 192 (576)
T KOG0585|consen 113 VKLARDEVDGKLYAIKILPKKELRRQYGFPRQPAMKLMPIEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYC 192 (576)
T ss_pred EEEEeecCCCcEEEEEeechhhhhhhcccccccccccCcHHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEec
Confidence 346889999999999886555433211 11 24556777888899998873 556677889999
Q ss_pred cCCchhhhhccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecccc---Ccc
Q 044746 62 AMGPFYLLCKKNI-LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE---HTH 137 (202)
Q Consensus 62 ~~~~l~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~---~~~ 137 (202)
+.|.+...-.... +++.+++.+.+++..||+|||. ++||||||||.|+|++.+|++||+|||.+...... ...
T Consensus 193 s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEYLH~---QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d 269 (576)
T KOG0585|consen 193 SKGEVKWCPPDKPELSEQQARKYLRDVVLGLEYLHY---QGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSD 269 (576)
T ss_pred cCCccccCCCCcccccHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEEcCCCcEEeeccceeeecccCCccccH
Confidence 9998876665556 9999999999999999999999 99999999999999999999999999999865221 111
Q ss_pred cccCCCCCCCcccCCcccCCCC----CCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 138 ITSTGRRRTPGCEAPELWMPYS----VTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 138 ~~~~~~~gt~~y~aPe~~~~~~----~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
.......|||.|+|||++.+.. .+.+.||||+|++||-++.|+.||.++...+
T Consensus 270 ~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGVTLYCllfG~~PF~~~~~~~ 326 (576)
T KOG0585|consen 270 DQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGVTLYCLLFGQLPFFDDFELE 326 (576)
T ss_pred HHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhhhHHHhhhccCCcccchHHH
Confidence 1123367899999999998732 3467899999999999999999998776543
|
|
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.3e-31 Score=222.76 Aligned_cols=181 Identities=20% Similarity=0.224 Sum_probs=141.3
Q ss_pred CCccccCCC-cceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNRGS-TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~~~-~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||+|.+... ++.|++|...... ......+..|...+...+|++++. ..+..+++++++++|+|...+.
T Consensus 83 vy~a~~~~~~~~~vv~K~~~~~~---~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 159 (478)
T PTZ00267 83 AFVATRGSDPKEKVVAKFVMLND---ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQR 159 (478)
T ss_pred EEEEEEcCCCCeEEEEEEcccCC---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHH
Confidence 466766554 4555554321111 111223556777788889998873 4456678999999999987653
Q ss_pred ---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 72 ---KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 72 ---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
...+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...............||+.
T Consensus 160 ~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~ 236 (478)
T PTZ00267 160 LKEHLPFQEYEVGLLFYQIVLALDEVHS---RKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPY 236 (478)
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccccccccccCCCcc
Confidence 3358999999999999999999999 9999999999999999999999999999987644332222344568999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+..++.++||||+||+++||++|+.||....
T Consensus 237 y~aPE~~~~~~~~~~~Dv~slG~~l~el~tg~~Pf~~~~ 275 (478)
T PTZ00267 237 YLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPS 275 (478)
T ss_pred ccCHhHhCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998899999999999999999999999997644
|
|
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-31 Score=206.97 Aligned_cols=182 Identities=21% Similarity=0.227 Sum_probs=143.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.++.|+.+..... ......+..|.......+|++++. ..+...+++++++++.+..+... .
T Consensus 17 v~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 95 (287)
T cd07848 17 VLKCRHKETKEIVAIKKFKDSEEN-EEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPN 95 (287)
T ss_pred EEEEEECCCCcEEEEEEEeccccc-ccchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCC
Confidence 688999888888888765443221 122334556666777788888763 34456789999998877665543 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ......|++.|+|||
T Consensus 96 ~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE 171 (287)
T cd07848 96 GVPPEKVRSYIYQLIKAIHWCHK---NDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNA-NYTEYVATRWYRSPE 171 (287)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccCcccccccccc-cccccccccccCCcH
Confidence 68999999999999999999999 99999999999999999999999999999865432211 122345789999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.+..++.++|+||+||++|||++|++||....
T Consensus 172 ~~~~~~~~~~~DiwslGvil~el~~g~~pf~~~~ 205 (287)
T cd07848 172 LLLGAPYGKAVDMWSVGCILGELSDGQPLFPGES 205 (287)
T ss_pred HHcCCCCCCchhHHhHHHHHHHHHhCCCCCCCCC
Confidence 9988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.6e-31 Score=212.36 Aligned_cols=182 Identities=16% Similarity=0.200 Sum_probs=138.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.||.|..+.... ......++..|.......+|+|++... ...+++++++. ++|...
T Consensus 16 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 93 (338)
T cd07859 16 VCSAIDTHTGEKVAIKKINDVFE-HVSDATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELME-SDLHQV 93 (338)
T ss_pred EEEEEECCCCCEEEEEEechhhc-cchhHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecCC-CCHHHH
Confidence 68888888788888775432211 112233466677777888999876421 12467788885 567666
Q ss_pred hc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCC
Q 044746 70 CK-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTP 147 (202)
Q Consensus 70 ~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~ 147 (202)
+. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ........||+
T Consensus 94 l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~ 170 (338)
T cd07859 94 IKANDDLTPEHHQFFLYQLLRALKYIHT---ANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPTAIFWTDYVATR 170 (338)
T ss_pred HHhcccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEccCccccccccccCccccccCCCCCC
Confidence 54 4469999999999999999999999 9999999999999999999999999999975432211 11123356799
Q ss_pred cccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 148 GCEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 148 ~y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.|+|||++.+ ..++.++||||+||+++||++|++||....
T Consensus 171 ~y~aPE~~~~~~~~~~~~~DvwSlGvvl~el~tg~~pf~~~~ 212 (338)
T cd07859 171 WYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKN 212 (338)
T ss_pred CcCCHHHHhccccccCchhHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999865 578899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=6.5e-32 Score=211.16 Aligned_cols=176 Identities=20% Similarity=0.274 Sum_probs=134.2
Q ss_pred CCccccCCCcceeeh-hhhchhhhhccCCcccCCcHHHHHHhccccccccc---------c--ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITR-TIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS---------E--DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~---------~--~~~~~~~~~~~~~~l~~ 68 (202)
||++..+...+.||. |+.... +--..|..++...+|+|++.- . -+..++++|++. +|+.
T Consensus 40 Vyq~~~~e~~~~vAIKKv~~d~--------r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleymP~-tL~~ 110 (364)
T KOG0658|consen 40 VYQAKLRETEEEVAIKKVLQDK--------RYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYMPE-TLYR 110 (364)
T ss_pred EEEEEEcCCCceeEEEEecCCC--------CcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhchH-HHHH
Confidence 677777777666664 433222 123345555668899999841 1 133355666663 5555
Q ss_pred hhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-CceEEeeeecceeccccCcccccCC
Q 044746 69 LCK-----KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 69 ~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
..+ +..++.-.++-+..||.+||.|||+ .+|+||||||+|+|++.+ |.+||+|||.|+.+....... .
T Consensus 111 ~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yLh~---~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~epni---S 184 (364)
T KOG0658|consen 111 VIRHYTRANQRMPLLEIKLYTYQLFRGLAYLHS---HGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEPNI---S 184 (364)
T ss_pred HHHHHhhcCCCCceeeeHHHHHHHHHHHHHHHh---cCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCCce---e
Confidence 555 5678889999999999999999999 999999999999999966 999999999999765443322 2
Q ss_pred CCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcccc
Q 044746 143 RRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~ 191 (202)
...|..|+|||++.+. .|+.+.||||.||++.||+.|++-|.+++..+|
T Consensus 185 YicSRyYRaPELifga~~Yt~~IDiWSaGCV~aELl~g~plFpG~s~~dQ 234 (364)
T KOG0658|consen 185 YICSRYYRAPELIFGATEYTTSIDIWSAGCVMAELLKGQPLFPGDSSVDQ 234 (364)
T ss_pred EEEeccccCHHHHcCccccCceeEEhhhhHHHHHHhcCCcccCCCCHHHH
Confidence 2338899999999875 799999999999999999999999999887665
|
|
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.2e-31 Score=216.18 Aligned_cols=182 Identities=19% Similarity=0.258 Sum_probs=137.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH-HHHHHhc--ccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAAD--NFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++...++.+|.|+..............+..+ ..+.... +|+++++ .....+++++++.+++|..++.
T Consensus 9 Vy~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~ 88 (330)
T cd05586 9 VYQVRKKDTRRIYAMKVLSKKEIVAKKEVAHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQ 88 (330)
T ss_pred EEEEEECCCCCEEEEEEEeHHHHhhhhHHHHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHH
Confidence 68899988888888877543322111111122222 2222222 6777764 3455678899999999987764
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 -KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+++....... ......||+.|+
T Consensus 89 ~~~~~~~~~~~~~~~qil~al~~LH~---~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~y~ 163 (330)
T cd05586 89 KEGRFSEDRAKFYIAELVLALEHLHK---YDIVYRDLKPENILLDATGHIALCDFGLSKANLTDNK--TTNTFCGTTEYL 163 (330)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCCC--CccCccCCcccc
Confidence 4569999999999999999999999 9999999999999999999999999999875322111 123456899999
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||++.+. .++.++|+||+||++|+|++|+.||....
T Consensus 164 aPE~~~~~~~~~~~~DvwslGvil~elltG~~Pf~~~~ 201 (330)
T cd05586 164 APEVLLDEKGYTKHVDFWSLGVLVFEMCCGWSPFYAED 201 (330)
T ss_pred CHHHHcCCCCCCCccceeccccEEEEeccCCCCCCCCC
Confidence 99998754 47899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=9.6e-31 Score=210.39 Aligned_cols=182 Identities=21% Similarity=0.252 Sum_probs=141.5
Q ss_pred CCcccc---CCCcceeehhhhchhhh-hccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRN---RGSTRFITRTIDKSLDA-MEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~---~~~~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++ ...++.+|.|+.+.... ........+..|..+....+|++++. ..+...++++++.+++|...+
T Consensus 12 V~~~~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 91 (323)
T cd05584 12 VFQVRKVTGADTGKIFAMKVLKKATIVRNQKDTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHL 91 (323)
T ss_pred EEEEEEcccCCCCCEEEEEEEEHHHHHhhhhhHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHH
Confidence 466654 34567777776544322 11222334556667777888998763 344567889999999998887
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.. +.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++....... ......||+.|
T Consensus 92 ~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y 166 (323)
T cd05584 92 EREGIFMEDTACFYLSEISLALEHLHQ---QGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEGT--VTHTFCGTIEY 166 (323)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCCC--cccccCCCccc
Confidence 54 457889999999999999999999 9999999999999999999999999999875322211 12334679999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||++.+..++.++||||+|+++|||++|+.||....
T Consensus 167 ~aPE~~~~~~~~~~~DiwslG~il~ell~G~~pf~~~~ 204 (323)
T cd05584 167 MAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAEN 204 (323)
T ss_pred cChhhccCCCCCCcceecccHHHHHHHhcCCCCCCCCC
Confidence 99999998888999999999999999999999997654
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.4e-30 Score=202.90 Aligned_cols=180 Identities=21% Similarity=0.225 Sum_probs=140.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.++.|...............+..|..+....+|++++. .+....++++++.+++|......
T Consensus 9 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~ 88 (277)
T cd05607 9 VCAVQVKNTGKMYACKKLDKKRLKKKSGEKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVG 88 (277)
T ss_pred EEEEEEccCCcEEEEEEEcHHHhhcchhhHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhcc
Confidence 6888888877777766543322211111222334656677778898763 34556789999999999776632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ .....|++.|+|
T Consensus 89 ~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~a 162 (277)
T cd05607 89 ERGLEMERVIHYSAQITCGILHLHS---MDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGKT---ITQRAGTNGYMA 162 (277)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHH---CCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCce---eeccCCCCCccC
Confidence 358899999999999999999999 9999999999999999999999999999876543221 123457899999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||++.+..++.++|+||+||++|||++|+.||...
T Consensus 163 PE~~~~~~~~~~~DvwslGv~l~el~~g~~p~~~~ 197 (277)
T cd05607 163 PEILKEEPYSYPVDWFAMGCSIYEMVAGRTPFKDH 197 (277)
T ss_pred HHHHccCCCCCchhHHHHHHHHHHHHhCCCCCCCC
Confidence 99998888999999999999999999999999753
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-31 Score=221.08 Aligned_cols=179 Identities=21% Similarity=0.258 Sum_probs=136.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc-cc-----cccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN-FS-----NLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-----~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
|-||.+...++.||.||.+....-... -..|..++...+ +. |+|. ..+..+++.|.+ ..+|++
T Consensus 202 Vvk~~d~~T~e~VAIKIiKN~k~f~~Q----~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYe 276 (586)
T KOG0667|consen 202 VVKAYDHKTGEIVAIKIIKNKKRFLRQ----AQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYE 276 (586)
T ss_pred eEEEEecCCCcEEEEEeeccChHHHHH----HHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHH
Confidence 568999999999999997766443222 222333333322 11 3332 222333444444 358888
Q ss_pred hhccCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC--CceEEeeeecceeccccCcccccCCC
Q 044746 69 LCKKNI---LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN--FFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 69 ~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~--~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
+++.+. ++...++.++.||+.||.+||+ .+|||+||||+|||+... ..+|++|||.|........ ..
T Consensus 277 llK~n~f~Glsl~~ir~~~~Qil~~L~~L~~---l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q~vy-----tY 348 (586)
T KOG0667|consen 277 LLKNNKFRGLSLPLVRKFAQQILTALLFLHE---LGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQRVY-----TY 348 (586)
T ss_pred HHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCChhheeeccCCcCceeEEecccccccCCcce-----ee
Confidence 887654 8899999999999999999998 999999999999999643 4789999999987655443 22
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccccc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQE 192 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~ 192 (202)
.-+..|.|||++.+.+|+.+.|||||||+++||.+|.+.|.++++.+|.
T Consensus 349 iQSRfYRAPEVILGlpY~~~IDmWSLGCIlAEL~tG~PLfpG~ne~DQl 397 (586)
T KOG0667|consen 349 IQSRFYRAPEVILGLPYDTAIDMWSLGCILAELFTGEPLFPGDNEYDQL 397 (586)
T ss_pred eeccccccchhhccCCCCCccceeehhhhHHhHhcCccccCCCCHHHHH
Confidence 3378899999999999999999999999999999999999998888763
|
|
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=212.32 Aligned_cols=172 Identities=21% Similarity=0.236 Sum_probs=135.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------cccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------EDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||++++...++.||.|.... ..+..|..+....+|+|++.. .....++++++. +.|..++ ...
T Consensus 108 V~~~~d~~~~~~vaiK~~~~---------~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 177 (391)
T PHA03212 108 AFACIDNKTCEHVVIKAGQR---------GGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRYK-TDLYCYLAAKR 177 (391)
T ss_pred EEEEEECCCCCEEEEechhh---------hhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecCC-CCHHHHHHhcC
Confidence 68888888888888875321 234567777888899988743 233445666664 5665555 445
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.+++.++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++....... ........||+.|+|||
T Consensus 178 ~l~~~~~~~i~~qi~~aL~ylH~---~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~-~~~~~~~~gt~~y~aPE 253 (391)
T PHA03212 178 NIAICDILAIERSVLRAIQYLHE---NRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN-ANKYYGWAGTIATNAPE 253 (391)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHhEEEcCCCCEEEEeCCccccccccc-ccccccccCccCCCChh
Confidence 69999999999999999999999 999999999999999999999999999987532211 11223456899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
++.+..++.++|+||+||++|||++|+.||...
T Consensus 254 ~~~~~~~~~~~DiwSlGvil~elltg~~p~~~~ 286 (391)
T PHA03212 254 LLARDPYGPAVDIWSAGIVLFEMATCHDSLFEK 286 (391)
T ss_pred hhcCCCCCcHHHHHHHHHHHHHHHHCCCCcCCc
Confidence 999889999999999999999999999887643
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.9e-30 Score=205.41 Aligned_cols=180 Identities=20% Similarity=0.297 Sum_probs=139.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..++..||.|+.+... .......+..|..+....+|+|++. ......++++++.+ +|..++..
T Consensus 21 Vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~ 97 (288)
T cd07871 21 VFKGRSKLTENLVALKEIRLEH--EEGAPCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLDS-DLKQYLDNCG 97 (288)
T ss_pred EEEEEECCCCCEEEEEEecccc--cCCcchhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCCc-CHHHHHHhcC
Confidence 6889888888888887654321 1122334556777778888998763 33345678888774 77766643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....... ......+++.|+||
T Consensus 98 ~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~y~aP 172 (288)
T cd07871 98 NLMSMHNVKIFMFQLLRGLSYCHK---RKILHRDLKPQNLLINEKGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPP 172 (288)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEECcCcceeeccCCCc--cccCceecccccCh
Confidence 347899999999999999999999 9999999999999999999999999999975432221 12334568999999
Q ss_pred cccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+ ..++.++|+||+||+++||++|++||.....
T Consensus 173 E~~~~~~~~~~~~DiwslG~~l~~l~~g~~pf~~~~~ 209 (288)
T cd07871 173 DVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTV 209 (288)
T ss_pred HHhcCCcccCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 98865 4688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=205.63 Aligned_cols=178 Identities=17% Similarity=0.267 Sum_probs=136.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.+|.|+.+.... ......+..|.......+|++++. ......++++++. +++..++..
T Consensus 21 V~~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 97 (303)
T cd07869 21 VYKGKSKVNGKLVALKVIRLQEE--EGTPFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHP 97 (303)
T ss_pred EEEEEECCCCCEEEEEEeccccc--cccchhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCC
Confidence 68888888888888776543321 112233445666777788888763 3445668888886 455555433
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ......|++.|+||
T Consensus 98 ~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 172 (303)
T cd07869 98 GGLHPENVKLFLFQLLRGLSYIHQ---RYILHRDLKPQNLLISDTGELKLADFGLARAKSVPSH--TYSNEVVTLWYRPP 172 (303)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECCCCcceeccCCCc--cCCCCcccCCCCCh
Confidence 458999999999999999999999 9999999999999999999999999999875432221 12334578999999
Q ss_pred cccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 153 ELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 153 e~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|++.+ ..++.++|+||+||+++||++|++||.+.
T Consensus 173 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 207 (303)
T cd07869 173 DVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGM 207 (303)
T ss_pred HHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 99865 45788999999999999999999999764
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.3e-30 Score=203.72 Aligned_cols=182 Identities=19% Similarity=0.210 Sum_probs=143.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++...+..||.|...............+..|.......+|++++. ......++++++++++|...+.
T Consensus 16 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 95 (285)
T cd05605 16 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMG 95 (285)
T ss_pred EEEEEEcCCCceEEEEEEehhhhhhhhhHHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcC
Confidence 6788887777888877654332222222233455666677778887753 3455778999999999977663
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ .....|++.|+|
T Consensus 96 ~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~y~a 169 (285)
T cd05605 96 NPGFDEERAVFYAAEITCGLEDLHR---ERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGET---IRGRVGTVGYMA 169 (285)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCCc---cccccCCCCccC
Confidence 2358999999999999999999999 9999999999999999999999999999986533221 123467899999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||++.+..++.++|+||+|+++||+++|+.||.+...
T Consensus 170 PE~~~~~~~~~~~Diws~G~~l~el~~g~~pf~~~~~ 206 (285)
T cd05605 170 PEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKE 206 (285)
T ss_pred cHHhcCCCCCccccchhHHHHHHHHHHCCCCCCCCch
Confidence 9999988899999999999999999999999986543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.97 E-value=3.8e-31 Score=218.66 Aligned_cols=184 Identities=22% Similarity=0.304 Sum_probs=151.4
Q ss_pred CCccccCCCcceeehhhhchhhh-hccCCcccCCcHHHHHHhcccccccccc--------ccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDA-MEMDKPIRFTSPQRMIAADNFSNLVGSE--------DTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------~~~~~~~~~~~~~~l~~~~~ 71 (202)
||||-|...+..||---.+..+. ...+...+|..|..++...+|+||+... ....++.+.+..|+|..+.+
T Consensus 56 VYka~De~~giEVAWnqvk~~d~~q~~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~k 135 (632)
T KOG0584|consen 56 VYKAFDEEEGIEVAWNQVKIRDVTQSPEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRK 135 (632)
T ss_pred eeeccccccchhhHHHHHhHHHhhcChHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHH
Confidence 79999988888888433322222 2223457899999999999999998532 33558999999999999997
Q ss_pred cC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-CceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 KN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 ~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
+. .+.....+.|++||++||.|||+.- .+|||||||.+||++.++ |.+||+|+|||+...... .....|||-|
T Consensus 136 k~~~vn~kaik~W~RQILkGL~yLHs~~-PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s~----aksvIGTPEF 210 (632)
T KOG0584|consen 136 KHRRVNIKAIKSWCRQILKGLVYLHSQD-PPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKSH----AKSVIGTPEF 210 (632)
T ss_pred HhccCCHHHHHHHHHHHHHHhhhhhcCC-CCccccccccceEEEcCCcCceeecchhHHHHhhccc----cceeccCccc
Confidence 75 5999999999999999999999853 799999999999999864 899999999999765433 2346899999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
||||+.- ..|+..+||||||++++||+|+..||.--..-.
T Consensus 211 MAPEmYE-E~YnE~VDVYaFGMCmLEMvT~eYPYsEC~n~A 250 (632)
T KOG0584|consen 211 MAPEMYE-ENYNELVDVYAFGMCMLEMVTSEYPYSECTNPA 250 (632)
T ss_pred cChHHHh-hhcchhhhhhhhhHHHHHHHhccCChhhhCCHH
Confidence 9999986 689999999999999999999999997544433
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1.1e-30 Score=197.94 Aligned_cols=176 Identities=21% Similarity=0.327 Sum_probs=141.7
Q ss_pred CCCcceeehhhhchhhhhccCCcccCCcH-----HHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-C
Q 044746 7 RGSTRFITRTIDKSLDAMEMDKPIRFTSP-----QRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN-I 74 (202)
Q Consensus 7 ~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~-~ 74 (202)
.+++++.++++.......+.+.+.++..+ .++.....||++|. +..+.+++.+.++.|.|++++... .
T Consensus 40 ~t~~e~a~kii~~~at~~~~e~~~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~Vt 119 (411)
T KOG0599|consen 40 ETGKEFAVKIIDVTATTESGETPYEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVT 119 (411)
T ss_pred ccccceeEEEEEecccccCCccHHHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhhee
Confidence 56777777777655444444444443322 33445578898773 566677888899999999999665 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+|+.+.+.+++|+..|++|||. ++|+||||||+|||++.+.+++|+|||.+..+..+.. ....+|||+|+|||.
T Consensus 120 lSEK~tR~iMrqlfegVeylHa---~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Gek---LrelCGTPgYLAPEt 193 (411)
T KOG0599|consen 120 LSEKETRRIMRQLFEGVEYLHA---RNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGEK---LRELCGTPGYLAPET 193 (411)
T ss_pred ecHHHHHHHHHHHHHHHHHHHH---hhhhhcccChhheeeccccceEEeccceeeccCCchh---HHHhcCCCcccChhh
Confidence 9999999999999999999999 9999999999999999999999999999987655443 345678999999999
Q ss_pred cCC------CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMP------YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~------~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.. ..|+..+|+||+|+++|.++.|.+||.....
T Consensus 194 ikC~m~e~~pGYs~EVD~Wa~GVImyTLLaGcpPFwHRkQ 233 (411)
T KOG0599|consen 194 IKCSMYENHPGYSKEVDEWACGVIMYTLLAGCPPFWHRKQ 233 (411)
T ss_pred eeeecccCCCCccchhhHHHHHHHHHHHHcCCCchhHHHH
Confidence 864 3578889999999999999999999976544
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.2e-30 Score=216.59 Aligned_cols=180 Identities=20% Similarity=0.248 Sum_probs=148.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----c-------cccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----S-------EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~-------~~~~~~~~~~~~~~~l~~ 68 (202)
||+.|++.+++.||+|.-+.. .......+.-.|..++...+|+||+. + .....++++++.+|+|..
T Consensus 29 V~rgrnketG~~vAvK~~~~~--~~~r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~ 106 (732)
T KOG4250|consen 29 VYRGRNKETGRLVAVKTFNKE--SSLRPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRK 106 (732)
T ss_pred eeeecccccccchhHHhhhhh--cccchHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHH
Confidence 799999999999999875443 23333445667777777888999872 1 223458999999999999
Q ss_pred hhccC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc--CCC--ceEEeeeecceeccccCccccc
Q 044746 69 LCKKN----ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD--ENF--FPKAADFGLAKLYNREHTHITS 140 (202)
Q Consensus 69 ~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~--~~~--~~kl~dfgl~~~~~~~~~~~~~ 140 (202)
.+... .+++.+.+.+...+..|+.|||+ ++|+||||||.||++- .+| ..||+|||.|+...++. ..
T Consensus 107 ~L~~PEN~~GLpE~e~l~lL~d~~~al~~LrE---n~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s---~~ 180 (732)
T KOG4250|consen 107 VLNSPENAYGLPESEFLDLLSDLVSALRHLRE---NGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNS---LF 180 (732)
T ss_pred HhcCcccccCCCHHHHHHHHHHHHHHHHHHHH---cCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCC---ee
Confidence 99654 49999999999999999999998 9999999999999884 223 46999999999776554 34
Q ss_pred CCCCCCCcccCCcccC-CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 141 TGRRRTPGCEAPELWM-PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~-~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
...+||+.|++||+.. ...|+..+|.|||||++|+.+||..||.....
T Consensus 181 ~S~vGT~~YLhPel~E~q~~y~~tVDLWS~GvtlY~caTG~lPF~p~~~ 229 (732)
T KOG4250|consen 181 TSLVGTEEYLHPELYERQKKYTATVDLWSFGVTLYECATGELPFIPFGG 229 (732)
T ss_pred eeecCchhhcChHHHhhccCcCceeehhhhhhHHHHHhccCCCCCcCCC
Confidence 5678999999999998 47899999999999999999999999976543
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.9e-30 Score=206.83 Aligned_cols=182 Identities=19% Similarity=0.239 Sum_probs=139.1
Q ss_pred CCccccCCCcce----eehhhhchhhhhccCCcccCCcHHHHHHhccccccccc-----cccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRF----ITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS-----EDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~----v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+++....+.. |+.|+.+.. .......++..|.......+|+|++.. .....++.+++.+|+|.+++.
T Consensus 23 Vy~~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~~~~~v~e~~~~g~l~~~l~ 100 (316)
T cd05108 23 VYKGLWIPEGEKVKIPVAIKELREA--TSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR 100 (316)
T ss_pred EEEEEEecCCCccceeEEEEecccc--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCCCceeeeecCCCCCHHHHHH
Confidence 577765444443 555543321 112223456667777788889987632 233457888999999998886
Q ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 KN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 ~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.. .+++.....++.|++.||+|||+ .+++||||||+||+++.++.+||+|||+++...............++..|
T Consensus 101 ~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y 177 (316)
T cd05108 101 EHKDNIGSQYLLNWCVQIAKGMNYLEE---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKW 177 (316)
T ss_pred hccccCCHHHHHHHHHHHHHHHHHHHh---cCeeccccchhheEecCCCcEEEccccccccccCCCcceeccCCccceee
Confidence 54 58899999999999999999999 99999999999999999999999999999876543332222233346789
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
+|||++....++.++|+||||+++||+++ |+.||.+..
T Consensus 178 ~apE~~~~~~~~~~~Di~slGv~l~el~t~g~~p~~~~~ 216 (316)
T cd05108 178 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIP 216 (316)
T ss_pred cChHHhccCCCCchhhhHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999998899999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.7e-30 Score=204.31 Aligned_cols=180 Identities=22% Similarity=0.309 Sum_probs=132.1
Q ss_pred CCccccC-CCcceeehhhhchhhhhccCCcccCCcHHHHHH---hccccccccc-----------cccceEEEEEccCCc
Q 044746 1 MEKPRNR-GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIA---ADNFSNLVGS-----------EDTETYIKGFLAMGP 65 (202)
Q Consensus 1 v~k~~~~-~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~i~~-----------~~~~~~~~~~~~~~~ 65 (202)
||++++. .++..||.|..+...... .....+..|..... ..+|+|++.. .....++++++. ++
T Consensus 17 Vy~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 94 (290)
T cd07862 17 VFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QD 94 (290)
T ss_pred EEEEEEcCCCCeEEEEEEEecccCCC-CchHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CC
Confidence 6888874 445677776543322111 11112222332222 2367877642 223456777775 56
Q ss_pred hhhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 66 FYLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 66 l~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
|..++.. ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...... ....
T Consensus 95 l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~ 168 (290)
T cd07862 95 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTS 168 (290)
T ss_pred HHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEcCCCCEEEccccceEeccCCc---cccc
Confidence 7666643 348999999999999999999999 999999999999999999999999999998654331 2234
Q ss_pred CCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
..|++.|+|||.+.+..++.++|+||+||++|||++|++||.+..+
T Consensus 169 ~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~~ 214 (290)
T cd07862 169 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214 (290)
T ss_pred ccccccccChHHHhCCCCCCccchHHHHHHHHHHHcCCCCcCCCCH
Confidence 4579999999999888899999999999999999999999986544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-30 Score=205.18 Aligned_cols=185 Identities=19% Similarity=0.249 Sum_probs=147.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccc-------ccccccceEEEEEccCCchhh-hhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNL-------VGSEDTETYIKGFLAMGPFYL-LCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------i~~~~~~~~~~~~~~~~~l~~-~~~~ 72 (202)
|..|..+++.++.|.|+.++.-....+...--..|...++...-|-. ...-+-.+++++|..+|.|.. +.+-
T Consensus 365 VlLaerkgtdELyAiKiLkKDViiQdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~ 444 (683)
T KOG0696|consen 365 VLLAERKGTDELYAIKILKKDVIIQDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV 444 (683)
T ss_pred eeeecccCcchhhhhhhhccceeeecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHh
Confidence 44677889999999999877655544443333334444444333322 133445568999999998754 4456
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+++.+..+..++.+|+-||-|||+ ++||.||||.+|++++.+|++||+|||+++.-- ....+....+|||-|+||
T Consensus 445 GkFKEp~AvFYAaEiaigLFFLh~---kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni--~~~~TTkTFCGTPdYiAP 519 (683)
T KOG0696|consen 445 GKFKEPVAVFYAAEIAIGLFFLHS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENI--FDGVTTKTFCGTPDYIAP 519 (683)
T ss_pred cccCCchhhhhhHHHHHHhhhhhc---CCeeeeeccccceEeccCCceEeeecccccccc--cCCcceeeecCCCccccc
Confidence 789999999999999999999999 999999999999999999999999999998422 222334567899999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
|.+...+|+..+|+||+|++||||+.|++||+++++++
T Consensus 520 EIi~YqPYgksvDWWa~GVLLyEmlaGQpPFdGeDE~e 557 (683)
T KOG0696|consen 520 EIIAYQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDE 557 (683)
T ss_pred ceEEecccccchhHHHHHHHHHHHHcCCCCCCCCCHHH
Confidence 99999999999999999999999999999999987765
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.7e-30 Score=209.08 Aligned_cols=184 Identities=20% Similarity=0.203 Sum_probs=149.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc-cccccc------ccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN-FSNLVG------SEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||+++...+++.+|.|+-.+...........+..|..++.... |+|++. ......++++++.+|.|++.+...
T Consensus 51 v~~~~~~~tg~~~A~K~i~k~~~~~~~~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~ 130 (382)
T KOG0032|consen 51 VYLCREKSTGKEVACKVIPKRKLRGKEDREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK 130 (382)
T ss_pred EEEEEecCCCceeEEEEeehhhccccccHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc
Confidence 5788888867777766654443333333445677777777776 998874 445567899999999998877554
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC----CceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN----FFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~----~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.+++..+..++.|++.++.|||+ .+++||||||+|+|+... +.++++|||++..... .......+||+.|
T Consensus 131 ~~sE~da~~~~~~il~av~~lH~---~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~---~~~~~~~~Gtp~y 204 (382)
T KOG0032|consen 131 HYSERDAAGIIRQILEAVKYLHS---LGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKP---GERLHTIVGTPEY 204 (382)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHh---CCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccC---CceEeeecCCccc
Confidence 69999999999999999999999 999999999999999643 4799999999998765 2234567889999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
+|||++...+|+..+|+||+|+++|.|+.|.+||......+
T Consensus 205 ~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~PF~~~~~~~ 245 (382)
T KOG0032|consen 205 VAPEVLGGRPYGDEVDVWSIGVILYILLSGVPPFWGETEFE 245 (382)
T ss_pred cCchhhcCCCCCcccchhHHHHHHHHHhhCCCCCcCCChhH
Confidence 99999999999999999999999999999999999887543
|
|
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-30 Score=208.65 Aligned_cols=182 Identities=19% Similarity=0.215 Sum_probs=135.8
Q ss_pred CCcccc---CCCcceeehhhhchhhhhc-cCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRN---RGSTRFITRTIDKSLDAME-MDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~---~~~~~~v~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++ ...+..+|.|+.+...... ......+..|..+.... +|++++. ..+...++++++++++|..+
T Consensus 16 Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~ 95 (332)
T cd05614 16 VFLVRKVTGHDTGKLYAMKVLQKAALVQKAKTVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTH 95 (332)
T ss_pred EEEEEEcccCCCCCEEEEEEEEHHHHhhhhhHHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHH
Confidence 465554 3466777777654432221 11222344454444444 4666542 34456689999999999887
Q ss_pred hc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 70 CK-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 70 ~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+. ...+++.++..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||+++........ ......||+.
T Consensus 96 l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~~-~~~~~~gt~~ 171 (332)
T cd05614 96 LYQRDNFSEDEVRFYSGEIILALEHLHK---LGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE-RTYSFCGTIE 171 (332)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCCC-ccccccCCcc
Confidence 74 4569999999999999999999999 99999999999999999999999999999754322211 1223568999
Q ss_pred ccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 149 CEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|+|||++.+. .++.++||||+||+++||++|+.||...
T Consensus 172 y~aPE~~~~~~~~~~~~DiwslG~il~elltg~~pf~~~ 210 (332)
T cd05614 172 YMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLE 210 (332)
T ss_pred ccCHHHhcCCCCCCCccccccchhhhhhhhcCCCCCCCC
Confidence 9999998765 4788999999999999999999999754
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.4e-30 Score=206.24 Aligned_cols=178 Identities=19% Similarity=0.252 Sum_probs=143.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...+..++.|+..... ......++..|.......+|++++. ..+...++++++++++|..++.. .
T Consensus 21 V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 98 (331)
T cd06649 21 VTKVQHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAK 98 (331)
T ss_pred EEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcC
Confidence 6788888888888887754321 1112234666777778888898763 34456789999999999988865 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+. .+++||||||+||+++.++.++|+|||++....... .....|++.|+|||
T Consensus 99 ~~~~~~~~~~~~~i~~~l~~lH~~--~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~g~~~y~aPE 172 (331)
T cd06649 99 RIPEEILGKVSIAVLRGLAYLREK--HQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPE 172 (331)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhc--CCEEcCCCChhhEEEcCCCcEEEccCcccccccccc----cccCCCCcCcCCHh
Confidence 589999999999999999999981 469999999999999999999999999987543221 23345799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
++.+..++.++|+||+||++|||++|+.||...
T Consensus 173 ~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~ 205 (331)
T cd06649 173 RLQGTHYSVQSDIWSMGLSLVELAIGRYPIPPP 205 (331)
T ss_pred HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCC
Confidence 999888999999999999999999999999654
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-29 Score=199.28 Aligned_cols=155 Identities=19% Similarity=0.283 Sum_probs=125.9
Q ss_pred cCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 044746 31 RFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKIV 103 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ii 103 (202)
++..+.......+|+|++. .+....++++++.+|+|..++.. ..+++..+..++.|++.||.|||+ ++++
T Consensus 55 ~~~~~~~~l~~l~h~~iv~~~~~~~~~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ii 131 (279)
T cd05111 55 EITDHMLAMGSLDHAYIVRLLGICPGASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEE---HRMV 131 (279)
T ss_pred HHHHHHHHHhcCCCCCcceEEEEECCCccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEe
Confidence 3445555556778888763 23344578889999999998854 468999999999999999999999 9999
Q ss_pred EecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 044746 104 HYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRN 182 (202)
Q Consensus 104 Hrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p 182 (202)
||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||||+++||+++ |+.|
T Consensus 132 H~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~g~~p 211 (279)
T cd05111 132 HRNLAARNILLKSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSYGAEP 211 (279)
T ss_pred ccccCcceEEEcCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcCCCCC
Confidence 999999999999999999999999986543322222233445778999999988889999999999999999998 9999
Q ss_pred Ccchhc
Q 044746 183 LEKEIS 188 (202)
Q Consensus 183 ~~~~~~ 188 (202)
|.+..+
T Consensus 212 ~~~~~~ 217 (279)
T cd05111 212 YAGMRP 217 (279)
T ss_pred CCCCCH
Confidence 976543
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-30 Score=214.48 Aligned_cols=182 Identities=19% Similarity=0.303 Sum_probs=141.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc---c---ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV---G---SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i---~---~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
|||++.-+ -||+|+.....-. .++...|..|......-+|.||+ | .-++ -++.-++++.+|+.+++-
T Consensus 408 V~Rg~whG---dVAVK~Lnv~~pt-~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~e 482 (678)
T KOG0193|consen 408 VYRGRWHG---DVAVKLLNVDDPT-PEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQE 482 (678)
T ss_pred eeeccccc---ceEEEEEecCCCC-HHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchh
Confidence 45555433 3666655443222 23677899999888888999987 2 2222 577888999999998854
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+|.....+.|++|++.|+.|||+ ++|||||||..||++..++.+||+|||++..-.......-.....|...||||
T Consensus 483 tkfdm~~~idIAqQiaqGM~YLHA---K~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAP 559 (678)
T KOG0193|consen 483 TKFDMNTTIDIAQQIAQGMDYLHA---KNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAP 559 (678)
T ss_pred hhhhHHHHHHHHHHHHHhhhhhhh---hhhhhhhccccceEEccCCcEEEecccceeeeeeeccccccCCCccchhhhcH
Confidence 458889999999999999999999 99999999999999999999999999999754333222223334568899999
Q ss_pred cccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchhcccc
Q 044746 153 ELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191 (202)
Q Consensus 153 e~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~ 191 (202)
|+++ ..+|+.++||||||+++|||++|..||. ....++
T Consensus 560 EvIRmqd~nPfS~qSDVYaFGiV~YELltg~lPys-i~~~dq 600 (678)
T KOG0193|consen 560 EVIRMQDDNPFSFQSDVYAFGIVWYELLTGELPYS-IQNRDQ 600 (678)
T ss_pred HHHhhcccCCCCcccchhhhhHHHHHHHhCcCCcC-CCChhh
Confidence 9986 4589999999999999999999999999 444433
|
|
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.96 E-value=8.5e-30 Score=223.98 Aligned_cols=184 Identities=17% Similarity=0.194 Sum_probs=143.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.||.|..+...........+|..|.......+|++++. .++...++++++++++|..++..
T Consensus 18 VYlA~d~~tg~~VAIK~I~~~l~~~e~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~ 97 (932)
T PRK13184 18 VYLAYDPVCSRRVALKKIREDLSENPLLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVW 97 (932)
T ss_pred EEEEEECCCCcEEEEEEECcccccCHHHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhh
Confidence 6889888888888877654322211122345777777888888998763 34456788999999999887642
Q ss_pred ----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc------
Q 044746 73 ----------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT------ 136 (202)
Q Consensus 73 ----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~------ 136 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||+++.......
T Consensus 98 ~~~~l~e~~~~~lsv~~iL~I~~QIa~AL~yLHs---~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~ 174 (932)
T PRK13184 98 QKESLSKELAEKTSVGAFLSIFHKICATIEYVHS---KGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDID 174 (932)
T ss_pred hccccchhhhcccCHHHHHHHHHHHHHHHHHHHH---CCccccCCchheEEEcCCCCEEEEecCcceecccccccccccc
Confidence 235667889999999999999999 9999999999999999999999999999986521100
Q ss_pred ----------ccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 137 ----------HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 137 ----------~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
........||+.|+|||.+.+..++.++|+||+||+++||+||+.||....
T Consensus 175 ~~~~~s~~s~~t~~g~~vGT~~YmAPE~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~ 235 (932)
T PRK13184 175 VDERNICYSSMTIPGKIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKK 235 (932)
T ss_pred cccccccccccccCCCCCCCCCCCCHHHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcc
Confidence 001122468999999999999899999999999999999999999997644
|
|
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=207.71 Aligned_cols=112 Identities=24% Similarity=0.403 Sum_probs=94.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...............++..|+|||
T Consensus 208 ~l~~~~~~~i~~qi~~aL~yLH~---~giiHrDLkp~Nil~~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 284 (374)
T cd05106 208 PLDLDDLLRFSSQVAQGMDFLAS---KNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPE 284 (374)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHH---CCEEeccCchheEEEeCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHH
Confidence 37888999999999999999999 999999999999999999999999999997654332211122233467899999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
++....++.++|+||+||++|||++ |+.||.....
T Consensus 285 ~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~~~ 320 (374)
T cd05106 285 SIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGILV 320 (374)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHhCCCCCCccccc
Confidence 9988889999999999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=204.13 Aligned_cols=176 Identities=20% Similarity=0.259 Sum_probs=136.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||++.+..+++.||.|..+.... .......+..|.......+|++++...+ ...++++ ..+++|..
T Consensus 31 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~-~~~~~l~~ 108 (343)
T cd07878 31 VCSAYDTRLRQKVAVKKLSRPFQ-SLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTN-LMGADLNN 108 (343)
T ss_pred EEEEEECCCCCEEEEEEeCchhh-hhHHHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEee-cCCCCHHH
Confidence 68888887888787776433211 1112233445667777788888764221 1223333 44778888
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+.....+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++..... .....||+.
T Consensus 109 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~ 180 (343)
T cd07878 109 IVKCQKLSDEHVQFLIYQLLRGLKYIHS---AGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-----MTGYVATRW 180 (343)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecccCChhhEEECCCCCEEEcCCccceecCCC-----cCCcccccc
Confidence 8888889999999999999999999999 99999999999999999999999999999865432 233467999
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|+|||++.+ ..++.++||||+||++++|++|+.||...
T Consensus 181 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 219 (343)
T cd07878 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGN 219 (343)
T ss_pred ccCchHhcCCccCCchhhhHhHHHHHHHHHHCCCCCCCC
Confidence 999999876 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=210.06 Aligned_cols=172 Identities=19% Similarity=0.208 Sum_probs=135.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------cccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------EDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.|+.|... ...+..|..++...+|+|++.. ++...++++++. ++|..++..
T Consensus 185 Vy~a~~~~~~~~vavK~~~---------~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 254 (461)
T PHA03211 185 VFESSHPDYPQRVVVKAGW---------YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYR-SDLYTYLGARL 254 (461)
T ss_pred EEEEEECCCCCEEEEeccc---------ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEccC-CCHHHHHHhcC
Confidence 6788888888878777421 1234467777888899988742 334456666664 567666643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||+++...............||+.|+||
T Consensus 255 ~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~AP 331 (461)
T PHA03211 255 RPLGLAQVTAVARQLLSAIDYIHG---EGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAP 331 (461)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEEECcCCHHHEEECCCCCEEEcccCCceecccccccccccccCCCcCCcCH
Confidence 369999999999999999999999 99999999999999999999999999999865433222222345689999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|++.+..++.++|||||||++|||++|..|+..
T Consensus 332 E~~~~~~~~~~sDvwSlGviL~El~~g~~~lf~ 364 (461)
T PHA03211 332 EVLAGDPYTPSVDIWSAGLVIFEAAVHTASLFS 364 (461)
T ss_pred HHHcCCCCCchHHHHHHHHHHHHHHHcCCCccc
Confidence 999998999999999999999999998876543
|
|
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=198.95 Aligned_cols=181 Identities=18% Similarity=0.187 Sum_probs=141.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.+|.|...............+..|.......+|++++. .++...++++++.+++|...+..
T Consensus 16 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 95 (285)
T cd05632 16 VCACQVRATGKMYACKRLEKKRIKKRKGESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMG 95 (285)
T ss_pred EEEEEECCCCcEEEEEEeehhhhhhhhHHHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhc
Confidence 5778887777777777654332222222233445656666777777652 34556788999999998776632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........ .....|+..|+|
T Consensus 96 ~~~~~~~~~~~~~~ql~~~l~~lH~---~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~---~~~~~g~~~~~a 169 (285)
T cd05632 96 NPGFEEERALFYAAEILCGLEDLHR---ENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGES---IRGRVGTVGYMA 169 (285)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEECCCCCEEEecCCcceecCCCCc---ccCCCCCcCccC
Confidence 359999999999999999999999 9999999999999999999999999999876433221 133467999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||++.+..++.++|+||+|++++|+++|+.||....
T Consensus 170 PE~~~~~~~~~~~Di~slG~~l~~l~~g~~P~~~~~ 205 (285)
T cd05632 170 PEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRK 205 (285)
T ss_pred hHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 999988889999999999999999999999997654
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=199.01 Aligned_cols=180 Identities=20% Similarity=0.240 Sum_probs=140.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+...++.++.|...............+..|..+....+|++++. ..+...++++++++++|..++..
T Consensus 16 v~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~ 95 (285)
T cd05630 16 VCACQVRATGKMYACKKLEKKRIKKRKGESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 95 (285)
T ss_pred EEEEEEcCCCceEEEEEEehhhccchHHHHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhc
Confidence 5778888777777776543322111111223445666667777877652 34556788999999999877632
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ .....|++.|+|
T Consensus 96 ~~~l~~~~~~~~~~qi~~~l~~lH~---~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~g~~~y~a 169 (285)
T cd05630 96 EAGFEEGRAVFYAAEICCGLEDLHQ---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMA 169 (285)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCcc---ccCCCCCccccC
Confidence 358999999999999999999999 9999999999999999999999999999875432221 123467999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||++.+..++.++|+||+|+++++|++|+.||...
T Consensus 170 PE~~~~~~~~~~~DiwslG~~l~~l~~g~~Pf~~~ 204 (285)
T cd05630 170 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQR 204 (285)
T ss_pred hHHHcCCCCCCccccHHHHHHHHHHHhCCCCCCCC
Confidence 99999888999999999999999999999999864
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-29 Score=211.10 Aligned_cols=174 Identities=19% Similarity=0.182 Sum_probs=132.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc--------------ccceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE--------------DTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~~~l 66 (202)
||++++...++.||.|..... ......|..+....+|++++... .+..++++++++ ++
T Consensus 82 Vy~~~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~-~l 153 (440)
T PTZ00036 82 VYEAICIDTSEKVAIKKVLQD-------PQYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TV 153 (440)
T ss_pred EEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCc-cH
Confidence 688888877777777643221 11123466677788899887421 123467788775 45
Q ss_pred hhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCccccc
Q 044746 67 YLLC-----KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHITS 140 (202)
Q Consensus 67 ~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~~~ 140 (202)
..++ ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||+++....... .
T Consensus 154 ~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~yLH~---~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~~---~ 227 (440)
T PTZ00036 154 HKYMKHYARNNHALPLFLVKLYSYQLCRALAYIHS---KFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQR---S 227 (440)
T ss_pred HHHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCcCHHHEEEcCCCCceeeeccccchhccCCCC---c
Confidence 4443 24569999999999999999999999 9999999999999998664 799999999986543221 2
Q ss_pred CCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 141 TGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
....||+.|+|||++.+. .++.++||||+||++|||++|.+||.+...
T Consensus 228 ~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 276 (440)
T PTZ00036 228 VSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSS 276 (440)
T ss_pred ccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 234568999999998764 689999999999999999999999987543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.8e-30 Score=201.97 Aligned_cols=179 Identities=15% Similarity=0.096 Sum_probs=138.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc----------ccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE----------DTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~l~~~~ 70 (202)
||++.. .++.||.|..+............|..|.......+|+|++... ....++++++.+|+|..++
T Consensus 36 v~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l 113 (283)
T PHA02988 36 IYKGIF--NNKEVIIRTFKKFHKGHKVLIDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVL 113 (283)
T ss_pred EEEEEE--CCEEEEEEeccccccccHHHHHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHH
Confidence 455655 3445665554333222211134566777888888999876422 2456899999999999988
Q ss_pred ccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 71 KKN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 71 ~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
... .+++.....++.+++.|+.|||+. .+++||||||+||+++.++.+|++|||+++...... ....|+..|
T Consensus 114 ~~~~~~~~~~~~~i~~~i~~~l~~lH~~--~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y 186 (283)
T PHA02988 114 DKEKDLSFKTKLDMAIDCCKGLYNLYKY--TNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSPP-----FKNVNFMVY 186 (283)
T ss_pred hhCCCCChhHHHHHHHHHHHHHHHHHhc--CCCCCCcCChhhEEECCCCcEEEcccchHhhhcccc-----ccccCcccc
Confidence 654 589999999999999999999972 488899999999999999999999999987653321 223568899
Q ss_pred cCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+|||++.+ ..++.++|||||||++|||++|+.||.....
T Consensus 187 ~aPE~~~~~~~~~~~k~Di~SlGvil~el~~g~~Pf~~~~~ 227 (283)
T PHA02988 187 FSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFENLTT 227 (283)
T ss_pred cCHHHhhhccccccchhhhhHHHHHHHHHHHCCCCCCCCCH
Confidence 99999976 6789999999999999999999999986543
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.6e-30 Score=208.61 Aligned_cols=152 Identities=22% Similarity=0.324 Sum_probs=131.1
Q ss_pred CcHHHHHHhcccccccc-------ccccceEEEEEccCCchhhhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 33 TSPQRMIAADNFSNLVG-------SEDTETYIKGFLAMGPFYLLCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 33 ~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
..|..+.....||+++. .+....++++|++||++.+.++.. .++++.+..++.|++.|+.|||+ ++|
T Consensus 51 ~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~ylH~---~~i 127 (426)
T KOG0589|consen 51 IQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYLHE---NRV 127 (426)
T ss_pred HHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh---hhh
Confidence 34444556688998874 444478999999999998888543 48999999999999999999998 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRN 182 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p 182 (202)
+|||||+.||++..++.++|+|||+|+.++.+.. ......||+.||+||++.+.+|+.|+||||+||++|||++-+++
T Consensus 128 LHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~~--~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm~~lk~a 205 (426)
T KOG0589|consen 128 LHRDLKCANIFLTKDKKVKLGDFGLAKILNPEDS--LASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEMCTLKPA 205 (426)
T ss_pred hcccchhhhhhccccCceeecchhhhhhcCCchh--hhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHHHhcccc
Confidence 9999999999999999999999999998776542 23457889999999999999999999999999999999999999
Q ss_pred Ccchhcc
Q 044746 183 LEKEISE 189 (202)
Q Consensus 183 ~~~~~~~ 189 (202)
|...+..
T Consensus 206 F~a~~m~ 212 (426)
T KOG0589|consen 206 FKASNMS 212 (426)
T ss_pred cCccchH
Confidence 9876544
|
|
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=206.26 Aligned_cols=178 Identities=16% Similarity=0.151 Sum_probs=136.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l~~ 68 (202)
||++++...+..+|.|+..... .......++..|.......+|++++... ....++++++.++ +..
T Consensus 37 V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~~-l~~ 114 (359)
T cd07876 37 VCAAFDTVLGINVAVKKLSRPF-QNQTHAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDAN-LCQ 114 (359)
T ss_pred EEEEEEcCCCceeEEEEecccc-cchhHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCCcC-HHH
Confidence 6788888878878777643321 1122233455667777788899876322 1235777887654 444
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
... ..++...+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+++...... ......||+.
T Consensus 115 ~~~-~~~~~~~~~~~~~qi~~~L~~LH~---~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~~t~~ 187 (359)
T cd07876 115 VIH-MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTNF---MMTPYVVTRY 187 (359)
T ss_pred HHh-ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEecCCCccccccCc---cCCCCcccCC
Confidence 443 358899999999999999999999 999999999999999999999999999997543221 1233467899
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+..++.++|+||+||++|+|++|+.||....
T Consensus 188 y~aPE~~~~~~~~~~~DiwSlG~il~el~tg~~pf~~~~ 226 (359)
T cd07876 188 YRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTD 226 (359)
T ss_pred CCCchhccCCCCCcchhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999999899999999999999999999999997554
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.2e-30 Score=214.17 Aligned_cols=176 Identities=15% Similarity=0.184 Sum_probs=125.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc------ccccc---c----ccccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN------FSNLV---G----SEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~i---~----~~~~~~~~~~~~~~~~l~ 67 (202)
||++.+...++.||+|+.+....... .+..|........ +.+++ + ..+..+++++++ ++.|.
T Consensus 145 V~~a~~~~~~~~vAvK~i~~~~~~~~----~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~ 219 (467)
T PTZ00284 145 VVEAWDRKRKEYCAVKIVRNVPKYTR----DAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLL 219 (467)
T ss_pred EEEEEEcCCCeEEEEEEEecchhhHH----HHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHH
Confidence 78899988889999887643221111 1111222222221 11222 1 122344555544 55666
Q ss_pred hhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC----------------ceEEeeeeccee
Q 044746 68 LLC-KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF----------------FPKAADFGLAKL 130 (202)
Q Consensus 68 ~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~----------------~~kl~dfgl~~~ 130 (202)
.++ +.+.+++..+..++.|++.||.|||+. .+||||||||+|||++.++ .+||+|||.+..
T Consensus 220 ~~l~~~~~l~~~~~~~i~~qi~~aL~yLH~~--~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~ 297 (467)
T PTZ00284 220 DWIMKHGPFSHRHLAQIIFQTGVALDYFHTE--LHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCD 297 (467)
T ss_pred HHHHHcCCCCHHHHHHHHHHHHHHHHHHHhc--CCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCcccc
Confidence 655 456799999999999999999999971 4999999999999998655 489999998753
Q ss_pred ccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 131 ~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
... ......||+.|+|||++.+..++.++|||||||++|||++|++||.....
T Consensus 298 ~~~-----~~~~~~gt~~Y~APE~~~~~~~~~~~DiwSlGvil~elltG~~pf~~~~~ 350 (467)
T PTZ00284 298 ERH-----SRTAIVSTRHYRSPEVVLGLGWMYSTDMWSMGCIIYELYTGKLLYDTHDN 350 (467)
T ss_pred Ccc-----ccccccCCccccCcHHhhcCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 221 12345679999999999999999999999999999999999999976554
|
|
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.1e-29 Score=198.24 Aligned_cols=182 Identities=19% Similarity=0.247 Sum_probs=136.3
Q ss_pred CCccccCCCcce----eehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRF----ITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~----v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+++....+.. ||.|+.+... .......+..+.......+|++++. ......++++++++|+|..++.
T Consensus 23 vy~~~~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~l~~~~~~~g~l~~~l~ 100 (279)
T cd05109 23 VYKGIWIPDGENVKIPVAIKVLRENT--SPKANKEILDEAYVMAGVGSPYVCRLLGICLTSTVQLVTQLMPYGCLLDYVR 100 (279)
T ss_pred EEEEEEecCCCccceEEEEEEecCCC--CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCCCcEEEEEcCCCCCHHHHHh
Confidence 577765444442 4555433211 1111234555666666677787652 2344568888999999998885
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 K--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 ~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
. ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...............+++.|
T Consensus 101 ~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y 177 (279)
T cd05109 101 ENKDRIGSQDLLNWCVQIAKGMSYLEE---VRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETEYHADGGKVPIKW 177 (279)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCCCceeecccccceeecCCCccchhh
Confidence 4 358999999999999999999999 99999999999999999999999999999876433322222223346789
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
+|||.+.+..++.++|+|||||++||+++ |.+||....
T Consensus 178 ~~PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~ 216 (279)
T cd05109 178 MALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDGIP 216 (279)
T ss_pred CCHHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 99999988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-29 Score=207.23 Aligned_cols=183 Identities=20% Similarity=0.266 Sum_probs=136.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------c-----cceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------D-----TETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------~-----~~~~~~~~~~~~~l~~~ 69 (202)
||++++...++.||.|....... ......++..|..+....+|+|++... . ...++++++.+ +|...
T Consensus 16 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~ 93 (372)
T cd07853 16 VWSVTDPRDGKRVALKKMPNVFQ-NLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS-DLHKI 93 (372)
T ss_pred EEEEEECCCCCEEEEEecccccc-chHHHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeecccc-CHHHH
Confidence 68888877777777665432111 111223455666677778888876321 1 34577777764 45544
Q ss_pred h-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 70 C-KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 70 ~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
. ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....... .......+++.
T Consensus 94 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~-~~~~~~~~~~~ 169 (372)
T cd07853 94 IVSPQPLSSDHVKVFLYQILRGLKYLHS---AGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES-KHMTQEVVTQY 169 (372)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHHEEECCCCCEEeccccceeecccCcc-ccCCCCCcCCC
Confidence 4 45679999999999999999999999 9999999999999999999999999999986433221 11233456889
Q ss_pred ccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 149 CEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 149 y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|+|||++.+. .++.++|+||+||+++||++|++||....+.
T Consensus 170 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~ 211 (372)
T cd07853 170 YRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSPI 211 (372)
T ss_pred cCCHHHHcCCCCCCcHHHHHhHHHHHHHHHcCCCCCCCCCHH
Confidence 9999998774 4789999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=9.1e-30 Score=211.30 Aligned_cols=181 Identities=19% Similarity=0.216 Sum_probs=150.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh--cc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC--KK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~--~~ 72 (202)
||||.++..+.++|.|+- +..+.+....|..|.-+++..+||++++ ..+-.++..+|+.||-+..++ -.
T Consensus 48 VyKA~nket~~lAAaKvI---etkseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~ 124 (1187)
T KOG0579|consen 48 VYKAVNKETKLLAAAKVI---ETKSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELG 124 (1187)
T ss_pred hhhhhcccchhhhhhhhh---cccchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhc
Confidence 799999988888888763 3334455667888999999999999886 334466889999999876655 34
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+++.++.-++.|++.||.|||+ +.|||||||..|||+..+|.++|+|||++........ ......|||+||||
T Consensus 125 r~LtE~QIqvvc~q~ldALn~LHs---~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~t~q--kRDsFIGTPYWMAP 199 (1187)
T KOG0579|consen 125 RVLTEDQIQVVCYQVLDALNWLHS---QNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKSTRQ--KRDSFIGTPYWMAP 199 (1187)
T ss_pred cccchHHHHHHHHHHHHHHHHHhh---cchhhhhccccceEEEecCcEeeecccccccchhHHh--hhccccCCcccccc
Confidence 679999999999999999999999 9999999999999999999999999999864332222 23457899999999
Q ss_pred cccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWMP-----YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~-----~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|+..+ .+|+.++||||||++|.||..+.||-..-+++
T Consensus 200 EVvmCET~KD~PYDykaDiWSlGITLIEMAqiEPPHhelnpM 241 (1187)
T KOG0579|consen 200 EVVMCETFKDQPYDYKADIWSLGITLIEMAQIEPPHHELNPM 241 (1187)
T ss_pred hheeeccccCCCchhhhhHHhhhhHHHHHhccCCCccccchH
Confidence 99764 58999999999999999999999998766654
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-30 Score=208.00 Aligned_cols=182 Identities=23% Similarity=0.256 Sum_probs=140.8
Q ss_pred CCcccc---CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRN---RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~---~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++ ...+..+|.|+.+..... .....++..|.......+|++++. ..+..+++++++++++|..++.
T Consensus 12 Vy~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 90 (318)
T cd05582 12 VFLVRKITGPDAGQLYAMKVLKKATLK-VRDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 90 (318)
T ss_pred EEEEEEeccCCCCCEEEEEEEEHHHhh-hhhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHH
Confidence 455554 345667777665433221 112233455666777788888763 3445668899999999988875
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ......|++.|+
T Consensus 91 ~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~g~~~y~ 165 (318)
T cd05582 91 KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYM 165 (318)
T ss_pred HcCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCCC--ceecccCChhhc
Confidence 4 458999999999999999999999 9999999999999999999999999999875433211 123356799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||.+.+..++.++|+||+||++|||++|+.||.....
T Consensus 166 aPE~~~~~~~~~~~DiwslG~il~el~tg~~p~~~~~~ 203 (318)
T cd05582 166 APEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKDR 203 (318)
T ss_pred CHHHHcCCCCCCccceeccceEeeeeccCCCCCCCCCH
Confidence 99999988889999999999999999999999976543
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.5e-30 Score=214.81 Aligned_cols=179 Identities=20% Similarity=0.190 Sum_probs=141.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||-+|+.....-+|.|--.. ........+-.|..+-.+..|.||+ +++++..++|+..+||+|..++..
T Consensus 591 VYA~RD~~tqvrIaIKEIpe---kdsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskW 667 (1226)
T KOG4279|consen 591 VYAARDMDTQVRIAIKEIPE---KDSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKW 667 (1226)
T ss_pred EEeeccccceeEEEeeeccc---ccchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhcc
Confidence 67888888877777653222 2222233455566666778888876 466777789999999999998865
Q ss_pred CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc-CCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 73 NIL--GFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 73 ~~~--~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
+++ .+...-.+.+||++||.|||+ +.|+|||||.+|+|+. -.|.+|++|||.++.+..-... .....||..|
T Consensus 668 GPlKDNEstm~fYtkQILeGLkYLHe---n~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAginP~--TETFTGTLQY 742 (1226)
T KOG4279|consen 668 GPLKDNESTMNFYTKQILEGLKYLHE---NKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGINPC--TETFTGTLQY 742 (1226)
T ss_pred CCCccchhHHHHHHHHHHHHhhhhhh---cceeeccccCCcEEEeeccceEEecccccchhhccCCcc--ccccccchhh
Confidence 345 778889999999999999999 9999999999999997 4799999999999866432222 2446689999
Q ss_pred cCCcccCCC--CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPY--SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~--~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||||++..+ .|+.++|||||||++.||.||+|||....
T Consensus 743 MAPEvIDqG~RGYG~aADIWS~GCT~vEMATGrPPF~Elg 782 (1226)
T KOG4279|consen 743 MAPEVIDQGPRGYGKAADIWSFGCTMVEMATGRPPFVELG 782 (1226)
T ss_pred hChHhhccCCcCCCchhhhhhccceeEeeccCCCCeeecC
Confidence 999999754 68899999999999999999999997443
|
|
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=197.58 Aligned_cols=156 Identities=20% Similarity=0.306 Sum_probs=126.3
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-----------------CCCCHHHHHHHHHH
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------------NILGFGQLREIEVS 86 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~ 86 (202)
..|..|.......+|++++. .....+++++++++++|..++.. ..+++..+..++.|
T Consensus 53 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 132 (283)
T cd05048 53 QEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLHIAIQ 132 (283)
T ss_pred HHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHHHHHH
Confidence 34666666677778887653 33446688899999999888743 45788999999999
Q ss_pred HHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhH
Q 044746 87 TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDV 166 (202)
Q Consensus 87 i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Di 166 (202)
++.||.|||+ ++++|+||||+||+++.++.++|+|||+++...............+++.|+|||.+....++.++|+
T Consensus 133 l~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDv 209 (283)
T cd05048 133 IAAGMEYLSS---HHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDI 209 (283)
T ss_pred HHHHHHHHHh---CCeeccccccceEEEcCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCchhhhH
Confidence 9999999999 9999999999999999999999999999986533222222233445788999999988889999999
Q ss_pred HHHHHHHHHHHc-CCCCCcchhc
Q 044746 167 FSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 167 ws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||||+++||++ |..||.+...
T Consensus 210 ~slG~il~el~~~g~~p~~~~~~ 232 (283)
T cd05048 210 WSFGVVLWEIFSYGLQPYYGFSN 232 (283)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999998 9999976443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.9e-29 Score=202.21 Aligned_cols=134 Identities=25% Similarity=0.321 Sum_probs=117.8
Q ss_pred cccccceEEEEEccCCchhhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeee
Q 044746 49 GSEDTETYIKGFLAMGPFYLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125 (202)
Q Consensus 49 ~~~~~~~~~~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~df 125 (202)
...+-.++++..|+||.|.-++.. ..+++..++.++.+|+.||++||. .+|+.|||||+|||+|..|+++|+|+
T Consensus 255 eTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH~---~~iVYRDLKPeNILLDd~GhvRISDL 331 (591)
T KOG0986|consen 255 ETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLHR---RRIVYRDLKPENILLDDHGHVRISDL 331 (591)
T ss_pred cCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHHh---cceeeccCChhheeeccCCCeEeecc
Confidence 456667899999999998655532 359999999999999999999999 99999999999999999999999999
Q ss_pred ecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 126 gl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||..+..... ..+.+||.+|||||++....|+..+|+||+||++|||+.|+.||.....
T Consensus 332 GLAvei~~g~~---~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~G~sPFr~~Ke 391 (591)
T KOG0986|consen 332 GLAVEIPEGKP---IRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIAGHSPFRQRKE 391 (591)
T ss_pred ceEEecCCCCc---cccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHcccCchhhhhh
Confidence 99987655443 3556899999999999998999999999999999999999999976543
|
|
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=2e-29 Score=205.81 Aligned_cols=178 Identities=17% Similarity=0.172 Sum_probs=136.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||++.+...++.+|.|...... .......++..|.......+|++++...+ ...++++++.+ ++..
T Consensus 40 V~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 117 (364)
T cd07875 40 VCAAYDAILERNVAIKKLSRPF-QNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQ 117 (364)
T ss_pred EEEEEECCCCcEEEEEEeCccc-cCchhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCCC-CHHH
Confidence 5778887777777776543321 11122334555666777788898764321 23577788765 4555
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
... ..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+++....... .....||+.
T Consensus 118 ~~~-~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~---~~~~~~t~~ 190 (364)
T cd07875 118 VIQ-MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 190 (364)
T ss_pred HHH-hcCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCCc---ccCCcccCC
Confidence 443 358899999999999999999999 9999999999999999999999999999986543221 233457999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+..++.++|+||+||++|+|++|+.||....
T Consensus 191 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~ 229 (364)
T cd07875 191 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTD 229 (364)
T ss_pred cCCHHHHhCCCCCchhhHHhHHHHHHHHHhCCCCCCCCC
Confidence 999999999899999999999999999999999997654
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.1e-29 Score=197.95 Aligned_cols=180 Identities=22% Similarity=0.290 Sum_probs=133.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHH---Hhcccccccccc-----------ccceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI---AADNFSNLVGSE-----------DTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l 66 (202)
||++++..+++.++.|..+...... .....+..|.... ...+|+|++... ....++++++.+ ++
T Consensus 16 v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 93 (288)
T cd07863 16 VYKARDPHSGHFVALKSVRVQTNED-GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVDQ-DL 93 (288)
T ss_pred EEEEEECCCCcEEEEEEeccCcCCC-CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEccccc-CH
Confidence 6889998888888877654321111 1111222232222 234678776322 224567777764 66
Q ss_pred hhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCC
Q 044746 67 YLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 67 ~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
..++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....... ....
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~~---~~~~ 167 (288)
T cd07863 94 RTYLDKVPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQMA---LTPV 167 (288)
T ss_pred HHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccCccccccCccc---CCCc
Confidence 665543 348999999999999999999999 9999999999999999999999999999986543221 2234
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|++.|+|||++.+..++.++|+||+||++++|++|++||.....
T Consensus 168 ~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~~f~~~~~ 212 (288)
T cd07863 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212 (288)
T ss_pred cccccccCchHhhCCCCCCcchhhhHHHHHHHHHhCCcCcCCCCH
Confidence 568899999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.6e-29 Score=205.12 Aligned_cols=151 Identities=22% Similarity=0.277 Sum_probs=122.2
Q ss_pred CcHHHHHHhccccccccc------cccceEEEEEccCCchhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 044746 33 TSPQRMIAADNFSNLVGS------EDTETYIKGFLAMGPFYLLC-KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHY 105 (202)
Q Consensus 33 ~~~~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHr 105 (202)
..|..+....+|++++.. ....+++++++. +++..++ ....+++.++..++.|++.||.|||+ .+|+||
T Consensus 134 ~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~---~givHr 209 (392)
T PHA03207 134 GREIDILKTISHRAIINLIHAYRWKSTVCMVMPKYK-CDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHG---RGIIHR 209 (392)
T ss_pred HHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhcC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccc
Confidence 456667777888887642 233445666665 4565555 34579999999999999999999999 999999
Q ss_pred cCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 106 DIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 106 dlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
||||+||+++.++.++|+|||++................||+.|+|||++.+..++.++||||+||++|||++|+.||.+
T Consensus 210 Dlkp~Nill~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 289 (392)
T PHA03207 210 DVKTENIFLDEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFG 289 (392)
T ss_pred CCCHHHEEEcCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999999999999999999765443322223345689999999999988999999999999999999999999976
Q ss_pred hh
Q 044746 186 EI 187 (202)
Q Consensus 186 ~~ 187 (202)
..
T Consensus 290 ~~ 291 (392)
T PHA03207 290 KQ 291 (392)
T ss_pred CC
Confidence 54
|
|
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.7e-29 Score=198.81 Aligned_cols=178 Identities=19% Similarity=0.240 Sum_probs=129.3
Q ss_pred CCccccCC--CcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRG--STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~--~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++.. .++.++.|..... .....+..|..+....+|+|++.. ....++++++.. +++..++
T Consensus 17 Vy~~~~~~~~~~~~~aiK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~ 90 (317)
T cd07868 17 VYKAKRKDGKDDRDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHII 90 (317)
T ss_pred EEEEEEccCCCCceEEEEEECCC-----CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEeccC-CCHHHHH
Confidence 67777543 4455555543221 111234457777788899988642 222345666655 4555544
Q ss_pred c----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE----cCCCceEEeeeecceeccccCc
Q 044746 71 K----------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYNREHT 136 (202)
Q Consensus 71 ~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~----~~~~~~kl~dfgl~~~~~~~~~ 136 (202)
. ...++...++.++.|++.||.|||+ .+++||||||+|||+ +..+.+||+|||+++.......
T Consensus 91 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~ 167 (317)
T cd07868 91 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167 (317)
T ss_pred HhcccccccCCcccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc
Confidence 2 1248899999999999999999999 999999999999999 4567899999999986543322
Q ss_pred c-cccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 137 H-ITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 137 ~-~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
. .......||+.|+|||++.+. .++.++|+||+||+++||++|++||....
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~f~~~~ 220 (317)
T cd07868 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cccccCCccccccccCCHHHcCCCCcCchhhHHHHHHHHHHHHhCCCCccCCc
Confidence 1 122345679999999998764 58899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=99.96 E-value=4.9e-29 Score=204.38 Aligned_cols=176 Identities=19% Similarity=0.295 Sum_probs=133.2
Q ss_pred CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhccC------
Q 044746 7 RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN------ 73 (202)
Q Consensus 7 ~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~------ 73 (202)
...+..||+|+.+..... .....+..|..+.... +|+|++. .++...++++++++|+|..++...
T Consensus 62 ~~~~~~vavK~l~~~~~~--~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~ 139 (375)
T cd05104 62 SDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFIC 139 (375)
T ss_pred CccceeEEEEeccCCcCc--HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhccccccc
Confidence 445556777765432211 1123455565555555 7888764 445567899999999988776421
Q ss_pred ----------------------------------------------------------------------CCCHHHHHHH
Q 044746 74 ----------------------------------------------------------------------ILGFGQLREI 83 (202)
Q Consensus 74 ----------------------------------------------------------------------~~~~~~~~~~ 83 (202)
.+++..+..+
T Consensus 140 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~ 219 (375)
T cd05104 140 PKHEDHAEAALYKNLLHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSF 219 (375)
T ss_pred ccccchhhhHHHHhhhhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHH
Confidence 4788889999
Q ss_pred HHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCch
Q 044746 84 EVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQK 163 (202)
Q Consensus 84 ~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~ 163 (202)
+.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.+
T Consensus 220 ~~qi~~~l~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 296 (375)
T cd05104 220 SYQVAKGMSFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFE 296 (375)
T ss_pred HHHHHHHHHHHHH---CCeeccCCchhhEEEECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCC
Confidence 9999999999999 9999999999999999999999999999986543322222222334678999999998899999
Q ss_pred hhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 164 CDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 164 ~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
+|+||||++++||++ |..||....
T Consensus 297 sDi~slG~~l~ellt~g~~p~~~~~ 321 (375)
T cd05104 297 SDVWSYGILLWEIFSLGSSPYPGMP 321 (375)
T ss_pred CCHHHHHHHHHHHHhcCCCCCCCCC
Confidence 999999999999997 899997654
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.6e-29 Score=208.39 Aligned_cols=192 Identities=20% Similarity=0.320 Sum_probs=142.5
Q ss_pred ccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhh-ccCCC
Q 044746 3 KPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLC-KKNIL 75 (202)
Q Consensus 3 k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~-~~~~~ 75 (202)
.++......+.|.|-.++..........-...|..+++..+-.=++ ...+..+++|+|++||.+..++ +.+.|
T Consensus 647 Lv~KvDT~~lYAmKTLrKaDVl~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIF 726 (1034)
T KOG0608|consen 647 LVRKVDTRALYAMKTLRKADVLMRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIF 726 (1034)
T ss_pred EEeecchhhHHHHhhhHHHHHHhhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccC
Confidence 4455555555555544444333333333344444455544333222 4566778999999999886655 66779
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccc---cCc----------------
Q 044746 76 GFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR---EHT---------------- 136 (202)
Q Consensus 76 ~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~---~~~---------------- 136 (202)
.+..++.++.++.+|+++.|. +|+|||||||+|||||.+|++||.||||+.-+.- ..+
T Consensus 727 eE~LARFYIAEltcAiesVHk---mGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~ 803 (1034)
T KOG0608|consen 727 EEDLARFYIAELTCAIESVHK---MGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSP 803 (1034)
T ss_pred HHHHHHHHHHHHHHHHHHHHh---ccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCch
Confidence 999999999999999999999 9999999999999999999999999999975420 000
Q ss_pred ---------------------ccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcccccc-c
Q 044746 137 ---------------------HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW-F 194 (202)
Q Consensus 137 ---------------------~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~-~ 194 (202)
.......+||+.|+|||++....++..+|+||.|++|+||+.|++||..+.+.+.+. .
T Consensus 804 e~~d~~~~lkvL~~ra~~~h~r~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv 883 (1034)
T KOG0608|consen 804 EWADISKCLKVLERRAMRQHQRILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKV 883 (1034)
T ss_pred hhccccccchHHHHHHHhhhhhhhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeee
Confidence 001123578999999999999999999999999999999999999999998876543 3
Q ss_pred ccc
Q 044746 195 PKW 197 (202)
Q Consensus 195 ~~~ 197 (202)
++|
T Consensus 884 ~nw 886 (1034)
T KOG0608|consen 884 INW 886 (1034)
T ss_pred eeh
Confidence 455
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.4e-29 Score=218.95 Aligned_cols=185 Identities=21% Similarity=0.268 Sum_probs=150.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc-------cccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV-------GSEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i-------~~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
|..+|.+++++++|.|+..+-+........-|..|..++...+ ..+| ....+.+++|+|++||.|..++.+.
T Consensus 91 V~lVr~k~t~~VYAMK~lnK~eMlKr~~tA~F~EERDimv~~n-s~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~ 169 (1317)
T KOG0612|consen 91 VALVRHKSTEKVYAMKILNKWEMLKRAETACFREERDIMVFGN-SEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKF 169 (1317)
T ss_pred eEEEEeeccccchhHHHhhHHHHhhchhHHHHHHHhHHHHcCC-cHHHHHHHHHhcCccceEEEEecccCchHHHHHhhc
Confidence 4456778888888888776655554444444555555565555 4333 4667788999999999999999776
Q ss_pred C-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 I-LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 ~-~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
. ++++-++.+...+..||.-+|+ .|.|||||||+|||++..|++||+|||.+-.+..+..- .+...+|||-|++|
T Consensus 170 ~~~pE~~ArFY~aEiVlAldslH~---mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG~V-~s~~aVGTPDYISP 245 (1317)
T KOG0612|consen 170 DRLPEDWARFYTAEIVLALDSLHS---MGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADGTV-RSSVAVGTPDYISP 245 (1317)
T ss_pred CCChHHHHHHHHHHHHHHHHHHHh---ccceeccCCcceeEecccCcEeeccchhHHhcCCCCcE-EeccccCCCCccCH
Confidence 5 9999999999999999999999 99999999999999999999999999999877654433 33556899999999
Q ss_pred cccC----C-CCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 153 ELWM----P-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 153 e~~~----~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
|++. + +.|+..+|+||+||++|||+.|.-||..++-.+
T Consensus 246 EvLqs~~~~~g~yG~ecDwWSlGV~~YEMlyG~TPFYadslve 288 (1317)
T KOG0612|consen 246 EVLQSQGDGKGEYGRECDWWSLGVFMYEMLYGETPFYADSLVE 288 (1317)
T ss_pred HHHHhhcCCccccCCccchhhhHHHHHHHHcCCCcchHHHHHH
Confidence 9985 2 568999999999999999999999998776543
|
|
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=3.2e-29 Score=203.88 Aligned_cols=178 Identities=17% Similarity=0.174 Sum_probs=135.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l~~ 68 (202)
||++.+...++.+|.|..+.... ......++..|.......+|++++... ....++++++.+ ++..
T Consensus 33 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 110 (355)
T cd07874 33 VCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMDA-NLCQ 110 (355)
T ss_pred EEEEEecCCCceEEEEEeCCccc-ChHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhcc-cHHH
Confidence 67888877777777765432211 112223455566677777888876322 123567777765 4544
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
... ..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....... .....||+.
T Consensus 111 ~~~-~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~ 183 (355)
T cd07874 111 VIQ-MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 183 (355)
T ss_pred HHh-hcCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEECCCCCEEEeeCcccccCCCccc---cCCccccCC
Confidence 443 358899999999999999999999 9999999999999999999999999999986433221 233467999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+..++.++|+||+||++++|++|+.||.+..
T Consensus 184 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 222 (355)
T cd07874 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRD 222 (355)
T ss_pred ccCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999998889999999999999999999999997644
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.2e-29 Score=202.13 Aligned_cols=175 Identities=21% Similarity=0.240 Sum_probs=134.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.|+.|+...... ......+..|..+....+|++++. ..+...++++++++++|... ..
T Consensus 90 V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~---~~ 164 (353)
T PLN00034 90 VYKVIHRPTGRLYALKVIYGNHE--DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT---HI 164 (353)
T ss_pred EEEEEECCCCCEEEEEEEecCCc--HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc---cc
Confidence 68888888888888776533211 112234667777778888888763 34455688999999887542 34
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
.+...+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....... ......||..|+|||+
T Consensus 165 ~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~~--~~~~~~gt~~y~aPE~ 239 (353)
T PLN00034 165 ADEQFLADVARQILSGIAYLHR---RHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTMD--PCNSSVGTIAYMSPER 239 (353)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEcccccceecccccc--cccccccCccccCccc
Confidence 5677888999999999999999 9999999999999999999999999999986543221 1123467999999998
Q ss_pred cCC-----CCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 155 WMP-----YSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 155 ~~~-----~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
+.. ...+.++|||||||++|||++|+.||..
T Consensus 240 ~~~~~~~~~~~~~~~DvwslGvil~el~~g~~pf~~ 275 (353)
T PLN00034 240 INTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGV 275 (353)
T ss_pred cccccccCcCCCcchhHHHHHHHHHHHHhCCCCCCC
Confidence 743 2344689999999999999999999973
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.9e-29 Score=194.42 Aligned_cols=183 Identities=20% Similarity=0.262 Sum_probs=149.3
Q ss_pred CccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccc------ccccccceEEEEEccCCchhhhhccC-C
Q 044746 2 EKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNL------VGSEDTETYIKGFLAMGPFYLLCKKN-I 74 (202)
Q Consensus 2 ~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------i~~~~~~~~~~~~~~~~~l~~~~~~~-~ 74 (202)
-.+|.+.++++.|.|+.++.--...+...--.-|...+...+||-+ ....+..+++++|..+|.|+-.+.+. .
T Consensus 185 IL~rEKat~k~YAiKIlkKeviiakdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~ 264 (516)
T KOG0690|consen 185 ILCREKATGKLYAIKILKKEVIIAKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERV 264 (516)
T ss_pred EEEeecccCceeehhhhhhhheeehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhc
Confidence 4567888999999999876544433322223345566667777732 24556678999999999998777654 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++...+.+...|.+||.|||+ ++|+.||||.+|.+++.+|++|+.|||+++.-- .........+|||.|+|||+
T Consensus 265 FsE~RtRFYGaEIvsAL~YLHs---~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I--~~g~t~kTFCGTPEYLAPEV 339 (516)
T KOG0690|consen 265 FSEDRTRFYGAEIVSALGYLHS---RNIVYRDLKLENLLLDKDGHIKITDFGLCKEEI--KYGDTTKTFCGTPEYLAPEV 339 (516)
T ss_pred ccchhhhhhhHHHHHHhhhhhh---CCeeeeechhhhheeccCCceEeeecccchhcc--cccceeccccCChhhcCchh
Confidence 9999999999999999999999 999999999999999999999999999998421 22334566889999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
+....|+..+|+|.+|+++|||+-|+.||...+.+
T Consensus 340 leDnDYgraVDWWG~GVVMYEMmCGRLPFyn~dh~ 374 (516)
T KOG0690|consen 340 LEDNDYGRAVDWWGVGVVMYEMMCGRLPFYNKDHE 374 (516)
T ss_pred hccccccceeehhhhhHHHHHHHhccCcccccchh
Confidence 99999999999999999999999999999876554
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=6.5e-29 Score=200.62 Aligned_cols=179 Identities=20% Similarity=0.238 Sum_probs=142.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..++..+++|+..... .......+..|.......+|++++. ..+..+++++++.+++|..++.. .
T Consensus 21 V~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 98 (333)
T cd06650 21 VFKVSHKPSGLIMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 98 (333)
T ss_pred EEEEEECCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcC
Confidence 6788888888888877643321 1111234666777777788888763 44556789999999999988754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+. .+++||||||+||+++.++.++|+|||++...... ......|+..|+|||
T Consensus 99 ~~~~~~~~~~~~~l~~~l~~lH~~--~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~----~~~~~~~~~~y~aPE 172 (333)
T cd06650 99 RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS----MANSFVGTRSYMSPE 172 (333)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhc--CCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh----ccccCCCCccccCHH
Confidence 589999999999999999999971 47999999999999999999999999998754321 122345789999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.+..++.++|+||+||++||+++|+.||....
T Consensus 173 ~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 206 (333)
T cd06650 173 RLQGTHYSVQSDIWSMGLSLVEMAIGRYPIPPPD 206 (333)
T ss_pred HhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcc
Confidence 9998889999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.3e-29 Score=214.77 Aligned_cols=182 Identities=18% Similarity=0.207 Sum_probs=138.2
Q ss_pred CCccccCCC-cceeehhhhchhhhhccCCcccCCcHHH-HHHhccccccccccc-------------cceEEEEEccCCc
Q 044746 1 MEKPRNRGS-TRFITRTIDKSLDAMEMDKPIRFTSPQR-MIAADNFSNLVGSED-------------TETYIKGFLAMGP 65 (202)
Q Consensus 1 v~k~~~~~~-~~~v~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~~~-------------~~~~~~~~~~~~~ 65 (202)
||.|++... .+++.+++-...+. .......|.. +....+|+|||+.-+ ...+.|+|+.+|.
T Consensus 53 VYla~~~~~~~~~AlKrm~~~de~----~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~ 128 (738)
T KOG1989|consen 53 VYLAQDVKGGKKYALKRMYVNDEE----ALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGS 128 (738)
T ss_pred EEEEEecCCCceeeeeeeecCCHH----HHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCc
Confidence 788999888 66666666544221 2333444433 444556888874222 2237788999999
Q ss_pred hhhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC-ccc---
Q 044746 66 FYLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH-THI--- 138 (202)
Q Consensus 66 l~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~-~~~--- 138 (202)
|.++++. ..|++.++++|+.++++|+.+||. +..+|||||||.+|+|+..++..||||||.+....... ...
T Consensus 129 Lvd~mn~Rlq~~lte~eVLkIf~dv~~AVa~mH~-~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~ 207 (738)
T KOG1989|consen 129 LVDFMNTRLQTRLTEDEVLKIFYDVCEAVAAMHY-LKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVN 207 (738)
T ss_pred HHHHHHHHHhccCChHHHHHHHHHHHHHHHHHhc-CCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHH
Confidence 9998863 359999999999999999999997 45779999999999999999999999999987432221 100
Q ss_pred ---ccCCCCCCCcccCCcccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 139 ---TSTGRRRTPGCEAPELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 139 ---~~~~~~gt~~y~aPe~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.....+.|+.|+|||++. +.+++.|+|||++||+||-|+....||+...
T Consensus 208 ~ve~eI~k~TTp~YRsPEMIDlysg~pI~eKsDIWALGclLYkLCy~t~PFe~sg 262 (738)
T KOG1989|consen 208 YVEEEIEKYTTPQYRSPEMIDLYSGLPIGEKSDIWALGCLLYKLCYFTTPFEESG 262 (738)
T ss_pred HHHHHHHhhCCccccChHHHhhhcCCCCcchhHHHHHHHHHHHHHHhCCCcCcCc
Confidence 011245699999999974 6789999999999999999999999998763
|
|
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=195.35 Aligned_cols=179 Identities=21% Similarity=0.318 Sum_probs=144.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.++.|+..............+..|.......+|++++. .+....++++++++++|..++.. .
T Consensus 17 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 96 (290)
T cd05580 17 VMLVRHKGSGKYYALKILSKAKIVKLKQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSG 96 (290)
T ss_pred EEEEEEcCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcC
Confidence 5778887778888887765443333333445666666677777887652 44556688999999999888754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.++...+..++.|++.||.|||+ .+++|+||+|.||+++.++.++|+|||++...... .....+++.|+|||
T Consensus 97 ~l~~~~~~~~~~qil~~l~~lH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y~aPE 168 (290)
T cd05580 97 RFPEPVARFYAAQVVLALEYLHS---LDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-----TYTLCGTPEYLAPE 168 (290)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-----CCCCCCCccccChh
Confidence 68999999999999999999999 99999999999999999999999999998865433 12345688999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.+.+...+.++|+||+|+++++|++|+.||....
T Consensus 169 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 202 (290)
T cd05580 169 IILSKGYGKAVDWWALGILIYEMLAGYPPFFDDN 202 (290)
T ss_pred hhcCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 9988888899999999999999999999997654
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.3e-29 Score=222.21 Aligned_cols=164 Identities=22% Similarity=0.298 Sum_probs=137.9
Q ss_pred hccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC--------CCCHHHHHHHHHHHHH
Q 044746 24 MEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN--------ILGFGQLREIEVSTSK 89 (202)
Q Consensus 24 ~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~--------~~~~~~~~~~~~~i~~ 89 (202)
.+.....+|..|.+++...+|+||+. ..+...++.++|++|.|..+++.. .++..+.+.++.++|+
T Consensus 734 ~~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~ 813 (1025)
T KOG1095|consen 734 SSEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAK 813 (1025)
T ss_pred CCHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhh
Confidence 34445667999999999999999873 355567999999999999999544 4899999999999999
Q ss_pred HHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHH
Q 044746 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSF 169 (202)
Q Consensus 90 ~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~ 169 (202)
|+.||++ ++.|||||..+|+|++....+|++|||+|+-+-....+.......-...|||||.+..+.|+.|+|||||
T Consensus 814 G~~YLe~---~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsF 890 (1025)
T KOG1095|consen 814 GMNYLES---KHFVHRDLAARNCLLDERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSF 890 (1025)
T ss_pred hhHHHHh---CCCcCcchhhhheeecccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhh
Confidence 9999999 9999999999999999999999999999994333322222222233679999999999999999999999
Q ss_pred HHHHHHHHc-CCCCCcchhccc
Q 044746 170 GMLLFEVVG-RRRNLEKEISEG 190 (202)
Q Consensus 170 G~~l~el~~-g~~p~~~~~~~~ 190 (202)
||++||++| |..||....+.+
T Consensus 891 GVllWEifslG~~PY~~~~n~~ 912 (1025)
T KOG1095|consen 891 GVLLWEIFSLGATPYPSRSNFE 912 (1025)
T ss_pred HHHHHHHHhCCCCCCCCcchHH
Confidence 999999998 999998776654
|
|
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=191.00 Aligned_cols=183 Identities=19% Similarity=0.244 Sum_probs=139.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.++.|...... ..+....+..|.......+|++++. ......++++++.+++|..++..
T Consensus 11 vy~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 88 (252)
T cd05084 11 VFSGRLRADNTPVAVKSCRETL--PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 88 (252)
T ss_pred EEEEEEecCCceEEEEecCccC--CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCC
Confidence 6888888777878777533211 1112234666766777788888763 33445688899999999988754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++................++..|+||
T Consensus 89 ~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aP 165 (252)
T cd05084 89 PRLKVKELIQMVENAAAGMEYLES---KHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAP 165 (252)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEEcCCCcEEECccccCcccccccccccCCCCCCceeecCc
Confidence 358999999999999999999999 99999999999999999999999999998754322111111111224569999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|++++|+++ |..||....+
T Consensus 166 E~~~~~~~~~~~Dv~slG~il~e~~~~~~~p~~~~~~ 202 (252)
T cd05084 166 EALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSN 202 (252)
T ss_pred hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccCH
Confidence 99988889999999999999999997 9999975543
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=99.96 E-value=2.5e-29 Score=214.05 Aligned_cols=177 Identities=19% Similarity=0.289 Sum_probs=146.4
Q ss_pred CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc----------
Q 044746 8 GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK---------- 71 (202)
Q Consensus 8 ~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~---------- 71 (202)
.....||+|..+...+. ....+|..|..+.+..+|+||+. .+.-...+.||+..|+|.+++.
T Consensus 514 ~~~~lVAVK~LKd~a~~--~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~ 591 (774)
T KOG1026|consen 514 QDEQLVAVKALKDKAEN--QARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLA 591 (774)
T ss_pred ccceehhHhhhcccccH--HHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCcccccc
Confidence 45577888876554333 24567999999999999999873 5666678999999999999882
Q ss_pred -----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceec-cccCcccccCCCCC
Q 044746 72 -----KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY-NREHTHITSTGRRR 145 (202)
Q Consensus 72 -----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~-~~~~~~~~~~~~~g 145 (202)
...++..+.+.++.|||.|++||-+ +.++||||..+|+|+..+..+||+|||+++.. +.+.+... ..-.-
T Consensus 592 ~g~~~~~~L~~~q~L~iA~QIAaGM~YLs~---~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYssDYYk~~-~~t~l 667 (774)
T KOG1026|consen 592 SGQDTPPPLSTSQFLHIATQIAAGMEYLSS---HHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSSDYYKVR-GNTLL 667 (774)
T ss_pred CCCCCCCCCCHHHHHHHHHHHHHHHHHHHh---CcccccchhhhhceeccceEEEecccccchhhhhhhhhccc-CCcee
Confidence 2238899999999999999999999 99999999999999999999999999999843 33322222 11122
Q ss_pred CCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhccc
Q 044746 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISEG 190 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~~ 190 (202)
+.+|||||.+..+.|++++|||||||+|||+++ |+.|+.+..+++
T Consensus 668 PIRWMppEsIly~kFTteSDVWs~GVvLWEIFsyG~QPy~glSn~E 713 (774)
T KOG1026|consen 668 PIRWMPPESILYGKFTTESDVWSFGVVLWEIFSYGKQPYYGLSNQE 713 (774)
T ss_pred eeecCCHHHhhcCcccchhhhhhhhhhhhhhhccccCcccccchHH
Confidence 678999999999999999999999999999998 999999988776
|
|
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.5e-28 Score=198.92 Aligned_cols=111 Identities=27% Similarity=0.402 Sum_probs=95.6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++..+.............++..|+|||
T Consensus 169 ~l~~~~~~~~~~qi~~aL~~lH~---~~ivHrDikp~Nill~~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE 245 (337)
T cd05054 169 PLTLEDLISYSFQVARGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 245 (337)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEeCCCcEEEeccccchhcccCcchhhccCCCCCccccCcH
Confidence 57899999999999999999999 999999999999999999999999999998654332222223344567899999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
++.+..++.++||||+||+++|+++ |+.||....
T Consensus 246 ~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~ 280 (337)
T cd05054 246 SIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQ 280 (337)
T ss_pred HhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCC
Confidence 9999999999999999999999997 999997643
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.2e-29 Score=197.13 Aligned_cols=180 Identities=18% Similarity=0.247 Sum_probs=142.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.++.|...... ......+..|.......+|++++. .+...+++++++++++|..+.....
T Consensus 36 v~~~~~~~~~~~v~ik~~~~~~---~~~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 112 (296)
T cd06654 36 VYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112 (296)
T ss_pred EEEEEECCCCcEEEEEEEecCC---cchHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHhcC
Confidence 5777777777777766543221 112234556666677778887663 2345678899999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... .....+++.|+|||.
T Consensus 113 ~~~~~~~~i~~ql~~aL~~LH~---~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~ 187 (296)
T cd06654 113 MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEV 187 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEECccccchhccccccc--cCcccCCccccCHHH
Confidence 9999999999999999999999 99999999999999999999999999988754322211 123456889999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+..++.++|+|||||++++|++|++||....+
T Consensus 188 ~~~~~~~~~~Dv~s~Gvil~~l~~g~~pf~~~~~ 221 (296)
T cd06654 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (296)
T ss_pred HcCCCCCccchHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9888889999999999999999999999976654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=99.96 E-value=7.3e-29 Score=197.58 Aligned_cols=173 Identities=18% Similarity=0.262 Sum_probs=131.0
Q ss_pred cceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC----------
Q 044746 10 TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN---------- 73 (202)
Q Consensus 10 ~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~---------- 73 (202)
...||.|+.+.... ......|..|.......+|++++. ..+...++++++.+++|..++...
T Consensus 46 ~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~ 123 (304)
T cd05096 46 PLLVAVKILRPDAN--KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGN 123 (304)
T ss_pred ceEEEEEEecCCCC--HHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccc
Confidence 33566665433211 112234666777777788888763 234467889999999998877432
Q ss_pred ----------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCC
Q 044746 74 ----------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 74 ----------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++..............
T Consensus 124 ~~~~~~~~~~~~~~~~~~~i~~~i~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~~~~~~~~ 200 (304)
T cd05096 124 DAVPPAHCLPAISYSSLLHVALQIASGMKYLSS---LNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDYYRIQGRA 200 (304)
T ss_pred cccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCcchhheEEcCCccEEECCCccceecccCceeEecCcC
Confidence 36788899999999999999999 99999999999999999999999999999865433222222233
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc--CCCCCcchh
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG--RRRNLEKEI 187 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~--g~~p~~~~~ 187 (202)
.++..|+|||++....++.++|+||||++++||++ +..||....
T Consensus 201 ~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~~~~~p~~~~~ 246 (304)
T cd05096 201 VLPIRWMAWECILMGKFTTASDVWAFGVTLWEILMLCKEQPYGELT 246 (304)
T ss_pred CCCccccCHHHHhcCCCCchhhhHHHHHHHHHHHHccCCCCCCcCC
Confidence 45788999999988889999999999999999986 567776543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=196.04 Aligned_cols=180 Identities=19% Similarity=0.298 Sum_probs=136.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...+..++.|..+.... ......+..|.......+|++++. ..+...++++++.+ ++...+..
T Consensus 22 Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~ 98 (309)
T cd07872 22 VFKGRSKLTENLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLDK-DLKQYMDDCG 98 (309)
T ss_pred EEEEEecCCCCeEEEEEeecccc--CCcchhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCCC-CHHHHHHhcC
Confidence 68888888888888776443221 112223445666777778887763 33445678888875 56555532
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||++........ ......+++.|+||
T Consensus 99 ~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 173 (309)
T cd07872 99 NIMSMHNVKIFLYQILRGLAYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSVPTK--TYSNEVVTLWYRPP 173 (309)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECccccceecCCCcc--ccccccccccccCC
Confidence 348999999999999999999999 9999999999999999999999999999975433221 11234568899999
Q ss_pred cccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+.+ ..++.++|+||+|+++++|++|++||.....
T Consensus 174 E~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 210 (309)
T cd07872 174 DVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTV 210 (309)
T ss_pred HHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 98865 4688999999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.1e-28 Score=193.10 Aligned_cols=183 Identities=18% Similarity=0.167 Sum_probs=135.8
Q ss_pred CCccccCCCcc--eeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------------ccceEEEEEccCCch
Q 044746 1 MEKPRNRGSTR--FITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~--~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l 66 (202)
||++.....+. .++.|..+... ........+..|.......+|++++... ....++++++.+++|
T Consensus 15 V~~~~~~~~~~~~~~a~k~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l 93 (272)
T cd05075 15 VMEGQLNQDDSILKVAVKTMKIAI-CTRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDL 93 (272)
T ss_pred EEEeEEccCCCeeeEEEEecccCc-CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcH
Confidence 56776655554 34544332211 1112234456666667777888876421 134688899999998
Q ss_pred hhhhc-------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc
Q 044746 67 YLLCK-------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT 139 (202)
Q Consensus 67 ~~~~~-------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~ 139 (202)
..++. ...+++.....++.|++.||.|||+ ++++||||||+||+++.++.++++|||+++..........
T Consensus 94 ~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~ 170 (272)
T cd05075 94 HSFLLYSRLGDCPQYLPTQMLVKFMTDIASGMEYLSS---KSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYYRQ 170 (272)
T ss_pred HHHHHHhcccCCcccCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhheEEcCCCCEEECCCCcccccCcccceec
Confidence 77652 2348899999999999999999999 9999999999999999999999999999986543322222
Q ss_pred cCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 140 STGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 140 ~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
.....+++.|++||......++.++|+||||+++||+++ |+.||....
T Consensus 171 ~~~~~~~~~~~~pe~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~ 219 (272)
T cd05075 171 GRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVE 219 (272)
T ss_pred CCcccCCcccCCHHHccCCCcChHHHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 222345778999999998889999999999999999999 899997643
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1e-28 Score=192.90 Aligned_cols=182 Identities=16% Similarity=0.258 Sum_probs=142.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++...++.++.|..+.......+....+..|.......+|++++. ..+...+++++.++++|..+..
T Consensus 18 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 97 (267)
T cd08228 18 VYRATCLLDRKPVALKKVQIFEMMDAKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFK 97 (267)
T ss_pred EEEEEEeCCCCEEEEEEeeccccCCHHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhh
Confidence 6788887777777777543322222233344666777777888887653 2344568899999999887663
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
...++...+..++.|++.||.|||+ ++++|+||||+||+++.++.++++|||++......... .....|++.|
T Consensus 98 ~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~ 172 (267)
T cd08228 98 KQKRLIPERTVWKYFVQLCSAVEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYY 172 (267)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCCHHHEEEcCCCCEEECccccceeccchhHH--HhcCCCCccc
Confidence 3458999999999999999999999 99999999999999999999999999998865432211 1234568899
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||.+.+..++.++|+||+|++++|+++|+.||....
T Consensus 173 ~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~p~~~~~ 210 (267)
T cd08228 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cChhhhccCCCCchhhHHHHHHHHHHHhcCCCCCcccc
Confidence 99999988888999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.7e-28 Score=191.20 Aligned_cols=183 Identities=18% Similarity=0.275 Sum_probs=137.9
Q ss_pred CCccccC--CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNR--GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~--~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++..+ ..+..|+.|+.+... .......+..|.......+|++++. ......++++++++++|..++.
T Consensus 11 v~~~~~~~~~~~~~vavk~~~~~~--~~~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 88 (257)
T cd05115 11 VKKGVYKMRKKQIDVAIKVLKNEN--EKSVRDEMMREAEIMHQLDNPYIVRMIGVCEAEALMLVMEMASGGPLNKFLSGK 88 (257)
T ss_pred EEEEEEecCCCceeEEEEEccccc--ChHHHHHHHHHHHHHHhcCCCCeEEEEEEEcCCCeEEEEEeCCCCCHHHHHHhC
Confidence 4555443 334456666543321 1122345667777778888888763 2344568899999999998884
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCccc
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCE 150 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~ 150 (202)
...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......... ......+++.|+
T Consensus 89 ~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 165 (257)
T cd05115 89 KDEITVSNVVELMHQVSMGMKYLEG---KNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWY 165 (257)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---cCeeecccchheEEEcCCCcEEeccCCccccccCCccceeccCCCCCCcccC
Confidence 4568999999999999999999999 999999999999999999999999999997554332211 112223357899
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||.+....++.++|+||||+++||+++ |..||.....
T Consensus 166 aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 204 (257)
T cd05115 166 APECINFRKFSSRSDVWSYGITMWEAFSYGQKPYKKMKG 204 (257)
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 9999988888999999999999999996 9999976543
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=5.1e-30 Score=211.05 Aligned_cols=172 Identities=21% Similarity=0.244 Sum_probs=142.9
Q ss_pred eehhhhchhhhhccCCcccCCcHHHHHHhccccccccccccc------eEEEEEccCCchhhhhccCC--CCHHHHHHHH
Q 044746 13 ITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTE------TYIKGFLAMGPFYLLCKKNI--LGFGQLREIE 84 (202)
Q Consensus 13 v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~------~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~ 84 (202)
||+|..+.......+...+|-.|..+....+|+|++...|.. .+++|++.+|+|..++++.. ++..+...++
T Consensus 189 VAvK~~k~~~~~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~ 268 (474)
T KOG0194|consen 189 VAVKTTKGSSELTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFC 268 (474)
T ss_pred eEEEeecccccccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHH
Confidence 777776654455566777899999999999999998644433 48999999999999998765 9999999999
Q ss_pred HHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchh
Q 044746 85 VSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKC 164 (202)
Q Consensus 85 ~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~ 164 (202)
.+++.||+|||+ +++|||||-.+|+|++.++.+|++|||+++.... .........-+..|+|||.+....|+.++
T Consensus 269 ~~AA~Gl~YLh~---k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~--~~~~~~~~klPirWLAPEtl~~~~~s~kT 343 (474)
T KOG0194|consen 269 YDAARGLEYLHS---KNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQ--YVMKKFLKKLPIRWLAPETLNTGIFSFKT 343 (474)
T ss_pred HHHHhHHHHHHH---CCCcchhHhHHHheecCCCeEEeCccccccCCcc--eeeccccccCcceecChhhhccCcccccc
Confidence 999999999999 9999999999999999999999999999875431 11111011236789999999999999999
Q ss_pred hHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 165 DVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 165 Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
|||||||++||+++ |..||.+....
T Consensus 344 DV~sfGV~~~Eif~~g~~Py~g~~~~ 369 (474)
T KOG0194|consen 344 DVWSFGVLLWEIFENGAEPYPGMKNY 369 (474)
T ss_pred chhheeeeEEeeeccCCCCCCCCCHH
Confidence 99999999999998 88899876643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.6e-28 Score=195.09 Aligned_cols=111 Identities=23% Similarity=0.240 Sum_probs=95.5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-----cccCCCCCCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-----ITSTGRRRTPG 148 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-----~~~~~~~gt~~ 148 (202)
..++..+..++.|++.||.|||+ .+++||||||+|||++.++.++|+|||+++........ .......||+.
T Consensus 122 ~~~~~~~~~i~~qi~~~l~~lH~---~~iiHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~ 198 (294)
T PHA02882 122 CKNKKLIKNIMKDMLTTLEYIHE---HGISHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLY 198 (294)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCcc
Confidence 46788899999999999999999 99999999999999999999999999999865322111 11123458999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+..++.++||||+||+++||++|++||....
T Consensus 199 y~ape~~~~~~~~~~~DiwSlG~~l~el~~g~~P~~~~~ 237 (294)
T PHA02882 199 YAGLDAHNGACVTRRGDLESLGYCMLKWAGIKLPWKGFG 237 (294)
T ss_pred ccCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCccc
Confidence 999999999899999999999999999999999998763
|
|
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.4e-28 Score=194.02 Aligned_cols=180 Identities=17% Similarity=0.253 Sum_probs=134.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHH---HHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQR---MIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++...+..++.|...............+..+.. .....+|++++. ..+...++++++++++|..++.
T Consensus 10 Vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~ 89 (279)
T cd05633 10 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLS 89 (279)
T ss_pred EEEEEECCCCcEEEEEEEEccccccchHHHHHHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHH
Confidence 6888888888888877643322111111111222222 222235666542 3456678999999999987764
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 -KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||++....... .....|++.|+
T Consensus 90 ~~~~l~~~~~~~i~~qi~~al~~lH~---~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~ 162 (279)
T cd05633 90 QHGVFSEKEMRFYATEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 162 (279)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC----ccCcCCCcCcc
Confidence 3569999999999999999999999 999999999999999999999999999987543221 12235789999
Q ss_pred CCcccC-CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWM-PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~-~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+. +..++.++|+||+||+++++++|+.||....
T Consensus 163 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 200 (279)
T cd05633 163 APEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHK 200 (279)
T ss_pred CHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcCCCC
Confidence 999986 4568899999999999999999999997543
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.96 E-value=6e-30 Score=210.81 Aligned_cols=180 Identities=22% Similarity=0.235 Sum_probs=152.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------cceEEEEEccCCc--hhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------TETYIKGFLAMGP--FYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------~~~~~~~~~~~~~--l~~~~~~ 72 (202)
||-|++..+.+.||.|-....-..+.++...+..|..-+...+|||.|...+ ..+++++|+-|.- +..+ .+
T Consensus 42 VYfArd~~n~evVAIKKMsySGKQs~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYClGSAsDlleV-hk 120 (948)
T KOG0577|consen 42 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYCLGSASDLLEV-HK 120 (948)
T ss_pred eEEeeccCccceeeeeeccccccccHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHHhccHHHHHHH-Hh
Confidence 7889999999999987777777777888888889999999999999997543 3457788876542 2222 45
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.++.+-++..|+.+.+.||.|||+ .+.||||||..|||++.+|.+||+|||.+..... ....+|||.||||
T Consensus 121 KplqEvEIAAi~~gaL~gLaYLHS---~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~P------AnsFvGTPywMAP 191 (948)
T KOG0577|consen 121 KPLQEVEIAAITHGALQGLAYLHS---HNRIHRDIKAGNILLSEPGLVKLADFGSASIMAP------ANSFVGTPYWMAP 191 (948)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHH---hhHHhhhccccceEecCCCeeeeccccchhhcCc------hhcccCCccccch
Confidence 678888999999999999999999 9999999999999999999999999999876543 3457889999999
Q ss_pred cccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 153 ELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 153 e~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
|++. .+.|+.++||||+|+++.||..++||+...+-+.
T Consensus 192 EVILAMDEGqYdgkvDvWSLGITCIELAERkPPlFnMNAMS 232 (948)
T KOG0577|consen 192 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMS 232 (948)
T ss_pred hHheeccccccCCccceeeccchhhhhhhcCCCccCchHHH
Confidence 9986 4689999999999999999999999998776553
|
|
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-28 Score=195.35 Aligned_cols=179 Identities=19% Similarity=0.261 Sum_probs=141.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++...+..++.|....... .....+..|.......+|++++. .++...++++++++++|..++....
T Consensus 38 v~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 114 (292)
T cd06658 38 VCIATEKHTGKQVAVKKMDLRKQ---QRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVTHTR 114 (292)
T ss_pred EEEEEECCCCCEEEEEEEecchH---HHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHhcCC
Confidence 56777766666777665322211 12233556666667778887652 4556678999999999999888788
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ......|+..|+|||.
T Consensus 115 l~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~ 189 (292)
T cd06658 115 MNEEQIATVCLSVLRALSYLHN---QGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEVP--KRKSLVGTPYWMAPEV 189 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCEEEccCcchhhcccccc--cCceeecCccccCHHH
Confidence 9999999999999999999999 9999999999999999999999999999875433221 1123456889999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||+|++++|+++|+.||....
T Consensus 190 ~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 222 (292)
T cd06658 190 ISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEP 222 (292)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 988889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-28 Score=189.34 Aligned_cols=184 Identities=19% Similarity=0.161 Sum_probs=140.4
Q ss_pred CCccccCCCcceeehhhhchhhhh--ccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM--EMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+...++.++.|........ .......+..|.......+|++++. ......++++++++++|......
T Consensus 18 vy~~~~~~~~~~~~lk~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~ 97 (263)
T cd06625 18 VYLCYDVDTGRELAVKQVPFDPDSPETKKEVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKA 97 (263)
T ss_pred EEEEEEcCCCcEEEEEEEeecccchhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHH
Confidence 567777666677776654322111 1112234566666777788887753 33456688899999999887754
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc-cCCCCCCCccc
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT-STGRRRTPGCE 150 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~-~~~~~gt~~y~ 150 (202)
..++......++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||+++.......... .....++..|+
T Consensus 98 ~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 174 (263)
T cd06625 98 YGALTETVTRKYTRQILEGVEYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWM 174 (263)
T ss_pred hCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceeccccccccccccCCCcCcccc
Confidence 458999999999999999999999 9999999999999999999999999999876533211111 12244678999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||++.+..++.++|+||+|+++||+++|+.||....
T Consensus 175 aPE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 211 (263)
T cd06625 175 SPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFE 211 (263)
T ss_pred CcceeccCCCCchhhhHHHHHHHHHHHhCCCCccccc
Confidence 9999998889999999999999999999999997643
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=194.34 Aligned_cols=178 Identities=17% Similarity=0.226 Sum_probs=128.6
Q ss_pred CCccccCC--CcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRG--STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~--~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||+++... ....++.|..... .....+..|.......+|+|++.. .....++++++.+ ++..++
T Consensus 17 Vy~~~~~~~~~~~~~a~k~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 90 (317)
T cd07867 17 VYKAKRKDGKDEKEYALKQIEGT-----GISMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAEH-DLWHII 90 (317)
T ss_pred EEEEEecCCCccceEEEEEecCC-----CCcHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeCC-cHHHHH
Confidence 67777543 3345555433221 112235566777777889987632 2334566777664 454443
Q ss_pred c----------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE----cCCCceEEeeeecceeccccCc
Q 044746 71 K----------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYNREHT 136 (202)
Q Consensus 71 ~----------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~----~~~~~~kl~dfgl~~~~~~~~~ 136 (202)
. ...+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.++|+|||+++.......
T Consensus 91 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~ 167 (317)
T cd07867 91 KFHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 167 (317)
T ss_pred HhhhccccCCCCccCCHHHHHHHHHHHHHHHHHHHh---CCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcc
Confidence 2 1248889999999999999999999 999999999999999 4567899999999986543322
Q ss_pred c-cccCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 137 H-ITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 137 ~-~~~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
. .......||+.|+|||++.+ ..++.++||||+||+++||+||++||....
T Consensus 168 ~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~el~tg~~~f~~~~ 220 (317)
T cd07867 168 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQ 220 (317)
T ss_pred cccccCcceecccccCcHHhcCCCccCcHHHHHhHHHHHHHHHhCCCCccccc
Confidence 1 12234567899999999876 457899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-28 Score=195.37 Aligned_cols=179 Identities=20% Similarity=0.259 Sum_probs=142.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..++..++.|+...... .....+..|.......+|++++. .+....++++++++++|..+.....
T Consensus 37 v~~~~~~~~~~~v~iK~~~~~~~---~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~ 113 (297)
T cd06659 37 VCIAREKHSGRQVAVKMMDLRKQ---QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQTR 113 (297)
T ss_pred EEEEEEcCCCCEEEEEEEEeccc---chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhhcC
Confidence 57777776677777766432211 12233555666667778887652 3455678899999999999888888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ......|+..|+|||+
T Consensus 114 ~~~~~~~~~~~qi~~~L~~LH~---~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~ 188 (297)
T cd06659 114 LNEEQIATVCESVLQALCYLHS---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVP--KRKSLVGTPYWMAPEV 188 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHeEEccCCcEEEeechhHhhcccccc--cccceecCccccCHHH
Confidence 9999999999999999999999 9999999999999999999999999999875433221 1223457899999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||+|++++||++|+.||....
T Consensus 189 ~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 221 (297)
T cd06659 189 ISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDS 221 (297)
T ss_pred HccCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 988889999999999999999999999997554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-28 Score=192.09 Aligned_cols=179 Identities=17% Similarity=0.265 Sum_probs=134.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHH---HHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQR---MIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++...++.+|.|+..............+..+.. .....+|++++. ..+...++++++.+++|..+..
T Consensus 10 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~ 89 (278)
T cd05606 10 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 89 (278)
T ss_pred EEEEEEecCCCEEEEEEeeccccccchhHHHHHHHHHHHHHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHH
Confidence 6888888888888887643322111111111222222 223346676653 3455668899999999987774
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. ..+++..+..++.|++.|+.|||+ .+++|||+||+||+++.++.++|+|||++....... .....|+..|+
T Consensus 90 ~~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~y~ 162 (278)
T cd05606 90 QHGVFSEAEMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 162 (278)
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCCCCHHHEEECCCCCEEEccCcCccccCccC----CcCcCCCcCCc
Confidence 4 468999999999999999999999 999999999999999999999999999987543221 12345789999
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|||.+... .++.++|+||+|++++||++|+.||...
T Consensus 163 aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~ 199 (278)
T cd05606 163 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 199 (278)
T ss_pred CcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCC
Confidence 99998754 6889999999999999999999999765
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=9.6e-29 Score=197.02 Aligned_cols=181 Identities=21% Similarity=0.279 Sum_probs=130.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||+++++..+..+..++..............+..|....... +|++++. ..+..+++++++.+++|..++..
T Consensus 23 V~~a~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 102 (303)
T cd05088 23 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 102 (303)
T ss_pred EEEEEEccCCceeeEEEEEecccCCHHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhc
Confidence 577776554433322222111111111223344554544454 7787652 44567788999999999888743
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc
Q 044746 73 ----------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT 136 (202)
Q Consensus 73 ----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~ 136 (202)
..+++..+..++.|++.|++|||+ ++++||||||+||+++.++.++|+|||++.......
T Consensus 103 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~- 178 (303)
T cd05088 103 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV- 178 (303)
T ss_pred ccccccccccccccccCcCCHHHHHHHHHHHHHHHHHHHh---CCccccccchheEEecCCCcEEeCccccCcccchhh-
Confidence 247899999999999999999999 999999999999999999999999999986322111
Q ss_pred ccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 137 HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 137 ~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
......++..|+|||.+.+..++.++|+||||++++|++| |..||....
T Consensus 179 --~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~ 228 (303)
T cd05088 179 --KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 228 (303)
T ss_pred --hcccCCCcccccCHHHHhccCCcccccchhhhhHHHHHHhcCCCCcccCC
Confidence 1111223567999999988888999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.4e-28 Score=191.48 Aligned_cols=179 Identities=21% Similarity=0.262 Sum_probs=130.2
Q ss_pred CCccccCCCcce--eehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRF--ITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~--v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..++.. ++.|..+.. ........+..|....... +|++++. ..+..+++++++.+++|..++.
T Consensus 11 v~~~~~~~~~~~~~~~~k~~~~~--~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~ 88 (270)
T cd05047 11 VLKARIKKDGLRMDAAIKRMKEY--ASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 88 (270)
T ss_pred EEEEEEcCCCCeeEEEEEEcccc--CCHHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHH
Confidence 567776555442 344433221 1111122344554544444 6777653 3455678999999999988875
Q ss_pred cC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecccc
Q 044746 72 KN-----------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134 (202)
Q Consensus 72 ~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~ 134 (202)
.. .+++.++..++.|++.||+|||+ .+++||||||+||+++.++.++++|||++......
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~al~~lH~---~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~ 165 (270)
T cd05047 89 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 165 (270)
T ss_pred hccccccccccccccCCcCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccccceEEEcCCCeEEECCCCCccccchh
Confidence 32 37899999999999999999999 99999999999999999999999999998632211
Q ss_pred CcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 135 ~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
. .......+..|+|||++....++.++|+||||++++||++ |..||....
T Consensus 166 ~---~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~el~~~g~~pf~~~~ 216 (270)
T cd05047 166 V---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 216 (270)
T ss_pred h---hccCCCCccccCChHHHccCCCCchhhHHHHHHHHHHHHcCCCCCccccC
Confidence 1 1111223567999999988889999999999999999997 999997543
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=191.20 Aligned_cols=183 Identities=19% Similarity=0.257 Sum_probs=137.4
Q ss_pred CCccccCC-----CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRG-----STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~-----~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++.... ....++.|..+.... .+....+..|..+....+|++++. .+....++++++++++|..+
T Consensus 21 v~~~~~~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 98 (280)
T cd05049 21 VFLGECYHLEPENDKELVAVKTLKETAS--NDARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKF 98 (280)
T ss_pred EeeeeeccccCcCCcceEEEEeecccCC--HHHHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHH
Confidence 46665533 345566655432211 112245666666677777887652 34556788899999999888
Q ss_pred hcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecccc
Q 044746 70 CKK---------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134 (202)
Q Consensus 70 ~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~ 134 (202)
+.. ..+++..+..++.|++.|+.|||+ ++++||||||+||+++.++.++|+|||++......
T Consensus 99 i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~ 175 (280)
T cd05049 99 LRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQIASGMVYLAS---QHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTT 175 (280)
T ss_pred HHhcCCchhhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeeccccccceEEEcCCCeEEECCcccceecccC
Confidence 743 247889999999999999999999 99999999999999999999999999999754332
Q ss_pred CcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 135 ~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
..........+++.|+|||++.+..++.++|+||+|++++||++ |+.||.....
T Consensus 176 ~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~e~~~~g~~p~~~~~~ 230 (280)
T cd05049 176 DYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSN 230 (280)
T ss_pred cceecCCCCcccceecChhhhccCCcchhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 22122223345778999999998899999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4e-28 Score=188.79 Aligned_cols=184 Identities=21% Similarity=0.312 Sum_probs=138.0
Q ss_pred CCccc--cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPR--NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~--~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++. ....+..++.|+.+.... .......+..|..+....+|++++. .+....+++++..+++|..++..
T Consensus 11 v~~~~~~~~~~~~~~aiK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 89 (257)
T cd05116 11 VKKGMYKMKKSEKTVAVKILKNDNN-DPALKDELLREANVMQQLDNPYIVRMIGICEAESWMLVMELAELGPLNKFLQKN 89 (257)
T ss_pred eEEeEEecCCCceEEEEEEccCCCC-cHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCcEEEEecCCCCcHHHHHHhc
Confidence 46653 344556677666432211 1122334666667777788887662 23344678889999999888754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCcccC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCEA 151 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ ++++||||||.||+++.++.++|+|||+++......... ......++..|+|
T Consensus 90 ~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 166 (257)
T cd05116 90 KHVTEKNITELVHQVSMGMKYLEE---TNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYA 166 (257)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchhhEEEcCCCeEEECCCccccccCCCCCeeeecCCCCCCccccC
Confidence 468999999999999999999999 999999999999999999999999999998654332211 1122233578999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||.+....++.++|+||||+++||+++ |++||.....
T Consensus 167 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 204 (257)
T cd05116 167 PECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKG 204 (257)
T ss_pred HhHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999988888999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=193.03 Aligned_cols=180 Identities=19% Similarity=0.223 Sum_probs=142.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.++.|..... .......+..|.......+|++++. .+....++++++.+++|..+.....
T Consensus 35 vy~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 111 (296)
T cd06655 35 VFTAIDVATGQEVAIKQINLQ---KQPKKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETC 111 (296)
T ss_pred EEEEEEcCCCcEEEEEEEecc---cCchHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHhcC
Confidence 577777777777776643221 1222334555666667778887663 3445678899999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++......... .....++..|+|||.
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~---~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~ 186 (296)
T cd06655 112 MDEAQIAAVCRECLQALEFLHA---NQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEV 186 (296)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccchhccccccc--CCCcCCCccccCcch
Confidence 9999999999999999999999 99999999999999999999999999998754332211 123456889999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+..++.++|+|||||++|++++|+.||....+
T Consensus 187 ~~~~~~~~~~Dv~slGvil~~lltg~~pf~~~~~ 220 (296)
T cd06655 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (296)
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9888899999999999999999999999987554
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-28 Score=191.73 Aligned_cols=155 Identities=19% Similarity=0.248 Sum_probs=120.0
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN------ILGFGQLREIEVSTSKGIAYLHEEC 98 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~ 98 (202)
.|..|.......+|+|++. ......++++++++|+|..++... ..++.....++.|++.||.|||+
T Consensus 41 ~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~-- 118 (269)
T cd05042 41 LFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWLHQ-- 118 (269)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHHHh--
Confidence 3555555566678888763 344567899999999999887543 24677889999999999999999
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCC-------CCCCchhhHHHHHH
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMP-------YSVTQKCDVFSFGM 171 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~-------~~~~~~~Diws~G~ 171 (202)
.+++||||||+||+++.++.++++|||++................+++.|+|||++.. ..++.++|+||+||
T Consensus 119 -~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 197 (269)
T cd05042 119 -ADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGV 197 (269)
T ss_pred -cCEecccccHhheEecCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHHHHHH
Confidence 9999999999999999999999999999865332222112223344678999998742 35678999999999
Q ss_pred HHHHHHc-CCCCCcchhc
Q 044746 172 LLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 172 ~l~el~~-g~~p~~~~~~ 188 (202)
++|||++ |..||....+
T Consensus 198 ~l~el~~~~~~p~~~~~~ 215 (269)
T cd05042 198 TMWELFTAADQPYPDLSD 215 (269)
T ss_pred HHHHHHhCCCCCCCcCCH
Confidence 9999998 8889876543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=192.03 Aligned_cols=155 Identities=21% Similarity=0.331 Sum_probs=126.1
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-----------------CCCCHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------------NILGFGQLREIEVST 87 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~i 87 (202)
.+..|.......+|++++. .+....++++++++++|.+++.. ..+++..+..++.|+
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 132 (291)
T cd05094 53 DFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHIASQI 132 (291)
T ss_pred HHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHHHHHH
Confidence 4556666677778887652 34556788999999999888743 238999999999999
Q ss_pred HHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHH
Q 044746 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVF 167 (202)
Q Consensus 88 ~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diw 167 (202)
+.||.|||+ ++++||||||+||+++.++.++|+|||++................++..|+|||.+.+..++.++|+|
T Consensus 133 ~~al~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 209 (291)
T cd05094 133 ASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVW 209 (291)
T ss_pred HHHHHHHHh---CCeeecccCcceEEEccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCchhhHH
Confidence 999999999 99999999999999999999999999999754432222222334457889999999988899999999
Q ss_pred HHHHHHHHHHc-CCCCCcchhc
Q 044746 168 SFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 168 s~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||++++||++ |+.||.....
T Consensus 210 slG~il~el~t~g~~p~~~~~~ 231 (291)
T cd05094 210 SFGVILWEIFTYGKQPWFQLSN 231 (291)
T ss_pred HHHHHHHHHHhCCCCCCCCCCH
Confidence 99999999999 9999866443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-28 Score=193.17 Aligned_cols=184 Identities=18% Similarity=0.175 Sum_probs=136.3
Q ss_pred CCccccCC-----CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRG-----STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~-----~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++...+ .++.|+.|..+..... .....+..|..+....+|++++. ......++.++..+++|..+
T Consensus 21 V~~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~ 98 (283)
T cd05091 21 VYKGHLFGTAPGEQTQAVAIKTLKDKAEG--PLREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEF 98 (283)
T ss_pred EEEEEEecCCCCCceeEEEEEEccCCCCH--HHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHH
Confidence 45555433 2455666664432111 11234666777777788888763 23345677888888888777
Q ss_pred hc-----------------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecc
Q 044746 70 CK-----------------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132 (202)
Q Consensus 70 ~~-----------------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~ 132 (202)
+. ...+++..+..++.|++.||.|+|+ ++++||||||+||+++.++.+||+|||+++...
T Consensus 99 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ql~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~ 175 (283)
T cd05091 99 LVMRSPHSDVGSTDDDKTVKSTLEPADFVHIVTQIAAGMEFLSS---HHVVHKDLATRNVLVFDKLNVKISDLGLFREVY 175 (283)
T ss_pred HHhcCCCccccccccccccccccCHHHHHHHHHHHHHHHHHHHH---cCccccccchhheEecCCCceEecccccccccc
Confidence 63 2347888999999999999999999 999999999999999999999999999987653
Q ss_pred ccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 133 REHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 133 ~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
............+++.|+|||.+....++.++|+||+|++++||++ |.+||.+....
T Consensus 176 ~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~ 233 (283)
T cd05091 176 AADYYKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 233 (283)
T ss_pred cchheeeccCccCCccccCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 3222222233345788999999988889999999999999999998 88898765443
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=191.65 Aligned_cols=175 Identities=20% Similarity=0.224 Sum_probs=138.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.++.|+..... ..+...++..|.......+|++++. ......+++++++++++..+ ..
T Consensus 17 v~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~---~~ 91 (279)
T cd06619 17 VYKAYHLLTRRILAVKVIPLDI--TVELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY---RK 91 (279)
T ss_pred EEEEEEcCCCcEEEEEEEecCC--ChHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh---hc
Confidence 6888888888888888654321 1112234666666677778887763 23345578889999988654 35
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++....... .....|+..|+|||+
T Consensus 92 ~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~aPE~ 164 (279)
T cd06619 92 IPEHVLGRIAVAVVKGLTYLWS---LKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNSI----AKTYVGTNAYMAPER 164 (279)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCCHHHEEECCCCCEEEeeCCcceeccccc----ccCCCCChhhcCcee
Confidence 7888999999999999999999 999999999999999999999999999997543221 233467899999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||+|+++|++++|+.||....
T Consensus 165 ~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 197 (279)
T cd06619 165 ISGEQYGIHSDVWSLGISFMELALGRFPYPQIQ 197 (279)
T ss_pred ecCCCCCCcchHHHHHHHHHHHHhCCCCchhhc
Confidence 998889999999999999999999999997543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=191.02 Aligned_cols=180 Identities=20% Similarity=0.205 Sum_probs=145.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.++.|+..... .......+..|.......+|++++. .+....++++++.+++|..+.....
T Consensus 17 v~~~~~~~~~~~~~ik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 94 (274)
T cd06609 17 VYKAIDKRTNQVVAIKVIDLEE--AEDEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPGK 94 (274)
T ss_pred EEEEEECCCCeEEEEEEeeccc--cchHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhcC
Confidence 5788888888888877654321 1122234556666666777887653 3345568889999999999998889
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||+++....... ......+++.|+|||.
T Consensus 95 ~~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~PE~ 169 (274)
T cd06609 95 LDETYIAFILREVLLGLEYLHE---EGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTMS--KRNTFVGTPFWMAPEV 169 (274)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEcccccceeeccccc--ccccccCCccccChhh
Confidence 9999999999999999999999 9999999999999999999999999999987654321 1233456888999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||+|+++|++++|++||....
T Consensus 170 ~~~~~~~~~sDv~slG~il~~l~tg~~p~~~~~ 202 (274)
T cd06609 170 IKQSGYDEKADIWSLGITAIELAKGEPPLSDLH 202 (274)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCcccCc
Confidence 998889999999999999999999999997544
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=191.85 Aligned_cols=155 Identities=20% Similarity=0.293 Sum_probs=125.7
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc------------------CCCCHHHHHHHHH
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK------------------NILGFGQLREIEV 85 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~------------------~~~~~~~~~~~~~ 85 (202)
..+..|.......+|+|++. .+...+++++++.+++|..++.. ..+++.+...++.
T Consensus 52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 131 (283)
T cd05090 52 GEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLHIAI 131 (283)
T ss_pred HHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHHHHH
Confidence 34666777777888888763 34556788999999999887731 2478889999999
Q ss_pred HHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhh
Q 044746 86 STSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCD 165 (202)
Q Consensus 86 ~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~D 165 (202)
|++.||.|||+ ++++||||||+||+++.++.++|+|||+++...............++..|+|||++.+..++.++|
T Consensus 132 ~i~~al~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 208 (283)
T cd05090 132 QIAAGMEYLSS---HFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSD 208 (283)
T ss_pred HHHHHHHHHHh---cCeehhccccceEEEcCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCchhh
Confidence 99999999999 999999999999999999999999999998653332222223334467899999998888999999
Q ss_pred HHHHHHHHHHHHc-CCCCCcchh
Q 044746 166 VFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 166 iws~G~~l~el~~-g~~p~~~~~ 187 (202)
+||||++++||++ |..||....
T Consensus 209 v~slG~il~el~~~g~~p~~~~~ 231 (283)
T cd05090 209 IWSFGVVLWEIFSFGLQPYYGFS 231 (283)
T ss_pred hHHHHHHHHHHHcCCCCCCCCCC
Confidence 9999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-28 Score=194.04 Aligned_cols=185 Identities=18% Similarity=0.218 Sum_probs=141.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.|+.|...............+..|.......+|++++. ..+...++++++++++|..++.. .
T Consensus 17 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~ 96 (305)
T cd05609 17 VYLVRHKETRQRFAMKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIG 96 (305)
T ss_pred EEEEEECCCCcEEEEEEeehhhhhhHHHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcC
Confidence 5778888877777777644332222222334556666666778887653 33445789999999999888754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-------------cccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-------------HITS 140 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-------------~~~~ 140 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||+++....... ....
T Consensus 97 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (305)
T cd05609 97 ALPVDMARMYFAETVLALEYLHN---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173 (305)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccc
Confidence 68999999999999999999999 9999999999999999999999999998864211100 0011
Q ss_pred CCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 141 TGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
....++..|+|||.+....++.++|+||||++++|+++|+.||.+...
T Consensus 174 ~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~vl~el~~g~~pf~~~~~ 221 (305)
T cd05609 174 KQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTP 221 (305)
T ss_pred cCCccCccccCchhccCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 123568889999999888899999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-28 Score=190.15 Aligned_cols=182 Identities=17% Similarity=0.250 Sum_probs=140.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++..++..++.|..............++..|.......+|++++. ..+...+++++..+++|..++.
T Consensus 18 v~~~~~~~~~~~~~vK~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 97 (267)
T cd08229 18 VYRATCLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 97 (267)
T ss_pred EEEEeecCCCceEEEEeeeehhhhhHHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhh
Confidence 5778876666666666433322222222335666767777778887663 3345568888999999988764
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
...+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++++|||++......... .....|+..|
T Consensus 98 ~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~ 172 (267)
T cd08229 98 KQKRLIPEKTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTA--AHSLVGTPYY 172 (267)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCcc--cccccCCcCc
Confidence 3458999999999999999999999 99999999999999999999999999998765432211 1234578899
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||.+.+..++.++|+||+|+++++|++|..||....
T Consensus 173 ~ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 210 (267)
T cd08229 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 210 (267)
T ss_pred cCHHHhcCCCccchhhHHHHHHHHHHHHhCCCCccccc
Confidence 99999988889999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-28 Score=193.96 Aligned_cols=152 Identities=25% Similarity=0.314 Sum_probs=119.3
Q ss_pred cCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-----------------CCCCHHHHHHHHHH
Q 044746 31 RFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------------NILGFGQLREIEVS 86 (202)
Q Consensus 31 ~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~ 86 (202)
.+..|....... +|++++. ..+...+++++.++++|..++.. ..+++..+..++.|
T Consensus 48 ~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~q 127 (297)
T cd05089 48 DFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQFASD 127 (297)
T ss_pred HHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHHHHHH
Confidence 355554444444 6787653 33446788999999999888743 24888999999999
Q ss_pred HHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhH
Q 044746 87 TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDV 166 (202)
Q Consensus 87 i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Di 166 (202)
++.||+|||+ ++++||||||+||+++.++.++|+|||++........ ......+..|+|||++....++.++|+
T Consensus 128 i~~al~~lH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~Dv 201 (297)
T cd05089 128 VATGMQYLSE---KQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYVK---KTMGRLPVRWMAIESLNYSVYTTKSDV 201 (297)
T ss_pred HHHHHHHHHH---CCcccCcCCcceEEECCCCeEEECCcCCCccccceec---cCCCCcCccccCchhhccCCCCchhhH
Confidence 9999999999 9999999999999999999999999999864321111 111122557999999988889999999
Q ss_pred HHHHHHHHHHHc-CCCCCcchhc
Q 044746 167 FSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 167 ws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||||+++||++ |..||.....
T Consensus 202 wSlG~il~el~t~g~~pf~~~~~ 224 (297)
T cd05089 202 WSFGVLLWEIVSLGGTPYCGMTC 224 (297)
T ss_pred HHHHHHHHHHHcCCCCCCCCCCH
Confidence 999999999997 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=188.93 Aligned_cols=179 Identities=24% Similarity=0.347 Sum_probs=136.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++....+..++.+.+.... .....+..|.......+|++++ .......++++++++++|..++..
T Consensus 22 v~~~~~~~~~~v~iK~~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 96 (261)
T cd05072 22 VWMGYYNNSTKVAVKTLKPGT-----MSVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDE 96 (261)
T ss_pred EEEEEecCCceEEEEEccCCc-----hhHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhc
Confidence 567776555444333332211 1123466677777778888766 244556688999999999888753
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++......... ......++..|+|
T Consensus 97 ~~~~~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~a 172 (261)
T cd05072 97 GGKVLLPKLIDFSAQIAEGMAYIER---KNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEYT-AREGAKFPIKWTA 172 (261)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccchhhEEecCCCcEEECCCccceecCCCcee-ccCCCccceecCC
Confidence 458899999999999999999999 99999999999999999999999999999865432221 1122334678999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||++....++.++|+||+|+++|++++ |+.||.....
T Consensus 173 PE~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~~ 210 (261)
T cd05072 173 PEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210 (261)
T ss_pred HHHhccCCCChhhhhhhhHHHHHHHHccCCCCCCCCCH
Confidence 999988889999999999999999998 9999976443
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-28 Score=189.58 Aligned_cols=181 Identities=22% Similarity=0.299 Sum_probs=145.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++...++.++.|+..............+..|.......+|++++. .+....+++++.++++|..++.+.
T Consensus 9 v~~~~~~~~~~~~~iK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 88 (262)
T cd05572 9 VELVKVKSKNRTFALKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRG 88 (262)
T ss_pred EEEEEECCCCcEEEEEEEehhcchhhhHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcC
Confidence 5788887777777777654433332233345667777777778887753 445567889999999999887654
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......+++.|++||
T Consensus 89 ~l~~~~~~~~~~~i~~~l~~lH~---~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~---~~~~~~~~~~~~~PE 162 (262)
T cd05572 89 LFDEYTARFYIACVVLAFEYLHN---RGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ---KTWTFCGTPEYVAPE 162 (262)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc---ccccccCCcCccChh
Confidence 58999999999999999999999 999999999999999999999999999998654332 112345688999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.+....++.++|+||+|+++|++++|..||....
T Consensus 163 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 196 (262)
T cd05572 163 IILNKGYDFSVDYWSLGILLYELLTGRPPFGEDD 196 (262)
T ss_pred HhcCCCCCChhhhhhhHHHHHHHHhCCCCcCCCC
Confidence 9988888999999999999999999999997665
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-28 Score=191.52 Aligned_cols=155 Identities=19% Similarity=0.278 Sum_probs=124.6
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-----------CCCCHHHHHHHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------NILGFGQLREIEVSTSKGIAY 93 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~ 93 (202)
.+..|.......+|++++. .++...++++++++++|..++.. ..+++..+..++.|++.||.|
T Consensus 55 ~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 134 (277)
T cd05062 55 EFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADGMAY 134 (277)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 4556666677778887752 44556788999999999888743 235778899999999999999
Q ss_pred HHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHH
Q 044746 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLL 173 (202)
Q Consensus 94 lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l 173 (202)
||+ .+++|+||||+||+++.++.++++|||+++...............+++.|+|||.+.+..++.++|+||||+++
T Consensus 135 lH~---~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 211 (277)
T cd05062 135 LNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVL 211 (277)
T ss_pred HHH---CCcccCCcchheEEEcCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHHHHH
Confidence 999 99999999999999999999999999998754433222222223447789999999888899999999999999
Q ss_pred HHHHc-CCCCCcchhc
Q 044746 174 FEVVG-RRRNLEKEIS 188 (202)
Q Consensus 174 ~el~~-g~~p~~~~~~ 188 (202)
+|+++ |..||.....
T Consensus 212 ~el~~~~~~p~~~~~~ 227 (277)
T cd05062 212 WEIATLAEQPYQGMSN 227 (277)
T ss_pred HHHHcCCCCCCCCCCH
Confidence 99999 7899876543
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=8e-28 Score=196.01 Aligned_cols=167 Identities=20% Similarity=0.271 Sum_probs=130.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||++++...+..|+.|+.... ....|..+....+|++++. .+....++++++. ++|..++. .
T Consensus 82 Vy~~~~~~~~~~valK~~~~~---------~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~ 151 (357)
T PHA03209 82 VFVATKPGQPDPVVLKIGQKG---------TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRS 151 (357)
T ss_pred EEEEEECCCCceEEEEeCCcc---------ccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhcc
Confidence 688888888888887763221 2234666777888898774 3334456667665 56666553 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.++|+|||+++...... ......||+.|+||
T Consensus 152 ~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~gt~~y~aP 225 (357)
T PHA03209 152 RPLPIDQALIIEKQILEGLRYLHA---QRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP---AFLGLAGTVETNAP 225 (357)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEecCccccccccCc---ccccccccccccCC
Confidence 468999999999999999999999 999999999999999999999999999987532221 12334579999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNL 183 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~ 183 (202)
|++.+..++.++|+||+||++|||+++..|+
T Consensus 226 E~~~~~~~~~~~DiwSlGvvl~ell~~~~~~ 256 (357)
T PHA03209 226 EVLARDKYNSKADIWSAGIVLFEMLAYPSTI 256 (357)
T ss_pred eecCCCCCCchhhHHHHHHHHHHHHHcCCcc
Confidence 9999889999999999999999999865554
|
|
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=190.12 Aligned_cols=182 Identities=19% Similarity=0.212 Sum_probs=136.2
Q ss_pred CCccccC---CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++... .....|+.|..+.... ......|..|.......+|++++. .++...++++++++++|..++.
T Consensus 21 V~~~~~~~~~~~~~~vaik~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 98 (266)
T cd05064 21 LCRGCLKLPSKRELPVAIHTLRAGCS--DKQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLR 98 (266)
T ss_pred EEEEEEecCCCceeeEEEEecCCCCC--HHHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHH
Confidence 4555432 3445666665433211 111234556666666678888763 4556779999999999998876
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 K--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 ~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||.+......... ......++..|
T Consensus 99 ~~~~~l~~~~~~~~~~~i~~al~~lH~---~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y 174 (266)
T cd05064 99 KHEGQLVAGQLMGMLPGLASGMKYLSE---MGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEAIY-TTMSGKSPVLW 174 (266)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeeccccHhhEEEcCCCcEEECCCcccccccccchh-cccCCCCceee
Confidence 5 368999999999999999999999 99999999999999999999999999987643222111 11122346789
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
+|||.+.+..++.++|+||+||+++|+++ |++||.....
T Consensus 175 ~aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~p~~~~~~ 214 (266)
T cd05064 175 AAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSG 214 (266)
T ss_pred cCHHHHhhCCccchhHHHHHHHHHHHHhcCCCCCcCcCCH
Confidence 99999988899999999999999999775 9999976543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=188.63 Aligned_cols=179 Identities=22% Similarity=0.265 Sum_probs=138.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH-HHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||+|.+...++.++.|+.+............+..+ .......+|++++. .++..+++++++.+++|..++..
T Consensus 12 v~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 91 (260)
T cd05611 12 VYLAKKRSTGDYFAIKVLKKSDMIAKNQVTNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTL 91 (260)
T ss_pred EEEEEecCCCCeEEEEEecchhhhHHHHHHHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHc
Confidence 68888888888888776543322111112222233 33334446676553 34556789999999999988855
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++..... .....+++.|++|
T Consensus 92 ~~~~~~~~~~i~~qi~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~------~~~~~~~~~y~~p 162 (260)
T cd05611 92 GGLPEDWAKQYIAEVVLGVEDLHQ---RGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE------NKKFVGTPDYLAP 162 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCcEEEeecccceeccc------cccCCCCcCccCh
Confidence 468999999999999999999999 9999999999999999999999999998875432 1223468899999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|++++++++|+.||.....
T Consensus 163 e~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 198 (260)
T cd05611 163 ETILGVGDDKMSDWWSLGCVIFEFLFGYPPFHAETP 198 (260)
T ss_pred hhhcCCCCcchhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 999888889999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-28 Score=191.51 Aligned_cols=155 Identities=20% Similarity=0.300 Sum_probs=125.2
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC--------------CCCHHHHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN--------------ILGFGQLREIEVSTSKG 90 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~--------------~~~~~~~~~~~~~i~~~ 90 (202)
.+..|.......+|++++. .++...++++++.+++|..++... .+++..+..++.|++.|
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~a 132 (288)
T cd05093 53 DFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIAQQIAAG 132 (288)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHHHHHHHH
Confidence 4556666666777887652 445567889999999998877432 38999999999999999
Q ss_pred HHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHH
Q 044746 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFG 170 (202)
Q Consensus 91 l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G 170 (202)
|.|||+ .+++||||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|+||||
T Consensus 133 L~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG 209 (288)
T cd05093 133 MVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLG 209 (288)
T ss_pred HHHHHh---CCeeecccCcceEEEccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchhhHHHHH
Confidence 999999 99999999999999999999999999999755332221122223346789999999988899999999999
Q ss_pred HHHHHHHc-CCCCCcchhc
Q 044746 171 MLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 171 ~~l~el~~-g~~p~~~~~~ 188 (202)
+++++|++ |.+||.....
T Consensus 210 ~il~~l~t~g~~p~~~~~~ 228 (288)
T cd05093 210 VVLWEIFTYGKQPWYQLSN 228 (288)
T ss_pred HHHHHHHhCCCCCCCCCCH
Confidence 99999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=195.65 Aligned_cols=182 Identities=13% Similarity=0.099 Sum_probs=137.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||+++++.+++.||.|..+.... .......+..|..+....+|+|++. ..+..+++++++++++|..++..
T Consensus 16 v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 94 (327)
T cd08227 16 VNLARYKPTGEYVTVRRINLEAC-TNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 94 (327)
T ss_pred EEEEeecccCcEEEEEEechhhc-cHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhc
Confidence 67888888888888876433211 1112233555666777778998874 33456788999999999888743
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-cc----ccCCCCCC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HI----TSTGRRRT 146 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~----~~~~~~gt 146 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++||+.......... .. ......++
T Consensus 95 ~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (327)
T cd08227 95 MDGMSELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKV 171 (327)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccce
Confidence 358999999999999999999999 9999999999999999999999999986543221110 00 01122456
Q ss_pred CcccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 147 PGCEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 147 ~~y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
..|+|||++.+ ..++.++|+||+||+++|+++|+.||...
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~ 213 (327)
T cd08227 172 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDM 213 (327)
T ss_pred ecccChHHhhcccCCCCchhhHHHHHHHHHHHHHCCCCCCCc
Confidence 78999999876 45889999999999999999999999753
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=189.39 Aligned_cols=179 Identities=22% Similarity=0.230 Sum_probs=140.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++...+..++.|+.+..... ....+..|.......+|++++. ..+...++++++++++|..++. .+
T Consensus 25 v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 101 (267)
T cd06645 25 VYKARNVNTGELAAIKVIKLEPGE---DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTG 101 (267)
T ss_pred EEEEEEcCCCcEEEEEEEecCchh---HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcC
Confidence 578888888888888765432211 1223455666677778887653 3455678899999999988775 44
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.|+.|||+ .+++|+||||+||+++.++.++|+|||++........ ......|++.|+|||
T Consensus 102 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 176 (267)
T cd06645 102 PLSESQIAYVSRETLQGLYYLHS---KGKMHRDIKGANILLTDNGHVKLADFGVSAQITATIA--KRKSFIGTPYWMAPE 176 (267)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEECcceeeeEccCccc--ccccccCcccccChh
Confidence 69999999999999999999999 9999999999999999999999999999876543221 123346789999999
Q ss_pred ccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++. ...++.++|+||+||++++|++|++||....
T Consensus 177 ~~~~~~~~~~~~~~DvwSlG~il~~l~~~~~p~~~~~ 213 (267)
T cd06645 177 VAAVERKGGYNQLCDIWAVGITAIELAELQPPMFDLH 213 (267)
T ss_pred hhccccCCCCCchhhhHHHHHHHHHHhcCCCCccccc
Confidence 874 4457889999999999999999999986544
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-28 Score=190.91 Aligned_cols=183 Identities=22% Similarity=0.231 Sum_probs=134.0
Q ss_pred CCccccCC-----CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRG-----STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~-----~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++.... ....|+.|........ .....|..|.......+|++++. ......++++++.+++|..+
T Consensus 22 vy~~~~~~~~~~~~~~~v~ik~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~ 99 (277)
T cd05036 22 VYEGLYRGRDGDAVELQVAVKTLPESCSE--QDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSF 99 (277)
T ss_pred EEEEEEecCCCCCCceeEEEEEcCCCCCH--HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHH
Confidence 46666654 4455555543322111 11233556666677778887653 23345688899999999988
Q ss_pred hccC--------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC---ceEEeeeecceeccccCccc
Q 044746 70 CKKN--------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF---FPKAADFGLAKLYNREHTHI 138 (202)
Q Consensus 70 ~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~---~~kl~dfgl~~~~~~~~~~~ 138 (202)
+... .+++..+..++.|++.||.|||+ ++++|+||||+||+++.++ .++|+|||+++.........
T Consensus 100 i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~ 176 (277)
T cd05036 100 LRENRPRPERPSSLTMKDLLFCARDVAKGCKYLEE---NHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYR 176 (277)
T ss_pred HHHhCCCCCCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccchheEEEeccCCCcceEeccCccccccCCcccee
Confidence 7443 48999999999999999999999 9999999999999998654 68999999998653222211
Q ss_pred ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
.......+..|+|||++.+..++.++|||||||+++||++ |+.||.....
T Consensus 177 ~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~~g~~pf~~~~~ 227 (277)
T cd05036 177 KGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227 (277)
T ss_pred cCCCCCccHhhCCHHHHhcCCcCchhHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 1122233567999999988889999999999999999997 9999986543
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=193.96 Aligned_cols=185 Identities=21% Similarity=0.247 Sum_probs=142.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.++.|...............+..|.......+|++++. .+...+++++++.+++|..+...
T Consensus 17 vy~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 96 (316)
T cd05574 17 VFLVRLKGTGKLFALKVLDKKEMIKRNKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQP 96 (316)
T ss_pred EEEEEEcCCCcEEEEEEEeccccchHHHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCC
Confidence 5788888777777776554332222223345666666777777887652 34456788999999999988754
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc--------------
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-------------- 137 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-------------- 137 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 97 ~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (316)
T cd05574 97 GKCLSEEVARFYAAEVLLALEYLHL---LGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSV 173 (316)
T ss_pred CCccCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccc
Confidence 458999999999999999999999 99999999999999999999999999998754221100
Q ss_pred -------------cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 138 -------------ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 138 -------------~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.......|+..|+|||++.+..++.++|+||+|+++|++++|+.||.....
T Consensus 174 ~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~ 237 (316)
T cd05574 174 NSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNR 237 (316)
T ss_pred cccchhhhcccccCCCCCCcCccCCcCHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCch
Confidence 011123578889999999988899999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.1e-28 Score=187.62 Aligned_cols=182 Identities=24% Similarity=0.325 Sum_probs=140.9
Q ss_pred CCccccCCC---cceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGS---TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~---~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++.+... ...++.|+........ ....+..|.......+|++++. ......++++++++++|..++.
T Consensus 11 v~~~~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 88 (262)
T cd00192 11 VYKGKLKGKDGKTTEVAVKTLKEDASEE--ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLR 88 (262)
T ss_pred EEEEEEecCCCCCceEEeEeeccccchh--HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHh
Confidence 466666654 6666666544332221 2334555656666666776552 3455678899999999999886
Q ss_pred c----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccC
Q 044746 72 K----------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141 (202)
Q Consensus 72 ~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~ 141 (202)
. ..+++.++..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||.+.............
T Consensus 89 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~ 165 (262)
T cd00192 89 KSRPVFPSPEKSTLSLKDLLSFAIQIAKGMEYLAS---KKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDYYRKKT 165 (262)
T ss_pred hccccccccccccCCHHHHHHHHHHHHHHHHHHHc---CCcccCccCcceEEECCCCcEEEccccccccccccccccccc
Confidence 5 568999999999999999999999 999999999999999999999999999998765433222233
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
...+++.|+|||.+....++.++|+||+|++++++++ |+.||....
T Consensus 166 ~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~ 212 (262)
T cd00192 166 GGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLS 212 (262)
T ss_pred CCCcCccccCHHHhccCCcchhhccHHHHHHHHHHHhcCCCCCCCCC
Confidence 4456889999999988889999999999999999999 699997654
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-29 Score=221.62 Aligned_cols=185 Identities=23% Similarity=0.213 Sum_probs=148.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccccc------ceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDT------ETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||-+.+...++..|.|--+..... .........|..+....+|||++...+. ..++++|+++|+|......+.
T Consensus 1251 VYtavN~~tGellAvKEI~iq~~~-~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gr 1329 (1509)
T KOG4645|consen 1251 VYTAVNLDTGELLAVKEIKIQDSD-HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGR 1329 (1509)
T ss_pred eEEeecCCccchhhhhhhhcCccc-cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcc
Confidence 567777778888887654333332 4444556777888888999999865544 348899999999999987665
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc--cccCCCCCCCcccC
Q 044746 75 -LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH--ITSTGRRRTPGCEA 151 (202)
Q Consensus 75 -~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~--~~~~~~~gt~~y~a 151 (202)
.++...+.+..|++.|+.|||+ .||+|||+||.||+++.+|.+|++|||.|..+...... .......||+.|||
T Consensus 1330 i~dE~vt~vyt~qll~gla~LH~---~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMA 1406 (1509)
T KOG4645|consen 1330 IEDEMVTRVYTKQLLEGLAYLHE---HGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMA 1406 (1509)
T ss_pred hhhhhHHHHHHHHHHHHHHHHHh---cCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcC
Confidence 6777788899999999999999 99999999999999999999999999999977654321 12334678999999
Q ss_pred CcccCCC---CCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 152 PELWMPY---SVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 152 Pe~~~~~---~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
||++.+. ....++||||+||++.||+||+.||...+.+
T Consensus 1407 PEvit~t~~kG~~~A~DiWslGCVVlEM~tGkrPW~~~dne 1447 (1509)
T KOG4645|consen 1407 PEVITGTKGKGHGGAADIWSLGCVVLEMATGKRPWAELDNE 1447 (1509)
T ss_pred chhhcccccCCCCcchhhhcccceEEEeecCCCchhhccch
Confidence 9999863 4567899999999999999999999866554
|
|
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.3e-28 Score=187.99 Aligned_cols=182 Identities=22% Similarity=0.258 Sum_probs=142.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+...+..++.|...... ........+..+.......+|++++. ......++++++++++|..++..
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 94 (256)
T cd08529 16 VFKVVRKADKRVYAMKQIDLSK-MNRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQR 94 (256)
T ss_pred EEEEEEcCCCcEEEEEEeehhh-CCHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhc
Confidence 5777777666766666533221 11122344666666777788887763 33456788999999999888754
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++........ .....|++.|+|
T Consensus 95 ~~~~~~~~~~~i~~~l~~al~~lH~---~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~~--~~~~~~~~~y~a 169 (256)
T cd08529 95 GRPLPEDQVWRFFIQILLGLAHLHS---KKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTNF--ANTIVGTPYYLS 169 (256)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEeCCCCEEEcccccceeccCccch--hhccccCccccC
Confidence 468999999999999999999999 99999999999999999999999999998865433221 123456889999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||++.+..++.++|+||||+++++|++|+.||....+
T Consensus 170 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 206 (256)
T cd08529 170 PELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQ 206 (256)
T ss_pred HHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999988899999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.1e-28 Score=188.48 Aligned_cols=183 Identities=19% Similarity=0.145 Sum_probs=139.0
Q ss_pred CCccccCCCcceeehhhhchhhhhc--cCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME--MDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++...+..|+.|......... ......+..|.......+|++++.. .....++++++++++|..++
T Consensus 18 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l 97 (265)
T cd06652 18 VYLCYDADTGRELAVKQVQFDPESPETSKEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQL 97 (265)
T ss_pred EEEEEEcCCCcEEEEEEeecCcCCcccHHHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHH
Confidence 5777777777777776543221111 1112345566677777788877631 12344678899999998887
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCCc
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTPG 148 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~~ 148 (202)
.. ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ........|+..
T Consensus 98 ~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (265)
T cd06652 98 KSYGALTENVTRKYTRQILEGVSYLHS---NMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPY 174 (265)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEecCCCCEEECcCccccccccccccccccccCCCCcc
Confidence 54 458999999999999999999999 9999999999999999999999999999875432111 111223457889
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|+|||.+.+..++.++|+||||+++||+++|+.||...
T Consensus 175 y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~ 212 (265)
T cd06652 175 WMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEF 212 (265)
T ss_pred ccChhhhcCCCCCcchhHHHHHHHHHHHhhCCCCCCcc
Confidence 99999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-28 Score=190.72 Aligned_cols=181 Identities=19% Similarity=0.224 Sum_probs=142.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++.+...+..++.|+..............+..|..+....+|++++. ..+..+++++++++++|..++.. .
T Consensus 9 vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 88 (277)
T cd05577 9 VCACQVKATGKMYACKKLDKKRLKKRKGEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVG 88 (277)
T ss_pred EEEEEEcCCCcEEEEEEEehhhhhhhhhhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcC
Confidence 6788887777777776654332222223334455666677778887652 44567789999999999877643 2
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 74 --ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 74 --~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+........ .....++..|+|
T Consensus 89 ~~~~~~~~~~~~~~ql~~~l~~lH~---~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~~ 162 (277)
T cd05577 89 EPGFPEARAIFYAAQIICGLEHLHQ---RRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGKK---IKGRAGTPGYMA 162 (277)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEECCCCCEEEccCcchhhhccCCc---cccccCCCCcCC
Confidence 58999999999999999999999 9999999999999999999999999999875433211 123446788999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||.+.+..++.++|+||+|++++++++|+.||....
T Consensus 163 PE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 198 (277)
T cd05577 163 PEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQRK 198 (277)
T ss_pred HHHhcCCCCCchhhhHHHHHHHHHHhhCCCCCCCCc
Confidence 999988888999999999999999999999997644
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=187.46 Aligned_cols=183 Identities=20% Similarity=0.259 Sum_probs=136.0
Q ss_pred CCccccCCCc---ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGST---RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~---~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.....+ ..++.|........ .....+..|.......+|++++. .+....++++++.+++|..++..
T Consensus 11 v~~~~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~ 88 (257)
T cd05060 11 VVKGVYLMKSGKEVEVAVKTLKQEHIA--AGKKEFLREASVMAQLDHPCIVRLIGVCKGEPLMLVMELAPLGPLLKYLKK 88 (257)
T ss_pred EEEeEeeccCCCcceEEEEecccccch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEcCCceEEEEEeCCCCcHHHHHHh
Confidence 4555543333 45555543322211 12234555666666777887653 33445688889999999988865
Q ss_pred C-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc-cCCCCCCCccc
Q 044746 73 N-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT-STGRRRTPGCE 150 (202)
Q Consensus 73 ~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~-~~~~~gt~~y~ 150 (202)
. .+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++.......... .....++..|+
T Consensus 89 ~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~ 165 (257)
T cd05060 89 RREIPVSDLKELAHQVAMGMAYLES---KHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWY 165 (257)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhh---cCeeccCcccceEEEcCCCcEEeccccccceeecCCcccccccCcccccccc
Confidence 4 49999999999999999999999 9999999999999999999999999999986543322111 11222356799
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||.+....++.++|+||||++++++++ |.+||....+
T Consensus 166 aPE~~~~~~~~~~~Di~slG~~l~~~~~~g~~p~~~~~~ 204 (257)
T cd05060 166 APECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKG 204 (257)
T ss_pred CHHHhcCCCCCccchHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999988889999999999999999998 9999976543
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.5e-28 Score=192.66 Aligned_cols=180 Identities=19% Similarity=0.245 Sum_probs=143.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++.+...++.++.|...... ......+..|.......+|++++. .+....++++++++++|..+.....
T Consensus 35 v~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 111 (297)
T cd06656 35 VYTAIDIATGQEVAIKQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 111 (297)
T ss_pred EEEEEECCCCCEEEEEEEecCc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHhCC
Confidence 5778877667777776543221 112234556666677778887663 3445678899999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++++|||++......... .....+++.|+|||.
T Consensus 112 ~~~~~~~~~~~~l~~~L~~LH~---~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE~ 186 (297)
T cd06656 112 MDEGQIAAVCRECLQALDFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEV 186 (297)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEECcCccceEccCCccC--cCcccCCccccCHHH
Confidence 9999999999999999999999 99999999999999999999999999998765433221 123456889999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+..++.++|+||+|++++++++|++||....+
T Consensus 187 ~~~~~~~~~~Di~slGvil~~l~tg~~pf~~~~~ 220 (297)
T cd06656 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (297)
T ss_pred HcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 9988889999999999999999999999976544
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.4e-28 Score=189.50 Aligned_cols=176 Identities=23% Similarity=0.300 Sum_probs=135.5
Q ss_pred ccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc--------ccceEEEEEccCCchhhhhccCCCC
Q 044746 5 RNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE--------DTETYIKGFLAMGPFYLLCKKNILG 76 (202)
Q Consensus 5 ~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------~~~~~~~~~~~~~~l~~~~~~~~~~ 76 (202)
.....+..|+.|+.+.... ......+..|.......+|++++... ....++++++++++|..++....++
T Consensus 28 ~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~l~ 105 (283)
T cd05080 28 ANDGTGEMVAVKTLKRECG--QQNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLN 105 (283)
T ss_pred ccCCCCceEEEEEeccccC--hHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHcCCC
Confidence 3445556667666433211 11223455666677778888876422 2345788899999999999888899
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCcccCCccc
Q 044746 77 FGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCEAPELW 155 (202)
Q Consensus 77 ~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPe~~ 155 (202)
+.++..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++......... ......++..|+|||.+
T Consensus 106 ~~~~~~i~~~l~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~ 182 (283)
T cd05080 106 LAQLLLFAQQICEGMAYLHS---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECL 182 (283)
T ss_pred HHHHHHHHHHHHHHHHHHHH---CCeeccccChheEEEcCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHh
Confidence 99999999999999999999 999999999999999999999999999998654322211 11223346679999999
Q ss_pred CCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 156 MPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 156 ~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
....++.++|+||||++++||++|..||..
T Consensus 183 ~~~~~~~~~Di~slG~~l~el~tg~~p~~~ 212 (283)
T cd05080 183 KENKFSYASDVWSFGVTLYELLTHCDSKQS 212 (283)
T ss_pred cccCCCcccccHHHHHHHHHHHhCCCCCCC
Confidence 888899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.8e-28 Score=187.79 Aligned_cols=179 Identities=21% Similarity=0.254 Sum_probs=137.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+...+..++.|+.+... .....+..|.......+|++++. ..+...++++++++++|..++..
T Consensus 22 v~~~~~~~~~~~~~~K~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 97 (263)
T cd05052 22 VYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 97 (263)
T ss_pred EEEEEEecCCceEEEEEecCCc----hHHHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCC
Confidence 5677776667777776643221 11234555666666777887653 34445688999999999888753
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......... .....++..|+|
T Consensus 98 ~~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~~~-~~~~~~~~~y~a 173 (263)
T cd05052 98 RQEVNAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYTA-HAGAKFPIKWTA 173 (263)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCcEEeCCCccccccccceeec-cCCCCCccccCC
Confidence 358999999999999999999999 999999999999999999999999999998654332211 112223567999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
||.+.+..++.++|+||||++++||++ |..||....
T Consensus 174 PE~~~~~~~~~~~Dv~slG~il~el~t~g~~p~~~~~ 210 (263)
T cd05052 174 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGID 210 (263)
T ss_pred HHHhccCCCCchhHHHHHHHHHHHHHcCCCCCCCCCC
Confidence 999988889999999999999999998 999997644
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5e-28 Score=189.28 Aligned_cols=155 Identities=20% Similarity=0.239 Sum_probs=124.0
Q ss_pred cCCcHHHHHHhcccccccccc------------ccceEEEEEccCCchhhhhc-------cCCCCHHHHHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPFYLLCK-------KNILGFGQLREIEVSTSKGI 91 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l~~~~~-------~~~~~~~~~~~~~~~i~~~l 91 (202)
.+..|.......+|++++... ....++++++.+++|..++. ...+++..+..++.|++.||
T Consensus 47 ~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~aL 126 (273)
T cd05035 47 EFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIALGM 126 (273)
T ss_pred HHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHHHHH
Confidence 456666667777888876321 12568889999999977762 23589999999999999999
Q ss_pred HHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHH
Q 044746 92 AYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGM 171 (202)
Q Consensus 92 ~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~ 171 (202)
.|||+ .+++||||||+||+++.++.++|+|||+++...............++..|+|||.+....++.++|+||+||
T Consensus 127 ~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~SlG~ 203 (273)
T cd05035 127 EYLSN---RNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGV 203 (273)
T ss_pred HHHHh---CCeeccccchheEEECCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccchHHHHH
Confidence 99999 999999999999999999999999999998654333222222233467899999998888999999999999
Q ss_pred HHHHHHc-CCCCCcchhc
Q 044746 172 LLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 172 ~l~el~~-g~~p~~~~~~ 188 (202)
+++|+++ |.+||.+..+
T Consensus 204 il~el~~~g~~p~~~~~~ 221 (273)
T cd05035 204 TMWEIATRGQTPYPGVEN 221 (273)
T ss_pred HHHHHHhCCCCCCCCCCH
Confidence 9999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=188.72 Aligned_cols=180 Identities=24% Similarity=0.325 Sum_probs=143.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++...++.++.|+............. ...|.......+|++++. ......++++++.+++|..++. ..
T Consensus 15 v~~~~~~~~~~~~~~K~~~~~~~~~~~~~~-~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~ 93 (260)
T PF00069_consen 15 VYKAKNKKNGQKVAVKIIDKSEIEEEEREE-NIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNK 93 (260)
T ss_dssp EEEEEETTTTEEEEEEEEESTTHHHHHHHH-HHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHS
T ss_pred EEEEEECCCCeEEEEEEeccccccccccch-hhhhhhccccccccccccccccccccccccccccccccccccccccccc
Confidence 688999988877777765554433322211 122555555567887663 4555668999999999998886 77
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.+||+ .+++|+||||+||+++.++.++|+|||.+...... ........+++.|+|||
T Consensus 94 ~~~~~~~~~~~~qi~~~L~~Lh~---~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~~--~~~~~~~~~~~~y~aPE 168 (260)
T PF00069_consen 94 PLSEEEILKIAYQILEALAYLHS---KGIVHRDIKPENILLDENGEVKLIDFGSSVKLSEN--NENFNPFVGTPEYMAPE 168 (260)
T ss_dssp SBBHHHHHHHHHHHHHHHHHHHH---TTEEESSBSGGGEEESTTSEEEESSGTTTEESTST--TSEBSSSSSSGGGSCHH
T ss_pred ccccccccccccccccccccccc---ccccccccccccccccccccccccccccccccccc--ccccccccccccccccc
Confidence 89999999999999999999999 99999999999999999999999999999754211 11233456689999999
Q ss_pred ccC-CCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 154 LWM-PYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 154 ~~~-~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
++. +...+.++|+||+|+++++|++|..||...
T Consensus 169 ~~~~~~~~~~~~Di~slG~il~~l~~~~~p~~~~ 202 (260)
T PF00069_consen 169 VLQQGKKYTRKSDIWSLGIILYELLTGKLPFEES 202 (260)
T ss_dssp HHTTTSSBSTHHHHHHHHHHHHHHHHSSSSSTTS
T ss_pred cccccccccccccccccccccccccccccccccc
Confidence 998 778899999999999999999999999976
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.5e-27 Score=185.95 Aligned_cols=179 Identities=24% Similarity=0.324 Sum_probs=135.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++.+.++. .++.|..+... .....+..|.......+|++++. ......++++++.+++|..++...
T Consensus 22 v~~~~~~~~~-~v~iK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 96 (261)
T cd05068 22 VWEGLWNNTT-PVAVKTLKPGT----MDPKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGA 96 (261)
T ss_pred EEEEEecCCe-EEEEEeeCCCc----ccHHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccC
Confidence 5677665544 45554432211 11234556666777778887763 334456888899999999888543
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 74 --ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 74 --~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++........ ...+...+..|+|
T Consensus 97 ~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~a 172 (261)
T cd05068 97 GRALKLPQLIDMAAQVASGMAYLEA---QNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIYE-AREGAKFPIKWTA 172 (261)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCcceEEEcCCCCEEECCcceEEEccCCccc-ccCCCcCceeccC
Confidence 48999999999999999999999 99999999999999999999999999999876532211 1112222457999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||.+.+..++.++|+||||++++|+++ |+.||.+...
T Consensus 173 PE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 210 (261)
T cd05068 173 PEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTN 210 (261)
T ss_pred ccccccCCCCchhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=187.01 Aligned_cols=179 Identities=26% Similarity=0.361 Sum_probs=137.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--- 72 (202)
||++++.++.. |+.|..+... ....++..|.......+|++++. ......++++++.+++|..++..
T Consensus 22 v~~~~~~~~~~-valK~~~~~~----~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 96 (262)
T cd05071 22 VWMGTWNGTTR-VAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGEMG 96 (262)
T ss_pred EEEEEecCCce-EEEEecccCc----cCHHHHHHHHHHHHhCCCCCcceEEEEECCCCcEEEEEcCCCCcHHHHHhhccc
Confidence 57777666555 4544433211 11234666666777778887652 23445688999999999888864
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|+|+ .+++|+||||+||+++.++.++|+|||.+.......... .....++..|+||
T Consensus 97 ~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~~~-~~~~~~~~~y~~P 172 (262)
T cd05071 97 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYTA-RQGAKFPIKWTAP 172 (262)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---CCccccccCcccEEEcCCCcEEeccCCceeecccccccc-ccCCcccceecCH
Confidence 358999999999999999999999 999999999999999999999999999998654332211 1223456789999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|+..+..++.++|+||+|++++|+++ |+.||....+
T Consensus 173 E~~~~~~~~~~~DvwslG~~l~ellt~g~~p~~~~~~ 209 (262)
T cd05071 173 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 209 (262)
T ss_pred hHhccCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCh
Confidence 99988889999999999999999999 8889876543
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.4e-28 Score=188.47 Aligned_cols=182 Identities=21% Similarity=0.298 Sum_probs=147.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..++..++.|+..............+..|.......+|++++. .+....++++++.+++|..++...
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 95 (258)
T cd05578 16 VCIVQKRDTKKMFAMKYMNKQKCVEKGSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKV 95 (258)
T ss_pred EEEEEEccCCcEEEEEEEehhhhcchhHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcC
Confidence 5788888777778877655433322233445666767777888998763 455677889999999999888766
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ .....|+..|+|||
T Consensus 96 ~l~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~~PE 169 (258)
T cd05578 96 KFSEEQVKFWICEIVLALEYLHS---KGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDTL---TTSTSGTPGYMAPE 169 (258)
T ss_pred CcCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEEcCCCCEEEeecccccccCCCcc---ccccCCChhhcCHH
Confidence 89999999999999999999999 9999999999999999999999999999876543321 22345688999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+....++.++|+||+|++++++++|+.||.....
T Consensus 170 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 204 (258)
T cd05578 170 VLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSR 204 (258)
T ss_pred HHcccCCCCcccchhhHHHHHHHHhCCCCCCCCCc
Confidence 99888889999999999999999999999987653
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=188.79 Aligned_cols=180 Identities=20% Similarity=0.271 Sum_probs=136.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.++.|..+... ........+..|.......+|++++. .+...++++++++ +++..+...
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~ 93 (285)
T cd07861 16 VYKGRNKKTGQIVAMKKIRLES-EEEGVPSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLP 93 (285)
T ss_pred EEEEEECCCCcEEEEEEecccc-ccCCchHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCC
Confidence 6788887777777776543321 11122334556767777778887653 3455567788887 566665532
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......+++.|+
T Consensus 94 ~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 168 (285)
T cd07861 94 KGQYMDAELVKSYLYQILQGILFCHS---RRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPVR--VYTHEVVTLWYR 168 (285)
T ss_pred CCCcCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCCHHHEEEcCCCcEEECcccceeecCCCcc--cccCCccccccc
Confidence 468999999999999999999999 9999999999999999999999999999975433221 122335588999
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+.+. .++.++|+||+|+++++|++|++||....
T Consensus 169 aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~~~~~~~~ 206 (285)
T cd07861 169 APEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDS 206 (285)
T ss_pred ChHHhcCCCCcCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99988654 57889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=188.40 Aligned_cols=180 Identities=23% Similarity=0.220 Sum_probs=140.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.++.|+...... .....+..|.......+|++++. ..+...++++++++++|..++. ..
T Consensus 25 vy~~~~~~~~~~~aik~~~~~~~---~~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~ 101 (267)
T cd06646 25 VYKARNLHTGELAAVKIIKLEPG---DDFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTG 101 (267)
T ss_pred EEEEEECCCCeEEEEEEEecCcc---chHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcC
Confidence 67888888888888877543211 11223555666777788888764 3344567889999999988764 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++|||++|+||+++.++.++++|||++........ ......|++.|+|||
T Consensus 102 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~PE 176 (267)
T cd06646 102 PLSELQIAYVCRETLQGLAYLHS---KGKMHRDIKGANILLTDNGDVKLADFGVAAKITATIA--KRKSFIGTPYWMAPE 176 (267)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCCEEECcCccceeeccccc--ccCccccCccccCHh
Confidence 68999999999999999999999 9999999999999999999999999999986543221 112345688999999
Q ss_pred ccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+. ...++.++|+||+|++++||++|++||....+
T Consensus 177 ~~~~~~~~~~~~~~Dvws~G~il~el~~g~~p~~~~~~ 214 (267)
T cd06646 177 VAAVEKNGGYNQLCDIWAVGITAIELAELQPPMFDLHP 214 (267)
T ss_pred HcccccCCCCcchhhHHHHHHHHHHHHhCCCCccccch
Confidence 874 34577899999999999999999999965543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.7e-28 Score=193.57 Aligned_cols=154 Identities=23% Similarity=0.344 Sum_probs=124.8
Q ss_pred cCCcHHHHHHhccccccccc-----cccceEEEEEccCCchhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 044746 31 RFTSPQRMIAADNFSNLVGS-----EDTETYIKGFLAMGPFYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIV 103 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~ii 103 (202)
.+..+.......+|+|++.. .....++++++++|+|..+.... .+++..+..++.|++.||.|||+ ++++
T Consensus 55 ~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~iv 131 (303)
T cd05110 55 EFMDEALIMASMDHPHLVRLLGVCLSPTIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEE---RRLV 131 (303)
T ss_pred HHHHHHHHHHhCCCCCcccEEEEEcCCCceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhh---cCee
Confidence 45566667777788887642 23345788899999998887543 58999999999999999999999 9999
Q ss_pred EecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCC
Q 044746 104 HYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRN 182 (202)
Q Consensus 104 Hrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p 182 (202)
|+||||+||+++.++.+||+|||+++...............++..|+|||++.+..++.++|+||||+++||+++ |..|
T Consensus 132 H~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g~~p 211 (303)
T cd05110 132 HRDLAARNVLVKSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFGGKP 211 (303)
T ss_pred ccccccceeeecCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCCCCC
Confidence 999999999999999999999999986543322222223345678999999988889999999999999999997 9999
Q ss_pred Ccchh
Q 044746 183 LEKEI 187 (202)
Q Consensus 183 ~~~~~ 187 (202)
|.+..
T Consensus 212 ~~~~~ 216 (303)
T cd05110 212 YDGIP 216 (303)
T ss_pred CCCCC
Confidence 97643
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=186.14 Aligned_cols=171 Identities=19% Similarity=0.265 Sum_probs=132.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++...+..++.|+........ ... .......+|++++. ..+...++++++++++|..++...
T Consensus 32 v~~~~~~~~~~~~~~k~~~~~~~~~------~e~-~~~~~~~~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~ 104 (267)
T PHA03390 32 VSVLKHKPTQKLFVQKIIKAKNFNA------IEP-MVHQLMKDNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEG 104 (267)
T ss_pred EEEEEEcCCCcEEEEEEEehhhcch------hhH-HHHHHhhcCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcC
Confidence 5677776677777776643321111 111 11111225666542 344567889999999999988665
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .++++|||+++..... ....++..|+||
T Consensus 105 ~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~y~aP 175 (267)
T PHA03390 105 KLSEAEVKKIIRQLVEALNDLHK---HNIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP------SCYDGTLDYFSP 175 (267)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC------ccCCCCCcccCh
Confidence 79999999999999999999999 8999999999999999888 9999999998765432 123468899999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.+..++.++|+||+|++++|+++|+.||....
T Consensus 176 E~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~ 210 (267)
T PHA03390 176 EKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDE 210 (267)
T ss_pred hhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 99998889999999999999999999999998543
|
|
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.1e-28 Score=189.81 Aligned_cols=180 Identities=23% Similarity=0.263 Sum_probs=138.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||++++...+..++.+....... .....+..|.......+|++++. ......++++++.++++..++. .
T Consensus 21 v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 97 (282)
T cd06643 21 VYKAQNKETGVLAAAKVIDTKSE---EELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 97 (282)
T ss_pred EEEEEECCCCeEEEEEEeCCCCH---HHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcC
Confidence 57777777777777665432211 12234555666667778887652 3455678899999999987764 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++........ ......+++.|+||
T Consensus 98 ~~l~~~~~~~~~~qi~~~L~~LH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 172 (282)
T cd06643 98 RPLTEPQIRVVCKQTLEALNYLHE---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAP 172 (282)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEccCCCEEEcccccccccccccc--ccccccccccccCH
Confidence 569999999999999999999999 9999999999999999999999999999875432221 12234578899999
Q ss_pred cccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++. ...++.++|+||+||++|||++|++||....+
T Consensus 173 E~~~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~~ 213 (282)
T cd06643 173 EVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNP 213 (282)
T ss_pred hhccccCCCCCCCCccchhhhHHHHHHHHccCCCCccccCH
Confidence 9984 34577899999999999999999999976543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.7e-28 Score=188.75 Aligned_cols=155 Identities=19% Similarity=0.250 Sum_probs=122.0
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC------CCCHHHHHHHHHHHHHHHHHHHhCC
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN------ILGFGQLREIEVSTSKGIAYLHEEC 98 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~~ 98 (202)
.+..|.......+|++++. ......++++++++++|..++... ..++..++.++.|++.|+.|||+
T Consensus 41 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~-- 118 (269)
T cd05087 41 KFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHLHK-- 118 (269)
T ss_pred HHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--
Confidence 4566667777888898763 233456889999999998887532 35677888999999999999999
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCC-------CCCchhhHHHHHH
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY-------SVTQKCDVFSFGM 171 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~-------~~~~~~Diws~G~ 171 (202)
.+++||||||+||+++.++.++|+|||++................++..|+|||++... .++.++|+||||+
T Consensus 119 -~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 197 (269)
T cd05087 119 -NNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVWSLGV 197 (269)
T ss_pred -CCEeccccCcceEEEcCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhHHHHH
Confidence 99999999999999999999999999998754333222223334567889999998642 3578999999999
Q ss_pred HHHHHHc-CCCCCcchhc
Q 044746 172 LLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 172 ~l~el~~-g~~p~~~~~~ 188 (202)
+++|+++ |+.||....+
T Consensus 198 ~l~el~~~g~~p~~~~~~ 215 (269)
T cd05087 198 TIWELFELGSQPYRHLSD 215 (269)
T ss_pred HHHHHHhCCCCCCCCCCh
Confidence 9999996 9999975443
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=198.57 Aligned_cols=111 Identities=25% Similarity=0.334 Sum_probs=94.4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++...............+++.|+|||
T Consensus 233 ~l~~~~~~~~~~qi~~aL~~LH~---~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE 309 (400)
T cd05105 233 GLTTLDLLSFTYQVARGMEFLAS---KNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPE 309 (400)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChHhEEEeCCCEEEEEeCCcceeccccccccccCCcCCCcceEChh
Confidence 37788889999999999999999 999999999999999999999999999998654332222223344578899999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
.+.+..++.++||||||++++||++ |..||....
T Consensus 310 ~~~~~~~~~~~DiwSlGvil~ellt~g~~P~~~~~ 344 (400)
T cd05105 310 SIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPGMI 344 (400)
T ss_pred hhcCCCCCchhhHHHHHHHHHHHHHCCCCCCcccc
Confidence 9988889999999999999999997 999987643
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-28 Score=214.41 Aligned_cols=183 Identities=18% Similarity=0.251 Sum_probs=140.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc--------ccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE--------DTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++...+..++.|+....... ......|..|..++...+|++++... ...+++++++.+++|..++..
T Consensus 29 VYLAkdk~tg~~vAlKvIk~~~l~-e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k 107 (1021)
T PTZ00266 29 VFLVKHKRTQEFFCWKAISYRGLK-EREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQK 107 (1021)
T ss_pred EEEEEECCCCeEEEEEEEeccccC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHH
Confidence 688999888888888765432111 11234466677788888999876422 235688999999999887753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCC----CCCeEEecCCCCcEEEcC-----------------CCceEEeeee
Q 044746 73 -----NILGFGQLREIEVSTSKGIAYLHEEC----RQKIVHYDIKPESVLLDE-----------------NFFPKAADFG 126 (202)
Q Consensus 73 -----~~~~~~~~~~~~~~i~~~l~~lH~~~----~~~iiHrdlk~~nil~~~-----------------~~~~kl~dfg 126 (202)
..+++..+..++.||+.||.|||+.. ..+||||||||+|||++. ...+||+|||
T Consensus 108 ~~~~~g~L~E~~Il~Ia~QIL~ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFG 187 (1021)
T PTZ00266 108 CYKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFG 187 (1021)
T ss_pred HhhccCCCCHHHHHHHHHHHHHHHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCC
Confidence 46999999999999999999999721 134999999999999954 2358999999
Q ss_pred cceeccccCcccccCCCCCCCcccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 127 l~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++........ .....||+.|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 188 lAr~l~~~s~---~~s~vGTp~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~ 247 (1021)
T PTZ00266 188 LSKNIGIESM---AHSCVGTPYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKAN 247 (1021)
T ss_pred cccccccccc---ccccCCCccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCC
Confidence 9986543221 223467999999999864 458899999999999999999999997543
|
|
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.3e-28 Score=188.95 Aligned_cols=180 Identities=22% Similarity=0.204 Sum_probs=143.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++.+...+..|+.|+.+..... .....+..|.......+|++++. ......++++++.+++|..++..+.
T Consensus 20 vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 97 (277)
T cd06642 20 VYKGIDNRTKEVVAIKIIDLEEAE--DEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKPGP 97 (277)
T ss_pred EEEEEEcCCCeEEEEEEeccccch--HHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhcCC
Confidence 678877777777777764322111 12234666666777778887653 3345678999999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.|+.|||+ ++++|+||+|+||+++.++.++++|||++........ ......++..|+|||.
T Consensus 98 ~~~~~~~~~~~~i~~~l~~lH~---~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~ 172 (277)
T cd06642 98 LEETYIATILREILKGLDYLHS---ERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEV 172 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHhc---CCeeccCCChheEEEeCCCCEEEccccccccccCcch--hhhcccCcccccCHHH
Confidence 9999999999999999999999 9999999999999999999999999999876543221 1122356888999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||||++++|+++|+.||....
T Consensus 173 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~ 205 (277)
T cd06642 173 IKQSAYDFKADIWSLGITAIELAKGEPPNSDLH 205 (277)
T ss_pred hCcCCCchhhhHHHHHHHHHHHHhCCCCCcccc
Confidence 998889999999999999999999999987543
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=187.48 Aligned_cols=178 Identities=19% Similarity=0.246 Sum_probs=134.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||++++...+..++.|..+... ........+..|.......+|++++. .....+++++++++ ++..+.. .
T Consensus 16 vy~~~~~~~g~~~~~k~~~~~~-~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~ 93 (284)
T cd07839 16 VFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCDQ-DLKKYFDSCN 93 (284)
T ss_pred EEEEEECCCCcEEEEEEeeccc-ccccCccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCCC-CHHHHHHhcC
Confidence 5788887777777766543321 12223344566766777778887652 44556678888874 5655553 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++....... ......+++.|+||
T Consensus 94 ~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 168 (284)
T cd07839 94 GDIDPEIVKSFMFQLLKGLAFCHS---HNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPVR--CYSAEVVTLWYRPP 168 (284)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEcCCCcEEECccchhhccCCCCC--CcCCCccccCCcCh
Confidence 569999999999999999999999 9999999999999999999999999999875433221 11234568899999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|++.+. .++.++|+||+||++++|++|..|+..
T Consensus 169 E~~~~~~~~~~~~DiwslG~il~~l~tg~~p~~~ 202 (284)
T cd07839 169 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 202 (284)
T ss_pred HHHhCCcccCcHHHHHHHHHHHHHHHhcCCCCcC
Confidence 998764 478999999999999999999888643
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.7e-28 Score=186.61 Aligned_cols=181 Identities=18% Similarity=0.253 Sum_probs=138.4
Q ss_pred CCccccCC-Ccc--eeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRG-STR--FITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~-~~~--~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+.. ++. .++.|..+..... ....++..|.......+|++++. ......++++++++++|...+..
T Consensus 11 v~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~~ 88 (257)
T cd05040 11 VRRGEWSTSGGKVIPVAVKCLKSDKLS--DIMDDFLKEAAIMHSLDHENLIRLYGVVLTHPLMMVTELAPLGSLLDRLRK 88 (257)
T ss_pred EEeeeEecCCCCceEEEEeecCCcccH--HHHHHHHHHHHHHhhcCCCCccceeEEEcCCeEEEEEEecCCCcHHHHHHh
Confidence 57776644 222 3555543332221 33445677777778888887763 22455688889999999988855
Q ss_pred C---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCCc
Q 044746 73 N---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPG 148 (202)
Q Consensus 73 ~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~~ 148 (202)
. .+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||+++........ .......++..
T Consensus 89 ~~~~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 165 (257)
T cd05040 89 DALGHFLISTLCDYAVQIANGMRYLES---KRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFA 165 (257)
T ss_pred cccccCcHHHHHHHHHHHHHHHHHHHh---CCccccccCcccEEEecCCEEEeccccccccccccccceecccCCCCCce
Confidence 3 48999999999999999999999 99999999999999999999999999999865432211 11123445788
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcch
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~ 186 (202)
|+|||.+....++.++|+||+|++++||++ |+.||...
T Consensus 166 y~~pE~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~ 204 (257)
T cd05040 166 WCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGL 204 (257)
T ss_pred ecCHHHhcccCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 999999988889999999999999999998 99999644
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.8e-28 Score=189.01 Aligned_cols=157 Identities=23% Similarity=0.340 Sum_probs=127.6
Q ss_pred ccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 30 IRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
..+..|.......+|++++. ..+...++++++++++|.+++.. ..+++..+..++.|++.||.|||+ +++
T Consensus 54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~i 130 (279)
T cd05057 54 KEILDEAYVMASVDHPHVVRLLGICLSSQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEE---KRL 130 (279)
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEecCceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh---CCE
Confidence 34566666777778887653 23556788999999999988865 358999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRR 181 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~ 181 (202)
+||||||+||+++.++.++|+|||+++...............++..|+|||.+....++.++|+||||++++|+++ |+.
T Consensus 131 ~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~~g~~ 210 (279)
T cd05057 131 VHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMTFGAK 210 (279)
T ss_pred EecccCcceEEEcCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999986543322222222233568999999988889999999999999999998 999
Q ss_pred CCcchhcc
Q 044746 182 NLEKEISE 189 (202)
Q Consensus 182 p~~~~~~~ 189 (202)
||.....+
T Consensus 211 p~~~~~~~ 218 (279)
T cd05057 211 PYEGIPAV 218 (279)
T ss_pred CCCCCCHH
Confidence 99875543
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=6.6e-28 Score=188.51 Aligned_cols=184 Identities=20% Similarity=0.167 Sum_probs=139.0
Q ss_pred CCccccCCCcceeehhhhchhhhh--ccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM--EMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++.+...+..++.|..+..... .......+..|.......+|++++.. .....++++++++++|...+
T Consensus 18 vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l 97 (266)
T cd06651 18 VYLCYDVDTGRELAAKQVQFDPESPETSKEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQL 97 (266)
T ss_pred EEEEEEcCCCcEEEEEEeecCcCCchhHHHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHH
Confidence 577877776667776654322111 11122345666667777788887632 23345678888999998877
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCCc
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTPG 148 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~~ 148 (202)
.. ..+++.....++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ........++..
T Consensus 98 ~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (266)
T cd06651 98 KAYGALTESVTRKYTRQILEGMSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPY 174 (266)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCCCccccccccccCCccccCCcccc
Confidence 54 468999999999999999999999 9999999999999999999999999999875432111 111122446889
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||.+.+..++.++|+||+||+++|+++|+.||....
T Consensus 175 y~aPE~~~~~~~~~~~Dv~slG~i~~el~~g~~pf~~~~ 213 (266)
T cd06651 175 WMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWAEYE 213 (266)
T ss_pred ccCHHHhCCCCCCchhhhHHHHHHHHHHHHCCCCccccc
Confidence 999999988889999999999999999999999997543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=99.95 E-value=1e-27 Score=188.84 Aligned_cols=155 Identities=17% Similarity=0.300 Sum_probs=124.4
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC----------------CCCHHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN----------------ILGFGQLREIEVSTS 88 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~----------------~~~~~~~~~~~~~i~ 88 (202)
.+..|.......+|++++. .++...++++++.+++|..++... .+++..+..++.|++
T Consensus 53 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~ 132 (280)
T cd05092 53 DFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLAIASQIA 132 (280)
T ss_pred HHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHHHHHHHH
Confidence 4566666667778887653 334566888999999998877542 478999999999999
Q ss_pred HHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHH
Q 044746 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFS 168 (202)
Q Consensus 89 ~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws 168 (202)
.|+.|||+ .+++||||||+||+++.++.++|+|||++................+++.|+|||.+.+..++.++|+||
T Consensus 133 ~al~~LH~---~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 209 (280)
T cd05092 133 SGMVYLAS---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDIWS 209 (280)
T ss_pred HHHHHHHH---CCeecccccHhhEEEcCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCchhhHHH
Confidence 99999999 999999999999999999999999999987553322211222233467899999999888999999999
Q ss_pred HHHHHHHHHc-CCCCCcchhc
Q 044746 169 FGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 169 ~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||+++||++ |++||.....
T Consensus 210 lG~il~el~~~g~~p~~~~~~ 230 (280)
T cd05092 210 FGVVLWEIFTYGKQPWYQLSN 230 (280)
T ss_pred HHHHHHHHHcCCCCCCccCCH
Confidence 9999999998 9999965443
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=188.44 Aligned_cols=182 Identities=19% Similarity=0.200 Sum_probs=140.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.++.|....... .......+..|..+....+|++++. .+....+++++++++.+..+... .
T Consensus 17 v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 95 (286)
T cd07847 17 VFKCRNRETGQIVAIKKFVESED-DPVIKKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPR 95 (286)
T ss_pred EEEEEECCCCcEEEEEEEeeccc-CccccHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCC
Confidence 57888887777777765432211 1112233556666777778887653 33445688899999888877644 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ......++..|+|||
T Consensus 96 ~~~~~~~~~~~~ql~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~aPE 170 (286)
T cd07847 96 GVPEHLIKKIIWQTLQAVNFCHK---HNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD--DYTDYVATRWYRAPE 170 (286)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCChhhEEEcCCCcEEECccccceecCCCcc--cccCcccccccCCHH
Confidence 69999999999999999999999 9999999999999999999999999999986543321 112334678899999
Q ss_pred ccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+.+ ..++.++|+||+|+++++|++|++||.+..+
T Consensus 171 ~~~~~~~~~~~~Di~slG~i~~~l~~g~~p~~~~~~ 206 (286)
T cd07847 171 LLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSD 206 (286)
T ss_pred HHhCCCCcCchhhhHHHHHHHHHHHhCCCCCCCCCh
Confidence 9876 4578899999999999999999999976554
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.8e-28 Score=189.56 Aligned_cols=154 Identities=19% Similarity=0.284 Sum_probs=124.6
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-----------CCCCHHHHHHHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------NILGFGQLREIEVSTSKGIAY 93 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~ 93 (202)
.+..+.......+|++++. .+....++++++++++|..++.. ..+++..+..++.|++.||.|
T Consensus 55 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~ 134 (277)
T cd05032 55 EFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIADGMAY 134 (277)
T ss_pred HHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHHHHHH
Confidence 4555666666778887653 34557788999999999888743 237888999999999999999
Q ss_pred HHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHH
Q 044746 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLL 173 (202)
Q Consensus 94 lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l 173 (202)
||+ .+++||||||+||+++.++.++|+|||+++...............++..|+|||.+....++.++|+||||+++
T Consensus 135 lH~---~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 211 (277)
T cd05032 135 LAA---KKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVL 211 (277)
T ss_pred HHh---CCccccccChheEEEcCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHHHHHH
Confidence 999 99999999999999999999999999998765433222222333457889999999888899999999999999
Q ss_pred HHHHc-CCCCCcchh
Q 044746 174 FEVVG-RRRNLEKEI 187 (202)
Q Consensus 174 ~el~~-g~~p~~~~~ 187 (202)
+|+++ |++||....
T Consensus 212 ~el~t~g~~p~~~~~ 226 (277)
T cd05032 212 WEMATLAEQPYQGLS 226 (277)
T ss_pred HHhhccCCCCCccCC
Confidence 99998 999997544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=99.95 E-value=7.5e-28 Score=190.47 Aligned_cols=156 Identities=24% Similarity=0.334 Sum_probs=126.1
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-------------------------CCCCHH
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-------------------------NILGFG 78 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-------------------------~~~~~~ 78 (202)
..+..|.......+|++++. ..+...++++++.+++|..++.. ..+++.
T Consensus 48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 127 (290)
T cd05045 48 RDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERALTMG 127 (290)
T ss_pred HHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCccccccCHH
Confidence 34666766777788898763 44556788999999999887632 247889
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCC
Q 044746 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY 158 (202)
Q Consensus 79 ~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~ 158 (202)
.+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+.
T Consensus 128 ~~~~i~~~i~~~l~~LH~---~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~ 204 (290)
T cd05045 128 DLISFAWQISRGMQYLAE---MKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDH 204 (290)
T ss_pred HHHHHHHHHHHHHHHHHH---CCeehhhhhhheEEEcCCCcEEeccccccccccCccchhcccCCCCCccccCHHHHccC
Confidence 999999999999999999 99999999999999999999999999999754332222222233456789999999888
Q ss_pred CCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 159 SVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 159 ~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
.++.++|+||||++++||++ |+.||.+..+
T Consensus 205 ~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 235 (290)
T cd05045 205 IYTTQSDVWSFGVLLWEIVTLGGNPYPGIAP 235 (290)
T ss_pred CcchHhHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 89999999999999999998 9999976544
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-28 Score=195.48 Aligned_cols=176 Identities=24% Similarity=0.374 Sum_probs=138.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHH--hccccccc---c---c----cccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIA--ADNFSNLV---G---S----EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~i---~---~----~~~~~~~~~~~~~~~l~~ 68 (202)
||||...+ +.||+|+-...+..+ |+.|..+-. ...|+||+ + . ....+++++|.+.|+|.+
T Consensus 226 V~KaqL~~--~~VAVKifp~~~kqs------~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~d 297 (534)
T KOG3653|consen 226 VWKAQLDN--RLVAVKIFPEQEKQS------FQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCD 297 (534)
T ss_pred eehhhccC--ceeEEEecCHHHHHH------HHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHH
Confidence 67777665 889999876655443 333322222 22444544 2 1 224569999999999999
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCC------CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEEC------RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~------~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
+++.+.++|.+..+++..+++||+|||+.. +.+|+|||||..|||+.+++.+.|+|||+|..+..........+
T Consensus 298 yL~~ntisw~~~cria~SmarGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~~d~~~ 377 (534)
T KOG3653|consen 298 YLKANTISWNSLCRIAESMARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQGDTHG 377 (534)
T ss_pred HHHhccccHHHHHHHHHHHHHHHHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCCcchhh
Confidence 999999999999999999999999999854 46899999999999999999999999999998776655555566
Q ss_pred CCCCCcccCCcccCCC-CCC-----chhhHHHHHHHHHHHHcCCCCCc
Q 044746 143 RRRTPGCEAPELWMPY-SVT-----QKCDVFSFGMLLFEVVGRRRNLE 184 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~-~~~-----~~~Diws~G~~l~el~~g~~p~~ 184 (202)
.+||.+|||||++.+. .+. .+.||||+|.++||++++-.-++
T Consensus 378 qVGT~RYMAPEvLEgainl~d~~Afkr~DvYamgLVLWEi~SRC~~~~ 425 (534)
T KOG3653|consen 378 QVGTRRYMAPEVLEGAINLQDRDAFKRIDVYAMGLVLWEIASRCTDAD 425 (534)
T ss_pred hhhhhhhcCHHHHhhhcccccHHHHHHHHHHHHHHHHHHHHhhccccc
Confidence 8999999999999763 222 45899999999999998765554
|
|
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.7e-27 Score=184.82 Aligned_cols=181 Identities=21% Similarity=0.303 Sum_probs=137.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc---c----cccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG---S----EDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~---~----~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.++.|...... ........+..+.......+|++++. . .....++++++++++|..++..
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~ 94 (257)
T cd08223 16 VSLVRHRTDGKQYVIKKLNLRN-ASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQ 94 (257)
T ss_pred EEEEEEcCCCcEEEEEEEehhh-cCHHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHh
Confidence 5677777666666655432211 11112233555556666677887653 1 2234578889999999887743
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++.++..++.+++.|+.+||+ .+++|+||||+||+++.++.++|+|||++........ ......+++.|+
T Consensus 95 ~~~~l~~~~~~~~~~~l~~~l~~lH~---~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~y~ 169 (257)
T cd08223 95 KGKLLPENQVVEWFVQIAMALQYLHE---KHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQCD--MASTLIGTPYYM 169 (257)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCchhEEEecCCcEEEecccceEEecccCC--ccccccCCcCcc
Confidence 358999999999999999999999 9999999999999999999999999999986533221 123345688999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||++.+..++.++|+||+|++++++++|+.||....
T Consensus 170 aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 206 (257)
T cd08223 170 SPELFSNKPYNYKSDVWALGCCVYEMATLKHAFNAKD 206 (257)
T ss_pred ChhHhcCCCCCchhhhHHHHHHHHHHHcCCCCCCCCC
Confidence 9999998888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=190.67 Aligned_cols=155 Identities=25% Similarity=0.338 Sum_probs=122.9
Q ss_pred cCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-----------------CCCCHHHHHHHHHH
Q 044746 31 RFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------------NILGFGQLREIEVS 86 (202)
Q Consensus 31 ~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~ 86 (202)
.+..|....... +|++++. ......++++++.+++|..++.. ..+++..+..++.|
T Consensus 66 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~q 145 (304)
T cd05101 66 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLVSCTYQ 145 (304)
T ss_pred HHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHHHHHHH
Confidence 445554444444 6777653 34456789999999999888743 24788899999999
Q ss_pred HHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhH
Q 044746 87 TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDV 166 (202)
Q Consensus 87 i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Di 166 (202)
++.||.|||+ ++++||||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|+
T Consensus 146 i~~al~~LH~---~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 222 (304)
T cd05101 146 VARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 222 (304)
T ss_pred HHHHHHHHHH---CCeeecccccceEEEcCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCCchhhH
Confidence 9999999999 9999999999999999999999999999986644332222233345678999999988889999999
Q ss_pred HHHHHHHHHHHc-CCCCCcchhc
Q 044746 167 FSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 167 ws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||||++++++++ |..||.....
T Consensus 223 ~slG~~l~el~~~g~~p~~~~~~ 245 (304)
T cd05101 223 WSFGVLMWEIFTLGGSPYPGIPV 245 (304)
T ss_pred HHHHHHHHHHHcCCCCCcccCCH
Confidence 999999999998 8888865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=99.95 E-value=8.1e-28 Score=189.19 Aligned_cols=182 Identities=17% Similarity=0.203 Sum_probs=135.1
Q ss_pred CCccccCC----CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRG----STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~----~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++.+.. ....|+.|..+.. ........+..|.......+|++++. .+....++.++..+++|..+
T Consensus 22 V~~~~~~~~~~~~~~~v~~k~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~ 99 (280)
T cd05043 22 IFYGILIDEKPGKEEEVFVKTVKDH--ASEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLF 99 (280)
T ss_pred EEEEEEecCCCCceeEEEEEEccCC--CCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHH
Confidence 45555543 2455555543321 11122334555666666778888653 23445677888888999888
Q ss_pred hcc---------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccccc
Q 044746 70 CKK---------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS 140 (202)
Q Consensus 70 ~~~---------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~ 140 (202)
+.. ..+++..+..++.|++.||+|||+ ++++|+||||+||+++.++.++++|||+++.+.........
T Consensus 100 l~~~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~LH~---~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~ 176 (280)
T cd05043 100 LQQCRLGEANNPQALSTQQLVHMAIQIACGMSYLHK---RGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYHCLG 176 (280)
T ss_pred HHhccccccccccCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceEEeC
Confidence 744 458999999999999999999999 99999999999999999999999999999865333222222
Q ss_pred CCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 141 TGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
....++..|+|||++.+..++.++||||+|++++|+++ |+.||....
T Consensus 177 ~~~~~~~~y~apE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 224 (280)
T cd05043 177 DNENRPVKWMALESLVNKEYSSASDVWSFGVLLWELMTLGQTPYVEID 224 (280)
T ss_pred CCCCcchhccCHHHHhcCCCCchhhHHHhHHHHHHHhcCCCCCcCcCC
Confidence 23345678999999988889999999999999999999 999997644
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=185.05 Aligned_cols=179 Identities=21% Similarity=0.321 Sum_probs=133.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++.....+ +.|+...... ....+..|.......+|++++. ..+...++++++++++|.+++..
T Consensus 20 v~~~~~~~~~~~-~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 94 (256)
T cd05059 20 VHLGKWRGKIDV-AIKMIREGAM----SEDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERK 94 (256)
T ss_pred EEEeEecCCccE-EEEEeccCCC----CHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcc
Confidence 566666544444 4443221111 1123445655666677887662 33456688889999999988754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||+++........ ......++..|+||
T Consensus 95 ~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~y~~P 170 (256)
T cd05059 95 GKLGTEWLLDMCSDVCEAMEYLES---NGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQYT-SSQGTKFPVKWAPP 170 (256)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---CCcccccccHhhEEECCCCcEEECCcccceeccccccc-ccCCCCCCccccCH
Confidence 358999999999999999999999 99999999999999999999999999998765432211 11122234579999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||||+++||+++ |+.||....+
T Consensus 171 e~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 207 (256)
T cd05059 171 EVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSN 207 (256)
T ss_pred HHhccCCCCchhhHHHHHHHHHHHhccCCCCCCCCCH
Confidence 99998889999999999999999999 8999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.6e-27 Score=185.45 Aligned_cols=179 Identities=22% Similarity=0.234 Sum_probs=140.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..++..++.|+....... ....+..|.......+|++++. .+...++++++..+++|..+...
T Consensus 19 v~~~~~~~~~~~~~ik~~~~~~~~---~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~ 95 (262)
T cd06613 19 VYKARDIATGELVAIKVIKLEPGD---DFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTR 95 (262)
T ss_pred EEEeEecCCCCEEEEEEEEcCchh---hHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhc
Confidence 567777766677777665432211 2345666666777788888763 34445678889999999887754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..++..++..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++........ ......++..|+||
T Consensus 96 ~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~~P 170 (262)
T cd06613 96 GPLSELQIAYVCRETLKGLAYLHE---TGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATIA--KRKSFIGTPYWMAP 170 (262)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCceecCCChhhEEECCCCCEEECccccchhhhhhhh--ccccccCCccccCc
Confidence 479999999999999999999999 9999999999999999999999999999876443211 12234568889999
Q ss_pred cccCCC---CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPY---SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~---~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+... .++.++|+||+|++++||++|++||....
T Consensus 171 e~~~~~~~~~~~~~~Di~slG~~l~~~~tg~~p~~~~~ 208 (262)
T cd06613 171 EVAAVERKGGYDGKCDIWALGITAIELAELQPPMFDLH 208 (262)
T ss_pred hhhcccccCCcCchhhhHHHHHHHHHHHhCCCCCCCCC
Confidence 998776 78899999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=190.57 Aligned_cols=180 Identities=18% Similarity=0.280 Sum_probs=136.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.|+.|..+.... ......+..|.......+|++++. ......++++++. ++|..++..
T Consensus 22 vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~ 98 (301)
T cd07873 22 VYKGRSKLTDNLVALKEIRLEHE--EGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG 98 (301)
T ss_pred EEEEEEcCCCcEEEEEEEecccc--cCchhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcC
Confidence 68888888888888776432211 112233455667777788888763 3344567888887 467666543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ......+++.|+||
T Consensus 99 ~~~~~~~~~~~~~qi~~aL~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~~P 173 (301)
T cd07873 99 NSINMHNVKLFLFQLLRGLNYCHR---RKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYSNEVVTLWYRPP 173 (301)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCCC--cccccceeecccCc
Confidence 458999999999999999999999 9999999999999999999999999999875432221 11233458899999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+.+. .++.++|+||+|++++||++|++||.....
T Consensus 174 E~~~~~~~~~~~~Dv~slG~~l~el~tg~~~f~~~~~ 210 (301)
T cd07873 174 DILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTV 210 (301)
T ss_pred HHHhCCCCCccHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 988654 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.8e-28 Score=186.08 Aligned_cols=171 Identities=19% Similarity=0.243 Sum_probs=129.4
Q ss_pred cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc---c-------ccccceEEEEEccCCchhhhhccC--
Q 044746 6 NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV---G-------SEDTETYIKGFLAMGPFYLLCKKN-- 73 (202)
Q Consensus 6 ~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i---~-------~~~~~~~~~~~~~~~~l~~~~~~~-- 73 (202)
++.+++-.|.|+........ ..-+.......|++++ . .-...-++++.++||.|+..+..+
T Consensus 83 ~k~T~ekfALKvL~Ds~KAR-------rEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~ 155 (400)
T KOG0604|consen 83 HKRTQEKFALKVLLDSPKAR-------REVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGD 155 (400)
T ss_pred eccchhhhHHHHHhcCHHHH-------hHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHccc
Confidence 44455555555554433332 2223334455566554 2 223344889999999998877543
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.+++.++..|+.||+.|+.|||+ .+|.||||||+|+|... +..+||+|||.|+....... ....+-||.|
T Consensus 156 ~afTErea~eI~~qI~~Av~~lH~---~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~---L~TPc~TPyY 229 (400)
T KOG0604|consen 156 QAFTEREASEIMKQIGLAVRYLHS---MNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGD---LMTPCFTPYY 229 (400)
T ss_pred ccchHHHHHHHHHHHHHHHHHHHh---cchhhccCChhheeeecCCCCcceEecccccccccCCCcc---ccCCcccccc
Confidence 49999999999999999999999 99999999999999964 56789999999986543222 3344559999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.|||++....|+..+|+||+|+++|-|+-|.+||.+....
T Consensus 230 vaPevlg~eKydkscdmwSlgVimYIlLCGyPPFYS~hg~ 269 (400)
T KOG0604|consen 230 VAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 269 (400)
T ss_pred cCHHHhCchhcCCCCCccchhHHHHHhhcCCCcccccCCc
Confidence 9999999989999999999999999999999999876553
|
|
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=186.86 Aligned_cols=183 Identities=20% Similarity=0.231 Sum_probs=139.4
Q ss_pred CCccccCCCcceeehhhhchhhhhc------cCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME------MDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
||++.+...+..++.|......... .+....+..|..+....+|++++. ......+++++.++++|..
T Consensus 16 v~~a~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 95 (267)
T cd06628 16 VYLGMNASSGELMAVKQVELPSVSASSKDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAA 95 (267)
T ss_pred EEEEEecCCCcEEEEEEecCCCcccchhHHHHHHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHH
Confidence 5777776666666665432221111 111234556666777778887653 3445668889999999988
Q ss_pred hhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc----ccCCC
Q 044746 69 LCKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI----TSTGR 143 (202)
Q Consensus 69 ~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~----~~~~~ 143 (202)
++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.++......... .....
T Consensus 96 ~l~~~~~l~~~~~~~~~~~l~~~l~~lH~---~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~ 172 (267)
T cd06628 96 LLNNYGAFEETLVRNFVRQILKGLNYLHN---RGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSL 172 (267)
T ss_pred HHHhccCccHHHHHHHHHHHHHHHHHHHh---cCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCcccccccc
Confidence 8865 468999999999999999999999 999999999999999999999999999988654221111 11123
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
.|+..|+|||.+.+..++.++|+||+|++++++++|+.||...
T Consensus 173 ~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 215 (267)
T cd06628 173 QGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDC 215 (267)
T ss_pred CCCcCccChhHhccCCCCchhhhHHHHHHHHHHhhCCCCCCCc
Confidence 4688999999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=186.14 Aligned_cols=185 Identities=19% Similarity=0.274 Sum_probs=143.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.++.|+..............+..|.......+|++++. .+...+++++++.+++|..++.. +
T Consensus 9 vy~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 88 (265)
T cd05579 9 VFLAKKKSTGDIYAIKVIKKADMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVG 88 (265)
T ss_pred EEEEEECCCCCEEEEEEecchhhhhhhHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcC
Confidence 5788888777777777654433322233445666666666777887653 34556688899999999888765 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc------ccccCCCCCCC
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT------HITSTGRRRTP 147 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~------~~~~~~~~gt~ 147 (202)
.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ........++.
T Consensus 89 ~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~ 165 (265)
T cd05579 89 SLDEDVARIYIAEIVLALEYLHS---NGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTP 165 (265)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCc
Confidence 68999999999999999999999 9999999999999999999999999999875432211 01122345678
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|++||.......+.++|+||+|++++++++|+.||.....
T Consensus 166 ~~~~Pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~~ 206 (265)
T cd05579 166 DYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206 (265)
T ss_pred cccCHHHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 89999999888888999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.1e-27 Score=185.24 Aligned_cols=181 Identities=18% Similarity=0.265 Sum_probs=141.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++.+..+++.++.|..+...........++..|.......+|++++. ......++++++++++|..++.
T Consensus 18 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 97 (267)
T cd08224 18 VYKAICLLDGRVVALKKVQIFEMMDAKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFK 97 (267)
T ss_pred EEEEEEcCCCCEEEEEEeecccccchhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhc
Confidence 5777787677777776544333332233445666666677778887652 3345668899999999987763
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
...+++.++..++.+++.||.|||+ .+++|+||+|+||+++.++.++++|||++........ ......+++.|
T Consensus 98 ~~~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y 172 (267)
T cd08224 98 KQKRLIPERTIWKYFVQLCSALEHMHS---KRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYY 172 (267)
T ss_pred ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc--ccceecCCccc
Confidence 2458999999999999999999999 9999999999999999999999999999876433221 11224568889
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
+|||.+.+..++.++|+||+|++++++++|+.||...
T Consensus 173 ~apE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 209 (267)
T cd08224 173 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 209 (267)
T ss_pred cCHHHhccCCCCchhcHHHHHHHHHHHHHCCCCcccC
Confidence 9999998888999999999999999999999999654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.4e-27 Score=186.51 Aligned_cols=183 Identities=18% Similarity=0.146 Sum_probs=139.9
Q ss_pred CCccccCCCcceeehhhhchhhh--hccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDA--MEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++...+..++.|....... ........+..|.......+|++++.. +....+++++.++++|..++
T Consensus 18 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 97 (264)
T cd06653 18 VYLCYDADTGRELAVKQVPFDPDSQETSKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQL 97 (264)
T ss_pred EEEEEEcCCCCEEEEEEEecCcccchhhHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHH
Confidence 57788877777777775422111 111223356666667777788877631 23345688899999998877
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCCc
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTPG 148 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~~ 148 (202)
.. ..+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++....... ........++..
T Consensus 98 ~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (264)
T cd06653 98 KAYGALTENVTRRYTRQILQGVSYLHS---NMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPY 174 (264)
T ss_pred HHcCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECccccccccccccccCccccccCCccc
Confidence 54 568999999999999999999999 9999999999999999999999999999975432111 111123457889
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|+|||++.+..++.++|+||+|++++++++|++||...
T Consensus 175 y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 212 (264)
T cd06653 175 WMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWAEY 212 (264)
T ss_pred ccCHhhhcCCCCCccccHHHHHHHHHHHHhCCCCCCcc
Confidence 99999998888899999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=187.30 Aligned_cols=155 Identities=15% Similarity=0.201 Sum_probs=118.7
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCC
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN-----ILGFGQLREIEVSTSKGIAYLHEEC 98 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~ 98 (202)
..|..+.......+|++++. ......++++++++++|..++... ..+...+..++.|++.||.|||+
T Consensus 40 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~-- 117 (268)
T cd05086 40 NEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMHK-- 117 (268)
T ss_pred HHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHHH--
Confidence 34555555666778888763 234457899999999998887542 35667788999999999999999
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCC-------CCCCchhhHHHHHH
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMP-------YSVTQKCDVFSFGM 171 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~-------~~~~~~~Diws~G~ 171 (202)
.+++||||||+||+++.++.++|+|||++................++..|+|||++.. ..++.++|+||||+
T Consensus 118 -~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~ 196 (268)
T cd05086 118 -HNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWALGV 196 (268)
T ss_pred -CCeeccCCccceEEEcCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHHHHH
Confidence 9999999999999999999999999998864222111112233456889999998743 24578899999999
Q ss_pred HHHHHHc-CCCCCcchh
Q 044746 172 LLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 172 ~l~el~~-g~~p~~~~~ 187 (202)
+++||++ |.+||....
T Consensus 197 ~l~el~~~~~~p~~~~~ 213 (268)
T cd05086 197 TLWELFENAAQPYSHLS 213 (268)
T ss_pred HHHHHHhCCCCCCCCCC
Confidence 9999997 577886543
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=186.76 Aligned_cols=182 Identities=20% Similarity=0.314 Sum_probs=137.3
Q ss_pred CCccccCCC---cceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGS---TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~---~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+++.... ...|+.|+.+... .......|..|.......+|++++. ..+...++++++++++|..++.
T Consensus 20 vy~~~~~~~~~~~~~vaik~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~ 97 (266)
T cd05033 20 VCRGRLKLPGKKEIDVAIKTLKAGS--SDKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLR 97 (266)
T ss_pred EEEEEEccCCCCcceEEEEEcCCCC--ChHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHH
Confidence 566665432 3455655543221 1112234555666677778887653 3455678899999999998875
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 K--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 ~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
. ..+++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++++|||++................++..|
T Consensus 98 ~~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y 174 (266)
T cd05033 98 ENDGKFTVGQLVGMLRGIASGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRW 174 (266)
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCCEEECccchhhcccccccceeccCCCCCccc
Confidence 4 468999999999999999999999 99999999999999999999999999999876422222222223346789
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
+|||.+.+..++.++|+||||++++++++ |..||....
T Consensus 175 ~~Pe~~~~~~~~~~~Dv~slG~~l~~l~~~g~~p~~~~~ 213 (266)
T cd05033 175 TAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMS 213 (266)
T ss_pred cChhhhccCCCccccchHHHHHHHHHHHccCCCCCCCCC
Confidence 99999998889999999999999999998 999986543
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.2e-27 Score=188.15 Aligned_cols=181 Identities=22% Similarity=0.205 Sum_probs=144.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++.+...+..++.|+.+.... ......+..|.......+|++++. ......++++++.+++|..++..+.
T Consensus 20 vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~ 97 (277)
T cd06640 20 VFKGIDNRTQQVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRAGP 97 (277)
T ss_pred EEEEEEccCCEEEEEEEEecccc--HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhcCC
Confidence 57788877777777776442211 112234666666667778887652 3455678899999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++........ ......++..|+|||+
T Consensus 98 l~~~~~~~~~~~l~~~l~~lh~---~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~apE~ 172 (277)
T cd06640 98 FDEFQIATMLKEILKGLDYLHS---EKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEV 172 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCccCcCCChhhEEEcCCCCEEEcccccceeccCCcc--ccccccCcccccCHhH
Confidence 9999999999999999999999 9999999999999999999999999999976543221 1223356888999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+..++.++|+||||++++||++|++||....+
T Consensus 173 ~~~~~~~~~~Dv~slG~il~el~tg~~p~~~~~~ 206 (277)
T cd06640 173 IQQSAYDSKADIWSLGITAIELAKGEPPNSDMHP 206 (277)
T ss_pred hccCCCccHHHHHHHHHHHHHHHHCCCCCCCcCh
Confidence 9888899999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.3e-27 Score=190.89 Aligned_cols=179 Identities=21% Similarity=0.252 Sum_probs=140.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..++..+++|...... ..+...++..|.......+|++++. ..+...++++++++++|..++.. .
T Consensus 17 v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~ 94 (308)
T cd06615 17 VTKVLHRPSGLIMARKLIHLEI--KPAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 94 (308)
T ss_pred EEEEEEcCCCeEEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcC
Confidence 5777777777777776643221 1112234556666777778888763 34566788999999999888754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++++|||++....... .....|++.|+|||
T Consensus 95 ~~~~~~~~~~~~~i~~~l~~lH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~aPE 168 (308)
T cd06615 95 RIPENILGKISIAVLRGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPE 168 (308)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhh--CCEEECCCChHHEEEecCCcEEEccCCCcccccccc----cccCCCCcCccChh
Confidence 689999999999999999999971 589999999999999999999999999987543221 23345788999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.+.+..++.++|+||||++++++++|+.||....
T Consensus 169 ~~~~~~~~~~~DiwslG~~l~~l~~g~~p~~~~~ 202 (308)
T cd06615 169 RLQGTHYTVQSDIWSLGLSLVEMAIGRYPIPPPD 202 (308)
T ss_pred HhcCCCCCccchHHHHHHHHHHHHhCCCCCCCcc
Confidence 9988888999999999999999999999997543
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=184.30 Aligned_cols=154 Identities=21% Similarity=0.363 Sum_probs=125.6
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
.+..|.......+|++++. ......+++++.++++|..+... ..+++..+..++.|++.||.|||+ +++
T Consensus 45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i 121 (256)
T cd05114 45 DFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLER---NSF 121 (256)
T ss_pred HHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 4566777777788888653 33445688999999999988753 458999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRR 181 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~ 181 (202)
+||||||+||+++.++.++++|||.++........ ......++..|+|||.+.+..++.++|+||||++++|+++ |++
T Consensus 122 ~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~~ 200 (256)
T cd05114 122 IHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEYT-SSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKM 200 (256)
T ss_pred cccccCcceEEEcCCCeEEECCCCCccccCCCcee-ccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998754332211 1122234568999999988889999999999999999999 999
Q ss_pred CCcchhc
Q 044746 182 NLEKEIS 188 (202)
Q Consensus 182 p~~~~~~ 188 (202)
||.....
T Consensus 201 p~~~~~~ 207 (256)
T cd05114 201 PFEKKSN 207 (256)
T ss_pred CCCCCCH
Confidence 9976554
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=189.65 Aligned_cols=154 Identities=23% Similarity=0.346 Sum_probs=124.5
Q ss_pred cCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 044746 31 RFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQ 100 (202)
Q Consensus 31 ~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~ 100 (202)
.+..|....... +|++++. ..+...++++++.+++|..++... .+++.++..++.|++.||.|||+ +
T Consensus 84 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH~---~ 160 (302)
T cd05055 84 ALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLAS---K 160 (302)
T ss_pred HHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHH---C
Confidence 455565666666 7888763 334456888999999999888543 28999999999999999999999 9
Q ss_pred CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-C
Q 044746 101 KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-R 179 (202)
Q Consensus 101 ~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g 179 (202)
+++|+||||+||+++.++.++++|||+++...............++..|+|||.+.+..++.++|+||+|++++|+++ |
T Consensus 161 ~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~t~g 240 (302)
T cd05055 161 NCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLG 240 (302)
T ss_pred CeehhhhccceEEEcCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHHHHhCC
Confidence 999999999999999999999999999986543322111222345678999999988889999999999999999998 9
Q ss_pred CCCCcchh
Q 044746 180 RRNLEKEI 187 (202)
Q Consensus 180 ~~p~~~~~ 187 (202)
..||....
T Consensus 241 ~~p~~~~~ 248 (302)
T cd05055 241 SNPYPGMP 248 (302)
T ss_pred CCCcCCCC
Confidence 99987544
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.3e-27 Score=183.93 Aligned_cols=178 Identities=20% Similarity=0.249 Sum_probs=140.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||+++...++..++.|..+.... ...+..|.......+|++++. .....++++++..+++|..++. .
T Consensus 19 v~~~~~~~~~~~~~~k~~~~~~~-----~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~ 93 (256)
T cd06612 19 VYKAIHKETGQVVAIKVVPVEED-----LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITN 93 (256)
T ss_pred EEEEEEcCCCcEEEEEEeecHHH-----HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCc
Confidence 46777776666666655433221 345666666667778887653 3345668899999999988875 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.|+.|||+ .+++|+|++|+||+++.++.++|+|||++........ ......++..|+||
T Consensus 94 ~~l~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~P 168 (256)
T cd06612 94 KTLTEEEIAAILYQTLKGLEYLHS---NKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA--KRNTVIGTPFWMAP 168 (256)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEECCCCcEEEcccccchhcccCcc--ccccccCCccccCH
Confidence 568999999999999999999999 9999999999999999999999999999886543321 11223468899999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|+++++|++|++||....+
T Consensus 169 E~~~~~~~~~~~Di~s~G~il~~l~~g~~p~~~~~~ 204 (256)
T cd06612 169 EVIQEIGYNNKADIWSLGITAIEMAEGKPPYSDIHP 204 (256)
T ss_pred HHHhcCCCCchhhHHHHHHHHHHHHhCCCCCCCcch
Confidence 999888899999999999999999999999976543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.2e-27 Score=183.99 Aligned_cols=179 Identities=26% Similarity=0.382 Sum_probs=135.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccC--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKN-- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~-- 73 (202)
||++.+.++.+++.+.+. ... .....+..|.......+|++++. ......++++++.+++|..+....
T Consensus 22 v~~~~~~~~~~~~lK~~~-~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~ 96 (260)
T cd05069 22 VWMGTWNGTTKVAIKTLK-PGT----MMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEPIYIVTEFMGKGSLLDFLKEGDG 96 (260)
T ss_pred EEEEEEcCCceEEEEEcc-cCC----ccHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCcEEEEEcCCCCCHHHHHhhCCC
Confidence 567776665554433332 111 11234556666777778887652 233456888899999998888543
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... ......++..|+||
T Consensus 97 ~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~P 172 (260)
T cd05069 97 KYLKLPQLVDMAAQIADGMAYIER---MNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAP 172 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccCcceEEEcCCCeEEECCCccceEccCCccc-ccCCCccchhhCCH
Confidence 38899999999999999999999 99999999999999999999999999999765432211 11223346789999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|...+..++.++|+||+|++++|+++ |+.||....+
T Consensus 173 e~~~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~ 209 (260)
T cd05069 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVN 209 (260)
T ss_pred HHhccCCcChHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99988889999999999999999999 9999976544
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=182.06 Aligned_cols=170 Identities=18% Similarity=0.186 Sum_probs=132.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.++.|..+... .+..+........|++++. ......++++++++++|.+++.. .
T Consensus 9 v~~~~~~~~~~~~~~K~i~~~~--------~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 80 (237)
T cd05576 9 VLLVMDTRTQQTFILKGLRKSS--------EYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFL 80 (237)
T ss_pred EEEEEEccCCcEEEEEeecchh--------hhhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhc
Confidence 6888898887777766543321 1222333333445566552 34456788999999999887643 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||.+....... ....++..|+|||
T Consensus 81 ~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~y~aPE 152 (237)
T cd05576 81 NIPEECVKRWAAEMVVALDALHR---EGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDSC-----DGEAVENMYCAPE 152 (237)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEecccchhcccccc-----ccCCcCccccCCc
Confidence 69999999999999999999999 999999999999999999999999999876543221 2233467899999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
.+....++.++|+||+|++++|+++|+.|+...
T Consensus 153 ~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~ 185 (237)
T cd05576 153 VGGISEETEACDWWSLGAILFELLTGKTLVECH 185 (237)
T ss_pred ccCCCCCCchhhHHHHHHHHHHHHHCcchhhcC
Confidence 998888899999999999999999999887643
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.8e-27 Score=186.49 Aligned_cols=181 Identities=21% Similarity=0.229 Sum_probs=138.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++.+...++.++.|......... .....+..|.......+|++++ .......++++++.++.+..+... .
T Consensus 17 vy~~~~~~~~~~~~iK~~~~~~~~~-~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 95 (286)
T cd07846 17 VMKCKHKETGQIVAIKKFLESEDDK-MVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPN 95 (286)
T ss_pred EEEEEECCCCCEEEEEeHhhccCcc-hhhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccC
Confidence 5788887777777776543322221 2233455566666777888765 234456788899999888877644 3
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......++..|+|||
T Consensus 96 ~~~~~~~~~~~~~i~~~l~~LH~---~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 170 (286)
T cd07846 96 GLDESRVRKYLFQILRGIEFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYTDYVATRWYRAPE 170 (286)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCcc--ccCcccceeeccCcH
Confidence 58999999999999999999999 9999999999999999999999999999886543221 122345688999999
Q ss_pred ccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.+. .++.++|+||||++++||++|++||....
T Consensus 171 ~~~~~~~~~~~~Dv~slG~~l~el~~g~~~~~~~~ 205 (286)
T cd07846 171 LLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDS 205 (286)
T ss_pred HhccccccCchHhHHHHHHHHHHHHcCCCCCCCCc
Confidence 98753 46789999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=187.69 Aligned_cols=179 Identities=21% Similarity=0.221 Sum_probs=137.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||++++...+..++.|+..... .+....+..+.......+|++++. ..+..++++++++++++..+.. .
T Consensus 28 vy~~~~~~~~~~~~~k~~~~~~---~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 104 (292)
T cd06644 28 VYKAKNKETGALAAAKVIETKS---EEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELD 104 (292)
T ss_pred EEEEEECCCCceEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhc
Confidence 5788887777777777654321 112334555666677778887653 3445678899999999877653 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.|+.|||+ .+++||||||+||+++.++.++|+|||++......... .....+++.|+||
T Consensus 105 ~~l~~~~~~~~~~ql~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~y~aP 179 (292)
T cd06644 105 RGLTEPQIQVICRQMLEALQYLHS---MKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTLQR--RDSFIGTPYWMAP 179 (292)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhc---CCeeecCCCcceEEEcCCCCEEEccCccceeccccccc--cceecCCccccCc
Confidence 468999999999999999999999 99999999999999999999999999988754322111 1233468899999
Q ss_pred cccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++. ...++.++|+||+||++|||++|++||....
T Consensus 180 E~~~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~ 219 (292)
T cd06644 180 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 219 (292)
T ss_pred eeeccccccCCCCCchhhhHhHHHHHHHHhcCCCCCcccc
Confidence 9985 3457889999999999999999999997644
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=185.04 Aligned_cols=183 Identities=15% Similarity=0.221 Sum_probs=138.9
Q ss_pred cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-CCCHH
Q 044746 6 NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN-ILGFG 78 (202)
Q Consensus 6 ~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~ 78 (202)
...++...|+|+-.+.+... ..+-|..-+.......|+||+. ..+..+++++.+.+|+|...+.++ .+++.
T Consensus 99 ~i~t~~EYAVKiidKq~gHs--R~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~ 176 (463)
T KOG0607|consen 99 SIQTGKEYAVKIIDKQPGHS--RSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNER 176 (463)
T ss_pred eeccchhhhhhhhhcCCchH--HHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHH
Confidence 34455555666544443332 2334666666667778888763 445567889999999988877655 59999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC---ceEEeeeecceecccc-----CcccccCCCCCCCccc
Q 044746 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF---FPKAADFGLAKLYNRE-----HTHITSTGRRRTPGCE 150 (202)
Q Consensus 79 ~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~---~~kl~dfgl~~~~~~~-----~~~~~~~~~~gt~~y~ 150 (202)
++..+.++|+.||.|||. +||.||||||+|||-.... -+||+||.+...+... .........+|+..||
T Consensus 177 EAs~vvkdia~aLdFlH~---kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfM 253 (463)
T KOG0607|consen 177 EASRVVKDIASALDFLHT---KGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFM 253 (463)
T ss_pred HHHHHHHHHHHHHHHHhh---cCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhc
Confidence 999999999999999999 9999999999999997543 4699999887643221 1222234567888999
Q ss_pred CCcccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCcchhcccccc
Q 044746 151 APELWMP-----YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193 (202)
Q Consensus 151 aPe~~~~-----~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~ 193 (202)
|||+..- .-|+.++|.||+|+++|-|+.|.+||.+....++.|
T Consensus 254 APEVVd~fv~qA~~YDKrCDlwSLGvIlYImLsGYpPFvG~Cg~dCGW 301 (463)
T KOG0607|consen 254 APEVVDVFVDQATFYDKRCDLWSLGVILYIMLSGYPPFVGHCGADCGW 301 (463)
T ss_pred chhHHhhhccccccccccccHHHHHHHHHHHHhCCCCccCccCCcCCc
Confidence 9998742 358899999999999999999999999999888766
|
|
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.9e-29 Score=211.78 Aligned_cols=163 Identities=21% Similarity=0.350 Sum_probs=138.4
Q ss_pred ccCCcccCCcHHHHHHhcccccccccccc------ceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 044746 25 EMDKPIRFTSPQRMIAADNFSNLVGSEDT------ETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHE 96 (202)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~i~~~~~------~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~ 96 (202)
.......|..|..++...+|||||.-.+. ..++.|||++|+|..+++. +.+++.+...+.++|+.|++||-+
T Consensus 670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd 749 (996)
T KOG0196|consen 670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD 749 (996)
T ss_pred cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence 33455679999999999999999854433 3488999999999999854 459999999999999999999999
Q ss_pred CCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC-cccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHH
Q 044746 97 ECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH-THITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175 (202)
Q Consensus 97 ~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~-~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~e 175 (202)
++.+||||..+|||++.+-.+|++|||+++.+.++. ...+..+-.-+.+|.|||.+..+.++.++|+||||+++||
T Consensus 750 ---m~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE 826 (996)
T KOG0196|consen 750 ---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 826 (996)
T ss_pred ---cCchhhhhhhhheeeccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence 999999999999999999999999999999765443 2222233333678999999999999999999999999999
Q ss_pred HHc-CCCCCcchhccc
Q 044746 176 VVG-RRRNLEKEISEG 190 (202)
Q Consensus 176 l~~-g~~p~~~~~~~~ 190 (202)
+++ |++|+.+.++++
T Consensus 827 VmSyGERPYWdmSNQd 842 (996)
T KOG0196|consen 827 VMSYGERPYWDMSNQD 842 (996)
T ss_pred ecccCCCcccccchHH
Confidence 886 999999887765
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.3e-27 Score=191.34 Aligned_cols=111 Identities=28% Similarity=0.408 Sum_probs=93.0
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++|||++................++..|+|||
T Consensus 175 ~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 251 (343)
T cd05103 175 VLTLEDLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPE 251 (343)
T ss_pred cCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCccCeEEEcCCCcEEEEecccccccccCcchhhcCCCCCCcceECcH
Confidence 36788899999999999999999 999999999999999999999999999987643322212222233467899999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
.+.+..++.++|+||||++++++++ |..||....
T Consensus 252 ~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 286 (343)
T cd05103 252 TIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 286 (343)
T ss_pred HhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 9988889999999999999999996 999997543
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.9e-27 Score=183.53 Aligned_cols=182 Identities=20% Similarity=0.223 Sum_probs=143.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH-HHHHHhcccccccc------ccccceEEEEEccCCchhhhh-cc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~ 72 (202)
|-.++.....++.|.|+-++.-....+...=.+.| ..-.+..|+|-++| ...-.+++.+|.++|.|.-.+ ..
T Consensus 266 vl~~~~~~t~qiyamkvvkkel~nddedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrq 345 (593)
T KOG0695|consen 266 VLLVRLKKTDQIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 345 (593)
T ss_pred hhheehcccceeeehhhHHHHhcCCcccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhh
Confidence 44677888899999888766544433332222222 23345677887766 344456889999999875544 55
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
++++++.++.+...|+.||.|||+ +|||.||||.+|+|++..|++||.|+|+++.--. ........+|||.|+||
T Consensus 346 rklpeeharfys~ei~lal~flh~---rgiiyrdlkldnvlldaeghikltdygmcke~l~--~gd~tstfcgtpnyiap 420 (593)
T KOG0695|consen 346 RKLPEEHARFYSAEICLALNFLHE---RGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLG--PGDTTSTFCGTPNYIAP 420 (593)
T ss_pred hcCcHHHhhhhhHHHHHHHHHHhh---cCeeeeeccccceEEccCCceeecccchhhcCCC--CCcccccccCCCcccch
Confidence 679999999999999999999999 9999999999999999999999999999984221 12234557889999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+.+..|...+|+|++|++++||+.|+.||+--.
T Consensus 421 eilrgeeygfsvdwwalgvlmfemmagrspfdivg 455 (593)
T KOG0695|consen 421 EILRGEEYGFSVDWWALGVLMFEMMAGRSPFDIVG 455 (593)
T ss_pred hhhcccccCceehHHHHHHHHHHHHcCCCCcceec
Confidence 99999999999999999999999999999997433
|
|
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.6e-29 Score=191.67 Aligned_cols=180 Identities=20% Similarity=0.230 Sum_probs=147.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------cccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------EDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||||.++.+++.+|.|-.... ....++..|..+....+.+.++.. ....+++++|+.-|+..+++. +
T Consensus 49 V~KAIH~EsG~v~AIK~VPV~-----sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~ 123 (502)
T KOG0574|consen 49 VHKAIHRESGHVLAIKKVPVD-----TDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARR 123 (502)
T ss_pred HHHHHHhccCcEEEEEecCcc-----chHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhc
Confidence 689999999999986543222 223445566666666666665532 234578999999999988875 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.++++.++..+.+..++||+|||. ..-||||+|..|||+..+|.+||+|||++..+.+... ....+.|||.||||
T Consensus 124 K~L~E~EIs~iL~~TLKGL~YLH~---~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTMA--KRNTVIGTPFWMAP 198 (502)
T KOG0574|consen 124 KPLSEQEISAVLRDTLKGLQYLHD---LKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAP 198 (502)
T ss_pred CCccHHHHHHHHHHHHhHHHHHHH---HHHHHhhcccccEEEcccchhhhhhccccchhhhhHH--hhCccccCcccccH
Confidence 469999999999999999999999 8899999999999999999999999999986654332 23557899999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
|++..-.|+.++||||+|++..||..|++|+.+..++-
T Consensus 199 EVI~EIGY~~~ADIWSLGITaIEMAEG~PPYsDIHPMR 236 (502)
T KOG0574|consen 199 EVIEEIGYDTKADIWSLGITAIEMAEGRPPYSDIHPMR 236 (502)
T ss_pred HHHHHhccchhhhHhhhcchhhhhhcCCCCcccccccc
Confidence 99998899999999999999999999999999888764
|
|
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.1e-27 Score=183.93 Aligned_cols=179 Identities=23% Similarity=0.326 Sum_probs=138.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++.. +..++.|+.+.... .....+..+.......+|++++. ......++++++++++|..++..
T Consensus 22 vy~~~~~~-~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 97 (261)
T cd05148 22 VWEGLWKN-RVRVAIKILKSDDL---LKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97 (261)
T ss_pred EEEeEecC-CCcEEEEeccccch---hhHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCC
Confidence 57777777 55666655433222 11234555666666777887653 44456789999999999998854
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++++|||.+.......... ....++..|+|
T Consensus 98 ~~~~~~~~~~~~~~~i~~al~~lH~---~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~~~~--~~~~~~~~~~~ 172 (261)
T cd05148 98 GQVLPVASLIDMACQVAEGMAYLEE---QNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDVYLS--SDKKIPYKWTA 172 (261)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccccCcceEEEcCCceEEEccccchhhcCCccccc--cCCCCceEecC
Confidence 358999999999999999999999 999999999999999999999999999997654332221 12334678999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||.+....++.++|+||||++++++++ |+.||.....
T Consensus 173 PE~~~~~~~~~~~DiwslG~~l~~l~~~g~~p~~~~~~ 210 (261)
T cd05148 173 PEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNN 210 (261)
T ss_pred HHHHccCCCCchhhHHHHHHHHHHHHcCCCCCCCcCCH
Confidence 999988889999999999999999998 8999976553
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=189.52 Aligned_cols=153 Identities=24% Similarity=0.329 Sum_probs=121.6
Q ss_pred CCcHHHHHHhc-cccccc------cccccceEEEEEccCCchhhhhcc-----------------CCCCHHHHHHHHHHH
Q 044746 32 FTSPQRMIAAD-NFSNLV------GSEDTETYIKGFLAMGPFYLLCKK-----------------NILGFGQLREIEVST 87 (202)
Q Consensus 32 ~~~~~~~~~~~-~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~i 87 (202)
+..|....... +|++++ ...+...++++++.+++|..++.. ..+++..+..++.|+
T Consensus 62 ~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi 141 (293)
T cd05053 62 LVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLVSFAYQV 141 (293)
T ss_pred HHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHHHHH
Confidence 44444444344 678765 244556789999999999888742 358899999999999
Q ss_pred HHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHH
Q 044746 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVF 167 (202)
Q Consensus 88 ~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diw 167 (202)
+.||.|||+ ++++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+|
T Consensus 142 ~~al~~LH~---~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 218 (293)
T cd05053 142 ARGMEFLAS---KKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVW 218 (293)
T ss_pred HHHHHHHHH---CCccccccceeeEEEcCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcCccccee
Confidence 999999999 99999999999999999999999999999865433222222223346789999999888899999999
Q ss_pred HHHHHHHHHHc-CCCCCcchh
Q 044746 168 SFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 168 s~G~~l~el~~-g~~p~~~~~ 187 (202)
||||++||+++ |..||....
T Consensus 219 slG~il~el~~~g~~p~~~~~ 239 (293)
T cd05053 219 SFGVLLWEIFTLGGSPYPGIP 239 (293)
T ss_pred ehhhHHHHHhcCCCCCCCCCC
Confidence 99999999997 999987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.1e-27 Score=183.35 Aligned_cols=179 Identities=24% Similarity=0.371 Sum_probs=135.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--- 72 (202)
||++.+..+..++++.+.... . ....+..|.......+|++++. ......++++++.+++|..+...
T Consensus 22 v~~~~~~~~~~~~~k~~~~~~-~----~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~ 96 (260)
T cd05070 22 VWMGTWNGNTKVAVKTLKPGT-M----SPESFLEEAQIMKKLRHDKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKDGEG 96 (260)
T ss_pred EEEEEecCCceeEEEEecCCC-C----CHHHHHHHHHHHHhcCCCceEEEEeEECCCCcEEEEEecCCCcHHHHHHhcCC
Confidence 567766655554444443211 1 1234666666777778887642 23345688999999999888754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.+++.||.|||+ ++++||||||+||+++.++.++|+|||++......... ......++..|+||
T Consensus 97 ~~~~~~~~~~~~~~l~~al~~lH~---~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 172 (260)
T cd05070 97 RALKLPNLVDMAAQVAAGMAYIER---MNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT-ARQGAKFPIKWTAP 172 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc-cccCCCCCccccCh
Confidence 348999999999999999999999 99999999999999999999999999999865432211 11222345679999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+....++.++|+||||++++++++ |++||.+...
T Consensus 173 E~~~~~~~~~~~Di~slG~~l~~l~~~g~~p~~~~~~ 209 (260)
T cd05070 173 EAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNN 209 (260)
T ss_pred HHHhcCCCcchhhhHHHHHHHHHHHhcCCCCCCCCCH
Confidence 99988889999999999999999999 9999976543
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.9e-27 Score=189.70 Aligned_cols=154 Identities=25% Similarity=0.338 Sum_probs=120.2
Q ss_pred CCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-----------------CCCCHHHHHHHHHHH
Q 044746 32 FTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------------NILGFGQLREIEVST 87 (202)
Q Consensus 32 ~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~i 87 (202)
+..|....... +|++++. ..+..+++++++.+++|..++.. ..+++.+++.++.|+
T Consensus 70 ~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 149 (307)
T cd05098 70 LISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLVSCAYQV 149 (307)
T ss_pred HHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHHH
Confidence 44444444443 6776652 34556788999999999888753 248899999999999
Q ss_pred HHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHH
Q 044746 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVF 167 (202)
Q Consensus 88 ~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diw 167 (202)
+.||+|||+ ++++||||||+||+++.++.++|+|||+++...............+++.|+|||.+.+..++.++|+|
T Consensus 150 ~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dvw 226 (307)
T cd05098 150 ARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVW 226 (307)
T ss_pred HHHHHHHHH---CCcccccccHHheEEcCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCCcHHHHH
Confidence 999999999 99999999999999999999999999998755322211111222335689999999888899999999
Q ss_pred HHHHHHHHHHc-CCCCCcchhc
Q 044746 168 SFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 168 s~G~~l~el~~-g~~p~~~~~~ 188 (202)
|+|+++|||++ |.+||.....
T Consensus 227 slG~~l~el~~~g~~p~~~~~~ 248 (307)
T cd05098 227 SFGVLLWEIFTLGGSPYPGVPV 248 (307)
T ss_pred HHHHHHHHHHcCCCCCCCcCCH
Confidence 99999999998 8899865443
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=189.74 Aligned_cols=153 Identities=24% Similarity=0.342 Sum_probs=120.3
Q ss_pred CCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-----------------CCCCHHHHHHHHHHH
Q 044746 32 FTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------------NILGFGQLREIEVST 87 (202)
Q Consensus 32 ~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~i 87 (202)
+..|....... +|++++. ..+...++++++.+++|..++.. ..+++.++..++.|+
T Consensus 64 ~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi 143 (314)
T cd05099 64 LISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLVSCAYQV 143 (314)
T ss_pred HHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHHHHHHHH
Confidence 44554444444 5887663 33446688899999999888743 348899999999999
Q ss_pred HHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHH
Q 044746 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVF 167 (202)
Q Consensus 88 ~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diw 167 (202)
+.||.|||+ ++++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+|
T Consensus 144 ~~aL~~lH~---~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diw 220 (314)
T cd05099 144 ARGMEYLES---RRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYTHQSDVW 220 (314)
T ss_pred HHHHHHHHH---CCeeeccccceeEEEcCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcCccchhh
Confidence 999999999 99999999999999999999999999999865432211111122235679999999888899999999
Q ss_pred HHHHHHHHHHc-CCCCCcchh
Q 044746 168 SFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 168 s~G~~l~el~~-g~~p~~~~~ 187 (202)
|||+++||+++ |..||....
T Consensus 221 slG~~l~el~~~g~~p~~~~~ 241 (314)
T cd05099 221 SFGILMWEIFTLGGSPYPGIP 241 (314)
T ss_pred HHHHHHHHHHhCCCCCCCCCC
Confidence 99999999999 899987654
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.5e-27 Score=187.31 Aligned_cols=179 Identities=20% Similarity=0.262 Sum_probs=140.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++.+...++.++.|...... ......+..|.......+|++++. .++...++++++.+++|..++....
T Consensus 35 v~~~~~~~~~~~~~iK~~~~~~---~~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 111 (285)
T cd06648 35 VCIATDKSTGRQVAVKKMDLRK---QQRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTHTR 111 (285)
T ss_pred EEEEEECCCCCEEEEEEEeccc---hhHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHhCC
Confidence 4667766666666666432211 111223455656666778887653 3455678899999999999888888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.||.|||+ ++++||||+|+||+++.++.++++|||.+........ ......|++.|+|||.
T Consensus 112 ~~~~~~~~~~~ql~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~aPE~ 186 (285)
T cd06648 112 MNEEQIATVCLAVLKALSFLHA---QGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEV 186 (285)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChhhEEEcCCCcEEEcccccchhhccCCc--ccccccCCccccCHHH
Confidence 9999999999999999999999 9999999999999999999999999998875433221 1223457889999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||+|++++++++|+.||....
T Consensus 187 ~~~~~~~~~~Dv~slGv~l~ell~g~~p~~~~~ 219 (285)
T cd06648 187 ISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEP 219 (285)
T ss_pred hcCCCCCCcccHHHHHHHHHHHHhCCCCCcCCC
Confidence 988889999999999999999999999997644
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.8e-27 Score=180.60 Aligned_cols=175 Identities=22% Similarity=0.283 Sum_probs=128.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccccceEEEEEccCCchhh-----------h
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGPFYL-----------L 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~-----------~ 69 (202)
|+|++.++++.+.|+|-.......+.. .+.+..-.+++...+-+-|+... |+ |+.+.+... +
T Consensus 108 V~k~~~rs~~~iiAVK~M~rt~Nkee~-kRILmDldvv~~s~dcpyIV~c~--Gy----Fi~n~dV~IcMelMs~C~ekL 180 (391)
T KOG0983|consen 108 VWKMRFRSTGHIIAVKQMRRTGNKEEN-KRILMDLDVVLKSHDCPYIVQCF--GY----FITNTDVFICMELMSTCAEKL 180 (391)
T ss_pred eEEEEEcccceEEEEEeecccCCHHHH-HHHHHhhhHHhhccCCCeeeeee--eE----EeeCchHHHHHHHHHHHHHHH
Confidence 688999999999998876554433322 22233334444444445555322 22 222222211 1
Q ss_pred h--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 70 C--KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 70 ~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
+ -++++++..+-.+...+.+||.||-. +++|||||+||+|||++..|++||+|||.+-.+.+..-. +...|.+
T Consensus 181 lkrik~piPE~ilGk~tva~v~AL~YLKe--KH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkAh---trsAGC~ 255 (391)
T KOG0983|consen 181 LKRIKGPIPERILGKMTVAIVKALYYLKE--KHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKAH---TRSAGCA 255 (391)
T ss_pred HHHhcCCchHHhhhhhHHHHHHHHHHHHH--hcceeecccCccceEEccCCCEEeecccccceeeccccc---ccccCCc
Confidence 1 24568888888999999999999998 589999999999999999999999999999876554332 3456799
Q ss_pred cccCCcccCCC---CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 148 GCEAPELWMPY---SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 148 ~y~aPe~~~~~---~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.|||||-+... .|+.++||||||++++||.||+.||.+..
T Consensus 256 ~YMaPERidp~~~~kYDiRaDVWSlGITlveLaTg~yPy~~c~ 298 (391)
T KOG0983|consen 256 AYMAPERIDPPDKPKYDIRADVWSLGITLVELATGQYPYKGCK 298 (391)
T ss_pred cccCccccCCCCCCccchhhhhhhhccchhhhhcccCCCCCCC
Confidence 99999998754 58899999999999999999999998743
|
|
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=1.1e-27 Score=187.52 Aligned_cols=178 Identities=24% Similarity=0.248 Sum_probs=135.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccccc------------ccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGSE------------DTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~------------~~~~~~~~~~~~~~l~ 67 (202)
||++++...++.++.|...... .....+..|....... +|++++... ....++++++.+++|.
T Consensus 22 vy~~~~~~~~~~~aik~~~~~~----~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~ 97 (272)
T cd06637 22 VYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 97 (272)
T ss_pred EEEEEEcCCCcEEEEEEEEcCC----ccHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHH
Confidence 5788888888888887754321 1112333444444333 677765321 2346888999999998
Q ss_pred hhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCC
Q 044746 68 LLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 68 ~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
.++.. ..+++..+..++.|++.|+.|||+ ++++|+||||+||+++.++.++|+|||++........ ......
T Consensus 98 ~~l~~~~~~~l~~~~~~~~~~qi~~~l~~LH~---~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~ 172 (272)
T cd06637 98 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFI 172 (272)
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHEEECCCCCEEEccCCCceecccccc--cCCccc
Confidence 88764 358999999999999999999999 9999999999999999999999999999976533221 123355
Q ss_pred CCCcccCCcccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 145 RTPGCEAPELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 145 gt~~y~aPe~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.|+|||++. ...++.++|+||+||++|||++|+.||....
T Consensus 173 g~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGv~l~el~~g~~p~~~~~ 220 (272)
T cd06637 173 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMH 220 (272)
T ss_pred ccccccCHhHhccccCcCCCCCchhhHHHHHHHHHHHHhCCCCccccC
Confidence 788999999986 3357889999999999999999999997543
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.6e-27 Score=187.16 Aligned_cols=180 Identities=19% Similarity=0.253 Sum_probs=140.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++.+...+..++.|..... .......+..|.......+|++++. .....+++++++++++|..+.....
T Consensus 35 v~~~~~~~~~~~v~iK~~~~~---~~~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 111 (293)
T cd06647 35 VYTAIDVATGQEVAIKQMNLQ---QQPKKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 111 (293)
T ss_pred EEEEEEcCCCCEEEEEEeccc---cchHHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhhcC
Confidence 567776656666665543221 1111234555656666777887663 3345678899999999999998888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.|+.|||+ ++++|+||+|+||+++.++.++|+|||++......... .....+++.|++||.
T Consensus 112 l~~~~~~~i~~~l~~al~~LH~---~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~ 186 (293)
T cd06647 112 MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQSK--RSTMVGTPYWMAPEV 186 (293)
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCEeeccCCHHHEEEcCCCCEEEccCcceecccccccc--cccccCChhhcCchh
Confidence 9999999999999999999999 99999999999999999999999999988754432221 123356888999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+....++.++|+||||+++|++++|+.||....+
T Consensus 187 ~~~~~~~~~~Dv~slG~ll~~ll~g~~pf~~~~~ 220 (293)
T cd06647 187 VTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENP 220 (293)
T ss_pred hccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9888889999999999999999999999986654
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.8e-27 Score=183.97 Aligned_cols=183 Identities=20% Similarity=0.249 Sum_probs=138.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccC-------CcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMD-------KPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~ 67 (202)
||++.+...++.++.|..+........ ....+..|.......+|++++. ......++++++.+++|.
T Consensus 17 vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 96 (272)
T cd06629 17 VYLALNVTTGEMMAVKQVELPATIAGRHDSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIG 96 (272)
T ss_pred EEEEeecCCCceeeeeeeechhhhhcccchHHHHHHHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHH
Confidence 577877777777777654322111111 1123555666667777887642 334456888999999998
Q ss_pred hhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 68 LLCKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 68 ~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++................|+
T Consensus 97 ~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~ 173 (272)
T cd06629 97 SCLRTYGRFEEQLVRFFTEQVLEGLAYLHS---KGILHRDLKADNLLVDADGICKISDFGISKKSDDIYDNDQNMSMQGS 173 (272)
T ss_pred HHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CCeeecCCChhhEEEcCCCeEEEeeccccccccccccccccccccCC
Confidence 88755 568999999999999999999999 99999999999999999999999999999764432222222334568
Q ss_pred CcccCCcccCCCC--CCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 147 PGCEAPELWMPYS--VTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 147 ~~y~aPe~~~~~~--~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
..|+|||.+.... ++.++|+||+|++++++++|..||...
T Consensus 174 ~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 215 (272)
T cd06629 174 VFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDE 215 (272)
T ss_pred ccccCHHHhccccCCCCccchhHHHHHHHHHHHhCCCCCcCc
Confidence 8999999987654 789999999999999999999999653
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=99.95 E-value=3.5e-27 Score=184.36 Aligned_cols=172 Identities=20% Similarity=0.273 Sum_probs=130.5
Q ss_pred ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--------CCCC
Q 044746 11 RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK--------NILG 76 (202)
Q Consensus 11 ~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~--------~~~~ 76 (202)
..++.|..... ........+..+.......+|++++. ......++++++++++|..++.. ..++
T Consensus 27 ~~~~iK~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~ 104 (269)
T cd05044 27 IRVAVKTLRKG--ATDQEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLT 104 (269)
T ss_pred eeehhhhhhcc--cchhhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCcccc
Confidence 55665553221 11122334666777777788888763 23445688899999999888743 2378
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-----ceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 77 FGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-----FPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 77 ~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-----~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
+.++..++.|++.||.|||+ .+++|+||||+||+++.++ .++++|||++................++..|+|
T Consensus 105 ~~~~~~~~~~l~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~a 181 (269)
T cd05044 105 LKELLDICLDVAKGCVYLEQ---MHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMA 181 (269)
T ss_pred HHHHHHHHHHHHHHHHHHHh---CCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccC
Confidence 89999999999999999999 8999999999999999877 899999999875533222222222344678999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
||.+.+..++.++|+||||++++||++ |+.||....
T Consensus 182 PE~~~~~~~~~~~Dv~slG~il~ellt~g~~p~~~~~ 218 (269)
T cd05044 182 PESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALN 218 (269)
T ss_pred HHHHccCCcccchhHHHHHHHHHHHHHcCCCCCcccC
Confidence 999998889999999999999999998 999986543
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=99.95 E-value=2.7e-27 Score=192.46 Aligned_cols=178 Identities=16% Similarity=0.191 Sum_probs=136.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l~~ 68 (202)
||++++...+..++.|..+.... ......++..|.......+|++++... ....++++++. ++|..
T Consensus 32 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 109 (353)
T cd07850 32 VCAAYDTVTGQNVAIKKLSRPFQ-NVTHAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQ 109 (353)
T ss_pred EEEEEECCCCCEEEEEecCcccc-ChhHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHH
Confidence 57788877777777775432111 111222344566667777888776321 23467788876 46666
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
..... ++...+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....... .....+++.
T Consensus 110 ~~~~~-l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~ 182 (353)
T cd07850 110 VIQMD-LDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 182 (353)
T ss_pred HHhhc-CCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCCC---CCCCccccc
Confidence 66544 8999999999999999999999 9999999999999999999999999999986543222 223456889
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||.+.+..++.++|+||+||++++|++|+.||....
T Consensus 183 y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~pf~~~~ 221 (353)
T cd07850 183 YRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTD 221 (353)
T ss_pred ccCHHHHhCCCCCCchhhHhHHHHHHHHHHCCCCCCCCC
Confidence 999999999899999999999999999999999997543
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.95 E-value=4.2e-27 Score=182.74 Aligned_cols=150 Identities=19% Similarity=0.284 Sum_probs=122.5
Q ss_pred cccCCcHHHHHHhcccccccccc-----ccceEEEEEccCCchhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 044746 29 PIRFTSPQRMIAADNFSNLVGSE-----DTETYIKGFLAMGPFYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQK 101 (202)
Q Consensus 29 ~~~~~~~~~~~~~~~~~~~i~~~-----~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 101 (202)
...|..+.......+|++++... ....++++++.+++|..++... .+++..+..++.|++.||.|||+ ++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~---~~ 121 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVRDENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLED---KK 121 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEecCCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhh---CC
Confidence 34566666677777888776322 3557899999999999888643 48999999999999999999999 99
Q ss_pred eEEecCCCCcEEEcCCC-------ceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCC--CCCchhhHHHHHHH
Q 044746 102 IVHYDIKPESVLLDENF-------FPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY--SVTQKCDVFSFGML 172 (202)
Q Consensus 102 iiHrdlk~~nil~~~~~-------~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~--~~~~~~Diws~G~~ 172 (202)
++||||||+||+++.++ .++++|||++..... .....++..|+|||++.+. .++.++|+||+|++
T Consensus 122 i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~ 195 (259)
T cd05037 122 LVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS------REERVERIPWIAPECIRNGQASLTIAADKWSFGTT 195 (259)
T ss_pred eecccCccceEEEecCccccCCceeEEeCCCCccccccc------ccccccCCCccChhhhcCCCCCcchhhHHHHHHHH
Confidence 99999999999999877 799999999875432 1123346789999998876 78899999999999
Q ss_pred HHHHHc-CCCCCcchh
Q 044746 173 LFEVVG-RRRNLEKEI 187 (202)
Q Consensus 173 l~el~~-g~~p~~~~~ 187 (202)
++|+++ |..||....
T Consensus 196 ~~~l~~~~~~p~~~~~ 211 (259)
T cd05037 196 LLEICSNGEEPLSTLS 211 (259)
T ss_pred HHHHHhCCCCCcccCC
Confidence 999999 688886654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.6e-27 Score=184.82 Aligned_cols=155 Identities=23% Similarity=0.278 Sum_probs=126.5
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-NILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
..+..|.......+|++++. ......++++++.+++|..++.. ..+++..+..++.|++.||.|||+ .++
T Consensus 47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i 123 (265)
T cd06631 47 EKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHN---NCV 123 (265)
T ss_pred HHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCc
Confidence 34666666777778887652 44556788999999999988755 568999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccC----cccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREH----THITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG 178 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~----~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~ 178 (202)
+|+||+|+||+++.++.++|+|||++....... .........|+..|+|||++.+..++.++|+||+|++++++++
T Consensus 124 ~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 203 (265)
T cd06631 124 VHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMAT 203 (265)
T ss_pred ccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHHHHHh
Confidence 999999999999999999999999987542111 1111223457889999999998888999999999999999999
Q ss_pred CCCCCcchh
Q 044746 179 RRRNLEKEI 187 (202)
Q Consensus 179 g~~p~~~~~ 187 (202)
|+.||....
T Consensus 204 g~~p~~~~~ 212 (265)
T cd06631 204 GKPPLASMD 212 (265)
T ss_pred CCCccccCC
Confidence 999997543
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-27 Score=190.86 Aligned_cols=180 Identities=21% Similarity=0.319 Sum_probs=135.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.|+.|..+... ......++..|.......+|++++... ....++++++. +++...
T Consensus 21 vy~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~ 97 (336)
T cd07849 21 VCSATHKPTGVKVAIKKISPFE--HQTFCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKL 97 (336)
T ss_pred EEEEEEcCCCCeEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHH
Confidence 5788887777778777643211 111223344566666677788766422 12346666665 577778
Q ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCc
Q 044746 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPG 148 (202)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~ 148 (202)
.....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......... ......|++.
T Consensus 98 ~~~~~l~~~~~~~i~~ql~~aL~~LH~---~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (336)
T cd07849 98 IKTQHLSNDHIQYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDHTGFLTEYVATRW 174 (336)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEECCCCCEEECcccceeeccccccccCCcCCcCcCCC
Confidence 877889999999999999999999999 999999999999999999999999999998654322111 1223457889
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|+|||.+.+ ..++.++|+||+|+++++|++|++||...
T Consensus 175 y~aPE~~~~~~~~~~~~DvwslGvil~el~~G~~~f~~~ 213 (336)
T cd07849 175 YRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213 (336)
T ss_pred ccChHHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCC
Confidence 999998754 46889999999999999999999999654
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=193.94 Aligned_cols=109 Identities=28% Similarity=0.379 Sum_probs=92.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++...............+++.|+|||.
T Consensus 236 l~~~~~~~~~~qi~~aL~~LH~---~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~ 312 (401)
T cd05107 236 LSYMDLVGFSYQVANGMEFLAS---KNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPES 312 (401)
T ss_pred CCHHHHHHHHHHHHHHHHHHhc---CCcCcccCCcceEEEeCCCEEEEEecCcceecccccccccCCCcCCCCceeChHH
Confidence 6777889999999999999999 9999999999999999999999999999986433222112223346788999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHc-CCCCCcch
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKE 186 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~ 186 (202)
+....++.++|+||||++++|+++ |..||...
T Consensus 313 ~~~~~~~~~~DvwslGvil~e~l~~g~~P~~~~ 345 (401)
T cd05107 313 IFNNLYTTLSDVWSFGILLWEIFTLGGTPYPEL 345 (401)
T ss_pred hcCCCCCcHhHHHHHHHHHHHHHHcCCCCCCCC
Confidence 988889999999999999999998 89998654
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=185.69 Aligned_cols=179 Identities=21% Similarity=0.215 Sum_probs=136.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++...+..++.|..+... .......+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 17 v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 94 (286)
T cd06622 17 VYKVLHRPTGVTMAMKEIRLEL--DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGV 94 (286)
T ss_pred EEEEEEcCCCcEEEEEEeeccc--CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhcc
Confidence 5778887677777766433211 1111234555666666777887652 345567889999999998888664
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+. .+++|+||||+||+++.++.++++|||++....... .....+++.|+
T Consensus 95 ~~~~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~y~ 168 (286)
T cd06622 95 ATEGIPEDVLRRITYAVVKGLKFLKEE--HNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVASL----AKTNIGCQSYM 168 (286)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhc--CCEeeCCCCHHHEEECCCCCEEEeecCCcccccCCc----cccCCCccCcc
Confidence 799999999999999999999962 599999999999999999999999999987543221 12234688999
Q ss_pred CCcccCCC------CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPY------SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~------~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+.+. .++.++|+||+||+++++++|+.||....
T Consensus 169 aPE~~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 211 (286)
T cd06622 169 APERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPPET 211 (286)
T ss_pred CcchhcCCCCCccCCCCcccchHhHHHHHHHHHhCCCCCCCcc
Confidence 99998543 35789999999999999999999996543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-27 Score=190.39 Aligned_cols=155 Identities=25% Similarity=0.332 Sum_probs=122.1
Q ss_pred cCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-----------------CCCCHHHHHHHHHH
Q 044746 31 RFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-----------------NILGFGQLREIEVS 86 (202)
Q Consensus 31 ~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-----------------~~~~~~~~~~~~~~ 86 (202)
.+..|....... +|++++. ..+...++++++.+++|..++.. ..+++..+..++.|
T Consensus 63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~q 142 (334)
T cd05100 63 DLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLVSCAYQ 142 (334)
T ss_pred HHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHHHHHHH
Confidence 455555555444 6887763 33456688999999999887743 24788999999999
Q ss_pred HHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhH
Q 044746 87 TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDV 166 (202)
Q Consensus 87 i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Di 166 (202)
++.||.|||+ ++++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+
T Consensus 143 i~~al~~LH~---~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 219 (334)
T cd05100 143 VARGMEYLAS---QKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDV 219 (334)
T ss_pred HHHHHHHHHH---CCeeccccccceEEEcCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcCchhhh
Confidence 9999999999 9999999999999999999999999999986543222211222334567999999988889999999
Q ss_pred HHHHHHHHHHHc-CCCCCcchhc
Q 044746 167 FSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 167 ws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||||++++||++ |..||.....
T Consensus 220 ~slG~il~el~~~g~~p~~~~~~ 242 (334)
T cd05100 220 WSFGVLLWEIFTLGGSPYPGIPV 242 (334)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCH
Confidence 999999999998 8899876543
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.2e-27 Score=187.93 Aligned_cols=185 Identities=16% Similarity=0.208 Sum_probs=136.1
Q ss_pred CCccccCC--CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------c--cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRG--STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------S--EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~--~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~--~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++.+.. .+..+|.|...............+..|..+....+|++++. . .....++++++++ ++...+
T Consensus 16 v~~~~~~~~~~~~~~alK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 94 (316)
T cd07842 16 VYKAKRKNGKDGKEYAIKKFKGDKEQYTGISQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAEH-DLWQII 94 (316)
T ss_pred EEEEEecCCCCCCeEEEEEeccccccccCccHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCCc-CHHHHH
Confidence 57777766 67777777655432222222333455666677778887652 1 2445677787765 444443
Q ss_pred c------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC----CCceEEeeeecceeccccCc-ccc
Q 044746 71 K------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE----NFFPKAADFGLAKLYNREHT-HIT 139 (202)
Q Consensus 71 ~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~----~~~~kl~dfgl~~~~~~~~~-~~~ 139 (202)
. ...++...+..++.|++.||.|||+ .+++||||||+||+++. ++.+|++|||++........ ...
T Consensus 95 ~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~ 171 (316)
T cd07842 95 KFHRQAKRVSIPPSMVKSLLWQILNGVHYLHS---NWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLAD 171 (316)
T ss_pred HhhccCCCcCcCHHHHHHHHHHHHHHHHHHHh---CCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccc
Confidence 2 1268899999999999999999999 99999999999999999 89999999999986543322 122
Q ss_pred cCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 140 STGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 140 ~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.....+++.|+|||.+.+ ..++.++|+||+|+++++|++|++||......
T Consensus 172 ~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~~~ 222 (316)
T cd07842 172 LDPVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGREAK 222 (316)
T ss_pred cCCccccccccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhcCCCCcCCccc
Confidence 233456888999998766 45789999999999999999999999866543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=184.75 Aligned_cols=155 Identities=21% Similarity=0.279 Sum_probs=125.4
Q ss_pred ccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 30 IRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
..+..|.......+|++++. ......++++++++++|..++... .+++..+..++.+++.||.|||+ .++
T Consensus 52 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~ 128 (270)
T cd05056 52 EKFLQEAYIMRQFDHPHIVKLIGVITENPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLES---KRF 128 (270)
T ss_pred HHHHHHHHHHHhCCCCchhceeEEEcCCCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 35666777777778887763 233456888999999999988643 48999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRR 181 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~ 181 (202)
+|+||||+||+++.++.++++|||+++......... .....++..|+|||.+....++.++|+||||++++|+++ |+.
T Consensus 129 ~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~ 207 (270)
T cd05056 129 VHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESYYK-ASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVK 207 (270)
T ss_pred eccccChheEEEecCCCeEEccCceeeeccccccee-cCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHHcCCC
Confidence 999999999999999999999999998654432211 112233568999999988889999999999999999886 999
Q ss_pred CCcchhc
Q 044746 182 NLEKEIS 188 (202)
Q Consensus 182 p~~~~~~ 188 (202)
||.....
T Consensus 208 pf~~~~~ 214 (270)
T cd05056 208 PFQGVKN 214 (270)
T ss_pred CCCCCCH
Confidence 9976543
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=184.71 Aligned_cols=181 Identities=18% Similarity=0.210 Sum_probs=138.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc---ccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD---NFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++.+..++..++.|+.+... .......+..|..+.... .|++++. .+....++++++.+++|..+..
T Consensus 17 v~~~~~~~~~~~~~iK~~~~~~--~~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~ 94 (277)
T cd06917 17 VYRGKHVPTGRVVALKIINLDT--PDDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMK 94 (277)
T ss_pred EEEEEEcCCCcEEEEEEecCCC--CchhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHH
Confidence 5778877777777777643211 111122344444444443 3676652 3344568889999999999988
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.+.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++........ ......|+..|+|
T Consensus 95 ~~~l~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~a 169 (277)
T cd06917 95 AGPIAEKYISVIIREVLVALKYIHK---VGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNSS--KRSTFVGTPYWMA 169 (277)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCcc--ccccccCCcceeC
Confidence 8889999999999999999999999 9999999999999999999999999999986543321 1223457889999
Q ss_pred CcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 152 PELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||.+.. ..++.++|+||+|+++|+|++|++||.....
T Consensus 170 PE~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~~~~ 207 (277)
T cd06917 170 PEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDA 207 (277)
T ss_pred HHHhccCCccccchhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 998865 4578899999999999999999999976544
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=185.74 Aligned_cols=182 Identities=22% Similarity=0.304 Sum_probs=136.7
Q ss_pred CCccccCCCcceeehhhhchhhhhc--cCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME--MDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+..+++.++.|..+...... ......+..|.......+|++++. ......++++++ +++|..++..
T Consensus 16 vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~ 94 (298)
T cd07841 16 VYKARDKETGRIVAIKKIKLGERKEAKDGINFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKD 94 (298)
T ss_pred EEEEEECCCCcEEEEEEEeccccccccchhhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhc
Confidence 5788887767777766543332211 111222344555566667787652 344567888888 8899888866
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 N--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. .+++..+..++.|+++||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ......+++.|+
T Consensus 95 ~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~ 169 (298)
T cd07841 95 KSIVLTPADIKSYMLMTLRGLEYLHS---NWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPNR--KMTHQVVTRWYR 169 (298)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeecCCChhhEEEcCCCCEEEccceeeeeccCCCc--cccccccceeee
Confidence 5 49999999999999999999999 9999999999999999999999999999986543321 112234577899
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||.+.+ ..++.++|+||+||+++|+++|.+||....+
T Consensus 170 aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~~~~~~~~~ 208 (298)
T cd07841 170 APELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSD 208 (298)
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHcCCccccCCcc
Confidence 9998854 4578899999999999999999888875543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.1e-27 Score=180.47 Aligned_cols=180 Identities=21% Similarity=0.268 Sum_probs=134.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.... +..++.|+...... .+....+..|.......+|++++. ..+...++++++++++|..++..
T Consensus 11 vy~~~~~~-~~~~a~K~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 87 (250)
T cd05085 11 VFKGTLKD-KTPVAVKTCKEDLP--QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKK 87 (250)
T ss_pred EEEEEecC-CcEEEEEecCCcCC--HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcC
Confidence 57776554 44455544322111 111123555666677778887653 33456788999999999888754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.+++.||.|+|+ ++++|+||||+||+++.++.++|+|||++.......... .....++..|+||
T Consensus 88 ~~~~~~~~~~~~~~i~~~l~~lH~---~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~~-~~~~~~~~~y~aP 163 (250)
T cd05085 88 DELKTKQLVKFALDAAAGMAYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIYSS-SGLKQIPIKWTAP 163 (250)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccChheEEEcCCCeEEECCCccceecccccccc-CCCCCCcccccCH
Confidence 358899999999999999999999 999999999999999999999999999987543322211 1122335679999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
|++....++.++|+||+|++++++++ |..||....
T Consensus 164 E~~~~~~~~~~~Di~slG~ll~~~~~~g~~p~~~~~ 199 (250)
T cd05085 164 EALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMT 199 (250)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHhcCCCCCCCCCC
Confidence 99988889999999999999999998 999997543
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.4e-27 Score=181.54 Aligned_cols=181 Identities=19% Similarity=0.273 Sum_probs=135.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+.. ++.++.|..+..... +....+..|..+....+|++++. ......++++++.+++|..++..
T Consensus 11 v~~~~~~~-~~~v~~K~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~ 87 (251)
T cd05041 11 VYKGVLKG-NTEVAVKTCRSTLPP--DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKK 87 (251)
T ss_pred EEEEEEeC-CCcEEEEeccccCCH--HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcC
Confidence 56777666 556665543222111 12234566666677778887652 34445688889999999888744
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.+++.||.|||+ ++++||||+|+||+++.++.++|+|||++................++..|+||
T Consensus 88 ~~~~~~~~~~~~~~~~~~l~~lH~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~P 164 (251)
T cd05041 88 NRLTVKKLLQMSLDAAAGMEYLES---KNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAP 164 (251)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCEehhhcCcceEEEcCCCcEEEeeccccccccCCcceeccccCcceeccCCh
Confidence 458899999999999999999999 99999999999999999999999999998754322211111122235679999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
|.+.+..++.++|+||+|++++|+++ |..||....
T Consensus 165 E~~~~~~~~~~~Di~slG~i~~~l~t~~~~p~~~~~ 200 (251)
T cd05041 165 EALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMS 200 (251)
T ss_pred HhhccCCCCcchhHHHHHHHHHHHHhccCCCCccCC
Confidence 99988889999999999999999999 889986544
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=186.21 Aligned_cols=154 Identities=19% Similarity=0.273 Sum_probs=123.4
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-------------CCCHHHHHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN-------------ILGFGQLREIEVSTSKGI 91 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~-------------~~~~~~~~~~~~~i~~~l 91 (202)
.|..|.......+|++++. ......++++++.+++|..++... .+++..+..++.|++.||
T Consensus 63 ~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i~~al 142 (295)
T cd05097 63 DFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQIASGM 142 (295)
T ss_pred HHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHHHHHHH
Confidence 4666767777788887653 345567899999999998877432 368889999999999999
Q ss_pred HHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHH
Q 044746 92 AYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGM 171 (202)
Q Consensus 92 ~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~ 171 (202)
.|||+ .+++|+||||+||+++.++.++|+|||++................++..|+|||.+....++.++|+||||+
T Consensus 143 ~~lH~---~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~ 219 (295)
T cd05097 143 KYLAS---LNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDVWAFGV 219 (295)
T ss_pred HHHHh---cCeeccccChhhEEEcCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhHHHHHH
Confidence 99999 999999999999999999999999999987543322222222334567899999998888999999999999
Q ss_pred HHHHHHc--CCCCCcchh
Q 044746 172 LLFEVVG--RRRNLEKEI 187 (202)
Q Consensus 172 ~l~el~~--g~~p~~~~~ 187 (202)
++++|++ |..||....
T Consensus 220 ~l~el~~~~~~~p~~~~~ 237 (295)
T cd05097 220 TLWEMFTLCKEQPYSLLS 237 (295)
T ss_pred HHHHHHHcCCCCCCcccC
Confidence 9999988 677886543
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-27 Score=182.93 Aligned_cols=154 Identities=25% Similarity=0.350 Sum_probs=121.1
Q ss_pred ccCCcHHHHHHhcccccccc-------ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 044746 30 IRFTSPQRMIAADNFSNLVG-------SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQ 100 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 100 (202)
..+..|.......+|++++. ..+...++++++.+++|..++.. ...++..+..++.|++.||.|||+ .
T Consensus 41 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~ 117 (262)
T cd05058 41 EQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLAS---K 117 (262)
T ss_pred HHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 34556666667778888763 23345688889999999998854 346788889999999999999999 9
Q ss_pred CeEEecCCCCcEEEcCCCceEEeeeecceeccccCc--ccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc
Q 044746 101 KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT--HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG 178 (202)
Q Consensus 101 ~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~--~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~ 178 (202)
+++||||||+||+++.++.++|+|||+++....... ........++..|+|||.+....++.++|+||||++++||++
T Consensus 118 ~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~ 197 (262)
T cd05058 118 KFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMT 197 (262)
T ss_pred CccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHHHHc
Confidence 999999999999999999999999999875432211 011123345678999999988889999999999999999999
Q ss_pred -CCCCCcch
Q 044746 179 -RRRNLEKE 186 (202)
Q Consensus 179 -g~~p~~~~ 186 (202)
|.+||...
T Consensus 198 ~~~~~~~~~ 206 (262)
T cd05058 198 RGAPPYPDV 206 (262)
T ss_pred CCCCCCCCC
Confidence 56666543
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.7e-27 Score=183.66 Aligned_cols=183 Identities=20% Similarity=0.198 Sum_probs=140.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.....+..++.|+........ ....+..|.......+|++++. ......++++++++++|..++..
T Consensus 17 v~~~~~~~~~~~~~ik~~~~~~~~~--~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~ 94 (267)
T cd06610 17 VYAAICLPNNEKVAIKRIDLEKCQT--SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSY 94 (267)
T ss_pred EEEEEEcCCCcEEEEEEeccCCcch--HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhc
Confidence 5677766666667766543221111 2344566666666777887653 34455688899999999888754
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc--ccCCCCCCCc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI--TSTGRRRTPG 148 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~--~~~~~~gt~~ 148 (202)
..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......... ......|+..
T Consensus 95 ~~~~~~~~~~~~~~~ql~~al~~lh~---~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (267)
T cd06610 95 PRGGLDEAIIATVLKEVLKGLEYLHS---NGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPC 171 (267)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChh
Confidence 358999999999999999999999 999999999999999999999999999987654332221 1233457889
Q ss_pred ccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||.+... .++.++|+||+|+++++|++|+.||....+
T Consensus 172 y~~Pe~~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~~ 212 (267)
T cd06610 172 WMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYSKYPP 212 (267)
T ss_pred hcChHHHccccCcCcccchHhHhHHHHHHHhCCCCccccCh
Confidence 9999998776 788999999999999999999999976543
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=184.07 Aligned_cols=182 Identities=21% Similarity=0.312 Sum_probs=135.8
Q ss_pred CCccccCCCcc---eeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTR---FITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+++....+. .++.|+.+.. ........|..|.......+|+|++. .+....++++++.+++|..++.
T Consensus 20 vy~~~~~~~~~~~~~vaiK~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 97 (269)
T cd05065 20 VCRGRLKLPGKREIFVAIKTLKSG--YTEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLR 97 (269)
T ss_pred EEEEEEecCCCCceeEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHh
Confidence 46666654433 4555554322 11112345667777777788888763 3344568889999999988875
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC---CCCC
Q 044746 72 K--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG---RRRT 146 (202)
Q Consensus 72 ~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~---~~gt 146 (202)
. +.+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++.............. ...+
T Consensus 98 ~~~~~~~~~~~~~i~~~l~~al~~lH~---~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 174 (269)
T cd05065 98 QNDGQFTVIQLVGMLRGIAAGMKYLSE---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIP 174 (269)
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcc
Confidence 4 458999999999999999999999 9999999999999999999999999999876543222111111 1124
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
..|+|||.+.+..++.++|+||+|++++|+++ |..||....
T Consensus 175 ~~y~~PE~~~~~~~~~~~DvwslG~~l~e~l~~g~~p~~~~~ 216 (269)
T cd05065 175 IRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMS 216 (269)
T ss_pred eeecCHhHhccCcccchhhhhhhHHHHHHHhcCCCCCCCCCC
Confidence 57999999998889999999999999999886 999997644
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-28 Score=195.68 Aligned_cols=135 Identities=21% Similarity=0.289 Sum_probs=119.3
Q ss_pred ccccceEEEEEccCCchhhhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecc
Q 044746 50 SEDTETYIKGFLAMGPFYLLCK-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA 128 (202)
Q Consensus 50 ~~~~~~~~~~~~~~~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~ 128 (202)
...+.+..++-+-+|.+..++. ++.+....++.++..+.+|++|||+ ++||.|||||+|++++.+|.+||.|||.|
T Consensus 491 d~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~---k~iIYRDLKPENllLd~~Gy~KLVDFGFA 567 (732)
T KOG0614|consen 491 DSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHR---KGIIYRDLKPENLLLDNRGYLKLVDFGFA 567 (732)
T ss_pred cchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHh---cCceeccCChhheeeccCCceEEeehhhH
Confidence 3444556667788898877774 5579999999999999999999999 99999999999999999999999999999
Q ss_pred eeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 129 KLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 129 ~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
+.+..... .++.+|||.|.|||.+.....+..+|.||+|++++||++|++||.+.+++-
T Consensus 568 Kki~~g~K---TwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~pPFs~~dpmk 626 (732)
T KOG0614|consen 568 KKIGSGRK---TWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGSPPFSGVDPMK 626 (732)
T ss_pred HHhccCCc---eeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCCCCCCCCchHH
Confidence 98766544 466788999999999999999999999999999999999999999888764
|
|
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=181.31 Aligned_cols=154 Identities=21% Similarity=0.376 Sum_probs=124.8
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
.|..|.......+|++++. ......++++++.+++|..++.. ..+++..+..++.|++.||.|||+ .++
T Consensus 45 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i 121 (256)
T cd05113 45 EFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLES---KQF 121 (256)
T ss_pred HHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 3556666677778887653 23345788999999999888754 358999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRR 181 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~ 181 (202)
+|+||||.||+++.++.++++|||+++....... .......++..|+|||.+.+..++.++|+||||+++|+|++ |+.
T Consensus 122 ~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~~ 200 (256)
T cd05113 122 IHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKM 200 (256)
T ss_pred eccccCcceEEEcCCCCEEECCCccceecCCCce-eecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCCC
Confidence 9999999999999999999999999886543322 11222334678999999988889999999999999999998 999
Q ss_pred CCcchhc
Q 044746 182 NLEKEIS 188 (202)
Q Consensus 182 p~~~~~~ 188 (202)
||....+
T Consensus 201 p~~~~~~ 207 (256)
T cd05113 201 PYERFNN 207 (256)
T ss_pred CcCcCCH
Confidence 9875443
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=183.21 Aligned_cols=180 Identities=18% Similarity=0.252 Sum_probs=138.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+...++.++.|..+..... .....+..|.......+|++++. ..+...+++++++++++..+...
T Consensus 16 v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 93 (255)
T cd08219 16 ALLVQHVNSDQKYAMKEIRLPKSS--SAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQR 93 (255)
T ss_pred EEEEEEcCCCceEEEEEEEcCcch--HHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhcc
Confidence 466777766777776653221111 11234455656666777887652 44566788999999999887643
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..++...+..++.|++.||.|||+ ++++|+||||+||+++.++.++++|||++......... .....|++.|+|
T Consensus 94 ~~~~~~~~~~~~~~~i~~al~~lH~---~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~a 168 (255)
T cd08219 94 GKLFPEDTILQWFVQMCLGVQHIHE---KRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGAY--ACTYVGTPYYVP 168 (255)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEECCCCcEEEcccCcceeecccccc--cccccCCccccC
Confidence 358999999999999999999999 99999999999999999999999999999765432211 123456889999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||++.+..++.++|+||+|+++++|++|+.||....
T Consensus 169 PE~~~~~~~~~~~Dv~slG~i~~~l~~g~~p~~~~~ 204 (255)
T cd08219 169 PEIWENMPYNNKSDIWSLGCILYELCTLKHPFQANS 204 (255)
T ss_pred HHHHccCCcCchhhhhhhchhheehhhccCCCCCCC
Confidence 999988889999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.9e-27 Score=185.74 Aligned_cols=154 Identities=18% Similarity=0.281 Sum_probs=121.6
Q ss_pred cCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhcc-----------CCCCHHHHHHHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK-----------NILGFGQLREIEVSTSKGIAY 93 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~-----------~~~~~~~~~~~~~~i~~~l~~ 93 (202)
.+..+.......+|++++ .......++++++.+|+|..++.. ...+...+..++.|++.||.|
T Consensus 55 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 134 (288)
T cd05061 55 EFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGMAY 134 (288)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 345555566667777665 244456788999999999988853 235677889999999999999
Q ss_pred HHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHH
Q 044746 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLL 173 (202)
Q Consensus 94 lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l 173 (202)
||+ ++++||||||+||+++.++.++|+|||+++...............++..|+|||.+.+..++.++|+||+||++
T Consensus 135 lH~---~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~~l 211 (288)
T cd05061 135 LNA---KKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVL 211 (288)
T ss_pred HHh---CCCcCCCCChheEEEcCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHHHH
Confidence 999 99999999999999999999999999998754332221112222346789999999888899999999999999
Q ss_pred HHHHc-CCCCCcchh
Q 044746 174 FEVVG-RRRNLEKEI 187 (202)
Q Consensus 174 ~el~~-g~~p~~~~~ 187 (202)
+|+++ |..||....
T Consensus 212 ~el~~~~~~p~~~~~ 226 (288)
T cd05061 212 WEITSLAEQPYQGLS 226 (288)
T ss_pred HHHHhCCCCCCCCCC
Confidence 99998 788987544
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=183.75 Aligned_cols=179 Identities=18% Similarity=0.235 Sum_probs=132.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+...+..++.|+.+.... ......+..|.......+|++++. .+...+++++++. +++...+..
T Consensus 21 v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 97 (291)
T cd07870 21 VYKGISRINGQLVALKVISMKTE--EGVPFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHP 97 (291)
T ss_pred EEEEEEcCCCcEEEEEEecccCc--CCCcHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCC
Confidence 57777777777777766433211 111223445666666778888752 3344567788886 555554432
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||+++....... ......+++.|+||
T Consensus 98 ~~~~~~~~~~~~~qi~~~L~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~~--~~~~~~~~~~y~aP 172 (291)
T cd07870 98 GGLHPYNVRLFMFQLLRGLAYIHG---QHILHRDLKPQNLLISYLGELKLADFGLARAKSIPSQ--TYSSEVVTLWYRPP 172 (291)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChHHEEEcCCCcEEEeccccccccCCCCC--CCCCccccccccCC
Confidence 457889999999999999999999 9999999999999999999999999999875432211 11223458899999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+.+. .++.++|+||+|++++++++|+.||....
T Consensus 173 E~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~f~~~~ 208 (291)
T cd07870 173 DVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVS 208 (291)
T ss_pred ceeecCCCCCcHHHHHHHHHHHHHHHhCCCCCCCch
Confidence 998753 57889999999999999999999997544
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=5e-27 Score=186.91 Aligned_cols=183 Identities=19% Similarity=0.247 Sum_probs=135.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc--------------ccceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE--------------DTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~~~l 66 (202)
||++++...++.++.|........ ......+..|.......+|++++... ....++++++.+ ++
T Consensus 28 v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 105 (310)
T cd07865 28 VFKARHKKTKQIVALKKVLMENEK-EGFPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEH-DL 105 (310)
T ss_pred EEEEEECCCCcEEEEEEEeccCCc-CCchhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCc-CH
Confidence 678888888888887754332111 11122334466666777888776322 223677777764 56
Q ss_pred hhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc--cccCC
Q 044746 67 YLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH--ITSTG 142 (202)
Q Consensus 67 ~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~--~~~~~ 142 (202)
...+... .+++.++..++.|++.||.|||+ ++++|+||||+||+++.++.++|+|||++......... .....
T Consensus 106 ~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~ 182 (310)
T cd07865 106 AGLLSNKNVKFTLSEIKKVMKMLLNGLYYIHR---NKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTN 182 (310)
T ss_pred HHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccC
Confidence 5555443 68999999999999999999999 99999999999999999999999999999865432211 11223
Q ss_pred CCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 143 RRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
..++..|+|||.+.+. .++.++|+||+|++++||++|++||....+
T Consensus 183 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~el~t~~~~~~~~~~ 229 (310)
T cd07865 183 RVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTE 229 (310)
T ss_pred cccCccccCcHHhcCCcccCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 4567889999988664 468899999999999999999999976554
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=183.15 Aligned_cols=181 Identities=20% Similarity=0.243 Sum_probs=138.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..++..++.|........ ......+..|.......+|++++. .+....++++++ +++|..++..
T Consensus 16 v~~~~~~~~~~~~~vK~~~~~~~~-~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~ 93 (286)
T cd07832 16 VFKAKDRETGETVALKKVALRRLE-GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEE 93 (286)
T ss_pred EEEEEECCCCceEEEEEEEccccc-chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcC
Confidence 578888777777776654332211 122334566666666777887652 345566888888 8999887743
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++........ .......++..|+||
T Consensus 94 ~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~y~aP 169 (286)
T cd07832 94 RPLPEAQVKSYMRMLLKGVAYMHA---NGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP-RLYSHQVATRWYRAP 169 (286)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC-CccccccCcccccCc
Confidence 468999999999999999999999 9999999999999999999999999999886543321 112234578899999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+.+. .++.++|+||+|++++|+++|.+||....
T Consensus 170 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~ 205 (286)
T cd07832 170 ELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGEN 205 (286)
T ss_pred eeeeccccCCchhHHHHHHHHHHHHHcCCcCcCCCC
Confidence 998654 46889999999999999999988886544
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.7e-27 Score=182.78 Aligned_cols=155 Identities=22% Similarity=0.348 Sum_probs=123.3
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
.+..|.......+|++++. ..+...++++++++++|..++.. ..+++.++..++.|++.|+.|||+ .++
T Consensus 52 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~---~~i 128 (268)
T cd05063 52 DFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSD---MNY 128 (268)
T ss_pred HHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCe
Confidence 3555666666777887653 33445688999999999888754 468999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RR 180 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~ 180 (202)
+|+||||+||+++.++.++++|||++.......... .......+..|+|||++....++.++|+||||+++||+++ |+
T Consensus 129 ~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~ell~~g~ 208 (268)
T cd05063 129 VHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGE 208 (268)
T ss_pred eccccchhhEEEcCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHHHhCCC
Confidence 999999999999999999999999997654322111 1111223457999999988888999999999999999997 99
Q ss_pred CCCcchhc
Q 044746 181 RNLEKEIS 188 (202)
Q Consensus 181 ~p~~~~~~ 188 (202)
.||.....
T Consensus 209 ~p~~~~~~ 216 (268)
T cd05063 209 RPYWDMSN 216 (268)
T ss_pred CCCCcCCH
Confidence 99965443
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.2e-27 Score=181.20 Aligned_cols=181 Identities=22% Similarity=0.229 Sum_probs=140.6
Q ss_pred CCccccCCCcceeehhhhchhhh--hccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDA--MEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+...+..++.|....... ...+....+..|.......+|++++. .+....+++++.++++|..++..
T Consensus 16 vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 95 (258)
T cd06632 16 VYEGLNLDDGDFFAVKEVSLADDGQTGQEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKK 95 (258)
T ss_pred EEEEEEcCCCcEEEEEEEEEccccccchHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHh
Confidence 57777776666666665433221 11222345666767777778887652 33445688999999999888865
Q ss_pred CC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 NI-LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 ~~-~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.. +++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... ......|+..|++
T Consensus 96 ~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~---~~~~~~~~~~y~~ 169 (258)
T cd06632 96 YGSFPEPVIRLYTRQILLGLEYLHD---RNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS---FAKSFKGSPYWMA 169 (258)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEccCccceeccccc---cccccCCCcceeC
Confidence 44 8999999999999999999999 999999999999999999999999999987654332 1233456889999
Q ss_pred CcccCCCC-CCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYS-VTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~-~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||.+.... ++.++|+||+|++++++++|++||....
T Consensus 170 pe~~~~~~~~~~~~D~~slG~~l~~l~~g~~pf~~~~ 206 (258)
T cd06632 170 PEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLE 206 (258)
T ss_pred HHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCcccCc
Confidence 99987766 8899999999999999999999997654
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.5e-27 Score=184.49 Aligned_cols=180 Identities=21% Similarity=0.229 Sum_probs=139.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...+..++.|+.+..... ....+..|.......+|++++. ......++++++++++|..+...
T Consensus 21 v~~~~~~~~~~~~~iK~~~~~~~~---~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 97 (280)
T cd06611 21 VYKAQHKETGLFAAAKIIQIESEE---ELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELE 97 (280)
T ss_pred EEEEEEcCCCcEEEEEEEeeCCHH---HHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhc
Confidence 577887777777777765432211 1234555666667777887653 34456788999999999888754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......... .....+++.|+||
T Consensus 98 ~~l~~~~~~~~~~ql~~~l~~lh~---~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~y~~P 172 (280)
T cd06611 98 RGLTEPQIRYVCRQMLEALNFLHS---HKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTLQK--RDTFIGTPYWMAP 172 (280)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEECCCCCEEEccCccchhhcccccc--cceeecchhhcCH
Confidence 469999999999999999999999 99999999999999999999999999988754322211 1234568899999
Q ss_pred cccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+. ...++.++|+||+|+++|++++|++||.....
T Consensus 173 E~~~~~~~~~~~~~~~sDi~slG~il~~l~~g~~p~~~~~~ 213 (280)
T cd06611 173 EVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHHELNP 213 (280)
T ss_pred HHHhhcccCCCCCCccccHHHHHHHHHHHHhCCCCcccCCH
Confidence 9875 34577899999999999999999999976543
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.7e-27 Score=184.96 Aligned_cols=154 Identities=18% Similarity=0.289 Sum_probs=122.8
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC------------CCCHHHHHHHHHHHHHHHH
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN------------ILGFGQLREIEVSTSKGIA 92 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~------------~~~~~~~~~~~~~i~~~l~ 92 (202)
.+..|.......+|++++. ......++++++.+++|..++... .+++..+..++.|++.||.
T Consensus 65 ~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al~ 144 (296)
T cd05095 65 DFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIASGMK 144 (296)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHHHHHH
Confidence 4566666677778888653 345567889999999998877542 3677889999999999999
Q ss_pred HHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHH
Q 044746 93 YLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGML 172 (202)
Q Consensus 93 ~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~ 172 (202)
|||+ .+++|+||||+||+++.++.++|+|||+++...............+++.|++||......++.++|+|||||+
T Consensus 145 ~lH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwSlG~~ 221 (296)
T cd05095 145 YLSS---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVT 221 (296)
T ss_pred HHHH---CCeecccCChheEEEcCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhHHHHH
Confidence 9999 9999999999999999999999999999876533222111222334678999999888889999999999999
Q ss_pred HHHHHc--CCCCCcchh
Q 044746 173 LFEVVG--RRRNLEKEI 187 (202)
Q Consensus 173 l~el~~--g~~p~~~~~ 187 (202)
+|||++ |..||....
T Consensus 222 l~el~~~~~~~p~~~~~ 238 (296)
T cd05095 222 LWEILTLCKEQPYSQLS 238 (296)
T ss_pred HHHHHHhCCCCCccccC
Confidence 999998 778886543
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=183.63 Aligned_cols=179 Identities=19% Similarity=0.284 Sum_probs=135.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+...++.++.|..+.... ......+..|..+....+|++++. ......++++++.+ +|..++..
T Consensus 21 vy~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~L~~~~~~~~ 97 (291)
T cd07844 21 VYKGRSKLTGQLVALKEIRLEHE--EGAPFTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCG 97 (291)
T ss_pred EEEEEEcCCCcEEEEEEEecccc--cCCchhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCCC-CHHHHHHhCC
Confidence 57888877777777776433221 112223445666777778887653 34456688888875 77776643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....... ......++..|+||
T Consensus 98 ~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~aP 172 (291)
T cd07844 98 GGLSMHNVRLFLFQLLRGLAYCHQ---RRVLHRDLKPQNLLISERGELKLADFGLARAKSVPSK--TYSNEVVTLWYRPP 172 (291)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeecccCCHHHEEEcCCCCEEECccccccccCCCCc--cccccccccccCCc
Confidence 358999999999999999999999 9999999999999999999999999999875432211 11223457889999
Q ss_pred cccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.+ ..++.++|+||+|+++++|++|++||....
T Consensus 173 E~~~~~~~~~~~~Dv~slG~il~~l~~g~~~~~~~~ 208 (291)
T cd07844 173 DVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGST 208 (291)
T ss_pred HHhhcCcccCcHHHHHHHHHHHHHHHhCCCCCCCCc
Confidence 99875 457899999999999999999999996544
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-27 Score=198.45 Aligned_cols=149 Identities=21% Similarity=0.281 Sum_probs=115.3
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC------CCCHHHHHHHHHHHHHHHHHHHhC
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN------ILGFGQLREIEVSTSKGIAYLHEE 97 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~------~~~~~~~~~~~~~i~~~l~~lH~~ 97 (202)
..+..|..+....+|+|++. ..+..+++++++. +.+..++... .....+++.++.|++.||.|||+
T Consensus 208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH~- 285 (501)
T PHA03210 208 IQLENEILALGRLNHENILKIEEILRSEANTYMITQKYD-FDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIHD- 285 (501)
T ss_pred HHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEeccc-cCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHHh-
Confidence 34566777788889998874 2333445555554 4555554332 23456788899999999999999
Q ss_pred CCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHH
Q 044746 98 CRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177 (202)
Q Consensus 98 ~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~ 177 (202)
++|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||++.+..++.++|||||||++|||+
T Consensus 286 --~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell 362 (501)
T PHA03210 286 --KKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKEREA-FDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDML 362 (501)
T ss_pred --CCeecCCCCHHHEEECCCCCEEEEeCCCceecCccccc-ccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999999999999999999865433221 123356899999999999989999999999999999999
Q ss_pred cCCCCC
Q 044746 178 GRRRNL 183 (202)
Q Consensus 178 ~g~~p~ 183 (202)
+|..++
T Consensus 363 ~~~~~p 368 (501)
T PHA03210 363 SHDFCP 368 (501)
T ss_pred HCCCCC
Confidence 987543
|
|
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.9e-27 Score=181.33 Aligned_cols=149 Identities=25% Similarity=0.383 Sum_probs=121.9
Q ss_pred cCCcHHHHHHhcccccccc-------ccccceEEEEEccCCchhhhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 044746 31 RFTSPQRMIAADNFSNLVG-------SEDTETYIKGFLAMGPFYLLCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQ 100 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~ 100 (202)
.+..|.......+|++++. .++...++++++++++|..++... .+++..+..++.|++.||.|||+ +
T Consensus 45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~ 121 (256)
T cd05082 45 AFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEA---N 121 (256)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---C
Confidence 4566766777777886653 234456889999999998887543 38899999999999999999999 9
Q ss_pred CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-C
Q 044746 101 KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-R 179 (202)
Q Consensus 101 ~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g 179 (202)
+++||||||+||+++.++.++|+|||+++...... ....++..|+|||++....++.++|+||+||+++||++ |
T Consensus 122 ~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g 196 (256)
T cd05082 122 NFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred CEeccccchheEEEcCCCcEEecCCccceeccccC-----CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999999999999999987543221 11233568999999988889999999999999999997 9
Q ss_pred CCCCcchh
Q 044746 180 RRNLEKEI 187 (202)
Q Consensus 180 ~~p~~~~~ 187 (202)
+.||....
T Consensus 197 ~~p~~~~~ 204 (256)
T cd05082 197 RVPYPRIP 204 (256)
T ss_pred CCCCCCCC
Confidence 99987543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.4e-27 Score=176.46 Aligned_cols=137 Identities=24% Similarity=0.329 Sum_probs=110.1
Q ss_pred cceEEEEEccCCchhhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeec
Q 044746 53 TETYIKGFLAMGPFYLLC-----KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127 (202)
Q Consensus 53 ~~~~~~~~~~~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl 127 (202)
..++...+...|+|.+.+ ++..+++.+.+.++.++++||++||+.. .+..||||||.|||+..++.+++.|||.
T Consensus 97 ~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~gL~~lH~~~-~~yAH~DiKP~NILls~~~~~vl~D~GS 175 (302)
T KOG2345|consen 97 EAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICRGLEALHEKE-PPYAHRDIKPANILLSDSGLPVLMDLGS 175 (302)
T ss_pred eEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHHHHHHHhccC-CcccccCCCcceeEecCCCceEEEeccC
Confidence 355777788999887776 3446999999999999999999999832 3599999999999999999999999999
Q ss_pred ceeccccCc-------ccccCCCCCCCcccCCcccCC---CCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 128 AKLYNREHT-------HITSTGRRRTPGCEAPELWMP---YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 128 ~~~~~~~~~-------~~~~~~~~gt~~y~aPe~~~~---~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
+....-... .........|..|.|||++.. ...+.++|||||||++|+|+.|..||+..-..+
T Consensus 176 ~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~G 248 (302)
T KOG2345|consen 176 ATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTITERTDIWSLGCTLYAMMFGESPFERIYQQG 248 (302)
T ss_pred ccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCcccccccchhhhhHHHHHHHHcCCcchHHhhcC
Confidence 875431110 001112344889999999864 457899999999999999999999999887755
|
|
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=180.57 Aligned_cols=178 Identities=24% Similarity=0.334 Sum_probs=135.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--- 72 (202)
||++....+.. ++.|...... .....+..|.......+|++++. ......++++++.+++|..++..
T Consensus 22 v~~~~~~~~~~-~a~K~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~ 96 (260)
T cd05067 22 VWMGYYNGHTK-VAIKSLKQGS----MSPEAFLAEANLMKQLQHPRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPEG 96 (260)
T ss_pred EEeeecCCCce-EEEEEecCCC----CcHHHHHHHHHHHHhcCCcCeeeEEEEEccCCcEEEEEcCCCCCHHHHHHhcCC
Confidence 57777666555 4444322211 11234666766777778887653 23345688889999999887643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||+|||+ .+++|+||||+||+++.++.++++|||++......... ......++..|+||
T Consensus 97 ~~~~~~~~~~i~~~i~~al~~LH~---~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~y~~p 172 (260)
T cd05067 97 IKLTINKLIDMAAQIAEGMAFIER---KNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP 172 (260)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHHhEEEcCCCCEEEccCcceeecCCCCcc-cccCCcccccccCH
Confidence 358999999999999999999999 99999999999999999999999999999765422211 11223346789999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
|++....++.++|+||||++++|+++ |++||....
T Consensus 173 e~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~ 208 (260)
T cd05067 173 EAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMT 208 (260)
T ss_pred HHhccCCcCcccchHHHHHHHHHHHhCCCCCCCCCC
Confidence 99988888999999999999999998 999997544
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=182.74 Aligned_cols=180 Identities=23% Similarity=0.229 Sum_probs=143.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++.+..++..++.|+...... ......+..+.......+|++++. .+....++++++.+++|..+.....
T Consensus 20 vy~~~~~~~~~~~aiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~ 97 (277)
T cd06641 20 VFKGIDNRTQKVVAIKIIDLEEA--EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP 97 (277)
T ss_pred EEEEEECCCCcEEEEEEeccccc--hHHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhcCC
Confidence 67887777777777776432211 112234666666777788887662 3455678999999999999988888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++......... .....++..|+|||.
T Consensus 98 ~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~y~~PE~ 172 (277)
T cd06641 98 LDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQIK--RNTFVGTPFWMAPEV 172 (277)
T ss_pred CCHHHHHHHHHHHHHHHHHHcc---CCeecCCCCHHhEEECCCCCEEEeecccceecccchhh--hccccCCccccChhh
Confidence 9999999999999999999999 99999999999999999999999999998765432211 122456888999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||+|++++++++|..||....
T Consensus 173 ~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 205 (277)
T cd06641 173 IKQSAYDSKADIWSLGITAIELAKGEPPHSELH 205 (277)
T ss_pred hccCCCCchhhHHHHHHHHHHHHcCCCCCCccc
Confidence 988888999999999999999999999997543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.3e-27 Score=180.74 Aligned_cols=181 Identities=17% Similarity=0.242 Sum_probs=138.0
Q ss_pred CccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC--
Q 044746 2 EKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN-- 73 (202)
Q Consensus 2 ~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~-- 73 (202)
|.+++...++.++.|...... .......++..|.......+|++++. ......++++++.+++|.+++...
T Consensus 17 ~~~~~~~~~~~~~~k~~~~~~-~~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~ 95 (256)
T cd08221 17 TLYRRTEDDSLVVWKEVNLTR-LSEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKG 95 (256)
T ss_pred EEEEEcCCCcEEEEEEEeecc-cchhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccc
Confidence 445555555555554322111 11122334556666677778887653 344556788999999999888653
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++........ ......+++.|+||
T Consensus 96 ~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~--~~~~~~~~~~y~ap 170 (256)
T cd08221 96 QLFEEEMVLWYLFQIVSAVSYIHK---AGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS--MAETVVGTPYYMSP 170 (256)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChHhEEEeCCCCEEECcCcceEEcccccc--cccccCCCccccCH
Confidence 58999999999999999999999 8999999999999999999999999999986544332 12334578999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+|++++||++|+.||.....
T Consensus 171 e~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~~ 206 (256)
T cd08221 171 ELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNP 206 (256)
T ss_pred hhcCCCCCCCcchhHHHHHHHHHHHHCCCCCCCCCH
Confidence 999888889999999999999999999999976443
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=179.93 Aligned_cols=180 Identities=22% Similarity=0.322 Sum_probs=138.4
Q ss_pred CCccccCCCc----ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGST----RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~----~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++...+ ..++.|..+..... +....+..|.......+|++++. ..+...++++++.+++|..++
T Consensus 15 v~~~~~~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~ 92 (258)
T smart00219 15 VYKGTLKGLSGEKEVEVAVKTLKEDADE--QQIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYL 92 (258)
T ss_pred eEEEEecCCCCCCCceEEEEEccCCCCh--HHHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHH
Confidence 4666665544 66776664332211 12345666666666678887653 334567888999999998888
Q ss_pred ccCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 71 KKNI---LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 71 ~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
.... +++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++............ ...+++
T Consensus 93 ~~~~~~~~~~~~~~~~~~ql~~~l~~lh~---~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~-~~~~~~ 168 (258)
T smart00219 93 RKNRPKELSLSDLLSFALQIARGMEYLES---KNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYYKKK-GGKLPI 168 (258)
T ss_pred HhhhhccCCHHHHHHHHHHHHHHHHHHhc---CCeeecccccceEEEccCCeEEEcccCCceecccccccccc-cCCCcc
Confidence 6543 9999999999999999999999 99999999999999999999999999999866544222211 223578
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcch
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKE 186 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~ 186 (202)
.|+|||.+....++.++|+||+|+++++|++ |++||...
T Consensus 169 ~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~g~~p~~~~ 208 (258)
T smart00219 169 RWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGESPYPGM 208 (258)
T ss_pred cccChHHhccCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999988888999999999999999998 88998754
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=186.63 Aligned_cols=176 Identities=22% Similarity=0.317 Sum_probs=132.9
Q ss_pred CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC---CCCHH
Q 044746 8 GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN---ILGFG 78 (202)
Q Consensus 8 ~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~ 78 (202)
..+..|++|+.+.. ...+....|..+.......+|+|++. ..+...++++++++|+|..++... .+++.
T Consensus 26 ~~~~~V~vk~~~~~--~~~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~ 103 (259)
T PF07714_consen 26 DKNQPVAVKILKPS--SSEEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQ 103 (259)
T ss_dssp SSEEEEEEEEESTT--SSHHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHH
T ss_pred CCCEEEEEEEeccc--cccccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 44555666554332 11112345666777777778998763 234467889999999999988765 79999
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCC
Q 044746 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY 158 (202)
Q Consensus 79 ~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~ 158 (202)
.+..++.|++.||.|||+ ++++|++|+++||+++.++.+||+|||++....................|+|||.+...
T Consensus 104 ~~~~i~~~i~~~l~~Lh~---~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~ 180 (259)
T PF07714_consen 104 QRLSIAIQIAEALSYLHS---NNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDG 180 (259)
T ss_dssp HHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHS
T ss_pred cccccccccccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999999 99999999999999999999999999999876332222223334457789999999888
Q ss_pred CCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 159 SVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 159 ~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
.++.++||||||+++||+++ |+.||.....
T Consensus 181 ~~~~ksDVysfG~~l~ei~~~~~~p~~~~~~ 211 (259)
T PF07714_consen 181 EYTKKSDVYSFGMLLYEILTLGKFPFSDYDN 211 (259)
T ss_dssp EESHHHHHHHHHHHHHHHHTTSSGTTTTSCH
T ss_pred ccccccccccccccccccccccccccccccc
Confidence 89999999999999999999 7899876533
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.8e-27 Score=185.13 Aligned_cols=174 Identities=21% Similarity=0.282 Sum_probs=131.0
Q ss_pred CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc----------
Q 044746 9 STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK---------- 72 (202)
Q Consensus 9 ~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~---------- 72 (202)
....++.|+.+.... ......+..|.......+|++++. .+....++++++.+++|..++..
T Consensus 34 ~~~~~aiK~~~~~~~--~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~ 111 (288)
T cd05050 34 PFTMVAVKMLKEEAS--ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLS 111 (288)
T ss_pred cceeEEEEecCCCcC--HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCcccccccc
Confidence 345555555432211 111234666767777778887763 34456788999999999888742
Q ss_pred -------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc
Q 044746 73 -------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT 139 (202)
Q Consensus 73 -------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~ 139 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++++|||++...........
T Consensus 112 ~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~ 188 (288)
T cd05050 112 HSTSSARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKA 188 (288)
T ss_pred ccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCeecccccHhheEecCCCceEECccccceecccCccccc
Confidence 237788899999999999999999 9999999999999999999999999999875433222222
Q ss_pred cCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 140 STGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 140 ~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
......+..|+|||.+.+..++.++|+|||||+++||++ |..||.+..
T Consensus 189 ~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~ 237 (288)
T cd05050 189 SENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQPYYGMA 237 (288)
T ss_pred cCCCccChhhcCHHHHhcCCCCchhHHHHHHHHHHHHHhCCCCCCCCCC
Confidence 222334667999999988889999999999999999997 888986543
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.3e-27 Score=189.14 Aligned_cols=178 Identities=21% Similarity=0.267 Sum_probs=133.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccccc-----------ceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDT-----------ETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~-----------~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.||.|..+.... .......+..|.......+|+++++..+. ..++.+...+++|..+
T Consensus 33 v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~~~~L~~~ 111 (345)
T cd07877 33 VCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 111 (345)
T ss_pred EEEEEEcCCCeEEEEEEecCcch-hhHHHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhcccCHHHH
Confidence 56777766677777665432211 11112335556667777788987753321 1233334457788888
Q ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++...... .....++..|
T Consensus 112 ~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~y 183 (345)
T cd07877 112 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 183 (345)
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEcCCCCEEEeccccccccccc-----ccccccCCCc
Confidence 877789999999999999999999999 99999999999999999999999999998754321 2234568899
Q ss_pred cCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||.+.+ ..++.++|+||+||+++|+++|++||....
T Consensus 184 ~aPE~~~~~~~~~~~~DvwslG~il~el~~g~~pf~~~~ 222 (345)
T cd07877 184 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTD 222 (345)
T ss_pred cCHHHHhCccCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998866 467889999999999999999999996543
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.3e-27 Score=185.20 Aligned_cols=179 Identities=21% Similarity=0.221 Sum_probs=133.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc---c--------cccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG---S--------EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~---~--------~~~~~~~~~~~~~~~l~~ 68 (202)
||++.+..+++.++.|+....... ...+..+....... +|+|++. . ++...++++++++++|..
T Consensus 38 vy~~~~~~~~~~~aik~~~~~~~~----~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~ 113 (291)
T cd06639 38 VYKVTNKKDGSLAAVKILDPISDV----DEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTE 113 (291)
T ss_pred EEEEEECCCCCEEEEEEecccccH----HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHH
Confidence 577777777777777765332111 11233333333333 6776653 1 134578999999999988
Q ss_pred hhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCC
Q 044746 69 LCK-----KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 69 ~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
+++ ...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... ....
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~ 188 (291)
T cd06639 114 LVKGLLICGQRLDEAMISYILYGALLGLQHLHN---NRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRLR--RNTS 188 (291)
T ss_pred HHHHhhhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHEEEcCCCCEEEeecccchhccccccc--ccCc
Confidence 764 3568999999999999999999999 99999999999999999999999999998764332211 1234
Q ss_pred CCCCcccCCcccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPY-----SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~-----~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|+..|+|||.+... .++.++|+||+||+++||++|++||....+
T Consensus 189 ~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slGvi~~el~~g~~p~~~~~~ 238 (291)
T cd06639 189 VGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHP 238 (291)
T ss_pred cCCccccChhhhcCCCCcccccCCccchHHHHHHHHHHhhCCCCCCCCcH
Confidence 568899999987543 367899999999999999999999976543
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.6e-27 Score=183.17 Aligned_cols=184 Identities=17% Similarity=0.207 Sum_probs=133.4
Q ss_pred CCccccC---CCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCc
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGP 65 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~ 65 (202)
||++... +.++.++.|+.+..... .....++..|.......+|++++...+ ...++.++..+++
T Consensus 15 v~~~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 93 (273)
T cd05074 15 VREAQLKSEDGSFQKVAVKMLKADIFS-SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGD 93 (273)
T ss_pred EEeeEeeccCCCceEEEEEEeccccCC-hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCc
Confidence 4555532 34566666654322111 112234556666777778888763221 1246677888898
Q ss_pred hhhhhcc-------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc
Q 044746 66 FYLLCKK-------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138 (202)
Q Consensus 66 l~~~~~~-------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~ 138 (202)
|..++.. ..+++.....++.|++.||.|||+ .+++||||||+||+++.++.++++|||+++.........
T Consensus 94 l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~~~ 170 (273)
T cd05074 94 LHTFLLMSRIGEEPFTLPLQTLVRFMIDIASGMEYLSS---KNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDYYR 170 (273)
T ss_pred HHHHHHHhcccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCEeecccchhhEEEcCCCCEEECcccccccccCCccee
Confidence 8766521 247889999999999999999999 999999999999999999999999999988654332222
Q ss_pred ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
......+++.|++||.+....++.++|+||||+++||+++ |++||.....
T Consensus 171 ~~~~~~~~~~~~~pe~~~~~~~~~~sDi~slG~il~el~~~g~~p~~~~~~ 221 (273)
T cd05074 171 QGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVEN 221 (273)
T ss_pred cCCCccCchhhcCHhHHhcCccchhhhhHHHHHHHHHHhhCCCCCCCCCCH
Confidence 2223345678999999988888999999999999999999 8999875543
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-26 Score=185.39 Aligned_cols=182 Identities=12% Similarity=0.102 Sum_probs=138.1
Q ss_pred CccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc---
Q 044746 2 EKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK--- 72 (202)
Q Consensus 2 ~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~--- 72 (202)
|.+++...++.+|.|..+... ...+....+..|.......+|++++. ......++++++.++++..++..
T Consensus 17 ~~~~~~~~~~~~avK~~~~~~-~~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~ 95 (314)
T cd08216 17 HLAKHKPTNTLVAVKKINLDS-CSKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFP 95 (314)
T ss_pred EEEEecCCCCEEEEEEEeccc-cchhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcc
Confidence 455666667777777654321 22223445667777777778887663 33456688899999999888754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-----ccccCCCCCCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-----HITSTGRRRTP 147 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-----~~~~~~~~gt~ 147 (202)
..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++++|||.+........ ........++.
T Consensus 96 ~~~~~~~~~~~~~~l~~~L~~LH~---~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 172 (314)
T cd08216 96 EGLPELAIAFILKDVLNALDYIHS---KGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNL 172 (314)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccc
Confidence 358899999999999999999999 9999999999999999999999999998875432111 01112234577
Q ss_pred cccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 148 GCEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 148 ~y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.|+|||++.. ..++.++|+||+|++++|+++|+.||....
T Consensus 173 ~y~aPE~~~~~~~~~~~~~Diws~G~il~el~~g~~pf~~~~ 214 (314)
T cd08216 173 PWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFKDMP 214 (314)
T ss_pred cccCHHHhcCCCCCCCcchhHHHHHHHHHHHHhCCCCCCCCC
Confidence 8999999875 357889999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=181.64 Aligned_cols=181 Identities=20% Similarity=0.266 Sum_probs=140.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+...+..++.|+...... ......++..+.......+|++++.. +....++++++.+++|..++..
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~ 94 (265)
T cd08217 16 VRKVRRKSDGKILVWKEIDYGNM-TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQK 94 (265)
T ss_pred EEEeeecCCCCEEEEEEEecccC-CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHH
Confidence 57888877777777765432211 11122345556666777788877632 2334678889999999887743
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHH-----hCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 73 -----NILGFGQLREIEVSTSKGIAYLH-----EECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 73 -----~~~~~~~~~~~~~~i~~~l~~lH-----~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
..+++..+..++.|++.||.||| + .+++|+||+|+||+++.++.++++|||++......... ...
T Consensus 95 ~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~~~---~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~ 169 (265)
T cd08217 95 CKKERKYIEEEFIWRILTQLLLALYECHNRSDPG---NTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSSF--AKT 169 (265)
T ss_pred HhhcccCCCHHHHHHHHHHHHHHHHHHhcCcccc---CcceecCCCHHHEEEecCCCEEEecccccccccCCccc--ccc
Confidence 56899999999999999999999 6 89999999999999999999999999999865433221 123
Q ss_pred CCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
..+++.|+|||.+....++.++|+||+|++++++++|+.||....
T Consensus 170 ~~~~~~~~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 214 (265)
T cd08217 170 YVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTARN 214 (265)
T ss_pred cccCCCccChhhhcCCCCCchhHHHHHHHHHHHHHHCCCcccCcC
Confidence 456889999999988888999999999999999999999998653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=184.15 Aligned_cols=154 Identities=21% Similarity=0.304 Sum_probs=124.6
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC------------CCCHHHHHHHHHHHHHHH
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN------------ILGFGQLREIEVSTSKGI 91 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~------------~~~~~~~~~~~~~i~~~l 91 (202)
..+..|.......+|++++. ..+...++++++.+++|..++... .+++..+..++.|++.||
T Consensus 64 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~al 143 (296)
T cd05051 64 EDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQIASGM 143 (296)
T ss_pred HHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHHHHHH
Confidence 34556666677778887653 335667888999999998887443 489999999999999999
Q ss_pred HHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHH
Q 044746 92 AYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGM 171 (202)
Q Consensus 92 ~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~ 171 (202)
.|||+ .+++||||||+||+++.++.++|+|||+++...............+++.|+|||.+....++.++||||||+
T Consensus 144 ~~LH~---~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~ 220 (296)
T cd05051 144 RYLES---LNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGV 220 (296)
T ss_pred HHHHH---cCccccccchhceeecCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhhhhHH
Confidence 99999 999999999999999999999999999987654332222223344577899999998888999999999999
Q ss_pred HHHHHHc--CCCCCcch
Q 044746 172 LLFEVVG--RRRNLEKE 186 (202)
Q Consensus 172 ~l~el~~--g~~p~~~~ 186 (202)
++||+++ |..||...
T Consensus 221 ~l~el~~~~~~~p~~~~ 237 (296)
T cd05051 221 TLWEILTLCREQPYEHL 237 (296)
T ss_pred HHHHHHhcCCCCCCCCc
Confidence 9999998 77787653
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=181.83 Aligned_cols=182 Identities=21% Similarity=0.253 Sum_probs=139.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++.+..+++.++.|..+.... .......+..|.......+|++++. .++...++++++.++.+..+... .
T Consensus 17 v~~~~~~~~~~~v~vK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~ 95 (288)
T cd07833 17 VLKCRNKATGEIVAIKKFKESED-DEDVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPG 95 (288)
T ss_pred EEEEEeCCCCcEEEEehhhhhcc-cccchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCC
Confidence 57788877777777776433221 2222344566666666667777653 33445688888888777665543 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......... ......++..|+|||
T Consensus 96 ~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~~-~~~~~~~~~~~~~PE 171 (288)
T cd07833 96 GLPPDAVRSYIWQLLQAIAYCHS---HNIIHRDIKPENILVSESGVLKLCDFGFARALRARPAS-PLTDYVATRWYRAPE 171 (288)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEEeeecccccCCCccc-cccCcccccCCcCCc
Confidence 58999999999999999999999 99999999999999999999999999998865433221 112345688899999
Q ss_pred ccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++... .++.++|+||+|++++++++|++||....
T Consensus 172 ~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~ 206 (288)
T cd07833 172 LLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDS 206 (288)
T ss_pred hhcCCCCcCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99887 78899999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=182.08 Aligned_cols=180 Identities=21% Similarity=0.284 Sum_probs=136.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++..+++.++.|..+... ........+..|.......+|++++. .+....++++++. ++|..+..
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~ 93 (284)
T cd07860 16 VYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASP 93 (284)
T ss_pred EEEEEECCCCCEEEEEEccccc-cccccchHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCC
Confidence 5788887777777776543221 12222334666777777888888663 3445567888885 56666553
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......+++.|+|
T Consensus 94 ~~~l~~~~~~~~~~~i~~~l~~lh~---~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~a 168 (284)
T cd07860 94 LSGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRA 168 (284)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEeeccchhhcccCcc--ccccccccccccC
Confidence 3568999999999999999999999 9999999999999999999999999999875432211 1122345788999
Q ss_pred CcccCCCC-CCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYS-VTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~-~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||.+.+.. ++.++|+||||++++|++||+.||....
T Consensus 169 PE~~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 205 (284)
T cd07860 169 PEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDS 205 (284)
T ss_pred CeEEecCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99887644 5888999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.4e-27 Score=187.93 Aligned_cols=182 Identities=18% Similarity=0.230 Sum_probs=136.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc----------ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG----------SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~----------~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++...+..++.|...... ........+..|..+....+|++++. .+....++++++. ++|..++
T Consensus 21 v~~~~~~~~~~~valK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~ 98 (334)
T cd07855 21 VCSAIDTRSGKKVAIKKIPHAF-DVPTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHII 98 (334)
T ss_pred EEEEEEcCCCCEEEEEEecccc-ccccchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHh
Confidence 5777777767777766543221 11222334555666777778888764 2234568888886 5777776
Q ss_pred c-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc--ccCCCCCCC
Q 044746 71 K-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI--TSTGRRRTP 147 (202)
Q Consensus 71 ~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~--~~~~~~gt~ 147 (202)
. ...+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++.......... ......|+.
T Consensus 99 ~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~ 175 (334)
T cd07855 99 HSDQPLTEEHIRYFLYQLLRGLKYIHS---ANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATR 175 (334)
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccc
Confidence 4 4458999999999999999999999 999999999999999999999999999997654322111 112345788
Q ss_pred cccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 148 GCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 148 ~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.|+|||.+.. ..++.++|+||+|++++||++|++||....
T Consensus 176 ~y~~PE~~~~~~~~~~~~Di~slG~~l~el~~g~~pf~~~~ 216 (334)
T cd07855 176 WYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKN 216 (334)
T ss_pred cccChHHhcCCcccccccchHHHHHHHHHHHcCCCccCCCC
Confidence 9999998765 457899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.1e-27 Score=184.27 Aligned_cols=179 Identities=20% Similarity=0.198 Sum_probs=135.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc-----------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG-----------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~-----------~~~~~~~~~~~~~~~~l~~ 68 (202)
||++++...+..++.|+.+..... ...+..|....... +|++++. .++...++++++++++|..
T Consensus 34 vy~~~~~~~~~~~~ik~~~~~~~~----~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 109 (286)
T cd06638 34 VFKVLNKKNGSKAAVKILDPIHDI----DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTD 109 (286)
T ss_pred EEEEEECCCCceeEEEeeccccch----HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHH
Confidence 577888777777777764332111 12233344444443 6777653 2345679999999999987
Q ss_pred hhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCC
Q 044746 69 LCK-----KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 69 ~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
++. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....... .....
T Consensus 110 ~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~ 184 (286)
T cd06638 110 LVKGFLKRGERMEEPIIAYILHEALMGLQHLHV---NKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL--RRNTS 184 (286)
T ss_pred HHHHhhccCccccHHHHHHHHHHHHHHHHHHHh---CCccccCCCHHhEEECCCCCEEEccCCceeecccCCC--ccccc
Confidence 653 3458899999999999999999999 9999999999999999999999999999886543221 12234
Q ss_pred CCCCcccCCcccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMP-----YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~-----~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|++.|+|||++.. ..++.++|+||+||+++||++|+.||....+
T Consensus 185 ~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvi~~el~~g~~p~~~~~~ 234 (286)
T cd06638 185 VGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLADLHP 234 (286)
T ss_pred cCCCcccChhhhchhhhccccccchhhhhhHHHHHHHHhcCCCCCCCCch
Confidence 57899999998753 3478899999999999999999999976543
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.6e-27 Score=183.26 Aligned_cols=179 Identities=23% Similarity=0.257 Sum_probs=134.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------------ccccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------------SEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------------~~~~~~~~~~~~~~~~l~ 67 (202)
||++++...++.++.|+...... ....+..+....... +|++++. ......++++++.+++|.
T Consensus 32 v~~~~~~~~~~~~a~K~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~ 107 (282)
T cd06636 32 VYKGRHVKTGQLAAIKVMDVTED----EEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVT 107 (282)
T ss_pred EEEEEEcCCCcEEEEEEEecChH----HHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHH
Confidence 57788877788888876433211 112233343333333 6777652 234457899999999998
Q ss_pred hhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCC
Q 044746 68 LLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 68 ~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
.+... ..+++..+..++.|++.|+.|||+ .+++|+|++|+||+++.++.++|+|||++........ ......
T Consensus 108 ~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~ 182 (282)
T cd06636 108 DLVKNTKGNALKEDWIAYICREILRGLAHLHA---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFI 182 (282)
T ss_pred HHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCcchhhhhcccc--CCCccc
Confidence 87754 348888899999999999999999 9999999999999999999999999999875432211 123345
Q ss_pred CCCcccCCcccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 145 RTPGCEAPELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 145 gt~~y~aPe~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.|+|||.+. ...++.++|+||+|+++|||++|+.||....+
T Consensus 183 ~~~~y~aPE~l~~~~~~~~~~~~~~DvwslG~~l~el~~g~~p~~~~~~ 231 (282)
T cd06636 183 GTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPLCDMHP 231 (282)
T ss_pred ccccccCHhhcCcccCcCcCCCcccchhHHHHHHHHHHhCCCCccccCH
Confidence 788999999875 34578899999999999999999999976543
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9e-27 Score=183.79 Aligned_cols=173 Identities=20% Similarity=0.247 Sum_probs=133.0
Q ss_pred cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhccC--CC
Q 044746 6 NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCKKN--IL 75 (202)
Q Consensus 6 ~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~~~--~~ 75 (202)
....+..++.|..+.. ........+..|.......+|++++.. +....+++++.++++|..++... .+
T Consensus 29 ~~~~~~~va~K~~~~~--~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~ 106 (284)
T cd05079 29 GDNTGEQVAVKSLKPE--SGGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKI 106 (284)
T ss_pred CCCccceEEEEEcCcc--ccHHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCC
Confidence 3455566666654322 112223456777777888888887632 23456889999999999887543 58
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCCcccCCcc
Q 044746 76 GFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 76 ~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~~y~aPe~ 154 (202)
++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||+++........ .......++..|+|||+
T Consensus 107 ~~~~~~~i~~~i~~aL~~lH~---~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~ 183 (284)
T cd05079 107 NLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPEC 183 (284)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCeeecccchheEEEcCCCCEEECCCccccccccCccceeecCCCCCCccccCHHH
Confidence 999999999999999999999 99999999999999999999999999999865432221 11123445778999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCC
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNL 183 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~ 183 (202)
+.+..++.++|+||+|++++|+++++.|.
T Consensus 184 ~~~~~~~~~~Di~slG~il~ellt~~~~~ 212 (284)
T cd05079 184 LIQSKFYIASDVWSFGVTLYELLTYCDSE 212 (284)
T ss_pred hccCCCCccccchhhhhhhhhhhcCCCCC
Confidence 98888999999999999999999987764
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=9.2e-27 Score=184.82 Aligned_cols=179 Identities=20% Similarity=0.251 Sum_probs=140.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++.....++.++.|...... ......+..|.......+|++++. .+....++++++++++|..+...+.
T Consensus 36 v~~~~~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 112 (292)
T cd06657 36 VCIATVKSSGKLVAVKKMDLRK---QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR 112 (292)
T ss_pred EEEEEEcCCCeEEEEEEecccc---hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHhcCC
Confidence 4667776666666666432111 112233555656666777887652 3556678999999999999988888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.....++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++........ ......|++.|+|||.
T Consensus 113 ~~~~~~~~~~~ql~~~l~~lH~---~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~y~~pE~ 187 (292)
T cd06657 113 MNEEQIAAVCLAVLKALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEL 187 (292)
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCCEEEcccccceecccccc--cccccccCccccCHHH
Confidence 9999999999999999999999 9999999999999999999999999998875543221 1223456889999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+....++.++|+||+|++++++++|.+||....
T Consensus 188 ~~~~~~~~~~Dv~slGvil~el~tg~~p~~~~~ 220 (292)
T cd06657 188 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEP 220 (292)
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 988888999999999999999999999987543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.9e-27 Score=189.77 Aligned_cols=181 Identities=18% Similarity=0.224 Sum_probs=144.3
Q ss_pred ccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhccC--C
Q 044746 3 KPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKKN--I 74 (202)
Q Consensus 3 k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~~--~ 74 (202)
.||+.=.+.-||+|+-.+.......... +..|........|+|++ ...+-.+++.+.-.+|.|++++-++ .
T Consensus 36 LArHVFTGekVAVKviDKTKlD~~st~h-lfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~G 114 (864)
T KOG4717|consen 36 LARHVFTGEKVAVKVIDKTKLDTLSTGH-LFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEG 114 (864)
T ss_pred hhhhhcccceeEEEEecccccchhhhhH-HHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhcc
Confidence 4666667778888876555444333333 33445555667788776 4555667888998999999988554 5
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc-CCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
+.++.++.++.||..|+.|+|+ ..++||||||+|+++- .-|.+||.|||.+..+..... .+..+|+..|-|||
T Consensus 115 l~E~La~kYF~QI~~AI~YCHq---LHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~k---L~TsCGSLAYSAPE 188 (864)
T KOG4717|consen 115 LNEDLAKKYFAQIVHAISYCHQ---LHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGKK---LTTSCGSLAYSAPE 188 (864)
T ss_pred ccHHHHHHHHHHHHHHHHHHhh---hhhhcccCCcceeEEeeecCceEeeeccccccCCCcch---hhcccchhhccCch
Confidence 9999999999999999999999 8999999999999764 668999999999976655443 35567899999999
Q ss_pred ccCCCCCC-chhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 154 LWMPYSVT-QKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 154 ~~~~~~~~-~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
++.+..|+ +++||||+|++||-|+-|++||...++.+
T Consensus 189 ILLGDsYDAPAVDiWSLGVILyMLVCGq~PFqeANDSE 226 (864)
T KOG4717|consen 189 ILLGDSYDAPAVDIWSLGVILYMLVCGQPPFQEANDSE 226 (864)
T ss_pred hhhcCccCCcchhhhHHHHHHHHHHhCCCccccccchh
Confidence 99998887 66999999999999999999998776654
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=180.39 Aligned_cols=179 Identities=26% Similarity=0.358 Sum_probs=135.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+.++.. ++.|...... .....+..|.......+|++++. ......++++++++++|..++..
T Consensus 22 v~~~~~~~~~~-~~vK~~~~~~----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~ 96 (261)
T cd05034 22 VWMGTWNGTTK-VAVKTLKPGT----MSPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGE 96 (261)
T ss_pred EEEEEEcCCce-EEEEEecCCc----cCHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccc
Confidence 57777655434 4444332211 11234566666777778887652 33456688889999999988854
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.+++.|+.|||+ ++++|+||||+||+++.++.++++|||++......... ......++..|+|
T Consensus 97 ~~~~~~~~~~~~~~~i~~al~~lh~---~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~~ 172 (261)
T cd05034 97 GKKLRLPQLVDMAAQIAEGMAYLES---RNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEYT-AREGAKFPIKWTA 172 (261)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcchheEEEcCCCCEEECccccceeccchhhh-hhhccCCCccccC
Confidence 358999999999999999999999 99999999999999999999999999998865432111 1112233568999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||.+.+..++.++|+||+|++++++++ |+.||.+...
T Consensus 173 PE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 210 (261)
T cd05034 173 PEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTN 210 (261)
T ss_pred HHHhccCCcCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999998889999999999999999998 9999976443
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=99.94 E-value=7.5e-27 Score=188.06 Aligned_cols=183 Identities=16% Similarity=0.172 Sum_probs=138.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.||.|+....... .+....+..|..+....+|+|++. .++..+++++++.++++..++..
T Consensus 16 v~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~ 94 (328)
T cd08226 16 VYLARHTPTGTLVTVRITDLENCT-EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYF 94 (328)
T ss_pred EEEEEEcCCCcEEEEEEeccccCC-HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhc
Confidence 678888888889998876432211 122345666777777788998763 44556788899999999887754
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-----ccCCCCCC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-----TSTGRRRT 146 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-----~~~~~~gt 146 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++||+.+.......... ......++
T Consensus 95 ~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (328)
T cd08226 95 PEGMSEALIGNILFGALRGLNYLHQ---NGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSV 171 (328)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCc
Confidence 348999999999999999999999 999999999999999999999999997554221111000 00112235
Q ss_pred CcccCCcccCCC--CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWMPY--SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~--~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
..|+|||++.+. .++.++|+||+||+++|+++|++||....
T Consensus 172 ~~y~aPE~~~~~~~~~~~~~DiwslG~~l~el~~g~~p~~~~~ 214 (328)
T cd08226 172 LPWLSPELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDML 214 (328)
T ss_pred cCccChhhhcCCCCCCCchhhHHHHHHHHHHHHhCCCCCCCcC
Confidence 679999998763 47899999999999999999999997543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=99.94 E-value=1e-26 Score=181.81 Aligned_cols=154 Identities=21% Similarity=0.373 Sum_probs=125.0
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
.+..|.......+|++++. ..+...++++++++++|..++... .+++.++..++.|++.|+.|||+ .++
T Consensus 51 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i 127 (267)
T cd05066 51 DFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSD---MGY 127 (267)
T ss_pred HHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCE
Confidence 4566666677778888763 345567889999999998887543 58999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RR 180 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~ 180 (202)
+||||||+||+++.++.++++|||++.......... ......++..|+|||++.+..++.++|+||||++++|+++ |+
T Consensus 128 ~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~ell~~g~ 207 (267)
T cd05066 128 VHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGE 207 (267)
T ss_pred eehhhchhcEEECCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHHhcCCC
Confidence 999999999999999999999999998654332211 1122223567999999998889999999999999999886 99
Q ss_pred CCCcchh
Q 044746 181 RNLEKEI 187 (202)
Q Consensus 181 ~p~~~~~ 187 (202)
.||....
T Consensus 208 ~p~~~~~ 214 (267)
T cd05066 208 RPYWEMS 214 (267)
T ss_pred CCcccCC
Confidence 9997654
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.5e-26 Score=183.17 Aligned_cols=180 Identities=19% Similarity=0.245 Sum_probs=134.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------c--ccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------E--DTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~--~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+...+..++.|..+..... ......+..|.......+|++++.. . ...+++++++. ++|..++..
T Consensus 21 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~ 98 (293)
T cd07843 21 VYRARDKKTGEIVALKKLKMEKEK-EGFPITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMET 98 (293)
T ss_pred EEEEEECCCCcEEEEEEEeecccc-ccchhhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHh
Confidence 577888766666666554332221 1222234456666667778876531 2 55667778776 477666643
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++.++..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... .....+++.|+
T Consensus 99 ~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~ 173 (293)
T cd07843 99 MKQPFLQSEVKCLMLQLLSGVAHLHD---NWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPLKP--YTQLVVTLWYR 173 (293)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCcEEEeecCceeeccCCccc--ccccccccccc
Confidence 348999999999999999999999 99999999999999999999999999999865443211 12234588899
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+.+. .++.++|+||+|+++++|++|++||....
T Consensus 174 aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~f~~~~ 211 (293)
T cd07843 174 APELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKS 211 (293)
T ss_pred CchhhcCCccccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998754 46889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=8.5e-27 Score=183.93 Aligned_cols=180 Identities=19% Similarity=0.228 Sum_probs=141.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.++.|+..... .......+..|..+....+|++++. ..+...++++++++++|..+... +
T Consensus 21 v~~~~~~~~~~~~a~k~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 98 (284)
T cd06620 21 VSKVKHIPTGTVMAKKVVHIGA--KSSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGG 98 (284)
T ss_pred EEEEEEcCCCcEEEEEEEEecC--cchHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhcc
Confidence 5777777777778877643321 1222344666666677778887653 33456688999999999887755 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.+++.||.|||+. .+++|+||+|+||+++.++.++|+|||++....... .....|+..|+|||
T Consensus 99 ~~~~~~~~~~~~~i~~~l~~LH~~--~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~----~~~~~~~~~~~aPE 172 (284)
T cd06620 99 PIPVEILGKIAVAVVEGLTYLYNV--HRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI----ADTFVGTSTYMSPE 172 (284)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHh--cCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc----cCccccCcccCCHH
Confidence 689999999999999999999962 589999999999999999999999999986542211 12345789999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++|+||+||+++++++|+.||.....
T Consensus 173 ~~~~~~~~~~~Di~slG~~l~~l~tg~~p~~~~~~ 207 (284)
T cd06620 173 RIQGGKYTVKSDVWSLGISIIELALGKFPFAFSNI 207 (284)
T ss_pred HHccCCCCccchHHHHHHHHHHHHhCCCCCcccch
Confidence 99888889999999999999999999999986554
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.6e-26 Score=186.70 Aligned_cols=182 Identities=20% Similarity=0.225 Sum_probs=134.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccccc--------cccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGS--------EDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++.+..++..++.|...... ........+..|....... +|++++.. +....++++++. ++|..+..
T Consensus 23 v~~~~~~~~~~~~~vK~~~~~~-~~~~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 100 (337)
T cd07852 23 VWKAIDRRTKEVVALKKIFDAF-RNATDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIR 100 (337)
T ss_pred EEEEEEcCCCeEEEEEeecccc-CcchhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHh
Confidence 5777777666666555332111 1111223345566666666 88887532 123457777776 58888887
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc---cccCCCCCCCc
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH---ITSTGRRRTPG 148 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~---~~~~~~~gt~~ 148 (202)
.+.+++.....++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .......|+..
T Consensus 101 ~~~~~~~~~~~i~~qi~~~L~~LH~---~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~ 177 (337)
T cd07852 101 ANILEDVHKRYIMYQLLKALKYIHS---GNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRW 177 (337)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhccccccc
Confidence 7788999999999999999999999 99999999999999999999999999999865432211 12223457889
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||.+.+ ..++.++|+||+|+++++|++|++||....
T Consensus 178 y~aPE~~~~~~~~~~~sDi~slG~~l~el~tg~~pf~~~~ 217 (337)
T cd07852 178 YRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTS 217 (337)
T ss_pred ccCceeeeccccccccchHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998765 457889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.3e-27 Score=181.25 Aligned_cols=152 Identities=20% Similarity=0.288 Sum_probs=121.1
Q ss_pred CcHHHHHHhcccccccc-------ccccceEEEEEccCCchhhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCC
Q 044746 33 TSPQRMIAADNFSNLVG-------SEDTETYIKGFLAMGPFYLLCK------KNILGFGQLREIEVSTSKGIAYLHEECR 99 (202)
Q Consensus 33 ~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~l~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~ 99 (202)
-.|..++....|+|++. .....++..+|.+. .|..+++ .+.++...++.+..||+.|+.|||+
T Consensus 75 cREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAEh-DL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH~--- 150 (438)
T KOG0666|consen 75 CREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAEH-DLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLHS--- 150 (438)
T ss_pred HHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhhh-hHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHhh---
Confidence 35666777788888763 23444555555554 4555552 3358889999999999999999999
Q ss_pred CCeEEecCCCCcEEEcCC----CceEEeeeecceeccccCccc-ccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHH
Q 044746 100 QKIVHYDIKPESVLLDEN----FFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLL 173 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~----~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l 173 (202)
+-|+||||||.||++..+ |.+||+|+|+++.+.++.... ....++-|..|.|||++.+. .|+.+.|+||.||++
T Consensus 151 NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCIf 230 (438)
T KOG0666|consen 151 NWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCIF 230 (438)
T ss_pred hheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHHH
Confidence 999999999999999877 999999999999887654333 33445568999999999875 699999999999999
Q ss_pred HHHHcCCCCCcchhc
Q 044746 174 FEVVGRRRNLEKEIS 188 (202)
Q Consensus 174 ~el~~g~~p~~~~~~ 188 (202)
.||+|-+|.|.+...
T Consensus 231 aElLtl~PlF~g~E~ 245 (438)
T KOG0666|consen 231 AELLTLEPLFKGREE 245 (438)
T ss_pred HHHHccCccccchhh
Confidence 999999999987654
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.1e-27 Score=192.01 Aligned_cols=181 Identities=20% Similarity=0.237 Sum_probs=131.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc---ccccceEEEEEccCC--chhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG---SEDTETYIKGFLAMG--PFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~---~~~~~~~~~~~~~~~--~l~~~~~~~~ 74 (202)
|||++..+..-++++++.-.... ..-..-|..|...+.. ..+.++|. ..-...++.+.|+.| .|..++++..
T Consensus 377 V~kV~~s~~~iyalkkv~~~~~D--~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~Gd~DL~kiL~k~~ 454 (677)
T KOG0596|consen 377 VFKVLNSDKQIYALKKVVLLEAD--NQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECGDIDLNKILKKKK 454 (677)
T ss_pred eeeeecCCCcchhhhHHHHhhcC--HHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecccccHHHHHHhcc
Confidence 68888887777887777422211 1112335555444433 34445543 221122334444444 6777776554
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 75 --LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 75 --~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
++...++.+..|++.++.+.|+ .||||.||||.|+|+- .|.+||+|||.|..+..+.........+||+.||+|
T Consensus 455 ~~~~~~~lk~ywkqML~aV~~IH~---~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsP 530 (677)
T KOG0596|consen 455 SIDPDWFLKFYWKQMLLAVKTIHQ---HGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSP 530 (677)
T ss_pred CCCchHHHHHHHHHHHHHHHHHHH---hceeecCCCcccEEEE-eeeEEeeeechhcccCccccceeeccccCcccccCH
Confidence 3433789999999999999999 9999999999999984 578999999999988877777777788999999999
Q ss_pred cccCCCC-----------CCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPYS-----------VTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~-----------~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+.... .+.++||||+||+||+|+.|++||....
T Consensus 531 EAl~~~~s~~~~~~~k~Ki~r~SDvWSLGCILYqMvYgktPf~~~~ 576 (677)
T KOG0596|consen 531 EALTDMSSSRENGKSKIKISRKSDVWSLGCILYQMVYGKTPFGQII 576 (677)
T ss_pred HHHhhccccccCCCcceeecCccchhhhhhHHHHHHhcCCchHHHH
Confidence 9986422 5688999999999999999999998655
|
|
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.8e-26 Score=181.36 Aligned_cols=178 Identities=20% Similarity=0.232 Sum_probs=128.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc---c-----ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV---G-----SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i---~-----~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+...+..++.|..+..... ......+.....+....+|++++ + ..+...++++++.+ ++...+..
T Consensus 15 v~~~~~~~~~~~~aik~~~~~~~~-~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~ 92 (282)
T cd07831 15 VLKAQSRKTGKYYAIKCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMDM-NLYELIKG 92 (282)
T ss_pred EEEEEEcCCCcEEEEEEehhccCC-chhhhHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCCc-cHHHHHHh
Confidence 577887777777777764332111 11112222223333333467654 2 22556778888874 66555543
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++.++..++.|++.||.|||+ .+++||||+|+||+++. +.++|+|||++......... ....++..|+
T Consensus 93 ~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~~~---~~~~~~~~y~ 165 (282)
T cd07831 93 RKRPLPEKRVKSYMYQLLKSLDHMHR---NGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKPPY---TEYISTRWYR 165 (282)
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEcC-CCeEEEecccccccccCCCc---CCCCCCcccC
Confidence 468999999999999999999999 99999999999999999 99999999999865432221 2234688999
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+.. ..++.++|+||+||+++||++|++||....
T Consensus 166 aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~p~~~~~ 203 (282)
T cd07831 166 APECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTN 203 (282)
T ss_pred ChhHhhcCCCCCcchhHHHHHHHHHHHHcCCcCCCCCC
Confidence 9997654 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=181.00 Aligned_cols=184 Identities=20% Similarity=0.247 Sum_probs=141.2
Q ss_pred CCccccCCCcceeehhhhchhhhhc---cCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME---MDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..+++.++.|+.+...... ......+..|.......+|++++. .++...++++++.+++|..++.
T Consensus 16 v~~~~~~~~~~~~alk~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~ 95 (268)
T cd06630 16 CYQARDVKTGTLMAVKQVTYVRNTSSEQEEVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLS 95 (268)
T ss_pred EEEEEEcCCCcEEEEEEeecccCCchhHHHHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHH
Confidence 5777777777777776654322111 112345666777777778887663 4455678899999999988875
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCccc--ccCCCCCCC
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHI--TSTGRRRTP 147 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~--~~~~~~gt~ 147 (202)
. ..+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++ .++|+|||.+.......... ......++.
T Consensus 96 ~~~~~~~~~~~~~~~ql~~al~~LH~---~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~ 172 (268)
T cd06630 96 KYGAFKEAVIINYTEQLLRGLSYLHE---NQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTI 172 (268)
T ss_pred HhCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCcccccccccc
Confidence 4 468999999999999999999999 9999999999999998775 58999999987654332111 112235688
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.|+|||.+.+..++.++|+||+|++++++++|+.||....
T Consensus 173 ~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 212 (268)
T cd06630 173 AFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEK 212 (268)
T ss_pred ceeCHhHhccCCCCcccchHHHHHHHHHHHhCCCCCCCCC
Confidence 9999999988888999999999999999999999996543
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=180.11 Aligned_cols=149 Identities=18% Similarity=0.282 Sum_probs=119.7
Q ss_pred ccCCcHHHHHHhccccccccc------cccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 044746 30 IRFTSPQRMIAADNFSNLVGS------EDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQK 101 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 101 (202)
..|..+.......+|++++.. .....++++++++++|..+... ..+++..+..++.|++.||+|||+ ++
T Consensus 49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ 125 (262)
T cd05077 49 LAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLED---KD 125 (262)
T ss_pred HHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhh---CC
Confidence 345566667777889987742 3346688999999998877753 458999999999999999999999 99
Q ss_pred eEEecCCCCcEEEcCCCc-------eEEeeeecceeccccCcccccCCCCCCCcccCCcccC-CCCCCchhhHHHHHHHH
Q 044746 102 IVHYDIKPESVLLDENFF-------PKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWM-PYSVTQKCDVFSFGMLL 173 (202)
Q Consensus 102 iiHrdlk~~nil~~~~~~-------~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~-~~~~~~~~Diws~G~~l 173 (202)
++||||||+||+++.++. ++++|||++...... ....++..|+|||.+. +..++.++||||||+++
T Consensus 126 ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 199 (262)
T cd05077 126 LVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR------QECVERIPWIAPECVEDSKNLSIAADKWSFGTTL 199 (262)
T ss_pred eECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc------ccccccccccChhhhcCCCCCCchhHHHHHHHHH
Confidence 999999999999986653 899999988654221 2234578899999886 46688999999999999
Q ss_pred HHHH-cCCCCCcchh
Q 044746 174 FEVV-GRRRNLEKEI 187 (202)
Q Consensus 174 ~el~-~g~~p~~~~~ 187 (202)
|||+ +|+.||....
T Consensus 200 ~el~~~~~~p~~~~~ 214 (262)
T cd05077 200 WEICYNGEIPLKDKT 214 (262)
T ss_pred HHHHhCCCCCCCCcc
Confidence 9997 6888887544
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=179.55 Aligned_cols=149 Identities=19% Similarity=0.225 Sum_probs=119.2
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
.+..+.......+|++++. .+....++++++.+|+|..++... .+++..+..++.|++.||.|||+ +++
T Consensus 45 ~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i 121 (258)
T cd05078 45 SFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLED---KGL 121 (258)
T ss_pred HHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCe
Confidence 4566666777778887763 335566899999999999988643 48999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCc--------eEEeeeecceeccccCcccccCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHH
Q 044746 103 VHYDIKPESVLLDENFF--------PKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLL 173 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~--------~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l 173 (202)
+||||||+||+++.++. ++++|||++...... ....+++.|+|||++.+ ..++.++|+||+|+++
T Consensus 122 iH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~------~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l 195 (258)
T cd05078 122 THGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK------EILLERIPWVPPECIENPQNLSLAADKWSFGTTL 195 (258)
T ss_pred ecCCCccceEEEecccccccCCCceEEecccccccccCCc------hhccccCCccCchhccCCCCCCchhhHHHHHHHH
Confidence 99999999999987654 689999988643221 12345788999999876 3578899999999999
Q ss_pred HHHHcC-CCCCcchhc
Q 044746 174 FEVVGR-RRNLEKEIS 188 (202)
Q Consensus 174 ~el~~g-~~p~~~~~~ 188 (202)
||+++| .+|+....+
T Consensus 196 ~~l~~g~~~~~~~~~~ 211 (258)
T cd05078 196 WEIFSGGDKPLSALDS 211 (258)
T ss_pred HHHHcCCCCChhhccH
Confidence 999998 466655443
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=184.97 Aligned_cols=177 Identities=24% Similarity=0.237 Sum_probs=133.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------cccceEEEEEccCCchhhhh--cc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------EDTETYIKGFLAMGPFYLLC--KK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l~~~~--~~ 72 (202)
||++.+..+++.|+.|..........+....+..|.......+|++++.. .....++++++. |++..+. ..
T Consensus 31 vy~~~~~~~~~~v~iK~~~~~~~~~~~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~ 109 (307)
T cd06607 31 VYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHK 109 (307)
T ss_pred EEEEEEcCCCcEEEEEEEeccccCcHHHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcc
Confidence 57777777777777765433322222233446666667777889987642 233456677766 4554444 24
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...... ....+++.|+||
T Consensus 110 ~~l~~~~~~~~~~ql~~~L~~LH~---~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~------~~~~~~~~y~aP 180 (307)
T cd06607 110 KPLQEVEIAAICHGALQGLAYLHS---HERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA------NSFVGTPYWMAP 180 (307)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEECCCCCEEEeecCcceecCCC------CCccCCccccCc
Confidence 569999999999999999999999 99999999999999999999999999998754321 223568899999
Q ss_pred cccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++. ...++.++|+||||+++||+++|++||....
T Consensus 181 E~~~~~~~~~~~~~sDv~s~G~il~el~tg~~p~~~~~ 218 (307)
T cd06607 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (307)
T ss_pred eeeeccCCCCCCcccchHHHHHHHHHHHcCCCCCCCcc
Confidence 9874 3568889999999999999999999997644
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=180.32 Aligned_cols=182 Identities=23% Similarity=0.289 Sum_probs=141.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++.+..+++.++.|+.+..... ......+..|.......+|++++. ......+++++..+++|.++...+
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 94 (264)
T cd06626 16 VYTAVNLDTGELMAVKEIRIQDND-PKTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGR 94 (264)
T ss_pred EEEEEECCCCcEEEEEEEECcccc-hHHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcC
Confidence 467777667777777765433222 223445666766777778887653 334566888999999999988664
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc--cCCCCCCCcccC
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT--STGRRRTPGCEA 151 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~--~~~~~gt~~y~a 151 (202)
.+++..+..++.+++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++........... .....+++.|+|
T Consensus 95 ~~~~~~~~~i~~~i~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~ 171 (264)
T cd06626 95 ILDEHVIRVYTLQLLEGLAYLHS---HGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMA 171 (264)
T ss_pred CCChHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccC
Confidence 48899999999999999999999 9999999999999999999999999999986543322111 113456889999
Q ss_pred CcccCCCC---CCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 152 PELWMPYS---VTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 152 Pe~~~~~~---~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||++.+.. .+.++|+||||++++++++|+.||...
T Consensus 172 PE~~~~~~~~~~~~~~Dv~s~G~il~~l~~g~~pf~~~ 209 (264)
T cd06626 172 PEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSEL 209 (264)
T ss_pred hhhccCCCCCCCCcccchHHHHHHHHHHHhCCCCccCC
Confidence 99998765 889999999999999999999999754
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.9e-26 Score=179.69 Aligned_cols=178 Identities=22% Similarity=0.322 Sum_probs=134.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc-----cccceEEEEEccCCchhhhhcc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS-----EDTETYIKGFLAMGPFYLLCKK--- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~l~~~~~~--- 72 (202)
||++....+..++.+.+..... ....+..|.......+|++++.. .....++++++.+++|.+++..
T Consensus 22 vy~~~~~~~~~~~iK~~~~~~~-----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~ 96 (260)
T cd05073 22 VWMATYNKHTKVAVKTMKPGSM-----SVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEG 96 (260)
T ss_pred EEEEEecCCccEEEEecCCChh-----HHHHHHHHHHHHHhcCCCCcceEEEEEcCCCeEEEEEeCCCCcHHHHHHhCCc
Confidence 5677655555544443332111 12345566666777788876632 2445688889999999888854
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++......... ......++..|+||
T Consensus 97 ~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~-~~~~~~~~~~y~~P 172 (260)
T cd05073 97 SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEYT-AREGAKFPIKWTAP 172 (260)
T ss_pred cccCHHHHHHHHHHHHHHHHHHHh---CCccccccCcceEEEcCCCcEEECCCcceeeccCCCcc-cccCCcccccccCH
Confidence 347889999999999999999999 99999999999999999999999999998765432211 11223346779999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
|++....++.++|+||+|++++++++ |+.||....
T Consensus 173 E~~~~~~~~~~~Di~slG~~l~~l~t~g~~p~~~~~ 208 (260)
T cd05073 173 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMS 208 (260)
T ss_pred hHhccCCcCccccchHHHHHHHHHHhcCCCCCCCCC
Confidence 99988888999999999999999998 999997654
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.3e-26 Score=183.59 Aligned_cols=181 Identities=22% Similarity=0.279 Sum_probs=135.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+...++.|+.|..+.... .......+..|.......+|++++.. .+...++++++.+ +|..++..
T Consensus 23 v~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~ 100 (309)
T cd07845 23 VYRARDTTSGEIVALKKVRMDNE-RDGIPISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDN 100 (309)
T ss_pred EEEEEECCCCcEEEEEEEEeccC-CCCCcchhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCCC-CHHHHHHh
Confidence 57888887778888776443221 11222334456667777788876531 1334677777764 56555543
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .....+++.|+
T Consensus 101 ~~~~l~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~y~ 175 (309)
T cd07845 101 MPTPFSESQVKCLMLQLLRGLQYLHE---NFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPAKP--MTPKVVTLWYR 175 (309)
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECccceeeecCCccCC--CCccccccccc
Confidence 568999999999999999999999 99999999999999999999999999999865432211 12223477899
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||.+.+ ..++.++|+||+|+++|||++|++||....+
T Consensus 176 aPE~~~~~~~~~~~~DvwslG~il~el~~g~~~f~~~~~ 214 (309)
T cd07845 176 APELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSE 214 (309)
T ss_pred ChhhhcCCCCcCchHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999865 4578999999999999999999999975543
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-26 Score=181.81 Aligned_cols=184 Identities=17% Similarity=0.282 Sum_probs=142.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc-cccccc------ccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN-FSNLVG------SEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++.++.+++.++.|+..............+..+.......+ |++++. ..+...++++++++++|..++...
T Consensus 17 vy~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 96 (280)
T cd05581 17 VVLAKEKETNKEYAIKILDKRQLIKEKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKY 96 (280)
T ss_pred EEEEEEcCCCCEEEEEEechHhccchHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHc
Confidence 5788888788888887755432222222234555555555555 887652 344566888899999998888665
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc---------------
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH--------------- 137 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~--------------- 137 (202)
.+++..+..++.|++.||.|||+ .+++|+|++|+||+++.++.++++|||++.........
T Consensus 97 ~~l~~~~~~~i~~ql~~~l~~Lh~---~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (280)
T cd05581 97 GSLDEKCTRFYAAEILLALEYLHS---KGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIE 173 (280)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCcccccccc
Confidence 79999999999999999999999 99999999999999999999999999998865432211
Q ss_pred ---cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 138 ---ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 138 ---~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.......++..|+|||......++.++|+||+|++++++++|+.||....
T Consensus 174 ~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (280)
T cd05581 174 KNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSN 226 (280)
T ss_pred ccccccccccCCccccCHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 11223456789999999888888999999999999999999999998654
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=180.22 Aligned_cols=180 Identities=23% Similarity=0.290 Sum_probs=135.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++.+..++..++.|...... ........+..|.......+|++++. .++...++++++. ++|..++...
T Consensus 15 vy~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~ 92 (283)
T cd07835 15 VYKARDKLTGEIVALKKIRLET-EDEGVPSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSP 92 (283)
T ss_pred EEEEEEcCCCCEEEEEEeeccc-ccccchhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCC
Confidence 5788877667777766543221 11122234555666677777887652 3455667788875 6787776544
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 74 --ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 74 --~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.+++..+..++.|++.||.|||+ ++++|+||+|+||+++.++.++|+|||++........ ......+++.|+|
T Consensus 93 ~~~~~~~~~~~~~~~i~~~L~~lH~---~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~a 167 (283)
T cd07835 93 LTGLDPPLIKSYLYQLLQGIAYCHS---HRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPVR--TYTHEVVTLWYRA 167 (283)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCcc--ccCccccccCCCC
Confidence 58999999999999999999999 9999999999999999999999999999875432211 1122345788999
Q ss_pred CcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||++.+. .++.++|+||+|+++|+|++|++||....
T Consensus 168 PE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 204 (283)
T cd07835 168 PEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDS 204 (283)
T ss_pred CceeecCcccCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9987654 57889999999999999999999997544
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.1e-26 Score=182.60 Aligned_cols=181 Identities=19% Similarity=0.259 Sum_probs=137.4
Q ss_pred CCcccc----CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhh
Q 044746 1 MEKPRN----RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~----~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~ 68 (202)
||+++. ...+..++.|+.+..... .....|..|.......+|++++.. +....++++++++++|..
T Consensus 20 v~~~~~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~ 97 (284)
T cd05038 20 VELCRYDPLGDNTGEQVAVKSLNHSGEE--QHRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRD 97 (284)
T ss_pred EEEeeecCCCCCCceEEEEEEeccccch--HHHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHH
Confidence 455553 233556666654332221 223456667666777788876532 334668889999999999
Q ss_pred hhccCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc-cCCCCC
Q 044746 69 LCKKNI--LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT-STGRRR 145 (202)
Q Consensus 69 ~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~-~~~~~g 145 (202)
++.... +++..+..++.|++.||.|||+ ++++|+||||+||+++.++.++++|||++........... .....+
T Consensus 98 ~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~ 174 (284)
T cd05038 98 YLQRHRDQINLKRLLLFSSQICKGMDYLGS---QRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYVKEPGES 174 (284)
T ss_pred HHHhCccccCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcceeccCCCCC
Confidence 887655 9999999999999999999999 9999999999999999999999999999987653222111 112234
Q ss_pred CCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
+..|++||.+....++.++|+||||++++||++|..|+...
T Consensus 175 ~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el~tg~~p~~~~ 215 (284)
T cd05038 175 PIFWYAPECLRTSKFSSASDVWSFGVTLYELFTYGDPSQSP 215 (284)
T ss_pred cccccCcHHHccCCCCcccchHHHhhhhheeeccCCCcccc
Confidence 56799999998888999999999999999999999998654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.7e-26 Score=186.32 Aligned_cols=182 Identities=19% Similarity=0.236 Sum_probs=128.0
Q ss_pred CCccccCCC--cceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccccccc----------cceEEEEEccCCchh
Q 044746 1 MEKPRNRGS--TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGSED----------TETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~--~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~----------~~~~~~~~~~~~~l~ 67 (202)
||++++... +..++.|..+..... ......+..|....... +|++++...+ ...++++++. ++|.
T Consensus 16 vy~~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~~-~~L~ 93 (332)
T cd07857 16 VCSARNAETSEEETVAIKKITNVFSK-KILAKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELME-ADLH 93 (332)
T ss_pred EEEEEeCCCCcCceEEEEEecccccc-chhHHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEeccc-CCHH
Confidence 567777665 666666653322111 11122333344444333 5777653221 1234455554 5676
Q ss_pred hhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc--cccCCCC
Q 044746 68 LLC-KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH--ITSTGRR 144 (202)
Q Consensus 68 ~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~--~~~~~~~ 144 (202)
..+ ....+++..++.++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++........ .......
T Consensus 94 ~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~ 170 (332)
T cd07857 94 QIIRSGQPLTDAHFQSFIYQILCGLKYIHS---ANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYV 170 (332)
T ss_pred HHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcc
Confidence 665 44568999999999999999999999 99999999999999999999999999999865432211 1122346
Q ss_pred CCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 145 RTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 145 gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.|+|||.+.+ ..++.++|+||+|++++++++|++||....
T Consensus 171 g~~~y~aPE~~~~~~~~~~~~Di~slGv~l~~l~~g~~pf~~~~ 214 (332)
T cd07857 171 ATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKD 214 (332)
T ss_pred cCccccCcHHHhCCCCCCcHHHHHHHHHHHHHHHhCCcCCCCCC
Confidence 7899999998765 468899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=178.86 Aligned_cols=178 Identities=19% Similarity=0.167 Sum_probs=135.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..++..++.|........ ....+..|.......+|++++. .++...++++++.+++|..++..
T Consensus 24 v~~~~~~~~~~~v~~k~~~~~~~~---~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 100 (268)
T cd06624 24 VYAARDLSTQVRIAIKEIPERDSR---YVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKW 100 (268)
T ss_pred EEEeEecCCCcEEEEEEecCCCHH---HHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhc
Confidence 578887777777777653322111 2234566666777778887663 33456688889999999988754
Q ss_pred CCC--CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 73 NIL--GFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 73 ~~~--~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
..+ +...+..++.|++.||.|||+ .+++||||||+||+++. ++.++|+|||++........ ......|++.|
T Consensus 101 ~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~ 175 (268)
T cd06624 101 GPLKDNEQTIIFYTKQILEGLKYLHD---NQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP--CTETFTGTLQY 175 (268)
T ss_pred ccCCCcHHHHHHHHHHHHHHHHHHHH---CCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC--ccccCCCCccc
Confidence 345 788899999999999999999 99999999999999976 67999999999876532221 11223468899
Q ss_pred cCCcccCCC--CCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 150 EAPELWMPY--SVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 150 ~aPe~~~~~--~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
+|||++... .++.++|+||+|++++++++|++||...
T Consensus 176 ~aPE~~~~~~~~~~~~~Dv~slGvvl~~l~~g~~p~~~~ 214 (268)
T cd06624 176 MAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPFIEL 214 (268)
T ss_pred cChhhhccccccCCchhhhHHHHHHHHHHHhCCCCCccc
Confidence 999998654 3788999999999999999999999653
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.8e-26 Score=183.88 Aligned_cols=177 Identities=23% Similarity=0.228 Sum_probs=134.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh--cc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC--KK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~--~~ 72 (202)
||++++..++..++.|..........+....+..|.......+|++++. ......++++++.+ ++.... ..
T Consensus 41 v~~~~~~~~~~~valK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~g-~l~~~~~~~~ 119 (317)
T cd06635 41 VYFARDVRTNEVVAIKKMSYSGKQSNEKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHK 119 (317)
T ss_pred EEEEEEcCCCcEEEEEEEecCCCCchHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCCC-CHHHHHHHhc
Confidence 5777777777777777644332222223334556666667778887663 33445678888864 555554 34
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++...... ....|++.|+||
T Consensus 120 ~~l~~~~~~~i~~~i~~~l~~lH~---~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aP 190 (317)
T cd06635 120 KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA------NSFVGTPYWMAP 190 (317)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcccEEECCCCCEEEecCCCccccCCc------ccccCCccccCh
Confidence 568999999999999999999999 99999999999999999999999999988654321 223568899999
Q ss_pred cccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++. ...++.++|+||+|++++||++|++||....
T Consensus 191 E~~~~~~~~~~~~~~Dv~slGvil~el~~g~~p~~~~~ 228 (317)
T cd06635 191 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 228 (317)
T ss_pred hhhhcCCCCCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 9974 4568899999999999999999999987643
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=179.89 Aligned_cols=173 Identities=18% Similarity=0.259 Sum_probs=130.0
Q ss_pred cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhcc--CCC
Q 044746 6 NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCKK--NIL 75 (202)
Q Consensus 6 ~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~~--~~~ 75 (202)
+...+..++.|...... ......+..|.......+|++++.. .....++++++++++|..++.. ..+
T Consensus 29 ~~~~~~~v~iK~~~~~~---~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l 105 (284)
T cd05081 29 QDNTGEVVAVKKLQHST---AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERL 105 (284)
T ss_pred cCCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCC
Confidence 33445556655533221 1122346667667777888886632 1235688999999999988754 358
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc-cCCCCCCCcccCCcc
Q 044746 76 GFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT-STGRRRTPGCEAPEL 154 (202)
Q Consensus 76 ~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~-~~~~~gt~~y~aPe~ 154 (202)
++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........... .....++..|+|||+
T Consensus 106 ~~~~~~~~~~~l~~aL~~LH~---~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~ 182 (284)
T cd05081 106 DHRKLLLYASQICKGMEYLGS---KRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPES 182 (284)
T ss_pred CHHHHHHHHHHHHHHHHHHHH---CCceeccCCHhhEEECCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHH
Confidence 999999999999999999999 9999999999999999999999999999986543322111 111223456999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLE 184 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~ 184 (202)
+.+..++.++|+||+|++++||++|..|+.
T Consensus 183 ~~~~~~~~~~Di~slG~~l~el~~~~~~~~ 212 (284)
T cd05081 183 LTESKFSVASDVWSFGVVLYELFTYSDKSC 212 (284)
T ss_pred hccCCcChHHHHHHHHHHHHHHhhcCCcCC
Confidence 988889999999999999999999877654
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.6e-26 Score=175.99 Aligned_cols=182 Identities=21% Similarity=0.285 Sum_probs=142.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++.+...++.++.|+..............+..|.......+|++++ ..+....++++++.+++|..++...
T Consensus 9 v~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~ 88 (250)
T cd05123 9 VLLVRKKDTGKLYAMKVLKKKKIIKRKEVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEG 88 (250)
T ss_pred EEEEEECCCCcEEEEEEeehhhhcchHHHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcC
Confidence 467777766677776654443322222334566666666677788765 3455667888999999998888655
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.....++.|++.|+.|+|+ .+++|+||+|+||+++.++.++++|||++....... .......++..|++||
T Consensus 89 ~l~~~~~~~~~~qi~~~l~~lh~---~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~--~~~~~~~~~~~~~~Pe 163 (250)
T cd05123 89 RFSEERARFYAAEIVLALEYLHS---LGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG--SRTNTFCGTPEYLAPE 163 (250)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcceEEEcCCCcEEEeecCcceecccCC--CcccCCcCCccccChH
Confidence 68999999999999999999999 999999999999999999999999999987654321 1123345688999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
...+...+.++|+||+|++++++++|+.||....
T Consensus 164 ~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~ 197 (250)
T cd05123 164 VLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAED 197 (250)
T ss_pred HhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9988888899999999999999999999997554
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.3e-26 Score=177.75 Aligned_cols=174 Identities=22% Similarity=0.339 Sum_probs=134.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++... ++.|+.|..+.... ...++..|.......+|++++. ..+...++++++++++|..++...
T Consensus 22 v~~~~~~--~~~v~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 95 (256)
T cd05039 22 VMLGDYR--GQKVAVKCLKDDST----AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRG 95 (256)
T ss_pred EEEEEec--CcEEEEEEeccchh----HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcC
Confidence 4555544 34455544332211 2344666766777778887653 245566889999999999988544
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 74 --ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 74 --~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.+++.....++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||.++....... ...++..|+|
T Consensus 96 ~~~~~~~~~~~~~~qi~~~l~~lh~---~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~~-----~~~~~~~~~a 167 (256)
T cd05039 96 RAVITLAQQLGFALDVCEGMEYLEE---KNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQD-----SGKLPVKWTA 167 (256)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCccchhcccceEEEeCCCCEEEcccccccccccccc-----cCCCcccccC
Confidence 58999999999999999999999 9999999999999999999999999999986533222 1223567999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||.+....++.++|+||+|++++|+++ |+.||.....
T Consensus 168 pe~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 205 (256)
T cd05039 168 PEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 205 (256)
T ss_pred chhhcCCcCCcHHHHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999988888999999999999999997 9999876543
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.4e-26 Score=180.42 Aligned_cols=178 Identities=22% Similarity=0.276 Sum_probs=139.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+...++.++.|........ +...++..|.......+|++++. ......++++++.+++|..++..
T Consensus 17 v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 94 (265)
T cd06605 17 VSKVLHRPTGKIMAVKTIRLEINE--AIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQ 94 (265)
T ss_pred EEEEEEcCCCcEEEEEEEecccCh--HHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHcc
Confidence 577888877777777654332111 22334555655566667887653 34556788899999999988865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..++......++.|++.|+.|||+. .+++|+||||+||+++.++.++|+|||.+......... ...++..|+||
T Consensus 95 ~~~~~~~~~~~~~~l~~~l~~lH~~--~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~~----~~~~~~~y~~P 168 (265)
T cd06605 95 GRIPERILGKIAVAVLKGLTYLHEK--HKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAK----TFVGTSSYMAP 168 (265)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHcCC--CCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHhh----cccCChhccCH
Confidence 5689999999999999999999973 69999999999999999999999999998754322211 14568899999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|.+.+..++.++|+||+|++++++++|+.||...
T Consensus 169 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 202 (265)
T cd06605 169 ERIQGNDYSVKSDIWSLGLSLIELATGRFPYPPE 202 (265)
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 9999889999999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=2.1e-26 Score=181.81 Aligned_cols=179 Identities=21% Similarity=0.281 Sum_probs=139.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++.+...+..++.|+.+.... ....+..|.......+|++++. .....+++++++++++|.+++...
T Consensus 35 v~~~~~~~~~~~~~iK~~~~~~~----~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 110 (286)
T cd06614 35 VYKATDRATGKEVAIKKMRLRKQ----NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNF 110 (286)
T ss_pred EEEEEEccCCcEEEEEEEecCch----hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhc
Confidence 46666665555566555432211 2234555656667777887652 345567888999999999998776
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......++..|+||
T Consensus 111 ~~l~~~~~~~i~~~i~~~L~~lH~---~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y~~P 185 (286)
T cd06614 111 VRMNEPQIAYVCREVLQGLEYLHS---QNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS--KRNSVVGTPYWMAP 185 (286)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh--hhccccCCcccCCH
Confidence 79999999999999999999999 9999999999999999999999999998865433221 11223467889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|++++++++|+.||....+
T Consensus 186 E~~~~~~~~~~~Dv~slGvil~~l~~g~~p~~~~~~ 221 (286)
T cd06614 186 EVIKRKDYGPKVDIWSLGIMCIEMAEGEPPYLREPP 221 (286)
T ss_pred hHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCCCH
Confidence 999888899999999999999999999999876543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.9e-26 Score=179.77 Aligned_cols=180 Identities=17% Similarity=0.217 Sum_probs=130.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccccc------c-----cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGSE------D-----TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~------~-----~~~~~~~~~~~~~l~~ 68 (202)
||++++...++.|+.|..+..... ......+..|....... +|++++... . ...++++++++ ++..
T Consensus 17 vy~~~~~~~~~~v~lK~~~~~~~~-~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 94 (295)
T cd07837 17 VYKARDKNTGKLVALKKTRLEMDE-EGIPPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKK 94 (295)
T ss_pred EEEEEECCCCcEEEEEeehhhccc-cCCchHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHH
Confidence 688888888888887764332211 12223444555445444 456654211 1 14678888875 5665
Q ss_pred hhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccC
Q 044746 69 LCK------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITST 141 (202)
Q Consensus 69 ~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~ 141 (202)
++. ...+++..+..++.|++.||.|||+ ++++||||+|+||+++. ++.++|+|||++........ ...
T Consensus 95 ~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~~--~~~ 169 (295)
T cd07837 95 FMDSNGRGPGRPLPAKTIKSFMYQLLKGVAHCHK---HGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPVK--SYT 169 (295)
T ss_pred HHHHhcccCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChHHEEEecCCCeEEEeecccceecCCCcc--ccC
Confidence 552 2358999999999999999999999 99999999999999998 88999999999875432211 112
Q ss_pred CCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 142 GRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
...+++.|+|||.+.+ ..++.++|+||+|+++++|++|.+||....
T Consensus 170 ~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 216 (295)
T cd07837 170 HEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216 (295)
T ss_pred CcccccCCCChHHhhCCCCCCchHHHHHHHHHHHHHHcCCCCCCCCC
Confidence 2345788999998865 457899999999999999999999997643
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=180.04 Aligned_cols=180 Identities=20% Similarity=0.283 Sum_probs=134.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..++..++.|..+.... ......+..|.......+|++++. ..+...++++++++ ++..+...
T Consensus 16 v~~~~~~~~~~~~~iK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~ 92 (284)
T cd07836 16 VYKGRNRTTGEIVALKEIHLDAE--EGTPSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHG 92 (284)
T ss_pred EEEEEECCCCeEEEEEEeccccc--ccchHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCCc-cHHHHHHhcC
Confidence 57888887777777775443221 111223444555666667887653 33445688888875 66666533
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++++|||++........ ......++..|+
T Consensus 93 ~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~y~ 167 (284)
T cd07836 93 VRGALDPNTVKSFTYQLLKGIAFCHE---NRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPVN--TFSNEVVTLWYR 167 (284)
T ss_pred CCCCcCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCcc--cccccccccccc
Confidence 358999999999999999999999 9999999999999999999999999999875433211 112234578899
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+||++.+. .++.++|+||+|++++++++|++||.....
T Consensus 168 ~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~~~~~~~~ 206 (284)
T cd07836 168 APDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNN 206 (284)
T ss_pred ChHHhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99988664 468899999999999999999999986543
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.94 E-value=4e-26 Score=179.60 Aligned_cols=182 Identities=21% Similarity=0.285 Sum_probs=136.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------cc--ccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SE--DTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~--~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++...++.++.|..+... ........+..|.......+|++++. .. +...++++++.+ +|..+...
T Consensus 15 vy~~~~~~~~~~~~~K~~~~~~-~~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 92 (287)
T cd07840 15 VYKARNKKTGELVALKKIRMEN-EKEGFPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDS 92 (287)
T ss_pred EEEEEECCCCeEEEEEEEeccc-ccccchHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEeccccc-cHHHHHhc
Confidence 6788888777777776654432 11122233555655666667787552 22 556688888874 77776654
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 N--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++......... ......++..|+
T Consensus 93 ~~~~~~~~~~~~i~~~i~~al~~LH~---~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~y~ 168 (287)
T cd07840 93 PEVKFTESQIKCYMKQLLEGLQYLHS---NGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNSA-DYTNRVITLWYR 168 (287)
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEEcCCCCEEEccccceeeccCCCcc-cccccccccccC
Confidence 3 69999999999999999999999 99999999999999999999999999999865443211 122334578899
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||.+.+ ..++.++|+||||++++|+++|+.||.....
T Consensus 169 ~PE~~~~~~~~~~~~Dv~slG~~l~el~t~~~p~~~~~~ 207 (287)
T cd07840 169 PPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTE 207 (287)
T ss_pred CceeeEccccCChHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9998765 4578999999999999999999999976543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.1e-26 Score=177.53 Aligned_cols=180 Identities=19% Similarity=0.310 Sum_probs=139.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+..+++.++.|...... ........+..|.......+|++++. ..+...++++++++++|..++..
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 94 (256)
T cd08220 16 VHLCRRKADQKLVIIKQIPVEQ-MTKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRC 94 (256)
T ss_pred EEEEEEcCCCcEEEEEEEeccc-cccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhc
Confidence 4677777777777766543221 12222345666666777778887653 34456788899999999988854
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-CceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++..+..++.+++.|+.|||+ ++++|+||+|+||+++.+ +.++++|||++........ .....++..|+
T Consensus 95 ~~~~~~~~~~~~~~~i~~~l~~lh~---~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~y~ 168 (256)
T cd08220 95 NSLLDEDTILHFFVQILLALHHVHT---KLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKSK---AYTVVGTPCYI 168 (256)
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCcc---ccccccCCccc
Confidence 248999999999999999999999 999999999999999854 5689999999986543322 12245688999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+.+..++.++|+||+|++++++++|+.||....
T Consensus 169 aPE~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 205 (256)
T cd08220 169 SPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAAN 205 (256)
T ss_pred CchhccCCCCCcccchHHHHHHHHHHHhCCCCcccCc
Confidence 9999988888999999999999999999999997643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=5.7e-27 Score=171.40 Aligned_cols=179 Identities=20% Similarity=0.217 Sum_probs=123.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh----
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC---- 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~---- 70 (202)
|.|-|+..++.+.|+|--+..-. +++..+.+..-.+...+..-|-++. ..+-.+..++.|. .+|..+.
T Consensus 62 vekmrh~~sg~imAvKri~~tvn-~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M~-tSldkfy~~v~ 139 (282)
T KOG0984|consen 62 VEKMRHIQSGTIMAVKRIRATVN-SQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELMD-TSLDKFYRKVL 139 (282)
T ss_pred hhheeeccCCeEEEEeeehhhcC-hHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHhh-hhHHHHHHHHH
Confidence 34566777777777654322211 1222222333333444444443332 1122233444433 3443333
Q ss_pred -ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 71 -KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 71 -~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
+...+++.-.-+++..+..||.|||+ +..+||||+||.|||++.+|.+|++|||.+-.+.+..- .+...|...|
T Consensus 140 ~~g~~ipE~vlGkIa~Svv~al~~L~~--kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSiA---kt~daGCkpY 214 (282)
T KOG0984|consen 140 KKGGTIPEDVLGKIAVSVVHALEFLHS--KLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSIA---KTMDAGCKPY 214 (282)
T ss_pred hcCCcCchHHhhHhHHHHHHHHHHHHH--HhhhhhccCCcceEEEccCCcEEEcccccceeehhhhH---HHHhcCCCcc
Confidence 45679999999999999999999999 48999999999999999999999999999987654332 1224568899
Q ss_pred cCCcccCC----CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 150 EAPELWMP----YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 150 ~aPe~~~~----~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||||.+.. ..|+.++||||+|+++.||.+++.|++.-
T Consensus 215 maPEri~~e~n~~gY~vksDvWSLGItmiElA~lr~PY~~w 255 (282)
T KOG0984|consen 215 MAPERINPELNQKGYSVKSDVWSLGITMIEMAILRFPYESW 255 (282)
T ss_pred CChhhcCcccCcccceeehhhhhhhhhhhhhhhcccccccc
Confidence 99999864 36999999999999999999999998743
|
|
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.3e-27 Score=194.98 Aligned_cols=181 Identities=18% Similarity=0.245 Sum_probs=150.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhh--cc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLC--KK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~--~~ 72 (202)
||-+.++.+++-||+|+-.++.-. ..+...+..|..++...+||-++ ...+-.+++++.+.+.-|..++ .+
T Consensus 580 VYgg~hRktGrdVAvKvIdKlrFp-~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~GDMLEMILSsEk 658 (888)
T KOG4236|consen 580 VYGGKHRKTGRDVAVKVIDKLRFP-TKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHGDMLEMILSSEK 658 (888)
T ss_pred eecceecccCceeeeeeeecccCC-CchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcchHHHHHHHhhc
Confidence 678889999999999987665432 23335677888888999999765 3455567888988887777776 45
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC---CceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN---FFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~---~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
+++++...+.+..||+.||+|||. ++|+|+||||+|+|+... -.+||+|||.|+.++..... ....|||.|
T Consensus 659 gRL~er~TkFlvtQIL~ALr~LH~---knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFR---rsVVGTPAY 732 (888)
T KOG4236|consen 659 GRLPERITKFLVTQILVALRYLHF---KNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFR---RSVVGTPAY 732 (888)
T ss_pred ccchHHHHHHHHHHHHHHHHHhhh---cceeeccCCchheeeccCCCCCceeeccccceeecchhhhh---hhhcCCccc
Confidence 679999999999999999999999 999999999999999643 46899999999988654432 446789999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+|||++....|+..-|+||.|+++|--++|..||..+.+
T Consensus 733 LaPEVLrnkGyNrSLDMWSVGVIiYVsLSGTFPFNEdEd 771 (888)
T KOG4236|consen 733 LAPEVLRNKGYNRSLDMWSVGVIIYVSLSGTFPFNEDED 771 (888)
T ss_pred cCHHHHhhccccccccceeeeEEEEEEecccccCCCccc
Confidence 999999999999999999999999999999999975544
|
|
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=99.94 E-value=3.5e-26 Score=182.13 Aligned_cols=183 Identities=23% Similarity=0.277 Sum_probs=131.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc--------------ccceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE--------------DTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------~~~~~~~~~~~~~~l 66 (202)
||++.+..+++.++.|........ ......+..|.......+|++++... ....++++++.. ++
T Consensus 24 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~-~l 101 (311)
T cd07866 24 VYKARQIKTGRVVALKKILMHNEK-DGFPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDH-DL 101 (311)
T ss_pred EEEEEECCCCcEEEEEEEEeccCC-CCcchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCc-CH
Confidence 578888777666766654322111 11122344566667777888776422 123566666654 45
Q ss_pred hhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-------
Q 044746 67 YLLCK--KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH------- 137 (202)
Q Consensus 67 ~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~------- 137 (202)
..... ...+++..+..++.|+++||.|||+ .+++|+||||+||+++.++.++|+|||++.........
T Consensus 102 ~~~~~~~~~~~~~~~~~~i~~~l~~al~~lH~---~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~ 178 (311)
T cd07866 102 SGLLENPSVKLTESQIKCYMLQLLEGINYLHE---NHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGG 178 (311)
T ss_pred HHHHhccccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcc
Confidence 44443 3469999999999999999999999 99999999999999999999999999999754322111
Q ss_pred --cccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 138 --ITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 138 --~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.......+++.|+|||.+.+. .++.++|+||+|++++||++|++||.+..+
T Consensus 179 ~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~~g~~~~~~~~~ 232 (311)
T cd07866 179 GTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQGKSD 232 (311)
T ss_pred cccccccceeccCcCChHHhhCCCccCchhHhHHHHHHHHHHHhCCCCCCCCCH
Confidence 111223457889999987654 578899999999999999999999976543
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=99.94 E-value=4.8e-26 Score=180.40 Aligned_cols=180 Identities=22% Similarity=0.285 Sum_probs=131.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.++.|..+.... .......+..|.......+|++++. .+....++++++.+ ++...... .
T Consensus 18 v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~ 95 (294)
T PLN00009 18 VYKARDRVTNETIALKKIRLEQE-DEGVPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDL-DLKKHMDSSP 95 (294)
T ss_pred EEEEEecCCCcEEEEEehhhccc-cccchHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEecccc-cHHHHHHhCC
Confidence 57788877777677665433221 1122334556666777778887753 33456678888864 56555532 2
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 --ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 --~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ ++++|+||+|+||+++. ++.+|++|||++........ ......+++.|+
T Consensus 96 ~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~ 170 (294)
T PLN00009 96 DFAKNPRLIKTYLYQILRGIAYCHS---HRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPVR--TFTHEVVTLWYR 170 (294)
T ss_pred CCCcCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCcceEEEECCCCEEEEcccccccccCCCcc--ccccCceeeccc
Confidence 35788889999999999999999 99999999999999985 56789999999975433211 112335578999
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||++.+ ..++.++|+||+|+++++|+||++||....
T Consensus 171 ~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg~~pf~~~~ 208 (294)
T PLN00009 171 APEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDS 208 (294)
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9998865 457899999999999999999999997654
|
|
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=3.8e-26 Score=180.57 Aligned_cols=177 Identities=23% Similarity=0.237 Sum_probs=139.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCK- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~- 71 (202)
||++.+...++.++.|....... .....++..|.......+|++++.. .+...++++++++++|..++.
T Consensus 17 v~~~~~~~~~~~~~~k~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 94 (287)
T cd06621 17 VTKCRLKNTGMIFALKTITTDPN--PDLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKK 94 (287)
T ss_pred EEEEEECCCCeEEEEEEEecCCc--hHHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHH
Confidence 57778877777777776443211 1223446667667777788887632 223467889999999977653
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 72 ----KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 72 ----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
...++...+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ....++.
T Consensus 95 ~~~~~~~l~~~~~~~i~~~i~~~L~~lH~---~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~ 167 (287)
T cd06621 95 VKKRGGRIGEKVLGKIAESVLKGLSYLHS---RKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSLA----GTFTGTS 167 (287)
T ss_pred HHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecCCeEEEeecccccccccccc----ccccCCc
Confidence 3458999999999999999999999 9999999999999999999999999999875432211 1234578
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
.|+|||.+.+..++.++|+||+|+++|+|++|+.||...
T Consensus 168 ~y~~pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 206 (287)
T cd06621 168 FYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPFPPE 206 (287)
T ss_pred cccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCCcc
Confidence 899999998888999999999999999999999999866
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-26 Score=181.75 Aligned_cols=177 Identities=20% Similarity=0.235 Sum_probs=129.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++..++..||.|..+...... .....+..........+|++++. ..+...+++++++ ++|..+..
T Consensus 17 v~~~~~~~~~~~vaiK~~~~~~~~~-~~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~ 94 (283)
T cd06617 17 VDKMRHVPTGTIMAVKRIRATVNSQ-EQKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVY 94 (283)
T ss_pred EEEEEEcCCCcEEEEEEEecCCCcH-HHHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhc
Confidence 6888888888888877543321111 11112223333455667887763 3344567777776 55554442
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQ-KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
...+++..+..++.|++.||.|||+ + +++||||||+||+++.++.++|+|||++........ .....++..
T Consensus 95 ~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~ 168 (283)
T cd06617 95 DKGLTIPEDILGKIAVSIVKALEYLHS---KLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVA---KTIDAGCKP 168 (283)
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecccccccccccc---cccccCCcc
Confidence 2458999999999999999999998 6 999999999999999999999999999876533211 122356888
Q ss_pred ccCCcccCC----CCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 149 CEAPELWMP----YSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 149 y~aPe~~~~----~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|+|||.+.+ ..++.++|+||+|+++++|++|+.||..
T Consensus 169 y~aPE~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~ 209 (283)
T cd06617 169 YMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDS 209 (283)
T ss_pred ccChhhcCCcccccccCccccchhhHHHHHHHHhCCCCCCc
Confidence 999998864 4568899999999999999999999964
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.4e-27 Score=168.19 Aligned_cols=184 Identities=20% Similarity=0.244 Sum_probs=142.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
|||+|++.+.++||.|-.+-.+.. ...+..-..|..++....|.|++. +..-.+++.+++.. .|..+.. .
T Consensus 18 vfkarn~~t~eivalkrvrldddd-egvpssalreicllkelkhknivrl~dvlhsdkkltlvfe~cdq-dlkkyfdsln 95 (292)
T KOG0662|consen 18 VFKARNRETHEIVALKRVRLDDDD-EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSLN 95 (292)
T ss_pred eEecccCCccceEEEEEEeccCCC-CCCcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHhhH-HHHHHHHhcC
Confidence 789999999999998765433322 233445567778888888888774 33344566666543 3333322 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+..+.++.++.|+++||.|+|+ ++++||||||+|.++..+|..|++|||+++.++-+..+.. ...-|..|.+|
T Consensus 96 g~~d~~~~rsfmlqllrgl~fchs---hnvlhrdlkpqnllin~ngelkladfglarafgipvrcys--aevvtlwyrpp 170 (292)
T KOG0662|consen 96 GDLDPEIVRSFMLQLLRGLGFCHS---HNVLHRDLKPQNLLINRNGELKLADFGLARAFGIPVRCYS--AEVVTLWYRPP 170 (292)
T ss_pred CcCCHHHHHHHHHHHHhhhhhhhh---hhhhhccCCcceEEeccCCcEEecccchhhhcCCceEeee--ceeeeeeccCc
Confidence 458899999999999999999999 9999999999999999999999999999998765543332 23348899999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHc-CCCCCcchhcccc
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVG-RRRNLEKEISEGQ 191 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~~~ 191 (202)
.++.+. -|++..|+||.||++.|+.. |++.|.+.+.++|
T Consensus 171 dvlfgakly~tsidmwsagcifaelanagrplfpg~dvddq 211 (292)
T KOG0662|consen 171 DVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211 (292)
T ss_pred ceeeeeehhccchHhhhcchHHHHHhhcCCCCCCCCcHHHH
Confidence 998874 68999999999999999986 8888887776654
|
|
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.8e-26 Score=183.24 Aligned_cols=184 Identities=20% Similarity=0.246 Sum_probs=135.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccC-----------CcccCCcHHHHHHhcccccccc------ccccceEEEEEccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMD-----------KPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAM 63 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~ 63 (202)
||++++...++.++.|..+........ ....+..|.......+|++++. .+....++++++.
T Consensus 25 vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~- 103 (335)
T PTZ00024 25 VEKAYDTLTGKIVAIKKVKIIEISNDVTKDRQLVGMCGIHFTTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA- 103 (335)
T ss_pred EEEEEECCCCCeEEEEEeeccccccccccchhhhcccccchhHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-
Confidence 688888777777777764432221100 0112445666677778887653 3445567788876
Q ss_pred Cchhhhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC-------
Q 044746 64 GPFYLLCK-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH------- 135 (202)
Q Consensus 64 ~~l~~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~------- 135 (202)
++|..++. ...++......++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++.......
T Consensus 104 ~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~---~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~ 180 (335)
T PTZ00024 104 SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHK---WYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSK 180 (335)
T ss_pred cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHeEECCCCCEEECCccceeecccccccccccc
Confidence 56766664 3568999999999999999999999 999999999999999999999999999998654111
Q ss_pred -----cccccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 136 -----THITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 136 -----~~~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.........+++.|+|||.+.+. .++.++|+||+|++++||++|++||....+
T Consensus 181 ~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~tg~~p~~~~~~ 239 (335)
T PTZ00024 181 DETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENE 239 (335)
T ss_pred cccccccccccccccccCCCCChhcccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 01111223457889999998764 468999999999999999999999976654
|
|
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=99.93 E-value=3e-26 Score=185.28 Aligned_cols=179 Identities=19% Similarity=0.252 Sum_probs=134.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..++..|+.|..+..... .....++..|.......+|++++... ...+++++++. ++|..+
T Consensus 21 vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 98 (337)
T cd07858 21 VCSAKNSETNEKVAIKKIANAFDN-RIDAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELMD-TDLHQI 98 (337)
T ss_pred EEEEEecCCCCeEEEEEecccccc-cchhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCCC-CCHHHH
Confidence 578888777777877754332111 11223344566666677888876321 23467777775 567666
Q ss_pred hc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 70 CK-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 70 ~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
.. .+.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.++|+|||++........ ......++..
T Consensus 99 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~ 173 (337)
T cd07858 99 IRSSQTLSDDHCQYFLYQLLRGLKYIHS---ANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKGD--FMTEYVVTRW 173 (337)
T ss_pred HhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEECcCccccccCCCcc--cccccccccC
Confidence 54 4569999999999999999999999 9999999999999999999999999999986543211 1223456889
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|+|||.+.. ..++.++|+||+|+++++|++|++||...
T Consensus 174 y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~ 212 (337)
T cd07858 174 YRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGK 212 (337)
T ss_pred ccChHHHhcCCCCCCcccHHHHHHHHHHHHcCCCCCCCC
Confidence 999998764 46889999999999999999999999754
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.8e-26 Score=182.20 Aligned_cols=182 Identities=22% Similarity=0.303 Sum_probs=136.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHH--Hhcccccccc----------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI--AADNFSNLVG----------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~----------~~~~~~~~~~~~~~~~l~~ 68 (202)
|+|.+.+ ++.||+|+-...++.+ +..|.-+- .-.+|.||+| +.+..+++..|.+.|+|++
T Consensus 227 VwrG~wr--Ge~VAVKiF~srdE~S------WfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~D 298 (513)
T KOG2052|consen 227 VWRGRWR--GEDVAVKIFSSRDERS------WFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYD 298 (513)
T ss_pred eeecccc--CCceEEEEecccchhh------hhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHH
Confidence 4455544 4567777755544332 22222222 2256667663 4455679999999999999
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC--cccccC
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEEC-----RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH--THITST 141 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~--~~~~~~ 141 (202)
++....++.+..++++..+++||.+||... +..|.|||||..|||+..++.+.|+|+|||....... -....+
T Consensus 299 yL~r~tv~~~~ml~LalS~AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N 378 (513)
T KOG2052|consen 299 YLNRNTVTTEGMLKLALSIASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPN 378 (513)
T ss_pred HHhhccCCHHHHHHHHHHHhhhHHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCC
Confidence 999999999999999999999999999743 5689999999999999999999999999998665432 222345
Q ss_pred CCCCCCcccCCcccCCCC----C--CchhhHHHHHHHHHHHHcC----------CCCCcchhccc
Q 044746 142 GRRRTPGCEAPELWMPYS----V--TQKCDVFSFGMLLFEVVGR----------RRNLEKEISEG 190 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~----~--~~~~Diws~G~~l~el~~g----------~~p~~~~~~~~ 190 (202)
..+||.+|||||++.... | -..+||||||.++||++.+ ++||.+..+.+
T Consensus 379 ~rVGTKRYMAPEvLdetin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~D 443 (513)
T KOG2052|consen 379 PRVGTKRYMAPEVLDETINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSD 443 (513)
T ss_pred CccceeeccChHHhhhhcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCC
Confidence 678999999999986421 1 1458999999999999754 36777666554
|
|
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4.7e-26 Score=178.65 Aligned_cols=154 Identities=19% Similarity=0.193 Sum_probs=124.2
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC----------CCCHHHHHHHHHHHHHHHHH
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN----------ILGFGQLREIEVSTSKGIAY 93 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~----------~~~~~~~~~~~~~i~~~l~~ 93 (202)
..+..|.......+|++++. .....+++++++++++|..++... .+++..+..++.|++.||.|
T Consensus 53 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l~~ 132 (275)
T cd05046 53 SEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGMDH 132 (275)
T ss_pred HHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHHHH
Confidence 34666777777778887652 345567899999999999887543 48999999999999999999
Q ss_pred HHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHH
Q 044746 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLL 173 (202)
Q Consensus 94 lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l 173 (202)
||+ .+++||||||+||+++.++.++++|||++........ .......++..|+|||.+.+...+.++|+||+|+++
T Consensus 133 LH~---~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~~-~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l 208 (275)
T cd05046 133 LSN---ARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSEY-YKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLM 208 (275)
T ss_pred hhh---cCcccCcCccceEEEeCCCcEEEcccccccccCcccc-cccCCceeEEeecChhhhccCCCCchhhHHHHHHHH
Confidence 999 9999999999999999999999999999874322211 112233456779999999888888999999999999
Q ss_pred HHHHc-CCCCCcchh
Q 044746 174 FEVVG-RRRNLEKEI 187 (202)
Q Consensus 174 ~el~~-g~~p~~~~~ 187 (202)
+++++ |..||....
T Consensus 209 ~~l~~~~~~p~~~~~ 223 (275)
T cd05046 209 WEVFTQGELPFYGLS 223 (275)
T ss_pred HHHHhCCCCCccccc
Confidence 99998 888986543
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.3e-26 Score=175.10 Aligned_cols=177 Identities=23% Similarity=0.280 Sum_probs=138.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++.+..++..++.|....... .....+..|.......+|++++. ......++++++.+++|..+....
T Consensus 16 v~~~~~~~~~~~~~~k~~~~~~~---~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~ 92 (253)
T cd05122 16 VYKARHKRTGKEVAIKVIKLESK---EKKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTN 92 (253)
T ss_pred EEEEEECCCCcEEEEEEecccch---hHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcC
Confidence 46777765566555554433221 22334555666666666776542 234566888899999999888665
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.+||+ .+++|+||+|+||+++.++.++|+|||.+........ .....++..|+||
T Consensus 93 ~~~~~~~~~~i~~~i~~~l~~lh~---~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~~P 166 (253)
T cd05122 93 QTLTESQIAYVCKELLKGLEYLHS---NGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA---RNTMVGTPYWMAP 166 (253)
T ss_pred CCCCHHHHHHHHHHHHHHHHHhhc---CCEecCCCCHHHEEEccCCeEEEeecccccccccccc---ccceecCCcccCH
Confidence 79999999999999999999999 9999999999999999999999999999876544321 2234568899999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|.+.+..++.++|+||+|++++++++|+.||...
T Consensus 167 E~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~ 200 (253)
T cd05122 167 EVINGKPYDYKADIWSLGITAIELAEGKPPYSEL 200 (253)
T ss_pred HHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCC
Confidence 9998888899999999999999999999999765
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=179.56 Aligned_cols=178 Identities=24% Similarity=0.284 Sum_probs=133.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccccc------------cccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGS------------EDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~------------~~~~~~~~~~~~~~~l~ 67 (202)
||++.+...++.++.|+...... ....+..|....... +|++++.. +...+++++++++++|.
T Consensus 22 v~~~~~~~~~~~~~~k~~~~~~~----~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 97 (275)
T cd06608 22 VYKARHKKTGQLVAIKIMDIIED----EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVT 97 (275)
T ss_pred EEEEEECCCCcEEEEEEEecCch----hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHH
Confidence 46777777777777766443222 112344554444443 67766531 33357889999999988
Q ss_pred hhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 68 LLCK-----KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 68 ~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
.+.. ...+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ....
T Consensus 98 ~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~---~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~~--~~~~ 172 (275)
T cd06608 98 DLVKGLRKKGKRLKEEWIAYILRETLRGLAYLHE---NKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTLG--RRNT 172 (275)
T ss_pred HHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEEccCCeEEECCCccceecccchh--hhcC
Confidence 7764 3468999999999999999999999 9999999999999999999999999999875433221 1233
Q ss_pred CCCCCcccCCcccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 143 RRRTPGCEAPELWMP-----YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~-----~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
..|++.|+|||.+.. ..++.++|+||+|++++++++|++||....
T Consensus 173 ~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 222 (275)
T cd06608 173 FIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLCDMH 222 (275)
T ss_pred ccccccccCHhHhcccccccCCccccccHHHhHHHHHHHHhCCCCccccc
Confidence 457889999998753 346788999999999999999999997543
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=175.45 Aligned_cols=153 Identities=22% Similarity=0.386 Sum_probs=123.1
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
.|..|.......+|++++. ......++++++.+++|..++.. ..+++..+..++.|++.|+.|||+ .++
T Consensus 45 ~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~~i 121 (256)
T cd05112 45 DFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLES---SNV 121 (256)
T ss_pred HHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHH---CCc
Confidence 3556666666777886652 33445688889999999888754 458999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRR 181 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~ 181 (202)
+|+||||+||+++.++.++|+|||++......... ......++..|+|||.+.+..++.++|+||+|+++||+++ |+.
T Consensus 122 ~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 200 (256)
T cd05112 122 IHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQYT-SSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKT 200 (256)
T ss_pred cccccccceEEEcCCCeEEECCCcceeecccCccc-ccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCCC
Confidence 99999999999999999999999998765332211 1122234678999999988889999999999999999998 999
Q ss_pred CCcchh
Q 044746 182 NLEKEI 187 (202)
Q Consensus 182 p~~~~~ 187 (202)
||....
T Consensus 201 p~~~~~ 206 (256)
T cd05112 201 PYENRS 206 (256)
T ss_pred CCCcCC
Confidence 997554
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.7e-26 Score=178.89 Aligned_cols=181 Identities=17% Similarity=0.207 Sum_probs=131.1
Q ss_pred CCccccC---CCcceeehhhhchhhhh-ccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDAM-EMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++. ..+..++.|+.+..... .......+..|..+.... +|++++. .+....++++++++++|..+
T Consensus 16 v~~~~~~~~~~~g~~~aiK~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 95 (290)
T cd05613 16 VFLVRKVSGHDSGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTH 95 (290)
T ss_pred EEEEEeccCCCCCceEEEEEeehhhhhhcchHHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHH
Confidence 3555543 34556666654432221 111223344454444444 5676653 33445688999999999887
Q ss_pred hcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 70 CKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 70 ~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+.. ..+++..+..++.|++.||.|||+ .+++||||+|+||+++.++.++|+|||++......... ......|+..
T Consensus 96 l~~~~~l~~~~~~~~~~qi~~al~~lH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~ 171 (290)
T cd05613 96 LSQRERFKEQEVQIYSGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEVE-RAYSFCGTIE 171 (290)
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeEECCCCCEEEeeCccceeccccccc-ccccccCCcc
Confidence 744 458999999999999999999999 99999999999999999999999999999865432211 1223457889
Q ss_pred ccCCcccCCC--CCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 149 CEAPELWMPY--SVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 149 y~aPe~~~~~--~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|+|||.+... .++.++|+||+|++++++++|+.||..
T Consensus 172 y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~g~~p~~~ 210 (290)
T cd05613 172 YMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTV 210 (290)
T ss_pred cCChhhccCCCCCCCccccHHHHHHHHHHHhcCCCCCCc
Confidence 9999998753 467889999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.7e-27 Score=175.74 Aligned_cols=190 Identities=21% Similarity=0.304 Sum_probs=138.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCC-cccCCcHHHHHHhcccccccc------------ccccceEEE--EEccCCc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDK-PIRFTSPQRMIAADNFSNLVG------------SEDTETYIK--GFLAMGP 65 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~i~------------~~~~~~~~~--~~~~~~~ 65 (202)
|||||.+..++-|+.+.. +-+.+.+. +..-..+..++....|+|++. .+.-+.+|+ .+++ ..
T Consensus 33 VFkAr~~n~~kkvalkkv--lmeneKeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hD 109 (376)
T KOG0669|consen 33 VFKARSKNTGKKVALKKV--LMENEKEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HD 109 (376)
T ss_pred HHHHhhcCccchhHHHHH--HHhccccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hh
Confidence 689999999988776543 32222222 222334555556666665431 111222333 3333 46
Q ss_pred hhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc--ccccC
Q 044746 66 FYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT--HITST 141 (202)
Q Consensus 66 l~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~--~~~~~ 141 (202)
|.+++... +++..+++.++.++..||.|+|. +.|+|||+|+.|+||+.++.+||+|||+++.++.... ....+
T Consensus 110 LaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~iHr---~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kpryt 186 (376)
T KOG0669|consen 110 LAGLLSNRKVRFSLSEIKKVMKGLMNGLYYIHR---NKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYT 186 (376)
T ss_pred HHHHhcCccccccHHHHHHHHHHHHHHHHHHHH---hhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcc
Confidence 77777554 58999999999999999999999 9999999999999999999999999999976543211 11123
Q ss_pred CCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhccccccccc
Q 044746 142 GRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPK 196 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~~~~ 196 (202)
.++-|..|.+||.+.+. .++++.|+|..||++.||.||.+-+.++.++.+..+++
T Consensus 187 nrvvTLwYrppEllLG~r~yg~~iDiWgAgCimaeMwtrspimqgnteqqql~~Is 242 (376)
T KOG0669|consen 187 NRVVTLWYRPPELLLGDREYGPPIDIWGAGCIMAEMWTRSPIMQGNTEQQQLHLIS 242 (376)
T ss_pred cceeeeecCCHHHhhcccccCCcchhHhHHHHHHHHHccCccccCChHHHHHHHHH
Confidence 34458999999998874 78999999999999999999999999988887655543
|
|
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=177.95 Aligned_cols=181 Identities=22% Similarity=0.285 Sum_probs=135.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+..+++.++.|..+.... .......+..|.......+|++++ ..+....++++++++ ++..++..
T Consensus 15 v~~~~~~~~~~~~~ik~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~-~l~~~l~~~~ 92 (283)
T cd05118 15 VYKARDKLTGEIVAIKKIKLRFE-SEGIPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQ 92 (283)
T ss_pred EEEEEcCCCCcEEEEEEeccccc-cchhHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccCC-CHHHHHHhhc
Confidence 57777766666666654322211 112233455555556666677654 244556688888875 66666544
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||.+........ ......++..|+||
T Consensus 93 ~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~~--~~~~~~~~~~~~~P 167 (283)
T cd05118 93 RGLPESLIKSYLYQLLQGLAFCHS---HGILHRDLKPENLLINTEGVLKLADFGLARSFGSPVR--PYTHYVVTRWYRAP 167 (283)
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHH---CCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCcc--cccCccCcccccCc
Confidence 378999999999999999999999 9999999999999999999999999999986644321 12234567889999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+.+. .++.++|+||+|++++++++|+.||.....
T Consensus 168 E~~~~~~~~~~~~Di~slG~~l~~l~tg~~~~~~~~~ 204 (283)
T cd05118 168 ELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSE 204 (283)
T ss_pred HHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 998776 788999999999999999999999976553
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=99.93 E-value=4e-26 Score=184.94 Aligned_cols=180 Identities=16% Similarity=0.247 Sum_probs=134.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc--------------------ccceEEEEE
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE--------------------DTETYIKGF 60 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------------~~~~~~~~~ 60 (202)
||++.+...++.|+.|....... .....+..|.......+|++++... ...++++++
T Consensus 21 vy~~~~~~~~~~v~iK~i~~~~~---~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 97 (342)
T cd07854 21 VFSAVDSDCDKRVAVKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEY 97 (342)
T ss_pred EEEEEECCCCcEEEEEEEecCCC---chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeec
Confidence 57888877777777665433221 2223355566666777888766321 124577777
Q ss_pred ccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccc
Q 044746 61 LAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHIT 139 (202)
Q Consensus 61 ~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~ 139 (202)
+. ++|..+...+.+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.++++|||++...........
T Consensus 98 ~~-~~L~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~~~ 173 (342)
T cd07854 98 ME-TDLANVLEQGPLSEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSHKG 173 (342)
T ss_pred cc-ccHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccccc
Confidence 76 578888877789999999999999999999999 99999999999999974 56789999999976543221111
Q ss_pred -cCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 140 -STGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 140 -~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.....++..|+|||.+.. ..++.++|+||+||++++|++|+.||....
T Consensus 174 ~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~ 223 (342)
T cd07854 174 YLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAH 223 (342)
T ss_pred ccccccccccccCHHHHhCccccCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 122346888999998654 567889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=99.93 E-value=5.1e-26 Score=176.96 Aligned_cols=181 Identities=20% Similarity=0.221 Sum_probs=142.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++.+...++.++.|........ .....+..+.......+|++++. ......++++++++++|..++.. .
T Consensus 17 v~~~~~~~~~~~~~vk~~~~~~~~--~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 94 (264)
T cd06623 17 VYKVRHKPTGKIYALKKIHVDGDE--EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVG 94 (264)
T ss_pred EEEEEEcCCCcEEEEEEeccCcch--HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcC
Confidence 577888877777776654332111 22345666666666777887653 33456688899999999998865 6
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.++......++.|++.|+.|||+. .+++|+||+|+||+++.++.++|+|||++.......... ....++..|+|||
T Consensus 95 ~l~~~~~~~~~~~l~~~l~~lh~~--~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~~~--~~~~~~~~y~~pE 170 (264)
T cd06623 95 KIPEPVLAYIARQILKGLDYLHTK--RHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLDQC--NTFVGTVTYMSPE 170 (264)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhcc--CCCccCCCCHHHEEECCCCCEEEccCccceecccCCCcc--cceeecccccCHh
Confidence 799999999999999999999963 799999999999999999999999999998654332221 2234688899999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.+....++.++|+||||++++++++|+.||....
T Consensus 171 ~~~~~~~~~~~Dv~slG~il~~l~tg~~p~~~~~ 204 (264)
T cd06623 171 RIQGESYSYAADIWSLGLTLLECALGKFPFLPPG 204 (264)
T ss_pred hhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 9988888999999999999999999999997764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.8e-26 Score=174.99 Aligned_cols=150 Identities=24% Similarity=0.382 Sum_probs=121.9
Q ss_pred cCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 31 RFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
.+..|.......+|++++. ......++++++.+++|..++... .+++..+..++.|++.||.|||+ .++
T Consensus 45 ~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~~ 121 (254)
T cd05083 45 AFLEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLES---KKL 121 (254)
T ss_pred HHHHHHHHHHhCCCCCcCeEEEEEcCCCcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHh---CCe
Confidence 4556666677778887652 223346888899999998887543 48999999999999999999999 999
Q ss_pred EEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCC
Q 044746 103 VHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRR 181 (202)
Q Consensus 103 iHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~ 181 (202)
+||||||+||+++.++.++|+|||++....... .....+..|+|||.+.+..++.++|+||+|++++||++ |++
T Consensus 122 ~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~~ 196 (254)
T cd05083 122 VHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-----DNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRA 196 (254)
T ss_pred eccccCcceEEEcCCCcEEECCCccceeccccC-----CCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999999999999999987543221 11223567999999988889999999999999999997 999
Q ss_pred CCcchhc
Q 044746 182 NLEKEIS 188 (202)
Q Consensus 182 p~~~~~~ 188 (202)
||.....
T Consensus 197 p~~~~~~ 203 (254)
T cd05083 197 PYPKMSL 203 (254)
T ss_pred CCccCCH
Confidence 9976544
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=5e-26 Score=184.46 Aligned_cols=177 Identities=22% Similarity=0.245 Sum_probs=135.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||++++...+..|+.|...... ........+..|.......+|++++...+ ...++++++ +++|..
T Consensus 31 V~~~~~~~~~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~ 108 (343)
T cd07880 31 VCSALDRRTGAKVAIKKLYRPF-QSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGK 108 (343)
T ss_pred EEEEEECCCCcEEEEEEecccc-cchHHHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHH
Confidence 5777777777777776543211 11111223556667777788888763211 124666666 678888
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+.....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++++|||++...... .....+++.
T Consensus 109 ~~~~~~l~~~~~~~i~~qi~~al~~LH~---~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-----~~~~~~~~~ 180 (343)
T cd07880 109 LMKHEKLSEDRIQFLVYQMLKGLKYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-----MTGYVVTRW 180 (343)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccccccccC-----ccccccCCc
Confidence 8887889999999999999999999999 99999999999999999999999999998754322 123345889
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||.+.+ ..++.++|+||+|++++++++|++||....
T Consensus 181 y~aPE~~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~ 220 (343)
T cd07880 181 YRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHD 220 (343)
T ss_pred ccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999876 457889999999999999999999997543
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=6.8e-26 Score=175.17 Aligned_cols=183 Identities=23% Similarity=0.256 Sum_probs=143.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------cc--ccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SE--DTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~--~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++.+..++..++.|+....... ......+..+.......+|++++. .. ....+++++.++++|.++...
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~ 94 (260)
T cd06606 16 VYLALDKDTGELMAVKSVELSGDS-EEELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKK 94 (260)
T ss_pred EEEEEECCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHH
Confidence 577777766777776664333221 222345666666777777887653 22 456688899999999888765
Q ss_pred C-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 N-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 ~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
. .+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||.+................++..|+|
T Consensus 95 ~~~~~~~~~~~~~~~l~~~l~~lh~---~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~ 171 (260)
T cd06606 95 FGKLPEPVIRKYTRQILEGLAYLHS---NGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMA 171 (260)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEcCCCCEEEcccccEEecccccccccccCCCCCccccC
Confidence 5 79999999999999999999999 9999999999999999999999999999987654432111233456889999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||.+.....+.++|+||+|++++++++|..||....
T Consensus 172 pE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 207 (260)
T cd06606 172 PEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELG 207 (260)
T ss_pred HhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999988888999999999999999999999997654
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.3e-26 Score=191.52 Aligned_cols=180 Identities=22% Similarity=0.310 Sum_probs=146.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc------cccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
|..+++.-++..||.|+-.+.. .+......+..|..++...+|||++ ......+++++|..+|.++.++.+ +
T Consensus 72 V~La~~~~t~~~VaiK~idkt~-ln~~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~g 150 (596)
T KOG0586|consen 72 VKLARHILTGTEVAIKIIDKTQ-LNPSKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHG 150 (596)
T ss_pred EEeeEecCCCceEEEEEehhcc-cChHHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcc
Confidence 3456666667777776543332 2223334477788888899999885 355667799999999999888855 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+....+..++.|+.+|++|||+ +.|+|||||.+|++++.+.++||+|||++..+..... ....+|++.|.|||
T Consensus 151 r~~e~~ar~~F~q~vsaveYcH~---k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~~~---lqt~cgsppyAaPE 224 (596)
T KOG0586|consen 151 RMKEKEARAKFRQIVSAVEYCHS---KNIVHRDLKAENILLDENMNIKIADFGFSTFFDYGLM---LQTFCGSPPYAAPE 224 (596)
T ss_pred cchhhhhhhhhHHHHHHHHHHhh---cceeccccchhhcccccccceeeeccccceeeccccc---ccccCCCCCccChH
Confidence 57779999999999999999999 9999999999999999999999999999987764332 45578899999999
Q ss_pred ccCCCCCC-chhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVT-QKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~-~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.+..|+ +++|+||+|+++|-|+.|..||++..
T Consensus 225 l~~g~~y~gpe~D~Wslgvvly~LV~GsLPFDG~~ 259 (596)
T KOG0586|consen 225 LFNGKKYDGPEVDIWSLGVVLYALVEGSLPFDGQN 259 (596)
T ss_pred hhcCcccCCcceehhhhhhhheeeeecccccCCcc
Confidence 99988765 77999999999999999999999654
|
|
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=177.08 Aligned_cols=150 Identities=19% Similarity=0.262 Sum_probs=119.2
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCC
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQK 101 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ 101 (202)
..|..+.......+|+|++. ......++++++++++|..++.. +.+++..+..++.|++.||.|||+ ++
T Consensus 61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ 137 (274)
T cd05076 61 LAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLED---KN 137 (274)
T ss_pred HHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHc---CC
Confidence 34555666667778888763 34456789999999999888743 568999999999999999999999 99
Q ss_pred eEEecCCCCcEEEcCCC-------ceEEeeeecceeccccCcccccCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHH
Q 044746 102 IVHYDIKPESVLLDENF-------FPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLL 173 (202)
Q Consensus 102 iiHrdlk~~nil~~~~~-------~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l 173 (202)
++||||||+||+++..+ .++++|||++...... ....++..|+|||.+.. ..++.++|+||||+++
T Consensus 138 iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l 211 (274)
T cd05076 138 LVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR------EERVERIPWIAPECVPGGNSLSTAADKWSFGTTL 211 (274)
T ss_pred ccCCCCCcccEEEeccCcccCccceeeecCCccccccccc------cccccCCcccCchhhcCCCCCCcHHHHHHHHHHH
Confidence 99999999999997543 4799999987643211 12345778999998865 5688999999999999
Q ss_pred HHH-HcCCCCCcchhc
Q 044746 174 FEV-VGRRRNLEKEIS 188 (202)
Q Consensus 174 ~el-~~g~~p~~~~~~ 188 (202)
||+ ++|+.||....+
T Consensus 212 ~el~~~g~~p~~~~~~ 227 (274)
T cd05076 212 LEICFDGEVPLKERTP 227 (274)
T ss_pred HHHHhCCCCCccccCh
Confidence 998 479999976543
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.5e-26 Score=196.01 Aligned_cols=181 Identities=23% Similarity=0.228 Sum_probs=148.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH-HHHHHhccccccc-----------cccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAADNFSNLV-----------GSEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i-----------~~~~~~~~~~~~~~~~~l~~ 68 (202)
|||++.+..++.+|+||......... ++..| ++.....+|+|+. |.++..+++++|+.+|+.-+
T Consensus 35 v~k~k~~~~~~~aa~kI~~~~~d~de----EiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTD 110 (953)
T KOG0587|consen 35 VYKGRHVKTGQLAAIKIMDPTEDEEE----EIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTD 110 (953)
T ss_pred EEEEeeeecCceeeeEeecCCccccH----HHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHH
Confidence 78999999999999999765543332 22233 3344556777754 67788899999999999887
Q ss_pred hhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCC
Q 044746 69 LCK---KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR 145 (202)
Q Consensus 69 ~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~g 145 (202)
+.+ ..++.|.-+..|+..++.|+.+||. +.+||||+|-.|||++.++.+||.|||++..+..... ......|
T Consensus 111 LVKn~~g~rl~E~~IaYI~re~lrgl~HLH~---nkviHRDikG~NiLLT~e~~VKLvDFGvSaQldsT~g--rRnT~iG 185 (953)
T KOG0587|consen 111 LVKNTKGNRLKEEWIAYILREILRGLAHLHN---NKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDSTVG--RRNTFIG 185 (953)
T ss_pred HHhhhcccchhhHHHHHHHHHHHHHHHHHhh---cceeeecccCceEEEeccCcEEEeeeeeeeeeecccc--cccCcCC
Confidence 775 4569999999999999999999999 9999999999999999999999999999987654332 2344678
Q ss_pred CCcccCCcccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 146 TPGCEAPELWMPY-----SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 146 t~~y~aPe~~~~~-----~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
||.|||||++... .|+.++|+||+|++..||..|.+|+++..+.-
T Consensus 186 tP~WMAPEViac~e~~d~tyd~R~D~WsLGITaIEladG~PPl~DmHPmr 235 (953)
T KOG0587|consen 186 TPYWMAPEVIACDESPDATYDYRSDLWSLGITAIEMAEGAPPLCDMHPMR 235 (953)
T ss_pred CcccccceeeecccCCCCCcccccchhhccceeehhcCCCCCccCcchhh
Confidence 9999999999753 47889999999999999999999999988764
|
|
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=177.05 Aligned_cols=142 Identities=25% Similarity=0.331 Sum_probs=118.0
Q ss_pred hcccccccc------ccccceEEEEEccCCchhhhh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCC
Q 044746 41 ADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-----KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKP 109 (202)
Q Consensus 41 ~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~ 109 (202)
..+|++++. ..+...++++++++++|..++ ....+++..+..++.|++.||.|||+. .+++|+||+|
T Consensus 65 ~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~--~~i~H~dl~~ 142 (269)
T cd08528 65 QLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRYLHKE--KRIVHRDLTP 142 (269)
T ss_pred cCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHhccC--CceeecCCCH
Confidence 457776652 445667889999999998765 234689999999999999999999962 6899999999
Q ss_pred CcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 110 ESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 110 ~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+||+++.++.++|+|||++....... ......|+..|+|||.+.+..++.++|+||+|+++|++++|++||....
T Consensus 143 ~nil~~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~l~~g~~p~~~~~ 217 (269)
T cd08528 143 NNIMLGEDDKVTITDFGLAKQKQPES---KLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTN 217 (269)
T ss_pred HHEEECCCCcEEEecccceeeccccc---ccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHHHHhCCCcccccC
Confidence 99999999999999999998654432 2233456889999999998889999999999999999999999996543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.8e-27 Score=183.57 Aligned_cols=180 Identities=22% Similarity=0.299 Sum_probs=131.1
Q ss_pred CccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccc--------ccccccccceEEEEEccCCchhhhhccC
Q 044746 2 EKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFS--------NLVGSEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 2 ~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~i~~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
-++.++..+..||.||.+.-.........++..-+.+....... ++....+..+++.+.+ |-+++++++.+
T Consensus 106 ~ec~D~~~~~~vAlKIik~V~kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N 184 (415)
T KOG0671|consen 106 VECWDRETKEHVALKIIKNVDKYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKEN 184 (415)
T ss_pred EEEeecCCCceehHHHHHHHHHHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccC
Confidence 34556667888998887766555444344343333333332111 1122333333444443 34788888765
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC--------------------CCceEEeeeeccee
Q 044746 74 ---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE--------------------NFFPKAADFGLAKL 130 (202)
Q Consensus 74 ---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~--------------------~~~~kl~dfgl~~~ 130 (202)
+++...++.++.|++.++.|||+ .+++|-||||+|||+.+ +..++++|||.|+.
T Consensus 185 ~y~~fpi~~ir~m~~QL~~sv~fLh~---~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf 261 (415)
T KOG0671|consen 185 NYIPFPIDHIRHMGYQLLESVAFLHD---LKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATF 261 (415)
T ss_pred CccccchHHHHHHHHHHHHHHHHHHh---cceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcce
Confidence 48889999999999999999999 99999999999999921 33579999999987
Q ss_pred ccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 131 ~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
....... .+.|..|.|||++.+-+++.++||||+||+|.|+.||...|....+.+
T Consensus 262 ~~e~hs~-----iVsTRHYRAPEViLgLGwS~pCDvWSiGCIL~ElytG~~LFqtHen~E 316 (415)
T KOG0671|consen 262 DHEHHST-----IVSTRHYRAPEVILGLGWSQPCDVWSIGCILVELYTGETLFQTHENLE 316 (415)
T ss_pred eccCcce-----eeeccccCCchheeccCcCCccCceeeeeEEEEeeccceecccCCcHH
Confidence 6554432 344889999999999999999999999999999999999998776443
|
|
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.2e-26 Score=182.20 Aligned_cols=183 Identities=19% Similarity=0.256 Sum_probs=138.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||++++...++.++.|....... .......+..|.......+|++++... ....++++++. ++|..+
T Consensus 16 v~~~~~~~~~~~~~iK~~~~~~~-~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~ 93 (330)
T cd07834 16 VCSAVDKRTGRKVAIKKISNVFD-DLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKV 93 (330)
T ss_pred EEEEEeCCCCcEEEEEeeccccc-cchhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHH
Confidence 57788877667777664432211 123334566676777777888765211 24457777777 467666
Q ss_pred hcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCC
Q 044746 70 CKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTP 147 (202)
Q Consensus 70 ~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~ 147 (202)
+.. ..+++..+..++.|++.||.|||+ .+++|+||||.||+++.++.++|+|||++......... .......+++
T Consensus 94 l~~~~~l~~~~~~~i~~~l~~~l~~LH~---~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~ 170 (330)
T cd07834 94 IKSPQPLTDDHIQYFLYQILRGLKYLHS---ANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTR 170 (330)
T ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccCceEeeccccccccccccccccc
Confidence 654 479999999999999999999999 99999999999999999999999999999876543210 1123345688
Q ss_pred cccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 148 GCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 148 ~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|+|||.+.+. .++.++|+||+|+++++|++|++||.....
T Consensus 171 ~y~aPE~~~~~~~~~~~sDi~slG~il~~l~~g~~pf~~~~~ 212 (330)
T cd07834 171 WYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDY 212 (330)
T ss_pred CcCCceeeecccCCCcchhHHHHHHHHHHHHcCCCCcCCCCH
Confidence 89999999877 789999999999999999999999976553
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.2e-25 Score=181.16 Aligned_cols=177 Identities=19% Similarity=0.233 Sum_probs=135.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc---c----cccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG---S----EDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~---~----~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++++...+..++.|...... ........+..|..+....+|++++. . +....++++++ +++|..+++..
T Consensus 26 v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 103 (328)
T cd07856 26 VCSARDQLTGQNVAIKKIMKPF-STPVLAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLTSR 103 (328)
T ss_pred EEEEEECCCCCEEEEEEecccc-cccchhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHhcC
Confidence 5778877777777766432211 11122334556666777778887763 1 23345666666 56888888888
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.++......++.|+++||.|||+ .+++|+||+|+||+++.++.++|+|||++...... .....+++.|+|||
T Consensus 104 ~~~~~~~~~~~~ql~~aL~~LH~---~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~y~aPE 175 (328)
T cd07856 104 PLEKQFIQYFLYQILRGLKYVHS---AGVVHRDLKPSNILINENCDLKICDFGLARIQDPQ-----MTGYVSTRYYRAPE 175 (328)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEeECCCCCEEeCccccccccCCC-----cCCCcccccccCce
Confidence 89999999999999999999999 99999999999999999999999999998754321 12234578899999
Q ss_pred ccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.+.+ ..++.++|+||+|++++++++|++||....
T Consensus 176 ~~~~~~~~~~~~Dv~slG~il~el~tg~~~f~~~~ 210 (328)
T cd07856 176 IMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKD 210 (328)
T ss_pred eeeccCCcCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 8765 568899999999999999999999997544
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=178.68 Aligned_cols=179 Identities=25% Similarity=0.306 Sum_probs=127.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCC--chhhhh-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMG--PFYLLC- 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~--~l~~~~- 70 (202)
||++++...++.++.|........ .....+..|....... +|++++. ..+...++++++... ++....
T Consensus 20 vy~~~~~~~~~~~aiK~~~~~~~~--~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~~~l~~l~~~~~ 97 (288)
T cd06616 20 VNKMLHKPSGTIMAVKRIRSTVDE--KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMDISLDKFYKYVY 97 (288)
T ss_pred EEEEEECCCCCEEEEEEehhccCh--HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEecccCCHHHHHHHHH
Confidence 577888877788877754322111 1223345555444444 4777663 223344566665432 222222
Q ss_pred --ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 71 --KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 71 --~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
....+++..+..++.+++.||+|||+. .+++||||||+||+++.++.++|+|||++......... ....|++.
T Consensus 98 ~~~~~~l~~~~~~~i~~~i~~~l~~lh~~--~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~---~~~~~~~~ 172 (288)
T cd06616 98 EVLKSVIPEEILGKIAVATVKALNYLKEE--LKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAK---TRDAGCRP 172 (288)
T ss_pred HhhcCCCCHHHHHHHHHHHHHHHHHHhhc--CCeeccCCCHHHEEEccCCcEEEeecchhHHhccCCcc---ccccCccC
Confidence 235699999999999999999999972 59999999999999999999999999998754332211 22346889
Q ss_pred ccCCcccCCC---CCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 149 CEAPELWMPY---SVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~~---~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|+|||.+.+. .++.++|+||+|++++|+++|++||...
T Consensus 173 y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 213 (288)
T cd06616 173 YMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213 (288)
T ss_pred ccCHHHhccccccCCcchhhhhHHHHHHHHHHhCCCCchhc
Confidence 9999998765 6889999999999999999999999754
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=175.78 Aligned_cols=180 Identities=21% Similarity=0.282 Sum_probs=136.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++.....++.++.|+..... ........+..|.......+|++++. ......+++++.. ++|..++...
T Consensus 15 vy~~~~~~~~~~~~iK~~~~~~-~~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~ 92 (282)
T cd07829 15 VYKARDKKTGEIVALKKIRLDN-EEEGIPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRP 92 (282)
T ss_pred EEEeeecCCCcEEEEEEecccc-ccccccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhc
Confidence 5777887777777776654332 11122233444555556666776652 3345667777777 5788888665
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ ......++..|+||
T Consensus 93 ~~~~~~~~~~~~~~i~~~l~~LH~---~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~aP 167 (282)
T cd07829 93 GPLSPNLIKSIMYQLLRGLAYCHS---HRILHRDLKPQNILINRDGVLKLADFGLARAFGIPLR--TYTHEVVTLWYRAP 167 (282)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChheEEEcCCCCEEEecCCcccccCCCcc--ccCccccCcCcCCh
Confidence 79999999999999999999999 9999999999999999999999999999886543321 11223346789999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+... .++.++|+||+|++++|+++|++||....
T Consensus 168 E~~~~~~~~~~~~Dv~slG~~l~~l~~~~~~~~~~~ 203 (282)
T cd07829 168 EILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDS 203 (282)
T ss_pred HHhcCCcCCCccccHHHHHHHHHHHHhCCCCCCCcc
Confidence 998766 78899999999999999999999997654
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=175.08 Aligned_cols=180 Identities=22% Similarity=0.335 Sum_probs=137.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+...++.++.|........ .....++..|.......+|++++. ......+++++.++++|..+...
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 94 (256)
T cd08530 16 VYKVKRLSDNQFYALKEVDLGSMS-QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRK 94 (256)
T ss_pred EEEEEECCCCCEEEEEEEehhhcc-HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHH
Confidence 466766666666665543322111 111233444555566667776652 33556688888999999887754
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 73 ---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 73 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++....... .....+++.|
T Consensus 95 ~~~~~~~~~~~~~~~~~l~~al~~lh~---~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~ 167 (256)
T cd08530 95 KKRKLIPEQEIWRIFIQLLRGLQALHE---QKILHRDLKSANILLVANDLVKIGDLGISKVLKKNM----AKTQIGTPHY 167 (256)
T ss_pred hhcCCCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCcceEEEecCCcEEEeeccchhhhccCC----cccccCCccc
Confidence 568999999999999999999999 999999999999999999999999999998654431 1224568899
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++||.+.+..++.++|+||+|++++++++|+.||.....
T Consensus 168 ~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p~~~~~~ 206 (256)
T cd08530 168 MAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSM 206 (256)
T ss_pred cCHHHHCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999988889999999999999999999999976544
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.93 E-value=9.4e-26 Score=204.41 Aligned_cols=170 Identities=19% Similarity=0.296 Sum_probs=131.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||+++....+..||+|..+..... ...+.......+|++++. ......++++|+++|+|.++++ .
T Consensus 706 Vy~~~~~~~~~~vavK~~~~~~~~-------~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~--~ 776 (968)
T PLN00113 706 SYKGKSIKNGMQFVVKEINDVNSI-------PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR--N 776 (968)
T ss_pred EEEEEECCCCcEEEEEEccCCccc-------cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh--c
Confidence 688888777777777654322111 112244455668898774 3344579999999999999885 4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
++|..+..++.|++.|++|||..+..+++|||+||+||+++.++..++. ++....... .....+++.|+|||+
T Consensus 777 l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~------~~~~~~t~~y~aPE~ 849 (968)
T PLN00113 777 LSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT------DTKCFISSAYVAPET 849 (968)
T ss_pred CCHHHHHHHHHHHHHHHHHhccCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc------CCCccccccccCccc
Confidence 8999999999999999999995444899999999999999988887775 665543211 122356899999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
+.+..++.++|||||||++|||+||+.||+..
T Consensus 850 ~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~~~ 881 (968)
T PLN00113 850 RETKDITEKSDIYGFGLILIELLTGKSPADAE 881 (968)
T ss_pred ccCCCCCcccchhhHHHHHHHHHhCCCCCCcc
Confidence 99889999999999999999999999999644
|
|
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.5e-25 Score=178.04 Aligned_cols=181 Identities=22% Similarity=0.288 Sum_probs=133.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc----------------cccceEEEEEccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS----------------EDTETYIKGFLAMG 64 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~----------------~~~~~~~~~~~~~~ 64 (202)
||++.+...++.|+.|..+.... .......+..|.......+|++++.. .+...++++++.+
T Consensus 23 v~~~~~~~~~~~v~iK~~~~~~~-~~~~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~- 100 (302)
T cd07864 23 VYKARDKDTGELVALKKVRLDNE-KEGFPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH- 100 (302)
T ss_pred EEEEEECCCCcEEEEEEEeeccc-ccCchHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-
Confidence 57777777777777765433221 11222334456666677788877642 1245577777775
Q ss_pred chhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 65 PFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 65 ~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
++...+.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++........ .....
T Consensus 101 ~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~ 176 (302)
T cd07864 101 DLMGLLESGLVHFSEDHIKSFMKQLLEGLNYCHK---KNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES-RPYTN 176 (302)
T ss_pred cHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc-ccccc
Confidence 55555543 368999999999999999999999 9999999999999999999999999999986543221 11122
Q ss_pred CCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 143 RRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
..++..|+|||.+.+ ..++.++|+||+||+++||++|++||....
T Consensus 177 ~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~~~el~~g~~~~~~~~ 222 (302)
T cd07864 177 KVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQ 222 (302)
T ss_pred ceeccCccChHHhcCCCCCCchhHHHHHHHHHHHHHhCCCCCCCCC
Confidence 344778999998765 357889999999999999999999997543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=99.93 E-value=7.5e-26 Score=175.64 Aligned_cols=181 Identities=17% Similarity=0.214 Sum_probs=137.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
+|++++..+++.++.|........ ......+..|.......+|++++. ..+...++++++.+++|......
T Consensus 16 ~~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 94 (256)
T cd08218 16 AILVKSKEDGKQYVIKEINISKMS-PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQR 94 (256)
T ss_pred EEEEEEcCCCCEEEEEEEEhHhCC-hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhcc
Confidence 356666666666666543322111 111234556666677778887652 44556688999999999887754
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++.++..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++......... .....|++.|+|
T Consensus 95 ~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~~ 169 (256)
T cd08218 95 GVLFPEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVEL--ARTCIGTPYYLS 169 (256)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchhh--hhhccCCccccC
Confidence 257899999999999999999999 99999999999999999999999999999765432211 122346888999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||.+.+..++.++|+||||++++++++|+.||....
T Consensus 170 pe~~~~~~~~~~~Dv~slG~i~~~l~~g~~~~~~~~ 205 (256)
T cd08218 170 PEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGN 205 (256)
T ss_pred HHHhCCCCCCCccchhHHHHHHHHHHcCCCCccCCC
Confidence 999988888999999999999999999999997544
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=174.62 Aligned_cols=181 Identities=19% Similarity=0.265 Sum_probs=139.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++.+..++..++.|...... ........+..|.......+|++++. ..+...++++++.+++|..+....
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~-~~~~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 94 (257)
T cd08225 16 IYLAKAKSDSEHCVIKEIDLTK-MPVKEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQR 94 (257)
T ss_pred EEEEEEcCCCceEEEEEeeHhh-ccchhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhcc
Confidence 5777887777777776643321 11122334556666777778887653 344567889999999998877543
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 --ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 --~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++ .++++|||.+......... .....|++.|+
T Consensus 95 ~~~~~~~~~~~~~~~l~~~l~~lh~---~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~ 169 (257)
T cd08225 95 GVLFSEDQILSWFVQISLGLKHIHD---RKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSMEL--AYTCVGTPYYL 169 (257)
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEcCCCCeEEecccccchhccCCccc--ccccCCCcccc
Confidence 47999999999999999999999 9999999999999998875 5699999998765432211 12234688999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+....++.++|+||+|++++|+++|+.||....
T Consensus 170 ape~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 206 (257)
T cd08225 170 SPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNN 206 (257)
T ss_pred CHHHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCcc
Confidence 9999988889999999999999999999999997543
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=179.36 Aligned_cols=177 Identities=23% Similarity=0.240 Sum_probs=132.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||++++...+..++.|...............+..|.......+|++++. .....+++++++. +++..... .
T Consensus 37 v~~~~~~~~~~~v~ik~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~ 115 (313)
T cd06633 37 VYFATNSHTNEVVAVKKMSYSGKQTNEKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHK 115 (313)
T ss_pred EEEEEECCCCcEEEEEEEeccccCchHHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcC
Confidence 5777777777777776544332222222234555666667777887653 3344567788775 45555543 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.|+.|||+ .+++|+||+|+||+++.++.++|+|||++..... .....|+..|+||
T Consensus 116 ~~l~~~~~~~~~~qi~~al~~LH~---~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~~------~~~~~~~~~y~aP 186 (313)
T cd06633 116 KPLQEVEIAAITHGALQGLAYLHS---HNMIHRDIKAGNILLTEPGQVKLADFGSASKSSP------ANSFVGTPYWMAP 186 (313)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChhhEEECCCCCEEEeecCCCcccCC------CCCccccccccCh
Confidence 468999999999999999999999 9999999999999999999999999998864321 1234568899999
Q ss_pred cccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++. ...++.++|+||+|+++++|++|.+||....
T Consensus 187 E~~~~~~~~~~~~~sDv~slGvil~el~~g~~p~~~~~ 224 (313)
T cd06633 187 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 224 (313)
T ss_pred hhccccCCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 9974 3568889999999999999999999987654
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=9e-26 Score=182.91 Aligned_cols=177 Identities=19% Similarity=0.261 Sum_probs=134.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------cc------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SE------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~------~~~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.++.|...... ........+..|.......+|++++. .. ....++++++ +++|..
T Consensus 31 vy~~~~~~~~~~~aiK~~~~~~-~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~ 108 (343)
T cd07851 31 VCSAFDTKTGRKVAIKKLSRPF-QSAIHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNN 108 (343)
T ss_pred EEEEEECCCCcEEEEEeccccc-chhhHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHH
Confidence 5788887777777777543321 11112233444555666667787642 11 1244555555 678988
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
++....+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++...... .....++..
T Consensus 109 ~~~~~~l~~~~~~~~~~ql~~aL~~LH~---~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~ 180 (343)
T cd07851 109 IVKCQKLSDDHIQFLVYQILRGLKYIHS---AGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-----MTGYVATRW 180 (343)
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEECCCCCEEEcccccccccccc-----ccCCccccc
Confidence 8888889999999999999999999999 99999999999999999999999999998765332 223356888
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||.+.+ ..++.++|+||+|++++++++|+.||....
T Consensus 181 y~aPE~~~~~~~~~~~~DvwslGv~l~elltg~~pf~~~~ 220 (343)
T cd07851 181 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSD 220 (343)
T ss_pred ccCHHHHhCCCCCCchHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999998865 367889999999999999999999997544
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.6e-25 Score=181.34 Aligned_cols=176 Identities=18% Similarity=0.221 Sum_probs=129.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||++++...++.++.|..+... ........+..|.......+|++++...+ ...++++++. .++..
T Consensus 31 v~~~~~~~~~~~vaiK~~~~~~-~~~~~~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 108 (342)
T cd07879 31 VCSAIDKRTGEKVAIKKLSRPF-QSEIFAKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQK 108 (342)
T ss_pred EEEEEeCCCCcEEEEEEecCcc-ccccchhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHH
Confidence 5778877767777766543221 11112233455666677778888763221 1245555554 34544
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++..... .....+++.
T Consensus 109 ~~-~~~~~~~~~~~~~~qi~~aL~~LH~---~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~~-----~~~~~~~~~ 179 (342)
T cd07879 109 IM-GHPLSEDKVQYLVYQMLCGLKYIHS---AGIIHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRW 179 (342)
T ss_pred HH-cCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCCC-----CCCceeeec
Confidence 43 3468999999999999999999999 99999999999999999999999999998754321 123456888
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||.+.+ ..++.++|+||+|++++||++|+.||....
T Consensus 180 y~aPE~~~~~~~~~~~~Dv~slGvil~el~~g~~pf~~~~ 219 (342)
T cd07879 180 YRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 219 (342)
T ss_pred ccChhhhcCccccCchHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999876 468899999999999999999999998654
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.1e-25 Score=179.82 Aligned_cols=177 Identities=22% Similarity=0.253 Sum_probs=132.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh--cc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC--KK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~--~~ 72 (202)
||++++..++..++.|..............++..|.......+|++++. ......++++++. +++.... ..
T Consensus 31 v~~~~~~~~~~~~~ik~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 109 (308)
T cd06634 31 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK 109 (308)
T ss_pred EEEEEEcCCCcEEEEEEEecccccChHHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcC
Confidence 5778877777777766543221222222234555666667778887653 3345567888886 5665554 34
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.|+.|||+ .+++|+||+|+||+++.++.++++|||++...... ....+++.|+||
T Consensus 110 ~~l~~~~~~~~~~~l~~~l~~LH~---~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~y~aP 180 (308)
T cd06634 110 KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NXFVGTPYWMAP 180 (308)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHhEEECCCCcEEECCcccceeecCc------ccccCCccccCH
Confidence 458999999999999999999999 99999999999999999999999999998764321 223468899999
Q ss_pred cccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+. ...++.++|+||+||+++++++|+.||....
T Consensus 181 E~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 218 (308)
T cd06634 181 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218 (308)
T ss_pred HHHhhcccCCCCcccchHHHHHHHHHHHcCCCCCcccc
Confidence 9974 3457889999999999999999999986543
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.93 E-value=8.1e-26 Score=187.63 Aligned_cols=145 Identities=22% Similarity=0.296 Sum_probs=119.5
Q ss_pred HHHHhccccccc------cccccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC
Q 044746 37 RMIAADNFSNLV------GSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPE 110 (202)
Q Consensus 37 ~~~~~~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~ 110 (202)
......+|+|++ ..+...+++++.+.++-+.......+....++..|+.+|+.|+.|||+ +|++||||||+
T Consensus 368 ~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~~e~~~w~~~lv~Av~~LH~---~gvvhRDLkp~ 444 (612)
T KOG0603|consen 368 ISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFCSEASQWAAELVSAVDYLHE---QGVVHRDLKPG 444 (612)
T ss_pred hhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhHHHHHHHHHHHHHHHHHHHh---cCeeecCCChh
Confidence 445566778766 345556788888988877666655554448888999999999999999 99999999999
Q ss_pred cEEE-cCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 111 SVLL-DENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 111 nil~-~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||+ ++.++++|+|||.++..... ....+-|..|.|||++....++.++|+||+|++||+|++|+.||.....+
T Consensus 445 NIL~~~~~g~lrltyFG~a~~~~~~-----~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~~~~P~~ 519 (612)
T KOG0603|consen 445 NILLDGSAGHLRLTYFGFWSELERS-----CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLFAAHPAG 519 (612)
T ss_pred heeecCCCCcEEEEEechhhhCchh-----hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCccccCCch
Confidence 9999 58999999999999876544 12223378899999999999999999999999999999999999876655
|
|
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.7e-25 Score=172.95 Aligned_cols=181 Identities=21% Similarity=0.226 Sum_probs=139.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.++.|........ ......+..|.......+|++++. ......+++++.++++|..+... .
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 94 (254)
T cd06627 16 VYKGLNLETGDFVAIKQISLEKIK-EEALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFG 94 (254)
T ss_pred EEEEEEcCCCcEEEEEEecccccC-HHHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhcc
Confidence 467777766666666654433221 112234566666666667776542 34456688888999999887754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......... .....++..|+|||
T Consensus 95 ~l~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~y~~pe 169 (254)
T cd06627 95 PFPESLVAVYVYQVLQGLAYLHE---QGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSKD--DASVVGTPYWMAPE 169 (254)
T ss_pred CCCHHHHHHHHHHHHHHHHHHhh---CCcccCCCCHHHEEECCCCCEEEeccccceecCCCccc--ccccccchhhcCHh
Confidence 68999999999999999999999 99999999999999999999999999999866443221 22345688999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
...+..++.++|+||+|++++++++|+.||....
T Consensus 170 ~~~~~~~~~~~Dv~~lG~~l~~l~~g~~p~~~~~ 203 (254)
T cd06627 170 VIEMSGASTASDIWSLGCTVIELLTGNPPYYDLN 203 (254)
T ss_pred hhcCCCCCcchhHHHHHHHHHHHHhCCCCCCCcc
Confidence 9988778899999999999999999999997543
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.93 E-value=1.9e-25 Score=175.83 Aligned_cols=180 Identities=23% Similarity=0.306 Sum_probs=129.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHH---Hhcccccccccc------c-----cceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI---AADNFSNLVGSE------D-----TETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~~------~-----~~~~~~~~~~~~~l 66 (202)
||++++..++..++.|..+...... .....+..|.... ...+|++++..- . ...++++++. +++
T Consensus 15 v~~~~~~~~~~~~aiK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l 92 (287)
T cd07838 15 VYKARDLNTGRFVALKKVRVPLSEE-GIPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDL 92 (287)
T ss_pred EEEEEECCCCCEEEEEEeccccccc-hhhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCH
Confidence 5778887766677766554322211 1122233333222 223577655211 1 1445566665 466
Q ss_pred hhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCC
Q 044746 67 YLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 67 ~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
..++.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++|+|||++......... ...
T Consensus 93 ~~~l~~~~~~~l~~~~~~~~~~~i~~al~~LH~---~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~~~---~~~ 166 (287)
T cd07838 93 ATYLSKCPKPGLPPETIKDLMRQLLRGVDFLHS---HRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEMAL---TSV 166 (287)
T ss_pred HHHHHHccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhEEEccCCCEEEeccCcceeccCCccc---ccc
Confidence 665533 358999999999999999999999 99999999999999999999999999999875433221 223
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.++..|+|||.+.+..++.++|+||+|++++||++|++||.....
T Consensus 167 ~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~~l~~~~~~~~~~~~ 211 (287)
T cd07838 167 VVTLWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSE 211 (287)
T ss_pred cccccccChHHhccCCCCCcchhhhHHHHHHHHHhCCCcccCCCh
Confidence 458889999999988899999999999999999999999986553
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=99.93 E-value=2.3e-25 Score=176.05 Aligned_cols=181 Identities=19% Similarity=0.201 Sum_probs=131.8
Q ss_pred CCccccC---CCcceeehhhhchhhh-hccCCcccCCcHHHHHHhc-cccccc------cccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDA-MEMDKPIRFTSPQRMIAAD-NFSNLV------GSEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~i------~~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++. ..+..++.|+.+.... ........+..|....... +|++++ ..+....++++++.+++|...
T Consensus 16 vy~~~~~~~~~~~~~~avk~~~~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 95 (288)
T cd05583 16 VFLVRKVGGHDAGKLYAMKVLKKATIVQKAKTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTH 95 (288)
T ss_pred EEEEEEeccccCCcEEEEEEEehHHHHhhhhHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHH
Confidence 4555432 2344555555433222 1122233444555555444 567654 234456688999999999887
Q ss_pred hcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 70 CKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 70 ~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+.. ..+++..+..++.|++.||.|||+ .+++|+||+|+||+++.++.++++|||++.......... .....|+..
T Consensus 96 ~~~~~~~~~~~~~~~~~ql~~~l~~lH~---~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~ 171 (288)
T cd05583 96 LYQREHFTESEVRVYIAEIVLALDHLHQ---LGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEER-AYSFCGTIE 171 (288)
T ss_pred HhhcCCcCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHeEECCCCCEEEEECccccccccccccc-cccccCCcc
Confidence 754 568999999999999999999999 999999999999999999999999999987654332211 123456889
Q ss_pred ccCCcccCCCC--CCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 149 CEAPELWMPYS--VTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 149 y~aPe~~~~~~--~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|+|||.+.+.. .+.++|+||+|++++||++|..||..
T Consensus 172 y~aPE~~~~~~~~~~~~~Dv~slG~il~el~tg~~p~~~ 210 (288)
T cd05583 172 YMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTV 210 (288)
T ss_pred ccCHHHhcCCCCCCcchhhhHHHHHHHHHHHhCCCCccc
Confidence 99999987654 67899999999999999999999964
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.2e-25 Score=186.41 Aligned_cols=173 Identities=18% Similarity=0.244 Sum_probs=144.7
Q ss_pred ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccCC--CCHHHHHHH
Q 044746 11 RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKNI--LGFGQLREI 83 (202)
Q Consensus 11 ~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~ 83 (202)
-.||+|. .......++...|..|..+....+||+|+. ...-.+++++....|.|..+++.++ ++......+
T Consensus 419 iaVAvKt--CK~d~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly 496 (974)
T KOG4257|consen 419 IAVAVKT--CKTDCTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQPMWIVMELAPLGELREYLQQNKDSLPLRTLTLY 496 (974)
T ss_pred eeeeeeh--hccCCChhhHHHHHHHHHHHHhCCCcchhheeeeeeccceeEEEecccchhHHHHHHhccccchHHHHHHH
Confidence 3344444 344455566777999999999999998764 3444679999999999999997654 888899999
Q ss_pred HHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCch
Q 044746 84 EVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQK 163 (202)
Q Consensus 84 ~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~ 163 (202)
+.||+.||.|||+ .+++||||..+|||+.+...+||+|||+++.+.+...+..+. ..-+..|||||.+.-..++.+
T Consensus 497 ~~Qi~talaYLeS---krfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~yYkaS~-~kLPIKWmaPESINfRrFTtA 572 (974)
T KOG4257|consen 497 CYQICTALAYLES---KRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDAYYKASR-GKLPIKWMAPESINFRRFTTA 572 (974)
T ss_pred HHHHHHHHHHHHh---hchhhhhhhhhheeecCcceeeecccchhhhccccchhhccc-cccceeecCccccchhcccch
Confidence 9999999999999 999999999999999999999999999999887765554443 344778999999999999999
Q ss_pred hhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 164 CDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 164 ~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
+|||-||+++||++. |..||.+-.+.
T Consensus 573 SDVWMFgVCmWEIl~lGvkPfqgvkNs 599 (974)
T KOG4257|consen 573 SDVWMFGVCMWEILSLGVKPFQGVKNS 599 (974)
T ss_pred hhHHHHHHHHHHHHHhcCCcccccccc
Confidence 999999999999875 99999876554
|
|
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.1e-25 Score=171.58 Aligned_cols=181 Identities=21% Similarity=0.273 Sum_probs=138.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++.+..++..++.|........ .+....+..|.......+|++++. .++...+++++.++++|...+..
T Consensus 16 v~~~~~~~~~~~~~ik~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 94 (258)
T cd08215 16 VYLVRRKSDGKLYVLKEIDLSNMS-EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQK 94 (258)
T ss_pred EEEEEEcCCCcEEEEEEeecccCC-hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhh
Confidence 466666655556665554332111 122233555555666667777653 34566788899999999888754
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 73 ---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 73 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
..+++..+..++.+++.||.|||+ .+++|+||+|+||+++.++.++++|||.+........ ......|++.|
T Consensus 95 ~~~~~~~~~~~~~i~~~i~~~l~~lh~---~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~y 169 (258)
T cd08215 95 KEGKPFPEEQILDWFVQLCLALKYLHS---RKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTVD--LAKTVVGTPYY 169 (258)
T ss_pred ccCCCcCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHHeEEcCCCcEEECCccceeecccCcc--eecceeeeecc
Confidence 569999999999999999999999 8999999999999999999999999999986544321 12234568899
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||.+....++.++|+||+|++++++++|+.||....
T Consensus 170 ~~pe~~~~~~~~~~~Dv~slG~~~~~l~~g~~p~~~~~ 207 (258)
T cd08215 170 LSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGEN 207 (258)
T ss_pred cChhHhccCCCCccccHHHHHHHHHHHHcCCCCCCCCc
Confidence 99999988889999999999999999999999997653
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=99.92 E-value=4.8e-25 Score=173.47 Aligned_cols=178 Identities=22% Similarity=0.272 Sum_probs=130.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc-ccccc------cccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN-FSNLV------GSEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++.....++.++.|........ ........+.......+ |++++ -.++...++++++ ++++.......
T Consensus 15 v~~~~~~~~~~~~~ik~~~~~~~~--~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~ 91 (283)
T cd07830 15 VYLARNKETGELVAIKKMKKKFYS--WEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDR 91 (283)
T ss_pred EEEEEECCCCcEEEEEEehhhccc--hhHHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhc
Confidence 577888777777766543221110 01111122333344444 77654 2355667888888 77887766543
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.+|.|||+ ++++|+||+|+||+++.++.++|+|||++......... ....++..|+
T Consensus 92 ~~~~~~~~~~~~~~~~l~~~l~~Lh~---~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~~~---~~~~~~~~~~ 165 (283)
T cd07830 92 KGKPFSESVIRSIIYQILQGLAHIHK---HGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRPPY---TDYVSTRWYR 165 (283)
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCCEEEeecccceeccCCCCc---CCCCCccccc
Confidence 68999999999999999999999 99999999999999999999999999999865432221 2234688899
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+.. ..++.++|+||||++++|+++|++||....
T Consensus 166 aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~~~~~~~~ 203 (283)
T cd07830 166 APEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSS 203 (283)
T ss_pred CceeeecCcCcCCccchhhHHHHHHHHHhCCCccCCCC
Confidence 9998754 457889999999999999999999997654
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=99.92 E-value=2.8e-25 Score=176.36 Aligned_cols=177 Identities=19% Similarity=0.262 Sum_probs=126.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH-HHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++.+...++.+++|..+..... .....+..+ ..+....+|++++. .+....++++++. +.+..+..
T Consensus 31 v~~~~~~~~~~~~avK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~l~~~~ 107 (296)
T cd06618 31 VYKMRFKKTGHVMAVKQMRRTGNK--EENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELMS-TCLDKLLKRI 107 (296)
T ss_pred EEEEEECCCCeEEEEEEEeccCCh--HHHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeeccC-cCHHHHHHHh
Confidence 577788777777777765432111 111122222 23444445776653 3334556677764 34444443
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
...+++..+..++.|++.|+.|||+. .+++||||+|+||+++.++.++|+|||++......... ....++..|+|
T Consensus 108 ~~~l~~~~~~~i~~~i~~~l~~lH~~--~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~~~---~~~~~~~~y~a 182 (296)
T cd06618 108 QGPIPEDILGKMTVAIVKALHYLKEK--HGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSKAK---TRSAGCAAYMA 182 (296)
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhh--CCEecCCCcHHHEEEcCCCCEEECccccchhccCCCcc---cCCCCCccccC
Confidence 24689999999999999999999971 59999999999999999999999999998765332221 22345788999
Q ss_pred CcccCCCC----CCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 152 PELWMPYS----VTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 152 Pe~~~~~~----~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
||.+.+.. ++.++|+||||+++++|++|+.||..
T Consensus 183 PE~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~ 220 (296)
T cd06618 183 PERIDPPDPNPKYDIRADVWSLGISLVELATGQFPYKN 220 (296)
T ss_pred HhhcCCCCCccccccchhHHHHHHHHHHHHhCCCCCCc
Confidence 99987543 78899999999999999999999975
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=99.92 E-value=3.8e-25 Score=193.11 Aligned_cols=126 Identities=19% Similarity=0.283 Sum_probs=101.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...++.||.|+.+............+..+.......+|++++. .....+++++++.+++|..++.. +
T Consensus 20 Vy~a~~~~~~~~vAiKvi~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~ 99 (669)
T cd05610 20 VYLGRKKNNSKLYAVKVVKKADMINKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYG 99 (669)
T ss_pred EEEEEECCCCcEEEEEEEehhhccCHHHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcC
Confidence 6888998888889988765433222222344556666667778887663 34556788999999999888754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
.+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.++|+|||+++
T Consensus 100 ~l~~~~~~~i~~qil~aL~yLH~---~gIiHrDLKP~NILl~~~g~vkL~DFGls~ 152 (669)
T cd05610 100 YFDEEMAVKYISEVALALDYLHR---HGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152 (669)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence 58999999999999999999999 899999999999999999999999999986
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.7e-25 Score=179.63 Aligned_cols=188 Identities=20% Similarity=0.272 Sum_probs=147.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCccc----CCcHHHHHHhcccccccccccc-------ceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIR----FTSPQRMIAADNFSNLVGSEDT-------ETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~i~~~~~-------~~~~~~~~~~~~l~~~ 69 (202)
||||-+....++||.|+-........++... --.|..+-...+|+.|+...++ .+.+.+|+++..|.-+
T Consensus 479 VyKAFDl~EqRYvAvKIHqlNK~WrdEKKeNYhKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFY 558 (775)
T KOG1151|consen 479 VYKAFDLTEQRYVAVKIHQLNKNWRDEKKENYHKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFY 558 (775)
T ss_pred HHHhcccchhheeeEeeehhccchhhHhhhhHHHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHH
Confidence 7999999999999999965554443333222 2344555566788887753332 3467899999999888
Q ss_pred hccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc---CCCceEEeeeecceeccccCcccc-----c
Q 044746 70 CKKNI-LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFPKAADFGLAKLYNREHTHIT-----S 140 (202)
Q Consensus 70 ~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~---~~~~~kl~dfgl~~~~~~~~~~~~-----~ 140 (202)
++.++ +++.+++.|..||..||.||... +.+|||-||||.|||+. ..|.+||.|||+++.+..+..... .
T Consensus 559 LKQhklmSEKEARSIiMQiVnAL~YLNEi-kpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLT 637 (775)
T KOG1151|consen 559 LKQHKLMSEKEARSIIMQIVNALKYLNEI-KPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELT 637 (775)
T ss_pred HHhhhhhhHHHHHHHHHHHHHHHHHHhcc-CCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeee
Confidence 87765 89999999999999999999974 58999999999999995 468899999999998865543321 2
Q ss_pred CCCCCCCcccCCcccCCC----CCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 141 TGRRRTPGCEAPELWMPY----SVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~~~----~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
....||..|++||.+.-. .++.++||||+|+++|+.+.|+.||..+..+
T Consensus 638 SQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSvGVIFyQClYGrKPFGhnqsQ 690 (775)
T KOG1151|consen 638 SQGAGTYWYLPPECFVVGKEPPKISNKVDVWSVGVIFYQCLYGRKPFGHNQSQ 690 (775)
T ss_pred cccCceeeecCcceeecCCCCCccccceeeEeeehhhhhhhccCCCCCCchhH
Confidence 235689999999998643 4789999999999999999999999866554
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.92 E-value=8.7e-27 Score=176.11 Aligned_cols=181 Identities=25% Similarity=0.280 Sum_probs=131.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh----
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC---- 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~---- 70 (202)
|+|-.++.+++..|+|--+.... +.+..+.+..-+......+-++|+. ..+..+..++.|. -++..+.
T Consensus 80 V~KM~hk~sg~~mAVKrIr~~n~-~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELMd-~SlDklYk~vy 157 (361)
T KOG1006|consen 80 VNKMLHKPSGKLMAVKRIRSNNI-EKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELMD-ISLDKLYKRVY 157 (361)
T ss_pred hhhhhcCccCcEEEEEEeeeccc-hHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHHh-hhHHHHHHHHH
Confidence 56777888888888765444333 1222222333355566677788774 2334455555554 3333222
Q ss_pred --ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 71 --KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 71 --~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
++..+++.-.-.+..-...||.||-.. ..|||||+||+|||++..|.+||+|||.+..+.... ..+.-.|...
T Consensus 158 ~vq~~~ipE~Ilg~ItvatV~AL~yLK~~--lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si---AkT~daGCrp 232 (361)
T KOG1006|consen 158 SVQKSRIPENILGHITVATVDALDYLKEE--LKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI---AKTVDAGCRP 232 (361)
T ss_pred HHHhccCcHhhhhheeeeehhHHHHHHHH--hhhhhccCChhheEEecCCCEeeecccchHhHHHHH---HhhhccCCcc
Confidence 455688888888888889999999983 899999999999999999999999999987543322 2344567889
Q ss_pred ccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||||-+.. ..|+.++|+||+|++|+|+.||+.|+.+-.+
T Consensus 233 YmAPERi~p~~~gyDiRSDvWSLGITL~EvAtG~fPyr~w~s 274 (361)
T KOG1006|consen 233 YMAPERIDPSDKGYDIRSDVWSLGITLYEVATGNFPYRKWDS 274 (361)
T ss_pred ccChhccCCccCCcchhhhhhhhcceEeeeecCCCCcchHHH
Confidence 999999864 3589999999999999999999999876544
|
|
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=99.92 E-value=1.9e-24 Score=168.17 Aligned_cols=149 Identities=21% Similarity=0.320 Sum_probs=120.3
Q ss_pred CCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 044746 32 FTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-----KNILGFGQLREIEVSTSKGIAYLHEECRQ 100 (202)
Q Consensus 32 ~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~ 100 (202)
+..|.......+|++++. ......++++++.+++|..++. ...+++..+..++.|++.||.|||+ .
T Consensus 49 ~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~---~ 125 (260)
T cd08222 49 ANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ---R 125 (260)
T ss_pred HHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH---c
Confidence 444555666778888763 3344568899999999987663 3569999999999999999999999 9
Q ss_pred CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCC
Q 044746 101 KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180 (202)
Q Consensus 101 ~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~ 180 (202)
+++|+||+|+||+++. +.++++|||++........ ......|++.|+|||.+.+..++.++|+||+|++++++++|.
T Consensus 126 ~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~--~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~~~ 202 (260)
T cd08222 126 RILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD--LATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLA 202 (260)
T ss_pred CccccCCChhheEeec-CCEeecccCceeecCCCcc--cccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999975 5699999999876533221 122345688999999998888899999999999999999999
Q ss_pred CCCcch
Q 044746 181 RNLEKE 186 (202)
Q Consensus 181 ~p~~~~ 186 (202)
.||...
T Consensus 203 ~~~~~~ 208 (260)
T cd08222 203 HAFEGQ 208 (260)
T ss_pred CCCCCc
Confidence 999643
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.3e-25 Score=187.64 Aligned_cols=132 Identities=18% Similarity=0.213 Sum_probs=101.2
Q ss_pred ccccceEEEEEccCCchhhhhccCCCC---------------------HHHHHHHHHHHHHHHHHHHhCCCCCeEEecCC
Q 044746 50 SEDTETYIKGFLAMGPFYLLCKKNILG---------------------FGQLREIEVSTSKGIAYLHEECRQKIVHYDIK 108 (202)
Q Consensus 50 ~~~~~~~~~~~~~~~~l~~~~~~~~~~---------------------~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk 108 (202)
.+....++++|..+++|..++....++ ...+..++.|++.||.|||+ ++|+|||||
T Consensus 206 ~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~---~gIiHRDLK 282 (566)
T PLN03225 206 KEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHS---TGIVHRDVK 282 (566)
T ss_pred cCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHH---CCEEeCcCC
Confidence 445677899999999998887544321 23456799999999999999 999999999
Q ss_pred CCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCC----------------------CCCchhh
Q 044746 109 PESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY----------------------SVTQKCD 165 (202)
Q Consensus 109 ~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~----------------------~~~~~~D 165 (202)
|+|||++. ++.+||+|||+++........ ......+++.|+|||.+... .++.++|
T Consensus 283 P~NILl~~~~~~~KL~DFGlA~~l~~~~~~-~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~D 361 (566)
T PLN03225 283 PQNIIFSEGSGSFKIIDLGAAADLRVGINY-IPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFD 361 (566)
T ss_pred HHHEEEeCCCCcEEEEeCCCcccccccccc-CCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcc
Confidence 99999985 579999999999865332221 12335678999999965321 2345679
Q ss_pred HHHHHHHHHHHHcCCCCCcc
Q 044746 166 VFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 166 iws~G~~l~el~~g~~p~~~ 185 (202)
|||+||++|||+++..|++.
T Consensus 362 VwSlGviL~el~~~~~~~~~ 381 (566)
T PLN03225 362 IYSAGLIFLQMAFPNLRSDS 381 (566)
T ss_pred cHHHHHHHHHHHhCcCCCch
Confidence 99999999999998776554
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-24 Score=188.10 Aligned_cols=173 Identities=23% Similarity=0.266 Sum_probs=136.2
Q ss_pred cceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc---c---ccccceEEEEEccCCchhhhhccCC---------
Q 044746 10 TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV---G---SEDTETYIKGFLAMGPFYLLCKKNI--------- 74 (202)
Q Consensus 10 ~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i---~---~~~~~~~~~~~~~~~~l~~~~~~~~--------- 74 (202)
...||+|+.+..... .+..........+.....|+|++ | ..+...++.++.+.|+|..++...+
T Consensus 328 ~~~VaVK~~k~~~~~-~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~ 406 (609)
T KOG0200|consen 328 YVTVAVKMLKENASS-SEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSG 406 (609)
T ss_pred eEEEEEEecccccCc-HHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccC
Confidence 556777766555443 22223334445566667788765 4 4455778999999999999997766
Q ss_pred --------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccccc-CCCCC
Q 044746 75 --------LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS-TGRRR 145 (202)
Q Consensus 75 --------~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~-~~~~g 145 (202)
++..+...++.||+.|++||++ .+++||||-.+|||+..+..+|++|||+++........... ....-
T Consensus 407 ~~~~~~~~L~~~dLlsfa~QIa~GMe~L~~---~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~L 483 (609)
T KOG0200|consen 407 VFPNERDALTTKDLLSFAYQIANGMEYLAS---VPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYYRTKSSAGTL 483 (609)
T ss_pred CCccccCCcCHHHHHHHHHHHHHHHHHHhh---CCccchhhhhhhEEecCCCEEEEccccceeccCCCCceEecCCCCcc
Confidence 9999999999999999999999 89999999999999999999999999999965443333221 11113
Q ss_pred CCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcch
Q 044746 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKE 186 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~ 186 (202)
+..|||||.+....|+.++||||||++|||++| |..|+.+.
T Consensus 484 P~kWmApEsl~~~~ft~kSDVWSfGI~L~EifsLG~~PYp~~ 525 (609)
T KOG0200|consen 484 PVKWMAPESLFDRVFTSKSDVWSFGILLWEIFTLGGTPYPGI 525 (609)
T ss_pred ceeecCHHHhccCcccccchhhHHHHHHHHHhhCCCCCCCCC
Confidence 567999999999999999999999999999998 89999863
|
|
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=7.5e-25 Score=181.98 Aligned_cols=177 Identities=21% Similarity=0.258 Sum_probs=139.6
Q ss_pred ccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------ccceEEEEEccCCchhhhhc---cC
Q 044746 3 KPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------DTETYIKGFLAMGPFYLLCK---KN 73 (202)
Q Consensus 3 k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------~~~~~~~~~~~~~~l~~~~~---~~ 73 (202)
....+.-.--||+|..+... + ...+|..|..++....|+|++.-. .-.+++.+||.+|+|++++. +.
T Consensus 285 eGvWKkyslTvAVKtLKEDt---M-eveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ 360 (1157)
T KOG4278|consen 285 EGVWKKYSLTVAVKTLKEDT---M-EVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRS 360 (1157)
T ss_pred eeeeeccceeeehhhhhhcc---h-hHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchh
Confidence 33333334445665544332 2 234688888888889999876433 33458899999999999884 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.++.-..+.++.||.+|++||.. +++|||||...|+|+..+..+|++||||++++..+.+.... +..=...|.|||
T Consensus 361 ev~avvLlyMAtQIsSaMeYLEk---knFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDTYTAHA-GAKFPIKWTAPE 436 (1157)
T KOG4278|consen 361 EVPAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDTYTAHA-GAKFPIKWTAPE 436 (1157)
T ss_pred hcchhHHHHHHHHHHHHHHHHHH---hhhhhhhhhhhhccccccceEEeeccchhhhhcCCceeccc-CccCcccccCcc
Confidence 47777889999999999999999 99999999999999999999999999999998765544332 222367899999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
-+....++.|+|||+||++|||+.| |..|+.+.+
T Consensus 437 sLAyNtFSiKSDVWAFGVLLWEIATYGMsPYPGid 471 (1157)
T KOG4278|consen 437 SLAYNTFSIKSDVWAFGVLLWEIATYGMSPYPGID 471 (1157)
T ss_pred cccccccccchhhHHHHHHHHHHHhcCCCCCCCcc
Confidence 9999999999999999999999998 999987654
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=2.1e-25 Score=183.75 Aligned_cols=175 Identities=21% Similarity=0.234 Sum_probs=141.7
Q ss_pred cceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------cccceEEEEEccCCchhhhhccCCC---CHHHH
Q 044746 10 TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------EDTETYIKGFLAMGPFYLLCKKNIL---GFGQL 80 (202)
Q Consensus 10 ~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l~~~~~~~~~---~~~~~ 80 (202)
...||+|..+..... .....|..|..++....||||+.- .+-...+++|+++|.|.+++..+.. .-...
T Consensus 562 ~lkVAVK~Lr~~a~~--~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~ 639 (807)
T KOG1094|consen 562 PLKVAVKILRPDATK--NARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPG 639 (807)
T ss_pred ceEEEEeecCcccch--hHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchh
Confidence 456777766554332 234679999999999999998743 4445689999999999999977632 44567
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCC
Q 044746 81 REIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSV 160 (202)
Q Consensus 81 ~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~ 160 (202)
.+++.||++|++||.+ .+++|||+.+.|+|++.++++|++|||+++.+-...++.......-+.+|||+|.+.-+.+
T Consensus 640 vsi~tqiasgmaYLes---~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkF 716 (807)
T KOG1094|consen 640 VSICTQIASGMAYLES---LNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKF 716 (807)
T ss_pred HHHHHHHHHHHHHHHh---hchhhccccccceeecCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccc
Confidence 8899999999999999 8999999999999999999999999999995444444444344455789999999999999
Q ss_pred CchhhHHHHHHHHHHHHc--CCCCCcchhcc
Q 044746 161 TQKCDVFSFGMLLFEVVG--RRRNLEKEISE 189 (202)
Q Consensus 161 ~~~~Diws~G~~l~el~~--g~~p~~~~~~~ 189 (202)
++++|+|+||+++||+++ .+.||....++
T Consensus 717 ttaSDvWafgvTlwE~~~~C~e~Py~~lt~e 747 (807)
T KOG1094|consen 717 TTASDVWAFGVTLWEVFMLCREQPYSQLTDE 747 (807)
T ss_pred cchhhhhhhHHHHHHHHHHHhhCchhhhhHH
Confidence 999999999999999876 78898876655
|
|
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=1.1e-26 Score=176.48 Aligned_cols=185 Identities=21% Similarity=0.273 Sum_probs=130.6
Q ss_pred CccccCCCcceeeh-hhhchhhhhccCCcccCCcHHHHHHhccccccccccc-----------cceEEEEEccCCchhh-
Q 044746 2 EKPRNRGSTRFITR-TIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED-----------TETYIKGFLAMGPFYL- 68 (202)
Q Consensus 2 ~k~~~~~~~~~v~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~l~~- 68 (202)
|-..+-++++.|+. |+..... +.....++..|..++....|.|++...+ ..+++.+.+.. .|..
T Consensus 70 WsVTDPRdgrrvalkK~pnvfq--~L~s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQS-DLHKI 146 (449)
T KOG0664|consen 70 WSVTDPRSGKRVALKKMPNVFQ--NLASCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQS-DLHKI 146 (449)
T ss_pred EeccCCCCccchhHhhcchHHH--HHHHHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHHh-hhhhe
Confidence 44455555555554 3322221 1223455667777777778887763221 12233444332 3333
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+..-..++.+.++-+..||++||.|||+ .+|+||||||.|.|+.++..+|++|||+++....+.... .+...-|-.
T Consensus 147 IVSPQ~Ls~DHvKVFlYQILRGLKYLHs---A~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d~~~h-MTqEVVTQY 222 (449)
T KOG0664|consen 147 IVSPQALTPDHVKVFVYQILRGLKYLHT---ANILHRDIKPGNLLVNSNCILKICDFGLARTWDQRDRLN-MTHEVVTQY 222 (449)
T ss_pred eccCCCCCcchhhhhHHHHHhhhHHHhh---cchhhccCCCccEEeccCceEEecccccccccchhhhhh-hHHHHHHHH
Confidence 3345568999999999999999999999 899999999999999999999999999999654332222 222333778
Q ss_pred ccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcccccc
Q 044746 149 CEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193 (202)
Q Consensus 149 y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~ 193 (202)
|.|||++++. .|+...||||.||++.|++.++-.|...++-.+..
T Consensus 223 YRAPEiLMGaRhYs~AvDiWSVGCIFaELLgRrILFQAq~PiqQL~ 268 (449)
T KOG0664|consen 223 YRAPELLMGARRYTGAVDIWSVGCIFAELLQRKILFQAAGPIEQLQ 268 (449)
T ss_pred hccHHHhhcchhhcCccceehhhHHHHHHHhhhhhhhccChHHHHH
Confidence 9999999875 69999999999999999999998888777655533
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.6e-25 Score=187.51 Aligned_cols=170 Identities=22% Similarity=0.313 Sum_probs=144.3
Q ss_pred hhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHH
Q 044746 20 SLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIA 92 (202)
Q Consensus 20 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~ 92 (202)
..+....+...++..|...++..+|+|++. ..++..++..+++.|.|.++.+. .++.....+.|+.||++|+.
T Consensus 733 l~~~t~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~ 812 (1177)
T KOG1025|consen 733 LIEFTSPKASIELLDEALRMASLDHPNLLRLLGVCMLSTLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMK 812 (1177)
T ss_pred eeccCCchhhHHHHHHHHHHhcCCCchHHHHhhhcccchHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence 333445556778999999999999998764 34446688899999999998854 56999999999999999999
Q ss_pred HHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHH
Q 044746 93 YLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGML 172 (202)
Q Consensus 93 ~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~ 172 (202)
|||. ++++||||..+|+|+.....+|+.|||+++....+..........-.+.|||-|.+....|+.++|||||||+
T Consensus 813 YLe~---qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVt 889 (1177)
T KOG1025|consen 813 YLEE---QRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVT 889 (1177)
T ss_pred HHHh---cchhhhhhhhhheeecCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhh
Confidence 9998 9999999999999999999999999999998766554444444445788999999999999999999999999
Q ss_pred HHHHHc-CCCCCcchhccccc
Q 044746 173 LFEVVG-RRRNLEKEISEGQE 192 (202)
Q Consensus 173 l~el~~-g~~p~~~~~~~~~~ 192 (202)
+||++| |..|+++...++..
T Consensus 890 iWElmTFGa~Py~gi~~~eI~ 910 (1177)
T KOG1025|consen 890 IWELMTFGAKPYDGIPAEEIP 910 (1177)
T ss_pred HHHHHhcCCCccCCCCHHHhh
Confidence 999998 99999988776543
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=99.90 E-value=4.5e-24 Score=189.85 Aligned_cols=123 Identities=15% Similarity=0.095 Sum_probs=95.7
Q ss_pred ccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-------------------Cc
Q 044746 61 LAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-------------------FF 119 (202)
Q Consensus 61 ~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-------------------~~ 119 (202)
..+++|..++.. ..+++.+++.++.||+.||.|||+ ++|+||||||+|||++.. +.
T Consensus 61 ~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~gIvHrDlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~ 137 (793)
T PLN00181 61 CEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHS---QGIVVHNVRPSCFVMSSFNHVSFIESASCSDSGSDEDAT 137 (793)
T ss_pred cCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHh---CCeeeccCCchhEEEcccCcEEEeeccccCcccccccCc
Confidence 446789888854 359999999999999999999999 999999999999999654 44
Q ss_pred eEEeeeecceeccccCc--------------ccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 120 PKAADFGLAKLYNREHT--------------HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 120 ~kl~dfgl~~~~~~~~~--------------~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
+|++|||+++....... ........||+.|+|||++.+..++.++|||||||++|||++|.+|+..
T Consensus 138 ~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~ 217 (793)
T PLN00181 138 TKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPEEDNGSSSNCASDVYRLGVLLFELFCPVSSREE 217 (793)
T ss_pred ccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChhhhccCCCCchhhhhhHHHHHHHHhhCCCchhh
Confidence 55666666653211000 0001113578899999999998999999999999999999999999764
Q ss_pred h
Q 044746 186 E 186 (202)
Q Consensus 186 ~ 186 (202)
.
T Consensus 218 ~ 218 (793)
T PLN00181 218 K 218 (793)
T ss_pred H
Confidence 3
|
|
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=160.86 Aligned_cols=177 Identities=25% Similarity=0.353 Sum_probs=139.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++....+++.++.|+......... ...+..|.......+|++++. ......+++++..+++|..++....
T Consensus 5 v~~~~~~~~~~~~~~k~~~~~~~~~~--~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~ 82 (244)
T smart00220 5 VYLARDKKTGKLVAIKVIKKEKIKKK--RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRG 82 (244)
T ss_pred EEEEEECCCCcEEEEEEecccccccH--HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhcc
Confidence 57788877666666666433222111 345566666666667776652 2244567888899989988886555
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 75 -LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 75 -~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
+++..+..++.+++.++.+||+ .+++|+|++|.||+++.++.++++|||.+....... ......++..|++||
T Consensus 83 ~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~---~~~~~~~~~~~~~pE 156 (244)
T smart00220 83 RLSEDEARFYARQILSALEYLHS---NGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG---LLTTFVGTPEYMAPE 156 (244)
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---cCeecCCcCHHHeEECCCCcEEEccccceeeecccc---ccccccCCcCCCCHH
Confidence 8999999999999999999999 899999999999999999999999999998654432 123345688999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
.+....++.++|+||+|++++++++|..||..
T Consensus 157 ~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~~ 188 (244)
T smart00220 157 VLLGKGYGKAVDVWSLGVILYELLTGKPPFPG 188 (244)
T ss_pred HHccCCCCchhhHHHHHHHHHHHHhCCCCCCC
Confidence 99888889999999999999999999999976
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.4e-23 Score=154.48 Aligned_cols=106 Identities=23% Similarity=0.262 Sum_probs=91.5
Q ss_pred Cchhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccC
Q 044746 64 GPFYLLCK--KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141 (202)
Q Consensus 64 ~~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~ 141 (202)
|+|.+++. ...+++.++..++.|++.||.|||+ .+ ||+||+++.++.+++ ||++.......
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~------kp~Nil~~~~~~~~~--fG~~~~~~~~~------ 63 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHR---QA------KSGNILLTWDGLLKL--DGSVAFKTPEQ------ 63 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHh---cC------CcccEeEcCccceee--ccceEeecccc------
Confidence 46777775 3459999999999999999999998 55 999999999999999 99988654321
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
..||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 64 -~~g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~ 108 (176)
T smart00750 64 -SRVDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEER 108 (176)
T ss_pred -CCCcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccc
Confidence 246899999999999999999999999999999999999997543
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=2.5e-24 Score=166.26 Aligned_cols=155 Identities=19% Similarity=0.246 Sum_probs=122.2
Q ss_pred cCCcccCCcHHHHHHhccccccccccccce------------EEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHH
Q 044746 26 MDKPIRFTSPQRMIAADNFSNLVGSEDTET------------YIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAY 93 (202)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~------------~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~ 93 (202)
....++-..|.......+|+|+++-.+..+ ++++++. .++..... -.+.-...+.+..|++.|++|
T Consensus 56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m~-~nl~~vi~-~elDH~tis~i~yq~~~~ik~ 133 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELMD-ANLCQVIL-MELDHETISYILYQMLCGIKH 133 (369)
T ss_pred CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhhh-hHHHHHHH-HhcchHHHHHHHHHHHHHHHH
Confidence 445566777788888889999886433322 2233332 34444333 456778899999999999999
Q ss_pred HHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHH
Q 044746 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLL 173 (202)
Q Consensus 94 lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l 173 (202)
||+ .+|+||||||+||++..+..+|+.|||+++..+.. ...+....|..|.|||++.+.++...+||||+||++
T Consensus 134 lhs---~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~---~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~ 207 (369)
T KOG0665|consen 134 LHS---AGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD---FMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIM 207 (369)
T ss_pred HHh---cceeecccCcccceecchhheeeccchhhcccCcc---cccCchhheeeccCchheeccCCcccchhhhhhhHH
Confidence 999 99999999999999999999999999999865433 234555668899999999998899999999999999
Q ss_pred HHHHcCCCCCcchhc
Q 044746 174 FEVVGRRRNLEKEIS 188 (202)
Q Consensus 174 ~el~~g~~p~~~~~~ 188 (202)
.||++|+--|.+...
T Consensus 208 gEli~~~Vlf~g~d~ 222 (369)
T KOG0665|consen 208 GELILGTVLFPGKDH 222 (369)
T ss_pred HHHhhceEEecCchH
Confidence 999999999885443
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=99.90 E-value=6.8e-24 Score=157.64 Aligned_cols=174 Identities=20% Similarity=0.247 Sum_probs=132.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc-cccccc--------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN-FSNLVG--------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~--------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||.+++..+++-++.|+.+.-. ...+..|..++.... ++|++. ......++.++.++..+..+..
T Consensus 54 VFeg~~~~~~eK~ViKiLKPVk------kkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~ 127 (338)
T KOG0668|consen 54 VFEGINITNNEKCVIKILKPVK------KKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP 127 (338)
T ss_pred HhcccccCCCceEEEeeechHH------HHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh
Confidence 4566666777777777654432 234556666665544 788774 3334457788888877665553
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.++..+++.++.+++.||.|||| +||+|||+||.|++++. ...++|+|.|+|......... ..+..+..|-
T Consensus 128 --tl~d~dIryY~~elLkALdyCHS---~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~eY---nVRVASRyfK 199 (338)
T KOG0668|consen 128 --TLTDYDIRYYIYELLKALDYCHS---MGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGKEY---NVRVASRYFK 199 (338)
T ss_pred --hhchhhHHHHHHHHHHHHhHHHh---cCcccccCCcceeeechhhceeeeeecchHhhcCCCcee---eeeeehhhcC
Confidence 47778899999999999999999 99999999999999985 467899999999977554433 3334477888
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||++... .|+..-|+|||||++..|+..+.||....+
T Consensus 200 GPELLVdy~~YDYSLD~WS~GcmlA~miFrkepFFhG~d 238 (338)
T KOG0668|consen 200 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 238 (338)
T ss_pred CchheeechhccccHHHHHHHHHHHHHHhccCcccCCCC
Confidence 99998764 588999999999999999999999875544
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=5.6e-24 Score=178.47 Aligned_cols=176 Identities=16% Similarity=0.200 Sum_probs=142.3
Q ss_pred CCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccccce-----EEEEEccCCchhhhhcc---CCCCHHH
Q 044746 8 GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTET-----YIKGFLAMGPFYLLCKK---NILGFGQ 79 (202)
Q Consensus 8 ~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~-----~~~~~~~~~~l~~~~~~---~~~~~~~ 79 (202)
+...-||+|+.+...... ....|..|..++....|+++|.-.+... .++|..+.|+|.+.+.+ ..|....
T Consensus 136 gk~V~VAVKclr~d~l~~--~mddflrEas~M~~L~H~hliRLyGvVl~qp~mMV~ELaplGSLldrLrka~~~~llv~~ 213 (1039)
T KOG0199|consen 136 GKHVNVAVKCLRDDSLNA--IMDDFLREASHMLKLQHPHLIRLYGVVLDQPAMMVFELAPLGSLLDRLRKAKKAILLVSR 213 (1039)
T ss_pred CcEEeEEEEeccCCccch--hHHHHHHHHHHHHhccCcceeEEeeeeccchhhHHhhhcccchHHHHHhhccccceeHHH
Confidence 344556777665544332 4557889999999999999987655433 67788899999988865 3478888
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccccc-CCCCCCCcccCCcccCCC
Q 044746 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS-TGRRRTPGCEAPELWMPY 158 (202)
Q Consensus 80 ~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~-~~~~gt~~y~aPe~~~~~ 158 (202)
.-.++.||+.|+.||.+ +++|||||...|+|+.....+||+||||.+.+......... ....-...|.|||.+...
T Consensus 214 Lcdya~QiA~aM~YLes---krlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~ 290 (1039)
T KOG0199|consen 214 LCDYAMQIAKAMQYLES---KRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHR 290 (1039)
T ss_pred HHHHHHHHHHHHHHHhh---hhhhhhhhhhhhheecccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccc
Confidence 99999999999999999 99999999999999999999999999999977644333332 223346789999999999
Q ss_pred CCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 159 SVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 159 ~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
.|+.++|+|+|||++|||+| |+.||.+...
T Consensus 291 kFShaSDvWmyGVTiWEMFtyGEePW~G~~g 321 (1039)
T KOG0199|consen 291 KFSHASDVWMYGVTIWEMFTYGEEPWVGCRG 321 (1039)
T ss_pred cccccchhhhhhhhHHhhhccCCCCCCCCCH
Confidence 99999999999999999998 8999987543
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=2.2e-24 Score=163.60 Aligned_cols=179 Identities=17% Similarity=0.260 Sum_probs=132.4
Q ss_pred ccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccc-------cccccceEEEEEccCCchhhhhccCC
Q 044746 3 KPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLV-------GSEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 3 k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i-------~~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
.++++.+...++.|.-...... ...|..|..-.... .|.+|+ ..-++-.+.+++.+.|+|..-.....
T Consensus 42 L~eHr~s~t~ivlKavp~p~tt----~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~~G 117 (378)
T KOG1345|consen 42 LAEHRQSKTRIVLKAVPRPQTT----QADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEAAG 117 (378)
T ss_pred eeeccCCceEEEeeccCcchhh----HHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCccc
Confidence 4677888887777654333222 23444444433332 223444 34455667899999999999888888
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc--CCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD--ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~--~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+...+.++.|+++|++|||+ .+++|||||.+|||+- ....+||+|||+.+..+..... ...+..|-+|
T Consensus 118 igE~~~K~v~~ql~SAi~fMHs---knlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~tV~~-----~~~~~~y~~p 189 (378)
T KOG1345|consen 118 IGEANTKKVFAQLLSAIEFMHS---KNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTTVKY-----LEYVNNYHAP 189 (378)
T ss_pred ccHHHHHHHHHHHHHHHHHhhc---cchhhcccccceEEEecCCccEEEeeecccccccCceehh-----hhhhcccCCc
Confidence 9999999999999999999999 9999999999999994 3468999999998765432221 1225568899
Q ss_pred cccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCcchhcccccc
Q 044746 153 ELWMPY-----SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193 (202)
Q Consensus 153 e~~~~~-----~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~~~ 193 (202)
|.+... ...+..|+|.||++++..+||.+||.....+++.+
T Consensus 190 e~~~~~~ne~~~~~ps~D~WqfGIi~f~cltG~~PWQka~~~d~~Y 235 (378)
T KOG1345|consen 190 ELCDTVVNEKLVVNPSTDIWQFGIIFFYCLTGKFPWQKASIMDKPY 235 (378)
T ss_pred HHHhhccccceEecccccchheeeeeeeeecCCCcchhhhccCchH
Confidence 987532 34577899999999999999999999777777644
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.89 E-value=9.9e-23 Score=154.51 Aligned_cols=179 Identities=23% Similarity=0.331 Sum_probs=132.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++.....++.++.|........ .....+..|.......++++++. ......+++++..+++|..+.....
T Consensus 15 v~~~~~~~~~~~~~iK~~~~~~~~--~~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 92 (225)
T smart00221 15 VYLARDKGTGELVAVKVLKKEKTE--KQREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKG 92 (225)
T ss_pred EEEEEEcCCCcEEEEEeeccccch--HHHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcc
Confidence 466666665555555543322111 12233444544445556666542 2345668888999889998886654
Q ss_pred --CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 75 --LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 75 --~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+++.....++.+++.++.+||+ .+++|+|++|.|++++.++.++++|||.+......... ......++..|++|
T Consensus 93 ~~~~~~~~~~~~~~l~~~l~~lh~---~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~~~~~~~p 168 (225)
T smart00221 93 GKLSEEEARFYLRQILEALEYLHS---LGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA-LLKTVKGTPFYLAP 168 (225)
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc-cccceeccCCcCCH
Confidence 8999999999999999999999 89999999999999999999999999999876443200 11233457789999
Q ss_pred ccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 153 ELW-MPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 153 e~~-~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|.+ ....++.++|+|++|++++++++|+.||..
T Consensus 169 e~~~~~~~~~~~~Dv~~lG~~~~~l~~g~~pf~~ 202 (225)
T smart00221 169 EVLLGGKGYGEAVDIWSLGVILYELLWGPEPFSG 202 (225)
T ss_pred hHhcCCCCCCchhhHHHHHHHHHHHHHCCCCccc
Confidence 998 666788899999999999999999999966
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=4.8e-23 Score=169.72 Aligned_cols=178 Identities=21% Similarity=0.195 Sum_probs=136.2
Q ss_pred CCccccCCCcceeehhhhchhhhh-----ccCCcccCCcHHHHHHhcc---cccccccc----ccceEEEEEcc---CCc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM-----EMDKPIRFTSPQRMIAADN---FSNLVGSE----DTETYIKGFLA---MGP 65 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~---~~~~i~~~----~~~~~~~~~~~---~~~ 65 (202)
|+.|.++.....|+.|+-.+.+-. ...+.-....|..++++.+ |+||+.-- +..++|.+.-. +-.
T Consensus 577 V~lai~K~n~~eVViK~I~KeRIL~DtWvrDrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gID 656 (772)
T KOG1152|consen 577 VNLAIHKENNYEVVIKMIFKERILVDTWVRDRKLGTVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGID 656 (772)
T ss_pred EEEeeecccceEEEeeehhhhhhhhhhhhcccccCccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcc
Confidence 455666666666666654333321 2334556788988888887 88887522 22334444332 336
Q ss_pred hhhhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCC
Q 044746 66 FYLLCKKN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 66 l~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
|++++... .+++.+++-|++|++.|+++||+ .+|+|||+|-+|+.++++|.+||+|||.+........ ....
T Consensus 657 LFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~---~~ivhrdikdenvivd~~g~~klidfgsaa~~ksgpf----d~f~ 729 (772)
T KOG1152|consen 657 LFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHD---QGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKSGPF----DVFV 729 (772)
T ss_pred hhhhhhccCccchHHHHHHHHHHHhccccccc---cCceecccccccEEEecCCeEEEeeccchhhhcCCCc----ceee
Confidence 78888665 59999999999999999999999 9999999999999999999999999999876544332 3457
Q ss_pred CCCcccCCcccCCCCCC-chhhHHHHHHHHHHHHcCCCCCcc
Q 044746 145 RTPGCEAPELWMPYSVT-QKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 145 gt~~y~aPe~~~~~~~~-~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
||..|.|||++.+..|- ..-|||++|++||.++..+.||..
T Consensus 730 gtv~~aapevl~g~~y~gk~qdiwalgillytivykenpyyn 771 (772)
T KOG1152|consen 730 GTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKENPYYN 771 (772)
T ss_pred eeccccchhhhCCCccCCCcchhhhhhheeeEEEeccCCCcC
Confidence 89999999999998775 448999999999999999999863
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1.4e-22 Score=178.11 Aligned_cols=122 Identities=27% Similarity=0.367 Sum_probs=103.3
Q ss_pred cceEEEEEccCCchhhhhccCCCC--HHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 53 TETYIKGFLAMGPFYLLCKKNILG--FGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 53 ~~~~~~~~~~~~~l~~~~~~~~~~--~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++-|+|++...+..++..+.+. ....-+++++|++||.|+|+ .++|||||||.||+++.+..+||+|||++..
T Consensus 670 ~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~---~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~ 746 (1351)
T KOG1035|consen 670 ILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHD---QGIIHRDLKPRNIFLDSRNSVKIGDFGLATD 746 (1351)
T ss_pred EEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHh---CceeeccCCcceeEEcCCCCeeecccccchh
Confidence 345668889999999999888775 77889999999999999999 9999999999999999999999999999986
Q ss_pred cc----------------ccCcccccCCCCCCCcccCCcccCCCC---CCchhhHHHHHHHHHHHH
Q 044746 131 YN----------------REHTHITSTGRRRTPGCEAPELWMPYS---VTQKCDVFSFGMLLFEVV 177 (202)
Q Consensus 131 ~~----------------~~~~~~~~~~~~gt~~y~aPe~~~~~~---~~~~~Diws~G~~l~el~ 177 (202)
.. ........++..||--|+|||++.+.. |+.|+|+||+|++++||+
T Consensus 747 ~~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~ 812 (1351)
T KOG1035|consen 747 LKENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEML 812 (1351)
T ss_pred hhhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHh
Confidence 21 011111345678999999999998654 999999999999999986
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.86 E-value=8.3e-23 Score=166.68 Aligned_cols=182 Identities=18% Similarity=0.211 Sum_probs=130.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc---cc-----ccccccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN---FS-----NLVGSEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~-----~~i~~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
|-+|++...++.||+||-+..+........++.....+..... |. ...-.....+++.+-+. -+|..++++
T Consensus 448 Vvra~D~~r~~~vAiKIIRnNE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~Ls-lNLRevLKK 526 (752)
T KOG0670|consen 448 VVRARDQARGQEVAIKIIRNNEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPLS-LNLREVLKK 526 (752)
T ss_pred eeeccccCCCCeeEEEEeecchHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhhh-chHHHHHHH
Confidence 5688999999999999987776655444443332222221110 00 11122333345555443 245555543
Q ss_pred C----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 73 N----ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 73 ~----~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
. .+....++.++.|+..||..|-. .+|+|.||||+|||+.. ...+||||||.|...+...- +...-+.
T Consensus 527 yG~nvGL~ikaVRsYaqQLflALklLK~---c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~enei----tPYLVSR 599 (752)
T KOG0670|consen 527 YGRNVGLHIKAVRSYAQQLFLALKLLKK---CGVLHADIKPDNILVNESKNILKLCDFGSASFASENEI----TPYLVSR 599 (752)
T ss_pred hCcccceeehHHHHHHHHHHHHHHHHHh---cCeeecccCccceEeccCcceeeeccCccccccccccc----cHHHHHH
Confidence 2 47888999999999999999998 99999999999999975 46789999999976554322 1112256
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
.|.|||++.+.+|+...|+||.||+||||.||+..|.+..+..
T Consensus 600 FYRaPEIiLG~~yd~~iD~WSvgctLYElYtGkIlFpG~TNN~ 642 (752)
T KOG0670|consen 600 FYRAPEIILGLPYDYPIDTWSVGCTLYELYTGKILFPGRTNNQ 642 (752)
T ss_pred hccCcceeecCcccCCccceeeceeeEEeeccceecCCCCcHH
Confidence 7999999999999999999999999999999999998877653
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=2.1e-22 Score=168.08 Aligned_cols=181 Identities=22% Similarity=0.210 Sum_probs=150.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
|||||+..+++.+|.|+-+-.. .+...-.+.|+.+....+|+|++. ...-++..++|+.+|+|.++.. .+
T Consensus 31 vyKaRd~~s~elaavkvVkLep---~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~Tg 107 (829)
T KOG0576|consen 31 VYKARDKRSGELAAVKVVKLEP---GDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTG 107 (829)
T ss_pred hhhhcccccCchhhheeeeccC---CccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecc
Confidence 7999999999999999865432 234455777888888899999874 2344678999999999988775 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
++++.++..+++..+.|+.|||+ .+=+|||+|-.||+++..|.+|++|||.+..+.... .......||+.|||||
T Consensus 108 plselqiayvcRetl~gl~ylhs---~gk~hRdiKGanilltd~gDvklaDfgvsaqitati--~KrksfiGtpywmapE 182 (829)
T KOG0576|consen 108 PLSELQIAYVCRETLQGLKYLHS---QGKIHRDIKGANILLTDEGDVKLADFGVSAQITATI--AKRKSFIGTPYWMAPE 182 (829)
T ss_pred cchhHHHHHHHhhhhccchhhhc---CCcccccccccceeecccCceeecccCchhhhhhhh--hhhhcccCCccccchh
Confidence 79999999999999999999999 899999999999999999999999999987554322 2234578999999999
Q ss_pred ccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 154 LWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 154 ~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
+.. .+.|...+|+|+.|++..|+..-++|..+-.++
T Consensus 183 vaaverkggynqlcdiwa~gitAiel~eLqpplfdlhpm 221 (829)
T KOG0576|consen 183 VAAVERKGGYNQLCDIWALGITAIELGELQPPLFDLHPM 221 (829)
T ss_pred HHHHHhcccccccccccccccchhhhhhcCCcccccchH
Confidence 864 457899999999999999999989987766554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=1.6e-21 Score=154.58 Aligned_cols=162 Identities=16% Similarity=0.163 Sum_probs=134.3
Q ss_pred cCCcccCCcHHHHHHhccccccc-------cccccceEEEEEccCCchhhhhc---------cCCCCHHHHHHHHHHHHH
Q 044746 26 MDKPIRFTSPQRMIAADNFSNLV-------GSEDTETYIKGFLAMGPFYLLCK---------KNILGFGQLREIEVSTSK 89 (202)
Q Consensus 26 ~~~~~~~~~~~~~~~~~~~~~~i-------~~~~~~~~~~~~~~~~~l~~~~~---------~~~~~~~~~~~~~~~i~~ 89 (202)
+-+...+..|..+.....|+|++ ..+.+..+....+.-|+|..++. ...++-.+...++.|++.
T Consensus 328 ~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla~ 407 (563)
T KOG1024|consen 328 QIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLAM 407 (563)
T ss_pred HHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHHH
Confidence 33455677777778888899875 35666778888888888877664 224777889999999999
Q ss_pred HHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHH
Q 044746 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSF 169 (202)
Q Consensus 90 ~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~ 169 (202)
|++|||. .++||.||..+|++|+..-.+||+|-.+++-+-.............+..||+||.+....|+..+|+|||
T Consensus 408 am~hlh~---~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWsf 484 (563)
T KOG1024|consen 408 AMEHLHN---HGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWSF 484 (563)
T ss_pred HHHHHHh---cCcccchhhhhcceehhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHHH
Confidence 9999999 9999999999999999999999999999996554444444555566889999999999999999999999
Q ss_pred HHHHHHHHc-CCCCCcchhccc
Q 044746 170 GMLLFEVVG-RRRNLEKEISEG 190 (202)
Q Consensus 170 G~~l~el~~-g~~p~~~~~~~~ 190 (202)
|+++|||+| |+.|+-..++.+
T Consensus 485 GVllWELmtlg~~PyaeIDPfE 506 (563)
T KOG1024|consen 485 GVLLWELMTLGKLPYAEIDPFE 506 (563)
T ss_pred HHHHHHHHhcCCCCccccCHHH
Confidence 999999998 999998887765
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.85 E-value=3.8e-21 Score=155.80 Aligned_cols=111 Identities=23% Similarity=0.260 Sum_probs=73.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccc---cccc----------ccccceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFS---NLVG----------SEDTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~i~----------~~~~~~~~~~~~~~~~l 66 (202)
||.|.+..++++||.||.+.-..-......++..-..+.... +++ .+++ .|...+.+.+++.. +|
T Consensus 94 VWLawDtq~~r~VAlKVvKSAqhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvLGd-nL 172 (590)
T KOG1290|consen 94 VWLAWDTQNKRYVALKVVKSAQHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVLGD-NL 172 (590)
T ss_pred eEEEeeccCCeEEEEEEEehhhHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhhhh-HH
Confidence 789999999999999998766544333222222222222111 222 1221 23333445555544 44
Q ss_pred hhhh---ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE
Q 044746 67 YLLC---KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL 114 (202)
Q Consensus 67 ~~~~---~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~ 114 (202)
+.++ .-+.++...++.|++|++.||.|||.. .+|||-||||+|||+
T Consensus 173 LklI~~s~YrGlpl~~VK~I~~qvL~GLdYLH~e--cgIIHTDlKPENvLl 221 (590)
T KOG1290|consen 173 LKLIKYSNYRGLPLSCVKEICRQVLTGLDYLHRE--CGIIHTDLKPENVLL 221 (590)
T ss_pred HHHHHHhCCCCCcHHHHHHHHHHHHHHHHHHHHh--cCccccCCCcceeee
Confidence 4444 334599999999999999999999995 799999999999999
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.84 E-value=1.1e-21 Score=167.12 Aligned_cols=151 Identities=25% Similarity=0.339 Sum_probs=113.3
Q ss_pred HHHHHhcccccccccc----ccceEEEE-EccCCchhhhhccC--CC---CHHHHHHHHHHHHHHHHHHHhCCCCCeEEe
Q 044746 36 QRMIAADNFSNLVGSE----DTETYIKG-FLAMGPFYLLCKKN--IL---GFGQLREIEVSTSKGIAYLHEECRQKIVHY 105 (202)
Q Consensus 36 ~~~~~~~~~~~~i~~~----~~~~~~~~-~~~~~~l~~~~~~~--~~---~~~~~~~~~~~i~~~l~~lH~~~~~~iiHr 105 (202)
..+....+|+|+|... +..+.|.. .+...+|.+++... .+ .--....+..|+++||.+||+ .+|+||
T Consensus 554 ~lL~eSD~H~NviRyyc~E~d~qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~~GlaHLHs---l~iVHR 630 (903)
T KOG1027|consen 554 QLLQESDEHPNVIRYYCSEQDRQFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQIASGLAHLHS---LKIVHR 630 (903)
T ss_pred HHHHhccCCCceEEEEeeccCCceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHHHHHHHHHHh---cccccc
Confidence 4456678999998522 22222222 23345777777552 11 113457788999999999999 899999
Q ss_pred cCCCCcEEEcC---C--CceEEeeeecceeccccCccc-ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcC
Q 044746 106 DIKPESVLLDE---N--FFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGR 179 (202)
Q Consensus 106 dlk~~nil~~~---~--~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g 179 (202)
||||+||||+. + ..++|+|||+++.+..+.+.. ...+..||-+|+|||++....-+.++||+|+||++|+.++|
T Consensus 631 DLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avDiFslGCvfyYvltg 710 (903)
T KOG1027|consen 631 DLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVDIFSLGCVFYYVLTG 710 (903)
T ss_pred cCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccchhhcCceEEEEecC
Confidence 99999999975 2 578999999999876554322 24556789999999999988878899999999999998885
Q ss_pred -CCCCcchhcc
Q 044746 180 -RRNLEKEISE 189 (202)
Q Consensus 180 -~~p~~~~~~~ 189 (202)
+.||.+.-..
T Consensus 711 G~HpFGd~~~R 721 (903)
T KOG1027|consen 711 GSHPFGDSLER 721 (903)
T ss_pred CccCCCchHHh
Confidence 9999876654
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.6e-20 Score=156.91 Aligned_cols=129 Identities=19% Similarity=0.181 Sum_probs=100.0
Q ss_pred ccceEEEEEccCCchhhhhcc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEec
Q 044746 52 DTETYIKGFLAMGPFYLLCKK-------------------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYD 106 (202)
Q Consensus 52 ~~~~~~~~~~~~~~l~~~~~~-------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrd 106 (202)
+..+++++|+++++|..++.. ..+++..++.++.|++.||.|||+ .+++|||
T Consensus 258 ~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~---~~ivHrD 334 (507)
T PLN03224 258 GSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHR---IGIVHRD 334 (507)
T ss_pred CceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchhhhcccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCC
Confidence 345789999999988776642 124567889999999999999999 9999999
Q ss_pred CCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCC--------------------C--Cchh
Q 044746 107 IKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYS--------------------V--TQKC 164 (202)
Q Consensus 107 lk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~--------------------~--~~~~ 164 (202)
|||+||+++.++.++|+|||++.......... .....+++.|+|||.+.... + ..+.
T Consensus 335 LKp~NILl~~~~~~kL~DFGla~~~~~~~~~~-~~~g~~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~ 413 (507)
T PLN03224 335 IKPENLLVTVDGQVKIIDFGAAVDMCTGINFN-PLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLF 413 (507)
T ss_pred CchHhEEECCCCcEEEEeCcCccccccCCccC-ccccCCCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCcc
Confidence 99999999999999999999997543322111 11223478999999875321 1 1346
Q ss_pred hHHHHHHHHHHHHcCCC-CCc
Q 044746 165 DVFSFGMLLFEVVGRRR-NLE 184 (202)
Q Consensus 165 Diws~G~~l~el~~g~~-p~~ 184 (202)
|+||+||++++|++|.. ||.
T Consensus 414 DvwSlGvil~em~~~~l~p~~ 434 (507)
T PLN03224 414 DSYTAGVLLMQMCVPELRPVA 434 (507)
T ss_pred chhhHHHHHHHHHhCCCCCcc
Confidence 99999999999999875 664
|
|
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.6e-19 Score=132.72 Aligned_cols=169 Identities=28% Similarity=0.418 Sum_probs=123.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc---c---ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV---G---SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i---~---~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++....+++.++.|+........ ....+..|........+++++ + ......+++++..+++|..++...
T Consensus 9 v~~~~~~~~~~~~~~K~~~~~~~~~--~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~ 86 (215)
T cd00180 9 VYLARDKKTGKKVAIKIIKKEDSSS--LLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENE 86 (215)
T ss_pred EEEEEecCCCcEEEEEEeccccchh--HHHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhcc
Confidence 4667776645555555433222110 112344554444444555443 2 224567888899989999988765
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.+++..+..++.+++.++.+||+ .+++|+||+|.||+++. ++.++++|||.+........ ......+...|++
T Consensus 87 ~~~~~~~~~~~~~~l~~~l~~lh~---~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~~ 161 (215)
T cd00180 87 GKLSEDEILRILLQILEGLEYLHS---NGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS--LLKTIVGTPAYMA 161 (215)
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc--hhhcccCCCCccC
Confidence 79999999999999999999999 89999999999999998 89999999999986543321 1122345788999
Q ss_pred CcccCCC-CCCchhhHHHHHHHHHHH
Q 044746 152 PELWMPY-SVTQKCDVFSFGMLLFEV 176 (202)
Q Consensus 152 Pe~~~~~-~~~~~~Diws~G~~l~el 176 (202)
||..... ..+.+.|+|++|++++++
T Consensus 162 pe~~~~~~~~~~~~D~~~lg~~~~~l 187 (215)
T cd00180 162 PEVLLGKGYYSEKSDIWSLGVILYEL 187 (215)
T ss_pred hhHhcccCCCCchhhhHHHHHHHHHH
Confidence 9998876 778899999999999988
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.80 E-value=5.8e-20 Score=146.46 Aligned_cols=179 Identities=25% Similarity=0.359 Sum_probs=128.1
Q ss_pred CCccccCC---CcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccc------cccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRG---STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLV------GSEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~---~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i------~~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||+|.+.. ...+||.|--. ....+.+...|..++... ...|++ ..++....++++++.....++.
T Consensus 52 v~~a~~~~~~~~~~~valk~i~-----~ts~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~ 126 (418)
T KOG1167|consen 52 VYKATDIEQDTKRRYVALKAIY-----RTSSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLY 126 (418)
T ss_pred hhhhhHhhhccccceEeeeecc-----cccCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHH
Confidence 45555544 55555544311 123344555555544443 333444 3566667889999998887777
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccc--------c-------
Q 044746 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNR--------E------- 134 (202)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~--------~------- 134 (202)
. .++..+++.+...++.||.++|. +||||||+||.|+|.+. .+.-.|.|||++..... .
T Consensus 127 ~--~l~~~~i~~Yl~~ll~Al~~~h~---~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~ 201 (418)
T KOG1167|consen 127 R--SLSLAEIRWYLRNLLKALAHLHK---NGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHAT 201 (418)
T ss_pred h--cCCHHHHHHHHHHHHHHhhhhhc---cCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCC
Confidence 4 46688999999999999999999 99999999999999975 45678999999982100 0
Q ss_pred ---------------------------CcccccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 135 ---------------------------HTHITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 135 ---------------------------~~~~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
........+.||++|.|||++... ..++++||||.|++++-+++++.||...
T Consensus 202 ~~~g~~~~~~~~~~~~~p~g~~~~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a 281 (418)
T KOG1167|consen 202 PAMGKDVHCQSVATASKPAGYYRRCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKA 281 (418)
T ss_pred ccccCcccccccccccCCCCceeccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccC
Confidence 000001135789999999998754 4678999999999999999999999876
Q ss_pred hcc
Q 044746 187 ISE 189 (202)
Q Consensus 187 ~~~ 189 (202)
.++
T Consensus 282 ~dd 284 (418)
T KOG1167|consen 282 KDD 284 (418)
T ss_pred ccc
Confidence 654
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.79 E-value=7.3e-20 Score=157.11 Aligned_cols=131 Identities=22% Similarity=0.276 Sum_probs=116.3
Q ss_pred EEEccCCchhhhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc
Q 044746 58 KGFLAMGPFYLLCKKN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT 136 (202)
Q Consensus 58 ~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~ 136 (202)
++++++ +|+.++... .++..++-.+.+|++.|+.|+|+ .|+.|||+|++|+++..+|.+|++|||.+.....+..
T Consensus 400 mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~---~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e 475 (601)
T KOG0590|consen 400 MEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHS---MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWE 475 (601)
T ss_pred hhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHh---cCceeccCccccEEEecCCceEEeecCcceeeccCcc
Confidence 888888 888888776 89999999999999999999999 9999999999999999999999999999986654433
Q ss_pred c--cccCCCCCCCcccCCcccCCCCCCch-hhHHHHHHHHHHHHcCCCCCcchhccccc
Q 044746 137 H--ITSTGRRRTPGCEAPELWMPYSVTQK-CDVFSFGMLLFEVVGRRRNLEKEISEGQE 192 (202)
Q Consensus 137 ~--~~~~~~~gt~~y~aPe~~~~~~~~~~-~Diws~G~~l~el~~g~~p~~~~~~~~~~ 192 (202)
. ....+..|+..|+|||.+.+..|++. .||||.|+++..|.+|+.||.....++++
T Consensus 476 ~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~~Wk~a~~~~~~ 534 (601)
T KOG0590|consen 476 KNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRFPWKVAKKSDNS 534 (601)
T ss_pred hhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCCccccccccccc
Confidence 3 55677889999999999999888865 89999999999999999999887766553
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.78 E-value=2e-18 Score=138.99 Aligned_cols=182 Identities=16% Similarity=0.153 Sum_probs=130.0
Q ss_pred CCccccCCCc-ceeehhhhchhhhhccCCcccCCcHHHHHHh-------ccccccccccc-c--ceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGST-RFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-------DNFSNLVGSED-T--ETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~-~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------~~~~~~i~~~~-~--~~~~~~~~~~~~l~~~ 69 (202)
||++.+.... ..+|.|++........ ..+..|...... .++++++..|. . ..++.+.+.+.+|.++
T Consensus 34 V~~v~~~~~~~~~~a~K~e~~~~~~~~---~~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~G~sL~dl 110 (322)
T KOG1164|consen 34 VYLVSDKSEKNKEYAKKLEKKELGSKP---SVLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLLGPSLEDL 110 (322)
T ss_pred EEEEEecCCCCeeEEEEEEEecccCCC---ccchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEeccCccHHHH
Confidence 4666665553 5667776554422221 134444443332 25556665552 2 2344455667777776
Q ss_pred hc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-----CceEEeeeecce--eccccCc---
Q 044746 70 CK---KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-----FFPKAADFGLAK--LYNREHT--- 136 (202)
Q Consensus 70 ~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-----~~~kl~dfgl~~--~~~~~~~--- 136 (202)
.. .+.++...+..++.|++.+|+++|+ .|++||||||.|+++... ..+.+.|||+++ .......
T Consensus 111 ~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~---~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~ 187 (322)
T KOG1164|consen 111 RKRNPPGRFSRKTVLRIAIQNLNALEDLHS---KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNL 187 (322)
T ss_pred HHhCCCCCcCHhHHHHHHHHHHHHHHHHHh---cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCccc
Confidence 63 3569999999999999999999999 999999999999999854 468999999998 3222111
Q ss_pred -cc-c-cCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 137 -HI-T-STGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 137 -~~-~-~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.. . .....||..|.++.+..+...+.+.|+||++.++.|+..|..||.....
T Consensus 188 ~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDles~~Y~l~el~~g~LPW~~~~~ 242 (322)
T KOG1164|consen 188 RPPRPQKGLFRGTLRYASINVHLGIEQGRRDDLESLFYMLLELLKGSLPWEALEM 242 (322)
T ss_pred ccCCCCccCCCCccccccHHHhCCCccCCchhhhhHHHHHHHHhcCCCCCccccc
Confidence 11 1 1234589999999999999999999999999999999999999966553
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.75 E-value=1.6e-18 Score=140.58 Aligned_cols=149 Identities=17% Similarity=0.134 Sum_probs=104.5
Q ss_pred CCccccCC-Ccceeehhhhchhhh--hccCCcccCCcHHHHHHhccccccc---cccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRG-STRFITRTIDKSLDA--MEMDKPIRFTSPQRMIAADNFSNLV---GSEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~-~~~~v~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~i---~~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||+|++.. +++.+|.|....... ........|..|...+...+|++++ ...+..+++++++++++|......
T Consensus 34 Vy~a~~~~~~~~~vAiK~~~~~~~~~~~~~~~~~~~~E~~iL~~L~h~~iv~~l~~~~~~~LVmE~~~G~~L~~~~~~-- 111 (365)
T PRK09188 34 VERGYFAGDPGTARAVRRRVSEVPWWSKPLARHLAAREIRALKTVRGIGVVPQLLATGKDGLVRGWTEGVPLHLARPH-- 111 (365)
T ss_pred EEEEEEcCCCCeEEEEEEecccccccccHHHHHHHHHHHHHHHhccCCCCCcEEEEcCCcEEEEEccCCCCHHHhCcc--
Confidence 68887765 556556654321100 0111234577888888888888765 233456789999999998643211
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecC-CCCcEEEcCCCceEEeeeecceeccccCccc------ccCCCCCCC
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDI-KPESVLLDENFFPKAADFGLAKLYNREHTHI------TSTGRRRTP 147 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdl-k~~nil~~~~~~~kl~dfgl~~~~~~~~~~~------~~~~~~gt~ 147 (202)
. ...++.+++.||.|||+ ++|+|||| ||+|||++.++.++|+|||+++......... ..+...+++
T Consensus 112 -~---~~~~~~~i~~aL~~lH~---~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~ 184 (365)
T PRK09188 112 -G---DPAWFRSAHRALRDLHR---AGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHK 184 (365)
T ss_pred -c---hHHHHHHHHHHHHHHHH---CCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccC
Confidence 1 24678999999999999 99999999 9999999989999999999999764432111 113456788
Q ss_pred cccCCcccCCC
Q 044746 148 GCEAPELWMPY 158 (202)
Q Consensus 148 ~y~aPe~~~~~ 158 (202)
.|+|||++...
T Consensus 185 ~~~~pe~~~~~ 195 (365)
T PRK09188 185 RTYAPDALTPR 195 (365)
T ss_pred ccCCcccCChh
Confidence 89999998653
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.75 E-value=7.8e-18 Score=132.87 Aligned_cols=156 Identities=30% Similarity=0.400 Sum_probs=122.9
Q ss_pred cccCCcHHHHHHhcccc-ccccc------cccceEEEEEccCCchhhhhccC----CCCHHHHHHHHHHHHHHHHHHHhC
Q 044746 29 PIRFTSPQRMIAADNFS-NLVGS------EDTETYIKGFLAMGPFYLLCKKN----ILGFGQLREIEVSTSKGIAYLHEE 97 (202)
Q Consensus 29 ~~~~~~~~~~~~~~~~~-~~i~~------~~~~~~~~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~ 97 (202)
...+..+........++ +++.. .....+++++..++.+..+.... .++......+..|++.++.|+|+
T Consensus 41 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~- 119 (384)
T COG0515 41 VERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS- 119 (384)
T ss_pred HHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh-
Confidence 34455555556665555 34421 12236888888999888776655 69999999999999999999999
Q ss_pred CCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCccc----ccCCCCCCCcccCCcccCC---CCCCchhhHHHH
Q 044746 98 CRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHI----TSTGRRRTPGCEAPELWMP---YSVTQKCDVFSF 169 (202)
Q Consensus 98 ~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~----~~~~~~gt~~y~aPe~~~~---~~~~~~~Diws~ 169 (202)
.+++|||+||+||+++..+ .++++|||.+.......... ......|+..|++||.+.+ ...+...|+||+
T Consensus 120 --~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s~ 197 (384)
T COG0515 120 --KGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSL 197 (384)
T ss_pred --CCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHHH
Confidence 8999999999999999888 79999999998554433221 2355678999999999987 578889999999
Q ss_pred HHHHHHHHcCCCCCcchh
Q 044746 170 GMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 170 G~~l~el~~g~~p~~~~~ 187 (202)
|++++++++|..||....
T Consensus 198 g~~~~~~~~~~~p~~~~~ 215 (384)
T COG0515 198 GITLYELLTGLPPFEGEK 215 (384)
T ss_pred HHHHHHHHhCCCCCCCCC
Confidence 999999999999976654
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.71 E-value=3.2e-17 Score=128.00 Aligned_cols=179 Identities=13% Similarity=0.190 Sum_probs=129.9
Q ss_pred ccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc--c-ccccceEEEEEccCC--chhhhhccCCCCHHH
Q 044746 5 RNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV--G-SEDTETYIKGFLAMG--PFYLLCKKNILGFGQ 79 (202)
Q Consensus 5 ~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i--~-~~~~~~~~~~~~~~~--~l~~~~~~~~~~~~~ 79 (202)
.+.-.++.||.|++....+..+- ..++..-.++......|++. | +|-+..++++.+.-. .|+++| .+.++...
T Consensus 48 ~Nl~nne~VAIKfEPrkS~APQL-rdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLLGPSLEDLFD~C-gR~FSvKT 125 (449)
T KOG1165|consen 48 KNLYNNEPVAIKFEPRKSEAPQL-RDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLLGPSLEDLFDLC-GRRFSVKT 125 (449)
T ss_pred cccccCceEEEEeccccCCcchH-HHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhhCcCHHHHHHHh-cCcccHHh
Confidence 34456778888886554333221 12233334444555666544 2 222223444443221 466677 46799999
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-----CceEEeeeecceeccccC-----cccccCCCCCCCcc
Q 044746 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-----FFPKAADFGLAKLYNREH-----THITSTGRRRTPGC 149 (202)
Q Consensus 80 ~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-----~~~kl~dfgl~~~~~~~~-----~~~~~~~~~gt~~y 149 (202)
+..++.|++.-++|+|+ +.+|.|||||+|+||... ..+.++|||+|+...++. ...+.....||..|
T Consensus 126 V~miA~Qmi~rie~vH~---k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARY 202 (449)
T KOG1165|consen 126 VAMIAKQMITRIEYVHE---KDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARY 202 (449)
T ss_pred HHHHHHHHHHHHHHHHh---cceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceee
Confidence 99999999999999999 999999999999999754 357899999999775543 23345567789999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+-....+...+.+.|+-|+|-++.+.+.|..||.+-.-
T Consensus 203 MSINTHlGrEQSRRDDLEaLGHvFmYFLRGsLPWQGLKA 241 (449)
T KOG1165|consen 203 MSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 241 (449)
T ss_pred eEeeccccchhhhhhhHHHhhhhhhhhccCCCccccccC
Confidence 999999999999999999999999999999999987543
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.3e-17 Score=125.10 Aligned_cols=181 Identities=15% Similarity=0.168 Sum_probs=132.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHH----HHHhccccccc--c-ccccceEEEEEccCC--chhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQR----MIAADNFSNLV--G-SEDTETYIKGFLAMG--PFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i--~-~~~~~~~~~~~~~~~--~l~~~~~ 71 (202)
+|.+....++..||.|+++....... +..|.. +.....+|.+. + +..+..++++.+.-. +|+.+|.
T Consensus 31 Iy~~~~i~~ge~VAiK~Es~~a~hpq-----L~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLLGPsLEdLfnfC~ 105 (341)
T KOG1163|consen 31 IYLGISITSGEEVAIKLESSKAKHPQ-----LLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLLGPSLEDLFNFCS 105 (341)
T ss_pred eeeeeeccCCceEEEEeecccCCCcc-----hhHHHHHHHHhccCCCCchhhhhccccccceeeeeccCccHHHHHHHHh
Confidence 46778889999999999876544432 222322 22233444433 2 344455566554322 3555664
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceecccc-----CcccccCCC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNRE-----HTHITSTGR 143 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~-----~~~~~~~~~ 143 (202)
+.++...++.++-|++.-++|+|. ++.|||||||+|+|..- ...+.++|||+|+..-+. ....+....
T Consensus 106 -R~ftmkTvLMLaDQml~RiEyvH~---r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~l 181 (341)
T KOG1163|consen 106 -RRFTMKTVLMLADQMLSRIEYVHL---RNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNL 181 (341)
T ss_pred -hhhhHHhHHHHHHHHHHHHHHHHh---hccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCcc
Confidence 568899999999999999999998 99999999999999964 356789999999965432 223344567
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
.||..|.+-....+...+.+.|+-|+|.+|.....|..||.+.....
T Consensus 182 tGTaRYASinAh~g~eqSRRDDmeSvgYvLmYfnrG~LPWQglka~t 228 (341)
T KOG1163|consen 182 TGTARYASINAHLGIEQSRRDDMESVGYVLMYFNRGSLPWQGLKAAT 228 (341)
T ss_pred ceeeeehhhhhhhhhhhhhhhhhhhhcceeeeeecCCCcccccchhh
Confidence 78999988888877777889999999999999999999999876543
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.70 E-value=1.1e-17 Score=146.30 Aligned_cols=100 Identities=26% Similarity=0.358 Sum_probs=86.5
Q ss_pred HHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-------------cccCCCCCCCcccCCcc
Q 044746 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-------------ITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 88 ~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-------------~~~~~~~gt~~y~aPe~ 154 (202)
+.+++|+|+ .+|+|||+||+|.++..-|++|+.|||+++........ ......+|||.|+|||+
T Consensus 153 vla~Eylh~---ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeV 229 (1205)
T KOG0606|consen 153 VLAVEYLHS---YGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEV 229 (1205)
T ss_pred hHHhHhhcc---CCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhh
Confidence 788999999 99999999999999999999999999999853211111 11234689999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
+....|...+|+|++|+++||.+.|..||+++.+++
T Consensus 230 ilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpee 265 (1205)
T KOG0606|consen 230 ILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE 265 (1205)
T ss_pred hhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHH
Confidence 999999999999999999999999999999997765
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.69 E-value=8.8e-18 Score=140.13 Aligned_cols=170 Identities=22% Similarity=0.193 Sum_probs=127.2
Q ss_pred cccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccc------cccccceEEEEEccCCchhhhhccC-CC
Q 044746 4 PRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLV------GSEDTETYIKGFLAMGPFYLLCKKN-IL 75 (202)
Q Consensus 4 ~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~~-~~ 75 (202)
+.....+...+.|+.++......... ....+..+.... +++-++ ...+-..++..+..+|.+....... .+
T Consensus 16 ~~g~da~~~yamkvl~k~t~~~~~~~-~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f 94 (612)
T KOG0603|consen 16 AGGADAGHLYAMKVLKKATLKVRDRT-HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMF 94 (612)
T ss_pred hccccccchhhhhccccccccccccc-ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCch
Confidence 33445566666666655554444444 333444444433 355433 3444455777777887776666544 47
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCccc
Q 044746 76 GFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELW 155 (202)
Q Consensus 76 ~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~ 155 (202)
.+.....+...++.+++++|+ .++++||+|++||+++.+|++++.|||+++..-... ..+||.-|||||++
T Consensus 95 ~~~~~~~~~aelaLald~lh~---l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~------~~cgt~eymApEI~ 165 (612)
T KOG0603|consen 95 DELDVAFYLAELALALDHLHK---LGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEK------IACGTYEYRAPEII 165 (612)
T ss_pred HHHHHHHHHHHHHHHHhhcch---hHHHHhcccccceeecccCccccCCchhhhHhHhhh------hcccchhhhhhHhh
Confidence 788889999999999999999 999999999999999999999999999998643322 12789999999999
Q ss_pred CCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 156 MPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 156 ~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
. .....+|.||||++.+|++||..||..
T Consensus 166 ~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 166 N--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred h--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 8 456789999999999999999999987
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.68 E-value=1.8e-16 Score=118.28 Aligned_cols=74 Identities=15% Similarity=0.127 Sum_probs=64.1
Q ss_pred ceEEEEEccCCchhhh-hccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceec
Q 044746 54 ETYIKGFLAMGPFYLL-CKKNILGFGQLREIEVSTSKGIAYL-HEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131 (202)
Q Consensus 54 ~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~ 131 (202)
..+++++++++++... .....++..++..++.|++.+|.++ |+ .+++||||||+||+++ ++.++|+|||+|...
T Consensus 92 ~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~---~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~ 167 (190)
T cd05147 92 HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQD---CRLVHADLSEYNLLYH-DGKLYIIDVSQSVEH 167 (190)
T ss_pred CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEE-CCcEEEEEccccccC
Confidence 4799999998876543 4556799999999999999999999 67 8999999999999998 478999999998743
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.5e-16 Score=140.54 Aligned_cols=177 Identities=15% Similarity=0.113 Sum_probs=131.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCC----cccCCcHHHHHHhccccccccccccceEEEEEccCCchhhhhccCC-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDK----PIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAMGPFYLLCKKNI-L 75 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~-~ 75 (202)
||+|.... ++.||.|+.+.....+.-. ..|+. ........++....-..+-..++.+|.+.|+|.++++... +
T Consensus 714 vy~a~~~~-~~~~alK~e~P~~~WEfYI~~q~~~RLk-~~~~~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m 791 (974)
T KOG1166|consen 714 VYVATHSN-GKLVALKVEKPPNPWEFYICLQVMERLK-PQMLPSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVM 791 (974)
T ss_pred EEEeecCC-CcEEEEEeecCCCceeeeehHHHHHhhc-hhhhcchHHHHHHHccCCcceeeeeccccccHHHhhccCCCC
Confidence 68888888 9999999987665443211 11222 1111111122221223344568999999999999997554 8
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-------CCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 76 GFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-------NFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 76 ~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-------~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
++..+..++.|++.-++.||. .+|||+||||+|+++.. ...++|+|||.+--+.--..........+|-.
T Consensus 792 ~e~lv~~~~~qml~ive~lH~---~~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~ 868 (974)
T KOG1166|consen 792 DEYLVMFFSCQMLRIVEHLHA---MGIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDL 868 (974)
T ss_pred CchhhhHHHHHHHHHHHHHHh---cceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCCcEEeeeecccc
Confidence 999999999999999999999 99999999999999942 45689999998864432222223345566888
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRN 182 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p 182 (202)
+-++|+..+++++.++|.|-++.+++-|+.|+.-
T Consensus 869 f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~ 902 (974)
T KOG1166|consen 869 FDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM 902 (974)
T ss_pred chhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH
Confidence 9999999999999999999999999999998743
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.66 E-value=1.6e-16 Score=121.37 Aligned_cols=157 Identities=18% Similarity=0.305 Sum_probs=121.6
Q ss_pred ccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC---CCHHHHHHHHHHHHHHHHHHH
Q 044746 25 EMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI---LGFGQLREIEVSTSKGIAYLH 95 (202)
Q Consensus 25 ~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH 95 (202)
.....+.|..|.-.+....|||++. +-.....+..|++.|+|+..++... +.-.++.+++.+++.|+.|||
T Consensus 227 t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflh 306 (448)
T KOG0195|consen 227 TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLH 306 (448)
T ss_pred chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHh
Confidence 3445667888888888889998763 4455668899999999999997664 788899999999999999999
Q ss_pred hCCCCCeEEecCCCCcEEEcCCCceEEe--eeecceeccccCcccccCCCCCCCcccCCcccCCCCCC---chhhHHHHH
Q 044746 96 EECRQKIVHYDIKPESVLLDENFFPKAA--DFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVT---QKCDVFSFG 170 (202)
Q Consensus 96 ~~~~~~iiHrdlk~~nil~~~~~~~kl~--dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~---~~~Diws~G 170 (202)
+.. .-|.-..|....++++.+..++++ |--.+.. ..+..-.|.||+||.++..+-+ ..+|+|||+
T Consensus 307 sle-p~ipr~~lns~hvmidedltarismad~kfsfq---------e~gr~y~pawmspealqrkped~n~raadmwsfa 376 (448)
T KOG0195|consen 307 SLE-PMIPRFYLNSKHVMIDEDLTARISMADTKFSFQ---------EVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFA 376 (448)
T ss_pred hcc-hhhhhhhcccceEEecchhhhheecccceeeee---------ccccccCcccCCHHHHhcCchhcchhhhhHHHHH
Confidence 852 344455788999999988777765 3222110 1222337899999999876544 568999999
Q ss_pred HHHHHHHcCCCCCcchhcccc
Q 044746 171 MLLFEVVGRRRNLEKEISEGQ 191 (202)
Q Consensus 171 ~~l~el~~g~~p~~~~~~~~~ 191 (202)
+++||+.|++.||.+-+++++
T Consensus 377 illwel~trevpfadlspmec 397 (448)
T KOG0195|consen 377 ILLWELNTREVPFADLSPMEC 397 (448)
T ss_pred HHHHHhhccccccccCCchhh
Confidence 999999999999999888765
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.62 E-value=6.6e-16 Score=115.61 Aligned_cols=148 Identities=17% Similarity=0.113 Sum_probs=101.8
Q ss_pred cCCcHHHHHHhcc----ccccccccccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEec
Q 044746 31 RFTSPQRMIAADN----FSNLVGSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYD 106 (202)
Q Consensus 31 ~~~~~~~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrd 106 (202)
.+..|...+...+ +|++++.. ..++.++++.+.+|...... ....++.|++.+|.++|+ .||+|||
T Consensus 47 l~~rE~~iL~~L~~~~~vP~ll~~~-~~~lvmeyI~G~~L~~~~~~------~~~~~~~qi~~~L~~lH~---~GIvHrD 116 (218)
T PRK12274 47 LARREALALRQLDGLPRTPRLLHWD-GRHLDRSYLAGAAMYQRPPR------GDLAYFRAARRLLQQLHR---CGVAHND 116 (218)
T ss_pred HHHHHHHHHHhcCCCCCCCEEEEEc-CEEEEEeeecCccHHhhhhh------hhHHHHHHHHHHHHHHHH---CcCccCC
Confidence 4566666666653 44565543 35788899998888654321 124578899999999999 9999999
Q ss_pred C-CCCcEEEcCCCceEEeeeecceeccccCc-----cc-c-----cCCCCCCCcccCCcccCCC-CCC-chhhHHHHHHH
Q 044746 107 I-KPESVLLDENFFPKAADFGLAKLYNREHT-----HI-T-----STGRRRTPGCEAPELWMPY-SVT-QKCDVFSFGML 172 (202)
Q Consensus 107 l-k~~nil~~~~~~~kl~dfgl~~~~~~~~~-----~~-~-----~~~~~gt~~y~aPe~~~~~-~~~-~~~Diws~G~~ 172 (202)
| ||.||+++.++.++|+|||++........ .. . ......++.+++|+-..-. ..+ ...+.++-|+-
T Consensus 117 L~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~~~g~~ 196 (218)
T PRK12274 117 LAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWFATGKP 196 (218)
T ss_pred CCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHHHhcch
Confidence 9 79999999999999999999985443221 00 0 0011235566666543321 233 44566789999
Q ss_pred HHHHHcCCCCCcchhc
Q 044746 173 LFEVVGRRRNLEKEIS 188 (202)
Q Consensus 173 l~el~~g~~p~~~~~~ 188 (202)
+|.++||..|..++.+
T Consensus 197 ~~~~~~~~~~~~~~~~ 212 (218)
T PRK12274 197 VYRFVTRRVLHWEDNE 212 (218)
T ss_pred HHHHHhccCCccccCC
Confidence 9999999998776554
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.62 E-value=1.1e-16 Score=131.41 Aligned_cols=124 Identities=17% Similarity=0.270 Sum_probs=103.4
Q ss_pred cccccceEEEEEccCCchhhhhccC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEee
Q 044746 49 GSEDTETYIKGFLAMGPFYLLCKKN----ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAAD 124 (202)
Q Consensus 49 ~~~~~~~~~~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~d 124 (202)
+...+.++.|.++...+|.+++.++ .-++...+.++.|++.|++| ++.+|||+||.||....+..+||.|
T Consensus 326 ~~~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y------k~~ihrdlkp~nif~~~d~q~kIgD 399 (516)
T KOG1033|consen 326 GKKVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY------KGLIHRDLKPSNIFFSDDDQLKIGD 399 (516)
T ss_pred ccccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh------ccchhhhccccccccccchhhhhhh
Confidence 3344556667778888898888644 36778899999999999998 4789999999999999999999999
Q ss_pred eecceeccccC----cccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc
Q 044746 125 FGLAKLYNREH----THITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG 178 (202)
Q Consensus 125 fgl~~~~~~~~----~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~ 178 (202)
||+........ .....+...||..||+||.+.+..|+.++||||+|++++|+++
T Consensus 400 Fgl~ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~ 457 (516)
T KOG1033|consen 400 FGLVTSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLI 457 (516)
T ss_pred hhheeecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHH
Confidence 99988665443 2223455778999999999999999999999999999999987
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.58 E-value=1.3e-14 Score=116.12 Aligned_cols=122 Identities=20% Similarity=0.257 Sum_probs=94.0
Q ss_pred CchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc--CCC--ceEEeeeecceecccc----C
Q 044746 64 GPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD--ENF--FPKAADFGLAKLYNRE----H 135 (202)
Q Consensus 64 ~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~--~~~--~~kl~dfgl~~~~~~~----~ 135 (202)
.+|.+++-.+..+.....-+..|+++|+.|||. ++|.|||+|.+|||+. .++ .+.++|||++-.-... .
T Consensus 327 ~tLr~yl~~~~~s~r~~~~~laQlLEav~hL~~---hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlp 403 (598)
T KOG4158|consen 327 QTLREYLWTRHRSYRTGRVILAQLLEAVTHLHK---HGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLP 403 (598)
T ss_pred hhHHHHHhcCCCchHHHHHHHHHHHHHHHHHHH---ccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccc
Confidence 367777777778888899999999999999999 9999999999999994 333 4678999988642210 1
Q ss_pred cccccCCCCCCCcccCCcccCCCC-----C-CchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 136 THITSTGRRRTPGCEAPELWMPYS-----V-TQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 136 ~~~~~~~~~gt~~y~aPe~~~~~~-----~-~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.........|+-..||||+....+ . -.++|.|+.|.+.||+++...||.+...
T Consensus 404 y~S~~Vd~GGNa~lmAPEi~ta~PGp~avvny~kAD~WA~GalaYEIfg~~NPFY~rGe 462 (598)
T KOG4158|consen 404 YESDEVDLGGNAKLMAPEIATAVPGPNAVVNYEKADTWAAGALAYEIFGRSNPFYKRGE 462 (598)
T ss_pred cccccccCCCcceecchhhhhcCCCCceeeccchhhhhhhhhhHHHHhccCCcccccch
Confidence 111223345678899999986432 1 1589999999999999999999988443
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.7e-16 Score=136.20 Aligned_cols=119 Identities=23% Similarity=0.247 Sum_probs=91.3
Q ss_pred CchhhhhccCC-CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee--ccccCc----
Q 044746 64 GPFYLLCKKNI-LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL--YNREHT---- 136 (202)
Q Consensus 64 ~~l~~~~~~~~-~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~--~~~~~~---- 136 (202)
.+|++.+..++ +..-+.+.|+.|++.||.-+|. .+|+|+|||.+|||+++=..+.|+||...+. +..+..
T Consensus 105 hnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~---~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPeDNPadf~ 181 (1431)
T KOG1240|consen 105 HNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHK---LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPEDNPADFT 181 (1431)
T ss_pred hhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHH---cCccccccccceEEEeeechhhhhcccccCCccCCCCCcccce
Confidence 46777777666 6777899999999999999999 9999999999999999989999999987763 111110
Q ss_pred ccccCCCCCCCcccCCcccCC----------CC-CCchhhHHHHHHHHHHHHc-CCCCCcch
Q 044746 137 HITSTGRRRTPGCEAPELWMP----------YS-VTQKCDVFSFGMLLFEVVG-RRRNLEKE 186 (202)
Q Consensus 137 ~~~~~~~~gt~~y~aPe~~~~----------~~-~~~~~Diws~G~~l~el~~-g~~p~~~~ 186 (202)
..-.+. ..-.+|+|||-+.. .+ .+++.||+|+||+++|+++ |+|||...
T Consensus 182 fFFDTS-rRRtCYiAPERFv~~~~~~~~~q~~~~L~paMDIFS~GCViaELf~Eg~PlF~LS 242 (1431)
T KOG1240|consen 182 FFFDTS-RRRTCYIAPERFVSALGKTSVGQDAPLLTPAMDIFSAGCVIAELFLEGRPLFTLS 242 (1431)
T ss_pred EEEecC-CceeeecChHhhhccccccccCCcccccChhhhhhhhhHHHHHHHhcCCCcccHH
Confidence 000111 11347999998753 12 6688999999999999986 89998643
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.57 E-value=5.3e-15 Score=110.46 Aligned_cols=76 Identities=17% Similarity=0.105 Sum_probs=64.9
Q ss_pred ceEEEEEccCCchh-hhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecc
Q 044746 54 ETYIKGFLAMGPFY-LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132 (202)
Q Consensus 54 ~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~ 132 (202)
..+++++++++++. ..+....++..+...++.|++.++.++|+. .+++||||||+||+++ ++.++|+|||++....
T Consensus 92 ~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~--~givHrDlkP~NIll~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 92 NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQE--AGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHh--CCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence 46899999887543 334556788899999999999999999973 7999999999999998 8899999999997654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.52 E-value=1.3e-14 Score=113.70 Aligned_cols=107 Identities=24% Similarity=0.236 Sum_probs=78.4
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccC
Q 044746 77 FGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWM 156 (202)
Q Consensus 77 ~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~ 156 (202)
......+..|++..+++||+ .|++|+||+|+|++++.+|.+.|+||+.....+..... ...+..|.|||...
T Consensus 144 ~~arl~lT~Q~I~lvA~Lh~---~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~r~g~~~~~-----~~~~~~~~PPe~~~ 215 (288)
T PF14531_consen 144 FAARLSLTVQMIRLVANLHS---YGLVHGDIKPENFLLDQDGGVFLGDFSSLVRAGTRYRC-----SEFPVAFTPPELES 215 (288)
T ss_dssp HHHHHHHHHHHHHHHHHHHH---TTEEEST-SGGGEEE-TTS-EEE--GGGEEETTEEEEG-----GGS-TTTS-HHHHH
T ss_pred HHHHHHHHHHHHHHHHHHhh---cceEecccceeeEEEcCCCCEEEcChHHHeecCceeec-----cCCCcccCChhhhh
Confidence 44456677999999999999 99999999999999999999999999877655432222 11256788999764
Q ss_pred C--------CCCCchhhHHHHHHHHHHHHcCCCCCcchhcccc
Q 044746 157 P--------YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191 (202)
Q Consensus 157 ~--------~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~ 191 (202)
. ..++.+.|.|++|+++|.+..|+.||....++..
T Consensus 216 ~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~ 258 (288)
T PF14531_consen 216 CAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEAD 258 (288)
T ss_dssp HHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGST
T ss_pred hhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccc
Confidence 3 2478899999999999999999999997766544
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.50 E-value=7.4e-15 Score=111.84 Aligned_cols=99 Identities=11% Similarity=0.117 Sum_probs=74.4
Q ss_pred cceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecc
Q 044746 53 TETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132 (202)
Q Consensus 53 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~ 132 (202)
...+++++++|.+|.++. .++. ....+++.++..+|+ .+++|+|++|.|++++.++ ++++|||......
T Consensus 117 ~~~lvmEyi~G~tL~~~~---~~~~----~~~~~i~~~l~~lH~---~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~ 185 (232)
T PRK10359 117 TYIMLIEYIEGVELNDMP---EISE----DVKAKIKASIESLHQ---HGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTA 185 (232)
T ss_pred CeEEEEEEECCccHHHhh---hccH----HHHHHHHHHHHHHHH---cCCccCCCChHHEEEeCCC-EEEEECCCccccc
Confidence 456899999999987763 2332 345699999999999 9999999999999999888 9999999876432
Q ss_pred ccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHH
Q 044746 133 REHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176 (202)
Q Consensus 133 ~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el 176 (202)
..... ..+.....++.++|+||+|+++..+
T Consensus 186 e~~a~--------------d~~vler~y~~~~di~~lg~~~~~~ 215 (232)
T PRK10359 186 QRKAK--------------DRIDLERHYGIKNEIKDLGYYLLIY 215 (232)
T ss_pred chhhH--------------HHHHHHhHhcccccccceeEeehHH
Confidence 11110 1133445566789999999887654
|
|
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.42 E-value=3.6e-13 Score=103.88 Aligned_cols=82 Identities=11% Similarity=0.011 Sum_probs=66.3
Q ss_pred ccccccccceEEEEEccCCchhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-eEEecCCCCcEEEcCCCceEEe
Q 044746 46 NLVGSEDTETYIKGFLAMGPFYLLC-KKNILGFGQLREIEVSTSKGIAYLHEECRQK-IVHYDIKPESVLLDENFFPKAA 123 (202)
Q Consensus 46 ~~i~~~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~-iiHrdlk~~nil~~~~~~~kl~ 123 (202)
..+... ...++++++.++++.... ....+...+...++.|++.++.+||+ .+ ++|||+||+||+++ ++.++++
T Consensus 116 ~~~~~~-~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~g~iiH~Dikp~NIli~-~~~i~Li 190 (237)
T smart00090 116 KPIAWR-RNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYK---EGELVHGDLSEYNILVH-DGKVVII 190 (237)
T ss_pred eeeEec-CceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHh---cCCEEeCCCChhhEEEE-CCCEEEE
Confidence 344433 346889999998876554 44456666788999999999999999 88 99999999999999 8899999
Q ss_pred eeecceecc
Q 044746 124 DFGLAKLYN 132 (202)
Q Consensus 124 dfgl~~~~~ 132 (202)
|||.+....
T Consensus 191 DFg~a~~~~ 199 (237)
T smart00090 191 DVSQSVELD 199 (237)
T ss_pred EChhhhccC
Confidence 999887543
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.41 E-value=4.9e-13 Score=111.28 Aligned_cols=135 Identities=27% Similarity=0.367 Sum_probs=105.2
Q ss_pred ccceEEEEEccCCchhhhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCe-EEecCCCCcEEEcCCCceEEeeeecc
Q 044746 52 DTETYIKGFLAMGPFYLLCKKNI--LGFGQLREIEVSTSKGIAYLHEECRQKI-VHYDIKPESVLLDENFFPKAADFGLA 128 (202)
Q Consensus 52 ~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~~i-iHrdlk~~nil~~~~~~~kl~dfgl~ 128 (202)
+...++.+++..|+|.+.+.... +++.=...+.++++.|+.|+|. .+| .|+.|+..|++++..+.+|++|||+.
T Consensus 20 ~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~---s~i~~hg~l~s~nClvd~~w~lklt~~Gl~ 96 (484)
T KOG1023|consen 20 PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHN---SPIGYHGALKSSNCLVDSRWVLKLTDFGLN 96 (484)
T ss_pred CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhc---CcceeeeeeccccceeeeeEEEEechhhhc
Confidence 56678899999999999997654 6666678888999999999998 344 99999999999999999999999998
Q ss_pred eeccccCcccccCCCCCCCcccCCcccCCC---C----CCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 129 KLYNREHTHITSTGRRRTPGCEAPELWMPY---S----VTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 129 ~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~---~----~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
................-..-|.|||.+... . .+.+.|+||||++++|+++++.||+.....
T Consensus 97 ~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~~~~~~~~ 164 (484)
T KOG1023|consen 97 SLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGPFDLRNLV 164 (484)
T ss_pred ccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCcccccccc
Confidence 765321000111111124568999998763 1 456799999999999999999999875543
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.38 E-value=8e-14 Score=120.09 Aligned_cols=151 Identities=25% Similarity=0.326 Sum_probs=119.0
Q ss_pred cccccc------ccccceEEEEEccCCchhhhh-ccC--CCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEecCCCCcEE
Q 044746 44 FSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN--ILGFGQLREIEVSTSKGIAYLH-EECRQKIVHYDIKPESVL 113 (202)
Q Consensus 44 ~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~--~~~~~~~~~~~~~i~~~l~~lH-~~~~~~iiHrdlk~~nil 113 (202)
|.|+++ ...+.....++..++.++... ... ..+......+..|+..++.|+| . .++.|||+||+|.+
T Consensus 80 h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~~---~~~~h~~ikP~n~~ 156 (601)
T KOG0590|consen 80 HSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHPE---NGVTHRDIKPSNSL 156 (601)
T ss_pred cccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCcc---cccccCCCCCccch
Confidence 666653 444555667777777777666 444 4777889999999999999999 6 89999999999999
Q ss_pred EcCCC-ceEEeeeecceeccc-cCcccccCCCCC-CCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 114 LDENF-FPKAADFGLAKLYNR-EHTHITSTGRRR-TPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 114 ~~~~~-~~kl~dfgl~~~~~~-~~~~~~~~~~~g-t~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
++..+ ..+++|||+|..... ..........+| ++.|+|||...+. ......|+||.|+++.-+++|..|++.....
T Consensus 157 l~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~~l~~~~~g~~p~~~~~~~ 236 (601)
T KOG0590|consen 157 LDESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGIVLSAMLTGELPWDFPSRK 236 (601)
T ss_pred hccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccccccccccCCCCccccccc
Confidence 99998 999999999997665 443444455677 9999999998874 3456789999999999999999999876665
Q ss_pred ccccccccc
Q 044746 190 GQEWFPKWG 198 (202)
Q Consensus 190 ~~~~~~~~~ 198 (202)
.+ .+..|.
T Consensus 237 ~~-~~~~~~ 244 (601)
T KOG0590|consen 237 DG-RYSSWK 244 (601)
T ss_pred cc-cceeec
Confidence 53 444443
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.35 E-value=2.1e-12 Score=97.70 Aligned_cols=93 Identities=16% Similarity=0.144 Sum_probs=66.2
Q ss_pred cCCcHHHHHHhc-----cccccccc-------cccce---EEEEE--ccCCchhhhhccCCCCHHHHHHHHHHHHHHH-H
Q 044746 31 RFTSPQRMIAAD-----NFSNLVGS-------EDTET---YIKGF--LAMGPFYLLCKKNILGFGQLREIEVSTSKGI-A 92 (202)
Q Consensus 31 ~~~~~~~~~~~~-----~~~~~i~~-------~~~~~---~~~~~--~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l-~ 92 (202)
.+..|....... +|++++.. .+.+. +++++ ..+++|.+++....+++. ..++.+++.++ +
T Consensus 42 ~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~~~~~e~--~~~~~~~L~~l~~ 119 (210)
T PRK10345 42 EIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQCRYEED--VAQLRQLLKKLKR 119 (210)
T ss_pred HHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHcccccHh--HHHHHHHHHHHHH
Confidence 355555555555 56776631 11223 45677 446899999987777665 45678888887 9
Q ss_pred HHHhCCCCCeEEecCCCCcEEEcC----CCceEEeeeecc
Q 044746 93 YLHEECRQKIVHYDIKPESVLLDE----NFFPKAADFGLA 128 (202)
Q Consensus 93 ~lH~~~~~~iiHrdlk~~nil~~~----~~~~kl~dfgl~ 128 (202)
|||+ ++|+||||||+||+++. ++.++|+|++.+
T Consensus 120 yLh~---~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 120 YLLD---NRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHH---CCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 9999 99999999999999973 347999995433
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.30 E-value=3.5e-12 Score=109.41 Aligned_cols=90 Identities=18% Similarity=0.231 Sum_probs=71.1
Q ss_pred cCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEE
Q 044746 31 RFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVH 104 (202)
Q Consensus 31 ~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiH 104 (202)
++..|........++++.. ......++++++++++|..++. ....++.+++.+|.+||+ .+++|
T Consensus 382 ~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~-------~~~~~~~~i~~~L~~lH~---~giiH 451 (535)
T PRK09605 382 RTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE-------GNPELVRKVGEIVAKLHK---AGIVH 451 (535)
T ss_pred HHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH-------HHHHHHHHHHHHHHHHHh---CCCcc
Confidence 3555655565555554331 2334568999999999987764 467899999999999999 99999
Q ss_pred ecCCCCcEEEcCCCceEEeeeecceec
Q 044746 105 YDIKPESVLLDENFFPKAADFGLAKLY 131 (202)
Q Consensus 105 rdlk~~nil~~~~~~~kl~dfgl~~~~ 131 (202)
||+||+||++ .++.++++|||+++..
T Consensus 452 rDlkp~NILl-~~~~~~liDFGla~~~ 477 (535)
T PRK09605 452 GDLTTSNFIV-RDDRLYLIDFGLGKYS 477 (535)
T ss_pred CCCChHHEEE-ECCcEEEEeCcccccC
Confidence 9999999999 5778999999999764
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.28 E-value=7.6e-12 Score=94.57 Aligned_cols=72 Identities=21% Similarity=0.288 Sum_probs=62.8
Q ss_pred ccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 52 DTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 52 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
....++++++++++|..+...... ....++.+++.+|.++|+ .+++|+|++|.||+++ ++.++++|||++..
T Consensus 72 ~~~~lv~e~~~G~~L~~~~~~~~~---~~~~i~~~i~~~l~~lH~---~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 72 ENFIIVMEYIEGEPLKDLINSNGM---EELELSREIGRLVGKLHS---AGIIHGDLTTSNMILS-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCEEEEEEeCCcCHHHHHHhccH---HHHHHHHHHHHHHHHHHh---CCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence 445688999999999888754332 788999999999999999 9999999999999999 78899999999875
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=1.5e-11 Score=92.32 Aligned_cols=71 Identities=13% Similarity=0.088 Sum_probs=60.3
Q ss_pred cceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceec
Q 044746 53 TETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131 (202)
Q Consensus 53 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~ 131 (202)
...+++++++++++...... .....++.+++.++.++|+ .+++|+|++|.||+++.++.++|+|||++...
T Consensus 105 ~~~lv~e~~~g~~L~~~~~~-----~~~~~~~~~i~~~l~~lh~---~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~ 175 (198)
T cd05144 105 RHAVVMEYIDGVELYRVRVL-----EDPEEVLDEILEEIVKAYK---HGIIHGDLSEFNILVDDDEKIYIIDWPQMVST 175 (198)
T ss_pred CceEEEEEeCCcchhhcccc-----ccHHHHHHHHHHHHHHHHH---CCCCcCCCCcccEEEcCCCcEEEEECCccccC
Confidence 34688999999888655431 3456788999999999999 99999999999999999999999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.22 E-value=1.9e-11 Score=91.56 Aligned_cols=69 Identities=20% Similarity=0.276 Sum_probs=59.2
Q ss_pred cceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceec
Q 044746 53 TETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131 (202)
Q Consensus 53 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~ 131 (202)
...++++++++++|......... .++.+++.+|.++|+ .+++|+|++|.||+++ ++.++++|||++...
T Consensus 71 ~~~lv~e~~~g~~l~~~~~~~~~------~~~~~i~~~l~~lH~---~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~ 139 (199)
T TIGR03724 71 NKTIVMEYIEGKPLKDVIEEGND------ELLREIGRLVGKLHK---AGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS 139 (199)
T ss_pred CCEEEEEEECCccHHHHHhhcHH------HHHHHHHHHHHHHHH---CCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence 34688999999999877644321 789999999999999 9999999999999999 789999999998753
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.20 E-value=4.6e-11 Score=92.33 Aligned_cols=69 Identities=20% Similarity=0.171 Sum_probs=59.1
Q ss_pred eEEEEEccC-CchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 55 TYIKGFLAM-GPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 55 ~~~~~~~~~-~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
.++++++++ .+|..++....++... ..+++.++.+||+ .||+||||||.|||++.++.++|+|||.+..
T Consensus 122 ~lV~e~l~G~~~L~~~l~~~~l~~~~----~~~i~~~l~~lH~---~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 122 DILIERIEGARDLVALLQEAPLSEEQ----WQAIGQLIARFHD---AGVYHADLNAHNILLDPDGKFWLIDFDRGEL 191 (239)
T ss_pred eEEEEecCCCCCHHHHHhcCCCCHHH----HHHHHHHHHHHHH---CCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence 378888887 6888887776666543 5789999999999 9999999999999999888999999998865
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.13 E-value=1.3e-10 Score=86.19 Aligned_cols=75 Identities=17% Similarity=0.045 Sum_probs=57.7
Q ss_pred cceEEEEEccCCchhhh-hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceec
Q 044746 53 TETYIKGFLAMGPFYLL-CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131 (202)
Q Consensus 53 ~~~~~~~~~~~~~l~~~-~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~ 131 (202)
...+++++++++.+... +...... .+...++.+++.++.++|+. .+++|+|+||+||+++ ++.++++|||.+...
T Consensus 89 ~~~lv~e~~~g~~~~~~~l~~~~~~-~~~~~~~~~~~~~l~~lh~~--~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~ 164 (187)
T cd05119 89 RHVLVMEFIGGDGIPAPRLKDVRLL-EDPEELYDQILELMRKLYRE--AGLVHGDLSEYNILVD-DGKVYIIDVPQAVEI 164 (187)
T ss_pred CCEEEEEEeCCCCccChhhhhhhhc-ccHHHHHHHHHHHHHHHhhc--cCcCcCCCChhhEEEE-CCcEEEEECcccccc
Confidence 34688999988543211 1111111 67889999999999999973 7999999999999999 889999999998644
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.11 E-value=2.4e-10 Score=80.93 Aligned_cols=82 Identities=15% Similarity=0.170 Sum_probs=64.9
Q ss_pred ccccccccc---ccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc
Q 044746 43 NFSNLVGSE---DTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF 119 (202)
Q Consensus 43 ~~~~~i~~~---~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~ 119 (202)
..+.+++.. +...++++++.++++..+ +......++.+++.++..+|.....+++|+|++|.|++++..+.
T Consensus 54 ~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~------~~~~~~~~~~~~~~~l~~lh~~~~~~i~H~Dl~~~Nil~~~~~~ 127 (155)
T cd05120 54 PVPKVLASGESDGWSYLLMEWIEGETLDEV------SEEEKEDIAEQLAELLAKLHQLPLLVLCHGDLHPGNILVDDGKI 127 (155)
T ss_pred CCCeEEEEcCCCCccEEEEEecCCeecccC------CHHHHHHHHHHHHHHHHHHhCCCceEEEecCCCcceEEEECCcE
Confidence 344555433 357788888888777544 66777888999999999999843347999999999999998899
Q ss_pred eEEeeeeccee
Q 044746 120 PKAADFGLAKL 130 (202)
Q Consensus 120 ~kl~dfgl~~~ 130 (202)
++++|||.+..
T Consensus 128 ~~l~Df~~~~~ 138 (155)
T cd05120 128 LGIIDWEYAGY 138 (155)
T ss_pred EEEEecccccC
Confidence 99999998764
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.03 E-value=2.2e-10 Score=101.39 Aligned_cols=183 Identities=17% Similarity=0.181 Sum_probs=123.6
Q ss_pred ccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-CCCH
Q 044746 5 RNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN-ILGF 77 (202)
Q Consensus 5 ~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~-~~~~ 77 (202)
+..+++.+.+.++.+...............+.....+..+|-+++ ...-..+.+++..++.|...++.- ..+.
T Consensus 824 ~pa~sgh~~~~~v~~~ap~i~~~~~~s~r~~s~~~i~p~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~sa 903 (1205)
T KOG0606|consen 824 SPAGSGHTRPSKVHGLAPKIRTNDYESIRSKSNILITPRSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSA 903 (1205)
T ss_pred CccccccccchhhhccchhhccccccccCCccCccccCCCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCccc
Confidence 344444445555554444444433333433333333333343332 222334667777777776665443 3666
Q ss_pred HHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecccc-----C-----------------
Q 044746 78 GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE-----H----------------- 135 (202)
Q Consensus 78 ~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~-----~----------------- 135 (202)
+-.+.+...+..++++||+ ..+.|||++|.|+++..++..++.|||.......- .
T Consensus 904 epaRs~i~~~vqs~e~L~s---~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~ 980 (1205)
T KOG0606|consen 904 EPARSPILERVQSLESLHS---SLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSER 980 (1205)
T ss_pred ccccchhHHHHhhhhcccc---chhhcccccccchhhcccCCcccCccccccccccccCcCCcccccccCcccccccccc
Confidence 6677788888899999998 66999999999999999999999999844321100 0
Q ss_pred ----cc---cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 136 ----TH---ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 136 ----~~---~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
.. .......||+.|.+||...+......+|+|+.|++++|.++|.+||....++.
T Consensus 981 ~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~~~~g~~l~e~l~g~pp~na~tpq~ 1042 (1205)
T KOG0606|consen 981 RPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADWWSSGVCLFEVLTGIPPFNAETPQQ 1042 (1205)
T ss_pred ccccccchhhccccccCCCcccCCcccccccCCCcchhhhhhhhhhhhhcCCCCCCCcchhh
Confidence 00 01123568999999999999998999999999999999999999999877654
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.99 E-value=1.2e-09 Score=86.02 Aligned_cols=130 Identities=18% Similarity=0.290 Sum_probs=97.8
Q ss_pred cccceEEEEEccCCchhhhhccC-----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeee
Q 044746 51 EDTETYIKGFLAMGPFYLLCKKN-----ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125 (202)
Q Consensus 51 ~~~~~~~~~~~~~~~l~~~~~~~-----~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~df 125 (202)
.....++.++++.|++..++++. .+......+++.||++||.|||+ |..+|+|+++..+.|++..+|.+|+.-.
T Consensus 144 ~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs-~~PpiihgnlTc~tifiq~ngLIkig~~ 222 (458)
T KOG1266|consen 144 KPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHS-CDPPIIHGNLTCDTIFIQHNGLIKIGSV 222 (458)
T ss_pred ccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhc-cCCccccCCcchhheeecCCceEEeccc
Confidence 34456889999999998888543 47788899999999999999997 5689999999999999999998887643
Q ss_pred ecceeccccCcc--cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCC
Q 044746 126 GLAKLYNREHTH--ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181 (202)
Q Consensus 126 gl~~~~~~~~~~--~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~ 181 (202)
............ .......+.++|.+||.-...+.+..+|||+||+...||..++-
T Consensus 223 ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlemailEi 280 (458)
T KOG1266|consen 223 APDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEMAILEI 280 (458)
T ss_pred CccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHHHHhee
Confidence 322211111111 11122345788999998776677889999999999999877653
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.92 E-value=2.7e-09 Score=89.49 Aligned_cols=128 Identities=22% Similarity=0.219 Sum_probs=99.5
Q ss_pred eEEEEEccCCchhhhhccC--CCCHHHHHHHHHHHHH----HHHHHHhCCCCCeEEecCCCCcEEEcCC-CceEEeeeec
Q 044746 55 TYIKGFLAMGPFYLLCKKN--ILGFGQLREIEVSTSK----GIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGL 127 (202)
Q Consensus 55 ~~~~~~~~~~~l~~~~~~~--~~~~~~~~~~~~~i~~----~l~~lH~~~~~~iiHrdlk~~nil~~~~-~~~kl~dfgl 127 (202)
.++..-..+.++..+|... .++.........+... ||..+|+ ..++|-|+||.||++..+ ..+++.|||+
T Consensus 193 lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~hs---~~~~~~~~kp~~i~~~~~~~s~~~~df~~ 269 (524)
T KOG0601|consen 193 LFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLHS---NNIVHDDLKPANIFTTSDWTSCKLTDFGL 269 (524)
T ss_pred ceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccccccCC---CcccccccchhheecccccceeecCCcce
Confidence 3555556667888888654 3777888888888888 9999999 999999999999999998 8899999999
Q ss_pred ceeccccCcccc---cCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 128 AKLYNREHTHIT---STGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 128 ~~~~~~~~~~~~---~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
...++....... .....|...|++||...+ .++...|++++|.+..+..++..+....
T Consensus 270 v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~-l~~~~~di~sl~ev~l~~~l~~~~~~~g 330 (524)
T KOG0601|consen 270 VSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG-LATFASDIFSLGEVILEAILGSHLPSVG 330 (524)
T ss_pred eEEccCCccccceeeeecCCCCceEeChhhhcc-ccchHhhhcchhhhhHhhHhhcccccCC
Confidence 987765432111 122245778999999876 4578899999999999988877665544
|
|
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=98.80 E-value=9.6e-09 Score=74.78 Aligned_cols=75 Identities=21% Similarity=0.132 Sum_probs=55.9
Q ss_pred ccccccc-ccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEecCCCCcEEEcCCC
Q 044746 45 SNLVGSE-DTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQK-----IVHYDIKPESVLLDENF 118 (202)
Q Consensus 45 ~~~i~~~-~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~-----iiHrdlk~~nil~~~~~ 118 (202)
|.++... +.+.++++++++.++... . ........+++.+|..||+ .+ ++|+|++|.||+++ ++
T Consensus 56 P~~~~~~~~~~~lv~e~i~G~~l~~~----~---~~~~~~~~~l~~~l~~LH~---~~~~~~~~~HgD~~~~Nil~~-~~ 124 (170)
T cd05151 56 PKLYYFDPETGVLITEFIEGSELLTE----D---FSDPENLEKIAKLLKKLHS---SPLPDLVPCHNDLLPGNFLLD-DG 124 (170)
T ss_pred CceEEEeCCCCeEEEEecCCCccccc----c---ccCHHHHHHHHHHHHHHhC---CCCCCceeecCCCCcCcEEEE-CC
Confidence 4455433 235788999999877542 1 1123456889999999998 55 59999999999998 66
Q ss_pred ceEEeeeeccee
Q 044746 119 FPKAADFGLAKL 130 (202)
Q Consensus 119 ~~kl~dfgl~~~ 130 (202)
.++++||+.+..
T Consensus 125 ~~~liDf~~a~~ 136 (170)
T cd05151 125 RLWLIDWEYAGM 136 (170)
T ss_pred eEEEEecccccC
Confidence 799999998753
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=98.74 E-value=7.2e-08 Score=72.06 Aligned_cols=84 Identities=13% Similarity=0.040 Sum_probs=62.7
Q ss_pred cccccccccccceEEEEEccCCchh-hhhccCCCCHHHHHHHHHHHHHHHHHH-HhCCCCCeEEecCCCCcEEEcCCCce
Q 044746 43 NFSNLVGSEDTETYIKGFLAMGPFY-LLCKKNILGFGQLREIEVSTSKGIAYL-HEECRQKIVHYDIKPESVLLDENFFP 120 (202)
Q Consensus 43 ~~~~~i~~~~~~~~~~~~~~~~~l~-~~~~~~~~~~~~~~~~~~~i~~~l~~l-H~~~~~~iiHrdlk~~nil~~~~~~~ 120 (202)
+.|..+.. ....++|+++.++.+. ..++...++..+...+..+++.++..+ |. .+++|+||++.||++. ++.+
T Consensus 89 ~vP~pi~~-~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~---~glVHGDLs~~NIL~~-~~~v 163 (197)
T cd05146 89 PCPEVVVL-KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKE---CNLVHADLSEYNMLWH-DGKV 163 (197)
T ss_pred CCCeEEEe-cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEE-CCcE
Confidence 44455554 4566889998765332 123333456667778889999999988 88 8999999999999997 4679
Q ss_pred EEeeeecceec
Q 044746 121 KAADFGLAKLY 131 (202)
Q Consensus 121 kl~dfgl~~~~ 131 (202)
.++|||.+...
T Consensus 164 ~iIDF~qav~~ 174 (197)
T cd05146 164 WFIDVSQSVEP 174 (197)
T ss_pred EEEECCCceeC
Confidence 99999988654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.56 E-value=3e-08 Score=83.28 Aligned_cols=168 Identities=18% Similarity=0.212 Sum_probs=107.9
Q ss_pred CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------cccceEEEEEccCCchhhhh-ccCCCCHHH
Q 044746 7 RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------EDTETYIKGFLAMGPFYLLC-KKNILGFGQ 79 (202)
Q Consensus 7 ~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------~~~~~~~~~~~~~~~l~~~~-~~~~~~~~~ 79 (202)
.++..++++.+.+.+.... .+...+..-.......-|...+|. ...++.-.++++++++.... -...+....
T Consensus 289 ~~~~~Y~~ke~~~~l~~~~-~di~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~ 367 (524)
T KOG0601|consen 289 EGDCIYAAKELLNGLATFA-SDIFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDP 367 (524)
T ss_pred CCCceEeChhhhccccchH-hhhcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcch
Confidence 4556666666554443332 222223333333333444445551 12233445677777654433 223477788
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-CceEEeeeecceeccccCcccccCCCCCCCcc-cCCcccCC
Q 044746 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTHITSTGRRRTPGC-EAPELWMP 157 (202)
Q Consensus 80 ~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y-~aPe~~~~ 157 (202)
.+++..|++.++.++|+ +.++|+|+||.||++..+ +..++.|||++..+........ -.+..| .+++....
T Consensus 368 ~~~~~~q~~~~l~~i~s---~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~~~~~~----~~~r~~p~~~~~~e~ 440 (524)
T KOG0601|consen 368 RLRLTAQILTALNVIHS---KLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFSSGVFH----HIDRLYPIAEILLED 440 (524)
T ss_pred hhhhHHHHHhccccccc---hhhhcccccccceeeccchhhhhccccccccccceeccccc----ccccccccchhhccc
Confidence 99999999999999998 999999999999999886 7889999998864321111111 112233 35556666
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCC
Q 044746 158 YSVTQKCDVFSFGMLLFEVVGRRRN 182 (202)
Q Consensus 158 ~~~~~~~Diws~G~~l~el~~g~~p 182 (202)
..+..++|++|+|..+.+.+++.+-
T Consensus 441 ~~~~~~~~~~sl~~~~~e~~~~~~l 465 (524)
T KOG0601|consen 441 YPHLSKADIFSLGLSVDEAITGSPL 465 (524)
T ss_pred cccccccccccccccccccccCccc
Confidence 7888999999999999998888753
|
|
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.54 E-value=5.3e-07 Score=73.80 Aligned_cols=110 Identities=17% Similarity=0.148 Sum_probs=88.2
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
...|.-.++.++.++.+..-||. .|-.-+|++++|+|++.++.+.|.|-.......+ .....+..|...|.+||
T Consensus 113 ~~~w~fllrvaRnlA~aFA~lH~---~Gh~vGDVn~~~~lVsd~~~V~LVdsDsfqi~~n---g~~~~cpVg~~eftPPE 186 (637)
T COG4248 113 HCAWDFLLRVARNLASAFATLHE---HGHVVGDVNQNSFLVSDDSKVVLVDSDSFQINAN---GTLHLCPVGVSEFTPPE 186 (637)
T ss_pred ccccHHHHHHHHHHHHHHHHHHh---cCCcccccCccceeeecCceEEEEcccceeeccC---CceEecccCccccCCHH
Confidence 37888999999999999999999 8999999999999999999999987543333222 22234567889999999
Q ss_pred ccC-----CCCCCchhhHHHHHHHHHHHHcC-CCCCcchhcc
Q 044746 154 LWM-----PYSVTQKCDVFSFGMLLFEVVGR-RRNLEKEISE 189 (202)
Q Consensus 154 ~~~-----~~~~~~~~Diws~G~~l~el~~g-~~p~~~~~~~ 189 (202)
... +..-+...|.+-+|+++++++.| +.||.+....
T Consensus 187 lQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~ 228 (637)
T COG4248 187 LQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLI 228 (637)
T ss_pred HhccccccccCCCccccchhHHHHHHHHHhcCCCCCCccccc
Confidence 876 33445678999999999998875 9999876543
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=98.50 E-value=2.8e-07 Score=77.32 Aligned_cols=77 Identities=12% Similarity=0.187 Sum_probs=58.7
Q ss_pred ccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHH-HHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 52 DTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSK-GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 52 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~-~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
+...+++++++++++.++........ ....++..++. .+..+|. .|++|+|++|.||++..++.++++|||++..
T Consensus 231 ~~~vLvmE~i~G~~L~~~~~~~~~~~-~~~~ia~~~~~~~l~ql~~---~g~~H~D~hPgNilv~~~g~i~liDfG~~~~ 306 (437)
T TIGR01982 231 SERVLTMEWIDGIPLSDIAALDEAGL-DRKALAENLARSFLNQVLR---DGFFHADLHPGNIFVLKDGKIIALDFGIVGR 306 (437)
T ss_pred CCceEEEEeECCcccccHHHHHhcCC-CHHHHHHHHHHHHHHHHHh---CCceeCCCCcccEEECCCCcEEEEeCCCeeE
Confidence 34568999999999877654321111 23456666655 4677887 8999999999999999999999999999987
Q ss_pred cc
Q 044746 131 YN 132 (202)
Q Consensus 131 ~~ 132 (202)
++
T Consensus 307 l~ 308 (437)
T TIGR01982 307 LS 308 (437)
T ss_pred CC
Confidence 65
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=98.49 E-value=6e-07 Score=70.46 Aligned_cols=75 Identities=20% Similarity=0.091 Sum_probs=62.3
Q ss_pred cceEEEEEccCC-chhhhhc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-------CCceE
Q 044746 53 TETYIKGFLAMG-PFYLLCK---KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-------NFFPK 121 (202)
Q Consensus 53 ~~~~~~~~~~~~-~l~~~~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-------~~~~k 121 (202)
...++++++++. +|.+++. ....+......++.+++..+.-||+ .|++|+|+++.|||++. +..+.
T Consensus 109 ~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~LH~---~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~ 185 (268)
T PRK15123 109 TSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRDMHA---AGINHRDCYICHFLLHLPFPGREEDLKLS 185 (268)
T ss_pred eeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCccCCCChhhEEEeccccCCCCCceEE
Confidence 356888888876 7877764 3446667788999999999999999 99999999999999975 46789
Q ss_pred Eeeeeccee
Q 044746 122 AADFGLAKL 130 (202)
Q Consensus 122 l~dfgl~~~ 130 (202)
++||+.++.
T Consensus 186 LIDl~r~~~ 194 (268)
T PRK15123 186 VIDLHRAQI 194 (268)
T ss_pred EEECCcccc
Confidence 999998753
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.49 E-value=5.3e-07 Score=66.12 Aligned_cols=69 Identities=17% Similarity=0.248 Sum_probs=56.8
Q ss_pred ccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 52 DTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 52 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..+.+++++.++..|.+.+... ...++..+-.-+.-||. .+|+|+||.++|+++.+.. +.++||||+..
T Consensus 72 ~~~~I~me~I~G~~lkd~l~~~------~~~~~r~vG~~vg~lH~---~givHGDLTtsNiIl~~~~-i~~IDfGLg~~ 140 (204)
T COG3642 72 DNGLIVMEYIEGELLKDALEEA------RPDLLREVGRLVGKLHK---AGIVHGDLTTSNIILSGGR-IYFIDFGLGEF 140 (204)
T ss_pred CCCEEEEEEeCChhHHHHHHhc------chHHHHHHHHHHHHHHh---cCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence 4456889999998888777655 24567777777888999 9999999999999998765 89999999974
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.37 E-value=5.3e-07 Score=77.04 Aligned_cols=72 Identities=14% Similarity=0.137 Sum_probs=50.6
Q ss_pred ccceEEEEEccCCchhhhh--ccCC-----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC----ce
Q 044746 52 DTETYIKGFLAMGPFYLLC--KKNI-----LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF----FP 120 (202)
Q Consensus 52 ~~~~~~~~~~~~~~l~~~~--~~~~-----~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~----~~ 120 (202)
+...++++++.|+++.++. .... +....+..++.|+ .. .|++|+|++|.||+++.++ .+
T Consensus 234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qi-------f~---~GffHaDpHPGNIlv~~~g~~~~~i 303 (537)
T PRK04750 234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQV-------FR---DGFFHADMHPGNIFVSYDPPENPRY 303 (537)
T ss_pred CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHH-------Hh---CCeeeCCCChHHeEEecCCCCCCeE
Confidence 3455889999999986642 2222 2222233333333 23 7999999999999999887 89
Q ss_pred EEeeeecceeccc
Q 044746 121 KAADFGLAKLYNR 133 (202)
Q Consensus 121 kl~dfgl~~~~~~ 133 (202)
++.|||+...++.
T Consensus 304 ~llDFGivg~l~~ 316 (537)
T PRK04750 304 IALDFGIVGSLNK 316 (537)
T ss_pred EEEecceEEECCH
Confidence 9999999987643
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.36 E-value=5e-06 Score=71.34 Aligned_cols=162 Identities=14% Similarity=0.135 Sum_probs=97.9
Q ss_pred CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc----cccceEEEEEccCCchhhhhccCCCCHHHHHH
Q 044746 7 RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS----EDTETYIKGFLAMGPFYLLCKKNILGFGQLRE 82 (202)
Q Consensus 7 ~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~ 82 (202)
+..+..|.+.+-+.... +...........+.+.+||+++.. ...+.+|...-.-.+|..+++. ++.....-
T Consensus 34 k~~~~~vsVF~~~~~~~---~~~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV~Pl~~~lk~--l~~~~v~~ 108 (690)
T KOG1243|consen 34 KADGGPVSVFVYKRSNG---EVTELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERVRPLETVLKE--LGKEEVCL 108 (690)
T ss_pred eccCCceEEEEEeCCCc---hhhHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeeccccHHHHHHH--hHHHHHHH
Confidence 34444555544333322 222223444556678899988731 1222233322223344444432 23555666
Q ss_pred HHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCc
Q 044746 83 IEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQ 162 (202)
Q Consensus 83 ~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~ 162 (202)
-+.||+.||.|||.- .+++|++|.-+.++++..|.-||++|.++........ .......-..|..|+.+.... -
T Consensus 109 Gl~qIl~AL~FL~~d--~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~~~~~s~~~P~~~~~s~--~ 182 (690)
T KOG1243|consen 109 GLFQILAALSFLNDD--CNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSLYLIESFDDPEEIDPSE--W 182 (690)
T ss_pred HHHHHHHHHHHHhcc--CCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccchhhhcccChhhcCccc--c
Confidence 779999999999863 7999999999999999999999999987753321110 001111122355565443322 3
Q ss_pred hhhHHHHHHHHHHHHcC
Q 044746 163 KCDVFSFGMLLFEVVGR 179 (202)
Q Consensus 163 ~~Diws~G~~l~el~~g 179 (202)
..|.|-|||+++|++.|
T Consensus 183 s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 183 SIDSWGLGCLIEELFNG 199 (690)
T ss_pred chhhhhHHHHHHHHhCc
Confidence 46999999999999999
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.34 E-value=2.2e-06 Score=62.93 Aligned_cols=77 Identities=21% Similarity=0.230 Sum_probs=57.8
Q ss_pred cccceEEEEEccCC-chhhhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC---ceEEe
Q 044746 51 EDTETYIKGFLAMG-PFYLLCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF---FPKAA 123 (202)
Q Consensus 51 ~~~~~~~~~~~~~~-~l~~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~---~~kl~ 123 (202)
...+.+||+++++. ++.++.... .........++..+-..+.-||. +++||+||..+||++..++ .+.++
T Consensus 82 ~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH~---ndiiHGDLTTSNill~~~~~~~~~~lI 158 (229)
T KOG3087|consen 82 TYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLHD---NDIIHGDLTTSNILLRSDGNQITPILI 158 (229)
T ss_pred cCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhhh---CCeecccccccceEEecCCCcCceEEE
Confidence 44567999999873 455554222 22223337889999999999999 9999999999999997654 35799
Q ss_pred eeeccee
Q 044746 124 DFGLAKL 130 (202)
Q Consensus 124 dfgl~~~ 130 (202)
|||++..
T Consensus 159 dfgls~~ 165 (229)
T KOG3087|consen 159 DFGLSSV 165 (229)
T ss_pred eecchhc
Confidence 9999864
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.31 E-value=2.6e-06 Score=64.39 Aligned_cols=74 Identities=24% Similarity=0.241 Sum_probs=61.9
Q ss_pred ceEEEEEccCC-chhhhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC---ceEEeeeecc
Q 044746 54 ETYIKGFLAMG-PFYLLCKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF---FPKAADFGLA 128 (202)
Q Consensus 54 ~~~~~~~~~~~-~l~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~---~~kl~dfgl~ 128 (202)
..++++.+++. +|..+... ...+......++.+++..+.-||+ .|++|+|+++.|||++.+. .+.++||+.+
T Consensus 92 s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~lH~---~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~ 168 (206)
T PF06293_consen 92 SYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAKLHD---AGIYHGDLNPSNILVDPDDGQYRFYLIDLDRM 168 (206)
T ss_pred EEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHHHHH---CcCCCCCCCcccEEEeCCCCceeEEEEcchhc
Confidence 35777888774 67777765 236677888999999999999999 9999999999999998876 7899999877
Q ss_pred ee
Q 044746 129 KL 130 (202)
Q Consensus 129 ~~ 130 (202)
+.
T Consensus 169 ~~ 170 (206)
T PF06293_consen 169 RF 170 (206)
T ss_pred ee
Confidence 64
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.21 E-value=1.1e-05 Score=60.89 Aligned_cols=77 Identities=21% Similarity=0.155 Sum_probs=60.8
Q ss_pred cceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------------------
Q 044746 53 TETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEEC---------------------------------- 98 (202)
Q Consensus 53 ~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---------------------------------- 98 (202)
...++++++++.++........++..+...++.+++.+|..||+..
T Consensus 74 ~~~~v~e~i~G~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 153 (223)
T cd05154 74 TPFYVMERVDGRVLRDRLLRPELSPEERRALARALADTLAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDE 153 (223)
T ss_pred CceEEEEEeCCEecCCCCCCCCCCHHHHHHHHHHHHHHHHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccc
Confidence 4568999999988876554356777888888888988888888521
Q ss_pred -------------------CCCeEEecCCCCcEEEcC--CCceEEeeeecce
Q 044746 99 -------------------RQKIVHYDIKPESVLLDE--NFFPKAADFGLAK 129 (202)
Q Consensus 99 -------------------~~~iiHrdlk~~nil~~~--~~~~kl~dfgl~~ 129 (202)
...++|+|+.+.||+++. ++.+.++||+.+.
T Consensus 154 ~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~~~~~~~iID~e~~~ 205 (223)
T cd05154 154 PPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPDEPRVVAVLDWELAT 205 (223)
T ss_pred cHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCCCCcEEEEEeccccc
Confidence 145699999999999988 5678999998765
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=98.13 E-value=5.1e-06 Score=61.77 Aligned_cols=74 Identities=23% Similarity=0.223 Sum_probs=50.2
Q ss_pred cceEEEEEcc--CCchhhhhccCCCCHHHHHHHHHHHHHHHHH-HHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 53 TETYIKGFLA--MGPFYLLCKKNILGFGQLREIEVSTSKGIAY-LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 53 ~~~~~~~~~~--~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~-lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
-..++|++++ +.++..+.. ..++..+...+..+++..+.. +|. .+++|+||.+.||+++.+ .+.++|||.+.
T Consensus 80 ~~~ivME~I~~~G~~~~~l~~-~~~~~~~~~~~~~~il~~~~~~~~~---~givHGDLs~~NIlv~~~-~~~iIDf~qav 154 (188)
T PF01163_consen 80 RNVIVMEYIGEDGVPLPRLKD-VDLSPEEPKELLEEILEEIIKMLHK---AGIVHGDLSEYNILVDDG-KVYIIDFGQAV 154 (188)
T ss_dssp TTEEEEE--EETTEEGGCHHH-CGGGGSTHHHHHHHHHHHHHHHHHC---TTEEESS-STTSEEEETT-CEEE--GTTEE
T ss_pred CCEEEEEecCCCccchhhHHh-ccccchhHHHHHHHHHHHHHHHHHh---cCceecCCChhhEEeecc-eEEEEecCcce
Confidence 3458999998 555544333 222245567778888885555 567 899999999999999877 89999999886
Q ss_pred ec
Q 044746 130 LY 131 (202)
Q Consensus 130 ~~ 131 (202)
..
T Consensus 155 ~~ 156 (188)
T PF01163_consen 155 DS 156 (188)
T ss_dssp ET
T ss_pred ec
Confidence 54
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.99 E-value=1.1e-06 Score=75.52 Aligned_cols=101 Identities=26% Similarity=0.355 Sum_probs=74.1
Q ss_pred HHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc--ccc-----CCCCCCCcccCCcccC
Q 044746 84 EVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH--ITS-----TGRRRTPGCEAPELWM 156 (202)
Q Consensus 84 ~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~--~~~-----~~~~gt~~y~aPe~~~ 156 (202)
+.+.+.|+.|+|.. .+++|+++.|++|.+...+..|++-|+.+......... ... ....-..-|.|||++.
T Consensus 105 l~~v~dgl~flh~s--Ak~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~ 182 (700)
T KOG2137|consen 105 LGNVADGLAFLHRS--AKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLL 182 (700)
T ss_pred hhcccchhhhhccC--cceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhc
Confidence 34555899999984 79999999999999999999999998877643321110 000 0011135699999999
Q ss_pred CCCCCchhhHHHHHHHHHHHH-cCCCCCcch
Q 044746 157 PYSVTQKCDVFSFGMLLFEVV-GRRRNLEKE 186 (202)
Q Consensus 157 ~~~~~~~~Diws~G~~l~el~-~g~~p~~~~ 186 (202)
+..-+.++|++|+|++++.+. .|+.-+...
T Consensus 183 ~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~ 213 (700)
T KOG2137|consen 183 GTTNTPASDVFSLGVLIYTIYNGGKSIIAAN 213 (700)
T ss_pred cccccccccceeeeeEEEEEecCCcchhhcc
Confidence 877889999999999999988 555555443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=97.75 E-value=0.00015 Score=54.79 Aligned_cols=72 Identities=6% Similarity=-0.096 Sum_probs=57.1
Q ss_pred eEEEEEccC-CchhhhhccCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc--eEEeeeecc
Q 044746 55 TYIKGFLAM-GPFYLLCKKNI---LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF--PKAADFGLA 128 (202)
Q Consensus 55 ~~~~~~~~~-~~l~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~--~kl~dfgl~ 128 (202)
.++.+-+.+ .+|..++.... .+......+..+++..+.-||+ .++.|+|+.+.||+++..+. ++++||.-+
T Consensus 101 ~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ia~LH~---~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~ 177 (216)
T PRK09902 101 LLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALAFKKMHS---VNRQHGCCYVRHIYVKTEGKAEAGFLDLEKS 177 (216)
T ss_pred EEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHhheeecCCCCeeEEEEEhhcc
Confidence 355554443 46777775543 4677788999999999999999 99999999999999986666 899999766
Q ss_pred e
Q 044746 129 K 129 (202)
Q Consensus 129 ~ 129 (202)
+
T Consensus 178 r 178 (216)
T PRK09902 178 R 178 (216)
T ss_pred c
Confidence 5
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0025 Score=53.98 Aligned_cols=88 Identities=14% Similarity=0.203 Sum_probs=67.6
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
...++...-.++.|+..||.++|+ .|+.-+-|.+.+|++.++-+++++..|.......+.. +|
T Consensus 388 ~~~~e~~lW~y~~QLtaaL~sIHs---sGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~~--------------~~ 450 (655)
T KOG3741|consen 388 LKAPEEVLWSYISQLTAALYSIHS---SGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDPT--------------EP 450 (655)
T ss_pred CCchHHHHHHHHHHHHHHHHHHHh---cCceeecccHhHeEeeCcceEEEecccceeeecCCCC--------------cc
Confidence 357788899999999999999999 8999999999999999888888886665544332220 11
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCC
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRN 182 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p 182 (202)
+.. -.+-|.-.+|.++..|.||..-
T Consensus 451 --le~---~Qq~D~~~lG~ll~aLAt~~~n 475 (655)
T KOG3741|consen 451 --LES---QQQNDLRDLGLLLLALATGTEN 475 (655)
T ss_pred --hhH---HhhhhHHHHHHHHHHHhhcccc
Confidence 111 1356888999999999999654
|
|
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=97.40 E-value=0.00051 Score=52.19 Aligned_cols=64 Identities=14% Similarity=0.159 Sum_probs=49.3
Q ss_pred eEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 55 TYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 55 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
.+++++++|.++.++.. ++. .+...+..++.-+|+ .|+.|+|..|.|++++.++ ++++||+..+
T Consensus 119 ~ll~EYIeG~~l~d~~~---i~e----~~~~ki~~~ikqlH~---~G~~HGD~hpgNFlv~~~~-i~iID~~~k~ 182 (229)
T PF06176_consen 119 VLLMEYIEGVELNDIED---IDE----DLAEKIVEAIKQLHK---HGFYHGDPHPGNFLVSNNG-IRIIDTQGKR 182 (229)
T ss_pred EEEEEEecCeecccchh---cCH----HHHHHHHHHHHHHHH---cCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence 46888888877755432 222 345667788999999 9999999999999998655 8999998665
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.0014 Score=48.78 Aligned_cols=87 Identities=17% Similarity=0.188 Sum_probs=66.4
Q ss_pred cccccccccccceEEEEEccCCchhh----hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC
Q 044746 43 NFSNLVGSEDTETYIKGFLAMGPFYL----LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF 118 (202)
Q Consensus 43 ~~~~~i~~~~~~~~~~~~~~~~~l~~----~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~ 118 (202)
.+|.++|.-+. .++.++...+++.+ +.+-...+|..+.+++.+++..+++++......+.-.|++++|+.++.++
T Consensus 21 ~~pk~lG~CG~-~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~~~lcDv~~~nfgv~~~~ 99 (188)
T PF12260_consen 21 PFPKLLGSCGR-FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGFFYLCDVSPDNFGVNDDG 99 (188)
T ss_pred CCCCeeeECCC-EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCcEEEeecchHHeEEeCCC
Confidence 56677776544 35666766665542 22334579999999999999999999874445678889999999999999
Q ss_pred ceEEeeeeccee
Q 044746 119 FPKAADFGLAKL 130 (202)
Q Consensus 119 ~~kl~dfgl~~~ 130 (202)
.+|++|......
T Consensus 100 ~lk~iDld~v~~ 111 (188)
T PF12260_consen 100 RLKLIDLDDVFV 111 (188)
T ss_pred cEEEEechhcch
Confidence 999999876654
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.19 E-value=0.00058 Score=53.34 Aligned_cols=69 Identities=19% Similarity=0.130 Sum_probs=49.5
Q ss_pred eEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 55 TYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 55 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
.++|++.++-.|+..- +..+....++..|+.-+.-.-. .|++|+|+++=||+++.+|.+.++||-.+..
T Consensus 183 aVvMe~ieG~eL~~~r----~~~en~~~il~~il~~~~~~~~---~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v~ 251 (304)
T COG0478 183 AVVMEYIEGVELYRLR----LDVENPDEILDKILEEVRKAYR---RGIVHGDLSEFNILVTEDGDIVVIDWPQAVP 251 (304)
T ss_pred eeeeehcccceeeccc----CcccCHHHHHHHHHHHHHHHHH---cCccccCCchheEEEecCCCEEEEeCccccc
Confidence 4889999987775433 1234444455555554443334 8999999999999999999999999976543
|
|
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=96.48 E-value=0.012 Score=45.43 Aligned_cols=31 Identities=19% Similarity=0.258 Sum_probs=26.9
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.|.|++++.++...|+||+.+..
T Consensus 163 ~~l~HgD~~~~Nil~~~~~~~~iIDwe~a~~ 193 (244)
T cd05150 163 LVVTHGDACLPNIIVDPGKFSGFIDLGRLGV 193 (244)
T ss_pred eEEECCCCCCccEEEeCCcEEEEEEcccccc
Confidence 4589999999999999887788999987753
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=96.40 E-value=0.0013 Score=56.93 Aligned_cols=95 Identities=21% Similarity=0.131 Sum_probs=70.9
Q ss_pred HHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCC
Q 044746 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY 158 (202)
Q Consensus 79 ~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~ 158 (202)
+...+.+.-.++++++|+ -.=+|+| ||+... +..+..||+....+.... ......+++.++|||.....
T Consensus 337 ~~~~~~r~et~~l~~l~~---~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~---~~~t~~~~~~~~~pev~~~~ 405 (829)
T KOG0576|consen 337 QFAYPLRKETRPLAELHS---SYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM---KPRTAIGTPEPLAPEVIQEN 405 (829)
T ss_pred hhhhhhhhhccccccccc---ccccCcc----cccccc-cccccccccCCcccCccc---ccccCCCCCCCCCchhhccc
Confidence 344555666788999998 4446777 776654 667999999887665443 23445679999999999999
Q ss_pred CCCchhhHHHHHHHHHHHHcCCCCCc
Q 044746 159 SVTQKCDVFSFGMLLFEVVGRRRNLE 184 (202)
Q Consensus 159 ~~~~~~Diws~G~~l~el~~g~~p~~ 184 (202)
.+....|.|+.+.--.++.-|-+|-.
T Consensus 406 ~~~~~p~~~~~~~~~~~~ap~~pPr~ 431 (829)
T KOG0576|consen 406 TIDGCPDSGSLAVSAIQMAPGLPPRS 431 (829)
T ss_pred ccccCCCccCCCcchhhcCCCCCCCC
Confidence 99999999999986677777776644
|
|
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.23 E-value=0.023 Score=44.08 Aligned_cols=76 Identities=16% Similarity=0.106 Sum_probs=55.7
Q ss_pred ceEEEEEccCCc-hhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecc
Q 044746 54 ETYIKGFLAMGP-FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132 (202)
Q Consensus 54 ~~~~~~~~~~~~-l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~ 132 (202)
..++|+|+.... -.-.++.-.+...+...+..+++..+.-|-.. .+++|+||+.=|||+. ++.+.++|+|-|....
T Consensus 141 nVLvMEfIg~~g~pAP~LkDv~~e~~e~~~~~~~~v~~~~~l~~~--a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 141 NVLVMEFIGDDGLPAPRLKDVPLELEEAEGLYEDVVEYMRRLYKE--AGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID 217 (268)
T ss_pred CeEEEEeccCCCCCCCCcccCCcCchhHHHHHHHHHHHHHHHHHh--cCcccccchhhheEEE-CCeEEEEECccccccC
Confidence 447888886551 11122233344456888888888888777652 7999999999999999 8899999999886544
|
|
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.21 E-value=0.048 Score=43.80 Aligned_cols=32 Identities=22% Similarity=0.326 Sum_probs=27.4
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++||+|+.|.||+++.+....++||+.+..
T Consensus 186 p~~liHgD~~~~Nil~~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 186 PRGVIHADLFRDNVLFEGDRLSGFIDFYFACN 217 (319)
T ss_pred CcccCCCCCCCCcEEEECCceEEEEecccccC
Confidence 36899999999999999776668999998753
|
|
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.18 E-value=0.088 Score=45.33 Aligned_cols=75 Identities=13% Similarity=0.134 Sum_probs=51.5
Q ss_pred ccceEEEEEccCCchhhhh--ccCCCCHHHHHHHHHHHHHHH-HHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecc
Q 044746 52 DTETYIKGFLAMGPFYLLC--KKNILGFGQLREIEVSTSKGI-AYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA 128 (202)
Q Consensus 52 ~~~~~~~~~~~~~~l~~~~--~~~~~~~~~~~~~~~~i~~~l-~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~ 128 (202)
+-..+.+++++|-++.++. +...++. ..++..++.+. .-+-. .|.+|.|..|-||++..++.+.+.|||+.
T Consensus 239 ~~~VLtmE~i~Gi~i~d~~~l~~~g~d~---k~ia~~~~~~f~~q~~~---dgffHaDpHpGNi~v~~~g~i~~lDfGi~ 312 (517)
T COG0661 239 TRRVLTMEWIDGIKISDIAALKSAGIDR---KELAELLVRAFLRQLLR---DGFFHADPHPGNILVRSDGRIVLLDFGIV 312 (517)
T ss_pred CCcEEEEEeeCCEecccHHHHHhcCCCH---HHHHHHHHHHHHHHHHh---cCccccCCCccceEEecCCcEEEEcCcce
Confidence 4445788899988887774 3334443 23333333222 11111 68999999999999999999999999998
Q ss_pred eecc
Q 044746 129 KLYN 132 (202)
Q Consensus 129 ~~~~ 132 (202)
..++
T Consensus 313 g~l~ 316 (517)
T COG0661 313 GRLD 316 (517)
T ss_pred ecCC
Confidence 7654
|
|
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=94.83 E-value=0.13 Score=44.37 Aligned_cols=75 Identities=13% Similarity=0.061 Sum_probs=52.1
Q ss_pred cceEEEEEccCCchhhh--hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc----CCCceEEeeee
Q 044746 53 TETYIKGFLAMGPFYLL--CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD----ENFFPKAADFG 126 (202)
Q Consensus 53 ~~~~~~~~~~~~~l~~~--~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~----~~~~~kl~dfg 126 (202)
...+.|||++|..+.+. +....++...+..-..++..-.-+. .|.+|.|-.|-||++. .++.+.+-|||
T Consensus 276 ~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i~~~l~~~~~~qIf~-----~GffHaDPHPGNilv~~~~~~~~~ivllDhG 350 (538)
T KOG1235|consen 276 KRVLTMEYVDGIKINDLDAIDKRGISPHDILNKLVEAYLEQIFK-----TGFFHADPHPGNILVRPNPEGDEEIVLLDHG 350 (538)
T ss_pred ceEEEEEecCCccCCCHHHHHHcCCCHHHHHHHHHHHHHHHHHh-----cCCccCCCCCCcEEEecCCCCCccEEEEccc
Confidence 34588999999876544 4556677665444433333222222 6899999999999998 36788999999
Q ss_pred cceecc
Q 044746 127 LAKLYN 132 (202)
Q Consensus 127 l~~~~~ 132 (202)
+.....
T Consensus 351 l~~~is 356 (538)
T KOG1235|consen 351 LYAVIS 356 (538)
T ss_pred cccccc
Confidence 987654
|
|
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=94.69 E-value=0.084 Score=43.43 Aligned_cols=53 Identities=17% Similarity=0.133 Sum_probs=44.4
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..+++...++.+.+.-+.-+.. ....=||++.-.||||+ .|++.|+||-++++
T Consensus 318 ~~~~e~lsff~s~~sil~~lek--kf~fehrnlt~~niLId-~GnvtLIDfklsRl 370 (488)
T COG5072 318 DRSEEELSFFWSCISILDILEK--KFPFEHRNLTLDNILID-EGNVTLIDFKLSRL 370 (488)
T ss_pred ccHHHHHHHHHHHHHHHhhhhh--cCCcccccccccceeee-cCceEEEEeeeeec
Confidence 4577888888887776666665 36788999999999999 99999999999984
|
|
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.60 E-value=0.11 Score=41.26 Aligned_cols=32 Identities=22% Similarity=0.189 Sum_probs=27.8
Q ss_pred CCCeEEecCCCCcEEEcCC----CceEEeeeeccee
Q 044746 99 RQKIVHYDIKPESVLLDEN----FFPKAADFGLAKL 130 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~----~~~kl~dfgl~~~ 130 (202)
...++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 178 ~~~lcH~Dl~~~Nil~~~~~~~~~~i~lIDwEya~~ 213 (302)
T cd05156 178 PVVFCHNDLQEGNILLLNPSSETKKLVLIDFEYASY 213 (302)
T ss_pred CceEEecCCCcCeEEecCCCCCCCcEEEEeeCCCCC
Confidence 3678999999999999874 7899999998864
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.56 E-value=0.046 Score=44.29 Aligned_cols=51 Identities=18% Similarity=0.328 Sum_probs=32.3
Q ss_pred HHHHHHHHHHHHHHH-HhCCCCCeEEecCCCCcEEEcCCC------------------ceEEeeeeccee
Q 044746 80 LREIEVSTSKGIAYL-HEECRQKIVHYDIKPESVLLDENF------------------FPKAADFGLAKL 130 (202)
Q Consensus 80 ~~~~~~~i~~~l~~l-H~~~~~~iiHrdlk~~nil~~~~~------------------~~kl~dfgl~~~ 130 (202)
++.+..|++.-.-.. .-.|....+|-||||+|||+-... .++|.||.+++.
T Consensus 281 ikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv 350 (444)
T PHA03111 281 IKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKDATYVFNEPIKACLNDFDFSQV 350 (444)
T ss_pred HHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECCeEEEeccchhhhhcccCHHHH
Confidence 555667776544223 222236789999999999993322 346677777764
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=94.50 E-value=0.039 Score=42.35 Aligned_cols=31 Identities=23% Similarity=0.423 Sum_probs=26.2
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.|++++......++||+.+..
T Consensus 164 ~~l~HGD~~~~Nvlv~~~~i~giIDw~~a~~ 194 (235)
T cd05155 164 PVWFHGDLAPGNLLVQDGRLSAVIDFGCLGV 194 (235)
T ss_pred ceEEeCCCCCCcEEEECCCEEEEEeCcccCc
Confidence 5589999999999998776667999997753
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=94.49 E-value=0.0048 Score=58.70 Aligned_cols=103 Identities=12% Similarity=-0.016 Sum_probs=72.9
Q ss_pred HHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCC
Q 044746 80 LREIEVSTSKGIAYLHEEC--RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMP 157 (202)
Q Consensus 80 ~~~~~~~i~~~l~~lH~~~--~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~ 157 (202)
+.....+...+..-+|+.. ..-.+|++||+-|.+|..+..+++.++|+.+...+.. .......+++.|+.|+....
T Consensus 1337 v~~~~kvsvl~~~~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIknp~~--sf~Gl~l~sp~~v~qli~N~ 1414 (2724)
T KOG1826|consen 1337 VHLRHKVSVLNRNVILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKNPVL--SFFGLELCSPIYVLQLIKNE 1414 (2724)
T ss_pred HHHHHHHHHhccchhhhcccCCccchhhhhhhhccceecCCcccccccccccccCchH--hhhhhhhCCHHHHHHHHHHH
Confidence 3333334344444444321 2345899999999999999999999999998433222 12233456778889988887
Q ss_pred CCCCchhhHHHHHHHHHHHHcCCCCCc
Q 044746 158 YSVTQKCDVFSFGMLLFEVVGRRRNLE 184 (202)
Q Consensus 158 ~~~~~~~Diws~G~~l~el~~g~~p~~ 184 (202)
-.++.++|+|+.|+-+++...|.++|-
T Consensus 1415 ik~t~rsdilr~s~~ly~rs~~n~~fi 1441 (2724)
T KOG1826|consen 1415 IKFTKRSDILRRSLSLYLRSDGNAYFI 1441 (2724)
T ss_pred HhhhhHHHHHHHHHHHHHHhcccHHHH
Confidence 788888999999999999888887763
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.26 E-value=0.082 Score=40.35 Aligned_cols=30 Identities=20% Similarity=0.258 Sum_probs=26.2
Q ss_pred CCeEEecCCCCcEEEcC-CCceEEeeeecce
Q 044746 100 QKIVHYDIKPESVLLDE-NFFPKAADFGLAK 129 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~ 129 (202)
..++|+|+.+.||+++. ++.+.++||..|.
T Consensus 170 ~~l~H~Dl~~~Nil~~~~~~~~~lIDwe~a~ 200 (235)
T cd05157 170 IVFCHNDLLSGNIIYNEEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEEcCCCCcCcEEEeCCCCCEEEEEcccCC
Confidence 46899999999999997 5789999997664
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=94.23 E-value=0.13 Score=41.19 Aligned_cols=32 Identities=28% Similarity=0.452 Sum_probs=28.1
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..+++|+|+.+.|++++.++...++||+.+..
T Consensus 186 ~~~l~HgD~~~~Nvl~~~~~~~~vIDfd~~~~ 217 (307)
T TIGR00938 186 PRGVIHADLFPDNVLFDGDSVKGVIDFYFACT 217 (307)
T ss_pred CCccCCCCCCcCcEEEECCceEEEeecccccC
Confidence 47899999999999999888778999998753
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=94.21 E-value=0.05 Score=41.74 Aligned_cols=39 Identities=26% Similarity=0.304 Sum_probs=33.3
Q ss_pred HHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeec
Q 044746 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127 (202)
Q Consensus 88 ~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl 127 (202)
+++|.-.|++. .+.+|+|..|+||+-+..|.+||.|=+.
T Consensus 151 i~~L~~fH~~~-~~~lHGD~np~NiM~D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 151 IKDLMDFHSEN-QHCLHGDCNPDNIMCDKFGYLKLVDPVC 189 (308)
T ss_pred HHHHHHhhccC-CCeecCCCChhheeecCCCCEEecChhh
Confidence 46788888643 7899999999999999999999999653
|
The function of this family is unknown. |
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=93.87 E-value=0.27 Score=45.99 Aligned_cols=106 Identities=17% Similarity=0.216 Sum_probs=68.9
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCC---cEEEcCCCceEEe--eeecceeccccCcccccCCCCC
Q 044746 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPE---SVLLDENFFPKAA--DFGLAKLYNREHTHITSTGRRR 145 (202)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~---nil~~~~~~~kl~--dfgl~~~~~~~~~~~~~~~~~g 145 (202)
....++....+.+..++.+|+.|+|+ ...-|.-+... +-..+..+....+ ||+.++.......... ...
T Consensus 279 ~v~~i~~~~~r~~~~~~~~GL~~~h~---~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~---~~~ 352 (1351)
T KOG1035|consen 279 SVGSIPLETLRILHQKLLEGLAYLHS---LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFS---DLL 352 (1351)
T ss_pred hccccCHHHHHHHHHHHhhhHHHHHH---hccceeEEecccccccccCccceeecchhhhcccccCCCcccchh---hcC
Confidence 44568899999999999999999998 55545444433 2223344555555 7877765443322111 122
Q ss_pred CCcccCCcccCCCCCCc--hhhHHHHHHHHHHHHcCCCC
Q 044746 146 TPGCEAPELWMPYSVTQ--KCDVFSFGMLLFEVVGRRRN 182 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~--~~Diws~G~~l~el~~g~~p 182 (202)
+..+.+||.......+. ..|+|.+|.....+..|..+
T Consensus 353 ~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~~~~~~~~i 391 (1351)
T KOG1035|consen 353 AEIRNADEDLKENTAKKSRLTDLWCLGLLLLQLSQGEDI 391 (1351)
T ss_pred ccccccccccccccchhhhhhHHHHHHHHHhhhhhcCcc
Confidence 45567777766554443 36999999999988877654
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=93.66 E-value=0.042 Score=41.42 Aligned_cols=31 Identities=26% Similarity=0.341 Sum_probs=21.6
Q ss_pred CCeEEecCCCCcEEEc-CCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLD-ENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~-~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.|.||+++ .++.+.++||+.+..
T Consensus 166 ~~~~HgD~~~~Nil~~~~~~~i~iID~e~a~~ 197 (239)
T PF01636_consen 166 PVLIHGDLHPGNILVDPSDGRIGIIDFEDAGW 197 (239)
T ss_dssp EEEE-SS-SGGGEEEESSTTEEEE--GTT-EE
T ss_pred cEEEEeccccccceeeeccceeEEEecccceE
Confidence 6799999999999999 666668999987643
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=93.63 E-value=0.05 Score=43.14 Aligned_cols=31 Identities=26% Similarity=0.404 Sum_probs=27.4
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
.+++|+|+.|.|++++.++.+.++||+.+..
T Consensus 175 ~~l~HgD~~~~Nil~~~~~~~~iIDfe~a~~ 205 (296)
T cd05153 175 RGVIHADLFRDNVLFDGDELSGVIDFYFACT 205 (296)
T ss_pred CcCCccCcCcccEEEeCCceEEEeehhhhcC
Confidence 5799999999999999887788999987754
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=93.60 E-value=0.19 Score=40.02 Aligned_cols=29 Identities=21% Similarity=0.261 Sum_probs=25.5
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
.+++|+|+.+.|++++. +.+.++||+.+.
T Consensus 187 ~~liHgD~~~~Nil~~~-~~i~lIDfd~~~ 215 (313)
T TIGR02906 187 RGFCHQDYAYHNILLKD-NEVYVIDFDYCT 215 (313)
T ss_pred CceEcCCCCcccEEEeC-CcEEEEECcccc
Confidence 68899999999999987 568899998664
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=93.02 E-value=0.1 Score=40.00 Aligned_cols=29 Identities=14% Similarity=0.069 Sum_probs=25.6
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
..++|+|+.|.|++++..+ +.++||+.+.
T Consensus 153 ~~~~HgD~~~~Nii~~~~~-~~iIDwe~a~ 181 (226)
T TIGR02172 153 STCLHGDFQIGNLITSGKG-TYWIDLGDFG 181 (226)
T ss_pred CceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence 4678999999999999887 8999998775
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=92.94 E-value=0.067 Score=43.57 Aligned_cols=32 Identities=22% Similarity=0.459 Sum_probs=24.0
Q ss_pred CCeEEecCCCCcEEEcC------------------CCceEEeeeecceec
Q 044746 100 QKIVHYDIKPESVLLDE------------------NFFPKAADFGLAKLY 131 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~------------------~~~~kl~dfgl~~~~ 131 (202)
...+|-||||+|||+-. ...++|.||.+|+..
T Consensus 298 ~nF~H~DLKPdNILiFds~~~i~I~~~~~~~vF~Epi~~~LnDFDfSqv~ 347 (434)
T PF05445_consen 298 TNFLHVDLKPDNILIFDSKEPIRIKFGNRNYVFKEPIRCCLNDFDFSQVA 347 (434)
T ss_pred ceeeecccCcCcEEEecCCCceEEEECCeEEEecccceeeecccCHHHhc
Confidence 67899999999999932 224577788877643
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=92.89 E-value=0.093 Score=40.78 Aligned_cols=30 Identities=17% Similarity=0.171 Sum_probs=26.0
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.|.||+++.++ +.++||..+..
T Consensus 146 ~~l~H~Dl~~~Nil~~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 146 LAPLHMDVHAYNLVVTPQG-LKLIDWEYASD 175 (256)
T ss_pred CeeecCCCCcCcEEEeCCC-CEEEeccccCc
Confidence 3589999999999999877 78999988764
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.75 E-value=0.098 Score=38.88 Aligned_cols=30 Identities=13% Similarity=0.145 Sum_probs=25.5
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
.-.+|+|+.|.|++++.++ ++++|++.+..
T Consensus 77 ~~p~H~D~~~~N~~~~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 77 LAPLHMDVHAGNLVHSASG-LRLIDWEYAGD 106 (188)
T ss_pred eeeecCCCCCccEEEECCC-EEEEeCCcccC
Confidence 3558999999999998777 88999998764
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.13 E-value=0.096 Score=39.45 Aligned_cols=31 Identities=26% Similarity=0.391 Sum_probs=21.4
Q ss_pred CCeEEecCCCCcEEE-cCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLL-DENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~-~~~~~~kl~dfgl~~~ 130 (202)
.-++|+|+.+.||++ ..++.++++||..|..
T Consensus 143 ~v~cHnDl~~~Nil~~~~~~~~~lIDfEya~~ 174 (211)
T PF01633_consen 143 LVFCHNDLNPGNILINNKDGEVKLIDFEYAGY 174 (211)
T ss_dssp EEEE-S--SGGGEEETSSSSCEEE--GTT-EE
T ss_pred ceEeeccCccccEEeccCCCeEEEecHHHHhh
Confidence 457899999999999 7889999999987753
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.02 E-value=0.31 Score=39.03 Aligned_cols=32 Identities=25% Similarity=0.218 Sum_probs=28.2
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..+++|+|+.++|++++.++.+.++||..+..
T Consensus 195 ~~~lcHgD~~~~Nvl~~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 195 RTVLVHGKLSLSHFLYDETRGGYFINFEKASF 226 (309)
T ss_pred ceeeeCCCCcHHhEEEcCCCCEEEEEhhhccc
Confidence 36899999999999999988899999987754
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.01 E-value=0.47 Score=38.57 Aligned_cols=28 Identities=36% Similarity=0.603 Sum_probs=25.1
Q ss_pred eEEecCCCCcEEEcCCC-ceEEeeeecce
Q 044746 102 IVHYDIKPESVLLDENF-FPKAADFGLAK 129 (202)
Q Consensus 102 iiHrdlk~~nil~~~~~-~~kl~dfgl~~ 129 (202)
+||.|+.|.||+++.+. .+.++||+-+.
T Consensus 199 iIH~D~~~~NVl~d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLFDDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeEcCCCCeeeEEEccccc
Confidence 99999999999999887 48899999775
|
|
| >PRK06148 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=91.88 E-value=0.4 Score=44.90 Aligned_cols=32 Identities=25% Similarity=0.303 Sum_probs=26.3
Q ss_pred CCCeEEecCCCCcEEEcCCC--ce-EEeeeeccee
Q 044746 99 RQKIVHYDIKPESVLLDENF--FP-KAADFGLAKL 130 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~--~~-kl~dfgl~~~ 130 (202)
..++||.|+.+.||+++.+. .+ -++|||-+..
T Consensus 202 p~~vIHgDln~~NiLv~~~~~~~isGiIDFgDa~~ 236 (1013)
T PRK06148 202 PAQVIHNDANDYNILVDADDGERISGLIDFGDAVH 236 (1013)
T ss_pred CcceECCCCCcccEEEcCCCCcceEEEEECccccc
Confidence 46899999999999998774 44 4999997753
|
|
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=91.78 E-value=0.39 Score=37.89 Aligned_cols=30 Identities=27% Similarity=0.273 Sum_probs=26.9
Q ss_pred CeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 101 KIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 101 ~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
-++|.|+.|.|++.+..+.+.|+||.-|..
T Consensus 154 v~cH~Dl~~~N~l~t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 154 VPCHNDLNPGNLLLTDKGGLFLIDWEYAGL 183 (269)
T ss_pred eeecCCCCccceEEcCCCcEEEEecccCCC
Confidence 489999999999999989999999987753
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=91.53 E-value=0.2 Score=37.43 Aligned_cols=31 Identities=16% Similarity=0.204 Sum_probs=25.5
Q ss_pred CCeEEecCCCCcEEEcCCC-----ceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENF-----FPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~-----~~kl~dfgl~~~ 130 (202)
..++|+|+.+.|+++..++ .+.++||..+..
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~~~ 155 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLSHY 155 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccCCc
Confidence 5789999999999997543 588999987753
|
subfamily of choline kinases |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=91.38 E-value=0.4 Score=39.20 Aligned_cols=31 Identities=19% Similarity=0.303 Sum_probs=26.8
Q ss_pred CCeEEecCCCCcEEEcC-CCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDE-NFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~ 130 (202)
..++|+|+++.||+++. ++.+.++||..+..
T Consensus 200 ~~~cH~Dl~~~Nil~~~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 200 IGFCHNDLQYGNIMIDEETRAITIIDYEYASY 231 (344)
T ss_pred ceEEeCCCCcCcEEEeCCCCcEEEEeehhccc
Confidence 46899999999999976 47899999988864
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=90.90 E-value=0.91 Score=34.11 Aligned_cols=53 Identities=21% Similarity=0.185 Sum_probs=36.9
Q ss_pred chhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC--C--ceEEee
Q 044746 65 PFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN--F--FPKAAD 124 (202)
Q Consensus 65 ~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~--~--~~kl~d 124 (202)
+|..++..+.++. ...... -.-.+||-+ ..|+.+|++|.||++... + .+.++|
T Consensus 109 TL~~~l~~~~~~~-~~~~~L---~~f~~~l~~---~~Iv~~dl~~~NIv~~~~~~~~~~lvlID 165 (199)
T PF10707_consen 109 TLEDYLKEGGLTE-ELRQAL---DEFKRYLLD---HHIVIRDLNPHNIVVQRRDSGEFRLVLID 165 (199)
T ss_pred cHHHHHHcCCccH-HHHHHH---HHHHHHHHH---cCCeecCCCcccEEEEecCCCceEEEEEe
Confidence 6788887777766 333333 334466676 899999999999999632 2 466776
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=90.88 E-value=0.21 Score=39.55 Aligned_cols=31 Identities=32% Similarity=0.484 Sum_probs=25.6
Q ss_pred CCeEEecCCCCcEEEcCCCc-eEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFF-PKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~-~kl~dfgl~~~ 130 (202)
..++|+|+.|.|++++.++. .-++||+.+..
T Consensus 185 ~~lvHGD~~~~Nilv~~~~~~~gviDWe~a~i 216 (276)
T cd05152 185 TVLVHGDLHPGHILIDEDARVTGLIDWTEAKV 216 (276)
T ss_pred CeeEeCCCCCCcEEEeCCCCEEEEECcHhccc
Confidence 45899999999999987454 56999998764
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=90.16 E-value=0.32 Score=39.68 Aligned_cols=67 Identities=10% Similarity=0.027 Sum_probs=43.0
Q ss_pred eEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 55 TYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 55 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
.+++++..+-+|.+.-+-.. .. .+...+..-+--|-. +|+||+|.+-=||+++.++.++++||--..
T Consensus 184 ~Vvmelv~g~Pl~~v~~v~d--~~---~ly~~lm~~Iv~la~---~GlIHgDFNEFNimv~dd~~i~vIDFPQmv 250 (465)
T KOG2268|consen 184 CVVMELVDGYPLRQVRHVED--PP---TLYDDLMGLIVRLAN---HGLIHGDFNEFNIMVKDDDKIVVIDFPQMV 250 (465)
T ss_pred eeHHHhhcccceeeeeecCC--hH---HHHHHHHHHHHHHHH---cCceecccchheeEEecCCCEEEeechHhh
Confidence 36777777777755442221 11 122222222223333 899999999999999999999999996443
|
|
| >PRK06149 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=89.58 E-value=0.63 Score=43.44 Aligned_cols=31 Identities=26% Similarity=0.288 Sum_probs=25.4
Q ss_pred CCCeEEecCCCCcEEEcCCC--c---eEEeeeecce
Q 044746 99 RQKIVHYDIKPESVLLDENF--F---PKAADFGLAK 129 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~--~---~kl~dfgl~~ 129 (202)
..++||.|+.+.||+++.+. . ..++|||-+.
T Consensus 207 ~~g~IH~Dl~~~Nilv~~~~~~~~~v~giIDFgD~~ 242 (972)
T PRK06149 207 PLQAVHLDITDDNVVGSRDADGRWQPDGVIDFGDLV 242 (972)
T ss_pred cccccCCCCCcccEEEcCCCCCCcceeEEEEcccch
Confidence 47899999999999998652 2 4799999765
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=89.42 E-value=0.39 Score=38.81 Aligned_cols=32 Identities=28% Similarity=0.393 Sum_probs=28.7
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeecceec
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~ 131 (202)
..++|+|+.+.|++++..+-+-+.||+++..-
T Consensus 198 ~~lvHGD~~~gNlii~~~~~~gVlDwe~~~lG 229 (321)
T COG3173 198 PVLVHGDYRPGNLIIDPGRPTGVLDWELATLG 229 (321)
T ss_pred ceeeeCCcccCCEEEeCCCeeEEEeccccccC
Confidence 57899999999999998888999999998753
|
|
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=88.01 E-value=1.2 Score=36.00 Aligned_cols=30 Identities=27% Similarity=0.380 Sum_probs=24.9
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++||+|+.+.||+++ + .+.++||+-+..
T Consensus 195 ~~~liHgD~h~~NvL~~-d-~~~iIDFDd~~~ 224 (325)
T PRK11768 195 RLLRLHGDCHPGNILWR-D-GPHFVDLDDARM 224 (325)
T ss_pred CccceecCCCchhcccc-C-CcEEEeCCCCCC
Confidence 36789999999999995 4 578999997753
|
|
| >COG4499 Predicted membrane protein [Function unknown] | Back alignment and domain information |
|---|
Probab=87.65 E-value=2.5 Score=34.78 Aligned_cols=105 Identities=10% Similarity=0.132 Sum_probs=67.4
Q ss_pred EEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC
Q 044746 56 YIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH 135 (202)
Q Consensus 56 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~ 135 (202)
++..+-...+...+-.-..+......+++.+.+..|.-+- +.-.|-=|.|+||+++.+..+.+..+|+-..+.
T Consensus 63 ~vIsy~i~~~~~~F~~~k~~~k~~Klr~a~~~I~~l~e~~----~tr~~~~laPeNilf~~~l~p~~vH~Glk~~lp--- 135 (434)
T COG4499 63 FVISYPIPEAAKSFASAKRKEKTRKLRLALQNIATLSELN----NTRYTFFLAPENILFDGGLTPFFVHRGLKNSLP--- 135 (434)
T ss_pred eEEEecCccccchHHHHHHHHHHHHHHHHHHHHHHHHHhh----ccceeEEecchheEEcCCCceEEEecchhccCC---
Confidence 4444444444444444445566666776777777776544 345566788999999999999999999764321
Q ss_pred cccccCCCCCCCcccCCcccCCCCCCchhhHH-HHHHHHHHHHcCCCCCcchhcc
Q 044746 136 THITSTGRRRTPGCEAPELWMPYSVTQKCDVF-SFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 136 ~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diw-s~G~~l~el~~g~~p~~~~~~~ 189 (202)
|.=+. ..+.| ++-+++..++.|+.+|+.--..
T Consensus 136 -----------Pye~t-----------ee~f~~~ykA~~~~~fn~k~~Fe~l~~g 168 (434)
T COG4499 136 -----------PYEMT-----------EERFLKEYKALAIYAFNGKFSFESLVNG 168 (434)
T ss_pred -----------CCCCC-----------HHHHHHHHHHHHHHHHcCCccHHHHhcc
Confidence 11122 23444 5677778888899888765543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=87.39 E-value=0.56 Score=38.05 Aligned_cols=30 Identities=20% Similarity=0.232 Sum_probs=25.6
Q ss_pred CeEEecCCCCcEEEcC-CCceEEeeeeccee
Q 044746 101 KIVHYDIKPESVLLDE-NFFPKAADFGLAKL 130 (202)
Q Consensus 101 ~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~ 130 (202)
-.+|.|+.+.||+++. ++.++++||..|..
T Consensus 183 v~CHnDl~~~NiL~~~~~~~l~lID~EYag~ 213 (330)
T PLN02421 183 VFAHNDLLSGNLMLNEDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEEECCCCcccEEEeCCCCcEEEEcccccCC
Confidence 3699999999999974 57899999988764
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=84.83 E-value=3.2 Score=34.58 Aligned_cols=30 Identities=20% Similarity=0.049 Sum_probs=24.4
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
...+|.|+-+.||+.+. ..+.++||.-|..
T Consensus 227 ~VfCHNDL~~gNIL~~~-~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILDFN-QGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEecC-CCEEEEEeccccC
Confidence 45699999999998764 4589999987753
|
|
| >PF02958 EcKinase: Ecdysteroid kinase; InterPro: IPR004119 This family includes proteins of unknown function | Back alignment and domain information |
|---|
Probab=83.90 E-value=0.6 Score=36.94 Aligned_cols=31 Identities=23% Similarity=0.234 Sum_probs=25.0
Q ss_pred CCeEEecCCCCcEEEcCC--C---ceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDEN--F---FPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~--~---~~kl~dfgl~~~ 130 (202)
.-++|+|+.+.||++..+ | .+++.||.+++.
T Consensus 215 ~vl~HGD~w~nNilf~~~~~g~~~~~~liDfQ~~~~ 250 (294)
T PF02958_consen 215 NVLCHGDFWTNNILFKYDDDGKPIDVVLIDFQLARY 250 (294)
T ss_pred eEEEcCccCHHhEeEccccccccccceeeccccccC
Confidence 567999999999999654 3 588999987653
|
All known members of this group are proteins from drosophila and Caenorhabditis elegans. |
| >PRK09550 mtnK methylthioribose kinase; Reviewed | Back alignment and domain information |
|---|
Probab=83.69 E-value=2.5 Score=35.35 Aligned_cols=29 Identities=24% Similarity=0.332 Sum_probs=25.0
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
..++|+|+.+.||++..+ .++++|+..+.
T Consensus 223 ~~l~HgDl~~gni~~~~~-~~~viD~E~a~ 251 (401)
T PRK09550 223 EALLHGDLHTGSIFVTEE-ETKVIDPEFAF 251 (401)
T ss_pred CceeeccCCcccEEeeCC-CcEEEeccccc
Confidence 679999999999999765 58999998665
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=82.67 E-value=2.4 Score=32.08 Aligned_cols=41 Identities=24% Similarity=0.214 Sum_probs=32.6
Q ss_pred HHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecc
Q 044746 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA 128 (202)
Q Consensus 80 ~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~ 128 (202)
...-+.++.+-+..+|. .+|+-+|+++.|.. .-+|+|||.+
T Consensus 166 ~~~~~~~~~~dl~~~~k---~gI~~~Dv~~~ny~-----~G~lvDfs~~ 206 (207)
T PF13095_consen 166 QIRDIPQMLRDLKILHK---LGIVPRDVKPRNYR-----GGKLVDFSSS 206 (207)
T ss_pred chhHHHHHHHHHHHHHH---CCeeeccCcccccc-----CCEEEecccC
Confidence 33445677778889998 99999999999986 3489999853
|
|
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=82.60 E-value=1.9 Score=36.40 Aligned_cols=58 Identities=12% Similarity=0.137 Sum_probs=44.6
Q ss_pred EEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc
Q 044746 56 YIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD 115 (202)
Q Consensus 56 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~ 115 (202)
++..+..+-++..+++....+++...+++.-...|+.-|--. -+.+|.|+.|.||++.
T Consensus 322 l~E~~~~Gl~v~~~v~~~~~pe~l~kkva~lg~~AllkMl~v--DNFvHaDlHPGNVlir 379 (565)
T KOG1236|consen 322 LVETYERGLSVLRFVKWKSQPEALVKKVAKLGVNALLKMLIV--DNFVHADLHPGNVLIR 379 (565)
T ss_pred eeeeccccccHHhhhhcccChHHHHHHHHHHHHHHHHHHHHh--hcceecccCCCcEEEE
Confidence 444556666788888777777777888888778887655542 6899999999999995
|
|
Homologous Structure Templates
Structure Templates Detected by BLAST 
Original result of BLAST against Protein Data Bank
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() | |
| Query | 202 | ||||
| 3tl8_A | 349 | The Avrptob-Bak1 Complex Reveals Two Structurally S | 5e-16 | ||
| 3uim_A | 326 | Structural Basis For The Impact Of Phosphorylation | 1e-15 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 2e-14 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-14 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 1e-10 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 4e-10 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 4e-10 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 4e-10 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 4e-10 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 4e-10 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 4e-10 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 4e-10 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 4e-10 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 4e-10 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 6e-10 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 6e-10 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 6e-10 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 1e-09 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-09 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 3e-09 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 3e-09 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-09 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 3e-09 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 3e-09 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 4e-09 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 4e-09 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 5e-09 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 5e-09 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 5e-09 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 6e-09 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 6e-09 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 7e-09 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 7e-09 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 7e-09 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 7e-09 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 7e-09 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 7e-09 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 7e-09 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 7e-09 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 7e-09 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 7e-09 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 7e-09 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 7e-09 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 8e-09 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 8e-09 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-09 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-08 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 1e-08 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 1e-08 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 1e-08 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 1e-08 | ||
| 3q4t_A | 322 | Crystal Structure Of Activin Receptor Type-Iia (Acv | 1e-08 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 2e-08 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 2e-08 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-08 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-08 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 2e-08 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 2e-08 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 2e-08 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 2e-08 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-08 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 2e-08 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 2e-08 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 2e-08 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 2e-08 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 3e-08 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 3e-08 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-08 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 5e-08 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 5e-08 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 7e-08 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 7e-08 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 7e-08 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 8e-08 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 8e-08 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 1e-07 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 1e-07 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 1e-07 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 2e-07 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-07 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 2e-07 | ||
| 2qlu_A | 314 | Crystal Structure Of Activin Receptor Type Ii Kinas | 2e-07 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 3e-07 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 3e-07 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 3e-07 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 3e-07 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 3e-07 | ||
| 3nr9_A | 368 | Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length | 3e-07 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-07 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 3e-07 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-07 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 3e-07 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 3e-07 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 3e-07 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-07 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 4e-07 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 4e-07 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 4e-07 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 4e-07 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 4e-07 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 4e-07 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 4e-07 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 4e-07 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 4e-07 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 4e-07 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 4e-07 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 4e-07 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 4e-07 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 4e-07 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 4e-07 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 5e-07 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 5e-07 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 5e-07 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 5e-07 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 5e-07 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 6e-07 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-07 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 6e-07 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 6e-07 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 6e-07 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 6e-07 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 6e-07 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 6e-07 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 6e-07 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 6e-07 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 6e-07 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 7e-07 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 7e-07 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 7e-07 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 7e-07 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 7e-07 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-07 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 7e-07 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 8e-07 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 8e-07 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 8e-07 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 8e-07 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 8e-07 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 8e-07 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 8e-07 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 9e-07 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 9e-07 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-07 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 9e-07 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 9e-07 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 9e-07 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 9e-07 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 9e-07 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 9e-07 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-07 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 9e-07 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 9e-07 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 9e-07 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-06 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 1e-06 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 1e-06 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-06 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-06 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 1e-06 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 1e-06 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 1e-06 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 1e-06 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 1e-06 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 1e-06 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 1e-06 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 1e-06 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 1e-06 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 1e-06 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 1e-06 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 1e-06 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 1e-06 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 1e-06 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 1e-06 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-06 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-06 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 1e-06 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 1e-06 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 1e-06 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-06 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 1e-06 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 1e-06 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-06 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 1e-06 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-06 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-06 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 1e-06 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 1e-06 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 1e-06 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 1e-06 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 1e-06 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 1e-06 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 1e-06 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 1e-06 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 1e-06 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 1e-06 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-06 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 1e-06 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-06 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-06 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 1e-06 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 1e-06 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-06 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 1e-06 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 1e-06 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 1e-06 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-06 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 1e-06 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 1e-06 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 1e-06 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-06 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 1e-06 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-06 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 1e-06 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 1e-06 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 1e-06 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 1e-06 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 1e-06 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 1e-06 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 1e-06 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-06 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 1e-06 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 1e-06 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 1e-06 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 1e-06 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 1e-06 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 1e-06 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 1e-06 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 1e-06 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 2e-06 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 2e-06 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 2e-06 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 2e-06 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 2e-06 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-06 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-06 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 2e-06 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-06 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-06 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-06 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-06 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-06 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 2e-06 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-06 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 2e-06 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-06 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 2e-06 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 2e-06 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 2e-06 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-06 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 2e-06 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 2e-06 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 2e-06 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 2e-06 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 2e-06 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-06 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 2e-06 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 2e-06 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 3e-06 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-06 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-06 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 3e-06 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 3e-06 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 3e-06 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 3e-06 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 3e-06 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 3e-06 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 3e-06 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-06 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-06 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 3e-06 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-06 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-06 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 4e-06 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 4e-06 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 4e-06 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 4e-06 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 4e-06 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 4e-06 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 4e-06 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 4e-06 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 4e-06 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 4e-06 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 4e-06 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 4e-06 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 4e-06 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-06 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 4e-06 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 4e-06 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 4e-06 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 4e-06 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 5e-06 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 5e-06 | ||
| 3mtf_A | 301 | Crystal Structure Of The Acvr1 Kinase In Complex Wi | 5e-06 | ||
| 4dym_A | 301 | Crystal Structure Of The Acvr1 Kinase Domain In Com | 5e-06 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 5e-06 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 5e-06 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 6e-06 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 6e-06 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 6e-06 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 6e-06 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 6e-06 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 6e-06 | ||
| 3h9r_A | 330 | Crystal Structure Of The Kinase Domain Of Type I Ac | 6e-06 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-06 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 6e-06 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 7e-06 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 1z57_A | 339 | Crystal Structure Of Human Clk1 In Complex With 10z | 7e-06 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 7e-06 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 7e-06 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 7e-06 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 7e-06 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 7e-06 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 7e-06 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 7e-06 | ||
| 3lco_A | 324 | Inhibitor Bound To A Dfg-Out Structure Of The Kinas | 8e-06 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 8e-06 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 8e-06 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 8e-06 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 8e-06 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 8e-06 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-06 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-06 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-06 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-06 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 8e-06 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 8e-06 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 8e-06 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 9e-06 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 9e-06 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 9e-06 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 9e-06 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 9e-06 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 9e-06 | ||
| 2i0v_A | 335 | C-Fms Tyrosine Kinase In Complex With A Quinolone I | 9e-06 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 9e-06 | ||
| 2eu9_A | 355 | Crystal Structure Of Clk3 Length = 355 | 9e-06 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 9e-06 | ||
| 2exe_A | 357 | Crystal Structure Of The Phosphorylated Clk3 Length | 9e-06 | ||
| 2wu6_A | 381 | Crystal Structure Of The Human Clk3 In Complex With | 9e-06 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 1e-05 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 1e-05 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 1e-05 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-05 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-05 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 1e-05 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 1e-05 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 1e-05 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-05 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 1e-05 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-05 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-05 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 1e-05 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-05 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 1e-05 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-05 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 1e-05 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 1e-05 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 1e-05 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-05 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 1e-05 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 1e-05 | ||
| 3my0_A | 305 | Crystal Structure Of The Acvrl1 (Alk1) Kinase Domai | 1e-05 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 1e-05 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 1e-05 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 1e-05 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 1e-05 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-05 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-05 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 1e-05 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 1e-05 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-05 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 1e-05 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-05 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-05 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 2e-05 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 2e-05 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-05 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-05 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 2e-05 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 2e-05 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 2e-05 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-05 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-05 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 2e-05 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 2e-05 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-05 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-05 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 2e-05 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 2e-05 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-05 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 2e-05 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 2e-05 | ||
| 4g5p_A | 330 | Crystal Structure Of Egfr Kinase T790m In Complex W | 2e-05 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 2e-05 | ||
| 3ug1_A | 334 | Crystal Structure Of The Mutated Egfr Kinase Domain | 2e-05 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-05 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-05 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-05 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 2e-05 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 2e-05 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 2e-05 | ||
| 4i24_A | 329 | Structure Of T790m Egfr Kinase Domain Co-crystalliz | 2e-05 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 2e-05 | ||
| 2jit_A | 327 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 2e-05 | ||
| 2jiu_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 2e-05 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 2e-05 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 2e-05 | ||
| 2jiv_A | 328 | Crystal Structure Of Egfr Kinase Domain T790m Mutat | 2e-05 | ||
| 3ika_A | 331 | Crystal Structure Of Egfr 696-1022 T790m Mutant Cov | 2e-05 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 2e-05 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-05 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 3e-05 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-05 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 3e-05 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 3e-05 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 3e-05 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 3e-05 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-05 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 3e-05 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 3e-05 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 3e-05 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 3e-05 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 3e-05 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 3e-05 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 3e-05 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 3e-05 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 3e-05 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 3e-05 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 4e-05 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 4e-05 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 4e-05 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 4e-05 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 4e-05 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 4e-05 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 4e-05 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 4e-05 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 4e-05 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 4e-05 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 4e-05 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 4e-05 | ||
| 1vjy_A | 303 | Crystal Structure Of A Naphthyridine Inhibitor Of H | 4e-05 | ||
| 1b6c_B | 342 | Crystal Structure Of The Cytoplasmic Domain Of The | 4e-05 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 4e-05 | ||
| 1rw8_A | 301 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-05 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 4e-05 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 4e-05 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 4e-05 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 4e-05 | ||
| 1py5_A | 326 | Crystal Structure Of Tgf-Beta Receptor I Kinase Wit | 4e-05 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 4e-05 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 4e-05 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 4e-05 | ||
| 3tzm_A | 309 | Tgf-Beta Receptor Type 1 In Complex With Sb431542 L | 4e-05 | ||
| 2wot_A | 306 | Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl) | 4e-05 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 5e-05 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-05 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 5e-05 | ||
| 3lzb_A | 327 | Egfr Kinase Domain Complexed With An Imidazo[2,1-B] | 5e-05 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-05 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-05 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-05 | ||
| 4hjo_A | 337 | Crystal Structure Of The Inactive Egfr Tyrosine Kin | 5e-05 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 5e-05 | ||
| 3gop_A | 361 | Crystal Structure Of The Egf Receptor Juxtamembrane | 5e-05 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 5e-05 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 5e-05 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 5e-05 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 5e-05 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 5e-05 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 5e-05 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 5e-05 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 5e-05 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-05 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 4g5j_A | 330 | Crystal Structure Of Egfr Kinase In Complex With Bi | 5e-05 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-05 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 5e-05 | ||
| 2gs2_A | 330 | Crystal Structure Of The Active Egfr Kinase Domain | 5e-05 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 5e-05 | ||
| 3vjo_A | 334 | Crystal Structure Of The Wild-Type Egfr Kinase Doma | 5e-05 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 5e-05 | ||
| 2gs7_A | 330 | Crystal Structure Of The Inactive Egfr Kinase Domai | 5e-05 | ||
| 3bel_A | 315 | X-Ray Structure Of Egfr In Complex With Oxime Inhib | 5e-05 | ||
| 2j5f_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 5e-05 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 5e-05 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 6e-05 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 6e-05 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 6e-05 | ||
| 2eb2_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (G7 | 6e-05 | ||
| 2j5e_A | 327 | Crystal Structure Of Egfr Kinase Domain In Complex | 6e-05 | ||
| 4i23_A | 329 | Crystal Structure Of The Wild-type Egfr Kinase Doma | 6e-05 | ||
| 2itn_A | 327 | Crystal Structure Of Egfr Kinase Domain G719s Mutat | 6e-05 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 1xkk_A | 352 | Egfr Kinase Domain Complexed With A Quinazoline Inh | 6e-05 | ||
| 1m14_A | 333 | Tyrosine Kinase Domain From Epidermal Growth Factor | 6e-05 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 6e-05 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 6e-05 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 6e-05 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 6e-05 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 6e-05 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 6e-05 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 3pp0_A | 338 | Crystal Structure Of The Kinase Domain Of Human Her | 6e-05 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 6e-05 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 7e-05 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 7e-05 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 7e-05 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 7e-05 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 7e-05 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 8e-05 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 8e-05 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 8e-05 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 8e-05 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 8e-05 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 8e-05 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 8e-05 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 8e-05 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 8e-05 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 8e-05 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 8e-05 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 9e-05 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 9e-05 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 9e-05 | ||
| 3lxk_A | 327 | Structural And Thermodynamic Characterization Of Th | 9e-05 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 9e-05 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 9e-05 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 1e-04 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-04 | ||
| 3pjc_A | 315 | Crystal Structure Of Jak3 Complexed With A Potent A | 1e-04 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-04 | ||
| 2vag_A | 339 | Crystal Structure Of Di-Phosphorylated Human Clk1 I | 1e-04 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 1e-04 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 1e-04 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 1e-04 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 1e-04 | ||
| 4i1z_A | 329 | Crystal Structure Of The Monomeric (v948r) Form Of | 1e-04 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-04 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 1e-04 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-04 | ||
| 4i21_A | 329 | Crystal Structure Of L858r + T790m Egfr Kinase Doma | 1e-04 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 1e-04 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 1e-04 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 1e-04 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-04 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 1e-04 | ||
| 3w2o_A | 331 | Egfr Kinase Domain T790m/l858r Mutant With Tak-285 | 1e-04 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 1e-04 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 1e-04 | ||
| 1yvj_A | 290 | Crystal Structure Of The Jak3 Kinase Domain In Comp | 1e-04 | ||
| 3g0f_A | 336 | Kit Kinase Domain Mutant D816h In Complex With Suni | 2e-04 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 2e-04 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 2e-04 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-04 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 2e-04 | ||
| 1pkg_A | 329 | Structure Of A C-kit Kinase Product Complex Length | 2e-04 | ||
| 1t45_A | 331 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 2rfd_A | 324 | Crystal Structure Of The Complex Between The Egfr K | 2e-04 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 2e-04 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-04 | ||
| 1t46_A | 313 | Structural Basis For The Autoinhibition And Sti-571 | 2e-04 | ||
| 3g0e_A | 336 | Kit Kinase Domain In Complex With Sunitinib Length | 2e-04 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 2e-04 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 2e-04 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 2e-04 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 2e-04 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 2e-04 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 2e-04 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 2e-04 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 2e-04 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 2e-04 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-04 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 2e-04 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 2e-04 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 2e-04 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 2e-04 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 2e-04 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 2e-04 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 2e-04 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 2e-04 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 2e-04 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 2e-04 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 2e-04 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 2e-04 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 2e-04 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 3e-04 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 3e-04 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 3e-04 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 3e-04 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 3e-04 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 3e-04 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 3e-04 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 3e-04 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 3e-04 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 3e-04 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 3e-04 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 3e-04 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 3e-04 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 3e-04 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 3e-04 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 3e-04 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 3e-04 | ||
| 2eb3_A | 334 | Crystal Structure Of Mutated Egfr Kinase Domain (L8 | 3e-04 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 3e-04 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 3e-04 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 3e-04 | ||
| 4i20_A | 329 | Crystal Structure Of Monomeric (v948r) Primary Onco | 3e-04 | ||
| 2itt_A | 327 | Crystal Structure Of Egfr Kinase Domain L858r Mutat | 3e-04 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 3e-04 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 3e-04 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 3e-04 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 3e-04 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 3e-04 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 3e-04 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 3e-04 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 3e-04 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 3e-04 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 3e-04 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 3e-04 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 4e-04 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 4e-04 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-04 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 4e-04 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 4e-04 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 4e-04 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 4e-04 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 4e-04 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 4e-04 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 4e-04 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 4e-04 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 4e-04 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 4e-04 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 4e-04 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 4e-04 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 4e-04 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 4e-04 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 4e-04 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 4e-04 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-04 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 4e-04 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 4e-04 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 4e-04 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-04 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 4e-04 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 4e-04 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 4e-04 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 4e-04 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 5e-04 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 5e-04 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 5e-04 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 5e-04 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 5e-04 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 5e-04 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 5e-04 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 5e-04 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 5e-04 | ||
| 3mdy_A | 337 | Crystal Structure Of The Cytoplasmic Domain Of The | 5e-04 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 5e-04 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 5e-04 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 5e-04 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 5e-04 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 5e-04 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 5e-04 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 5e-04 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 5e-04 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 5e-04 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 5e-04 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 5e-04 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 5e-04 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 5e-04 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 5e-04 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 5e-04 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 5e-04 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 5e-04 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 5e-04 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 5e-04 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 5e-04 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 5e-04 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 5e-04 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 5e-04 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 6e-04 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 6e-04 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 6e-04 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 6e-04 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 7e-04 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 7e-04 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 7e-04 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 7e-04 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 7e-04 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 7e-04 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 7e-04 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 7e-04 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 8e-04 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 8e-04 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 8e-04 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 8e-04 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 8e-04 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 8e-04 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 9e-04 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-04 | ||
| 2pml_X | 348 | Crystal Structure Of Pfpk7 In Complex With An Atp A | 9e-04 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 9e-04 |
| >pdb|3TL8|A Chain A, The Avrptob-Bak1 Complex Reveals Two Structurally Similar Kinaseinteracting Domains In A Single Type Iii Effector Length = 349 | Back alignment and structure |
|
| >pdb|3UIM|A Chain A, Structural Basis For The Impact Of Phosphorylation On Plant Receptor- Like Kinase Bak1 Activation Length = 326 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357 | Back alignment and structure |
|
| >pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|3MY0|A Chain A, Crystal Structure Of The Acvrl1 (Alk1) Kinase Domain Bound To Ldn- 193189 Length = 305 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328 | Back alignment and structure |
|
| >pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303 | Back alignment and structure |
|
| >pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309 | Back alignment and structure |
|
| >pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330 | Back alignment and structure |
|
| >pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315 | Back alignment and structure |
|
| >pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334 | Back alignment and structure |
|
| >pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327 | Back alignment and structure |
|
| >pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329 | Back alignment and structure |
|
| >pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352 | Back alignment and structure |
|
| >pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3PP0|A Chain A, Crystal Structure Of The Kinase Domain Of Human Her2 (Erbb2). Length = 338 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|4I1Z|A Chain A, Crystal Structure Of The Monomeric (v948r) Form Of The Gefitinib/erlotinib Resistant Egfr Kinase Domain L858r+t790m Length = 329 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|4I21|A Chain A, Crystal Structure Of L858r + T790m Egfr Kinase Domain In Complex With Mig6 Peptide Length = 329 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3W2O|A Chain A, Egfr Kinase Domain T790m/l858r Mutant With Tak-285 Length = 331 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290 | Back alignment and structure |
|
| >pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329 | Back alignment and structure |
|
| >pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331 | Back alignment and structure |
|
| >pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313 | Back alignment and structure |
|
| >pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|2EB3|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (L858r) In Complex With Amppnp Length = 334 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|4I20|A Chain A, Crystal Structure Of Monomeric (v948r) Primary Oncogenic Mutant L858r Egfr Kinase Domain Length = 329 | Back alignment and structure |
|
| >pdb|2ITT|A Chain A, Crystal Structure Of Egfr Kinase Domain L858r Mutation In Complex With Aee788 Length = 327 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST 
Original result of RPS-BLAST against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| Query | 202 | |||
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 4e-38 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 4e-30 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 4e-28 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 4e-26 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 2e-23 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 4e-22 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 8e-22 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 1e-21 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 2e-21 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 7e-21 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 1e-20 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 1e-20 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 2e-20 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 2e-20 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 5e-20 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 2e-19 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 1e-18 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 9e-18 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 6e-17 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 1e-16 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 2e-15 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 5e-15 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 6e-15 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 9e-15 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 1e-14 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 1e-14 | |
| 4apc_A | 350 | Serine/threonine-protein kinase NEK1; transferase; | 2e-14 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 3e-14 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 3e-14 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 5e-14 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 5e-14 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 6e-14 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 6e-14 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 7e-14 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 7e-14 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 8e-14 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 8e-14 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 8e-14 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 1e-13 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 1e-13 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 1e-13 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 2e-13 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 2e-13 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 2e-13 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 2e-13 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 2e-13 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 3e-13 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 4e-13 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 4e-13 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 4e-13 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 4e-13 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 5e-13 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 5e-13 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 6e-13 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 6e-13 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-13 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 8e-13 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 8e-13 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 8e-13 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 9e-13 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 9e-13 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 1e-12 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 1e-12 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 1e-12 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 1e-12 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 1e-12 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 1e-12 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 2e-12 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 2e-12 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 2e-12 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 2e-12 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 2e-12 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 2e-12 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 3e-12 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 3e-12 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 4e-12 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 5e-12 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 7e-12 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 7e-12 | |
| 3pvu_A | 695 | Beta-adrenergic receptor kinase 1; transferase, se | 7e-12 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 8e-12 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 8e-12 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 9e-12 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 1e-11 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 1e-11 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 1e-11 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 1e-11 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 1e-11 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 1e-11 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 1e-11 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 2e-11 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 2e-11 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 2e-11 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 2e-11 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 3e-11 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 3e-11 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 3e-11 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 3e-11 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 4e-11 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 4e-11 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 4e-11 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 5e-11 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 6e-11 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 6e-11 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 6e-11 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 6e-11 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 6e-11 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 6e-11 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 7e-11 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 7e-11 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 1e-10 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 1e-10 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 1e-10 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 1e-10 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 1e-10 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 1e-10 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 1e-10 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 1e-10 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 1e-10 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 1e-10 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 1e-10 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 1e-10 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 1e-10 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 2e-10 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 2e-10 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 2e-10 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 2e-10 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 2e-10 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 2e-10 | |
| 1uu3_A | 310 | HPDK1, 3-phosphoinositide dependent protein kinase | 2e-10 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 2e-10 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 3e-10 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 3e-10 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 3e-10 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 3e-10 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 3e-10 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 3e-10 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 4e-10 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 4e-10 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 5e-10 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 6e-10 | |
| 3g51_A | 325 | Ribosomal protein S6 kinase alpha-3; N-terminal ki | 6e-10 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 6e-10 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 7e-10 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 8e-10 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 8e-10 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 9e-10 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 9e-10 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 9e-10 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 1e-09 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 1e-09 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 1e-09 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 1e-09 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 1e-09 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 1e-09 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 1e-09 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 2e-09 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 2e-09 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 2e-09 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 2e-09 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 2e-09 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 3e-09 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 3e-09 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 3e-09 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 3e-09 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 4e-09 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 4e-09 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 4e-09 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 6e-09 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 7e-09 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 7e-09 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 8e-09 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 8e-09 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 8e-09 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 9e-09 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 9e-09 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 1e-08 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 1e-08 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 2e-08 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 2e-08 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 2e-08 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 2e-08 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 2e-08 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 2e-08 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 2e-08 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 3e-08 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 3e-08 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 3e-08 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 3e-08 | |
| 3v5q_A | 297 | NT-3 growth factor receptor; kinase domain, kinase | 4e-08 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 5e-08 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 5e-08 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 5e-08 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 6e-08 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 7e-08 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 7e-08 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 7e-08 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 7e-08 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 9e-08 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 9e-08 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 9e-08 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 9e-08 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 1e-07 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 1e-07 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 1e-07 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 1e-07 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 1e-07 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 2e-07 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 2e-07 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 2e-07 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 2e-07 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 2e-07 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 2e-07 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 3e-07 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 3e-07 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 3e-07 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 3e-07 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 4e-07 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 4e-07 | |
| 3zzw_A | 289 | Tyrosine-protein kinase transmembrane receptor RO; | 5e-07 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 7e-07 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 8e-07 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 8e-07 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 1e-06 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 2e-06 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 5e-06 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 6e-06 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 8e-05 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 2e-04 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 3e-04 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 4e-04 |
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 133 bits (336), Expect = 4e-38
Identities = 41/112 (36%), Positives = 66/112 (58%), Gaps = 1/112 (0%)
Query: 81 REIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS 140
+ I + +++G+AYLH+ C KI+H D+K ++LLDE F DFGLAKL + + TH+ +
Sbjct: 134 QRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTHV-T 192
Query: 141 TGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQE 192
T R T G APE ++K DVF +G++L E++ +R + +
Sbjct: 193 TAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLARLANDD 244
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 4e-30
Identities = 43/119 (36%), Positives = 68/119 (57%), Gaps = 5/119 (4%)
Query: 82 EIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY-NREHTHITS 140
EI + ++G+ YLH I+H D+K ++LLDENF PK DFG++K + TH+ S
Sbjct: 143 EICIGAARGLHYLHTRA---IIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHL-S 198
Query: 141 TGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKWGR 199
T + T G PE ++ +T+K DV+SFG++LFEV+ R + + + +W
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREMVNLAEWAV 257
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 106 bits (267), Expect = 4e-28
Identities = 39/150 (26%), Positives = 67/150 (44%), Gaps = 12/150 (8%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEE-------CRQKIVHYDIKPESV 112
F G K N++ + +L I + ++G+AYLHE+ + I H DIK ++V
Sbjct: 103 FHEKGSLSDFLKANVVSWNELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNV 162
Query: 113 LLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE-----LWMPYSVTQKCDVF 167
LL N ADFGLA + + + G+ T APE + + D++
Sbjct: 163 LLKNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMY 222
Query: 168 SFGMLLFEVVGRRRNLEKEISEGQEWFPKW 197
+ G++L+E+ R + + E F +
Sbjct: 223 AMGLVLWELASRCTAADGPVDEYMLPFEEE 252
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 101 bits (253), Expect = 4e-26
Identities = 34/107 (31%), Positives = 54/107 (50%), Gaps = 12/107 (11%)
Query: 83 IEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY-NREHTHITST 141
I + GI +LHE +H DIK ++LLDE F K +DFGLA+ T + ++
Sbjct: 138 IAQGAANGINFLHENH---HIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVM-TS 193
Query: 142 GRRRTPGCEAPELWMPYS---VTQKCDVFSFGMLLFEVVGRRRNLEK 185
T APE +T K D++SFG++L E++ +++
Sbjct: 194 RIVGTTAYMAPE----ALRGEITPKSDIYSFGVVLLEIITGLPAVDE 236
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 93.5 bits (233), Expect = 2e-23
Identities = 33/109 (30%), Positives = 58/109 (53%), Gaps = 3/109 (2%)
Query: 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131
+ L + + +KG+ YLH IVH ++K ++L+D+ + K DFGL++L
Sbjct: 131 REQLDERRRLSMAYDVAKGMNYLHN-RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRL- 188
Query: 132 NREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
+ T ++S TP APE+ +K DV+SFG++L+E+ +
Sbjct: 189 -KASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQ 236
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 90.0 bits (224), Expect = 4e-22
Identities = 32/116 (27%), Positives = 57/116 (49%), Gaps = 10/116 (8%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L + +L +I T++G+ YLH + I+H D+K ++ L E+ K DFG
Sbjct: 109 HLHASETKFEMKKLIDIARQTARGMDYLH---AKSIIHRDLKSNNIFLHEDNTVKIGDFG 165
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPEL-----WMPYSVTQKCDVFSFGMLLFEVV 177
LA +R + APE+ PY + + DV++FG++L+E++
Sbjct: 166 LATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPY--SFQSDVYAFGIVLYELM 219
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 88.9 bits (221), Expect = 8e-22
Identities = 34/129 (26%), Positives = 55/129 (42%), Gaps = 12/129 (9%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF 119
F GP + + L V ++G+ YLH+E I+H D+K ++L+ +
Sbjct: 87 FARGGPLNRVLSGKRIPPDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVE 146
Query: 120 P--------KAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGM 171
K DFGLA RE T APE+ ++ DV+S+G+
Sbjct: 147 NGDLSNKILKITDFGLA----REWHRTTKMSAAGAYAWMAPEVIRASMFSKGSDVWSYGV 202
Query: 172 LLFEVVGRR 180
LL+E++
Sbjct: 203 LLWELLTGE 211
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 89.3 bits (222), Expect = 1e-21
Identities = 34/95 (35%), Positives = 55/95 (57%), Gaps = 6/95 (6%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFF-PKAADFGLAKLYNREHTHITSTGRRRT 146
S+G+AYLH + ++H D+KP ++LL K DFG A T + G +
Sbjct: 112 SQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTHMT--NNKG---S 166
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
APE++ + ++KCDVFS+G++L+EV+ RR+
Sbjct: 167 AAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRK 201
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 88.6 bits (220), Expect = 2e-21
Identities = 35/145 (24%), Positives = 67/145 (46%), Gaps = 14/145 (9%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEE-----CRQKIVHYDIKPESVLL 114
+ MG Y + L I +S + G+A+LH E + I H D+K +++L+
Sbjct: 87 YHEMGSLYDYLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV 146
Query: 115 DENFFPKAADFGLAKLYNREHTH--ITSTGRRRTPGCEAPELW------MPYSVTQKCDV 166
+N AD GLA ++++ + + R T APE+ + ++ D+
Sbjct: 147 KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDI 206
Query: 167 FSFGMLLFEVVGRRRNLEKEISEGQ 191
++FG++L+EV RR + + +
Sbjct: 207 WAFGLVLWEVA-RRMVSNGIVEDYK 230
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 86.2 bits (214), Expect = 1e-20
Identities = 33/133 (24%), Positives = 56/133 (42%), Gaps = 19/133 (14%)
Query: 60 FLAMGPFY--LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE- 116
F+ G Y LL K + + + + + + GI Y+ IVH D++ ++ L
Sbjct: 102 FVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQN-QNPPIVHRDLRSPNIFLQSL 160
Query: 117 ----NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWM----PYSVTQKCDVFS 168
K ADFGL+ ++ H + +G APE Y T+K D +S
Sbjct: 161 DENAPVCAKVADFGLS----QQSVH-SVSGLLGNFQWMAPETIGAEEESY--TEKADTYS 213
Query: 169 FGMLLFEVVGRRR 181
F M+L+ ++
Sbjct: 214 FAMILYTILTGEG 226
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 85.7 bits (213), Expect = 1e-20
Identities = 28/118 (23%), Positives = 50/118 (42%), Gaps = 12/118 (10%)
Query: 67 YLLCKKNI-LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
L N + Q + + ++G+A+LH I + + SV++DE+ + +
Sbjct: 99 VLHEGTNFVVDQSQAVKFALDMARGMAFLHT-LEPLIPRHALNSRSVMIDEDMTARISMA 157
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWM--PYSV-TQKCDVFSFGMLLFEVVGRR 180
+ + S GR P APE P + D++SF +LL+E+V R
Sbjct: 158 DVKFSF-------QSPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTRE 208
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 85.9 bits (213), Expect = 2e-20
Identities = 36/145 (24%), Positives = 59/145 (40%), Gaps = 14/145 (9%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEE-----CRQKIVHYDIKPESVLL 114
+ G Y K L + ++ S+ G+ +LH E + I H D+K +++L+
Sbjct: 116 YHENGSLYDYLKSTTLDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV 175
Query: 115 DENFFPKAADFGLAKLY--NREHTHITSTGRRRTPGCEAPELWMPYS------VTQKCDV 166
+N AD GLA + + I R T PE+ D+
Sbjct: 176 KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADM 235
Query: 167 FSFGMLLFEVVGRRRNLEKEISEGQ 191
+SFG++L+EV RR + E Q
Sbjct: 236 YSFGLILWEVA-RRCVSGGIVEEYQ 259
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 85.2 bits (211), Expect = 5e-20
Identities = 29/133 (21%), Positives = 60/133 (45%), Gaps = 13/133 (9%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEE-----CRQKIVHYDIKPESVLL 114
+ G + + + + ++ +ST+ G+A+LH E + I H D+K +++L+
Sbjct: 121 YHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV 180
Query: 115 DENFFPKAADFGLAKLYNREHTH--ITSTGRRRTPGCEAPELWM------PYSVTQKCDV 166
+N AD GLA ++ I R T APE+ + ++ D+
Sbjct: 181 KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADI 240
Query: 167 FSFGMLLFEVVGR 179
++ G++ +E+ R
Sbjct: 241 YAMGLVFWEIARR 253
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 83.2 bits (206), Expect = 2e-19
Identities = 37/130 (28%), Positives = 54/130 (41%), Gaps = 21/130 (16%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+ + + Q + G+AYLH I+H D+ + L+ EN ADFG
Sbjct: 97 IIKSMDSQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFG 153
Query: 127 LAKLYNREHTHIT-------STGRRRTPGCEAPELWM--------PYSVTQKCDVFSFGM 171
LA+L E T ++R P WM Y +K DVFSFG+
Sbjct: 154 LARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPY-WMAPEMINGRSY--DEKVDVFSFGI 210
Query: 172 LLFEVVGRRR 181
+L E++GR
Sbjct: 211 VLCEIIGRVN 220
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 81.0 bits (200), Expect = 1e-18
Identities = 28/143 (19%), Positives = 53/143 (37%), Gaps = 19/143 (13%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEE------CRQKIVHYDIKPESVL 113
+ G + + + S ++G+AYLH E + I H D+ +VL
Sbjct: 93 YYPNGSLXKYLSLHTSDWVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL 152
Query: 114 LDENFFPKAADFGLAKLYNR------EHTHITSTGRRRTPGCEAPE-------LWMPYSV 160
+ + +DFGL+ + T APE L S
Sbjct: 153 VKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESA 212
Query: 161 TQKCDVFSFGMLLFEVVGRRRNL 183
++ D+++ G++ +E+ R +L
Sbjct: 213 LKQVDMYALGLIYWEIFMRCTDL 235
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 78.6 bits (194), Expect = 9e-18
Identities = 30/128 (23%), Positives = 49/128 (38%), Gaps = 20/128 (15%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+ K +L + R+I KG+ YLH + I+H D+K ++V D DFG
Sbjct: 119 VVRDAKIVLDVNKTRQIAQEIVKGMGYLH---AKGILHKDLKSKNVFYDNGKV-VITDFG 174
Query: 127 LAKLYNREHTHITS---TGRRRTPGCEAPELWM-----------PYSVTQKCDVFSFGML 172
L + + APE+ P+S + DVF+ G +
Sbjct: 175 LFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFS--KHSDVFALGTI 232
Query: 173 LFEVVGRR 180
+E+ R
Sbjct: 233 WYELHARE 240
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 76.2 bits (188), Expect = 6e-17
Identities = 31/99 (31%), Positives = 40/99 (40%), Gaps = 9/99 (9%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
Q+ T +A+LH Q +VH D+KP ++ L K DFGL
Sbjct: 158 QVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214
Query: 139 TSTGRRRTPGCEAPELWM-PYSVTQKCDVFSFGMLLFEV 176
G P APEL Y DVFS G+ + EV
Sbjct: 215 VQEG---DPRYMAPELLQGSY--GTAADVFSLGLTILEV 248
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 75.0 bits (185), Expect = 1e-16
Identities = 24/89 (26%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
KG+ Y+H +K+++ D+KP ++ L + K DFGL + S G T
Sbjct: 133 KGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDGKRTRSKG---TLR 186
Query: 149 CEAPELW--MPYSVTQKCDVFSFGMLLFE 175
+PE Y ++ D+++ G++L E
Sbjct: 187 YMSPEQISSQDYG--KEVDLYALGLILAE 213
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 72.9 bits (179), Expect = 2e-15
Identities = 39/176 (22%), Positives = 72/176 (40%), Gaps = 42/176 (23%)
Query: 38 MIAADNFSNLV---GSEDTETYIKGFLAM-----GPFYLLCKKNILGFGQLREIEVSTSK 89
+ +D+ N++ SE T+ ++ ++A+ L+ KN+ + E +
Sbjct: 62 LTESDDHPNVIRYYCSETTDRFL--YIALELCNLNLQDLVESKNVSDENLKLQKEYNPIS 119
Query: 90 -------GIAYLHEECRQKIVHYDIKPESVLLD-------------ENFFPKAADFGLAK 129
G+A+LH KI+H D+KP+++L+ EN +DFGL K
Sbjct: 120 LLRQIASGVAHLHS---LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCK 176
Query: 130 LYNREHTHITSTGRRR--TPGCEAPEL-------WMPYSVTQKCDVFSFGMLLFEV 176
+ + + T G APEL +T+ D+FS G + + +
Sbjct: 177 KLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMGCVFYYI 232
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 71.6 bits (175), Expect = 5e-15
Identities = 18/103 (17%), Positives = 36/103 (34%), Gaps = 21/103 (20%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+ +A LH +VH ++P ++LD+ F S+ + G
Sbjct: 217 RLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGARV---VSSV---SRG 267
Query: 149 CEAPELWMPYS-----------VTQKCDVFSFGMLLFE-VVGR 179
E PEL + +T D ++ G++++
Sbjct: 268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCAD 310
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 6e-15
Identities = 34/115 (29%), Positives = 53/115 (46%), Gaps = 18/115 (15%)
Query: 90 GIAYLHE--ECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRT 146
+ H + ++H D+KP +V LD K DFGLA++ N + + T G T
Sbjct: 123 ALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSFAKTFVG---T 179
Query: 147 PGCEAPELW--MPYSVTQKCDVFSFGMLLFEVVGRRR--------NLEKEISEGQ 191
P +PE M Y+ +K D++S G LL+E+ L +I EG+
Sbjct: 180 PYYMSPEQMNRMSYN--EKSDIWSLGCLLYELCALMPPFTAFSQKELAGKIREGK 232
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 70.0 bits (172), Expect = 9e-15
Identities = 37/121 (30%), Positives = 55/121 (45%), Gaps = 20/121 (16%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPG 148
GI YLH QKI+H DIKP ++L+ E+ K ADFG++ + + + G TP
Sbjct: 149 GIEYLH---YQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSDALLSNTVG---TPA 202
Query: 149 CEAPEL----WMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPK 196
APE +S + DV++ G+ L+ V G+ L +I FP
Sbjct: 203 FMAPESLSETRKIFS-GKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD 261
Query: 197 W 197
Sbjct: 262 Q 262
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 70.4 bits (173), Expect = 1e-14
Identities = 33/118 (27%), Positives = 54/118 (45%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
+ Y H +++IVH D+K E++LLD + K ADFG + + G P
Sbjct: 126 AVQYCH---QKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAFCG---APPY 179
Query: 150 EAPELWM--PYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APEL+ Y + DV+S G++L+ V G + L + + G+ P +
Sbjct: 180 AAPELFQGKKYD-GPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVLRGKYRIPFY 236
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 1e-14
Identities = 33/130 (25%), Positives = 57/130 (43%), Gaps = 26/130 (20%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR--- 145
+ ++Y+H Q I+H D+KP ++ +DE+ K DFGLAK +R + +
Sbjct: 127 EALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGS 183
Query: 146 ---------TPGCEAPELWM---PYSVTQKCDVFSFGMLLFEVV------GRRRNLEKEI 187
T A E+ Y +K D++S G++ FE++ R N+ K++
Sbjct: 184 SDNLTSAIGTAMYVATEVLDGTGHY--NEKIDMYSLGIIFFEMIYPFSTGMERVNILKKL 241
Query: 188 SEGQEWFPKW 197
FP
Sbjct: 242 RSVSIEFPPD 251
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 69.7 bits (171), Expect = 2e-14
Identities = 25/89 (28%), Positives = 49/89 (55%), Gaps = 11/89 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS-TGRRRTPG 148
+ ++H+ +KI+H DIK +++ L ++ + DFG+A++ N + G TP
Sbjct: 137 ALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVELARACIG---TPY 190
Query: 149 CEAPELW--MPYSVTQKCDVFSFGMLLFE 175
+PE+ PY+ K D+++ G +L+E
Sbjct: 191 YLSPEICENKPYN--NKSDIWALGCVLYE 217
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 69.4 bits (170), Expect = 3e-14
Identities = 32/97 (32%), Positives = 48/97 (49%), Gaps = 12/97 (12%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKA--ADFGLAK-LYNREHTHITSTG 142
G+A+LH IVH D+KP ++L+ + + KA +DFGL K L H+ +G
Sbjct: 129 SGLAHLHS---LNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSG 185
Query: 143 RRRTPGCEAPEL---WMPYSVTQKCDVFSFGMLLFEV 176
T G APE+ + T D+FS G + + V
Sbjct: 186 VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYV 222
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 68.6 bits (168), Expect = 3e-14
Identities = 28/112 (25%), Positives = 50/112 (44%), Gaps = 14/112 (12%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
+ +I T + + ++H + I+H D+K E++LL K DFG A + +
Sbjct: 137 TVLKIFYQTCRAVQHMHR-QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYS 195
Query: 139 TSTGRRR----------TPGCEAPELWMPYS---VTQKCDVFSFGMLLFEVV 177
S RR TP PE+ YS + +K D+++ G +L+ +
Sbjct: 196 WSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLC 247
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 68.9 bits (168), Expect = 5e-14
Identities = 34/108 (31%), Positives = 48/108 (44%), Gaps = 14/108 (12%)
Query: 78 GQLREIEVST-----SKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFPKAADFGLAK 129
L+E + T S + YLHE +I+H D+KPE+++L + K D G AK
Sbjct: 116 CGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAK 172
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
++ G T APEL T D +SFG L FE +
Sbjct: 173 ELDQGELCTEFVG---TLQYLAPELLEQKKYTVTVDYWSFGTLAFECI 217
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 5e-14
Identities = 11/91 (12%), Positives = 26/91 (28%), Gaps = 10/91 (10%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+ A L + +VH P+++ + + D +S
Sbjct: 205 RLAANLQ---SKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVG-TRGPASSV----PVT 256
Query: 149 CEAPELWMP--YSVTQKCDVFSFGMLLFEVV 177
E + T + + G+ ++ V
Sbjct: 257 YAPREFLNASTATFTHALNAWQLGLSIYRVW 287
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 68.5 bits (167), Expect = 6e-14
Identities = 17/98 (17%), Positives = 35/98 (35%), Gaps = 12/98 (12%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR-TP 147
+ +A LH +VH ++P ++LD+ F + ++ GR P
Sbjct: 222 RLLASLH---HYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDG--ASAVSPIGRGFAPP 276
Query: 148 GCEAPELW-----MPYSVTQKCDVFSFGMLLFE-VVGR 179
A + P +T D ++ G+ ++
Sbjct: 277 ETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCAD 314
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 68.0 bits (166), Expect = 6e-14
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 17/99 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE-----HTHITSTGR 143
+ + +LH + ++H D+KP ++ + K DFGL +++
Sbjct: 175 EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 144 RRTPGC-----EAPELW--MPYSVTQKCDVFSFGMLLFE 175
T +PE YS K D+FS G++LFE
Sbjct: 232 THTGQVGTKLYMSPEQIHGNNYS--HKVDIFSLGLILFE 268
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 67.7 bits (166), Expect = 7e-14
Identities = 25/89 (28%), Positives = 44/89 (49%), Gaps = 11/89 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPG 148
+ ++H ++++H DIKP +V + K D GL + ++ + T + G TP
Sbjct: 148 ALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTTAAHSLVG---TPY 201
Query: 149 CEAPELWM--PYSVTQKCDVFSFGMLLFE 175
+PE Y+ K D++S G LL+E
Sbjct: 202 YMSPERIHENGYN--FKSDIWSLGCLLYE 228
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 67.8 bits (166), Expect = 7e-14
Identities = 27/143 (18%), Positives = 52/143 (36%), Gaps = 28/143 (19%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-- 136
Q+ + + +G+ +H + H D+KP ++LL + P D G
Sbjct: 135 QILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGS 191
Query: 137 --------HITSTGRRRTPGCEAPELWMPYS---VTQKCDVFSFGMLL---------FEV 176
T APEL+ S + ++ DV+S G +L +++
Sbjct: 192 RQALTLQDWAAQRC---TISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248
Query: 177 VGRRRNLEKEISEGQEWFPKWGR 199
V ++ + + Q P+ R
Sbjct: 249 VFQKGDSVALAVQNQLSIPQSPR 271
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 67.3 bits (165), Expect = 8e-14
Identities = 27/94 (28%), Positives = 44/94 (46%), Gaps = 16/94 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+ I LH+ IVH D+KPE++LLD++ K DFG + + G TP
Sbjct: 135 EVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEKLREVCG---TPS 188
Query: 149 CEAPE--------LWMPYSVTQKCDVFSFGMLLF 174
APE Y ++ D++S G++++
Sbjct: 189 YLAPEIIECSMNDNHPGYG--KEVDMWSTGVIMY 220
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 67.5 bits (165), Expect = 8e-14
Identities = 32/91 (35%), Positives = 45/91 (49%), Gaps = 9/91 (9%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL--DENFFPKAADFGLAKLYNREHTHITSTGRRR-- 145
+ YLH Q I H DIKPE+ L +++F K DFGL+K + + + +
Sbjct: 180 ALHYLHN---QGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAG 236
Query: 146 TPGCEAPELW--MPYSVTQKCDVFSFGMLLF 174
TP APE+ S KCD +S G+LL
Sbjct: 237 TPYFVAPEVLNTTNESYGPKCDAWSAGVLLH 267
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 68.2 bits (167), Expect = 8e-14
Identities = 32/90 (35%), Positives = 47/90 (52%), Gaps = 12/90 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
GI Y+H+ KIVH D+KPE++LL ++ + DFGL+ + G
Sbjct: 137 SGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIG--- 190
Query: 146 TPGCEAPE-LWMPYSVTQKCDVFSFGMLLF 174
T APE L Y +KCDV+S G++L+
Sbjct: 191 TAYYIAPEVLHGTYD--EKCDVWSTGVILY 218
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 66.8 bits (164), Expect = 1e-13
Identities = 37/118 (31%), Positives = 59/118 (50%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
+ Y H R +VH D+KPE+VLLD + K ADFGL+ + + TS G +P
Sbjct: 123 AVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG---SPNY 176
Query: 150 EAPELWM--PYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ Y+ + D++S G++L+ + G L K+I G + P++
Sbjct: 177 AAPEVISGRLYA-GPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY 233
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 67.4 bits (165), Expect = 1e-13
Identities = 32/94 (34%), Positives = 44/94 (46%), Gaps = 16/94 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+ YLHE I+H D+KPE+VLL +E+ K DFG +K+ T G
Sbjct: 250 LAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG--- 303
Query: 146 TPGCEAPE-----LWMPYSVTQKCDVFSFGMLLF 174
TP APE Y + D +S G++LF
Sbjct: 304 TPTYLAPEVLVSVGTAGY--NRAVDCWSLGVILF 335
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 66.5 bits (163), Expect = 2e-13
Identities = 26/90 (28%), Positives = 41/90 (45%), Gaps = 12/90 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+AY H+ + H D+KPE+ L + K DFGLA + T G
Sbjct: 117 SAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVG--- 170
Query: 146 TPGCEAPE-LWMPYSVTQKCDVFSFGMLLF 174
TP +P+ L Y +CD +S G++++
Sbjct: 171 TPYYVSPQVLEGLYG--PECDEWSAGVMMY 198
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 67.0 bits (164), Expect = 2e-13
Identities = 33/90 (36%), Positives = 49/90 (54%), Gaps = 12/90 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
G+ YLH+ IVH D+KPE++LL +++ K DFGL+ ++ + G
Sbjct: 147 SGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLG--- 200
Query: 146 TPGCEAPE-LWMPYSVTQKCDVFSFGMLLF 174
T APE L Y +KCDV+S G++LF
Sbjct: 201 TAYYIAPEVLRKKYD--EKCDVWSIGVILF 228
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 66.6 bits (163), Expect = 2e-13
Identities = 32/89 (35%), Positives = 48/89 (53%), Gaps = 12/89 (13%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRT 146
GI Y+H+ IVH D+KPE++LL +++ K DFGL+ + + G T
Sbjct: 133 GITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG---T 186
Query: 147 PGCEAPE-LWMPYSVTQKCDVFSFGMLLF 174
APE L Y +KCDV+S G++L+
Sbjct: 187 AYYIAPEVLRGTYD--EKCDVWSAGVILY 213
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-13
Identities = 30/88 (34%), Positives = 47/88 (53%), Gaps = 10/88 (11%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRT 146
+AY H Q +VH D+KPE++L + K DFGLA+L+ + + G T
Sbjct: 136 ALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAG---T 189
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLF 174
APE+ VT KCD++S G++++
Sbjct: 190 ALYMAPEV-FKRDVTFKCDIWSAGVVMY 216
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 66.1 bits (162), Expect = 2e-13
Identities = 42/118 (35%), Positives = 62/118 (52%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
I Y H R KIVH D+KPE++LLD+N K ADFGL+ + + TS G +P
Sbjct: 120 AIEYCH---RHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSCG---SPNY 173
Query: 150 EAPELWM--PYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ Y+ + DV+S G++L+ +VGR NL K+++ P +
Sbjct: 174 AAPEVINGKLYA-GPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF 230
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 65.9 bits (161), Expect = 3e-13
Identities = 32/115 (27%), Positives = 48/115 (41%), Gaps = 17/115 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
+ YL + I+H DIK E++++ E+F K DFG A R T G T
Sbjct: 142 AVGYLR---LKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLFYTFCG---TIEY 195
Query: 150 EAPELWM--PYSVTQKCDVFSFGMLLFE-VVGRRRNL----EKEISEGQEWFPKW 197
APE+ M PY + +++S G+ L+ V +E E P
Sbjct: 196 CAPEVLMGNPYR-GPELEMWSLGVTLYTLVFEE---NPFCELEETVEAAIHPPYL 246
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 66.3 bits (162), Expect = 4e-13
Identities = 33/89 (37%), Positives = 49/89 (55%), Gaps = 12/89 (13%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRT 146
GI YLH+ IVH DIKPE++LL + K DFGL+ +++++ G T
Sbjct: 158 GICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLG---T 211
Query: 147 PGCEAPE-LWMPYSVTQKCDVFSFGMLLF 174
APE L Y +KCDV+S G++++
Sbjct: 212 AYYIAPEVLKKKY--NEKCDVWSCGVIMY 238
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 65.8 bits (161), Expect = 4e-13
Identities = 32/93 (34%), Positives = 44/93 (47%), Gaps = 16/93 (17%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRT 146
+ YLHE I+H D+KPE+VLL +E+ K DFG +K+ T G T
Sbjct: 126 AVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCG---T 179
Query: 147 PGCEAPE-----LWMPYSVTQKCDVFSFGMLLF 174
P APE Y + D +S G++LF
Sbjct: 180 PTYLAPEVLVSVGTAGY--NRAVDCWSLGVILF 210
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-13
Identities = 30/116 (25%), Positives = 48/116 (41%), Gaps = 15/116 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
+ Y H +K++H DIKPE++L+ K ADFG + T G T
Sbjct: 126 ALHYCH---ERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLRRR-TMCG---TLDY 178
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
PE+ + +K D++ G+L +E +VG + I FP +
Sbjct: 179 LPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNVDLKFPPF 234
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 65.3 bits (160), Expect = 4e-13
Identities = 32/90 (35%), Positives = 48/90 (53%), Gaps = 12/90 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
GI Y+H+ IVH D+KPE++LL +++ K DFGL+ + + G
Sbjct: 132 SGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIG--- 185
Query: 146 TPGCEAPE-LWMPYSVTQKCDVFSFGMLLF 174
T APE L Y +KCDV+S G++L+
Sbjct: 186 TAYYIAPEVLRGTYD--EKCDVWSAGVILY 213
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 65.5 bits (160), Expect = 5e-13
Identities = 28/94 (29%), Positives = 46/94 (48%), Gaps = 16/94 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+ +++LH IVH D+KPE++LLD+N + +DFG + G TPG
Sbjct: 211 EAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEKLRELCG---TPG 264
Query: 149 CEAPE--------LWMPYSVTQKCDVFSFGMLLF 174
APE Y ++ D+++ G++LF
Sbjct: 265 YLAPEILKCSMDETHPGYG--KEVDLWACGVILF 296
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 65.1 bits (159), Expect = 5e-13
Identities = 24/99 (24%), Positives = 41/99 (41%), Gaps = 17/99 (17%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+ + +LH + ++H D+KP ++ + K DFGL +++ T
Sbjct: 129 EAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 185
Query: 149 CE----------APELW--MPYSVTQKCDVFSFGMLLFE 175
+PE YS K D+FS G++LFE
Sbjct: 186 RHTGQVGTKLYMSPEQIHGNSYS--HKVDIFSLGLILFE 222
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 65.6 bits (160), Expect = 6e-13
Identities = 38/118 (32%), Positives = 61/118 (51%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
G+ Y H R +VH D+KPE+VLLD + K ADFGL+ + + TS G +P
Sbjct: 128 GVDYCH---RHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTSCG---SPNY 181
Query: 150 EAPELWM--PYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ Y+ + D++S G++L+ + G L K+I +G + P++
Sbjct: 182 AAPEVISGRLYA-GPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY 238
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 65.0 bits (159), Expect = 6e-13
Identities = 34/157 (21%), Positives = 57/157 (36%), Gaps = 37/157 (23%)
Query: 47 LVGSEDTETYIKGFLAM----GPFYLLCKKNILGFGQLREIEVST-----SKGIAYLHEE 97
L E T+ YI ++ M KK + E + + + +H+
Sbjct: 93 LYDYEITDQYI--YMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ- 145
Query: 98 CRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI---TSTGRRRTPGCEAPEL 154
IVH D+KP + L+ + K DFG+A + T + + G T PE
Sbjct: 146 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVG---TVNYMPPEA 199
Query: 155 WM-----------PYSVTQKCDVFSFGMLLFE-VVGR 179
++ K DV+S G +L+ G+
Sbjct: 200 IKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 64.8 bits (158), Expect = 8e-13
Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 18/100 (18%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
G+ +L E IVH +IKP +++ D K DFG A+ + ++ G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG--- 177
Query: 146 TPGCEAPELWMPYSV--------TQKCDVFSFGMLLFEVV 177
T P+++ + D++S G+ +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 64.9 bits (158), Expect = 8e-13
Identities = 21/100 (21%), Positives = 39/100 (39%), Gaps = 18/100 (18%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
G+ +L E IVH +IKP +++ D K DFG A+ + ++ G
Sbjct: 124 GMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYG--- 177
Query: 146 TPGCEAPELWMPYSV--------TQKCDVFSFGMLLFEVV 177
T P+++ + D++S G+ +
Sbjct: 178 TEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAA 217
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 64.5 bits (158), Expect = 8e-13
Identities = 32/140 (22%), Positives = 52/140 (37%), Gaps = 32/140 (22%)
Query: 78 GQLREIEVST-----SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
E E G+ YLH I+H D+ ++LL N K ADFGLA
Sbjct: 107 KPFSENEARHFMHQIITGMLYLH---SHGILHRDLTLSNLLLTRNMNIKIADFGLA---- 159
Query: 133 REHTHITSTGRRR-----TPGCEAPELWM--PYSVTQKCDVFSFGMLLFE-VVGR----- 179
T + + TP +PE+ + + DV+S G + + ++GR
Sbjct: 160 ---TQLKMPHEKHYTLCGTPNYISPEIATRSAHG--LESDVWSLGCMFYTLLIGRPPFDT 214
Query: 180 --RRNLEKEISEGQEWFPKW 197
+N ++ P +
Sbjct: 215 DTVKNTLNKVVLADYEMPSF 234
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 65.2 bits (159), Expect = 8e-13
Identities = 31/132 (23%), Positives = 55/132 (41%), Gaps = 14/132 (10%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
+ + L + S + YL + + +H ++ + L+ EN K ADFGL++L
Sbjct: 311 NRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRL 367
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190
T+ G + APE + K DV++FG+LL+E+ + G
Sbjct: 368 MT-GDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA----------TYG 416
Query: 191 QEWFPKWGREEV 202
+P +V
Sbjct: 417 MSPYPGIDLSQV 428
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 9e-13
Identities = 31/116 (26%), Positives = 48/116 (41%), Gaps = 19/116 (16%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFP-KAADFGLAKLYNREHTHITSTGRRRTPG 148
+ + H ++H DIK E++L+D N K DFG L G T
Sbjct: 161 AVRHCH---NCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYT-DFDG---TRV 213
Query: 149 CEAPELWM--PYSVTQKCDVFSFGMLLFE-VVGRRRNL----EKEISEGQEWFPKW 197
PE Y + V+S G+LL++ V G + ++EI GQ +F +
Sbjct: 214 YSPPEWIRYHRYH-GRSAAVWSLGILLYDMVCGD---IPFEHDEEIIRGQVFFRQR 265
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 64.7 bits (158), Expect = 9e-13
Identities = 33/154 (21%), Positives = 56/154 (36%), Gaps = 31/154 (20%)
Query: 47 LVGSEDTETYIKGFLAM----GPFYLLCKKNILGFGQLREIEVST-----SKGIAYLHEE 97
L E T+ YI ++ M KK + E + + + +H+
Sbjct: 74 LYDYEITDQYI--YMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ- 126
Query: 98 CRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL--- 154
IVH D+KP + L+ + K DFG+A + T + + T PE
Sbjct: 127 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKD 183
Query: 155 --------WMPYSVTQKCDVFSFGMLLFE-VVGR 179
++ K DV+S G +L+ G+
Sbjct: 184 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 64.6 bits (158), Expect = 1e-12
Identities = 32/140 (22%), Positives = 58/140 (41%), Gaps = 21/140 (15%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L + L L ++ + G+ YL + +H D+ + L+ E K +DFG
Sbjct: 202 FLRTEGARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFG 258
Query: 127 LAKLYNREHTHITSTGRRRTP----GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRN 182
+++ + + S G R+ P APE + + DV+SFG+LL+E
Sbjct: 259 MSR-EEADGVYAASGGLRQVPVKWT---APEALNYGRYSSESDVWSFGILLWETF----- 309
Query: 183 LEKEISEGQEWFPKWGREEV 202
S G +P ++
Sbjct: 310 -----SLGASPYPNLSNQQT 324
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 64.3 bits (157), Expect = 1e-12
Identities = 33/116 (28%), Positives = 48/116 (41%), Gaps = 19/116 (16%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
I + H + +VH DIK E++L+D K DFG L + E G T
Sbjct: 151 AIQHCH---SRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEPYT-DFDG---TRV 203
Query: 149 CEAPELWM--PYSVTQKCDVFSFGMLLFE-VVGRRRNL----EKEISEGQEWFPKW 197
PE Y V+S G+LL++ V G + ++EI E + FP
Sbjct: 204 YSPPEWISRHQYH-ALPATVWSLGILLYDMVCGD---IPFERDQEILEAELHFPAH 255
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 1e-12
Identities = 27/156 (17%), Positives = 46/156 (29%), Gaps = 35/156 (22%)
Query: 51 EDTETYIK-GFLAMGPFYLLCKKNILGFGQLREIEVST-----SKGIAYLHEECRQKIVH 104
ED I+ + G +N +E E+ +G+ Y+H +VH
Sbjct: 82 EDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVH 138
Query: 105 YDIKPESVLLDEN-------------------FFPKAADFGLAKLYNREHTHITSTGRRR 145
DIKP ++ + K D G + G
Sbjct: 139 MDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQVE---EG--- 192
Query: 146 TPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRR 180
A E+ Y+ K D+F+ + + G
Sbjct: 193 DSRFLANEVLQENYTHLPKADIFALALTVVCAAGAE 228
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 1e-12
Identities = 28/118 (23%), Positives = 47/118 (39%), Gaps = 19/118 (16%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
+Y+H + I H D+KP ++L+D+N K +DFG ++ + S G T
Sbjct: 163 SFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIK-GSRG---TYEF 216
Query: 150 EAPELWM---PYSVTQKCDVFSFGMLLFE-VVGR--------RRNLEKEISEGQEWFP 195
PE + Y+ K D++S G+ L+ L I +P
Sbjct: 217 MPPEFFSNESSYN-GAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYP 273
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 1e-12
Identities = 32/116 (27%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
++Y H ++++H DIKPE++LL K ADFG + + G T
Sbjct: 121 ALSYCH---SKRVIHRDIKPENLLLGSAGELKIADFGWSV-HAPSSRRTDLCG---TLDY 173
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
PE+ +K D++S G+L +E +VG+ + K IS + FP +
Sbjct: 174 LPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRVEFTFPDF 229
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 64.5 bits (157), Expect = 1e-12
Identities = 32/154 (20%), Positives = 55/154 (35%), Gaps = 31/154 (20%)
Query: 47 LVGSEDTETYIKGFLAM----GPFYLLCKKNILGFGQLREIEVST-----SKGIAYLHEE 97
L E T+ YI ++ M KK + E + + + +H+
Sbjct: 121 LYDYEITDQYI--YMVMECGNIDLNSWLKK----KKSIDPWERKSYWKNMLEAVHTIHQ- 173
Query: 98 CRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL--- 154
IVH D+KP + L+ + K DFG+A + T + + PE
Sbjct: 174 --HGIVHSDLKPANFLIVDGML-KLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKD 230
Query: 155 --------WMPYSVTQKCDVFSFGMLLFE-VVGR 179
++ K DV+S G +L+ G+
Sbjct: 231 MSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 63.8 bits (156), Expect = 2e-12
Identities = 36/136 (26%), Positives = 57/136 (41%), Gaps = 24/136 (17%)
Query: 78 GQLREIEVST-----SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLY 131
L E E G YLH R +++H D+K ++ L+E+ K DFGLA K+
Sbjct: 110 KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 166
Query: 132 NREHTHITSTGRRRTPGCEAPELWM--PYSVTQKCDVFSFGMLLFE-VVGR-------RR 181
G TP APE+ +S + DV+S G +++ +VG+ +
Sbjct: 167 YDGERKKVLCG---TPNYIAPEVLSKKGHS--FEVDVWSIGCIMYTLLVGKPPFETSCLK 221
Query: 182 NLEKEISEGQEWFPKW 197
I + + PK
Sbjct: 222 ETYLRIKKNEYSIPKH 237
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-12
Identities = 33/140 (23%), Positives = 51/140 (36%), Gaps = 16/140 (11%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL KN + Q + V KG+ YL ++ VH D+ +VL++ K DFG
Sbjct: 115 YLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFG 171
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV--G 178
L K + + T R +P W S DV+SFG+ L E++
Sbjct: 172 LTKAIETDKEYYTVKDDRDSPVF-----WYAPECLMQSKFYIASDVWSFGVTLHELLTYC 226
Query: 179 RRRNLEKEISEGQEWFPKWG 198
+ +
Sbjct: 227 DSDSSPMALFLKMIGPTHGQ 246
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-12
Identities = 34/120 (28%), Positives = 56/120 (46%), Gaps = 18/120 (15%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
G+ LH ++IV+ D+KPE++LLD++ + +D GLA T G T G
Sbjct: 298 GLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQTIKGRVG---TVGY 351
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-----------RRNLEKEISEGQEWFPKW 197
APE+ T D ++ G LL+E + G+ R +E+ + E E + +
Sbjct: 352 MAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVPEEYSER 411
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 64.4 bits (157), Expect = 2e-12
Identities = 34/122 (27%), Positives = 57/122 (46%), Gaps = 21/122 (17%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
G+ +LH+ + I++ D+KPE+VLLD++ + +D GLA + T G TP
Sbjct: 301 GLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVE-LKAGQTKTKGYAG---TP 353
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-----------RRNLEKEISEGQEWFP 195
G APEL + D F+ G+ L+E + R + L++ + E +P
Sbjct: 354 GFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGEKVENKELKQRVLEQAVTYP 413
Query: 196 KW 197
Sbjct: 414 DK 415
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 63.9 bits (156), Expect = 2e-12
Identities = 36/108 (33%), Positives = 54/108 (50%), Gaps = 21/108 (19%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL-AKLYNREHTH 137
L +I ++T K + +L E KI+H DIKP ++LLD + K DFG+ +L
Sbjct: 126 ILGKITLATVKALNHLKEN--LKIIHRDIKPSNILLDRSGNIKLCDFGISGQL------- 176
Query: 138 ITSTGRRRTPGCE---APE------LWMPYSVTQKCDVFSFGMLLFEV 176
+ S + R GC APE Y V + DV+S G+ L+E+
Sbjct: 177 VDSIAKTRDAGCRPYMAPERIDPSASRQGYDV--RSDVWSLGITLYEL 222
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 63.8 bits (155), Expect = 2e-12
Identities = 19/126 (15%), Positives = 37/126 (29%), Gaps = 19/126 (15%)
Query: 66 FYLLCKKNILGFGQLREIEVST-----SKGIAYLHEECRQKIVHYDIKPESVLLDENFFP 120
+ + + V + I +H+ +I+H DIKP++ +L F
Sbjct: 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLE 211
Query: 121 -----------KAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSF 169
D G + T + T G + E+ + D F
Sbjct: 212 QDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGV 271
Query: 170 GMLLFE 175
++
Sbjct: 272 AATVYC 277
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 63.1 bits (154), Expect = 3e-12
Identities = 35/136 (25%), Positives = 56/136 (41%), Gaps = 24/136 (17%)
Query: 78 GQLREIEVST-----SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
L E E G YLH R +++H D+K ++ L+E+ K DFGLA
Sbjct: 136 KALTEPEARYYLRQIVLGCQYLH---RNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVE 192
Query: 133 RE-HTHITSTGRRRTPGCEAPELWM--PYSVTQKCDVFSFGMLLFE-VVGR-------RR 181
+ G TP APE+ +S + DV+S G +++ +VG+ +
Sbjct: 193 YDGERKKVLCG---TPNYIAPEVLSKKGHS--FEVDVWSIGCIMYTLLVGKPPFETSCLK 247
Query: 182 NLEKEISEGQEWFPKW 197
I + + PK
Sbjct: 248 ETYLRIKKNEYSIPKH 263
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 62.6 bits (153), Expect = 3e-12
Identities = 37/122 (30%), Positives = 53/122 (43%), Gaps = 21/122 (17%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTHITSTGRRRT 146
G+ YLH I H DIKPE++LLDE K +DFGLA ++ NRE G T
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG---T 170
Query: 147 PGCEAPELWM--PYSVTQKCDVFSFGMLL---------FEVVGRRRNLEKEISEGQEWFP 195
APEL + + DV+S G++L ++ + E + +
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 196 KW 197
W
Sbjct: 230 PW 231
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 62.7 bits (153), Expect = 4e-12
Identities = 31/89 (34%), Positives = 48/89 (53%), Gaps = 9/89 (10%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+ +AYLHE IVH D+KPE++L + K ADFGL+K+ + T G
Sbjct: 159 EAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCG--- 212
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
TPG APE+ + + D++S G++ +
Sbjct: 213 TPGYCAPEILRGCAYGPEVDMWSVGIITY 241
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 62.3 bits (152), Expect = 5e-12
Identities = 35/122 (28%), Positives = 53/122 (43%), Gaps = 21/122 (17%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR---EHTHITSTGRRRT 146
G+ YLH Q IVH DIKP ++LL K + G+A+ + + T TS G +
Sbjct: 121 GLEYLH---SQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQG---S 174
Query: 147 PGCEAPELWM---PYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFP 195
P + PE+ +S K D++S G+ L+ G L + I +G P
Sbjct: 175 PAFQPPEIANGLDTFS-GFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYAIP 233
Query: 196 KW 197
Sbjct: 234 GD 235
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 7e-12
Identities = 32/91 (35%), Positives = 46/91 (50%), Gaps = 13/91 (14%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+ IAY H IVH ++KPE++LL + K ADFGLA N G
Sbjct: 116 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG--- 169
Query: 146 TPGCEAPE--LWMPYSVTQKCDVFSFGMLLF 174
TPG +PE PYS + D+++ G++L+
Sbjct: 170 TPGYLSPEVLKKDPYS--KPVDIWACGVILY 198
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 7e-12
Identities = 33/107 (30%), Positives = 53/107 (49%), Gaps = 18/107 (16%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL-AKLYNREHTH 137
L ++ V+ K + YL E+ ++H D+KP ++LLDE K DFG+ +L +
Sbjct: 125 ILGKMTVAIVKALYYLKEK--HGVIHRDVKPSNILLDERGQIKLCDFGISGRLVD----- 177
Query: 138 ITSTGRRRTPGCE---APELWMPYSVTQ-----KCDVFSFGMLLFEV 176
+ R+ GC APE P T+ + DV+S G+ L E+
Sbjct: 178 --DKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVEL 222
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 62.6 bits (152), Expect = 7e-12
Identities = 31/122 (25%), Positives = 55/122 (45%), Gaps = 23/122 (18%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
G+ ++H + +V+ D+KP ++LLDE+ + +D GLA ++++ H S G T G
Sbjct: 304 GLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKKPH-ASVG---THGY 356
Query: 150 EAPELWM---PYSVTQKCDVFSFGMLLFE-VVGR----------RRNLEKEISEGQEWFP 195
APE+ Y D FS G +LF+ + G + +++ P
Sbjct: 357 MAPEVLQKGVAY--DSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVELP 414
Query: 196 KW 197
Sbjct: 415 DS 416
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 61.8 bits (151), Expect = 8e-12
Identities = 33/91 (36%), Positives = 46/91 (50%), Gaps = 14/91 (15%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+ YLHE IVH D+KPE++L +EN DFGL+K+ T+ G
Sbjct: 117 SAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIMS-TACG--- 169
Query: 146 TPGCEAPE--LWMPYSVTQKCDVFSFGMLLF 174
TPG APE PYS + D +S G++ +
Sbjct: 170 TPGYVAPEVLAQKPYS--KAVDCWSIGVITY 198
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 61.9 bits (151), Expect = 8e-12
Identities = 37/122 (30%), Positives = 53/122 (43%), Gaps = 21/122 (17%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTHITSTGRRRT 146
G+ YLH I H DIKPE++LLDE K +DFGLA ++ NRE G T
Sbjct: 117 GVVYLH---GIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCG---T 170
Query: 147 PGCEAPELWM--PYSVTQKCDVFSFGMLL---------FEVVGRRRNLEKEISEGQEWFP 195
APEL + + DV+S G++L ++ + E + +
Sbjct: 171 LPYVAPELLKRREFH-AEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLN 229
Query: 196 KW 197
W
Sbjct: 230 PW 231
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 62.0 bits (151), Expect = 9e-12
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
I +LH I H D+KPE++L +++ K DFG AK + T
Sbjct: 139 TAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNALQ-TPCY--- 191
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
TP APE+ P + CD++S G++++
Sbjct: 192 TPYYVAPEVLGPEKYDKSCDMWSLGVIMY 220
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-11
Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 12/95 (12%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFP--KAADFGLAKLYNREHTHITSTGRRRTP 147
G++Y H +I H D+K E+ LLD + P K DFG +K ++ G TP
Sbjct: 128 GVSYCH---SMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPKSTVG---TP 181
Query: 148 GCEAPELWM--PYSVTQKCDVFSFGMLLFE-VVGR 179
APE+ + Y + DV+S G+ L+ +VG
Sbjct: 182 AYIAPEVLLRQEYD-GKIADVWSCGVTLYVMLVGA 215
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 61.5 bits (150), Expect = 1e-11
Identities = 30/143 (20%), Positives = 58/143 (40%), Gaps = 15/143 (10%)
Query: 48 VGSEDTETYIKGFLAMGPFY--------LLCKKNILGFGQLREIEVSTSKGIAYLHEECR 99
G +T ++ M Y ++ + + + E+ + + + H +
Sbjct: 80 TGEAETPAGPLPYIVME--YVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFSH---Q 134
Query: 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR-TPGCEAPELWMPY 158
I+H D+KP ++++ K DFG+A+ +T T T +PE
Sbjct: 135 NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGD 194
Query: 159 SVTQKCDVFSFGMLLFE-VVGRR 180
SV + DV+S G +L+E + G
Sbjct: 195 SVDARSDVYSLGCVLYEVLTGEP 217
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 61.6 bits (150), Expect = 1e-11
Identities = 36/120 (30%), Positives = 54/120 (45%), Gaps = 20/120 (16%)
Query: 67 YLLCKKNI---LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFP--- 120
L KK + +++I G+ Y+H C I+H DIKPE+VL++ P
Sbjct: 117 LALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCG--IIHTDIKPENVLMEIVDSPENL 174
Query: 121 ---KAADFGLAKLYNREHTHITSTGRRRTPGCEAPE--LWMPYSVTQKCDVFSFGMLLFE 175
K AD G A Y+ +T+ T R +PE L P+ D++S L+FE
Sbjct: 175 IQIKIADLGNACWYDEHYTNSIQTREYR-----SPEVLLGAPWG--CGADIWSTACLIFE 227
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-11
Identities = 23/93 (24%), Positives = 39/93 (41%), Gaps = 7/93 (7%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR-TPG 148
+ H H D+KPE++L+ + F DFG+A +T G T
Sbjct: 146 ALDAAH---AAGATHRDVKPENILVSADDFAYLVDFGIASA--TTDEKLTQLGNTVGTLY 200
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVV-GRR 180
APE + T + D+++ +L+E + G
Sbjct: 201 YMAPERFSESHATYRADIYALTCVLYECLTGSP 233
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 61.3 bits (149), Expect = 1e-11
Identities = 29/89 (32%), Positives = 43/89 (48%), Gaps = 9/89 (10%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+ I YLH I H D+KPE++L N K DFG AK ++ T
Sbjct: 172 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCY--- 225
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
TP APE+ P + CD++S G++++
Sbjct: 226 TPYYVAPEVLGPEKYDKSCDMWSLGVIMY 254
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 61.2 bits (149), Expect = 1e-11
Identities = 32/97 (32%), Positives = 47/97 (48%), Gaps = 14/97 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
+ YL Q+I+H D+KP+++LLDE+ DF +A + RE T G T
Sbjct: 127 ALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQITTMAG---TKPY 180
Query: 150 EAPEL-----WMPYSVTQKCDVFSFGMLLFE-VVGRR 180
APE+ YS D +S G+ +E + GRR
Sbjct: 181 MAPEMFSSRKGAGYSFA--VDWWSLGVTAYELLRGRR 215
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 61.1 bits (149), Expect = 1e-11
Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 25/142 (17%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
Y+ K+ +G L V +KG+ YL + +++VH D+ +VL+ K DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRR 180
LAKL E + G + P WM + + T + DV+S+G+ ++E++
Sbjct: 163 LAKLLGAEEKEYHAEGGK------VPIKWMALESILHRIYTHQSDVWSYGVTVWELM--- 213
Query: 181 RNLEKEISEGQEWFPKWGREEV 202
+ G + + E+
Sbjct: 214 -------TFGSKPYDGIPASEI 228
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 61.0 bits (148), Expect = 2e-11
Identities = 27/112 (24%), Positives = 52/112 (46%), Gaps = 12/112 (10%)
Query: 68 LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
+L K + L ++ ++ KG+ YL E+ KI+H D+KP ++L++ K DFG+
Sbjct: 121 VLKKAGRIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGV 178
Query: 128 AKLYNREHTHITSTGRRRTPGCE---APELWMPYSVTQKCDVFSFGMLLFEV 176
+ + + G +PE + + D++S G+ L E+
Sbjct: 179 S-------GQLIDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEM 223
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 2e-11
Identities = 34/140 (24%), Positives = 51/140 (36%), Gaps = 18/140 (12%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL ++ +G QL +G+AYLH Q +H D+ +VLLD + K DFG
Sbjct: 125 YL--PRHSIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFG 179
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV--G 178
LAK H + +P W DV+SFG+ L+E++
Sbjct: 180 LAKAVPEGHEYYRVREDGDSPVF-----WYAPECLKEYKFYYASDVWSFGVTLYELLTHC 234
Query: 179 RRRNLEKEISEGQEWFPKWG 198
+
Sbjct: 235 DSSQSPPTKFLELIGIAQGQ 254
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 60.8 bits (148), Expect = 2e-11
Identities = 28/91 (30%), Positives = 41/91 (45%), Gaps = 12/91 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+ + Y H+ I+H D+KP VLL + + K FG+A + GR
Sbjct: 141 EALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRVG 195
Query: 146 TPGCEAPE--LWMPYSVTQKCDVFSFGMLLF 174
TP APE PY + DV+ G++LF
Sbjct: 196 TPHFMAPEVVKREPYG--KPVDVWGCGVILF 224
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 60.4 bits (147), Expect = 3e-11
Identities = 32/91 (35%), Positives = 47/91 (51%), Gaps = 13/91 (14%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+ IAY H IVH ++KPE++LL + K ADFGLA N G
Sbjct: 139 ESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAG--- 192
Query: 146 TPGCEAPELWM--PYSVTQKCDVFSFGMLLF 174
TPG +PE+ PYS + D+++ G++L+
Sbjct: 193 TPGYLSPEVLKKDPYS--KPVDIWACGVILY 221
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-11
Identities = 38/135 (28%), Positives = 59/135 (43%), Gaps = 20/135 (14%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
L QL ++ + G+AY+ VH D++ ++L+ EN K ADFGLA+L
Sbjct: 273 TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 131 YNREHTHITSTGR---RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187
+ + T APE + T K DV+SFG+LL E+
Sbjct: 330 IEDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELT---------- 375
Query: 188 SEGQEWFPKWGREEV 202
++G+ +P EV
Sbjct: 376 TKGRVPYPGMVNREV 390
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 60.7 bits (147), Expect = 3e-11
Identities = 38/135 (28%), Positives = 59/135 (43%), Gaps = 20/135 (14%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
L QL ++ + G+AY+ VH D++ ++L+ EN K ADFGLA+L
Sbjct: 356 TGKYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 131 YNREHTHITSTGR---RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187
+ + T APE + T K DV+SFG+LL E+
Sbjct: 413 IEDNEYTARQGAKFPIKWT----APEAALYGRFTIKSDVWSFGILLTELT---------- 458
Query: 188 SEGQEWFPKWGREEV 202
++G+ +P EV
Sbjct: 459 TKGRVPYPGMVNREV 473
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 60.5 bits (147), Expect = 3e-11
Identities = 28/108 (25%), Positives = 44/108 (40%), Gaps = 12/108 (11%)
Query: 77 FGQLREIEVSTS-----KGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKL 130
G L E +G+ YLH ++I+H D+K ++VLL + DFG A
Sbjct: 144 MGCLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALC 200
Query: 131 YNREHTHITSTGRRRTPGCE---APELWMPYSVTQKCDVFSFGMLLFE 175
+ + PG E APE+ M K D++S ++
Sbjct: 201 LQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLH 248
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 59.9 bits (146), Expect = 4e-11
Identities = 26/89 (29%), Positives = 45/89 (50%), Gaps = 10/89 (11%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFP----KAADFGLAKLYNREHTHITSTGRRR 145
G+ YLH ++I H+D+KPE+++L + P K DFG+A + G
Sbjct: 120 GVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFG--- 173
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
TP APE+ + + D++S G++ +
Sbjct: 174 TPEFVAPEIVNYEPLGLEADMWSIGVITY 202
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-11
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 10/89 (11%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFP----KAADFGLAKLYNREHTHITSTGRRR 145
G+ YLH +KI H+D+KPE+++L + P K DFGLA G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--- 180
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
TP APE+ + + D++S G++ +
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITY 209
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 60.0 bits (146), Expect = 4e-11
Identities = 25/88 (28%), Positives = 42/88 (47%), Gaps = 9/88 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRT 146
G+ YLH+ IVH D+KP+++LL K DFG+++ G T
Sbjct: 143 GVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMG---T 196
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLF 174
P APE+ +T D+++ G++ +
Sbjct: 197 PEYLAPEILNYDPITTATDMWNIGIIAY 224
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 59.8 bits (145), Expect = 5e-11
Identities = 27/93 (29%), Positives = 43/93 (46%), Gaps = 13/93 (13%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
I +H+ VH DIKP+++L+D N + ADFG + T +S G TP
Sbjct: 187 AIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTVQSSVAVG---TP 240
Query: 148 GCEAPELWMPYSVTQK-----CDVFSFGMLLFE 175
+PE+ + CD +S G+ ++E
Sbjct: 241 DYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-11
Identities = 27/117 (23%), Positives = 50/117 (42%), Gaps = 14/117 (11%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL K + +L + KG+ YL ++ +H D+ ++L++ K DFG
Sbjct: 134 YLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 190
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
L K+ ++ + +P W S + DV+SFG++L+E+
Sbjct: 191 LTKVLPQDKEYYKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELF 242
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-11
Identities = 32/101 (31%), Positives = 50/101 (49%), Gaps = 7/101 (6%)
Query: 82 EIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141
GI + H +IVH DIKP+++L+D N K DFG+AK + T +T T
Sbjct: 115 NFTNQILDGIKHAH---DMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSE--TSLTQT 169
Query: 142 GRRR-TPGCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGRR 180
T +PE + + D++S G++L+E +VG
Sbjct: 170 NHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLVGEP 210
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-11
Identities = 26/89 (29%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
G+ YLH +I H+D+KPE+++L K DFGLA + + G
Sbjct: 126 GVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG--- 179
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
TP APE+ + + D++S G++ +
Sbjct: 180 TPEFVAPEIVNYEPLGLEADMWSIGVITY 208
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 59.6 bits (145), Expect = 6e-11
Identities = 28/91 (30%), Positives = 42/91 (46%), Gaps = 11/91 (12%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFP-KAADFGLAKLYNREHTHITST-GR 143
K + YLH Q +VH D+KP ++L N + DFG AK E+ + +
Sbjct: 127 KTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCY- 182
Query: 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
T APE+ CD++S G+LL+
Sbjct: 183 --TANFVAPEVLERQGYDAACDIWSLGVLLY 211
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 6e-11
Identities = 26/88 (29%), Positives = 40/88 (45%), Gaps = 7/88 (7%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
KG+ +LH I+H D+K +++ + K D GLA L G TP
Sbjct: 140 KGLQFLHT-RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASFAK-AVIG---TP 194
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
APE++ + DV++FGM + E
Sbjct: 195 EFMAPEMYEE-KYDESVDVYAFGMCMLE 221
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 6e-11
Identities = 27/117 (23%), Positives = 49/117 (41%), Gaps = 14/117 (11%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL K + +L + KG+ YL ++ +H D+ ++L++ K DFG
Sbjct: 103 YLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFG 159
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
L K+ ++ +P W S + DV+SFG++L+E+
Sbjct: 160 LTKVLPQDKEFFKVKEPGESPIF-----WYAPESLTESKFSVASDVWSFGVVLYELF 211
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 59.3 bits (144), Expect = 7e-11
Identities = 28/89 (31%), Positives = 44/89 (49%), Gaps = 10/89 (11%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFP----KAADFGLAKLYNREHTHITSTGRRR 145
G+ YLH +KI H+D+KPE+++L + P K DFGLA G
Sbjct: 127 GVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFG--- 180
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
TP APE+ + + D++S G++ +
Sbjct: 181 TPEFVAPEIVNYEPLGLEADMWSIGVITY 209
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 59.2 bits (144), Expect = 7e-11
Identities = 37/118 (31%), Positives = 60/118 (50%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
G+ +LH + IV+ D+K +++LLD++ K ADFG+ K N T+T G TP
Sbjct: 130 GLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNTFCG---TP 182
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ + D +SFG+LL+E ++G+ L I ++P+W
Sbjct: 183 DYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSIRMDNPFYPRW 240
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-10
Identities = 34/136 (25%), Positives = 64/136 (47%), Gaps = 22/136 (16%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
+ + +L + ++G+A++ + + +H D++ ++L+ + K ADFGLA++
Sbjct: 277 EGSKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARV 333
Query: 131 YNREHTHITSTGR----RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186
++ + G + T APE S T K DV+SFG+LL E+V
Sbjct: 334 IE-DNEYTAREGAKFPIKWT----APEAINFGSFTIKSDVWSFGILLMEIV--------- 379
Query: 187 ISEGQEWFPKWGREEV 202
+ G+ +P EV
Sbjct: 380 -TYGRIPYPGMSNPEV 394
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-10
Identities = 25/90 (27%), Positives = 47/90 (52%), Gaps = 10/90 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITST-GRR 144
++++H+ +VH D+KPE++L ++N K DFG A+L ++ + +
Sbjct: 117 SAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCF-- 171
Query: 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
T APEL + CD++S G++L+
Sbjct: 172 -TLHYAAPELLNQNGYDESCDLWSLGVILY 200
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-10
Identities = 30/108 (27%), Positives = 51/108 (47%), Gaps = 21/108 (19%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
L +I VS K + +LH + ++H D+KP +VL++ K DFG++ ++
Sbjct: 110 ILGKIAVSIVKALEHLHSK--LSVIHRDVKPSNVLINALGQVKMCDFGISG-------YL 160
Query: 139 TSTGRRRT-PGCE---APE------LWMPYSVTQKCDVFSFGMLLFEV 176
+ GC+ APE YSV K D++S G+ + E+
Sbjct: 161 VDDVAKDIDAGCKPYMAPERINPELNQKGYSV--KSDIWSLGITMIEL 206
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-10
Identities = 33/143 (23%), Positives = 58/143 (40%), Gaps = 26/143 (18%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L QL + G+ YL + VH D+ +VL+D N K +DFG
Sbjct: 140 FLRTHDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFG 196
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGR 179
L++ L + T+TG + P W + + DV+SFG++++EV+
Sbjct: 197 LSRVLEDDPDAAYTTTGGK------IPIRWTAPEAIAFRTFSSASDVWSFGVVMWEVL-- 248
Query: 180 RRNLEKEISEGQEWFPKWGREEV 202
+ G+ + +V
Sbjct: 249 --------AYGERPYWNMTNRDV 263
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-10
Identities = 35/142 (24%), Positives = 63/142 (44%), Gaps = 25/142 (17%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
Y+ K+ +G L V +KG+ YL + +++VH D+ +VL+ K DFG
Sbjct: 106 YVREHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFG 162
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRR 180
LAKL E + G + P WM + + T + DV+S+G+ ++E++
Sbjct: 163 LAKLLGAEEKEYHAEGGK------VPIKWMALESILHRIYTHQSDVWSYGVTVWELM--- 213
Query: 181 RNLEKEISEGQEWFPKWGREEV 202
+ G + + E+
Sbjct: 214 -------TFGSKPYDGIPASEI 228
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 58.9 bits (143), Expect = 1e-10
Identities = 29/117 (24%), Positives = 54/117 (46%), Gaps = 14/117 (11%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L + L +L KG+ YL ++ VH D+ ++L++ K ADFG
Sbjct: 116 FLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFG 172
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
LAKL + + ++P W ++ +++ DV+SFG++L+E+
Sbjct: 173 LAKLLPLDKDYYVVREPGQSPIF-----WYAPESLSDNIFSRQSDVWSFGVVLYELF 224
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 1e-10
Identities = 27/87 (31%), Positives = 42/87 (48%), Gaps = 8/87 (9%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL--DENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
G+ ++HE IVH DIKPE+++ + K DFGLA N + +T T
Sbjct: 161 GLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIVKVTTA---TA 214
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLF 174
APE+ V D+++ G+L +
Sbjct: 215 EFAAPEIVDREPVGFYTDMWAIGVLGY 241
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 58.4 bits (142), Expect = 1e-10
Identities = 35/118 (29%), Positives = 57/118 (48%), Gaps = 15/118 (12%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
++ + L + ++G+ YL E QK VH D+ + +LDE+F K ADFG
Sbjct: 113 FIRSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFG 169
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
LA+ + +RE+ ++ P W T K DV+SFG+LL+E++
Sbjct: 170 LARDILDREYY-----SVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLWELL 222
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 58.8 bits (143), Expect = 1e-10
Identities = 21/88 (23%), Positives = 38/88 (43%), Gaps = 8/88 (9%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL--DENFFPKAADFGLAKLYNREHTHITSTGRRRT 146
+ + +LH I H+DI+PE+++ + K +FG A+
Sbjct: 113 EALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNFRLLFT---A 166
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLF 174
P APE+ V+ D++S G L++
Sbjct: 167 PEYYAPEVHQHDVVSTATDMWSLGTLVY 194
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 59.2 bits (143), Expect = 1e-10
Identities = 35/137 (25%), Positives = 64/137 (46%), Gaps = 14/137 (10%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L+ K+ + + E+ S G+ YL E + VH ++ +VLL + K +DFG
Sbjct: 425 FLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFG 481
Query: 127 LAKLYNREHTHITSTGRRRTP-GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185
L+K + ++ T+ + P APE + + DV+S+G+ ++E
Sbjct: 482 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA--------- 532
Query: 186 EISEGQEWFPKWGREEV 202
+S GQ+ + K EV
Sbjct: 533 -LSYGQKPYKKMKGPEV 548
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 29/117 (24%), Positives = 53/117 (45%), Gaps = 15/117 (12%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
++ + LG L V +KG+ YL E +VH ++ +VLL + ADFG
Sbjct: 104 HVRQHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFG 160
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
+A L + + + + P WM + T + DV+S+G+ ++E++
Sbjct: 161 VADLLPPDDKQLLYSEAK------TPIKWMALESIHFGKYTHQSDVWSYGVTVWELM 211
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 26/90 (28%), Positives = 42/90 (46%), Gaps = 10/90 (11%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ +LH+ I++ DIK E++LLD N DFGL+K + + T G T
Sbjct: 171 ALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCG---TI 224
Query: 148 GCEAPE--LWMPYSVTQKCDVFSFGMLLFE 175
AP+ + D +S G+L++E
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYE 254
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 58.5 bits (142), Expect = 1e-10
Identities = 36/137 (26%), Positives = 63/137 (45%), Gaps = 26/137 (18%)
Query: 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+++LG L + + + + YL VH D+ +VL+ E+ K +DFGL
Sbjct: 281 RGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT- 336
Query: 130 LYNREHTHITSTGR---RRTPGCEAPELWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEK 185
+E + TG+ + T APE + + K DV+SFG+LL+E+
Sbjct: 337 ---KEASSTQDTGKLPVKWT----APE-ALREKKFSTKSDVWSFGILLWEIY-------- 380
Query: 186 EISEGQEWFPKWGREEV 202
S G+ +P+ ++V
Sbjct: 381 --SFGRVPYPRIPLKDV 395
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 27/89 (30%), Positives = 43/89 (48%), Gaps = 10/89 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
KG+ ++HE VH D+KPE+++ N K DFGL + + + +TG
Sbjct: 266 KGLCHMHE---NNYVHLDLKPENIMFTTKRSNEL-KLIDFGLTAHLDPKQSVKVTTG--- 318
Query: 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
T APE+ V D++S G+L +
Sbjct: 319 TAEFAAPEVAEGKPVGYYTDMWSVGVLSY 347
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 58.4 bits (141), Expect = 2e-10
Identities = 32/112 (28%), Positives = 51/112 (45%), Gaps = 15/112 (13%)
Query: 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131
K+ L L +KG+ +L +K +H D+ ++LL E K DFGLA+
Sbjct: 187 KDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDI 243
Query: 132 NREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
++ ++ R P WM V T + DV+SFG+LL+E+
Sbjct: 244 YKDPDYVRKGDAR------LPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 289
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 58.7 bits (142), Expect = 2e-10
Identities = 31/114 (27%), Positives = 49/114 (42%), Gaps = 10/114 (8%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L +K L L S +AYL ++ VH DI +VL+ N K DFG
Sbjct: 480 FLQVRKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 536
Query: 127 LAKLYNREHTHITSTGR---RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
L++ + S G+ + APE T DV+ FG+ ++E++
Sbjct: 537 LSRYMEDSTYYKASKGKLPIKWM----APESINFRRFTSASDVWMFGVCMWEIL 586
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 58.2 bits (141), Expect = 2e-10
Identities = 34/118 (28%), Positives = 58/118 (49%), Gaps = 15/118 (12%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
++ + + L + +KG+ +L +K VH D+ + +LDE F K ADFG
Sbjct: 181 FIRNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFG 237
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
LA+ +Y++E + + + P WM T K DV+SFG+LL+E++
Sbjct: 238 LARDMYDKEFDSVHNKTGAKLPVK-----WMALESLQTQKFTTKSDVWSFGVLLWELM 290
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 58.1 bits (141), Expect = 2e-10
Identities = 27/92 (29%), Positives = 46/92 (50%), Gaps = 14/92 (15%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITST-GRR 144
+ + + H+ +VH ++KPE++LL + K ADFGLA E G
Sbjct: 121 EAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAG-- 175
Query: 145 RTPGCEAPELWM--PYSVTQKCDVFSFGMLLF 174
TPG +PE+ PY + D+++ G++L+
Sbjct: 176 -TPGYLSPEVLRKDPYG--KPVDLWACGVILY 204
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 58.3 bits (141), Expect = 2e-10
Identities = 26/93 (27%), Positives = 40/93 (43%), Gaps = 13/93 (13%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR-TPG 148
++YLH +V+ D+KPE+++L E K D G I S G TPG
Sbjct: 194 ALSYLH---SIGLVYNDLKPENIMLTEE-QLKLIDLGAVS-------RINSFGYLYGTPG 242
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
+APE+ T D+++ G L +
Sbjct: 243 FQAPEIVR-TGPTVATDIYTVGRTLAALTLDLP 274
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 2e-10
Identities = 26/88 (29%), Positives = 46/88 (52%), Gaps = 9/88 (10%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITST--GRRRTP 147
+ YLH + I+H D+KPE++LL+E+ + DFG AK L ++ G T
Sbjct: 143 LEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVG---TA 196
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
+PEL S + D+++ G ++++
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQ 224
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 57.8 bits (140), Expect = 2e-10
Identities = 32/121 (26%), Positives = 54/121 (44%), Gaps = 15/121 (12%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF 119
FL G + + L Q+ + + + +AYLH Q ++H DIK +S+LL +
Sbjct: 123 FLQGGALTDIVSQVRLNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGR 179
Query: 120 PKAADFGLAKLYNREHTHITSTGRRR-----TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
K +DFG I+ +R TP APE+ + D++S G+++
Sbjct: 180 VKLSDFGFC-------AQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVI 232
Query: 175 E 175
E
Sbjct: 233 E 233
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 58.1 bits (140), Expect = 3e-10
Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
G+ +L + I++ D+K ++V+LD K ADFG+ K N T T G TP
Sbjct: 454 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCG---TP 506
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ + D ++FG+LL+E + G+ L + I E +PK
Sbjct: 507 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 564
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 57.7 bits (140), Expect = 3e-10
Identities = 34/143 (23%), Positives = 60/143 (41%), Gaps = 26/143 (18%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L K QL + + G+ YL VH D+ ++L++ N K +DFG
Sbjct: 136 FLREKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFG 192
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGR 179
L++ L + T++G + P W Y T DV+SFG++++EV+
Sbjct: 193 LSRVLEDDPEATYTTSGGK------IPIRWTAPEAISYRKFTSASDVWSFGIVMWEVM-- 244
Query: 180 RRNLEKEISEGQEWFPKWGREEV 202
+ G+ + + EV
Sbjct: 245 --------TYGERPYWELSNHEV 259
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 57.6 bits (140), Expect = 3e-10
Identities = 32/118 (27%), Positives = 52/118 (44%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ YLH + +V+ DIK E+++LD++ K DFGL K T G TP
Sbjct: 117 ALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKE-GISDGATMKTFCG---TP 169
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ + D + G++++E + GR L + I + FP+
Sbjct: 170 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELILMEEIRFPRT 227
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-10
Identities = 37/112 (33%), Positives = 54/112 (48%), Gaps = 20/112 (17%)
Query: 74 ILGFGQLREIEVS-----TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA 128
+L G L E +++ KG+ YLH +K +H DIK +VLL E+ K ADFG+A
Sbjct: 110 LLEPGPLDETQIATILREILKGLDYLH---SEKKIHRDIKAANVLLSEHGEVKLADFGVA 166
Query: 129 KLYNREHTHITSTGRRR-----TPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
+T T +R TP APE+ + K D++S G+ E
Sbjct: 167 -------GQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIE 211
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 3e-10
Identities = 30/118 (25%), Positives = 55/118 (46%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ +LH+ + I++ D+KPE+++L+ K DFGL K + +T T G T
Sbjct: 133 ALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKE-SIHDGTVTHTFCG---TI 185
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ M + D +S G L+++ + G R+ +I + + P +
Sbjct: 186 EYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLPPY 243
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 57.3 bits (139), Expect = 3e-10
Identities = 35/118 (29%), Positives = 47/118 (39%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ YLH IV+ D+KPE++LLD DFGL K N EH TST G TP
Sbjct: 151 ALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNSTTSTFCG---TP 203
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ + D + G +L+E + G + I
Sbjct: 204 EYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKPN 261
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 57.4 bits (139), Expect = 4e-10
Identities = 32/118 (27%), Positives = 54/118 (45%), Gaps = 16/118 (13%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ YLH E + +V+ D+K E+++LD++ K DFGL K + T G TP
Sbjct: 260 ALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKE-GIKDGATMKTFCG---TP 313
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ + D + G++++E + GR L + I + FP+
Sbjct: 314 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELILMEEIRFPRT 371
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 57.2 bits (139), Expect = 4e-10
Identities = 35/118 (29%), Positives = 55/118 (46%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
G+ +L + I++ D+K ++V+LD K ADFG+ K N T T G TP
Sbjct: 133 GLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKE-NIWDGVTTKTFCG---TP 185
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ + D ++FG+LL+E + G+ L + I E +PK
Sbjct: 186 DYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIMEHNVAYPKS 243
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 56.9 bits (138), Expect = 5e-10
Identities = 33/118 (27%), Positives = 55/118 (46%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ +LH+ + I++ D+K ++VLLD K ADFG+ K + T+T G TP
Sbjct: 136 ALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKE-GICNGVTTATFCG---TP 188
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ D ++ G+LL+E + G +L + I + +P W
Sbjct: 189 DYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILNDEVVYPTW 246
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 6e-10
Identities = 31/91 (34%), Positives = 44/91 (48%), Gaps = 14/91 (15%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRT 146
GI ++H+ I+H D+KPE++L D K DFGLA+ Y + G T
Sbjct: 199 GIRHMHQ---MYILHLDLKPENILCVNRDAKQI-KIIDFGLARRYKPREKLKVNFG---T 251
Query: 147 PGCEAPELWMPYSVTQKCDVFSFG----MLL 173
P APE+ V+ D++S G MLL
Sbjct: 252 PEFLAPEVVNYDFVSFPTDMWSVGVIAYMLL 282
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 56.4 bits (137), Expect = 6e-10
Identities = 36/118 (30%), Positives = 57/118 (48%), Gaps = 17/118 (14%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ +LH I++ D+KPE++LLDE K DFGL+K + +H + G T
Sbjct: 138 ALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKE-SIDHEKKAYSFCG---TV 190
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE+ TQ D +SFG+L+FE + G R+ I + + P++
Sbjct: 191 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMPQF 248
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 6e-10
Identities = 34/142 (23%), Positives = 63/142 (44%), Gaps = 24/142 (16%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L+ K+ + + E+ S G+ YL E + VH D+ +VLL + K +DFG
Sbjct: 99 FLVGKREEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFG 155
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRR 180
L+K + ++ T+ + P W + + + DV+S+G+ ++E
Sbjct: 156 LSKALGADDSYYTARSAGKW-----PLKWYAPECINFRKFSSRSDVWSYGVTMWEA---- 206
Query: 181 RNLEKEISEGQEWFPKWGREEV 202
+S GQ+ + K EV
Sbjct: 207 ------LSYGQKPYKKMKGPEV 222
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 56.1 bits (136), Expect = 7e-10
Identities = 31/117 (26%), Positives = 49/117 (41%), Gaps = 16/117 (13%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L +K L L S +AYL ++ VH DI +VL+ N K DFG
Sbjct: 105 FLQVRKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFG 161
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
L++ + S G+ P WM + T DV+ FG+ ++E++
Sbjct: 162 LSRYMEDSTYYKASKGK-------LPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 211
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-10
Identities = 37/148 (25%), Positives = 62/148 (41%), Gaps = 38/148 (25%)
Query: 46 NLV---GSEDTETYIKGFL---AMGPFYLLCKKNILGFGQLREIEVSTS-------KGIA 92
N+V GS +IK F+ G L + +G L++ E + +G+
Sbjct: 80 NIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSK---WGPLKDNEQTIGFYTKQILEGLK 136
Query: 93 YLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITS-TGRRRTPGCE 150
YLH+ +IVH DIK ++VL++ + K +DFG +K + + TG T
Sbjct: 137 YLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINPCTETFTG---TL--- 187
Query: 151 APELWM--------PYSVTQKCDVFSFG 170
+M P + D++S G
Sbjct: 188 ---QYMAPEIIDKGPRGYGKAADIWSLG 212
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 8e-10
Identities = 33/108 (30%), Positives = 48/108 (44%), Gaps = 20/108 (18%)
Query: 78 GQLREIEVS-----TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
L E E++ T KG+ YLH + +H DIK ++LL+ K ADFG+A
Sbjct: 120 KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVA---- 172
Query: 133 REHTHITSTGRRR-----TPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
+T T +R TP APE+ D++S G+ E
Sbjct: 173 ---GQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIE 217
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 56.3 bits (136), Expect = 9e-10
Identities = 26/97 (26%), Positives = 40/97 (41%), Gaps = 19/97 (19%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
I +H VH DIKP+++LLD + ADFG + T + G TP
Sbjct: 174 AIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTVRSLVAVG---TP 227
Query: 148 GCEAPEL---------WMPYSVTQKCDVFSFGMLLFE 175
+PE+ Y +CD ++ G+ +E
Sbjct: 228 DYLSPEILQAVGGGPGTGSY--GPECDWWALGVFAYE 262
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 56.2 bits (136), Expect = 9e-10
Identities = 28/93 (30%), Positives = 45/93 (48%), Gaps = 16/93 (17%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTPG 148
+ +H +H D+KP+++LLD++ K ADFG N+E T G TP
Sbjct: 181 LDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMVRCDTAVG---TPD 234
Query: 149 CEAPEL------WMPYSVTQKCDVFSFGMLLFE 175
+PE+ Y ++CD +S G+ L+E
Sbjct: 235 YISPEVLKSQGGDGYY--GRECDWWSVGVFLYE 265
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 9e-10
Identities = 33/139 (23%), Positives = 57/139 (41%), Gaps = 26/139 (18%)
Query: 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
C + + L + S + YL + + +H D+ + L+ EN K ADFGL++
Sbjct: 103 CNRQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSR 159
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRRRNL 183
L T+ G + P W Y+ + K DV++FG+LL+E+
Sbjct: 160 LMT-GDTYTAHAGAK------FPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIA------ 206
Query: 184 EKEISEGQEWFPKWGREEV 202
+ G +P +V
Sbjct: 207 ----TYGMSPYPGIDLSQV 221
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-09
Identities = 30/123 (24%), Positives = 55/123 (44%), Gaps = 15/123 (12%)
Query: 60 FLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF 119
+LA G + + + GQ+ + + + +LH +++H DIK +++LL +
Sbjct: 98 YLAGGSLTDVVTETCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGS 154
Query: 120 PKAADFGLAKLYNREHTHITSTGRRR-----TPGCEAPELWMPYSVTQKCDVFSFGMLLF 174
K DFG IT +R TP APE+ + K D++S G++
Sbjct: 155 VKLTDFGFC-------AQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAI 207
Query: 175 EVV 177
E++
Sbjct: 208 EMI 210
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 55.8 bits (135), Expect = 1e-09
Identities = 33/143 (23%), Positives = 59/143 (41%), Gaps = 26/143 (18%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L QL + + G+ YL + VH D+ ++L++ N K +DFG
Sbjct: 136 FLRKHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFG 192
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGR 179
L + L + T+ G + P W Y T DV+S+G++L+EV
Sbjct: 193 LGRVLEDDPEAAYTTRGGK------IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEV--- 243
Query: 180 RRNLEKEISEGQEWFPKWGREEV 202
+S G+ + + ++V
Sbjct: 244 -------MSYGERPYWEMSNQDV 259
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 55.7 bits (135), Expect = 1e-09
Identities = 35/118 (29%), Positives = 59/118 (50%), Gaps = 15/118 (12%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
++ + + L + +KG+ YL +K VH D+ + +LDE F K ADFG
Sbjct: 117 FIRNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFG 173
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
LA+ +Y++E+ + + + P WM T K DV+SFG+LL+E++
Sbjct: 174 LARDMYDKEYYSVHNKTGAKLPVK-----WMALESLQTQKFTTKSDVWSFGVLLWELM 226
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-09
Identities = 35/142 (24%), Positives = 61/142 (42%), Gaps = 26/142 (18%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL ++ + L + + +G+AYL E ++H D+ + L+ EN K +DFG
Sbjct: 93 YLRTQRGLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFG 149
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRR 180
+ + + + G + P W +S + K DV+SFG+L++EV
Sbjct: 150 MTRF-------VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVF--- 199
Query: 181 RNLEKEISEGQEWFPKWGREEV 202
SEG+ + EV
Sbjct: 200 -------SEGKIPYENRSNSEV 214
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 1e-09
Identities = 30/142 (21%), Positives = 61/142 (42%), Gaps = 26/142 (18%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL ++ QL E+ + + YL ++ +H D+ + L+++ K +DFG
Sbjct: 109 YLREMRHRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFG 165
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRR 180
L++ + + G + P W P YS + K D+++FG+L++E+
Sbjct: 166 LSRY-------VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIY--- 215
Query: 181 RNLEKEISEGQEWFPKWGREEV 202
S G+ + ++ E
Sbjct: 216 -------SLGKMPYERFTNSET 230
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 55.4 bits (134), Expect = 1e-09
Identities = 32/95 (33%), Positives = 51/95 (53%), Gaps = 13/95 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
KG+ Y+H I+H D+KP ++ ++E+ K DFGLA+ + E T T R
Sbjct: 139 KGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSEMTGYVVTRWYR--- 192
Query: 149 CEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ WM Y TQ D++S G ++ E++ +
Sbjct: 193 --APEVILNWMRY--TQTVDIWSVGCIMAEMITGK 223
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 1e-09
Identities = 33/142 (23%), Positives = 58/142 (40%), Gaps = 26/142 (18%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL L QL E+ +G+A+L + +H D+ + L+D + K +DFG
Sbjct: 93 YLRSHGKGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFG 149
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRR 180
+ + + + G + P W Y + K DV++FG+L++EV
Sbjct: 150 MTRY-------VLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVF--- 199
Query: 181 RNLEKEISEGQEWFPKWGREEV 202
S G+ + + EV
Sbjct: 200 -------SLGKMPYDLYTNSEV 214
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 55.5 bits (134), Expect = 2e-09
Identities = 31/116 (26%), Positives = 51/116 (43%), Gaps = 16/116 (13%)
Query: 66 FYLLCKKNILGF--GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFP--K 121
+ L+ K GF +R+ S + + LH + +I+H D+KPE++LL + K
Sbjct: 186 YELIKKNKFQGFSLPLVRKFAHSILQCLDALH---KNRIIHCDLKPENILLKQQGRSGIK 242
Query: 122 AADFGLAKLYNREHTHITSTGRRRTPGCEAPE--LWMPYSVTQKCDVFSFGMLLFE 175
DFG + ++ + R APE L Y D++S G +L E
Sbjct: 243 VIDFGSSCYEHQRVYTYIQSRFYR-----APEVILGARYG--MPIDMWSLGCILAE 291
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 55.3 bits (134), Expect = 2e-09
Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ YLHE + I++ D+K ++VLLD K D+G+ K TST G TP
Sbjct: 122 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCG---TP 174
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
APE+ D ++ G+L+FE
Sbjct: 175 NYIAPEILRGEDYGFSVDWWALGVLMFE 202
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 54.9 bits (133), Expect = 2e-09
Identities = 26/96 (27%), Positives = 44/96 (45%), Gaps = 15/96 (15%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
+KG+A+L + +H D+ ++LL K DFGLA+ + ++ R
Sbjct: 155 AKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSNYVVKGNARL-- 209
Query: 148 GCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM V T + DV+S+G+ L+E+
Sbjct: 210 ----PVKWMAPESIFNCVYTFESDVWSYGIFLWELF 241
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 2e-09
Identities = 31/138 (22%), Positives = 54/138 (39%), Gaps = 16/138 (11%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
L + G L V ++G+ YL ++ +H D+ ++LL K DFG
Sbjct: 110 RLRKHQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFG 166
Query: 127 LAKLYNREHTHITSTGRRRTPG--CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLE 184
L + + H R+ P C APE + + D + FG+ L+E+
Sbjct: 167 LMRALPQNDDHYVMQEHRKVPFAWC-APESLKTRTFSHASDTWMFGVTLWEM-------- 217
Query: 185 KEISEGQEWFPKWGREEV 202
+ GQE + ++
Sbjct: 218 --FTYGQEPWIGLNGSQI 233
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 55.0 bits (133), Expect = 2e-09
Identities = 29/88 (32%), Positives = 43/88 (48%), Gaps = 9/88 (10%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ YLHE + I++ D+K ++VLLD K D+G+ K TST G TP
Sbjct: 165 ALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKE-GLRPGDTTSTFCG---TP 217
Query: 148 GCEAPELWMPYSVTQKCDVFSFGMLLFE 175
APE+ D ++ G+L+FE
Sbjct: 218 NYIAPEILRGEDYGFSVDWWALGVLMFE 245
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-09
Identities = 22/99 (22%), Positives = 39/99 (39%), Gaps = 16/99 (16%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRR 145
+ +LH + I H D+KPE++L ++ K DF L +
Sbjct: 122 SALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPEL 178
Query: 146 -----TPGCEAPELWMPYSVTQK-----CDVFSFGMLLF 174
+ APE+ +S CD++S G++L+
Sbjct: 179 LTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY 217
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 54.5 bits (132), Expect = 3e-09
Identities = 31/117 (26%), Positives = 46/117 (39%), Gaps = 16/117 (13%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL KN L L + K +AYL VH DI ++L+ K DFG
Sbjct: 102 YLERNKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFG 158
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
L++ E + S R P WM + T DV+ F + ++E++
Sbjct: 159 LSRYIEDEDYYKASVTR-------LPIKWMSPESINFRRFTTASDVWMFAVCMWEIL 208
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 54.6 bits (132), Expect = 3e-09
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 13/95 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
KG+ Y+H +VH D+KP ++ ++E+ K DFGLA+ + E T T R
Sbjct: 137 KGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEMTGYVVTRWYR--- 190
Query: 149 CEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ WM Y Q D++S G ++ E++ +
Sbjct: 191 --APEVILSWMHY--NQTVDIWSVGCIMAEMLTGK 221
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 3e-09
Identities = 28/113 (24%), Positives = 50/113 (44%), Gaps = 25/113 (22%)
Query: 78 GQLREIEVS-----TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
L E ++ + + +LH ++I+H D+K +VL+ + ADFG++
Sbjct: 112 RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVS---- 164
Query: 133 REHTHITSTGRRR-----TPGCEAPELWMPYSVTQ-----KCDVFSFGMLLFE 175
T ++R TP APE+ M ++ K D++S G+ L E
Sbjct: 165 ---AKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIE 214
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 54.2 bits (131), Expect = 4e-09
Identities = 31/96 (32%), Positives = 49/96 (51%), Gaps = 18/96 (18%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
++G+ YL + ++ +H D+ ++L+ EN+ K ADFGL+ R R P
Sbjct: 152 ARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLS----RGQEVYVKKTMGRLP 204
Query: 148 GCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
WM YSV T DV+S+G+LL+E+V
Sbjct: 205 VR-----WMAIESLNYSVYTTNSDVWSYGVLLWEIV 235
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 53.8 bits (130), Expect = 4e-09
Identities = 38/138 (27%), Positives = 60/138 (43%), Gaps = 17/138 (12%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL ++ + + E+ S G+ YL E VH D+ +VLL + K +DFG
Sbjct: 107 YLQQNRH-VKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFG 162
Query: 127 LAKLYNREHTHITSTGRRRTPG--CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLE 184
L+K + + + + P APE Y + K DV+SFG+L++E
Sbjct: 163 LSKALRADENYYKAQTHGKWPVKWY-APECINYYKFSSKSDVWSFGVLMWEA-------- 213
Query: 185 KEISEGQEWFPKWGREEV 202
S GQ+ + EV
Sbjct: 214 --FSYGQKPYRGMKGSEV 229
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 53.9 bits (130), Expect = 4e-09
Identities = 32/113 (28%), Positives = 51/113 (45%), Gaps = 25/113 (22%)
Query: 78 GQLREIEVS-----TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
L+E ++ +G+++LH+ K++H DIK ++VLL EN K DFG++
Sbjct: 124 NTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVS---- 176
Query: 133 REHTHITSTGRRR-----TPGCEAPELWMPYSVTQ-----KCDVFSFGMLLFE 175
+ T RR TP APE+ K D++S G+ E
Sbjct: 177 ---AQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIE 226
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 6e-09
Identities = 28/96 (29%), Positives = 45/96 (46%), Gaps = 15/96 (15%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
++G+A+L + +H D+ +VLL K DFGLA+ + +I R
Sbjct: 174 AQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSNYIVKGNARL-- 228
Query: 148 GCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM V T + DV+S+G+LL+E+
Sbjct: 229 ----PVKWMAPESIFDCVYTVQSDVWSYGILLWEIF 260
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 53.5 bits (129), Expect = 7e-09
Identities = 22/97 (22%), Positives = 46/97 (47%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRT 146
+ G+ YL + +H D+ + +L E+ ADFGL+ K+Y+ ++ +
Sbjct: 147 ACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYRQGCASKL-- 201
Query: 147 PGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P W+ ++ T DV++FG+ ++E++
Sbjct: 202 -----PVKWLALESLADNLYTVHSDVWAFGVTMWEIM 233
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 7e-09
Identities = 23/97 (23%), Positives = 45/97 (46%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNREHTHITSTGRRRT 146
+ G+ YL + +H D+ + +L ++ ADFGL+K +Y+ ++ +
Sbjct: 157 ALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQGRIAKM-- 211
Query: 147 PGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P W+ V T K DV++FG+ ++E+
Sbjct: 212 -----PVKWIAIESLADRVYTSKSDVWAFGVTMWEIA 243
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 53.4 bits (129), Expect = 8e-09
Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 15/96 (15%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
+KG+ +L +K +H D+ ++LL E K DFGLA+ ++ ++ R
Sbjct: 158 AKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARL-- 212
Query: 148 GCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM V T + DV+SFG+LL+E+
Sbjct: 213 ----PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 244
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 53.0 bits (128), Expect = 8e-09
Identities = 35/134 (26%), Positives = 62/134 (46%), Gaps = 26/134 (19%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L +L ++ ++G+A++ E + +H D++ ++L+ + K ADFGLA+L +
Sbjct: 106 LTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIE-D 161
Query: 135 HTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRRRNLEKEIS 188
+ + G + P W Y T K DV+SFG+LL E+V +
Sbjct: 162 NEYTAREGAK------FPIKWTAPEAINYGTFTIKSDVWSFGILLTEIV----------T 205
Query: 189 EGQEWFPKWGREEV 202
G+ +P EV
Sbjct: 206 HGRIPYPGMTNPEV 219
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 8e-09
Identities = 27/96 (28%), Positives = 44/96 (45%), Gaps = 15/96 (15%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
+KG+ +L + VH D+ +VL+ K DFGLA+ + ++ R
Sbjct: 182 AKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSNYVVRGNARL-- 236
Query: 148 GCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM + T K DV+S+G+LL+E+
Sbjct: 237 ----PVKWMAPESLFEGIYTIKSDVWSYGILLWEIF 268
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-09
Identities = 31/97 (31%), Positives = 52/97 (53%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRT 146
++G+ YL +K +H D+ +VL+ E+ K ADFGLA +++ ++ T+ GR
Sbjct: 201 ARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYYKKTTNGRL-- 255
Query: 147 PGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM + T + DV+SFG+LL+E+
Sbjct: 256 -----PVKWMAPEALFDRIYTHQSDVWSFGVLLWEIF 287
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 53.1 bits (128), Expect = 9e-09
Identities = 28/97 (28%), Positives = 45/97 (46%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRT 146
+ G+AYL+ K VH D+ + ++ E+F K DFG+ +Y ++ G
Sbjct: 148 ADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGL--- 201
Query: 147 PGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM V T DV+SFG++L+E+
Sbjct: 202 ----LPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIA 234
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-08
Identities = 32/109 (29%), Positives = 48/109 (44%), Gaps = 29/109 (26%)
Query: 80 LREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL-AKLYNREHTHI 138
LRE +G+ YLH + +H D+K ++LL E+ + ADFG+ A L
Sbjct: 127 LRE----VLEGLEYLH---KNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLAT---GGD 176
Query: 139 TSTGRRR-----TPGCEAPELWM-PYSVTQ------KCDVFSFGMLLFE 175
+ + R TP WM P + Q K D++SFG+ E
Sbjct: 177 ITRNKVRKTFVGTP------CWMAPEVMEQVRGYDFKADIWSFGITAIE 219
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 1e-08
Identities = 34/131 (25%), Positives = 53/131 (40%), Gaps = 33/131 (25%)
Query: 68 LLCKKNILGF--GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAA-- 123
L + N + +R + + +LHE ++ H D+KPE++L + F
Sbjct: 111 FLKENNFQPYPLPHVRHMAYQLCHALRFLHEN---QLTHTDLKPENILFVNSEFETLYNE 167
Query: 124 -----------------DFGLAKLYNREHTHITSTGRRRTPGCEAPE--LWMPYSVTQKC 164
DFG A + HT I +T R PE L + ++ Q C
Sbjct: 168 HKSCEEKSVKNTSIRVADFGSATFDHEHHTTIVATRHYR-----PPEVILELGWA--QPC 220
Query: 165 DVFSFGMLLFE 175
DV+S G +LFE
Sbjct: 221 DVWSIGCILFE 231
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-08
Identities = 26/87 (29%), Positives = 44/87 (50%), Gaps = 12/87 (13%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTPG 148
YLH +++ D+KPE++L+D+ + + DFG AK T T G TP
Sbjct: 154 FEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAK----RVKGRTWTLCG---TPE 203
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFE 175
APE+ + + D ++ G+L++E
Sbjct: 204 ALAPEIILSKGYNKAVDWWALGVLIYE 230
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 52.6 bits (126), Expect = 2e-08
Identities = 18/96 (18%), Positives = 34/96 (35%), Gaps = 24/96 (25%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
K + Y+H VH +K +L+ + + + S G+R+
Sbjct: 139 KALDYIH---HMGYVHRSVKASHILISVDGKVYLSGLRSN-------LSMISHGQRQRVV 188
Query: 149 CEAPEL------WM-PYSVTQ-------KCDVFSFG 170
+ P+ W+ P + Q K D++S G
Sbjct: 189 HDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG 224
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 52.3 bits (126), Expect = 2e-08
Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRT 146
++G+ YL QK +H D+ +VL+ EN K ADFGLA + N ++ T+ GR
Sbjct: 167 ARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL-- 221
Query: 147 PGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM V T + DV+SFG+L++E+
Sbjct: 222 -----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 253
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 52.1 bits (126), Expect = 2e-08
Identities = 38/120 (31%), Positives = 57/120 (47%), Gaps = 24/120 (20%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST--GRRRTP 147
+ YLH + I++ D+KPE++LLD+N K DFG AK +T T G TP
Sbjct: 118 ALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAK----YVPDVTYTLCG---TP 167
Query: 148 GCEAPE--LWMPYSVTQKCDVFSFGMLLFE-VVGR-------RRNLEKEISEGQEWFPKW 197
APE PY + D +SFG+L++E + G ++I + FP +
Sbjct: 168 DYIAPEVVSTKPY--NKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPF 225
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 2e-08
Identities = 24/92 (26%), Positives = 42/92 (45%), Gaps = 6/92 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
GI +LH I+H D+KP ++++ + K DFGLA+ T T
Sbjct: 138 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 191
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ + + D++S G ++ E++
Sbjct: 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGG 223
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-08
Identities = 35/131 (26%), Positives = 57/131 (43%), Gaps = 33/131 (25%)
Query: 68 LLCKKNILGF--GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAA-- 123
+ + L F +R++ K + +LH K+ H D+KPE++L ++ + +A
Sbjct: 106 FIKENGFLPFRLDHIRKMAYQICKSVNFLHSN---KLTHTDLKPENILFVQSDYTEAYNP 162
Query: 124 -----------------DFGLAKLYNREHTHITSTGRRRTPGCEAPE--LWMPYSVTQKC 164
DFG A + H+ + ST R APE L + +S Q C
Sbjct: 163 KIKRDERTLINPDIKVVDFGSATYDDEHHSTLVSTRHYR-----APEVILALGWS--QPC 215
Query: 165 DVFSFGMLLFE 175
DV+S G +L E
Sbjct: 216 DVWSIGCILIE 226
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 2e-08
Identities = 31/96 (32%), Positives = 51/96 (53%), Gaps = 15/96 (15%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147
S+G+ YL E K+VH D+ ++L+ E K +DFGL++ E +++ + R
Sbjct: 160 SQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDSYVKRSQGRI-- 214
Query: 148 GCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM + T + DV+SFG+LL+E+V
Sbjct: 215 ----PVKWMAIESLFDHIYTTQSDVWSFGVLLWEIV 246
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 3e-08
Identities = 31/95 (32%), Positives = 50/95 (52%), Gaps = 13/95 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+G+ Y+H I+H D+KP ++ ++E+ K DFGLA+ E T +T R
Sbjct: 143 RGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADEMTGYVATRWYR--- 196
Query: 149 CEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ WM Y Q D++S G ++ E++ R
Sbjct: 197 --APEIMLNWMHY--NQTVDIWSVGCIMAELLTGR 227
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 51.9 bits (125), Expect = 3e-08
Identities = 26/99 (26%), Positives = 48/99 (48%), Gaps = 16/99 (16%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLY--NREHTHITSTGRRR 145
K + Y H I+H D+KP +V++D E+ + D+GLA+ Y +E+ ++ +
Sbjct: 141 KALDYCH---SMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFK 197
Query: 146 TPGCEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRRR 181
PEL + Y D++S G +L ++ R+
Sbjct: 198 -----GPELLVDYQMY--DYSLDMWSLGCMLASMIFRKE 229
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 51.6 bits (124), Expect = 3e-08
Identities = 30/114 (26%), Positives = 44/114 (38%), Gaps = 14/114 (12%)
Query: 68 LLCKKNILGF--GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFP--KAA 123
LL N G R+ + +L I+H D+KPE++LL K
Sbjct: 145 LLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIV 203
Query: 124 DFGLAKLYNREHTHITSTGRRRTPGCEAPE--LWMPYSVTQKCDVFSFGMLLFE 175
DFG + + + R +PE L MPY D++S G +L E
Sbjct: 204 DFGSSCQLGQRIYQYIQSRFYR-----SPEVLLGMPYD--LAIDMWSLGCILVE 250
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 51.4 bits (124), Expect = 3e-08
Identities = 34/139 (24%), Positives = 59/139 (42%), Gaps = 30/139 (21%)
Query: 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+++LG L + + + + YL VH D+ +VL+ E+ K +DFGL
Sbjct: 109 RGRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLT- 164
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVVGRRRNL 183
+E + TG+ P W + K DV+SFG+LL+E+
Sbjct: 165 ---KEASSTQDTGK-------LPVKWTAPEALREKKFSTKSDVWSFGILLWEIY------ 208
Query: 184 EKEISEGQEWFPKWGREEV 202
S G+ +P+ ++V
Sbjct: 209 ----SFGRVPYPRIPLKDV 223
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 4e-08
Identities = 32/114 (28%), Positives = 52/114 (45%), Gaps = 17/114 (14%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK- 129
K LG Q+ I + G+ YL Q VH D+ + L+ N K DFG+++
Sbjct: 126 AKGELGLSQMLHIASQIASGMVYLAS---QHFVHRDLATRNCLVGANLLVKIGDFGMSRD 182
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
+Y+ ++ + P WMP Y T + DV+SFG++L+E+
Sbjct: 183 VYSTDYYRVGGHTM-------LPIRWMPPESIMYRKFTTESDVWSFGVILWEIF 229
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 51.1 bits (123), Expect = 5e-08
Identities = 29/99 (29%), Positives = 42/99 (42%), Gaps = 16/99 (16%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLY--NREHTH-ITSTGRR 144
+ I LH + H DIKP +VL++ + K DFG AK + + I S R
Sbjct: 140 RSIGCLHLPS-VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEPNVAYICSRYYR 198
Query: 145 RTPGCEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APEL Y T D++S G + E++
Sbjct: 199 ------APELIFGNQHY--TTAVDIWSVGCIFAEMMLGE 229
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 5e-08
Identities = 30/110 (27%), Positives = 51/110 (46%), Gaps = 17/110 (15%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK-LYNR 133
LG GQL + + G+ YL VH D+ + L+ + K DFG+++ +Y+
Sbjct: 155 LGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYST 211
Query: 134 EHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
++ + P WMP Y T + DV+SFG++L+E+
Sbjct: 212 DYYRVGGRTM-------LPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 50.7 bits (122), Expect = 5e-08
Identities = 30/96 (31%), Positives = 50/96 (52%), Gaps = 9/96 (9%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS-TGRRRTP 147
+G+ Y+H ++H D+KP ++LL+ K DFGLA++ + +H H T T
Sbjct: 139 RGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATR 195
Query: 148 GCEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ Y T+ D++S G +L E++ R
Sbjct: 196 WYRAPEIMLNSKGY--TKSIDIWSVGCILAEMLSNR 229
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 50.8 bits (122), Expect = 6e-08
Identities = 34/97 (35%), Positives = 51/97 (52%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRT 146
++G+ YL QK +H D+ +VL+ EN K ADFGLA + N ++ T+ GR
Sbjct: 213 ARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGRL-- 267
Query: 147 PGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WM V T + DV+SFG+L++E+
Sbjct: 268 -----PVKWMAPEALFDRVYTHQSDVWSFGVLMWEIF 299
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 50.5 bits (121), Expect = 7e-08
Identities = 27/99 (27%), Positives = 45/99 (45%), Gaps = 18/99 (18%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLY--NREHTH-ITSTGRR 144
+ + ++H I H DIKP+++L++ ++ K DFG AK + I S R
Sbjct: 152 RAVGFIHS---LGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPSVAYICSRFYR 208
Query: 145 RTPGCEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APEL Y T D++S G + E++ +
Sbjct: 209 ------APELMLGATEY--TPSIDLWSIGCVFGELILGK 239
|
| >2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 7e-08
Identities = 18/52 (34%), Positives = 33/52 (63%), Gaps = 6/52 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTH 137
+G+A+ H +++H D+KP+++L++ K ADFGLA+ + R +TH
Sbjct: 114 QGLAFCH---SHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVRTYTH 162
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 50.2 bits (121), Expect = 7e-08
Identities = 16/52 (30%), Positives = 32/52 (61%), Gaps = 6/52 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTH 137
KG+ + H + ++H D+KP+++L++ N K A+FGLA+ + R ++
Sbjct: 112 KGLGFCH---SRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRCYSA 160
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 7e-08
Identities = 14/56 (25%), Positives = 29/56 (51%), Gaps = 6/56 (10%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTHITST 141
+ + + H + +H D+KPE++L+ ++ K DFG A+L + + +T
Sbjct: 113 QAVNFCH---KHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDYYDDEVAT 165
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 9e-08
Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 6/52 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTH 137
+G+AY H RQK++H D+KP+++L++E K ADFGLA+ + + +
Sbjct: 111 RGLAYCH---RQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTKTYDN 159
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 50.3 bits (121), Expect = 9e-08
Identities = 26/52 (50%), Positives = 35/52 (67%), Gaps = 6/52 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTH 137
+G+ YLH + I+H D+KP ++LLDEN K ADFGLAK + NR +TH
Sbjct: 123 QGLEYLH---QHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRAYTH 171
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 9e-08
Identities = 19/52 (36%), Positives = 35/52 (67%), Gaps = 6/52 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTH 137
+G+A+ H + +I+H D+KP+++L++ + K ADFGLA+ + R +TH
Sbjct: 130 RGVAHCH---QHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVRSYTH 178
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 50.0 bits (120), Expect = 9e-08
Identities = 29/98 (29%), Positives = 45/98 (45%), Gaps = 16/98 (16%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFP-KAADFGLAKLY--NREHTHITSTGRRR 145
+ +AY+H I H DIKP+++LLD K DFG AK+ + + R
Sbjct: 152 RSLAYIH---SIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEPNVSYICSRYYR 208
Query: 146 TPGCEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APEL Y T D++S G ++ E++ +
Sbjct: 209 -----APELIFGATNY--TTNIDIWSTGCVMAELMQGQ 239
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 49.8 bits (120), Expect = 1e-07
Identities = 20/52 (38%), Positives = 34/52 (65%), Gaps = 6/52 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTH 137
GIAY H ++++H D+KP+++L++ K ADFGLA+ + R++TH
Sbjct: 111 NGIAYCH---DRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH 159
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 50.1 bits (120), Expect = 1e-07
Identities = 31/103 (30%), Positives = 49/103 (47%), Gaps = 21/103 (20%)
Query: 78 GQLREIEVS-----TSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
L+E+E++ +G+AYLH ++H D+K ++LL E K DFG A +
Sbjct: 149 KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMA 205
Query: 133 REHTHITSTGRRRTPGCEAPELWM-----PYSVTQKCDVFSFG 170
++ + G TP APE+ + Y K DV+S G
Sbjct: 206 PANSFV---G---TPYWMAPEVILAMDEGQY--DGKVDVWSLG 240
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 49.9 bits (120), Expect = 1e-07
Identities = 17/56 (30%), Positives = 27/56 (48%), Gaps = 6/56 (10%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN---REHTHITST 141
GI + H I+H DIKPE++L+ ++ K DFG A+ + +T
Sbjct: 135 NGIGFCH---SHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGEVYDDEVAT 187
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-07
Identities = 35/139 (25%), Positives = 57/139 (41%), Gaps = 43/139 (30%)
Query: 68 LLCKKNILGF--GQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAA-- 123
++ + N GF ++ + K + YL + + H D+KPE++LLD+ +F K+
Sbjct: 125 IITRNNYNGFHIEDIKLYCIEILKALNYLRKM---SLTHTDLKPENILLDDPYFEKSLIT 181
Query: 124 -----------------------DFGLAKLYNREHTHITSTGR--RRTPGCEAPE--LWM 156
DFG A + H I +T R R APE L +
Sbjct: 182 VRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDYHGSIINT-RQYR------APEVILNL 234
Query: 157 PYSVTQKCDVFSFGMLLFE 175
+ D++SFG +L E
Sbjct: 235 GWD--VSSDMWSFGCVLAE 251
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 49.6 bits (119), Expect = 1e-07
Identities = 28/97 (28%), Positives = 46/97 (47%), Gaps = 15/97 (15%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH--THITSTGRRRT 146
G+ LHE +VH D+ P ++LL +N DF LA+ + TH + R
Sbjct: 145 LGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADANKTHYVTHRWYR- 200
Query: 147 PGCEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APEL + + T+ D++S G ++ E+ R+
Sbjct: 201 ----APELVMQFKGF--TKLVDMWSAGCVMAEMFNRK 231
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 49.7 bits (119), Expect = 2e-07
Identities = 31/98 (31%), Positives = 45/98 (45%), Gaps = 16/98 (16%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFP-KAADFGLAKLY--NREHTHITSTGRRR 145
+ +AY+H I H DIKP+++LLD + K DFG AK + + R
Sbjct: 167 RSLAYIH---SFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYR 223
Query: 146 TPGCEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APEL Y T DV+S G +L E++ +
Sbjct: 224 -----APELIFGATDY--TSSIDVWSAGCVLAELLLGQ 254
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 49.1 bits (118), Expect = 2e-07
Identities = 16/52 (30%), Positives = 30/52 (57%), Gaps = 6/52 (11%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY---NREHTH 137
+G+A+ H KI+H D+KP+++L+++ K DFGLA+ + +
Sbjct: 119 QGLAFCH---ENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVNTFSS 167
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-07
Identities = 18/44 (40%), Positives = 22/44 (50%), Gaps = 6/44 (13%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAK 129
+ I YLH I H D+KPE++L N K DFG AK
Sbjct: 128 EAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAK 168
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 2e-07
Identities = 17/48 (35%), Positives = 32/48 (66%), Gaps = 3/48 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT 136
+G+ +LH ++VH D+KP+++L+ + K ADFGLA++Y+ +
Sbjct: 131 RGLDFLH---SHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQMA 175
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 2e-07
Identities = 31/113 (27%), Positives = 44/113 (38%), Gaps = 20/113 (17%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFPKAADFGLAK-L 130
L L + + G YL E +H DI + LL K DFG+A+ +
Sbjct: 137 LAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 193
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
Y + G P WMP + T K D +SFG+LL+E+
Sbjct: 194 YRASYY--RKGGCAMLPVK-----WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 239
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 49.1 bits (117), Expect = 2e-07
Identities = 25/92 (27%), Positives = 43/92 (46%), Gaps = 6/92 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
GI +LH I+H D+KP ++++ + K DFGLA+ T T
Sbjct: 175 CGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 228
Query: 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
APE+ + + D++S G ++ E+V +
Sbjct: 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHK 260
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 48.7 bits (117), Expect = 3e-07
Identities = 19/48 (39%), Positives = 30/48 (62%), Gaps = 3/48 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT 136
+G+ +LH IVH D+KPE++L+ K ADFGLA++Y+ +
Sbjct: 131 RGLDFLH---ANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA 175
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-07
Identities = 17/57 (29%), Positives = 30/57 (52%), Gaps = 11/57 (19%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFP-----KAADFGLAKLY---NREHTH 137
G+ + H ++ +H D+KP+++LL + K DFGLA+ + R+ TH
Sbjct: 143 NGVNFCH---SRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTH 196
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 48.9 bits (117), Expect = 3e-07
Identities = 28/114 (24%), Positives = 46/114 (40%), Gaps = 27/114 (23%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
K I YLH ++H D+KP ++LL+ K ADFGL++ + +
Sbjct: 120 KVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINEN 176
Query: 149 CE-------------------APEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
E APE+ Y T+ D++S G +L E++ +
Sbjct: 177 TENFDDDQPILTDYVATRWYRAPEILLGSTKY--TKGIDMWSLGCILGEILCGK 228
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 48.8 bits (117), Expect = 3e-07
Identities = 27/103 (26%), Positives = 49/103 (47%), Gaps = 16/103 (15%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
+ + LH ++H D+KP ++L++ N K DFGLA++ + + +++
Sbjct: 123 RAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGM 179
Query: 149 CE--------APEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
E APE+ Y ++ DV+S G +L E+ RR
Sbjct: 180 VEFVATRWYRAPEVMLTSAKY--SRAMDVWSCGCILAELFLRR 220
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 48.5 bits (116), Expect = 4e-07
Identities = 31/113 (27%), Positives = 44/113 (38%), Gaps = 20/113 (17%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFPKAADFGLAK-L 130
L L + + G YL E +H DI + LL K DFG+A+ +
Sbjct: 178 LAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDI 234
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
Y + G P WMP + T K D +SFG+LL+E+
Sbjct: 235 YRAGYY--RKGGCAMLPVK-----WMPPEAFMEGIFTSKTDTWSFGVLLWEIF 280
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 48.1 bits (115), Expect = 4e-07
Identities = 30/97 (30%), Positives = 50/97 (51%), Gaps = 17/97 (17%)
Query: 88 SKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-KLYNREHTHITSTGRRRT 146
+ G+AYL E +K VH D+ + L+ EN K ADFGL+ +Y+ ++
Sbjct: 184 AAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDA--- 237
Query: 147 PGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
P WMP Y+ T + DV+++G++L+E+
Sbjct: 238 ----IPIRWMPPESIFYNRYTTESDVWAYGVVLWEIF 270
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 48.0 bits (115), Expect = 5e-07
Identities = 25/114 (21%), Positives = 47/114 (41%), Gaps = 17/114 (14%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLA-K 129
K+ L + + G+ YL +VH D+ +VL+ + K +D GL +
Sbjct: 121 VKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFRE 177
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMP-----YSV-TQKCDVFSFGMLLFEVV 177
+Y ++ + P WM Y + D++S+G++L+EV
Sbjct: 178 VYAADYYKLLGNSL-------LPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVF 224
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 47.6 bits (114), Expect = 7e-07
Identities = 18/44 (40%), Positives = 28/44 (63%), Gaps = 3/44 (6%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
G+ Y+H R KI+H D+K +VL+ + K ADFGLA+ ++
Sbjct: 135 NGLYYIH---RNKILHRDMKAANVLITRDGVLKLADFGLARAFS 175
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 47.3 bits (113), Expect = 8e-07
Identities = 23/97 (23%), Positives = 49/97 (50%), Gaps = 10/97 (10%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITS-TGRRRT 146
+G+ Y+H ++H D+KP ++ ++ E+ K DFGLA++ + ++H + T
Sbjct: 131 RGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVT 187
Query: 147 PGCEAPEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
+P L Y T+ D+++ G + E++ +
Sbjct: 188 KWYRSPRLLLSPNNY--TKAIDMWAAGCIFAEMLTGK 222
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 47.6 bits (113), Expect = 8e-07
Identities = 29/152 (19%), Positives = 49/152 (32%), Gaps = 56/152 (36%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL------------------------ 114
+++I +G+ YLH +C +I+H DIKPE++LL
Sbjct: 147 CVKKIIQQVLQGLDYLHTKC--RIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPP 204
Query: 115 -------------------------DENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
E K AD G A ++ T T + R
Sbjct: 205 PSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDIQTRQYR---- 260
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
+ E+ + D++S + FE+
Sbjct: 261 -SLEVLIGSGYNTPADIWSTACMAFELATGDY 291
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 47.1 bits (112), Expect = 1e-06
Identities = 28/135 (20%), Positives = 48/135 (35%), Gaps = 33/135 (24%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
G+ Y+H I+H D+KP + L++++ K DFGLA+ + +
Sbjct: 167 VGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223
Query: 149 CE-------------------------APEL---WMPYSVTQKCDVFSFGMLLFEVVGRR 180
APEL Y T+ DV+S G + E++
Sbjct: 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENY--TEAIDVWSIGCIFAELLNMI 281
Query: 181 RNLEKEISEGQEWFP 195
+ ++ FP
Sbjct: 282 KENVAYHADRGPLFP 296
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 46.7 bits (111), Expect = 2e-06
Identities = 30/130 (23%), Positives = 49/130 (37%), Gaps = 28/130 (21%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148
G ++HE I+H D+KP + LL+++ K DFGLA+ N E
Sbjct: 140 LGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196
Query: 149 CE--------------------APEL---WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185
APEL Y T+ D++S G + E++ ++
Sbjct: 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENY--TKSIDIWSTGCIFAELLNMLQSHIN 254
Query: 186 EISEGQEWFP 195
+ + FP
Sbjct: 255 DPTNRFPLFP 264
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 45.0 bits (107), Expect = 5e-06
Identities = 21/127 (16%), Positives = 44/127 (34%), Gaps = 32/127 (25%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDI--------KPESVLLDENF 118
YL KN + E+ + + +L E ++H ++ + E
Sbjct: 102 YLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPP 158
Query: 119 FPKAADFGLAK-LYNREHTHITSTGRRRTPGCEAPELWMP-------YSVTQKCDVFSFG 170
F K +D G++ + ++ + W+P ++ D +SFG
Sbjct: 159 FIKLSDPGISITVLPKDIL-------------QERIPWVPPECIENPKNLNLATDKWSFG 205
Query: 171 MLLFEVV 177
L+E+
Sbjct: 206 TTLWEIC 212
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 44.8 bits (106), Expect = 6e-06
Identities = 17/59 (28%), Positives = 27/59 (45%), Gaps = 10/59 (16%)
Query: 89 KGIAYLHEECRQKIVHYDIKPESVLLDENFFP----KAADFGLAKLYN---REHTHITS 140
GI YLH ++H D+KP ++L+ K AD G A+L+N + +
Sbjct: 139 DGIHYLH---ANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDP 194
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 41.6 bits (98), Expect = 8e-05
Identities = 12/50 (24%), Positives = 23/50 (46%), Gaps = 5/50 (10%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKA--ADFGLAKLYNREHTHI 138
+ +LHE + VH ++ E++ +D + A +G A Y H+
Sbjct: 172 LEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHV 218
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 40.5 bits (95), Expect = 2e-04
Identities = 17/52 (32%), Positives = 25/52 (48%), Gaps = 7/52 (13%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKA--ADFGLAKLY--NREHTHI 138
+ Y+HE + VH DIK ++LL + AD+GL+ Y N H
Sbjct: 164 LEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQY 212
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 39.8 bits (93), Expect = 3e-04
Identities = 16/52 (30%), Positives = 24/52 (46%), Gaps = 7/52 (13%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKA--ADFGLAKLY--NREHTHI 138
+ Y+HE + VH DIK ++LL+ + D+GLA Y H
Sbjct: 165 LEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAY 213
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 39.3 bits (92), Expect = 4e-04
Identities = 10/92 (10%), Positives = 17/92 (18%), Gaps = 33/92 (35%)
Query: 90 GIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149
H R + P V + + A
Sbjct: 141 AADAAH---RAGVALSIDHPSRVRVSIDGDVVLAYPATM--------------------- 176
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFE-VVGRR 180
+ D+ G L+ +V R
Sbjct: 177 -PD-------ANPQDDIRGIGASLYALLVNRW 200
|
Structure Templates Detected by HHsearch 
Original result of HHsearch against PDB70 database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 202 | |||
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 99.98 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 99.98 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 99.98 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 99.98 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 99.98 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 99.98 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 99.98 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 99.97 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 99.97 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 99.97 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 99.97 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 99.97 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 99.97 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 99.97 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 99.97 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 99.97 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 99.97 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 99.97 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 99.97 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 99.97 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 99.97 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 99.97 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 99.97 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 99.97 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 99.97 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 99.97 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 99.97 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 99.97 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 99.97 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 99.97 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 99.97 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 99.97 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 99.97 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 99.97 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 99.97 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 99.97 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 99.97 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 99.97 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 99.97 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 99.97 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 99.97 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 99.97 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 99.97 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 99.97 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 99.97 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 99.97 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 99.97 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 99.97 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 99.97 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 99.97 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 99.97 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 99.97 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 99.97 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 99.97 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 99.97 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 99.97 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 99.97 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 99.97 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 99.97 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 99.97 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 99.97 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 99.97 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 99.97 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 99.97 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 99.97 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 99.97 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 99.97 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 99.97 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 99.97 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 99.97 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 99.97 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 99.97 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 99.97 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 99.97 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 99.97 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 99.97 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 99.97 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 99.97 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 99.97 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 99.97 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 99.97 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 99.97 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 99.97 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 99.97 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 99.97 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 99.97 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 99.97 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 99.97 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 99.97 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 99.97 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 99.97 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 99.97 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 99.97 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 99.97 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 99.97 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 99.97 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 99.97 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 99.97 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 99.97 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 99.97 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 99.97 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 99.97 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 99.97 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 99.97 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 99.97 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 99.97 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 99.97 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 99.97 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 99.97 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 99.97 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 99.97 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 99.97 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 99.97 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 99.97 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 99.97 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 99.97 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 99.97 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 99.97 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 99.97 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 99.96 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 99.96 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 99.96 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 99.96 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 99.96 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 99.96 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 99.96 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 99.96 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 99.96 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 99.96 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 99.96 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 99.96 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 99.96 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 99.96 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 99.96 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 99.96 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 99.96 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 99.96 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 99.96 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 99.96 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 99.96 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 99.96 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 99.96 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 99.96 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 99.96 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 99.96 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 99.96 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 99.96 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 99.96 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 99.96 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 99.96 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 99.96 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 99.96 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 99.96 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 99.96 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 99.96 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 99.96 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 99.96 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 99.96 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 99.96 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 99.96 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 99.96 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 99.96 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 99.96 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 99.96 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 99.96 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 99.96 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 99.96 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 99.96 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 99.96 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 99.96 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 99.96 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 99.96 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 99.96 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 99.96 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 99.96 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 99.96 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 99.96 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 99.96 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 99.96 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 99.96 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 99.96 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 99.96 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 99.95 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 99.95 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 99.95 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 99.95 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 99.95 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 99.95 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 99.95 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 99.95 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 99.94 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 99.93 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 99.92 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.85 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.7 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.45 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.16 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.31 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 98.18 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.04 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 97.81 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 97.35 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 96.56 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 96.45 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 95.93 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 95.67 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 94.57 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 93.41 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 93.27 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 92.62 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 92.39 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 92.37 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 91.31 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 89.58 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 89.39 | |
| 4ann_A | 215 | ESSB; membrane protein, membrane secretion, ESS ty | 88.97 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 88.67 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 88.55 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 87.76 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 87.42 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 86.26 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 85.95 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 85.21 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 84.97 |
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-44 Score=287.56 Aligned_cols=185 Identities=19% Similarity=0.285 Sum_probs=160.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||+|+++.+++.||.|+..............+..|..++...+|||++. ..+..+++++++++|+|..++.. +
T Consensus 48 V~~a~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~ 127 (311)
T 4aw0_A 48 VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG 127 (311)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS
T ss_pred EEEEEECCCCCEEEEEEEEHHHCCCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC
Confidence 7999999999999998866554444455567888888899999999874 44556789999999999998854 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+.+............+||+.|||||
T Consensus 128 ~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPE 204 (311)
T 4aw0_A 128 SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 204 (311)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHH
Confidence 79999999999999999999999 999999999999999999999999999999775444333445678999999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..|+.++||||+||++|||++|++||.+.+.
T Consensus 205 vl~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 239 (311)
T 4aw0_A 205 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 239 (311)
T ss_dssp HHHHSCBCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999999999999987554
|
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=284.86 Aligned_cols=180 Identities=20% Similarity=0.252 Sum_probs=156.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||+|+++.+++.||.|+.... .......+..|..++...+|+||+. ..+..+++++|+++|+|..++..+.
T Consensus 90 V~~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~ 166 (346)
T 4fih_A 90 VCIATVRSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR 166 (346)
T ss_dssp EEEEEETTTCCEEEEEEEEGG---GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHHSC
T ss_pred EEEEEECCCCCEEEEEEEecC---chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC
Confidence 799999999999998875433 2233455778888899999999884 3455679999999999999999899
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+|+....... .....+||+.|||||+
T Consensus 167 l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEv 241 (346)
T 4fih_A 167 MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEL 241 (346)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSC--CBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEECCCCCEEEecCcCceecCCCCC--cccccccCcCcCCHHH
Confidence 9999999999999999999999 9999999999999999999999999999987654332 2345689999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+..|+.++||||+||++|||++|++||.+...
T Consensus 242 l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 275 (346)
T 4fih_A 242 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 275 (346)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 9999999999999999999999999999987654
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=285.82 Aligned_cols=180 Identities=20% Similarity=0.252 Sum_probs=156.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||+|+++.+++.||.|+.... .......+..|..++...+|+||+. ..+..+++++|+++|+|..+++.+.
T Consensus 167 V~~a~~~~tg~~vAiK~i~~~---~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~~~ 243 (423)
T 4fie_A 167 VCIATVRSSGKLVAVKKMDLR---KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTHTR 243 (423)
T ss_dssp EEEEEETTTCCEEEEEEEEST---TCSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHSC
T ss_pred EEEEEECCCCCEEEEEEEecc---chhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhccC
Confidence 799999999999998875433 2233455778888899999999884 3455679999999999999999999
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+....... .....+||+.|||||+
T Consensus 244 l~e~~~~~~~~qil~aL~ylH~---~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GTp~YmAPEv 318 (423)
T 4fie_A 244 MNEEQIAAVCLAVLQALSVLHA---QGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEVP--RRKSLVGTPYWMAPEL 318 (423)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSCC--CBCCCEECTTTCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEecCccceECCCCCc--cccccccCcCcCCHHH
Confidence 9999999999999999999999 9999999999999999999999999999987654322 2345679999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+..|+.++||||+||++|||++|++||.+...
T Consensus 319 l~~~~y~~~~DiWSlGvilyeml~G~~PF~~~~~ 352 (423)
T 4fie_A 319 ISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPP 352 (423)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 9999999999999999999999999999987654
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-42 Score=276.30 Aligned_cols=178 Identities=17% Similarity=0.148 Sum_probs=146.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||+++++.+++.||.|+.+.. .....|..++...+||||+. ..+..+++++|+++|+|..+++. +
T Consensus 74 Vy~a~~~~~g~~vAiK~i~~~--------~~~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~ 145 (336)
T 4g3f_A 74 VHRMKDKQTGFQCAVKKVRLE--------VFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMG 145 (336)
T ss_dssp EEEEEETTTCCEEEEEEEETT--------TCCTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS
T ss_pred EEEEEECCCCCEEEEEEECHH--------HhHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcC
Confidence 799999999999998875421 12345777788889999874 34556789999999999998854 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCcc---cccCCCCCCCcc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTH---ITSTGRRRTPGC 149 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~---~~~~~~~gt~~y 149 (202)
.+++.+++.++.|++.||.|||+ ++||||||||+|||++.++ .+||+|||+|+........ ......+||+.|
T Consensus 146 ~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~Y 222 (336)
T 4g3f_A 146 CLPEDRALYYLGQALEGLEYLHT---RRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETH 222 (336)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccc
Confidence 79999999999999999999999 9999999999999999987 6999999999976543221 122345799999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
||||++.+..|+.++||||+||++|||++|++||.+....
T Consensus 223 mAPE~~~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~~ 262 (336)
T 4g3f_A 223 MAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRG 262 (336)
T ss_dssp CCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSTTTCCS
T ss_pred cCHHHHCCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCHH
Confidence 9999999999999999999999999999999999875543
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=274.06 Aligned_cols=181 Identities=22% Similarity=0.316 Sum_probs=141.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc--C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--~ 73 (202)
||+++..+. ||+|+.+.... ..+...+|..|..+....+|+|++. ..+...++++|+++|+|..++.. .
T Consensus 52 Vy~~~~~~~---vAvK~~~~~~~-~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~iVmEy~~gGsL~~~l~~~~~ 127 (307)
T 3omv_A 52 VYKGKWHGD---VAVKILKVVDP-TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTKDNLAIVTQWCEGSSLYKHLHVQET 127 (307)
T ss_dssp EEEEESSSE---EEEEECCCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCSSCBHHHHHHTSCC
T ss_pred EEEEEECCc---EEEEEEEecCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEECCeEEEEEEcCCCCCHHHHHhhcCC
Confidence 688876543 56665433221 1223456888999999999999874 23345689999999999998843 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+...............||+.|||||
T Consensus 128 ~l~~~~~~~i~~qia~gL~yLH~---~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE 204 (307)
T 3omv_A 128 KFQMFQLIDIARQTAQGMDYLHA---KNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPE 204 (307)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCSSSEEEETTEEEEECCCSSCBC------------CCCCTTSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccCCccCHHHEEECCCCcEEEeeccCceecccCCcceeecccccCCCccCHH
Confidence 69999999999999999999999 999999999999999999999999999998765433333345567999999999
Q ss_pred ccCC---CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMP---YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~---~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+ .+|+.++|||||||++|||+||++||.+..+
T Consensus 205 ~l~~~~~~~y~~ksDVwS~Gvvl~Elltg~~Pf~~~~~ 242 (307)
T 3omv_A 205 VIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINN 242 (307)
T ss_dssp HHHCCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred HhhccCCCCCCcHHHhHhHHHHHHHHHHCCCCCCCCCh
Confidence 9863 4689999999999999999999999986543
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-43 Score=280.73 Aligned_cols=182 Identities=16% Similarity=0.212 Sum_probs=152.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||+++++.+++.||.|+....... .....++..|..++...+|+||+. ..+..+++++|+++|+|.+++..
T Consensus 40 V~~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~ 118 (350)
T 4b9d_A 40 AILVKSTEDGRQYVIKEINISRMS-SKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118 (350)
T ss_dssp EEEEEETTTCCEEEEEEEECTTSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTT
T ss_pred EEEEEECCCCCEEEEEEEehHHCC-HHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcC
Confidence 799999999999998875433221 122346778888899999999884 34556789999999999998843
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++.+++.++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+....... .....+||+.|||
T Consensus 119 ~~~~~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~YmA 193 (350)
T 4b9d_A 119 GVLFQEDQILDWFVQICLALKHVHD---RKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE--LARACIGTPYYLS 193 (350)
T ss_dssp TCCCCHHHHHHHHHHHHHHHHHHHH---TTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHHH--HHHHHHSCCTTCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHHHEEECCCCCEEEcccccceeecCCcc--cccccCCCccccC
Confidence 347999999999999999999999 9999999999999999999999999999987643221 1233568999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||++.+..|+.++||||+||++|||++|++||.+.+.
T Consensus 194 PE~l~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~ 230 (350)
T 4b9d_A 194 PEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230 (350)
T ss_dssp HHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHHHCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCH
Confidence 9999999999999999999999999999999987654
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-42 Score=270.82 Aligned_cols=178 Identities=20% Similarity=0.290 Sum_probs=146.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc----------ccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE----------DTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~l~~~~ 70 (202)
||+|++..++..||.|........ .....+|..|..+....+|||++... ...+++++++++|+|..++
T Consensus 42 Vy~a~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l 120 (290)
T 3fpq_A 42 VYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120 (290)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHH
T ss_pred EEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHH
Confidence 799999999999987765433211 12235688899999999999998532 2246889999999999988
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCC
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQK--IVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.. +.+++..++.++.|++.||.|||+ ++ ||||||||+|||++. ++.+||+|||+|+...... ....+||
T Consensus 121 ~~~~~l~~~~~~~~~~qi~~aL~ylH~---~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~~~----~~~~~GT 193 (290)
T 3fpq_A 121 KRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 193 (290)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSS
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCCCc----cCCcccC
Confidence 54 569999999999999999999998 77 999999999999974 7899999999997543221 2345789
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.|||||++.+ .|+.++||||+||++|||+||++||.+..
T Consensus 194 p~YmAPE~~~~-~y~~~~DiwSlGvilyelltg~~Pf~~~~ 233 (290)
T 3fpq_A 194 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ccccCHHHcCC-CCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 99999999875 69999999999999999999999997543
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-41 Score=266.67 Aligned_cols=181 Identities=21% Similarity=0.297 Sum_probs=139.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||+++++.+++.||.|+.........+...++..|..+....+|||++. ..+..+++++++ +|+|.+++ +.+
T Consensus 29 V~~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~ 107 (275)
T 3hyh_A 29 VKLAYHTTTGQKVALKIINKKVLAKSDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRD 107 (275)
T ss_dssp EEEEECTTTCCEEEEEEEECC------CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSC
T ss_pred EEEEEECCCCCEEEEEEEeHHHcCCHHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcC
Confidence 7899999999999988765443333344556788888889999999874 344556889988 56776665 556
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....... ....+||+.|||||
T Consensus 108 ~l~e~~~~~~~~qi~~al~ylH~---~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~~---~~~~~GT~~Y~APE 181 (275)
T 3hyh_A 108 KMSEQEARRFFQQIISAVEYCHR---HKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPE 181 (275)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTCCEEECCSSCC------------------CTTSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCChHHeEECCCCCEEEeecCCCeecCCCCc---cCCeeECcccCChh
Confidence 79999999999999999999999 9999999999999999999999999999986543322 23467899999999
Q ss_pred ccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..+ +.++||||+||++|||++|++||.+.+.
T Consensus 182 ~~~~~~y~~~~~DiwSlGvily~lltg~~PF~~~~~ 217 (275)
T 3hyh_A 182 VISGKLYAGPEVDVWSCGVILYVMLCRRLPFDDESI 217 (275)
T ss_dssp HHSSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhcCCCCCCChhhhHHHHHHHHHHHHCCCCCCCCCH
Confidence 9998876 5799999999999999999999986543
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.8e-42 Score=273.23 Aligned_cols=183 Identities=22% Similarity=0.248 Sum_probs=143.6
Q ss_pred CCccccC---CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+|++. ..++.||.|+.+..... .....++..|..++...+|||++. ..+..+++++++++|+|..++.
T Consensus 40 Vy~a~~~~~~~~~~~vAiK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~ 118 (304)
T 3ubd_A 40 VFLVKKISGSDARQLYAMKVLKKATLK-VRDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLS 118 (304)
T ss_dssp EEEEEECSSTTTTCEEEEEEEESEEEE-EEECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHH
T ss_pred EEEEEEccCCCCCEEEEEEEEehHHcC-hHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHH
Confidence 6778763 45677888775443222 223345777877888889999874 3455679999999999998885
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. +.+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+....... .....+||+.||
T Consensus 119 ~~~~l~e~~~~~~~~qi~~aL~ylH~---~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~~--~~~~~~GT~~Ym 193 (304)
T 3ubd_A 119 KEVMFTEEDVKFYLAELALALDHLHS---LGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHEK--KAYSFCGTVEYM 193 (304)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTSCEEEESSEEEEC-----C--CCCSCCCCGGGC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHeEEcCCCCEEecccccceeccCCCc--cccccccCcccC
Confidence 4 579999999999999999999999 9999999999999999999999999999986433221 234467899999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||++.+..|+.++||||+||++|||++|++||.+.+..
T Consensus 194 APE~~~~~~y~~~~DiwSlGvilyemltG~~PF~~~~~~ 232 (304)
T 3ubd_A 194 APEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRK 232 (304)
T ss_dssp CHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHhccCCCCCCCcccchHHHHHHHHhCCCCCCCcCHH
Confidence 999999999999999999999999999999999876543
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=270.67 Aligned_cols=184 Identities=18% Similarity=0.169 Sum_probs=149.7
Q ss_pred CCccccC-----CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNR-----GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~-----~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
|||++.. ..++.||+|..+.. .......+|..|..+....+|||++. ..+...++++|+++|+|..+
T Consensus 42 Vykg~~~~~~~~~~~~~VAvK~l~~~--~~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~ 119 (308)
T 4gt4_A 42 VYKGHLFGPAPGEQTQAVAIKTLKDK--AEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEF 119 (308)
T ss_dssp EEEEEEC-------CEEEEEEECCC---CCC-CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHH
T ss_pred EEEEEEcCCccCCCCeEEEEEEECcc--cChHHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHH
Confidence 6777643 35677887765432 22233456888999999999999884 33445799999999999998
Q ss_pred hcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecc
Q 044746 70 CKK-----------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132 (202)
Q Consensus 70 ~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~ 132 (202)
+.. ..+++.++..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+++...
T Consensus 120 L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~ 196 (308)
T 4gt4_A 120 LVMRSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSS---HHVVHKDLATRNVLVYDKLNVKISDLGLFREVY 196 (308)
T ss_dssp HHTTCSSCCCC-----CCEECCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCSCCBCGGG
T ss_pred HHhhCccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCccccceEECCCCCEEECCcccceecc
Confidence 842 358999999999999999999999 999999999999999999999999999998765
Q ss_pred ccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 133 REHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 133 ~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
............||+.|||||++.+..++.++|||||||++|||+| |++||.+....
T Consensus 197 ~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~ 254 (308)
T 4gt4_A 197 AADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQ 254 (308)
T ss_dssp GGGCBCSSSSSCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTCCHH
T ss_pred CCCceeEecccccCCcccCHHHHhCCCCCccchhhhHHHHHHHHHhCCCCCCCCCCHH
Confidence 4443334455678999999999999999999999999999999998 89999876543
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-42 Score=271.79 Aligned_cols=183 Identities=17% Similarity=0.238 Sum_probs=149.7
Q ss_pred CCccccC-----CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNR-----GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~-----~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||+++.. .++..||+|+.+.... ....+|..|..+....+|||++. ..+...+++||+++|+|..+
T Consensus 29 Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~ 105 (299)
T 4asz_A 29 VFLAECYNLCPEQDKILVAVKTLKDASD---NARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKF 105 (299)
T ss_dssp EEEEEECSCC----CEEEEEEEECSCCH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred EEEEEECCcccCCCCEEEEEEEeCCCCh---HHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHH
Confidence 6777654 3567788776543221 22346888989999999999884 33456799999999999998
Q ss_pred hcc--------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC
Q 044746 70 CKK--------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH 135 (202)
Q Consensus 70 ~~~--------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~ 135 (202)
+.. ..+++.++..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+......
T Consensus 106 l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~ 182 (299)
T 4asz_A 106 LRAHGPDAVLMAEGNPPTELTQSQMLHIAQQIAAGMVYLAS---QHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTD 182 (299)
T ss_dssp HHHTSHHHHHC----CCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG
T ss_pred HHhcCcccccccccCCCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccCHhhEEECCCCcEEECCcccceecCCCC
Confidence 854 359999999999999999999999 999999999999999999999999999998665444
Q ss_pred cccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 136 THITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 136 ~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
.........||+.|||||++.+..++.++|||||||++|||+| |++||.+..+.
T Consensus 183 ~~~~~~~~~gt~~ymAPE~~~~~~~~~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~ 237 (299)
T 4asz_A 183 YYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNN 237 (299)
T ss_dssp CEEETTTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred ceeecCceecChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCCCHH
Confidence 3333444568999999999999999999999999999999999 89999876543
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-41 Score=270.59 Aligned_cols=182 Identities=16% Similarity=0.251 Sum_probs=140.7
Q ss_pred CCccccC-----CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNR-----GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~-----~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||+++.+ .++..||+|+.+.... ....+|..|..++...+|+|++. ......++++|+++|+|..+
T Consensus 57 Vy~a~~~~~~~~~~~~~vAvK~l~~~~~---~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~ 133 (329)
T 4aoj_A 57 VFLAECHNLLPEQDKMLVAVKALKEASE---SARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRF 133 (329)
T ss_dssp EEEEEESSSCC---CEEEEEEEESCCSH---HHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHH
T ss_pred EEEEEECCcccCCCCeEEEEEEECcCCH---HHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHH
Confidence 6777643 4567788776543222 22346888999999999999874 34456789999999999998
Q ss_pred hcc----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccc
Q 044746 70 CKK----------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR 133 (202)
Q Consensus 70 ~~~----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~ 133 (202)
+.. ..+++.++..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+++....
T Consensus 134 l~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~ 210 (329)
T 4aoj_A 134 LRSHGPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAG---LHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYS 210 (329)
T ss_dssp HHTSSCC-----------CCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC-------
T ss_pred HHhcCcccccccccccccCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecccccHhhEEECCCCcEEEcccccceeccC
Confidence 753 359999999999999999999999 9999999999999999999999999999987654
Q ss_pred cCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 134 EHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 134 ~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
...........||+.|||||++.+..++.++|||||||++|||+| |+.||.....
T Consensus 211 ~~~~~~~~~~~gt~~ymAPE~~~~~~~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~ 266 (329)
T 4aoj_A 211 TDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIFTYGKQPWYQLSN 266 (329)
T ss_dssp ---------CCCCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSSCH
T ss_pred CCcceecCcccccccccChhhhcCCCCCccccccchHHHHHHHHcCCCCCCCCCCH
Confidence 433333445678999999999999999999999999999999999 8999986554
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-40 Score=259.80 Aligned_cols=181 Identities=19% Similarity=0.217 Sum_probs=135.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc----------cceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED----------TETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~l~~~~ 70 (202)
|||++.. ++.||+|+.+...... ..+..|.......+|+|++...+ ..+++++|+++|+|..++
T Consensus 19 Vy~~~~~--g~~VAvK~l~~~~~~~----~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l 92 (303)
T 3hmm_A 19 VWRGKWR--GEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92 (303)
T ss_dssp EEEEEET--TEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHH
T ss_pred EEEEEEC--CEEEEEEEECccchhh----HHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHH
Confidence 7888874 5667777654332211 11222333445678999874222 236899999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc--ccCCC
Q 044746 71 KKNILGFGQLREIEVSTSKGIAYLHEEC-----RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI--TSTGR 143 (202)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~--~~~~~ 143 (202)
+...++++.+..++.|++.||.|||+.+ ..+||||||||+|||++.++.+||+|||+|+......... .....
T Consensus 93 ~~~~l~~~~~~~i~~~ia~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~ 172 (303)
T 3hmm_A 93 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172 (303)
T ss_dssp HHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC----
T ss_pred HhCCCCHHHHHHHHHHHHHHHHHHHHhhhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccc
Confidence 9999999999999999999999999721 1399999999999999999999999999998765433221 22345
Q ss_pred CCCCcccCCcccCCC------CCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 144 RRTPGCEAPELWMPY------SVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~------~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.||+.|||||++.+. .++.++|||||||++|||+||.+||....
T Consensus 173 ~GT~~ymAPE~l~~~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~ 222 (303)
T 3hmm_A 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 222 (303)
T ss_dssp -CCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCC
T ss_pred cccccccCHHHhcccccccCCccChhHhhhhHHHHHHHHHHCCCCCCccc
Confidence 789999999999764 36789999999999999999998875443
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-40 Score=266.31 Aligned_cols=183 Identities=21% Similarity=0.278 Sum_probs=143.9
Q ss_pred CCccccCCC-----cceeehhhhchhhhhccCCcccCCcHHHHHHhcc-cccccc---c----cccceEEEEEccCCchh
Q 044746 1 MEKPRNRGS-----TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN-FSNLVG---S----EDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~-----~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~---~----~~~~~~~~~~~~~~~l~ 67 (202)
||+|+..+. .+.||+|..+..... .....|..|..++...+ |+|++. . ++...++++|+++|+|.
T Consensus 80 Vy~a~~~~~~~~~~~k~VAvK~l~~~~~~--~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~ 157 (353)
T 4ase_A 80 VIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 157 (353)
T ss_dssp EEEEEEETSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHH
T ss_pred EEEEEEcCCCcccCCeEEEEEEEccccCh--HHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHH
Confidence 677765443 356776654332211 12345667776666654 477763 2 23456899999999999
Q ss_pred hhhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 68 LLCKK-----------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 68 ~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
.+++. ..+++.++..++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+.
T Consensus 158 ~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~yLH~---~~iiHRDLK~~NILl~~~~~vKi~DFGlar~ 234 (353)
T 4ase_A 158 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD 234 (353)
T ss_dssp HHHHHTGGGBCCC-------CTTCBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred HHHHhcccccccccccchhhccccCCHHHHHHHHHHHHHHHHhHhh---CCeecCccCccceeeCCCCCEEECcchhhhh
Confidence 98843 348999999999999999999999 9999999999999999999999999999987
Q ss_pred ccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 131 ~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
..............||+.|||||++.+..|+.++|||||||++|||+| |++||.+...
T Consensus 235 ~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~ 293 (353)
T 4ase_A 235 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 293 (353)
T ss_dssp TTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred cccCCCceeeccccccccccCHHHHhcCCCCCcccEeehHHHHHHHHhCCCCCCCCCCH
Confidence 655444444455678999999999999999999999999999999998 9999987543
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-39 Score=257.55 Aligned_cols=179 Identities=16% Similarity=0.195 Sum_probs=137.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------------cceEEEEEcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------------TETYIKGFLA 62 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------------~~~~~~~~~~ 62 (202)
||+|+++.+++.||.|+.+.... .....++..|..++...+|||++...+ +.++++++++
T Consensus 21 V~~a~~~~~~~~vAiK~i~~~~~--~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~ 98 (299)
T 4g31_A 21 VFEAKNKVDDCNYAIKRIRLPNR--ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98 (299)
T ss_dssp EEEEEETTTCCEEEEEEEEECSS--HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCC
T ss_pred EEEEEECCCCCEEEEEEEeccCC--HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCC
Confidence 79999999899888876433211 112235677888888999999985332 2468899999
Q ss_pred CCchhhhhccCC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-
Q 044746 63 MGPFYLLCKKNI----LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH- 137 (202)
Q Consensus 63 ~~~l~~~~~~~~----~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~- 137 (202)
+|+|..++.... .++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+|+........
T Consensus 99 gg~L~~~l~~~~~~~~~~~~~~~~i~~qi~~al~ylH~---~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~ 175 (299)
T 4g31_A 99 KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQ 175 (299)
T ss_dssp SCCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCCCC----------
T ss_pred CCcHHHHHHhcCCCChhHHHHHHHHHHHHHHHHHHHHH---CcCccccCcHHHeEECCCCcEEEccCccceecCCCcccc
Confidence 999999886542 4566789999999999999999 99999999999999999999999999999876433211
Q ss_pred ---------cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 138 ---------ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 138 ---------~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
....+.+||+.|||||++.+..|+.++||||+||++|||++ ||....
T Consensus 176 ~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~ 231 (299)
T 4g31_A 176 TVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFSLGLILFELLY---PFSTQM 231 (299)
T ss_dssp ----------------CCCTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHH
T ss_pred ccccccccccccCCcccCccccCHHHHcCCCCCCHHHHHHHHHHHHHHcc---CCCCcc
Confidence 11234579999999999999999999999999999999996 776543
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-39 Score=264.65 Aligned_cols=184 Identities=19% Similarity=0.270 Sum_probs=146.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l~~ 68 (202)
||+|+++.+++.||.|+.+..... .....++..|..++...+|+|++... +..++++++++ |+|..
T Consensus 70 V~~a~~~~t~~~vAiK~i~~~~~~-~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~ 147 (398)
T 4b99_A 70 VSSARRRLTGQQVAIKKIPNAFDV-VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQ 147 (398)
T ss_dssp EEEEEETTTCCEEEEEEETTTTSS-HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHH
T ss_pred EEEEEECCCCCEEEEEEECccccc-hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHH
Confidence 799999999999998875432211 12234566788888899999987532 34578899996 56766
Q ss_pred hh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC--cccccCCCCC
Q 044746 69 LC-KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH--THITSTGRRR 145 (202)
Q Consensus 69 ~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~--~~~~~~~~~g 145 (202)
++ ..+.+++.+++.++.|++.||.|||+ ++||||||||+|||++.++.+|++|||+|+.+.... ........+|
T Consensus 148 ~i~~~~~l~~~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~G 224 (398)
T 4b99_A 148 IIHSSQPLTLEHVRYFLYQLLRGLKYMHS---AQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVA 224 (398)
T ss_dssp HHTSSSCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCC
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CcCcCCCcCccccccCCCCCEEEeecceeeecccCcccccccccccee
Confidence 66 45679999999999999999999999 999999999999999999999999999998654321 1222345689
Q ss_pred CCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 146 TPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 146 t~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|+.|+|||++.+. .++.++||||+||++|||++|++||.+.+..
T Consensus 225 T~~Y~APEv~~~~~~~~~~~DiWSlG~il~ell~G~~pF~g~~~~ 269 (398)
T 4b99_A 225 TRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYV 269 (398)
T ss_dssp CCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTSCSSCCSSHH
T ss_pred ChHhcCHHHhcCCCCCCChhheehhHHHHHHHHHCCCCCCCCCHH
Confidence 9999999998875 5689999999999999999999999876543
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-39 Score=274.97 Aligned_cols=182 Identities=17% Similarity=0.270 Sum_probs=147.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHH---HHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQ---RMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+|+++.+++.+|.|+..+..............|. .+....+||+++. ..+..+++++++++|+|..++.
T Consensus 205 V~la~~~~tg~~~AiK~i~K~~i~~~~~~~~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~ 284 (689)
T 3v5w_A 205 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 284 (689)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEeHHHcchhhhHHHHHHHHHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHH
Confidence 799999999999999886554333322222233332 2334568898874 4456678999999999998885
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. +.+++..++.++.||+.||+|||+ ++||||||||+|||++.+|.+||+|||+|+...... ....+||+.||
T Consensus 285 ~~~~l~E~~a~~y~~qIl~aL~yLH~---~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~~----~~t~~GTp~Ym 357 (689)
T 3v5w_A 285 QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 357 (689)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSCC----CCSCCSCGGGC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCchHHeEEeCCCCEEecccceeeecCCCC----CCCccCCcCcc
Confidence 4 579999999999999999999999 999999999999999999999999999998765432 24468999999
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||++.. ..|+.++|+||+||++|||++|++||.+....
T Consensus 358 APEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~~~ 397 (689)
T 3v5w_A 358 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 397 (689)
T ss_dssp CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGGCC
T ss_pred CHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 9999974 57999999999999999999999999875543
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.9e-38 Score=253.47 Aligned_cols=178 Identities=23% Similarity=0.333 Sum_probs=136.7
Q ss_pred CCccccC---CCcceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc------ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG------SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||+|+++ ..++.||.|..... ....++..|...+.. .+|+|++. ..+..+++++++++|+|..++
T Consensus 37 Vy~a~~~~~~~~~~~vAiK~i~~~-----~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~ 111 (361)
T 4f9c_A 37 VYLATAQLQVGPEEKIALKHLIPT-----SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDIL 111 (361)
T ss_dssp EEEEEEEBTTSCEEEEEEEEECTT-----SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHH
T ss_pred EEEEEEcccCCCCCEEEEEEEccc-----cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHH
Confidence 6888753 45677777753222 122334455554444 47898874 345567889999999999988
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-CceEEeeeecceeccccCcc------------
Q 044746 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTH------------ 137 (202)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-~~~kl~dfgl~~~~~~~~~~------------ 137 (202)
+ .+++.+++.++.|++.||+|||+ ++|+||||||+|||++.+ +.+||+|||+|+........
T Consensus 112 ~--~l~~~~~~~~~~qll~al~ylH~---~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~ 186 (361)
T 4f9c_A 112 N--SLSFQEVREYMLNLFKALKRIHQ---FGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQE 186 (361)
T ss_dssp T--TCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC-------
T ss_pred c--CCCHHHHHHHHHHHHHHHHHHHH---CCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccc
Confidence 4 59999999999999999999999 999999999999999876 79999999999865332110
Q ss_pred --------------cccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 138 --------------ITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 138 --------------~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
......+||+.|+|||++.+. .++.++||||+||++|||++|++||....+
T Consensus 187 ~~~~~~~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~ 252 (361)
T 4f9c_A 187 RCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASD 252 (361)
T ss_dssp -------------------CCCCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred ccccccccccccccccccccccCccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCC
Confidence 112345799999999999875 489999999999999999999999965443
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-36 Score=260.32 Aligned_cols=180 Identities=18% Similarity=0.257 Sum_probs=149.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||+++++.+++.||.|+........ ...+..|..++...+|+|++. ..+..+++++++++|+|..++. .
T Consensus 173 V~~~~~~~tg~~~AiK~i~~~~~~~---~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~ 249 (573)
T 3uto_A 173 VHRVTERATGNNFAAKFVMTPHESD---KETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH 249 (573)
T ss_dssp EEEEEETTTCCEEEEEEEECCSHHH---HHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTT
T ss_pred EEEEEECCCCCEEEEEEEeccchhh---HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhC
Confidence 6899999999999887654332221 234566778888899999874 4555678999999999998874 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC--CceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN--FFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~--~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
+.+++.+++.++.||+.||.|||+ ++|+||||||+|||++.+ +.+||+|||+|+.+...... ...+||+.||
T Consensus 250 ~~l~e~~~~~~~~qi~~al~ylH~---~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~~~~---~~~~GT~~y~ 323 (573)
T 3uto_A 250 NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFA 323 (573)
T ss_dssp SCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTTSEE---EEECSSGGGC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeeccCChhhccccCCCCCCEEEeeccceeEccCCCce---eeeEECcccc
Confidence 569999999999999999999999 999999999999999854 89999999999976543322 2346899999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||++.+..|+.++||||+||++|||++|++||.+....
T Consensus 324 APEv~~~~~y~~~~DiWSlGvilyeml~G~~Pf~~~~~~ 362 (573)
T 3uto_A 324 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 362 (573)
T ss_dssp CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred CHHHhCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCcCHH
Confidence 999999999999999999999999999999999876543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-36 Score=246.06 Aligned_cols=185 Identities=18% Similarity=0.251 Sum_probs=156.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.+|.|+.+............+..|..+....+|++++. .....+++++++++|+|..++....
T Consensus 85 V~~~~~~~~~~~~AiK~~~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~ 164 (410)
T 3v8s_A 85 VQLVRHKSTRKVYAMKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD 164 (410)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTCCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHCC
T ss_pred EEEEEECCCCcEEEEEEEehhhhhhhHHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHcCC
Confidence 7899999999999998876655555555556777888888889998874 4455678999999999999998889
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........ ......||+.|+|||+
T Consensus 165 ~~e~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~~~-~~~~~~gt~~Y~APE~ 240 (410)
T 3v8s_A 165 VPEKWARFYTAEVVLALDAIHS---MGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGMV-RCDTAVGTPDYISPEV 240 (410)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSEE-ECCSCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeEeccCCHHHeeECCCCCEEEeccceeEeeccCCcc-cccCCcCCccccCHHH
Confidence 9999999999999999999999 99999999999999999999999999999876543221 2234678999999999
Q ss_pred cCCCC----CCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 155 WMPYS----VTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 155 ~~~~~----~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
+.+.. ++.++|+||+||++|||++|++||......
T Consensus 241 l~~~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 279 (410)
T 3v8s_A 241 LKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLV 279 (410)
T ss_dssp HHTTTTTCEEETHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred hhccCCCcCCCCcceEecchHHHHHHHhCCCCCCCCChh
Confidence 97655 788999999999999999999999865543
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-35 Score=245.75 Aligned_cols=184 Identities=18% Similarity=0.248 Sum_probs=154.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.+|.|+.+............+..|..+....+|++++. ..+...++++++++|+|..++..
T Consensus 90 V~~~~~~~~~~~vAvK~~~~~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~ 169 (437)
T 4aw2_A 90 VAVVKLKNADKVFAMKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFE 169 (437)
T ss_dssp EEEEEETTTTEEEEEEEEEHHHHHHTTTTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTT
T ss_pred EEEEEEcCCCcEEEEEEEEHHHhhhHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHcc
Confidence 7899999999999988876655444444555777877888889998763 44556789999999999999865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........ ......||+.|+||
T Consensus 170 ~~l~e~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~~-~~~~~~GT~~Y~AP 245 (437)
T 4aw2_A 170 DRLPEEMARFYLAEMVIAIDSVHQ---LHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGTV-QSSVAVGTPDYISP 245 (437)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECCSCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCCc-ccccccCCcCeeCh
Confidence 579999999999999999999999 99999999999999999999999999999865443222 23345789999999
Q ss_pred cccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++. ...++.++|+||+||++|||++|++||.....
T Consensus 246 E~l~~~~~~~~~~~~~~DvwSlGvil~elltG~~Pf~~~~~ 286 (437)
T 4aw2_A 246 EILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESL 286 (437)
T ss_dssp HHHHHHHTSCCEECTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HHHhhcccCCCCCCCcCeeHHHHHHHHHHHhCCCCCCCCCh
Confidence 9986 45789999999999999999999999986554
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-34 Score=237.95 Aligned_cols=181 Identities=22% Similarity=0.270 Sum_probs=145.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+.+............+..|..+... .+|++++. ..+...++++++++|+|..++..
T Consensus 68 V~~~~~~~~~~~~AvK~~~k~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~ 147 (396)
T 4dc2_A 68 VLLVRLKKTDRIYAMRVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 147 (396)
T ss_dssp EEEEEETTTTEEEEEEEEEGGGTC----CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHc
Confidence 78999999999999888665443333334445555554443 47888764 34556789999999999887754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ......+||+.|+||
T Consensus 148 ~~l~~~~~~~~~~qi~~aL~~LH~---~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~--~~~~~~~gt~~Y~aP 222 (396)
T 4dc2_A 148 RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAP 222 (396)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCBCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEECCCCCEEEeecceeeecccCC--CccccccCCcccCCc
Confidence 579999999999999999999999 999999999999999999999999999998532221 123456789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|++.+..++.++|+||+||++|||++|++||...
T Consensus 223 E~l~~~~~~~~~DiwslGvllyell~G~~Pf~~~ 256 (396)
T 4dc2_A 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIV 256 (396)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSTTT
T ss_pred hhhcCCCCChHHHHHHHHHHHHHHHhCCCCCccc
Confidence 9999999999999999999999999999999643
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-35 Score=233.94 Aligned_cols=183 Identities=19% Similarity=0.279 Sum_probs=151.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.+|.|+.+............+..|..+....+|++++. ..+...++++++++|+|..++.. +
T Consensus 21 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~ 100 (337)
T 1o6l_A 21 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER 100 (337)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred EEEEEECCCCCEEEEEEEeHHHhhhhhHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcC
Confidence 6889999889999988876554434444455667777778888998763 34456789999999999887754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...... .......||+.|+|||
T Consensus 101 ~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE 175 (337)
T 1o6l_A 101 VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG--ATMKTFCGTPEYLAPE 175 (337)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT--CCBCCCEECGGGCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC--CcccccccChhhCChh
Confidence 69999999999999999999999 999999999999999999999999999998532221 1234457899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++|+||+||++|||++|++||.....
T Consensus 176 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 210 (337)
T 1o6l_A 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 210 (337)
T ss_dssp GGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhcCCCCCchhhcccchhHHHHHhcCCCCCCCCCH
Confidence 99998999999999999999999999999976543
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-35 Score=240.40 Aligned_cols=185 Identities=18% Similarity=0.229 Sum_probs=152.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.||.|+.+............+..|..+....+|++++. .....+++++++++|+|..++..
T Consensus 77 V~~~~~~~~~~~vAiK~l~k~~~~~~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~ 156 (412)
T 2vd5_A 77 VAVVKMKQTGQVYAMKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFG 156 (412)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHHGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred EEEEEECCCCCEEEEEEEeHHHhhhHHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcC
Confidence 6889998888999988866544333344455667777777888888763 34556789999999999998865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ ......||+.|+||
T Consensus 157 ~~l~~~~~~~~~~qi~~aL~~LH~---~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~~-~~~~~~Gt~~Y~AP 232 (412)
T 2vd5_A 157 ERIPAEMARFYLAEIVMAIDSVHR---LGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGTV-RSLVAVGTPDYLSP 232 (412)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSCE-ECSSCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccCHHHeeecCCCCEEEeechhheeccCCCcc-ccceeccccCcCCH
Confidence 479999999999999999999999 99999999999999999999999999999876443221 22345789999999
Q ss_pred cccC-------CCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWM-------PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~-------~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++. ...++.++|+||+||++|||++|++||......
T Consensus 233 E~l~~~~~~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 276 (412)
T 2vd5_A 233 EILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQTPFYADSTA 276 (412)
T ss_dssp HHHHHHHTCTTCSEECTHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred HHHhhcccCcCCCCCChHHhhhHHhHHHHHHHhCCCCCCCCCHH
Confidence 9987 356899999999999999999999999876543
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-34 Score=233.31 Aligned_cols=183 Identities=19% Similarity=0.246 Sum_probs=147.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.||.|+.+............+..|..+... .+|++++. .....+++++++++|+|..++..
T Consensus 33 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 112 (345)
T 1xjd_A 33 VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC 112 (345)
T ss_dssp EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhHHhhhhhhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence 78999998899999887665443333333344445444443 47887763 34556789999999999888864
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...... .......||+.|+||
T Consensus 113 ~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aP 187 (345)
T 1xjd_A 113 HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD--AKTNTFCGTPDYIAP 187 (345)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC--CcccCCCCCcccCCh
Confidence 679999999999999999999999 999999999999999999999999999997532221 123446789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||++|||++|++||.....
T Consensus 188 E~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (345)
T 1xjd_A 188 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 223 (345)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhcCCCCCChhhhHHHHHHHHHHhcCCCCCCCCCH
Confidence 999998999999999999999999999999986554
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-35 Score=237.96 Aligned_cols=184 Identities=21% Similarity=0.270 Sum_probs=144.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+.+............+..|..+.... +|++++. ..+..+++++++++|+|..++..
T Consensus 39 V~~~~~~~~~~~~AvK~~~~~~~~~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 118 (353)
T 3txo_A 39 VMLARVKETGDLYAVKVLKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKS 118 (353)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred EEEEEEcCCCCEEEEEEEEHHHhcchhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence 789999988999998876654333333334444555555443 7887763 34556789999999999888754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++...... ......+||+.|+||
T Consensus 119 ~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aP 193 (353)
T 3txo_A 119 RRFDEARARFYAAEIISALMFLHD---KGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG--VTTATFCGTPDYIAP 193 (353)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-----------CCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCCcccCCCHHHEEECCCCCEEEccccceeecccCC--ccccccCCCcCeECh
Confidence 579999999999999999999999 999999999999999999999999999997532221 123345789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++.+..++.++|+||+||++|||++|++||......
T Consensus 194 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~~ 230 (353)
T 3txo_A 194 EILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENED 230 (353)
T ss_dssp HHHHHHHCTTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhcCCCCcCCccCCCcchHHHHHHHhCCCCCCCCCHH
Confidence 9998888999999999999999999999999876543
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-34 Score=230.22 Aligned_cols=180 Identities=21% Similarity=0.303 Sum_probs=150.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.+|.|+.+............+..|..+....+|++++. ......++++++++++|..++.. .
T Consensus 22 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~ 101 (318)
T 1fot_A 22 VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ 101 (318)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhhhhHHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcC
Confidence 6889999889999988866554444444455666777778888998764 34456688999999999988864 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++..... .....||+.|+|||
T Consensus 102 ~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~~-----~~~~~gt~~y~aPE 173 (318)
T 1fot_A 102 RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPE 173 (318)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChheEEEcCCCCEEEeecCcceecCCc-----cccccCCccccCHh
Confidence 69999999999999999999999 99999999999999999999999999999865432 23456899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++|+||+||++|||++|++||.....
T Consensus 174 ~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 208 (318)
T 1fot_A 174 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208 (318)
T ss_dssp HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HhcCCCCCcccchhhhHHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999999999999976543
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-34 Score=234.16 Aligned_cols=183 Identities=20% Similarity=0.251 Sum_probs=148.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+.+............+..|..+.... +|++++. ..+..+++++++++|+|..++..
T Consensus 36 V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 115 (353)
T 2i0e_A 36 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV 115 (353)
T ss_dssp EEEEEETTEEEEEEEEEEEHHHHHHTTCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEHHHhhcchHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhc
Confidence 688999998999998887655443333344455555555443 6776653 34556789999999999888764
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...... .......||+.|+||
T Consensus 116 ~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~--~~~~~~~gt~~y~aP 190 (353)
T 2i0e_A 116 GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG--VTTKTFCGTPDYIAP 190 (353)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT--CCBCCCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC--cccccccCCccccCh
Confidence 679999999999999999999999 999999999999999999999999999998532221 123446789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||++|||++|++||.....
T Consensus 191 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 226 (353)
T 2i0e_A 191 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDE 226 (353)
T ss_dssp HHHTTCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hhhcCCCcCCcccccchHHHHHHHHcCCCCCCCCCH
Confidence 999999999999999999999999999999986554
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=225.72 Aligned_cols=180 Identities=18% Similarity=0.246 Sum_probs=151.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.||.|+..... ......+..|.......+|++++. .++..+++++++++++|..++....
T Consensus 36 V~~~~~~~~~~~vaiK~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 112 (297)
T 3fxz_A 36 VYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112 (297)
T ss_dssp EEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC
T ss_pred EEEEEECCCCcEEEEEEeeccc---ccHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhcC
Confidence 6899998888888887654322 222344667777788889998874 3445678999999999999999889
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ......||+.|+|||+
T Consensus 113 ~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE~ 187 (297)
T 3fxz_A 113 MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEV 187 (297)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEECCCCCEEEeeCCCceecCCccc--ccCCccCCcCccChhh
Confidence 9999999999999999999999 9999999999999999999999999999986554332 2234568999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+..++.++||||+|+++|||++|+.||....+
T Consensus 188 ~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 221 (297)
T 3fxz_A 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (297)
T ss_dssp HHCSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred hcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999999999976543
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-34 Score=232.06 Aligned_cols=180 Identities=19% Similarity=0.294 Sum_probs=152.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.+|.|+..............+..|..+....+|++++. .....+++++++++++|..++.. +
T Consensus 57 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~ 136 (350)
T 1rdq_E 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136 (350)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC
T ss_pred EEEEEECCCCCEEEEEEEEhHHhccHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcC
Confidence 6889998888899988866554444444555667777778889998764 34556789999999999888864 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++..... .....||+.|+|||
T Consensus 137 ~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-----~~~~~gt~~y~aPE 208 (350)
T 1rdq_E 137 RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPE 208 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccccCccceEEECCCCCEEEcccccceeccCC-----cccccCCccccCHH
Confidence 79999999999999999999999 99999999999999999999999999999865432 23456899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++|+||+||++|||++|++||.....
T Consensus 209 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 243 (350)
T 1rdq_E 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HhcCCCCCCcCCEecccHhHhHHhhCCCCCCCCCH
Confidence 99998999999999999999999999999986543
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-34 Score=231.94 Aligned_cols=179 Identities=13% Similarity=0.142 Sum_probs=138.5
Q ss_pred CCcc-----ccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc---ccccccc------ccccceEEEEEccCCch
Q 044746 1 MEKP-----RNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD---NFSNLVG------SEDTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~-----~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~i~------~~~~~~~~~~~~~~~~l 66 (202)
||++ ++...++.||.|+.+... ...+..+....... .|++++. ..+...++++++++|+|
T Consensus 81 Vy~~~~~~~~~~~~~~~vavK~~~~~~------~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L 154 (365)
T 3e7e_A 81 VYEATQGDLNDAKNKQKFVLKVQKPAN------PWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTL 154 (365)
T ss_dssp EEEEEC-------CCCCEEEEEESSCC------HHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBH
T ss_pred EEEEEecCCcccccCcEEEEEEeCCCC------hhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcH
Confidence 6777 466777788887754322 12233333333333 3566553 34556789999999999
Q ss_pred hhhhc------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-----------CCceEEeeeecce
Q 044746 67 YLLCK------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-----------NFFPKAADFGLAK 129 (202)
Q Consensus 67 ~~~~~------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-----------~~~~kl~dfgl~~ 129 (202)
..++. ...+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++
T Consensus 155 ~~~l~~~~~~~~~~l~~~~~~~i~~qi~~~L~~lH~---~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~ 231 (365)
T 3e7e_A 155 LNAINLYKNTPEKVMPQGLVISFAMRMLYMIEQVHD---CEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSI 231 (365)
T ss_dssp HHHHHHHHTSTTCSCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCE
T ss_pred HHHHHHhhcccccCCCHHHHHHHHHHHHHHHHHHhh---CCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhh
Confidence 99885 4569999999999999999999999 99999999999999988 8999999999998
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
...............||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 232 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 290 (365)
T 3e7e_A 232 DMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFGTYMKVKNEG 290 (365)
T ss_dssp EGGGSCTTEEECCSSCTTSCCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSSCCCEEEET
T ss_pred hhhccCCCceeeeecCCCCCCChHHhcCCCCCccccHHHHHHHHHHHHhCCCccccCCC
Confidence 65433333344556789999999999999999999999999999999999999976544
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.4e-34 Score=232.91 Aligned_cols=183 Identities=20% Similarity=0.282 Sum_probs=142.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHH-HHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRM-IAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+.+............+..|... ....+|++++. ..+..+++++++++|+|..++..
T Consensus 54 V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~ 133 (373)
T 2r5t_A 54 VLLARHKAEEVFYAVKVLQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRE 133 (373)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGBC-------------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHH
T ss_pred EEEEEEcCCCCEEEEEEEEHHHhhhhHHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhc
Confidence 68999999999999888655443332333333333333 45567887763 34556789999999999888754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+++..++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++...... .......||+.|+||
T Consensus 134 ~~~~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~--~~~~~~~gt~~y~aP 208 (373)
T 2r5t_A 134 RCFLEPRARFYAAEIASALGYLHS---LNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN--STTSTFCGTPEYLAP 208 (373)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC--CCCCSBSCCCCCCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEeeCccccccccCC--CccccccCCccccCH
Confidence 569999999999999999999999 999999999999999999999999999997532221 123445789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++|+||+||++|||++|++||.....
T Consensus 209 E~~~~~~~~~~~DiwslG~il~ell~G~~Pf~~~~~ 244 (373)
T 2r5t_A 209 EVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNT 244 (373)
T ss_dssp HHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSBH
T ss_pred HHhCCCCCCchhhhHHHHHHHHHHHcCCCCCCCCCH
Confidence 999999999999999999999999999999976544
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=231.49 Aligned_cols=181 Identities=19% Similarity=0.272 Sum_probs=151.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..+++.+|.|+..............+..|..+....+|++++. ..+..+++++++.+|+|..++...
T Consensus 31 V~~~~~~~~~~~~AiK~~~~~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~ 110 (384)
T 4fr4_A 31 VCIVQKNDTKKMYAMKYMNKQKCVERNEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNV 110 (384)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTC
T ss_pred EEEEEECCCCCEEEEEEEehhhcccHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcC
Confidence 6889999999999988765554444445556777888888889998874 334556889999999998888654
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++....... .....||+.|+|||
T Consensus 111 ~l~~~~~~~~~~qi~~aL~~LH~---~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~~---~~~~~gt~~Y~aPE 184 (384)
T 4fr4_A 111 HFKEETVKLFICELVMALDYLQN---QRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRETQ---ITTMAGTKPYMAPE 184 (384)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTCC---BCCCCSCGGGCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCcHHHeEECCCCCEEEeccceeeeccCCCc---eeccCCCccccCCe
Confidence 69999999999999999999999 9999999999999999999999999999987643322 34467899999999
Q ss_pred ccCC---CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMP---YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~---~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.. ..++.++|+||+||++|||++|+.||....
T Consensus 185 ~~~~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~ 221 (384)
T 4fr4_A 185 MFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRS 221 (384)
T ss_dssp GTCCCSSCCBCTTHHHHHHHHHHHHHHHSSCSSCCCT
T ss_pred eeccCCCCCCCccceeechHHHHHHHHhCCCCCCCCC
Confidence 9874 458899999999999999999999997544
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-33 Score=246.11 Aligned_cols=184 Identities=20% Similarity=0.250 Sum_probs=149.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh-ccccccc------cccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLV------GSEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.||.|+.+............+..|..+... .+|++++ ...+..+++++++++|+|..++..
T Consensus 357 V~~~~~~~~~~~vAvK~l~~~~~~~~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~ 436 (674)
T 3pfq_A 357 VMLSERKGTDELYAVKILKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQV 436 (674)
T ss_dssp EEEEEESSSCCEEEEEEEEHHHHHHTTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEeccccccHHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhc
Confidence 78999999999999888765443333344444555554444 3566654 234456789999999999888865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
+.+++..++.++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... ......||+.|+||
T Consensus 437 ~~~~~~~~~~~~~qi~~aL~~LH~---~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~~--~~~~~~GT~~Y~AP 511 (674)
T 3pfq_A 437 GRFKEPHAVFYAAEIAIGLFFLQS---KGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDGV--TTKTFCGTPDYIAP 511 (674)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTTC--CBCCCCSCSSSCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeEeccCChhhEEEcCCCcEEEeecceeeccccCCc--ccccccCCCcccCH
Confidence 679999999999999999999999 9999999999999999999999999999985432221 23456789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++.+..++.++|+||+|+++|||++|++||.+....
T Consensus 512 E~l~~~~~~~~~DvwSlGvilyelltG~~Pf~~~~~~ 548 (674)
T 3pfq_A 512 EIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDED 548 (674)
T ss_dssp HHHTCCCBSTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hhhcCCCCCccceEechHHHHHHHHcCCCCCCCCCHH
Confidence 9999999999999999999999999999999876543
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-34 Score=230.01 Aligned_cols=180 Identities=22% Similarity=0.275 Sum_probs=144.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+.+............+..|..+.... +|++++. .....+++++++++|+|..++..
T Consensus 25 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~ 104 (345)
T 3a8x_A 25 VLLVRLKKTDRIYAMKVVKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQ 104 (345)
T ss_dssp EEEEEETTTTEEEEEEEEEGGGSCSHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhHHhcchHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHc
Confidence 688999888888888876544322222233344555555443 7888763 34456788999999999887754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..++.++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... .......||+.|+||
T Consensus 105 ~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~--~~~~~~~gt~~y~aP 179 (345)
T 3a8x_A 105 RKLPEEHARFYSAEISLALNYLHE---RGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG--DTTSTFCGTPNYIAP 179 (345)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT--CCBCCCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEECCCCCEEEEeccccccccCCC--CcccccCCCccccCc
Confidence 579999999999999999999999 999999999999999999999999999998532221 123445789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|++.+..++.++|+||+||++|||++|++||..
T Consensus 180 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~ 212 (345)
T 3a8x_A 180 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDI 212 (345)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred cccCCCCCChHHhHHHHHHHHHHHHhCCCCcCC
Confidence 999998999999999999999999999999975
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-33 Score=238.55 Aligned_cols=182 Identities=19% Similarity=0.222 Sum_probs=151.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.+|.|+..............+..|..+....+|++++. .....+++++++++|+|..++..
T Consensus 201 Vy~a~~~~tg~~vAiK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~ 280 (543)
T 3c4z_A 201 VFACQMKATGKLYACKKLNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVD 280 (543)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSS
T ss_pred EEEEEECCCCcEEEEEEEEhHHhhhhHHHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhh
Confidence 7889998888888888765554444444455677777888889998763 34456789999999999887753
Q ss_pred ---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 73 ---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 73 ---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........ .....||+.|
T Consensus 281 ~~~~~l~e~~~~~~~~qi~~aL~~LH~---~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~~~--~~~~~GT~~Y 355 (543)
T 3c4z_A 281 EDNPGFQEPRAIFYTAQIVSGLEHLHQ---RNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQTK--TKGYAGTPGF 355 (543)
T ss_dssp TTSCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCCC--BCCCCSCTTT
T ss_pred cccccccHHHHHHHHHHHHHHHHHHHH---cCCcccCCChHHEEEeCCCCEEEeecceeeeccCCCcc--cccccCCccc
Confidence 359999999999999999999999 99999999999999999999999999999875433221 2345789999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||++.+..++.++|+||+||++|||++|++||....
T Consensus 356 ~APE~l~~~~~~~~~DiwSlGvilyelltG~~PF~~~~ 393 (543)
T 3c4z_A 356 MAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARG 393 (543)
T ss_dssp SCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCTT
T ss_pred cChhhhcCCCCChHHhcCcchHHHHHHHhCCCCCCCCc
Confidence 99999999999999999999999999999999998754
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-34 Score=225.83 Aligned_cols=184 Identities=18% Similarity=0.197 Sum_probs=144.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++...+..||.|+.........+...++..|.......+|++++. ..+..+++++++++++|..++.. .
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~ 106 (294)
T 4eqm_A 27 VYLAEDTILNIKVAIKAIFIPPREKEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHG 106 (294)
T ss_dssp EEEEEETTTCSEEEEEEEECCSSCCHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC
T ss_pred EEEEEECCCCCeEEEEEeccCccccHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcC
Confidence 6889988888888887653332222233345677777778888998763 34455688999999999988754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++........ ......||+.|+|||
T Consensus 107 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt~~y~aPE 182 (294)
T 4eqm_A 107 PLSVDTAINFTNQILDGIKHAHD---MRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLT-QTNHVLGTVQYFSPE 182 (294)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCSSSTTC--------------CCSSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCCEEEEeCCCcccccccccc-ccCccccCccccCHh
Confidence 69999999999999999999999 99999999999999999999999999999865432221 123356899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+.+..++.++|+||+|+++|+|++|+.||.....
T Consensus 183 ~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 217 (294)
T 4eqm_A 183 QAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETA 217 (294)
T ss_dssp HHHTCCCCTTHHHHHHHHHHHHHHHSSCSSCSSCH
T ss_pred HhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 99998999999999999999999999999986553
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-33 Score=226.04 Aligned_cols=183 Identities=22% Similarity=0.256 Sum_probs=147.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..+++.||.|+...... ......+..|..+....+|++++. .++...++++++++++|..++...
T Consensus 23 V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 100 (323)
T 3tki_A 23 VQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI 100 (323)
T ss_dssp EEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTT
T ss_pred EEEEEECCCCcEEEEEEEEcccc--cchHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcC
Confidence 68899988888888887543322 122345667777788888998774 345557899999999999888755
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...............||+.|+|||
T Consensus 101 ~~~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE 177 (323)
T 3tki_A 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177 (323)
T ss_dssp BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccccchHHEEEeCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcH
Confidence 59999999999999999999999 999999999999999999999999999998664433333334567899999999
Q ss_pred ccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..+ +.++||||+||++++|++|+.||.....
T Consensus 178 ~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 213 (323)
T 3tki_A 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (323)
T ss_dssp HHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSCT
T ss_pred HhccCCCCCCcccHHHHHHHHHHHHhCCCCCCCCch
Confidence 9987765 6789999999999999999999976544
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-34 Score=231.81 Aligned_cols=185 Identities=19% Similarity=0.229 Sum_probs=140.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc-cccccc--------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN-FSNLVG--------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~--------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..+++.||.|......... ....++..|........ |++++. .+...++++++++ ++|..++.
T Consensus 25 V~~~~~~~~~~~vaiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~ 102 (388)
T 3oz6_A 25 VWKSIDRRTGEVVAVKKIFDAFQNS-TDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIR 102 (388)
T ss_dssp EEEEEETTTCCEEEEEEECC--CCH-HHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHH
T ss_pred EEEEEECCCCCEEEEEEecccccCh-HHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHH
Confidence 6889988888888877543221111 11223444555555554 888763 1224568888887 68888888
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC----------------
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH---------------- 135 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~---------------- 135 (202)
...+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++......
T Consensus 103 ~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~ 179 (388)
T 3oz6_A 103 ANILEPVHKQYVVYQLIKVIKYLHS---GGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTEN 179 (388)
T ss_dssp HTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC-----
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHh---CCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccc
Confidence 8899999999999999999999999 999999999999999999999999999998653211
Q ss_pred ---cccccCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 136 ---THITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 136 ---~~~~~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
.........||+.|+|||++.+ ..++.++||||+||+++||++|++||.+....+
T Consensus 180 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~ 238 (388)
T 3oz6_A 180 FDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMN 238 (388)
T ss_dssp ----------CCCGGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHH
T ss_pred cccccccccCCcccCCcCCHHHhcCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 0111234578999999999886 578999999999999999999999998765443
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-34 Score=228.06 Aligned_cols=181 Identities=24% Similarity=0.322 Sum_probs=141.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc----------ccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE----------DTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++. ++.||.|+.+...... ..+..|.......+|+|++... ....++++++++|+|..++
T Consensus 40 Vy~~~~~--~~~vavK~~~~~~~~~----~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 113 (322)
T 3soc_A 40 VWKAQLL--NEYVAVKIFPIQDKQS----WQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFL 113 (322)
T ss_dssp EEEEEET--TEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHH
T ss_pred EEEEEEC--CCEEEEEEeecCchHH----HHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHH
Confidence 6778765 4667766643322211 1222344455667788876421 1236889999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCCC----------CeEEecCCCCcEEEcCCCceEEeeeecceeccccCccccc
Q 044746 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQ----------KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITS 140 (202)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~----------~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~ 140 (202)
....+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||+++...........
T Consensus 114 ~~~~~~~~~~~~i~~qi~~al~~LH~---~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~~~~~ 190 (322)
T 3soc_A 114 KANVVSWNELCHIAETMARGLAYLHE---DIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKSAGDT 190 (322)
T ss_dssp HHCCBCHHHHHHHHHHHHHHHHHHTC---CEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSCCCCC
T ss_pred HhcCCCHHHHHHHHHHHHHHHHHHHh---hccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccCcccc
Confidence 98999999999999999999999998 7 9999999999999999999999999999876554443334
Q ss_pred CCCCCCCcccCCcccCCC-----CCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 141 TGRRRTPGCEAPELWMPY-----SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~~~-----~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
....||+.|+|||++.+. .++.++|||||||++|||++|+.||.+..+..
T Consensus 191 ~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~el~tg~~pf~~~~~~~ 245 (322)
T 3soc_A 191 HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADGPVDEY 245 (322)
T ss_dssp TTCCCCGGGCCHHHHTTCCCCCHHHHHHHHHHHHHHHHHHHHTTBTTSSSCCCCC
T ss_pred ccCccCccccCHhhcccccccCcCCCccchhHHHHHHHHHHHhCCCCCCCCcchh
Confidence 456789999999999863 45567899999999999999999998765543
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.7e-33 Score=222.36 Aligned_cols=179 Identities=20% Similarity=0.248 Sum_probs=149.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.||.|+..... ......+..|.......+|++++. .++...++++++++++|..++....
T Consensus 61 V~~a~~~~~g~~vavK~~~~~~---~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 137 (321)
T 2c30_A 61 VCLAREKHSGRQVAVKMMDLRK---QQRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQVR 137 (321)
T ss_dssp EEEEEETTTCCEEEEEEEETTT---CCSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTTCC
T ss_pred EEEEEECCCCcEEEEEEEeccc---hhHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHhcC
Confidence 6889988888888888754321 222344667777778888998764 3445668899999999999998889
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......... .....||+.|+|||+
T Consensus 138 l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~gt~~y~aPE~ 212 (321)
T 2c30_A 138 LNEEQIATVCEAVLQALAYLHA---QGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDVPK--RKSLVGTPYWMAPEV 212 (321)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSSCC--BCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCccc--cccccCCccccCHhh
Confidence 9999999999999999999999 99999999999999999999999999999876543221 234568999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||+|++++||++|+.||....
T Consensus 213 ~~~~~~~~~~Dv~slG~il~el~~g~~pf~~~~ 245 (321)
T 2c30_A 213 ISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDS 245 (321)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999899999999999999999999999997654
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-33 Score=221.66 Aligned_cols=179 Identities=12% Similarity=0.146 Sum_probs=144.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++++..+++.||.|+..... ....+..|....... +|++++. .+....++++++ +++|..++.
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 98 (330)
T 2izr_A 25 LRLGKNLYTNEYVAIKLEPMKS-----RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLC 98 (330)
T ss_dssp EEEEEETTTTEEEEEEEEETTC-----SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred EEEEEECCCCcEEEEEEecccc-----chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHc
Confidence 6889988888999988754321 123455666666665 7887653 334456888888 899998886
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc-----eEEeeeecceeccccCccc-----ccC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF-----PKAADFGLAKLYNREHTHI-----TST 141 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~-----~kl~dfgl~~~~~~~~~~~-----~~~ 141 (202)
...+++..+..++.|++.||.|||+ .+|+||||||+||+++.++. ++|+|||+++......... ...
T Consensus 99 ~~~~~~~~~~~i~~qi~~~l~~LH~---~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~ 175 (330)
T 2izr_A 99 DRTFSLKTVLMIAIQLISRMEYVHS---KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHK 175 (330)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccC
Confidence 4679999999999999999999999 99999999999999998887 9999999998754332211 124
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
...||+.|+|||++.+..++.++||||||++++||++|+.||.....
T Consensus 176 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~Pf~~~~~ 222 (330)
T 2izr_A 176 SLTGTARYMSINTHLGKEQSRRDDLEALGHMFMYFLRGSLPWQGLKA 222 (330)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred CcCCCccccChHHHcCCCCCchhHHHHHHHHHHHHhcCCCCcccccc
Confidence 56789999999999999999999999999999999999999987543
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=237.68 Aligned_cols=181 Identities=19% Similarity=0.218 Sum_probs=151.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..+++.||.|+..............+..|..++...+|++++. .....+++++++++|+|..++...
T Consensus 200 Vy~a~~~~tg~~vAvK~l~k~~~~~~~~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~ 279 (576)
T 2acx_A 200 VCACQVRATGKMYACKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMG 279 (576)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSS
T ss_pred EEEEEECCCCCEEEEEEEEhHhhhhhHHHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcC
Confidence 6889998888888888765544443444455667777788889998763 345567899999999998877543
Q ss_pred --CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 74 --ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 74 --~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++....... .....||+.|+|
T Consensus 280 ~~~l~e~~~~~i~~qIl~aL~yLH~---~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~~---~~~~~GT~~Y~A 353 (576)
T 2acx_A 280 QAGFPEARAVFYAAEICCGLEDLHR---ERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQT---IKGRVGTVGYMA 353 (576)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTCC---EECCCSCGGGCC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCchheEEEeCCCCeEEEecccceecccCcc---ccccCCCccccC
Confidence 39999999999999999999999 9999999999999999999999999999987644322 233578999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||++.+..++.++|+||+||++|||++|++||....
T Consensus 354 PEvl~~~~~~~~~DiwSLGvilyeLltG~~PF~~~~ 389 (576)
T 2acx_A 354 PEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRK 389 (576)
T ss_dssp HHHHTTCEESSHHHHHHHHHHHHHHHHSSCSSSCSS
T ss_pred HHHHcCCCCCccchHHHHHHHHHHHHhCCCCCcccc
Confidence 999999889999999999999999999999998754
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-33 Score=222.26 Aligned_cols=184 Identities=26% Similarity=0.375 Sum_probs=144.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++.. ++.||.|..... .......+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 55 Vy~~~~~~-~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 130 (321)
T 2qkw_B 55 VYKGVLRD-GAKVALKRRTPE---SSQGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSD 130 (321)
T ss_dssp EEEEECTT-CCEEEEEECCSC---CSSHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSC
T ss_pred EEEEEECC-CCEEEEEEeccc---ChHHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccC
Confidence 67888654 445555543221 1122344666777777778888763 345567899999999999888554
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 74 ----ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 74 ----~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++...............||+.|
T Consensus 131 ~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y 207 (321)
T 2qkw_B 131 LPTMSMSWEQRLEICIGAARGLHYLHT---RAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLSTVVKGTLGY 207 (321)
T ss_dssp CCSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTT
T ss_pred CCccccCHHHHHHHHHHHHHHHHHhcC---CCeecCCCCHHHEEECCCCCEEEeecccccccccccccccccccCCCccc
Confidence 48999999999999999999999 99999999999999999999999999999865433322233445679999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcccc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~~ 191 (202)
+|||++.+..++.++||||+|++++||++|+.||....+.+.
T Consensus 208 ~aPE~~~~~~~~~~~Di~slG~il~ell~g~~p~~~~~~~~~ 249 (321)
T 2qkw_B 208 IDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSAIVQSLPREM 249 (321)
T ss_dssp CCHHHHHHCBCCTHHHHHHHHHHHHHHHHCCTTCSCSSSSSC
T ss_pred cCHHHhcCCCCCcccchHhHHHHHHHHHhCCCcccccCcHHH
Confidence 999999888899999999999999999999999987665443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-33 Score=224.70 Aligned_cols=181 Identities=20% Similarity=0.279 Sum_probs=147.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||++++..+++.||.|+.........+...++..|.......+|++++. ..+...++++++ +|+|..++ ...
T Consensus 25 V~~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~ 103 (336)
T 3h4j_B 25 VKLATHYKTQQKVALKFISRQLLKKSDMHMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKK 103 (336)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCSHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHC
T ss_pred EEEEEECCCCCEEEEEEEehHHccchhHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcC
Confidence 6889998888889888765544334444556777888888889998774 334456778888 56666655 556
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .....||+.|+|||
T Consensus 104 ~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~~---~~~~~gt~~y~aPE 177 (336)
T 3h4j_B 104 RMTEDEGRRFFQQIICAIEYCHR---HKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNF---LKTSCGSPNYAAPE 177 (336)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---HTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSBT---TCCCTTSTTTSCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCchhhEEEcCCCCEEEEEeccceeccCCcc---cccccCCcCcCCHH
Confidence 79999999999999999999999 9999999999999999999999999999986544322 23456899999999
Q ss_pred ccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..+ +.++||||+|+++|+|++|+.||.+...
T Consensus 178 ~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~~ 213 (336)
T 3h4j_B 178 VINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFI 213 (336)
T ss_dssp GSCCSGGGCHHHHHHHHHHHHHHHHHSSCSSBCSSS
T ss_pred HHcCCCCCCCccchhHHHHHHHHHHhCCCCCCCccH
Confidence 9988775 6899999999999999999999986543
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-33 Score=234.75 Aligned_cols=184 Identities=19% Similarity=0.287 Sum_probs=141.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.||.|+.+............+..|.......+|++++. ..+...++++++++++|..++.. .
T Consensus 164 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 243 (446)
T 4ejn_A 164 VILVKEKATGRYYAMKILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRER 243 (446)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHC-------------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHS
T ss_pred EEEEEEcCCCCEEEEEEEEhhhhhhhHHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcC
Confidence 6889999999999998866544333344455666777777778888763 33455688999999999887754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+. .+|+||||||+|||++.++.+||+|||+++...... .......||+.|+|||
T Consensus 244 ~~~~~~~~~~~~qi~~aL~~LH~~--~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~--~~~~~~~gt~~y~aPE 319 (446)
T 4ejn_A 244 VFSEDRARFYGAEIVSALDYLHSE--KNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG--ATMKTFCGTPEYLAPE 319 (446)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHH--TCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC-------CCSSSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhhc--CCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC--cccccccCCccccCHh
Confidence 699999999999999999999952 689999999999999999999999999997533222 1234467899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++||||+||+++||++|+.||.....
T Consensus 320 ~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 354 (446)
T 4ejn_A 320 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDH 354 (446)
T ss_dssp HHHTSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred hcCCCCCCCccchhhhHHHHHHHhhCCCCCCCCCH
Confidence 99999999999999999999999999999976544
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-33 Score=223.00 Aligned_cols=183 Identities=20% Similarity=0.227 Sum_probs=145.1
Q ss_pred CCccccCCCcceee----hhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFIT----RTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++...++.++ .|... ..........+..+.......+|+|++. .++...++++++.+++|..++.
T Consensus 29 Vy~~~~~~~~~~~~~kv~~K~~~--~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~~~L~~~l~ 106 (325)
T 3kex_A 29 VHKGVWIPEGESIKIPVCIKVIE--DKSGRQSFQAVTDHMLAIGSLDHAHIVRLLGLCPGSSLQLVTQYLPLGSLLDHVR 106 (325)
T ss_dssp EEEEEECCTTCSCCEEEEEEEEC--CTTSCSCBCSCCHHHHHHHTCCCTTBCCEEEEECBSSEEEEEECCTTCBSHHHHH
T ss_pred EEEEEEcCCCceEEEEEEEEecc--ccccHHHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCccEEEEEeCCCCCHHHHHH
Confidence 68888877766533 33321 1222344566778888888889998874 3445668999999999998886
Q ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 KN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 ~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.. .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...............|++.|
T Consensus 107 ~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y 183 (325)
T 3kex_A 107 QHRGALGPQLLLNWGVQIAKGMYYLEE---HGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKW 183 (325)
T ss_dssp SSGGGSCTTHHHHHHHHHHHHHHHHHH---TTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTTCCC-----CCTTT
T ss_pred HccccCCHHHHHHHHHHHHHHHHHHHh---CCCCCCccchheEEECCCCeEEECCCCcccccCcccccccccCCCCcccc
Confidence 53 69999999999999999999999 99999999999999999999999999999876544333333445678899
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
+|||.+.+..++.++||||+|+++||+++ |+.||.....
T Consensus 184 ~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~ 223 (325)
T 3kex_A 184 MALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRL 223 (325)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCT
T ss_pred cChHHhccCCCChhhHhHHhHHHHHHHHhCCCCCccccCH
Confidence 99999998889999999999999999999 9999986543
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.3e-33 Score=225.16 Aligned_cols=182 Identities=18% Similarity=0.248 Sum_probs=148.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccC---CcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMD---KPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..+++.+|.|+.+........ ....+..|..+....+|++++. ......++++++++++|..++.
T Consensus 28 V~~~~~~~~~~~~avK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~ 107 (361)
T 2yab_A 28 VKKCREKSTGLEYAAKFIKKRQSRASRRGVCREEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLA 107 (361)
T ss_dssp EEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT
T ss_pred EEEEEECCCCCEEEEEEEEccccccccchhHHHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHH
Confidence 688999888888888765443322111 1234667777777888998763 3445678999999999998885
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC----ceEEeeeecceeccccCcccccCCCCCC
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF----FPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~----~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||++........ .....||
T Consensus 108 ~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~gt 181 (361)
T 2yab_A 108 QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181 (361)
T ss_dssp TCSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTCC---CCCCCSC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCCc---cccCCCC
Confidence 4 469999999999999999999999 9999999999999998776 799999999987654322 2345689
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||++.+..++.++|+||+||++|+|++|.+||.+...
T Consensus 182 ~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~~Pf~~~~~ 223 (361)
T 2yab_A 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (361)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred ccEECchHHcCCCCCccccHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999998999999999999999999999999976544
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-33 Score=225.35 Aligned_cols=181 Identities=22% Similarity=0.282 Sum_probs=147.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.||.|+....... .....++..|.......+|+|++. ..+...++++++++++|..++. .+
T Consensus 31 V~~a~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 109 (328)
T 3fe3_A 31 VKLARHILTGREVAIKIIDKTQLN-PTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHG 109 (328)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC
T ss_pred EEEEEECCCCCEEEEEEEEhhcCC-HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcC
Confidence 688999888888888875433211 122334666777788888998774 3445568899999999988774 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ .....||+.|+|||
T Consensus 110 ~l~~~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aPE 183 (328)
T 3fe3_A 110 RMKEKEARSKFRQIVSAVQYCHQ---KRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGK---LDAFCGAPPYAAPE 183 (328)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSCG---GGTTSSSGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCCc---cccccCCcceeCcc
Confidence 79999999999999999999999 9999999999999999999999999999976543322 24456899999999
Q ss_pred ccCCCCCC-chhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVT-QKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~-~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++ .++||||+||++++|++|+.||.+...
T Consensus 184 ~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 219 (328)
T 3fe3_A 184 LFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNL 219 (328)
T ss_dssp HHHTCCCCSHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cccCCCcCCchhhhhhhHHHHHHHHhCCCCCCCCCH
Confidence 99887765 789999999999999999999987553
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-32 Score=217.73 Aligned_cols=182 Identities=23% Similarity=0.268 Sum_probs=146.0
Q ss_pred CCccccCCCcceeehhhhchhhhhc-----------------------cCCcccCCcHHHHHHhccccccccc-------
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME-----------------------MDKPIRFTSPQRMIAADNFSNLVGS------- 50 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~-----------------------~~~~~~~~~~~~~~~~~~~~~~i~~------- 50 (202)
||++++..+++.||.|+........ ......+..|.......+|++++..
T Consensus 29 Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~ 108 (298)
T 2zv2_A 29 VKLAYNENDNTYYAMKVLSKKKLIRQAGFPRRPPPRGTRPAPGGCIQPRGPIEQVYQEIAILKKLDHPNVVKLVEVLDDP 108 (298)
T ss_dssp EEEEEETTTTEEEEEEEEECC-------------------------------CHHHHHHHHHHTCCCTTBCCEEEEEECS
T ss_pred EEEEEECCCCcEEEEEEeehhhhhhhcccccccccccccccccccccccchHHHHHHHHHHHHhCCCCCCCeEEEEEEcC
Confidence 6899998888888888754432111 1123446677778888899987631
Q ss_pred -cccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 51 -EDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 51 -~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
.....++++++++++|..+.....+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 109 ~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~ 185 (298)
T 2zv2_A 109 NEDHLYMVFELVNQGPVMEVPTLKPLSEDQARFYFQDLIKGIEYLHY---QKIIHRDIKPSNLLVGEDGHIKIADFGVSN 185 (298)
T ss_dssp SSSEEEEEEECCTTCBSCCSSCSSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCE
T ss_pred CCCEEEEEEecCCCCcHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEECCCCCEEEecCCCcc
Confidence 3455788999999999998888889999999999999999999999 999999999999999999999999999998
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCCC---CCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPYS---VTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~---~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
....... ......||+.|+|||.+.+.. ++.++||||+|+++++|++|+.||....
T Consensus 186 ~~~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 244 (298)
T 2zv2_A 186 EFKGSDA--LLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDER 244 (298)
T ss_dssp ECSSSSC--EECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccccc--cccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCcc
Confidence 7543322 123456899999999998654 3778999999999999999999997643
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-33 Score=225.46 Aligned_cols=175 Identities=23% Similarity=0.280 Sum_probs=138.9
Q ss_pred CcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhccC--------
Q 044746 9 STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN-------- 73 (202)
Q Consensus 9 ~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~-------- 73 (202)
.+..||.|+.+... .......+..|....... +|+|++. ..+..+++++++++|+|..++...
T Consensus 112 ~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~ 189 (370)
T 2psq_A 112 EAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYS 189 (370)
T ss_dssp CEEEEEEEECCTTC--BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----
T ss_pred cceeEEEEEecCCc--CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCcccccc
Confidence 44557766654321 112233466676666666 7888763 344567899999999999888543
Q ss_pred ---------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCC
Q 044746 74 ---------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 74 ---------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
.+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...............
T Consensus 190 ~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~ 266 (370)
T 2psq_A 190 YDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDYYKKTTNGR 266 (370)
T ss_dssp ------CCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCTTCTTTTTT
T ss_pred ccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeccccchhhEEECCCCCEEEccccCCcccCcccceecccCCC
Confidence 48999999999999999999999 999999999999999999999999999998765443333334455
Q ss_pred CCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 145 gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
+|+.|+|||++.+..++.++|||||||++|||++ |+.||.....
T Consensus 267 ~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~p~~~~~~ 311 (370)
T 2psq_A 267 LPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 311 (370)
T ss_dssp SCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred cccceECHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCCCCCCH
Confidence 6889999999999899999999999999999999 9999986543
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-34 Score=226.95 Aligned_cols=185 Identities=18% Similarity=0.242 Sum_probs=140.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc----------cceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED----------TETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~l~~~~ 70 (202)
||++++...++.||.|+.+...........++..|.......+|+|++...+ ..+++++++++++|..++
T Consensus 28 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l 107 (311)
T 3ork_A 28 VHLARDLRDHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 107 (311)
T ss_dssp EEEEEETTTTEEEEEEEECTTTTTSHHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHH
T ss_pred EEEEEECCCCceEEEEEeCccccCCHHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHH
Confidence 6889998888888888765432222222334556666666778888774221 227889999999999888
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCCc
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPG 148 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~~ 148 (202)
.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........ .......||+.
T Consensus 108 ~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~ 184 (311)
T 3ork_A 108 HTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 184 (311)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEETTSCEEECCCSCC------------------CCT
T ss_pred HhcCCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEcCCCCEEEeeccCcccccccccccccccccCcCcc
Confidence 54 569999999999999999999999 99999999999999999999999999999865433221 12233568999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||++.+..++.++||||+|+++|||++|+.||....+
T Consensus 185 y~aPE~~~~~~~~~~~Di~slG~~l~~ll~g~~pf~~~~~ 224 (311)
T 3ork_A 185 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSP 224 (311)
T ss_dssp TCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999998999999999999999999999999986654
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=99.98 E-value=6.5e-33 Score=224.11 Aligned_cols=182 Identities=18% Similarity=0.197 Sum_probs=146.8
Q ss_pred CCccccCCCcceeehhhhchhhhhcc--CCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEM--DKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++..+++.||.|+......... .....+..|..+....+|+|++. ..+..+++++++++++|...+..
T Consensus 40 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~ 119 (351)
T 3c0i_A 40 VRRCINRETGQQFAVKIVDVAKFTSSPGLSTEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVK 119 (351)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHTSSSCCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhhhccccccchHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHH
Confidence 68999988888888887544332221 22345777888888889998874 34456789999999999766532
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc---eEEeeeecceeccccCcccccCCCC
Q 044746 73 -----NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF---PKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 73 -----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~---~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++. +||+|||++........ ......
T Consensus 120 ~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~--~~~~~~ 194 (351)
T 3c0i_A 120 RADAGFVYSEAVASHYMRQILEALRYCHD---NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGL--VAGGRV 194 (351)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSC--BCCCCC
T ss_pred hcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCe--eecCCc
Confidence 248999999999999999999999 99999999999999976554 99999999987654322 223456
Q ss_pred CCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 145 gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||+.|+|||++.+..++.++||||+||++|+|++|+.||....
T Consensus 195 gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~ 237 (351)
T 3c0i_A 195 GTPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTK 237 (351)
T ss_dssp SCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCSSH
T ss_pred CCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHHCCCCCCCcH
Confidence 8999999999999899999999999999999999999997654
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=219.64 Aligned_cols=182 Identities=19% Similarity=0.249 Sum_probs=147.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccC---CcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMD---KPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..+++.+|.|+.+........ ....+..|.......+|++++. ......++++++++++|..++.
T Consensus 27 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 106 (326)
T 2y0a_A 27 VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA 106 (326)
T ss_dssp EEEEEETTTCCEEEEEEEEBCCSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHT
T ss_pred EEEEEECCCCcEEEEEEEEccccccccchhhHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHH
Confidence 688999888888888765443222111 2234667777788888998763 3445678899999999998885
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC----ceEEeeeecceeccccCcccccCCCCCC
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF----FPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~----~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||+++....... .....||
T Consensus 107 ~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt 180 (326)
T 2y0a_A 107 EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 180 (326)
T ss_dssp TSSCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTSC---CCCCCSC
T ss_pred hcCCcCHHHHHHHHHHHHHHHHHHHH---CCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCCc---cccccCC
Confidence 4 469999999999999999999999 9999999999999998877 799999999987643322 2345689
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||++.+..++.++|+||+||++++|++|++||.....
T Consensus 181 ~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 222 (326)
T 2y0a_A 181 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222 (326)
T ss_dssp TTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred cCcCCceeecCCCCCcHHHHHHHHHHHHHHHHCcCCCCCCCH
Confidence 999999999988999999999999999999999999976543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.3e-32 Score=218.27 Aligned_cols=183 Identities=25% Similarity=0.344 Sum_probs=146.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..++..|+.|...... .+....|..|.......+|++++. ..+...++++++++++|..++..
T Consensus 26 V~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 102 (310)
T 3s95_A 26 AIKVTHRETGEVMVMKELIRFD---EETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMD 102 (310)
T ss_dssp EEEEEETTTCCEEEEEEESCCC---HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCC
T ss_pred EEEEEECCCCcEEEEEEeccCC---HHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhcc
Confidence 6889988888888877543221 122345667777788888998774 34456689999999999998865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc------------cc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI------------TS 140 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~------------~~ 140 (202)
..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++......... ..
T Consensus 103 ~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~ 179 (310)
T 3s95_A 103 SQYPWSQRVSFAKDIASGMAYLHS---MNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKR 179 (310)
T ss_dssp TTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccc
Confidence 569999999999999999999999 999999999999999999999999999998754332211 11
Q ss_pred CCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 141 TGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
....||+.|+|||++.+..++.++||||+|++++||++|..|+....+.
T Consensus 180 ~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~~~~~~~~~ 228 (310)
T 3s95_A 180 YTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPR 228 (310)
T ss_dssp CCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHTCCSSTTTSCB
T ss_pred cccCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHhcCCCCCcchhhh
Confidence 1456899999999999999999999999999999999999998765443
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=99.98 E-value=3e-33 Score=223.87 Aligned_cols=183 Identities=20% Similarity=0.248 Sum_probs=138.9
Q ss_pred CCccccCCCcceee----hhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFIT----RTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++...++.++ .|..+. ........+|..|.......+|+|++. ..+...++++++.+|+|..++.
T Consensus 31 Vy~~~~~~~~~~~~~~vaiK~~~~--~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~v~e~~~~g~L~~~l~ 108 (327)
T 3poz_A 31 VYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR 108 (327)
T ss_dssp EEEEEECC----CCEEEEEEEC---------CHHHHHHHHHHHHHCCBTTBCCEEEEEESSSEEEEEECCTTCBHHHHHH
T ss_pred EEEEEEcCCCceEEEEEEEeeccc--ccCHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCcHHHHHH
Confidence 68888776666553 332221 122233456777888888889998773 2233568889999999998885
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 K--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 ~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...............+|+.|
T Consensus 109 ~~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y 185 (327)
T 3poz_A 109 EHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 185 (327)
T ss_dssp HSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC-------CCCGGG
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCChheEEECCCCCEEEccCcceeEccCCcccccccCCCccccc
Confidence 4 469999999999999999999999 99999999999999999999999999999876544443334445668899
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
+|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 186 ~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 225 (327)
T 3poz_A 186 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPA 225 (327)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred cChHHhccCCCCchhhhhhhHHHHHHHHhcCCCCccCCCH
Confidence 99999999899999999999999999999 9999986544
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=99.98 E-value=2.3e-32 Score=218.86 Aligned_cols=183 Identities=18% Similarity=0.235 Sum_probs=137.5
Q ss_pred CCccccC---CCcceeehhhhchhhh-hccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDA-MEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++. ..++.+|.|+.+.... ........+..|..+....+|++++. ..+..+++++++++++|..++
T Consensus 33 V~~~~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 112 (327)
T 3a62_A 33 VFQVRKVTGANTGKIFAMKVLKKAMIVRNAKDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQL 112 (327)
T ss_dssp EEEEEECSSTTTTCEEEEEEECCC--------------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHH
T ss_pred EEEEEEeccCCCCcEEEEEEEEHHHhhhhhhHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHH
Confidence 5676663 5677777776543321 12233445677878888888998764 345567899999999998887
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.. +.+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... ......||+.|
T Consensus 113 ~~~~~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y 187 (327)
T 3a62_A 113 EREGIFMEDTACFYLAEISMALGHLHQ---KGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDGT--VTHTFCGTIEY 187 (327)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCTTTEEECTTSCEEECCCSCC------------CTTSSCCTT
T ss_pred HhCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEcccCCHHHeEECCCCcEEEEeCCcccccccCCc--cccccCCCcCc
Confidence 54 568999999999999999999999 9999999999999999999999999999875432221 12345689999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+|||++.+..++.++|+||+|+++|||++|+.||.....
T Consensus 188 ~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 226 (327)
T 3a62_A 188 MAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENR 226 (327)
T ss_dssp SCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCHhhCcCCCCCCcccchhHHHHHHHHHHCCCCCCCCCH
Confidence 999999988999999999999999999999999986543
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.98 E-value=1.2e-32 Score=229.10 Aligned_cols=182 Identities=18% Similarity=0.198 Sum_probs=146.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.+|.|+....... ......+..|..+....+|+|++. ..+...++++++.+|+|...+. ..
T Consensus 27 V~~~~~~~~~~~~a~K~i~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~ 105 (444)
T 3soa_A 27 VRRCVKVLAGQEYAAMIINTKKLS-ARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVARE 105 (444)
T ss_dssp EEEEEETTTTEEEEEEEEESCSCH-HHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCS
T ss_pred EEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcC
Confidence 688888888888887764332211 112344667777888889998874 4455678899999999977664 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc---CCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~---~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++.++..++.|++.||.|||+ .+|+||||||+||+++ .++.+||+|||++........ ......||+.|+
T Consensus 106 ~~~e~~~~~i~~qil~aL~~lH~---~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~--~~~~~~gt~~Y~ 180 (444)
T 3soa_A 106 YYSEADASHCIQQILEAVLHCHQ---MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQ--AWFGFAGTPGYL 180 (444)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCC--BCCCSCSCGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCc--eeecccCCcccC
Confidence 69999999999999999999999 9999999999999998 467899999999976543322 223467899999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||++.+..++.++||||+||++|+|++|++||.+...
T Consensus 181 APE~l~~~~~~~~~DIwSlGvilyell~G~~Pf~~~~~ 218 (444)
T 3soa_A 181 SPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQ 218 (444)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CHHHhcCCCCCCccccHHHHHHHHHHHhCCCCCCCccH
Confidence 99999998999999999999999999999999976543
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=99.98 E-value=1.6e-32 Score=224.39 Aligned_cols=184 Identities=14% Similarity=0.106 Sum_probs=147.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.||.|+...... ..+....+..|..+....+|+|++. ..+..+++++++++++|..++..
T Consensus 43 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 121 (389)
T 3gni_B 43 VNLARYKPTGEYVTVRRINLEAC-SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHF 121 (389)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGS-CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTC
T ss_pred EEEEEEcCCCCEEEEEEeccccc-ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhc
Confidence 68999998888888887644321 1223345667778888889998874 34456688999999999888754
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-----ccccCCCCCC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-----HITSTGRRRT 146 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-----~~~~~~~~gt 146 (202)
..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||.+........ ........||
T Consensus 122 ~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt 198 (389)
T 3gni_B 122 MDGMNELAIAYILQGVLKALDYIHH---MGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKV 198 (389)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTT
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEcccccceeecccccccccccccccccccc
Confidence 569999999999999999999999 9999999999999999999999999998875432111 1112234679
Q ss_pred CcccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||++.+ ..++.++||||+||+++||++|++||.+...
T Consensus 199 ~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 242 (389)
T 3gni_B 199 LPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFKDMPA 242 (389)
T ss_dssp GGGSCHHHHSTTSSCBCTHHHHHHHHHHHHHHHHSSCTTTTCCS
T ss_pred ccccCHHHHhccCCCCCcHhHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999987 5789999999999999999999999976544
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7e-33 Score=231.67 Aligned_cols=179 Identities=17% Similarity=0.175 Sum_probs=137.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||++++...++.||.|+...... ......++..|..+....+|+|++...+ ...+++++++++ +..
T Consensus 78 V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~~-l~~ 155 (464)
T 3ttj_A 78 VCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQ 155 (464)
T ss_dssp EEEEEETTTTEEEEEEEEESGGG-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHH
T ss_pred EEEEEECCCCCEEEEEEECcccc-ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCCC-HHH
Confidence 68898888888888876543211 1122345667777788889998874322 236888888765 444
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
... ..+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++...... ......||+.
T Consensus 156 ~~~-~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~gt~~ 228 (464)
T 3ttj_A 156 VIQ-MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 228 (464)
T ss_dssp HHT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCCC-----CC---CC----CCCT
T ss_pred HHh-hcCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCCc---ccCCCccccc
Confidence 443 359999999999999999999999 999999999999999999999999999998654322 2244567999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||++.+..++.++||||+||+++||++|++||.+...
T Consensus 229 y~aPE~~~~~~~~~~~DiwSlG~il~ell~g~~pF~g~~~ 268 (464)
T 3ttj_A 229 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 268 (464)
T ss_dssp TCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCHHHHcCCCCCHHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999999999999999987653
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-33 Score=227.16 Aligned_cols=183 Identities=19% Similarity=0.259 Sum_probs=147.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.||.|+.+.. ...+...+|..|.......+|+|++. ..+...++++++++|+|..++..
T Consensus 130 V~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~ 207 (377)
T 3cbl_A 130 VFSGRLRADNTLVAVKSCRET--LPPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEG 207 (377)
T ss_dssp EEEEEETTTCCEEEEEECCTT--SCHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHG
T ss_pred EEEEEEecCCeEEEEEEcccc--CCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcC
Confidence 688888888888888875432 11222346888888888889998773 33456789999999999988854
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...............+++.|+||
T Consensus 208 ~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aP 284 (377)
T 3cbl_A 208 ARLRVKTLLQMVGDAAAGMEYLES---KCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAP 284 (377)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCH
Confidence 359999999999999999999999 99999999999999999999999999999865433222222222346789999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+....++.++||||||+++||+++ |+.||.....
T Consensus 285 E~~~~~~~~~~~DvwslG~il~el~t~g~~p~~~~~~ 321 (377)
T 3cbl_A 285 EALNYGRYSSESDVWSFGILLWETFSLGASPYPNLSN 321 (377)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHTTSCCSSTTSCH
T ss_pred hHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99988889999999999999999998 9999986544
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-32 Score=228.96 Aligned_cols=181 Identities=18% Similarity=0.276 Sum_probs=150.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.||.|+.........+....+..|.......+|++++. ..+...++++++++++|..++.. +
T Consensus 32 V~~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~ 111 (476)
T 2y94_A 32 VKVGKHELTGHKVAVKILNRQKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG 111 (476)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTTHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSS
T ss_pred EEEEEECCCCCEEEEEEEEhhhccCHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC
Confidence 6889998888889888765544444444456777777888888998763 34456789999999999988854 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ .....||+.|+|||
T Consensus 112 ~l~~~~~~~i~~qi~~aL~~LH~---~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~~---~~~~~gt~~y~aPE 185 (476)
T 2y94_A 112 RLDEKESRRLFQQILSGVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE 185 (476)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTCC---BCCCCSCSTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCCcccccHHHEEEecCCCeEEEeccchhhcccccc---ccccCCCcCeEChh
Confidence 69999999999999999999999 9999999999999999999999999999987654322 23456899999999
Q ss_pred ccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.+..+ +.++||||+||++++|++|+.||.+..
T Consensus 186 ~~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~ 220 (476)
T 2y94_A 186 VISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDH 220 (476)
T ss_dssp HHTTCCBCSHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred hccCCCCCCCcceehhhHHHHHHHhhCCCCCCCCC
Confidence 9988765 689999999999999999999998654
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=222.36 Aligned_cols=183 Identities=14% Similarity=0.097 Sum_probs=136.9
Q ss_pred CCccccCCC-----cceeehhhhchhhhh---ccCCcccCCc-----HHHHHHhcccccccccc----------ccceEE
Q 044746 1 MEKPRNRGS-----TRFITRTIDKSLDAM---EMDKPIRFTS-----PQRMIAADNFSNLVGSE----------DTETYI 57 (202)
Q Consensus 1 v~k~~~~~~-----~~~v~~~~~~~~~~~---~~~~~~~~~~-----~~~~~~~~~~~~~i~~~----------~~~~~~ 57 (202)
||++++..+ ++.||.|+....... +.....++.. +.......+|++++... .+..++
T Consensus 51 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv 130 (364)
T 3op5_A 51 IYLADMNSSESVGSDAPCVVKVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130 (364)
T ss_dssp EEEEEECCSSCCCTTCSEEEEEEETTCHHHHHHHHHHHHHCCHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEE
T ss_pred EEEeeecCccccccccceEEEEeeccchhHHHHHHHHHhhhhhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEE
Confidence 677777654 466777764332211 0111111222 22334455678776321 335688
Q ss_pred EEEccCCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc--CCCceEEeeeecceeccc
Q 044746 58 KGFLAMGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD--ENFFPKAADFGLAKLYNR 133 (202)
Q Consensus 58 ~~~~~~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~--~~~~~kl~dfgl~~~~~~ 133 (202)
++++ +++|..++.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||++ .++.+||+|||+++....
T Consensus 131 ~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~---~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~ 206 (364)
T 3op5_A 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE---HEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCP 206 (364)
T ss_dssp EECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSG
T ss_pred EeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeEEecCCHHHEEEecCCCCeEEEEECCcceeccc
Confidence 8888 8999988865 469999999999999999999999 9999999999999999 889999999999987643
Q ss_pred cCccc-----ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 134 EHTHI-----TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 134 ~~~~~-----~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
..... ......||+.|+|||++.+..++.++|||||||++|||++|+.||....
T Consensus 207 ~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~g~~Pf~~~~ 265 (364)
T 3op5_A 207 EGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGYCMIQWLTGHLPWEDNL 265 (364)
T ss_dssp GGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred CCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHHHHHHHHhCCCCccccc
Confidence 32211 1133458999999999999999999999999999999999999998643
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=222.52 Aligned_cols=180 Identities=20% Similarity=0.246 Sum_probs=145.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.+|.|+....... ......+..|..+....+|+|++. ..+..+++++++.+++|...+. ..
T Consensus 45 V~~~~~~~~~~~~avK~~~~~~~~-~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~ 123 (362)
T 2bdw_A 45 VRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 123 (362)
T ss_dssp EEEEEETTTCCEEEEEEEETTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS
T ss_pred EEEEEECCCCCEEEEEEEEcccCC-HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcC
Confidence 688988888888888775432211 112344667777888889998874 3445668899999999977764 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC---CceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN---FFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~---~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++.++..++.|++.||.|||+ .+|+||||||+||+++.+ +.+||+|||++........ .....||+.|+
T Consensus 124 ~~~~~~~~~~~~qi~~al~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~ 197 (362)
T 2bdw_A 124 FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYL 197 (362)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCS---CCCSCSCTTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcc---cccCCCCcccc
Confidence 68999999999999999999999 999999999999999764 4599999999986543221 23456899999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||++.+..++.++||||+||++|+|++|++||.+..
T Consensus 198 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~Pf~~~~ 234 (362)
T 2bdw_A 198 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDED 234 (362)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CHHHHccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999899999999999999999999999997654
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-32 Score=217.13 Aligned_cols=179 Identities=16% Similarity=0.214 Sum_probs=144.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++..+++.||.|+.+.... ......+..|.......+|++++.. .....++++++++++|..++..
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 102 (319)
T 4euu_A 25 VFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102 (319)
T ss_dssp EEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHS
T ss_pred EEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHH
Confidence 68999998888888887544322 1223445567777788889987642 2244689999999999988865
Q ss_pred CC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE----cCCCceEEeeeecceeccccCcccccCCCC
Q 044746 73 NI----LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 73 ~~----~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~----~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
.. +++.++..++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||+++....... .....
T Consensus 103 ~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~ 176 (319)
T 4euu_A 103 PSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLY 176 (319)
T ss_dssp GGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCC---BCCCC
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCc---eeecc
Confidence 32 9999999999999999999999 999999999999999 7778899999999987654332 23356
Q ss_pred CCCcccCCcccC--------CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 145 RTPGCEAPELWM--------PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 145 gt~~y~aPe~~~--------~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||+.|+|||++. +..++.++||||+||++|||++|+.||....
T Consensus 177 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 227 (319)
T 4euu_A 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (319)
T ss_dssp SCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred cCCCccCHHHhhhccccccccCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 799999999985 5678899999999999999999999997543
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=220.52 Aligned_cols=178 Identities=16% Similarity=0.235 Sum_probs=145.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..+++.++.|+.+.... ....+..|..+....+|+|++. ..+...++++++++++|..++...
T Consensus 21 Vy~~~~~~~~~~~a~K~~~~~~~----~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~ 96 (321)
T 1tki_A 21 VHRCVETSSKKTYMAKFVKVKGT----DQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA 96 (321)
T ss_dssp EEEEEETTTTEEEEEEEECCCTH----HHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS
T ss_pred EEEEEECCCCcEEEEEEEecCcc----cHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcC
Confidence 68899988888888876543211 1233566777778888998774 334556889999999999988654
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC--CCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE--NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~--~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||+++........ ....||+.|+
T Consensus 97 ~~~~~~~~~~i~~qi~~al~~lH~---~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~ 170 (321)
T 1tki_A 97 FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYY 170 (321)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE---EEEESCGGGS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCCcc---ccccCChhhc
Confidence 59999999999999999999999 99999999999999987 789999999999876443222 2345799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||++.+..++.++||||+|+++|+|++|++||.....
T Consensus 171 aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 208 (321)
T 1tki_A 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETN 208 (321)
T ss_dssp CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred CcHHhcCCCCCchhhHHHHHHHHHHHHhCCCCCcCCCH
Confidence 99999988889999999999999999999999976554
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-32 Score=217.09 Aligned_cols=180 Identities=21% Similarity=0.286 Sum_probs=143.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.||.|+.+... .......+..|.......+|++++. ..+...+++++++ ++|..++..
T Consensus 21 V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~ 97 (317)
T 2pmi_A 21 VYKGLNKTTGVYVALKEVKLDS--EEGTPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRT 97 (317)
T ss_dssp EEEEECSSSCCEEEEEEEECCS--TTCSCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHH
T ss_pred EEEEEECCCCcEEEEEEeeccc--ccccHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhcc
Confidence 6899998888888888654332 1222344566777778888998763 3344568888888 577776643
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 73 -----NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 73 -----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... ......||+
T Consensus 98 ~~~~~~~~~~~~~~~~~~qi~~aL~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~ 172 (317)
T 2pmi_A 98 VGNTPRGLELNLVKYFQWQLLQGLAFCHE---NKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPVN--TFSSEVVTL 172 (317)
T ss_dssp SSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCCC--CCCCCCSCC
T ss_pred ccccccCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCChHHeEEcCCCCEEECcCccceecCCCcc--cCCCCcccc
Confidence 358999999999999999999999 9999999999999999999999999999987543222 123456799
Q ss_pred cccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 148 GCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 148 ~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|+|||++.+ ..++.++||||+||+++||++|++||.....
T Consensus 173 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 214 (317)
T 2pmi_A 173 WYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214 (317)
T ss_dssp TTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCchHhhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCh
Confidence 9999999976 4689999999999999999999999976554
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=99.97 E-value=3.4e-32 Score=223.57 Aligned_cols=174 Identities=21% Similarity=0.290 Sum_probs=134.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHH-HHhcccccccc---c-------cccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRM-IAADNFSNLVG---S-------EDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~---~-------~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.||.|+.+... .+..|... ....+|++++. . ....+++++++++|+|..+
T Consensus 78 V~~~~~~~~~~~vAiK~~~~~~--------~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~ 149 (400)
T 1nxk_A 78 VLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 149 (400)
T ss_dssp EEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred EEEEEECCCCCEEEEEEeCcch--------hHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHH
Confidence 6889998888888888754321 12223222 24456776653 1 3345688999999999998
Q ss_pred hccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCC
Q 044746 70 CKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 70 ~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
+... .+++.++..++.|++.||.|||+ .+|+||||||+|||++. ++.+||+|||+++....... ....
T Consensus 150 l~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~ 223 (400)
T 1nxk_A 150 IQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTP 223 (400)
T ss_dssp HHCC---CCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------
T ss_pred HHHhCCCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCcceEEEecCCCCccEEEEecccccccCCCCc---cccC
Confidence 8653 49999999999999999999999 99999999999999987 78999999999986543221 2345
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||+.|+|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 224 ~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 268 (400)
T 1nxk_A 224 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 268 (400)
T ss_dssp ---CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHHSSCSCCCCTT
T ss_pred CCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHhCCCCCCCCcc
Confidence 679999999999998999999999999999999999999976554
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.1e-32 Score=217.21 Aligned_cols=182 Identities=18% Similarity=0.205 Sum_probs=148.0
Q ss_pred CCccccCCCcceeehhhhchhhhhc-----cCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCC-chhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME-----MDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMG-PFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~-~l~~ 68 (202)
||++++..+++.||.|+.+...... ......+..|.......+|++++. ..+...++++++.+| +|..
T Consensus 40 Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~ 119 (335)
T 3dls_A 40 VWTAVDKEKNKEVVVKFIKKEKVLEDCWIEDPKLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFA 119 (335)
T ss_dssp EEEEEETTTTEEEEEEEEESTTSCTTSEEEETTTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHH
T ss_pred EEEEEECCCCcEEEEEEEehhhcccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHH
Confidence 7899988888888888755443221 124456777888888889998764 344556788888766 8888
Q ss_pred hhccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 69 LCKKN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 69 ~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......... ....||+
T Consensus 120 ~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~~---~~~~gt~ 193 (335)
T 3dls_A 120 FIDRHPRLDEPLASYIFRQLVSAVGYLRL---KDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGKLF---YTFCGTI 193 (335)
T ss_dssp HHHTCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTCCB---CEECSCG
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeEEeccCHHHEEEcCCCcEEEeecccceECCCCCce---eccCCCc
Confidence 87655 69999999999999999999999 99999999999999999999999999999876543322 2345799
Q ss_pred cccCCcccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 148 GCEAPELWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 148 ~y~aPe~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|+|||++.+..+ +.++||||+|+++|+|++|+.||.....
T Consensus 194 ~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 235 (335)
T 3dls_A 194 EYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCELEE 235 (335)
T ss_dssp GGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCSCSSGGG
T ss_pred cccChhhhcCCCCCCCcccchhHHHHHHHHHhCCCchhhHHH
Confidence 9999999988776 7889999999999999999999976544
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.6e-32 Score=221.95 Aligned_cols=178 Identities=21% Similarity=0.239 Sum_probs=144.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.||.|....... ......++..|.......+|+|++... ...+++++++ +++|..
T Consensus 41 V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~ 118 (367)
T 1cm8_A 41 VCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGK 118 (367)
T ss_dssp EEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHH
T ss_pred EEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHH
Confidence 68888888888888776432211 111234466777778888899887421 1236778887 789999
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
++....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++..... .....+|+.
T Consensus 119 ~~~~~~l~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~ 190 (367)
T 1cm8_A 119 LMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRW 190 (367)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGG
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCcCHHHEEEcCCCCEEEEeeecccccccc-----cCcCcCCCC
Confidence 9988899999999999999999999999 99999999999999999999999999999875432 234567999
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||++.+ ..++.++|+||+||+++||++|++||.+...
T Consensus 191 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 231 (367)
T 1cm8_A 191 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 231 (367)
T ss_dssp GCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCHHHHhCCCCCChhhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999876 6789999999999999999999999986554
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.8e-32 Score=211.86 Aligned_cols=179 Identities=15% Similarity=0.160 Sum_probs=141.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc-------cccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV-------GSEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i-------~~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++++...++.||.|+..... ....+..|.......+|++.+ ..+....++++++ +++|..++.
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 98 (296)
T 4hgt_A 25 IYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC 98 (296)
T ss_dssp EEEEEETTTTEEEEEEEEEC--------CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred EEEEEEcCCCceEEEEeecccc-----cchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHh
Confidence 6889988888888888643322 122455565556555555433 2344456788888 899988886
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE---cCCCceEEeeeecceeccccCcc-----cccCCC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTH-----ITSTGR 143 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~---~~~~~~kl~dfgl~~~~~~~~~~-----~~~~~~ 143 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.+||+|||+++........ ......
T Consensus 99 ~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~ 175 (296)
T 4hgt_A 99 SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175 (296)
T ss_dssp TSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCccccc
Confidence 5679999999999999999999999 999999999999999 78899999999999876543221 122345
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||+.|+|||.+.+..++.++||||+||++++|++|+.||.....
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 4hgt_A 176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CSCGGGCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCccccchHHhcCCCCCchhHHHHHHHHHHHHhcCCCCCcccch
Confidence 689999999999999999999999999999999999999987544
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-33 Score=223.59 Aligned_cols=183 Identities=21% Similarity=0.268 Sum_probs=142.6
Q ss_pred CCccc-----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccccc-------cccceEEEEEccCCchh
Q 044746 1 MEKPR-----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGS-------EDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~-----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~-------~~~~~~~~~~~~~~~l~ 67 (202)
||+++ +...++.||.|+.+..... .....+..|....... +|+|++.. +....++++++++|+|.
T Consensus 38 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~ 115 (359)
T 3vhe_A 38 VIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 115 (359)
T ss_dssp EEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHH
T ss_pred EEEEEeccccccccceEEEEEEecCcCCH--HHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHH
Confidence 57776 5666778888775432111 1123455565555555 77877632 33366889999999998
Q ss_pred hhhccCC-------------------------------------------------------------------CCHHHH
Q 044746 68 LLCKKNI-------------------------------------------------------------------LGFGQL 80 (202)
Q Consensus 68 ~~~~~~~-------------------------------------------------------------------~~~~~~ 80 (202)
.++.... +++..+
T Consensus 116 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 195 (359)
T 3vhe_A 116 TYLRSKRNEFVPYKTKGARFRQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHL 195 (359)
T ss_dssp HHHHTTTTSBCSCC------------------------------------------------------CTTTTCBCHHHH
T ss_pred HHHHhccccccccccccchhhcccccccccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHH
Confidence 8885432 899999
Q ss_pred HHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCC
Q 044746 81 REIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSV 160 (202)
Q Consensus 81 ~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~ 160 (202)
..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++...............||+.|+|||++.+..+
T Consensus 196 ~~~~~ql~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 272 (359)
T 3vhe_A 196 ICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 272 (359)
T ss_dssp HHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHH---CCcccCCCChhhEEEcCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCC
Confidence 9999999999999999 9999999999999999999999999999986644433333445567899999999988899
Q ss_pred CchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 161 TQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 161 ~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
+.++||||+|++++||++ |+.||.....
T Consensus 273 ~~~~Di~slG~il~ellt~g~~p~~~~~~ 301 (359)
T 3vhe_A 273 TIQSDVWSFGVLLWEIFSLGASPYPGVKI 301 (359)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CchhhhhhHHHHHHHHHhcCCCCCCccch
Confidence 999999999999999998 9999976543
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=5e-32 Score=211.61 Aligned_cols=183 Identities=17% Similarity=0.224 Sum_probs=130.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...++.|+.|+.............++..|.......+|++++. ..+...++++++++++|..++..
T Consensus 27 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 106 (278)
T 3cok_A 27 VYRAESIHTGLEVAIKMIDKKAMYKAGMVQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRV 106 (278)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCS
T ss_pred EEEEEEccCCceEEEEEeehhhhhhhhHHHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhcc
Confidence 6888888888888888765544333344456777777777888888763 34556788999999999988865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ......||+.|+||
T Consensus 107 ~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 181 (278)
T 3cok_A 107 KPFSENEARHFMHQIITGMLYLHS---HGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE--KHYTLCGTPNYISP 181 (278)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---TTEECSSCCGGGEEECTTCCEEECCCTTCEECC--------------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC--cceeccCCCCcCCc
Confidence 469999999999999999999999 9999999999999999999999999999986543221 12234579999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|+++++|++|+.||.....
T Consensus 182 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 217 (278)
T 3cok_A 182 EIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTV 217 (278)
T ss_dssp ----------CTHHHHHHHHHHHHHHSSCSSCCCSC
T ss_pred chhcCCCCCchhhHHHHHHHHHHHHhCCCCCCChhH
Confidence 999988899999999999999999999999986543
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.6e-32 Score=216.18 Aligned_cols=178 Identities=21% Similarity=0.186 Sum_probs=133.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.||.|+..............+..........+|++++. .++...++++++ +++|..++..
T Consensus 73 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~ 151 (311)
T 3p1a_A 73 VFKVRSKEDGRLYAVKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWG 151 (311)
T ss_dssp EEEEEETTTSCEEEEEEESSSCCSHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHC
T ss_pred EEEEEECCCCeEEEEEEecccccChHHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcC
Confidence 7899999888888888643322111111222333334444457887763 344456778888 5677666643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||++........ .....||+.|+||
T Consensus 152 ~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~aP 225 (311)
T 3p1a_A 152 ASLPEAQVWGYLRDTLLALAHLHS---QGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGA---GEVQEGDPRYMAP 225 (311)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECGGGCEEECCCTTCEECC---------CCCCCGGGCCG
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEecCCCCHHHEEECCCCCEEEccceeeeecccCCC---CcccCCCccccCH
Confidence 459999999999999999999999 9999999999999999999999999999986543322 2334579999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|++.+ .++.++||||+||+++||++|..|+...
T Consensus 226 E~~~~-~~~~~~DiwslG~il~el~~g~~~~~~~ 258 (311)
T 3p1a_A 226 ELLQG-SYGTAADVFSLGLTILEVACNMELPHGG 258 (311)
T ss_dssp GGGGT-CCSTHHHHHHHHHHHHHHHHTCCCCSSH
T ss_pred hHhcC-CCCchhhHHHHHHHHHHHHhCCCCCCCc
Confidence 99876 7899999999999999999997766543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=222.06 Aligned_cols=179 Identities=18% Similarity=0.253 Sum_probs=145.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..+++.+|.|+....... ....+..|..+....+|+|++. ......++++++++++|..++...
T Consensus 67 Vy~~~~~~~~~~~a~K~~~~~~~~---~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~ 143 (387)
T 1kob_A 67 VHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 143 (387)
T ss_dssp EEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT
T ss_pred EEEEEECCCCCEEEEEEecccchh---hHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhc
Confidence 688999888888888765432211 1224566777777888998763 344567889999999999888654
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC--CCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE--NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~--~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++.++..++.|++.||.|||+ .+|+||||||+||+++. .+.+||+|||+++........ ....||+.|+
T Consensus 144 ~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gt~~y~ 217 (387)
T 1kob_A 144 YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFA 217 (387)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccchHHeEEecCCCCceEEEecccceecCCCcce---eeeccCCCcc
Confidence 68999999999999999999999 99999999999999974 578999999999876543222 2235799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||++.+..++.++||||+||++|||++|++||.+...
T Consensus 218 aPE~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~ 255 (387)
T 1kob_A 218 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDD 255 (387)
T ss_dssp CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CchhccCCCCCCcccEeeHhHHHHHHHhCCCCCCCCCH
Confidence 99999998999999999999999999999999986543
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=210.48 Aligned_cols=178 Identities=12% Similarity=0.101 Sum_probs=138.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccc---cccc---ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFS---NLVG---SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~---~~i~---~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.||.|+..... ....+..|....... +|+ ++++ .+....++++++ +++|..++..
T Consensus 26 V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~ 99 (298)
T 1csn_A 26 IFEGTNLLNNQQVAIKFEPRRS-----DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC 99 (298)
T ss_dssp EEEEEETTTTEEEEEEEEECCT-----TSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred EEEEEECCCCcEEEEEEeccCC-----ccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHh
Confidence 6888888888888888653221 122344444444333 444 4443 344556888888 8999998864
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc-----eEEeeeecceeccccCcc-----cccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF-----PKAADFGLAKLYNREHTH-----ITST 141 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~-----~kl~dfgl~~~~~~~~~~-----~~~~ 141 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++. ++|+|||+++........ ....
T Consensus 100 ~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 176 (298)
T 1csn_A 100 GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 176 (298)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCcc
Confidence 459999999999999999999999 99999999999999987765 999999999876543221 1234
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
...||+.|+|||.+.+..++.++||||+|++++||++|+.||....
T Consensus 177 ~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 222 (298)
T 1csn_A 177 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLK 222 (298)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred CCCCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHcCCCCcchhh
Confidence 4568999999999999899999999999999999999999998744
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-32 Score=219.98 Aligned_cols=185 Identities=15% Similarity=0.172 Sum_probs=131.7
Q ss_pred CCccccCCCcc---eeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccccc------------ceEEEEEccCCc
Q 044746 1 MEKPRNRGSTR---FITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDT------------ETYIKGFLAMGP 65 (202)
Q Consensus 1 v~k~~~~~~~~---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~------------~~~~~~~~~~~~ 65 (202)
||++++...+. .||.|+.+.... ......++..|.......+|++++...+. ..++++++.+++
T Consensus 39 Vy~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~ 117 (323)
T 3qup_A 39 VREAQLKQEDGSFVKVAVKMLKADII-ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGD 117 (323)
T ss_dssp EEEEEC-------CEEEEEEC-------CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCB
T ss_pred EEEEEEcccCCcceeEEEEEeccccc-CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCc
Confidence 67888776664 566665433211 11223456677777778889987642221 278899999999
Q ss_pred hhhhhccC-------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc
Q 044746 66 FYLLCKKN-------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138 (202)
Q Consensus 66 l~~~~~~~-------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~ 138 (202)
|..++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++.........
T Consensus 118 L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~~~ 194 (323)
T 3qup_A 118 LHAFLLASRIGENPFNLPLQTLVRFMVDIACGMEYLSS---RNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDYYR 194 (323)
T ss_dssp HHHHHHHHHC---CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------
T ss_pred HHHHHHhhhccccccccCHHHHHHHHHHHHHHHHHHHc---CCcccCCCCcceEEEcCCCCEEEeecccccccccccccc
Confidence 98887432 58999999999999999999999 999999999999999999999999999998665443333
Q ss_pred ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
......+++.|+|||.+.+..++.++||||+||+++||++ |++||......
T Consensus 195 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 246 (323)
T 3qup_A 195 QGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENA 246 (323)
T ss_dssp ------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred ccccccCcccccCchhhcCCCCCCccchhhHHHHHHHHHhCCCCCccccChH
Confidence 3344556889999999998889999999999999999999 99999865543
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-32 Score=215.12 Aligned_cols=182 Identities=23% Similarity=0.282 Sum_probs=138.1
Q ss_pred CCccccCCCcceeehhhhchhhhhc--cCCcccCCcHHHHHHh---ccccccccccc-----------cceEEEEEccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME--MDKPIRFTSPQRMIAA---DNFSNLVGSED-----------TETYIKGFLAMG 64 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~--~~~~~~~~~~~~~~~~---~~~~~~i~~~~-----------~~~~~~~~~~~~ 64 (202)
||++++..+++.||.|+........ ......+..|...... .+|+|++...+ ...++++++. +
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~ 103 (308)
T 3g33_A 25 VYKARDPHSGHFVALKSVRVPNGGGGGGGLPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-Q 103 (308)
T ss_dssp EEEEECTTTCCEEEEEEEEEECCCTTSSCCCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-C
T ss_pred EEEEEECCCCcEEEEEEEecccccccccccchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-c
Confidence 7899998889999888754332211 1112223334333333 34787763211 2356677776 5
Q ss_pred chhhhhccCC---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccC
Q 044746 65 PFYLLCKKNI---LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITST 141 (202)
Q Consensus 65 ~l~~~~~~~~---~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~ 141 (202)
+|..++.... +++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ..
T Consensus 104 ~L~~~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~---~~ 177 (308)
T 3g33_A 104 DLRTYLDKAPPPGLPAETIKDLMRQFLRGLDFLHA---NCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQMA---LT 177 (308)
T ss_dssp BHHHHHHTCCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCCC---SG
T ss_pred CHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCcc---cC
Confidence 8877775543 8999999999999999999999 9999999999999999999999999999976543222 23
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
...||+.|+|||++.+..++.++||||+||+++||++|++||......
T Consensus 178 ~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 225 (308)
T 3g33_A 178 PVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEA 225 (308)
T ss_dssp GGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHHHTTTSSCSCCCSSHH
T ss_pred CccccccccCchHHcCCCCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 346799999999999889999999999999999999999999776543
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-32 Score=215.84 Aligned_cols=180 Identities=17% Similarity=0.199 Sum_probs=143.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc----------------------------
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED---------------------------- 52 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~---------------------------- 52 (202)
||++++..+++.||.|+.+... .......+..|.......+|+|++...+
T Consensus 22 V~~a~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 99 (332)
T 3qd2_B 22 VFEAKNKVDDCNYAIKRIRLPN--RELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPL 99 (332)
T ss_dssp EEEEEETTTCCEEEEEEEECCS--TTTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC------------
T ss_pred EEEEEEcCCCcEEEEEEeecCC--chhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccc
Confidence 7899998888888888754322 1122345677777888889998875322
Q ss_pred -----------------------------------cceEEEEEccCCchhhhhccC----CCCHHHHHHHHHHHHHHHHH
Q 044746 53 -----------------------------------TETYIKGFLAMGPFYLLCKKN----ILGFGQLREIEVSTSKGIAY 93 (202)
Q Consensus 53 -----------------------------------~~~~~~~~~~~~~l~~~~~~~----~~~~~~~~~~~~~i~~~l~~ 93 (202)
+..++++++++++|..++... ..++..+..++.|++.||.|
T Consensus 100 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~ 179 (332)
T 3qd2_B 100 SSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEF 179 (332)
T ss_dssp --------------------------------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHH
T ss_pred cCCCcccccccceeeccccCcccccccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHH
Confidence 256889999999999988654 35667799999999999999
Q ss_pred HHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc----------cccCCCCCCCcccCCcccCCCCCCch
Q 044746 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH----------ITSTGRRRTPGCEAPELWMPYSVTQK 163 (202)
Q Consensus 94 lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~----------~~~~~~~gt~~y~aPe~~~~~~~~~~ 163 (202)
||+ .+++||||||+||+++.++.+||+|||+++........ .......||+.|+|||++.+..++.+
T Consensus 180 LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~ 256 (332)
T 3qd2_B 180 LHS---KGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHK 256 (332)
T ss_dssp HHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTH
T ss_pred HHh---CCeeecCCCcccEEEeCCCCEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcch
Confidence 999 99999999999999999999999999999876543211 12234568999999999999899999
Q ss_pred hhHHHHHHHHHHHHcCCCCCcc
Q 044746 164 CDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 164 ~Diws~G~~l~el~~g~~p~~~ 185 (202)
+||||+|++++||++|..|+..
T Consensus 257 ~Di~slG~il~el~~~~~~~~~ 278 (332)
T 3qd2_B 257 VDIFSLGLILFELLYSFSTQME 278 (332)
T ss_dssp HHHHHHHHHHHHHHSCCCCHHH
T ss_pred hhHHHHHHHHHHHHHcCCChhH
Confidence 9999999999999999888754
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=9.8e-32 Score=214.51 Aligned_cols=180 Identities=28% Similarity=0.457 Sum_probs=141.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||+++... ++.||.|+...... ......+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 46 V~~~~~~~-~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 122 (326)
T 3uim_A 46 VYKGRLAD-GTLVAVKRLKEERT--QGGELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERP 122 (326)
T ss_dssp EEEECCSS-SCCEEEEECCC-------CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCS
T ss_pred EEEEEecC-CCEEEEEEeccccC--chHHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhcc
Confidence 67887665 45555554333221 122334667777777788898763 344556899999999999888543
Q ss_pred ----CCCHHHHHHHHHHHHHHHHHHHhCCCC---CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 74 ----ILGFGQLREIEVSTSKGIAYLHEECRQ---KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 74 ----~~~~~~~~~~~~~i~~~l~~lH~~~~~---~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.+++..+..++.|++.||.|||+ . +++||||||+||+++.++.++|+|||+++........ ......||
T Consensus 123 ~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~gt 198 (326)
T 3uim_A 123 ESQPPLDWPKRQRIALGSARGLAYLHD---HCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDTH-VTTAVRGT 198 (326)
T ss_dssp TTCCCCCHHHHHHHHHHHHHHHHHHHH---SSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSSC-EECCCCSC
T ss_pred ccCCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCeEeCCCchhhEEECCCCCEEeccCccccccCccccc-ccccccCC
Confidence 39999999999999999999999 7 9999999999999999999999999999876433322 22345589
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.|+|||++.+..++.++||||+|+++++|++|+.||....
T Consensus 199 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 239 (326)
T 3uim_A 199 IGHIAPEYLSTGKSSEKTDVFGYGVMLLELITGQRAFDLAR 239 (326)
T ss_dssp GGGCCHHHHHHSEECHHHHHHHHHHHHHHHHHCCCSBCHHH
T ss_pred cCccCHHHhccCCCCccccchhHHHHHHHHHhCCCcccccc
Confidence 99999999988889999999999999999999999997443
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=213.46 Aligned_cols=181 Identities=20% Similarity=0.261 Sum_probs=137.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++.. ++.||.|+.+... ........+..|.......+|++++. ......++++++++ ++...+..
T Consensus 37 V~~~~~~~-~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~ 113 (311)
T 3niz_A 37 VYKAKDSQ-GRIVALKRIRLDA-EDEGIPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENK 113 (311)
T ss_dssp EEEEEETT-SCEEEEEEEC-------CHHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCSE-EHHHHHHTCT
T ss_pred EEEEEECC-CCEEEEEEEeccc-ccchhhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCCC-CHHHHHHhcc
Confidence 68888865 5556655443221 11222344666777788888998763 34455688888885 56555543
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++....... ......||+.|+||
T Consensus 114 ~~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aP 188 (311)
T 3niz_A 114 TGLQDSQIKIYLYQLLRGVAHCHQ---HRILHRDLKPQNLLINSDGALKLADFGLARAFGIPVR--SYTHEVVTLWYRAP 188 (311)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCCC-----CCCCCCTTCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCchHhEEECCCCCEEEccCcCceecCCCcc--cccCCcccCCcCCH
Confidence 349999999999999999999999 9999999999999999999999999999987643322 12335679999999
Q ss_pred cccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++.+ ..++.++||||+||++++|++|++||......
T Consensus 189 E~~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 226 (311)
T 3niz_A 189 DVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDD 226 (311)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSTT
T ss_pred HHhcCCCCCCchHHhHHHHHHHHHHHhCCCCCCCCChH
Confidence 99876 56899999999999999999999999865544
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-32 Score=226.63 Aligned_cols=173 Identities=21% Similarity=0.257 Sum_probs=129.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.||.|+...... ......++..|..++...+|+|++... ...+++++++ +++|..+
T Consensus 69 V~~~~~~~~~~~vaiK~i~~~~~-~~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~ 146 (458)
T 3rp9_A 69 VCEAYDKLEKRVVAIKKILRVFE-DLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKL 146 (458)
T ss_dssp EEEEEECC--CEEEEEEECSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHH
T ss_pred EEEEEECCCCcEEEEEEechhhc-CHHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhh
Confidence 68899988888888875432211 112234566788888888999887422 2345667765 5677777
Q ss_pred hccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-----------
Q 044746 70 CKKN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH----------- 137 (202)
Q Consensus 70 ~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~----------- 137 (202)
+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 147 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~ 223 (458)
T 3rp9_A 147 FRTPVYLTELHIKTLLYNLLVGVKYVHS---AGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPRED 223 (458)
T ss_dssp HHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC------
T ss_pred cccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCcccc
Confidence 7554 59999999999999999999999 99999999999999999999999999999865422110
Q ss_pred --------------cccCCCCCCCcccCCccc-CCCCCCchhhHHHHHHHHHHHHc
Q 044746 138 --------------ITSTGRRRTPGCEAPELW-MPYSVTQKCDVFSFGMLLFEVVG 178 (202)
Q Consensus 138 --------------~~~~~~~gt~~y~aPe~~-~~~~~~~~~Diws~G~~l~el~~ 178 (202)
.......||+.|+|||++ ....++.++||||+||++|||++
T Consensus 224 ~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~DiwSlG~il~ellt 279 (458)
T 3rp9_A 224 DMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIFAELLN 279 (458)
T ss_dssp ---------------------CCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHHT
T ss_pred ccccccccccccccccccCCcccccccChHHhhCCCCCCcHhHHHHHHHHHHHHHH
Confidence 122445789999999976 45679999999999999999999
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.4e-32 Score=213.93 Aligned_cols=177 Identities=22% Similarity=0.287 Sum_probs=135.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh--cccccccccc----------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA--DNFSNLVGSE----------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~i~~~----------~~~~~~~~~~~~~~l~~ 68 (202)
||++++ .++.||.|+...... ..+..+...... .+|+|++... ....++++++++|+|..
T Consensus 24 V~~~~~--~~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 95 (301)
T 3q4u_A 24 VWRGSW--QGENVAVKIFSSRDE------KSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYD 95 (301)
T ss_dssp EEEEEE--TTEEEEEEEECGGGH------HHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHH
T ss_pred EEEEEE--CCEEEEEEEeccccc------hhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHH
Confidence 577766 355666665433211 122223333333 6788876432 23468889999999999
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc--
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLH--------EECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-- 138 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-- 138 (202)
+++...+++..+..++.|++.||.||| + .+++||||||+||+++.++.+||+|||+++.........
T Consensus 96 ~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 172 (301)
T 3q4u_A 96 YLQLTTLDTVSCLRIVLSIASGLAHLHIEIFGTQGK---PAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDV 172 (301)
T ss_dssp HHTTCCBCHHHHHHHHHHHHHHHHHHHSCBCSTTCB---CEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEEC
T ss_pred HHhhcccCHHHHHHHHHHHHHHHHHHHHhhhhccCC---CCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccc
Confidence 999899999999999999999999999 7 899999999999999999999999999998654432221
Q ss_pred ccCCCCCCCcccCCcccCCC------CCCchhhHHHHHHHHHHHHcC----------CCCCcchhc
Q 044746 139 TSTGRRRTPGCEAPELWMPY------SVTQKCDVFSFGMLLFEVVGR----------RRNLEKEIS 188 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~------~~~~~~Diws~G~~l~el~~g----------~~p~~~~~~ 188 (202)
......||+.|+|||++.+. .++.++||||+|+++|||++| ++||....+
T Consensus 173 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~ 238 (301)
T 3q4u_A 173 GNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVP 238 (301)
T ss_dssp CCCCCCCCGGGCCHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSC
T ss_pred cccccccccceeChhhhcCcCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCC
Confidence 12334689999999999876 445789999999999999999 888865443
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.2e-33 Score=225.16 Aligned_cols=184 Identities=21% Similarity=0.232 Sum_probs=140.8
Q ss_pred CCccc-----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPR-----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~-----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||+++ +...+..||+|+.+... .......+..|..+....+|+|++. ......++++++++|+|..+
T Consensus 87 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~ 164 (367)
T 3l9p_A 87 VYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSF 164 (367)
T ss_dssp EEEEEECC-----CCEEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred EEEEEEccCCCCCcceeEEEEeccccc--ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHH
Confidence 56666 44556677777643221 1112234666777777888998774 34455789999999999988
Q ss_pred hcc--------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC---ceEEeeeecceeccccCccc
Q 044746 70 CKK--------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF---FPKAADFGLAKLYNREHTHI 138 (202)
Q Consensus 70 ~~~--------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~---~~kl~dfgl~~~~~~~~~~~ 138 (202)
+.. ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++ .+||+|||+++.........
T Consensus 165 l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~ 241 (367)
T 3l9p_A 165 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYR 241 (367)
T ss_dssp HHHHSCCSSSCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCT
T ss_pred HHhhccccCccccccHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccc
Confidence 854 349999999999999999999999 9999999999999998554 59999999998654333222
Q ss_pred ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
......||+.|+|||++.+..++.++|||||||+++||++ |+.||......
T Consensus 242 ~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG~il~ellt~g~~pf~~~~~~ 293 (367)
T 3l9p_A 242 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQ 293 (367)
T ss_dssp TCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCHH
T ss_pred cCCCcCCcccEECHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 3334557899999999988899999999999999999998 99999865543
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-32 Score=219.81 Aligned_cols=186 Identities=19% Similarity=0.252 Sum_probs=138.3
Q ss_pred CCccccCCCcceeehhhhchh--hhhccCCcccCCcHHHHHHhccccccccc-----cccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSL--DAMEMDKPIRFTSPQRMIAADNFSNLVGS-----EDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++...++.++.++..+. ..........+..|.......+|++++.. .+...++++++.+++|..++..
T Consensus 31 Vy~~~~~~~~~~~~~kv~iK~~~~~~~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~v~~~~~~g~L~~~l~~~ 110 (327)
T 3lzb_A 31 VYKGLWIPEGEKVKIPVAIKELREATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREH 110 (327)
T ss_dssp EEEEEECCTTCSCCEEEEEEEECCCSSCCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSSEEEEECCCSSCBHHHHHHHT
T ss_pred EEEEEEcCCCceEEEEEEEEeeccccCHHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCCceEEEEecCCCcHHHHHHhc
Confidence 688888777776654432111 11222334456677778888899988742 2335678889999999988854
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++...............+|+.|+|
T Consensus 111 ~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~a 187 (327)
T 3lzb_A 111 KDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMA 187 (327)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCTTC----------------CCCGGGSC
T ss_pred CCCCCHHHHHHHHHHHHHHHHHHhh---CCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccccccccCCCccccccC
Confidence 469999999999999999999999 9999999999999999999999999999987654433333344556889999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
||.+.+..++.++||||+|+++|||++ |+.||......
T Consensus 188 PE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~~ 226 (327)
T 3lzb_A 188 LESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 226 (327)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred HHHHcCCCCChHHHHHHHHHHHHHHHHCCCCCCCCCCHH
Confidence 999998899999999999999999999 99999875543
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.7e-32 Score=216.16 Aligned_cols=180 Identities=23% Similarity=0.361 Sum_probs=134.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++. +..||.|+...... ..+...++..|.......+|++++. ..+...++++++++++|..++....
T Consensus 53 V~~~~~~--~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 129 (309)
T 3p86_A 53 VHRAEWH--GSDVAVKILMEQDF-HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSG 129 (309)
T ss_dssp EEEEEET--TEEEEEEEECCCCC-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTT
T ss_pred EEEEEEC--CCcEEEEEecCCCC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcC
Confidence 5777653 44466555432211 1122334667777788888998763 3445679999999999999887654
Q ss_pred ----CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 75 ----LGFGQLREIEVSTSKGIAYLHEECRQK--IVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 75 ----~~~~~~~~~~~~i~~~l~~lH~~~~~~--iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||+++....... ......||+.
T Consensus 130 ~~~~~~~~~~~~i~~qi~~aL~~LH~---~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~~--~~~~~~gt~~ 204 (309)
T 3p86_A 130 AREQLDERRRLSMAYDVAKGMNYLHN---RNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTFL--SSKSAAGTPE 204 (309)
T ss_dssp HHHHSCHHHHHHHHHHHHHHHHHHHT---SSSCCCCTTCCGGGEEECTTCCEEECCCC-------------------CCT
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHc---CCCCEECCCCChhhEEEeCCCcEEECCCCCCcccccccc--ccccCCCCcc
Confidence 9999999999999999999999 88 99999999999999999999999999975433221 1234567999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||++.+..++.++||||+|+++|||++|+.||....+
T Consensus 205 y~aPE~~~~~~~~~~~DiwslG~il~elltg~~Pf~~~~~ 244 (309)
T 3p86_A 205 WMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNP 244 (309)
T ss_dssp TSCHHHHTTCCCCTTHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred ccChhhhcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999999999999999999999999999999986554
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=99.97 E-value=9.2e-32 Score=215.27 Aligned_cols=177 Identities=19% Similarity=0.248 Sum_probs=122.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.||.|+...... ..+..|....... +|+|++. ......++++++++++|..++..
T Consensus 27 V~~~~~~~~~~~vavK~~~~~~~------~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 100 (325)
T 3kn6_A 27 CRKCVHKKSNQAFAVKIISKRME------ANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100 (325)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGH------HHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHC
T ss_pred EEEEEECCCCCEEEEEEEChhhh------hhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhc
Confidence 68899988888888887543211 1233444444444 4887763 34456688999999999888755
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC---ceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF---FPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~---~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++ .++|+|||+++....... ......||+.|
T Consensus 101 ~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y 175 (325)
T 3kn6_A 101 KHFSETEASYIMRKLVSAVSHMHD---VGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQ--PLKTPCFTLHY 175 (325)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCC--cccccCCCcCc
Confidence 459999999999999999999999 9999999999999997665 899999999986543322 12345679999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+|||++.+..++.++||||+|+++++|++|+.||.....
T Consensus 176 ~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 214 (325)
T 3kn6_A 176 AAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214 (325)
T ss_dssp --------CCCCHHHHHHHHHHHHHHHHHSSCTTC----
T ss_pred cCHHHhcCCCCCCccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 999999999999999999999999999999999986543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.4e-32 Score=212.25 Aligned_cols=179 Identities=19% Similarity=0.239 Sum_probs=140.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.||.|+.+.... .......+..|.......+|++++. ..+...+++++++++.+..+.. ..
T Consensus 18 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~l~~~~~~~~~ 96 (292)
T 3o0g_A 18 VFKAKNRETHEIVALKRVRLDDD-DEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96 (292)
T ss_dssp EEEEEETTTCCEEEEEEEESSCS-STTHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTT
T ss_pred EEEEEECCCCceEEEEeeeccCC-cCCcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCCCHHHHHHhCCC
Confidence 68999998888888887543321 1122234556777777788898764 3444568888888655444443 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ......||+.|+|||
T Consensus 97 ~l~~~~~~~~~~ql~~~l~~lH~---~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE 171 (292)
T 3o0g_A 97 DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVR--CYSAEVVTLWYRPPD 171 (292)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCCS--CCCSCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCCEEEeecccceecCCccc--cccCCccccCCcChH
Confidence 79999999999999999999999 9999999999999999999999999999987643322 223456799999999
Q ss_pred ccCCCC-CCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 154 LWMPYS-VTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 154 ~~~~~~-~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
++.+.. ++.++||||+||+++||++|..||..
T Consensus 172 ~~~~~~~~~~~~DiwslG~il~~l~~~~~p~~~ 204 (292)
T 3o0g_A 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFP 204 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCC
T ss_pred HHcCCCCcCchHHHHHHHHHHHHHHHcCCCCcC
Confidence 998765 79999999999999999998887643
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-32 Score=217.67 Aligned_cols=175 Identities=19% Similarity=0.238 Sum_probs=137.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-----ccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-----NFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.||.|+.+...... ..+..|..+.... +|++++. ..+...++++++ +++|..+
T Consensus 51 V~~~~~~~~~~~vavK~~~~~~~~~----~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~ 125 (360)
T 3llt_A 51 VLLCQHIDNKKYYAVKVVRNIKKYT----RSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEI 125 (360)
T ss_dssp EEEEEETTTCCEEEEEEECSCHHHH----HHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHH
T ss_pred EEEEEECCCCeEEEEEEeccchhhh----hhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHH
Confidence 6899998888999988764322111 1223344444333 3777763 334455778888 8899888
Q ss_pred hccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-------------------------CCceE
Q 044746 70 CKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-------------------------NFFPK 121 (202)
Q Consensus 70 ~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-------------------------~~~~k 121 (202)
+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++. ++.+|
T Consensus 126 ~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~k 202 (360)
T 3llt_A 126 ITRNNYNGFHIEDIKLYCIEILKALNYLRK---MSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIK 202 (360)
T ss_dssp HHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEE
T ss_pred HHhcCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEE
Confidence 8654 39999999999999999999999 99999999999999975 78899
Q ss_pred EeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 122 AADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 122 l~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||+++..... .....||+.|+|||++.+..++.++||||+||++++|++|+.||.....
T Consensus 203 l~DFG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 264 (360)
T 3llt_A 203 LIDFGCATFKSDY-----HGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEH 264 (360)
T ss_dssp ECCCTTCEETTSC-----CCSCCSCGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred EEeccCceecCCC-----CcCccCcccccCcHHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcH
Confidence 9999999864432 2335679999999999999999999999999999999999999976543
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-32 Score=221.18 Aligned_cols=179 Identities=19% Similarity=0.211 Sum_probs=146.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.||.|+.+..... ....+..|.......+|+|++. ..+...++++++++++|..++..
T Consensus 105 Vy~a~~~~~g~~vavK~~~~~~~~---~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~ 181 (373)
T 2x4f_A 105 VHKCEETATGLKLAAKIIKTRGMK---DKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDES 181 (373)
T ss_dssp EEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTG
T ss_pred EEEEEEcCCCcEEEEEEEcccccc---cHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcC
Confidence 688888888888888875443211 2235667777788888998763 34456789999999999877743
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE--cCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL--DENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~--~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++..+..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||+++....... .....||+.|+
T Consensus 182 ~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt~~y~ 255 (373)
T 2x4f_A 182 YNLTELDTILFMKQICEGIRHMHQ---MYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK---LKVNFGTPEFL 255 (373)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTCB---CCCCCSSCTTC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCccc---cccccCCCcEe
Confidence 359999999999999999999999 999999999999999 5678999999999987644322 23346899999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||++.+..++.++||||+||+++||++|+.||.....
T Consensus 256 aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~ 293 (373)
T 2x4f_A 256 APEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDND 293 (373)
T ss_dssp CHHHHTTCBCCHHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred ChhhccCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999988899999999999999999999999976544
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-32 Score=224.22 Aligned_cols=179 Identities=8% Similarity=-0.009 Sum_probs=130.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHH---HHHHhcccccccc-cc-------------------------
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQ---RMIAADNFSNLVG-SE------------------------- 51 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~-~~------------------------- 51 (202)
||++++..+++.||.|+..............+..|. ..+.. +|++++. ..
T Consensus 78 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~~~~l~~-~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~ 156 (371)
T 3q60_A 78 VFLVRDVERLEDFALKVFTMGAENSRSELERLHEATFAAARLLG-ESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQD 156 (371)
T ss_dssp EEEEEETTTTEEEEEEEEECCSTTHHHHHHHHHHHHHHHHHHHC-----------CBCCCCEEEEETTSCSSSBCSCC--
T ss_pred EEEEEECCCCceeEEEEEEecccccccHHHHHHHHHHHHHHhcc-cChhhhhhceeEEeeehheecCCCCCeeeccCCcc
Confidence 688998888888888876554322222233344442 23333 6887553 11
Q ss_pred ----ccceEEEEEccCCchhhhhccC--CCCHHHH------HHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc
Q 044746 52 ----DTETYIKGFLAMGPFYLLCKKN--ILGFGQL------REIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF 119 (202)
Q Consensus 52 ----~~~~~~~~~~~~~~l~~~~~~~--~~~~~~~------~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~ 119 (202)
...++++++++ ++|..++... .+++..+ ..++.|++.||.|||+ ++|+||||||+|||++.++.
T Consensus 157 ~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~ 232 (371)
T 3q60_A 157 DYAVANYLLLMPAAS-VDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQS---KGLVHGHFTPDNLFIMPDGR 232 (371)
T ss_dssp -CCEEEEEEEECCCS-EEHHHHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEECTTSC
T ss_pred cceeeeEEEEecCCC-CCHHHHHHHhccccchhhhhhhhhHHHHHHHHHHHHHHHHH---CCCccCcCCHHHEEECCCCC
Confidence 22467788888 8998888642 4555555 6778999999999999 99999999999999999999
Q ss_pred eEEeeeecceeccccCcccccCCCCCCCcccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 120 PKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 120 ~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
+||+|||+++....... ...+|+.|+|||++.+ ..++.++||||+||++|||++|+.||....+.
T Consensus 233 ~kL~DFG~a~~~~~~~~-----~~~~t~~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~ 299 (371)
T 3q60_A 233 LMLGDVSALWKVGTRGP-----ASSVPVTYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPG 299 (371)
T ss_dssp EEECCGGGEEETTCEEE-----GGGSCGGGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTT
T ss_pred EEEEecceeeecCCCcc-----CccCCcCCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcc
Confidence 99999999986543211 2345799999999987 67999999999999999999999999887543
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=8e-32 Score=217.61 Aligned_cols=177 Identities=19% Similarity=0.268 Sum_probs=132.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.||.|+.+... ....+..|.......+|++++. ......++++++++++|..++.. .
T Consensus 69 Vy~~~~~~~~~~vavK~~~~~~-----~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 143 (349)
T 2w4o_A 69 VYRCKQKGTQKPYALKVLKKTV-----DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKG 143 (349)
T ss_dssp EEEEEETTTCCEEEEEEEEC---------------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCS
T ss_pred EEEEEECCCCcEEEEEEeccch-----hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcC
Confidence 6889998888888888765432 2234666777777788898763 33445688999999999887754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++. ++.+||+|||+++....... .....||+.|+
T Consensus 144 ~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~ 217 (349)
T 2w4o_A 144 YYSERDAADAVKQILEAVAYLHE---NGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVL---MKTVCGTPGYC 217 (349)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESSSSTTCCEEECCCC-------------------CGGGS
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEecCCCcccEEEecCCCCCCEEEccCccccccCcccc---cccccCCCCcc
Confidence 58999999999999999999999 99999999999999975 88999999999986543221 23356799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||++.+..++.++||||+||++|||++|+.||.....
T Consensus 218 aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 255 (349)
T 2w4o_A 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERG 255 (349)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCTTC
T ss_pred CHHHhcCCCCCcccchHHHHHHHHHHHhCCCCCCCCcc
Confidence 99999998999999999999999999999999976543
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-32 Score=217.62 Aligned_cols=183 Identities=21% Similarity=0.266 Sum_probs=142.0
Q ss_pred CCcccc-----CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRN-----RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~-----~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
||++++ ...+..||.|+..... .......+..|....... +|++++. ..+...++++++++++|..
T Consensus 61 V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 138 (344)
T 1rjb_A 61 VMNATAYGISKTGVSIQVAVKMLKEKA--DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 138 (344)
T ss_dssp EEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred eEEeeeeccccCCcceEEEEEeccccc--CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHH
Confidence 466664 3455567777654321 222344566777766666 8888763 3455678999999999998
Q ss_pred hhccC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEee
Q 044746 69 LCKKN------------------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAAD 124 (202)
Q Consensus 69 ~~~~~------------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~d 124 (202)
++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|
T Consensus 139 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~D 215 (344)
T 1rjb_A 139 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICD 215 (344)
T ss_dssp HHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEETTTEEEECC
T ss_pred HHhhccccccccccchhhhcccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEEcCCCcEEeCC
Confidence 88543 37999999999999999999999 9999999999999999999999999
Q ss_pred eecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 125 fgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||++................||+.|+|||.+.+..++.++||||||++++||++ |+.||.....
T Consensus 216 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 280 (344)
T 1rjb_A 216 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPV 280 (344)
T ss_dssp CGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCC
T ss_pred CccCcccccCccceeccCccCccCccCHHHhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCc
Confidence 999986654433333344556889999999988889999999999999999998 9999977543
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1e-31 Score=222.79 Aligned_cols=182 Identities=19% Similarity=0.232 Sum_probs=138.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.||.|+.+.... ......++..|..++...+|++++... ...+++++++. ++|..+
T Consensus 42 V~~a~~~~~~~~vAiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 119 (432)
T 3n9x_A 42 VYLAYDKNTEKNVAIKKVNRMFE-DLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKL 119 (432)
T ss_dssp EEEEEETTTTEEEEEEEECSTTT-SHHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHH
T ss_pred EEEEEECCCCcEEEEEEeCchhc-ChHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHH
Confidence 78999988888888876543211 112234566777788888899877421 33567788765 588887
Q ss_pred hccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-----------
Q 044746 70 CKKN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH----------- 137 (202)
Q Consensus 70 ~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~----------- 137 (202)
+... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++.+||+|||+++........
T Consensus 120 ~~~~~~l~~~~~~~i~~qil~aL~~LH~---~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~ 196 (432)
T 3n9x_A 120 FKTPIFLTEEHIKTILYNLLLGENFIHE---SGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEE 196 (432)
T ss_dssp HHSSCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEEC-----------------
T ss_pred HhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCCCCCCCHHHeEECCCCCEEEccCCCccccccccccccccccccccc
Confidence 7654 59999999999999999999999 99999999999999999999999999999876433211
Q ss_pred ---------cccCCCCCCCcccCCccc-CCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 138 ---------ITSTGRRRTPGCEAPELW-MPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 138 ---------~~~~~~~gt~~y~aPe~~-~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.......||+.|+|||++ ....++.++||||+||+++||++|..||....
T Consensus 197 ~~~~~~~~~~~~~~~~gt~~Y~APE~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~ 256 (432)
T 3n9x_A 197 PGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLNMLQSHINDP 256 (432)
T ss_dssp --------------CCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSG
T ss_pred ccccccchhccccCCCCCccccCHHHHhcCCCCCcccccchHHHHHHHHHhccccccccc
Confidence 112456789999999986 45679999999999999999999766665443
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=218.16 Aligned_cols=175 Identities=13% Similarity=0.141 Sum_probs=138.3
Q ss_pred CCccccCC--------CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc----------------------c
Q 044746 1 MEKPRNRG--------STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG----------------------S 50 (202)
Q Consensus 1 v~k~~~~~--------~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~----------------------~ 50 (202)
||++++.. .++.||.|+.... ..+..|.......+|+|++. .
T Consensus 58 Vy~~~~~~t~~~~~~~~~~~vavK~~~~~--------~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~ 129 (352)
T 2jii_A 58 LYEAAPTSTLTCDSGPQKQKFSLKLDAKD--------GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ 129 (352)
T ss_dssp EEEEEECC-----------CEEEEEEETT--------STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET
T ss_pred EEEEeecCCccccccccCceEEEEEeccc--------chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC
Confidence 67777776 4677777765432 24555555666666666553 2
Q ss_pred cccceEEEEEccCCchhhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC--ceEEeee
Q 044746 51 EDTETYIKGFLAMGPFYLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF--FPKAADF 125 (202)
Q Consensus 51 ~~~~~~~~~~~~~~~l~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~--~~kl~df 125 (202)
.....++++++ +++|..++.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .++|+||
T Consensus 130 ~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dikp~NIl~~~~~~~~~kl~Df 205 (352)
T 2jii_A 130 DKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHE---NEYVHGNVTAENIFVDPEDQSQVTLAGY 205 (352)
T ss_dssp TTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCCGGGEEEETTEEEEEEECCG
T ss_pred CcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEEcCCCCceEEEecC
Confidence 45567888888 9999998865 579999999999999999999999 9999999999999999988 8999999
Q ss_pred ecceeccccCccc-----ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 126 GLAKLYNREHTHI-----TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 126 gl~~~~~~~~~~~-----~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+++......... ......||+.|+|||++.+..++.++||||||+++|||++|+.||....
T Consensus 206 g~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 272 (352)
T 2jii_A 206 GFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKGCGPSRRSDLQSLGYCMLKWLYGFLPWTNCL 272 (352)
T ss_dssp GGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSCCTTGGGT
T ss_pred cceeeccCCCccccccccccccccCCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCcccCC
Confidence 9998654332111 1233478999999999999899999999999999999999999998765
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-32 Score=219.96 Aligned_cols=183 Identities=21% Similarity=0.278 Sum_probs=144.6
Q ss_pred CCccccCC-----CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRG-----STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~-----~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++.+ .++.||.|+.+... ..+....+..|.......+|++++. ..+...++++++++++|..+
T Consensus 63 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 140 (343)
T 1luf_A 63 VFQARAPGLLPYEPFTMVAVKMLKEEA--SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 140 (343)
T ss_dssp EEEEEEETSSTTSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EEEEEecCcCCCCCceeEEEEEecccc--CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHH
Confidence 57777653 34677777654321 1122345777777888888998763 34556789999999999988
Q ss_pred hcc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEee
Q 044746 70 CKK-------------------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAAD 124 (202)
Q Consensus 70 ~~~-------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~d 124 (202)
+.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|
T Consensus 141 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~D 217 (343)
T 1luf_A 141 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIAD 217 (343)
T ss_dssp HHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred HHHhCcccccccccccccccccccccCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEECCCCeEEEee
Confidence 854 569999999999999999999999 9999999999999999999999999
Q ss_pred eecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 125 fgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||+++...............+|+.|+|||.+.+..++.++|+||+|+++|||++ |+.||.+...
T Consensus 218 fg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~ 282 (343)
T 1luf_A 218 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAH 282 (343)
T ss_dssp CSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred cCCCcccccCccccccCCCcccceecChhhhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCCh
Confidence 999986543332222334567889999999988889999999999999999999 9999976544
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.7e-32 Score=218.50 Aligned_cols=177 Identities=22% Similarity=0.255 Sum_probs=142.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh--cc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC--KK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~--~~ 72 (202)
||++++..+++.||.|+.........+....+..|.......+|+|++. ..+...++++++. |++..++ ..
T Consensus 70 Vy~a~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~ 148 (348)
T 1u5q_A 70 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHK 148 (348)
T ss_dssp EEEEEETTTTEEEEEEEEESCSSCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHT
T ss_pred EEEEEEccCCeEEEEEEEccccccchHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhc
Confidence 6889988888888887654332222223345667777788889998874 3344568888887 5666555 34
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...... ....||+.|+||
T Consensus 149 ~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~------~~~~gt~~y~aP 219 (348)
T 1u5q_A 149 KPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA------NSFVGTPYWMAP 219 (348)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSSB------CCCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEECCCCCEEEeeccCceecCCC------CcccCCcceeCH
Confidence 679999999999999999999999 99999999999999999999999999999765322 234679999999
Q ss_pred cccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++. ...++.++|||||||+++||++|++||....
T Consensus 220 E~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 257 (348)
T 1u5q_A 220 EVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 257 (348)
T ss_dssp HHHHTTSSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hhhccccCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 9984 5678999999999999999999999997654
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=208.25 Aligned_cols=183 Identities=22% Similarity=0.256 Sum_probs=146.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..+++.|+.|+...... ......+..|.......+|++++. .++...++++++++++|..++...
T Consensus 23 V~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 100 (276)
T 2yex_A 23 VQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI 100 (276)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGC--TTHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT
T ss_pred EEEEEECCCCcEEEEEEeeeccc--hhhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhcc
Confidence 68888888888888877543221 122345666777777788888763 334556889999999999888654
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++................|++.|+|||
T Consensus 101 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 177 (276)
T 2yex_A 101 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 177 (276)
T ss_dssp BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcchhcccCCccccCccChH
Confidence 69999999999999999999999 999999999999999999999999999998654333222234456899999999
Q ss_pred ccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+.+..+ +.++|+||+|+++++|++|+.||.....
T Consensus 178 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 213 (276)
T 2yex_A 178 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSD 213 (276)
T ss_dssp GGTCSSBCHHHHHHHHHHHHHHHHHHSSCCCSCSCT
T ss_pred HHhcCCCCCCcchHHHHHHHHHHHHhCCCCCCCCch
Confidence 9987665 6789999999999999999999976543
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.9e-32 Score=220.35 Aligned_cols=183 Identities=21% Similarity=0.243 Sum_probs=141.5
Q ss_pred CCccccC-------CCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCch
Q 044746 1 MEKPRNR-------GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~-------~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l 66 (202)
||++++. .....||+|+.+... ......++..|....... +|++++. ..+...++++++++++|
T Consensus 85 Vy~a~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L 162 (382)
T 3tt0_A 85 VVLAEAIGLDKDKPNRVTKVAVKMLKSDA--TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 162 (382)
T ss_dssp EEEEEEETSSTTCTTCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBH
T ss_pred EEEEEEccccccccccceEEEEEeecccc--CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcH
Confidence 5666643 233456666543321 111223455666556555 8888763 44556799999999999
Q ss_pred hhhhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 67 YLLCKKN-----------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 67 ~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
..++... .+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++
T Consensus 163 ~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~ 239 (382)
T 3tt0_A 163 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 239 (382)
T ss_dssp HHHHHHTCCSSSSSCCCCCSSCCCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSCSCCC
T ss_pred HHHHHHhcccccccccccccccccccCHHHHHHHHHHHHHHHHHHHh---CCEecCCCCcceEEEcCCCcEEEcccCccc
Confidence 9988653 49999999999999999999999 999999999999999999999999999998
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
...............+|+.|+|||++.+..++.++||||+||+++||++ |..||.....
T Consensus 240 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ellt~g~~p~~~~~~ 299 (382)
T 3tt0_A 240 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 299 (382)
T ss_dssp CSSCCCTTCCCTTCCCGGGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred ccccccccccccCCCCCcceeCHHHhcCCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 6654433333344556889999999999899999999999999999999 9999976543
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-33 Score=225.63 Aligned_cols=180 Identities=11% Similarity=0.102 Sum_probs=130.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHH---HHHHhcccccccccc-------------------------c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQ---RMIAADNFSNLVGSE-------------------------D 52 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~-------------------------~ 52 (202)
||++++..+++.||.|+..............+..|. ......+|+|++... +
T Consensus 89 V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 168 (377)
T 3byv_A 89 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 168 (377)
T ss_dssp EEEEEC-CCCCEEEEEEEEECC-CCTTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC-----
T ss_pred EEEEEECCCCcEEEEEEEeeccccchHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCC
Confidence 689999888888888875533222222233444554 333444677765321 0
Q ss_pred -----cceEEEEEccCCchhhhhccC-CCC-------HHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc
Q 044746 53 -----TETYIKGFLAMGPFYLLCKKN-ILG-------FGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF 119 (202)
Q Consensus 53 -----~~~~~~~~~~~~~l~~~~~~~-~~~-------~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~ 119 (202)
...++++++ +|+|..++... .++ +..+..++.|++.||.|||+ .+|+||||||+|||++.++.
T Consensus 169 ~~~i~~~~lv~E~~-~g~L~~~l~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivHrDikp~NIll~~~~~ 244 (377)
T 3byv_A 169 DMWVLSRFFLYPRM-QSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGG 244 (377)
T ss_dssp -CEEESEEEEEECC-SEEHHHHHHHHHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCC
T ss_pred ceEEEEEEEEEecc-CCCHHHHHHhccccccccccccHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEcCCCC
Confidence 244667777 68998887542 233 47888899999999999999 99999999999999999999
Q ss_pred eEEeeeecceeccccCcccccCCCCCCCcccCCcccCCC-----------CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 120 PKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY-----------SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 120 ~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~-----------~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+||+|||+++.... ......| +.|+|||++.+. .++.++|||||||++|||++|+.||.....
T Consensus 245 ~kL~DFG~a~~~~~-----~~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~ 318 (377)
T 3byv_A 245 VFLTGFEHLVRDGA-----RVVSSVS-RGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAA 318 (377)
T ss_dssp EEECCGGGCEETTC-----EEECCCC-TTCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred EEEEechhheecCC-----cccCCCC-cCccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCccccc
Confidence 99999999985432 1234466 899999999877 799999999999999999999999987654
Q ss_pred cc
Q 044746 189 EG 190 (202)
Q Consensus 189 ~~ 190 (202)
..
T Consensus 319 ~~ 320 (377)
T 3byv_A 319 LG 320 (377)
T ss_dssp -C
T ss_pred cc
Confidence 43
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.3e-32 Score=214.63 Aligned_cols=184 Identities=22% Similarity=0.282 Sum_probs=145.0
Q ss_pred CCcccc-----CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRN-----RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~-----~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++.+ ..++..||+|+.+... .......+..|.......+|++++. ..+...++++++++++|..+
T Consensus 39 V~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 116 (314)
T 2ivs_A 39 VVKATAFHLKGRAGYTTVAVKMLKENA--SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGF 116 (314)
T ss_dssp EEEEEEETGGGCSSEEEEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EEEEEEeccCcccCcceEEEEeccCCC--CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHH
Confidence 466654 3445677777654321 1122344666777777788998773 34556789999999999988
Q ss_pred hccC-------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEee
Q 044746 70 CKKN-------------------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAAD 124 (202)
Q Consensus 70 ~~~~-------------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~d 124 (202)
+... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|
T Consensus 117 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dikp~NIli~~~~~~kl~D 193 (314)
T 2ivs_A 117 LRESRKVGPGYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAE---MKLVHRDLAARNILVAEGRKMKISD 193 (314)
T ss_dssp HHHTTTSTTEEC----------------CEECHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTEEEECC
T ss_pred HHHHhhccCCcccccccccccccccccccCcCHHHHHHHHHHHHHHHHHHHH---CCCcccccchheEEEcCCCCEEEcc
Confidence 8542 38999999999999999999999 9999999999999999999999999
Q ss_pred eecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 125 fgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
||+++...............+++.|+|||.+.+..++.++||||+|++++||++ |+.||.....+
T Consensus 194 fg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~ 259 (314)
T 2ivs_A 194 FGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPE 259 (314)
T ss_dssp CTTCEECTTTSCEECSSCCCSCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ccccccccccccceeccCCCCcccccChhhhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHH
Confidence 999987654433333344556889999999988889999999999999999999 99999865543
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=8.3e-32 Score=210.58 Aligned_cols=181 Identities=18% Similarity=0.224 Sum_probs=145.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..++..++.|+..............+..|.......+|++++. ..+...++++++++++|..++.. .
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~ 104 (279)
T 3fdn_A 25 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 104 (279)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS
T ss_pred EEEEEEccCCcEEEEEEEeccccchhhHHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcC
Confidence 6889998888888888765443333333455667777777788888763 33445688899999999887754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... .....|++.|+|||
T Consensus 105 ~~~~~~~~~~~~qi~~~l~~LH~---~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~y~aPE 177 (279)
T 3fdn_A 105 KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTDLCGTLDYLPPE 177 (279)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHT---TTCEECCCCGGGEEECTTSCEEECSCCEESCC------------CCCCTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEecccCChHhEEEcCCCCEEEEeccccccCCccc----ccccCCCCCccCHh
Confidence 69999999999999999999999 999999999999999999999999999886443221 23346799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+.+..++.++|+||+|+++++|++|+.||.....
T Consensus 178 ~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 212 (279)
T 3fdn_A 178 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTY 212 (279)
T ss_dssp HHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HhccCCCCccchhHhHHHHHHHHHHCCCCCCCCcH
Confidence 99998899999999999999999999999986553
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=99.97 E-value=3.3e-31 Score=208.46 Aligned_cols=179 Identities=15% Similarity=0.160 Sum_probs=142.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc-------cccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV-------GSEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i-------~~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++++...++.||.|+..... ....+..|........|++.+ ..+....++++++ +++|..++.
T Consensus 25 V~~~~~~~~~~~vavK~~~~~~-----~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~ 98 (296)
T 3uzp_A 25 IYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFC 98 (296)
T ss_dssp EEEEEETTTTEEEEEEEEESCS-----SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred EEEEEEcCCCcEEEEEEecCCc-----chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhh
Confidence 6889988888888888743321 223455666666666655433 2344456888888 889988886
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE---cCCCceEEeeeecceeccccCcc-----cccCCC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTH-----ITSTGR 143 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~---~~~~~~kl~dfgl~~~~~~~~~~-----~~~~~~ 143 (202)
...+++..+..++.|++.||.|||+ ++++||||||+||++ +.++.+||+|||++......... ......
T Consensus 99 ~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 175 (296)
T 3uzp_A 99 SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 175 (296)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHeEEecCCCCCeEEEeeCCCccccccccccccccccccccc
Confidence 4579999999999999999999999 999999999999999 47889999999999876543221 112345
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||+.|+|||.+.+..++.++||||+|++++||++|+.||.....
T Consensus 176 ~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 220 (296)
T 3uzp_A 176 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKA 220 (296)
T ss_dssp CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred ccccccCChhhhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCcCc
Confidence 689999999999999999999999999999999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.1e-31 Score=220.10 Aligned_cols=182 Identities=19% Similarity=0.268 Sum_probs=137.7
Q ss_pred CCccccCCCcceeehhhhchhhhh-----ccCCcccCCcHHHHHHhccccccccc-----cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM-----EMDKPIRFTSPQRMIAADNFSNLVGS-----EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++..+++.||.|+....... .......+..|.......+|+|++.. .....++++++++++|..++
T Consensus 151 V~~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~lv~e~~~~g~L~~~l 230 (419)
T 3i6u_A 151 VKLAFERKTCKKVAIRIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV 230 (419)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGGTTC--------CCHHHHHHHHHHCCCTTBCCCCEEEESSEEEEEEECCTTCBGGGGT
T ss_pred EEEEEECCCCcEEEEEEEEechhcccccccchhHHHHHHHHHHHHhCCCCCEeeEEEEEecCceEEEEEcCCCCcHHHHH
Confidence 688999988888988875443211 12223456678888888899988742 23346889999999998877
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC---CceEEeeeecceeccccCcccccCCCCCC
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN---FFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~---~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.. ..+++.++..++.|++.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++....... .....||
T Consensus 231 ~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt 304 (419)
T 3i6u_A 231 VGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGT 304 (419)
T ss_dssp SSSCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC--------------
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEecCCCcceEEEeecccceecCCCcc---ccccCCC
Confidence 54 569999999999999999999999 999999999999999654 4599999999986543221 2345689
Q ss_pred CcccCCcccCC---CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWMP---YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~---~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||++.+ ..++.++||||+||++++|++|++||.....
T Consensus 305 ~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~pf~~~~~ 349 (419)
T 3i6u_A 305 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 349 (419)
T ss_dssp CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSCSSCCCSS
T ss_pred CCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCcc
Confidence 99999999863 5678899999999999999999999976443
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=214.28 Aligned_cols=181 Identities=18% Similarity=0.273 Sum_probs=139.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.||.|+.+...... .....+..|...... .+|++++. ..+...++++++.+++|..++..
T Consensus 45 V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 123 (327)
T 3lm5_A 45 VRQCISKSTGQEYAAKFLKKRRRGQ-DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPE 123 (327)
T ss_dssp EEEEEETTTCCEEEEEEEESEETTE-ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSC
T ss_pred EEEEEECCCCCEEEEEEEehhhcch-HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHh
Confidence 6889998888888888755432221 122334444444433 35576653 44556789999999999988754
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
..+++.++..++.|++.||.|||+ .+++||||||+||+++. ++.++|+|||+++....... .....||+
T Consensus 124 ~~~~~~~~~~~~i~~ql~~~L~~LH~---~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~---~~~~~gt~ 197 (327)
T 3lm5_A 124 LAEMVSENDVIRLIKQILEGVYYLHQ---NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACE---LREIMGTP 197 (327)
T ss_dssp C-CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC------------CCCG
T ss_pred cccCCCHHHHHHHHHHHHHHHHHHHH---CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccc---cccccCCc
Confidence 569999999999999999999999 99999999999999987 78999999999987643322 23346799
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|+|||++.+..++.++|+||+|+++++|++|+.||.....
T Consensus 198 ~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 238 (327)
T 3lm5_A 198 EYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDN 238 (327)
T ss_dssp GGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CccCCeeecCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99999999999999999999999999999999999976543
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.7e-32 Score=216.56 Aligned_cols=185 Identities=22% Similarity=0.214 Sum_probs=142.9
Q ss_pred CCccccCCCcceeehhhhchhhhh--ccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM--EMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++...+..+|.|+....... ......++..|.......+|++++. ..+...++++++++++|..++..
T Consensus 42 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~ 121 (345)
T 3hko_A 42 VRVAIENQTRAIRAIKIMNKNKIRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNV 121 (345)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHC---CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEE
T ss_pred EEEEEECCCCceEEEeehhhhhhcccCHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHH
Confidence 688999888888888875543322 2233456777888888888998874 34456789999999999888741
Q ss_pred -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCc
Q 044746 73 -----------------------------------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPES 111 (202)
Q Consensus 73 -----------------------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~n 111 (202)
..+++..+..++.|++.||.|||+ .+++||||||+|
T Consensus 122 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~N 198 (345)
T 3hko_A 122 FIDDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHN---QGICHRDIKPEN 198 (345)
T ss_dssp EEETTTTEEEEEEECCCCCCSHHHHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGG
T ss_pred hhcccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHH---CCccccCCChhh
Confidence 124677888999999999999999 999999999999
Q ss_pred EEEcCCC--ceEEeeeecceeccccCc--ccccCCCCCCCcccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 112 VLLDENF--FPKAADFGLAKLYNREHT--HITSTGRRRTPGCEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 112 il~~~~~--~~kl~dfgl~~~~~~~~~--~~~~~~~~gt~~y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|+++.++ .+||+|||+++....... ........||+.|+|||++.+ ..++.++||||+|++++||++|+.||..
T Consensus 199 Ill~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~ 278 (345)
T 3hko_A 199 FLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPG 278 (345)
T ss_dssp EEESCSSSCCEEECCCTTCEEGGGTTCC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCC
T ss_pred EEEecCCCceEEEeeccccccccccCccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCC
Confidence 9998766 899999999986543221 112334568999999999875 6788999999999999999999999976
Q ss_pred hhc
Q 044746 186 EIS 188 (202)
Q Consensus 186 ~~~ 188 (202)
...
T Consensus 279 ~~~ 281 (345)
T 3hko_A 279 VND 281 (345)
T ss_dssp SSH
T ss_pred CCh
Confidence 544
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-32 Score=220.37 Aligned_cols=178 Identities=19% Similarity=0.237 Sum_probs=129.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.||.|+...... ......++..|.......+|+|++... ....++++++ +++|..
T Consensus 45 V~~a~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~ 122 (367)
T 2fst_X 45 VCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNN 122 (367)
T ss_dssp EEEEEETTTTEEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC-
T ss_pred EEEEEECCCCCEEEEEEeCcccc-CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHH
Confidence 68898888888888776433211 111233455677777788899877422 2234556555 788988
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
++....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++..... .....||+.
T Consensus 123 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~-----~~~~~~t~~ 194 (367)
T 2fst_X 123 IVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE-----MTGYVATRW 194 (367)
T ss_dssp ----CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECC--------------------CCCT
T ss_pred HHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHhhEEECCCCCEEEeecccccccccc-----CCCcCcCcC
Confidence 8888889999999999999999999999 99999999999999999999999999999864432 233567999
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||++.+ ..++.++||||+||+++||++|++||.+...
T Consensus 195 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 235 (367)
T 2fst_X 195 YRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 235 (367)
T ss_dssp TCCHHHHTTCCSCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccChHHHcCCcCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999887 6789999999999999999999999987654
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=209.81 Aligned_cols=183 Identities=18% Similarity=0.225 Sum_probs=148.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.++.|+..............+..|.......+|++++. ..+...++++++++++|..+... .
T Consensus 31 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 110 (294)
T 2rku_A 31 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK 110 (294)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC
T ss_pred EEEEEECCCCceEEEEEechhhccCHHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcC
Confidence 6889998888888888754432222222344666777777888998764 34445688999999999887754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ......||+.|+|||
T Consensus 111 ~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aPE 185 (294)
T 2rku_A 111 ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPE 185 (294)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChHhEEEcCCCCEEEEeccCceecccCcc--ccccccCCCCcCCcc
Confidence 69999999999999999999999 9999999999999999999999999999986543222 123356799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+.+..++.++|+||+|+++++|++|+.||.....
T Consensus 186 ~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 220 (294)
T 2rku_A 186 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCL 220 (294)
T ss_dssp HHTTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred hhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99988899999999999999999999999976543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=209.43 Aligned_cols=181 Identities=17% Similarity=0.178 Sum_probs=148.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.|+.|+..............+..|.......+|++++. ......++++++++++|..++.. +
T Consensus 30 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 109 (284)
T 2vgo_A 30 VYLAREKQNKFIMALKVLFKSQLEKEGVEHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHG 109 (284)
T ss_dssp EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS
T ss_pred EEEEEEcCCCcEEEEEEEcccccchHHHHHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcC
Confidence 6888888888888888765443333333445677777778888898763 34455688899999999887754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... .....|++.|+|||
T Consensus 110 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~y~aPE 182 (284)
T 2vgo_A 110 RFDEQRSATFMEELADALHYCHE---RKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----RRTMCGTLDYLPPE 182 (284)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCSGGGEEECTTCCEEECCCTTCEECSSSC----BCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCHHHEEEcCCCCEEEecccccccCcccc----cccccCCCCcCCHH
Confidence 69999999999999999999999 999999999999999999999999999987654321 23356799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+.+..++.++|+||+|+++++|++|+.||.....
T Consensus 183 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 217 (284)
T 2vgo_A 183 MIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSH 217 (284)
T ss_dssp HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HhccCCCCcccchhhHHHHHHHHHHCCCCCCCCCH
Confidence 99998899999999999999999999999976543
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=217.17 Aligned_cols=183 Identities=20% Similarity=0.282 Sum_probs=144.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.||.|+..... ......++..|.......+|+|++... ....++++++. ++|..+
T Consensus 43 V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~ 119 (364)
T 3qyz_A 43 VCSAYDNLNKVRVAIKKISPFE--HQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKL 119 (364)
T ss_dssp EEEEEETTTTEEEEEEEECCTT--CHHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHH
T ss_pred EEEEEECCCCeEEEEEEecccc--CcHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHH
Confidence 6889888888888877654321 111224466777778888899887422 23356667666 689888
Q ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCc
Q 044746 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPG 148 (202)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~ 148 (202)
+....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......... ......||+.
T Consensus 120 l~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~ 196 (364)
T 3qyz_A 120 LKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRW 196 (364)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGG
T ss_pred HHhCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCCccccccccccccC
Confidence 888899999999999999999999999 999999999999999999999999999998765432211 1234578999
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|+|||++.+ ..++.++||||+||++++|++|++||.+....
T Consensus 197 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 238 (364)
T 3qyz_A 197 YRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYL 238 (364)
T ss_dssp GCCHHHHHTBCSCSTHHHHHHHHHHHHHHHHSSCSSCCSSGG
T ss_pred CCCCHHhcCCCCCCcchhHHHHHHHHHHHHHCCCCCCCCChH
Confidence 999998654 45899999999999999999999999876543
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3e-31 Score=213.92 Aligned_cols=184 Identities=20% Similarity=0.248 Sum_probs=141.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------------cccceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------------EDTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------------~~~~~~~~~~~~~~~l 66 (202)
||++++..+++.||.|+...... .......+..|.......+|++++.. .+...++++++++ ++
T Consensus 33 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l 110 (351)
T 3mi9_A 33 VFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DL 110 (351)
T ss_dssp EEEEEETTTCCEEEEEECCCSSC-SSSSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EH
T ss_pred EEEEEECCCCCEEEEEEEecccc-cccchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CH
Confidence 68899988888888776433221 22223345567777788889987642 2334678888875 55
Q ss_pred hhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC--cccccCC
Q 044746 67 YLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH--THITSTG 142 (202)
Q Consensus 67 ~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~--~~~~~~~ 142 (202)
...+.. ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... .......
T Consensus 111 ~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~ 187 (351)
T 3mi9_A 111 AGLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTN 187 (351)
T ss_dssp HHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCS
T ss_pred HHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCC
Confidence 554433 469999999999999999999999 999999999999999999999999999998654221 1122344
Q ss_pred CCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 143 RRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
..||+.|+|||++.+ ..++.++||||+||+++||++|++||......
T Consensus 188 ~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 235 (351)
T 3mi9_A 188 RVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 235 (351)
T ss_dssp SCSCGGGCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred cccccCccCchhhcCCCCCCcHhHHHHHHHHHHHHHhCCCCCCCCChH
Confidence 567999999999876 45899999999999999999999999876543
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=6.3e-32 Score=216.16 Aligned_cols=183 Identities=21% Similarity=0.293 Sum_probs=141.1
Q ss_pred CCccccCCCcc---eeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTR---FITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++...++ .||.|+.+... .......|..|.......+|++++. .+....++++++++++|..++.
T Consensus 65 V~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 142 (325)
T 3kul_A 65 VCYGRLRVPGQRDVPVAIKALKAGY--TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLR 142 (325)
T ss_dssp EEEEEECCTTSCCEEEEEEEECTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHH
T ss_pred EEEEEEecCCCCCceEEEEecCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHH
Confidence 57777764444 36666543321 1112245667777778888998763 4455678999999999999885
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCCc
Q 044746 72 K--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTPG 148 (202)
Q Consensus 72 ~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~~ 148 (202)
. ..+++.++..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++....... ........+|+.
T Consensus 143 ~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~ 219 (325)
T 3kul_A 143 THDGQFTIMQLVGMLRGVGAGMRYLSD---LGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIR 219 (325)
T ss_dssp TTTTCSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCSSCEECC----CCEECC---CCGG
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEECCCCCEEECCCCcccccccCccceeeccCCCCccc
Confidence 4 469999999999999999999999 9999999999999999999999999999987654322 122233455788
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|+|||++.+..++.++||||+|++++||++ |+.||.....
T Consensus 220 y~aPE~~~~~~~~~~~Di~slG~il~ell~~g~~p~~~~~~ 260 (325)
T 3kul_A 220 WTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTN 260 (325)
T ss_dssp GSCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTSCH
T ss_pred ccCHhHhcCCCCCcHHHHHHHHHHHHHHHcCCCCCcccCCH
Confidence 999999988889999999999999999999 9999976544
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=209.27 Aligned_cols=182 Identities=24% Similarity=0.347 Sum_probs=141.1
Q ss_pred CCccccCCCcceeehhhhch-hhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNRGSTRFITRTIDKS-LDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||+++.. +..++.|.... ......+....+..|.......+|++++. ..+...++++++++++|..++.
T Consensus 47 Vy~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 124 (307)
T 2nru_A 47 VYKGYVN--NTTVAVKKLAAMVDITTEELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCL 124 (307)
T ss_dssp EEEEESS--SCEEEEEEECCCTTSCTTTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTG
T ss_pred EEEEEEC--CceEEEEEEecccCcchHHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhc
Confidence 5677663 34455444322 21122223345677777788888998763 3445678999999999988774
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++................||+.|
T Consensus 125 ~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y 201 (307)
T 2nru_A 125 DGTPPLSWHMRCKIAQGAANGINFLHE---NHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAY 201 (307)
T ss_dssp GGCCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGG
T ss_pred cCCCCCCHHHHHHHHHHHHHHHHHHhc---CCeecCCCCHHHEEEcCCCcEEEeecccccccccccccccccccCCCcCc
Confidence 3459999999999999999999999 99999999999999999999999999999876543333333445689999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+|||.+.+ .++.++|+||+|+++++|++|++||.....
T Consensus 202 ~aPE~~~~-~~~~~~Dv~slG~il~~l~~g~~p~~~~~~ 239 (307)
T 2nru_A 202 MAPEALRG-EITPKSDIYSFGVVLLEIITGLPAVDEHRE 239 (307)
T ss_dssp CCHHHHTT-EECTHHHHHHHHHHHHHHHHCCCSBCTTBS
T ss_pred CChHHhcC-CCCccchhHHHHHHHHHHHHCCCCcccCcc
Confidence 99998875 578999999999999999999999986543
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=212.75 Aligned_cols=182 Identities=18% Similarity=0.250 Sum_probs=146.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccC---CcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMD---KPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..+++.+|.|+.......... ....+..|.......+|++++. ......++++++++++|..++.
T Consensus 28 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 107 (321)
T 2a2a_A 28 VKKCREKSTGLEYAAKFIKKRQSRASRRGVSREEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLA 107 (321)
T ss_dssp EEEEEETTTCCEEEEEEEEBCSSSSCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCeEEEEEEEecccccccccchhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHH
Confidence 688999888888887765443222111 1234667777778888998763 3445568899999999998886
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC----ceEEeeeecceeccccCcccccCCCCCC
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF----FPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~----~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++........ .....||
T Consensus 108 ~~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt 181 (321)
T 2a2a_A 108 QKESLSEEEATSFIKQILDGVNYLHT---KKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVE---FKNIFGT 181 (321)
T ss_dssp TCSCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTCC---CCCCCSC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCChHHEEEecCCCCcCCEEEccCccceecCcccc---ccccCCC
Confidence 4 458999999999999999999999 9999999999999999887 799999999987654322 2345679
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||.+.+..++.++|+||+|+++++|++|+.||.....
T Consensus 182 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 223 (321)
T 2a2a_A 182 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTK 223 (321)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSCCSSCCSSH
T ss_pred CCccCcccccCCCCCCccccHHHHHHHHHHHHCCCCCCCCCH
Confidence 999999999988999999999999999999999999976543
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2e-31 Score=215.68 Aligned_cols=183 Identities=17% Similarity=0.193 Sum_probs=140.1
Q ss_pred CCccccC---CCcceeehhhhchhhh-hccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDA-MEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++. ..++.||.|+.+.... ........+..|....... +|++++. ......++++++++++|..+
T Consensus 70 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 149 (355)
T 1vzo_A 70 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 149 (355)
T ss_dssp EEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHH
T ss_pred EEEEEEcccCCCCeEEEEEEEeHHHhhhhhhHHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHH
Confidence 5777763 4677777776543321 2223344566676666555 5777663 33455688999999999888
Q ss_pred hcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 70 CKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 70 ~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+.. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........ ......||+.
T Consensus 150 l~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~gt~~ 225 (355)
T 1vzo_A 150 LSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETE-RAYDFCGTIE 225 (355)
T ss_dssp HHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGG-GGCGGGSCCT
T ss_pred HHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCCC-cccCcccCcC
Confidence 754 569999999999999999999999 99999999999999999999999999999865433221 1233568999
Q ss_pred ccCCcccCC--CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMP--YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~--~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+ ..++.++|||||||++|||++|+.||....
T Consensus 226 y~aPE~~~~~~~~~~~~~DvwslG~il~ell~g~~pf~~~~ 266 (355)
T 1vzo_A 226 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDG 266 (355)
T ss_dssp TCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTT
T ss_pred ccChhhhcCCCCCCCchhhHHHHHHHHHHHHHCCCCCccCC
Confidence 999999985 347899999999999999999999997544
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=210.83 Aligned_cols=180 Identities=21% Similarity=0.253 Sum_probs=134.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+..++++++.... ........+..|.......+|++++. ..+...++++++.+ +|..++..
T Consensus 18 V~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~ 94 (288)
T 1ob3_A 18 VYKAQNNYGETFALKKIRLEK--EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCE 94 (288)
T ss_dssp EEEEEETTSCEEEEEEECCSS--GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSE-EHHHHHHTST
T ss_pred EEEEEcCCCCEEEEEEEeccc--cccccchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecCC-CHHHHHHhcc
Confidence 688888544444444443222 11222344566777777888998763 34455678888775 77776654
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++....... ......||+.|+||
T Consensus 95 ~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aP 169 (288)
T 1ob3_A 95 GGLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAP 169 (288)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHEEEcCCCCEEEeECccccccCcccc--ccccccccccccCc
Confidence 569999999999999999999999 9999999999999999999999999999976543221 12334679999999
Q ss_pred cccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+. .++.++||||+||+++||++|++||.....
T Consensus 170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 206 (288)
T 1ob3_A 170 DVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (288)
T ss_dssp HHHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hheeCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 998764 589999999999999999999999976543
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=212.71 Aligned_cols=184 Identities=15% Similarity=0.148 Sum_probs=138.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.|+.|+..............+..|.......+|++++. ..+...++++++++++|..++.. .
T Consensus 50 Vy~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 129 (309)
T 2h34_A 50 VYEAEDTVRERIVALKLMSETLSSDPVFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQG 129 (309)
T ss_dssp EEEEEETTTTEEEEEEECGGGGGGSHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHC
T ss_pred EEEEEEcCCCeEEEEEecCcccccCHHHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcC
Confidence 6889888888888888765443322222345667777777788888763 33445688999999999988865 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ......|++.|+|||
T Consensus 130 ~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aPE 205 (309)
T 2h34_A 130 PLAPPRAVAIVRQIGSALDAAHA---AGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLT-QLGNTVGTLYYMAPE 205 (309)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSCCC-----------------CCGGGCCGG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CcCCcCCCChHHEEEcCCCCEEEecCccCccccccccc-cccccCCCcCccCHH
Confidence 69999999999999999999999 99999999999999999999999999999765433211 123346799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+.+..++.++|+||+|++++||++|+.||.....
T Consensus 206 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 240 (309)
T 2h34_A 206 RFSESHATYRADIYALTCVLYECLTGSPPYQGDQL 240 (309)
T ss_dssp GTCC----CCCHHHHHHHHHHHHHHSSCSSCSCHH
T ss_pred HHcCCCCCchHhHHHHHHHHHHHHHCCCCCCCchH
Confidence 99988899999999999999999999999976553
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.4e-31 Score=215.65 Aligned_cols=182 Identities=13% Similarity=0.095 Sum_probs=139.1
Q ss_pred CCccccCC---Ccceeehhhhchhhhh--------ccCCcccCCcHHHHHHhccccccccc----------cccceEEEE
Q 044746 1 MEKPRNRG---STRFITRTIDKSLDAM--------EMDKPIRFTSPQRMIAADNFSNLVGS----------EDTETYIKG 59 (202)
Q Consensus 1 v~k~~~~~---~~~~v~~~~~~~~~~~--------~~~~~~~~~~~~~~~~~~~~~~~i~~----------~~~~~~~~~ 59 (202)
||++++.. ....++.|+....... .......+..+.......+|++++.. ....+++++
T Consensus 53 Vy~~~~~~~~~~~~~~aiK~~~~~~~~~~~e~~~~~~~~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e 132 (345)
T 2v62_A 53 IYLAFPTNKPEKDARHVVKVEYQENGPLFSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVME 132 (345)
T ss_dssp EEEEEESSSCGGGCCEEEEEEECC-CHHHHHHHHHHHHCCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEE
T ss_pred EEEEEecCCCCccceEEEEeeecCCcchHHHHHHHHHHhhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEe
Confidence 67888876 6666776654332111 00111223344455566788877631 445678889
Q ss_pred EccCCchhhhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC--ceEEeeeecceeccccCc
Q 044746 60 FLAMGPFYLLCKKN-ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF--FPKAADFGLAKLYNREHT 136 (202)
Q Consensus 60 ~~~~~~l~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~--~~kl~dfgl~~~~~~~~~ 136 (202)
++ +++|..++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||+++.......
T Consensus 133 ~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~ 208 (345)
T 2v62_A 133 RL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE---NEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGN 208 (345)
T ss_dssp CE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGC
T ss_pred cc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccc
Confidence 99 89999988654 69999999999999999999999 9999999999999998877 999999999987643221
Q ss_pred c-----cccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 137 H-----ITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 137 ~-----~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
. .......||+.|+|||++.+..++.++|||||||++|||++|+.||...
T Consensus 209 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~ 263 (345)
T 2v62_A 209 HKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEILGYCMLRWLCGKLPWEQN 263 (345)
T ss_dssp CCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHHHHHHHHHHHSSCTTGGG
T ss_pred cccchhccccccCCCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCCCCcccc
Confidence 1 1123456899999999999989999999999999999999999999753
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=214.49 Aligned_cols=182 Identities=18% Similarity=0.230 Sum_probs=148.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.++.|+..............+..|.......+|++++. ..+..+++++++++++|..+... .
T Consensus 57 Vy~~~~~~~~~~~a~K~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 136 (335)
T 2owb_A 57 CFEISDADTKEVFAGKIVPKSLLLKPHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRK 136 (335)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGCCSHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHC
T ss_pred EEEEEECCCCCEEEEEEechhhhcCHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccC
Confidence 6889998888888888754432222222344666777777888998764 33455688999999999887754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ......||+.|+|||
T Consensus 137 ~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~gt~~y~aPE 211 (335)
T 2owb_A 137 ALTEPEARYYLRQIVLGCQYLHR---NRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDGE--RKKVLCGTPNYIAPE 211 (335)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCCSSCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCEecCCCchhEEEcCCCCEEEeeccCceecccCcc--cccccCCCccccCHH
Confidence 69999999999999999999999 9999999999999999999999999999986543221 123356799999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
++.+..++.++|+||+|+++++|++|+.||....
T Consensus 212 ~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 245 (335)
T 2owb_A 212 VLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSC 245 (335)
T ss_dssp HHHTSCBCTHHHHHHHHHHHHHHHHSSCTTCCSS
T ss_pred HhccCCCCchhhHHHHHHHHHHHHHCcCCCCCCC
Confidence 9998889999999999999999999999997654
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=216.54 Aligned_cols=178 Identities=20% Similarity=0.193 Sum_probs=134.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.||.|+..... .....+..|.......+|+|++. ..+...++++++++++|..++. .+
T Consensus 36 V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 111 (361)
T 3uc3_A 36 ARLMRDKLTKELVAVKYIERGA----AIDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAG 111 (361)
T ss_dssp EEEEEETTTCCEEEEEEEESST----TSCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS
T ss_pred EEEEEECCCCcEEEEEEEecCc----cccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcC
Confidence 6889999888888888754321 11234556777777888998774 3445668999999999988774 46
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc--eEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF--PKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~--~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.+++..+..++.|++.||.|||+ ++|+||||||+||+++.++. +||+|||+++...... ......||+.|+|
T Consensus 112 ~~~~~~~~~i~~ql~~~L~~LH~---~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~y~a 185 (361)
T 3uc3_A 112 RFSEDEARFFFQQLLSGVSYCHS---MQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHS---QPKSTVGTPAYIA 185 (361)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCSCCCCGGGEEECSSSSCCEEECCCCCC------------------CTTSC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEcCCCCceEEEeecCccccccccC---CCCCCcCCCCcCC
Confidence 79999999999999999999999 99999999999999987665 9999999997432221 1233467999999
Q ss_pred CcccCCCCCCch-hhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 152 PELWMPYSVTQK-CDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~-~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||++.+..++.+ +||||+||++|+|++|+.||.....
T Consensus 186 PE~~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~~~ 223 (361)
T 3uc3_A 186 PEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEE 223 (361)
T ss_dssp HHHHHCSSCCHHHHHHHHHHHHHHHHHHSSCSCC----
T ss_pred hhhhcCCCCCCCeeeeehhHHHHHHHHhCCCCCCCCcc
Confidence 999988777666 8999999999999999999987544
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=208.34 Aligned_cols=180 Identities=22% Similarity=0.223 Sum_probs=149.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++..+++.|+.|+..... .......+..|.......+|++++. ......++++++++++|..++..+.
T Consensus 38 V~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 115 (303)
T 3a7i_A 38 VFKGIDNRTQKVVAIKIIDLEE--AEDEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEPGP 115 (303)
T ss_dssp EEEEEETTTCCEEEEEEEETTT--CSTTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTTSC
T ss_pred EEEEEECCCCcEEEEEEecccc--cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhcCC
Confidence 6888888888888888754332 1223345667777777788888763 3344568899999999999999889
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ......|++.|+|||.
T Consensus 116 ~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y~aPE~ 190 (303)
T 3a7i_A 116 LDETQIATILREILKGLDYLHS---EKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQI--KRNTFVGTPFWMAPEV 190 (303)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTBC--CBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChheEEECCCCCEEEeecccceecCcccc--ccCccCCCcCccCHHH
Confidence 9999999999999999999999 9999999999999999999999999999986544322 1234567999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.+..++.++|+||+|+++++|++|+.||....
T Consensus 191 ~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 223 (303)
T 3a7i_A 191 IKQSAYDSKADIWSLGITAIELARGEPPHSELH 223 (303)
T ss_dssp HTTCCBCTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred HhcCCCCchhhhHHHHHHHHHHccCCCCCCCcC
Confidence 999899999999999999999999999997644
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=99.97 E-value=5.2e-31 Score=221.18 Aligned_cols=179 Identities=15% Similarity=0.163 Sum_probs=141.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc-------cccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV-------GSEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i-------~~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++++...++.||.|+..... ....+..|..+.....+.+.+ ..+....++++++ +++|..++.
T Consensus 23 Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~ 96 (483)
T 3sv0_A 23 IYLGTNIQTNEEVAIKLENVKT-----KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFC 96 (483)
T ss_dssp EEEEEETTTCCEEEEEEEETTC-----SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred EEEEEECCCCcEEEEEEecccc-----ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhh
Confidence 7899988888999988754322 122355555555555443221 2344456778887 899988886
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE---cCCCceEEeeeecceeccccCcc-----cccCCC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTH-----ITSTGR 143 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~---~~~~~~kl~dfgl~~~~~~~~~~-----~~~~~~ 143 (202)
...+++..+..++.||+.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++........ ......
T Consensus 97 ~~~l~~~~~~~i~~qi~~aL~yLH~---~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~ 173 (483)
T 3sv0_A 97 SRKLSLKTVLMLADQMINRVEFVHS---KSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNL 173 (483)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCcccccccccccccc
Confidence 5679999999999999999999999 999999999999999 57899999999999876543221 122356
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||+.|+|||++.+..++.++|||||||++|||++|+.||.....
T Consensus 174 ~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil~elltG~~Pf~~~~~ 218 (483)
T 3sv0_A 174 TGTARYASVNTHLGIEQSRRDDLESLGYVLMYFLRGSLPWQGLKA 218 (483)
T ss_dssp CSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCC
T ss_pred CCCccccCHHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCccccc
Confidence 789999999999999999999999999999999999999987544
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.9e-31 Score=211.38 Aligned_cols=181 Identities=20% Similarity=0.305 Sum_probs=137.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+++.||.|+.+... .......+..|.......+|++++. ......+++++++ ++|..++..
T Consensus 18 V~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~ 94 (324)
T 3mtl_A 18 VYKGKSKLTDNLVALKEIRLEH--EEGAPCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCG 94 (324)
T ss_dssp EEEEEETTTCCEEEEEEECC--------CCCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTT
T ss_pred EEEEEECCCCcEEEEEEEeccc--ccccchhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcC
Confidence 7899998888888887654332 2222334566777777888898763 3445568888887 477666643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++........ ......||+.|+||
T Consensus 95 ~~~~~~~~~~~~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~aP 169 (324)
T 3mtl_A 95 NIINMHNVKLFLFQLLRGLAYCHR---QKVLHRDLKPQNLLINERGELKLADFGLARAKSIPTK--TYDNEVVTLWYRPP 169 (324)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCCGGGEEECTTCCEEECSSSEEECC--------------CGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCcCHHHEEECCCCCEEEccCcccccccCCcc--ccccccCcccccCh
Confidence 359999999999999999999999 9999999999999999999999999999986443221 12334679999999
Q ss_pred cccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++.+ ..++.++||||+||++++|++|++||.+....
T Consensus 170 E~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~~ 207 (324)
T 3mtl_A 170 DILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVE 207 (324)
T ss_dssp HHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred hhhcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 99876 56899999999999999999999999876543
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=7.5e-32 Score=226.29 Aligned_cols=181 Identities=18% Similarity=0.260 Sum_probs=147.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||++++..+++.||.|+..............+..|..+....+|+|++. ..+...++++++.+++|...+ ...
T Consensus 42 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 121 (484)
T 3nyv_A 42 VILCKDKITGQECAVKVISKRQVKQKTDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRK 121 (484)
T ss_dssp EEEEEETTTCCEEEEEEEETTTCCBSSCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS
T ss_pred EEEEEECCCCCEEEEEEEEhhhcccchHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcC
Confidence 6889998888888888765443333334455777777888889998874 344566888999999998766 445
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE---cCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ ++|+||||||+||++ +.++.+||+|||+++........ ....||+.|+
T Consensus 122 ~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~---~~~~gt~~y~ 195 (484)
T 3nyv_A 122 RFSEVDAARIIRQVLSGITYMHK---NKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKM---KDKIGTAYYI 195 (484)
T ss_dssp CCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSH---HHHTTGGGTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccccc---ccCCCCcccc
Confidence 79999999999999999999999 999999999999999 46789999999999865433221 2235799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||++.+ .++.++||||+||++|+|++|++||.+...
T Consensus 196 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 232 (484)
T 3nyv_A 196 APEVLHG-TYDEKCDVWSTGVILYILLSGCPPFNGANE 232 (484)
T ss_dssp CHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CceeecC-CCCCcceeHHHHHHHHHHHHCCCCCCCCCH
Confidence 9999876 689999999999999999999999987554
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=212.45 Aligned_cols=183 Identities=19% Similarity=0.290 Sum_probs=143.4
Q ss_pred CCccc-----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPR-----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~-----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
||+++ +...++.|+.|+.+..... .....+..|....... +|++++. ..+...++++++++++|..
T Consensus 39 V~~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~ 116 (313)
T 1t46_A 39 VVEATAYGLIKSDAAMTVAVKMLKPSAHL--TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116 (313)
T ss_dssp EEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred eEEEEEeeccccchhhhhHHHhcCcchhH--HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHH
Confidence 46665 4556677777765432211 1123455666666666 8888763 3455678999999999998
Q ss_pred hhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 69 LCKKN-------------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 69 ~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.
T Consensus 117 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~ 193 (313)
T 1t46_A 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 193 (313)
T ss_dssp HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred HHHhcccccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCccceEEEcCCCCEEEccccccc
Confidence 88543 38999999999999999999999 999999999999999999999999999998
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
...............+|+.|+|||.+.+..++.++||||+|++++||++ |+.||.....
T Consensus 194 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 253 (313)
T 1t46_A 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (313)
T ss_dssp CTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred cccccccceeccCCCCcceeeChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCCcccc
Confidence 7654433333344556889999999988889999999999999999999 9999976543
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=216.27 Aligned_cols=175 Identities=18% Similarity=0.193 Sum_probs=137.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||++++..++.++++++.... .....|..+....+|+|++...+ +..+++++++++.+..
T Consensus 56 V~~a~~~~~~~~aikk~~~~~--------~~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~ 127 (394)
T 4e7w_A 56 VFQAKLVESDEVAIKKVLQDK--------RFKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPETVYRA 127 (394)
T ss_dssp EEEEEETTTEEEEEEEEECCT--------TSCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSEEHHHH
T ss_pred EEEEEECCCCeEEEEEEecCc--------chHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCccHHHH
Confidence 688888888887666664321 22345777788889998874221 1447788887764433
Q ss_pred hh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc-CCCceEEeeeecceeccccCcccccCCC
Q 044746 69 LC----KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 69 ~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
.. ....+++..+..++.|++.||.|||+ .+|+||||||+||+++ .++.+||+|||+++....... ....
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~~---~~~~ 201 (394)
T 4e7w_A 128 SRHYAKLKQTMPMLLIKLYMYQLLRSLAYIHS---IGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGEP---NVSY 201 (394)
T ss_dssp HHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSS
T ss_pred HHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCCC---Cccc
Confidence 32 25679999999999999999999999 9999999999999999 789999999999987543322 2335
Q ss_pred CCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 144 RRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.||+.|+|||++.+. .++.++||||+||+++||++|++||.+....
T Consensus 202 ~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~ 248 (394)
T 4e7w_A 202 ICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGI 248 (394)
T ss_dssp CSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 679999999998765 5899999999999999999999999876543
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.8e-31 Score=207.52 Aligned_cols=179 Identities=21% Similarity=0.278 Sum_probs=141.1
Q ss_pred CCccccCCCcceeehhhhchhhhhc----cCCcccCCcHHHHHHhccccccccc----cccceEEEEEccCCchhhhhc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME----MDKPIRFTSPQRMIAADNFSNLVGS----EDTETYIKGFLAMGPFYLLCK- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~i~~----~~~~~~~~~~~~~~~l~~~~~- 71 (202)
||++++..+++.||.|+........ .+...++..|.......+|++++.. .....++++++++++|...+.
T Consensus 35 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 114 (287)
T 4f0f_A 35 VHKGRLVKDKSVVAIKSLILGDSEGETEMIEKFQEFQREVFIMSNLNHPNIVKLYGLMHNPPRMVMEFVPCGDLYHRLLD 114 (287)
T ss_dssp EEEEEETTTCCEEEEEECCCCTTTCCHHHHCCSHHHHHHHHHHTTCCCTTBCCEEEEETTTTEEEEECCTTCBHHHHHHC
T ss_pred EEEEEEcCCceEEEEEEeeccccccchhHHHHHHHHHHHHHHHHhCCCCCchhhheeecCCCeEEEEecCCCCHHHHHhc
Confidence 6889888888888887653322211 1223456777777888889987742 122368999999999987773
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCcEEEcCCCc-----eEEeeeecceeccccCcccccCCC
Q 044746 72 -KNILGFGQLREIEVSTSKGIAYLHEECRQK--IVHYDIKPESVLLDENFF-----PKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 72 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--iiHrdlk~~nil~~~~~~-----~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
...+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++. ++|+|||+++..... ....
T Consensus 115 ~~~~~~~~~~~~~~~~l~~~l~~lH~---~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~~-----~~~~ 186 (287)
T 4f0f_A 115 KAHPIKWSVKLRLMLDIALGIEYMQN---QNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVHS-----VSGL 186 (287)
T ss_dssp TTSCCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSSC-----EECC
T ss_pred ccCCccHHHHHHHHHHHHHHHHHHHh---CCCCeecCCCCcceEEEeccCCCCceeEEeCCCCcccccccc-----cccc
Confidence 3469999999999999999999999 88 999999999999987776 999999999754321 2335
Q ss_pred CCCCcccCCcccC--CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 144 RRTPGCEAPELWM--PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 144 ~gt~~y~aPe~~~--~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.||+.|+|||.+. ...++.++||||+|+++|||++|+.||....
T Consensus 187 ~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 232 (287)
T 4f0f_A 187 LGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYS 232 (287)
T ss_dssp CCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHHHHHSSCTTTTCC
T ss_pred CCCccccCchhhccCCCCcCchhhHHHHHHHHHHHHcCCCCCcccc
Confidence 6799999999984 4567899999999999999999999997644
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-31 Score=218.37 Aligned_cols=183 Identities=19% Similarity=0.282 Sum_probs=131.9
Q ss_pred CCccccC---CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++. ..+..||.|+.+... .......|..|..+....+|++++. ......++++++++++|..++.
T Consensus 61 Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~ 138 (373)
T 2qol_A 61 VCSGRLKLPSKKEISVAIKTLKVGY--TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLR 138 (373)
T ss_dssp EEEC-CBCTTSCBCCEEEEECCTTC--CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHH
T ss_pred EEEEEEecCCCCceeEEEEEecCcc--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHH
Confidence 6777765 445567766543321 1112345777777888888998763 3445678999999999999986
Q ss_pred cC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCCc
Q 044746 72 KN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPG 148 (202)
Q Consensus 72 ~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~~ 148 (202)
.. .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........ .......+++.
T Consensus 139 ~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 215 (373)
T 2qol_A 139 KHDAQFTVIQLVGMLRGIASGMKYLSD---MGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIR 215 (373)
T ss_dssp TTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC----------------------CT
T ss_pred hCCCCCCHHHHHHHHHHHHHHHHHHHH---CCeeCCCCCcceEEEcCCCCEEECcCccccccccCCccceeccCCCcCCC
Confidence 54 59999999999999999999999 99999999999999999999999999999865433221 11222345778
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|+|||++.+..++.++||||||+++||+++ |+.||.....
T Consensus 216 y~aPE~~~~~~~~~~~Dv~SlG~il~ellt~g~~P~~~~~~ 256 (373)
T 2qol_A 216 WTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSN 256 (373)
T ss_dssp TSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTC-CTTTTCCH
T ss_pred ccChhhhccCCcCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999999998899999999999999999998 9999975543
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=207.07 Aligned_cols=179 Identities=20% Similarity=0.282 Sum_probs=133.3
Q ss_pred CCccccCCCcceeehhhhchhhhhc-cCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME-MDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++++. +..+|.|+.+...... ......+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 23 V~~~~~~--~~~vavK~~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~ 100 (271)
T 3dtc_A 23 VYRAFWI--GDEVAVKAARHDPDEDISQTIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLSGK 100 (271)
T ss_dssp EEEEEET--TEEEEEEEC----------CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHTSS
T ss_pred EEEEEEc--CCeEEEEEEecCCcccHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhhcC
Confidence 5777765 4456655543332221 223345667777778888998763 344567899999999999999988
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCC---eEEecCCCCcEEEcC--------CCceEEeeeecceeccccCcccccCC
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQK---IVHYDIKPESVLLDE--------NFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~---iiHrdlk~~nil~~~--------~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
.+++..+..++.|++.||.|||+ .+ ++||||||+||+++. ++.++|+|||++........ ..
T Consensus 101 ~~~~~~~~~i~~~l~~~l~~lH~---~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~ 173 (271)
T 3dtc_A 101 RIPPDILVNWAVQIARGMNYLHD---EAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTTK----MS 173 (271)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---SSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC---------------
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCCCceeecCCchHHEEEecccccccccCcceEEccCCcccccccccc----cC
Confidence 99999999999999999999999 77 999999999999985 67899999999986543222 23
Q ss_pred CCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
..||+.|+|||.+.+..++.++|+||+|++++++++|+.||.....
T Consensus 174 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 219 (271)
T 3dtc_A 174 AAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDG 219 (271)
T ss_dssp --CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHHHHHCCCTTTTSCH
T ss_pred CCCccceeCHHHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 4579999999999888899999999999999999999999986543
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.7e-31 Score=215.26 Aligned_cols=174 Identities=18% Similarity=0.265 Sum_probs=136.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHH-HHHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQR-MIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.+|.|+...... ....|.. +....+|++++. .+...+++++++++|+|...+..
T Consensus 38 V~~~~~~~~~~~~avK~~~~~~~-------~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~ 110 (342)
T 2qr7_A 38 CKRCIHKATNMEFAVKIIDKSKR-------DPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQ 110 (342)
T ss_dssp EEEEEETTTTEEEEEEEEETTTC-------CCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTC
T ss_pred EEEEEECCCCCEEEEEEEEcccC-------ChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHc
Confidence 68899988888888887543211 1223333 333347887763 44556788999999999887754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC----CceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN----FFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~----~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+.+++.++..++.|++.||.|||+ .+|+||||||+||++... +.+||+|||+++....... ......||+.
T Consensus 111 ~~~~~~~~~~~~~qi~~al~~lH~---~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~gt~~ 185 (342)
T 2qr7_A 111 KFFSEREASAVLFTITKTVEYLHA---QGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENG--LLMTPCYTAN 185 (342)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTC--CBCCSSCCSS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCC--ceeccCCCcc
Confidence 469999999999999999999999 999999999999998432 3599999999986543322 1234567999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|+|||++.+..++.++|+||+||++|||++|++||...
T Consensus 186 y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~Pf~~~ 223 (342)
T 2qr7_A 186 FVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTPFANG 223 (342)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCSSCSS
T ss_pred ccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCCCCCC
Confidence 99999998877889999999999999999999999753
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=6.8e-31 Score=217.08 Aligned_cols=174 Identities=21% Similarity=0.211 Sum_probs=135.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.||.|..... ...+..|..+....+|+|++...+ +..++++++.+ .+..
T Consensus 70 Vy~~~~~~~~~~vaiK~~~~~-------~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 141 (420)
T 1j1b_A 70 VYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYR 141 (420)
T ss_dssp EEEEEETTTCCEEEEEEEECC-------TTSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHH
T ss_pred EEEEEECCCCcEEEEEEeccc-------chhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHH
Confidence 789999888888887754321 123445777788889999875311 13467777775 4443
Q ss_pred hh-----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC-CceEEeeeecceeccccCcccccCC
Q 044746 69 LC-----KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN-FFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 69 ~~-----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~-~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
.+ ....+++..+..++.|++.||.|||+ .+|+||||||+|||++.+ +.+||+|||+++....... ...
T Consensus 142 ~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~ 215 (420)
T 1j1b_A 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVS 215 (420)
T ss_dssp HHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCS
T ss_pred HHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCChhhEEEeCCCCeEEeccchhhhhcccCCC---cee
Confidence 33 24579999999999999999999999 999999999999999965 6789999999986543322 233
Q ss_pred CCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 143 RRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
..||+.|+|||++.+. .++.++||||+||++|||++|++||.+...
T Consensus 216 ~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~G~~pf~~~~~ 262 (420)
T 1j1b_A 216 YICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 262 (420)
T ss_dssp CCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHHHHHhCCCCCCCCCH
Confidence 5679999999998765 789999999999999999999999987654
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.8e-31 Score=218.63 Aligned_cols=179 Identities=15% Similarity=0.173 Sum_probs=129.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc--cccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN--FSNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++.. ++.||.|+...... .......+..|..+..... |++++. .....+++++ +.+++|..++..
T Consensus 72 Vy~~~~~~-~~~vaiK~~~~~~~-~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E-~~~~~L~~~l~~ 148 (390)
T 2zmd_A 72 VFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148 (390)
T ss_dssp EEEEECTT-CCEEEEEEEECTTC-CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEE-CCSEEHHHHHHH
T ss_pred EEEEEcCC-CCEEEEEEEecccc-cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEe-cCCCCHHHHHHh
Confidence 68888876 66666665432211 1112234555655555543 467663 2233456666 677888887754
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++.++..++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||+++...............||+.|+|
T Consensus 149 ~~~~~~~~~~~i~~qi~~aL~~lH~---~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 224 (390)
T 2zmd_A 149 KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMP 224 (390)
T ss_dssp CSSCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCCGGGEEES-SSCEEECCCSSSCCC---------CCSCCCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCccccCCCCCcCCCccC
Confidence 468999999999999999999999 9999999999999995 58899999999987654333323345678999999
Q ss_pred CcccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 152 PELWMP-----------YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 152 Pe~~~~-----------~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||++.+ ..++.++|||||||++|||++|++||...
T Consensus 225 PE~~~~~~~~~~~~~~~~~~~~~~DiwSlGvil~ell~G~~Pf~~~ 270 (390)
T 2zmd_A 225 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 270 (390)
T ss_dssp HHHHHCC------------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred hHHhhhccccccccccccCCCChhhHHHHHHHHHHHHHCCCcchhh
Confidence 999864 36889999999999999999999999764
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=5.4e-31 Score=212.30 Aligned_cols=182 Identities=25% Similarity=0.337 Sum_probs=140.4
Q ss_pred CCccccCCCcceeehhhhchhhhhc--cCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME--MDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++..+++.||.|+........ ......+..|.......+|++++. ..+...++++++++ +|..++..
T Consensus 26 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~ 104 (346)
T 1ua2_A 26 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKD 104 (346)
T ss_dssp EEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTT
T ss_pred EEEEEECCCCcEEEEEEEecCCcchhhhhhhHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHh
Confidence 6889998888888887654332221 112334556777778888998763 34556688888886 67666654
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 N--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ......||+.|+
T Consensus 105 ~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~y~ 179 (346)
T 1ua2_A 105 NSLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNR--AYTHQVVTRWYR 179 (346)
T ss_dssp CCSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCC--CCCCSCCCCTTC
T ss_pred cCcCCCHHHHHHHHHHHHHHHHHHHH---CCEECCCCCHHHEEEcCCCCEEEEecccceeccCCcc--cCCccccccccc
Confidence 3 58999999999999999999999 9999999999999999999999999999986543221 223456799999
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||.+.+. .++.++||||+||+++||++|.+||.+...
T Consensus 180 aPE~~~~~~~~~~~~DiwslG~il~ell~g~~~~~~~~~ 218 (346)
T 1ua2_A 180 APELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 218 (346)
T ss_dssp CHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CchHhhCCCCCCchhhhHhHHHHHHHHHHCCCCCCCCCH
Confidence 99998764 588999999999999999999999987553
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-31 Score=220.19 Aligned_cols=179 Identities=16% Similarity=0.213 Sum_probs=143.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++..+++.||.|+.+.... ......+..|.......+|++++.. +....++++++++++|..++..
T Consensus 25 Vy~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~ 102 (396)
T 4eut_A 25 VFRGRHKKTGDLFAIKVFNNISF--LRPVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEE 102 (396)
T ss_dssp EEEEEETTTCCEEEEEEECGGGG--GSCHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTS
T ss_pred EEEEEECCCCcEEEEEEeccccc--cchHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHh
Confidence 78999998888898887543322 1223345567777788889987632 2244688999999999998865
Q ss_pred CC----CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE----cCCCceEEeeeecceeccccCcccccCCCC
Q 044746 73 NI----LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 73 ~~----~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~----~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
.. +++..+..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+|||+++....... .....
T Consensus 103 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~---~~~~~ 176 (396)
T 4eut_A 103 PSNAYGLPESEFLIVLRDVVGGMNHLRE---NGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQ---FVSLY 176 (396)
T ss_dssp GGGTTCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGG---SSCSS
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCc---ccccc
Confidence 32 9999999999999999999999 999999999999999 7778899999999987644322 23456
Q ss_pred CCCcccCCcccCC--------CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 145 RTPGCEAPELWMP--------YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 145 gt~~y~aPe~~~~--------~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
||+.|+|||++.+ ..++.++||||+||++|||++|+.||....
T Consensus 177 gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSlG~il~el~tg~~Pf~~~~ 227 (396)
T 4eut_A 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFE 227 (396)
T ss_dssp SCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHHHHHHHHHHHSSCSEECTT
T ss_pred CCccccCHHHhhccccccccccCCCcHHHHHHHHHHHHHHHHCCCCCCCCC
Confidence 8999999999864 456789999999999999999999997543
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=210.27 Aligned_cols=180 Identities=19% Similarity=0.278 Sum_probs=128.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc--cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK--KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~--~~ 73 (202)
||++++.+. ++.|+.+.... .......|..|.......+|++++. ......++++++++++|..++. ..
T Consensus 40 Vy~~~~~~~---vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~ 115 (289)
T 3og7_A 40 VYKGKWHGD---VAVKMLNVTAP-TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHASET 115 (289)
T ss_dssp EEEEESSSE---EEEEEESCSSC-CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHTTC--
T ss_pred EEEEEEcCc---eEEEEEeccCC-CHHHHHHHHHHHHHHHhCCCCcEEEEEeeccCCccEEEEEecCCCcHHHHHhhccC
Confidence 567766542 55544322211 1122345667777788888998763 3344568999999999988884 34
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++................||+.|+|||
T Consensus 116 ~~~~~~~~~i~~qi~~~L~~lH~---~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE 192 (289)
T 3og7_A 116 KFEMKKLIDIARQTARGMDYLHA---KSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPE 192 (289)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEEccceeccccccccccccccccCCCccccCch
Confidence 59999999999999999999999 999999999999999999999999999998654332222334456899999999
Q ss_pred ccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.+. +..++.++||||+|+++++|++|+.||....
T Consensus 193 ~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 229 (289)
T 3og7_A 193 VIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNIN 229 (289)
T ss_dssp HHC----CCSCHHHHHHHHHHHHHHHHHSSCTTSSCC
T ss_pred hhcccCCCCCCcccchHHHHHHHHHHHHCCCCccccc
Confidence 986 5678899999999999999999999997644
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-31 Score=223.92 Aligned_cols=180 Identities=20% Similarity=0.246 Sum_probs=147.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...+..||.|+.+... .....|..|..+....+|+|++. ......++++++++|+|..++..
T Consensus 236 Vy~~~~~~~~~~vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~ 311 (495)
T 1opk_A 236 VYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 311 (495)
T ss_dssp EEEEEEGGGTEEEEEEECCSSS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC
T ss_pred EEEEEEcCCCeEEEEEEecCcc----cchHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcC
Confidence 6888888878888887754321 22345777888888889998874 34456789999999999998854
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .......+++.|+|
T Consensus 312 ~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~a 387 (495)
T 1opk_A 312 RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTA 387 (495)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCCE-ECCTTCCCCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCChhhEEECCCCcEEEeecccceeccCCce-eecCCCcCCcceeC
Confidence 459999999999999999999999 9999999999999999999999999999987643322 22233455789999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||++....++.++||||||+++|||++ |+.||.....
T Consensus 388 PE~~~~~~~~~~sDvwSlG~~l~el~t~g~~p~~~~~~ 425 (495)
T 1opk_A 388 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 425 (495)
T ss_dssp HHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred HhHHhcCCCCcHHhHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 999988889999999999999999999 9999976543
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.6e-31 Score=221.43 Aligned_cols=176 Identities=21% Similarity=0.252 Sum_probs=135.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh------cccccccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA------DNFSNLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~~~~~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
||++++...++.||.|+.+...... ..+..|..+... .+|++++. ......++++++. ++|..
T Consensus 113 V~~a~~~~~~~~vAvK~~~~~~~~~----~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~ 187 (429)
T 3kvw_A 113 VVKAYDHKVHQHVALKMVRNEKRFH----RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYE 187 (429)
T ss_dssp EEEEEETTTTEEEEEEEECSCHHHH----HHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHH
T ss_pred EEEEEECCCCcEEEEEEECCccchH----HHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHH
Confidence 7899999888999988764432211 122233333322 25556653 2344456777775 57777
Q ss_pred hhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc--eEEeeeecceeccccCcccccCCC
Q 044746 69 LCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF--PKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 69 ~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~--~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
++... .+++..+..++.|++.||.|||+ .+|+||||||+|||++.++. +||+|||++...... ....
T Consensus 188 ~l~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~~-----~~~~ 259 (429)
T 3kvw_A 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHK---NRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQR-----VYTY 259 (429)
T ss_dssp HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---HTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSS
T ss_pred HHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEccCCCcceEEeecccceecCCc-----cccc
Confidence 76543 39999999999999999999999 99999999999999998887 999999999764332 2335
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.||+.|+|||++.+..++.++|||||||+++||++|++||......
T Consensus 260 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~pf~~~~~~ 305 (429)
T 3kvw_A 260 IQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEG 305 (429)
T ss_dssp CSCGGGCCHHHHHTBCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCCccChHHHhCCCCCchHHHHhHHHHHHHHHhCCCCCCCCCHH
Confidence 6799999999999989999999999999999999999999876543
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=212.49 Aligned_cols=182 Identities=16% Similarity=0.177 Sum_probs=136.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.||.|+..... .....++..|...... .+|++++. ..+...++++++++++|..++..
T Consensus 29 V~~~~~~~~~~~vavK~~~~~~---~~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 105 (316)
T 2ac3_A 29 VQTCINLITSQEYAVKIIEKQP---GHIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKR 105 (316)
T ss_dssp EEEEECSSSCCEEEEEEEECCS---SCCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEcCCCcEEEEEEEeeCc---chhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhcc
Confidence 6888888888888888754321 1222345555555544 57888763 34456789999999999888854
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc---eEEeeeecceeccccCc-----ccccCCCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF---PKAADFGLAKLYNREHT-----HITSTGRR 144 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~---~kl~dfgl~~~~~~~~~-----~~~~~~~~ 144 (202)
..+++.++..++.|++.||.|||+ .+++||||||+||+++.++. +||+|||++........ ........
T Consensus 106 ~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~ 182 (316)
T 2ac3_A 106 RHFNELEASVVVQDVASALDFLHN---KGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPC 182 (316)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------C
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCcccccccccccccc
Confidence 569999999999999999999999 99999999999999987765 99999999875432211 11122345
Q ss_pred CCCcccCCcccCC-----CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 145 RTPGCEAPELWMP-----YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 145 gt~~y~aPe~~~~-----~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||+.|+|||++.. ..++.++||||+||+++||++|++||.....
T Consensus 183 gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~~ 231 (316)
T 2ac3_A 183 GSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231 (316)
T ss_dssp CSGGGCCHHHHHHTSHHHHHHTTTHHHHHHHHHHHHHHHSSCSCCCCCC
T ss_pred CCcCccChHHhhcccccccCCCcccccHhHHHHHHHHHHCCCCCccccc
Confidence 8999999999864 4578899999999999999999999987654
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=212.83 Aligned_cols=183 Identities=22% Similarity=0.260 Sum_probs=139.9
Q ss_pred CCccccC-------CCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCch
Q 044746 1 MEKPRNR-------GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~-------~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l 66 (202)
||++++. ..+..||.|+.+... ......++..|....... +|++++. ..+...++++++++++|
T Consensus 51 Vy~~~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L 128 (334)
T 2pvf_A 51 VVMAEAVGIDKDKPKEAVTVAVKMLKDDA--TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 128 (334)
T ss_dssp EEEEEETTCSTTCC---CEEEEEECCTTC--CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBH
T ss_pred EEEeEeccccccccccceEEEEeeeccCC--cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcH
Confidence 5666654 345567766644321 111223455565555555 7887763 34456789999999999
Q ss_pred hhhhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 67 YLLCKKN-----------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 67 ~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
..++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++
T Consensus 129 ~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~ 205 (334)
T 2pvf_A 129 REYLRARRPPGMEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLAS---QKCIHRDLAARNVLVTENNVMKIADFGLAR 205 (334)
T ss_dssp HHHHHTTSCTTCCSCC--------CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCE
T ss_pred HHHHHHhccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCccceEEEcCCCCEEEccccccc
Confidence 9988643 38999999999999999999999 999999999999999999999999999998
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
...............+|+.|+|||++.+..++.++||||+|++++||++ |+.||.....
T Consensus 206 ~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 265 (334)
T 2pvf_A 206 DINNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPV 265 (334)
T ss_dssp ECTTTSSEECCSCCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cccccccccccCCCCcccceeChHHhcCCCcChHHHHHHHHHHHHHHHhCCCCCcCcCCH
Confidence 7654433333344556889999999988889999999999999999999 9999976543
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.3e-31 Score=206.75 Aligned_cols=181 Identities=20% Similarity=0.243 Sum_probs=144.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.|+.|+....... ......+..|.......+|++++. ..+...++++++++++|...+. ..
T Consensus 22 V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~ 100 (284)
T 3kk8_A 22 VRRCVHKTTGLEFAAKIINTKKLS-ARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVARE 100 (284)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred EEEEEEcCCCceEEEEEeecccCC-HHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcC
Confidence 688888888888888875433221 122344666777777888898763 3444568899999999866654 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc---eEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF---PKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~---~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++. ++|+|||++........ .....||+.|+
T Consensus 101 ~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~y~ 174 (284)
T 3kk8_A 101 FYSEADASHCIQQILESIAYCHS---NGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA---WHGFAGTPGYL 174 (284)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCB---CCCSCSCGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCcc---ccCCCCCcCCc
Confidence 69999999999999999999999 99999999999999976554 99999999986544322 23456799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||.+.+..++.++||||+|+++++|++|+.||.....
T Consensus 175 aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~pf~~~~~ 212 (284)
T 3kk8_A 175 SPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQ 212 (284)
T ss_dssp CHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CchhhcCCCCCcccchHHHHHHHHHHHHCCCCCCCCch
Confidence 99999998999999999999999999999999976543
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.3e-31 Score=211.02 Aligned_cols=181 Identities=18% Similarity=0.263 Sum_probs=139.6
Q ss_pred CCccc----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc--------ccceEEEEEccCCchhh
Q 044746 1 MEKPR----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE--------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------~~~~~~~~~~~~~~l~~ 68 (202)
||+++ +...++.||.|+...... .....+..|.......+|++++... ....++++++++++|..
T Consensus 26 V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 102 (295)
T 3ugc_A 26 VEMCRYDPLQDNTGEVVAVKKLQHSTE---EHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 102 (295)
T ss_dssp EEEEEECTTCSSCCEEEEEEEESCCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHH
T ss_pred EEEEEEecccCCCCcEEEEEEcccCCH---HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHH
Confidence 56666 667778888776543221 2234566777788888899887422 23568999999999999
Q ss_pred hhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCC
Q 044746 69 LCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRR 145 (202)
Q Consensus 69 ~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~g 145 (202)
++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++......... .......+
T Consensus 103 ~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 179 (295)
T 3ugc_A 103 YLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKVKEPGES 179 (295)
T ss_dssp HHHHCGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCSCC-------------CTTC
T ss_pred HHHhcccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcceeeeccCCCC
Confidence 88654 49999999999999999999999 99999999999999999999999999999865433221 12233446
Q ss_pred CCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+..|+|||.+.+..++.++||||+|++++||++|..|+....
T Consensus 180 ~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~~~~~~~ 221 (295)
T 3ugc_A 180 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPP 221 (295)
T ss_dssp GGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTTCTTCSHH
T ss_pred ccceeCcHHhcCCCCChHHHHHHHHHHHHHHHhcccccCCCh
Confidence 778999999998899999999999999999999999987543
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=219.55 Aligned_cols=181 Identities=10% Similarity=0.032 Sum_probs=132.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccc-------------------ccc--------cc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSN-------------------LVG--------SE-- 51 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------~i~--------~~-- 51 (202)
||++++...++.||+|+.+............|..|........|.. +.+ ..
T Consensus 94 Vy~a~~~~~g~~vAvK~~~~~~~~~~~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 173 (413)
T 3dzo_A 94 YLEATDQETGESFEVHVPYFTERPPSNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDER 173 (413)
T ss_dssp EEEEEETTTCCEEEEEEECCSCC----CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC------------
T ss_pred EEEEEecCCCCceEEEEEecCCCccHHHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCc
Confidence 7999999888899988766433333333344545544444443310 000 00
Q ss_pred ---ccceEEEEEccCCchhhhhc--------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCce
Q 044746 52 ---DTETYIKGFLAMGPFYLLCK--------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFP 120 (202)
Q Consensus 52 ---~~~~~~~~~~~~~~l~~~~~--------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~ 120 (202)
....++.....+++|..++. ...+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+
T Consensus 174 ~~~~~~~~~~~~~~~~~L~~ll~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~~iiHrDiKp~NILl~~~~~~ 250 (413)
T 3dzo_A 174 DMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHH---YGLVHTYLRPVDIVLDQRGGV 250 (413)
T ss_dssp ---CCSEEEEEECCSEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCE
T ss_pred cccccceEEEeehhcCCHHHHHHHhhcccccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCcccceEEEecCCeE
Confidence 12234444556778877773 3447888999999999999999999 999999999999999999999
Q ss_pred EEeeeecceeccccCcccccCCCCCCCcccCCccc----------CCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 121 KAADFGLAKLYNREHTHITSTGRRRTPGCEAPELW----------MPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 121 kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~----------~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
||+|||+++..... .....| +.|+|||++ ....++.++|||||||++|||++|+.||.......
T Consensus 251 kL~DFG~a~~~~~~-----~~~~~g-~~y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~ 324 (413)
T 3dzo_A 251 FLTGFEHLVRDGAS-----AVSPIG-RGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALG 324 (413)
T ss_dssp EECCGGGCEETTEE-----ECCCCC-TTTCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGS
T ss_pred EEEeccceeecCCc-----cccCCC-CceeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhh
Confidence 99999999865432 234566 999999999 55568899999999999999999999998766543
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=215.31 Aligned_cols=179 Identities=15% Similarity=0.171 Sum_probs=126.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccc--ccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNF--SNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++.. ++.||.|+..... ........+..|........| ++++. ......++++ +.+++|..++..
T Consensus 25 Vy~~~~~~-~~~vavK~~~~~~-~~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~ 101 (343)
T 3dbq_A 25 VFQVLNEK-KQIYAIKYVNLEE-ADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 101 (343)
T ss_dssp EEEEECTT-SCEEEEEEEECTT-CCHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred EEEEEeCC-CCEEEEEEeeccc-cchHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEe-CCCCCHHHHHHh
Confidence 67888765 5556655433221 111122345556665555544 66653 2334456666 677888887755
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++.++..++.|++.||.|||+ .+|+||||||+|||++ ++.+||+|||+++...............||+.|+|
T Consensus 102 ~~~~~~~~~~~i~~qi~~al~~lH~---~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~a 177 (343)
T 3dbq_A 102 KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 177 (343)
T ss_dssp SCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC------------CCCCSSCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCcceEEEE-CCcEEEeecccccccCcccccccCCCCcCCcCcCC
Confidence 469999999999999999999999 9999999999999997 67899999999987654433333345678999999
Q ss_pred CcccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 152 PELWMP-----------YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 152 Pe~~~~-----------~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||++.+ ..++.++||||+||+++||++|+.||...
T Consensus 178 PE~~~~~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~ 223 (343)
T 3dbq_A 178 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 223 (343)
T ss_dssp HHHHHHCC-----------CCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred HHHHhhccccccccccccCCCchhhHHHHHHHHHHHHhCCCcchhh
Confidence 999854 67889999999999999999999999753
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=206.94 Aligned_cols=179 Identities=20% Similarity=0.307 Sum_probs=141.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..+.. ||.|+...... ....+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 26 V~~~~~~~~~~-vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 100 (269)
T 4hcu_A 26 VHLGYWLNKDK-VAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 100 (269)
T ss_dssp EEEEEETTTEE-EEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTT
T ss_pred EEEEEecCCCe-EEEEEeccccc----CHHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcC
Confidence 67888776555 44444322211 1234667777788888998763 344557899999999999988543
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ .......+|+.|+||
T Consensus 101 ~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aP 176 (269)
T 4hcu_A 101 GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 176 (269)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCH
T ss_pred cccCHHHHHHHHHHHHHHHHHHHh---CCeecCCcchheEEEcCCCCEEecccccccccccccc-ccccCcccccccCCH
Confidence 49999999999999999999999 9999999999999999999999999999986543321 122334567889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|+++++|++ |+.||.....
T Consensus 177 E~~~~~~~~~~~Di~slG~~l~~ll~~g~~p~~~~~~ 213 (269)
T 4hcu_A 177 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 213 (269)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred HHhcCCCCCchhhhHHHHHHHHHHhcCCCCCCCCCCH
Confidence 99988889999999999999999999 9999976544
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.4e-31 Score=213.63 Aligned_cols=175 Identities=18% Similarity=0.177 Sum_probs=138.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc----------------------------
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED---------------------------- 52 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~---------------------------- 52 (202)
||++++..+++.||.|..... ......|..+....+|+|++...+
T Consensus 23 V~~a~~~~~~~~vAiK~~~~~-------~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 95 (383)
T 3eb0_A 23 VCEVFDIESGKRFALKKVLQD-------PRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95 (383)
T ss_dssp EEEEEETTTCCEEEEEEEECC-------TTSCCHHHHHHTTCCCTTBCCEEEEEEEC-----------------------
T ss_pred EEEEEECCCCCEEEEEEEecC-------cchHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccc
Confidence 689999888888888754322 223446777778888998874221
Q ss_pred ----------------cceEEEEEccCCchhhhhc-----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCc
Q 044746 53 ----------------TETYIKGFLAMGPFYLLCK-----KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPES 111 (202)
Q Consensus 53 ----------------~~~~~~~~~~~~~l~~~~~-----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~n 111 (202)
+..+++++++ ++|...+. ...+++..+..++.|++.||.|||+ .+|+||||||+|
T Consensus 96 ~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~---~gi~H~Dikp~N 171 (383)
T 3eb0_A 96 VNNHHKSVIVNPSQNKYLNVIMEYVP-DTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHS---LGICHRDIKPQN 171 (383)
T ss_dssp --------------CCEEEEEECCCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECSCCCGGG
T ss_pred cccccccccccCCCceEEEEEEecCC-ccHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH---CcCccCccCHHH
Confidence 2447778887 46555443 3579999999999999999999999 999999999999
Q ss_pred EEEc-CCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 112 VLLD-ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 112 il~~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|+++ .++.+||+|||+++....... .....||+.|+|||.+.+. .++.++||||+||+++||++|++||.+....
T Consensus 172 il~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~ 248 (383)
T 3eb0_A 172 LLVNSKDNTLKLCDFGSAKKLIPSEP---SVAYICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSI 248 (383)
T ss_dssp EEEETTTTEEEECCCTTCEECCTTSC---CCCCCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred EEEcCCCCcEEEEECCCCcccCCCCC---CcCcccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChH
Confidence 9997 688999999999986543322 2334669999999998765 4899999999999999999999999876543
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=203.76 Aligned_cols=178 Identities=16% Similarity=0.253 Sum_probs=143.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++...+..++.|...... .....++..|.......+|++++. ......++++++++++|..++. ..
T Consensus 25 V~~~~~~~~~~~~a~k~~~~~~---~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 101 (277)
T 3f3z_A 25 VKIAVQKGTRIRRAAKKIPKYF---VEDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKR 101 (277)
T ss_dssp EEEEEETTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC
T ss_pred EEEEEeCCCCcEEEEEeehhhc---cchHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcC
Confidence 6888888888777776543322 223445677777788888998763 3445578899999999977664 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE---cCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.++|+|||++........ .....||+.|+
T Consensus 102 ~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~t~~y~ 175 (277)
T 3f3z_A 102 VFRESDAARIMKDVLSAVAYCHK---LNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKM---MRTKVGTPYYV 175 (277)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSC---BCCCCSCTTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCccc---hhccCCCCCcc
Confidence 68999999999999999999999 999999999999999 7889999999999986543322 23346799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||.+.+. ++.++|+||+|+++++|++|+.||.....
T Consensus 176 aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~ 212 (277)
T 3f3z_A 176 SPQVLEGL-YGPECDEWSAGVMMYVLLCGYPPFSAPTD 212 (277)
T ss_dssp CHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ChHHhccc-CCchhhehhHHHHHHHHHHCCCCCCCCCH
Confidence 99998764 89999999999999999999999976543
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.6e-31 Score=220.48 Aligned_cols=181 Identities=20% Similarity=0.297 Sum_probs=144.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||++++..++..+|.|+.+..... ......+..|..+....+|+|++. .....+++++++++|+|...+ ...
T Consensus 53 V~~~~~~~~~~~~aiK~~~~~~~~-~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~ 131 (494)
T 3lij_A 53 VLLCRDKVTHVERAIKIIRKTSVS-TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRM 131 (494)
T ss_dssp EEEEEETTTCCEEEEEEEEC------CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHS
T ss_pred EEEEEECCCCcEEEEEEEeccccC-chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcC
Confidence 688999888888888875543222 222445667888888889998874 344566889999999997766 446
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ .+|+||||||+||+++. ++.+||+|||++........ .....||+.|+
T Consensus 132 ~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~---~~~~~gt~~y~ 205 (494)
T 3lij_A 132 KFNEVDAAVIIKQVLSGVTYLHK---HNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKK---MKERLGTAYYI 205 (494)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBC---BCCCCSCTTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCcc---ccccCCCcCee
Confidence 79999999999999999999999 99999999999999975 45599999999987654322 23456899999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||++.+ .++.++||||+||++|+|++|++||.+....
T Consensus 206 aPE~l~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 243 (494)
T 3lij_A 206 APEVLRK-KYDEKCDVWSIGVILFILLAGYPPFGGQTDQ 243 (494)
T ss_dssp CHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHHcc-cCCCchhHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999864 6899999999999999999999999875543
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.2e-30 Score=204.21 Aligned_cols=182 Identities=18% Similarity=0.273 Sum_probs=143.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccC---CcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMD---KPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..+++.++.|+.+........ ....+..|.......+|++++. ......++++++++++|..++.
T Consensus 21 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 100 (283)
T 3bhy_A 21 VRKCRQKGTGKEYAAKFIKKRRLSSSRRGVSREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLA 100 (283)
T ss_dssp EEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEEcCCCCeeehHHhhhccccccccchHHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHH
Confidence 688999888888887765443222111 2344666777777888898763 3445668899999999988875
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC----ceEEeeeecceeccccCcccccCCCCCC
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF----FPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~----~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||++........ .....|+
T Consensus 101 ~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~ 174 (283)
T 3bhy_A 101 EKESLTEDEATQFLKQILDGVHYLHS---KRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNE---FKNIFGT 174 (283)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-----------CCC
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCCc---ccccCCC
Confidence 4 569999999999999999999999 9999999999999998776 799999999986543322 2234579
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||++.+..++.++|+||+|+++++|++|+.||.....
T Consensus 175 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 216 (283)
T 3bhy_A 175 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETK 216 (283)
T ss_dssp GGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred cCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCCCCCcch
Confidence 999999999988999999999999999999999999976543
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=212.34 Aligned_cols=181 Identities=15% Similarity=0.199 Sum_probs=135.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.||.|+.+.... .......+..|.......+|++++. ......+++++++ ++|..++.. .
T Consensus 50 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~ 127 (329)
T 3gbz_A 50 VYKAIDTVTNETVAIKRIRLEHE-EEGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNP 127 (329)
T ss_dssp EEEEEETTTTEEEEEEECCCCC---------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCT
T ss_pred EEEEEECCCCceEEEEEEccccc-ccccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcC
Confidence 68899888888888887643322 2223445667777788888998774 3445568888887 477777754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc-----CCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-----ENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~-----~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
.+++..+..++.|++.||.|||+ .+|+||||||+||+++ ..+.+||+|||+++....... ......||+.
T Consensus 128 ~~~~~~~~~i~~ql~~~l~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~t~~ 202 (329)
T 3gbz_A 128 DVSMRVIKSFLYQLINGVNFCHS---RRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIR--QFTHEIITLW 202 (329)
T ss_dssp TCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-------------CCT
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCccc--ccCCCcCCcc
Confidence 69999999999999999999999 9999999999999994 455699999999986543222 1233467999
Q ss_pred ccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||++.+. .++.++||||+||+++||++|++||.....
T Consensus 203 y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~ 243 (329)
T 3gbz_A 203 YRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243 (329)
T ss_dssp TCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCHHHhcCCCCCCcHHHHHHHHHHHHHHHHCCCCcCCCCH
Confidence 9999999874 489999999999999999999999976554
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=3.1e-31 Score=210.19 Aligned_cols=183 Identities=18% Similarity=0.189 Sum_probs=139.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.||.|+....... ......+..|.......+|++++. ..+...++++++++++|..+.. ..
T Consensus 19 V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 97 (311)
T 4agu_A 19 VFKCRNRDTGQIVAIKKFLESEDD-PVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQR 97 (311)
T ss_dssp EEEEEETTTCCEEEEEEECCCCC--HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSS
T ss_pred EEEEEeCCCCcEEEEEEeeccccc-hHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhc
Confidence 688999888888887754322111 111234556777777788898763 3445568899999999888775 44
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .....||+.|+|||
T Consensus 98 ~~~~~~~~~i~~~l~~~l~~lH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~y~aPE 172 (311)
T 4agu_A 98 GVPEHLVKSITWQTLQAVNFCHK---HNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPSDY--YDDEVATRWYRSPE 172 (311)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECC--------------GGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcccc--cCCCcCCccccChH
Confidence 69999999999999999999999 99999999999999999999999999999875433221 23346799999999
Q ss_pred ccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 154 LWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 154 ~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.+.+ ..++.++|+||+|+++++|++|++||.+....
T Consensus 173 ~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~~ 209 (311)
T 4agu_A 173 LLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDV 209 (311)
T ss_dssp HHHTCSCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred HHhcCCCCCcchhhHHHHHHHHHHHhCCCCCCCCCHH
Confidence 9876 56899999999999999999999999876543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=208.34 Aligned_cols=182 Identities=18% Similarity=0.215 Sum_probs=131.5
Q ss_pred CCccccCCC---cceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGS---TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~---~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++... ...|+.|..+... ......++..|.......+|++++. ..+..+++++++++++|..++..
T Consensus 31 Vy~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 108 (281)
T 1mp8_A 31 VHQGIYMSPENPALAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV 108 (281)
T ss_dssp EEEEEECCC--CCEEEEEEECTTTT--SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHH
T ss_pred EEEEEEecCCCCceEEEEEeccccC--CHHHHHHHHHHHHHHHhCCCCccceEEEEEccCccEEEEecCCCCCHHHHHHh
Confidence 577776543 3456665543321 1122334667777777888998764 33455688999999999998864
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 N--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........ ......+++.|+
T Consensus 109 ~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~ 184 (281)
T 1mp8_A 109 RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWM 184 (281)
T ss_dssp TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGC
T ss_pred cCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecccccHHHEEECCCCCEEECccccccccCccccc-ccccCCCccccc
Confidence 4 59999999999999999999999 99999999999999999999999999999865433221 122334578899
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||.+.+..++.++|+||+|++++||++ |.+||.....
T Consensus 185 aPE~~~~~~~~~~~Di~slG~~l~ell~~g~~pf~~~~~ 223 (281)
T 1mp8_A 185 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 223 (281)
T ss_dssp CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCG
T ss_pred ChhhcccCCCCCccCchHHHHHHHHHHhcCCCCCCcCCH
Confidence 9999988889999999999999999997 9999986544
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=222.05 Aligned_cols=179 Identities=22% Similarity=0.305 Sum_probs=142.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccC--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKN-- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~-- 73 (202)
||+++...+. .||+|+.+... .....|..|..+....+|++++. ......++++++++|+|..++...
T Consensus 204 V~~~~~~~~~-~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~iv~l~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~ 278 (454)
T 1qcf_A 204 VWMATYNKHT-KVAVKTMKPGS----MSVEAFLAEANVMKTLQHDKLVKLHAVVTKEPIYIITEFMAKGSLLDFLKSDEG 278 (454)
T ss_dssp EEEEEETTTE-EEEEEEECTTS----BCHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHHSHHH
T ss_pred EEEEEECCcc-EEEEEEecCCC----ccHHHHHHHHHHHhhCCCCCEeeEEEEEeCCccEEEEeecCCCcHHHHHHhccC
Confidence 6777776544 45555433221 22445777888888889998774 234456899999999999988643
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++....... .......+++.|+||
T Consensus 279 ~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aP 354 (454)
T 1qcf_A 279 SKQPLPKLIDFSAQIAEGMAFIEQ---RNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY-TAREGAKFPIKWTAP 354 (454)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHHH-HTTCSSSSCGGGSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCce-eccCCCcccccccCH
Confidence 68999999999999999999999 9999999999999999999999999999986543221 112334457889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|++....++.++||||||+++|||++ |+.||.+...
T Consensus 355 E~~~~~~~~~~~DvwslG~~l~el~t~g~~P~~~~~~ 391 (454)
T 1qcf_A 355 EAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSN 391 (454)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred HHhccCCCCcHHHHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 99988889999999999999999999 9999976543
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.2e-31 Score=209.78 Aligned_cols=185 Identities=16% Similarity=0.174 Sum_probs=133.7
Q ss_pred CCccccCC---CcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc-----------cceEEEEEccCCch
Q 044746 1 MEKPRNRG---STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED-----------TETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~---~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-----------~~~~~~~~~~~~~l 66 (202)
||+++... .+..||.|+.+.... .......+..|.......+|++++...+ ...++++++++++|
T Consensus 50 V~~~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L 128 (313)
T 3brb_A 50 VMEGNLKQEDGTSLKVAVKTMKLDNS-SQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128 (313)
T ss_dssp EEEEEEECTTSCEEEEEEEEC---CC-CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBH
T ss_pred EEEEEEeccCCceeEEEEEEEecccc-chhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCH
Confidence 46665443 344566665432211 1112234667777778888998874322 23788999999999
Q ss_pred hhhh-------ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc
Q 044746 67 YLLC-------KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT 139 (202)
Q Consensus 67 ~~~~-------~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~ 139 (202)
..++ ....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||++...........
T Consensus 129 ~~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~~ 205 (313)
T 3brb_A 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSN---RNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDYYRQ 205 (313)
T ss_dssp HHHHHHTTBTTSCCCCCHHHHHHHHHHHHHHHHHHHT---TTCCCCCCSGGGEEECTTSCEEECSCSCC-----------
T ss_pred HHHHHHhhhhcCCccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEEeecCcceecccccccCc
Confidence 8887 23459999999999999999999999 9999999999999999999999999999986544332223
Q ss_pred cCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 140 STGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 140 ~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
.....+++.|+|||.+.+..++.++|+||+|+++++|++ |.+||......
T Consensus 206 ~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~~ 256 (313)
T 3brb_A 206 GRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGMTPYPGVQNH 256 (313)
T ss_dssp -----CCGGGSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCGG
T ss_pred ccccCCCccccCchhhcCCCccchhhhHHHHHHHHHHHhcCCCCCccCCHH
Confidence 334456889999999998899999999999999999999 99999765543
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=4.1e-31 Score=215.02 Aligned_cols=179 Identities=17% Similarity=0.170 Sum_probs=133.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------------~~~~~~~~~~~~~~l~~ 68 (202)
||++++...++.||.|+...... ......++..|.......+|++++... ....++++++.+ +|..
T Consensus 41 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~ 118 (371)
T 2xrw_A 41 VCAAYDAILERNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMDA-NLCQ 118 (371)
T ss_dssp EEEEEETTTTEEEEEEEEECTTS-SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCSE-EHHH
T ss_pred EEEEEECCCCceEEEEEeccccC-ChHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCCC-CHHH
Confidence 68888888888888876543211 112223455677777788899877421 134677888874 6666
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
.+. ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++...... ......||+.
T Consensus 119 ~~~-~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~---~~~~~~gt~~ 191 (371)
T 2xrw_A 119 VIQ-MELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---MMTPYVVTRY 191 (371)
T ss_dssp HHH-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCC-------------------CT
T ss_pred HHh-hccCHHHHHHHHHHHHHHHHHHHH---CCeecccCCHHHEEEcCCCCEEEEEeeccccccccc---ccCCceecCC
Confidence 664 468999999999999999999999 999999999999999999999999999998654322 1233567999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||++.+..++.++||||+||+++||++|+.||.+...
T Consensus 192 y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~ 231 (371)
T 2xrw_A 192 YRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDH 231 (371)
T ss_dssp TCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCHHHhcCCCCCchHhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999999998999999999999999999999999987554
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.9e-31 Score=213.56 Aligned_cols=176 Identities=17% Similarity=0.218 Sum_probs=130.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHH--HHHhcccccccccc-----------ccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQR--MIAADNFSNLVGSE-----------DTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~ 67 (202)
||+++. .++.||.|+....... .+..+.. .....+|++++... ....++++++++|+|.
T Consensus 29 Vy~~~~--~~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~ 100 (336)
T 3g2f_A 29 VYKGSL--DERPVAVKVFSFANRQ------NFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLX 100 (336)
T ss_dssp EEEEEE--TTEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHH
T ss_pred EEEEEE--CCeEEEEEEeeccchh------hHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHH
Confidence 577755 4566776664332211 1111222 22346777765422 1235889999999999
Q ss_pred hhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCC---------CeEEecCCCCcEEEcCCCceEEeeeecceeccccCc--
Q 044746 68 LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQ---------KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-- 136 (202)
Q Consensus 68 ~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~---------~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-- 136 (202)
.++.....++..+..++.|++.||.|||+ . +|+||||||+||+++.++.+||+|||+++.......
T Consensus 101 ~~l~~~~~~~~~~~~i~~qi~~~L~~LH~---~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~ 177 (336)
T 3g2f_A 101 KYLSLHTSDWVSSCRLAHSVTRGLAYLHT---ELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVR 177 (336)
T ss_dssp HHHHHCCBCHHHHHHHHHHHHHHHHHHHC---CBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC-
T ss_pred HHHhhcccchhHHHHHHHHHHHHHHHHHh---hhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccC
Confidence 99988889999999999999999999998 7 999999999999999999999999999987643221
Q ss_pred ----ccccCCCCCCCcccCCcccCC-------CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 137 ----HITSTGRRRTPGCEAPELWMP-------YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 137 ----~~~~~~~~gt~~y~aPe~~~~-------~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
........||+.|+|||++.+ ..++.++|||||||++|||++|..||....
T Consensus 178 ~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~ 239 (336)
T 3g2f_A 178 PGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGE 239 (336)
T ss_dssp --------CCTTSCGGGCCHHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTS
T ss_pred ccccccccccCCCccceeCchhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCcc
Confidence 112234568999999999986 345678999999999999999977765443
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-31 Score=212.14 Aligned_cols=182 Identities=21% Similarity=0.277 Sum_probs=140.2
Q ss_pred CCccc-----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc-------ccccceEEEEEccCCchh
Q 044746 1 MEKPR-----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG-------SEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~-----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~-------~~~~~~~~~~~~~~~~l~ 67 (202)
||+++ +...++.||.|+.+..... .....+..|....... +|++++. .+....++++++++++|.
T Consensus 43 Vy~~~~~~~~~~~~~~~vavK~~~~~~~~--~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~ 120 (316)
T 2xir_A 43 VIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 120 (316)
T ss_dssp EEEEEEESSSSTTCEEEEEEEEECTTCCH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHH
T ss_pred EEEEEEecCCccccceEEEEEecccCCCc--HHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHH
Confidence 56665 3456677777765432111 1123455555555554 6787653 233467889999999999
Q ss_pred hhhccCC-----------------CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 68 LLCKKNI-----------------LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 68 ~~~~~~~-----------------~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
.++.... +++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++.
T Consensus 121 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~ 197 (316)
T 2xir_A 121 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD 197 (316)
T ss_dssp HHHHTCTTSEECC-------CTTCEEHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCGGGSC
T ss_pred HHHHhcccccccccccchhhhccccCHHHHHHHHHHHHHHHHHHHh---CCcccccCccceEEECCCCCEEECCCccccc
Confidence 9886543 8899999999999999999999 9999999999999999999999999999986
Q ss_pred ccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 131 ~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
..............||+.|+|||++.+..++.++||||+|++++||++ |+.||....
T Consensus 198 ~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~ 255 (316)
T 2xir_A 198 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 255 (316)
T ss_dssp TTTCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred cccCccceeccCCCcceeecCchhhccccccchhHHHHHHHHHHHHHhCCCCCCcccc
Confidence 544333333344556889999999988889999999999999999998 999997654
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=220.26 Aligned_cols=182 Identities=20% Similarity=0.294 Sum_probs=144.7
Q ss_pred CCccccCCCcceeehhhhchhhhhc----------cCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME----------MDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMG 64 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~ 64 (202)
||++++..++..+|.|+........ ......+..|..+....+|+|++. .....++++++++++
T Consensus 52 V~~~~~~~~~~~~aiK~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg 131 (504)
T 3q5i_A 52 VLLCKEKNGHSEKAIKVIKKSQFDKGRYSDDNKNIEKFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGG 131 (504)
T ss_dssp EEEEEETTTCCEEEEEEEEC----------------CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTC
T ss_pred EEEEEECCCCcEEEEEEEEhhhcccccccccchhhHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCC
Confidence 6889998888888887754432111 122334666777788889998773 445567899999999
Q ss_pred chhhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC---ceEEeeeecceeccccCccccc
Q 044746 65 PFYLLC-KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF---FPKAADFGLAKLYNREHTHITS 140 (202)
Q Consensus 65 ~l~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~---~~kl~dfgl~~~~~~~~~~~~~ 140 (202)
+|...+ ....+++..+..++.|++.||.|||+ .+|+||||||+||+++.++ .+||+|||++........ .
T Consensus 132 ~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~ 205 (504)
T 3q5i_A 132 ELFEQIINRHKFDECDAANIMKQILSGICYLHK---HNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYK---L 205 (504)
T ss_dssp BHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSC---B
T ss_pred cHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH---CCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCc---c
Confidence 997766 44679999999999999999999999 9999999999999998765 699999999987654322 2
Q ss_pred CCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 141 TGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
....||+.|+|||++.+ .++.++||||+||++|+|++|++||.+....
T Consensus 206 ~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~~ 253 (504)
T 3q5i_A 206 RDRLGTAYYIAPEVLKK-KYNEKCDVWSCGVIMYILLCGYPPFGGQNDQ 253 (504)
T ss_dssp CCCCSCTTTCCHHHHTT-CBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccCCcCCCCHHHhcc-CCCchHHHHHHHHHHHHHHhCCCCCCCCCHH
Confidence 34568999999999874 6899999999999999999999999875543
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=6.5e-31 Score=220.77 Aligned_cols=180 Identities=21% Similarity=0.309 Sum_probs=144.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||++++..+++.||.|+...... .......+..|..+....+|+|++. ......++++++.+++|...+ ...
T Consensus 38 V~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 116 (486)
T 3mwu_A 38 VLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK 116 (486)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHH-BCSCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred EEEEEECCCCCEEEEEEEecccc-cchHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcC
Confidence 78999988888888887544322 2223445667777888889998874 344556888999999997766 456
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc---CCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~---~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ .+|+||||||+||+++ .++.+||+|||+++....... .....||+.|+
T Consensus 117 ~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~gt~~y~ 190 (486)
T 3mwu_A 117 RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYI 190 (486)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC-------CCTTGGGGC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCc---cCCCcCCCCCC
Confidence 79999999999999999999999 9999999999999995 456799999999976543321 23456899999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||++.+ .++.++||||+||++|+|++|++||.+...
T Consensus 191 aPE~~~~-~~~~~~DiwslG~il~~ll~g~~pf~~~~~ 227 (486)
T 3mwu_A 191 APEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227 (486)
T ss_dssp CGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred CHHHhCC-CCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 9999876 589999999999999999999999976554
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=99.97 E-value=5.1e-31 Score=214.11 Aligned_cols=181 Identities=19% Similarity=0.269 Sum_probs=141.4
Q ss_pred CCccccCCCcceeehhhhchhhhh-----ccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM-----EMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.||+|+.+..... ..+....+..|....... +|++++. ..+...++++++++++|..
T Consensus 110 Vy~a~~~~~g~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~ 189 (365)
T 2y7j_A 110 VRRCVHRATGHEFAVKIMEVTAERLSPEQLEEVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFD 189 (365)
T ss_dssp EEEEEETTTCCEEEEEEEETTSSCCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHH
T ss_pred EEEEEECCCCcEEEEEEEEccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHH
Confidence 789999888888888875432210 011122344555555554 7887663 3455678899999999988
Q ss_pred hhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 69 LCKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 69 ~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .....||+
T Consensus 190 ~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~~---~~~~~gt~ 263 (365)
T 2y7j_A 190 YLTEKVALSEKETRSIMRSLLEAVSFLHA---NNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGEK---LRELCGTP 263 (365)
T ss_dssp HHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSCG
T ss_pred HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEECCCCCEEEEecCcccccCCCcc---cccCCCCC
Confidence 8754 469999999999999999999999 9999999999999999999999999999987654322 23456899
Q ss_pred cccCCcccCC------CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 148 GCEAPELWMP------YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 148 ~y~aPe~~~~------~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.|+|||++.+ ..++.++||||+||++|+|++|+.||....
T Consensus 264 ~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~ 309 (365)
T 2y7j_A 264 GYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRR 309 (365)
T ss_dssp GGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred CccChhhccccccccCcCCCchhhHHhHHHHHHHHHHCCCCCCCCC
Confidence 9999999853 357889999999999999999999997643
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=4.9e-31 Score=215.23 Aligned_cols=176 Identities=21% Similarity=0.238 Sum_probs=133.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc--------ccccccc----------ccccceEEEEEcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD--------NFSNLVG----------SEDTETYIKGFLA 62 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--------~~~~~i~----------~~~~~~~~~~~~~ 62 (202)
||++++..+++.||.|+.+..... ...+..|....... +|++++. .+....++++++.
T Consensus 53 V~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~~ 128 (397)
T 1wak_A 53 VWLSWDIQGKKFVAMKVVKSAEHY----TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVLG 128 (397)
T ss_dssp EEEEEETTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCCC
T ss_pred EEEEEecCCCeEEEEEEEecCCcc----hHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEeccC
Confidence 789999888999998876433221 12233343333332 2555543 2334567778885
Q ss_pred CCchhhhhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEecCCCCcEEEcCCC---------------------
Q 044746 63 MGPFYLLCKK--NILGFGQLREIEVSTSKGIAYLHEECRQ-KIVHYDIKPESVLLDENF--------------------- 118 (202)
Q Consensus 63 ~~~l~~~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~iiHrdlk~~nil~~~~~--------------------- 118 (202)
++.+..+... ..+++..+..++.|++.||.|||+ + +|+||||||+|||++.++
T Consensus 129 ~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (397)
T 1wak_A 129 HHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHT---KCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPP 205 (397)
T ss_dssp CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECCCCSGGGEEECCCHHHHHHHHHHHC----------
T ss_pred ccHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---hCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCC
Confidence 4444444433 459999999999999999999999 8 999999999999998765
Q ss_pred ----------------------------ceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHH
Q 044746 119 ----------------------------FPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFG 170 (202)
Q Consensus 119 ----------------------------~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G 170 (202)
.++|+|||++...... .....||+.|+|||++.+..++.++||||+|
T Consensus 206 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DfG~a~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG 280 (397)
T 1wak_A 206 SGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKH-----FTEDIQTRQYRSLEVLIGSGYNTPADIWSTA 280 (397)
T ss_dssp -----------CCTTSCCTTSGGGGGGCCEEECCGGGCEETTBC-----SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHH
T ss_pred CCCccccCCcccccccccccccccccccceEecccccccccccc-----CccCCCCCcccCChhhcCCCCCcHHHHHHHH
Confidence 7999999999875432 2334679999999999998999999999999
Q ss_pred HHHHHHHcCCCCCcchhc
Q 044746 171 MLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 171 ~~l~el~~g~~p~~~~~~ 188 (202)
|++|||++|+.||.....
T Consensus 281 ~il~elltg~~pf~~~~~ 298 (397)
T 1wak_A 281 CMAFELATGDYLFEPHSG 298 (397)
T ss_dssp HHHHHHHHSSCSCCCCCC
T ss_pred HHHHHHhhCCCCCCCCcc
Confidence 999999999999986543
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-30 Score=206.93 Aligned_cols=171 Identities=20% Similarity=0.256 Sum_probs=138.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc-ccccccc--------cccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN-FSNLVGS--------EDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..+++.||.|+.+.. ....+..|..+..... |++++.. .....++++++++++|..+..
T Consensus 52 V~~~~~~~~~~~vavK~~~~~------~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~ 125 (330)
T 3nsz_A 52 VFEAINITNNEKVVVKILKPV------KKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 125 (330)
T ss_dssp EEEEEETTTCCEEEEEEECSC------CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG
T ss_pred EEEEEECCCCcEEEEEEeccc------chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH
Confidence 688998888888888875422 1234555655555554 7876631 444578899999999988875
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.++..++..++.|++.||.|||+ .+++||||||+||+++.++ .++|+|||+++....... .....|++.|+
T Consensus 126 --~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~~~~y~ 197 (330)
T 3nsz_A 126 --TLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFK 197 (330)
T ss_dssp --GCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTCC---CCSCCSCGGGC
T ss_pred --hCCHHHHHHHHHHHHHHHHHHHh---CCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCCc---ccccccccccc
Confidence 48999999999999999999999 9999999999999999776 899999999986544322 23346799999
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|||.+.+ ..++.++||||+||++++|++|+.||..
T Consensus 198 aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~p~~~ 233 (330)
T 3nsz_A 198 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFH 233 (330)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSC
T ss_pred ChhhhcCCCcCCchhhHHHHHHHHHHHHhCCCCccc
Confidence 9999877 6789999999999999999999999954
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=99.97 E-value=2.4e-31 Score=211.84 Aligned_cols=183 Identities=17% Similarity=0.239 Sum_probs=141.3
Q ss_pred CCccccC-----CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNR-----GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~-----~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++. ..+..|+.|+..... ......++..|.......+|++++. ......++++++++++|..+
T Consensus 41 Vy~~~~~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 118 (322)
T 1p4o_A 41 VYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 118 (322)
T ss_dssp EEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EEeeeecCccCCCCceEEEEEeccccc--CHHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHH
Confidence 4565554 345556666543221 1112234666777777788888763 44556789999999999888
Q ss_pred hcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc
Q 044746 70 CKK-----------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138 (202)
Q Consensus 70 ~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~ 138 (202)
+.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++.........
T Consensus 119 l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~~~ 195 (322)
T 1p4o_A 119 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195 (322)
T ss_dssp HHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEE
T ss_pred HHHhchhhccCCCCCCcCHHHHHHHHHHHHHHHHHHHH---CCCccCCCccceEEEcCCCeEEECcCccccccccccccc
Confidence 753 457999999999999999999999 999999999999999999999999999998654433333
Q ss_pred ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
......+|+.|+|||.+.+..++.++||||+|+++++|++ |+.||.....
T Consensus 196 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 246 (322)
T 1p4o_A 196 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 246 (322)
T ss_dssp GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred cccCCCCCCCccChhhhccCCCCchhhHHHHHHHHHHHHhcCCCccccCCH
Confidence 3334456889999999988889999999999999999999 8999976543
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=99.97 E-value=9.7e-31 Score=205.40 Aligned_cols=179 Identities=21% Similarity=0.257 Sum_probs=139.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++..++..++.|+..... .......+..|.......+|++++. ......++++++++++|...+.
T Consensus 38 V~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 115 (285)
T 3is5_A 38 VHLVEERSSGLERVIKTINKDR--SQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQ 115 (285)
T ss_dssp EEEEEETTTCCEEEEEEEEGGG--CCSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHH
T ss_pred EEEEEEccCCceEEEEEeeccc--cchhHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhh
Confidence 6888888888888777654332 2223445677777888888998764 3445568899999999987763
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE---cCCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.++|+|||++........ .....||
T Consensus 116 ~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~---~~~~~~t 189 (285)
T 3is5_A 116 ARGKALSEGYVAELMKQMMNALAYFHS---QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEH---STNAAGT 189 (285)
T ss_dssp HHTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC-------------CTT
T ss_pred hcccCCCHHHHHHHHHHHHHHHHHHHh---CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCccc---CcCcccc
Confidence 3569999999999999999999999 999999999999999 4567899999999986543322 2334579
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||.+. ..++.++|+||+|++++||++|+.||.....
T Consensus 190 ~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g~~pf~~~~~ 230 (285)
T 3is5_A 190 ALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSL 230 (285)
T ss_dssp GGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCcCChHHhc-cCCCcccCeehHHHHHHHHHhCCCCCCCCCH
Confidence 9999999986 4688999999999999999999999976543
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.3e-31 Score=212.92 Aligned_cols=182 Identities=20% Similarity=0.301 Sum_probs=140.8
Q ss_pred CCccccCCCcc-----eeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTR-----FITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~-----~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
||++++...++ .|+.|+...... ......+..|....... +|++++. ..+...++++++++++|..
T Consensus 62 Vy~~~~~~~~~~~~~~~vavK~~~~~~~--~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~ 139 (333)
T 2i1m_A 62 VVEATAFGLGKEDAVLKVAVKMLKSTAH--ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLN 139 (333)
T ss_dssp EEEEEETTCSSSCCCCEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred eEEEEecCCCcccchhHHHHHhcccccC--hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHH
Confidence 56777655443 466655433211 11223455666666666 7888763 3455678999999999988
Q ss_pred hhcc---------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccc
Q 044746 69 LCKK---------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR 133 (202)
Q Consensus 69 ~~~~---------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~ 133 (202)
++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.....
T Consensus 140 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~ 216 (333)
T 2i1m_A 140 FLRRKSRVLETDPAFAIANSTASTRDLLHFSSQVAQGMAFLAS---KNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMN 216 (333)
T ss_dssp HHHHHHHHHSCC-------CCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGG
T ss_pred HHHHhcccccccccccccccccCHHHHHHHHHHHHHHHHHHhc---CCcccCCcccceEEECCCCeEEECcccccccccc
Confidence 8742 358999999999999999999999 9999999999999999999999999999986544
Q ss_pred cCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 134 EHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 134 ~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
...........+|+.|+|||.+.+..++.++||||+|++++||++ |..||....
T Consensus 217 ~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~ 271 (333)
T 2i1m_A 217 DSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGIL 271 (333)
T ss_dssp CTTSEECSSCEECGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCC
T ss_pred ccceeecCCCCCCccccCHHHhccCCCChHHHHHHHHHHHHHHHcCCCCCCcccc
Confidence 433333334556889999999988889999999999999999998 999997654
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.8e-31 Score=229.48 Aligned_cols=184 Identities=21% Similarity=0.300 Sum_probs=142.4
Q ss_pred CCcc--ccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKP--RNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~--~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++ +....+..||+|+.+.... .......+..|..+....+|++++. ......++++++++|+|..++...
T Consensus 385 Vy~~~~~~~~~~~~vAvK~~~~~~~-~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~ 463 (635)
T 4fl3_A 385 VKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN 463 (635)
T ss_dssp EEEEEEECSSCEEEEEEEEECGGGG-CGGGHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC
T ss_pred EEEEEEcCCCcceEEEEEEeccccC-CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEEEccCCCCHHHHHhhC
Confidence 5777 4455667788776544322 1222355778888888889998874 223345889999999999988654
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCCcccC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTPGCEA 151 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~~y~a 151 (202)
.+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ........+|+.|+|
T Consensus 464 ~~l~~~~~~~i~~qi~~~L~yLH~---~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~A 540 (635)
T 4fl3_A 464 RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 540 (635)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC-------------CGGGSC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCccccccccCCCCceeeeC
Confidence 59999999999999999999999 9999999999999999999999999999986543322 112233456788999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||++.+..++.++|||||||++|||++ |+.||.+...
T Consensus 541 PE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 578 (635)
T 4fl3_A 541 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 578 (635)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hhhhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999998899999999999999999998 9999987554
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=1.1e-30 Score=203.72 Aligned_cols=181 Identities=18% Similarity=0.256 Sum_probs=140.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..+++.|+.|+.........+...++..|.......+|++++. ..+...++++++++++|..++.. .
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 106 (276)
T 2h6d_A 27 VKIGEHQLTGHKVAVKILNRQKIRSLDVVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHG 106 (276)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHC
T ss_pred EEEEEECCCCceEEEEEeccccccchhHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccC
Confidence 6888888778888888765544444444556777777778888888763 34456688999999999888754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .....|++.|+|||
T Consensus 107 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~y~aPE 180 (276)
T 2h6d_A 107 RVEEMEARRLFQQILSAVDYCHR---HMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF---LRTSCGSPNYAAPE 180 (276)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---HCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC----------------CCTG
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCChhhEEECCCCCEEEeecccccccCCCcc---eecccCCccccCHH
Confidence 69999999999999999999999 9999999999999999999999999999976543321 22345789999999
Q ss_pred ccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 154 LWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 154 ~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.+.+..+ +.++|+||+|+++++|++|+.||....
T Consensus 181 ~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 215 (276)
T 2h6d_A 181 VISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEH 215 (276)
T ss_dssp GGTTSCCCHHHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred HHcCCCCCCccchHHHHHHHHHHHHhCCCCCCCCc
Confidence 9987765 588999999999999999999997643
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=7.9e-31 Score=215.54 Aligned_cols=179 Identities=18% Similarity=0.227 Sum_probs=129.1
Q ss_pred CCccccC--CCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNR--GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~--~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++. ..++.||.|+.... .....+..|..++...+|+|++.. .....++++++.+ +|..++
T Consensus 37 Vy~~~~~~~~~~~~vaiK~~~~~-----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~ 110 (405)
T 3rgf_A 37 VYKAKRKDGKDDKDYALKQIEGT-----GISMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHII 110 (405)
T ss_dssp EEEEEESSSSCCCCEEEEECSSS-----SCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCSE-EHHHHH
T ss_pred EEEEEEccCCCCeEEEEEEECCC-----CCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCCC-CHHHHH
Confidence 6788854 45667776654321 112345567778888889988742 3344577777764 665555
Q ss_pred cc----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE----cCCCceEEeeeecceeccccCc
Q 044746 71 KK----------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL----DENFFPKAADFGLAKLYNREHT 136 (202)
Q Consensus 71 ~~----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~----~~~~~~kl~dfgl~~~~~~~~~ 136 (202)
.. ..+++..+..++.|++.||.|||+ .+|+||||||+|||+ +.++.+||+|||+++.......
T Consensus 111 ~~~~~~~~~~~~~~l~~~~~~~i~~qi~~al~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~ 187 (405)
T 3rgf_A 111 KFHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHA---NWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK 187 (405)
T ss_dssp HHHHHHC-------CCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-------
T ss_pred HHhccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCc
Confidence 31 249999999999999999999999 999999999999999 6778999999999986643221
Q ss_pred -ccccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 137 -HITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 137 -~~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
........||+.|+|||++.+. .++.++||||+||++|||++|++||.....
T Consensus 188 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~ 241 (405)
T 3rgf_A 188 PLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCRQE 241 (405)
T ss_dssp ---------CCCTTCCHHHHTTCCSCCHHHHHHHHHHHHHHHHHSSCTTCCCC-
T ss_pred ccccCCCceecCcccCchhhcCCCcccchhhhHHHHHHHHHHHhCCCCCCCccc
Confidence 1223345689999999999874 589999999999999999999999976544
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=2.2e-31 Score=212.82 Aligned_cols=179 Identities=21% Similarity=0.264 Sum_probs=136.6
Q ss_pred CCccccCCCccee--ehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFI--TRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++..++..+ +.|..+. ........++..|....... +|++++. ..+...++++++++++|..++.
T Consensus 41 Vy~~~~~~~~~~~~v~iK~~~~--~~~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~ 118 (327)
T 1fvr_A 41 VLKARIKKDGLRMDAAIKRMKE--YASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR 118 (327)
T ss_dssp EEEEEEEETTEEEEEEEEEEEC--C------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHH
T ss_pred EEEEEEccCCcccceeeeeecc--ccchHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHH
Confidence 6788887776654 4444322 22223344566676666666 8888763 3445668899999999998886
Q ss_pred cC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecccc
Q 044746 72 KN-----------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134 (202)
Q Consensus 72 ~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~ 134 (202)
.. .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++.....
T Consensus 119 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~ 195 (327)
T 1fvr_A 119 KSRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY 195 (327)
T ss_dssp TTCHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE
T ss_pred hcccccccccccccccccccCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCccceEEEcCCCeEEEcccCcCcccccc
Confidence 54 59999999999999999999999 99999999999999999999999999998743321
Q ss_pred CcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 135 ~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
. ......+++.|+|||.+.+..++.++||||+|++++||++ |+.||....
T Consensus 196 ~---~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 246 (327)
T 1fvr_A 196 V---KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 246 (327)
T ss_dssp C---CC----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred c---cccCCCCCccccChhhhccccCCchhcchHHHHHHHHHHcCCCCCCCCCc
Confidence 1 1222345789999999988888999999999999999998 999997654
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=99.97 E-value=1.5e-30 Score=216.69 Aligned_cols=173 Identities=23% Similarity=0.301 Sum_probs=138.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc-------cccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS-------EDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++... ++.||.|+.+.. .....|..|.......+|+|++.. .+...++++++++|+|..++...
T Consensus 209 V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~ 281 (450)
T 1k9a_A 209 VMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 281 (450)
T ss_dssp EEEEEET--TEEEEEEEESSC-----TTSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEec--CCeEEEEEeCCc-----hHHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhc
Confidence 5666654 345666654332 134457788888888899987632 22456889999999999988643
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++...... ....+++.|+
T Consensus 282 ~~~~~~~~~~~~~~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~-----~~~~~~~~y~ 353 (450)
T 1k9a_A 282 GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWT 353 (450)
T ss_dssp CTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTSCEEECCCTTCEECC-----------CCCTTTS
T ss_pred CCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEECCCCCEEEeeCCCcccccccc-----cCCCCCccee
Confidence 37999999999999999999999 999999999999999999999999999998543221 1224588999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||.+.+..++.++||||||+++|||++ |+.||.....
T Consensus 354 aPE~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 392 (450)
T 1k9a_A 354 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 392 (450)
T ss_dssp CHHHHHSSCCCHHHHHHHHHHHHHHHHTTTCCSSTTSCT
T ss_pred CHHHhcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999999899999999999999999998 9999986544
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=99.97 E-value=8.9e-31 Score=203.49 Aligned_cols=179 Identities=20% Similarity=0.330 Sum_probs=140.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++.++.. ||.|+.+.... ....+..|.......+|++++. ......++++++++++|..++..
T Consensus 24 V~~~~~~~~~~-vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 98 (268)
T 3sxs_A 24 VKLGKWKGQYD-VAVKMIKEGSM----SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHG 98 (268)
T ss_dssp EEEEEETTTEE-EEEEEECBTTB----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHG
T ss_pred EEEEEecCcee-EEEEEeccCCC----cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcC
Confidence 57777665444 55554332211 1234666777777788888763 34455789999999999888854
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ......+|+.|+||
T Consensus 99 ~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 174 (268)
T 3sxs_A 99 KGLEPSQLLEMCYDVCEGMAFLES---HQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQYV-SSVGTKFPVKWSAP 174 (268)
T ss_dssp GGCCHHHHHHHHHHHHHHHHHHHH---TTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCEE-ECCSCCCCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCcCcceEEECCCCCEEEccCccceecchhhhh-cccCCCcCcccCCH
Confidence 359999999999999999999999 99999999999999999999999999999866543322 22344567889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|+++++|++ |+.||.....
T Consensus 175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (268)
T 3sxs_A 175 EVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTN 211 (268)
T ss_dssp HHHHHSEEETTHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred HHHhccCCchhhhhHHHHHHHHHHHcCCCCCccccCh
Confidence 99988889999999999999999999 9999976543
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.97 E-value=4e-30 Score=204.05 Aligned_cols=177 Identities=19% Similarity=0.218 Sum_probs=145.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||++++..+++.|+.|+.... .....+..|.......+|++++. ..+...++++++++++|..++. .
T Consensus 45 Vy~~~~~~~~~~vaiK~~~~~-----~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 119 (314)
T 3com_A 45 VYKAIHKETGQIVAIKQVPVE-----SDLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRN 119 (314)
T ss_dssp EEEEEETTTCCEEEEEEEETT-----SCCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT
T ss_pred EEEEEECCCCCEEEEEecCch-----HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcC
Confidence 688888888888887765432 12344666777777788888763 3344578899999999998875 5
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ......|++.|+||
T Consensus 120 ~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~y~aP 194 (314)
T 3com_A 120 KTLTEDEIATILQSTLKGLEYLHF---MRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTMA--KRNTVIGTPFWMAP 194 (314)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTBS--CBCCCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhcc--ccCccCCCCCccCh
Confidence 679999999999999999999999 9999999999999999999999999999986543322 12345679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+.+..++.++|+||+|+++++|++|+.||....
T Consensus 195 E~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 229 (314)
T 3com_A 195 EVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIH 229 (314)
T ss_dssp HHHSSSCBCTTHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred hhcCCCCCCccccHHHHHHHHHHHHhCCCCCCCCC
Confidence 99998889999999999999999999999997644
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.97 E-value=2.5e-30 Score=206.83 Aligned_cols=168 Identities=21% Similarity=0.287 Sum_probs=125.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHH--HHHhcccccccccc----------ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQR--MIAADNFSNLVGSE----------DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~l~~ 68 (202)
||++++. ++.||.|+....... .+..+.. .....+|+|++... ....++++++++++|..
T Consensus 53 V~~~~~~--~~~vavK~~~~~~~~------~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 124 (337)
T 3mdy_A 53 VWMGKWR--GEKVAVKVFFTTEEA------SWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYD 124 (337)
T ss_dssp EEEEEET--TEEEEEEEEEGGGHH------HHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHH
T ss_pred EEEEEEC--CceEEEEEEeccccc------hhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHH
Confidence 5777765 556666654322211 1111222 22224788776321 34568899999999999
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCC--------CeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc--
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQ--------KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-- 138 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~--------~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-- 138 (202)
+++...+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||++..........
T Consensus 125 ~l~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~ 201 (337)
T 3mdy_A 125 YLKSTTLDAKSMLKLAYSSVSGLCHLHT---EIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDI 201 (337)
T ss_dssp HHHHCCBCHHHHHHHHHHHHHHHHHHHS---CBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC--------
T ss_pred HhhccCCCHHHHHHHHHHHHHHHHHHHH---hhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccC
Confidence 9998899999999999999999999998 6 99999999999999999999999999997654332211
Q ss_pred ccCCCCCCCcccCCcccCCCCCCch------hhHHHHHHHHHHHHcC
Q 044746 139 TSTGRRRTPGCEAPELWMPYSVTQK------CDVFSFGMLLFEVVGR 179 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~~~~~------~Diws~G~~l~el~~g 179 (202)
......||+.|+|||++.+...+.. +|||||||++|||++|
T Consensus 202 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~il~el~tg 248 (337)
T 3mdy_A 202 PPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARR 248 (337)
T ss_dssp -CCSSCSCGGGCCHHHHTTCCCTTCTHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCCCCccCcceeChhhcccccCCccccCccccchHHHHHHHHHHHhc
Confidence 1234568999999999987665554 9999999999999999
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=204.37 Aligned_cols=178 Identities=20% Similarity=0.298 Sum_probs=142.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc----------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS----------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~----------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++..++..|+.|+....... ......+..|.......+|++++.. .....++++++++++|..++
T Consensus 42 Vy~~~~~~~~~~va~k~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 120 (290)
T 1t4h_A 42 VYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120 (290)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHH
T ss_pred EEEeEecCCceEEEEEEecchhhC-HHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHH
Confidence 688988888888887765433211 1223456677777788889987742 23356888999999999988
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCcEEEc-CCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQK--IVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--iiHrdlk~~nil~~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.. ..+++..+..++.|++.||.|||+ .+ ++||||||+||+++ .++.++|+|||++....... .....||
T Consensus 121 ~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~t 193 (290)
T 1t4h_A 121 KRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 193 (290)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSS
T ss_pred HHccCCCHHHHHHHHHHHHHHHHHHHc---CCCCEEECCCCHHHEEEECCCCCEEEeeCCCcccccccc----cccccCC
Confidence 66 679999999999999999999999 78 99999999999997 78999999999997543322 1234579
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.|+|||.+.+ .++.++|+||+|+++++|++|+.||....
T Consensus 194 ~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~pf~~~~ 233 (290)
T 1t4h_A 194 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 233 (290)
T ss_dssp CCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred cCcCCHHHHhc-cCCCcchHHHHHHHHHHHHhCCCCCCCcC
Confidence 99999998875 58999999999999999999999997643
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=204.32 Aligned_cols=183 Identities=17% Similarity=0.205 Sum_probs=141.7
Q ss_pred CCccccCCCcceeehhhhchhhhhc-cCCcccCCcHHHHHHhcccccccc--------ccccceEEEEEccCCchhhhh-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME-MDKPIRFTSPQRMIAADNFSNLVG--------SEDTETYIKGFLAMGPFYLLC- 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~i~--------~~~~~~~~~~~~~~~~l~~~~- 70 (202)
||++++..+++.++.|+.+...... ......+..|.......+|++++. ......++++++.++ +..++
T Consensus 21 V~~~~~~~~~~~~avK~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~ 99 (305)
T 2wtk_C 21 VKEVLDSETLCRRAVKILKKKKLRRIPNGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLD 99 (305)
T ss_dssp EEEEEBTTTCCEEEEEEECHHHHHHSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHH
T ss_pred EEEEEECCCCcEEEEEEeccccccccchhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHH
Confidence 6888888888888887755443222 233445777777778888888763 223456888888877 43333
Q ss_pred --ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 71 --KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 71 --~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++................||+.
T Consensus 100 ~~~~~~~~~~~~~~~~~qi~~al~~LH~---~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~ 176 (305)
T 2wtk_C 100 SVPEKRFPVCQAHGYFCQLIDGLEYLHS---QGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTCRTSQGSPA 176 (305)
T ss_dssp HSTTCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCSSCEECCCCSCGG
T ss_pred hCcccccCHHHHHHHHHHHHHHHHHHHH---CCeeecCCCcccEEEcCCCcEEeeccccccccCccccccccccCCCCCC
Confidence 34569999999999999999999999 9999999999999999999999999999987643322223344567999
Q ss_pred ccCCcccCCCC--CCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYS--VTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~--~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+.. ++.++|+||+|++++||++|+.||....
T Consensus 177 y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 217 (305)
T 2wtk_C 177 FQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDN 217 (305)
T ss_dssp GCCHHHHTCCSCEESHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred CcChhhccCcccCCcchhhHHHHHHHHHHHHhCCCCCCCch
Confidence 99999987644 3779999999999999999999998654
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=9e-31 Score=210.94 Aligned_cols=181 Identities=18% Similarity=0.238 Sum_probs=140.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||++++..+++.||.|+...... .....++..|.......+|++++... ....++++++. ++|..+
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~ 103 (353)
T 2b9h_A 27 VCSATHKPTGEIVAIKKIEPFDK--PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRV 103 (353)
T ss_dssp EEEEEETTTTEEEEEEEECCCSS--HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHH
T ss_pred EEEEEECCCCcEEEEEeeccccc--chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHH
Confidence 68888888888888776532211 11123455677777778899876321 34457777776 688888
Q ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc--------ccC
Q 044746 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI--------TST 141 (202)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~--------~~~ 141 (202)
+....+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......... ...
T Consensus 104 ~~~~~~~~~~~~~~~~qi~~~L~~LH~---~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~ 180 (353)
T 2b9h_A 104 ISTQMLSDDHIQYFIYQTLRAVKVLHG---SNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMV 180 (353)
T ss_dssp HHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------C
T ss_pred HhhcCCCHHHHHHHHHHHHHHHHHHHH---CCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchh
Confidence 888889999999999999999999999 999999999999999999999999999998754321111 122
Q ss_pred CCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 142 GRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
...||+.|+|||++.. ..++.++|+||+||++++|++|++||.+..
T Consensus 181 ~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 227 (353)
T 2b9h_A 181 EFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPGRD 227 (353)
T ss_dssp CCCCCGGGCCHHHHHSCCCCCHHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred hccccccccCCeeeccCCCccchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 3467999999998754 678999999999999999999999998654
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.5e-31 Score=209.80 Aligned_cols=182 Identities=21% Similarity=0.224 Sum_probs=139.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.||.|+....... ......+..|.......+|++++. ..+...+++++++++++..+.. ..
T Consensus 41 V~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 119 (331)
T 4aaa_A 41 VMKCRNKDTGRIVAIKKFLESDDD-KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPN 119 (331)
T ss_dssp EEEEEETTTCCEEEEEEEESCSSC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTT
T ss_pred EEEEEECCCCceEEEEEEecCCCc-hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhcc
Confidence 688999888888888764322111 111223456666777788888763 3444568899999998887754 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ......||+.|+|||
T Consensus 120 ~~~~~~~~~~~~qi~~~l~~LH~---~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~t~~y~aPE 194 (331)
T 4aaa_A 120 GLDYQVVQKYLFQIINGIGFCHS---HNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPGE--VYDDEVATRWYRAPE 194 (331)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCTTC--------------CCCCCTTCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCEEccCcChheEEEcCCCcEEEEeCCCceeecCCcc--ccCCCcCCccccCcc
Confidence 69999999999999999999999 9999999999999999999999999999976543222 123346799999999
Q ss_pred ccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+. .++.++||||+|+++++|++|++||.....
T Consensus 195 ~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 230 (331)
T 4aaa_A 195 LLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSD 230 (331)
T ss_dssp HHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccCCCCcchHHHHHHHHHHHHHHHhCCCCCCCCCc
Confidence 99875 688999999999999999999999987654
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.2e-31 Score=208.88 Aligned_cols=181 Identities=22% Similarity=0.321 Sum_probs=144.5
Q ss_pred CccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhccC
Q 044746 2 EKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 2 ~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
|++.+...++.||.|+.+... .......+..|.......+|++++.. .....++++++++++|..++...
T Consensus 52 ~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 129 (318)
T 3lxp_A 52 YDPTNDGTGEMVAVKALKADA--GPQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH 129 (318)
T ss_dssp ECSCC--CCEEEEEEEECTTC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS
T ss_pred EccCCCCCCcEEEEEEecccc--ChHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC
Confidence 566777788888888754331 11223446677777888889987742 23346889999999999999998
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCCcccCC
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .......+|+.|+||
T Consensus 130 ~~~~~~~~~i~~~l~~~l~~LH~---~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aP 206 (318)
T 3lxp_A 130 SIGLAQLLLFAQQICEGMAYLHA---QHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAP 206 (318)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEEcCCCCEEECCccccccccccccccccccCCCCCceeeCh
Confidence 99999999999999999999999 99999999999999999999999999999876543221 122334568889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|.+.+..++.++||||+|+++++|++|+.||....
T Consensus 207 E~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~ 241 (318)
T 3lxp_A 207 ECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPP 241 (318)
T ss_dssp HHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHH
T ss_pred HHhcCCCCCcHHHHHHHHHHHHHHHhCCCcccccc
Confidence 99988888999999999999999999999997643
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=202.16 Aligned_cols=173 Identities=19% Similarity=0.229 Sum_probs=141.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc----------------------ccceEEE
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE----------------------DTETYIK 58 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------------------~~~~~~~ 58 (202)
||++++..+++.|+.|+.+... ..+..|.......+|++++... ....+++
T Consensus 27 V~~~~~~~~~~~vavK~~~~~~-------~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~ 99 (284)
T 2a19_B 27 VFKAKHRIDGKTYVIKRVKYNN-------EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99 (284)
T ss_dssp EEEEEETTTCCEEEEEEEECCS-------GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEE
T ss_pred EEEEEEcCCCeEEEEEEecccc-------HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEE
Confidence 6888888777777777653321 2455677777788899877432 2246788
Q ss_pred EEccCCchhhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC
Q 044746 59 GFLAMGPFYLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH 135 (202)
Q Consensus 59 ~~~~~~~l~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~ 135 (202)
+++++++|..++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......
T Consensus 100 e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~ 176 (284)
T 2a19_B 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHS---KKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG 176 (284)
T ss_dssp CCCCSCBHHHHHHHGGGSCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS
T ss_pred eccCCCCHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCCHHHEEEcCCCCEEECcchhheeccccc
Confidence 89999999988843 469999999999999999999999 999999999999999999999999999998765432
Q ss_pred cccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 136 THITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 136 ~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
. .....|++.|+|||.+.+..++.++|+||+|+++++|++|..|+...
T Consensus 177 ~---~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 224 (284)
T 2a19_B 177 K---RTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLHVCDTAFET 224 (284)
T ss_dssp C---CCCCCSCCTTSCHHHHHCSCCCTHHHHHHHHHHHHHHHSCCSSHHHH
T ss_pred c---ccccCCcccccChhhhccCCCcchhhhHHHHHHHHHHHhcCCcchhH
Confidence 2 23345799999999999888999999999999999999999998653
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=5.1e-31 Score=214.79 Aligned_cols=183 Identities=20% Similarity=0.272 Sum_probs=129.8
Q ss_pred CCccccCCC---cceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc-------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGS---TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS-------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~---~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||+++.... ...|++|..+.. .......+|..|..+....+|+|++.. .+...++++++++++|..++
T Consensus 105 Vy~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l 182 (373)
T 3c1x_A 105 VYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 182 (373)
T ss_dssp EEEEEEEETTTEEEEEEEEECCSC--SCSHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEEcCCC--CCHHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHH
Confidence 566665332 234555543321 111223446667667777788887632 23456899999999999998
Q ss_pred cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc--cccCCCCCC
Q 044746 71 KK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH--ITSTGRRRT 146 (202)
Q Consensus 71 ~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~--~~~~~~~gt 146 (202)
.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++........ .......+|
T Consensus 183 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~ 259 (373)
T 3c1x_A 183 RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 259 (373)
T ss_dssp HCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC---------------------CC
T ss_pred hhcccCCCHHHHHHHHHHHHHHHHHHHH---CCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCc
Confidence 65 358999999999999999999999 99999999999999999999999999999865332211 112334567
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
+.|+|||.+.+..++.++||||||+++|||++ |.+||.....
T Consensus 260 ~~y~aPE~~~~~~~~~~~DvwSlG~il~ellt~~~~p~~~~~~ 302 (373)
T 3c1x_A 260 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 302 (373)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCS
T ss_pred ccccChHHhcCCCCCcHHHHHHHHHHHHHHHhCcCCCCCCCCH
Confidence 89999999998899999999999999999999 7888876543
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=206.35 Aligned_cols=182 Identities=17% Similarity=0.252 Sum_probs=134.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++..+++.||.|+.+...........++..|.......+|++++. ..+...++++++++++|..++.
T Consensus 48 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 127 (310)
T 2wqm_A 48 VYRAACLLDGVPVALKKVQIFDLMDAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFK 127 (310)
T ss_dssp EEEEEETTTCCEEEEEEECTTSSCCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHH
T ss_pred EEEEEEcCCCceEEEEeeehhhccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhc
Confidence 6888887777888877654322222222344666777777888888764 3345568899999999988774
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
...+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ......|++.|
T Consensus 128 ~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y 202 (310)
T 2wqm_A 128 KQKRLIPERTVWKYFVQLCSALEHMHS---RRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT--AAHSLVGTPYY 202 (310)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCC--------------------CCSS
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHhh---CCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCCc--cccccCCCeeE
Confidence 3569999999999999999999999 9999999999999999999999999999876543221 12234579999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+|||.+.+..++.++|+||||+++++|++|+.||.+..
T Consensus 203 ~aPE~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~~~~ 240 (310)
T 2wqm_A 203 MSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDK 240 (310)
T ss_dssp CCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTC---
T ss_pred eChHHhCCCCCCchhhHHHHHHHHHHHHhCCCCCcccc
Confidence 99999999899999999999999999999999997543
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=205.37 Aligned_cols=183 Identities=21% Similarity=0.281 Sum_probs=136.2
Q ss_pred CCccccCCCc---ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-------ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGST---RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-------SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~---~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++...+ ..++.|..... ........+..|.......+|++++. ..+...++++++++++|..++
T Consensus 41 Vy~~~~~~~~~~~~~~avk~~~~~--~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l 118 (298)
T 3f66_A 41 VYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 118 (298)
T ss_dssp EEEEEEC-----CEEEEEEEETTC--CSHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHH
T ss_pred EEEEEEecCCCceeEEEEEecccC--CCHHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHH
Confidence 5777654332 23455443321 11122344667777778888998763 233456899999999999988
Q ss_pred cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc--ccccCCCCCC
Q 044746 71 KK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT--HITSTGRRRT 146 (202)
Q Consensus 71 ~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~--~~~~~~~~gt 146 (202)
.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....... ........+|
T Consensus 119 ~~~~~~~~~~~~~~i~~ql~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~ 195 (298)
T 3f66_A 119 RNETHNPTVKDLIGFGLQVAKGMKYLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLP 195 (298)
T ss_dssp HCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBC
T ss_pred HhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCC
Confidence 54 458999999999999999999999 9999999999999999999999999999986543321 1223345568
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
+.|+|||.+.+..++.++|+||+|++++++++ |.+||.....
T Consensus 196 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~ 238 (298)
T 3f66_A 196 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNT 238 (298)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTSCT
T ss_pred ccccChHHhcCCCCChHHHHHHHHHHHHHHHhCCCCCCccCCH
Confidence 89999999988889999999999999999999 6666665443
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.6e-31 Score=214.95 Aligned_cols=179 Identities=20% Similarity=0.238 Sum_probs=144.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||++++..++..||+|+..... .......+..|.......+|++++. ..+...++++++++++|..++.. .
T Consensus 49 V~~~~~~~~~~~va~K~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 126 (360)
T 3eqc_A 49 VFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 126 (360)
T ss_dssp EEEEEETTTCCEEEEEEEECCC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHS
T ss_pred EEEEEECCCCcEEEEEEecccc--CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcC
Confidence 6889999888889888754321 1112234666666777778888764 34455688999999999988865 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQ-KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~-~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ . +++||||||+||+++.++.++|+|||++....... .....||+.|+||
T Consensus 127 ~~~~~~~~~i~~~i~~~l~~lh~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~gt~~y~aP 199 (360)
T 3eqc_A 127 RIPEQILGKVSIAVIKGLTYLRE---KHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSP 199 (360)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---HHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHC--------CCCCTTCCH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---hCCEEcCCccHHHEEECCCCCEEEEECCCCccccccc----ccCCCCCCCeECH
Confidence 69999999999999999999998 5 89999999999999999999999999987543221 2334679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|++.+..++.++||||+|+++++|++|+.||.....
T Consensus 200 E~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 235 (360)
T 3eqc_A 200 ERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 235 (360)
T ss_dssp HHHTTCCCSHHHHHHHHHHHHHHHHHTSCCSSCCCH
T ss_pred HHHcCCCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 999999999999999999999999999999976543
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=204.68 Aligned_cols=180 Identities=24% Similarity=0.318 Sum_probs=137.1
Q ss_pred CCccccCCCcc---eeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc-------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTR---FITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS-------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++..... .++.|+..... .......+..|.......+|++++.. .....++++++.+++|..++
T Consensus 37 Vy~~~~~~~~~~~~~~aiK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~ 114 (298)
T 3pls_A 37 VYHGEYIDQAQNRIQCAIKSLSRIT--EMQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFI 114 (298)
T ss_dssp EEEEEEECSSSCEEEEEEEEETTCC--SHHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHH
T ss_pred EEEEEEecCCCceeeeeeeeccccc--cHHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHH
Confidence 57776543333 55655543221 11223456677777788889987742 22336889999999999988
Q ss_pred cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc--ccccCCCCCC
Q 044746 71 KK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT--HITSTGRRRT 146 (202)
Q Consensus 71 ~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~--~~~~~~~~gt 146 (202)
.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++....... ........++
T Consensus 115 ~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 191 (298)
T 3pls_A 115 RSPQRNPTVKDLISFGLQVARGMEYLAE---QKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLP 191 (298)
T ss_dssp HCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCG
T ss_pred hccccCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCC
Confidence 65 568999999999999999999999 9999999999999999999999999999985543221 1122344568
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCC-CCcc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR-NLEK 185 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~-p~~~ 185 (202)
+.|+|||.+.+..++.++|+||+|+++++|++|.. ||..
T Consensus 192 ~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~~~~~~ 231 (298)
T 3pls_A 192 VKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRH 231 (298)
T ss_dssp GGGSCHHHHTTCCCCHHHHHHHHHHHHHHHHHTSCCTTTT
T ss_pred ccccChhhhccCCCChhhchhhHHHHHHHHhhCCCCCCcc
Confidence 89999999999999999999999999999999554 4443
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.6e-30 Score=205.23 Aligned_cols=181 Identities=22% Similarity=0.253 Sum_probs=142.3
Q ss_pred CCccc----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhh
Q 044746 1 MEKPR----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~ 68 (202)
||+++ +...++.||.|+.+... .......+..|.......+|++++.. +....++++++++++|..
T Consensus 37 V~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 114 (302)
T 4e5w_A 37 VELCRYDPEGDNTGEQVAVKSLKPES--GGNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKE 114 (302)
T ss_dssp EEEEEECTTSSSCSEEEEEEEEC-------CCHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHH
T ss_pred EEEEEEccccCccCeEEEEEEecccc--cchhHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHH
Confidence 56666 66777888877754332 22233456677777888889987642 133468899999999999
Q ss_pred hhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCC
Q 044746 69 LCK--KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRR 145 (202)
Q Consensus 69 ~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~g 145 (202)
++. ...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .......|
T Consensus 115 ~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 191 (302)
T 4e5w_A 115 YLPKNKNKINLKQQLKYAVQICKGMDYLGS---RQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTVKDDRDS 191 (302)
T ss_dssp HHHHHTTTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCCEEECCCCTTC
T ss_pred HHHhccccCCHHHHHHHHHHHHHHHHHhhc---CCcccCCCchheEEEcCCCCEEECcccccccccCCCcceeccCCCCC
Confidence 883 3469999999999999999999999 99999999999999999999999999999876543322 22334567
Q ss_pred CCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
|..|+|||.+.+..++.++|+||+|+++++|++|..|+...
T Consensus 192 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~ 232 (302)
T 4e5w_A 192 PVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSP 232 (302)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSH
T ss_pred CccccCCeeecCCCCCcchhHHHHHHHHHHHHHccCCCcch
Confidence 88899999998888899999999999999999999986543
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=203.36 Aligned_cols=176 Identities=16% Similarity=0.179 Sum_probs=136.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++++..+++.|+.|+.+....... ....+..+....... +|++++. ..+...++++++++++|..++..
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~~~~~-~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 105 (289)
T 1x8b_A 27 VFKCVKRLDGCIYAIKRSKKPLAGSV-DEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISEN 105 (289)
T ss_dssp EEEEEETTTCCEEEEEEEECCCTTSH-HHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEEcCCCceEEEEEecccccccH-HHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhh
Confidence 68899988888888887543221111 122344454444444 8888763 34455688999999999988854
Q ss_pred ----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-------------------CCceEEeeeecce
Q 044746 73 ----NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-------------------NFFPKAADFGLAK 129 (202)
Q Consensus 73 ----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-------------------~~~~kl~dfgl~~ 129 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++. ...++|+|||++.
T Consensus 106 ~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~ 182 (289)
T 1x8b_A 106 YRIMSYFKEAELKDLLLQVGRGLRYIHS---MSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVT 182 (289)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEC--------------------CCCEEECCCTTCE
T ss_pred cccccCCCHHHHHHHHHHHHHHHHHHHh---CCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEccccccc
Confidence 569999999999999999999999 99999999999999984 4478999999998
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
..... ....||+.|+|||.+.+. .++.++||||+|+++++|++|.+|+...
T Consensus 183 ~~~~~------~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~ 234 (289)
T 1x8b_A 183 RISSP------QVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNG 234 (289)
T ss_dssp ETTCS------CCCCCCGGGCCHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSS
T ss_pred ccCCc------cccCCCccccChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcch
Confidence 65432 223479999999999865 5668999999999999999999876543
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.2e-31 Score=204.91 Aligned_cols=179 Identities=19% Similarity=0.317 Sum_probs=140.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++.++.. ||.|+.+.... ....+..|.......+|++++. ......++++++++++|..++..
T Consensus 40 V~~~~~~~~~~-vavK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 114 (283)
T 3gen_A 40 VKYGKWRGQYD-VAIKMIKEGSM----SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 114 (283)
T ss_dssp EEEEEETTTEE-EEEEEECTTSB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGG
T ss_pred EEEEEEcCCCe-EEEEEecCCCC----CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhc
Confidence 56776664444 45544332211 1234666777777888888763 34455688999999999998865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ .......+|+.|+||
T Consensus 115 ~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~y~aP 190 (283)
T 3gen_A 115 HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPP 190 (283)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHHH-HSTTSTTSCGGGCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHH---CCccCCCCccceEEEcCCCCEEEcccccccccccccc-ccccCCccCcccCCH
Confidence 579999999999999999999999 9999999999999999999999999999986543221 122334567889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|+++++|++ |+.||.....
T Consensus 191 E~~~~~~~~~~~Dv~slG~~l~~l~t~g~~p~~~~~~ 227 (283)
T 3gen_A 191 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTN 227 (283)
T ss_dssp HHHHHCCCSHHHHHHHHHHHHHHHHTTTCCTTTTSCH
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCccccCh
Confidence 99988889999999999999999998 9999976543
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.2e-30 Score=205.65 Aligned_cols=182 Identities=19% Similarity=0.264 Sum_probs=140.0
Q ss_pred CCccccCCCcceeehhhhchhhh-----hccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDA-----MEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++..+++.||.|+...... ........+..|.......+|++++. ......++++++++++|..++
T Consensus 26 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~~ 105 (322)
T 2ycf_A 26 VKLAFERKTCKKVAIKIISKRKFAIGSAREADPALNVETEIEILKKLNHPCIIKIKNFFDAEDYYIVLELMEGGELFDKV 105 (322)
T ss_dssp EEEEEETTTTEEEEEEEECC---------------CHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEETHHHH
T ss_pred EEEEEEcCCCcEEEEEEeehhhhhhcccccchhhhhHHHHHHHHHhCCCCCCceEeeEEcCCceEEEEecCCCCcHHHHH
Confidence 68899988888888877543221 11222345667777788889998764 223356889999999998877
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC---ceEEeeeecceeccccCcccccCCCCCC
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF---FPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~---~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++ .+||+|||++........ .....||
T Consensus 106 ~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt 179 (322)
T 2ycf_A 106 VGNKRLKEATCKLYFYQMLLAVQYLHE---NGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSL---MRTLCGT 179 (322)
T ss_dssp STTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHH---HHHHHSC
T ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHHHEEEecCCCCCeEEEccCccceecccccc---cccccCC
Confidence 54 469999999999999999999999 9999999999999998655 499999999987543221 1223569
Q ss_pred CcccCCcccC---CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWM---PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~---~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||++. ...++.++||||+|+++++|++|+.||.....
T Consensus 180 ~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (322)
T 2ycf_A 180 PTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRT 224 (322)
T ss_dssp CTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSSCSSCSTTC
T ss_pred cCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCCcccch
Confidence 9999999973 45788999999999999999999999976543
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.9e-30 Score=207.73 Aligned_cols=179 Identities=17% Similarity=0.137 Sum_probs=134.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc-------------cceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED-------------TETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-------------~~~~~~~~~~~~~l~ 67 (202)
||++++..+++.||.|+..... ....++..+.......+|+|++...+ +..+++++++++.+.
T Consensus 39 V~~~~~~~~~~~vavK~~~~~~----~~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~ 114 (360)
T 3e3p_A 39 VQLGKEKSTGMSVAIKKVIQDP----RFRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPDTLHR 114 (360)
T ss_dssp CEEEEETTTCCEEEEEEEECCT----TCCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSCBHHH
T ss_pred EEEEEECCCCCEEEEEEEecCc----cccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccccHHH
Confidence 7899998888888887643221 11122333333445567888764221 145778888865332
Q ss_pred hhh----ccCCCCHHHHHHHHHHHHHHHHHHH--hCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCccccc
Q 044746 68 LLC----KKNILGFGQLREIEVSTSKGIAYLH--EECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITS 140 (202)
Q Consensus 68 ~~~----~~~~~~~~~~~~~~~~i~~~l~~lH--~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~ 140 (202)
.+. ....+++..+..++.|++.||.||| + .+|+||||||+||+++. ++.+||+|||+++....... .
T Consensus 115 ~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~---~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~~---~ 188 (360)
T 3e3p_A 115 CCRNYYRRQVAPPPILIKVFLFQLIRSIGCLHLPS---VNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSEP---N 188 (360)
T ss_dssp HHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHTSTT---TCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTSC---C
T ss_pred HHHHHhhcccCCCHHHHHHHHHHHHHHHHHHhCCC---CCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCCC---c
Confidence 222 3456899999999999999999999 8 99999999999999996 89999999999986554322 2
Q ss_pred CCCCCCCcccCCcccCCCC-CCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 141 TGRRRTPGCEAPELWMPYS-VTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 141 ~~~~gt~~y~aPe~~~~~~-~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
....||+.|+|||++.+.. ++.++||||+||+++||++|++||......
T Consensus 189 ~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~ell~g~~pf~~~~~~ 238 (360)
T 3e3p_A 189 VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238 (360)
T ss_dssp CSTTSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred ccccCCcceeCHHHHcCCCCCCcHHHHHHHHHHHHHHHhCCCCcCCCChH
Confidence 3346799999999987654 899999999999999999999999876543
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=204.29 Aligned_cols=182 Identities=19% Similarity=0.207 Sum_probs=137.5
Q ss_pred CCccccC---CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNR---GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~---~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++. +.+..|+.|+..... ......++..|.......+|++++. ..+...++++++++++|..++..
T Consensus 28 Vy~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~ 105 (281)
T 3cc6_A 28 VYEGVYTNHKGEKINVAVKTCKKDC--TLDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEEPTWIIMELYPYGELGHYLER 105 (281)
T ss_dssp EEEEEEECTTCCEEEEEEEECCTTS--CHHHHHHHHHHHHHHHHHCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHH
T ss_pred EEEeEEcCCCCCcceEEEEeccccc--CchHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCEEEEecCCCCCHHHHHHh
Confidence 5676643 233456666543321 1122345667777777778898763 23345688999999999988854
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ......+++.|+
T Consensus 106 ~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~ 181 (281)
T 3cc6_A 106 NKNSLKVLTLVLYSLQICKAMAYLES---INCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDYY-KASVTRLPIKWM 181 (281)
T ss_dssp HTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEEETTEEEECCCCGGGCC----------CCCCCGGGC
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCccceEEECCCCcEEeCccCCCccccccccc-ccccCCCCccee
Confidence 359999999999999999999999 99999999999999999999999999999865433221 123345688999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||.+.+..++.++|+||+|++++||++ |+.||.....
T Consensus 182 aPE~~~~~~~~~~~Di~slG~il~~llt~g~~p~~~~~~ 220 (281)
T 3cc6_A 182 SPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLEN 220 (281)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCG
T ss_pred CchhhccCCCCchhccHHHHHHHHHHHhCCCCCcccCCh
Confidence 9999988889999999999999999998 9999975443
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=8.9e-31 Score=225.62 Aligned_cols=183 Identities=17% Similarity=0.257 Sum_probs=139.9
Q ss_pred CCccccC--CCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc-----cccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNR--GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS-----EDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~--~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-----~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||++..+ ..+..||+|+.+.. ........|..|..+....+|+|++.. .....++++++.+|+|..++..
T Consensus 352 Vy~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~il~~l~hpniv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~~ 429 (613)
T 2ozo_A 352 VRQGVYRMRKKQIDVAIKVLKQG--TEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK 429 (613)
T ss_dssp EEEEEEECSSCEEEEEEEECCCC--CSSTTHHHHHHHHHHHTTCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHTTC
T ss_pred EEEEEEecCCCcEEEEEEEcCCC--CChHHHHHHHHHHHHHHhCCCCCEeeEEEEeccCCeEEEEEeCCCCcHHHHHhhc
Confidence 5666543 34556777765432 122234557778888888899988742 2345689999999999988853
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCccc
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCE 150 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~ 150 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......... ......+++.|+
T Consensus 430 ~~~l~~~~~~~i~~qi~~~L~~LH~---~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~ 506 (613)
T 2ozo_A 430 REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 506 (613)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC--------------CCTTS
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCceeeeccCCCCcccee
Confidence 459999999999999999999999 999999999999999999999999999998654332211 122234568899
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||++....++.++|||||||++|||++ |+.||.....
T Consensus 507 APE~~~~~~~~~~sDvwSlGv~l~ellt~G~~Pf~~~~~ 545 (613)
T 2ozo_A 507 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 545 (613)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCS
T ss_pred CHhhhcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCCH
Confidence 9999988899999999999999999998 9999987544
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.1e-30 Score=217.70 Aligned_cols=179 Identities=26% Similarity=0.364 Sum_probs=137.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--- 72 (202)
||++++.+... ||.|+.+... .....|..|..+....+|++++. ......++++++++|+|..++..
T Consensus 200 Vy~~~~~~~~~-vavK~~~~~~----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~iv~e~~~~gsL~~~l~~~~~ 274 (452)
T 1fmk_A 200 VWMGTWNGTTR-VAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETG 274 (452)
T ss_dssp EEEEEETTTEE-EEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHH
T ss_pred EEEEEECCCce-EEEEEeccCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEcCCceEEEehhhcCCCHHHHHHhcCC
Confidence 67777766544 5555443221 12345777888888889998763 22445689999999999998864
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ ++++||||||+|||++.++.+||+|||+++........ ......+++.|+||
T Consensus 275 ~~~~~~~~~~i~~qi~~~l~~LH~---~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~-~~~~~~~~~~y~aP 350 (452)
T 1fmk_A 275 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAP 350 (452)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChhhEEECCCCCEEECCCccceecCCCcee-cccCCcccccccCH
Confidence 459999999999999999999999 99999999999999999999999999999865432211 12334457889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+....++.++||||||+++|||++ |+.||.+...
T Consensus 351 E~~~~~~~~~~sDvwslG~~l~el~t~g~~P~~~~~~ 387 (452)
T 1fmk_A 351 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 387 (452)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hHHhcCCCCccccHHhHHHHHHHHHhCCCCCCCCCCH
Confidence 99988889999999999999999999 9999976543
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-30 Score=211.29 Aligned_cols=176 Identities=19% Similarity=0.226 Sum_probs=136.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------c------ceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------T------ETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------~------~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.||.|+....... .....++..|.......+|+|++...+ . ..++++++. ++|..
T Consensus 58 Vy~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 135 (371)
T 4exu_A 58 VCSAIDKRSGEKVAIKKLSRPFQS-EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQK 135 (371)
T ss_dssp EEEEEETTTTEEEEEEEECSTTSS-HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHH
T ss_pred EEEEEECCCCCEEEEEEecccccc-hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHH
Confidence 688999888888888765432111 112344566777778888998774211 1 167777777 57777
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
... ..+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.++|+|||+++..... .....||+.
T Consensus 136 ~~~-~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~-----~~~~~~t~~ 206 (371)
T 4exu_A 136 IMG-MEFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRW 206 (371)
T ss_dssp HTT-SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECSTTCC-------------CTTCCCT
T ss_pred Hhh-cCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCcCHHHeEECCCCCEEEEecCcccccccC-----cCCcccCcc
Confidence 664 459999999999999999999999 99999999999999999999999999999864332 234567999
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+ ..++.++||||+||++++|++|+.||.+..
T Consensus 207 y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~ 246 (371)
T 4exu_A 207 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 246 (371)
T ss_dssp TSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred ccCHHHhcCCCCCCcHHhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999887 678999999999999999999999998654
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=99.96 E-value=5.2e-30 Score=204.26 Aligned_cols=180 Identities=21% Similarity=0.296 Sum_probs=136.4
Q ss_pred CCccccC-CCcceeehhhhchhhhhccCCcccCCcHHHHHHh---ccccccccc-----------cccceEEEEEccCCc
Q 044746 1 MEKPRNR-GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA---DNFSNLVGS-----------EDTETYIKGFLAMGP 65 (202)
Q Consensus 1 v~k~~~~-~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~i~~-----------~~~~~~~~~~~~~~~ 65 (202)
||++++. .+++.||.|+.+..... ......+..|...... .+|++++.. .....++++++. ++
T Consensus 27 V~~~~~~~~~~~~vavK~~~~~~~~-~~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 104 (326)
T 1blx_A 27 VFKARDLKNGGRFVALKRVRVQTGE-EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QD 104 (326)
T ss_dssp EEEEEETTTTTEEEEEEEEEEEBCT-TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CB
T ss_pred EEEEEecCCCCEEEEEEEeccCccc-ccCCchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CC
Confidence 6888884 66777887765433221 1112233334333332 378877642 233457777777 68
Q ss_pred hhhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 66 FYLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 66 l~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
|..++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++...... ....
T Consensus 105 L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~ 178 (326)
T 1blx_A 105 LTTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTS 178 (326)
T ss_dssp HHHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCC
T ss_pred HHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCceeccCCHHHeEEcCCCCEEEecCcccccccCCC---Cccc
Confidence 8777754 349999999999999999999999 999999999999999999999999999998654322 2234
Q ss_pred CCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
..||+.|+|||++.+..++.++||||+|+++++|++|++||.....
T Consensus 179 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 224 (326)
T 1blx_A 179 VVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224 (326)
T ss_dssp CCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cccccceeCHHHHhcCCCCcchhHHHHHHHHHHHHcCCCCCCCCCH
Confidence 5679999999999988999999999999999999999999986543
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.5e-30 Score=206.81 Aligned_cols=181 Identities=18% Similarity=0.217 Sum_probs=141.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc----------ccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE----------DTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++...++.||.|+...... .....+..|.......+|++++... ....++++++.+++|..++
T Consensus 45 V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l 121 (317)
T 2buj_A 45 VDLVEGLHDGHFYALKRILCHEQ---QDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEI 121 (317)
T ss_dssp EEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHH
T ss_pred EEEEEecCCCcEEEEEEEecCCH---HHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHH
Confidence 68888888888888876433211 1233466777777888899876432 2445889999999998877
Q ss_pred cc-----CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-------
Q 044746 71 KK-----NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI------- 138 (202)
Q Consensus 71 ~~-----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~------- 138 (202)
.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++..........
T Consensus 122 ~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 198 (317)
T 2buj_A 122 ERLKDKGNFLTEDQILWLLLGICRGLEAIHA---KGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQ 198 (317)
T ss_dssp HHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHH
T ss_pred HHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEcCCCCEEEEecCcchhccccccccccccccc
Confidence 53 569999999999999999999999 999999999999999999999999999987543211100
Q ss_pred ccCCCCCCCcccCCcccCCCC---CCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 139 TSTGRRRTPGCEAPELWMPYS---VTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~---~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
......||+.|+|||++.+.. ++.++||||+|++++||++|+.||....
T Consensus 199 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~ 250 (317)
T 2buj_A 199 DWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDMVF 250 (317)
T ss_dssp HHHHHHSCGGGCCGGGSSCCSEEEECTHHHHHHHHHHHHHHHHSSCTTHHHH
T ss_pred ccccccCCcccCCHhHhccCCCcCCCchhhHHHHHHHHHHHHhCCCChhhhh
Confidence 011234689999999987654 6889999999999999999999997643
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=208.16 Aligned_cols=182 Identities=20% Similarity=0.269 Sum_probs=145.0
Q ss_pred CCccc----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhh
Q 044746 1 MEKPR----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~ 68 (202)
||+++ +...++.|+.|+...... .....+..|.......+|++++.. .....++++++++++|..
T Consensus 39 V~~~~~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 115 (327)
T 3lxl_A 39 VELCRYDPLGDNTGALVAVKQLQHSGP---DQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRD 115 (327)
T ss_dssp EEEEEECTTSSSCSEEEEEEEESSCCH---HHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHH
T ss_pred EEEEEeccCCCCcceEEEEEEeccCCH---HHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHH
Confidence 56666 667777788776543221 122346677777788888887642 233558899999999998
Q ss_pred hhcc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCC
Q 044746 69 LCKK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRR 145 (202)
Q Consensus 69 ~~~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~g 145 (202)
++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... .......|
T Consensus 116 ~l~~~~~~~~~~~~~~i~~qi~~al~~lH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~ 192 (327)
T 3lxl_A 116 FLQRHRARLDASRLLLYSSQICKGMEYLGS---RRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVVREPGQS 192 (327)
T ss_dssp HHHHHGGGCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCSEEECSSCCCS
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCccCCCCChhhEEECCCCCEEEcccccceecccCCccceeeccCCc
Confidence 8864 459999999999999999999999 99999999999999999999999999999876543322 22334557
Q ss_pred CCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+.|+|||.+.+..++.++||||+|+++++|++|+.||.....
T Consensus 193 ~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~g~~p~~~~~~ 235 (327)
T 3lxl_A 193 PIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSA 235 (327)
T ss_dssp CGGGSCHHHHHHCEEEHHHHHHHHHHHHHHHHTTTCGGGSHHH
T ss_pred cccccCHHHhccCCCChHHhHHHHHHHHHHHHhCCCCCccccc
Confidence 8889999999888889999999999999999999999976554
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-30 Score=201.85 Aligned_cols=179 Identities=23% Similarity=0.325 Sum_probs=140.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccC--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKN-- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~-- 73 (202)
||++++.++. .|+.|+.+... .....+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 29 Vy~~~~~~~~-~vavK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~ 103 (279)
T 1qpc_A 29 VWMGYYNGHT-KVAVKSLKQGS----MSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG 103 (279)
T ss_dssp EEEEEETTTE-EEEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHH
T ss_pred EEEEEEcCCc-EEEEEEecCCc----ccHHHHHHHHHHHHhCCCcCcceEEEEEcCCCcEEEEecCCCCCHHHHHhcCCC
Confidence 5777766544 45554432211 12345667777777888888763 234456899999999999988654
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++......... ......+++.|+||
T Consensus 104 ~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~y~aP 179 (279)
T 1qpc_A 104 IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEYT-AREGAKFPIKWTAP 179 (279)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCEE-CCTTCCCCTTTSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCCHhhEEEcCCCCEEECCCcccccccCcccc-cccCCCCccCccCh
Confidence 69999999999999999999999 99999999999999999999999999999876543221 22334567889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|++++||++ |+.||.....
T Consensus 180 E~~~~~~~~~~~Di~slG~il~el~~~g~~p~~~~~~ 216 (279)
T 1qpc_A 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTN 216 (279)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hhhccCCCCchhhhHHHHHHHHHHHhCCCCCCcccCH
Confidence 99988888999999999999999999 9999976443
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-30 Score=205.65 Aligned_cols=183 Identities=19% Similarity=0.217 Sum_probs=129.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++...++.|+.|+...... .....++..|.......+|++++. ..+...++++++++++|..++.
T Consensus 31 V~~~~~~~~~~~vaiK~~~~~~~--~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 108 (303)
T 2vwi_A 31 VQAAYCAPKKEKVAIKRINLEKC--QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIV 108 (303)
T ss_dssp EEEEEC----CEEEEECCC------------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEEhhhc--chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHh
Confidence 67888887788888776543221 122334556666666667887763 3345678999999999988874
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc---ccccCC
Q 044746 72 ------KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT---HITSTG 142 (202)
Q Consensus 72 ------~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~---~~~~~~ 142 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ ......
T Consensus 109 ~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 185 (303)
T 2vwi_A 109 AKGEHKSGVLDESTIATILREVLEGLEYLHK---NGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKT 185 (303)
T ss_dssp HTTTTTTCSSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC-------------
T ss_pred hccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcc
Confidence 3459999999999999999999999 9999999999999999999999999999875533211 111233
Q ss_pred CCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 143 RRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
..||+.|+|||++.+ ..++.++|+||+|++++||++|+.||.....
T Consensus 186 ~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 232 (303)
T 2vwi_A 186 FVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYHKYPP 232 (303)
T ss_dssp --CCCTTCCHHHHHHHHCCCTHHHHHHHHHHHHHHHHSSCTTTTSCG
T ss_pred cCCCccccCHHHhccccCCCchhhHHHHHHHHHHHHhCCCCCccCch
Confidence 467999999999865 4688999999999999999999999976543
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=99.96 E-value=3.7e-30 Score=203.64 Aligned_cols=177 Identities=20% Similarity=0.263 Sum_probs=141.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||++++..+++.|+.|+.+.... .....+..|.......+|++++. ..+...++++++++++|..++. .+
T Consensus 25 V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 101 (304)
T 2jam_A 25 VFLVKQRLTGKLFALKCIKKSPA---FRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERG 101 (304)
T ss_dssp EEEEEETTTCCEEEEEEEECC---------HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred EEEEEECCCCCEEEEEEEecccc---cchHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcC
Confidence 68888888888888877543321 12234666777777888898763 3445568889999999987764 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE---cCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL---DENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||++ +.++.++|+|||++........ ....||+.|+
T Consensus 102 ~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~----~~~~~~~~y~ 174 (304)
T 2jam_A 102 VYTEKDASLVIQQVLSAVKYLHE---NGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNGIM----STACGTPGYV 174 (304)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCBTT----HHHHSCCCBC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCCcc----ccccCCCCcc
Confidence 79999999999999999999999 999999999999999 7788999999999875433211 2234699999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+.+..++.++|+||+|+++++|++|+.||....
T Consensus 175 aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 211 (304)
T 2jam_A 175 APEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEET 211 (304)
T ss_dssp CTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred ChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCCCCC
Confidence 9999999899999999999999999999999997654
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.7e-31 Score=209.63 Aligned_cols=183 Identities=21% Similarity=0.239 Sum_probs=136.4
Q ss_pred CCccc-----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPR-----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~-----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||+++ +..++..||.|+..... ......++..|.......+|++++. .....+++++++++++|..+
T Consensus 46 Vy~~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~ 123 (327)
T 2yfx_A 46 VYEGQVSGMPNDPSPLQVAVKTLPEVC--SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSF 123 (327)
T ss_dssp EEEEEC--------CCEEEEEECCSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHH
T ss_pred EEEEEEcCCCCCCccceEEEEEecccc--chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHH
Confidence 56666 44556667776643221 1112234666777777788998763 33455789999999999998
Q ss_pred hccC--------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCccc
Q 044746 70 CKKN--------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHI 138 (202)
Q Consensus 70 ~~~~--------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~ 138 (202)
+... .+++..+..++.|++.||.|||+ .+++||||||+||+++. +..++|+|||++..........
T Consensus 124 l~~~~~~~~~~~~~~~~~~~~i~~qi~~al~~LH~---~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~ 200 (327)
T 2yfx_A 124 LRETRPRPSQPSSLAMLDLLHVARDIACGCQYLEE---NHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYR 200 (327)
T ss_dssp HHHTSCCSSSTTSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC-----
T ss_pred HHhhcccccccccccHHHHHHHHHHHHHHHHHHhh---CCeecCcCCHhHEEEecCCCcceEEECccccccccccccccc
Confidence 8653 38999999999999999999999 99999999999999984 4569999999997544333222
Q ss_pred ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
......|++.|+|||.+.+..++.++||||+|+++++|++ |+.||.....
T Consensus 201 ~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 251 (327)
T 2yfx_A 201 KGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSN 251 (327)
T ss_dssp -CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cCCCcCCCcceeCHhHhcCCCCCchhhHHHHHHHHHHHHcCCCCCCCCcCH
Confidence 2333456889999999988889999999999999999998 9999976543
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2e-30 Score=205.77 Aligned_cols=181 Identities=15% Similarity=0.239 Sum_probs=140.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc--------------------ccceEEEEE
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE--------------------DTETYIKGF 60 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~--------------------~~~~~~~~~ 60 (202)
||++++...++.||.|....... .....+..|.......+|++++... ....+++++
T Consensus 27 V~~~~~~~~~~~vaiK~~~~~~~---~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~ 103 (320)
T 2i6l_A 27 VFSAVDNDCDKRVAIKKIVLTDP---QSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY 103 (320)
T ss_dssp EEEEEETTTTEEEEEEEEECCSH---HHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEEC
T ss_pred EEEEEECCCCeEEEEEEEecCCh---HHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeec
Confidence 68888888888888776433211 1223456677777888899876432 334578888
Q ss_pred ccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc-CCCceEEeeeecceeccccCcc-c
Q 044746 61 LAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTH-I 138 (202)
Q Consensus 61 ~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~-~~~~~kl~dfgl~~~~~~~~~~-~ 138 (202)
+. ++|..++..+.+++..+..++.|++.||.|||+ .+++||||||+||+++ .++.+||+|||+++........ .
T Consensus 104 ~~-~~L~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~~~~ 179 (320)
T 2i6l_A 104 ME-TDLANVLEQGPLLEEHARLFMYQLLRGLKYIHS---ANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYSHKG 179 (320)
T ss_dssp CS-EEHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC--------
T ss_pred cC-CCHHHHhhcCCccHHHHHHHHHHHHHHHHHHHh---CCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCccccc
Confidence 87 689999988899999999999999999999999 9999999999999997 5679999999999865432111 1
Q ss_pred ccCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 139 TSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
......+++.|+|||.+.. ..++.++|+||+|++++||++|+.||.....
T Consensus 180 ~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 230 (320)
T 2i6l_A 180 HLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230 (320)
T ss_dssp CCCGGGSCCTTCCHHHHHCTTCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccccccccccccCcHHhcCcccCCchhhhHhHHHHHHHHHhCCCCCCCCCH
Confidence 1223456889999998765 6789999999999999999999999986554
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-30 Score=204.50 Aligned_cols=183 Identities=18% Similarity=0.274 Sum_probs=141.7
Q ss_pred CCcccc--CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRN--RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~--~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++.+ ...+..|+.|+.+... .......+..|.......+|++++. ..+...++++++++++|..++.
T Consensus 26 Vy~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 103 (287)
T 1u59_A 26 VRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK 103 (287)
T ss_dssp EEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTC
T ss_pred EEEeEeccCCCcceEEEEecCCcc--chhHHHHHHHHHHHHHhCCCCCEeEEEEEecCCCcEEEEEeCCCCCHHHHHHhC
Confidence 566654 3455667766654321 1122345667777777788998764 3344568899999999999884
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCccc
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCE 150 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~ 150 (202)
...+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......... ......+|+.|+
T Consensus 104 ~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~ 180 (287)
T 1u59_A 104 REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 180 (287)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGC
T ss_pred CccCCHHHHHHHHHHHHHHHHHHHH---CCEeeCCCchheEEEcCCCCEEECcccceeeeccCcceeecccccccccccc
Confidence 3459999999999999999999999 999999999999999999999999999998764332221 123345688999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||.+.+..++.++|+||+|++++||++ |+.||.....
T Consensus 181 aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~ 219 (287)
T 1u59_A 181 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 219 (287)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred CHHHhccCCCCchhhHHHHHHHHHHHHcCCCCCcccCCH
Confidence 9999988889999999999999999998 9999976543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=204.49 Aligned_cols=180 Identities=21% Similarity=0.251 Sum_probs=145.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++...+..|+.|+..... .....+..|.......+|++++. ......++++++++++|..++..
T Consensus 29 V~~~~~~~~~~~vaiK~~~~~~----~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~ 104 (288)
T 3kfa_A 29 VYEGVWKKYSLTVAVKTLKEDT----MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 104 (288)
T ss_dssp EEEEEEGGGTEEEEEEEECSCS----THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCC
T ss_pred EEEeEecCCCEEEEEEecCcCH----HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcc
Confidence 6888888888888877654321 12334667777778888898763 34455688999999999988854
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........ .......+|+.|+|
T Consensus 105 ~~~~~~~~~~~i~~~i~~~l~~lH~---~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~y~a 180 (288)
T 3kfa_A 105 RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY-TAHAGAKFPIKWTA 180 (288)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHH---HTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS-EEETTEEECGGGCC
T ss_pred cCCccHhHHHHHHHHHHHHHHHHHH---CCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc-ccccCCccccCcCC
Confidence 459999999999999999999999 9999999999999999999999999999986543322 22233456788999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||.+.+..++.++|+||+|+++++|++ |.+||.....
T Consensus 181 PE~~~~~~~~~~~Di~slG~il~~ll~~g~~p~~~~~~ 218 (288)
T 3kfa_A 181 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 218 (288)
T ss_dssp HHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCG
T ss_pred hhhhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 999988889999999999999999999 9999976543
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.3e-30 Score=205.03 Aligned_cols=184 Identities=21% Similarity=0.303 Sum_probs=141.4
Q ss_pred CCcc--ccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKP--RNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~--~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++ +....++.|+.|+.+.... ......++..|.......+|++++. ..+...++++++++++|..++...
T Consensus 33 Vy~~~~~~~~~~~~vavK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 111 (291)
T 1xbb_A 33 VKKGYYQMKKVVKTVAVKILKNEAN-DPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN 111 (291)
T ss_dssp EEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC
T ss_pred eEeeeecCCCceeeEEEEeeccccc-CHHHHHHHHHHHHHHHhCCCCCEEEEEEEECCCCcEEEEEeCCCCCHHHHHHhC
Confidence 5677 4455667777776543321 1122345677777788888898763 334456889999999999888654
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCcccC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGCEA 151 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y~a 151 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......... ......+++.|+|
T Consensus 112 ~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~a 188 (291)
T 1xbb_A 112 RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 188 (291)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---CCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCcccccccCCCCceeeC
Confidence 59999999999999999999999 999999999999999999999999999998764433221 1222345788999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||.+.+..++.++|+||+|+++++|++ |+.||.....
T Consensus 189 PE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 226 (291)
T 1xbb_A 189 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 226 (291)
T ss_dssp HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred hHHhccCCCChhhhHHHHHHHHHHHHhcCCCCCCCCCH
Confidence 999988888999999999999999999 9999986543
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.4e-30 Score=206.72 Aligned_cols=181 Identities=21% Similarity=0.261 Sum_probs=120.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccccccc--------------cceEEEEEccCCc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGSED--------------TETYIKGFLAMGP 65 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~~~--------------~~~~~~~~~~~~~ 65 (202)
||++++...++.||.|+...... .....+..|....... +|++++...+ ...++++++. |+
T Consensus 44 V~~~~~~~~~~~vavK~~~~~~~---~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~ 119 (337)
T 3ll6_A 44 VYEAQDVGSGREYALKRLLSNEE---EKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQ 119 (337)
T ss_dssp EEEEEETTTCCEEEEEEEEESSH---HHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EE
T ss_pred EEEEEECCCCcEEEEEEecCCch---HHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CC
Confidence 68899888888888875432211 1122344555555554 5888764321 1346666665 77
Q ss_pred hhhhhc----cCCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-
Q 044746 66 FYLLCK----KNILGFGQLREIEVSTSKGIAYLHEECRQK--IVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI- 138 (202)
Q Consensus 66 l~~~~~----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~- 138 (202)
|..++. ...+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.+||+|||+++.........
T Consensus 120 L~~~l~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~ 196 (337)
T 3ll6_A 120 LVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHR---QKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSW 196 (337)
T ss_dssp HHHHHHHHHTTCSCCHHHHHHHHHHHHHHHHHHHT---SSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC----
T ss_pred HHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh---CCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccc
Confidence 777663 3569999999999999999999999 88 9999999999999999999999999998654322111
Q ss_pred ---------ccCCCCCCCcccCCccc---CCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 139 ---------TSTGRRRTPGCEAPELW---MPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 139 ---------~~~~~~gt~~y~aPe~~---~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
......||+.|+|||++ .+..++.++||||||+++++|++|+.||.....
T Consensus 197 ~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~ 258 (337)
T 3ll6_A 197 SAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAK 258 (337)
T ss_dssp ---------------------------CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC-----
T ss_pred cccccccchhhccccCCCCcCChhhhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhH
Confidence 11134579999999998 566788999999999999999999999976543
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=209.80 Aligned_cols=177 Identities=18% Similarity=0.218 Sum_probs=132.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccc-----cc------cccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSN-----LV------GSEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~-----~i------~~~~~~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.||.|+.+..... ...+..|....... .+++ ++ ...+...++++++. ++|..
T Consensus 70 V~~~~~~~~~~~vaiK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~ 144 (382)
T 2vx3_A 70 VVKAYDRVEQEWVAIKIIKNKKAF----LNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYD 144 (382)
T ss_dssp EEEEEETTTTEEEEEEEECSSHHH----HHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHH
T ss_pred EEEEEEcCCCcEEEEEEEeccHHH----HHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHH
Confidence 789999888888998876432211 11222233222222 1221 32 13345568888886 58877
Q ss_pred hhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc--CCCceEEeeeecceeccccCcccccCCC
Q 044746 69 LCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD--ENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 69 ~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~--~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
++... .+++..+..++.|++.||.|||+. ..+|+||||||+|||++ .++.+||+|||+++..... ....
T Consensus 145 ~l~~~~~~~~~~~~~~~i~~qi~~al~~lH~~-~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~~-----~~~~ 218 (382)
T 2vx3_A 145 LLRNTNFRGVSLNLTRKFAQQMCTALLFLATP-ELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQR-----IYQY 218 (382)
T ss_dssp HHHHTTTSCCCHHHHHHHHHHHHHHHHHHTST-TTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTCC-----CCSS
T ss_pred HHhhcCcCCCCHHHHHHHHHHHHHHHHHhccC-CCCEEcCCCCcccEEEecCCCCcEEEEeccCceecccc-----cccc
Confidence 77543 599999999999999999999941 17999999999999995 4788999999999876432 2335
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||+.|+|||++.+..++.++||||+||+++||++|++||.....
T Consensus 219 ~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~pf~~~~~ 263 (382)
T 2vx3_A 219 IQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263 (382)
T ss_dssp CSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCccccChHHHcCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCCH
Confidence 679999999999999999999999999999999999999987554
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=204.69 Aligned_cols=179 Identities=23% Similarity=0.257 Sum_probs=134.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-cccccccc------------cccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVGS------------EDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~~------------~~~~~~~~~~~~~~~l~ 67 (202)
||++++..+++.|+.|+..... .....+..|....... +|++++.. .....++++++++++|.
T Consensus 40 Vy~~~~~~~~~~vaiK~~~~~~----~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~ 115 (326)
T 2x7f_A 40 VYKGRHVKTGQLAAIKVMDVTG----DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVT 115 (326)
T ss_dssp EEEEEETTTCCEEEEEEEECCS----STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHH
T ss_pred EEEEEECCCCCeEEEEEEecCc----ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHH
Confidence 6888888888888888754321 1223455555555444 68876531 34567889999999999
Q ss_pred hhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCC
Q 044746 68 LLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 68 ~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
.++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ ......
T Consensus 116 ~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~ 190 (326)
T 2x7f_A 116 DLIKNTKGNTLKEEWIAYICREILRGLSHLHQ---HKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTVG--RRNTFI 190 (326)
T ss_dssp HHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTCCEEECCCTTTC---------------
T ss_pred HHHHhcccCCCCHHHHHHHHHHHHHHHHHHHH---CCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCcc--cccccc
Confidence 88864 469999999999999999999999 9999999999999999999999999999876543221 123346
Q ss_pred CCCcccCCcccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 145 RTPGCEAPELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 145 gt~~y~aPe~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||+.|+|||++. ...++.++||||+|+++++|++|+.||.....
T Consensus 191 ~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 239 (326)
T 2x7f_A 191 GTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLCDMHP 239 (326)
T ss_dssp CCGGGCCHHHHC--------CCTTHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred CCccccChhhhccccccCcCCCccchHHHHHHHHHHHHhCCCCCCCCcH
Confidence 799999999987 45688999999999999999999999976543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=208.13 Aligned_cols=179 Identities=18% Similarity=0.209 Sum_probs=129.1
Q ss_pred CCccccCCCcceeehh-hhchhhhhcc-------CCcccCCcHHHHHHhccccccccccc-----------cceEEEEEc
Q 044746 1 MEKPRNRGSTRFITRT-IDKSLDAMEM-------DKPIRFTSPQRMIAADNFSNLVGSED-----------TETYIKGFL 61 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~-~~~~~~~~~~-------~~~~~~~~~~~~~~~~~~~~~i~~~~-----------~~~~~~~~~ 61 (202)
||++++.. +..||.| +......... ....++..|.......+|++++...+ ...++++++
T Consensus 38 V~~~~~~~-~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~ 116 (362)
T 3pg1_A 38 VCAGVDSE-GIPVAIKRVFNTVSDGRTVNILSDSFLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELM 116 (362)
T ss_dssp EEEEECTT-SCEEEEEEECEECCTTSCEEGGGSHHHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECC
T ss_pred EEEEECCC-CCeEEEEeccccCCccchhhhhhhhhHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccC
Confidence 68888876 4445544 4322211110 01145667777888889998874322 236778888
Q ss_pred cCCchhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccc
Q 044746 62 AMGPFYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHIT 139 (202)
Q Consensus 62 ~~~~l~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~ 139 (202)
. +++...+... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 117 ~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--- 189 (362)
T 3pg1_A 117 R-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHVLHE---AGVVHRDLHPGNILLADNNDITICDFNLAREDTADAN--- 189 (362)
T ss_dssp S-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCTTC------------
T ss_pred C-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH---CcCEecCCChHHEEEcCCCCEEEEecCcccccccccc---
Confidence 7 5666665443 59999999999999999999999 9999999999999999999999999999975433222
Q ss_pred cCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 140 STGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 140 ~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
.....||+.|+|||++.+ ..++.++|+||+||++++|++|+.||....
T Consensus 190 ~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~pf~~~~ 238 (362)
T 3pg1_A 190 KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGST 238 (362)
T ss_dssp ------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHSSCSCCCSS
T ss_pred cceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHHHHhCCCCCCCCC
Confidence 233457899999999876 678999999999999999999999998654
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.3e-31 Score=206.27 Aligned_cols=182 Identities=20% Similarity=0.246 Sum_probs=141.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++..+++.|+.|+....... ......+..|.......+|++++.. .....++++++++++|..++..
T Consensus 22 V~~~~~~~~~~~vaiK~~~~~~~~-~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 100 (279)
T 2w5a_A 22 CQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100 (279)
T ss_dssp EEEEEETTTCCEEEEEEEECTTCC-HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHH
T ss_pred EEEEEECCCCcEEEEEEEEcccCC-HHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHh
Confidence 688888888888887765432211 1123456677777777888987632 3345788999999999888753
Q ss_pred -----CCCCHHHHHHHHHHHHHHHHHHHhCCCCC-----eEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 73 -----NILGFGQLREIEVSTSKGIAYLHEECRQK-----IVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 73 -----~~~~~~~~~~~~~~i~~~l~~lH~~~~~~-----iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
..+++..+..++.|++.||.|||+ .+ ++||||||+||+++.++.++|+|||+++........ ...
T Consensus 101 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~~~--~~~ 175 (279)
T 2w5a_A 101 GTKERQYLDEEFVLRVMTQLTLALKECHR---RSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTSF--AKT 175 (279)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHHHHH---HC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---CHH--HHH
T ss_pred hcccCCCCCHHHHHHHHHHHHHHHHHHhc---ccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccccc--ccc
Confidence 249999999999999999999999 77 999999999999999999999999999765432211 112
Q ss_pred CCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
..|++.|+|||.+.+..++.++|+||+|+++++|++|+.||.....
T Consensus 176 ~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~~ 221 (279)
T 2w5a_A 176 FVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQ 221 (279)
T ss_dssp HHSCCTTCCHHHHHCC-CCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred cCCCccccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCCcccCH
Confidence 3568999999999988899999999999999999999999986543
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=207.70 Aligned_cols=182 Identities=20% Similarity=0.283 Sum_probs=133.4
Q ss_pred CCccccCCCc----ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGST----RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~----~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++...+ ..|+.|+.+... .......+..|.......+|++++. ......++++++++++|..++
T Consensus 60 Vy~~~~~~~~~~~~~~vavK~~~~~~--~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l 137 (333)
T 1mqb_A 60 VYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 137 (333)
T ss_dssp EEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred EEEEEEecCCCCccccEEEEEcCCCC--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHH
Confidence 5677665433 236655543221 1112234666777777888898763 344567899999999999988
Q ss_pred cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCC
Q 044746 71 KK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTP 147 (202)
Q Consensus 71 ~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~ 147 (202)
.. ..+++.++..++.|++.||.|||+ .+++||||||+||+++.++.+||+|||+++....... ........+|+
T Consensus 138 ~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~ 214 (333)
T 1mqb_A 138 REKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 214 (333)
T ss_dssp HHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCG
T ss_pred HhCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCChheEEECCCCcEEECCCCcchhhccccccccccCCCCccc
Confidence 64 469999999999999999999999 9999999999999999999999999999986543321 11122334578
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
.|+|||.+.+..++.++||||+|++++||++ |+.||....
T Consensus 215 ~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~pf~~~~ 255 (333)
T 1mqb_A 215 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELS 255 (333)
T ss_dssp GGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred cccCchhcccCCCCchhhhHHHHHHHHHHHcCCCCCcccCC
Confidence 8999999998899999999999999999999 999997544
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.8e-30 Score=207.68 Aligned_cols=176 Identities=19% Similarity=0.227 Sum_probs=136.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.||.|+...... ......++..|.......+|++++...+ ...++++++. ++|..
T Consensus 40 V~~~~~~~~~~~vaiK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~ 117 (353)
T 3coi_A 40 VCSAIDKRSGEKVAIKKLSRPFQ-SEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQK 117 (353)
T ss_dssp EEEEEETTTTEEEEEEEESSTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGG
T ss_pred EEEEEECCCCCEEEEEEeccccc-chHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHH
Confidence 68899888888888876533211 1112234566777777888998774211 1267777776 57777
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||+++..... .....||+.
T Consensus 118 ~~~~-~~~~~~~~~i~~qi~~al~~LH~---~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~t~~ 188 (353)
T 3coi_A 118 IMGL-KFSEEKIQYLVYQMLKGLKYIHS---AGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-----MTGYVVTRW 188 (353)
T ss_dssp TTTS-CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECTTCCEEECSTTCTTC-------------CCSBC
T ss_pred HhcC-CCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-----ccccccCcC
Confidence 6643 59999999999999999999999 99999999999999999999999999999764322 233467999
Q ss_pred ccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+ ..++.++|+||+|+++++|++|+.||.+..
T Consensus 189 y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 228 (353)
T 3coi_A 189 YRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKD 228 (353)
T ss_dssp CSCHHHHSCCSCCCTTHHHHHHHHHHHHHHHSSCSSBSSC
T ss_pred cCCHHHHhCcCCCCchhhHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999877 678999999999999999999999998654
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=4.6e-30 Score=201.81 Aligned_cols=178 Identities=17% Similarity=0.161 Sum_probs=140.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++..+++.|+.|..... .......+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 38 Vy~~~~~~~~~~vaiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 114 (295)
T 2clq_A 38 VYAGRDLSNQVRIAIKEIPER---DSRYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKW 114 (295)
T ss_dssp EEEEEETTTCCEEEEEEEECC---CC---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTT
T ss_pred EEEEEECCCCeEEEEEEccCC---chHHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhc
Confidence 688888888888888765432 1222345667777778888998764 334556889999999998888643
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 74 ---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 74 ---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
.+++..+..++.|++.||.|||+ .+++|+||||+||+++. ++.++|+|||++........ ......|++.|
T Consensus 115 ~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~y 189 (295)
T 2clq_A 115 GPLKDNEQTIGFYTKQILEGLKYLHD---NQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGINP--CTETFTGTLQY 189 (295)
T ss_dssp CCCTTCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC-------CCCCCCGGG
T ss_pred cCCCccHHHHHHHHHHHHHHHHHHHh---CCEEccCCChhhEEEECCCCCEEEeecccccccCCCCC--cccccCCCccc
Confidence 46788999999999999999999 99999999999999987 89999999999986543221 12334679999
Q ss_pred cCCcccCCC--CCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 150 EAPELWMPY--SVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 150 ~aPe~~~~~--~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
+|||++.+. .++.++|+||+|+++++|++|+.||...
T Consensus 190 ~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~ 228 (295)
T 2clq_A 190 MAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYEL 228 (295)
T ss_dssp CCHHHHHHGGGGCSHHHHHHHHHHHHHHHHHTSCTTGGG
T ss_pred cChhhhcCCCCCCCcHHHHHHHHHHHHHHHHCCCCccCC
Confidence 999998754 3789999999999999999999999754
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.2e-30 Score=203.93 Aligned_cols=176 Identities=23% Similarity=0.297 Sum_probs=134.3
Q ss_pred CCcccc-CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccc------cc------cccccceEEEEEccCCchh
Q 044746 1 MEKPRN-RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSN------LV------GSEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~-~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~i------~~~~~~~~~~~~~~~~~l~ 67 (202)
||++.+ ..+++.||+|+.+..... ...+..|.......++++ ++ ...+...++++++ +++|.
T Consensus 30 V~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~ 104 (339)
T 1z57_A 30 VVECIDHKAGGRHVAVKIVKNVDRY----CEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTY 104 (339)
T ss_dssp EEEEEETTTTTEEEEEEEECSSHHH----HHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHH
T ss_pred EEEEEecCCCCcEEEEEEEecCCch----hHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHH
Confidence 678877 557788888875433211 122334444444433332 32 2345566888888 78888
Q ss_pred hhhccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-------------------CCceEEeee
Q 044746 68 LLCKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-------------------NFFPKAADF 125 (202)
Q Consensus 68 ~~~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-------------------~~~~kl~df 125 (202)
.++... .+++..+..++.|++.||.|||+ ++++||||||+||+++. ++.++|+||
T Consensus 105 ~~l~~~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 181 (339)
T 1z57_A 105 DFIKENGFLPFRLDHIRKMAYQICKSVNFLHS---NKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDF 181 (339)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCC
T ss_pred HHHHhcCCCCCcHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeC
Confidence 777544 58999999999999999999999 99999999999999987 667999999
Q ss_pred ecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 126 gl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|+++..... .....||+.|+|||++.+..++.++||||+||+++||++|+.||......
T Consensus 182 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~~ 240 (339)
T 1z57_A 182 GSATYDDEH-----HSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYYLGFTVFPTHDSK 240 (339)
T ss_dssp SSCEETTSC-----CCSSCSCGGGCCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSCSCCCSCHH
T ss_pred cccccCccc-----cccccCCccccChHHhhCCCCCcchhhHHHHHHHHHHHhCCCCCCCCChH
Confidence 999864332 23346799999999999989999999999999999999999999865543
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.3e-30 Score=203.20 Aligned_cols=185 Identities=18% Similarity=0.246 Sum_probs=136.9
Q ss_pred CCccccCC-C--cceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRG-S--TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~-~--~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++.. + ...|+.|+.+.......+....+..|.......+|++++. ......++++++++++|..++..
T Consensus 34 Vy~~~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~ 113 (291)
T 1u46_A 34 VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK 113 (291)
T ss_dssp CEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHH
T ss_pred EEEEEeccCCCceeEEEEEEEccCccCCHHHHHHHHHHHHHHHhCCCCCcccEEEEEccCCceeeEecccCCCHHHHHHh
Confidence 67776432 2 2246666544332222233445667777777788898763 22335688999999999888854
Q ss_pred --CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCcc
Q 044746 73 --NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGC 149 (202)
Q Consensus 73 --~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y 149 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++.......... ......+|+.|
T Consensus 114 ~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y 190 (291)
T 1u46_A 114 HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 190 (291)
T ss_dssp HGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGG
T ss_pred ccCCcCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEEcCCCCEEEccccccccccccccchhhhccCCCCcee
Confidence 459999999999999999999999 999999999999999999999999999998764432211 22334568889
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
+|||.+.+..++.++|+||+|+++++|++ |+.||.....
T Consensus 191 ~aPE~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 230 (291)
T 1u46_A 191 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 230 (291)
T ss_dssp CCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred eCchhhcCCCCCchhhHHHHHHHHHHHHhCCCCCcccCCH
Confidence 99999988888999999999999999999 9999976543
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=99.96 E-value=2.2e-30 Score=203.19 Aligned_cols=177 Identities=19% Similarity=0.196 Sum_probs=126.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--- 71 (202)
||++++..+++.||.|+.+...... .....+..+.......+|++++. ..+...++++++++ +|..++.
T Consensus 23 V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~ 100 (290)
T 3fme_A 23 VEKMRHVPSGQIMAVKRIRATVNSQ-EQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMDT-SLDKFYKQVI 100 (290)
T ss_dssp EEEEEETTTTEEEEEEEEC---CHH-HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCSE-EHHHHHHHHH
T ss_pred EEEEEecCCCeEEEEEEeecccCcH-HHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhcc-chHHHHHHHH
Confidence 6889998888888887654332111 11222334444466678887763 34455688888874 6655542
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQ-KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
...+++..+..++.|++.||.|||+ . +++||||||+||+++.++.++|+|||++........ .....||+.
T Consensus 101 ~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~t~~ 174 (290)
T 3fme_A 101 DKGQTIPEDILGKIAVSIVKALEHLHS---KLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDVA---KDIDAGCKP 174 (290)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHH---HSCCCCCCCSGGGCEECTTCCEEBCCC------------------CCCCC
T ss_pred hcCCCCCHHHHHHHHHHHHHHHHHHhh---cCCeecCCCCHHHEEECCCCCEEEeecCCccccccccc---ccccCCCcc
Confidence 4579999999999999999999999 7 999999999999999999999999999986544322 222357999
Q ss_pred ccCCccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 149 CEAPELW----MPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 149 y~aPe~~----~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|+|||.+ ....++.++|+||+|+++++|++|+.||..
T Consensus 175 y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~ 215 (290)
T 3fme_A 175 YMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDS 215 (290)
T ss_dssp CSCHHHHSCCTTC--CCHHHHHHHHHHHHHHHHHTSCSSCC
T ss_pred ccChhhcChhhcCcCCCcHHHHHHHHHHHHHHHHCCCCccc
Confidence 9999996 456789999999999999999999999975
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=200.57 Aligned_cols=179 Identities=20% Similarity=0.312 Sum_probs=139.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++..+.. |+.|+...... ....+..|.......+|++++. ..+...++++++++++|..++..
T Consensus 24 V~~~~~~~~~~-vaiK~~~~~~~----~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~ 98 (267)
T 3t9t_A 24 VHLGYWLNKDK-VAIKTIREGAM----SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQR 98 (267)
T ss_dssp EEEEEETTTEE-EEEEEECTTTB----CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTT
T ss_pred EEEEEecCCCe-EEEEEccccCC----CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCc
Confidence 57777765444 44444332211 1234666777777788888763 34456789999999999988865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .......+++.|+||
T Consensus 99 ~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~y~aP 174 (267)
T 3t9t_A 99 GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY-TSSTGTKFPVKWASP 174 (267)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHHH-HSTTSTTCCGGGCCH
T ss_pred ccCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCchheEEECCCCCEEEcccccccccccccc-cccccccccccccCh
Confidence 358999999999999999999999 9999999999999999999999999999986543221 122334567889999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|.+.+..++.++|+||+|+++++|++ |+.||.....
T Consensus 175 E~~~~~~~~~~~Di~slG~il~~l~~~g~~p~~~~~~ 211 (267)
T 3t9t_A 175 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSN 211 (267)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred hhhcCCCccchhchhhhHHHHHHHhccCCCCCCCCCH
Confidence 99988889999999999999999999 8999976543
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.4e-30 Score=205.02 Aligned_cols=176 Identities=19% Similarity=0.277 Sum_probs=134.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHh--ccccccccc------c----ccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAA--DNFSNLVGS------E----DTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~i~~------~----~~~~~~~~~~~~~~l~~ 68 (202)
||++++. ++.||.|+...... ..+..|..+... .+|+|++.. . ....++++++++++|..
T Consensus 58 Vy~~~~~--~~~vavK~~~~~~~------~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~ 129 (342)
T 1b6c_B 58 VWRGKWR--GEEVAVKIFSSREE------RSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 129 (342)
T ss_dssp EEEEEET--TEEEEEEEECGGGH------HHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHH
T ss_pred EEEEEEc--CccEEEEEeCchhH------HHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHH
Confidence 5777763 55666665432211 223334443433 678877631 1 25578899999999999
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHH--------hCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc--
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLH--------EECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-- 138 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH--------~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-- 138 (202)
++....+++.++..++.|++.||.||| + .+++||||||+||+++.++.+||+|||++..........
T Consensus 130 ~l~~~~~~~~~~~~i~~~i~~~l~~lH~~~~~~~~~---~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~ 206 (342)
T 1b6c_B 130 YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGK---PAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDI 206 (342)
T ss_dssp HHHHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCB---CEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEE
T ss_pred HHhccCccHHHHHHHHHHHHHHHHHHHHHHhhhccc---CCeeeCCCCHHHEEECCCCCEEEEECCCceecccccccccc
Confidence 999889999999999999999999999 7 899999999999999999999999999998654433211
Q ss_pred ccCCCCCCCcccCCcccCCCC------CCchhhHHHHHHHHHHHHcC----------CCCCcchh
Q 044746 139 TSTGRRRTPGCEAPELWMPYS------VTQKCDVFSFGMLLFEVVGR----------RRNLEKEI 187 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~------~~~~~Diws~G~~l~el~~g----------~~p~~~~~ 187 (202)
......||+.|+|||++.+.. ++.++||||||+++|||++| +.||....
T Consensus 207 ~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~ 271 (342)
T 1b6c_B 207 APNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLV 271 (342)
T ss_dssp CCCSCCCCGGGCCHHHHTSCCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTS
T ss_pred ccccCCcCcccCCHhhhcccccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccC
Confidence 223456899999999997652 33689999999999999999 77887653
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=2.5e-30 Score=207.72 Aligned_cols=175 Identities=19% Similarity=0.242 Sum_probs=118.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc---cc-------cccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV---GS-------EDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i---~~-------~~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++..+++.||.|+....... ...........+|++++ +. +....++++++++++|..++
T Consensus 45 V~~~~~~~~~~~vavK~~~~~~~~-------~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l 117 (336)
T 3fhr_A 45 VLECFHRRTGQKCALKLLYDSPKA-------RQEVDHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRI 117 (336)
T ss_dssp EEEEEETTTCCEEEEEEEESSHHH-------HHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHH
T ss_pred EEEEEECCCCCEEEEEEecCcHHH-------HHHHHHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHH
Confidence 688999988888888875432211 11122223444566554 22 23356889999999999888
Q ss_pred ccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCCC
Q 044746 71 KKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 71 ~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
... .+++.++..++.|++.||.|||+ .+++||||||+||+++. ++.++|+|||+++...... .....
T Consensus 118 ~~~~~~~l~~~~~~~i~~ql~~~l~~LH~---~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~ 190 (336)
T 3fhr_A 118 QERGDQAFTEREAAEIMRDIGTAIQFLHS---HNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQNA----LQTPC 190 (336)
T ss_dssp HTC-CCCCBHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC-------------
T ss_pred HhcCCCCCCHHHHHHHHHHHHHHHHHHHh---CCeecCCCCHHHEEEEecCCCceEEEeccccceeccccc----cccCC
Confidence 654 59999999999999999999999 99999999999999975 4569999999998654322 23345
Q ss_pred CCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 145 RTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 145 gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
||+.|+|||++.+..++.++||||+|+++++|++|+.||......
T Consensus 191 ~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~~ 235 (336)
T 3fhr_A 191 YTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235 (336)
T ss_dssp -------------CHHHHHHHHHHHHHHHHHHHHSSCCC------
T ss_pred CCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCCccch
Confidence 699999999998888999999999999999999999999765543
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=8.3e-30 Score=204.91 Aligned_cols=175 Identities=19% Similarity=0.250 Sum_probs=130.1
Q ss_pred CCccccCCCc-ceeehhhhchhhhhccCCcccCCcHHHHHHhccccc------cc------cccccceEEEEEccCCchh
Q 044746 1 MEKPRNRGST-RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSN------LV------GSEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~-~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~------~i------~~~~~~~~~~~~~~~~~l~ 67 (202)
||++++...+ ..||+|+.+..... ...+..|........+++ ++ ...+...++++++. +++.
T Consensus 35 V~~~~~~~~~~~~vavK~~~~~~~~----~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~ 109 (355)
T 2eu9_A 35 VVECLDHARGKSQVALKIIRNVGKY----REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELLG-KNTF 109 (355)
T ss_dssp EEEEEETTTTTEEEEEEEECSCHHH----HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECCC-CBHH
T ss_pred EEEEEecCCCceEEEEEEEcccccc----hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEeccC-CChH
Confidence 6788886655 67888775432211 122333433333333322 22 23445568888884 4554
Q ss_pred hhhc-c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEE-------------------cCCCceEEeee
Q 044746 68 LLCK-K--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL-------------------DENFFPKAADF 125 (202)
Q Consensus 68 ~~~~-~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~-------------------~~~~~~kl~df 125 (202)
..+. . ..+++.++..++.|++.||.|||+ .+|+||||||+||++ +.++.+||+||
T Consensus 110 ~~l~~~~~~~~~~~~~~~i~~qi~~~L~~lH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Df 186 (355)
T 2eu9_A 110 EFLKENNFQPYPLPHVRHMAYQLCHALRFLHE---NQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADF 186 (355)
T ss_dssp HHHHHTTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCC
T ss_pred HHHHhccCCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeec
Confidence 4443 3 359999999999999999999999 999999999999999 56789999999
Q ss_pred ecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 126 gl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+++..... .....||+.|+|||++.+..++.++||||+||+++||++|++||.....
T Consensus 187 g~~~~~~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~~ 244 (355)
T 2eu9_A 187 GSATFDHEH-----HTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYYRGFTLFQTHEN 244 (355)
T ss_dssp TTCEETTSC-----CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred Ccccccccc-----ccCCcCCCcccCCeeeecCCCCCccchHHHHHHHHHHHhCCCCCCCCCH
Confidence 999864332 2335679999999999998999999999999999999999999986554
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=1.7e-29 Score=200.47 Aligned_cols=174 Identities=25% Similarity=0.366 Sum_probs=130.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc----ccceEEEEEccCCchhhhhccC---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE----DTETYIKGFLAMGPFYLLCKKN--- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~----~~~~~~~~~~~~~~l~~~~~~~--- 73 (202)
||+++.. ++.|+.|..... .....|..|.......+|+|++... +...++++++++++|..++...
T Consensus 24 V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~ 96 (307)
T 2eva_A 24 VCKAKWR--AKDVAIKQIESE-----SERKAFIVELRQLSRVNHPNIVKLYGACLNPVCLVMEYAEGGSLYNVLHGAEPL 96 (307)
T ss_dssp EEEEEET--TEEEEEEECSST-----THHHHHHHHHHHHHHCCCTTBCCEEEBCTTTTEEEEECCTTCBHHHHHHCSSSE
T ss_pred EEEEEEC--CeeEEEEEecCh-----hHHHHHHHHHHHHhcCCCCCcCeEEEEEcCCcEEEEEcCCCCCHHHHHhccCCC
Confidence 5677664 344555543221 1223466777777888899887422 3356899999999999988654
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc-eEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF-PKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~-~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
.++...+..++.|++.||.|||+...++++||||||+||+++.++. +||+|||++...... .....||+.|+|
T Consensus 97 ~~~~~~~~~~~~~qi~~~l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-----~~~~~gt~~y~a 171 (307)
T 2eva_A 97 PYYTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-----MTNNKGSAAWMA 171 (307)
T ss_dssp ECCCHHHHHHHHHHHHHHHHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-----------------CCTTSSC
T ss_pred CccCHHHHHHHHHHHHHHHHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-----cccCCCCCceEC
Confidence 3789999999999999999999743358999999999999988876 799999999754322 123357999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||++.+..++.++||||+|++++||++|+.||...
T Consensus 172 PE~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~ 206 (307)
T 2eva_A 172 PEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEI 206 (307)
T ss_dssp HHHHTCCCCCTHHHHHHHHHHHHHHHHTCCTTTTT
T ss_pred hhhhCCCCCCcHHHHHHHHHHHHHHHHCCCCchhh
Confidence 99999989999999999999999999999999754
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=4.1e-30 Score=202.85 Aligned_cols=179 Identities=17% Similarity=0.198 Sum_probs=139.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||++++..+++.++.|+.... .......+..|.......+|++++. ..+...++++++++++|..++. .
T Consensus 35 V~~~~~~~~~~~~aiK~~~~~---~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~ 111 (302)
T 2j7t_A 35 VYKAKNKETGALAAAKVIETK---SEEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELD 111 (302)
T ss_dssp EEEEEETTTCCEEEEEEEC-------CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHT
T ss_pred EEEEEEcCCCcEEEEEEecCC---CHHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhc
Confidence 688888888888888765432 2223345666777777788898763 3445678899999999988775 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... .......||+.|+||
T Consensus 112 ~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~--~~~~~~~~~~~y~aP 186 (302)
T 2j7t_A 112 RGLTEPQIQVVCRQMLEALNFLHS---KRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL--QKRDSFIGTPYWMAP 186 (302)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH--HC-----CCGGGCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHHhc---CCcccCCCCHHHEEECCCCCEEEEECCCCccccccc--cccccccCChhhcCC
Confidence 569999999999999999999999 999999999999999999999999999876432111 112234579999999
Q ss_pred ccc-----CCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 153 ELW-----MPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 153 e~~-----~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++ ....++.++|+||+|+++++|++|+.||....
T Consensus 187 E~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~p~~~~~ 226 (302)
T 2j7t_A 187 EVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELN 226 (302)
T ss_dssp HHHHHHHTTSTTTTTHHHHHHHHHHHHHHHHSSCTTTTSC
T ss_pred eeeccccCCCCCCchhhhHHHHHHHHHHHhcCCCCCccCC
Confidence 998 46678899999999999999999999997654
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=7.8e-30 Score=200.88 Aligned_cols=181 Identities=17% Similarity=0.217 Sum_probs=140.6
Q ss_pred CCccccCCCcceeehhhhchhhhh------ccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM------EMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~ 67 (202)
||++++..+++.||.|+....... .......+..|....... +|++++. ......++++++++++|.
T Consensus 33 V~~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 112 (298)
T 1phk_A 33 VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 112 (298)
T ss_dssp EEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHH
T ss_pred EEEEEEcCcCceEEEEEEecccccccCHHHHHHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHH
Confidence 688899888888888775433210 011122344454444444 5887763 344567889999999998
Q ss_pred hhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 68 LLCKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 68 ~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.++.. ..+++..+..++.|++.||.|||+ .+++|+||||+||+++.++.++|+|||++........ .....|+
T Consensus 113 ~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~ 186 (298)
T 1phk_A 113 DYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 186 (298)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSC
T ss_pred HHHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcccCCCCcceEEEcCCCcEEEecccchhhcCCCcc---cccccCC
Confidence 88864 469999999999999999999999 9999999999999999999999999999986543322 2335679
Q ss_pred CcccCCcccC------CCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWM------PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~------~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.|+|||++. ...++.++|+||+|+++++|++|+.||....
T Consensus 187 ~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 233 (298)
T 1phk_A 187 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233 (298)
T ss_dssp GGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ccccCHHHhccccccccccCCcccccHhHHHHHHHHHHCCCCCcCcc
Confidence 9999999884 4567899999999999999999999997544
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=99.96 E-value=9.3e-30 Score=203.02 Aligned_cols=180 Identities=17% Similarity=0.152 Sum_probs=139.4
Q ss_pred CCccccCCCcceeehhhhchhhhhc---cCCcccCCcHHHHHHhcc--cccccc------ccccceEEEEEccC-Cchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME---MDKPIRFTSPQRMIAADN--FSNLVG------SEDTETYIKGFLAM-GPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~--~~~~i~------~~~~~~~~~~~~~~-~~l~~ 68 (202)
||++++..+++.||.|+........ .....++..|.......+ |++++. ..+...+++++..+ ++|..
T Consensus 59 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~ 138 (320)
T 3a99_A 59 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 138 (320)
T ss_dssp EEEEEETTTTEEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHH
T ss_pred EEEEEECCCCcEEEEEEEecccchhhhhhhhhhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHH
Confidence 6889888888888888754433221 123345666666666554 466653 33445577777765 78888
Q ss_pred hhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc-CCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 69 LCK-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 69 ~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
++. ...+++..+..++.|++.||.|||+ .+++||||||+||+++ .++.+||+|||+++...... .....||
T Consensus 139 ~l~~~~~l~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~~----~~~~~gt 211 (320)
T 3a99_A 139 FITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGT 211 (320)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSC
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCcEeCCCCHHHEEEeCCCCCEEEeeCcccccccccc----ccCCCCC
Confidence 775 4579999999999999999999999 9999999999999999 77999999999998765332 2334679
Q ss_pred CcccCCcccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.|+|||++.+..+ +.++||||||++++||++|+.||....
T Consensus 212 ~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 253 (320)
T 3a99_A 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 253 (320)
T ss_dssp GGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred ccCCChHHhccCCCCCccchHHhHHHHHHHHHHCCCCCCChh
Confidence 99999999876665 678999999999999999999997654
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=99.96 E-value=2.8e-30 Score=219.42 Aligned_cols=179 Identities=26% Similarity=0.363 Sum_probs=141.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--- 72 (202)
||++++.+... ||+|+.+... .....|..|..+....+|++++. ......++++++++|+|.+++..
T Consensus 283 Vy~~~~~~~~~-vavK~~~~~~----~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~lv~e~~~~gsL~~~l~~~~~ 357 (535)
T 2h8h_A 283 VWMGTWNGTTR-VAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETG 357 (535)
T ss_dssp EEEEEETTTEE-EEEEEECTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTEEHHHHHSHHHH
T ss_pred EEEEEECCCce-EEEEEeCCCC----CCHHHHHHHHHHHHhCCCCCEeeEEEEEeeccceEeeehhcCCcHHHHHhhcCC
Confidence 67777766544 5555443221 12345777888888889998773 22445689999999999998864
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .......++..|+||
T Consensus 358 ~~l~~~~~~~i~~qi~~~L~~LH~---~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~-~~~~~~~~~~~y~aP 433 (535)
T 2h8h_A 358 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP 433 (535)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHHH-HTTCSTTSCGGGSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCce-ecccCCcCcccccCH
Confidence 459999999999999999999999 9999999999999999999999999999986543221 112334467899999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|++....++.++||||||+++|||++ |+.||.+...
T Consensus 434 E~~~~~~~~~~sDvwSlGv~l~el~t~g~~P~~~~~~ 470 (535)
T 2h8h_A 434 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVN 470 (535)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHTTTTCCSSTTCCH
T ss_pred HHhccCCCCchhhHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 99988889999999999999999999 9999976543
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.9e-29 Score=202.88 Aligned_cols=180 Identities=19% Similarity=0.238 Sum_probs=141.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCc--------------ccCCcHHHHHHhcccccccc------ccccceEEEEE
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKP--------------IRFTSPQRMIAADNFSNLVG------SEDTETYIKGF 60 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~--------------~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~ 60 (202)
||++++ +++.||.|+............ ..+..|.......+|++++. ..+...+++++
T Consensus 47 V~~~~~--~~~~vavK~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~ 124 (348)
T 2pml_X 47 IILCEK--DNKFYALKKYEKSLLEKKRDFTKSNNDKISIKSKYDDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEY 124 (348)
T ss_dssp EEEEEE--TTEEEEEEEEEHHHHSSCEEECCCSSSSCCEEEHHHHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEEC
T ss_pred EEEEEc--CCceEEEEEeecccccchhhhccccchhhhHHhHHHHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEec
Confidence 577777 566666665443322221111 45667777778888998763 33456688999
Q ss_pred ccCCchhhh------hc---cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceec
Q 044746 61 LAMGPFYLL------CK---KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131 (202)
Q Consensus 61 ~~~~~l~~~------~~---~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~ 131 (202)
+++++|..+ +. ...+++..+..++.|++.||.|||+ ..+++|+||||+||+++.++.++|+|||++...
T Consensus 125 ~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~--~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~ 202 (348)
T 2pml_X 125 MENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYIHN--EKNICHRDVKPSNILMDKNGRVKLSDFGESEYM 202 (348)
T ss_dssp CTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHHHH--TSCEECCCCCGGGEEECTTSCEEECCCTTCEEC
T ss_pred cCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHHhc--cCCEeecCCChHhEEEcCCCcEEEecccccccc
Confidence 999999887 54 3569999999999999999999996 279999999999999999999999999999865
Q ss_pred cccCcccccCCCCCCCcccCCcccCCC-CCCc-hhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 132 NREHTHITSTGRRRTPGCEAPELWMPY-SVTQ-KCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 132 ~~~~~~~~~~~~~gt~~y~aPe~~~~~-~~~~-~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
... ......|++.|+|||.+.+. .++. ++|+||+|++++||++|+.||.....
T Consensus 203 ~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~~ 257 (348)
T 2pml_X 203 VDK----KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKIS 257 (348)
T ss_dssp BTT----EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHHHHHHSSCSSCCSSC
T ss_pred ccc----cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHHHHHhCCCCCCCCCc
Confidence 433 22345679999999999877 6666 99999999999999999999986554
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=5.7e-30 Score=200.83 Aligned_cols=173 Identities=17% Similarity=0.188 Sum_probs=134.5
Q ss_pred CCccccCCCcc-------eeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTR-------FITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~-------~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~ 67 (202)
||++++...++ .|+.|+..... ......+..|.......+|++++. ..+...++++++++++|.
T Consensus 24 V~~~~~~~~~~~~~~~~~~va~K~~~~~~---~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~ 100 (289)
T 4fvq_A 24 IFKGVRREVGDYGQLHETEVLLKVLDKAH---RNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLD 100 (289)
T ss_dssp EEEEEEEEECGGGCEEEEEEEEEEECGGG---GGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHH
T ss_pred EEEEEEecccccccccchhhhhhhccccc---HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHH
Confidence 57777766553 45555543221 222345667777788888998773 344567899999999999
Q ss_pred hhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc--------eEEeeeecceeccccCcc
Q 044746 68 LLCKKNI--LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF--------PKAADFGLAKLYNREHTH 137 (202)
Q Consensus 68 ~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~--------~kl~dfgl~~~~~~~~~~ 137 (202)
.++.... +++..+..++.|++.||.|||+ ++++||||||+||+++.++. ++|+|||++.......
T Consensus 101 ~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~---~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-- 175 (289)
T 4fvq_A 101 TYLKKNKNCINILWKLEVAKQLAAAMHFLEE---NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPKD-- 175 (289)
T ss_dssp HHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCHH--
T ss_pred HHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh---CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCcc--
Confidence 9886554 9999999999999999999999 99999999999999988876 9999999986543221
Q ss_pred cccCCCCCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcC-CCCCcc
Q 044746 138 ITSTGRRRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGR-RRNLEK 185 (202)
Q Consensus 138 ~~~~~~~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g-~~p~~~ 185 (202)
...||+.|+|||++.+ ..++.++||||+|++++||++| .+||..
T Consensus 176 ----~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~~~~~~ 221 (289)
T 4fvq_A 176 ----ILQERIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSA 221 (289)
T ss_dssp ----HHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHHHHHHTTTCCTTTT
T ss_pred ----ccCCcCcccCHHHhCCCCCCCchhHHHHHHHHHHHHHcCCCCCccc
Confidence 1235788999999987 6789999999999999999995 455543
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=6e-30 Score=204.45 Aligned_cols=180 Identities=18% Similarity=0.263 Sum_probs=141.8
Q ss_pred CCccc----cCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhh
Q 044746 1 MEKPR----NRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~----~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~ 68 (202)
||+++ +...++.||.|+.... ..+....+..|.......+|++++.. .....++++++++++|..
T Consensus 57 V~~~~~~~~~~~~~~~vavK~~~~~---~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~ 133 (326)
T 2w1i_A 57 VEMCRYDPLQDNTGEVVAVKKLQHS---TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRD 133 (326)
T ss_dssp EEEEEECTTSSSCCEEEEEEEESSC---CSHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHH
T ss_pred EEEEEeccccCCCceEEEEEEeccC---CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHH
Confidence 46665 5666777777764332 12223456777777888888987642 224568899999999999
Q ss_pred hhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCC
Q 044746 69 LCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRR 145 (202)
Q Consensus 69 ~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~g 145 (202)
++... .+++.++..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++.......... ......+
T Consensus 134 ~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~ 210 (326)
T 2w1i_A 134 YLQKHKERIDHIKLLQYTSQICKGMEYLGT---KRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYKVKEPGES 210 (326)
T ss_dssp HHHHSTTSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSEEECSSCCSC
T ss_pred HHHhcccCCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEEcCCCcEEEecCcchhhccccccccccccCCCC
Confidence 88654 49999999999999999999999 999999999999999999999999999998765433221 1233456
Q ss_pred CCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
+..|+|||.+.+..++.++||||+|++++||++|..||...
T Consensus 211 ~~~y~aPE~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~ 251 (326)
T 2w1i_A 211 PIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSP 251 (326)
T ss_dssp CGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHHTTCGGGSH
T ss_pred ceeEECchhhcCCCCCchhhHHHHHHHHHHHHhcCCCCCCC
Confidence 78899999998888899999999999999999999998743
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=3.6e-30 Score=199.85 Aligned_cols=175 Identities=21% Similarity=0.298 Sum_probs=133.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc--------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG--------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~--------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++. +..+|.|+.+.... .......+..|.......+|+|++. ......++++++++++|..++..
T Consensus 26 V~~~~~~--~~~~avK~~~~~~~-~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~ 102 (271)
T 3kmu_A 26 LWKGRWQ--GNDIVVKVLKVRDW-STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHE 102 (271)
T ss_dssp EEEEEET--TEEEEEEEECCTTC-CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHS
T ss_pred EEEEEEC--CeeEEEEEeccccc-CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhh
Confidence 5777775 44455555432211 1112234556666666778888763 12455799999999999999876
Q ss_pred CC---CCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCC
Q 044746 73 NI---LGFGQLREIEVSTSKGIAYLHEECRQK--IVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTP 147 (202)
Q Consensus 73 ~~---~~~~~~~~~~~~i~~~l~~lH~~~~~~--iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~ 147 (202)
.. +++.++..++.|++.||.|||+ .+ ++||||||+||+++.++.++++|||++.... .....||+
T Consensus 103 ~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~-------~~~~~~t~ 172 (271)
T 3kmu_A 103 GTNFVVDQSQAVKFALDMARGMAFLHT---LEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ-------SPGRMYAP 172 (271)
T ss_dssp CSSCCCCHHHHHHHHHHHHHHHHHHTT---SSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS-------CTTCBSCG
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHhc---CCCceecCCCccceEEEcCCcceeEEeccceeeec-------ccCccCCc
Confidence 53 8999999999999999999998 78 9999999999999999999999988765322 23345799
Q ss_pred cccCCcccCCCCCCc---hhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 148 GCEAPELWMPYSVTQ---KCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~---~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.|+|||.+.+..++. ++||||+|++++||++|+.||.....
T Consensus 173 ~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 216 (271)
T 3kmu_A 173 AWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSN 216 (271)
T ss_dssp GGSCHHHHHSCGGGSCHHHHHHHHHHHHHHHHHHCSCTTTTSCH
T ss_pred cccChhhhccCCCCCCCchhhHHHHHHHHHHHHhCCCCccccCh
Confidence 999999998755444 79999999999999999999976544
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=2.7e-29 Score=199.23 Aligned_cols=180 Identities=18% Similarity=0.198 Sum_probs=138.0
Q ss_pred CCccccCCCcceeehhhhchhhhhc---cCCcccCCcHHHHHHhc----ccccccc------ccccceEEEEE-ccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAME---MDKPIRFTSPQRMIAAD----NFSNLVG------SEDTETYIKGF-LAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~----~~~~~i~------~~~~~~~~~~~-~~~~~l 66 (202)
||++++..+++.||.|+........ ......+..|....... +|++++. ..+...+++++ +.+++|
T Consensus 47 Vy~~~~~~~~~~vavK~~~~~~~~~~~~~~~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L 126 (312)
T 2iwi_A 47 VFAGHRLTDRLQVAIKVIPRNRVLGWSPLSDSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDL 126 (312)
T ss_dssp EEEEECTTTCCEEEEEECCSTTTC--------CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEH
T ss_pred EEEEEEccCCeEEEEEEEecccccccccchhhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCH
Confidence 6889888888888887754432211 12334566666666555 7887763 23344577777 688899
Q ss_pred hhhhcc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc-CCCceEEeeeecceeccccCcccccCCCC
Q 044746 67 YLLCKK-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGRR 144 (202)
Q Consensus 67 ~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~ 144 (202)
..++.. ..+++..+..++.|++.||.|||+ .+++||||||+||+++ .++.++|+|||++....... .....
T Consensus 127 ~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~ 199 (312)
T 2iwi_A 127 FDYITEKGPLGEGPSRCFFGQVVAAIQHCHS---RGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDEP----YTDFD 199 (312)
T ss_dssp HHHHHHHCSCCHHHHHHHHHHHHHHHHHHHH---HTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSSC----BCCCC
T ss_pred HHHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---CCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccCc----ccccC
Confidence 888754 469999999999999999999999 9999999999999999 78999999999998765432 23345
Q ss_pred CCCcccCCcccCCCCCC-chhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 145 RTPGCEAPELWMPYSVT-QKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 145 gt~~y~aPe~~~~~~~~-~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|++.|+|||++.+..+. .++||||+|++++||++|+.||....
T Consensus 200 ~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 243 (312)
T 2iwi_A 200 GTRVYSPPEWISRHQYHALPATVWSLGILLYDMVCGDIPFERDQ 243 (312)
T ss_dssp SCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred CcccccCceeeecCCCCCccchHHHHHHHHHHHHHCCCCCCChH
Confidence 79999999998766654 58999999999999999999997654
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=6.6e-29 Score=214.17 Aligned_cols=178 Identities=23% Similarity=0.260 Sum_probs=145.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------------cccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------------EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------------~~~~~~~~~~~~~~~l~~ 68 (202)
||++++..+++.||.|+.+... ......++..|..+....+|+|++.. ++...++++++++++|..
T Consensus 30 Vyla~~~~tg~~VAVKvi~~~~--~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~ 107 (676)
T 3qa8_A 30 VLRWIHQDTGEQVAIKQCRQEL--SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRK 107 (676)
T ss_dssp CCCCCCTTTTCCEEECCCCSCC--CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHH
T ss_pred EEEEEECCCCcEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHH
Confidence 7999998888888888754321 11223446677778888899987632 455679999999999999
Q ss_pred hhccC----CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCc---eEEeeeecceeccccCcccccC
Q 044746 69 LCKKN----ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF---PKAADFGLAKLYNREHTHITST 141 (202)
Q Consensus 69 ~~~~~----~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~---~kl~dfgl~~~~~~~~~~~~~~ 141 (202)
++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++. ++|+|||++........ ..
T Consensus 108 ~L~~~~~~~~lse~~i~~I~~QLl~aL~yLHs---~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~---~~ 181 (676)
T 3qa8_A 108 YLNQFENCCGLKEGPIRTLLSDISSALRYLHE---NRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGEL---CT 181 (676)
T ss_dssp HHHSSSCTTCCCSSHHHHHHHHHHHHHHHHHH---TTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCC---CC
T ss_pred HHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH---CCCccCCCCHHHeEeecCCCceeEEEcccccccccccccc---cc
Confidence 88653 48999999999999999999999 99999999999999986654 89999999986544322 23
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
...||+.|+|||.+.+..++.++|+||+|++++++++|+.||...
T Consensus 182 ~~~gt~~Y~APE~l~~~~~s~ksDIwSLGviLyeLltG~~Pf~~~ 226 (676)
T 3qa8_A 182 EFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPN 226 (676)
T ss_dssp CCCSCCTTCSSCSSCCSCCSTTHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred cccCCcccCChHHhccCCCCchhHHHHHHHHHHHHHHCCCCCCcc
Confidence 456799999999999999999999999999999999999999653
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=99.96 E-value=9.1e-30 Score=204.20 Aligned_cols=124 Identities=13% Similarity=0.071 Sum_probs=108.4
Q ss_pred cccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEecCCCCcEEEcCCC-----------
Q 044746 51 EDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLH-EECRQKIVHYDIKPESVLLDENF----------- 118 (202)
Q Consensus 51 ~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~~iiHrdlk~~nil~~~~~----------- 118 (202)
.+..+++++++++|++...+....+++..++.++.|++.||.||| + ++|+||||||+|||++.++
T Consensus 134 ~~~~~lv~E~~~~g~ll~~~~~~~~~~~~~~~i~~qi~~aL~~lH~~---~~ivHrDlKp~NILl~~~~~~~~~~~~~~~ 210 (336)
T 2vuw_A 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLATAKSILHQLTASLAVAEAS---LRFEHRDLHWGNVLLKKTSLKKLHYTLNGK 210 (336)
T ss_dssp TTCEEEEEEEECCCEETGGGTTTCCCHHHHHHHHHHHHHHHHHHHHH---HCCBCSCCCGGGEEEEECSCSEEEEEETTE
T ss_pred cCeEEEEEEecCCCccHHHHHhcCCCHHHHHHHHHHHHHHHHHHHHh---CCEeECCCCHHHEEEeccCCcceeeeccCc
Confidence 567789999999998777776678999999999999999999999 8 9999999999999999887
Q ss_pred ---------ceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHH-HHHHHcCCCCCcc
Q 044746 119 ---------FPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGML-LFEVVGRRRNLEK 185 (202)
Q Consensus 119 ---------~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~-l~el~~g~~p~~~ 185 (202)
.+||+|||+++..... ...||+.|+|||++.+.. +.++||||++++ .+++++|..||..
T Consensus 211 ~~~~~~~~~~vkL~DFG~a~~~~~~-------~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~ 279 (336)
T 2vuw_A 211 SSTIPSCGLQVSIIDYTLSRLERDG-------IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSN 279 (336)
T ss_dssp EEEEECTTEEEEECCCTTCBEEETT-------EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHH
T ss_pred cccccCCCceEEEeeccccEecCCC-------cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcc
Confidence 8999999999865432 236799999999998766 899999998766 7778899999975
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=99.96 E-value=1.4e-29 Score=205.28 Aligned_cols=174 Identities=20% Similarity=0.242 Sum_probs=127.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-----------cccccc---ccc-------ccceEEEE
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-----------NFSNLV---GSE-------DTETYIKG 59 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~i---~~~-------~~~~~~~~ 59 (202)
||++++..+++.||.|+........ ..+..|....... .|++++ +.. ....++++
T Consensus 35 V~~~~~~~~~~~vaiK~~~~~~~~~----~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e 110 (373)
T 1q8y_A 35 VWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 110 (373)
T ss_dssp EEEEEETTTTEEEEEEEECSCHHHH----HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred EEEEEecCCCcEEEEEEecCCccch----hhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEe
Confidence 6889988888888888754322111 1122232222222 244444 221 13345555
Q ss_pred EccCCchhhhhcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEecCCCCcEEEc------CCCceEEeeeecce
Q 044746 60 FLAMGPFYLLCKK---NILGFGQLREIEVSTSKGIAYLHEECRQ-KIVHYDIKPESVLLD------ENFFPKAADFGLAK 129 (202)
Q Consensus 60 ~~~~~~l~~~~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~iiHrdlk~~nil~~------~~~~~kl~dfgl~~ 129 (202)
++ +++|..++.. ..+++..+..++.|++.||.|||+ + +|+||||||+||+++ ..+.+||+|||++.
T Consensus 111 ~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~lH~---~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~ 186 (373)
T 1q8y_A 111 VL-GENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR---RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 186 (373)
T ss_dssp CC-CEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH---TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCE
T ss_pred cC-CCCHHHHHHHhhccCCcHHHHHHHHHHHHHHHHHHHh---cCCEEecCCChHHeEEeccCCCcCcceEEEccccccc
Confidence 66 7888887754 459999999999999999999999 8 999999999999994 34589999999998
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
..... .....||+.|+|||++.+..++.++||||+||++|||++|+.||....
T Consensus 187 ~~~~~-----~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~~ 239 (373)
T 1q8y_A 187 WYDEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 239 (373)
T ss_dssp ETTBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccCCC-----CCCCCCCccccCcHHHhCCCCCchHhHHHHHHHHHHHHhCCCCCCCCc
Confidence 65432 233467999999999999899999999999999999999999998654
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=220.07 Aligned_cols=182 Identities=18% Similarity=0.216 Sum_probs=138.2
Q ss_pred CCccccCCC---cceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGS---TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~---~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++... ...|+.|..+... .......|..|.......+|+|++. ..+..+++++++++|+|..++..
T Consensus 406 Vy~a~~~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~lv~E~~~~g~L~~~l~~ 483 (656)
T 2j0j_A 406 VHQGIYMSPENPAMAVAIKTCKNCT--SDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV 483 (656)
T ss_dssp EEEEEECCSSSCCEEEEEEECSSTT--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHH
T ss_pred EEEEEEecCCCccEEEEEEEecccC--CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCceEEEEEcCCCCcHHHHHHh
Confidence 567766433 3445555433221 1112245667777788889998763 33445789999999999998864
Q ss_pred C--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 N--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. .+++..+..++.|++.||.|||+ .+|+||||||+||+++.++.+||+|||+++........ ......+|+.|+
T Consensus 484 ~~~~l~~~~~~~i~~qi~~aL~~LH~---~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~~-~~~~~~~t~~y~ 559 (656)
T 2j0j_A 484 RKFSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWM 559 (656)
T ss_dssp TTTTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-----------CCGGGC
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHh---CCccccccchHhEEEeCCCCEEEEecCCCeecCCCcce-eccCCCCCccee
Confidence 4 58999999999999999999999 99999999999999999999999999999865433221 122344578999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||++.+..++.++||||+|+++|||++ |.+||.+...
T Consensus 560 aPE~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~ 598 (656)
T 2j0j_A 560 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKN 598 (656)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCH
T ss_pred CHHHhcCCCCCchhhHHHHHHHHHHHHHcCCCCCCCCCH
Confidence 9999988899999999999999999997 9999976543
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.96 E-value=3.3e-29 Score=199.05 Aligned_cols=180 Identities=21% Similarity=0.263 Sum_probs=132.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||++++.+ . ++.|+.+.. .........+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 49 V~~~~~~~--~-~avk~~~~~-~~~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~ 124 (319)
T 2y4i_B 49 VYHGRWHG--E-VAIRLIDIE-RDNEDQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAK 124 (319)
T ss_dssp EEEEEESS--S-EEEEECCCC-SCCCCCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSC
T ss_pred EEEEEEcC--e-EEEEEeecC-CCCHHHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcC
Confidence 46666543 2 444433222 122334456777777788888898763 334456888999999999998765
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccC---cccccCCCCCCCcc
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREH---THITSTGRRRTPGC 149 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~---~~~~~~~~~gt~~y 149 (202)
.+++..+..++.|++.||.|||+ .+++||||||+||+++ ++.++|+|||++....... .........|++.|
T Consensus 125 ~~~~~~~~~~i~~qi~~al~~lH~---~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y 200 (319)
T 2y4i_B 125 IVLDVNKTRQIAQEIVKGMGYLHA---KGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCH 200 (319)
T ss_dssp CCCCSHHHHHHHHHHHHHHHHHHH---TTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGT
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccc
Confidence 49999999999999999999999 9999999999999998 6799999999987543211 11122334578999
Q ss_pred cCCcccCC---------CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMP---------YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~---------~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+|||.+.. ..++.++||||+|++++||++|+.||.....
T Consensus 201 ~aPE~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~p~~~~~~ 248 (319)
T 2y4i_B 201 LAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPA 248 (319)
T ss_dssp SCHHHHSCBSCC--CCCSCCCHHHHHHHHHHHHHHHHHSSCSSSSCCH
T ss_pred cChHHhhhccccccccccCCCchhhHHHHHHHHHHHHhCCCCCCCCCH
Confidence 99999874 3578999999999999999999999986543
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=99.96 E-value=1.2e-29 Score=198.16 Aligned_cols=173 Identities=23% Similarity=0.291 Sum_probs=129.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-------ccccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-------SEDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
||++++. +..|+.|+.+.. .....+..|.......+|++++. ..+...++++++++++|..++...
T Consensus 37 V~~~~~~--~~~vavK~~~~~-----~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~ 109 (278)
T 1byg_A 37 VMLGDYR--GNKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 109 (278)
T ss_dssp EEEEEET--TEEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH
T ss_pred EEEEEEc--CCEEEEEEecch-----hHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhc
Confidence 5666654 445555554321 12334666777777778887753 223457889999999999888654
Q ss_pred C---CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 I---LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~---~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
. +++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++....... ....+++.|+
T Consensus 110 ~~~~~~~~~~~~~~~~i~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~y~ 181 (278)
T 1byg_A 110 GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWT 181 (278)
T ss_dssp HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTS
T ss_pred ccccCCHHHHHHHHHHHHHHHHHHHh---CCccccCCCcceEEEeCCCcEEEeeccccccccccc-----cCCCcccccc
Confidence 2 8999999999999999999999 999999999999999999999999999987543321 1234588999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||.+.+..++.++|+||+|+++++|++ |+.||.....
T Consensus 182 aPE~~~~~~~~~~~Di~slG~il~~l~t~g~~p~~~~~~ 220 (278)
T 1byg_A 182 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPL 220 (278)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCG
T ss_pred CHHHhCCCCCCchhcHHHHHHHHHHHHhCCCCCCCCCCH
Confidence 9999988889999999999999999998 9999976543
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=1.8e-29 Score=201.53 Aligned_cols=178 Identities=22% Similarity=0.251 Sum_probs=117.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH-HHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++++..+++.||.|+.+..... ....++..+ .......+|++++. ..+...++++++.+ +|..+..
T Consensus 38 Vy~~~~~~~~~~vaiK~~~~~~~~--~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~ 114 (327)
T 3aln_A 38 VNKMVHKPSGQIMAVKRIRSTVDE--KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMST-SFDKFYKYV 114 (327)
T ss_dssp EEEEEETTTTEEEEEEEEECCCCH--HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCSE-EHHHHHHHH
T ss_pred EEEEEEcCCCCEEEEEEeecccCc--hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecCC-ChHHHHHHH
Confidence 688888888888888765432111 111122223 33555667887763 23445577777775 6655553
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 72 ----KNILGFGQLREIEVSTSKGIAYLHEECRQ-KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 72 ----~~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
...+++..+..++.|++.||.|||+ . +++||||||+||+++.++.+||+|||+++....... .....||
T Consensus 115 ~~~~~~~~~~~~~~~i~~~i~~~l~~lH~---~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~~---~~~~~gt 188 (327)
T 3aln_A 115 YSVLDDVIPEEILGKITLATVKALNHLKE---NLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSIA---KTRDAGC 188 (327)
T ss_dssp HHTTCCCCCHHHHHHHHHHHHHHHHHHHH---HHSCCCSCCCGGGEEEETTTEEEECCCSSSCC----------------
T ss_pred HhhhcccCcHHHHHHHHHHHHHHHHHHhc---cCCEeECCCCHHHEEEcCCCCEEEccCCCceecccccc---cccCCCC
Confidence 5679999999999999999999999 8 999999999999999999999999999976543322 2233579
Q ss_pred CcccCCccc----CCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELW----MPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~----~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.|+|||++ .+..++.++||||+|+++++|++|+.||....
T Consensus 189 ~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~~~ 233 (327)
T 3aln_A 189 RPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWN 233 (327)
T ss_dssp -----------------CCSHHHHHHHHHHHHHHHHSCCCSSCC-
T ss_pred ccccCceeeccccCcCCCCchhhHHHHHHHHHHHHHCCCCCCCcc
Confidence 999999998 45678999999999999999999999997643
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=99.95 E-value=2e-29 Score=219.57 Aligned_cols=173 Identities=17% Similarity=0.160 Sum_probs=134.2
Q ss_pred CCccccCC-CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc------cc-----ceEEEEEccCCchhh
Q 044746 1 MEKPRNRG-STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE------DT-----ETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~-~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~------~~-----~~~~~~~~~~~~l~~ 68 (202)
||++++.. +++.|+.|+..... ..+....+..|.......+|+|++... +. .+++++++++++|..
T Consensus 96 Vy~a~~~~~~~~~vaiK~~~~~~--~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~ 173 (681)
T 2pzi_A 96 IYLALDRNVNGRPVVLKGLVHSG--DAEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKR 173 (681)
T ss_dssp EEEEEEGGGTTEEEEEEESCSSC--CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC-
T ss_pred EEEEEEcCCCCcEEEEEEeCccC--CHHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHH
Confidence 68888865 56777777543221 111223456677777778899876321 11 478999999999988
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+... .+++.++..++.|++.||.|||+ ++|+||||||+||+++.+ .+||+|||+++..... ....||+.
T Consensus 174 ~~~~-~l~~~~~~~~~~qi~~aL~~lH~---~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~------~~~~gt~~ 242 (681)
T 2pzi_A 174 SKGQ-KLPVAEAIAYLLEILPALSYLHS---IGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF------GYLYGTPG 242 (681)
T ss_dssp ---C-CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC------SCCCCCTT
T ss_pred HHhC-CCCHHHHHHHHHHHHHHHHHHHH---CCCeecccChHHeEEeCC-cEEEEecccchhcccC------CccCCCcc
Confidence 7765 89999999999999999999999 999999999999999875 8999999999865432 33567999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|+|||++.+.. +.++|||||||++++|++|.+||....
T Consensus 243 y~aPE~~~~~~-~~~sDi~slG~~l~~l~~g~~~~~~~~ 280 (681)
T 2pzi_A 243 FQAPEIVRTGP-TVATDIYTVGRTLAALTLDLPTRNGRY 280 (681)
T ss_dssp TSCTTHHHHCS-CHHHHHHHHHHHHHHHHSCCCEETTEE
T ss_pred ccCHHHHcCCC-CCceehhhhHHHHHHHHhCCCCCcccc
Confidence 99999987654 889999999999999999999987643
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=3.4e-29 Score=198.86 Aligned_cols=179 Identities=15% Similarity=0.178 Sum_probs=124.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcc--cccccc------ccccceEEEEEccCCchhhhhcc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADN--FSNLVG------SEDTETYIKGFLAMGPFYLLCKK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~ 72 (202)
||++++.. ++.||.|+...... .......+..|........ +++++. ......++++ ..+++|..++..
T Consensus 44 Vy~~~~~~-~~~vavK~~~~~~~-~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e-~~~~~L~~~l~~ 120 (313)
T 3cek_A 44 VFQVLNEK-KQIYAIKYVNLEEA-DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120 (313)
T ss_dssp EEEEECTT-CCEEEEEEEECSSC-CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEEC-CCSEEHHHHHHH
T ss_pred EEEEEcCC-CcEEEEEEeccccc-cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEe-cCCCcHHHHHHh
Confidence 67888865 55566555322111 1112234555555554443 366553 2333445565 677888888754
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++.++..++.|++.||.|||+ .+++||||||+||+++. +.+||+|||++................|++.|+|
T Consensus 121 ~~~~~~~~~~~i~~qi~~aL~~LH~---~~ivH~dlkp~NIl~~~-~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~a 196 (313)
T 3cek_A 121 KKSIDPWERKSYWKNMLEAVHTIHQ---HGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMP 196 (313)
T ss_dssp CSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEEET-TEEEECCCSSSCC--------------CCGGGCC
T ss_pred cCCCCHHHHHHHHHHHHHHHHHHHH---CCceecCCCcccEEEEC-CeEEEeeccccccccCccccccccCCCCCCCcCC
Confidence 569999999999999999999999 99999999999999964 8999999999986644333222334567999999
Q ss_pred CcccCC-----------CCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 152 PELWMP-----------YSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 152 Pe~~~~-----------~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||.+.+ ..++.++||||+|++++||++|+.||...
T Consensus 197 PE~~~~~~~~~~~~~~~~~~~~~~Di~slG~il~el~~g~~pf~~~ 242 (313)
T 3cek_A 197 PEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQI 242 (313)
T ss_dssp HHHHTTCC----------CCCHHHHHHHHHHHHHHHHHSSCTTTTC
T ss_pred HHHHhhcccccccccccccCCchHHHHHHHHHHHHHHhCCCchhhH
Confidence 999875 46888999999999999999999999754
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=99.95 E-value=8.9e-29 Score=194.72 Aligned_cols=171 Identities=24% Similarity=0.289 Sum_probs=131.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc-------------------cccceEEEEEc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS-------------------EDTETYIKGFL 61 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-------------------~~~~~~~~~~~ 61 (202)
||++++..+++.|+.|+.+.... ....+..|.......+|++++.. .+...++++++
T Consensus 22 V~~~~~~~~~~~vaiK~~~~~~~----~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~ 97 (303)
T 1zy4_A 22 VVKARNALDSRYYAIKKIRHTEE----KLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYC 97 (303)
T ss_dssp EEEEEETTTCCEEEEEEEEEEHH----HHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECC
T ss_pred EEEEEEcCCCeEEEEEEEeccHH----HHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecC
Confidence 68888888888888876543221 22346667777777888987642 34456889999
Q ss_pred cCCchhhhhccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc---
Q 044746 62 AMGPFYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT--- 136 (202)
Q Consensus 62 ~~~~l~~~~~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~--- 136 (202)
++++|..++... .+++..+..++.|++.||.|||+ .+++||||||+||+++.++.++|+|||++........
T Consensus 98 ~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~ 174 (303)
T 1zy4_A 98 ENGTLYDLIHSENLNQQRDEYWRLFRQILEALSYIHS---QGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILK 174 (303)
T ss_dssp CSCBHHHHHHHSCGGGCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC------
T ss_pred CCCCHHHhhhccccccchHHHHHHHHHHHHHHHHHHh---CCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhc
Confidence 999999988643 47889999999999999999999 9999999999999999999999999999986542210
Q ss_pred ---------ccccCCCCCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHc
Q 044746 137 ---------HITSTGRRRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVG 178 (202)
Q Consensus 137 ---------~~~~~~~~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~ 178 (202)
........||+.|+|||++.+. .++.++|+||+|+++|||++
T Consensus 175 ~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 226 (303)
T 1zy4_A 175 LDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMIY 226 (303)
T ss_dssp -------------------CTTSCHHHHTSCSCCCTHHHHHHHHHHHHHHHS
T ss_pred cccccccccccccccCCCcccccCcccccCCCCCcchhhHHHHHHHHHHHHh
Confidence 1112334679999999999864 68999999999999999998
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=4.6e-29 Score=195.83 Aligned_cols=179 Identities=21% Similarity=0.306 Sum_probs=140.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||++++..+++.|+.|+...... .......+..|.......+|++++. ..+...++++++++++|...+ ...
T Consensus 38 V~~~~~~~~~~~valK~~~~~~~-~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~ 116 (287)
T 2wei_A 38 VLKCKDRITQQEYAVKVINKASA-KNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRK 116 (287)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGB-SSSCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHS
T ss_pred EEEEEEcCCCcEEEEEEeccccc-chHHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcC
Confidence 68888888888888877543322 1223345666777777788888763 334456788889999987766 445
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCC---CceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN---FFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~---~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++.++..++.|++.||.|||+ .+++|+||||+||+++.+ +.++|+|||++........ .....|++.|+
T Consensus 117 ~~~~~~~~~i~~qi~~~l~~LH~---~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~---~~~~~~~~~y~ 190 (287)
T 2wei_A 117 RFSEHDAARIIKQVFSGITYMHK---HNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTK---MKDRIGTAYYI 190 (287)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSS---CSCHHHHHTTC
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCCc---cccccCccccc
Confidence 79999999999999999999999 999999999999999754 4799999999876543221 12234688999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
|||.+.+ .++.++|+||+|+++++|++|+.||....
T Consensus 191 aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p~~~~~ 226 (287)
T 2wei_A 191 APEVLRG-TYDEKCDVWSAGVILYILLSGTPPFYGKN 226 (287)
T ss_dssp CHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCSSCCSS
T ss_pred ChHHhcC-CCCCchhhHhHHHHHHHHHhCCCCCCCCC
Confidence 9999876 48899999999999999999999997654
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=9.8e-29 Score=196.13 Aligned_cols=177 Identities=20% Similarity=0.220 Sum_probs=125.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||++++..+++.||.|+........ .....+..+.......+|++++. ..+...++++++ ++.+..+.. .
T Consensus 41 V~~~~~~~~~~~vavK~~~~~~~~~-~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~ 118 (318)
T 2dyl_A 41 VWKMRFRKTGHVIAVKQMRRSGNKE-ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQ 118 (318)
T ss_dssp EEEEEETTTCCEEEEEEEETTSCHH-HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHT
T ss_pred EEEEEEecCCeEEEEEEecccccch-HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhc
Confidence 6888888888888887654332111 11122333444556667887763 334445777777 444444443 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCC-CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQ-KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~-~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ . +++|+||||+||+++.++.++|+|||++........ .....||+.|+|
T Consensus 119 ~~~~~~~~~~~~~~i~~~l~~lH~---~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~y~a 192 (318)
T 2dyl_A 119 GPIPERILGKMTVAIVKALYYLKE---KHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA---KDRSAGCAAYMA 192 (318)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---HHCCCCCCCCGGGEEECTTSCEEECCCTTC-----------------CCTTCC
T ss_pred cCCCHHHHHHHHHHHHHHHHHHHh---hCCEEeCCCCHHHEEECCCCCEEEEECCCchhccCCcc---ccccCCCccccC
Confidence 679999999999999999999998 6 999999999999999999999999999976543222 223457999999
Q ss_pred CcccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 152 PELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 152 Pe~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
||.+. ...++.++||||+|++++||++|+.||..
T Consensus 193 PE~~~~~~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (318)
T 2dyl_A 193 PERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKN 231 (318)
T ss_dssp HHHHC--------CCTHHHHHHHHHHHHHHHHSSCTTTT
T ss_pred hhhcccccccccCCccccchhhHHHHHHHHHhCCCCCCC
Confidence 99984 45688999999999999999999999976
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=99.95 E-value=7.9e-28 Score=199.46 Aligned_cols=151 Identities=21% Similarity=0.272 Sum_probs=112.1
Q ss_pred CCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhccCC--CCHHHHHHHHHHHHHHHHHHHhCCCCCe
Q 044746 32 FTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI--LGFGQLREIEVSTSKGIAYLHEECRQKI 102 (202)
Q Consensus 32 ~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~--~~~~~~~~~~~~i~~~l~~lH~~~~~~i 102 (202)
+..|..+.... +|+|++. ......++++++. ++|..++.... .+...+..++.|++.||.|||+ .+|
T Consensus 64 ~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~---~~i 139 (432)
T 3p23_A 64 ADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGLAHLHS---LNI 139 (432)
T ss_dssp CHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHHHHH---TTC
T ss_pred HHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHHHHHHH---CcC
Confidence 44565556555 7998874 3344567777776 68888876553 5555678999999999999999 999
Q ss_pred EEecCCCCcEEEcC-----CCceEEeeeecceeccccCc-ccccCCCCCCCcccCCcccC---CCCCCchhhHHHHHHHH
Q 044746 103 VHYDIKPESVLLDE-----NFFPKAADFGLAKLYNREHT-HITSTGRRRTPGCEAPELWM---PYSVTQKCDVFSFGMLL 173 (202)
Q Consensus 103 iHrdlk~~nil~~~-----~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~~y~aPe~~~---~~~~~~~~Diws~G~~l 173 (202)
+||||||+||+++. ...++|+|||+++....... ........||+.|+|||++. ...++.++||||+||++
T Consensus 140 vHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~DiwSlG~il 219 (432)
T 3p23_A 140 VHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVF 219 (432)
T ss_dssp CCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHHHHHHHHHH
T ss_pred EeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHHHHHHHHHH
Confidence 99999999999943 34578999999986643321 12234466899999999997 45678899999999999
Q ss_pred HHHHc-CCCCCcch
Q 044746 174 FEVVG-RRRNLEKE 186 (202)
Q Consensus 174 ~el~~-g~~p~~~~ 186 (202)
+||++ |..||...
T Consensus 220 ~ellt~g~~pf~~~ 233 (432)
T 3p23_A 220 YYVISEGSHPFGKS 233 (432)
T ss_dssp HHHHTTSCBTTBST
T ss_pred HHHHcCCCCCcchh
Confidence 99999 99999654
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=99.95 E-value=5.5e-28 Score=200.44 Aligned_cols=151 Identities=20% Similarity=0.324 Sum_probs=109.6
Q ss_pred CcHHHHHH-hcccccccc------ccccceEEEEEccCCchhhhhccCCCC--------HHHHHHHHHHHHHHHHHHHhC
Q 044746 33 TSPQRMIA-ADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNILG--------FGQLREIEVSTSKGIAYLHEE 97 (202)
Q Consensus 33 ~~~~~~~~-~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~~~--------~~~~~~~~~~i~~~l~~lH~~ 97 (202)
..|..... ..+|+|++. ......++++++. |+|..++...... +..+..++.|++.||.|||+
T Consensus 56 ~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~- 133 (434)
T 2rio_A 56 LMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLRQIASGVAHLHS- 133 (434)
T ss_dssp HHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHHHHHHHHHHHHH-
T ss_pred HHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHHHHHHHHHHHHH-
Confidence 34444444 348898874 3344567788875 6998888655422 22356799999999999999
Q ss_pred CCCCeEEecCCCCcEEEcCC-------------CceEEeeeecceeccccCccc--ccCCCCCCCcccCCcccCC-----
Q 044746 98 CRQKIVHYDIKPESVLLDEN-------------FFPKAADFGLAKLYNREHTHI--TSTGRRRTPGCEAPELWMP----- 157 (202)
Q Consensus 98 ~~~~iiHrdlk~~nil~~~~-------------~~~kl~dfgl~~~~~~~~~~~--~~~~~~gt~~y~aPe~~~~----- 157 (202)
.+|+||||||+||+++.+ +.+||+|||+++......... ......||+.|+|||++.+
T Consensus 134 --~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 211 (434)
T 2rio_A 134 --LKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQ 211 (434)
T ss_dssp --TTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHHSCCCTTS
T ss_pred --CCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHhccccccc
Confidence 999999999999999754 489999999998765432211 1234568999999999975
Q ss_pred --CCCCchhhHHHHHHHHHHHHc-CCCCCcchh
Q 044746 158 --YSVTQKCDVFSFGMLLFEVVG-RRRNLEKEI 187 (202)
Q Consensus 158 --~~~~~~~Diws~G~~l~el~~-g~~p~~~~~ 187 (202)
..++.++||||+||+++||++ |+.||....
T Consensus 212 ~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~ 244 (434)
T 2rio_A 212 TKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKY 244 (434)
T ss_dssp CCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTT
T ss_pred cccCcchhhhhHhHHHHHHHHHhCCCCCCCCch
Confidence 568999999999999999999 999997543
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=99.94 E-value=1.7e-27 Score=187.45 Aligned_cols=157 Identities=10% Similarity=-0.015 Sum_probs=126.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||++++...++.||.|+.........+....+..|.......+|+|++. ..+..+++++++++++|..+++.+.
T Consensus 47 Vy~a~~~~~~~~vavK~~~~~~~~~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~ 126 (286)
T 3uqc_A 47 FWQALDTALDRQVALTFVDPQGVLPDDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADTSP 126 (286)
T ss_dssp EEEEEETTTTEEEEEEESCTTCCSCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTTCC
T ss_pred EEEEEecCCCceEEEEEECcccccCHHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhcCC
Confidence 6899998888888888765443222223355777777788889998763 3345668899999999999997654
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
...++..++.|++.||.|||+ .+|+||||||+||+++.++.++|++++ |++
T Consensus 127 -~~~~~~~i~~ql~~aL~~lH~---~givH~Dikp~NIll~~~g~~kl~~~~----------------------~~~--- 177 (286)
T 3uqc_A 127 -SPVGAIRAMQSLAAAADAAHR---AGVALSIDHPSRVRVSIDGDVVLAYPA----------------------TMP--- 177 (286)
T ss_dssp -CHHHHHHHHHHHHHHHHHHHH---TTCCCCCCSGGGEEEETTSCEEECSCC----------------------CCT---
T ss_pred -ChHHHHHHHHHHHHHHHHHHH---CCCccCCCCcccEEEcCCCCEEEEecc----------------------ccC---
Confidence 566789999999999999999 999999999999999999999987432 333
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
+++.++||||+||++|||++|+.||.......
T Consensus 178 ----~~~~~~Di~slG~il~elltg~~Pf~~~~~~~ 209 (286)
T 3uqc_A 178 ----DANPQDDIRGIGASLYALLVNRWPLPEAGVRS 209 (286)
T ss_dssp ----TCCHHHHHHHHHHHHHHHHHSEECSCCCSBCC
T ss_pred ----CCCchhHHHHHHHHHHHHHHCCCCCCcCCcch
Confidence 36889999999999999999999998766543
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=99.93 E-value=2e-26 Score=181.89 Aligned_cols=153 Identities=20% Similarity=0.281 Sum_probs=119.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHH-HHhccccccccc----------cccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRM-IAADNFSNLVGS----------EDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~----------~~~~~~~~~~~~~~~l~~~ 69 (202)
||++++...++.||.|+.+... .+..|... ....+|++++.. .....++++++++++|..+
T Consensus 34 V~~~~~~~~~~~vaiK~~~~~~--------~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 105 (299)
T 3m2w_A 34 VLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 105 (299)
T ss_dssp EEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHH
T ss_pred EEEEEEcCCCcEEEEEEecccH--------HHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHH
Confidence 6888888888888888754322 12233322 355577776531 3445688899999999988
Q ss_pred hccC---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCC
Q 044746 70 CKKN---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 70 ~~~~---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
+... .+++..+..++.|++.||.|||+ .+++||||||+||+++. ++.++|+|||++....
T Consensus 106 l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~---~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~----------- 171 (299)
T 3m2w_A 106 IQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT----------- 171 (299)
T ss_dssp HHHCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT-----------
T ss_pred HHhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCcccCCCCHHHEEEecCCCCCcEEEeccccccccc-----------
Confidence 8654 59999999999999999999999 99999999999999997 7899999999886432
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+..++.++|+||+||+++||++|+.||.....
T Consensus 172 -------------~~~~~~~~DiwslG~il~el~tg~~pf~~~~~ 203 (299)
T 3m2w_A 172 -------------GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203 (299)
T ss_dssp -------------TCGGGGHHHHHHHHHHHHHHHHSSCSCCC---
T ss_pred -------------cccCCchhhHHHHHHHHHHHHHCCCCCCCCcc
Confidence 13467899999999999999999999976543
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=99.92 E-value=9e-28 Score=205.14 Aligned_cols=146 Identities=14% Similarity=0.044 Sum_probs=99.0
Q ss_pred cccCCcHHHHHHhc-cccccc------cccccceEEEEEccCCchhhhhccC-CCCHHHHHHHHHHHHHHHHHHHhCCCC
Q 044746 29 PIRFTSPQRMIAAD-NFSNLV------GSEDTETYIKGFLAMGPFYLLCKKN-ILGFGQLREIEVSTSKGIAYLHEECRQ 100 (202)
Q Consensus 29 ~~~~~~~~~~~~~~-~~~~~i------~~~~~~~~~~~~~~~~~l~~~~~~~-~~~~~~~~~~~~~i~~~l~~lH~~~~~ 100 (202)
..+|..|...+... +|+|++ ...+..+++|++++|++|.+++..+ .++.. .|+.||+.||+|+|+ +
T Consensus 285 ~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~---~ 358 (569)
T 4azs_A 285 KYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK---Q 358 (569)
T ss_dssp HHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH---T
T ss_pred HHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH---C
Confidence 34566776666654 566654 2455678999999999999998654 46653 588999999999999 9
Q ss_pred CeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCC
Q 044746 101 KIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180 (202)
Q Consensus 101 ~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~ 180 (202)
|||||||||+|||++.++.+||+|||+|+....... .....+||+.|+|||++.+. +..++|+||+|++++++.++.
T Consensus 359 GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~~--~~~t~vGTp~YmAPE~l~g~-~~~~~d~~s~g~~~~~l~~~~ 435 (569)
T 4azs_A 359 GFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDCS--WPTNLVQSFFVFVNELFAEN-KSWNGFWRSAPVHPFNLPQPW 435 (569)
T ss_dssp TCEESCCCGGGEEECTTSCEEECCCTTEESCC---C--CSHHHHHHHHHHHHHHC------------------CCCCTTH
T ss_pred CceeccCchHhEEECCCCCEEEeecccCeeCCCCCc--cccCceechhhccHHHhCCC-CCCcccccccccchhhhcccc
Confidence 999999999999999999999999999986543322 12335689999999998764 567899999999887766554
Q ss_pred CCC
Q 044746 181 RNL 183 (202)
Q Consensus 181 ~p~ 183 (202)
.|+
T Consensus 436 ~~~ 438 (569)
T 4azs_A 436 SNW 438 (569)
T ss_dssp HHH
T ss_pred chh
Confidence 443
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.85 E-value=2.6e-23 Score=176.62 Aligned_cols=143 Identities=17% Similarity=0.192 Sum_probs=116.5
Q ss_pred ccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeE
Q 044746 30 IRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIV 103 (202)
Q Consensus 30 ~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~ii 103 (202)
.++..|..+....+|+|++. .....+++++++++++|..++.. +..++.|++.||.|||+ ++|+
T Consensus 384 ~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~-------~~~i~~qi~~aL~~LH~---~gIi 453 (540)
T 3en9_A 384 SRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED-------NLDIAYKIGEIVGKLHK---NDVI 453 (540)
T ss_dssp HHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT-------CTHHHHHHHHHHHHHHH---TTEE
T ss_pred HHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH-------HHHHHHHHHHHHHHHHH---CcCc
Confidence 44677888888889999871 23445799999999999998876 66899999999999999 9999
Q ss_pred EecCCCCcEEEcCCCceEEeeeecceeccccCccc-----ccCCCCCCCcccCCcccCC--CCCCchhhHHHHHHHHHHH
Q 044746 104 HYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-----TSTGRRRTPGCEAPELWMP--YSVTQKCDVFSFGMLLFEV 176 (202)
Q Consensus 104 Hrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-----~~~~~~gt~~y~aPe~~~~--~~~~~~~Diws~G~~l~el 176 (202)
||||||+|||++. .+||+|||+++......... ......||+.|+|||++.. ..|+..+|+||..+-..+-
T Consensus 454 HrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~l~~ 531 (540)
T 3en9_A 454 HNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILELMKD 531 (540)
T ss_dssp CTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHHHHH
T ss_pred cCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHHHHH
Confidence 9999999999998 99999999999765432211 1123567999999999976 5677888999999888888
Q ss_pred HcCCCCCc
Q 044746 177 VGRRRNLE 184 (202)
Q Consensus 177 ~~g~~p~~ 184 (202)
+.++.++.
T Consensus 532 v~~r~rY~ 539 (540)
T 3en9_A 532 VERRARYV 539 (540)
T ss_dssp HHTCSCCC
T ss_pred HHhccccC
Confidence 87777764
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.70 E-value=1.4e-18 Score=136.24 Aligned_cols=130 Identities=11% Similarity=-0.051 Sum_probs=88.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccC---------------CcccCCcHHHHHHhcccccccc--ccccceEEEEEccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMD---------------KPIRFTSPQRMIAADNFSNLVG--SEDTETYIKGFLAM 63 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~~~~~i~--~~~~~~~~~~~~~~ 63 (202)
||++++ .+++.||.|+.+........ ....+..|.......++.++.+ ..+...++++++++
T Consensus 106 Vy~~~~-~~g~~valK~~~~~~~~~~~~~~~~~~~~~~w~~~~~~~~~~E~~~l~~l~~~~v~~~~~~~~~~lvmE~~~g 184 (282)
T 1zar_A 106 VFNCYS-EKFGECVVKFHKVGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLMELIDA 184 (282)
T ss_dssp EEEEEE-TTTEEEEEEEECC------CCCC-------CHHHHHHHHHHHHHHHHHHTTTSSSCCEEEEETTEEEEECCCC
T ss_pred EEEEEe-CCCCEEEEEEEECCCCchhhhhhhhhhcchhhHHHHHHHHHHHHHHHHhccCCCcCeEEeccceEEEEEecCC
Confidence 688888 66677777765432211110 1122444544444433243332 22445799999999
Q ss_pred CchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCC
Q 044746 64 GPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 64 ~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
++|.. +. ......++.|++.||.|||+ .+++||||||+||+++ ++.++|+|||+++.
T Consensus 185 ~~L~~-l~-----~~~~~~i~~qi~~~l~~lH~---~giiHrDlkp~NILl~-~~~vkl~DFG~a~~------------- 241 (282)
T 1zar_A 185 KELYR-VR-----VENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE------------- 241 (282)
T ss_dssp EEGGG-CC-----CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEE-TTEEEECCCTTCEE-------------
T ss_pred CcHHH-cc-----hhhHHHHHHHHHHHHHHHHH---CCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-------------
Confidence 99987 32 23456799999999999999 9999999999999999 99999999999864
Q ss_pred CCCCcccCCcccC
Q 044746 144 RRTPGCEAPELWM 156 (202)
Q Consensus 144 ~gt~~y~aPe~~~ 156 (202)
+..++|||++.
T Consensus 242 --~~~~~a~e~l~ 252 (282)
T 1zar_A 242 --VGEEGWREILE 252 (282)
T ss_dssp --TTSTTHHHHHH
T ss_pred --CCCCCHHHHHH
Confidence 33456787764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.45 E-value=2.7e-14 Score=110.33 Aligned_cols=80 Identities=15% Similarity=0.122 Sum_probs=61.7
Q ss_pred ccccccccccceEEEEEccC-C----chhhhhccCCCCHHHHHHHHHHHHHHHHHHH-hCCCCCeEEecCCCCcEEEcCC
Q 044746 44 FSNLVGSEDTETYIKGFLAM-G----PFYLLCKKNILGFGQLREIEVSTSKGIAYLH-EECRQKIVHYDIKPESVLLDEN 117 (202)
Q Consensus 44 ~~~~i~~~~~~~~~~~~~~~-~----~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH-~~~~~~iiHrdlk~~nil~~~~ 117 (202)
++..+.. ....++++++.+ | +|...... .++..+..++.|++.||.||| + .+|+||||||.|||++.
T Consensus 134 ~p~~~~~-~~~~lVmE~~g~~g~~~~~L~~~~~~--~~~~~~~~i~~qi~~~l~~lH~~---~givHrDlkp~NILl~~- 206 (258)
T 1zth_A 134 VPQPYTY-MKNVLLMEFIGEDELPAPTLVELGRE--LKELDVEGIFNDVVENVKRLYQE---AELVHADLSEYNIMYID- 206 (258)
T ss_dssp CCCEEEE-ETTEEEEECCEETTEECCBHHHHGGG--GGGSCHHHHHHHHHHHHHHHHHT---SCEECSSCSTTSEEESS-
T ss_pred CCeEEEc-CCCEEEEEecCCCCCccccHHHHhhc--cChHHHHHHHHHHHHHHHHHHHH---CCEEeCCCCHHHEEEcC-
Confidence 3444443 345688999842 4 55544322 235577899999999999999 8 99999999999999988
Q ss_pred CceEEeeeecceec
Q 044746 118 FFPKAADFGLAKLY 131 (202)
Q Consensus 118 ~~~kl~dfgl~~~~ 131 (202)
.++|+|||+|...
T Consensus 207 -~~~liDFG~a~~~ 219 (258)
T 1zth_A 207 -KVYFIDMGQAVTL 219 (258)
T ss_dssp -SEEECCCTTCEET
T ss_pred -cEEEEECcccccC
Confidence 8999999999754
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.16 E-value=1.5e-11 Score=99.96 Aligned_cols=69 Identities=14% Similarity=0.138 Sum_probs=57.2
Q ss_pred eEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC----------ceEEee
Q 044746 55 TYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF----------FPKAAD 124 (202)
Q Consensus 55 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~----------~~kl~d 124 (202)
.+++++++++++..+.. .+....++.|++.+|.+||+ .+||||||||.|||++.++ .+.++|
T Consensus 187 ~LVME~i~G~~L~~l~~-----~~~~~~l~~qll~~l~~lH~---~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID 258 (397)
T 4gyi_A 187 TIVMSLVDALPMRQVSS-----VPDPASLYADLIALILRLAK---HGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIX 258 (397)
T ss_dssp EEEEECCSCEEGGGCCC-----CSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECC
T ss_pred eEEEEecCCccHhhhcc-----cHHHHHHHHHHHHHHHHHHH---CCCcCCCCCHHHEEEeCCCCcccccccccceEEEE
Confidence 58999999988866543 23456788999999999999 9999999999999998766 388999
Q ss_pred eecceec
Q 044746 125 FGLAKLY 131 (202)
Q Consensus 125 fgl~~~~ 131 (202)
|+-+...
T Consensus 259 ~~Q~V~~ 265 (397)
T 4gyi_A 259 FPQMVSM 265 (397)
T ss_dssp CTTCEET
T ss_pred eCCcccC
Confidence 9977654
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=98.31 E-value=4.4e-07 Score=69.45 Aligned_cols=84 Identities=8% Similarity=-0.011 Sum_probs=60.7
Q ss_pred ccccccc---ccccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------
Q 044746 43 NFSNLVG---SEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEEC--------------------- 98 (202)
Q Consensus 43 ~~~~~i~---~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--------------------- 98 (202)
..|.+++ ..+..++++++++|.++..... +......++.+++.++..||+..
T Consensus 71 ~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~----~~~~~~~~~~~l~~~l~~LH~~~~~~~~~~~~~~~~~~~~~~~~ 146 (263)
T 3tm0_A 71 PVPKVLHFERHDGWSNLLMSEADGVLCSEEYE----DEQSPEKIIELYAECIRLFHSIDISDCPYTNSLDSRLAELDYLL 146 (263)
T ss_dssp CCCCEEEEEEETTEEEEEEECCSSEEHHHHCC----TTTCHHHHHHHHHHHHHHHHHSCCTTCSCBCCHHHHHHHHHHHH
T ss_pred CCCeEEEEEecCCceEEEEEecCCeehhhccC----CcccHHHHHHHHHHHHHHHhCCCcccCCCcchHHHHHHHHHHHH
Confidence 3445553 3345568999999998876531 22334578889999999999811
Q ss_pred -----------------------------------CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 -----------------------------------RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 -----------------------------------~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
...++|+|++|.||+++....+.++||+.+..
T Consensus 147 ~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T 3tm0_A 147 NNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp HTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEETTEEEEECCCTTCEE
T ss_pred hccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEECCcEEEEEEchhccc
Confidence 13489999999999998766667999987754
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=98.18 E-value=9.2e-07 Score=67.21 Aligned_cols=80 Identities=13% Similarity=0.103 Sum_probs=55.7
Q ss_pred cccccccc---ccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCC----------------------
Q 044746 44 FSNLVGSE---DTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEEC---------------------- 98 (202)
Q Consensus 44 ~~~~i~~~---~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~---------------------- 98 (202)
.|.+++.. +...++++++++.++. .. ..+ ...++.+++..|..||+..
T Consensus 77 vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~--~~~---~~~~~~~l~~~l~~lh~~~~~~~~~~~~~~~~~~~~~~~~~ 149 (264)
T 1nd4_A 77 CAAVLDVVTEAGRDWLLLGEVPGQDLL--SS--HLA---PAEKVSIMADAMRRLHTLDPATCPFDHQAKHRIERARTRME 149 (264)
T ss_dssp BCCEEEEEECSSCEEEEEECCSSEETT--TS--CCC---HHHHHHHHHHHHHHHTTSCGGGCCCBCCHHHHHHHHHHHHH
T ss_pred CCeEEEeccCCCCCEEEEEecCCcccC--cC--cCC---HhHHHHHHHHHHHHHhCCCCCCCCCchHHHHHHHHHHHHHh
Confidence 34455432 3457889999998884 21 122 2356778888888888621
Q ss_pred ---------------------------------CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 ---------------------------------RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 ---------------------------------~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
...++|+|++|.||+++.++.+.++||+.+..
T Consensus 150 ~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~~~~~liD~~~a~~ 214 (264)
T 1nd4_A 150 AGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENGRFSGFIDCGRLGV 214 (264)
T ss_dssp TTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECCcEEEEEcchhccc
Confidence 01299999999999998776677999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.04 E-value=1.4e-06 Score=68.36 Aligned_cols=130 Identities=16% Similarity=0.082 Sum_probs=82.3
Q ss_pred ceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCC-----------------------------------
Q 044746 54 ETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEEC----------------------------------- 98 (202)
Q Consensus 54 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~----------------------------------- 98 (202)
.++++++++|.++..... ..++..+...++.+++..+..||+..
T Consensus 91 ~~~vm~~i~G~~l~~~~~-~~l~~~~~~~~~~~l~~~la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (304)
T 3sg8_A 91 SFAGFTKIKGVPLTPLLL-NNLPKQSQNQAAKDLARFLSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQ 169 (304)
T ss_dssp SCEEEECCCCEECCHHHH-HTSCHHHHHHHHHHHHHHHHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHH
T ss_pred ceEEEcccCCeECCcccc-ccCCHHHHHHHHHHHHHHHHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCccc
Confidence 456788899888754321 35677788888888888888888611
Q ss_pred --------------------CCCeEEecCCCCcEEEcC--CCceEEeeeecceeccccCcccccCCCCCCCcccCCcccC
Q 044746 99 --------------------RQKIVHYDIKPESVLLDE--NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWM 156 (202)
Q Consensus 99 --------------------~~~iiHrdlk~~nil~~~--~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~ 156 (202)
...++|+|++|.||+++. ...+.++||+.+............... . .-..|+...
T Consensus 170 ~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~~~~~~~iD~~~~~~~~~~~Dl~~~~~~--~-~~~~~~~~~ 246 (304)
T 3sg8_A 170 MKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFDTEKNTICGIIDFGDAAISDPDNDFISLMED--D-EEYGMEFVS 246 (304)
T ss_dssp HHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEETTTTEEEEECCCTTCEEECTTHHHHTTCCT--T-TSCCHHHHH
T ss_pred HHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEeCCCCCEEEEEeCCCCccCChHHHHHHHHhh--c-cccCHHHHH
Confidence 135799999999999987 556789999988753221110000000 0 001111110
Q ss_pred ------CCC--------CCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 157 ------PYS--------VTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 157 ------~~~--------~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.. .....+.|+++.+++.+.+|.++|....
T Consensus 247 ~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~~~g 291 (304)
T 3sg8_A 247 KILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWYEEG 291 (304)
T ss_dssp HHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHHHHH
T ss_pred HHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHHHHH
Confidence 000 1122578999999999999999886443
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=97.81 E-value=4.4e-05 Score=61.04 Aligned_cols=78 Identities=18% Similarity=0.176 Sum_probs=61.2
Q ss_pred ccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------------------
Q 044746 52 DTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEEC--------------------------------- 98 (202)
Q Consensus 52 ~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--------------------------------- 98 (202)
+..+++++++++..+.... ...++..+...++.+++..|..||+..
T Consensus 114 g~~~~vme~v~G~~l~~~~-~~~l~~~~~~~~~~~l~~~La~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 192 (359)
T 3dxp_A 114 GRAFYIMEFVSGRVLWDQS-LPGMSPAERTAIYDEMNRVIAAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETE 192 (359)
T ss_dssp SSCEEEEECCCCBCCCCTT-CTTCCHHHHHHHHHHHHHHHHHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCS
T ss_pred CCeEEEEEecCCeecCCCc-cccCCHHHHHHHHHHHHHHHHHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCc
Confidence 3467899999987774321 234778889999999999999999731
Q ss_pred ----------------------CCCeEEecCCCCcEEEcCCC--ceEEeeeeccee
Q 044746 99 ----------------------RQKIVHYDIKPESVLLDENF--FPKAADFGLAKL 130 (202)
Q Consensus 99 ----------------------~~~iiHrdlk~~nil~~~~~--~~kl~dfgl~~~ 130 (202)
...++|+|+++.||+++.++ .+.++||+.+..
T Consensus 193 ~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~~~~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 193 SIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHPTEPRVLAVLDWELSTL 248 (359)
T ss_dssp CCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECSSSSCEEEECCCTTCEE
T ss_pred CChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeCCCCcEEEEECcccccc
Confidence 25699999999999998764 368999998875
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=96.56 E-value=0.0014 Score=49.88 Aligned_cols=85 Identities=12% Similarity=0.109 Sum_probs=56.5
Q ss_pred ccccccc---ccccceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCC---------------------
Q 044746 43 NFSNLVG---SEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEEC--------------------- 98 (202)
Q Consensus 43 ~~~~~i~---~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~--------------------- 98 (202)
..|.+++ ..+..+++++++++.++....... ......+..+++..|.-||+..
T Consensus 81 PVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~---~~~~~~~~~~l~~~L~~Lh~~~~~~~~~~~~~~~~~~~~~~~~ 157 (272)
T 4gkh_A 81 PLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY---PDSGENIVDALAVFLRRLHSIPVCNCPFNSDRVFRLAQAQSRM 157 (272)
T ss_dssp CCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC---GGGHHHHHHHHHHHHHHHHTSCGGGCCBBCCHHHHHHHHHHHH
T ss_pred CcCeEEEEEEECCeEEEEEEeeCCccccccccCC---HHHHHHHHHHHHHHHHHhcCCCcccCCcCcccccchhhHHHHH
Confidence 3456654 345567899999988776544321 2233445566666666666411
Q ss_pred ----------------------------------CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 ----------------------------------RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 ----------------------------------~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
...++|+|+.+.||+++..+.+-|+||+.+..
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~~~~~viDwe~a~~ 223 (272)
T 4gkh_A 158 NNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEGKLIGCIDVGRVGI 223 (272)
T ss_dssp HTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred HHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECCeEEEEEECccccc
Confidence 01368999999999999877778999998764
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=96.45 E-value=0.007 Score=47.21 Aligned_cols=32 Identities=25% Similarity=0.414 Sum_probs=25.7
Q ss_pred CCeEEecCCCCcEEEcC---CCc-eEEeeeecceec
Q 044746 100 QKIVHYDIKPESVLLDE---NFF-PKAADFGLAKLY 131 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~---~~~-~kl~dfgl~~~~ 131 (202)
..++|+|+.+.|++++. ++. +.++||+.+..-
T Consensus 190 ~~~~HgD~~~~N~l~~~~~~~~~~~~~iD~~~a~~g 225 (306)
T 3tdw_A 190 PRLIHGDLSPDHFLTNLNSRQTPLTGIIDFGDAAIS 225 (306)
T ss_dssp CEEECSCCSGGGEEECTTCSSCCEEEECCCTTCEEE
T ss_pred CeeEeCCCCcccEEEecCCCCCceEEEEehhhcCCC
Confidence 35699999999999987 344 589999987653
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=95.93 E-value=0.0096 Score=46.61 Aligned_cols=31 Identities=23% Similarity=0.224 Sum_probs=27.9
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~~ 252 (346)
T 2q83_A 222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVSF 252 (346)
T ss_dssp CCEECSSCSTTSEEECGGGCEEECCCTTCEE
T ss_pred CceecCCCCcccEEEeCCCcEEEEehhhccc
Confidence 7899999999999998778899999998764
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=95.67 E-value=0.022 Score=45.09 Aligned_cols=31 Identities=16% Similarity=0.150 Sum_probs=26.5
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.||+++....+.++||+.+..
T Consensus 222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~ 252 (357)
T 3ats_A 222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL 252 (357)
T ss_dssp CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence 5789999999999998654578999998864
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=94.57 E-value=0.032 Score=45.39 Aligned_cols=31 Identities=19% Similarity=0.278 Sum_probs=27.5
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeecceec
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKLY 131 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~ 131 (202)
..++|+|++|.||+++.++ +.++||+.+..-
T Consensus 232 ~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G 262 (420)
T 2pyw_A 232 QALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG 262 (420)
T ss_dssp CEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred CeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence 7899999999999998776 999999988753
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=93.41 E-value=0.049 Score=44.12 Aligned_cols=29 Identities=24% Similarity=0.309 Sum_probs=24.7
Q ss_pred eEEecCCCCcEEE------cCCCceEEeeeeccee
Q 044746 102 IVHYDIKPESVLL------DENFFPKAADFGLAKL 130 (202)
Q Consensus 102 iiHrdlk~~nil~------~~~~~~kl~dfgl~~~ 130 (202)
++|+|+.+.||++ +.+..+.++||..|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 5799999999999 3457799999998875
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=93.27 E-value=0.023 Score=44.24 Aligned_cols=31 Identities=19% Similarity=0.247 Sum_probs=26.8
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.||+++.++.+.++||+.+..
T Consensus 187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 187 AGVIHADLFQDNVFFLGDELSGLIDFYFACN 217 (322)
T ss_dssp EEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred cccCCCCCCccCEEEeCCceEEEecchhccC
Confidence 5789999999999998876668999987764
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=92.62 E-value=0.16 Score=39.73 Aligned_cols=32 Identities=28% Similarity=0.208 Sum_probs=27.6
Q ss_pred CCeEEecCCCCcEEEcCC----CceEEeeeecceec
Q 044746 100 QKIVHYDIKPESVLLDEN----FFPKAADFGLAKLY 131 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~----~~~kl~dfgl~~~~ 131 (202)
..++|+|+.+.||+++.+ +.+.++||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 689999999999999864 67899999988753
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=92.39 E-value=1.1 Score=33.27 Aligned_cols=96 Identities=9% Similarity=0.020 Sum_probs=59.4
Q ss_pred chhhhhc--cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCC
Q 044746 65 PFYLLCK--KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTG 142 (202)
Q Consensus 65 ~l~~~~~--~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~ 142 (202)
+|..++. ..+++++++-.++.|.+.+|.-+-... .. ..+=..|..|++..+|.+.+.+ ..+. .
T Consensus 34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~-~~-~~~i~~~~~i~l~~dG~V~f~~-~~s~----~-------- 98 (229)
T 2yle_A 34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRR-QP-RHRVRSAAQIRVWRDGAVTLAP-AADD----A-------- 98 (229)
T ss_dssp EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTT-CC-CCCCCSGGGEEEETTSCEEECC-C----------------
T ss_pred cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcc-cC-CceecCCcceEEecCCceeccc-cccc----c--------
Confidence 6777764 567999999999999999987662100 11 1223446788888898887764 2111 0
Q ss_pred CCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc
Q 044746 143 RRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG 178 (202)
Q Consensus 143 ~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~ 178 (202)
....+.|||... ...+.+.=|||+|+++|.-+-
T Consensus 99 --~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALD 131 (229)
T 2yle_A 99 --GEPPPVAGKLGY-SQCMETEVIESLGIIIYKALD 131 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHT
T ss_pred --cccCCCChhhcc-ccchHHHHHHHHHHHHHHHhh
Confidence 022355787653 344677889999999997654
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=91.31 E-value=0.19 Score=39.03 Aligned_cols=29 Identities=21% Similarity=0.167 Sum_probs=25.2
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+++.||+++ + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence 5689999999999998 4 789999987754
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=89.58 E-value=0.29 Score=40.44 Aligned_cols=16 Identities=13% Similarity=0.304 Sum_probs=14.6
Q ss_pred CCeEEecCCCCcEEEc
Q 044746 100 QKIVHYDIKPESVLLD 115 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~ 115 (202)
..++|+|+.+.|||++
T Consensus 290 ~v~cHnDl~~gNIL~~ 305 (458)
T 2qg7_A 290 IVLCHCDLLSSNIINT 305 (458)
T ss_dssp EEEECSCCCGGGEEEC
T ss_pred eeEEecCCCCCcEEee
Confidence 4689999999999998
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=89.39 E-value=0.15 Score=40.51 Aligned_cols=30 Identities=13% Similarity=0.306 Sum_probs=24.9
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.||+++.+. +.++||..+..
T Consensus 212 ~~l~HgDl~~~Nil~~~~~-~~lID~e~a~~ 241 (369)
T 3c5i_A 212 IVFCHNDLQENNIINTNKC-LRLIDFEYSGF 241 (369)
T ss_dssp EEEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred eEEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence 5689999999999997655 89999987764
|
| >4ann_A ESSB; membrane protein, membrane secretion, ESS type VII secretion virulence; 1.05A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=88.97 E-value=1.2 Score=32.90 Aligned_cols=106 Identities=8% Similarity=0.131 Sum_probs=74.3
Q ss_pred eEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecccc
Q 044746 55 TYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134 (202)
Q Consensus 55 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~ 134 (202)
.+...+-.......+..-...+..+..+++..++....++++ -+|--|.|+|++++.++.+++.-.|+...
T Consensus 58 ~v~~~y~~~~~~~~f~~ik~~~~~eKlr~l~ni~~l~~~~~~-----r~tf~L~P~NL~f~~~~~p~i~~RGik~~---- 128 (215)
T 4ann_A 58 SFQIHYDINDNHTPFDNIKSFTKNEKLRYLLNIKNLEEVNRT-----RYTFVLAPDELFFTRDGLPIAKTRGLQNV---- 128 (215)
T ss_dssp EEEEEECCCTTSEEGGGGGGSCHHHHHHHHHHGGGGGGGGGS-----SEECCCSGGGEEECTTSCEEESCCEETTT----
T ss_pred EEEEEEEcCcccCCHHHHHhcCHHHHHHHHHHHHHHHHHhcC-----ceEEEEecceEEEcCCCCEEEEEccCccC----
Confidence 455556555555555666678899999999999887755543 46888999999999999999998875421
Q ss_pred CcccccCCCCCCCcccCCcccCCCCCCchhhHH-HHHHHHHHHHcCCCCCcchhccc
Q 044746 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVF-SFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 135 ~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diw-s~G~~l~el~~g~~p~~~~~~~~ 190 (202)
++|. ..+ ..|.+ .+=|++..+++++..|+.--...
T Consensus 129 ---------------l~P~-----~~~-ee~fL~qyKAliiall~~K~~Fe~l~~G~ 164 (215)
T 4ann_A 129 ---------------VDPL-----PVS-EAEFLTRYKALVICAFNEKQSFDALVEGN 164 (215)
T ss_dssp ---------------BSCC-----CCC-HHHHHHHHHHHHHHHHCTTCCHHHHHHSC
T ss_pred ---------------CCCC-----CCC-HHHHHHHHHHHHHHHHcCCCCHHHHHcCh
Confidence 1221 122 33444 56788888999988887655443
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=88.67 E-value=0.33 Score=38.21 Aligned_cols=31 Identities=23% Similarity=0.215 Sum_probs=27.6
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.|++++.++.+.++||+.+..
T Consensus 206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~ 236 (339)
T 3i1a_A 206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML 236 (339)
T ss_dssp CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence 5789999999999998777899999987765
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=88.55 E-value=0.36 Score=37.09 Aligned_cols=30 Identities=20% Similarity=0.111 Sum_probs=25.4
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.||+ ..++.+.++||..+..
T Consensus 173 ~~l~HgDl~~~Nil-~~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 173 LAACHCDPLCENFL-DTGERMWIVDWEYSGM 202 (301)
T ss_dssp CEEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred ceeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence 56899999999999 5566789999988764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=87.76 E-value=0.23 Score=39.85 Aligned_cols=30 Identities=23% Similarity=0.317 Sum_probs=25.7
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.||+++.+ .+.++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFASEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence 689999999999999765 489999987764
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=87.42 E-value=0.21 Score=40.79 Aligned_cols=31 Identities=23% Similarity=0.265 Sum_probs=25.3
Q ss_pred CCeEEecCCCCcEEEcCC----------------------------CceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDEN----------------------------FFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~----------------------------~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 249 ~v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~ 307 (429)
T 1nw1_A 249 VTFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY 307 (429)
T ss_dssp EEEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred eEEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence 468999999999999875 6789999987764
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=86.26 E-value=0.32 Score=39.13 Aligned_cols=31 Identities=23% Similarity=0.221 Sum_probs=27.2
Q ss_pred CCeEEecCCCCcEEEcCC----CceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDEN----FFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~----~~~kl~dfgl~~~ 130 (202)
..++|+|+.+.||+++.+ +.+.++||..+..
T Consensus 220 ~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~ 254 (379)
T 3feg_A 220 VVFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY 254 (379)
T ss_dssp EEEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred cEEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence 468999999999999876 6889999998874
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=85.95 E-value=2.2 Score=31.50 Aligned_cols=104 Identities=6% Similarity=0.076 Sum_probs=67.9
Q ss_pred eEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHH-HHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccc
Q 044746 55 TYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIA-YLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNR 133 (202)
Q Consensus 55 ~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~-~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~ 133 (202)
.+...+........+..-..++..+..+++..++.... +++ .-+|--|.|+|++++.++.+++.-.|+-..
T Consensus 62 ~~~i~y~~~~~~~~f~~i~~~~~~eKlrll~nl~~L~~~~~~-----~r~tf~l~P~NL~f~~~~~p~i~hRGi~~~--- 133 (219)
T 4ano_A 62 EVKVVIKPPSSFLTFAAIRKTTLLSRIRAAIHLVSKVKHHSA-----RRLIFIVCPENLMFNRALEPFFLHVGVKES--- 133 (219)
T ss_dssp EEEEEEECCTTCEEHHHHHTSCHHHHHHHHHHHHHHHSSCCS-----SSEECCCCGGGEEECTTCCEEESCCEETTT---
T ss_pred EEEEEEEcCcccCcHHHHHhcCHHHHHHHHHHHHHHHHHhhh-----CceeEEEeCceEEEeCCCcEEEEEcCCccc---
Confidence 34444443333333334467888999999999888665 444 456888999999999999999998885421
Q ss_pred cCcccccCCCCCCCcccCCcccCCCCCCchhhHH-HHHHHHHHHHcCCCCCcchhc
Q 044746 134 EHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVF-SFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 134 ~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diw-s~G~~l~el~~g~~p~~~~~~ 188 (202)
++|. .. ...|.+ .+=|++..++.++..|+.--.
T Consensus 134 ----------------lpP~-----e~-~ee~fl~qyKali~all~~K~~Fe~l~~ 167 (219)
T 4ano_A 134 ----------------LPPD-----EW-DDERLLREVKATVLALTEGEYRFDEYLK 167 (219)
T ss_dssp ----------------BSSC-----SC-CHHHHHHHHHHHHHHHTTCSSCHHHHHH
T ss_pred ----------------CCCC-----CC-CHHHHHHHHHHHHHHHHcCCCCHHHHHh
Confidence 2222 11 233444 566777788888777765444
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST 
Original result of RPS-BLAST against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
E-value ![]() |
| 202 | ||||
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-24 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 2e-22 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 1e-21 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 3e-21 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 8e-21 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 1e-20 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 8e-20 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 9e-20 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-19 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 5e-19 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-19 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 6e-19 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 1e-18 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 2e-18 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 2e-18 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 3e-18 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 6e-18 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 7e-18 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 8e-18 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 2e-17 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 2e-17 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-17 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 2e-17 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 3e-17 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 6e-17 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 8e-17 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 1e-16 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 2e-16 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-16 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 3e-16 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 5e-16 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 1e-15 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-15 | |
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 2e-15 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 6e-15 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 1e-14 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 1e-14 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 2e-14 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 2e-14 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 4e-14 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 6e-14 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 9e-14 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 1e-13 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-13 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-13 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 3e-13 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 8e-13 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 9e-13 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 1e-12 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 4e-12 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 4e-12 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 5e-12 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 6e-12 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 1e-11 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 2e-11 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 5e-11 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 2e-10 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 2e-09 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 2e-09 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 2e-09 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 5e-09 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 4e-08 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 5e-06 |
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 94.7 bits (235), Expect = 2e-24
Identities = 30/118 (25%), Positives = 57/118 (48%), Gaps = 6/118 (5%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L + +L +I T++G+ YLH + I+H D+K ++ L E+ K DFG
Sbjct: 93 HLHIIETKFEMIKLIDIARQTAQGMDYLH---AKSIIHRDLKSNNIFLHEDLTVKIGDFG 149
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMPYS---VTQKCDVFSFGMLLFEVVGRRR 181
LA + +R + APE+ + + DV++FG++L+E++ +
Sbjct: 150 LATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQL 207
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 90.5 bits (224), Expect = 2e-22
Identities = 29/116 (25%), Positives = 54/116 (46%), Gaps = 6/116 (5%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
+L K + L ++ ++ KG+ YL E + KI+H D+KP ++L++ K DF
Sbjct: 92 DQVLKKAGRIPEQILGKVSIAVIKGLTYLRE--KHKIMHRDVKPSNILVNSRGEIKLCDF 149
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
G++ + + G T +PE + + D++S G+ L E+ R
Sbjct: 150 GVSGQLIDSMAN-SFVG---TRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRY 201
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 87.0 bits (215), Expect = 1e-21
Identities = 27/105 (25%), Positives = 47/105 (44%), Gaps = 4/105 (3%)
Query: 79 QLREIEVSTSKGIAYLHE--ECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT 136
+ + + + H + ++H D+KP +V LD K DFGLA++ N + +
Sbjct: 110 FVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS 169
Query: 137 HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
+ TP +PE S +K D++S G LL+E+
Sbjct: 170 F--AKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMP 212
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.8 bits (214), Expect = 3e-21
Identities = 33/168 (19%), Positives = 71/168 (42%), Gaps = 19/168 (11%)
Query: 48 VGSEDTETYIKGFLAM-----GPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEEC---- 98
++D T+ + +L G + + + + ++ +ST+ G+A+LH E
Sbjct: 65 ADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQ 124
Query: 99 -RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN--REHTHITSTGRRRTPGCEAPELW 155
+ I H D+K +++L+ +N AD GLA ++ + I R T APE+
Sbjct: 125 GKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVL 184
Query: 156 MP------YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWFPKW 197
+ ++ D+++ G++ +E+ R + Q +
Sbjct: 185 DDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIH-EDYQLPYYDL 231
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 86.0 bits (212), Expect = 8e-21
Identities = 33/122 (27%), Positives = 52/122 (42%), Gaps = 3/122 (2%)
Query: 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
N+L F L +KG+ +L + VH D+ +VL+ K DFGLA+
Sbjct: 159 NVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICDFGLARDIM 215
Query: 133 REHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQE 192
+ ++ R APE T K DV+S+G+LL+E+ N I
Sbjct: 216 SDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDAN 275
Query: 193 WF 194
++
Sbjct: 276 FY 277
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 84.6 bits (209), Expect = 1e-20
Identities = 32/145 (22%), Positives = 55/145 (37%), Gaps = 15/145 (10%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
+ L K + + + ++Y H ++++H DIKPE++LL K ADF
Sbjct: 94 YRELQKLSKFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADF 150
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR---- 181
G + T PE+ +K D++S G+L +E + +
Sbjct: 151 GWSVHAPSSRRTTLCG----TLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEA 206
Query: 182 ----NLEKEISEGQEWFPKWGREEV 202
K IS + FP + E
Sbjct: 207 NTYQETYKRISRVEFTFPDFVTEGA 231
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.5 bits (203), Expect = 8e-20
Identities = 45/195 (23%), Positives = 75/195 (38%), Gaps = 17/195 (8%)
Query: 5 RNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSEDTETYIKGFLAM- 63
G+TR +T+ + E F +++ LV + ++
Sbjct: 37 TWNGTTRVAIKTLKPGTMSPE-----AFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTE 91
Query: 64 ----GPFYLLCKKNILGFG---QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE 116
G K + QL ++ + G+AY+ R VH D++ ++L+ E
Sbjct: 92 YMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVE---RMNYVHRDLRAANILVGE 148
Query: 117 NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEV 176
N K ADFGLA+L G + APE + T K DV+SFG+LL E+
Sbjct: 149 NLVCKVADFGLARLIEDNEYT-ARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTEL 207
Query: 177 VGRRRNLEKEISEGQ 191
+ R + +
Sbjct: 208 TTKGRVPYPGMVNRE 222
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 82.3 bits (203), Expect = 9e-20
Identities = 33/121 (27%), Positives = 52/121 (42%), Gaps = 10/121 (8%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
+L + L Q++ + T + YLH+ KI+H D+K ++L + K ADF
Sbjct: 98 AVMLELERPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADF 154
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYS-----VTQKCDVFSFGMLLFEVVGRR 180
G++ R S TP APE+ M + K DV+S G+ L E+
Sbjct: 155 GVSAKNTRTIQRRDS--FIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIE 212
Query: 181 R 181
Sbjct: 213 P 213
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 81.8 bits (201), Expect = 2e-19
Identities = 29/133 (21%), Positives = 49/133 (36%), Gaps = 3/133 (2%)
Query: 49 GSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIK 108
+ L+ L + I + G+AYL E +K VH D+
Sbjct: 111 SPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLA 167
Query: 109 PESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFS 168
+ L+ EN K ADFGL++ + PE T + DV++
Sbjct: 168 TRNCLVGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWA 227
Query: 169 FGMLLFEVVGRRR 181
+G++L+E+
Sbjct: 228 YGVVLWEIFSYGL 240
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.4 bits (198), Expect = 5e-19
Identities = 32/169 (18%), Positives = 70/169 (41%), Gaps = 11/169 (6%)
Query: 19 KSLDAMEMDKPIRFTSPQRMIAADNFSNLV-----GSEDTETYI-KGFLAMGPFYLLCKK 72
+ ++ + K + ++ + N+V E ++ +LA G + +
Sbjct: 51 RQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE 110
Query: 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132
+ GQ+ + + + +LH +++H DIK +++LL + K DFG
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQIT 167
Query: 133 REHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
E + ++ TP APE+ + K D++S G++ E++
Sbjct: 168 PEQSKRST--MVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.1 bits (197), Expect = 6e-19
Identities = 34/129 (26%), Positives = 53/129 (41%), Gaps = 4/129 (3%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
F + + + G+ YLH I H DIKPE++LLDE K +DF
Sbjct: 91 FDRIEPDIGMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDF 147
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLE 184
GLA ++ + T APEL + DV+S G++L ++ +
Sbjct: 148 GLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWD 207
Query: 185 KEISEGQEW 193
+ QE+
Sbjct: 208 QPSDSCQEY 216
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 80.2 bits (197), Expect = 6e-19
Identities = 30/117 (25%), Positives = 50/117 (42%), Gaps = 4/117 (3%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
L + + + E+ S G+ YL VH D+ +VLL + K +DF
Sbjct: 95 NKYLQQNRHVKDKNIIELVHQVSMGMKYLE---ESNFVHRDLAARNVLLVTQHYAKISDF 151
Query: 126 GLAKLYNREHTHITSTGRRR-TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
GL+K + + + + APE Y + K DV+SFG+L++E +
Sbjct: 152 GLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQ 208
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 79.3 bits (195), Expect = 1e-18
Identities = 28/117 (23%), Positives = 46/117 (39%), Gaps = 7/117 (5%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL-DENFFPKAAD 124
L + ++ LR KG+ +LH I+H D+K +++ + K D
Sbjct: 100 KTYLKRFKVMKIKVLRSWCRQILKGLQFLHTRTPP-IIHRDLKCDNIFITGPTGSVKIGD 158
Query: 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
GLA L TP APE++ + DV++FGM + E+
Sbjct: 159 LGLATLKRASFA----KAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEY 210
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.9 bits (194), Expect = 2e-18
Identities = 33/116 (28%), Positives = 58/116 (50%), Gaps = 4/116 (3%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
F L +L ++ ++G+A++ E + +H D++ ++L+ + K ADF
Sbjct: 97 FLKTPSGIKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADF 153
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
GLA+L ++ + G + APE + T K DV+SFG+LL E+V R
Sbjct: 154 GLARLIE-DNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGR 208
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 79.3 bits (195), Expect = 2e-18
Identities = 31/119 (26%), Positives = 51/119 (42%), Gaps = 12/119 (10%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
L K L ++ + +G+AYLH ++H D+K ++LL E K DF
Sbjct: 103 DLLEVHKKPLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDF 159
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYS---VTQKCDVFSFGMLLFEVVGRRR 181
G A + ++ + TP APE+ + K DV+S G+ E+ R+
Sbjct: 160 GSASIMAPANSFVG------TPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 78.7 bits (193), Expect = 3e-18
Identities = 33/136 (24%), Positives = 57/136 (41%), Gaps = 5/136 (3%)
Query: 48 VGSEDTETYIKGFLAMGPFYLLCKKNILGFG--QLREIEVSTSKGIAYLHEECRQKIVHY 105
+ T I + G +++ G L V +KG+ YL +++VH
Sbjct: 79 ICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYL---EDRRLVHR 135
Query: 106 DIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCD 165
D+ +VL+ K DFGLAKL E + G + A E + T + D
Sbjct: 136 DLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSD 195
Query: 166 VFSFGMLLFEVVGRRR 181
V+S+G+ ++E++
Sbjct: 196 VWSYGVTVWELMTFGS 211
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.9 bits (191), Expect = 6e-18
Identities = 30/100 (30%), Positives = 46/100 (46%), Gaps = 2/100 (2%)
Query: 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLY--NREHTHITSTGRRRTPGCEA 151
+ +K VH D+ + +LDE F K ADFGLA+ + TG + A
Sbjct: 143 MKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMA 202
Query: 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191
E T K DV+SFG+LL+E++ R +++
Sbjct: 203 LESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFD 242
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.1 bits (189), Expect = 7e-18
Identities = 28/116 (24%), Positives = 54/116 (46%), Gaps = 4/116 (3%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
+L+ K+ + + E+ S G+ YL + VH D+ +VLL + K +DFG
Sbjct: 98 FLVGKREEIPVSNVAELLHQVSMGMKYLE---EKNFVHRDLAARNVLLVNRHYAKISDFG 154
Query: 127 LAK-LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
L+K L + + + + APE + + DV+S+G+ ++E + +
Sbjct: 155 LSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQ 210
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 77.4 bits (190), Expect = 8e-18
Identities = 30/140 (21%), Positives = 62/140 (44%), Gaps = 11/140 (7%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
+ K R T++ ++ L + I+H D+KPE++LL+E+ + DF
Sbjct: 96 LKYIRKIGSFDETCTRFY---TAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDF 152
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR---- 181
G AK+ + E + T +PEL S + D+++ G +++++V
Sbjct: 153 GTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRA 212
Query: 182 ----NLEKEISEGQEWFPKW 197
+ ++I + + FP+
Sbjct: 213 GNEYLIFQKIIKLEYDFPEK 232
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.9 bits (186), Expect = 2e-17
Identities = 22/88 (25%), Positives = 43/88 (48%), Gaps = 1/88 (1%)
Query: 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153
+ ++H D+ + L+ EN K +DFG+ + + + TG + +PE
Sbjct: 114 MAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYTSS-TGTKFPVKWASPE 172
Query: 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
++ + K DV+SFG+L++EV +
Sbjct: 173 VFSFSRYSSKSDVWSFGVLMWEVFSEGK 200
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.8 bits (186), Expect = 2e-17
Identities = 30/111 (27%), Positives = 49/111 (44%), Gaps = 8/111 (7%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
+++LG L + + + + YL VH D+ +VL+ E+ K +DFGL K
Sbjct: 96 GRSVLGGDCLLKFSLDVCEAMEYLE---GNNFVHRDLAARNVLVSEDNVAKVSDFGLTKE 152
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
+ + APE + K DV+SFG+LL+E+ R
Sbjct: 153 ASSTQDT-----GKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 198
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 76.3 bits (187), Expect = 2e-17
Identities = 28/106 (26%), Positives = 49/106 (46%), Gaps = 6/106 (5%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138
QL + + G+ YL VH D+ ++L++ N K +DFGL++ + +
Sbjct: 129 QLVGMLRGIAAGMKYLA---DMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDP 185
Query: 139 TST---GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
T T G + APE T DV+S+G++++EV+
Sbjct: 186 TYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGE 231
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 75.9 bits (186), Expect = 2e-17
Identities = 32/121 (26%), Positives = 56/121 (46%), Gaps = 12/121 (9%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
F L +K L + R+I + + I LH+ IVH D+KPE++LLD++ K DF
Sbjct: 98 FDYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDF 154
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSV------TQKCDVFSFGMLLFEVVGR 179
G + + G TP APE+ ++ D++S G++++ ++
Sbjct: 155 GFSCQLDPGEKLREVCG---TPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAG 211
Query: 180 R 180
Sbjct: 212 S 212
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.6 bits (185), Expect = 3e-17
Identities = 26/102 (25%), Positives = 48/102 (47%), Gaps = 1/102 (0%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGC 149
A + VH D+ ++L++ N K +DFGL+++ + T++G +
Sbjct: 120 AAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRW 179
Query: 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191
APE T DV+SFG++++EV+ E+S +
Sbjct: 180 TAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHE 221
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 75.2 bits (184), Expect = 6e-17
Identities = 27/120 (22%), Positives = 50/120 (41%), Gaps = 3/120 (2%)
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L L +KG+A+L + +H D+ ++LL K DFGLA+ +
Sbjct: 142 LDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLARDIKND 198
Query: 135 HTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEWF 194
++ R APE T + DV+S+G+ L+E+ + + +++
Sbjct: 199 SNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFY 258
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 74.5 bits (182), Expect = 8e-17
Identities = 33/140 (23%), Positives = 58/140 (41%), Gaps = 3/140 (2%)
Query: 58 KGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDEN 117
F+ K+ L L +KG+ +L +K +H D+ ++LL E
Sbjct: 114 NEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEK 170
Query: 118 FFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
K DFGLA+ ++ ++ R APE T + DV+SFG+LL+E+
Sbjct: 171 NVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIF 230
Query: 178 GRRRNLEKEISEGQEWFPKW 197
+ + +E+ +
Sbjct: 231 SLGASPYPGVKIDEEFCRRL 250
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.6 bits (180), Expect = 1e-16
Identities = 26/115 (22%), Positives = 55/115 (47%), Gaps = 4/115 (3%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFG 126
YL ++ QL E+ + + YL ++ +H D+ + L+++ K +DFG
Sbjct: 89 YLREMRHRFQTQQLLEMCKDVCEAMEYLE---SKQFLHRDLAARNCLVNDQGVVKVSDFG 145
Query: 127 LAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
L++ + +S G + PE+ M + K D+++FG+L++E+ +
Sbjct: 146 LSRYVLDDEYT-SSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGK 199
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 2e-16
Identities = 26/122 (21%), Positives = 48/122 (39%), Gaps = 4/122 (3%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
+ G L V ++G+ YL ++ +H D+ ++LL K DFGL +
Sbjct: 104 HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRA 160
Query: 131 YNREHTHITSTGRRR-TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189
+ H R+ APE + + D + FG+ L+E+ + ++
Sbjct: 161 LPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNG 220
Query: 190 GQ 191
Q
Sbjct: 221 SQ 222
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 73.6 bits (180), Expect = 2e-16
Identities = 31/122 (25%), Positives = 52/122 (42%), Gaps = 4/122 (3%)
Query: 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
C + + L + S + YL ++ +H D+ + L+ EN K ADFGL++
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLE---KKNFIHRDLAARNCLVGENHLVKVADFGLSR 163
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189
L + G + APE + K DV++FG+LL+E+ + I
Sbjct: 164 LMTGDTYT-AHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDL 222
Query: 190 GQ 191
Q
Sbjct: 223 SQ 224
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 73.3 bits (179), Expect = 3e-16
Identities = 28/111 (25%), Positives = 48/111 (43%), Gaps = 6/111 (5%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
+ L QL ++G+ YL + ++ +H D+ ++L+ EN+ K ADFGL++
Sbjct: 120 TASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRG 176
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
A E T DV+S+G+LL+E+V
Sbjct: 177 QEVYVKKTMGRL---PVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGG 224
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 72.6 bits (177), Expect = 5e-16
Identities = 27/116 (23%), Positives = 57/116 (49%), Gaps = 6/116 (5%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
+ + + ++++ +G+ +LH ++VH D+KP+++L+ + K ADF
Sbjct: 104 YLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADF 160
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
GLA++Y+ + + T APE+ + S D++S G + E+ R+
Sbjct: 161 GLARIYSFQMALTSVVV---TLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKP 213
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 71.3 bits (174), Expect = 1e-15
Identities = 32/120 (26%), Positives = 53/120 (44%), Gaps = 13/120 (10%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150
L + I++ D+KPE++LLD+N K DFG AK + TP
Sbjct: 114 CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYTLC-----GTPDYI 168
Query: 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRR--------RNLEKEISEGQEWFPKWGREEV 202
APE+ + D +SFG+L++E++ ++I + FP + E+V
Sbjct: 169 APEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFPPFFNEDV 228
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 71.3 bits (174), Expect = 2e-15
Identities = 27/132 (20%), Positives = 58/132 (43%), Gaps = 6/132 (4%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
Y L + + +R G+ ++H + +V+ D+KP ++LLDE+ + +D
Sbjct: 95 HYHLSQHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDL 151
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185
GLA ++++ H + G E + + Y D FS G +LF+++ +
Sbjct: 152 GLACDFSKKKPHAS-VGTHGYMAPEVLQKGVAY--DSSADWFSLGCMLFKLLRGHSPFRQ 208
Query: 186 EISEGQEWFPKW 197
++ + +
Sbjct: 209 HKTKDKHEIDRM 220
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 70.9 bits (173), Expect = 2e-15
Identities = 27/117 (23%), Positives = 50/117 (42%), Gaps = 8/117 (6%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLL--DENFFPKAAD 124
+ + N + + E KG+ ++HE VH D+KPE+++ + K D
Sbjct: 113 KVADEHNKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLID 169
Query: 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
FGL + + + +TG APE+ V D++S G+L + ++
Sbjct: 170 FGLTAHLDPKQSVKVTTGT---AEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLS 223
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 69.5 bits (169), Expect = 6e-15
Identities = 32/111 (28%), Positives = 51/111 (45%), Gaps = 3/111 (2%)
Query: 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130
+ L L ++G+ YL +K +H D+ +VL+ E+ K ADFGLA+
Sbjct: 128 PEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLARD 184
Query: 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
+ + +T R APE T + DV+SFG+LL+E+
Sbjct: 185 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGG 235
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.5 bits (167), Expect = 1e-14
Identities = 22/117 (18%), Positives = 44/117 (37%), Gaps = 8/117 (6%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD--ENFFPKAAD 124
+ L ++ + + +LH I H+DI+PE+++ + K +
Sbjct: 91 RINTSAFELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIE 147
Query: 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
FG A+ P APE+ V+ D++S G L++ ++
Sbjct: 148 FGQARQLKPGDNFRLLFT---APEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.6 bits (167), Expect = 1e-14
Identities = 39/196 (19%), Positives = 71/196 (36%), Gaps = 20/196 (10%)
Query: 17 IDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV-----GSEDTETYIKGFLAMGP--FYLL 69
+ K + M+ D + + A L + G Y +
Sbjct: 35 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 94
Query: 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129
+ + G+ +LH + IV+ D+K +++LLD++ K ADFG+ K
Sbjct: 95 QSCHKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCK 151
Query: 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR-------- 181
+ TP APE+ + D +SFG+LL+E++ +
Sbjct: 152 ENMLGDAKTNT--FCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209
Query: 182 NLEKEISEGQEWFPKW 197
L I ++P+W
Sbjct: 210 ELFHSIRMDNPFYPRW 225
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.5 bits (164), Expect = 2e-14
Identities = 24/98 (24%), Positives = 40/98 (40%), Gaps = 1/98 (1%)
Query: 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153
L ++ VH DI +VL+ N K DFGL++ + S G + APE
Sbjct: 121 LAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYYKASKG-KLPIKWMAPE 179
Query: 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQ 191
T DV+ FG+ ++E++ + +
Sbjct: 180 SINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNND 217
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 68.0 bits (165), Expect = 2e-14
Identities = 34/168 (20%), Positives = 62/168 (36%), Gaps = 8/168 (4%)
Query: 20 SLDAMEMDKPIRFTSPQRMIAADNFSNLV-----GSEDTETYIKGFLAMGPFYLLCKKNI 74
LD P ++ N N+V + + Y+ +
Sbjct: 36 RLDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASA 95
Query: 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNRE 134
L L I+ + + L +++H D+KP+++L++ K ADFGLA+ +
Sbjct: 96 LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155
Query: 135 HTHITSTGRRRTPGCEAPELWMPYS-VTQKCDVFSFGMLLFEVVGRRR 181
T APE+ + + D++S G + E+V RR
Sbjct: 156 VRTYTHEVVT--LWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRA 201
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 67.1 bits (163), Expect = 4e-14
Identities = 19/122 (15%), Positives = 39/122 (31%), Gaps = 13/122 (10%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFP----- 120
L + + +HE + +V+ DIKP++ L+
Sbjct: 89 DLLDLCGRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMI 145
Query: 121 KAADFGLAKLYNREHTHITSTGRRR-----TPGCEAPELWMPYSVTQKCDVFSFGMLLFE 175
DFG+ K Y T R + T + + +++ D+ + G +
Sbjct: 146 YVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMY 205
Query: 176 VV 177
+
Sbjct: 206 FL 207
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 67.2 bits (163), Expect = 6e-14
Identities = 33/127 (25%), Positives = 55/127 (43%), Gaps = 5/127 (3%)
Query: 56 YIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD 115
Y+ L Y L K L + +G+ Y+H ++H D+KP ++LL+
Sbjct: 87 YLVTHLMGADLYKLLKTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLN 143
Query: 116 ENFFPKAADFGLAKLYNREHTHITSTGRRRT-PGCEAPE-LWMPYSVTQKCDVFSFGMLL 173
K DFGLA++ + +H H APE + T+ D++S G +L
Sbjct: 144 TTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCIL 203
Query: 174 FEVVGRR 180
E++ R
Sbjct: 204 AEMLSNR 210
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 9e-14
Identities = 34/134 (25%), Positives = 54/134 (40%), Gaps = 4/134 (2%)
Query: 48 VGSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDI 107
+ + ++ K N L I+ + L + I+H D+
Sbjct: 68 AFGHKSNISLVFDFMETDLEVIIKDNSLVL-TPSHIKAYMLMTLQGLEYLHQHWILHRDL 126
Query: 108 KPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE-LWMPYSVTQKCDV 166
KP ++LLDEN K ADFGLAK + + T T APE L+ D+
Sbjct: 127 KPNNLLLDENGVLKLADFGLAKSFGSPNRAYTHQV--VTRWYRAPELLFGARMYGVGVDM 184
Query: 167 FSFGMLLFEVVGRR 180
++ G +L E++ R
Sbjct: 185 WAVGCILAELLLRV 198
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 66.2 bits (161), Expect = 1e-13
Identities = 27/117 (23%), Positives = 50/117 (42%), Gaps = 8/117 (6%)
Query: 67 YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFP--KAAD 124
+ + + ++ +G+ ++HE IVH DIKPE+++ + K D
Sbjct: 116 RIAAEDYKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIID 172
Query: 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
FGLA N + +T T APE+ V D+++ G+L + ++
Sbjct: 173 FGLATKLNPDEIVKVTTA---TAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 226
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 66.0 bits (160), Expect = 1e-13
Identities = 28/117 (23%), Positives = 48/117 (41%), Gaps = 6/117 (5%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAAD 124
+ K L ++ + +AY+H I H DIKP+++LLD + K D
Sbjct: 110 RHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCD 166
Query: 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
FG AK R +++ ++ T DV+S G +L E++ +
Sbjct: 167 FGSAKQLVRGEPNVSYI--CSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQP 221
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 65.1 bits (158), Expect = 2e-13
Identities = 32/136 (23%), Positives = 54/136 (39%), Gaps = 11/136 (8%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFF-PKAAD 124
F + ++ L R + + + H ++H DIK E++L+D N K D
Sbjct: 98 FDFITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLID 154
Query: 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSV-TQKCDVFSFGMLLFEVVGRRR-- 181
FG L T T PE + + V+S G+LL+++V
Sbjct: 155 FGSGALLKDTVY----TDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPF 210
Query: 182 NLEKEISEGQEWFPKW 197
++EI GQ +F +
Sbjct: 211 EHDEEIIRGQVFFRQR 226
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 64.7 bits (157), Expect = 3e-13
Identities = 34/121 (28%), Positives = 53/121 (43%), Gaps = 11/121 (9%)
Query: 66 FYLLCKKNILGFG--QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFP 120
F + + F + EI S + I YLH I H D+KPE++L N
Sbjct: 97 FSRIQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAIL 153
Query: 121 KAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR 180
K DFG AK ++ T TP APE+ P + CD++S G++++ ++
Sbjct: 154 KLTDFGFAKETTSHNSLTT---PCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGY 210
Query: 181 R 181
Sbjct: 211 P 211
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.3 bits (153), Expect = 8e-13
Identities = 22/100 (22%), Positives = 39/100 (39%)
Query: 94 LHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153
+ K VH D+ + ++ E+F K DFG+ + + +PE
Sbjct: 146 MAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPE 205
Query: 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193
T DV+SFG++L+E+ + +S Q
Sbjct: 206 SLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVL 245
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 63.6 bits (154), Expect = 9e-13
Identities = 27/116 (23%), Positives = 54/116 (46%), Gaps = 5/116 (4%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
F+ L ++ + + R ++ ++ L + +V+ DIK E+++LD++ K DF
Sbjct: 93 FFHLSRERVFTEERARFY---GAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDF 149
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
GL K + T TP APE+ + D + G++++E++ R
Sbjct: 150 GLCKEGISDGA--TMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 63.3 bits (153), Expect = 1e-12
Identities = 30/140 (21%), Positives = 55/140 (39%), Gaps = 16/140 (11%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
F L + R YLH +++ D+KPE++L+D+ + + DF
Sbjct: 129 FSHLRRIGRFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDF 185
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR---- 181
G AK + TP APE+ + + D ++ G+L++E+
Sbjct: 186 GFAKRVKGRTWTLCG-----TPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFA 240
Query: 182 ----NLEKEISEGQEWFPKW 197
+ ++I G+ FP
Sbjct: 241 DQPIQIYEKIVSGKVRFPSH 260
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 61.3 bits (148), Expect = 4e-12
Identities = 25/117 (21%), Positives = 50/117 (42%), Gaps = 4/117 (3%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
++ + + + E+ + + + + I+H D+KP ++++ K DF
Sbjct: 99 RDIVHTEGPMTPKRAIEVIADACQALNFS---HQNGIIHRDVKPANIMISATNAVKVMDF 155
Query: 126 GLAKLYNREHTHITSTGRRR-TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
G+A+ +T T T +PE SV + DV+S G +L+EV+
Sbjct: 156 GIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEP 212
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 61.6 bits (149), Expect = 4e-12
Identities = 24/116 (20%), Positives = 44/116 (37%), Gaps = 3/116 (2%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADF 125
F + +K + + YLH+ LDE+ +DF
Sbjct: 95 FDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDF 154
Query: 126 GLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
GL+K+ + T+ G TPG APE+ ++ D +S G++ + ++
Sbjct: 155 GLSKMEDPGSVLSTACG---TPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYP 207
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (147), Expect = 5e-12
Identities = 20/119 (16%), Positives = 45/119 (37%), Gaps = 1/119 (0%)
Query: 63 MGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKA 122
+ G ++ + + L + ++H D+KP+++L++ N K
Sbjct: 83 CDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKL 142
Query: 123 ADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRR 181
A+FGLA+ + ++ L+ + D++S G + E+ R
Sbjct: 143 ANFGLARAFGIPVRCYSAEVVTL-WYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 200
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 61.1 bits (147), Expect = 6e-12
Identities = 25/94 (26%), Positives = 42/94 (44%), Gaps = 3/94 (3%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR--TPG 148
+ L+ R KI+H D+K +VL+ + K ADFGLA+ ++ + R T
Sbjct: 127 LNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLW 186
Query: 149 CEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRR 181
PEL + D++ G ++ E+ R
Sbjct: 187 YRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSP 220
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 60.2 bits (145), Expect = 1e-11
Identities = 21/92 (22%), Positives = 38/92 (41%), Gaps = 1/92 (1%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150
+ L + I++ DIK E++LLD N DFGL+K + + T
Sbjct: 139 VLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMA 198
Query: 151 APELW-MPYSVTQKCDVFSFGMLLFEVVGRRR 181
+ + D +S G+L++E++
Sbjct: 199 PDIVRGGDSGHDKAVDWWSLGVLMYELLTGAS 230
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 59.5 bits (143), Expect = 2e-11
Identities = 34/129 (26%), Positives = 61/129 (47%), Gaps = 9/129 (6%)
Query: 53 TETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESV 112
T+ Y+ L K LG +++ + KG+ Y+H I+H D+KP ++
Sbjct: 96 TDFYLVMPFMGTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNL 152
Query: 113 LLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYS-VTQKCDVFSFGM 171
++E+ K DFGLA+ + E T T APE+ + + TQ D++S G
Sbjct: 153 AVNEDCELKILDFGLARQADSEMTGYVV-----TRWYRAPEVILNWMRYTQTVDIWSVGC 207
Query: 172 LLFEVVGRR 180
++ E++ +
Sbjct: 208 IMAEMITGK 216
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 58.4 bits (140), Expect = 5e-11
Identities = 28/146 (19%), Positives = 55/146 (37%), Gaps = 4/146 (2%)
Query: 37 RMIAADNFSNLVGSEDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIA-YLH 95
+ + N L T+ + L ++ G S + +
Sbjct: 55 KELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA 114
Query: 96 EECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELW 155
++++H D+KP+++L++ K ADFGLA+ + T T AP++
Sbjct: 115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVRKYTH--EIVTLWYRAPDVL 172
Query: 156 MPYS-VTQKCDVFSFGMLLFEVVGRR 180
M + D++S G + E+V
Sbjct: 173 MGSKKYSTTIDIWSVGCIFAEMVNGT 198
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 56.4 bits (135), Expect = 2e-10
Identities = 26/156 (16%), Positives = 48/156 (30%), Gaps = 13/156 (8%)
Query: 48 VGSEDTETYIKGFLAMGPFYLLCKKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHY 105
G+E + L L + + I Y+H + +H
Sbjct: 71 CGAEGDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS---KNFIHR 127
Query: 106 DIKPESVL---LDENFFPKAADFGLAKLYNREHTH-----ITSTGRRRTPGCEAPELWMP 157
D+KP++ L + DFGLAK Y TH + T + +
Sbjct: 128 DVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLG 187
Query: 158 YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISEGQEW 193
+++ D+ S G +L + + +
Sbjct: 188 IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATKRQ 223
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 54.1 bits (129), Expect = 2e-09
Identities = 34/131 (25%), Positives = 60/131 (45%), Gaps = 9/131 (6%)
Query: 51 EDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPE 110
E + Y+ L + K L ++ + +G+ Y+H I+H D+KP
Sbjct: 94 EFNDVYLVTHLMGADLNNIVKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPS 150
Query: 111 SVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYS-VTQKCDVFSF 169
++ ++E+ K DFGLA+ HT TG T APE+ + + Q D++S
Sbjct: 151 NLAVNEDCELKILDFGLAR-----HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSV 205
Query: 170 GMLLFEVVGRR 180
G ++ E++ R
Sbjct: 206 GCIMAELLTGR 216
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.8 bits (128), Expect = 2e-09
Identities = 26/130 (20%), Positives = 52/130 (40%), Gaps = 7/130 (5%)
Query: 51 EDTETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPE 110
E + Y+ L + + + ++ + GI +LH +H D+KP
Sbjct: 93 EFQDVYLVMELMDANLCQVIQMEL-DHERMSYLLYQMLCGIKHLHSAGI---IHRDLKPS 148
Query: 111 SVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFG 170
++++ + K DFGLA+ T APE+ + + D++S G
Sbjct: 149 NIVVKSDCTLKILDFGLARTAGTSFMMTPYVV---TRYYRAPEVILGMGYKENVDIWSVG 205
Query: 171 MLLFEVVGRR 180
++ E+V +
Sbjct: 206 CIMGEMVRHK 215
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 53.2 bits (127), Expect = 2e-09
Identities = 23/91 (25%), Positives = 45/91 (49%), Gaps = 7/91 (7%)
Query: 91 IAYLHEECRQKIVHYDIKPESVLLDENFFP----KAADFGLAKLYNREHTHITSTGRRRT 146
+ ++ +I H+D+KPE+++L + P K DFGLA + + G T
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFG---T 179
Query: 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
P APE+ + + D++S G++ + ++
Sbjct: 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILL 210
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 52.5 bits (125), Expect = 5e-09
Identities = 26/105 (24%), Positives = 48/105 (45%), Gaps = 8/105 (7%)
Query: 79 QLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTH 137
+R K + Y H I+H D+KP +V++D E+ + D+GLA+ Y+ +
Sbjct: 130 DIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQEY 186
Query: 138 ITSTGRRRTPGCEAPELWMPYS-VTQKCDVFSFGMLLFEVVGRRR 181
+ + PEL + Y D++S G +L ++ R+
Sbjct: 187 NVRVA---SRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKE 228
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 50.0 bits (118), Expect = 4e-08
Identities = 26/113 (23%), Positives = 48/113 (42%), Gaps = 3/113 (2%)
Query: 66 FYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD-ENFFPKAAD 124
+ + +++I G+ Y+H R I+H DIKPE+VL++ +
Sbjct: 113 LIKKYEHRGIPLIYVKQISKQLLLGLDYMH--RRCGIIHTDIKPENVLMEIVDSPENLIQ 170
Query: 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVV 177
+A L N T +T +PE+ + D++S L+FE++
Sbjct: 171 IKIADLGNACWYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELI 223
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 42.8 bits (100), Expect = 5e-06
Identities = 19/128 (14%), Positives = 37/128 (28%), Gaps = 10/128 (7%)
Query: 13 ITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNL-----VGSEDTETYIKGFLAMGPFY 67
+ T K + + F+ A + F L + + + M
Sbjct: 34 VGHTSFKKVKEKRDYGDLHFSVLAIRSARNEFRALQKLQGLAVPKVYAWEGNAVLM-ELI 92
Query: 68 LLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGL 127
+ + E+ + +A + IVH D+ +VL+ E DF
Sbjct: 93 DAKELYRVRVENPDEVLDMILEEVAKFYHRG---IVHGDLSQYNVLVSE-EGIWIIDFPQ 148
Query: 128 AKLYNREH 135
+ E
Sbjct: 149 SVEVGEEG 156
|
Homologous Domains Detected by HHsearch 
Original result of HHsearch against SCOP70(version1.75) database
ID ![]() | Alignment Graph ![]() | Length ![]() |
Definition ![]() |
Probability ![]() |
| Query | 202 | |||
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 99.98 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 99.98 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 99.95 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.56 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 96.76 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 95.14 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 92.57 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 87.88 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 87.22 |
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-42 Score=265.42 Aligned_cols=184 Identities=22% Similarity=0.246 Sum_probs=151.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||+|+++.+++.||.|+...... .+...++..|..+....+|+|++. ..+..+++++++++|+|..++.. .
T Consensus 21 V~~~~~~~~~~~vAiK~i~~~~~--~~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~ 98 (271)
T d1nvra_ 21 VQLAVNRVTEEAVAVKIVDMKRA--VDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDI 98 (271)
T ss_dssp EEEEEETTTCCEEEEEEEECC---------CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTT
T ss_pred EEEEEECCCCCEEEEEEEehhhc--chHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCC
Confidence 78999999999999887543321 223346778888889999999874 44456689999999999988865 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...............||+.|+|||
T Consensus 99 ~l~e~~~~~i~~qi~~al~ylH~---~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE 175 (271)
T d1nvra_ 99 GMPEPDAQRFFHQLMAGVVYLHG---IGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPE 175 (271)
T ss_dssp BCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---cCCccCcccHHHEEECCCCCEEEccchhheeeccCCccccccceeeCcCccCHh
Confidence 69999999999999999999999 999999999999999999999999999999765544433445678999999999
Q ss_pred ccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 154 LWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 154 ~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
++.+..+ +.++||||+||++|||++|++||......
T Consensus 176 ~~~~~~~~~~~~DiwSlGvilyeml~G~~pf~~~~~~ 212 (271)
T d1nvra_ 176 LLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDS 212 (271)
T ss_dssp HHHCSSBCHHHHHHHHHHHHHHHHHHSSCSCSSSSTT
T ss_pred HhcCCCCCCCceeeeHhHHHHHHHHhCCCCCCCCChH
Confidence 9988776 56799999999999999999999765543
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.8e-42 Score=268.01 Aligned_cols=185 Identities=18% Similarity=0.275 Sum_probs=152.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||+|+++.+++.||.|+..............+..|..+....+|+|++. .....+++++++++|+|..++. .+
T Consensus 24 Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~ 103 (288)
T d1uu3a_ 24 VVLARELATSREYAIKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIG 103 (288)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHS
T ss_pred EEEEEECCCCCEEEEEEEehHHccCHHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccC
Confidence 7999999989999988765544444445566788888888899999874 3445578899999999988764 56
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+|+...............||+.|+|||
T Consensus 104 ~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE 180 (288)
T d1uu3a_ 104 SFDETCTRFYTAEIVSALEYLHG---KGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPE 180 (288)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECC----------CCCCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHhhcc---ccEEcCcCCccccccCCCceEEecccccceecccCCcccccccccCCccccCce
Confidence 79999999999999999999999 999999999999999999999999999999775444333344567899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++||||+||++|||++|+.||...+.
T Consensus 181 ~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 215 (288)
T d1uu3a_ 181 LLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNE 215 (288)
T ss_dssp HHHTCCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred eeccCCCCcccceehhhHHHHHHhhCCCCCCCcCH
Confidence 99999999999999999999999999999986544
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-41 Score=264.71 Aligned_cols=180 Identities=18% Similarity=0.246 Sum_probs=154.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccCC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKNI 74 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~~ 74 (202)
||+|+++.+++.||.|+.+... ......+..|..+....+|+|++. ..+..+++++++++|+|..+...+.
T Consensus 36 Vy~a~~~~~~~~vAvK~~~~~~---~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~ 112 (293)
T d1yhwa1 36 VYTAMDVATGQEVAIRQMNLQQ---QPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETC 112 (293)
T ss_dssp EEEEEBTTTCCEEEEEEEEGGG---CSCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHSC
T ss_pred EEEEEECCCCCEEEEEEEeccc---ChHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhccC
Confidence 7999999989999988754332 223345778888888999999874 3455678999999999999998889
Q ss_pred CCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCcc
Q 044746 75 LGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPEL 154 (202)
Q Consensus 75 ~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe~ 154 (202)
+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ......||+.|+|||+
T Consensus 113 l~~~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~~--~~~~~~gt~~Y~aPE~ 187 (293)
T d1yhwa1 113 MDEGQIAAVCRECLQALEFLHS---NQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS--KRSTMVGTPYWMAPEV 187 (293)
T ss_dssp CCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTTC--CBCCCCSCGGGCCHHH
T ss_pred CCHHHHHHHHHHHHHHHHHHHH---CCCcccCCcHHHeEECCCCcEeeccchhheeeccccc--cccccccCCCccChhh
Confidence 9999999999999999999999 9999999999999999999999999999987644322 2344578999999999
Q ss_pred cCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 155 WMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 155 ~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.+..++.++||||+||++|||++|++||.+...
T Consensus 188 ~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 221 (293)
T d1yhwa1 188 VTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENP 221 (293)
T ss_dssp HSSSCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred hcCCCCCchhceehHhHHHHHHhhCCCCCCCCCH
Confidence 9999999999999999999999999999976554
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-41 Score=263.67 Aligned_cols=182 Identities=18% Similarity=0.224 Sum_probs=154.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||+|+++.+++.||.|+..............+..|..+....+|||++. ..+..+++++++++|+|..++.. .
T Consensus 22 Vy~~~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~ 101 (263)
T d2j4za1 22 VYLAREKQSKFILALKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLS 101 (263)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred EEEEEECCCCcEEEEEEEchHHccChHHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcC
Confidence 7899999999999988765544444444556777888888999999874 44456689999999999888754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...... .....||+.|+|||
T Consensus 102 ~l~e~~~~~i~~qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~~----~~~~~Gt~~Y~APE 174 (263)
T d2j4za1 102 KFDEQRTATYITELANALSYCHS---KRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSSR----RTTLCGTLDYLPPE 174 (263)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCCC----CEETTEEGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHH---CCeeeeeeccccceecCCCCEeecccceeeecCCCc----ccccCCCCcccCHH
Confidence 79999999999999999999999 999999999999999999999999999998654332 23356899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
++.+..++.++||||+||++|||++|++||.+.+..
T Consensus 175 ~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 210 (263)
T d2j4za1 175 MIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQ 210 (263)
T ss_dssp HHTTCCCCTTHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred HHcCCCCCchhhhhhHhHHHHHHhcCCCCCCCCCHH
Confidence 999999999999999999999999999999876543
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.5e-40 Score=262.24 Aligned_cols=180 Identities=21% Similarity=0.303 Sum_probs=154.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||+|+++.+++.||.|+.+............+..|..+....+|||++. ..+..+++++++++|++..+... .
T Consensus 20 Vy~a~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~ 99 (316)
T d1fota_ 20 VHLIRSRHNGRYYAMKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQ 99 (316)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTS
T ss_pred EEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccc
Confidence 7999999999999988865544444455566888888899999999874 44556788999999998877754 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+..... .....||+.|+|||
T Consensus 100 ~~~~~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE 171 (316)
T d1fota_ 100 RFPNPVAKFYAAEVCLALEYLHS---KDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-----TYTLCGTPDYIAPE 171 (316)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-----BCCCCSCTTTCCHH
T ss_pred cccccHHHHHHHHHHHhhhhhcc---CcEEccccCchheeEcCCCCEEEecCccceEeccc-----cccccCcccccCHH
Confidence 58999999999999999999999 99999999999999999999999999999876432 23457899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++||||+||++|||++|+.||.+.+.
T Consensus 172 ~l~~~~y~~~~DiwSlGvilyemltG~~Pf~~~~~ 206 (316)
T d1fota_ 172 VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 206 (316)
T ss_dssp HHTTCCBCTTHHHHHHHHHHHHHHHSSCTTCCSSH
T ss_pred HHcCCCCCchhhccccchhHHHHHhCCCCCCCcCH
Confidence 99999999999999999999999999999987654
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.4e-40 Score=264.34 Aligned_cols=184 Identities=20% Similarity=0.287 Sum_probs=155.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||+++++.+++.||.|+.+............+..|..++...+|++++. .....+++++++++|+|..++.. +
T Consensus 21 V~~~~~~~~~~~~AiK~i~k~~~~~~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~ 100 (337)
T d1o6la_ 21 VILVREKATGRYYAMKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRER 100 (337)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHS
T ss_pred EEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhccc
Confidence 7899999999999988765544444444556777888888899998874 44556789999999999888765 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..++.++.|++.||+|||+ ++|+||||||+|||++.+|.+||+|||+|+....... .....+||+.|+|||
T Consensus 101 ~~~e~~~~~~~~qil~al~ylH~---~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~~--~~~~~~GT~~Y~aPE 175 (337)
T d1o6la_ 101 VFTEERARFYGAEIVSALEYLHS---RDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDGA--TMKTFCGTPEYLAPE 175 (337)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTTC--CBCCCEECGGGCCGG
T ss_pred CCcHHHHHHHHHHHhhhhhhhhh---cCccccccCHHHeEecCCCCEEEeecccccccccCCc--ccccceeCHHHhhhh
Confidence 69999999999999999999999 9999999999999999999999999999986533222 234467899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
++.+..++.++|+||+||++|||++|++||.+.+..
T Consensus 176 ~~~~~~y~~~~DiwSlGvilyeml~G~~pf~~~~~~ 211 (337)
T d1o6la_ 176 VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211 (337)
T ss_dssp GGSSSCBCTTHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred hccCCCCChhhcccchhhHHHHHHHCCCCCCCcCHH
Confidence 999999999999999999999999999999876543
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-40 Score=258.10 Aligned_cols=181 Identities=22% Similarity=0.254 Sum_probs=150.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||+++++.+++.||+|+.+.. ..+....+..|..+....+|+|++. ..+..+++++++++|+|..++. .
T Consensus 28 Vy~~~~~~~~~~vAvK~i~~~---~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~ 104 (288)
T d2jfla1 28 VYKAQNKETSVLAAAKVIDTK---SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELE 104 (288)
T ss_dssp EEEEEETTTCCEEEEEEEECS---SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHT
T ss_pred EEEEEECCCCeEEEEEEECcC---CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcC
Confidence 799999999999998875432 2233456788888889999999874 3445568999999999988763 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+....... ......||+.|+||
T Consensus 105 ~~l~e~~~~~i~~qi~~gL~ylH~---~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~~--~~~~~~Gt~~y~AP 179 (288)
T d2jfla1 105 RPLTESQIQVVCKQTLDALNYLHD---NKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTIQ--RRDSFIGTPYWMAP 179 (288)
T ss_dssp SCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHHH--HHTCCCSCCTTCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCEEEeecChhheeECCCCCEEEEechhhhccCCCcc--cccccccccccCCH
Confidence 569999999999999999999999 9999999999999999999999999999986543221 22346789999999
Q ss_pred cccC-----CCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWM-----PYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~-----~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++. ...++.++||||+||++|||++|++||.+..+.
T Consensus 180 E~l~~~~~~~~~y~~k~DiwSlGvilyemltg~~Pf~~~~~~ 221 (288)
T d2jfla1 180 EVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPM 221 (288)
T ss_dssp HHHTTCSTTTSSTTTHHHHHHHHHHHHHHHHSSCTTTTSCGG
T ss_pred HHHhhcccCCCCCChhhhHHHHHHHHHHHhhCCCCCCCCCHH
Confidence 9984 456889999999999999999999999876543
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-40 Score=258.73 Aligned_cols=181 Identities=19% Similarity=0.262 Sum_probs=139.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc--C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--~ 73 (202)
||+++..+ -||+|+.+... ........|..|..+....+|+|++. ..+...++++++++|+|..++.. .
T Consensus 24 Vy~~~~~~---~vAvK~~~~~~-~~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~ 99 (276)
T d1uwha_ 24 VYKGKWHG---DVAVKMLNVTA-PTPQQLQAFKNEVGVLRKTRHVNILLFMGYSTAPQLAIVTQWCEGSSLYHHLHIIET 99 (276)
T ss_dssp EEEEESSS---EEEEEECCCSS-CCTTHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSCEEEEECCCEEEHHHHHHTSCC
T ss_pred EEEEEECC---EEEEEEEEccc-CCHHHHHHHHHHHHHHHhCCCCCEeeeeEEEeccEEEEEEecCCCCCHHHHHhhccC
Confidence 67887654 26666543321 12233456778888889999999874 23345689999999999998843 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...............||+.|+|||
T Consensus 100 ~~~~~~~~~i~~qi~~gl~yLH~---~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE 176 (276)
T d1uwha_ 100 KFEMIKLIDIARQTAQGMDYLHA---KSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPE 176 (276)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEETTSSEEECCCCCSCC------------CCCCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHhc---CCEeccccCHHHEEEcCCCCEEEccccceeeccccCCcccccccccCcccCCHH
Confidence 59999999999999999999999 999999999999999999999999999998765443333445567899999999
Q ss_pred ccCC---CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMP---YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~---~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+ ..++.++|||||||++|||+||+.||.+..+
T Consensus 177 ~l~~~~~~~~~~~sDiwS~Gv~l~el~tg~~Pf~~~~~ 214 (276)
T d1uwha_ 177 VIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINN 214 (276)
T ss_dssp HHTTCSSCCCCHHHHHHHHHHHHHHHHHSSCTTTTCCC
T ss_pred HHhcccCCCCCchhhhhhhHHHHHHHHHCCCCCCCCCh
Confidence 9864 3589999999999999999999999986544
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-40 Score=258.09 Aligned_cols=186 Identities=19% Similarity=0.240 Sum_probs=138.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------cccceEEEEEccCCchhhhhc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------EDTETYIKGFLAMGPFYLLCK- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------~~~~~~~~~~~~~~~l~~~~~- 71 (202)
||+++++.+++.||.|+....... ......+..|..+....+|||++.. .+..+++++++++|+|..++.
T Consensus 20 Vy~~~~~~~~~~vAvK~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~ 98 (269)
T d2java1 20 CQKIRRKSDGKILVWKELDYGSMT-EAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98 (269)
T ss_dssp EEEEEETTTCCEEEEEEECCTTSC-HHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEChhhCC-HHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHh
Confidence 799999998988888864333211 1123456677777888899998742 233467899999999998874
Q ss_pred ----cCCCCHHHHHHHHHHHHHHHHHHHhCC--CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCC
Q 044746 72 ----KNILGFGQLREIEVSTSKGIAYLHEEC--RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRR 145 (202)
Q Consensus 72 ----~~~~~~~~~~~~~~~i~~~l~~lH~~~--~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~g 145 (202)
...+++..+..++.|++.||.|||+.. ..+|+||||||+|||++.++.+||+|||+++....... ......|
T Consensus 99 ~~~~~~~l~e~~~~~i~~qi~~al~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~g 176 (269)
T d2java1 99 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDTS--FAKAFVG 176 (269)
T ss_dssp HHHHTCCCCHHHHHHHHHHHHHHHHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC-------------C
T ss_pred ccccCCCCCHHHHHHHHHHHHHHHHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCCC--ccccCCC
Confidence 356999999999999999999999810 12499999999999999999999999999987654322 2234678
Q ss_pred CCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 146 TPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 146 t~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|+.|+|||++.+..++.++||||+||++|||+||++||...+..
T Consensus 177 t~~Y~APE~l~~~~~~~~~DIwSlGvilyel~tg~~Pf~~~~~~ 220 (269)
T d2java1 177 TPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFTAFSQK 220 (269)
T ss_dssp CCSCCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred CcccCCHHHHcCCCCChHHHHHhhCHHHHHHhhCCCCCCCCCHH
Confidence 99999999999999999999999999999999999999865543
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-40 Score=264.59 Aligned_cols=180 Identities=19% Similarity=0.232 Sum_probs=148.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||+++++.+++.||.|+.+... ......++..|..++...+|||++. ..+..+++++++++|+|..++. .+
T Consensus 22 V~~~~~~~~~~~vAiK~i~~~~--~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~ 99 (322)
T d1s9ja_ 22 VFKVSHKPSGLVMARKLIHLEI--KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAG 99 (322)
T ss_dssp EEEEEETTTTEEEEEEEEECCC--CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHS
T ss_pred EEEEEECCCCcEEEEEEEChhh--CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcC
Confidence 7999999999999988754321 1122345667777888889999874 4445678999999999998875 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..++.++.|++.||.|||+. ++|+||||||+|||++.++.+||+|||+|+...... .....||+.|+|||
T Consensus 100 ~l~~~~~~~~~~qil~aL~yLH~~--~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~~----~~~~~GT~~Y~APE 173 (322)
T d1s9ja_ 100 RIPEQILGKVSIAVIKGLTYLREK--HKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDSM----ANSFVGTRSYMSPE 173 (322)
T ss_dssp SCCHHHHHHHHHHHHHHHHHHHHH--HCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHHT----C---CCSSCCCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHHh--CCEEccccCHHHeeECCCCCEEEeeCCCccccCCCc----cccccCCccccCch
Confidence 799999999999999999999971 489999999999999999999999999998654322 23457899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++||||+||+++||++|+.||.+...
T Consensus 174 vl~~~~y~~~~DiWSlGvil~ell~G~~Pf~~~~~ 208 (322)
T d1s9ja_ 174 RLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDA 208 (322)
T ss_dssp HHHCSCCCTTHHHHHHHHHHHHHHHSSCCSSCCCT
T ss_pred HHcCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCCH
Confidence 99999999999999999999999999999986543
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.2e-39 Score=261.55 Aligned_cols=180 Identities=19% Similarity=0.294 Sum_probs=152.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||+|+++.+++.||.|+..............+..|..++...+|++++. ......++++++.+|+|..++.. +
T Consensus 57 Vy~a~~~~~g~~~AvK~i~~~~~~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~ 136 (350)
T d1rdqe_ 57 VMLVKHKESGNHYAMKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIG 136 (350)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHTTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHC
T ss_pred EEEEEECCCCCEEEEEEEchHHccCHHHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcC
Confidence 7999999989999988755443344444556777888888899999874 33445688999999998877754 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..++.++.|++.||.|||+ ++||||||||+|||++.++.+||+|||+|+..... .....||+.|+|||
T Consensus 137 ~l~e~~~~~i~~qi~~aL~yLH~---~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-----~~~~~Gt~~Y~APE 208 (350)
T d1rdqe_ 137 RFSEPHARFYAAQIVLTFEYLHS---LDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-----TWTLCGTPEALAPE 208 (350)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-----BCCCEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-----cccccCccccCCHH
Confidence 79999999999999999999999 99999999999999999999999999999876432 23457899999999
Q ss_pred ccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+..++.++||||+||++|||+||++||.+...
T Consensus 209 ~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~ 243 (350)
T d1rdqe_ 209 IILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQP 243 (350)
T ss_dssp HHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHcCCCCCccccccchhHHHHHHHhCCCCCCCcCH
Confidence 99999999999999999999999999999986544
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=7.6e-40 Score=258.67 Aligned_cols=179 Identities=22% Similarity=0.249 Sum_probs=148.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh-ccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC-KKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~-~~~ 73 (202)
||+|++..+++.||.|+.........+....+..|..+....+|+|++. ..+..+++++++.+|++..+. ...
T Consensus 31 Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~ 110 (309)
T d1u5ra_ 31 VYFARDVRNSEVVAIKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKK 110 (309)
T ss_dssp EEEEEETTTTEEEEEEEEECCSSCHHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTS
T ss_pred EEEEEECCCCcEEEEEEEchhhccCHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCC
Confidence 7999999999999988754433222333445777888888999999874 344566899999999887654 456
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.... .....||+.|+|||
T Consensus 111 ~l~e~~~~~i~~qi~~aL~yLH~---~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~------~~~~~GT~~Y~APE 181 (309)
T d1u5ra_ 111 PLQEVEIAAVTHGALQGLAYLHS---HNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP------ANSFVGTPYWMAPE 181 (309)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS------BCCCCSCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHh---CCEeccCCCcceEEECCCCCEEEeecccccccCC------CCccccCccccCHH
Confidence 79999999999999999999999 9999999999999999999999999999986432 23356899999999
Q ss_pred ccCC---CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMP---YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~---~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
++.+ ..|+.++||||+||++|||++|++||.+...
T Consensus 182 ~~~~~~~~~y~~~~DiwSlGvilyel~~g~~Pf~~~~~ 219 (309)
T d1u5ra_ 182 VILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNA 219 (309)
T ss_dssp HHTTTTSCCBCTHHHHHHHHHHHHHHHHSSCTTTTSCH
T ss_pred HHhccCCCCcCchhhhhhHHHHHHHHHHCCCCCCCCCH
Confidence 9864 4589999999999999999999999976544
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=3.2e-39 Score=254.92 Aligned_cols=180 Identities=19% Similarity=0.249 Sum_probs=136.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||+|+++.+++.||.|+....... .....+..|..+....+|||++. ..+..+++++++++|+|..++. .+
T Consensus 25 Vy~~~~~~~~~~vAvK~i~~~~~~--~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~ 102 (307)
T d1a06a_ 25 VILAEDKRTQKLVAIKCIAKKALE--GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKG 102 (307)
T ss_dssp EEEEEETTTCCEEEEEEEEC------------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCS
T ss_pred EEEEEECCCCCEEEEEEEchHHhh--hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhccc
Confidence 799999999999998875433222 22345778888889999999874 4455678999999999988875 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc---CCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD---ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~---~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++.++..++.|++.||.|||+ ++|+||||||+||++. .++.+||+|||+++....... .....||+.|+
T Consensus 103 ~l~e~~~~~~~~qi~~al~ylH~---~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~---~~~~~GT~~y~ 176 (307)
T d1a06a_ 103 FYTERDASRLIFQVLDAVKYLHD---LGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSV---LSTACGTPGYV 176 (307)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEESSSSTTCCEEECCC---------------------CTTS
T ss_pred CCCHHHHHHHHHHHHHHHHhhhh---ceeeeEEecccceeecccCCCceEEEeccceeEEccCCCe---eeeeeeCcccc
Confidence 79999999999999999999999 9999999999999995 478999999999986543322 23456899999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||++.+..++.++||||+||++|||++|++||.+...
T Consensus 177 APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~ 214 (307)
T d1a06a_ 177 APEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDEND 214 (307)
T ss_dssp CHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred CcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCCCCCCCH
Confidence 99999999999999999999999999999999986543
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-39 Score=251.64 Aligned_cols=178 Identities=20% Similarity=0.290 Sum_probs=144.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc----------ccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE----------DTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~l~~~~ 70 (202)
||++++..+++.||.|........ .....+|..|..+....+|+|++... ...+++++++++|+|..++
T Consensus 25 Vy~~~~~~~~~~va~K~i~~~~~~-~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l 103 (270)
T d1t4ha_ 25 VYKGLDTETTVEVAWCELQDRKLT-KSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 103 (270)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGSC-HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHH
T ss_pred EEEEEECCCCeEEEEEEEchhhCC-HHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHH
Confidence 799999998888887764333211 12234577888888899999988532 2245789999999998887
Q ss_pred cc-CCCCHHHHHHHHHHHHHHHHHHHhCCCCC--eEEecCCCCcEEEc-CCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 71 KK-NILGFGQLREIEVSTSKGIAYLHEECRQK--IVHYDIKPESVLLD-ENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 71 ~~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~--iiHrdlk~~nil~~-~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.. ..+++.+++.++.|++.||+|||+ ++ |+||||||+|||++ .++.+||+|||+++...... .....||
T Consensus 104 ~~~~~~~~~~~~~~~~qi~~gl~yLH~---~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~~----~~~~~GT 176 (270)
T d1t4ha_ 104 KRFKVMKIKVLRSWCRQILKGLQFLHT---RTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF----AKAVIGT 176 (270)
T ss_dssp HHHSSCCHHHHHHHHHHHHHHHHHHHT---SSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTTS----BEESCSS
T ss_pred hccccccHHHHHHHHHHHHHHHHHHHH---CCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCCc----cCCcccC
Confidence 54 579999999999999999999998 77 99999999999996 47899999999997543322 2345789
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.|+|||++.+ .++.++||||+||++|||++|+.||....
T Consensus 177 ~~Y~aPE~~~~-~~~~~~DIwSlGvilyel~~g~~Pf~~~~ 216 (270)
T d1t4ha_ 177 PEFMAPEMYEE-KYDESVDVYAFGMCMLEMATSEYPYSECQ 216 (270)
T ss_dssp CCCCCGGGGGT-CCCTHHHHHHHHHHHHHHHHSSCTTTTCS
T ss_pred ccccCHHHhCC-CCCCcCchhhHHHHHHHHHHCCCCCCCcc
Confidence 99999999876 59999999999999999999999997544
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.8e-39 Score=256.45 Aligned_cols=184 Identities=21% Similarity=0.273 Sum_probs=143.6
Q ss_pred CCccccCCCcc-----eeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTR-----FITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~-----~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
||+|++.+.++ .||+|..... ........+..|....... +|+|++. ..+...++++++++|+|..
T Consensus 53 Vy~a~~~~~~~~~~~~~vavK~~~~~--~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~ 130 (325)
T d1rjba_ 53 VMNATAYGISKTGVSIQVAVKMLKEK--ADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLN 130 (325)
T ss_dssp EEEEEEESCSSSSCEEEEEEEEECC--------CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHH
T ss_pred EEEEEEcCCCcccceeEEEEEEeccc--cCHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHH
Confidence 67887755443 4565543322 2223334566666666554 8999874 4455679999999999999
Q ss_pred hhccC------------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEee
Q 044746 69 LCKKN------------------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAAD 124 (202)
Q Consensus 69 ~~~~~------------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~d 124 (202)
++... .+++.+++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|
T Consensus 131 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~yLH~---~~IiHRDlKp~Nill~~~~~~Kl~D 207 (325)
T d1rjba_ 131 YLRSKREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEF---KSCVHRDLAARNVLVTHGKVVKICD 207 (325)
T ss_dssp HHHTTTTCC---------------------CCHHHHHHHHHHHHHHHHHHHH---TTEEETTCSGGGEEEETTTEEEECC
T ss_pred HHHhccCCCcchhhhhccccccccccccCCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCchhccccccCCeEEEee
Confidence 88542 48999999999999999999999 9999999999999999999999999
Q ss_pred eecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 125 fgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
||+|+...............||+.|+|||++.+..++.++|||||||++|||+| |++||.+...+
T Consensus 208 FGla~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~ 273 (325)
T d1rjba_ 208 FGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVD 273 (325)
T ss_dssp CGGGSCGGGCTTSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred ccccccccCCCceeeeccccCCCccCChHHHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHH
Confidence 999987655444434445667999999999999999999999999999999998 89999865543
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-38 Score=253.24 Aligned_cols=184 Identities=20% Similarity=0.248 Sum_probs=151.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHH-HHhcccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRM-IAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||+|++..+++.||.|+.+.......+....+..|... ....+||+++. .++..+++++++++|+|..++..
T Consensus 18 Vy~~~~~~t~~~vAvK~i~k~~~~~~~~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~ 97 (320)
T d1xjda_ 18 VFLAEFKKTNQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSC 97 (320)
T ss_dssp EEEEEETTTTEEEEEEEEEHHHHHHTTCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchhhccChHHHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhcc
Confidence 79999999999999888654433333333344444443 45689998873 55667799999999999988854
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ......||+.|+||
T Consensus 98 ~~~~e~~~~~~~~qi~~al~ylH~---~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~aP 172 (320)
T d1xjda_ 98 HKFDLSRATFYAAEIILGLQFLHS---KGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGDA--KTNTFCGTPDYIAP 172 (320)
T ss_dssp SSCCHHHHHHHHHHHHHHHHHHHH---TTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTTC--CBCCCCSCGGGCCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCeeeccCcccceeecCCCceeccccchhhhcccccc--cccccCCCCCcCCH
Confidence 569999999999999999999999 9999999999999999999999999999986543322 23445789999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|++.+..++.++||||+||++|||++|+.||.+.+..
T Consensus 173 E~~~~~~~~~~~DiwSlGvilyemltG~~PF~~~~~~ 209 (320)
T d1xjda_ 173 EILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEE 209 (320)
T ss_dssp HHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred HHHcCCCCCchhhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 9999999999999999999999999999999875543
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=1.1e-38 Score=257.12 Aligned_cols=182 Identities=17% Similarity=0.262 Sum_probs=145.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcH---HHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSP---QRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+|++..+++.||.|+..............+..+ ..+....+||+++. ..+..+++++++++|+|..++.
T Consensus 20 Vy~~~~~~t~~~vAiK~i~~~~~~~~~~~~~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~ 99 (364)
T d1omwa3 20 VYGCRKADTGKMYAMKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLS 99 (364)
T ss_dssp EEEEEETTTCCEEEEEEEEHHHHHHHTCHHHHHHHHHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchHHcchhhHHHHHHHHHHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHH
Confidence 79999999999999887543322222222223333 33345567888874 4455678999999999998875
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 -KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
...+++.++..++.||+.||.|||+ ++|+||||||+|||++.++.+||+|||+|+...... .....||+.|+
T Consensus 100 ~~~~~~e~~~~~~~~qi~~aL~ylH~---~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~~----~~~~~GT~~y~ 172 (364)
T d1omwa3 100 QHGVFSEADMRFYAAEIILGLEHMHN---RFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK----PHASVGTHGYM 172 (364)
T ss_dssp HHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECSSSCEEECCCTTCEECSSSC----CCSCCSCGGGC
T ss_pred hcccccHHHHHHHHHHHHHHHHHHHH---CCccceeeccceeEEcCCCcEEEeeeceeeecCCCc----ccccccccccc
Confidence 4568999999999999999999999 999999999999999999999999999998765432 23457899999
Q ss_pred CCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 151 APELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||++.. ..++.++||||+||++|||+||++||......
T Consensus 173 APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~~~ 212 (364)
T d1omwa3 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTK 212 (364)
T ss_dssp CHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSCSS
T ss_pred hhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCCHH
Confidence 9999874 56899999999999999999999999865443
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.1e-39 Score=250.90 Aligned_cols=186 Identities=18% Similarity=0.222 Sum_probs=146.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc----------ccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE----------DTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~----------~~~~~~~~~~~~~~l~~~~ 70 (202)
||+|++..+++.||.|+.+.......+...+|..|.......+|+|++... ...+++++++++++|..++
T Consensus 23 Vy~a~~~~~~~~vAiK~i~~~~~~~~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~ 102 (277)
T d1o6ya_ 23 VHLARDLRLHRDVAVKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIV 102 (277)
T ss_dssp EEEEEETTTTEEEEEEEECSTTTTCHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHH
T ss_pred EEEEEECCCCCEEEEEEEchhhccCHHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhh
Confidence 799999999999998876543333333345678888888999999987422 2346899999999998776
Q ss_pred c-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCCc
Q 044746 71 K-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTPG 148 (202)
Q Consensus 71 ~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~~ 148 (202)
. .+.+++.+++.++.|++.||.|||+ ++|+||||||+||+++.++..+++|||.+........ ........||+.
T Consensus 103 ~~~~~l~~~~~~~i~~qi~~al~~lH~---~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~ 179 (277)
T d1o6ya_ 103 HTEGPMTPKRAIEVIADACQALNFSHQ---NGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQ 179 (277)
T ss_dssp HHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTSCEEECCCTTCEECC----------------T
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHHh---CCccCccccCcccccCccccceeehhhhhhhhccccccccccccccCccc
Confidence 4 4579999999999999999999999 9999999999999999999999999999876543222 222344678999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|+|||++.+..++.++||||+||++|||+||++||....+.
T Consensus 180 Y~aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 220 (277)
T d1o6ya_ 180 YLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPV 220 (277)
T ss_dssp TCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ccCHHHHcCCCCCcceecccchHHHHHHHhCCCCCCCcCHH
Confidence 99999999999999999999999999999999999876543
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-39 Score=252.58 Aligned_cols=184 Identities=20% Similarity=0.316 Sum_probs=134.3
Q ss_pred CCccccCCCcc---eeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTR---FITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~---~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+++++.+++ .||+|.... ........+|..|..++...+|+|++. ..+...++++++++|+|..++.
T Consensus 42 Vy~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~ 119 (299)
T d1jpaa_ 42 VCSGHLKLPGKREIFVAIKTLKS--GYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLR 119 (299)
T ss_dssp EEEEEECC---CCEEEEEEECCS--SCCHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHH
T ss_pred EEEEEEeCCCCEEEEEEEEEECc--ccCHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeec
Confidence 78888765543 344443222 111222345778888888999999874 3455678999999999988775
Q ss_pred c--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc---ccCCCCCC
Q 044746 72 K--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI---TSTGRRRT 146 (202)
Q Consensus 72 ~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~---~~~~~~gt 146 (202)
. +.+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++......... ......||
T Consensus 120 ~~~~~l~~~~~~~i~~qia~gl~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t 196 (299)
T d1jpaa_ 120 QNDGQFTVIQLVGMLRGIAAGMKYLAD---MNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIP 196 (299)
T ss_dssp TTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCC-----------------------C
T ss_pred cccCCCCHHHHHHHHHHHHHHHHHHhh---CCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCC
Confidence 5 359999999999999999999999 999999999999999999999999999998765432221 12234578
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
+.|+|||.+.+..++.++|||||||++|||+| |++||.+....
T Consensus 197 ~~y~aPE~~~~~~~~~~sDvwS~Gvvl~el~t~g~~Pf~~~~~~ 240 (299)
T d1jpaa_ 197 IRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQ 240 (299)
T ss_dssp GGGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred ccccCHHHHhcCCCCcccccccchHHHHHHHhCCCCCCCCCCHH
Confidence 99999999999999999999999999999998 89999865543
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.6e-38 Score=254.97 Aligned_cols=180 Identities=18% Similarity=0.254 Sum_probs=148.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||+|+++.+++.||.|+....... ....+..|..++...+|+|++. ..+..+++++++++|+|..++. .
T Consensus 42 Vy~~~~~~~g~~vAvK~i~~~~~~---~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~ 118 (350)
T d1koaa2 42 VHRVTERATGNNFAAKFVMTPHES---DKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEH 118 (350)
T ss_dssp EEEEEETTTTEEEEEEEECCCSHH---HHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTT
T ss_pred EEEEEECCCCCEEEEEEEcccchh---hHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhc
Confidence 799999988888888764332222 1235667888888889999874 4455668899999999988873 3
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc--CCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD--ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~--~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
+.+++.++..++.||+.||.|||+ ++|+||||||+|||++ .++.+||+|||+++........ ....||+.|+
T Consensus 119 ~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~~~---~~~~gT~~Y~ 192 (350)
T d1koaa2 119 NKMSEDEAVEYMRQVCKGLCHMHE---NNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQSV---KVTTGTAEFA 192 (350)
T ss_dssp SCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTSCE---EEECSCTTTC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---cCCeeeeechhHeeeccCCCCeEEEeecchheeccccccc---ceecCccccc
Confidence 469999999999999999999999 9999999999999996 4678999999999876544332 2346799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||++.+..++.++||||+||++|||++|+.||.+.+..
T Consensus 193 aPEv~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~ 231 (350)
T d1koaa2 193 APEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDD 231 (350)
T ss_dssp CHHHHHTCCBCHHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CHHHHcCCCCChhHhhhhhhHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999999999999999999866543
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=3e-38 Score=253.52 Aligned_cols=180 Identities=18% Similarity=0.244 Sum_probs=148.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||+|+++.+++.||.|+.+..... ....+..|..++...+|+|++. ..+..+++++++++|+|...+..
T Consensus 45 V~~a~~~~~~~~vAiK~i~~~~~~---~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~ 121 (352)
T d1koba_ 45 VHRCVEKATGRVFVAKFINTPYPL---DKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAED 121 (352)
T ss_dssp EEEEEETTTCCEEEEEEEECCSHH---HHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTT
T ss_pred EEEEEECCCCCEEEEEEECCcchh---HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcC
Confidence 799999998999998875432221 1234566777888889999874 34455689999999999876643
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEc--CCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLD--ENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~--~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
..+++.++..++.|++.||.|||+ ++|+||||||+|||++ .++.+||+|||+|+........ ....||+.|+
T Consensus 122 ~~l~e~~~~~i~~qi~~aL~ylH~---~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~~~---~~~~gt~~y~ 195 (352)
T d1koba_ 122 YKMSEAEVINYMRQACEGLKHMHE---HSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDEIV---KVTTATAEFA 195 (352)
T ss_dssp CCBCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTSCE---EEECSSGGGC
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---CCeeecccccccccccccCCCeEEEeecccceecCCCCce---eeccCccccc
Confidence 359999999999999999999999 9999999999999997 5789999999999876544332 2345699999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||++.+..++.++||||+||++|||++|++||.+....
T Consensus 196 aPE~~~~~~~~~~~DiwSlGvilyelltG~~Pf~~~~~~ 234 (352)
T d1koba_ 196 APEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDL 234 (352)
T ss_dssp CHHHHTTCCBCHHHHHHHHHHHHHHHHHSCCSSCCSSHH
T ss_pred CHHHHcCCCCCCccchHHHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999999999999999999875543
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.5e-38 Score=248.90 Aligned_cols=178 Identities=21% Similarity=0.260 Sum_probs=147.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||+|++..+++.||+|+.+.. .....+|..|..+....+|+|++. .++...++++++++|+|..++..
T Consensus 33 Vy~a~~~~~~~~vAvK~i~~~----~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~ 108 (287)
T d1opja_ 33 VYEGVWKKYSLTVAVKTLKED----TMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECN 108 (287)
T ss_dssp EEEEEEGGGTEEEEEEECCTT----CSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSC
T ss_pred EEEEEECCCCeEEEEEEECCc----cchHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhcc
Confidence 799999998998888764332 122345778888899999999874 34556789999999999888743
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ......|++.|+|
T Consensus 109 ~~~~~~~~~~~i~~qi~~gL~yLH~---~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~~-~~~~~~g~~~y~a 184 (287)
T d1opja_ 109 RQEVSAVVLLYMATQISSAMEYLEK---KNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTYT-AHAGAKFPIKWTA 184 (287)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSSE-EETTEEECGGGCC
T ss_pred ccchHHHHHHHHHHHHHHHHHHHHH---CCcccCccccCeEEECCCCcEEEccccceeecCCCCce-eeccccccccccC
Confidence 468999999999999999999999 99999999999999999999999999999876543322 2334457899999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
||++.+..++.++|||||||++|||++|..||...
T Consensus 185 PE~~~~~~~~~k~DiwS~Gv~l~ell~~~~p~~~~ 219 (287)
T d1opja_ 185 PESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 219 (287)
T ss_dssp HHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCSSTT
T ss_pred hHHHcCCCCCchhhhhhHHHHHHHHHhCCCCCCCc
Confidence 99999899999999999999999999977665443
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-38 Score=248.37 Aligned_cols=183 Identities=18% Similarity=0.274 Sum_probs=146.1
Q ss_pred CCccccC--CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc--
Q 044746 1 MEKPRNR--GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK-- 71 (202)
Q Consensus 1 v~k~~~~--~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~-- 71 (202)
||++..+ +.+..||+|+.+... ......+|..|..+....+|+|++. ..+...++++++++|+|..++.
T Consensus 25 Vy~~~~~~~~~~~~vAvK~l~~~~--~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~~~~~lvmE~~~~g~L~~~l~~~ 102 (285)
T d1u59a_ 25 VRQGVYRMRKKQIDVAIKVLKQGT--EKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEALMLVMEMAGGGPLHKFLVGK 102 (285)
T ss_dssp EEEEEEC---CCEEEEEEEECSSC--CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHTTC
T ss_pred EEEEEEecCCCcEEEEEEEEChhc--CHHHHHHHHHHHHHHHhCCCCCEeeEeeeeccCeEEEEEEeCCCCcHHHHhhcc
Confidence 6888554 444567776643221 1122346778888888999999874 2334568999999999998864
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCCccc
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPGCE 150 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~~y~ 150 (202)
+..+++.++..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++........ .......||+.|+
T Consensus 103 ~~~l~~~~~~~i~~qi~~gL~ylH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~ 179 (285)
T d1u59a_ 103 REEIPVSNVAELLHQVSMGMKYLEE---KNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWY 179 (285)
T ss_dssp TTTSCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHHHh---CCeecCcCchhheeeccCCceeeccchhhhcccccccccccccccccCcccc
Confidence 3469999999999999999999999 99999999999999999999999999999976543322 2233456799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
|||++....++.++|||||||++|||+| |++||.+...
T Consensus 180 aPE~~~~~~~~~ksDVwS~Gv~l~E~lt~G~~Pf~~~~~ 218 (285)
T d1u59a_ 180 APECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKG 218 (285)
T ss_dssp CHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCCT
T ss_pred ChHHHhCCCCCccchhhcchHHHHHHHhCCCCCCCCCCH
Confidence 9999998899999999999999999998 9999986543
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.1e-38 Score=245.38 Aligned_cols=183 Identities=19% Similarity=0.246 Sum_probs=150.4
Q ss_pred CCccccCCCcceeehhhhchhhhhcc---CCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEM---DKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+|+++.+++.||.|+.+....... .....+..|..++...+|+|++. ..+..+++++++++|+|..++.
T Consensus 26 Vy~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~ 105 (293)
T d1jksa_ 26 VKKCREKSTGLQYAAKFIKKRRTKSSRRGVSREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLA 105 (293)
T ss_dssp EEEEEETTTCCEEEEEEEEBCSSTTCSSSBCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHH
T ss_pred EEEEEECCCCCEEEEEEEEhhhcchhhhhHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhc
Confidence 79999999898888886543322211 12344667888888889999874 4455668999999999988875
Q ss_pred c-CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC----ceEEeeeecceeccccCcccccCCCCCC
Q 044746 72 K-NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF----FPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 72 ~-~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~----~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
. +.+++..++.++.|++.||.|||+ ++|+||||||+||+++.++ .+|++|||+++....... .....||
T Consensus 106 ~~~~l~~~~~~~~~~qi~~al~yLH~---~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~---~~~~~~t 179 (293)
T d1jksa_ 106 EKESLTEEEATEFLKQILNGVYYLHS---LQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNE---FKNIFGT 179 (293)
T ss_dssp HHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCB---CSCCCCC
T ss_pred cccccchhHHHHHHHHHHHHHHhhhh---cceeecccccceEEEecCCCcccceEecchhhhhhcCCCcc---ccccCCC
Confidence 4 579999999999999999999999 9999999999999998766 599999999987654332 2345679
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
+.|+|||++.+..++.++||||+||++|||++|+.||.+....
T Consensus 180 ~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~~~ 222 (293)
T d1jksa_ 180 PEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 222 (293)
T ss_dssp GGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCCCCCCCHH
Confidence 9999999999989999999999999999999999999876543
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-38 Score=247.40 Aligned_cols=184 Identities=20% Similarity=0.286 Sum_probs=144.8
Q ss_pred CCcccc--CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRN--RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~--~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
|||+.. ...++.||.|+.+... .......+|..|..+....+|+|++. ..+...++++++++|+|..++..
T Consensus 23 Vy~~~~~~~~~~~~vAvK~~~~~~-~~~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~~~~~lvmE~~~~g~L~~~l~~~ 101 (277)
T d1xbba_ 23 VKKGYYQMKKVVKTVAVKILKNEA-NDPALKDELLAEANVMQQLDNPYIVRMIGICEAESWMLVMEMAELGPLNKYLQQN 101 (277)
T ss_dssp EEEEEEECSSSEEEEEEEEEC------CHHHHHHHHHHHHHHTCCCTTBCCEEEEEESSSEEEEEECCTTEEHHHHHHHC
T ss_pred EEEEEEccCCcCeEEEEEEEChhh-CCHHHHHHHHHHHHHHHhCCCCCCceEEEEeccCCEEEEEEcCCCCcHHHHHhhc
Confidence 678864 3455678877653322 12222346788888888999999874 22334688999999999988865
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCCcccC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPGCEA 151 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~~y~a 151 (202)
..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||+++........ .......||+.|+|
T Consensus 102 ~~l~~~~~~~i~~qi~~gl~ylH~---~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~A 178 (277)
T d1xbba_ 102 RHVKDKNIIELVHQVSMGMKYLEE---SNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYA 178 (277)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCC
T ss_pred cCCCHHHHHHHHHHHHHHHhhHHh---CCcccCCCcchhhcccccCcccccchhhhhhccccccccccccccCCCceecC
Confidence 559999999999999999999999 99999999999999999999999999999876543322 22334568999999
Q ss_pred CcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 152 PELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
||.+.+..++.++|||||||++|||+| |++||.+...
T Consensus 179 PE~l~~~~~~~~sDiwS~Gv~l~ellt~g~~Pf~~~~~ 216 (277)
T d1xbba_ 179 PECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKG 216 (277)
T ss_dssp HHHHHHCEEEHHHHHHHHHHHHHHHHTTTCCSSTTCCH
T ss_pred chhhcCCCCCchhhhccchhhhhHHhhCCCCCCCCCCH
Confidence 999998899999999999999999998 8999986543
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.6e-38 Score=242.78 Aligned_cols=177 Identities=20% Similarity=0.298 Sum_probs=132.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-- 72 (202)
||++++.++. .||+|..+.. .....+|..|.......+|+|++. ..+...++++++++|+|..++..
T Consensus 21 Vy~~~~~~~~-~vAvK~i~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~ 95 (263)
T d1sm2a_ 21 VHLGYWLNKD-KVAIKTIREG----AMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQR 95 (263)
T ss_dssp EEEEEETTTE-EEEEEECCSS----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTT
T ss_pred EEEEEECCCC-EEEEEEECCC----cCcHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccc
Confidence 7888877554 4665543321 122345778888888999999874 34456689999999999998754
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++........ ......||+.|+||
T Consensus 96 ~~~~~~~~~~i~~qia~gl~~lH~---~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~~-~~~~~~gt~~y~aP 171 (263)
T d1sm2a_ 96 GLFAAETLLGMCLDVCEGMAYLEE---ACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQYT-SSTGTKFPVKWASP 171 (263)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCTTCSGGGEEECGGGCEEECSCC-------------------CTTSCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHhhhc---cceeecccchhheeecCCCCeEecccchheeccCCCce-eecceecCcccCCh
Confidence 458999999999999999999999 99999999999999999999999999999876543322 22345679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcC-CCCCcch
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGR-RRNLEKE 186 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g-~~p~~~~ 186 (202)
|++.+..++.++|||||||++|||+|+ ++||...
T Consensus 172 E~l~~~~~~~k~DVwS~Gvil~el~t~~~~~~~~~ 206 (263)
T d1sm2a_ 172 EVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENR 206 (263)
T ss_dssp HHHTTCCCCHHHHHHHHHHHHHHHHTTSCCTTCSC
T ss_pred HHhcCCCCCchhhhcchHHHHHHHHHCCCCCCCCC
Confidence 999999999999999999999999995 6666543
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.2e-38 Score=246.64 Aligned_cols=183 Identities=23% Similarity=0.307 Sum_probs=146.2
Q ss_pred CCccccCCCcceeehhhhchhhhhcc--CCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEM--DKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK- 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~- 71 (202)
||+|+++.+++.||.|+.+....... ....++..|..++...+|+|++. ..+..+++++++.++.+..+..
T Consensus 14 Vy~~~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~ 93 (299)
T d1ua2a_ 14 VYKARDKNTNQIVAIKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDN 93 (299)
T ss_dssp EEEEECSSCCSEEEEEEC------------CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTC
T ss_pred EEEEEECCCCcEEEEEEEehhhhhhhhHHHHHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhc
Confidence 79999999999999887544332222 22345667888888899998873 4556678999999888776665
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEA 151 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~a 151 (202)
...+++.++..++.|++.||+|||+ ++|+||||||+|||++.++.+||+|||+++........ .....||+.|+|
T Consensus 94 ~~~l~~~~~~~~~~qil~aL~~lH~---~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~~~--~~~~~gt~~y~a 168 (299)
T d1ua2a_ 94 SLVLTPSHIKAYMLMTLQGLEYLHQ---HWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPNRA--YTHQVVTRWYRA 168 (299)
T ss_dssp CSSCCSSHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCCCC--CCCSCCCCTTCC
T ss_pred ccCCCHHHHHHHHHHHHHHHHHhhc---cceecccCCcceEEecCCCccccccCccccccCCCccc--ccceecChhhcc
Confidence 4469999999999999999999999 99999999999999999999999999999865443322 234568999999
Q ss_pred CcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 152 PELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 152 Pe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
||++... .++.++||||+||++|||++|++||....+
T Consensus 169 PE~~~~~~~~~~~~DiwSlGvil~el~~g~~pf~~~~~ 206 (299)
T d1ua2a_ 169 PELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSD 206 (299)
T ss_dssp HHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred HHHHccCCCCChhhhhhhcchHHHHHHhCcCCCCCCCH
Confidence 9998754 679999999999999999999999986554
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-37 Score=247.31 Aligned_cols=175 Identities=21% Similarity=0.282 Sum_probs=143.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHH-HHhccccccccc----------cccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRM-IAADNFSNLVGS----------EDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~----------~~~~~~~~~~~~~~~l~~~ 69 (202)
||+|++..+++.||.|+.+... .+..|..+ ....+|+|++.. ....+++++|+++|+|..+
T Consensus 28 Vy~a~~~~~~~~vAiK~i~~~~--------~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~ 99 (335)
T d2ozaa1 28 VLQIFNKRTQEKFALKMLQDCP--------KARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSR 99 (335)
T ss_dssp EEEEEETTTCCEEEEEEEECSH--------HHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHH
T ss_pred EEEEEECCCCCEEEEEEECCcH--------HHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHH
Confidence 7999999889999988754322 23334433 445688988742 2345789999999999998
Q ss_pred hcc---CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcccccCCC
Q 044746 70 CKK---NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 70 ~~~---~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
+.. ..+++.+++.++.|++.||.|||+ ++|+||||||+|||++. .+.+||+|||+++....... ....
T Consensus 100 i~~~~~~~l~e~~~~~i~~qi~~al~ylH~---~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~---~~~~ 173 (335)
T d2ozaa1 100 IQDRGDQAFTEREASEIMKSIGEAIQYLHS---INIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNS---LTTP 173 (335)
T ss_dssp HHSCSCCCEEHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCC---CCCC
T ss_pred HHhcCCCCcCHHHHHHHHHHHHHHHHHHHH---cCCccccccccccccccccccccccccccceeeeccCCCc---cccc
Confidence 854 359999999999999999999999 99999999999999975 56799999999987654332 2445
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.||+.|+|||++.+..++.++||||+||++|+|+||++||.+....
T Consensus 174 ~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~lltg~~Pf~~~~~~ 219 (335)
T d2ozaa1 174 CYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGL 219 (335)
T ss_dssp SCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHTTSSCSCEETTCC
T ss_pred cCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHhhCCCCCCCCCHH
Confidence 7899999999999989999999999999999999999999876543
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-37 Score=241.42 Aligned_cols=175 Identities=23% Similarity=0.322 Sum_probs=140.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhccC--
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKKN-- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~~-- 73 (202)
||+++..++ ..||+|+.+.. ......|..|..+....+|+|++. ..+...++++++++|+|..++...
T Consensus 29 Vy~~~~~~~-~~vAvK~~~~~----~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~iv~Ey~~~g~L~~~~~~~~~ 103 (272)
T d1qpca_ 29 VWMGYYNGH-TKVAVKSLKQG----SMSPDAFLAEANLMKQLQHQRLVRLYAVVTQEPIYIITEYMENGSLVDFLKTPSG 103 (272)
T ss_dssp EEEEEETTT-EEEEEEEECTT----SSCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHTTSHHH
T ss_pred EEEEEECCC-CEEEEEEEccC----cCCHHHHHHHHHHHHhCCCCCEeEEEeeeccCCeEEEEEeCCCCcHHHHHhhcCC
Confidence 789987654 45665543322 122345778888888999999874 233456899999999998766433
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
.+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+....... .......||+.|+||
T Consensus 104 ~~l~~~~~~~i~~qi~~gl~~lH~---~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~gt~~y~AP 179 (272)
T d1qpca_ 104 IKLTINKLLDMAAQIAEGMAFIEE---RNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY-TAREGAKFPIKWTAP 179 (272)
T ss_dssp HTCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE-ECCTTCCCCTTTSCH
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHh---CCcccCccchhheeeecccceeeccccceEEccCCcc-ccccccCCcccccCh
Confidence 59999999999999999999999 9999999999999999999999999999997654332 223445679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLE 184 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~ 184 (202)
|++....++.++|||||||++|||+||..|+.
T Consensus 180 E~~~~~~~~~~sDvwS~Gvvl~ellt~~~~~~ 211 (272)
T d1qpca_ 180 EAINYGTFTIKSDVWSFGILLTEIVTHGRIPY 211 (272)
T ss_dssp HHHHHCEECHHHHHHHHHHHHHHHHTTTCCSS
T ss_pred HHHhCCCCCchhhhhhhHHHHHHHHhCCCCCC
Confidence 99998889999999999999999999655443
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.2e-38 Score=248.22 Aligned_cols=184 Identities=20% Similarity=0.251 Sum_probs=139.7
Q ss_pred CCccccCCCccee----ehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFI----TRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||++++...++.+ |.|..+. ........+|..|..+....+|+|++. ..+...++++++.+++|...+.
T Consensus 25 Vy~~~~~~~~~~~~~~vavK~~~~--~~~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~v~e~~~~~~l~~~~~ 102 (317)
T d1xkka_ 25 VYKGLWIPEGEKVKIPVAIKELRE--ATSPKANKEILDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVR 102 (317)
T ss_dssp EEEEEECC----CCEEEEEEEECC------CTHHHHHHHHHHHHHCCCTTBCCEEEEEESSSEEEEEECCTTCBHHHHHH
T ss_pred EEEEEEcCCCCEEEEEEEEEEecc--ccCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeeEEEEeccCCccccccc
Confidence 7888887776643 3332211 122233456788888888999999874 2334557888999999877664
Q ss_pred --cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 72 --KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 72 --~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
...+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++...............||+.|
T Consensus 103 ~~~~~~~~~~~~~i~~qi~~gl~yLH~---~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y 179 (317)
T d1xkka_ 103 EHKDNIGSQYLLNWCVQIAKGMNYLED---RRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKW 179 (317)
T ss_dssp HTSSSCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC--------CCTTT
T ss_pred ccccCCCHHHHHHHHHHHHHHHHHHHH---cCcccCcchhhcceeCCCCCeEeeccccceecccccccccccccccCccc
Confidence 4469999999999999999999999 99999999999999999999999999999976554444444555689999
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
+|||++.+..++.++|||||||++|||+| |++||......
T Consensus 180 ~APE~l~~~~~~~~sDvwS~Gvil~el~t~g~~p~~~~~~~ 220 (317)
T d1xkka_ 180 MALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPAS 220 (317)
T ss_dssp SCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCGG
T ss_pred cChHHHhcCCCChhhhhhhHHHHHHHHHHCCCCCCCCCCHH
Confidence 99999999999999999999999999998 89998765443
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-37 Score=244.22 Aligned_cols=182 Identities=22% Similarity=0.293 Sum_probs=131.3
Q ss_pred CCccccCC-----CcceeehhhhchhhhhccCCcccCCcH-HHHHHhcccccccc-------ccccceEEEEEccCCchh
Q 044746 1 MEKPRNRG-----STRFITRTIDKSLDAMEMDKPIRFTSP-QRMIAADNFSNLVG-------SEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~-----~~~~v~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~i~-------~~~~~~~~~~~~~~~~l~ 67 (202)
||+|++.. +.+.||+|+.+..... .....+..+ ..+....+|++++. ......++++++++|+|.
T Consensus 29 Vy~a~~~~~~~~~~~~~vAvK~l~~~~~~--~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~ 106 (299)
T d1ywna1 29 VIEADAFGIDKTATCRTVAVKMLKEGATH--SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLS 106 (299)
T ss_dssp EEEEEEESTTSSSCEEEEEEEEC----CH--HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHH
T ss_pred EEEEEEcCCCcccCCeEEEEEEEccccCc--HHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHH
Confidence 67776533 4456777664322111 112233334 33444456777653 233457889999999999
Q ss_pred hhhcc-----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 68 LLCKK-----------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 68 ~~~~~-----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
.++.. ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+|+.
T Consensus 107 ~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~---~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~ 183 (299)
T d1ywna1 107 TYLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLAS---RKCIHRDLAARNILLSEKNVVKICDFGLARD 183 (299)
T ss_dssp HHHHHTGGGBCC-----------CBCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECGGGCEEECC------
T ss_pred HHHHhccccccccccchhhhhcccCCHHHHHHHHHHHHHHHHHHHh---CCCcCCcCCccceeECCCCcEEEccCcchhh
Confidence 88742 348999999999999999999999 9999999999999999999999999999987
Q ss_pred ccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcC-CCCCcchh
Q 044746 131 YNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGR-RRNLEKEI 187 (202)
Q Consensus 131 ~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g-~~p~~~~~ 187 (202)
..............||+.|+|||++.+..++.++|||||||++|||++| .+||....
T Consensus 184 ~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gvil~ellt~~~~p~~~~~ 241 (299)
T d1ywna1 184 IYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVK 241 (299)
T ss_dssp CCSCTTSCCTTSCCCGGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCC
T ss_pred ccccccccccCceeeCccccchhHhhcCCCCcccceeehHHHHHHHHhCCCCCCCCCC
Confidence 6544443344556789999999999999999999999999999999986 56776544
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-36 Score=243.58 Aligned_cols=183 Identities=21% Similarity=0.300 Sum_probs=148.6
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc----------cceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED----------TETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~l~~~~ 70 (202)
||+|++..+++.||+|+.+.... .....++..|..++...+|++++...+ ...++++++.+++|..++
T Consensus 24 Vy~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~~~~g~L~~~l 101 (345)
T d1pmea_ 24 VCSAYDNVNKVRVAIKKISPFEH--QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLL 101 (345)
T ss_dssp EEEEEETTTCSEEEEEEECCTTC--HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCCEEHHHHH
T ss_pred EEEEEECCCCcEEEEEEEehhcC--hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEeecCCchhhhh
Confidence 79999998999999886543221 112235667888888899998874221 124667788899999999
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc-cccCCCCCCCcc
Q 044746 71 KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH-ITSTGRRRTPGC 149 (202)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~-~~~~~~~gt~~y 149 (202)
..+.+++..++.++.|++.||+|||+ ++||||||||+|||++.++.+||+|||+++........ .......||+.|
T Consensus 102 ~~~~l~~~~i~~i~~qil~al~yLH~---~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y 178 (345)
T d1pmea_ 102 KTQHLSNDHICYFLYQILRGLKYIHS---ANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWY 178 (345)
T ss_dssp HHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGG
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHH---CCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCccceeecccccccee
Confidence 88899999999999999999999999 99999999999999999999999999999876443222 223456789999
Q ss_pred cCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+|||++.. ..++.++||||+||+++||++|++||.....
T Consensus 179 ~aPE~l~~~~~~~~~~DiwSlG~il~eml~g~~pf~~~~~ 218 (345)
T d1pmea_ 179 RAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHY 218 (345)
T ss_dssp CCGGGTTTBCSCSTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred chHHHhhcCCCCCchhhhhccCceehHHhhCCCCCCCCCH
Confidence 99999854 5678999999999999999999999986554
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-37 Score=238.63 Aligned_cols=183 Identities=19% Similarity=0.219 Sum_probs=133.5
Q ss_pred CCccccCCCc---ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc-
Q 044746 1 MEKPRNRGST---RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK- 71 (202)
Q Consensus 1 v~k~~~~~~~---~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~- 71 (202)
||+|++...+ ..||.|..+.. ........|..|.......+|||++. ..+...++++++++|++..+..
T Consensus 23 Vy~a~~~~~~~~~~~vaik~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~~~~~~iv~E~~~~g~l~~~~~~ 100 (273)
T d1mp8a_ 23 VHQGIYMSPENPALAVAIKTCKNC--TSDSVREKFLQEALTMRQFDHPHIVKLIGVITENPVWIIMELCTLGELRSFLQV 100 (273)
T ss_dssp EEEEEECCC--CCEEEEEEECTTT--TSHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSCEEEEECCTTEEHHHHHHH
T ss_pred EEEEEEecCCceeEEEEEEEeccc--cCHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCeEEEEEEeccCCcHHhhhhc
Confidence 6888775543 23444433221 12222345778888888899999873 3345678999999999988754
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 -KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
...+++..++.++.|++.||.|||+ ++++||||||+||+++.++.+||+|||+++........ ......||+.|+
T Consensus 101 ~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~~-~~~~~~gt~~y~ 176 (273)
T d1mp8a_ 101 RKYSLDLASLILYAYQLSTALAYLES---KRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY-KASKGKLPIKWM 176 (273)
T ss_dssp TTTTSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEEETTEEEECC--------------------CCGGGC
T ss_pred cCCCCCHHHHHHHHHHHHHHhhhhcc---cCeeccccchhheeecCCCcEEEccchhheeccCCcce-eccceecCcccc
Confidence 3468999999999999999999999 99999999999999999999999999999875443222 223456799999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
|||++....++.++|||||||++|||++ |.+||......
T Consensus 177 apE~l~~~~~~~~~DiwSlGvil~e~lt~g~~P~~~~~~~ 216 (273)
T d1mp8a_ 177 APESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNN 216 (273)
T ss_dssp CHHHHHHCCCSHHHHHHHHHHHHHHHHTTSCCTTTTCCGG
T ss_pred hhhHhccCCCCCccccccchHHHHHHHhcCCCCCCCCCHH
Confidence 9999998899999999999999999998 89999876554
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=2.1e-36 Score=235.45 Aligned_cols=183 Identities=17% Similarity=0.221 Sum_probs=146.8
Q ss_pred CCccccCCCcceeehhhhchhhhhcc------CCcccCCcHHHHHHhcc-ccccc------cccccceEEEEEccCCchh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEM------DKPIRFTSPQRMIAADN-FSNLV------GSEDTETYIKGFLAMGPFY 67 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~-~~~~i------~~~~~~~~~~~~~~~~~l~ 67 (202)
||++++..+++.+|.|+.+....... ....++..|.......+ |+|++ ...+..+++++++++|+|.
T Consensus 19 V~~~~~~~~~~~~AvK~i~~~~~~~~~~~~~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~ 98 (277)
T d1phka_ 19 VRRCIHKPTCKEYAVKIIDVTGGGSFSAEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELF 98 (277)
T ss_dssp EEEEEETTTTEEEEEEEEETTCSTTCCHHHHHHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHH
T ss_pred EEEEEECCCCCEEEEEEEecccccchhHHHHHHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHH
Confidence 79999998999998887543322111 11223556666666654 88876 3455567999999999998
Q ss_pred hhhc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCC
Q 044746 68 LLCK-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 68 ~~~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
.++. .+.+++.+++.++.|++.||+|||+ ++|+||||||+||+++.++.+||+|||+++....... .....||
T Consensus 99 ~~l~~~~~l~e~~~~~~~~qi~~al~~lH~---~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~~---~~~~~gt 172 (277)
T d1phka_ 99 DYLTEKVTLSEKETRKIMRALLEVICALHK---LNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGEK---LREVCGT 172 (277)
T ss_dssp HHHHHHSSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCC---BCCCCSC
T ss_pred HHHHhcCCCCHHHHHHHHHHHHHHHHHHHH---cCCcccccccceEEEcCCCCeEEccchheeEccCCCc---eeeeecc
Confidence 8884 4579999999999999999999999 9999999999999999999999999999987654332 2445789
Q ss_pred CcccCCcccCC------CCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 147 PGCEAPELWMP------YSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 147 ~~y~aPe~~~~------~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
+.|+|||.+.+ ..++.++||||+||+++||++|+.||....+.
T Consensus 173 ~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvilyeml~g~~Pf~~~~~~ 221 (277)
T d1phka_ 173 PSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221 (277)
T ss_dssp GGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHHHHHHSSCSSCCSSHH
T ss_pred CCCCCHHHhhccccccCCCCCchheEcccchhhhhhccCCCCCCCCCHH
Confidence 99999999852 35788999999999999999999999876644
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.7e-37 Score=239.04 Aligned_cols=180 Identities=19% Similarity=0.275 Sum_probs=132.4
Q ss_pred CCccccCCCc----ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGST----RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~----~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~ 70 (202)
|||+..+..+ ..||+|...... ......+|..|..+....+|+|++. ......++++++.++++....
T Consensus 23 Vy~~~~~~~~~~~~~~vAvK~~~~~~--~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~ 100 (283)
T d1mqba_ 23 VYKGMLKTSSGKKEVPVAIKTLKAGY--TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100 (283)
T ss_dssp EEEEEEEC---CCEEEEEEEEECTTC--CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHH
T ss_pred EEEEEEeCCCCEEEEEEEEEEECccc--ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhh
Confidence 6788766544 346655432211 1122335777888888899999874 334556889999999988776
Q ss_pred cc--CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc-ccccCCCCCCC
Q 044746 71 KK--NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT-HITSTGRRRTP 147 (202)
Q Consensus 71 ~~--~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~-~~~~~~~~gt~ 147 (202)
.. ..+++.++..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... ........||+
T Consensus 101 ~~~~~~~~~~~~~~i~~~i~~gl~~lH~---~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~ 177 (283)
T d1mqba_ 101 REKDGEFSVLQLVGMLRGIAAGMKYLAN---MNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPI 177 (283)
T ss_dssp HHTTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC-----------------CCCG
T ss_pred hcccccccHHHHHHHHHHHHHhhhhccc---cccccCccccceEEECCCCeEEEcccchhhcccCCCccceEeccCCCCc
Confidence 43 469999999999999999999999 9999999999999999999999999999987644322 22234456799
Q ss_pred cccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 148 GCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 148 ~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
.|+|||++.+..++.++|||||||++|||++|..|+..
T Consensus 178 ~Y~APE~l~~~~~~~~sDI~S~Gvil~el~t~~~~~~~ 215 (283)
T d1mqba_ 178 RWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYW 215 (283)
T ss_dssp GGSCHHHHHSCCCCHHHHHHHHHHHHHHHHTTSCCTTT
T ss_pred cccCHHHHccCCCCCcccccccHHHHHHHHhCCCCccc
Confidence 99999999999999999999999999999996555543
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.7e-36 Score=236.89 Aligned_cols=181 Identities=22% Similarity=0.299 Sum_probs=137.5
Q ss_pred CCccccC-CCcceeehhhhchhhhhccCCcccCCcHHHHH---Hhccccccccc-----------cccceEEEEEccCCc
Q 044746 1 MEKPRNR-GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMI---AADNFSNLVGS-----------EDTETYIKGFLAMGP 65 (202)
Q Consensus 1 v~k~~~~-~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~i~~-----------~~~~~~~~~~~~~~~ 65 (202)
||+|++. .++++||.|+.+...... .....+..|..+. ...+|+|++.. .....++++++.++.
T Consensus 23 V~~a~~~~~~~~~vAiK~i~~~~~~~-~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~ 101 (305)
T d1blxa_ 23 VFKARDLKNGGRFVALKRVRVQTGEE-GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDL 101 (305)
T ss_dssp EEEEEETTTTTEEEEEEEEEEEBCTT-SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBH
T ss_pred EEEEEEECCCCEEEEEEEEehhhccc-hHHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCc
Confidence 7899985 456788877643322221 1122233333332 33478887642 223456777888876
Q ss_pred hhhhh--ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCC
Q 044746 66 FYLLC--KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 66 l~~~~--~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
+.... ....+++..++.++.|++.||+|||+ ++|+||||||+|||++.++.+|++|||+++...... .....
T Consensus 102 ~~~~~~~~~~~~~~~~~~~~~~qi~~aL~yLH~---~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~~---~~~~~ 175 (305)
T d1blxa_ 102 TTYLDKVPEPGVPTETIKDMMFQLLRGLDFLHS---HRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM---ALTSV 175 (305)
T ss_dssp HHHHHHSCTTCSCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG---GGCCC
T ss_pred hhhhhhccCCCCCHHHHHHHHHHHHHHHHHHHh---CCEEecCCCccEEEEcCCCCeeecchhhhhhhcccc---cCCCc
Confidence 64333 44569999999999999999999999 999999999999999999999999999988654332 23456
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||+.|+|||++.+.+++.++||||+||++|||++|++||.+..+
T Consensus 176 ~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ell~g~~pf~~~~~ 220 (305)
T d1blxa_ 176 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220 (305)
T ss_dssp CCCCTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred ccChhhcCcchhcCCCCChhehhhchHHHHHHHHHCCCCCCCCCH
Confidence 789999999999999999999999999999999999999986654
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=234.98 Aligned_cols=180 Identities=18% Similarity=0.148 Sum_probs=140.1
Q ss_pred CCccccCCCcceeehhhhchhhhh---ccCCcccCCcHHHHHHhcc--cccccc------ccccceEEEEEccC-Cchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAM---EMDKPIRFTSPQRMIAADN--FSNLVG------SEDTETYIKGFLAM-GPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~~i~------~~~~~~~~~~~~~~-~~l~~ 68 (202)
||+|++..+++.||.|+....... ......++..|..+....+ |+|++. ..+...++++++.+ +.+..
T Consensus 20 Vy~a~~~~~~~~vAvK~i~~~~~~~~~~~~~~~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~ 99 (273)
T d1xwsa_ 20 VYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFD 99 (273)
T ss_dssp EEEEEETTTCCEEEEEEEEGGGCCCEEECTTCCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHH
T ss_pred EEEEEECCCCCEEEEEEEehHHccchhhhhHHHHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHH
Confidence 799999988898888865433221 2223445666766665544 788763 33445678888765 46665
Q ss_pred hh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-CCceEEeeeecceeccccCcccccCCCCCC
Q 044746 69 LC-KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-NFFPKAADFGLAKLYNREHTHITSTGRRRT 146 (202)
Q Consensus 69 ~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt 146 (202)
++ ....+++.+++.++.|++.||.|||+ ++|+||||||+||+++. ++.+||+|||+|+...... .....||
T Consensus 100 ~~~~~~~l~e~~~~~~~~qi~~al~~lH~---~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~~----~~~~~GT 172 (273)
T d1xwsa_ 100 FITERGALQEELARSFFWQVLEAVRHCHN---CGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV----YTDFDGT 172 (273)
T ss_dssp HHHHHCSCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSSC----BCCCCSC
T ss_pred HHhccCCCCHHHHHHHHHHHHHHHHHHHH---CCCccccCcccceEEecCCCeEEECccccceeccccc----ccccccC
Confidence 55 45679999999999999999999999 99999999999999985 4799999999998654332 2345789
Q ss_pred CcccCCcccCCCCC-CchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 147 PGCEAPELWMPYSV-TQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 147 ~~y~aPe~~~~~~~-~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
+.|+|||++.+..+ +.++||||+||++|||++|+.||....
T Consensus 173 ~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~Pf~~~~ 214 (273)
T d1xwsa_ 173 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDE 214 (273)
T ss_dssp GGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSCSCCSHH
T ss_pred CCcCCHHHHcCCCCCCcccccccceeeehhHhhCCCCCCCch
Confidence 99999999987665 567899999999999999999998754
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-36 Score=239.91 Aligned_cols=179 Identities=16% Similarity=0.230 Sum_probs=147.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhccC-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKKN- 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~~- 73 (202)
||+|++..+++.||.|+-+..... ...+..|..++...+|+|++. ..+..+++++++++|+|..++...
T Consensus 21 Vy~~~~~~~~~~~AiK~i~~~~~~----~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~ 96 (321)
T d1tkia_ 21 VHRCVETSSKKTYMAKFVKVKGTD----QVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSA 96 (321)
T ss_dssp EEEEEETTTTEEEEEEEECCCTHH----HHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSS
T ss_pred EEEEEECCCCcEEEEEEEcCCccc----HHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcC
Confidence 799999988888888765432211 223556777788889998873 455567899999999999988643
Q ss_pred -CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC--CCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 -ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE--NFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 -~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~--~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++.++..++.|++.||+|||+ ++|+||||||+|||++. ...+|++|||+++........ ....||+.|+
T Consensus 97 ~~l~e~~~~~i~~qi~~al~yLH~---~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~~~---~~~~~t~~y~ 170 (321)
T d1tkia_ 97 FELNEREIVSYVHQVCEALQFLHS---HNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGDNF---RLLFTAPEYY 170 (321)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTCEE---EEEESCGGGS
T ss_pred CCCCHHHHHHHHHHHHHHHHHHHH---cCCCcccccccceeecCCCceEEEEcccchhhccccCCcc---cccccccccc
Confidence 58999999999999999999999 99999999999999984 458999999999876443322 2245699999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
|||...+..++.++||||+||++|+|++|++||......
T Consensus 171 ape~~~~~~~~~~~DiWSlGvily~ll~G~~Pf~~~~~~ 209 (321)
T d1tkia_ 171 APEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQ 209 (321)
T ss_dssp CHHHHTTCEECHHHHHHHHHHHHHHHHHSSCTTCCSSHH
T ss_pred cchhccCCCCCchhhcccHHHHHHHHHhCCCCCCCCCHH
Confidence 999999999999999999999999999999999876553
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=8.2e-37 Score=240.47 Aligned_cols=184 Identities=21% Similarity=0.269 Sum_probs=145.1
Q ss_pred CCccccC-----CCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNR-----GSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~-----~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||+|+.+ .++..||+|+.+.. ...+...+|..|.......+|+|++. ..+...++++++++|+|..+
T Consensus 29 Vy~a~~~~~~~~~~~~~vAvK~i~~~--~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~ 106 (301)
T d1lufa_ 29 VFQARAPGLLPYEPFTMVAVKMLKEE--ASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEF 106 (301)
T ss_dssp EEEEEEETSSTTSSEEEEEEEECCTT--CCHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EEEEEECCCccCCCCeEEEEEEEChh--cChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHH
Confidence 6788754 34567777664322 11222456778888889999999874 34456689999999999887
Q ss_pred hcc-------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEee
Q 044746 70 CKK-------------------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAAD 124 (202)
Q Consensus 70 ~~~-------------------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~d 124 (202)
+.. ..+++..+..++.|++.||+|||+ ++++||||||+|||++.++.+||+|
T Consensus 107 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~gl~ylH~---~~ivHrDlKp~NILld~~~~~Kl~D 183 (301)
T d1lufa_ 107 LRSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSE---RKFVHRDLATRNCLVGENMVVKIAD 183 (301)
T ss_dssp HHHTCC----------------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECC
T ss_pred HHhcCccccccccccccchhhhccccCCCCCCHHHHHHHHHHHHHHhhhccc---CCeEeeEEcccceEECCCCcEEEcc
Confidence 742 248999999999999999999999 9999999999999999999999999
Q ss_pred eecceeccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCC-CCCcchhcc
Q 044746 125 FGLAKLYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR-RNLEKEISE 189 (202)
Q Consensus 125 fgl~~~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~-~p~~~~~~~ 189 (202)
||+|+...............||+.|+|||.+.+..++.++|||||||++|||++|. +||....+.
T Consensus 184 FGls~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~ 249 (301)
T d1lufa_ 184 FGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHE 249 (301)
T ss_dssp CSCHHHHTGGGCBC----CCBCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHH
T ss_pred chhheeccCCccccccCCCCcCcCcCCHHHHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHH
Confidence 99998665444433444567899999999999999999999999999999999985 677765544
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-36 Score=231.14 Aligned_cols=180 Identities=18% Similarity=0.295 Sum_probs=145.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK--K 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~--~ 72 (202)
||+++.+ +++.||.|+.+... .....|..|.......+|+|++. ..+...++++++++|++..++. .
T Consensus 20 Vy~~~~~-~~~~vAvK~l~~~~----~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~ 94 (258)
T d1k2pa_ 20 VKYGKWR-GQYDVAIKMIKEGS----MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMR 94 (258)
T ss_dssp EEEEEET-TTEEEEEEEEESSS----SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGG
T ss_pred EEEEEEC-CCCEEEEEEECcCc----CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccc
Confidence 7888876 45556655543321 12235778888888999999874 3344568899999999988753 4
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++..+..++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++....... .......||+.|+||
T Consensus 95 ~~~~~~~~~~i~~qi~~gl~~LH~---~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~t~~y~aP 170 (258)
T d1k2pa_ 95 HRFQTQQLLEMCKDVCEAMEYLES---KQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY-TSSVGSKFPVRWSPP 170 (258)
T ss_dssp GCCCHHHHHHHHHHHHHHHHHHHH---TTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC-CCCCCSCCCGGGCCH
T ss_pred cCCcHHHHHHHHHHHHHHHHHHhh---cCcccccccceeEEEcCCCcEEECcchhheeccCCCc-eeecccCCCCCcCCc
Confidence 569999999999999999999999 9999999999999999999999999999986654322 233446689999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
|.+....++.++|||||||++|||+| |+.||......
T Consensus 171 E~~~~~~~~~ksDiwS~G~~l~el~t~g~~Pf~~~~~~ 208 (258)
T d1k2pa_ 171 EVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNS 208 (258)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTSCCTTTTSCHH
T ss_pred HHhcCCCCCcceeecccchhhHhHHhcCCCCCCCCCHH
Confidence 99998899999999999999999998 89999876554
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-36 Score=234.65 Aligned_cols=186 Identities=17% Similarity=0.238 Sum_probs=140.8
Q ss_pred CCccccCCC---cceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhc-
Q 044746 1 MEKPRNRGS---TRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCK- 71 (202)
Q Consensus 1 v~k~~~~~~---~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~- 71 (202)
||+++.... ...||+|+.+.......+...+|..|..+....+|+|++. ..+...++++++++|++.....
T Consensus 24 Vy~~~~~~~~~~~~~vAiK~l~~~~~~~~~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~~~~~lv~e~~~~~~l~~~~~~ 103 (273)
T d1u46a_ 24 VRRGEWDAPSGKTVSVAVKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLDRLRK 103 (273)
T ss_dssp CEEEEEECTTSCEEEEEEEC--------CHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEEECCTTCBHHHHHHH
T ss_pred EEEEEEECCCCcEEEEEEEEEChhhcCCHHHHHHHHHHHHHHHhCCCCCEEEEEEEEeecchheeeeeecCcchhhhhhc
Confidence 788875332 3356666544333333333456888888888999999873 2234468899999999887664
Q ss_pred -cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc-ccCCCCCCCcc
Q 044746 72 -KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI-TSTGRRRTPGC 149 (202)
Q Consensus 72 -~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~-~~~~~~gt~~y 149 (202)
...+++..++.++.|++.||.|||+ ++|+||||||+||+++.++.+||+|||+++......... ......|++.|
T Consensus 104 ~~~~l~~~~~~~~~~qi~~gl~ylH~---~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~ 180 (273)
T d1u46a_ 104 HQGHFLLGTLSRYAVQVAEGMGYLES---KRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAW 180 (273)
T ss_dssp HGGGSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCEEEC-----CCGGG
T ss_pred ccCCCCHHHHHHHHHHHHHHHHHhhh---CCEeeeeecHHHhccccccceeeccchhhhhcccCCCcceecCccccCccc
Confidence 3469999999999999999999999 999999999999999999999999999999765443322 22334568899
Q ss_pred cCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 150 EAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 150 ~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
+|||.+.+..++.++||||||+++|||+| |++||.+....
T Consensus 181 ~aPE~~~~~~~~~~~Di~S~Gvil~emlt~G~~Pf~~~~~~ 221 (273)
T d1u46a_ 181 CAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGS 221 (273)
T ss_dssp CCHHHHHHCEEEHHHHHHHHHHHHHHHHTTSCCTTTTCCHH
T ss_pred CCHHHHhCCCCCcchhhhhhHHHHHHHHhCCCCCCCCcCHH
Confidence 99999999999999999999999999998 89999765443
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=236.22 Aligned_cols=182 Identities=21% Similarity=0.272 Sum_probs=143.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhh--cc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLC--KK 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~--~~ 72 (202)
||+|++..+++.||.|+-+... ........+..|..+....+|++++. ..+..+++++++.++.+.... ..
T Consensus 18 Vy~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~ 96 (298)
T d1gz8a_ 18 VYKARNKLTGEVVALKKIRLDT-ETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL 96 (298)
T ss_dssp EEEEEETTTCCEEEEEEEC--------CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTTT
T ss_pred EEEEEECCCCCEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCCchhhhhhhhcc
Confidence 7999999999999988754332 22233456777888888999999874 445556788888766444333 34
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.++..++.|++.||+|||+ ++||||||||+|||++.++.+|++|||+|+....... ......||+.|+||
T Consensus 97 ~~l~e~~~~~~~~qil~~L~yLH~---~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~gt~~y~ap 171 (298)
T d1gz8a_ 97 TGIPLPLIKSYLFQLLQGLAFCHS---HRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPVR--TYTHEVVTLWYRAP 171 (298)
T ss_dssp TCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCSB--CTTCCBCCCTTCCH
T ss_pred cCCCHHHHHHHHHHHHHHHHHhhc---CCEEccccCchheeecccCcceeccCCcceeccCCcc--cceeecccceeeeh
Confidence 569999999999999999999999 9999999999999999999999999999986543322 23445689999999
Q ss_pred cccCCCC-CCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 153 ELWMPYS-VTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 153 e~~~~~~-~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|.+.... ++.++|+||+||++|+|++|+.||...+.
T Consensus 172 E~~~~~~~~~~~~DiwSlGvily~m~~G~~Pf~~~~~ 208 (298)
T d1gz8a_ 172 EILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSE 208 (298)
T ss_dssp HHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred hhhccccCCCccccccccchhhhHHhhCCCCCCCCCH
Confidence 9887665 57899999999999999999999976543
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4e-36 Score=234.70 Aligned_cols=176 Identities=27% Similarity=0.364 Sum_probs=136.0
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc-----ccccceEEEEEccCCchhhhhcc---
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG-----SEDTETYIKGFLAMGPFYLLCKK--- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~-----~~~~~~~~~~~~~~~~l~~~~~~--- 72 (202)
||+++++++.+ ||.|+.+... .....|..|.......+|+|++. ..+..+++++++++|++..++..
T Consensus 33 Vy~~~~~~~~~-vAiK~l~~~~----~~~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~lv~Ey~~~g~l~~~~~~~~~ 107 (285)
T d1fmka3 33 VWMGTWNGTTR-VAIKTLKPGT----MSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIYIVTEYMSKGSLLDFLKGETG 107 (285)
T ss_dssp EEEEEETTTEE-EEEEECCTTS----SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCEEEECCCTTCBHHHHHSHHHH
T ss_pred EEEEEECCCCE-EEEEEECccc----CCHHHHHHHHHHHHhcccCCEeEEEEEEecCCeEEEEEecCCCchhhhhhhccc
Confidence 78998877755 5655543221 12345788888889999999874 23345689999999998877743
Q ss_pred CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCC
Q 044746 73 NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAP 152 (202)
Q Consensus 73 ~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aP 152 (202)
..+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++....... .......||+.|+||
T Consensus 108 ~~l~~~~~~~i~~~i~~gl~~LH~---~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~-~~~~~~~gt~~y~aP 183 (285)
T d1fmka3 108 KYLRLPQLVDMAAQIASGMAYVER---MNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY-TARQGAKFPIKWTAP 183 (285)
T ss_dssp TTCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECGGGCEEECCCCTTC---------------CCGGGSCH
T ss_pred ccchHHHHHHHHHHHHHHHHHHhh---hheecccccceEEEECCCCcEEEcccchhhhccCCCc-eeeccccccccccCh
Confidence 469999999999999999999999 9999999999999999999999999999987643322 223345679999999
Q ss_pred cccCCCCCCchhhHHHHHHHHHHHHcCCCCCcc
Q 044746 153 ELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEK 185 (202)
Q Consensus 153 e~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~ 185 (202)
|++....++.++|||||||++|||++|..|+..
T Consensus 184 E~~~~~~~~~ksDI~S~Giil~el~t~~~p~~~ 216 (285)
T d1fmka3 184 EAALYGRFTIKSDVWSFGILLTELTTKGRVPYP 216 (285)
T ss_dssp HHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSST
T ss_pred HHHhCCCCCcHHhhhcchHHHHHHHhCCCCCCC
Confidence 999999999999999999999999996555543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-35 Score=233.77 Aligned_cols=182 Identities=19% Similarity=0.213 Sum_probs=135.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc----------cceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED----------TETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~----------~~~~~~~~~~~~~l~~~~ 70 (202)
|||++.. ++.||+|+.+...... ..+..|.......+|+|++...+ ..+++++++++|+|..++
T Consensus 19 Vy~~~~~--g~~vAvK~~~~~~~~~----~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l 92 (303)
T d1vjya_ 19 VWRGKWR--GEEVAVKIFSSREERS----WFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYL 92 (303)
T ss_dssp EEEEEET--TEEEEEEEECGGGHHH----HHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHH
T ss_pred EEEEEEC--CEEEEEEEECccchhH----HHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHH
Confidence 6888763 4567766543322111 11112333334568998874221 245899999999999999
Q ss_pred ccCCCCHHHHHHHHHHHHHHHHHHHhCC-----CCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc--cccCCC
Q 044746 71 KKNILGFGQLREIEVSTSKGIAYLHEEC-----RQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH--ITSTGR 143 (202)
Q Consensus 71 ~~~~~~~~~~~~~~~~i~~~l~~lH~~~-----~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~--~~~~~~ 143 (202)
+...+++.++..++.|++.||.|+|+.+ .++|+||||||+|||++.++.+||+|||+++........ ......
T Consensus 93 ~~~~l~~~~~~~~~~~ia~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~ 172 (303)
T d1vjya_ 93 NRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHR 172 (303)
T ss_dssp HHCCBCHHHHHHHHHHHHHHHHHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----C
T ss_pred hcCCCCHHHHHHHHHHHHHHHHHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccce
Confidence 9999999999999999999999999621 269999999999999999999999999999976543222 123456
Q ss_pred CCCCcccCCcccCCCC------CCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMPYS------VTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~------~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||+.|+|||++.+.. ++.++|||||||++|||+||.+||.....
T Consensus 173 ~gt~~y~aPE~~~~~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~ 223 (303)
T d1vjya_ 173 VGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHED 223 (303)
T ss_dssp CSCGGGCCHHHHTTCSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCC
T ss_pred ecccCcCChhhccccccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccc
Confidence 7899999999987643 56789999999999999999988765443
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-35 Score=233.74 Aligned_cols=183 Identities=22% Similarity=0.259 Sum_probs=142.4
Q ss_pred CCccccCCCc-------ceeehhhhchhhhhccCCcccCCcHHHHHHh-cccccccc------ccccceEEEEEccCCch
Q 044746 1 MEKPRNRGST-------RFITRTIDKSLDAMEMDKPIRFTSPQRMIAA-DNFSNLVG------SEDTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~-------~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~i~------~~~~~~~~~~~~~~~~l 66 (202)
||+++..+.+ ..||+|+.+.... ......+..|...... .+|+|++. ..+...++++++++|+|
T Consensus 29 Vy~~~~~~~~~~~~~~~~~vAvK~~~~~~~--~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l 106 (299)
T d1fgka_ 29 VVLAEAIGLDKDKPNRVTKVAVKMLKSDAT--EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNL 106 (299)
T ss_dssp EEEEEEECC----CCCEEEEEEECCCTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBH
T ss_pred EEEEEEcCCCcccccCceEEEEEEECcccC--hHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcH
Confidence 5777654443 3566655432211 1122345555554544 48998874 34456788999999999
Q ss_pred hhhhccC-----------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 67 YLLCKKN-----------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 67 ~~~~~~~-----------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
..++... .+++..++.++.|++.||+|||+ .+++||||||+|||++.++.+||+|||+++
T Consensus 107 ~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~al~ylH~---~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~ 183 (299)
T d1fgka_ 107 REYLQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLAS---KKCIHRDLAARNVLVTEDNVMKIADFGLAR 183 (299)
T ss_dssp HHHHHTTSCC------------CCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSTTCCC
T ss_pred HHHHHhhcCCccccccccccCccccCCHHHHHHHHHHHHHHHHHhhh---CCEEeeeecccceeecCCCCeEeccchhhc
Confidence 9988433 48999999999999999999999 999999999999999999999999999999
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
...............||+.|+|||.+.+..++.++||||||+++|||++ |++||.....
T Consensus 184 ~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~ 243 (299)
T d1fgka_ 184 DIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPV 243 (299)
T ss_dssp CGGGCCTTCCCTTSCCGGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSSTTCCH
T ss_pred cccccccccccccCCCChhhhhhhHhcCCCCCchhhhHHhHHHHHHhccCCCCCCCCCCH
Confidence 7765554444555678999999999999999999999999999999998 7888875544
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.7e-35 Score=231.34 Aligned_cols=185 Identities=20% Similarity=0.243 Sum_probs=143.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc--------------cccceEEEEEccCCch
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS--------------EDTETYIKGFLAMGPF 66 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--------------~~~~~~~~~~~~~~~l 66 (202)
||+|++..+++.||+|+...... ......++..|..++...+|+|++.. .+..+++++++.++.+
T Consensus 26 Vy~a~~~~~~~~vAvK~i~~~~~-~~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~ 104 (318)
T d3blha1 26 VFKARHRKTGQKVALKKVLMENE-KEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104 (318)
T ss_dssp EEEEEETTTCCEEEEEEC----C-TTSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHH
T ss_pred EEEEEECCCCCEEEEEEEehhhc-chHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCcc
Confidence 79999999999999887543322 22334556678888888899987642 1234577888887776
Q ss_pred hhhh-ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcc--cccCCC
Q 044746 67 YLLC-KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTH--ITSTGR 143 (202)
Q Consensus 67 ~~~~-~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~--~~~~~~ 143 (202)
.... ....++...++.++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||+++........ ......
T Consensus 105 ~~~~~~~~~~~~~~~~~i~~qil~~l~~lH~---~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~ 181 (318)
T d3blha1 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHR---NKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNR 181 (318)
T ss_dssp HHHTCTTCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSC
T ss_pred chhhhcccccccHHHHHHHHHHHHHHHHhcc---CCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccce
Confidence 5444 34569999999999999999999999 99999999999999999999999999999866533221 122335
Q ss_pred CCCCcccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 144 RRTPGCEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.||+.|+|||++.+. .++.++||||+||+++||++|++||.+..+.
T Consensus 182 ~gT~~Y~aPE~~~~~~~~~~k~DiwSlGvil~el~~g~~pf~~~~~~ 228 (318)
T d3blha1 182 VVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQ 228 (318)
T ss_dssp CSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSCCCSSHH
T ss_pred ecCHHHhhHHHHcCCCCCCcHHHcccCCceeeeHhhCCCCCCCCCHH
Confidence 689999999998765 6899999999999999999999999865543
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.1e-34 Score=227.82 Aligned_cols=180 Identities=14% Similarity=0.152 Sum_probs=137.1
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccc-------cccccceEEEEEccCCchhhhh--c
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLV-------GSEDTETYIKGFLAMGPFYLLC--K 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i-------~~~~~~~~~~~~~~~~~l~~~~--~ 71 (202)
||+|++..+++.||.|+..... ...++..|..+....+|++++ ..++...++++++. +++.... .
T Consensus 23 Vy~a~~~~~~~~vAvK~~~~~~-----~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~~-~~l~~~~~~~ 96 (299)
T d1ckia_ 23 IYLGTDIAAGEEVAIKLECVKT-----KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLG-PSLEDLFNFC 96 (299)
T ss_dssp EEEEEETTTTEEEEEEEEESCT-----TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECCC-CBHHHHHHHT
T ss_pred EEEEEECCCCCEEEEEEEchhc-----cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEcC-Cchhhhhhhc
Confidence 7999999999999998754421 123455666666666666543 12333445666654 5544443 3
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC---CCceEEeeeecceeccccCcc-----cccCCC
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE---NFFPKAADFGLAKLYNREHTH-----ITSTGR 143 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~---~~~~kl~dfgl~~~~~~~~~~-----~~~~~~ 143 (202)
...+++..+..++.|++.||+|||+ ++|+||||||+||++.. +..++++|||+|+........ ......
T Consensus 97 ~~~~~~~~~~~~~~qi~~~l~~lH~---~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~ 173 (299)
T d1ckia_ 97 SRKFSLKTVLLLADQMISRIEYIHS---KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNL 173 (299)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHH---TTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSC
T ss_pred cCCCcHHHHHHHHHHHHHHHHHHHH---CCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCc
Confidence 4569999999999999999999999 99999999999999853 457999999999976543221 123446
Q ss_pred CCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhcc
Q 044746 144 RRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEISE 189 (202)
Q Consensus 144 ~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~~ 189 (202)
.||+.|+|||.+.+..++.++|||||||+++||++|+.||......
T Consensus 174 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l~el~tg~~P~~~~~~~ 219 (299)
T d1ckia_ 174 TGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGLKAA 219 (299)
T ss_dssp CCCSSSCCHHHHTTBCCCHHHHHHHHHHHHHHHHHSSCTTCCCC--
T ss_pred CCCccccCHHHHhCCCCCChhhEEecCHHHHHHHhCCCcccccchH
Confidence 7899999999999999999999999999999999999999765543
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-34 Score=231.90 Aligned_cols=175 Identities=20% Similarity=0.193 Sum_probs=139.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||+|++..+++.||.|+.+.. ...+..|..++...+|+|++...+ +.++++++++++.+..
T Consensus 36 Vy~a~~~~~~~~vAiK~i~~~-------~~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~ 108 (350)
T d1q5ka_ 36 VYQAKLCDSGELVAIKKVLQD-------KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108 (350)
T ss_dssp EEEEEETTTCCEEEEEEEECC-------SSSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHH
T ss_pred EEEEEECCCCCEEEEEEECcc-------chHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHH
Confidence 799999999999998875332 123456777888889998874221 2356788888764433
Q ss_pred hh----ccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCcccccCCC
Q 044746 69 LC----KKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHITSTGR 143 (202)
Q Consensus 69 ~~----~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~~~~~~ 143 (202)
+. ....+++.+++.++.|++.||+|||+ ++|+||||||+|||++.++ .+||+|||+++....... ....
T Consensus 109 l~~~~~~~~~l~~~~~~~i~~qil~aL~yLH~---~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~~---~~~~ 182 (350)
T d1q5ka_ 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHS---FGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGEP---NVSY 182 (350)
T ss_dssp HHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTSC---CCSC
T ss_pred HHhhhhccCCCCHHHHHHHHHHHHHHHHHHHh---cCCcccCCCcceEEEecCCCceeEecccchhhccCCcc---cccc
Confidence 32 34569999999999999999999999 9999999999999999775 899999999987654332 2335
Q ss_pred CCCCcccCCcccCC-CCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 144 RRTPGCEAPELWMP-YSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 144 ~gt~~y~aPe~~~~-~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.||+.|+|||.+.+ ..++.++||||+||++|||++|++||.....
T Consensus 183 ~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~el~~g~~pf~~~~~ 228 (350)
T d1q5ka_ 183 ICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSG 228 (350)
T ss_dssp CSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHTSCSSCCSSH
T ss_pred cccccccChHHhhcccCCCcceeecccceEEEehhhCCCCCCCCCH
Confidence 67999999998775 4689999999999999999999999976554
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.9e-35 Score=232.54 Aligned_cols=178 Identities=22% Similarity=0.255 Sum_probs=144.7
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccccc------------cceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSED------------TETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~------------~~~~~~~~~~~~~l~~ 68 (202)
||+|+++.+++.||.|+.+.... ......++..|..++...+|++++...+ ..+++++++ +.+|..
T Consensus 34 V~~~~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~ 111 (346)
T d1cm8a_ 34 VCSAVDGRTGAKVAIKKLYRPFQ-SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGK 111 (346)
T ss_dssp EEEEEETTTCCEEEEEECSSTTS-SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHH
T ss_pred EEEEEECCCCCEEEEEEEchhhc-ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHH
Confidence 79999999899998877543211 1122345667777788889998874221 235777877 567888
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+.+...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||+++..... .....||+.
T Consensus 112 ~~~~~~l~~~~~~~~~~qi~~aL~~LH~---~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~t~~ 183 (346)
T d1cm8a_ 112 LMKHEKLGEDRIQFLVYQMLKGLRYIHA---AGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE-----MTGYVVTRW 183 (346)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCCGGGEEECTTCCEEECCCTTCEECCSS-----CCSSCSCGG
T ss_pred HHHhccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCcchhhcccccccccccccceeccCCc-----ccccccccc
Confidence 8888899999999999999999999999 99999999999999999999999999999875432 234567999
Q ss_pred ccCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||.+.+. .++.++||||+||+++||++|++||.+...
T Consensus 184 y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~ 224 (346)
T d1cm8a_ 184 YRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDH 224 (346)
T ss_dssp GCCTHHHHTTTCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccCHHHHcCCCCCCccchhhcchHHHHHHHHCcCCCCCCCh
Confidence 9999998764 568999999999999999999999987643
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.6e-34 Score=226.58 Aligned_cols=179 Identities=12% Similarity=0.101 Sum_probs=134.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccc-c---cccc---ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNF-S---NLVG---SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~---~~i~---~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||+|++..+++.||.|+.+.... ...+..|........+ + ++.+ .+....++++++ +++|..+...
T Consensus 21 Vy~a~~~~~~~~vAvK~~~~~~~-----~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~ 94 (293)
T d1csna_ 21 IFEGTNLLNNQQVAIKFEPRRSD-----APQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLC 94 (293)
T ss_dssp EEEEEETTTTEEEEEEEEECCTT-----SCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHT
T ss_pred EEEEEECCCCCEEEEEEEccccC-----cHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhh
Confidence 79999999999999887543221 1223334333333322 2 3322 334445566665 6787777643
Q ss_pred -CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcC-----CCceEEeeeecceeccccCcc-----cccC
Q 044746 73 -NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDE-----NFFPKAADFGLAKLYNREHTH-----ITST 141 (202)
Q Consensus 73 -~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~-----~~~~kl~dfgl~~~~~~~~~~-----~~~~ 141 (202)
..++...+..++.|++.||+|||+ ++|+||||||+||+++. ++.++|+|||+|+........ ....
T Consensus 95 ~~~~~~~~~~~i~~q~~~~l~~lH~---~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~ 171 (293)
T d1csna_ 95 GRKFSVKTVAMAAKQMLARVQSIHE---KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKK 171 (293)
T ss_dssp TTCCCHHHHHHHHHHHHHHHHHHHT---TTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCC
T ss_pred ccchhhHHHHHHHHHHHHHHHHHHH---CCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccC
Confidence 469999999999999999999999 99999999999999964 578999999999976533211 1233
Q ss_pred CCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 142 GRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 142 ~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
...||+.|+|||++.+..++.++||||+|+++|||+||+.||.....
T Consensus 172 ~~~GT~~y~aPE~~~~~~~~~~~DiwSlG~~l~elltg~~Pf~~~~~ 218 (293)
T d1csna_ 172 NLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQGLKA 218 (293)
T ss_dssp CCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHHHHHHHSSCTTSSCCS
T ss_pred ceEEchhhcCHHHhcCCCCChHHHHHHhhHHHHHHHhCCCcCCCccc
Confidence 46799999999999999999999999999999999999999976544
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=5.1e-35 Score=228.47 Aligned_cols=181 Identities=20% Similarity=0.218 Sum_probs=139.5
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhc-cC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCK-KN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~-~~ 73 (202)
||||++..+ +.||.|+.+... .......++..|..+....+|+|++. ..+...+++++..++.+..+.. .+
T Consensus 18 Vy~~~~~~~-~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~ 95 (286)
T d1ob3a_ 18 VYKAQNNYG-ETFALKKIRLEK-EDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG 95 (286)
T ss_dssp EEEEEETTS-CEEEEEEECCSS-GGGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTT
T ss_pred EEEEEeCCC-CEEEEEEEehhh-cChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcC
Confidence 799998744 566666543322 22334566778888888999999874 3444556777777776666654 45
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||+|||+ .+|+||||||+|||++.++.+|++|||.+........ ......|++.|+|||
T Consensus 96 ~l~~~~~~~i~~qi~~~L~~LH~---~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~y~~pE 170 (286)
T d1ob3a_ 96 GLESVTAKSFLLQLLNGIAYCHD---RRVLHRDLKPQNLLINREGELKIADFGLARAFGIPVR--KYTHEIVTLWYRAPD 170 (286)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-----------CCCTTCCHH
T ss_pred CcchhhhHHHHHHHHHHHHHhcc---CcEEecCCCCceeeEcCCCCEEecccccceecccCcc--ccceecccchhhhHH
Confidence 69999999999999999999999 9999999999999999999999999999986543322 123345799999999
Q ss_pred ccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 154 LWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 154 ~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
.+.+. .++.++|+||+||+++||++|++||.+..+
T Consensus 171 ~~~~~~~~~~~~DiwslGv~l~el~~G~~pf~~~~~ 206 (286)
T d1ob3a_ 171 VLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSE 206 (286)
T ss_dssp HHTTCCSCCTHHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred HHhCCCCCCcceeehhcCcHHHHHHHCCCCCCCCCH
Confidence 98754 578999999999999999999999976543
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.5e-35 Score=229.81 Aligned_cols=183 Identities=20% Similarity=0.274 Sum_probs=141.6
Q ss_pred CCccccCCCc---ceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-------ccceEEEEEccCCchhhhh
Q 044746 1 MEKPRNRGST---RFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-------DTETYIKGFLAMGPFYLLC 70 (202)
Q Consensus 1 v~k~~~~~~~---~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-------~~~~~~~~~~~~~~l~~~~ 70 (202)
|||++....+ ..||+|..+.. .......+|..|.......+|+|++... +...++++++++|+|..+.
T Consensus 43 Vyk~~~~~~~~~~~~vAvK~~~~~--~~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~ 120 (311)
T d1r0pa_ 43 VYHGTLLDNDGKKIHCAVKSLNRI--TDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFI 120 (311)
T ss_dssp EEEEEECC----CEEEEEEEECCC--CCHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHH
T ss_pred EEEEEEECCCCEEEEEEEEEECcc--cCHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhh
Confidence 6888775543 24565543221 1222345688888888889999987432 3345899999999998887
Q ss_pred ccC--CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc--ccccCCCCCC
Q 044746 71 KKN--ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT--HITSTGRRRT 146 (202)
Q Consensus 71 ~~~--~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~--~~~~~~~~gt 146 (202)
... .+++..+..++.|++.||.|+|+ .+|+||||||+|||++.++.+||+|||+++....... ........||
T Consensus 121 ~~~~~~~~~~~~~~i~~qia~gL~~lH~---~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt 197 (311)
T d1r0pa_ 121 RNETHNPTVKDLIGFGLQVAKGMKFLAS---KKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLP 197 (311)
T ss_dssp HCTTCCCBHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCC
T ss_pred ccccccchHHHHHHHHHHHHHhhhhhcc---cCcccCCccHHhEeECCCCCEEEecccchhhccccccccceeccccccc
Confidence 654 47888999999999999999999 9999999999999999999999999999987654322 2223345689
Q ss_pred CcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 147 PGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 147 ~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+.|+|||.+....++.++||||||+++|||++|..||.....
T Consensus 198 ~~y~aPE~~~~~~~~~ksDI~SfGivl~El~t~~~p~~~~~~ 239 (311)
T d1r0pa_ 198 VKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVN 239 (311)
T ss_dssp GGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCC---
T ss_pred ccccChHHHhcCCCCChhHhhhhHHHHHHHHHCCCCCCCCCC
Confidence 999999999988999999999999999999998777765443
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-35 Score=231.92 Aligned_cols=181 Identities=21% Similarity=0.277 Sum_probs=139.4
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhhhhcc-
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYLLCKK- 72 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~- 72 (202)
||+++++.++..+++++.+.......+....|..|....... +|+|++. ..+...++++++++|+|..++..
T Consensus 26 Vy~~~~~~~~~~~~vaiK~~~~~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~ 105 (309)
T d1fvra_ 26 VLKARIKKDGLRMDAAIKRMKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKS 105 (309)
T ss_dssp EEEEEEEETTEEEEEEEEEEECC------CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTT
T ss_pred EEEEEECCCCeEEEEEEEEECcccChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhc
Confidence 688888777765544443332222333445677787777776 7998874 34456688999999999998743
Q ss_pred ----------------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCc
Q 044746 73 ----------------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHT 136 (202)
Q Consensus 73 ----------------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~ 136 (202)
..+++..+..++.|++.||.|+|+ ++++||||||+|||++.++.+||+|||+++.......
T Consensus 106 ~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qia~gl~~lH~---~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~~ 182 (309)
T d1fvra_ 106 RVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQ---KQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYVK 182 (309)
T ss_dssp CHHHHCHHHHHHTTBSCSSCHHHHHHHHHHHHHHHHHHHH---TTEECSCCSGGGEEECGGGCEEECCTTCEESSCEECC
T ss_pred cccccchhhhccccccCCCCHHHHHHHHHHHHHHHHhhhc---CCccccccccceEEEcCCCceEEcccccccccccccc
Confidence 468999999999999999999999 9999999999999999999999999999986443222
Q ss_pred ccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCC-CCCcchh
Q 044746 137 HITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRR-RNLEKEI 187 (202)
Q Consensus 137 ~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~-~p~~~~~ 187 (202)
.....||..|+|||.+.+..++.++|||||||++|||++|. +||....
T Consensus 183 ---~~~~~gt~~y~aPE~l~~~~~~~~sDvwSfGvil~ell~~~~~p~~~~~ 231 (309)
T d1fvra_ 183 ---KTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMT 231 (309)
T ss_dssp ---C----CCTTTCCHHHHHHCEECHHHHHHHHHHHHHHHHTTSCCTTTTCC
T ss_pred ---ccceecCCcccchHHhccCCCCccceeehhHHHHHHHHhcCCCCCCCCC
Confidence 23345799999999999999999999999999999999965 5676543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.6e-35 Score=229.56 Aligned_cols=183 Identities=19% Similarity=0.288 Sum_probs=142.9
Q ss_pred CCcccc-----CCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc------ccccceEEEEEccCCchhh
Q 044746 1 MEKPRN-----RGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG------SEDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~-----~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~------~~~~~~~~~~~~~~~~l~~ 68 (202)
||+|+. ...+..||+|..+.... ......|..|....... +|+|++. ......++++++++|+|..
T Consensus 39 Vy~a~~~~~~~~~~~~~vAvK~i~~~~~--~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~ 116 (311)
T d1t46a_ 39 VVEATAYGLIKSDAAMTVAVKMLKPSAH--LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLN 116 (311)
T ss_dssp EEEEEEESSSSTTCEEEEEEEEECTTCC--HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHH
T ss_pred EEEEEEeccccCCCCeEEEEEEECcccC--HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHH
Confidence 566653 34556777766433221 11223455665555555 7999874 3344678999999999988
Q ss_pred hhccC-------------------CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecce
Q 044746 69 LCKKN-------------------ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAK 129 (202)
Q Consensus 69 ~~~~~-------------------~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~ 129 (202)
++... .+++..++.++.|++.||.|||+ ++++||||||+||+++.++.++++|||+++
T Consensus 117 ~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~gl~~LH~---~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~ 193 (311)
T d1t46a_ 117 FLRRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLAS---KNCIHRDLAARNILLTHGRITKICDFGLAR 193 (311)
T ss_dssp HHHHTTTTC--------------CCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEEETTTEEEECCCGGGS
T ss_pred HHHhccccccccccccccccccccCCCHHHHHHHHHHHHHHHHHHHh---CCeeecccccccccccccCcccccccchhe
Confidence 87432 58999999999999999999999 999999999999999999999999999999
Q ss_pred eccccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhc
Q 044746 130 LYNREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEIS 188 (202)
Q Consensus 130 ~~~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~ 188 (202)
...............||+.|+|||.+....++.++|||||||++|||+| |.+||.....
T Consensus 194 ~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DIwS~G~~l~ellt~g~p~~~~~~~ 253 (311)
T d1t46a_ 194 DIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMPV 253 (311)
T ss_dssp CTTSCTTSEECSSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTTCCSSTTCCS
T ss_pred eccCCCcceEeeecccChHHcCHHHhcCCCCCCcccccchHHHHHHHHhCCCCCCCCCCH
Confidence 7765544445566788999999999998899999999999999999998 5666655443
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-34 Score=230.21 Aligned_cols=179 Identities=20% Similarity=0.257 Sum_probs=143.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccccc-----------ccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGSE-----------DTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~-----------~~~~~~~~~~~~~~l~~~ 69 (202)
||+|++..+++.||.|+.+.... ......++..|..++...+|++++... ....++++++.+|+|..+
T Consensus 34 Vy~a~~~~~~~~vAiK~i~~~~~-~~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~ 112 (348)
T d2gfsa1 34 VCAAFDTKTGLRVAVKKLSRPFQ-SIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNI 112 (348)
T ss_dssp EEEEEETTTTEEEEEEECSCTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHH
T ss_pred EEEEEECCCCCEEEEEEECchhc-ChHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhh
Confidence 79999999999999887543221 112233566788888888999887422 223577888999999999
Q ss_pred hccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcc
Q 044746 70 CKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGC 149 (202)
Q Consensus 70 ~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y 149 (202)
+..+.+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++.+|++|||++...... .....|++.|
T Consensus 113 ~~~~~l~e~~~~~i~~qil~aL~~LH~---~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~~-----~~~~~g~~~y 184 (348)
T d2gfsa1 113 VKCQKLTDDHVQFLIYQILRGLKYIHS---ADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE-----MTGYVATRWY 184 (348)
T ss_dssp HTTCCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTCCEEECCC----CCTGG-----GSSSCHHHHT
T ss_pred cccccccHHHHHHHHHHHHHHHHHHHh---CCCcccccCCccccccccccccccccchhcccCcc-----cccccccccc
Confidence 998999999999999999999999999 99999999999999999999999999998754322 2345678999
Q ss_pred cCCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 150 EAPELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 150 ~aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
+|||...+. .++.++||||+||++++|++|++||.+.+.
T Consensus 185 ~apE~~~~~~~~~~~~DiwSlGv~l~~ll~g~~pF~~~~~ 224 (348)
T d2gfsa1 185 RAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDH 224 (348)
T ss_dssp SCHHHHTTCSCCCTTHHHHHHHHHHHHHHHSSCSCCCSSH
T ss_pred cCchhhcCCccCCcccchhhhhHHHHHHHhCCCCCCCCCH
Confidence 999987765 468899999999999999999999976543
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.6e-34 Score=223.11 Aligned_cols=174 Identities=23% Similarity=0.316 Sum_probs=132.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc-------cccceEEEEEccCCchhhhhccC
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS-------EDTETYIKGFLAMGPFYLLCKKN 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~-------~~~~~~~~~~~~~~~l~~~~~~~ 73 (202)
|||++..+ ..||+|+.+.. .....|..|.......+|+|++.. .+..+++++++++|+|..++...
T Consensus 23 Vy~~~~~~--~~vAvK~i~~~-----~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~ 95 (262)
T d1byga_ 23 VMLGDYRG--NKVAVKCIKND-----ATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSR 95 (262)
T ss_dssp EEEEEETT--EEEEEEECCCC-----C--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHH
T ss_pred EEEEEECC--eEEEEEEECcH-----HHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhc
Confidence 68888753 34555554322 123456778888888899988742 12346899999999999987543
Q ss_pred ---CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 74 ---ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 74 ---~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
.+++..++.++.|++.||.|||+ .+++||||||+||+++.++.+|++|||+++...... ....+|+.|+
T Consensus 96 ~~~~l~~~~~~~i~~~i~~al~ylH~---~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~~-----~~~~~~~~y~ 167 (262)
T d1byga_ 96 GRSVLGGDCLLKFSLDVCEAMEYLEG---NNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-----DTGKLPVKWT 167 (262)
T ss_dssp HHHHCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCSGGGEEECTTSCEEECCCCC-----------------CCTTTS
T ss_pred CCCCCCHHHHHHHHHHHHhhcccccc---CceeccccchHhheecCCCCEeecccccceecCCCC-----ccccccccCC
Confidence 48999999999999999999999 999999999999999999999999999998654322 2234588999
Q ss_pred CCcccCCCCCCchhhHHHHHHHHHHHHc-CCCCCcchhcc
Q 044746 151 APELWMPYSVTQKCDVFSFGMLLFEVVG-RRRNLEKEISE 189 (202)
Q Consensus 151 aPe~~~~~~~~~~~Diws~G~~l~el~~-g~~p~~~~~~~ 189 (202)
|||++.+..++.++|||||||++|||+| |++||......
T Consensus 168 aPE~l~~~~~t~~sDIwSfG~il~el~t~~~~p~~~~~~~ 207 (262)
T d1byga_ 168 APEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLK 207 (262)
T ss_dssp CHHHHHHCCCCHHHHHHHHHHHHHHHHTTSCCSCTTSCGG
T ss_pred ChHHHhCCCCChHHHHHhHHHHHHHHHHCCCCCCCCCCHH
Confidence 9999988899999999999999999998 78888765443
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.3e-34 Score=227.09 Aligned_cols=183 Identities=17% Similarity=0.250 Sum_probs=144.7
Q ss_pred CCccccCC-----CcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRNRG-----STRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~~~-----~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||+|.+.+ .+..||+|..+... .......|..|..+....+|+|++. ..+...++++++++|+|..+
T Consensus 36 Vy~a~~~~~~~~~~~~~VAvK~~~~~~--~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~ 113 (308)
T d1p4oa_ 36 VYEGVAKGVVKDEPETRVAIKTVNEAA--SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSY 113 (308)
T ss_dssp EEEEEEEEEETTEEEEEEEEEECCTTS--CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHH
T ss_pred EEEEEECCcccCCCCcEEEEEEECccc--ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHH
Confidence 56666542 34566766543221 1122345778888888899998874 34456789999999999887
Q ss_pred hcc-----------CCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCccc
Q 044746 70 CKK-----------NILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHI 138 (202)
Q Consensus 70 ~~~-----------~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~ 138 (202)
+.. ..+++..+..++.|++.||.|||+ ++|+||||||+|||++.++.+||+|||+++.........
T Consensus 114 ~~~~~~~~~~~~~~~~~~~~~~~~i~~~ia~gl~~LH~---~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~~~ 190 (308)
T d1p4oa_ 114 LRSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNA---NKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 190 (308)
T ss_dssp HHHHHHHHHHCTTCCCCCHHHHHHHHHHHHHHHHHHHH---TTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGCEE
T ss_pred HHhcccccccccccCCCCHHHHHHHHHHHHHHHHHHhh---CCeeeceEcCCceeecCCceEEEeecccceeccCCccee
Confidence 732 347899999999999999999999 999999999999999999999999999998766554444
Q ss_pred ccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcC-CCCCcchhc
Q 044746 139 TSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGR-RRNLEKEIS 188 (202)
Q Consensus 139 ~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g-~~p~~~~~~ 188 (202)
......||+.|+|||.+.+..++.++||||||+++|||+|| ++||.....
T Consensus 191 ~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~S~G~il~El~t~~~~p~~~~~~ 241 (308)
T d1p4oa_ 191 KGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSN 241 (308)
T ss_dssp GGGSSEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHHTSCCTTTTSCH
T ss_pred eccceecccccCCHHHHccCCCCcccccccHHHHHHHHHhCCCCCCCCCCH
Confidence 45556789999999999999999999999999999999998 477765443
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-33 Score=224.20 Aligned_cols=186 Identities=17% Similarity=0.194 Sum_probs=144.6
Q ss_pred CCcccc---CCCcceeehhhhchhh-hhccCCcccCCcHHHHHHhccc-ccccc------ccccceEEEEEccCCchhhh
Q 044746 1 MEKPRN---RGSTRFITRTIDKSLD-AMEMDKPIRFTSPQRMIAADNF-SNLVG------SEDTETYIKGFLAMGPFYLL 69 (202)
Q Consensus 1 v~k~~~---~~~~~~v~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~-~~~i~------~~~~~~~~~~~~~~~~l~~~ 69 (202)
||+|++ ..+++.||.|+-+... ........++..|.......+| ++++. ......++++++.+|+|..+
T Consensus 40 Vy~~~~~~~~~~g~~vAvK~i~~~~~~~~~~~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~ 119 (322)
T d1vzoa_ 40 VFLVRKISGHDTGKLYAMKVLKKATIVQKAKTTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTH 119 (322)
T ss_dssp EEEEEECSSTTTTCEEEEEEESEEEEEEEESSGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHH
T ss_pred EEEEEECccCCCCcEEEEEEEehHHhccchHHHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHH
Confidence 678875 4457778877643322 2233345668888887777766 67753 34455688899999999888
Q ss_pred hc-cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 70 CK-KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 70 ~~-~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
+. .+.++...+..++.|++.||+|+|+ ++|+||||||+||+++.++.++|+|||+++......... .....|++.
T Consensus 120 i~~~~~~~e~~~~~~~~Qi~~al~~lH~---~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~~~-~~~~~g~~~ 195 (322)
T d1vzoa_ 120 LSQRERFTEHEVQIYVGEIVLALEHLHK---LGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER-AYDFCGTIE 195 (322)
T ss_dssp HHHHSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGGGG-GCGGGSCCT
T ss_pred HHhcccccHHHHHHHHHHHHHHHHHhhc---CCEEeccCCccceeecCCCCEEEeeccchhhhccccccc-ccccccccc
Confidence 74 4568899999999999999999999 999999999999999999999999999998764433222 234567999
Q ss_pred ccCCcccCCC--CCCchhhHHHHHHHHHHHHcCCCCCcchhccc
Q 044746 149 CEAPELWMPY--SVTQKCDVFSFGMLLFEVVGRRRNLEKEISEG 190 (202)
Q Consensus 149 y~aPe~~~~~--~~~~~~Diws~G~~l~el~~g~~p~~~~~~~~ 190 (202)
|++||.+.+. .++.++||||+||++|||++|+.||......+
T Consensus 196 ~~~pe~~~~~~~~~~~ksDIWSlG~iLyelltG~~PF~~~~~~~ 239 (322)
T d1vzoa_ 196 YMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKN 239 (322)
T ss_dssp TCCHHHHTTCC---CTHHHHHHHHHHHHHHHHSSCTTSCTTSCC
T ss_pred cchhHHhhcCCcCCCchhhhHHHHHHHHHHHhCCCCCCCCCHHH
Confidence 9999998754 46789999999999999999999998765543
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=2.7e-33 Score=222.53 Aligned_cols=174 Identities=20% Similarity=0.261 Sum_probs=139.3
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-ccccccc--------ccccceEEEEEccCCchhhhhc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-NFSNLVG--------SEDTETYIKGFLAMGPFYLLCK 71 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~i~--------~~~~~~~~~~~~~~~~l~~~~~ 71 (202)
||+|++..+++.||.|+.+... ..++..|..++... +|++++. ......++++++.+++|..+.
T Consensus 51 V~~a~~~~~~~~vAiK~i~~~~------~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~- 123 (328)
T d3bqca1 51 VFEAINITNNEKVVVKILKPVK------KKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY- 123 (328)
T ss_dssp EEEEEETTTTEEEEEEEECSSC------HHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT-
T ss_pred EEEEEECCCCCEEEEEEECHHH------HHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh-
Confidence 7999999999999988754321 23455565555554 5888763 223456788999999987764
Q ss_pred cCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC-ceEEeeeecceeccccCcccccCCCCCCCccc
Q 044746 72 KNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF-FPKAADFGLAKLYNREHTHITSTGRRRTPGCE 150 (202)
Q Consensus 72 ~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~-~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~ 150 (202)
+.+++.+++.++.|++.||.|||+ ++|+||||||+|||++.++ .++++|||+|+....... .....||+.|+
T Consensus 124 -~~l~e~~i~~i~~qil~aL~~LH~---~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~~---~~~~~~t~~y~ 196 (328)
T d3bqca1 124 -QTLTDYDIRFYMYEILKALDYCHS---MGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQE---YNVRVASRYFK 196 (328)
T ss_dssp -TSCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTCC---CCSCCSCGGGC
T ss_pred -cCCCHHHHHHHHHHHHHHHHHHhh---cccccccccccceEEcCCCCeeeecccccceeccCCCc---ccccccCcccc
Confidence 469999999999999999999999 9999999999999998655 689999999987654332 23456799999
Q ss_pred CCcccCCC-CCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 151 APELWMPY-SVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 151 aPe~~~~~-~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|||.+.+. .++.++|+||+||+++|+++|+.||....+
T Consensus 197 aPE~~~~~~~~~~~~DiwslG~~l~e~~~g~~pf~~~~~ 235 (328)
T d3bqca1 197 GPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHD 235 (328)
T ss_dssp CHHHHTTCCCCCTHHHHHHHHHHHHHHHHTCSSSSCCSS
T ss_pred CcccccCCCCCCcccchhhhhhhhHHhccCCCCCCCCch
Confidence 99998765 579999999999999999999999976443
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=2.9e-33 Score=218.75 Aligned_cols=180 Identities=19% Similarity=0.223 Sum_probs=144.2
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhcccccccc------ccccceEEEEEccCCchhhhhcc-C
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVG------SEDTETYIKGFLAMGPFYLLCKK-N 73 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~------~~~~~~~~~~~~~~~~l~~~~~~-~ 73 (202)
||+|++..+++.||.|+.+... .......++..|..+....+|+|++. ......++++++.++.+..+... +
T Consensus 18 V~~~~~~~~~~~vAvK~i~~~~-~~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~ 96 (292)
T d1unla_ 18 VFKAKNRETHEIVALKRVRLDD-DDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96 (292)
T ss_dssp EEEEEETTTCCEEEEEEEESSC-SSTTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTT
T ss_pred EEEEEECCCCcEEEEEEEehhh-CChHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeecccccccccccccc
Confidence 7999999999999998864332 22233456777888888899998863 34444577778888877766544 4
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCcccCCc
Q 044746 74 ILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPGCEAPE 153 (202)
Q Consensus 74 ~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~y~aPe 153 (202)
.+++..+..++.|++.||+|||+ ++|+||||||+|||++.++.+|++|||.++........ .....+++.|+|||
T Consensus 97 ~~~~~~~~~~~~q~~~aL~~lH~---~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~~~--~~~~~~~~~~~~pe 171 (292)
T d1unla_ 97 DLDPEIVKSFLFQLLKGLGFCHS---RNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPVRC--YSAEVVTLWYRPPD 171 (292)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHH---TTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCCSC--CCSCCSCGGGCCHH
T ss_pred ccchhHHHHHHHHHHHHHHHhhc---CCEeeecccCcccccccCCceeeeecchhhcccCCCcc--ceeeccccchhhhh
Confidence 69999999999999999999999 99999999999999999999999999999876543322 22345688899999
Q ss_pred ccCCCC-CCchhhHHHHHHHHHHHHcCCCCCcch
Q 044746 154 LWMPYS-VTQKCDVFSFGMLLFEVVGRRRNLEKE 186 (202)
Q Consensus 154 ~~~~~~-~~~~~Diws~G~~l~el~~g~~p~~~~ 186 (202)
.+.... ++.++||||+||+++||++|+.||...
T Consensus 172 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~ 205 (292)
T d1unla_ 172 VLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG 205 (292)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHTTTSCCSCCC
T ss_pred HhccCCCCCchhhccccchHHHHHhhCCCCCCCC
Confidence 987654 689999999999999999999997543
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=99.98 E-value=3.2e-33 Score=224.49 Aligned_cols=179 Identities=17% Similarity=0.169 Sum_probs=137.8
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhccccccccc------------cccceEEEEEccCCchhh
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAADNFSNLVGS------------EDTETYIKGFLAMGPFYL 68 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~------------~~~~~~~~~~~~~~~l~~ 68 (202)
||+|++..+++.||+|+.+.... ......++..|..+....+|++++.. ....+++++++.++.+..
T Consensus 33 V~~~~d~~t~~~vAvK~i~~~~~-~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~l~~~ 111 (355)
T d2b1pa1 33 VCAAYDAVLDRNVAIKKLSRPFQ-NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDANLCQV 111 (355)
T ss_dssp EEEEEETTTTEEEEEEEEESTTS-SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEEHHHH
T ss_pred EEEEEECCCCCEEEEEEEChhhc-CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchHHHHh
Confidence 79999999999999887543321 12223456778888888899998742 234468889987665554
Q ss_pred hhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceeccccCcccccCCCCCCCc
Q 044746 69 LCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYNREHTHITSTGRRRTPG 148 (202)
Q Consensus 69 ~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~gt~~ 148 (202)
. ...+++..++.++.|++.||.|||+ ++|+||||||+|||++.++.++++|||+++....... .....||+.
T Consensus 112 ~--~~~~~~~~i~~~~~qil~gl~~LH~---~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~t~~ 183 (355)
T d2b1pa1 112 I--QMELDHERMSYLLYQMLCGIKHLHS---AGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSFM---MTPYVVTRY 183 (355)
T ss_dssp H--TSCCCHHHHHHHHHHHHHHHHHHHH---TTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCT
T ss_pred h--hcCCCHHHHHHHHHHHHHHHHHhhh---cccccccCCccccccccccceeeechhhhhccccccc---ccccccccc
Confidence 4 3468999999999999999999999 9999999999999999999999999999886544332 234567999
Q ss_pred ccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchhc
Q 044746 149 CEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEIS 188 (202)
Q Consensus 149 y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~~ 188 (202)
|+|||++.+..++.++||||+||+++||++|++||.+.+.
T Consensus 184 y~aPE~l~~~~~~~~~DiwSlG~~l~ell~g~~pF~~~~~ 223 (355)
T d2b1pa1 184 YRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDY 223 (355)
T ss_dssp TCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCSSCCSSH
T ss_pred ccChhhhcCCCCCCCcccccccchHHHHhhCCCCCCCCCH
Confidence 9999999999999999999999999999999999976543
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=99.95 E-value=7.2e-29 Score=199.02 Aligned_cols=176 Identities=19% Similarity=0.236 Sum_probs=121.9
Q ss_pred CCccccCCCcceeehhhhchhhhhccCCcccCCcHHHHHHhc-----------ccccccccccc--------ceEEEEEc
Q 044746 1 MEKPRNRGSTRFITRTIDKSLDAMEMDKPIRFTSPQRMIAAD-----------NFSNLVGSEDT--------ETYIKGFL 61 (202)
Q Consensus 1 v~k~~~~~~~~~v~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~i~~~~~--------~~~~~~~~ 61 (202)
||+|++..+++.||+|+.+...... ..+..|..+.... .|++++...+. ...++...
T Consensus 29 Vy~~~~~~~g~~vAvKvi~~~~~~~----~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~ 104 (362)
T d1q8ya_ 29 VWLAKDMVNNTHVAMKIVRGDKVYT----EAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFE 104 (362)
T ss_dssp EEEEEETTTTEEEEEEEECSCHHHH----HHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEEC
T ss_pred EEEEEECCCCCEEEEEEEeccccch----HHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeec
Confidence 7999999999999988754332211 1122222222222 33444432111 12233333
Q ss_pred cCC-ch---hhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCC------ceEEeeeecceec
Q 044746 62 AMG-PF---YLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENF------FPKAADFGLAKLY 131 (202)
Q Consensus 62 ~~~-~l---~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~------~~kl~dfgl~~~~ 131 (202)
..+ .. ........+++..+..++.|++.||.|||+ ..+|+||||||+|||++.++ .++++|||.+...
T Consensus 105 ~~~~~~~~~~~~~~~~~~~~~~i~~i~~qil~al~~lh~--~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~ 182 (362)
T d1q8ya_ 105 VLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHR--RCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWY 182 (362)
T ss_dssp CCCEEHHHHHHHTTTSCCCHHHHHHHHHHHHHHHHHHHH--TTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEET
T ss_pred ccccccccccccccccCCcHHHHHHHHHHHHHHHHHHhh--hcCcccccCChhHeeeeccCcccccceeeEeeccccccc
Confidence 222 22 222244568999999999999999999997 27899999999999997654 3899999999764
Q ss_pred cccCcccccCCCCCCCcccCCcccCCCCCCchhhHHHHHHHHHHHHcCCCCCcchh
Q 044746 132 NREHTHITSTGRRRTPGCEAPELWMPYSVTQKCDVFSFGMLLFEVVGRRRNLEKEI 187 (202)
Q Consensus 132 ~~~~~~~~~~~~~gt~~y~aPe~~~~~~~~~~~Diws~G~~l~el~~g~~p~~~~~ 187 (202)
... .....||+.|+|||++....++.++|+||+||++++|++|+.||....
T Consensus 183 ~~~-----~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~g~~pF~~~~ 233 (362)
T d1q8ya_ 183 DEH-----YTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDE 233 (362)
T ss_dssp TBC-----CCSCCSCGGGCCHHHHHTCCCCTHHHHHHHHHHHHHHHHSSCCC----
T ss_pred ccc-----cccccccccccChhhccccCCCccccccchHHHHHHHHHCCCCCCCCc
Confidence 332 233567999999999999999999999999999999999999997654
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.56 E-value=2.3e-15 Score=109.56 Aligned_cols=69 Identities=17% Similarity=0.152 Sum_probs=56.9
Q ss_pred ceEEEEEccCCchhhhhccCCCCHHHHHHHHHHHHHHHHHHHhCCCCCeEEecCCCCcEEEcCCCceEEeeeecceecc
Q 044746 54 ETYIKGFLAMGPFYLLCKKNILGFGQLREIEVSTSKGIAYLHEECRQKIVHYDIKPESVLLDENFFPKAADFGLAKLYN 132 (202)
Q Consensus 54 ~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~~~ 132 (202)
..++++++++.++.. ++......++.|++.++.|||+ .+|+||||||+|||++.+ .++++|||+|....
T Consensus 85 ~~lvme~~~~~~~~~------l~~~~~~~i~~ql~~~l~~lH~---~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~ 153 (191)
T d1zara2 85 NAVLMELIDAKELYR------VRVENPDEVLDMILEEVAKFYH---RGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVG 153 (191)
T ss_dssp TEEEEECCCCEEGGG------CCCSCHHHHHHHHHHHHHHHHH---TTEECSCCSTTSEEEETT-EEEECCCTTCEETT
T ss_pred CEEEEEeeccccccc------hhhHHHHHHHHHHHHHHHHHhh---CCEEEccCChhheeeeCC-CEEEEECCCcccCC
Confidence 357788888766533 4455667899999999999999 999999999999999865 48999999997654
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=96.76 E-value=0.00056 Score=50.03 Aligned_cols=29 Identities=14% Similarity=0.245 Sum_probs=25.2
Q ss_pred eEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 102 IVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 102 iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
++|+|+.|.||+++.++.+.++||+.+..
T Consensus 185 l~HgD~~~~Nil~~~~~~~~lIDwe~a~~ 213 (263)
T d1j7la_ 185 FSHGDLGDSNIFVKDGKVSGFIDLGRSGR 213 (263)
T ss_dssp EECSCCCTTSEEEETTEEEEECCCTTCEE
T ss_pred EEEeeccCcceeecCCceEEEeechhccc
Confidence 68999999999999877777999987764
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=95.14 E-value=0.0025 Score=47.89 Aligned_cols=32 Identities=19% Similarity=0.230 Sum_probs=28.6
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
+.++||+|+.++|++++.+...-++||+.+..
T Consensus 182 ~~giIHgDl~~dNvl~~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 182 PAGVIHADLFQDNVFFLGDELSGLIDFYFACN 213 (316)
T ss_dssp CEEEECSCCCGGGEEEETTEEEEECCCTTCEE
T ss_pred ccccccCCcchhhhhcccccceeEeccccccc
Confidence 47899999999999999988788999998864
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=92.57 E-value=0.019 Score=41.17 Aligned_cols=30 Identities=17% Similarity=0.247 Sum_probs=25.7
Q ss_pred CeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 101 KIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 101 ~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
.++|+|+.|.||+++.+..+.++||+.+..
T Consensus 176 ~liHgD~~~~Nvl~~~~~~~~iID~~~~~~ 205 (255)
T d1nd4a_ 176 VVTHGDACLPNIMVENGRFSGFIDCGRLGV 205 (255)
T ss_dssp EEECSSCCGGGEEEETTEEEEECCCTTCEE
T ss_pred eEEeCCCCCcceEEeCCceEEEEEchhccc
Confidence 379999999999999877778999987754
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=87.88 E-value=0.1 Score=40.13 Aligned_cols=30 Identities=23% Similarity=0.317 Sum_probs=25.7
Q ss_pred CCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 100 QKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 100 ~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++|+|+.|.||+++.+. ++++|+..+..
T Consensus 223 ~~LiHGDl~~gNIlv~~~~-~~vID~E~a~~ 252 (392)
T d2pula1 223 ETLIHGDLHTGSIFASEHE-TKVIDPEFAFY 252 (392)
T ss_dssp CEEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred cceeccCCcCCceeEcCCc-eEEechhhccc
Confidence 4689999999999998764 79999987764
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=87.22 E-value=0.092 Score=39.27 Aligned_cols=30 Identities=20% Similarity=0.227 Sum_probs=24.1
Q ss_pred CCCeEEecCCCCcEEEcCCCceEEeeeeccee
Q 044746 99 RQKIVHYDIKPESVLLDENFFPKAADFGLAKL 130 (202)
Q Consensus 99 ~~~iiHrdlk~~nil~~~~~~~kl~dfgl~~~ 130 (202)
..++||+|+.+.|||++.+ ..++||+-+..
T Consensus 191 p~~liHgDlh~~NvL~~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 191 TVLRLHGDCHAGNILWRDG--PMFVDLDDARN 220 (325)
T ss_dssp CCEECCSSCSGGGEEESSS--EEECCCTTCCE
T ss_pred CceeecCCCCcccEEEeCC--ceEEechhccc
Confidence 4678999999999999743 45899987753
|